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ABSTRACTS 
Abstracts of Papers to be Presented at the 37th Annual Scientific 
Session of the American College of Cardiology, Atlanta, Georgia, 
March 27-31, 1988 
This year, 3,554 abstracts (original contributions) were 
submitted for evaluation. Each was graded by eight recog· 
nized authorities in a special area of interest. Acceptance 
for presentation was based on the relative grade ranking in 
each of the 30 categories. 
Ample meeting space combined with the inclusion of 
poster sessions again this year permitted the 1988 Annual 
Scientific Session Program Committee to accept 1,016 abo 
stracts, approximately 33.5% of the number submitted. 
This represents the largest number of abstracts accepted at 
any Annual Scientific Session of the American College of 
Monday, March 28, 1988 
10:30AM-12:00NOON, Room 202, Level Two 
Young Investigators' Awards Competition 
The following five abstracts are from the winning entries in the 
Young Investigators' Awards Competition, 37th Annual Sci· 
entific Session. 
THE VASOACTIVE INTESTINAL PEPTIDE RECEPTOR IN FAILING 
AND NONFAILING HUMAN VENTRICULAR MYOCARDIUM: 
SUPERSENSITIVITY OF FAILING HEART DUE TO INCREASED 
RECEPTOR AFFINITY; DIMINISHED MAXIMAL INOTROPIC 
RESPONSE FROM DECREASED RECEPTOR DENSITY ~ 
Hershberger-MD, Fred L Anderson MD, Michael R Bristow 
MD PhD U Utah, Salt Lake City, UT 
We investigated peptide receptor pharmacology in 
failing and nonfailing (NF) human ventricular 
myocardium (HVM) by measuring VIP stimulation of 
adeny]ate cyclase and 12S(I)-VIP binding in crude 
membrane fractions, and inotropic effects of VIP in RV 
trabeculae mounted in muscle batb. 
ADENYLATE CYCLASE: NF LV'S(lO)§ FAILING LV'S(lO)§ 
net VIP (luM)* 10.S3±0.7S1 10.41±0.467 
EDSO [VIPlXIO-8M 1.744±.18S 1.038±.186*** 
net ISO (O.lmM)* 41.4S±2.870 30.30±1.807*** 
BINDING: NF LV'S(9) FAILING LV'S(9) 
12SI-VIP KDl (pM) 846±147.7 418±112.1*** 
Bmaxl (fmol/mg) 389±76.2 143±29.2*** 
KD2 (nM) 94.1±33.0 S9.2 ± 19.5 
Bmax2 (fmol/mg) 23,380±9704 20,600±6636 
12SI-CYP Bmax(fmol/mg) 74.3±S.8 47.4±S.7*** 
MUSCLE BATH: NF RV'S(8) FAILING RV'S(20) 
VIP (lOnM)** 101±21.0 179±24.6*** -
VIP (luM~** 810±129.6 314±44.1*** 
EDSOxlO- M [VIPl: lO.70±2.17 4.04±1.28*** 
Iso max** 2070±331.5 98S±lQ3.2*** 
*pmol/min/mg **mg tension ***p<O.OS§value±S.E.M. 
CONCLUSION: In failing HVM the high affinity VIP 
receptor, coupled to muscle contraction via adenyl ate 
cyclase, undergoes unique changes consisting of 
increased affinity and decreased density. Thes~ 
"pharmacologic footprints" suggest that VIP may be 
involved in heart failure compensatory mechanisms. 
Cardiology. Many excellent contributions were received for 
this year's competition, and we appreciate your support 
and interest. 
Robert L. Frye, MD, F ACC 
Chairman, 1988 Annual Scientific Session 
Program Committee 
Alfred A. Dove, MD, PhD, F ACC 
Co-Chairman, 1988 Annual Scientific Session 
Program Committee 
SCINTIGRAPHIC AND ELECTROPHYSIOLOGIC EVIDENCE OF CANINE 
MYOCARDIAL SYMPATHETIC DENERVATION AND REINNERVATION 
PRODUCED BY MYOCARDIAL INFARCTION OR PHENOL APPLICATION. 
J.D. Mlnardo, M.D., M.M. Tuli, M.D., B.H. Mock, Ph.D., 
R.E. Weiner, Ph.D., H.P. Pride, B.S., H.N. Wellman, M.D., 
and D.P. Zipes, M.D .. Indiana Univ. School of Med., 
Depts. of Med. and Nuclear Medicine, Indiana Univ. School 
of Med. and Krannert Inst. of Cardiology, Indianapolis, 
IN 46202 
Epicardial phenol application (PA) or transmural 
myocardial infarction (TMI) in the dog produces sympa-
thetic denervation of ~ocardium apical to the PA or !MI. 
Since efferent denervation is probably postganglionic, 
reinnervation most likely occurs, but has not been shown. 
We investigated whether 1-123 metaiodobenzylguanidine 
(MIBG) , a guanethidine analogue taken up by sympathetic 
nerve terminals, could provide a scintigraphic image that 
would detect apical sympathetic denervation and possible 
reinnervation. Dogs underwent MIBG imaging at various 
times after PA or TMI. Electrophysiologic (EP) results 
obtained during ansae subclaviae and norepinephrine 
stimulation were correlated with scintigraphic 
observations. MIBG reliably detected defects in apical 
sympathetic innervation, which were associ~ted with 
normal perfusion by thallium. MIBG scintigraphy detected 
reinnervation after 14 weeks (mean). Denervation and 
reinnervation correlated accurately with results of EP 
testing. Supersensitive ERP shortening in response to 
norepinephrine infusion was present after denervation and 
perSisted > 3 weeks after sCintigraphic and EP evidence 
of reinnervation. Conclusions: 1) MIBG can be used 
noninvasively to determine the presence of regional 
~ocardial efferent sympathetic denervation and 
subsequent reinnervation, 2) reinnervation occurs after 
PA or TMI; 3) denervation supersensitivity persists even 
after reinnervation occurs. 
IA 
2A ABSTRACTS 
IMPAIRED ENDOTHELIUM-DEPENDENT RELAXATION TO AGGREGATING 
PLATELETS AND RELATED VASOACTIVE SUBSTANCES IN PORCINE 
CORONARY ARTERIES IN HYPERCHOLESTEROLEMIA AND IN 
ATHEROSCLEROSIS. H. Shimokawa and P. M. Vanhoutte, 
M.D., Mayo Clinic, Rochester, MN. 
To examine the role of the endothelium in vascular hyper-
reactivity in hypercholesterolemia and in atherosclero-
sis, male Yorkshire pigs were fed either a normal diet 
(n-23) or 2% high cholesterol diet [with balloon 
endothelial removal of the left anterior descending 
coronary artery (LAD)] (n-29) for 10 weeks. Electron 
microscopic examination showed a full lining of 
endothelial cells in LAD and the left circumflex coronary 
artery (LCX). Endothelium-dependent responses were 
examined in vitro. In cholesterol-fed animals, 
endothelium-dependent relaxations to aggregating 
platelets, serotonin, adenosine diphosphate (ADP) , 
bradykinin and thrombin were depressed in LAD 
(atherosclerotic) , while relaxations to aggregating 
platelets, serotonin and ADP were depressed in LCX 
(hypercholesterolemia). Bioassay studies demonstrated a 
depressed release of endothelium-derived relaxing 
factor(s) from atherosclerotic LAD in response to sero-
tonin. Higher concentrations of serotonin induced 
endothelium-dependent contractions in atherosclerotic 
LAD, which were inhibited by blockers of cyclooxygenase. 
A significant correlation was noted between intimal or 
medial thickness and impairment of relaxations to 
bradykinin in atherosclerotic LAD. These experiments 
indicate that the protective role of the endothelium 
against contractions caused by aggregating platelets and 
their products is depressed in atherosclerosis and partly 
impaired in hypercholesterolemia. The depressed release 
of endothelium-derived relaxing factor(s), altered endo-
thelial prostaglandin metabolism and intimal and medial 
thickening contribute to the impaired relaxations. 
SPATIOTEMPORAL FOURIER FILTRATION FOR IMPROVED ACCURACY 
OF ECHOCARDIOGRAPHIC ENDOCARDIAL BORDERS: OPTIMIZATION 
OF FILTERING CUTOFF FREQUENCIES 
James 0 Thomas. MO, Albert A Hagege, MO, John B Newell, 
BA, Christopher Y Choong, MB BChir, PhD, Gerard T 
Wilkins, MB ChB, Arthur E Weyman, MO, FACC, 
Massachusetts General Hospital, Boston, MA. 
Automated echocardiographic LV wall motion analysis 
is hindered by induced error in the localization of 
extracted endocardi a 1 borders. We have developed 
spatiotemporal Fouriet filtration to reduce this random 
error. To quant i fy thi s noi se reduct i on and determi ne 
the optimal spatial (9,) and temporal (Te) frequency 
cutoffs for reconstruct 1 on, short axi s two-dimens i ona 1 
echocardiograms (20E) were obtained in normal open-chest 
dogs, along with simultaneous coplanar M-mode echocardi-
ograms (MM). Endocardial borders from complete cardiac 
cycles were hand traced, digitized, Fourier transformed, 
and reconstructed with Te and ge varying from 2 to 18 
harmonics, yielding significant smoothing (see figure). 
UNFILTERED 
LV diameters from these reconstructions were compared by 
linear correlation with MM, demonstrating significant 
improvement with filtering: MM vs raw 20E, r=0.88±0.OI 
(mean±SEM); MM vs fi ltered 20E, r=O. 97±0. 01; p<O. 0001, 
n=51. Optimal filtering occurred at Te = 5.5 and ge = 
6.9 harmonics. Conclusion: Fourier filtration is an 
important adjunct to echocardiographic image analysis. 
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DIFFERENCES IN ALPHA ADRENERGIC RESPONSIVENESS BETWEEN 
HUMAN INTERNAL MAMMARY ARTERIES AND SAPHENOUS VEINS. 
J,S Weinstein. M D , W. Grossman, M.D., F.A.C.C., R.M. 
Weintraub, M.D., F.A.C.C., R.L. Thurer, M.D., F.A.C.C., 
R.C. Johnson, M.D., F.A.C.C., K.G. Morgan, Ph.D. Harvard 
Medical School, Beth Israel Hospital, Boston, MA. 
To better define the role of a adrenoceptor mediated 
vasoconstriction in human internal mammary arteries 
(LIMA) and saphenous veins (SV), we obtained fresh 
specimens of LIMA and SV from 32 patients undergoing 
coronary bypass surgery. Dose response curves were 
generated for the a l agonist phenylephrine, the a, agonist BHT-920 and the a l /a2 agonist norepinephrIne. Phenylephrine elicited similar contractile responses(CR) 
in both LIMA and SV whereas BHT-920 elicited a marked CR 
in SV with little response in LIMA (see figure below). 
Norepinephrine elicited contraction at a significantly 
lower concentration in SV than in LIMA. The mean ECSO's 
were: PE BHT-920 m; 
LIMA 
SV 
-6 -6 -7 I.SxlO_ 6M 1.7xlO_ 7M 3.4xlO_ 8M 1.8xlO M 1.9xlO M** 7.8xlO M* 
Confirmatory antagonist studies with the a l antagonist prazosin and the a 2 antagonist yohimbine caused a rightward shift in the dose response curves of both 
vessels to phenylephrine and BHT-920 respectively. 
Conclusion: Alpha adrenoceptor mediated vasocon-
striction is caused by aJ receptors in human LIMA But 
by both a 1 and a 2 receptors in human SV. These findings 
have implications for maxi-
mizing flow rates in LIMA 
and SV post-bypass, and may 
be related to differences in 
long-term patency. 
*p<O.OI; **p<O.OS 
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Surgical Treatment of Valvular Heart Disease 
LONG-TERM RESULTS OF MITRAL VALVE REOPERATIONS 
Bruce W. Lytle, MD, FACC, Delos M. Cosgrove, MD, FACC, 
Floyd D. Loop, MD, FACC, Marlene Goormastic, MPH. 
The Cleveland Clinic Foundation, Cleveland, Ohio. 
Of 458 first cardiac reoperations for mitral valve 
surgery at The Cleveland Clinic Foundation from 1958-1984 
45 (lOS) in-hospital deaths occurred and 412 in-hospital 
survivors were followed at a mean interval of 77 months 
(range 1-315 mos,) with 1 patient lost to follOW-Up, 
Survival was 83% and 61S and reoperation-free survival 
77S and 49S at 5 and 10 postoperative years, respectively, 
Univariate and multivariate analyses identified age <50 
years, normal or mildly impaired left ventricular 
function, and a mitral valve repair procedure as factors 
associated with improved late survival and 
reoperation-free survival (all p<O.OOOl). Survival and 
reoperation-free survival were not affected by function 
class, valve pathology at reoperation or the prosthesis 
type used for valve replacement. Analysis of the subset 
reoperated for native mitral valve pathology showed 
reparative procedures were associated with improved 
survival when compared with valve replacements (p=0.003). 
First mitral valve reoperations for periprosthetic leak 
had equivalent late survival and reoperation-free 
survival,regardless of whether valve replacement or leak 
repair were performed. Second mitral valve reoperations 
for 77 patients resulted in 9 in-hospital deaths (12S), 
late survival of 80S and 45% and reoperation-free 
survival of 80S and 34% at 5 and 10 postoperative years, 
respectively. Of 130 late deaths which occurred after a 
first reoperation, 10 (8%) were clearly non-cardiac as 
was 1 (4~) late death of 28 Which occurred after a second 
reoperation. Seventy-two percent of late survivors had no 
symptoms at most recent follow-up. The risk of mitral 
valve reoperation is acceptable but the cardiac-related 
attrition over a 10 year follow-up is substantial. 
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-MALADIE DE CARPENTIER-: LOUD tlllUlJRS FOLLOWING MITRAL 
VALVE REPAIR. Martin E. Goldman, M.D., F.A.C.C., Theresa 
Guarino, B.S., Heidi Krenz, M.D., Xi-Guang li, M.D., 
Bruce P. Mindich, M.D., F.A.C.C. Mount Sinai Medical 
Center, New York, New York. 
Mitral va1vu10p1asty/annu10p1asty (MVA) popularized 
by A. Carpentier, is preferable to valve replacement 
when feasible to avoid anticoagulation and to preserve 
LV function. However, many pts have residual mitral 
regurgitation (MR) of varying degrees post MVA. To 
evaluate results of MVA, we evaluated 18 pts from 6 
weeks to 3 years following their operative procedure. 
MVA included valvuloplasty, annu10p1asty and annular 
ring insertion. All pts had a history, physical and 
color flow Doppler (ATL UM-6) imaging in multiple planes, 
interrogating for MR. The severity of MR was determined 
on a scale of 0-4+, by the maximum area of MR outlined 
in color compared to the left atrial size. MR murmurs 
were scored 0-6+. 
Grade 0 1+ 2+ 3+ 4+ 
Co lor MR 4 12 1 1 0 
MR murmur 4 3 4 7 0 
Importantly, while 16/18 pts had no or minimal residual 
MR, 11 had auscultatory fi ndings suggesti ve of moderate 
MR. Color-flow echo usually showed thin, long jets 
coursing in an angled direction, or turbulence between 
the leaflet closure pOint and annular ring, without 
extending into the LA. The disproportionate murmur 
may be due to high velocity flow through a narrow point 
of poor leaflet coaptation, due to residual redundant 
valve tissue. Although minimal or mild residual MR 
may be common following successful MVA, auscultation 
may overestimate MR severity. Color-flow echo can 
accurately identify the presence and quantify residual 
MR post mitral repair. 
LATE RESULTS OF RECONSTRUCTIVE MITRAL VALVE SURGERY FOR 
MITRAL REGURGITATION. 
Pierre-Louis Michel M.D., Christian Spaulding M.D., 
Fran~ois Boustani M.D., Alec Vahanian M.D., Bertrand 
Cormier M.D., Jean Acar M.D. 
Service de Cardiologie - Hopital TENON, PARIS, France. 
Ninety-five patients (pts) underwent valve repair using 
the Carpentier techniques between 1969 to 1986 for isola-
ted mitral regurgitation. Mean age was 46 : 18 (range 9 -
76) ; 57 pts (60%) were men. Before surgery, 60 (63%) pts 
were in NYHA functional class III or IV ; mean cardiotho-
racic ratio was .54 : .08 and atrial fibrillation was pre-
sent in 31 (32.6%) ; angiographic LV ejection fraction was 
.57: .12 (range .38 - .76). 
Surgical management included prosthetic ring annuloplasty 
(79 pts), leaflet resection (66 pts), fenestration of fi-
brotic chordae (17 pts), elongated chordae shortening 
(43 pts) and chordal transposition (6 pts). 
There were one hospital death (1.05%) and 7 late deaths 
with a cumulative follow-up of 428 pt/years. Five and ten 
years actuarial survival rates were respectively 88 and 
84%. Late survival rates were lower in patients with a 
pre-operative cardiothoracic ratio ~ .58 (p <.02) and a 
pre-operative L-V ejection fraction < .50 (p < .05). Nine 
pts were reoperated because of recurring regurgitation (8) 
or mitral stenosis (1). 
The linearized rates of endocarditis, thromboembolic events 
and reoperation were respectively: .7, .5 and 2.1 pt/yrs. 
Five and ten years actuarial rates of patients in NYHA 
class I and II were 82.7 and 72%. Based on clinical and 
Doppler data, 27 patients had still mitral regurgitation 
which was moderate in 15 and important in 12. 
We conclude that reconstructive surgery for mitral regur-
gitation is associated with a low operative mortality, ex-
cellent functional results and a low risk of reoperation. 
ABSTRACTS 
AORTIC VALVE SAlVAGE UTILIZING HIGH FREQUENCY VIBRATORY 
DEBRIDEMENT. Bruce P. Mindich, M.D., F.A.C.C. , Theresa 
Guarino, B.S., Heidi Krenz. M.D., Xi-Guang Li, M.D., 
Enrico Gonzales, M.D., St. Luke's Hospital, NY,NY. 
Aortic valve (AV) decalcification (AOVD) for aortic 
stenosis (AS) can achieve a significant reduction in 
gradients without producing excessive aortic regurgitation 
(AR) and may be the preferred procedure in pts wi th 
narrow, calcified aortic roots. However, AV salvage 
is frequently aborted due to leaflet perforation and/or 
inadequate decalcification. Therefore, to improve the 
AV salvage rate we have introduced the Cavitron Ultrasonic 
Surgical Aspirator (CUSA) which incorporates vibration, 
i rri gati on, and suction to achieve AOVD. The CUSA ti P 
vibrates at 23 K cycles/second, and the amplitude of 
vibration is adjustable allowing for modulation of depth 
penetration. Superficial calcium is fragmented with 
a higher setting while the calcific deposits within 
the leaflet structure are disrupted at a low setting 
to avoid leaflet injury. The fragmented tissue is 
simultaneously suspended in solution and suctioned. 
Fifteen pts have undergone AOVD with CUSA. All pts 
had significant intraoperative reduction in transaortic 
gradients from 47.5 ± 25 to 6.4 ± 4 mmHg (p=O), and 
a significant increase in valve area from .54 ± 0.2 
to 1.6 ± 0.3 cm2 (p=O). Importantly, intraoperative 
20 contrast echo demonstrated no increase in AR post 
AOVD. Leaflet perforation was avoided and leaflet 
coaptation improved. There have been no cardiac nor 
cerebral emboli. Preoperative contraindications for 
CUSA-AOVD are excessive AR and extensive AV deformity. 
If leaflet perforation or prolapse develop, AOVD should 
be abandoned. eUSA for AOVD is a safe, new moda 1 i ty 
which increases valve salvage rate, improves leaflet 
mobility by annular decalcification, and avoidS production 
of excessive AR. 
REPARATIVE SURGERY FOR TRICUSPID REGURGITATION: 
OPERATIVE AND FOLLOW-UP EVALUATION BY DOPPLER COLOR 
FLOW MAPPING. 
Lawrence Czer, M.D., FACC, Gerald Maurer, M.D., FACe, 
Steven Khan, M.D., Michele De Robertis, R.N., Kenneth 
Resser, M.S., Aurelio Chaux, M.D., FACC, Jack Mat1off, 
M.D., FACC. Cedars-Sinai Medical Center, Los Angeles, 
CA 
The capability of Doppler color flow mapping (CFM) to 
assess tricuspid regurgitation (TR) intraoperatively and 
evaluate the adequacy of tricuspid valve repair (TVr) 
was investigated in 85 patients (18 TVr, 36 MVR, 31 
CABG) before and after cardiopulmonary bypass (CPB). 
Pre-CPB TR grade by CFM (0-4+) correlated with pre-op 
CFM (kappa=O.64, p<.05) and with RV angio (kappa=0.92, 
N=8, p<.05). Simultaneous right atrial V waves (RAv; 
height, and height above mean) correlated poorly with 
CFM TR grade pre and post-CPB (r=O.30 and -.05). TR 
grade, jet length, and planimetered area were highly 
dependent on pulmonary systolic pressure (p<.OOI). 
After TVr, TR was reduced significantly (4.0±O.O vs 
I.O±0.8, p<.OOI), but fluid filling of arrested RV 
correlated poorly with TR grade (r=.28, p=NS). TR grade 
did not change significantly after MVR (I.7±I.I vs 
I.2±O.9) or CABG (I.2±I.O vs I.5±I.4). Follow-up closed-
chest CFM up to 22 weeks postop confirmed post-CPB TR 
grade (0.9±O.9 after TVr, and I.2±I.3 after CABG; P=NS 
for both). 
Conclusions: Doppler CFM provides more accurate 
intraop TR assessment than RA V waves or fluid filling 
of arrested RV. Intraop CFM may be especially useful in 
judging adequacy of tricuspid valve repair prior to 
chest closure, and appears to predict intermediate-term 
outcome. 
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LATE RESULTS AFTER MULTIPLE VALVE REPLACEMENT IN 513 
PATIENTS WITH ADVANCED VALVULAR HEART DISEASE 
A.C. Galloway, M.D., S.B. Colvin, M.D., A.T. Culliford, 
M.D., R. Esposito, M.D., N. K. Trehan, M.D., F.G. 
Baumann, Ph.D., and F.C. Spencer, M.D., New York 
University Medical Center, New York, NY 
In order to assess the value of DIlltiple valve 
replacement in patients with late valVUlar heart 
disease, follow-up information (mean 3.5 yrs.) was 
obtained on 97% of 513 patients (mean age 58.8 yrs.) 
who underwent multiple valve replacement between 6/76 
and 8/85. Pre-operatively 91.4% had significant 
congestive heart failure. Three groups accounted for 
98.6% of the patients: 57.7% aortic valve replacement 
and mitral valve replacement (AVR+MVR), 29.0% mitral 
valve replacement and tricuspid valve replacement 
(MVR+TVR), and 11.9% aortic valve replacement, mitral 
valve replacement, and tricuspid valve replacement 
(AVR+MVR+TVR). Hospital mortality was 12.5% and five 
year actuarial survival from late cardiac death was 
82.3% overall. The MVR+TVR group had a significantly 
lower 5 year survival (74.5%) than AVR+MVR (86.9%, 
p< .05) patients and lower than AVR+MVR+TVR (84.3%, 
p>.05). For AVR+MVR patients there was no significant 
di fference in 5 year survival among the 9 subgroups 
classified by various combinations of valvular defec ts. 
At follow-up 80% of patients had improved to NYHA Class 
I or II. These data demonstrate excellent late re s ul t s 
after mul t iple valve replacement in patients with late 
valvular heart disease, justifying aggressive surgical 
therapy in such patients. Decreased late survival 
after MVR+TVR is probably related to the significant 
degree of biventricular failure noted in these patients. 
Earlier operation may be indicated in patients with 
combined MV and TV disease. 
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Echocardiography: Advances in Instrumentation and Imaging 
Processing 
IN yrrRO ANALYSIS OF BACKSCA'ITERED AMPLITUDE FROM 
NORMAL AND DISEASED ARTERIES USING A NEW 
INfRALUMlNAL ULTRASONIC CATIIETER 
David T. Linker. M.D., Paul G. Yock, M.D., F.A.C.C., Hira V. 
Thapliyal, Ph.D., James W. Arenson, Ph.D., Erling Johansen, M.E., 
Age Grl'lnningslCter, M.E., Hans K. LI'lnstad, M.E., Bjl'lm A. J. 
Angelsen, Dr. Techn. University of Trondheim, Norway and 
University of California, San Francisco. 
We have analysed backscattered ultrasonic amplitude from normal and 
diseased arteries, in vitro, using a new intravascular imaging system 
consisting of a small, highly flexible, 20 MHz ultrasonic catheter and a 
custom scanner for real-time display. The system provides two-
dimensional, 360 degree imaging from the catheter surface up to a radius 
of 40 mm. The backscattered RF envelope signal can be sampled in real 
time at 40 MHz with 8 bit resolution, and transferred to a computer for 
further analysis. In a series of eight images of four human arteries, the 
mean amplitude (MA) and standard deviation (SD) of 34 regions were 
cotrelated with. the real-time images and the pathological appearance of 
the arteries. Each region consisted of an sector from ten beams, ten 
samples in depth. Regions were classified as normal, diffusely diseased, 
diffusely diseased with significant calcification, or localized calcification, 
based on echo and pathological appearance, and analyzed separately. All 
the diseased areas could have some degree of calcification. Increased 
calcification resulted in significant increased MA over normal, while the 
increase in the SD was much less: 
!me. N MA SI! 
Normal 8 86±8 20±6 
Diffuse 7 108±19 p<0.02 25±6 p>O.2 
Diffuse/Ca++ 9 151±17 p<O.OOI 36±6 p<O.OOI 
Local 10 182±19 p<O.OOI 32±5 p<O.OOI 
Catheter two-dimensional ultrasound reveals calcification and plaque 
within the vessel wall, as well as the morphology of the lumen itself. 
Quantitative evaluation of the amplitude of backscatter ruay provide a 
unique aid in the evaluation of vessel pathology prior to catheter-based 
intervention. 
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IMPROVED MONITORING OF LASER ANGIOPLASTY WITH LASER 
DOPPLER ECHOCARDIOGRAPHY. 
William J. Bommer, M.D., F.A.C.C., Garret Lee, M.D., 
F.A.C.C., Kevin Rebeck, Dan Rink, John Rink, Dean Mason, 
M.D., F.A.C.C., and Ming Chan, University of California, 
Davis. 
Al though laser energy is tremendously effective in 
ablating atherosclerotic placques, obstructions, and 
clots; a continuing concern has been the potential for 
adjacent tissue or vascular injury. In this study a 
modified laser Doppler catheter was used to obtain 
intracoronary Doppler recordings during laser 
angioplasty in 4 dogs. The laser Doppler catheter 
consisted of 100, 200 or 400 micron quartz fibers with 
or without hot tips which were incorporated or coaxial 
with a 20MHz Doppler transducer. 
Resul ts showed characteristic echo and blood flow 
patterns from the aorta, carotids, femoral, and coronary 
arteries. Coronary flow showed a diastolic peak (1-2 KHz 
shift) that was diminished «0.5KHz) by coronary osteal 
obstruction with the guiding catheter (deep throat), 
occlusive wedging of the subselective catheter, and 
total obstruction of the vessel. Coronary flow 
increased ()2.5-4 KHz) with catheter flushing, following 
laser ablation of intracoronary clots (100~ increase) (6 
watts x 0.5 sec YAG), and early coronary 'perforation (8 
watts x 3 sec) producing tamponade. Thus 2-D 
echocardiography and pulsed-wave Doppler-catheter 
monitoring can be used to provide information on 
catheter pOSition, laser firing, pre-and post-laser 
blood velocity, and potential complications. This 
additional information may assist in the performance and 
monitoring of human angioplasty studies. 
IMPLANTATION AND FOLLOW-UP OF ULTRASONICALLY 
MARKED PACING SYSTEM 
Ivo Cikes~, Krishnaswamy Chandrasekaran,M.D., 
James B. Seward, M.D., F.A.C.C., Abdul J. Tajik, 
M. D., F .A.C.C., Mayo Clinic, Rochester, Minnesota, 
U.S.A. 
To avoid x-ray guidance of pacemaker lead implan-
tation, and to improve pacing system follow-up, 
an ultrasonically marked pacing system (UMPS)has 
been developed. The pacing lead tip is ultrasoni-
cally marked with miniature piezoelectric trans-
ducer which is energized by ultrasound beams from 
the routine echoscope. Thus generated high fre-
quency pulses are conducted into the markingele-
ctronics. The implantable system has a special 
pacemaker comprising the high frequency circuits 
and telemetry of high frequency pulses. 
The prototype of UMPS was tested in vitro and in 
9 beating dog hearts. It was shown that t~eblin­
king marker adjacent to the pacing lead t~p allows 
its easy and precise placement in the desired po-
sitions under 2-D echocardiographic guidance. 
Aside from marking the pacing lead tip, the high 
frequency circuits provide the early detection 
of either lead wire or lead insulation fracture 
by means of: 1) High frequency vector detection, 
2) Spike-marker differential diagnosis, and 3) 
Impedance measurement by high frequency pulses. 
These data suggest that UMPS can be used for the 
fast and accurate positioning of the ultrasoni-
cally marked temporary and permanent pacing leads. 
In implantable system the early diagnosis of pa-
cing system malfunctions is possible. 
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INSTAm'ANIlXXlS AND a:tn'INUXB CARDIAC Cl1l'PUT USDK; A 
IlOFPLER PUIl'DWlY ARl'BRY CAmETJlR 
Jeraoe Segal ,M.D. , Ronald G. Pearl ,M.D. ,Ph.D., Andrew 
J. Ford, Jr. ,B.S., Roger A. Stem, Ph.D. , Steven M. 
Gehlbach,Ph.D. , Stanford University, Stanford, CA. 
Instantaneous, continuous cardiac output (00) was 
determined both in vitro and in viva using a flow 
directed, multi-rangegate doppler pUmona.ry artery (PA) 
catheter. The doppler catheter DBpped a 0«> 
dimensional velocity profile within the DBin PA, 00 
was determined from instantaneous space average 
velocity and area, as derived fram the velocity 
profile. QJantitative, doppler determined flow (Q.) was 
canpo.red to electro-,.gnetic flow (QEII) and 
thermodilution (QTD). The in vitro model consisted of 
a JmeUDBtically driven latex ventricle providing 
pulsatile blood flow through a section of bovine aorta. 
Doppler catheter determined Q. was highly predictive of 
QEII over the range 0.5 to 8.0 l/min (RS=.97, m=1.04, 
SEE::.33) and was more accurate than Qn (R2=.95, m=.84, 
SEE::. 34) • Next, 00 was measured in 0«> sheep using the 
doppler PA catheter and an electromagnetic probe placed 
around the ascending aorta. Again Q. was highly 
predictive of Q.N (R2=.87, m=.95, SEE=.45) and more 
accurate than QTD (R2=.80, m=.74, SEE=.45). Accurate, 
continuous and instantaneous 00 and pressure 
measurements appear possible using a flow directed 
doppler PA catheter. 
DETECTION OF MYOCARDIAL ISCHEMIA AND REPERFUSION IN 
INTACT DOGS WITH REAL-TIME ULTRASONIC BACKSCATTER IMAGING 
Zvi Vered, M.D., Benico Barzi1ai, M.D., F.A.C.C., Michael 
Courtols, M.A., G.A. Mohr, Ph.D., Keith A. Wear, Ph.D., 
Thomas A. Shoup, Ph.D., H.E. Melton, Ph.D., Philip A. 
Ludbrook, M.D., F.A.C.C., Burton E. Sobel, M.D., F.A.C.C. 
Jillles G. Miller, Ph.D., Julio E. Perez, M.D., F.A.C.C. 
Washington University, St. Louis, Missouri 
We have previously shown that cardi ac cycle-dependent 
variation of integrated backscatter occurs in normal myo-
cardium. To determi ne whether myocard i a1 i schemi a and 
reperfusion can be recognized with real-time integrated 
backscatter imaging we performed 10 min' balloon occlusion 
of the LAD coronary artery followed by reperfusion in 10 
closed-chest anesthetized dogs. Parasternal long axis 
images were obtained at baseline, during occlusion, and 
up to 120 min after reperfusion. We measured (n = 263 
sites) the magnitu.:le and del ay (R-wave-to-nadir corrected 
for heart rate) of cyclic variation of integrated back-
scatter in segments with and without asynergy. Radio1a-
be1ed microspheres were used to verify ischemia and 
reperfusion. Ischemic segments exhibited decreased mag-
nitude and increased delay of cyclic variation of inte-
grated backscatter (from 3.3 ± 1.3 dB to 1.9 ± 0.7 dB, 
mean ± SO; and from 284 ± 50 msec to 580 ± 222 ms, 
respectively, all p ~ 0.001). Reperfusion restored the 
magnitude of cyclic variation (3.5 ± 1.7 dB). However, 
the delay of the cyclic variation was corrected only par-
tially (397 ± llO msec; p ~ 0.001). In non-ischemic seg-
ments the magnitude of cyclic variation did not change 
and vari at ion was del ayed only mildly during occlusion. 
Thus, real-time integrated backscatter imaging permits 
detection of changes in myocardial acoustic properties 
indicative of ischemia and of subsequent reperfusion. 
ABSTRACTS 
REAL- TIME DETECTION OF MOVING ECHOCARDIOGRAPHIC 
ENDOCARDIAL BORDERS WITH AUTOMATED VELOCITY DERIVATION: 
DESCRIPTION OF A NEW ALGORITHM 
James ° Thomas, MO, Allen M Waxman, PhD, 
Higginbotham, Jr, MS, Arthur E Weyman, MO, 
Massachusetts General Hospital, Boston, MA 
Ronald 
FACC, 
Automated echocardiographic image analysis demands 
rapid and accurate detection of endocardial borders 
together with quant i fi cat i on of thei r motion. In the 
past, motion estimation has proven elusive due t9 the 
difficulty in automatically establ ishing correspondence 
between borders in successive video fields. Our group 
has recently developed a new algorithm which can track 
moving edges and quantify their velocity without the need 
to establish this correspondence explicitly. Termed 
convected activation, this algorithm takes as its input 
successive binary edge maps (postulated edge points = 1; 
nonedge points = 0) which may be produced by any of 
several edge detection methods. The algorithm then uses 
these edge maps to "act i vate" a spat i otempora 1 regi on 
about each border. Movement of the border between 
successive fields enhances that border in proportion to 
its velocity. This procedure has been implemented on an 
eight stage real-time video array processor in three 
parts: 1) symmetri c nearest nei ghbor operator, whi ch 
smooths the raw echo image without blurring edges; 2) 
edge detection by thresholded Sobel operator or zero-
crOSSings of a Laplacian; 3) motion quantification by 
convected activation. The output from this procedure is 
available for anatomic interpretation such as regional 
wall motion analYSis. Conclusion: Convected activation, 
which provides real-time information on both the location 
and motion of endocardial borders, should be of great 
value in the automated delineation of abnormal wall 
motion by echocardiography. 
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Ventricular Tachycardia and Fibrillation 
DAY-TO-DAY REPRODUCIBILITY OF RESPONSE TO PROGRAMMED 
VENTRICULAR STIMULATION IN PATIENTS WITH RECENT ACUTE 
MYOCARDIAL INFARCTION. 
Robert Hong, M.D., Anil Bhandari, M.D., F.A.C.C., Daniel 
Kulick, M.D., J. Nathan Rubin, M.D., Nancy McIntosh, 
R.N., Shahbudin H. Rahimtoola, M.D., F.A.C.C., LAC-USC 
Medical Center, Los Angeles, CA. 
Day-to-day reproducibility (rep) of response to 
programmed ventricular stimulation (PVS) has not been 
evaluated in pta with recent myocardial infarction (MI). 
To determine this, we performed PVS, cardiac 
catheterization and 24-hour Holter in 50 pts 1l±4 days 
after an acute MI. No pt had sustained (sus) 
ventricular tachycardia (VT) or fibrillation (VF) >48 
hours after MI. PVS was performed on 2 consecutive days 
with a uniform protocol that included up to 3 
extrastimuli delivered at twice diastolic threshold at 2 
RV sites. During PVS on day I, 15 pts (Group I) had 
induction of sus VT!VF (9 VT, 6VF) and 35 pts (Group II) 
had induction of nonsus VT (5 pts) or no VT (30 pts). 
Repeat PVS in Group I pts induced sus VT!VF in 10 pts 
(rep, 67%); the maximum induced response in the other 5 
pts was nonsus VT (3 pt8) or no VT (2 pts). The rep of 
induction was 78% for sus VT and 50% for VF (p=O.I) and 
was not influenced by other clinical, hemodynamic and 
angiographic characteristics. The repeat PVS in Group 
II pts did not induce sus VT!VF in 31 of 35 pts (rep, 
89%) but sus VT and VF were induced in 2 pts each. 
Thus, in survivors of acute MI, the short-term rep of 
negative response to PVS was high but there appeared to 
be a significant variability in inducibility of sus 
VT!VF. The rep was relatively higher for sus \IT (78%) 
than for VF (50%). This variability should be taken 
into account when evaluating the prognostic significance 
of PVS in post MI pts. 
SA 
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PROGNOSTIC SIGNIFICANCE OF PROGRAMMED VENTRICULAR 
STIMULATION IN HIGH RISK PATIENTS SURVIVING ACUTE 
MYOCARDIAL INFARCTION. 
Anil Bhandari, M.D., F.A.C.C., Robert Hong, M.D., Adam 
Kotlewski, M.D., F.A.C.C., J. Nathan Rubin, M.D. Nancy 
McIntosh, R.N., Shshbudin H. Rahimtoola, M.D., F.A.C.C., 
LAC-USC Medical Center, Los Angeles, CA. 
We prospectively performed programmed ventricular 
stimulation (PVS) , cardiac catheterization and 24-hour 
Holter in 53 "high-risk" pts surviving acute myocardial 
infarction (MI) 15f4 days after AMI. In these pts, AMI 
was complicated by heart failure, angina, and/or nonsus-
tained ventricular tachycardia (VT) )48 hours after AMI. 
The protocol for PVS was uniform and included up to 3 
extrastimuli delivered at twice diastolic threshold at 2 
RV sites. 
During PVS, 16 pts (33%) had induction of sustained 
(sus) VT or ventricular fibrillation (VF) (10 VT, 6 VF) 
and 37 pts (67%) did not have sus VT/VF. No pt received 
antiarrhythmic drug. During a mean follow-up of 10 (3 
to 18) months, there were 7 (13%) deaths: 3 nonsudden 
and 4 sudden cardiac deaths. In addition, 4 pts 
developed spontaneous sus VT. LV ejection fraction of 
<0.4 was a predictor of total events (p<O.04), but the 
occurrence of arrhythmic events correlated only with 
inducible sus VT (p<O.OI) and with the presence of 
repetitive ventricular ectopics on Holter (p<0.03). The 
arrhythmic events occurred in 5 (50%) of 10 pts with 
inducible sus VT, 1 (16%) of 6 pts with inducible VF, 
and 2 (6%) of 37 noninducible pts. 
Thus, in "high-risk" survivors of AMI, an induction 
of sus VT during PVS and repetitive ventricular ectopics 
on Holter were predictors of subsequent sudden death and 
spontaneous sus VT. Induced VF was a nonspecific 
response to PVS. 
SIGNIFICANCE OF INDUCIBLE VENTRICULAR FIBRILLATION IN 
SURVIVORS OF OUT-OF-HOSPITAL VENTRICULAR FIBRILLATION. 
Jeanne E. Poole, M.D., Peter J. Kudenchuk, M.D., 
F.A.C.C., Gust H. Bardy, M.D., F.A.C.C., H. Leon Greene, 
M.D., F.A.C.C., Charles D. Swerdlow, M.D., F.A.C.C., 
John H. McAnulty, M.D., F.A.C.C., Northwest 
Electrophysiology Society, Seattle ~, Stanford CA, 
Portland OR. 
The significance of induced ventricular fibrillation 
(VF) during electrophysiologic testing (EPS) is 
controversial. In 300 patients (pts) who underwent EPS 
for out-of-hospital ventricular fibrillation (OHVF) , not 
associated with an acute myocardial infarction (HI); VF 
was the only rhythm induced in 32 pts (11%). Of these, 
20 pts (63%) had coronary artery disease. The mean 
ejection fraction in the 32 pts was 0.36 + 0.13. VF was 
induced with rapid ventricular burst pacing in 3 pts 
(9%), 1 extrastimulus (ES) in 2 pts (6%), 2 ES in 14 pts 
(44%), 3 ES in 12 pts (38%) and 4 ES in one pt (3%). 
Final therapy was determined by EP testing in all but 7 
pts who were treated with amiodarone and 2 pts who died 
in-hospital. 
At a followup of 12 + 9 mo, 5 pts (16%) had died 
suddenly and 2 pts (6%) had died from other cardiac 
causes. Three additional pts (9%) had symptomatic 
ventricular arrhythmias and 22 pts (69%) are arrhythmia-
free. Life table analysis showed that 75% of pta were 
alive without recurrence of arrhythmias st 2 years. 
Conclusion: In survivors of OHVF in whom VF is the only 
rhythm induced during EPS, the mortality and incidence 
of arrhythmia recurrence is high. Inducible VF should 
not necessarily be considered a nonspecific finding in 
these pts. 
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THE ROLE OF SILENT ISCHEMIA AND THE ELECTROPHYSIO-
LOGIC SUBSTRATE IN THE GENESIS OF SUDDEN CARDIAC 
DEATH. 
J. Anthony Gomes, M.D., F.A.C.C., Oimitrios Alexopoulos, 
M.D., Stephen Winters, M.D •. , Valentin Fuster, M.D., F.A.C.C., 
Kyung Sub, R.N. The Mt. Sinai Medical Center, N. Y., NY. 
Although silent ischemia (SI) and/or the presence of an electro-
physiologic (EP) substrate have been postulated to be the major 
determinants of sudden death (SO) due to ventricular tachycardia-
fibrillation (VT/VF), their specific role and interactions remain 
undefined. Accordingly, we studied 34 patients (pts) (age = 
62±8 yrs) of which 12 had 20 episodes of VT and/or VF on 24-hour 
Holter tapes (Group I) (Gr) and 22 pts had out-of-hospital SO 
(Gr II), in the absence of acute myocardial infarction (MI). 
Gr II pts had 24-hour Holter monitoring and signal averaging 
to detect late potentials (LP's) prior to programmed stimula-
tion (PES) for induction of VT/VF. The Holter tapes were analyz-
ed for ST segment changes, prematurity index (PI) and charac-
teristics of ventricular premature depolarizations (VPD's). 
ST depression of >1 mm for >30 sec was taken as a reflection 
of SI and the indUCtion of VT/VF by PES and/or the presence 
of LP's as a reflection of the EP substrate. Results: Gr I - Only 
2/12 pts (17%) had SI prior to 2 VT/VF episodes, whereas 10/12 
pts (83%) did not. The PI was <1 in IS% and >1 in 8S% of VT/VF 
episodes. However, 13/20 (6S%) episodes of VT/VF in 8 pts 
were initiated by a VPD preceeded by a short long cycle (sinus-
VPD-sinus), with a ratio of O.S±.I. Gr II - A significantly (p=.006) 
higher number of pts had an EP substrate (20/22 pts - 91 %), 
as compared to >1 SI episodes (11/22 pts - SO%). Importantly, 
SI episodes did not result in VT/VF and/or high grade VPO's 
in these pts. Conclusions: 1) SI was not a major determinant 
of SO. 2) Although SI was common in survivors of SO, it did 
not result in VT/VF. 3) In the absence of acute MI, SO is usually 
triggered by VPD's with a preceeding short-long cycle that 
likely produces dispersion of refractoriness in the EP substrate. 
ACTUARIAL ANALYSIS OF THE EFFICACY OF ELECTRO-
PHYSIOLOGIC TESTING IN SELECTING DRUG THERAPY 
FOR VENTRICULAR TACHYARRHYTHMIAS 
Christopher A.Bonnet.K.D., James J.Elson,K.D. 
Susan B.Fiedler,R.N.,BSN,Richard N.Fogoros,K.D. 
UniverSity of Pittsburgh, Pittsburgh, PA 
There are few actuarial analyses of the long 
term efficacy of drug therapy selected by 
electrophysiologic study(EPS) in patients (pts) 
presenting with cardiac arrest(CA) or sustain-
ed (requiring intervention for termination) 
ventricular tachycardia(SVT). We followed 87 
consecutive pts presenting with CA (n=37) or 
SVT(n=SO)who had serial drug testing by EPS 
for inducible SVT. RESULTS. "Successful" drugs 
«10 beats of inducible VT using 3 extrastimu-
li and burst pacing to 200 msec coupling in-
tervals) were identified in 24 pts (Group I). 
Groups I pts. received long-term therapy with 
the drugs to which they responded. EmpiriC 
therapy with amiodarone was recommended for 
the remaining 63 pts (Group II). During a mean 
followup of 20.5 ±lS.5 months, three pts in 
Group I and 29 in Group II had recurrent SVT 
or sudden death. The actuarial risk of re-
current events was as follows: 
Recurrent SVT Sudden Death 
Group _1__ _II___ _P__ L..ll- __ P_ 
lamo. 10±6% 45±7% <.005 0 13±5% <.01 
24mo. 2l±12% 5l±7% <.04 0 l3±5% <.01 
CONCLUSION. By actuarial analysis,pts respond-
ing to drugs by EPS have significantly fewer 
arrhythmiC events up to 24 months of followup. 
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NEUROPHYSIOLOGIC ACCOMPANIMENTS OF VENTRICULAR ARRHYTHMIAS 
PRODUCING SYNCOPE 
Michael J. Aminoff, M.D., Melvin M. Scheinman, M.D., 
F.A.C.C., Jerry C. Griffin, M.D., F.A.C.C., and John M. 
Herre, M.D., F.A.C.C., University of California,~ 
Francisco. 
Syncope commonly accompanies sustained ventricular tachy-
cardia (VT) or fibrillation (VF) but the neurologic mani-
festations may vary from flaccid coma to coma with 
seizure-like motor activity. In order to assess the 
neurophysiologic events occurring during syncope caused by 
VT or VF, we correlated the electroencephalogram (EEG) and 
ECG with video recordings prior to and during VT/VF in-
duced in order to test the automatic implantable cardio-
verter defibrillator in 14 pts, ages 25 to 73 years. VT 
or VF was induced 22 times with definite loss of con-
sciousness 15 times. Syncope occurred 9 to 20 sec after 
onset of VT/VF. EEG showed: no change in 1/15 pts; at-
tenuation without slowing in 2/15; slowing without atten-
uation in 3/15 and slowing followed by attenuation in 
9/15. Tonic motor activity and/or muscle jerkin9 was 
seen with syncope 10/15 times but seizure activity was 
never recorded on EEG. No relationship was observed be-
tween presence or onset of syncope after induction of 
VT/VF and age or ejection fraction. Conclusions: 1) In 
contrast to pr~or studies in pts with asystollC arrest 
which almost always show high-voltage delta activity, EEG 
abnormalities in pts with syncope due to VT/VF are vari-
able but most often include mild slowing. 2) In pts with 
syncope due to VT/VF, there is no EEG evidence of seizure 
activity, but motor activity resembling a seizure is ob-
served frequently. 3) Arrhythmia should be considered in 
pts presenting with atypical seizure-like activity. 
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Lipids and Coronary Artery Disease 
SAPHENOUS VEIN GRAFT PATENCY AFTER 2 YEARS IS RELATED TO 
PREOPERATIVE SERUM CHOLESTEROL AND TRIGLYCERIDE LEVELS. 
William J. Stewart, M.D., F.A.C.C., Marlene Goormastic, 
Bruce W. Lytle, M.D., F.A.C.C., Bernadine P. Healy, 
M.D., F.A.C.C., Byron J. Hoogwerf, M.D., Michael D. 
Cressman, M.D., Floyd D. LOop, M.D., F.A.C.C. 
William C. Sheldon, M.D., F.A.C.C. 
The Cleveland Clinic Foundation, Cleveland, OH. 
Saphenous vein graft (SVG) occlusion early after 
coronary bypass (CABG) relates to thrombosis and flow-
related factors. Late SVG stenosis may be similar to 
native atherosclerosis and affected by the lipid milieu. 
We performed clinically indicated angiography of 11,166 
SVG in 6011 pts undergoing CABG from 1972 to 1981. 
yrs postop: 0-1 yrs. 2-4 yrs. 5-7 yrs. 8+ yrs. 
i SVG: 4691 2283 2411 1781 
preop---ai5L: Percentage of SVG with :2 50% stenosis 
:S 199 25 24 43 55 
200-249 26 29 44 59 
250-299 27 33 50 61 
~300 30 36 56 65 
p = .24 .007 .001 .096 
Preop 'm: 
~149 26 28 42 54 
150-199 26 28 45 60 
200-249 27 35 48 64 
~250 28 39 59 65 
P = .66 .001 .001 .002 
Higher preoperative levels of cholesterol (CHOL) and 
triglycerides ('m) were associated with accelerated 
stenosis in SVG after the first 2 years. That late, but 
not early, SVG stenosis was influenced by lipids sug-
gests a different pathogenesis in these intervals. 
Further study is needed to determine if lowering CHOL 
and 'm will reduce late saphenous vein graft failure. 
ABSTRACTS 7A 
CLINICAL CXJl'COME TEN YEARS AFTER CORONARY BYPASS: 
EFFECTS OF CHOLESTEROL AND TRIGLYCERIDES IN 4913 PTS. 
William J. Stewart, M.D., F.A.C.C., Marlene Goormastic, 
Bernadine P. Healy, M.D., F.A.C.C., Bruce W. Lytle, 
M.D., F.A.C.C., Byron J. Hoogwerf, M.D., Michael D. 
Cressman, M.D., William C. Sheldon, M.D., F.A.C.C., 
Floyd D. LOOp, M.D., F.A.C.C. 
The Cleveland Clinic Foundation, Cleveland, OH. 
Whether or not elevated serum lipid levels portend 
reduced survival or unfavorable clinical status late 
after coronary bypass (CABG) remains controversial. Of 
12,330 pts having CABG here from 1972 to 1976, we 
assessed the first 1000 pts having CABG each year at 5 
and 10 yrs postop. Using clinic visits and/or telephone 
interviews, follow-up regarding interval events of 
angina, myocardial infarction, or coronary reoperation 
was complete in 4953 (99.1%) of 5000 pts, of which 4928 
had preoperative cholesterol (CHOL) and 3661 had 
preoperative triglyceride ('m) levels. 
EVENr-FREE SURVIVAL (percentage of pts) 
CHOL n 5 yr 10 yr 'm n 5 yr 10 yr 
H49 82 91.5 65.4 ~ 99 396 92.9 67.2 
150-199 783 90.4 66.9 100-149 1140 90.3 65.0 
200-249 2066 88.9 63.6 150-199 1026 88.5 62.7 
250-299 1380 91.0 63.7 200-249 598 90.1 62.9 
~ 300 617 89.6 59.6 ~ 250 501 89.4 59.8 
wilcoxon test: p=0.003 p=0.005 
In this large cohort of pts followed prospectively after 
CABG, late outcome (event-free survival at 10 years) 
correlated inversely with both cholesterol and trigly-
ceride levels. These differences in outcome may be due 
to lipid effects on the rates of atherosclerosis in 
native coronary arteries and/or in vein grafts. An 
intervention trial is needed to study the effects of 
lipid lowering on clinical outcome after CABG. 
LEFT VENTRICULAR WALL MOTION AFTER CORONARY AR-
TERY BYPASS GRAFT SURGERY IN PATIENTS WITH COL-
LATERALS. Yoshinori Tanimoto,M.D., Yasuo 
Matsuda,MD,FACC, Kiyoshi Takashiba,MD, Yoshio 
Hamada,MD, Hiroshi Ohno,MD, Banyo Fujii,MD, 
Hironori Ebihara,MD, Eiji Hyakuna,MD, Yurio 
Kobayashi,MD, Kenji Hayashi,MD. Saiseikai Shi-
monoseki General Hospital, Shimonoseki, Japan. 
Left ventricular ejection changes obtained from 
left ventriculograms were analyzed before and 
after coronary bypass surgery, in 50 patients 
with obstructive coronary artery disease col-
lateralized before surgery. The left anterior 
descending coronary artery (LAD) recieved col-
laterals in 22 patients and the right coronary 
artery (RCA) in 28 patients. The collateral ves-
sels all disappeared after surgery. After sur-
gery, the ejection changes of anterobasal, ante-
rolateral and apical walls supplied by the LAD 
improved from 43.6 ± 9.7 to 48.5 ± 8.6% (p< 
0.05), from 35.2 ± 10.9 to 39.4 ± 9.5% (p<0.05) 
and from 46.0 ± 10.6 to 50.0± 8.7% (p<0.05), 
respectively. The ejection chages of diaphragm-
atic and posterobasal walls supplied by the RCA 
improved from 34.1 ± 12.4 to 43.9 ± 13.1% (p< 
0.01) and from 20.9 ± 11.3 to 30.2 ± 11.7% (p 
<0.01), respectively. Thus, the patients had 
impairment of left ventricular wall motion in 
the area supplied by collaterals, that was im-
proved after the surgery. These results suggest 
that patients with obstructive coronary artery 
disease would have insufficient coronary blood 
flow even with collaterals, and have chronic 
active or silent ischemia that produces left 
ventricular impairment. 
8A ABSTRACTS 
PRAVASTATIN: A TISSUE-SELECTIVE ONCE-DAILY HMG COA 
REDUCTASE INHIBITOR IN TIlE TREATMENT OF PRIMARY HYPER-
CHOLESTEROLEMIA. 
Donald B. Hunninghake, M.D., Anne C. Goldberg, M.D., 
William Insull, M.D., Peter Kuo, M.D., Margot Mellies, 
M.D., Henry Y. Pan, M.D., Ph.D., and Helmut Schrott, 
M.D., University of Minnesota, Minneapolis, MN. 
Pravastatin, pharmacologically similar to lovastatin, 
has been shown in previous clinical trials to be an 
effective cholesterol-lowering agent when given twice 
daily. To determine if this agent is effective given 
once daily, patients with primary hypercholesterolemia 
were randomized after dietary stabilization in double-
blind fashion to: placebo, 40 mg OD am, 20 mg BID or 40 
mg OD pm. Lipid parameters from 137 patients (33-35 per 
group) who completed 8 weeks of treatment are summarized 
as follows: 
Average % Change 
Treatment N Total-C LDL-C 
Placebo 35 ~ +1.5 
Q AM 35 -22.1a -28.4a 
BID 33 -25.5a -32.1a 
aQ PM 34 -25.6a -32.4a 
bP <0.001 vs placebo and baseline 
From Baseline 
HDL-C TG 
+1.7 -3.6 
+2.9b -12.2 +6.8 -25.1 a 
+9.3c -25.6a 
cp <0.01 vs baseline 
p <0.001 vs baseline and <0.05 vs placebo 
The mean baseline total-C, LDL-C, IIDL-C, and TG values 
for these patients were 322,247,45, and 130 mgldl, 
respectively. None of the patients experienced any sig-
nificant drug-related adverse events. In particular, no 
significant elevations of liver enzymes or lens changes 
were noted. These data indicate that pravastatin is an 
effective hypocholesterolemic agent that can be conveni-
ently given once daily with a good safety profile in 
this relatively short-term study. 
The Effect of Dietary Omega-3 Fatty Acid Supplementation 
on Platelet Survival in a Hyperlipidemic Population. 
Bonnie H. Weiner, M.D., FACC, Peter H. Levine, M.D., James 
J. Hoogasian, M.A., Mark H. Johnson, B.S., Marc Fisher, 
M.D., Univ. of Massachusetts Medical Center, Worcester, MA. 
Dietary supplementation with Omega-3 fatty acids (0-3 FA) 
has been associated with altered platelet function and 
with a reduced incidence of ischemic coronary artery 
disease. We measured platelet survival, bleeding time, 
platelet fatty acids and plasma lipids in moderately hyper-
lipidemic patients before and after 6 weeks of daily eico-
sapentanoic acid (EPA, 2.4g) and docDsahexanoic acid (DHA, 
1.8g) ingestion. Eight of 12 patients had angiographically 
documented or clinically obvious large or medium vessel 
disease. Platelet survival (n=12), as measured by 
chromium labeling and a multiple hit model data analysis, 
was significantly prolonged from 6.4 ! 1.5 days at base-
line to 7.7 ! 1.4 days after 0-3 FA (po( .025). Bleeding 
time was not significantly prolonged (S.0!2.2 min vs 5.4 
± 1.5 min). Platelet arachidonic acid levels (as % of 
total fatty acid, n=12) fell from 26.5 ! 2.9% to 20.5 ! 
2.5% after intervention (p <:: .005) . Initially undetectable 
levels of EPA and DHA rose to 3.3 ± 2.4% and 1.6 ± 1.2% 
respectively after 0-3 FA. Plasma cholesterol, LDL, and 
Apo B levels increased after 0-3 FA(270.5±9.16mg7 vi; 288.4 
± 89.4mg%; 172.7 ± 73.7mg% vs 202.6 ± 74.6mg%; 123.5 ± 
27.8mg% vs 141.1 ± 20.4mg% (all p.(.02». HDL, VLDL , and 
Triglycerides were unchanged. This study demonstrates 
that a modest amount of 0-3FA ingestion can significantly 
prolong platelet survival in a high risk population 
despite the inability to modify plasma lipids in a benefi-
cial direction. 
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REDUCTION IN TISSUE-PLASMINOGEN ACTIVATOR INHIBITOR WITH 
OME~A-3 PUFA INTAKE. Jawahar Mehta, M.D., F.A.C.C., 
Dan1el Lawson, B.S., Tom Saldeen, M.D., Ph.D., VAMC and 
University of Florida, Gainesville, FL. 
Acti~ity of inhibitor of tissue-plasminogen activator (t-
PAl 1n humans correl ates with thrombotic tendency and with 
serum triglyceride concentrations. Since intake of fish-
derived anega-3 polyunsaturated fatty acids (PUFA) de-
creases serum triglycerides, we examined the effects of 
omega-3 PUFA (Max EPA) intake on t-PA inhibitor levels in 
8 patients with coronary artery disease (CAD). After 4 
w~eks of Max-EPA .(18 ca~sules per day) intake by CAD pa-
t1ents, serum tr1glycerlde concentrations and t-PA inhi-
bitor level s decreased 43±8~ and 21±5~, respectively, 
(both p<O.Ol) without any change in t-PA level s (l4.8±1.7 
to 14.3±1.9 ng/ml). To determine the time course of 
change in t-PA inhibitor, 4 normal subjects were given Max 
EPA. No changes were noted at 1 week of Max EPA intake 
but at 3 weeks triglyceride concentrations and t-PA inhi~ 
bitor lev,:1 s decreased 32±13~ and 22±4%, respectively, 
(p<O.02) w1thout change in t-PA concentrations. The mag-
nitude of reduction in triglycerides in CAD as !reI I as 
normal subjects was dependent on the initial serum concen-
tration (r=O.68, p<O.Ol). In addition, decrease in t-PA 
inhibitor correl ated with reduction in serum triglycerides 
(r=O.79, p<O.Ol). This study shows that anega-3 PUFA in-
take reduces t-PA inhibitor level s without change in t-PA. 
The~e. observations may relate to increase in fibrinolytic 
act1v1ty upon .con~umpt~on of .fish or fish-derived pro-
ducts. Reduct10n 1n tr1 glycendes and t-PA i nhibi tor may 
be potentially beneficial in CAD patients. 
Monday, March 28, 1988 
10:30AM-12:00NOON, Room 364, Level Three 
Developmental and Fetal Studies 
METABOLIC CONTROL OF OX3yEN CONSUMPTION IN THE DEVEL-
OPING HEART IN VIVO: A P NMR STUDY 
Michael A. Pcirtiiian, M.D., F.W. Heineman, M.D., and 
Robert S. Balaban, PhD., National Heart Lung and Blood 
Institute, Bethesda, MD 
To study developmental adaptations in control of car-
diac oxidative metabolism we have developed an in vivo 
neonatal model in which we measure myocardial oxygen con-
sumption (MVO?) an~lsimultaneoUSlY monitor phosphate 
metabolites uSing P NMR spectroscopy. Experiments were 
performed on ~esthetized neonatal lambs (n=4, ages 5-23 
days). Followlng a left thoracotomy, a surgical shunt was 
created between the left internal jugular and hemiazygous 
veins. The coronary sinus was then ligated to divert all 
coronary sinus drainage into the shunt, where outflow was 
then measured using an ultrasonic transit time probe. 
Sampling of coronary outflow for 0 and lactate content 
was done via. the shunt. An ellip~ld shaped surface colI 
was sutured to the perica3~ium overlying the left ven-
tricle for collection of P NMR data at 81mHz. Mean 
resting myocardial oxygen consumption was 3.0 cc 
02/min/l00gm LV. cardiac work increases were performed 
systematically by stepwise increases in epinephrine infu-
sion. Maximu~ MVO increases of 295% ± 22%(mean ± SEM) of 
baseline were obt~ined which corresponded to decreases of 
26% ± 8% in the phosphocreatine(PCr)/YATP ratio. Changes 
in this ratio which is an indirect measurement of free 
cytosolic ADP, were primarily due to decreases in PCR. In 
contrast to studies in adult canines, this study indi-
cates that changes in ADP may be partially responsible 
for control of MVO? in the developing heart. 
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DEPRESSED MYOCARDIAL FUNCI10N PRECEDES 
DEVELOPMENT OF PERSISTENT TRUNCUS ARTERIOSUS IN 
NEURAL CREST ABLATED CHICK EMBRYOS 
Linda Leatherbury. M.D FA C.C., Harold E. Gauldin, Harriett A. Stadt, 
Margaret L. Kirby, Ph.D~ Medical College of Georgia, Augusta, Georgia. 
Microcinephotography was used to study a model of persistent 
truncus arteriosus created in chick embryos by cauterizing premigratory neural 
crest destined for the fourth aortic arches and truncal septum. When 
embryogenesis reached the looped cardiac tube stage, 12 experimentals and 12 
control embryos were filmed at 100 frames/second under controlled 
environmental conditions with the heart rate (HR) determined. End·diastolic 
and end-systolic ventricular dimensions were measured from the presumptive 
right ventricle and used to calculate percent shortening fraction (SF). Area of 
the bulbous cordis was measured at end-diastole (Bulbous Cordis ED Area) 
and end-systolic in order to calculate the difference in areas (Change in Area) 
as an indication of stroke volume. (Data as means,± S.E.M.) 
Bulbous Cor~ Change in 
.HR..lmm .sE$ EDArS;lmm Ars;amm2 
Controls 163,± 4 76,± 4 0.42,± 0.02 0.37,± 0.01 
Experimentals 157,± 4 45,± 3 0.52,± 0.04 0.36,± 0.04 
% Change 0 -41% +24% 0 
P value N.S. <0.001 <0.05 N.S. 
Experimental embryos in the looped cardiac tube stage had 
significantly depressed shortening fractions. Microcinephotography showed 
depressed contractility, dilatation of the bulbous cordis (particularly of the 
presumptive right ventricle), unlooping of the cardiac tube, and insufficiency of 
the truncal folds prior to the stage of development where persistent truncus 
arteriosus is structurally abnormal. Measurement of the change in bulbous 
cordis area supported cinephotography assessment that chamber dilatation 
compensated for the decrease in contractility to maintain an adequate cardiac 
flow. 
FETAL HEART DISEASE WITH CARDIOMEGALY MAY BE ASSOCIATED 
WITH LUNG HYPOPLASIA AS A DETERMINANT OF POOR PROGNOSIS. 
David J. Sahn, M.D.,FACC, Gregory P. Heldt, M.D., 
Kathryn L. Reed, M.D., Charles S, Kleinman, M.D., FACC, 
Erik J. Meijboom, M.D., FACC, Univ Calif, San Diego, 
Univ Arizona, Yale University, Univ Maryland. 
Hypoplasia of the lungs has been linked with in-utero 
diagnosed pulmonary atresia (PA), but associated pulm-
onary vascular hypoplasia is a possible contributing 
factor. We studied 13 fetuses between 24-38 weeks gest-
ational age (EGA),who had various forms of heart disease 
with gross cardiomegaly,and who had autopsy or clinical 
evidence of lung hypoplasia. Three fetuses had critical 
pulmonic stenosis (PS), 1 with critical PS progressing 
in-utero to PA, and a dysplastic tricuspid valve (TV); 2 
had Ebstein's malformation, 2 had isolated TV dysplasia, 
1 had an in-utero cardiomyopathy, 1 had venticular 
tachycardia, 2 had AV canal with heart block, 1 had 
hypoplastic AO and LV, and 1 had a constricted ductus 
arteriosus and severe anemia in-utero. Seven had severe 
regurgitation of one or both atrioventricular valves. 
Only 5/13 had hydrops, only 3 hsd significant pleural 
effusions. Five died in-utero, all had decreased lung 
weight for EGA at postmortem. Eight were liveborn, 5 of 
whom died after a clinical course consisting of failure 
to achieve adequate ventilation, even after adequate 
palliative surgery in 2. Four of these had autopsy 
documentation of their lung hypoplasia. The last 3 
babies survived prolonged respirator dependency with 
ventilation requirements suggesting lung hypoplasia. 
All these fetuses had substantial cardiomegaly, which we 
believe can be associated with impaired lung development 
by a "space occupying" etiology similar to that seen in 
diaphragmatic hernia. The poor prognosis of the fetus 
with significant heart disease may in part be related to 
inadequate development of the lungs. 
ABSTRACTS 
VALIDATION OF TWO-DIMENSIONAL ECHOCARDIO-
GRAPHIC DETERMINATION OF LEFT VENTRICULAR 
VOLUMES IN THE FETAL HEART. 
Klays G Schmidt M D ; Jean-L. Cloez, M.D.; John Hawkins, 
M.D.; Norman H. Silverman, M.D.,F.A.C.C.; Abraham M. 
Rudolph, M.D.,FAC.C.; Univ. of California, San Francisco, CA. 
Determination of ventricular volumes by two-dimensional 
echocardiography (2DE) has been validated in children and 
adults. However, no data are available concerning the 
accuracy of this technique during fetal life. To validate the 
determination of LV volumes by 2DE in the fetal heart, we 
studied 6 chronically instrumented fetal lambs at 127±2 days 
gestation (weight: 3.1 ±O.4 kg). Arterial and venous lines, a left 
atrial catheter, and an electromagnetic flow probe 'on the 
ascending aorta were introduced 2-4 days before study. LV 
end-diastOlic volume (EDV), LV end-systolic volume, and LV 
stroke volume (SV) were calculated from apical 2- and 4-
chamber views using a Simpson's rule biplane algorithm. 
After completion of baseline measurements, alterations of LV 
preload were made by rapid withdrawal or infusion of blood in 
4 animals. At different left atrial pressures ranging from 0 to 14 
mm Hg, 42 LVSV calculations were obtained. Using linear 
regression analysis SV calculations by 2DE were compared to 
actual flow probe readings. In addition, LVEDV calculated by 
2DE at baseline condition was compared to LV silicone rubber 
casts in 6 animals. We found a good correlation between SV 
obtained from 2DE and from flow probe readings (r=O.SO; y= 
O.64x+O.17; SEE±O.OS mllkg) and between EDV obtained from 
2DE and from casts (r=O.S9; y=O.S6x+O.15; SEE±O.25 ml). We 
conclude that 2DE allows an accurate determination of LV vol-
umes in fetal hearts over a wide range of LV filling pressures. 
DOPPLER STUDIES OF FETAL VENA CAVAL FLOW YIELD INSIGHTS 
INTO THE PHYSIOLOGY OF ARRHYTHMIAS. Kathryn L. Reed, 
M.D., Christopher Appleton, M.D., Caroline Anderson, 
RDMS, Lewis Shenker, M.D., David J. Sahn, M.D., FACC. 
Univ Arizona, Tucson, AZ and Univ Calif, San Diego, CA. 
Normal Doppler studies of vena caval (VC) inflow show 
flow reversals (flow away from the heart [-VEL]) with 
atrial (ATR) contraction and forward flow (+VEL) early 
in systole (SYS), during ATR relaxation, and later in 
SYS continuing into diastole (DIAST). We studied SVC and 
IVC flow in 15 normal (NL) fetuses during fetal apnea 
and timed SYS and DIAST by superimposing SVC flow on AO 
arch flow with a large sample volume. We then compared 
IVC results to those from 13 fetuses with premature 
atrial contractions (PAC), 3 with ATR tachycardia, 2 
with sinus bradycardia (heart rate <100/min), and 2 with 
complete heart block «60/min). PAC's could be deline-
ated by their DIAST -VEL waves, which when expressed as 
a % of total SYS and DIAST +VEL time integral (27.0±3.7% 
[SEll, were increased compared to the value for normal 
sinus beats (4.5± 0.3%, p < 0.001) in the same fetus. 
The post ectopic beats after a pause also had an 
increased DIAST ATR -VEL (8.2±0.8%, p < 0.01). During 
ATR tachycardias, -ATR VELS were increased to 44.1± 
13.2% of forward flow, even when compared to the same 
fetuses (5.2±0.8%) in NL sinus rhythm after conversion 
(p < 0.05) and the % of -ATR VEL increased with heart 
rate (r-0.95). The fetuses with sinus bradycardia 
showed slightly increased % -ATR VEL (14.9 ± 5.1%) but 
had a NL SYS/DIAST + VEL flow ratios (3.27±0.95-NL, vs 
3.3±0.2 bradycardia); whereas the fetuses with complete 
heart block showed decreased SYS/DIAST +VEL ratios 
(0.45±0.02) with loss of the early SYS +VEL associated 
with coordinate ATR relaxation. Studies of VC flows 
detect atrial contraction and give insights into the 
adverse physiologic effects of fetal arrhythmias. 
9A 
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ECHOCARDIOGRAPHIC STUDY OF THE MORPHOLOGY AND GROWTH OF 
THE AORTIC ARCH IN THE HUMAN FETUS: OBSERVATIONS RELATED 
TO THE PRENATAL DIAGNOSIS OF COARCTATION. Lisa K. 
Hornberger, B.A. Erkki Pesonen, M.D., lain A. Simpson, 
M.D., Sandra Hagen-Ansert, RDMS, David J. Sahn, 
M.D.,FACC. Univ of Calif, San Diego, CA. 
Echocardiographic and angiographic studies have shown 
that aortic coarctation (COA) in newborns is often 
associated with aortic isthmic hypoplasia such that in 
normals the diameter of the left common carotid artery 
(LCCA) is between 50-60% the size of the isthmic segment 
but in COA it is > 80% of the isthmic size. To develop 
normal data for the growth of AO arch segments in the 
human fetus, we reviewed 24 normal fetal echocardiograms 
(17-37 weeks estimated gestation) (EGA) in which high 
resolution imaging of the entire AO arch had been 
achieved (Acuson, 5KHz magnification mode), (24 of 27 
attempted, 88% success rate). We measured the AO root, 
the proximal LCCA, the isthmus just distal to the LCCA, 
and the descending AO (DAO) distal to the ductus 
arteriosus (PDA). Growth curves for the AO root, LCCA, 
isthmus, and DAO (r-0.94 to 0.98) vs EGA were developed. 
The AO root was routinely larger than the isthmus (p < 
0.01) which was smaller than the DAO distal to the PDA 
in the fetus and the normal LCCA/isthmus diameter ratio 
in the fetus throughout gestation was 0.55 t 0.04(SD). 
In 3 additional fetuses in whom the diagnosis of COA was 
made at 22-34 weeks EGA and substantiated postnatally, 
(2 isolated COA's, I with single ventricle, transposi-
tion and COA), the isthmus was small for EGA « 10th 
%tile) and LCCA/isthmus diameter ratio was >0.75. Our 
study establishes normals values for the sequential 
growth of the AO arch which can be useful in diagnosing 
COA in the fetus while the ductus is open and may also 
be helpful in the prenatal diagnosis of other forms of 
congenital heart disease. 
Monday, March 28, 1988 
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Nuclear Cardiology: PET 
TISSUE INJURY IN REPERFUSED AND NON-REPERFUSED 
EXPERIMENTAL MYOCARDIAL INFARCTION CHARACTERIZED 
WITII F-IS DEOXYGLUCOSE AND IN-lli ANTIMYOSIN ANTIBODIES_ 
Frell] Vaghaiwal14 Mod], M_D., Denis B. Buxton, Ph.D., LuisI Araujo, 
M.D., Herb Hansen, B.S., Carl E. Selin, M.S., Michael C. Fishbein, M.D., Heinrich R. 
Schelbert, M.D., F .A.C.C., Michael E. Phelps, Ph.D., Markus Schwaiger, MD., UCLA 
School of Medicine, Los Angeles, CA. 
To determine the relative merits of tracers of viability (F.18 fluorodeoxyglucose; 
FOO) and necrosis (In-Ill antimyosin; AM) for characterizing severity of ischemic 
tissue injury, 7 dogs underwent reperfusion (RM) after 3-4 hrs LAD balloon 
occlusion and 5 dogs were nonreperfused (NRM) after permanent ligation. AM 
was iI\iected 15 min after ligation or reperfusion, FOG 24 hrs later prior to sacrifice. 
Microsphere blood flow (MBF) was measured during occlusion, risk zone 
demarcated by dye iI\iection before sacrifice (post-ligation of occlusion area in 
RM). Tissue iI\iury was graded by dye and TTC staining (1 =dye/normal tissue, 
2=TTC +ve/risk area but normal, 3=patchy TTC, 4=TTC-ve/infarcted, 
5=hemorrhagic), graded samples assayed for tracer activity by well counting. 
FOG was normalized to arterial input function and expressed as a metabolic rate 
(MR). AM, MBF and MR were normalized to TTCI myocardium. 
1I1B oUt IWIf = lW IilUl BJIrI U1 BJIrI IilUl 1 1.O±O.O 1.O±O.O 1.O±O.O 1.O±O.O 1.O±O.O 1.O±O.O 
2 2.l±1.2 5.6±4.2 2.2t1.5 1.3±O.1 0.9±0.3 1.1±0.2' 
3 3.0±2.2 6.6±6.5 6.1±2.4 3.2±2.6 0.4±0.' 0.5±0.1' 
4 2.5±1.9 1.B±2.4 10.6±5.1 3.7±1.82 0.3±0.2',2 0.1±0.02',2 
5 2.5±3.4 14.6±0.83 0.3±0.2' 
, p<.OOI TTC 3,4,5 VBl for RM and 3,4 VB 2 for NRM 
2 p<.05 NRM vs RM, 3 p<.OOI TTC 4,5 vs 1,2 and 5 vs 3 
CONCLUSION: 1. AM is a specific marker for necrosis with >10 fold of uptake in 
infarcted tissue RM, correlating well with degree ofiI\iury (r=0.88). 2. AM uptake 
also correlated with tissue iI\iury in NRM (r=0.62) but was attenuated (p<O.OOI vs 
RM) reflecting reduced tracer delivery. 3. Persistent but variable FOG activity in 
severe tissue iI\iury in both RM and NRM suggest residual viability, resulting in 
infarct size overestimation if AM were used alone. Thus, with increasing use of 
thrombolytic therapy for reperfusion in clinical MI, combination of tracers is 
essential for accurate estimation ofinfarct size and salvageable tissue. 
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REGIONAL MYOCARDIAL OXIDATIVE METABOLISM ASSESSED NON-
INVASIVELY WITH C-11 ACETATE AND DYNAMIC POSITRON EMISSION 
TOMOGRAPHY • 
Denis B. Buxton, Ph.D., Christoph A. Nienaber, M.D., Andre 
Luxen, Ph.D., Herbert Hansen, B.S., Osman Ratib, M.D., 
Michael E. Phelps, Ph.D., Heinrich R. Schelbert, M.D., 
F.A.C.C., UCLA School of Medicine, Los Angeles, CA. 
C-ll labeled acetate (AC) has been evaluated as a tracer 
of myocardial tricarboxyl ic acid flux for determination of 
overall oxidative metabolism using positron emission tom-
ography (PET). Serial PET images were recorded for 40 min 
following an intravenous bolus of AC in 17 studies in 11 
closed chest dogs. A semi-automated edge detection routine 
was used to define myocardium and generate 8 regional time 
acti vi ty curves for AC clearance which were then, fi tted 
biexponentially. MV02 ' calculated from 02, concentrations 
in arterial and coronary sinus blood and mlcrosphere blood 
flow, ranged from 4.8 to 16.7 ml 02.min-1.100g-1 The 
clearance halftime for the first component of myocardial 
C-11 tissue clearance ranged from 2.1 to 8.1 min. The rate 
constant k for the initial C-11 tissue clearance component 
correlated well with MV02 (r=0.94; SEE 0.027). AC cleared 
homogeneously from left ventricular myocardium, as evi-
denced by a variabi Ii ty of only 9.7% in clearance rates 
for the 8 myocardial sectors Carbohydrate utilization 
(expressed as % MV02 ) , correlated with k/MV02 (r=0.55; 
p<0.05). However, a complete switch from fatty acid to 
carbohydrate utilization would increase k by only 
20.8±9.7% for a given oxygen consumption, probably 
reflecting greater energy production efficiency using 
carbohydrate. Our findings support the value of C-l1 
acetate as a tracer of myocardial oxidative metablism 
which is relatively insensitive to changes in myocardial 
fuel selection, permitting noninvasive measurement of 
regional oxygen consumption with dynamic PET imaging. 
NONINVASIVE QUANTIFICATION OF REGIONAL MYOCARDIAL BLOOD 
FLOW WITH N-13 AMMONIA AND DYNAMIC POSITRON TOMOGRAPHY. 
Christoph Nienaber, M.D., Osman Ratib, M.D., Irving 
Weinberg, Ph.D., Sung-Cheng Huang, D.Sc., Edward J. 
Hoffman, Ph.D., !iichael E. Phelps, Ph.D., and Heinrich R. 
Schelbert, M.D., F.A.C.C., UCLA School of Medicine, Los 
Angeles, CA. 
The possibility of Quantifying noninvasively regional 
myocardial blood flow (MBF) with a flow tracer and dynamic 
positron tomography (PET) was examined in 25 studiess in 9 
intact dogs. Regional MBF was varied by graded coronary 
stenoses and pharmacolo)~ic interventions ranging from 0.9 
to 4.8 ml/min/g as determined simultaneously with 
microspheres. Dynamic PET imaging for 6 min (l5x6-sec, 
4xl5-sec, and 6 60-sec frames) started with an i.v. N-13 
ammonia bolus (10 mCi). Regional time activity curves 
were constructed from a LV blood pool ROI and from 8 
circumferential myocardial sectors and corrected for 
activity spillover and partial volume. In vivo PET 
measurements of myocardial tracer concentrations, 
validated in 10 additional dogs with F-18 deoxyglucose, 
correlated with in vitro measurements (slope of 1.01; 
r=0.99; p<O.OOl). The integral of the arterial input 
function by dynamic PET, validated in 15 experiments, 
correlated with simultaneous in vitro on-line a-probe 
measurements by y=1.08x; r=0.98 (p<O.OOl). From the ratio 
of regional ti ssue N-13 ammonia concentrations at 60 sec 
and the arterial input function, the N-13 ammonia net 
extraction (as the product of extraction fraction and MBF) 
was derived. It correlated with regional microsphere MBF 
by y= -0.014+0.75x-0.006x2 ; r=0.97 (p<O.OOl). We conclude 
that regional tissue tracer concentrations and the arte-
rial input function can be determined accurately by dy-
namic PET. When used with N-13 ammonia, dynamic PET pro-
vides noninvasively a quantitative index of regional MBF 
in ischemic, normal and hyperemic myocardium. 
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CATECHOLAMINE SUPPRESSION OF MYOCARDIAL GLUCOSE UPTAKE 
IN VIVO: A METABOLIC EFFECT MEDIATED BY SUBSTRATE 
AVAILABILITY. 
Michael E. Merhige, M.D.,F.A.C.C., Dahlia Garza,M.D., 
Dav,d Sease, M.D., Salma Maran;, M.S .• Heinrich 
Taegtmeyer, M.D.,D.Phil.,F.A.C.C., K. Lance Gould, M.D .• 
F.A.C.C. University of Texas, Houston, Texas. 
This study was done to determine whether suppression of 
myocardial glucose uptake during dopamine infusion in 
vivo is mediated by changes in substrate availability. 
Chronically instrumented dogs were sedated and myocar-
dial positron emission tomographs (PET) obtained during 
glucose infusion 45 minutes after the IV injection of 
lOmCi 2-F-18-2-deoxyglucose (FOG). Each of four dogs was 
studied under three conditions: during infusion of insu-
lin (GI), dopamine (GO) and the infusion of both (GDI). 
Plasma levels of glucose (GLU). free fatty acids (FFA) 
and lactate (LAC) were obtained during image acquisition 
while intra-arterial pressure was recorded. Myocardial 
FOG uptake expressed as the ratio of myocardial to 
blood pool mean activity was highest during GI infu-
sion (2.21±0.49). lowest during GO (0.97±0.07) [p<.005] 
and intermediate during GDI infusion (1.67±0.33). Plasma 
FFA were lowest during GI infusion (0.42±0.36), highest 
during GO (3.98±1.63) [p<0.02] and intermediate during 
GDI infusion (1.43±0.92). Regression analysis after nor-
malization demonstrated a polynomial relationship bet-
ween plasma FFA and myocardial FOG uptake (r=-0.86). 
There was no correlation between myocardial FOG uptake 
and plasma LAC level or cardiac work (double product) 
and only a weak correlation with plasma GLU (r=-0.52). 
We conclude that dopamine induced suppression of myocar-
dial FOG uptake is mediated by increased availability of 
FFA. These effects of dopamine are at least partially 
reverSible by concurrent insulin administration. 
NONINVASIVE QUANTIFICATION OF CORONARY RESERVE BY N-13 
AMMONIA AND POSITRON EMISSION TOMOGRAPHY (PET) 
M. Schwaiger. M.D •• J. Krivokapich,M.D •• O. Ratib. M.D., 
S.C.Huang,Ph.D •• M.E.Phelps,Ph.D.,H.R.Schelbert,M.D •• FACC, 
UCLA School of Medicine Los Angeles, CA. 
Qualitative evaluation of bloodflow by PET has been 
shown to provide a sensitive and specific means to de-
tect coronary ~rtery disease. To fully exploit the 
quantitative capabilities of high resolution PET imag-
ing we studied regional bloodflow in 7 normal volun-
teers with N-13 ammonia (NH3) at control and follow-
ing dipyridamole (Dip) infusion (0.142 mg/Kg/min). Blood 
and regional myocardial activity was assessed from serial 
PET images. Myocardial tracer concentration (5-10 min-
utes after injection) was normalized to arterial input 
intergrated over varying time periods (Int) and expres-
sed in PET flow units: 
Int 60 sec. 90 sec. 180 sec. 600 sec. 
Rest 99+12 79+10 55+5 31+5 
Dip 216+48 161+24 109+18 48+7 
CR 2.2+0.4 2.05+0.2 1.99+0.3 1.6+0.3 
Coronary reserve (CR) varied within the myocardial cros-
section 8 + 0.8% indicating only little regional varia-
tion of CR- in normal human heart. The PET flow and 
magnitude of CR decreased with longer integration inter-
val indicating cross-contamination of activity from myo-
cardium to bloodpool at later images. The underesti-
mation of CR after Dip by PET (expected > 3 times con-
trol) suggests significant decrease of NH3 extraction 
fraction at higher flow. Thus. these results indicate 
the feasibility to quantitate regional coronary reserve 
noninvasively with PET and NH3. but a tracer kinetic 
model is needed to correct for underestimation of flow at 
high flow rates. 
ABSTRACTS 
DIAGNOSIS OF CORONARY ARTERY DISEASE BY POSITRON 
IMAGING: LARGE SCALE CLINICAL TRIAL 
Linda L. Derner. M.D •• Ph.D •• Kenneth L. Gould. M.D •• 
FACC. Richard A. Goldstein. M.D •• FACC. Richard L. 
Kirkeeide. Ph.D •• Richard W. Smalling. M.D .• FACC. 
University of Texas Medical School. Houston. Texas. 
To assess utility of positron emission tom09raphy 
(PET) for diagnosing coronary artery disease (CAD). 
193 patients (pts) were studied by non-invasive 
cardiac PET perfusion imaging and automated quantita-
tive arteriography (QA) for diagnosis or screening 
protocols. CAD was classified by QA-predicted coronary 
flow reserve (CFR) as significant (CFR<3), mild 
(3<CFR<4) or normal (CFR>4). PET scans were revi ewed 
by-2 independent readersi!nd graded on a 0-5 scale of 
defect severity. RESULTS: Rest and/or stress PET scans 
were abnormal in 109 (94%) of 116 pts with significant 
CAD with or without symptoms. including 69 pts with 
history of myocardial infarction. Fifty of these 69 
had fixed defects and the remainder had stress defects 
only. Of 7 false negatives. 2 pts had diagonal disease 
on ly and another 5 had CFR values > 2.5 with mostly 
distal stenoses. Rest/stress scans-were abnormal in 
16 (44%) of pts with mild CAD and normal in 39 (95%) 
of normals. Of 2 false positives. one pt had a severe 
myocardial bridge with marked ST change on treadmill 
and the other had cigarette induced spasm. Location of 
PET defects was consistent with coronary anatomy. For 
noninfarct related leSions. severity of coronary 
narrowing correlated well with subjective PET defect 
severity. CONCLUSION: PET cardiac imaging identifies 
significant CAD with 94% sensitivity and 95% specifi-
city in asymptomatic or symptomatic pts, with false 
negatives having less significant CAD and false posi-
tives having non-atheromatous coronary abnormalites. 
Monday, March 28, 1988 
10:30AM-12:00NOON, Room 215, Level Two 
Diastolic Function of the Heart 
Effects of Filling Interval OIl Rapid and Slow Filling 
Dynamics: aili! of Slow Filling 
Y.Nishikawa, M.D., M.Akaishi, M.D., H.Yokozuka, M.D., 
T.Ikegawa, M.D., Y.Nakamura, M.D. Keio University School 
of Medicine, Tokyo, Japan. 
We have shown that change of rapid filling rate rather 
than slow filling rate determines diastolic filling 
volume during constant heart rate. To clarify the 
effects of preceding RR interval(RRI) on filling 
dynamics, we studied 18 dogs with AV block and atrial 
fibrillation. LV diameter(LVD:sooomicrometry), mean rate 
(mm/s) of diameter change during ejection (Vej), rapid 
(vrf) and slow (Vsf) filling, and time constant (T) of LV 
pressure decay were measured. Ventricular pacing was 
discontinued s1rl:ienly to create sudden increase in RRI. 
Vej, Vrf, Vsf, and T in long RRI(3.1 ±1.6 sec) were 
compared with those in short RRl (0.6 seciHR100). 
RESULTS Increase in RRI caused increase in LV end-
diastolic D (LVEDDi 25.0±5.8 to 27 .4±5. 7 mm, P<.01) and 
decrease in LV end-systolic D(19.4±5.7 to 18.6±5.7 mm, 
P<.01). Change of LVEDD was correlated with RRI (r=0.51, 
P<.01 ) Despite the variation in LVEIlD and LVESD, LVD at 
ern of rapid filling(LVD-ERF) was little altered(24.0:l: 
6.2 to 23.5±7.1 mm, NS). Increase in RRI caused increase 
in Vej (26:1:10 to 32:1:8 mm/sec, P<.01) and vrf(39:1:15 to 46:1: 
19 mm/sec, NS), whereas T (30:1:5 to 33:1:6 msec, NS) and Vsf 
(7.4:1:2.3 to 6.9:1:5.2 mm/sec, P>.05) were unchanged. 
<DfCLUSlafS (1) Although Vej and vrf vary to RRl, RRl has 
LVID r:: ~~UlnSl no influence 00 LV relaxation am 
3' I Vsf. (2) Change of Vrf appears to 
---;;.-.; .. II.. keep LVD-ERF constant. Little 
change of LVD-ERF and Vsf show _ .... 0..... beat to beat change in LV preload 
-- ... ·2.5... during variable RRl is determined 
25L-______ -:-, .,...,... mainly by slow filling interval. 
llA 
12A ABSTRACTS 
A NEW METHOD TO MEASURE DIRECT DIASTOLIC VENTRICULAR 
INTERACTION GAIN IN THE INTACT DOG USING SINGLE BEAT 
HEMODYNAMIC PERTURBATIONS. 
Bryan K. Slinker, D.V.M., Ph.D., Yoichi Goto, M.D., and 
Martin M. LeWinter. M.D .• F.A.C.C, University of Vermont, 
Burl i ngton, VT. 
Changes in RV volume affect LV function via direct 
ventricular interaction across the septum and series 
interaction through the pulmonary circulation. To study 
direct interaction, series interaction must be held 
constant or removed from the experimental preparation. 
This has been done by using isolated hearts or, in the 
intact circulation, by using linear regression analyses. 
The former is unphysiological, while the latter is 
potentially subject to counfounding variables and 
numerical artifacts. We separated these interaction 
effects in the intact circulation of 13 open-chest 
anesthetized dogs with intact pericardia by combining 
abrupt occlusion of both venae cavae and quick withdrawal 
of 10-15 ml of blood from the RV. This decreased RV end-
diastolic pressure (RVEDP) on the next beat but did not 
decrease pulmonary venous return until the second beat 
after reducing RV volume. We repeated the protocol at 3 
steady-state levels of LVEDP: 5, 10, and 15 mm Hg. We 
quantified direct interaction gain as lILVEDP/lIRVEDP 
between the beats before and after reducing RV volume. 
Gain values (mean ± SO) were: 
LVEDP=5 LVEDP=10 
0.32 ± 0.32 0.38 ± 0.23 
LVEDP=15 
0.28 ± 0.32 
These gains are not significantly different (p > 0.50). 
The overall average gain is 0.33 (95% confidence inter-
erval: 0.16 to 0.51). Although this magnitude indicates 
important direct diastolic ventricular interaction, it is 
lower than reported in previous studies. 
VISCOUS PROPERTIES OF THE IN-SITU COMPLETELY RELAXED LEFT 
VENTRICLE ARE INSIGNIFICANT AT NORMAL STRAIN RATES 
Srdjan Nikolic, M.S., Edward L. Yellin, Ph.D., Koichi 
Tamura, M.D., Takako Tamura, M.D., Kwaku Owusu. B.S., 
Manfred Dahm, M.D., and Robert W.M. Frater, M.D., 
F.A.C.C., Albert Einstein College of Medicine, N.Y. 
We have observed long periods of diastasis in the 
conscious dog (chronically instrumented to measure mitral 
flow and AV pressures), with no signs of stress 
relaxation or creep. We therefore designed this study to 
test the hypothesis that viscous properties of the fully 
relaxed LV are insignificant. We implanted a remote 
controlled mitral prosthesis and I.A and LV micro-
manometers in 5 anesthetized dogs (fentanyl, 5Omcg/kg), 
and determined the passive diastolic P-V relation (both 
positive and negative phases) by vo lUDle clamping the 
ventricle at different diastolic volumes, i.e., allowing 
different amounts of filling, and measuring the pressure 
fo 1 lowing comp lete re laxat ion (mode I). In mode II, the 
LV was clamped at end systole and released after 
relaxation was completed. The new P-V relation was 
compared to the previous one at equal voluDle, 20% of the 
filling volume (FV), which is close to peak mitral flow 
(i.e., Dlax strain rate). Rat iona Ie: Viscous effects 
would produce a higher pressure at equal volumes in mode 
II because the filling rates are higher due to a greater 
AV pressure difference. Results at 20%FV, (I vs II): 
LVP (mmHg) MF (ml/s) SR (vols/s) 
I -1.0+1.1 141+51 4.2+1.1 
II -2.1+2.0 169+50 5.1+1.1 
NS p<.002 p<.05 
11F=mitral flow, SR-normalized strain rate (MF/LVV-20%FV). 
Thus, despite a significant increase in strain rate, 
there was no component of pressure due to viscous 
effects. 
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REGICRU. DDS'roLl:C ~ IS PREVElI'l'BD BY ~M 
PERI'U8:u. OORDO 0lIIHRlC ARl'ERY ocx:ws:u.. 
Gary L. Schaer. MD. FACe, steven P. Karas, MD, Midlael. G. 
M:>ront, MD, Ali R. AnalCAlei, RlD, Marc s. Visner, MD, 
FACe. Georgetown university, washin;Jtan, DC 
Regional diastolic abnonoalities durin;J coronary artery 
CXlClusion (CllD) include elorgation of W1Stressed dimen-
sion (creep) am a leftwaId shift of the diastolic 
relationship between LV pressure am nonnalized dimen-
sion. To test the hypothesis that intracoronary perfus-
ion with Flucsol-IlA (p02>600 Torr) durin;J CllD \VCUl.d 
prevent these abnonnalities, in 12 dogs, segment lergt:hs 
of regions perfused by the left anterior desoerxiin;J were 
measured with ultrasonic <limension transducers am LV 
pressure was measured with a micranananeter. Vena caval 
CXlClusions were perfonned to detennine W1Stressed 
regional <limension (1.0) at LV pressure = 0 1IIItig. Ern 
diastolic len;Jth (EDL), 1.0 am LVEDP were measured durin:} 
baseline am at 2 min of CllD with am withaIt intracoron-
ary Flucsol perfusion (2 mlJkgjmin, 37"C) • Data are 
expressed as mean±SEM; *=1><.05 vs baseline: 
Bl\SBLDIB ClIO Bl\SBLDIB Cl!O+nuosol 
LO (um) 10.2±O.7 11.2±0.8* 9.9±O.8 9.6±O.7 
EDL (rom) 11.6±O.8 12.5±O.9* 11.7±O.9 12.l±O.9 
LVEDP (mn JIg) 11±1 16±1* 11±1 14±1* 
When <limension was nonnalized to strain (fractional 
extension fran 1.0), the regional strain-pressure cmves 
for CllD were shifted to the left fran baseline, Wicat-
in;J a loss of diastolic CCllplian::e. In contrast, there 
was no loss of regional CCllplian::e durin;J Cl\O+Fluosol. 
Clcmcl.usians: 1) Fluosol perfusion durin;J CllD prevents the 
increased diastolic stiffness am the creep in unstressed 
<limension seen with sinple CllD. 2) 'Ihese data suggest 
that increased LVEDP durin;J Flucsol perfusion is due to 
volume loadinJ rather than increased diastolic stiffness. 
INFLUENCE OF INCREASED MYOCARDIAL COLLAGEN ON 
ACTIVE AND PASSIVE STIFFNESS IN LEFT VENTRICULAR 
HYPERTROPHY 
Jorge E. Jalil M.D, Christian W. Doering M.D.. Joseph S. 
Janicki Ph.D., Sanjeev G. Shroff Ph.D .• Ruth Pick M.D .• Karl 
T. Weber M.D., F.A.C.C. Cardiovascular Institute. Michael 
Reese Hospital, University of Chicago, Chicago. IL. 
To study the consequences of increased myocardial collagen 
concentration (MCC) on active and passive stiffness of the 
intact hypertrophied LV, we utilized several models of LV 
hypertrophy (L VH) that represented a range of MCC. Three 
groups of male Wistar rats were studied: sham operated 
controls (sham); suprarenal aortic constriction for S weeks 
(Swk); and suprarenal aortic constriction for S weeks followed 
by 500 I'g/kg of daily subcutaneous isoproterenol for 10 days 
(Swk+I). At sacrifice, LV pressure-volume data were obtained 
in the iSOlated, perfused heart (range of L VEDP: 0-22 mm Hg) 
and diastolic and peak isovolumetric stress-strain relations 
derived. Results (mean±SD) for LV /RV weight ratio (LV /RV). 
collagen volume fraction (CVF) and slopes (m) of diastolic (m 
Dias) and peak developed (m Sys) isovolumetric stress-strain 
relations (measures of myocardial passive and active stiffness 
respectively) are given below: 
sham (n-6) 8wk (n=7) 8wk+I (n=S) 
LV /RV+ 3.4±0.6 4.3±0.S* 4.8±0.8* 
CVF (%) 6.2±0.9 S.7±2.3* 19.7+6.1*# 
m Sys (g/cm2i 620±60 71S±71 266:;::127*# 
m Dias (g/cm ) 118±4 I 22±4 141±17 
(*: ps.0.05 vs sham; #: ps.0.05 vg-· 8wk; +: RV weights similar for 
the 3 groups). While there was a trend for passive stiffness 
(m Dias) to increase in the Swk+I group. this was not 
significant for the group. Thus.· in L VH with increased MCC 
(CVF> I 5%). a decline in active stiffness (m Sys) occurs. which 
in physiologic terms represents the setting for the appearance 
of ventricular systolic dysfunction and pathologic hypertrophy. 
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RELATIOO OF DlASlULIC SlBJ'IDXARDlAL TISSUE FRESSJRE 10 a:EOOARY 
PRESruRE IJ ZERO ru:AI IN OO;S. 
Bernard Cimtin, B.Sc., Join G. ~ Jr., Ph.D., Jean B. tBrt1n, 
H.Sc., Jacques R. lIDuleau, H.D., F.A.C.C., Laval University, ~ebec, 
Qmada. 
The III subendocardial layer (ENlO) is IOOSt wlnersble to ischemia. 
Among the factors whJch regulate ENlO blood fl.cIo1, intraqyocardial 
tissue pressure (l/I') is, at least in part, responsible for the 
genesis of a positive pressure 1nter:cept at zero fl.cIo1 (Pzf) • 
However, the relatiooship between lMP and Pzf in the ENlO has not 
been slum in the intact beating heart. 1b evaluate these paraneters 
ENlO presaum-flow relatioos were studied in 10 IIrJIlgrel. dogs. In 
each dog, the pressure-flow relation was establislEd ~ graded 
constriction of the circunflex artery Wring maximal vasodilatation, 
while l/I' was neasured sfJrultaneous1y in the ENlO (needle tip 
transducer). 1b modulate l/I': (A) LV pressure was decreased or (B) 
coronary shws outflow pressure was irx:reased, ~ inflating a bal.l.ocn 
catheter in the inferior vena cava or the coronary shws, 
respectively. Circunflex diastolic pressure, at 4 different levels, 
was correlated to ENlO blood fl.cIo1 (neasured ~ l~m radiolabeled 
spleres). Pzf was estimated fron the regression. In the ENlO, l/I' 
was constalt for each pressure-flow relation determination in each 
dog. In the ENlO, Pzf and diastolic l/I' were directly related, with 
a correlation coefficient of 0.84; the slope of the relation was not 
different fran one and the inteICept was DOt different fran zero. 
Ninety percent of the l/I' values were in a rSDge of 10-30 DIll ~ 
during diastole. In each dog in the ENlO, Pzf and diastolic l/I' were 
always h1gher than LVElP and were sf,gn1ficantly h1gher than diastolic 
coronary shws outfl.clo1 pressure (p < 0.0001). Therefore, in the 
ENro, diastolic l/I' (measured directly) correlated with Pzf (measured 
indirectly) in the intact beating heart. We conclude that in the 
ENlO, l/I' is ~rtalt in the genesis of Pzf and is also an ~rtaJ.t 
factor in the regulation of myocardial blood flow distriwt1on. 
Monday, March 28, 1988 
2:00PM-3:30PM, Room 314, Level Three 
Valvuloplasty: Technical Aspects 
CORONARY BLOOD FLOW AND HEMODYNAMICS DURING EXPERIMENTAL 
AORTIC VALVULOPLASTY: BENEFICIAL EFFECTS OF THE DUAL 
CATHETER METHOD. 
John W. Moore, M.D., Michael C. Slack, M.D., William C. 
Kirby, M.D., Geoffrey M. Graeber, M.D., Walter· Reed Army 
Medical Center and Walter Reed Army Institute of 
Research, Washington, D.C. 
Twelve swine were instrumented to include left anterior 
descending (LAD) coronary artery flow probe, main pul-
monary artery (MPA) flow probe, LV catheter, femoral 
artery (FA) catheter, and ECG. They were subjected to LV 
outflow occlusion for 30 seconds using a single val-
vuloplasty catheter (sized angiographically to be equal 
to the aortic annulus) and using dual valvuloplasty 
catheters (sized to have combined diameters equal to 1.2 
times the aortic annulus). During LV outflow occlUSion 
with a Single catheter: LAD flow decreased more than BO~, 
MPA flow decreased more than 90~, the LV to FA peak sys-
tolic gradient was over 160 mm Hg, and there were fre-
quent dysrhythmias. During LV outflow occlusion with 
dual catheters: LAD flow decreased less than 50~, MPA 
flow decreased less than 50~, the LV to FA peak systolic 
gradient was less than Bo mm Hg, and dysrhythmias were 
uncommon. After LV outflow occlUSion with a single cath-
eter: LAD and MPA required more than 30 seconds to return 
to baselines. After LV outflow occlusion with dual bal-
loons: LAD and MPA flows returned to baselines within 10 
seconds. Compared to the single catheter method, the 
dual catheter method resulted in higher LAD flOW, higher 
MPA flow, lower LV outflow tract gradient, and fewer dys-
rhythmias during occlusion and more rapid return to base-
line LAD and MPA flows after occlusion (all p<.05). By 
effective "venting" of the LV, the dual catheter method 
may improve tolerance of aortic valvuloplasty. 
ABSTRACTS 
DUAL-BALLOON APPROACH FOR PERCUTANEOUS AORTIC BALLOON 
VALVULOPLASTY 
13A 
David R. Holmes, Jr., F.A.C.C., Rick A. Nishimura, M.D., 
F.A.C.C., Guy S. Reeder, M.D., F.A.C.C., John F.Bresnahan, 
M.D., F.A.C.C., Roy S. Small, M.D., F.A.C.C., James H. 
O'Keefe, Jr., M.D., F.A.C.C., Mayo Clinic, Rochester, 
Minnesota. 
The use of two balloons for percutaneous aortic balloon 
valvuloplasty (PABV) in an attempt to optimize results or 
decrease peripheral vascular complications associated with 
a single large balloon is increasing. The safety and effi-
cacy of this needs to be determined. Fifty-eight pts under-
went PABV with a 2 balloon technique. There were 27 males 
and 31 females with a mean age of 79 yrs (range 60-93). 
The sizes of the 2 balloons were 15 and 12 mm (9 pts), 15 
and 15 mm (23 pts), 15 and IB mm (24 pts), 20 and 12 mm (1 
pt), and 20 and 15 mm (1 pt). The average mean gradient 
decreased from 59 mmRg (range 20-99) to 31 mmHg (range 
16-64); the aortic valve area increased from .51 cm2 
(range .23-1.07) to .76 cm2 (range .41-1.29). There were 3 
deaths during the hospital stay related to the procedure; 
2 occurred during the procedure, 1 secondary to severe 
hypotension and 1 secondary to left ventricular per-
foration. The third death occurred from anoxic encephalo-
pathy following profound procedure-related hypotension. 
One additional pt died suddenly immediately prior to 
dismissal. During the initial hospitalization 3 pts 
required peripheral vascular surgery for femoral arterial 
complications. There was no evidence for rupture of the 
aortic annulus in any pt. 
Conclusion: l)Dual-balloon PAPV results in moderate 
improvement in aortic valve hemodynamics. 2)The use of two 
balloons did not result in rupture of the aortic annulus. 
3)There remains a relatively high morbidity and mortality 
due to the critically ill nature of candidates for PABV. 
PREDICTION OF APPROPRIATE BALLOON SIZE SELECTION IN 
PERCUTANEOUS AORTIC VALVULOPLASTY. 
Ruben F. Lewin, M.D., James F. King, M.D., F.A.C.C., and 
Gerald Dorros, M.D., F.A.C.C., St. Luke's Hospital, 
Milwaukee, WI 
The purpose of the study was to correlate between the 
patients anatomy [aortic annulus area (AAA») as measured 
by echocardiogram and hemodynamic results with the big-
gest balloon area size (BAS) utilized in order to achieve 
successful percutaneous trans luminal aortic valvuloplasty 
(PTV) with the lowest complication rate. In order to 
avoid arbitrary balloon size selection, an attempt was 
made to match the AAA with the BAS. Multiple tandem bal-
loons (1-5 simultaneously, mean of 2.2±6/patient) were 
utilized: single in 5 patients, double in 52, triple in 
13 and quadruple and quintuple one each. AVA increased 
(.55±.19 to 1.0±.4 em') and peak aortic gradient de-
creased (B9±-40 to 30±-16 mmHg). The mean AAA was B.9 
cm' and the mean BAS was 7.4±2.4 em' with a mean ratio 
(BAS/AAA) of .B8±-.36). In 20/71 (28%) of the patients, 
the BAS/AAA ratio was >1.1. Significant increase in 
aortic insufficiency (by angio) of ~ 2 insufficiency 
grades was found in 3/20 (15%) including 2 with aortic 
annulus tear requiring surgical repair, vs. 1/51 patients 
in which the ratio was ~ 1.1 (2%; p<.OOOl). Lesser 
degrees of aortic insufficiency (grade I) were seen in 
similar instances in both groups [5/51 (9.B%) vs. 3/20 
(15%»). No linear correlation was found between the % of 
increase in AVA and 1) BAS utilized, or 2) BAS/AAA ratio. 
Conclusions: 1) in most of the cases, adequate AVA in-
crease is achieved with low risk of creation of new or 
worsening of preexistent insufficiency when BAS/AAA ratio 
~ 1.1 were used, 2) when this ratio is exceeded, signi-
ficant complications may result and further improvement 
in AVA may be hemodynamically insignificant. 
14A ABSTRACTS 
DETERMINANT OF BEST RESULTS OF BALLOON AORTIC 
VALVULOPLASTY IN ADULTS 
Alain. Cribier. M.D •• Jacques Berland. M.D •• F.A.C.C •• 
Ren~ Koning. M.D •• Jean-Paul Bellefleur. M.D •• and 
Brice Letac. M.D •• F.A.C.C •• University of Rouen. France. 
After balloon aortic valvuloplaaty (BAV) for calcific 
aortic stenosis (AS). increaae in valve area (VA) to or 
above lcm2 is usually considered as a good result. In our 
series of 218 patients (Pts). this was obtained in 69 
(mean VA : 1.3 + .3 cm2 ). To assess a possible predictive 
features of optimal results. we compared this group (GI) 
to the group of the remaining 139 Pts (G II. mean VA K .75 
+ .1 cm2 ) on 38 clinic and hemodynamic pre-BAV parameters. 
Significant differences came up as follow : 
CLINICS GI(n-69) GIl(n-139) p 
xge- 69 + 12 75 + 9 <.001 
Sexe male 44 (64%) 57 (41%) <.01 
NYHA class Ill-IV 35 (50%) 108 (78%) <.001 
HEMODYNAMICS 
Peak gradient (mm Hg) 62 + 20 78 + 25 <.001 
Valve area (cm2 ) 66 + .2 • 46 + .1 <.001 
Syst. Pulm. pressure (mm Hg) 32 + 15 38 + 19 <.01 
Cardiac index (l/mn/m2 ) 3 + .7 2.6 :;: .8 <.001 
Ejection fraction (%) 54 + 14 51 :;: 16 <.01 
Largest balloon size >20 mm 53 (76%) 86 (61%) <.001 
Thus. best BAV results are observed in younger patients. a 
majority of males. with less severe aortic stenosis. 
Largest balloon sizes are more frequently used. Until now. 
BAV has been mainly applied on non surgical elderly and 
very sick Pts. However. these results should be taken into 
account for discussion of further extension of BAV to less 
old and/or sick patients. 
EARLY AND LATE EVALUATION OF PERCUTANEOUS 
AORTIC VALVULOPLASTY. A COMBINED HEMODYNAMIC 
AND DOPPLER-ECHOCARDIOGRAPHIC STUDY. 
Y. Bernard MD, J.P. Bassand MD, T. Anguenot MD, F. Schiele 
MD, C. Habert MD, P. Jacoulet MD, C. Roche MD, J.P. 
Maurat MD. 
University Hospital Besan!;on F 25000 FRANCE. 
Late evolution of aortic valvular area (AVA) after success-
ful percutaneous aortic valvuloplasty (PAV) remains controver-
sial. This study was designed to evaluate the early as well 
as the late efficacy of PAV in elderly patients (Pts). Peak 
(P) and mean (M) gradients were determ~ using dopple~­
echocardiography and cardiac output (CO) uSIng the thermodi-
lution method prior to (Ex I), one day after (Ex2) and 12 
weeks after (Ex3) PAV in 30 patients. AVA was evaluated 
from CO and M using the Gortin formula. Data were analysed 
using paired t test. 
Exl 
Ex2 
Ex3 
*p 
PmmHg 
77+15 
57~12* 
6~13 
( 
MmmHg COl/min 
58+12 3.75+.90 
3~11* 4.01~.71* 
47+12 3.88+.62 
0.01 between Ex 1 iind Ex2 
AVAcmz 
0.40+.09 
0.6~.07* 
0.5.5~0.07 
Our results tended to demonstrate that a loss of the initial 
improvement after PAV occured between Ex2 and Ex3. 8 
pts out of 30 had the same AVA at Ex3 as at Exl demonstra-
ting the occurence of restenosis. 
We concluded that the initial improvement of AV A pro-
duced by PAV may be offset whithin few weeks by partial 
or total restenosis. 
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MITRAL VALVULOPLASTY: RETROGRADE, TRANSARTERIAL DOUBLE 
BALLOON TECHNIQUE. 
Uros U. Babic, M.D., Gerald Dorros, M.D., F.A.C.C., 
Petar Pejcic, M.D., Zoran Djurisic, M.D., Ruben F. Lewin, 
M.D., and Sreten N. Grujicic, M.D., Dragisa Misovic, 
Beograd, Yugoslavia and St. Luke's Hospital, Milwaukee, WI 
Retrograde, transarterial double balloon percutaneous 
trans luminal mitral valvuloplasty (PTMV) was utilized on 
54/72 (75%) mitral stenosis patients (PTS) (16 males, 38 
females; mean age: 39±11 years). Transseptal catheteri-
zation permitted two 0.035" (350 cm) exchange wires to be 
placed antegrade across the aortic valve into the ascend-
ing aorta. These wires were then snared with a retrieval 
catheter and exteriorized, each via a femoral artery. 
Over these wires, the balloon dilatation catheters were 
advanced transarterial and retrogradely positioned across 
the mitral valve for PTMV. The transmitral mean gradient 
fell (18±4 to 9±5 mmHg; p<O.OOl); the cardiac output 
increased (5.l±0.8 to 6.l±0.8 L/min; p<O.OOl), and the 
hemodynamically calculated mitral valve area increased 
(1.2±0.2 to 2.3±0.6 em'; p<O.OOl). PTMV was unsuccessful 
in 2 PTS (4%) because of the inability to maintain the 
balloons in the transmitral position during inflation . 
Significant complications were encountered in 2 PTS: 2 
strokes (3.7%), 1 mortality (1.4%). Worsening of mitral 
regurgitation occurred in 2 PTS (3.7%); no post-PTMV 
hemodynamically significant atrial septal defects were 
detected. Followup (mean time: ll±6 months) of 43 PTS 
showed a persistent improvement in echocardiographic 
findings in 27 (63%), and hemodynamically measured mitral 
valve area in 16 PTS. The retrograde, transarterial 
double balloon technique can successfully accomplish PTMV 
with good results and an acceptable low morbidity and 
mortality. 
Monday, March 28, 1988 
4:00PM-5:30PM, Room 314, Level Three 
Valvuloplasty: Clinical Outcome 
PERCUTANEOUS TRANSVENOUS MITRAL COMMISSUROTOMY: EARLY 
CLINICAL OUTCOME 
Masakiyo Nobuyoshi, M.D.,F.A.C.C., Naoya Hamasaki, M.D., 
Hideyuki Nosaka, M.D., Takeshi Kimura, M.D., Alfonso ~. 
Miyamoto, M.D., * Kanji Inoue,M.D., Kokura ~emor1al 
Hosp., Kitakyushu, * Kochi Municipal Hosp., Koch1, Japan 
To define the indication and potential complications 
of percutaneous transvenous mitral commissurotomy(PTMC). 
it was performed in 51 consecutive patients (pts) with 
symptomatic mitral stenosis (Feb. to Aug. 1987). 
Technical success was accomplished in 50 of 51 pts 
(98%). Significant symptomatic improvement or clinical 
success was achieved in 46 of 51 pts (90%), there was 
no mortality but one pt required emergency operation. 
Mean left atrial pressure (17.7411.3 mmHg, p(O.OOl), 
diastolic mitral pressure gradient{11.5 -;5.5mmHg, p < 
0.001), mitral valve area by 2D-Doppler (1.4~2.0 cm , 
p < 0.001) and exercise peak pulmonar.y artery pressure 
(Diast.: 28.4 -1 22.2 mmHg, p < 0.01) improve~. Thr~e 
groups of pts were.ma~e.according t? .ech?card10graph1c 
evaluation of pl1ab1l1ty, calc1f1cat10n of valve 
leaflets and severity of subvalvular lesions: 
No. of Clinical Pressure Incidence 
Group Pts Success Gradient of .MR 
l(pliable) 15~.f15/15(100%) 12.0p~5.2 2/15(13%) 
2(semi-pliable) 29~27/29(93%) 11.6~ 7.4 6/29(21%) 
3(rigid) 7~ - 4/ 7(57.1) 12.~~ 6.7 2/ 7(29%) 
Severe mitral regul'gitation occurred 1n two pts of group 
2 and 1 pt of group 3. The pt requiring emergency valve 
replacement revealed tearing of the' anterior leaflet 
without separation of the fused commisures.. Thus, PTMC 
can be considered to be a safe and effect1ve treatment 
for pts with pliable valves. Selection of pts with more 
rigid valves, should be carefully weighed. 
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ONE YEAR FOLLOW-UP RESULTS AFTER PERCUTANEOUS 
DOUBLE BALLOON MITRAL VALVOTOMY. 
Muayed A Alzaibag, MRCP, Paulo Ribeiro, MD, Saad 
AIkasab, MRCP, Mon-a-raris, MRCP, Murtada Halim, 
MRCP, Maie S Shahid MRCP, Moheeb Abdullah, MRCP. 
Adult Cardiology Division, Riyadh Military 
Hospital, Kingdom of Saudi Arabia. 
We have rreviousl y described our percutaneous 
trans-atr al double balloon technique for mitral 
valvotomy (PDBMV) for severe rheumatic mitral 
stenosis. To determine the long term follow-up 
results, 30 consecutive pts had mitral valve 
area (MVA) calculated by echocardiography (2-
DE), Doppler and Gorlin formula bef-ore and 6 
weeks after successful PDBMV, and at one year by 
2-DE and Doppler. The pts mean age was 29+11 
years. Two pts had moderate mitral calcificatTon 
by fluoroscopy, and a further 2 pts had previous 
mitral surgical valvotomy. The 9 French balloon 
catheter (Meditech) sizes used ranged from 15 to 
20 mm diameter, inserted through 12 to 14 French 
transseptal sheaths (Cook or UMI). 
Before After 1 Year 
NYHA Class I-II 
NYHA Class III-IV 
MVA-2DE 
~~~ g~~n~r 
7 29 
23 1 
0.7+0.2 1.5+0.2 
0.7~0.1 1.5~0.2 
0.8~0.2 1.5~0.3 
- p <0.001-
Grade 1/4 mitral 1 pts 9 pts 
regurgitation (angiography) 
30 o 
1.6+0.3 
1.6~0.3 
not-done 
not done 
Left to right atrial shunting was demonstrated 
in 3 pts at six weeks after PDBMV, but disap-
peared at one year follow-up bl oximetry and 
angiography. There was no mortal ty or signifi-
cant morbidity. 
We conclude that the marked symptomatic 
improvement and more than 100% increase in MVA 
achieved by successful PDBMV persisted at the 
~~Id~~~~ ~~l!f~;~t ;~~~~~o~r~~e was no objective 
ACUTE HEMODYNAMIC RESULTS AND CLINICAL FOLLOW-UP IN 
PATIENTS UNDERGOING BALLOON MITRAL VALVULOPLASTY 
MJ CUnningham. MD, DJ Diver, MD, AD Berman, MD, RD 
Safian, MO, RM Wyman, MD, JS Weinstein, MD, PC Come, MD, 
FACC, LL McKay, RN, W Grossman, MD, FACC, RG McKay, MD, 
Harvard-Thorndike Laboratory, Beth Israel Hospital, 
Boston. MA. 
We performed balloon mitral valvuloplasty successfully 
in 60 of 66 patients, ages 27 to 83 years, with critical 
mitral stenosis, using either a single (n;36) or double 
balloon (n;24) technique. Following valve dilatation, 
there was a significa~t increase in mitral valve area 
(0.9±O.3 to 1.8±O.8 cm ), a decrease in the mean mitral 
gradient (15±5 to 7±3 nunHg), a fall in left atrial 
pressure (24±7 to 16±6 nunHg), and a rise in cardiac 
output (4.2±1.2 to 5.l±1.8 l/min). Complications 
included one death during the procedure, one embolic 
stroke, and one TIA. Fourteen patients had small atrial 
septal defects following the procedure (mean 
Qp/Qs;l. 5±O. 3) . Late deaths occurred in three patients 
and two patients underwent mitral valve replacement for 
persistant symptoms despite valvuloplasty. Another 
patient underwent successful repeat balloon mitral 
valvuloplasty for recurrent symptoms due to valve 
restenosis. The remaining 54 patients remain clinically 
improved at 6±4 months follow-up. Follow-up 
catheterization in four of these patients revealed no 
evidence for restenosis. Serial echo studies at 6 weeks 
and 6 months in this group have shown no evidence of 
valve restenosis. 
CONCLUSION: Balloon mitral valvuloplasty results in 
longterm improvement in symptoms and valve function in 
adult patients with mitral stenosis. Careful follow-up 
is warranted to detect valvular restenosis although 
initial results suggest that this is a relatively 
infrequent problem. 
ABSTRACTS 
BALLOON AORTIC VALVULOPLASTY: PIlEDICTORS OF CLIBICAL 
SUCCESS. Ec!ward P Riuli MD, Sidney K Edelman PhD, Ali 
Massumi MD, FACC, James J. Ferguson MD, Joseph P Murgo 
MD FACC. Clayton Research Foundation, St. Luke's Epis-
copal Hospital, Texas Heart Institute, Houston, Texas. 
To determine the predictors of individual patient 
success of balloon aortic valvuloplasty (BAV), 35 con-
secutive patients (16 males, 19 females, 75 ± 11 years) 
with a minimum of 3 month follow-up (mean 4.6± 2.5 mos) 
were evaluated. They were divided into two groups based 
on clinical outcome: 22 (63%) were clinical successes 
(continued symptomatic improvement) and 13 (37%) were 
clinical failures (late death or persistent/recurrent 
symptoms reqUiring intervention). Univariate and 
multivariate analyses were performed on these two groups 
using 41 clinical, hemodynamic, and technical variables. 
The single most powerful predictor of clinical 
success was the absolute value of the post-BAY calcu-
lated aortic valve a!ea (AVA). Using the criteria of a 
post-BVA AVA ~ 0.6 cm yielded a predictive value of 85% 
for clinical success. The mear post-BAY AVA of the 
su~cess group was 0.72 ± 0.19 cm (nz 22 with 17 pts~ 0.6 
cm ) while the m1an post-BAV AVA of the ~ailure group was 0.52± 0.13 cm (n-13 with 3 pts~0.6 cm). Variables 
not predictive of clinical outcome included peak to peak 
and mean gradients, the % change of these gradients, the 
% change of AVA, CO, LVEDP, EF, age, balloon size, 
single vs double balloon technique, number of balloon 
inflations, and inflation time. 
Conclusion: Clinical success following BAV can be 
predicted from the absolute value of the immediate post-
BAV valve area, and not the percent increase of AVA or 
the percent decrease of mean or peak to peak gradfents. 
Patients who achieve an aortic valve area ~ 0.6 cm have 
a high liklihood of continuing clinical success at four 
months follow-up. 
15A 
POSTVALVULOPLASTY FOLLOW-UP OF ELDERLY PATIENTS WITH 
SEVERE AORTIC STENOSIS AND LOW EJECTION FRACTION. 
Jacques Berland,M.D.,Alain Cribier,M.D, Thierry Savin,M.D., 
J.Pau1 Be11ef1eur,M.D., Rene Koning,M.D., Nadir Saoudi, . 
M.D., Brice Letac,M.D., F.A.C.C., Univ of Rouen, France. 
Balloon aortic valvuloplasty (BAV) has been performed in 
55 elderly (mean age 76+9) critically ill patients (Pts) 
with aortic stenosis (AS) and decreased ejection fraction 
(EF) < 40%. No Pt died during the procedure. During the 
first days, 3 Pt. (5%) died (2 femoral complications and 1 
endocarditis) • For the 52 other Pts, BAV enlarged the 
valve area (VA) from 0.47+0.15 to 0.81+O.28cm2 (p<O.OOI). 
During follow-up (mean: 1 C months), although all these Pts 
exhibited temporary clinical improvement, 22 Pts (17 non 
surgical candidates) died (GrD): mainly of terminal heart 
failure (14 Pts) or sudden death (6 Pts). The actuarial 
survival rates were: 85% at 1 month (mth), 70% at 6 mths, 
60% at 12 mths, 55% at 18 mths. 
Among the 30 surviving Pts (GrS), 21 were clinically mar-
kedly improved and 9 had recurrence of symptoms. Between 
GrD and GrS, age ( 79+7 vs 75+11 ), post BAV VA (0.79+0.29 
vs 0.83+o.27cm2) and EF (30+7-vs 28+6%) were not different. 
Repeat catheterization could be performed in 20 Pts 7+4 
months after BAV; 12 were asymptomatic. In 11 non resteno-
sed Pts, EF increased from 29+7 to 52+10% (p<O.OOI) whe-
reas in the 9 restenosed Pts,-EF remained unchanged. 
Conclusions : In these elderly severely diseased high sur-
gical risk Pts, mortality rate remained high during the 11 
months post BAV follow-up, possibly because of insuffi-
cient VA enlargement. In non restenosed surviving Pts 
marked sustained improvement in clinical and hemodynamic 
status was observed. More effective BAV producing larger 
VA, as usually obtained in our late experience, should 
improve the results. 
16A ABSTRACTS 
BALLOON AORTIC VALWLOPLASTY OF CALCIFIC AORTIC 
STENOSIS: RESULTS IN 130 CASES. AD Berman MD, RD Safian 
MD, DJ Diver MD, MJ Cunningham MD, JS Weinstein MD, RM 
Wyman MD, LL McKay RN, PC Come MD FACC, W Grossman MD 
FACC, RG McKay MD. Harvard-Thorndike Laboratory, Beth 
Israel Hospital, Boston. 
Percutaneous balloon aortic valvuloplasty (BAV) was 
performed in 130 patients (pts) with calcific aortic 
stenosis (AS) (aged 35-93, mean 76 "Years). Peak aortic 
gradient fell (68±28 to 33±14 lIJIllIIg ) and aortic valve 
area (AVA,.6±.2 to.1.0±.3 cm2) and cardiac output 
(4. 5±1. 4 to 4. 9±1. 5) rose immediately following BAV. 
Acute complications following BAV included transient 
respiratory arrest (n=2) , cardiac tamponade (n=2), 
myocardial infarction (n=l), acute aortic regurgitation 
(n=l), vascular trauma requiring surgery (n=17), 
ventricular arrythmia requlrlng therapy (n=2) , and 
transient conduction defects/minor arrythmias (n=20). 
There were 5 early deaths and 3 pts underwent aortic 
valve replacement (AVR) prior to hospital discharge. Of 
the 122 pts discharged following BAV (mean followup time 
8±4 months), 96 continue to be symptomatically improved. 
Followup doppler examinations have documented persisten~ 
increases in AVA (. 6±. 2 cm2 priOJ;;. to BAV, .9±3 cm2 
immediately post-BAY, and .9±.3 cm2 8 months following 
BAV). There have been 15 late deaths (mean time to death 
6.5±4 months), 12 cardiac and 3 non-cardiac. 21 pts have 
undergone repeat catheterization: 14 have had restenosis 
of the aortic valve, and 8 symptomatic pts have undergone 
redilatation. 8 pts have undergone late AVR because of 
recurrent symptoms. CONCLUSION: BAV is an effective 
palliative treabEnt in selected pts with AS, but the 
late restenosis and mortality rates continue to be high, 
and the procedure may be appropriate only for the very 
elderly or high risk patient with AS .• p<.Ol •• p<.05 
Monday, March 28, 1988 
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Catheter Ablation Therapy for Arrhythmias 
Identification and Catheter Ablation of a Zone of Slow 
Conduction in the Reentry Circuit of Ventricular Tachycardia 
Robert Frank, M.D., Fred Morady, M.D., F.A.C.C., William H. 
Kou, M.D., J. Tonet, M.D., Steven D. Nelson, M.D., S. Kounde, 
M.D., Michael de Buitleir, M.D. and Guy Fontaine, M.D., 
F.A.C.C., Hopital Jean Rostand, Paris, France. 
A zone of slow conduction in the reentry circuit of ventricular 
tachycardia (Vn to date has not been localized in humans. In 
this report, 3 pts who had incessant VT and in whom a zone of 
slow conduction was identified are presented. Each pt was being 
treated with amiodarone and had a VT cycle length of 500-580 
ms. In pts nos. I and 2, a single site at the posterola,teral wall 
or low septum in the LV was identified at which overdrive 
pacing during VT resulted in ventricular capture with a stimulus-
to-QRS interval of 280 to 400 ms, and with little or no change in 
the configuration of the QRS complexes during pacing as 
compared to during VT. The timing relative to the QRS of the 
endocardial electrogram adjacent to the pacing site was the 
same during VT and pacing. In pt no. 3, the same phenomenon 
was observed at 2 areas in the LV: at the inferior wall, 
overdrive pacing during VT resulted in a stimulus-to-QRS 
interval of 440-470 ms, whereas at the posterolateral wall, the 
stimulus-to-QRS interval was 320-360 ms. Transcatheter shocks 
of 100 to 240 joules delivered at the pacing sites have been 
successful in preventing recurrences of VT over a follow-up 
per iod of 8 to 9 mos. 
These observations may be explained by the pacing site being 
located within a reentry circuit in a zone of slow conduction 
bounded by inexcitable tissue between the pacing site and the 
exit site of the reentry circuit. In pt no. 3, the variable 
stimulus-to-QRS intervals are explained by variable proximity of 
the pacing sites within the slow conduction zone to the exit site 
of the reentry circuit. Preliminary results suggest that the slow 
conduction zone may be an appropriate location to deliver 
transcatheter shocks for the purpose of VT ablation. 
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HIS BUNDLE ABLATION USING IMPULSES BELOW ONE JOULE. 
Phyllis M.Ho1t,M.D .• Edward G.C.A.Boyd,Ph.D., Departments 
of Cardiology and Ph~sics, Guy's Hospital. London. 
It is not known whether current density or barotrauma is 
responsible for ablation tissue damage. Research on 
e1ectroporation indicates that the former must be main-
tained for a minimum but brief period, but the latter 
requires a longer electrical pulse for significant 
transfer of energy. The object of this investigation was 
to subject the His bundle (HB) to a high current density 
with a low average energy to minimise barotrauma. 
In the laboratory new USCI 6F bipolar catheters were 
electrically stress tested. Using a recently developed 
accurate patient analogue apparatus and satisfactory 
electrodes, the minimum pulse spacings for negligible 
arcing and pressure effects were determined. Verification 
was by observation and using a high frequency hydrophone. 
Six beagle dogs, with a mean weight of 13.6 kg (12.0 -
18.2). were used. Under general anaesthesia the electrode 
was positioned for a maximum HB signal plus a good atrial 
signal. Impulses, 10us long varying from 1.8-2.8kV were 
applied via both unipolar and bipolar USCI type 
electrodes. Pulse currents were between 12 and 25A. Two 
to 16 impulses were applied, spaced at 500us to 1ms 
intervals. The initial pulse was synchronised to the R-
wave. After recovery the animals in CHB were externally 
paced at 60 b.p.m. and six lead ECGs were taken daily. 
Permanent heart block, in excess of seven days, was 
produced with 16 impulses at an amplitude of 2.8kV. The 
impulse energy was 0.65J. Transient heart block varied 
from 1 to 60 min using eight impulses or impulse voltages 
below 2.2kV. 
These results indicate that pressure and arcing are not 
necessary for successful His bundle ablation and impulse 
energies of less than one joule can be used. 
CONTROLLED GROWTH OF RADIOFREQUENCY LESIONS BY POWER 
REGULATION. 
Fred H. Wittkampf, M.Sc., Richard N. Hauer, M.D. and 
Etienne O. Robles de Medina, M.D., F.A.C.C., Heart-Lung 
Institute, University Hospital, Utrecht, The Netherlands. 
In vivo predictability of lesion size by dosimetry of 
radiofrequency (RF) energy is controversial. However, 
control of lesion size is important for purposes of 
accurate modification of the arrhythmogenic substrate. 
We therefore studied the time constant of lesion growth 
and controllability of lesion size by power regulation. 
In 9 closed chest dogs RF energy (500 kHz, sine wave) was 
delivered to the right and left ventricular endocardium 
between the tip of a 6F electrode catheter and a large 
surface electrode. 45 Ablations were performed at power 
levels of 1 to 10 Wand durations of 10, 20, 30 and 60 s. 
At necropsy one week later, lesion size ranged from 0 to 
8.5 mm in depth and 0 to 9.5 mm in width. At equal power 
setting 20, 30 and 60 s lesions were not significantly 
different whereas 10 s lesions were significantly smaller. 
Above 20 s mean lesion diameter (D) correlated with power 
(p) according to D = 1.2 x P mm. 
At levels exceeding 7 W the ablation procedure was 
terminated within 60 s because of an abrupt increase of 
impedance due to the formation of a thin insulating layer 
of blood degradation products on the electrode surface. 
Conclusion: 1) In the 1 to 7 W range, RF lesions at any 
given power are full-grown within 20 s. 2) Above 20 s 
lesion size is determined by power and not by total 
delivered energy. 3) Controlled growth of the lesion can 
be achieved by a gradual increase of RF power level. 
4) Effective energy transfer to the myocardium is limited 
by the formation of an insulating layer at levels 
exceeding 7 W. 
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RADIOFREQUENCY ABLATION WITH A COOLED POROUS ELECTRODE 
CATHETER 
Fred H. Wittkampf, M.Sc., Richard N. Hauer, M.D. and 
Etienne O. Robles de Medina, M.D., F.A.C.C., Heart-Lung 
Institute, University Hospital, Utrecht, The Netherlands. 
Radiofrequency (RF) offers several important advantages 
over DC ablation. However, in dog experiments where RF 
catheter ablations were performed, an abrupt increase of 
impedance was noted at power levels above 7 W due to the 
formation of a thin insulating layer of blood degradation 
products on the electrode surface. This effect occurred 
earlier at increasing power levels. At necropsy one week 
later, maximum lesion size was 8 mm in depth and 10 mm in 
width. To overcome this limitation we developed a 6F 
lumen catheter with a porous distal electrode which could 
be cooled by saline. In 2 closed chest dogs 4 left 
ventricular endocardial RF ablations were performed at 11, 
19, 25 and 35 J for 60 s. During RF energy delivery the 
electrodes were flushed with saline at room temperature 
at a rate of 10 ml per minute. All ablations could be 
performed without abrupt change in electrode impedance. 
At necropsy one week later lesion size ranged from 8 to 
13 mm in depth (transmural) and 8 to 19 mm in width. 
Conclusion: 1) With standard electrode catheters effective 
RF energy transfer to the myocardium and thus lesion size 
is limited by the formation of an insulating layer at 
power levels exceeding 7 W. 2) Cooling of the electrode 
enables the ablation of larger amounts of myocardium, 
making RF a potential alternative for DC ablation of 
arrhythmogenic foci. 
VENTRICULAR ABLATION WI1H RADIOFREQUENCY ENERGY: 
COMPARISON OF DIFFERENT CAmE1ER ENERGY DELIVERY 
SYSTEMS. 
HL An. MD, S Saksena, MD, FACC, F Lim, Jr, MD, S Prasher, MD, 
M Janssen, MS. Newark Beth Israel Med Ctr-NJ Med School, Newark, NJ. 
Radiofrequency (RF) energy has been delivered through different catheter 
delivety systems (CDS) for ablation of ventricular myocardium. In order to 
optimize catheter systems, we examined the qualitative & quantitative effects of 
RF energy on normal and diseased human ventricle using 4 different standard or 
custom CDS. A 500 kHz RF generator was used in the unipolar mode. Passive 
contact (custom ring electrode or standard USCI 4-pole catheters) or active fixa-
tion (custom screw·in or suction electrode) catheters were used. Continuous or 
pulsed RF energy modes were compared. Power outputs examined ranged from 2 
to 50 W. Delivered current, voltage & energy as well as impedance were recorded. 
Gross & microscopic lesion (L) dimensions were correlated with delivered energy 
by regression analysis. 
RESULTS: 173 RF energy induced lesions were examined. Mean tissue impe-
dance in normal & diseased ventricle was comparable (110 vs 111 Ohms, p >.2). 
No change in tissue impedance was observed during RF energy delivety without 
arcing. Lesion dimensions in normal ventricle correlated with total delivered 
energy as follows: 
illS L Diameter (mm) R Coefficient L Depth (mm) R Coefficient 
2W ~ 2W ~ 
Custom Ring 2.9±0.6 6.5±0.3 0.86 0.8tO.2 2.7t0.5 0.71 
USCI4-Pole 3.6±0.1 7.5±0.5 0.92 0.41.0.1 3.2:!:0.1 0.85 
Screw-in 3.0tO.5 6.3:!:0.3 0.91 1.0±0.2 2.3:!:0.4 0.73 
Suction 3.8±0.3 5.0±0.6 0.46 1.6±0.2 2.4± 1.2 0.34 
Marked variability in energy delivety was observed with the suction catheter at 
energies over 10 W due to arcing. L dimensions & delivered energy were compa-
rable for continuous or pulsed RF modes (p >.2) with all CDS. 
CONCLUSIONS: 1) A variety of CDS can be used for RF ablation in normal 
ventricle. 2) Pulsed energy delivety is comparable to continuous modes & is 
preferable for controlled ablation. 3) Impedance measurements during ablation 
cannot be used to guide the extent of ablation, but do detect arcing during the 
procedure. 4) RF energy delivety with these CDS should improve control & preci-
sion in ventricular ablation procedures. 
ABSTRACTS 17A 
PREDICTORS OF SUCCESSFUL HIS BUNDLE ABLATION: A 
REPORT OF THE PERCUTANEOUS CARDIAC MAPPING AND 
ABLATION REGISTRY 
G Thomas Eyans Ir M D, Melvin M. Scheinman, M.D., FACC, 
Cary Fox, M.A., Maria Rodrigues and the Executive Committee of the 
Registry, University of California,San Francisco,CA 
To date, outcome data on SOl patients (Pt) who have undergone 
attempted His bundle ablation have been reported to the Registry, with a 
mean follow-up time of 12±11 months. Outcome groups were: Class I 
(64%): third degree A-V block WAVB), pt asymptomatic and taking no 
antiarrhythmic drugs, Class II (9%): resumption of conduction, pt 
asymptomatic and taking no antiarrhythmic drugs; Class III (12%): 
resumption of conduction, pt asymptomatic, but antiarrhythmic drugs 
required for arrhythmia control; Class IV (15%): unsuccessful 
(resumption of conduction, symptomatic). 
Ablation session data were available for 481 pt. 21 % haa a second 
session and < 2% had a third session. 
Analysis of session #1 separately compared pt in Class I with those 
in Classes II-IV. Those pt in Class I were more likely to have the 
following characteristics: female sex (p=0.10); LV ejection fraction 
>40% (p= 0.05); His bundle deflection >0.30 mV (p=0.02); lower 
number of shocks per session (p=O.ool); higher average energy per 
shock (p=0.03). Increasing magnitude of the first and second shocks 
was predictive of production of 30 A VB. Shocks of ~ 300 joules were 
more likely to produce 30 A VB (p=0.02). 
Complications which occurred more often in pt who received shocks 
of ~300 joules included immediate post-shock ventricular fibrillation (no 
deaths), nonsustained VT, pericarditis and chest pain. Sudden death 
during follow-up in 8 pt was not statistically related to the magnitude of 
shock. 
Conclusion: Linear regression analysis revealed that predictors of 
stable 3°AVB were: a His bundle deflection ~ 0.30 mV, an ejection 
fraction > 40% and an energy setting of 300 joules or more. The 
significantly higher success rate which occurred with shocks of ~ 300 
joules was accompanied by an acceptably low complication rate. 
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Automatic Implantable Cardioverter: Defibrillator 
AUTOMATIC ANTITACHYCARDIA PACEMAKER AND THE AUTOMATIC 
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR AS THERAPY FOR 
RECURRENT DRUG REFRACTORY VENTRICULAR TACHYCARDIA 
Martin Masterson, M.D., James D. Maloney, M.D., 
F.A.C.C., Bruce Wilkoff, M.D., Tony Simmons, M.D., 
Victor Morant, M.D., Leonard A.R. Golding, MD, Lon 
Castle, M.D., F.A.C.C., Cleveland Clinic, Cleveland, OH 
Eighty-one patients were implanted with the automatic 
implantable cardioverter defibrillator (ArCD). Despite 
'full antiarrhythmic drug therapy 18 pts had recurrent VT 
(m = 130 bpm) below the rate cut-off of their devices (m 
~ 157 bpm). Of these 7 men (m - 62 yrs, ASHD 7, EF 
31.4%, mean VT rate 135 bpm, clinical drug trial 
failures 5 + 1.8) with paced terminable VT were also 
implanted -with an anti tachycardia pacemaker (AP) 
(Orthocor II - 4 pts , Intertach - 3 pts). All had 
electrophysiologic evaluation using the respective 
external AP devices to determine the optimum number of 
stimuli for successful termination on a first attempt (m 
= 5) without triggering the AICD. AICD implantation 
involved patch/patch defibrillation configuration 
(threshold 21.4 + 7 joules) and LV epimyocardial sense 
electrodes. The- AP's were implanted using RV 
endocardial electrodes - active fixation - 6. At 
follow-up (m = 6 + 4.8 m) there have been 3 deaths 
hepatitis 1. (6- weeks), sudden cardiac death 2 - 1 
documented primary VF at 1 week, and 1 undocumented. 
Four other patients continue to have both devices active 
in the autdmatic mode. All patients have had AICD 
discharges (m = 16.8 + 15) for episodes of VT (m = 195 
bpm) and all pts have used their AP (m = 190) to 
terminate episodes of VT (m - 146 bpm). Three pts have 
had VT episodes undetected by both devices (m = 118 
bpm). CONCLUSIONS: Combination of AP and the AICD for 
patients with recurrent, slow and rapid, VT is 
feasible. AICD backup was required for rapid VT. 
18A ABSTRACTS 
RELATIONSHIP OF AUTOMATIC IMPLANTABLE CARDIOVERTER-
DEFIBRILLATOR SHOCKS TO ARRHYTIIMIA CHARACTERISTICS 
lule N Wetherbee. M p.; Peter D. Chapman, MD., F.A.C.C.; Paul I. Troup, 
MD., F.A.C.C.; Gordon N. Olinger, MD., F.A.C.C.; G. Hossein Almassi, MD.; 
Sharon E. Duquette, RN; Jan Veseth-Rogers, RN. V A Medical Center and the 
Medical College of Wisconsin, Milwaukee, Wisconsin. 
We have followed 82 patients (pt) with automatic implantable caIdioverter-
defibrillatoli (AJCD) for 19.9 ± 12.7 months. To assess the value of presenting, 
induced or spontaneous arrhythmia, we retrospectively determined what factors would 
predict appropriate AJCD shocks. Sixty-two pt had ASHD, 17 caIdiomyopathy, 3 
primary electrical disease. Mean EF 34.6 ± 16.5%. Presenting arrhythmia - 63 pt 
VP, 19 sustained VT. Prior to AJCD implantation 19 pt had undergone 
ablation/aneurysm resection judged ineffective by Holter or EP. At discharge 
following AJCD, Holter was classified as + if VT present or seen on telemetry, - if 
no VT. By EP and Holter results 6S pt were maintained on best antiarrhythmic, 37 
of these on amiodarone; 17 pt were followed on no antiarrhythmic. Shocks were 
deemed appropriate if VT/VP documented by ECG or if preceded by symptoms of 
presyncopelsyncope, inappropriate if documented by ECG, unknown if unable to 
classify as above, and none. Results: 24 pt received appropriate shocks (fIrSt shock 
- mean of 5.45 months), 8 pt received inappropriate shocks, 15 pt received unknown 
shocks, 35 pt none. The 24 pt with appropriate shocks were compared to the 58 pt 
without appropriate shocks. Appropriate shocks were not predicted by type of 
disease, EF, treatment with antiarrhythmic, amiodarone or no drug, + or - Holter, 
inducibility of VT (i.e., no VT, nonsustained VT or sustained VT), or the number of 
prematures required to induce VT at EP. Of pt presenting with VP 20163 (31.8%), 
and 3119 (15.8%)ofptpresenting with VTreceived appropriate shocks (p < 0.01). 
Only 1119 (5.3%) pt received appropriate shock after aneurysm resection compared to 
6114 (42.9%) pt with unresected aneurysm (p < 0.01). 
Conclusions: Ablation/aneurysm resection appears to offer protection against 
appropriate AJCD shocks even when judged ineffective by Holter or EP. Of the 
variables we examined, only a presenting history of VP predicts appropriate AJCD 
shocks in our pt population. Therefore, pt with a history of VP should receive 
strong consideration for AJCD even with negative Holter and EP. 
CLINICAL PERFORMANCE OF AUTOMATIC IMPLANTABLE CARDIO-
VERTER DEFIBRILLATOR: ELECTROCARDIOGRAPHIC DOCUMENT-
ATION OF 82 SPONTANEOUS DISCHARGES 
Martin Masterson, M.D., James D. Maloney, M.D., 
F.A.C.C., Bruce Wilkoff, M.D, Tony Simmons, M.D., Victor 
Morant, M.D., Leonard A.R. Golding, MD, Lon Castle, 
M.D., F.A.C.C., Cleveland Clinic, Cleveland, Ohio 
Eighty-one patients (m-72, mean age 58 + 9 yrs, ASHD 62 
pts, suddend cardiac death 41 pts, LVEF 34 + 12%) were 
implanted with the automatic implantable cardioverter 
defibrillator (AICD), rate only devices 34. At follow-
up (m - 12.3 + 10 months) 36 pts (44%) have had 385 
spontaneous AICD- discharges, 82 (21%) of which were 
electrocardiographically documented in 15 pts. All pts 
were maintained on full antiarrhythmic drug therapy and 
9 had rate only devices implanted. All records ana-
lyzed had the preceding rhythm, total arrhythmia up to 
the discharge and the post-discharge rhythm documented. 
All AICD discharges were confirmed. 
Fifty-three discharges were for sustained ventricular 
tachycardia (VT) (CL 318.5 + 5Oms) which persisted up to 
the time of discharge at mean-ll.7 + 3 sec. Most pts 
were unaware of arrhythmia prior to discharge. 
Twelve discharges were for episodes of non-sustained VT 
(NSVT) (CL 317 + 57ms) which lasted mean 7.3 + 1.4 sec 
triggering an -AICD discharge at 10.8 + 3 sec-(rate only 
devices 10) and the AICD discharge induced further NSVT 
5 pts, VT 1 pt inducing 6 further discharges. 
Eight disharges were for ventricular fibrillation which 
persisted up to the time of discharge (m = 12.98 + 2 
sec). All patients lost consciousness. -
Two discharges were for supraventricular arrhythmias. 
CONCLUSIONS: 1) 74% of AICD discharges are appropriate 
for the patient. 2) Inability to confirm that an 
arrhythmia has terminated prior to AICD discharges is a 
major limitation of the available device. 
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DEFIBRILLATON EFFICACY IN MAN AFTER 5 VS 15 SECONDS OF 
VmTRICULAR FIBRILLATION. 
Roger A.. Winkle. !1.!h.. F.A.C.C., R. Hardwin Mead, M.D., 
Michael A. Ruder, M.D., Nellis A. Smith, M.D., Vincent 
Gaudiani, M.D., Wally S. Buoh, M.D., Paula SOhmidt, R.N., 
and Tamara Shipman, R.N., Sequoia Hospital, Redwood City, 
CA. 
The automatio implantable defibrillator delivers life 
saving 25J shooks 15-20 seoonds after the onset of VF. 
During intraoperative testing repeated fibrillation-
defibrillation episodes are induoed to evaluate defibril-
lation efficacy (DFT's). The most appropriate duration of 
VF prior to defibrillation is not established. In 22 pts 
undergoing AICD implantation or generator change we com-
pared the defibrillation efficacy of a truncated exponen-
tial wa1feform at 4 energy levels after 5 and 15 eeoonds 
of induoed VF. The percent suocessful defibrillations 
Volts 300 400 500 600 
Joules 5.9 10.4 16.7 24.2 
5 seoonds 8~ 73J 86J 90J 
15 seconds 45J 73J 82J 76J 
show no significant differenoe between 5 and 15 seoonds 
exoeptat 300V (5.9 joules) when defibrillation was more 
efficaoious when delivered earlier (p<.05). There was no 
differenoe in the time to the first post defibrillation 
QRS complex. Postshook aortio pressure was significantly 
(p<.01) lower (85/44 vs 97152) after 15 seoonds of VF. 
We oonol ude that the duration of VF effeots defibrilla-
tion efficacy but only at energies which are relatively 
low oompared to the implanted devioe output. Longer 
episodes of VF cause more post shook hemodynamio depres-
sion. Relatively short durations of VF (5 seconds) are 
aooeptable for DFT testing when the "threshold" is well 
below the implanted devioe output. If "thresholds" are 
high compared to devioe output, longer durations of VF 
shoul d be tested. 
T I ME TO FIRST SHOCK AI{) LONG-TERM OUTCeJolE I N PATIENTS WITH 
AUTOMATIC IMPLANTABLE DEFIBRILLATORS. Robert J. Myerburg, 
MD, FAce, Richard Thurer, MD, FAce, Richard M. Lucerl, MD, 
FAce, Deborah K. Cooper, RN, Llaqat Zaman, MD, FAce, 
Richard G. Trohman, MD, FAce, Agustin Castellanos, MD, 
FACC, University of Miami, Miami Florida 
Automatic cardloverter defibrillators (AlCO) were Implant-
ed In 41 patients (pts) at our center between 8/83 and 
7/87. AI I pts had failed antiarrhythmic efficacy criteria 
after either out-of-hospltal VF (n=30) or recurrent symp-
tomatic sustained VT (n~11). There were 32 males and 9 
females, ranging In age from 34 to 77 years (mean=62.3± 
9.7). Coronary artery disease was present In 35, cardio-
myopathy In 4, and a primary electrical disturbance In 2. 
The mean duration of follow-up to death or last evaluation 
was 15.9±13.2 months (mo) (medlan=13 mol. Antiarrhythmic 
agents were used during follow-up In 25 pts (61%). A 
total of 8 deaths (19.5% of pts), 3 of which (7% of pts) 
were sudden (SO), occurred during follow-up. Two 50's 
occurred In the first mon after Implant, and the third at 
10 mono The non-sudden deaths occurred at 5, 5, 28, 29, 
and 33 mon, respectively. By actuarial analysis, the 1 
year SO rate was 9%, and total mortality rate 15%. Analy-
sis of time to first shock demonstrated a "potential" SO 
rate of 50% at 1 year. Furthermore, among the 21 pts (51%) 
who had any shocks, 12 pts (57%) had their first shock 
within 2 mon of AICD Implant, 17 (81%) within 6 mon, and 
no first shocks occurred later than 16 mono However, pts 
who received any shock durrng fol low-up, received a mean 
of 7 additional shocks; and 6/8 fatal events occurred In 
pts who had had prior AICO shocks. We conclude that first 
appropriate AICO shocks tend to cluster early after 
Implantation, and pts who have any shocks are at risk for 
multiple shocks despite antiarrhythmic therapy. Those who 
had no shocks during the first 12-18 mos were at low risk 
for having a later shock or fatal event. 
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DOES THE STATE OF ANXIETY DECREASE IN PATIENTS WITH THE 
AUTOMATIC INTERNAL CARDIOVERTER DEFIBRILLATOR? 
Stephen C. Vlay, M.D., F'.A.C.C., Linda Olson, R.N., 
Gregory Fricchione, M.D., Richard Friedman, Ph.D., 
Cardiology Division, SUNY Health Sciences Center, Stony 
Brook, New York. 
To judge the impact of the automatic internal cardioverter 
defibrillator (AICD) on the psychologic profile of pa-
tients (pts) with malignant ventricular arrhythmias, 6 
men and 2 women with a mean age of 53.3 yrs were evalua-
ted a mean time of 30 mos after implant. Exams included 
SCL-90 (Symptom Checklist-90), STPI (State Trait Person-
ality Inventory), and specific questions about the AICD. 
Baseline SCL-90 revealed slight to moderate elevation in 
anxiety characteristics but no change after AICD. Base-
line STPI revealed high scores in both the trait of and 
state of anxiety. After AICD, anxiety trait scores re-
mained elevated but the state of anxiety was markedly 
diminished (p<.05). Pts had elevated anger traits. After 
implant, 7/8 pts felt more at ease with protection pro-
vided by the AICD. Becoming accustomed to the pulse 
generator took a mean of 3.6 mos. Daily awareness of the 
AICD was only occasional (7/8 pts). One pt was no longer 
aware. If AICD replacement became necessary due to 
battery depletion, 7/8 pts would refuse repeat electro-
physiologic study (EPS) to determine continued necessity, 
but would insist on replacement without EPS. The AICD 
permitted return to a full and active life in 6 pts with 
the remaining 2 limited by cardiomyopathy. Standardized 
psychologic tests thus demonstrated increased anger and 
anxiety traits and a decreased state of anxiety post 
AICD in pts with malignant ventricular arrhythmias. 
Monday, March 28, 1988 
2:00PM-3:30PM, Room 260, Level Two 
EcholDoppler Assessment of Valvular Regurgitation: Color 
Flow Mapping 
THE VOLUME OF A COLOR FLOW JET VARIES DIRECTLY WITH FLOW 
RATE AND INVERSELY WITH ORIFICE SIZE: A HYDRODYNAMIC IN 
VITRO ASSESSMENT 
James 0 Thomas. MD, Ravin Davidoff MB, Gerard T Wilkins, 
MB BChir, Christopher Y Choong, MB BChir, PhD, Tracy 
Svizzero, Arthur E Weyman, MD, FACC, Massachusetts 
General Hospital, Boston, MA 
Before color flow Doppler echocardiography can 
provide quantitative data on regurgitant lesions, the 
relationship between the physical jet and its color flow 
appearance must be delineated. We have previously 
demonstrated that for a constant orifice size, the 
volume of color flow disturbance (CV) is directly 
proportional to the flow rate of a fully developed jet. 
To investigate the effect of orifice size on jet appear-
ance, we measured CV (assuming conical shape) for 41 jets 
pass i ng through ci rcul ar ori fi c,es wi th area (A) 0.1 to 
0.75 cm2, with flow (Q) between 11 and 80 cm3/sec. For 
each orifice, CV was linearly related to Q (r = 0.60 to 
0.82). However, the constant relating CV to Q varied 
from 1.5 at A=O.1 cm2 to 0.67 at A=0.75 cm2, best fit by 
the relation: 
CV = O. 58QA- .41 • (1) 
Using this relationship, color flow volumes were accu-
rately predicted at all orifice sizes (r - 0.73, P < 
0.01). This effect of A on CV may be related to the 
increased momentum of jets flowing through smaller 
orifices (due to higher velocity). Assuming that CV 
is proportional to the square root of momentum flux, 
pQ2/A, yielded correlations to the observed data indi-
stinguishable from Equation 1 (r = 0.72, P = NS from 
equation 1). Since momentum flux may also be written as 
Q/liPT'l., where p is driving pressure, quantitation of 
volumetric flow from color flow data may be possible if 
driving pressure is considered. 
ABSTRACTS 
IN-VITRO RELATIONSHIP OF JET FLOW WITH AREA BY 
DOPPLER COLOR FLOW: ARE THERE CORRELATIONS? 
Magnus Ohman, MD, Sherif Helmy, MD, Herbert 
stern, MD, David Adams, AS, Joseph Kisslo, MD, 
FACC. Duke Hospital, Durham, NC. 
The volume of a regurgitant jet (J) is pre-
sumed to relate to its area imaged by Doppler 
color flow methods. In-vitro studies of simu-
lated regurgitant J were performed in a 50 gal-
lon water tank where multiple volumes of 3% hy-
drogen peroxide were automatically injected in-
to the water (Medriad injector). J flows were 
imaged in long axis using a Hewlett-Packard 
77020CF imaging device equipped with a 2.5 MHz 
transducer and recorded for playback and anal-
ysis. Volumes and flow rates were varied with 
the delivery orifice held constant. Time inte-
grated maximum jet area (JA) and the area of 
variance (VA) contained within were measured 
and mea ned from a series of multiple injections 
for each experimental run. The JA from injec-
tions of 5 ml and 10 m1 with flow rates of 10 
ml/sec varied little (means 62 sq cm and 73 sq 
cm). Similarly, the VA was 20 sq cm and 17 sq 
cm respectively. Ratios of VA/JA were 32% and 
24% respectively. For identical volumes of 10 
ml with flow rates of 10 ml/sec and 20 ml/sec 
JA was 71 sq cm and 73 sq cm. The VA, however, 
differed markedly (means 20 sq cm and 30 sq cm 
respectively, and the VA/JA ratio was 24% and 
53%. The diameter of the J at, or near, the 
delivery orifice did not vary. These data 
indicate that volume had little effect on any 
of our parameters. Changes in flow rate may be 
a more primary determinant of the area of vari-
ance resulting from a regurgitant J. 
DETERMINANTS OF COLOR FLOW DOPPLER IMAGING OF REGUR-
GITANT FLOWS IN A PHYSIOLOGICAL IN-VITRO MODEL OF ~IITRAL 
INSUFFICIENCY EVALUATED BY DIGITAL COMPUTER ANALYSIS OF 
COLOR CODED VELOCITIES. lain A. Simpson, M.D., Lilliam 
M. Valdes-Cruz, M.D., FACC, Tadashi Tamura, B.S., David 
J. Sahn, M.D., FACC, Univ of Calif, San Diego, CA. 
We simulated mitral regurgitation (REG) and performed 
color Doppler flow mapping in the velocity (VEL)-
variance and power modes in a phYSiological pulsatile 
flow model with REG orifices 0.2, 0.6 or 2.0 mm2, and 
varying hemodynamic conditions of driving pressure, 
afterload and atrial compliance. Images were evaluated 
with a Sony 70G digitizing computer providing numerical 
VEL assignments for the red, blue and green (turbulent) 
pixel components, calibrated for VEL against the on-
screen color bar. We calculated for each jet, the REG 
color area (A), a summation of the individual color 
pixel VEL values integrated over the entire jet area- (A 
x VEL) and a similar integration of area x VEL after 
each pixel VEL was squared (A x VEL2). The sum of the 
power mode jet A x numerical power mode pixel color 
intensity was also determined. Measured REG pressure 
drop (related to potential energy) correlated better to 
the sum of A x VEL2 (related to kinetic energy) 
(r-0.84), than to the sum of A x VEL (r-0.72), or the 
REG A alone which ignores the pixel VEL contribution 
(r-0.76). The correlation of both A x VEL and A x VEL2 
to actual REG volume flow however was poor (r-0.56 and 
0.50, respectively), but the summation of the power mode 
A x pixel intensity, which sums the strength of the 
Doppler shift correlated well with REG volume (r-0.80), 
but not with pressure drop (r- 0.42). VEL-variance 
images are most closely related to the kinetic energy of 
REG jets and consequently to the REG pressure drop. 
Summation of power mode information may be more predic-
tive of REG stroke volume. 
19A 
20A ABSTRACTS 
HETEROGENEITY OF SHAPE AND DIRECTION OF MITRAL REGURGITANT 
JETS: CHARACTERIZATION BY COLOR DOPPLER FLOW IMAGING. 
Edward Harlamert, M.D., Mikel Smith, M.D., F.A.C.C. 
Oi Ling Kwan, Claudine Banks, Annette Cater, Helga Miles, 
Anthony N. DeMaria, M.D., F.A.C.C., Univ. of Kentucky 
Medical Center, Lexington, KY 
The spatial characteristics of mitral regurgitant(MR) jets 
may be of significance with regard to the physical 
findings and propensity to atrial arrhythmias or thrombi 
associated with this lesion. Although color Doppler flow 
imaging(CDFI) has enabled assessment of the shape and 
direction of disturbed flow, no systematic 
characterization of MR jets has been reported. Thus, we 
performed CDFI imaging in 66 pts with (MR) of multiple 
etiologies. The left atrium was divided into 3 equivalent 
sectors: anteroposterior (A-P) in parasternal long axis, 
and septal-lateral (S-L) in apical 4-chamber, and into 6 
sectors in the short axis views. Jet area was measured as 
the outer border of the largest clearly definable flow 
disturbances and jet direction taken as the sector 
encompassing the majority of the flow disturbance. 
Direction results in A-P: 47% of jets were directed 
posteriorly, 41% were directed mid and 12% were directed 
anteriorly. Direction results in S-L: 48% were directed 
mid, 39% were directed laterally, and 13% were directed 
septally. Jet was triangular (65%), oval (23%), scimitar 
(8%) and ellipsoid (4%). MR jets changed in s2ape as they 
enlarged: smallest2were ellipsoid (mean 2. 1 c~ ), larger triangular (3.7 cm ) and largest oval (7.3 cm ). No 
relationship existed between jet direction and either 
area, shape or etiology. Thus, these data indicate that MR 
jets are markedly heterogeneous in shape and direction. 
Although jet size is not related to direction, as area 
enlarges, shape appears to change. Spatial properties of 
the jet area may enable classification of MR pts into 
subgroups with differing clincal characteristics. 
COMPARISON OF INTRAOPERATIVE TRANSESOPHAGEAL AND 
EPICARDIAL COLOR FLOW DOPPLER IN MITRAL VALVE REPAIR. 
Philip J. Currie, MBBS, William J. Stewart, MD, FACC, 
Ernesto E. Salcedo, MD, FACC, Debbie A. Agler, Bruce M. 
Lytle, MD, FACC, Carl C. Gill, MD, FACC, Delos M. 
Cosgrove, MD, FACC. Cleveland Clinic, Cleveland, Ohio. 
Intraoperative epicardial color flow Doppler (E-CFD) 
permits immediate assessment of the integrity of the 
mitral valve following surgical repair for mitral 
regurgitation (MR). To assess the value of trans-
esophageal color flow Doppler (T-CFD) for this purpose, 
we studied 24 pts during repair for MR with 
intraoperative E-CFD and T-CFD, before and after 
cardiopulmonary bypass. Pre repair T-CFD showed 
comparable severity of MR (within +1) with E-CFD and 
with preop LV angiography in all pts. The location and 
direction of MR jets were identical by T-CFD and E-CFD 
in all pts. Leaflet morphology was assessed well by 
both E-CFD and T-CFD, but subvalvular mitral morphology 
was better assessed with E-CFD. T-CFM studies did not 
require a sterile transducer or interruption of surgery 
and was therefore longer in duration. However, T-CFD 
was limited to fewer tomographic imaging planes and did 
not have CW Doppler. In 21 pts after repair, both E-CFD 
and T-CFD showed successful repair. In 3 pts, both E-CFM 
and T-CFM diagnosed failed repair leading to immediate 
further surgery; LV outflow tract obstruction in 1 pt, 
persistent MR in 1 pt and residual flail leaflet in 1 
pt. Only E-CFM could measure the LV outflow gradient. 
Intraoperative E-CFD and T-CFD were comparable in 
assessing severity of MR. Temporal advantages and ease 
of application make T-CFM the standard method for intra-
operative screening of pts for failed mitral repair, but 
when abnormalities are suspected, E-CFD provides more 
complete diagnostic data for decision making. 
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PERIPROSnlETIC MITRAL AND AORTIC REGURGITATION: UTILITY 
OF PRE- AND INl'RAOPERATIVE OOPPLER COLOR FLOW MAPPING. 
William J. Stewart, M.D., F.A.C.C., Philip J. Currie, 
M.B.B.S., Deborah A. Agler, Bruce W. Lytle, M.D., 
F.A.C.C., Helga P. Lombardo, Delos M. Cosgrove, M.D., 
F.A.C.C., The Cleveland Clinic Foundation, Cleveland, OH. 
Periprosthetic regurgitation often necessitates re-
operation at substantial risk. Despite an intrinSically 
normal prosthesiS, a new prosthesis is often implanted 
due to the uncertain success of determining the location 
and repairing the leak. We studied 15 pts (7 with AVR 
and 8 with MVR) in whom peri valvular regurgitation was 
demonstrated on preoperative Doppler color flow mapping 
(CFM) (standard precordial in 15/15, transesophageal in 
5/15); all subsequently required surgery and underwent 
intraoperative CFM (epicardial in 11/15, transesophageal 
in 6/15). A new prosthesis was inserted in 6 pts. Of 
the 9 in whom the leak was oversewn without a new pros-
thesis, 7 showed no persistent leak and 2 showed persiS-
tent regurgitation on the postrepair intraoperative CFM 
necessitating a second cardiopulmonary bypass for suc-
cessful repair. All pts had a satisfactory clinical 
outcome. The location of the leak identified by CFM was 
verified by the surgeon in allIS. Transesophageal CFM 
was quite sensitive in discriminating the medial-lateral 
location of mitral regurgitation, but was less able to 
discriminate its anterior-posterior location compared to 
epicardial CFM. Both precordial and epicardial CFM were 
excellent in discriminating the location of peripros-
thetic aortic regurgitation. 
Conclusions: Doppler color flow mapping correctly 
identified the location of periprosthetic regurgita-
tion. Intraoperative CFM can accurately identify and 
locate postrepair peri valvular regurgitation when 
further surgery during that thoracotomy can be performed. 
Monday, March 28, 1988 
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Echo/Doppler: Assessment of Valvular Stenosis 
1'IIE EFFECT OF MEAN PRESSURE GRADIENT, CHAMBER COMPLIANCE, 
AND ORIFICE SIZE UPON THE DOPPLER HALFTIME METHOD. 
Steve M. Teague,MD;MS, FACC, William Marty, MS, Vahid 
Saadatmanesh, MS, John Cheung, PhD, Wyatt F. Voyles, MD, 
FACC, and Udho Thadani, MD, FACC. Univ of Oklahoma 
Schools of Medicine and Engineering, Oklahoma City, OK. 
Doppler Halftime (DH) methods are used to grade mitral 
stenosis and aortic regurgitation, although proof is 
lacking that chamber compliance and transvalvular pressure 
gradient do not perturb the measurement. To study the 
influence of these parameters upon DH, we constructed a 
hydrauliC simulator consisting of a driving pressure 
standpipe, variable round orifice, and compliant receiving 
chamber. The blood analog fluid was composed of water, 
glycerine, and cornstarch. Mean orifice pressure gradient 
varied from 7 to 70 mmHg. Standpipe compliance could be 
varied from 0.3 to 3.8 mmHg/cc. Chamber pressure varied 
from 0 to 45 mmHg, while compliance ranged from 0.01 to 
1.6 mmHg/cc. Round orifices 0.1 to 1.7 cm2 in area were 
studied. Decrescendo diastolic orifice flow was monitored 
by continuous wave Doppler ultrasound and differential 
pressure transducers. Keeping orifice size constant, DH 
was observed to vary by 400% inversely between extremes 
of standpipe and chamber compliance. Similarly, DH varied 
proportionally between minimum and maximum pressure 
gradient by 202%. Under conditions of similar compliances 
and pressure, DH varied inversely with orifice size. The 
Gorlin orifice constant showed similar but less dependence 
on compliance and more dependence on pressure gradient. 
These data indicate that pressure and Doppler halftime 
methods, as well as the Gorlin equation, reliably predict 
orifice size only within narrow hydraulic ranges. These 
data must be considered in evaluations of valvular heart 
disease complicated by extremes of chamber compliances and 
transvalvular pressure gradients. 
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The Mitral Valve Pressure Halftime: Accuracy 
at Six Months After Mitral Balloon Valvotomy 
Gerard T Vilkins MB ChB, Vivian M Abascal MD, James D 
Thomas MD, Christopher Y Choong MD, Ravin Davidoff MB 
BCh, Peter C Block MD FACC, Igor F Palacios MD FACC, 
Arthur E Veyman MD FACC. 
Massachusetts General Hospital, Boston. MA. 
Ve have previously shown that the accuracy of the 
pressure halftime method (H) of estimating the mitral 
valve area may be seriously affected in the immediate 
post-valvotomy (PMV) period by acute changes in left 
atrial pressure, compliance and flow. It is unknown 
whether this discordance with direct echocardiographic 
planimetry (P) or the Gorlin method (G) persists or 
disappears with hemodynamic equilibration. Ve therefore 
performed Doppler-echo studies in 13 patients (11 
female, 2 male; aged 21-72, mean 50 years) pre- and 
post- (within 24hrs) PMV, and at 6 months follow-up 
(FO), from which H (area = 220/t'/2) and P were 
calculated. During PMV and at follow-up 
catheterization, pressures (LA and LV), CO and G were 
measured. Mean valve areas were: 
P G H 
Pre-valvotomy 0.91cm2 0.84cm2 0.94cm2 
Post-valvotomy 1.90cm2 2.10cm2 1.40cm2 
Follow-up 1.60cm2 1.70cm2 1.55cm2 
The change in area from pre-PMV to FO for each method 
correlated well. G vs P (r=.70,p<.01), G vs H (r=.65, 
p<.04), P vs H (r=.73, p<.01). As reported, H 
underestimated the immediate post- PMV change, however, 
this discordance was not evident in comparison to P and 
G at the FO study. 
Conclusion: Six months after PMV, H gives an accurate 
and easily obtained measure of the mitral valve area. H 
should be used with caution in the immediate post-PMV 
period. 
TWO-DIMENSIONAL ECHOCARDIOGRAPHIC ASSESSMENT OF CHANGES 
IN MITRAL VALVE MORPHOLOGY AND LEFT ATRIAL VOLUMES 
3 MONTHS AFTER CATHETER BALLOON VALVULOPLASTY FOR MITRAL 
STENOSIS. Cheryl L. Reid, MD, FACC, Charles R. McKay, 
MD, FACC, P. Anthony N. Chandraratna, MD, FACC, David T. 
Kawanishi, MD, FACC, Shahbudin H. Rahimtoola, MD, FACC, 
LAC-USC Medical Center, Los Angeles, CA 
Two-dimensional echocardiography/Doppler was performed 
in 20 consecutive pts (age 40±14 yrs) with mitral valve 
(MV) stenosis immediately after and 3 mos post catheter 
balloon valvuloplasty (CBV) in order to determine changes 
in MV morphology and left atrial volumes (LAVol). 
Morphologic measurements included MV transverse diameter 
(TO) and commissural angle of opening as described by us 
previously. A >15% reduction in mitral valve area (MVA) 
by cardiac catheterization from immediate to 3 mos 
post-CBV was considered significant. 
MVA decreased at 3 mos post-CBV in 8 of 20 pts (40%) 
from 2.6±.5cm' to 1.7±.3cm',p<.001. In these 8 pts TO did 
not change (24.6±2.8mm vs 24±3.6mm) but the anterior 
commissural opening decreased from 56±21· to 48±22·, 
p<.05. For all 20 pts, a >10· decrease in either 
commissural angle tended to predict reduction in MVA, 
p<.05 by X', sensitivity = 62%, specificity = 89%. LAVol 
decreased from 114±46ml to 89±41ml, p<.001. The decrease 
in LAVol was seen in those who developed atrial septal 
defect, mitral regurgitation, reduction in MVA, and also 
those who had atrial fibrillation. 
We conclude that at 3 mos post-CBV: 1. MVA was reduced 
in 40% of pts; 2. Reduction of >10· in opening of either 
commissural angle was associated with a decrease in MVA; 
3. Since TO was unchanged, reduction in MVA is not due to 
re-fusion of commissures but likely due to rigidity of 
the valvular mechanism; and 4. Increased LAVol returned 
towards normal. 
ABSTRACTS 21A 
EVALUATION OF THE DOPPLER CONTINUITY EQUATION FOR 
IlEASURING AORTIC VALVE AREA IN TVO SETTINGS: MECHANICAL 
DILATATION OF THE STENOTIC VALVE AND INCREASE IN CARDIAC 
OUTPUT. 
Vivian M. Abascal, MD, Christopher Y. Choong, MB, PhD, 
Gerard ~Vilkins, M~Paul N. Casale, MD, Ravin Davidoff, 
MB, Igor F. Palacios, MD, FACC, Michael A. Fifer, MD, 
FACC, Peter C. Block, MD, FACC, Arthur E. Veyman, MD, 
FACC. Massachusetts General Hospital, Boston, MA. 
Ve evaluated the Doppler continuity equation (DCE) for 
measuring aortic valve area (AVA) in aortic stenosis in 
two settings, namely 1) mechanical dilatation of the valve 
orifice, and 2) increase in flow veloci ty across the 
valve. In 24 patients undergoing percutaneous aortic 
valvuloplasty (PAV), we measured AVA simultaneously by DCE 
and the Gorlin method (GOR). Before PAV, AVA measured by 
both techniques were not different (0.58 + 0.19 cm 2 by DCE 
vs. 0.53 + 0.22 cm2 by GOR, p=NS) and correlated signifi-
cantly (r-;;0.79, p<O.OOOI, SEE=0.12 cm 2 ). Similarly, AVA 
measured by both techniques after PAV were also not 
different (0.87 + 0.32 cm 2 by DCE vs. 0.84 + 0.34 cm 2 by 
GOR, p=NS; p<O.OOOI vs pre-PAV) and correlated signifi 
cantly (r=0.82, p<0.0001, SEE=0.19 cm 2 ). The magnitude of 
increase in AVA after PAV by both techniques correlated 
well (r=0.82, p=O.OOI, SEE=0.11 cm 2 ). To examine whether 
an increase in cardiac output alters AVA measured by DCE, 
we infused dobutamine in 7 of these patients immediately 
after PAV. Cardiac output increased from 3.62 + 0.83 to 
4.57 + 0.83 l/min (p<0.001) and heart rate from-70 + 10 to 
91 + 18 beats/min (p<0.008). Peak and mean velocitIes in 
the-LV outflow tract and post stenotic jet increased in 
all patients. LV outflow tract area did not change. AVA 
measured by DCE post-PAV was 0.74 + 0.26 cm 2 and did not 
change after dobutamine (0.76 + -0.25 cm 2 , p=NS). 
Conclusion: DCE is a reliable technique for measuring 
changes in AVA after PAV. This technique appears 
independen t of flow rate under the condit ions studied. 
EFFECTS OF THE SHAPE OF PRE- AND POST-STENOTIC REGIONS ON THE ACCURACY OF 
DOPPLER IN MEASURING PRESSURE GRADIENTS ACROSS LONG SEGMENT STENOSIS. 
Karl Isaaz. MO. Regis Rieu. MS. Robert Pelissier. MS. opt of Cardiology. 
CHU. Nancy; Institut de Mecanique des Fluides de Marseille. France. 
Real tunnellike obstructions (TO) as those created by some congenital 
heart disease or coronary artery disease are often irregular with varia-
ble cross-sectional area (CSA). To test the effects of geometric non-
uniformity of stenotic region on the accuracy of Doppler (D) using the 
modified Bernoulli equation (MBE) for predicting PG across TO. we cons-
tructed a pulsatile flow model
2
of stepwise obstructed channels. Six tun-
nels (t) (CSA 0.07 and 0.03 em ; lengths (L) 52 10 and 20 mm ]were each 
inserted between 2 larger channels (CSA 0.28 em and 2 cm L). t2ese lat-
ter being aligned between inlet and outflow chambers of 3.14 cm CSA (MO-
.J P3 1 P2 IP1 POll.. ,~~~, 
I I I I 
~lJ' : 
I ' i' I I 
-"I--J'V'I---.J:1.. -==-~....Im now 
IlllEl 2 
DEL I). A regular TO was constructed by 
inserting directly t between inlet and 
outflow chambers (MODEL 2). Pressure taps 
were placed 35 mm (PO) and 3 mm (PI) in 
front of t. and 3 mm (P2) and 30 mm (P3) 
beyond t. The following PG : PI-P2. PO-P2 
PO-P3 were measured and compared to va-
lues obtained by a continuous wave 0 
(D2PTEK) using MBE. In MODEL I. for 0.07 
cm CSA MBE overestimated PO-P3 at all 
lengths £1-18%) but underestimated PI-P2 
(5-14%) and PO-P2 (1l-24S.) ; for 0.03 cm CSA. PO-P3 was accurately pre-
dicted at all lengths .PI-P2 was underestimated (mean 20%) as well as 
PO-P2 (mean 25%). In MODEL 2. for 0.07 cm2CSA MBE underestimat2d at all lengths PO-P3 (17-42%). PI-P2 and PO-P2 (19-39%) ; for 0.03 cm CSA. all 
PG were severely underestimated at all lengths (44-92%). CONCLUSIONS: 
These results suggest that the shape of pre- and post-stenotic regions 
influences the accuracy of 0 using MBE in predicting PG. M8E always un-
derestimates PG across regular obstructed channels where the constriction 
and the re-expansion are abrupt. By contrast. in gradual TO with progres-
sive re-expansion. PG may be overestimated by MBE even in severe and long 
stenosis. These findings apply to clinical studies where D-derived PG are 
compared to catheterization data. 
22A ABSTRACTS 
II VITRO VALIDATIOI OF THE ASSESSKEIT BY DOPPLER 
ULTRASOUID OF IORIAL .ITRAL BIOPROSTHETIC FUICTIOI 
Jobn Cbambers JRCP, Thomas Cochrane PhD, ~rtin BlacK PhD, 
Graham JacKson FRCP. Cardiac Unit, King's College 
Hospital, London, UK. 
In native mitral valves, pressure half time (T~) is 
relatively independent of flow and gives a better 
indication of orifice area (OA) than peak left ventricular 
inflow velocity (V max), but this has not been validated 
for bioprostheses. Ve therefore measured V max, T~ and OA 
for 3 unimplanted Carpentier-Edwards valves (model 6650 
sizes 31 and 29 ma, model 6625 size 29ma) and 1 explant 
(model 6625 29=-). Ve used a cODputer-controlled positive 
displacement pulse duplicator with 20 rate/stroke volume 
combinations (diastolic mean flow 3.1-16.9 L/min) , a 
Vingmed SD 50 Doppler ultrasound system and a video 
camera. Both V max and OA were directly proportional to 
rate and stroke volume. T~ however, was independent of 
stroke volume, but directly proportional to diastolic time 
interval (r=0.98). There was no significant difference in 
T~ between any of the valves (F=0.04, p=0.99) and there 
was only a weak negative correlation between T~ and OA 
(r=-0.61). There was however, a strong correlation between 
OA and flow/Vmax (r=0.94). V max in the 2 model 6650 
valves was similar, but in the 6650 was significantly 
lower than the 6625 of the same size <p<O.OOOOl) and in 
all unimplanted valves was lower than in the explant 
<p<0.00001). OA in the 6650-31,.. was greater than in the 
6650-29mm <p<0.0001), in the 6650-29 .. was greater than 
the 6625-29mm <p<O.00001) and in all unimplanted valves 
was greater than the explant <p<O.00001). 
For Carpentier-Edwards mitral prostheses in vitro, T~ 
is dependent on the ventricular filling curve and varies 
with flow. Orifice area is more closely related to 
flow/Vmax than to T~. 
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Coronary Artery Disease: Basic I 
INTRAVASCULAR ULTRASOUND IMAGING CATHETER ASSESSMENT OF 
NORMAL AND ATHEROSCLEROTIC ARTERIAL WALL THICKNESS 
John A. Mallery M.D., James Griffith Ph.D., James 
Gessert, N. Charle Morcos M.D., Ph.D., Jonathan M. Tobis 
M.D., FACC, Walter L. Henry M.D., FACC, University of 
California, Irvine, CA. 
Atherosclerosis is a diffuse disease that produces 
thickening of the vascular wall due to the deposition of 
lipid, fibrous and calcific material. Presently available 
diagnostic methods do not allow this thickening to be 
measured in the coronary arteries except by ultrasound 
imaging during direct exposure at operation. In the 
present study, we evaluated a 1.4mm diameter 
intravascular ultrasound imaging catheter with five 20 
mH~ ultrasound transducers oriented radially at its tip. 
Th1S catheter was designed to allow circumferential 
measurement of vessel diameter and wall thickness during 
routine cardiac catheterization. 'A' mode imaging from 
each transducer was obtained in sequence in normal 
porcine carotid, atheromatous human carotid, and mildly 
atheromatous human carotid and coronary arteries. While 
echos from the luminal surface were highly angle 
dependent, echos returning from within the wall of the 
artery were less so, and therefore, were used for 
measurement. Wall thickness measurements from the 
ultrasound catheter were compared to direct measurement 
by caliper. Altogether 15 different arterial segments 
were evaluated. The R value for linear regression of 
ultrasound vs caliper measurements was 0.97. 
We conclude that a radially oriented,S transducer, 
intravascular ultrasound imaging catheter shows promise 
as a method for accurately measuring normal and diseased 
arterial wall thickness and thereby obtaining a 
cross-sectional perspective of atheromatous involvement 
of the artery wall. 
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3D RECONSTRUCTION OF NATIVE DISEASED HUMAN CORONARY 
ARTERIES AND GRAFTS BY NONINVASIVE RESOLUTION-ENHANCED 
NMR. JD Pearlman MD ME PhD, M Leavitt, G Holmvang MD, HL 
Kantor MD PhD FACC, Mass. General Hosp., Boston, MA. 
3D imaging of coronary artery disease is essential to 
clarify pathogenesis and flow effects. NMR may be used to 
generate 3D images, by 3D encoding methods, which are 
time-consuming, or by reconstruction from parallel multi-
sl ice image planes. We report here the results of the 
latter, using advanced image processing to yield a nomi-
nal final in plane linear resolution of 1 micron based on 
conversion of dynamic range information to edge localiza-
t ion. The method is based on the abil i ty a pri ori to 
dichotomize signal from vessel wall vs lumen. Field of 
view is 21 cm. Human studies were performed prone on a 
surface coil. Initial validation of spatial accuracy was 
performed on 25 tube phanotms down to 0.07 cm in diame-
ter. Correlation with true diameter was r=.99, mean error 
0.00±0.015 cm. The method was applied to 15 patients 
generating 3D images which include stenoses observed at 
angiography, and show correct relation to ostia and 
venous bypass graft insertion. Catheteri zat i on data was 
available in 14 cases, and correlation of the extent of 
mean cross-sectional diameter narrowing with the extent 
of narrowing by angiography was r=.81. 
CONCLUSION: We have obtained 3D reconstructions of native 
coronary arteries, in vivo, by NMR imaging of cardiac 
patients. Comparison of 3D data with tube phantoms demon-
strated transverse spatial accuracy within measurement 
error by micrometry, as the mean linear dimensions in 
each transverse plane. Correl at ion with catheteri zat ion 
data was good, despite the known 1 imitations. Further 
improvement in our 3D NMR coronary artery imagi ng is 
expected by using thinner image planes, presaturation 
optimal timing, and gradient moment nUlling. ' 
PHYCOCYANIN: CYTOTOXIC EFFECTS AND UPTAKE IN HUMAN 
ATHEROSCLEROTIC PLAQUE. 
N. Charle Morcos. M.D .• Ph.D., Michael Berns, Ph.D., and 
Walter L. Henry, M.D., FACC, University of California, 
Irvine, CA. 
Hematoporphyrin derivative (HPD) has been proposed 
for use in photodynamic therapy of atherosclerosis. Phy-
cocyanin (PHYCO) is a phycobiliprotein with many prop-
erties similar to HPD. However, unlike HPD, PHYCO has an 
activation wavelength that is minimally absorbed by 
blood. As a result, we studied its laser activation 
cytotoxic effects and uptake into atherosclerotic pl~que. 
Optimal activation of PHYCO was produced by laser energy 
at 620 and 650nm as evidenced by reduction of optical 
density due to NADPH oxidation in a buffered reaction 
solution containing O.lmg/ml of PHYCO. Cytotoxicity was 
evaluated by measuring viability of mouse myeloma cells 
in culture 72 hours post-treatment. After incubation with 
PHYCO (2.5mg/ml) followed by irradiation with laser 
energy. cell viability was 15% compared to 69 and 71% for 
control cells exposed to laser only or PHYCO only, 
respectively. Uptake into atherosclerotic plaque was 
assessed in atherosclerotic artery segments obtained 
within 5 hours post mortem and perfused with 0.1 mg/ml 
PHYCO in oxygenated Krebs Ringer solution for 5 minutes 
followed by washout with PHYCO-free Krebs for 10 minutes. 
Artery sections examined histologically by fluorescence 
and light microscopy showed specific florescence local-
ization within the plaque particularly at the elastic 
l~minea but not in the medial muscle layer. In conclu-
S10n, phycocyanin is a cytotoxic photosensitizer that 
~xhibits specific binding to atherosclerotic plaque and 
1S activated at a wave lengt~ minimally absorbed by 
blood. These properties suggest potential therapeutic use 
of phycocyanin for plaque regression. 
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ALPHA-ADRENERGIC CORONARY VASOCONSTRICTOR RECEPTOR 
SlBTYPES IN AWAKE DOGS. 
Xue-Zheng Dai, M.D., David D. Laxson, M.D., Paul V. 
Hautamaa, M.D., Jeffrey S. Schwartz, M.D., Robert J. 
Bache, M.D., F.A.C.C. University of Minnesota, 
Mi nneapol is, MN 
Previous studies in open chest dogs have provided evidence 
that adrenergic coronary vasoconstriction is mediat~d 
principally by post junctional a2-adrenoceptors. TIlls 
study examined adrenergic vasoconstriction free from 
effects of general anesthesia and acute surgical trauna in 
6 awake dogs with circunfl ex coronary artery catheters and 
fl o~eters; a-adrenergic blockade was produced with 
propranolol (I mg/kg i.v.). The response of 1 ate d iasto-
lic coronary resistance (LDCR) to equipotent intracoronary 
doses of norepinephrine (NE), phenylephrine {PEl . 
(OJ. -agonist), and BHT 933 (BHT) (a2-agonist) we:e studled 
during basel ine conditions, after aI-blockade Wlth prazo-
~in (PRAZ) and after the addition of a2-blockade with 
i "tracoronary i dazoxan (IDAZ) (1-5 \Ig/kg/min x 10 min) • 
Percent increases in LDCR are shown below: 
CONTROL PRAz PRAz+IDAz 
NE{O.1 \Ig/kg) 45'±12 23±7* 3 ± 2*+ 
PE{3.0 \Ig/kg) 37 ± 9 2 ± 3* 4 ± 2* 
BHT{10 \Ig/kg) 41 ± 11 51 ± 9 -1 ± 1*+ 
* P < 0.05 vs Control; +p < 0.05 vs PRAZ 
These data denonstrate that in the awake dog al- and 
a2-adrenoceptors participate approximately equally in the 
coronary vasoconstrictor response to norepinephrine. 
,. BLOCKADE RBSOL'lS III OECllBASBD CORCIIARY 
BLOOD PL<M DUE 'l'O OIlOPPOSBD eo( DOIADO 
VASOCOIIS2RICTIOII John McB. Hodgson. M.D •• 
~ Mark D. Cohen, M.D., FACC; Marc D. 
Thames, M.D., FACC; McGuire VAMC and Medical 
College of Virginia, Richmond, Virginia. 
We have previously reported decreased resting 
coronary blood flow (CBF) in human denervated 
hearts after nonspecific regional ~ blockade. 
To investigate the mechanism we compared the 
effect of regional nonspecificP blockade 
(propranolol 2mg ic), PI blockade (metoprolol 
3mg ic) and fJ bloc kade preceded by 0\. bloc kade 
with phentolamine 3mg ic. We measured relative 
CBF, mean arterial pressure (MAP) and epicardi-
al artery diameter (DIAM) in 41 cardiac 
transplant recipients (14 + 1 month after 
transplant) using digital angiography. Heart 
rate was controlled by atrial pacing. Coronary 
vascular resistance (CVR) was calculated as 
MAP/CBF. MAP did not change with any drug. Data 
expressed as % change from pre-blockade. 
BLOCKER CBZ DlAM C[B 
/11+2 -12% * +3% * +24% * 
PI -25% * -1% +23% * 
pI +2 POST d:. +3% 0% +2% 
*p<0.05 (paired T test) 
Both nonselective and selective ~l blockade 
reduced resting CBF via an increase in small 
vessel resistance. Pretreatment withe< blockade 
abolished this effect. These data a) support 
the hypothesis that decreased CBF following ~ 
blockade is the result of unopposed ~ mediated 
vasoconstriction; b) suggest important /31 
effects on small arterioles in addition to 
previously described P2 effects. 
ABSTRACTS 23A 
RIGHT VENTRICULAR "STEAL" DURING HYPERPERFUSION 
OF THE LEFT ANTERIOR DESCENDING ARTERY IN SWINE 
Brian D. Guth, Ph.D., Rainer Schulz, Mark 
MIller, ErIk Thaulow, M.D., John Ross, Jr. M.D., 
FACC. Univ of California San Diego 
Transmural "steal" from subendocardium to 
subepicardium has been described during exercise-
induced ischemia in dogs. This phenomenon occurs 
because the subepicardium has greater vasodilator 
reserve than subendocardium (ENDOI. Another 
potential setting for "steal'. is dur~ng 
hypoperfusion of the left anterIor descendIng 
artery (LAD) w\:lich perfuses . both t.he. left 
ventricular anterIor wall and rIght ventrIcular 
outflow tract in swine and human subJects. Seven 
swine were instrumented for measurIng regIonal 
wall thickness and midwall segment length 
(sonomicrometers) and regional blood flow (RBF, 
microspheres). The LAD was cannulated and 
perfused at a constant rate through a pump-
controlled extracorporeal circuit. Dobutamine 
(DOB) infusion into the circuit (4 ug/min) cau~ed 
significant increases in systolic wall th,ckenIng 
(%WT) and segmental shortening (%SI in the 
rerfused region when coronary perfusi~n pressure CAP) was 123+4 (mean+SD) mmHg; regIonal blood low was unchanged. CAP was then reduced to 55±5 
mmHg and the DOB infusion repeated: 
Before DOB After DOB 
%WT 8.0+4.7% -1.3+4.2 
%S 6.7+4.0% -1.7+3.8 
CAP 55+5' 49+7-
LV RBF 0.Z7+.11 0.T7+.07 
RV RBF 0.61+.44 0.74+.49 
CAP, mmHg; RBF, (ml/min)/g; LV RBF=ENDO 
P value 
<0.001 
<0,003 
<0.001 
<0.005 
<0.002 
Thus, DOB infusion under conditions of 
hypoperfusion with ischemia at constant total 
coronary flow caused a reduction of CAP 
associated with increased blood flow to the RV, 
but reduced blood flow to the ENDO of the LV. 
These data indicate that inotropic stimulation of 
the RV can lead to reduced blood flow to the 
ischemic LV thereby constituting RV "steal". 
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Ischemic Indices in Exercise Testing 
SILENT MYOCARDIAL ISCHAEMIA IN DIABETES 
MELLITUS. 
DP Murray M.D., T O'Brien M.R.C.P., DJ O' 
Sullivan M.D. University Dept. of Medicine, 
Cork Regional Hospital Cork, Ireland. 
While painless myocardial infarction is well 
recognized in diabetes mellitus, the incidence 
of silent ischaemia on exercise testing has 
not been studied. Therefore, all exercise 
tests (EXT) performed during during the past 5 
years in a regional hospital were reviewed. 
Of 1653 EXT, 247 were positive - > 0.1 mV ST 
segment depression (STD) at 80 msec from the J 
point on the ECG. The diabetic and 
non-diabetic patients had a similar sex 
distribution and incidence of previous 
myocardial infarction. The diabetics were 
older - 62.8±9.5 Vs 55.3±8.4 years (p<0.001). 
Ninteen (7670) of the 25 patients with diabetes 
who had positive tests had painless STD 
compared to 78 (3570) of the 222 non-diabetics 
(p<0.001). Among the diabetic, those with 
painful and painless STD were matched for age, 
sex, duration of disease and therapy. The 19 
diabetic patients with painless STD did have a 
higher incidence of microvascular disease 
compared to the 6 with angina pectoris 
associated with their STD - 7470 Vs 3370. 
Thus, silent, inducible myocardial ischaemia 
is more common among patients with diabetes 
mellitus compared to the rest of the 
population and is particularly common among 
those with microvascular disease. 
24A ABSTRACTS 
PROGNOSTIC SIGNIFICANCE OF SILENT MYOCARDIAL ISCHEMIA 
DISCOVERED DURING EXERCISE TESTING. 
Peter Callaham. MR.' Paul Dubach, M.D., Jacob Klein, 
M.D., Mona Risch; .A., Victor Froelicher, M.D., 
F.A.C.C., VAMC Long Beach, California. 
Since silent ischemia (SI) is associated with a poor 
prognosis in patients with unstable angina, we 
hypothesized that it should identify high risk in 
patients referred for treadmill testing (TET). 
Therefore, we analyzed the average one year survival of 
patients who underwent initial (TET) from mid 1984 to 
1987. When patients with LBBB LVH with strain and 
digoxin were excluded from anaiysis, 1743 out of 2044 
remained; 68 deaths occurred. The presence or absence 
of angina pectoris (AP) and abnormal ST se&ment 
depression (STd) allows analysis by four d~stinct 
subgroups: AP present with STd (AP+STd), AP present 
without STd (AP only), AP absent with STd (SI), and AP 
absent without STd (no ischemia-NI). Subgroup analyses 
were performed by age groups. 
SI 
Overall Mortality ~% 
age < 50 10% 
age 50-59 6% 
age 60-69 6% 
age> 70 8% 
AP+ST --rr-
14% 
4% 
6% 
14% 
AP 2~l,y 
0% 
1% 
2% 
0% 
NI 
ji 
1% 
5% 
3% 
6% 
TET characteristics were then analyzed for prediction of 
1 year mortality. Death rates were calculated for 
maximal STd, ana time for normalization of STd fOllowing 
exercise (TMNL). Death rates are listed. 
Amount ST Depression 
°3 2mm .znmm 3i~mm >4mm AP+ST '" % %-rbi 
SI 5% 9% 16% 31% 
Patients dying with AP+STd and SI exercised to lower MET 
levels: 4.2 and 5.9 respectively versus 6.4 and 7.4 for 
surviving patients. Thus, SI has a similar overall risk 
of death as angina with ST depression while "angina 
only" indicates lower risk. Marked degrees of STd and 
prolonged TMNL predict decreased 1 year survival in 
patients with STd particularly when it is "silent". 
HEART RATE ADJUSTED INDICES OF ST SEGMENT DEPRESSION 
IDENTIFY CORONARY ARTERY DISEASE IN PATIENTS WITH 
NEGATIVE STANDARD EXERCISE TEST RESPONSES 
Peter M. Okin. M.D., F.A.C.C., Paul Kligfield, M.D., 
F.A.C.C., Olivier Ameisen, M.D., Harvey Goldberg, M.D., 
F.A.C.C., Jeffrey S. Borer, M.D., F.A.C.C. Cornell 
Medical Center, New York, NY. 
To assess the ability of heart rate adjusted indices of 
ST segment depression to improve the detection of 
coronary artery disease (CAD) in patients (pts) with 
negative «0.1 mV ST depression) or equivocal (lO.l mV 
upsloping ST depression) standard exercise tests (-ETTs), 
40 consecutive pts with -ETTs and angiographically 
documented CAD were examined. All pts had typical angina 
and symptom-limited exercise tests. There were 18 pts 
with 1 vessel CAD, 14 with 2 vessel CAD and 8 with 3 
vessel CAD. Two different heart rate adjusted indices of 
ST segment depression were tested (using partition values 
with previously established specificity of 95J in 
clinically normal subjects): the ST/HR slope, calculated 
by linear regression analysis; and the delta ST/HR 
index, a simplification of the ST/HR slope derived by 
dividing maximal additional ST depression by the total 
change in heart rate during exercise. An STIHR slope >2.4 
uV/beat/min identified 85J (34/40) of pts with CAD and 
-ETTs: 78~ (14/18) of pts with 1 vessel CAD, 86~ (12/1,) 
of pts with 2 vessel CAD, and 100J (8/8) of pts with 3 
vessel CAD. A delta ST/HR index >1.6 uV/beat/min 
identified 78J (31/40) of these pts: 78J (14/18) of pts 
with 1 vessel CAD, 79J (11/14) of pts with 2 vessel CAD, 
and 75~ (6/8) of pts w~th 3 vessel CAD (each p=ns vs the 
ST/HR slope). These findings suggest that even simple 
heart rate adjustment of ST segment depression can 
approximate the improved sensitivity of the STIHR slope 
for CAD in patients with -ETTs. 
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HEART RATE ADJUSTMENT OF EXERCISE-INDUCED ST SEGMENT 
DEPRESSION FOR PREDICTING TRIPLE VESSEL AND LEFT MAIN 
CORONARY ARTERY DISEASE: A META-ANALYSIS. 
Renato Gianrossi, M.D., Robert Detrano, M.D., Ph.D., 
Daniel Mulvihill, M.D., Kenneth Lehmann, M.D., F.A.C.C., 
Antonio Colombo, M.D., Victor Froelicher, M.D., F.A.C.C. 
Veterans Administration Medical Center, Long Beach, CA 
To determine the factors independently related to the 
reported accuracy of the exercise electrocardiogram for 
predicting multivessel or critical (triple vessel or left 
main) coronary disease, we applied meta-analysis to 60 
consecutively published reports comparing exercise-
induced ST depression with these coronary angiographic 
findings. Six of these studies involving 600 patients 
used heart rate adjustment while 52 studies involving 
11,130 patients did not. Both technical and methodologic 
factors were analyzed. The mean sensitivities for 
predicting multivessel disease and critical disease were 
91% and 85% respectively for the studies using heart rate 
adjustment, and 76% and 82% for those not using heart 
rate adjustment. The mean specificities, using heart 
rate adjustment, were 89% (multivessel disease) and 98% 
(critical disease); without heart rate a.djustment these 
were 61% (multivessel disease) and 53% (critical diseas~. 
Multivariate analysis found adjustment for heart rate to 
be the only technical factor independently associated 
with specificity for predicting critical disease 
(partial R2 = 0.44, P = .0001). The medical literature 
strongly supports the employment of heart rate adjust-
ment of exercise-induced ST depression for predicting 
very serious coronary atherosclerosis. 
DOES EXERCISE INTENSITY INFLUENCE THE ISCHEMIC THRESHOLD? 
Carol E. Garber, M.A., Lisa S. Warren, M.S., George Hanna, 
M.D., Richard A. Carleton, M.D., F.A.C.C., Gary V. Heller, 
M.D., Memorial Hospital and Brown University, Pawtucket 
and Providence, R.I. 
There is controversy regarding whether the ischemic 
threshold occurs at a fixed blood pressure-heart rate 
produce (PRP). The relationship between the ischemic 
threshold (horizontal ST-segment depression < I.OmV) and 
exercise intensity was studied in 14 male subjects (6 
symptomatic, 8 asymptomatic) with myocardial ischemia 
documented by exercise-induced reversible thallium 
defects. Two exercise tests were completed: Bruce 
protocol to fatigue and 20 minute submaximal steady state 
at 70% of the peak heart rate attained during the Bruce. 
Oxygen uptake (VOZ) and PRP were measured at the time of the ischemic threshold. 
SYMPTOMATIC TIME (MIN) 
Bruce 6 ± 3 
Submaximal 8 ± 4* 
ASYMPTOMATIC 
Bruce 8 ± 3 
Submaximal 11 ± 6* 
*p <0.05 compared to Bruce 
PRP(10') 
21 ± 9 
16 ± 5* 
21 ± 9 
15 ± 4* 
VOz 
20.6 ± 
13.3 ± 
6.4 
1.3* 
25.2 ± 9.9 
20.0 ± 7.6* 
Ischemic ECG changes occurred at a significantly lower 
PRP and VOZ during the submaximal steady state exercise 
than during the Bruce protocol in both symptomatic and 
asymptomatic subjects. 
Conclusion: The ischemic threshold occurs at a different 
PRP depending upon exercise intensity and duration. 
These differences reflect oxygen uptake and are similar 
in symptomatic and asymptomatic patients. 
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WHAT ARE THE CLINICAL IMPLICATIONS OF PSEUDO-
NORMALIZATION OF THE T WAVES DURING ERGOMETRIC STUDIES? 
:I,a.nv.ir -,,!.ajw~.~_M.O .• Donald H. Schmidt, M.D., and Andrew 
J. Feiring, M.D., F.A.C.C. Univ. of Wisconsin. Mt. 
Sinai Medical Center, Milwaukee, WI. 
The clinical implications of exercise related Pseudo-
normalization of T waves (PSNT) is controversial. To 
investigate this issue, we retrospectively analyzed 600 
consecutive graded exercise stress (GXT) thallium (TL) 
over I year period. A total of 49 pts. (8%) had PSNT 
defined as T wave inversion in at least 2 leads other 
than leads III AVR VI which became upright (~2.5mm) 
above the baseline. Pts. were classified into 3 
groups. Group A: pts. with history of documented 
myocardial infarction (MI) but no angina (N=25). Group 
B: pts. with angina but without prior MI (N=8). Group 
C: pts. evaluated because of resting ECG changes and 
positive risk factors without angina or MI (N=16). 
Results: Of the 25 pts. in Group A, all had positive TL 
studies of which 14 had evidence of reversible ischemia 
(56%) and II had fixed TL deficits (44%). In Group 8, 
75% (N=6) had evidence of reversible ischemia and 2 had 
normal studies. In Group C, all pts. had a negative 
TL. This group was comprised primarily of hypertensive 
black females (81%). 
Conclusion: In 56% of patients with prior MI, PSNT is 
associated with reversible ischemia. In pts. with 
angina and PSNT, 75% had reversible ischemia. Pts. 
without overt angina (subgroup of hypertensive black 
females) PSNT is a nonspecific finding. Contrary to 
previous beliefs, PSNT is a marker of reversible 
ischemia in a significant proportion of patients with 
angina. 
Monday, March 28, 1988 
2:00PM-3:30PM, Room 367, Level Three 
Myocardial Infarction-Clinical: PrognosislDiagnosis 
EARLY POST-INFARCTION ANGINA IS A PREDICTOR OF POOR 
LONG-TERM PROGNOSIS AFTER ACUTE NON-Q WAVE MYOCARDIAL 
INFARCTION: THE DILTIAZEM REINFARCTION STUDY 
William E. Boden, MD, FACC, Robert S. Gibson, MD, Robert 
J. Capone: MD, FACC:-Kenneth B. Schechtman. PhD, Robert 
Roberts, MD, FACC, and the Diltiazem Reinfarction Study 
(DRS) Research Group; Harper Hospital and Wayne State 
University, Detroit. Michigan. 
The multicenter DRS has shown previously that non-Q wave 
(NQ) myocardial infarction (MI) pts with early 
post-infarction angina (PIA);, 24 hr after NQMI are at 
increased risk of reinfarction and death within 14 days. 
and that PIA associated with ischemic ECG changes (fJ.) 
identified a particularly high risk subset. To determine 
whether PIA prior to hospital discharge also predicts 
poor long-term outcome. we prospectively assessed the 
incidence of death. late reinfarction, myocardial 
revascularization (CABG/PTCA), readmissions for chest 
pain, or a combination of any cardiac event (ACE) during 
a 1 yr followup of DRS pts who exhibited PIA after NQMI 
(n=246) compared to pts without PIA (n=330). Overall at 
1 yr. 74/576 pts died (13%). As a group. pts with early 
PIA had higher 1 yr event rates for death (20% vs. 11%, 
p=0.04), CABG/PTCA (51% vs. 36%, p=O.OOOI), and ACE (57% 
vs. 39%, p=0.0002) compared to pts without PIA. Of note, 
when 115 pts with PIA + ischemic ECG fJ. s were compared to 
461 pts without PIA + ECG fJ. s, there was a higher 
comparative event rate for 1 yr death (20% vs 9%. 
p=O.OOOI). late reinfarction (27% vs. 18%, p=0.023), 
CABG/PTCA (25% vs. 13%, p=O.OOOI), and ACE (33% vs. 16%, 
p=O.OOOI). CONCLUSION: Pts with acute NQMI and early 
recurrent ischemia during hospitalization represent a 
high-risk subset with poor 1 yr prognosis and subsequent 
high cardiac event rate. Such NQMI pts may warrant more 
intensive diagnostic evaluation and therapeutic 
intervention prior to hospital discharge. 
ABSTRACTS 25A 
ONE YEAR FOLLOW-UP AFTER ACUTE NON Q-WAVE MYOCARDIAL 
INFARCTION: THE DILTIAZEM REINFARCTION STUDY (DRS) 
Kenneth B. Schechtman, Ph.D., Robert J. Capone, MD, FACC, 
Robert E. Kleiger, MD, FACC, William E. Boden, MD, FACC, 
David J. Schwartz, MD, FACC, Robert S. Gibson, MD, FACC, 
Robert Roberts, MD, FACC, and the DRS Research Group, 
Biostatistics at Washington University, St. Louis, MO. 
Follow-up on 515 patients (P) with MBCK confirmed acute 
non Q-wave Myocardial Infarct (NqMI) were analyzed for 
factors related to one year mortality (M, N-57) and 
reinfarction (R, N-64). Factors related to M by 
univariate analysis were older age (p-.OOOl), ST + 
(p·.0269, 43% vs 28%) and ST + (p .0001, 54% vs 27%) on 
discharge ECG, localizability (p-.0456, 89% vs 79%), 
Killip class 1 (K, p-.0002, 8% vs 21%), in hospital angina 
associated with ECG changes (p-.0176, 28% vs 16%), LVR 
(p-.0435, 33% vs 22%), in hospital extension of infarct 
(EXT, p-.0303, 12% vs 6%) and previous MI (PMI, p-.Ol04, 
57% vs 40%). Factors related to R were older age 
(p-.0047), ST -I- (p-.0002, 49% vs 27%) K (p <.0001, 10% vs 
24%), LVR (p-.0050, 37% vs 21%) and PMI (p-.0255, 57% vs 
40%). Cox regression found that age (p-.0035), ST + 
(p-.0133), EXT (p-.0288) and ST t(p-.0535), were 
independent predictors of M while ST -I-(p-.0054) K 
(p-.0126) and LVR (p-.0426) predicted R independently. 
Among P of mean age (61 + 10) relative risks (RR) of M 
comparing P with unfavorable status on one or more of EXT, 
ST +, ST t and K to those with favorable status on these 
factors were: EXT (2.28), ST -I- (2.18), ST t (1.76), I{ 
(1.65), ST ++ K (3.63), ST -1-+ ST t (3.56), ST t+ K (2.90) 
and ST + + ST t + K (6.36). RR of age 70 compared to age 50 
was 2.40. The higher RR for ST + as compared to ST t and 
the marginal significance of ST t suggest that ST + is the 
more important predictor of M. We conclude also that 
simply obtained clinical and demographic variables can 
stratify NQMI P to risk of M or R. 
SILENT LEFT VENTRICULAR DYSFUNCTION DURING AMBULATORY 
RADIONUCLIDE MONITORING FOLLOWING THROMBOLYSIS: A 
POTENTIAL PREDICTOR OF SUBSEQUENT CARDIAC MORBIDITY 
David S. Kayden, M.D., Frans J. Wackers, M.D., F.A.C.C., 
Charles K. Francis, M.D., F.A.C.C., Barry L. Zaret, M.D., 
F.A.C.C., Yale Univ and TIMI, New Haven, CT. 
Both clinical angina and silent ischemia are associated 
with a poor prognosis in unstable coronary syndromes. No 
data are available concerning silent ischemia following 
thrombolysis for infarction (MI). Furthermore, left 
ventricular dysfunction (LV Dys) is believed to be a more 
sensitive marker of ischemia than either symptoms or EeG. 
Consequently, we evaluated 21 TIMI patients treated with 
rt-PA for MI (10 pts also received angioplasty) with a new 
technique for continuous ambulatory radionuclide LV 
function monitoring (VEST) and ECG. Following eguilibrium 
radionuclide ventriculography (RVG) at the time of 
hospital discharge, pts were monitored with the VEST for 
an average of 185 mins (range 64-262 mins) during 
ambulatory hospital activity. In contrast to normals, 9/21 
pts had transient LV Dys (fall in LV ejection fraction >5% 
lasting >1 min); only 1 pt had angina and 2 pts had EeG 
changes during the monitoring period. At a follow-up of 
19±9 weeks, cardiac events (unstable angina, MI, urgent 
coronary surgery) occurred in 6 of these 9 pts and in only 
1 of 12 pts without VEST transient LV Dys (p <.02). 
Submaxima1 supine bicycle exercise RVG was performed in 
20/21 pts. Whereas transient VEST LV Dys occurred in 9 
pts, a fall in LV ejection fraction >5% during exercise 
RVG was se.en in only 4 pts. -
Thus, in this series of thrombolysis pts, transient LV 
Dys in the absence of symptoms or EeG changes was detected 
during normal activity, and occurred more often than with 
exercise. LV Dys detected during normal activity was 
associated with future cardiac events and therefore has 
potential for risk stratification of thrombolysis pts. 
26A ABSTRACTS 
WHAT IS THE BEST PREDICTOR OF SUDDEN DEATH FOllOWING 
MYOCARDIAL INFARCTION? 
David Richards, M.D., F .A.C.C., David Ross, M.B., 
r.A.C.C., Msrk Cooper, F.R.A.C.P., Michael Skinner, 
F.R.A.C.P. and John Uther, F.R.A.C.P. Westmead Hospital, 
Westmead, NSW, Australia. 
This study examined in a single cohort of myocardial 
infarction patients the predictive values of inducible 
ventricular tachycardia (rate <260 per minute inducible 
at programmed ventricular stimulation), delayed 
potentials (ventricular activation time > 120 ms on 
signal averaged ECG), high grade ventricular ectopy 
(lown grade 4-5), low ejection fraction (lVEF < 0.40) and 
positive exercise test (ST segment displacement) 2 mm). 
Between January 1985 and February 1987 361 patienta aged 
<71 years were studied 6-28 days after myocardial 
infarction and then followed for 1 year. End points were 
sudden death (witnessed instantaneous death) and 
spontaneous VT. 
Probability of audden death or spontaneous VT 
Inducible VT 2611; vs III; (p < 0.0001) 
Delayed potentials 2011; vs 711; (p < 0.01) 
lown Grade 4-5 711; vs 311; (p < 0.01) 
lVEF < 0.40 lU vs U (p < 0.0001) 
Positive exercise test III; vs Oil; (p = NS) 
At multiple logistic regression, inducible VT was the 
best predictor of outcome (p < 0.10). After allowing for 
inducible VT, none of the other testa provided any 
additional significant predictive information. We 
conclude that inducible VT is the best predictor of 
sudden death following myocardial infarction. 
PROGNOSIS OF VENTRICULAR FIBRILLATION 
COMPLICATING ACUTE MYOCARDIAL INFARCTION. 
Ronald WF Campbell MB, Suda Tansuphaswadiku1 
MD, J Campbell Cowan D.Phi1,MB, Judy M simpson 
Ph.D., John P Bourke MB, and Yau-Ting Tai MB. 
Freeman Hospital, Newcastle upon Tyne, U.K. 
The clinical features prior to VF which 
contribute to prognosis were studied in 166 pts 
with VF complicating AMI, of whom 142 (86%) 
were resuscitated and 93 (56%) survived to 
discharge. Follow up was continued up to 5yrs. 
Hospital SUrvival: Heart failure prior to VF 
was the major predictor of resuscitation and 
hospital survival - Ki11ip 1/11, 98% 
resuscitated, 81% discharged; Ki11ip III/IV, 
66% resuscitated, 14% discharged (p<0.0001). 
Other factors significantly associated with 
hospital survival after resuscitation were VF 
recurrence, previous MI, age and angina. 
Long Term SUrvival: Time of VF from onset of 
acute MI (T-VF) was the major determinant of 
post discharge survival. VF in the first 6 
hours of AMI carried the most favorable long 
term prognosis. 
---% survival Post Discharge---
n 6mths 1yr 2yrs 3yrs 5yrs 
T-VF ~ 6h 45 98 93 93 91 85)* 
T-VF 6-48h 43 91 84 74 70 67 
Anterior MI 49 92 86 82 80 77)ns 
Inferior MI 41 95 88 83 80 75 
(ns=nonsignificant; *p=0.03 Logrank test) 
Conclusions: 1) Pre VF heart failure was the 
major predictor of hospital survival. 2) T-VF 
is important for late prognosis. 3) Long term 
prognosis is independent of infarct site. 
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RAPID DIAGNOSIS BY ANALYSIS OF PLASMA MM 
CREATINE KINASE ISOFORMS IN PATIENTS WITH 
SUSPECfED ACUTE MYOCARDIAL INFARCTION. 
Allan S. Jaffe. M.D .. F.A.C.C .. Lynne M. Seacord, M.D., Ryuji 
Nohara, M.D., Burton E. Sobel, M.D., F.A.C.C., Dana R. 
Abendschein, Ph.D., Washington University, St. Louis, Missouri. 
Low levels of MM 3, the tissue isoform of MM creatine kinase (CK) 
are maintained in plasma by conversion to MM 2 and MM 1 (the 
final conversion product). Increases of MM 3 in plasma occur 
rapidly after myocardial injury and alter the ratio of MM 3/MM 1, 
pemritting early detection of myocardial infarction prior to elevations 
of total and MBCK. Recently, we have developed a rapid method 
(30 minutes or less) for quantification of isoforms with 
chromatofocusing and on-line analysis of enzyme activity to facilitate 
rapid diagnosis. To detemrine whether isoform analysis with this 
system prospectively separates patients with and without infarction, 
we analysed the initial plasma samples from 36 consecutive patients 
with acute myocardial infarction and 28 patients with chest pain in 
whom infarction was ultimately excluded. The mean ratio of MM 
3/MM 1 was 0.6 ± 0.2 (SE) in controls; in only 2 controls did the 
ratio exceed 1. In contrast, the mean ratio of MM 3/MM 1 in 
patients with infarction was 3.6 ± 0.9 (p<.OO5 compared with 
controls). Twenty-four of the thirty-six had a ratio> 1. Among the 
others, 9 presented late after the onset of infarction (mean time after 
symptoms to presentation = 15.5 ± 2.4 hr), at a time when 
conversion of MM 3 to MM 1 had already occurred, depressing the 
ratio of MM 3/MM 1. Each of the 9 had elevated MBCK (mean = 
47 ± 15 lUlL). The remaining 3 patients with infarction and a 
normal MBCK but MM 3/MM 1 < 1 had recurrent injury and a prior 
recent infarction which had caused the accumulation of MM 1 and 
blunted the rise in the ratio of MM 3/MM 1. Thus, criteria based on 
analysis of MM creatine kinase isoforms in the initial plasma 
samples of patients who present with chest pain relatively early after 
the onset of symptoms are highly sensitive and specific. 
Monday, March 28, 1988 
4:00PM-5:30PM, Room 367, Level Three 
Myocardial Infarclion-Clinical: TherapylDiurnal Changes 
PREVENTION OF LEFT VENTRICULAR MURAL THROMBOSIS IN ACUTE 
MYOCARDIAL INFARCTION: A DOUBLE-BLIND TRIAL COMPARING 
HIGH DOSE WITH LOW DOSE SUBCUTANEOUS CALCIUM HEPARIN. 
Alexander G.G. Turpie, M.D., John Robinson, M.D.,F.A.C.C., 
Amin S. Mulji, M.D., Gregory J. Mishkel, M.D., Brian J. 
Sealey, M.D., Daniel J. Doyle, M.D., John A. Cairns, M.D., 
F.A.C.C., Jack Hirsh, M.D., and Michael Gent, M.Sc., 
McMaster University, Hami1ton, Ontario, Canada. 
Retrospective and post-mortem studies suggest that anti-
coagulants reduce the incidence of systemic embolism (S£) 
in acute myocardial infarction (AMI), but the real benefit 
remains in doubt. Since left ventricular mural thrombosis 
(MT) is the likely source of SE in AMI, we carried out a 
double-blind randomized trial comparing high dose (HD; 
12,500 units q12h) with low dose (LD; 5,000 units q12h) 
subcutaneous calcium heparin in the prevention of MT in 
patients with anterior transmural AMI. Two hundred 
patients were randomized within 36 hours of pain onset to 
HD or LD regimens continued for 10 days. The principal 
outcome measure was the detection of MT by 2-D echo at day 
10, read by three independent investigators blinded to 
treatment allocation. Thirty-three patients did not have 
day 10 2-D echos (15 HD, 18 LD); 24 died prior to day 10 
(11 HD, 13 LD), 4 refused, 2 were too ill and 3 for techn-
ical reasons. MT was detected in 8 of 87 (9.2%) of the HD 
group and 25 of 80 (31.3%) of the LD group (peo.OO). SE 
occurred in 1 HD (cerebral) and~) LD (2 cerebral, I mesen-
teric) patients; 1 LD patient had a fatal pulmonary 
embolism. Minor hemorrhage occurred in 3 HD and 1 LD 
patients. The activated partial thrombop1astin times and 
plasma heparin concentrations (batch processed but not 
reported) in the HD group were 50 - 70 seconds and 0.2 -
0.) units/mI., and the LD group were <:40 seconds and <0.05 
units/ml respectively. This study indicates that fixed 
therapeutic-dose calcium heparin is effective in preven-
ting mural thrombosis in patients with AMI. 
JACC Vol. 11, No.2 
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LONG-TERM EFFECT OF DILTIAZEM ON MORTALITY AND 
REINFARCTION AFTER MYOCARDIAL INFARCTION (MI)-
THE MOPIT STUDY. Arthur J. Moss, M.D., F.A.C.C. 
and the Multicenter Diltiazem Post infarction 
Research Group, Univ. of Rochester Med Cntr. , 
Rochester, NY, and Participating Institutions. 
The safety and efficacy of diltiazem (D) admin-
istration was investigated in a randomized, 
double-blind study of 2,466 post-MI patients 
(pts) from 38 hospitals in U.S. and Canada. 
Within 15 days of enzyme-confirmed MI, pts were 
randomized to D, 240 mg/dy, or placebo (P), and 
followed 12-52 mos. Primary end points were 
total mortality (M) and first cardiac event 
(CE) (cardiac death or non-fatal MI). D and P 
groups were equivalent in baseline characteris-
tics, compliance, and non-study interventions. 
Cumulative life-table M and total M (167 vs 
166) were nearly identical in P and D groups. 
CE (221 vs 201) were 10% lower in D group; Cox 
hazard ratio (CHR)=0.91, NS. Analyses, speci-
fied prior to unblinding, revealed bidirect-
ional interaction between D and pulmonary con-
gestion (PC) on X-ray (p=0.0017, two-tailed). 
In 1909 pts (80%) without PC, D was associated 
with significantly reduced CE (CHR=0.77, 90% CI 
0.63-0.94); in 490 pts (20%) with PC, D was 
associated with increased CE (CHR=1.49, 90% CI 
1.12-1.98). Similar bidirectional interaction 
was observed with ejection fraction. Thus, D 
exerted no overall effect on M or CE in post-MI 
pts; this appears to reflect a balance between 
D-related reduction of CE in 80% of pts without 
LV dysfunction and D-related increase in CE in 
20% of pts'with LV dysfunction. 
EARLY HOSPITAL DISCHARGE 3 DAYS AFTER MYOCARDIAL INFARCTION: 
A RANDOMIZED, CONTROLLED CLINICAL TRIAL IN THE ERA OF 
REPERFUSION. 
Eric J. Topol MD FACC, Karen furek RN, William W. O'Neill 
MD, Michael J. Shea MD, Jennifer Kirscht MPH, M. Anthony 
Schork MPH, Jack E. Juni MD, Bertran Pitt HD FACC, Univer-
sity of Michigan Medical Center, Ann Arbor, MI. 
To evaluate the safety, efficacy and cost-saving poten-
tial of a new discharge strategy after myocardial infarction 
(HI), 507 pts presenting to our center from 5/86-7187 were 
prospectively categorized as complicated (n=318, 63%) or 
uncomplicated CUNC, free of angina, heart failure or 
arrhythmias, n=189, 37%). Of lINC pts, 132 performed exercise 
treadmill testing with tomographic thallium (ExTh) at 3 days 
with a negative result in 93 (65%), positive in 35 (32%), 
and equivocal in 4 (3%). UNC pts with a negative ExTh were 
eligible for randomization to EARLY (3 days post-HIl or 
conventional ("LATE" 7-10 days) discharge. Of 93 random-
izable pts, 80 oonsented; there were no Significant differ-
ences in age, sex, location of MI, exercise workload 
aChieved or type of reperfusion therapy between the 2 
groups. At 7-10 days, none of the 40 EARLY pts had angina, 
readmission or re-HI but 2 of 40 LATE pts had re-HI. At a 
mean 7 month follow-up, negative clinical outcomes for the 
EARLY and LATE groups, respectively, are: Death 0,0; 
Readmission 13,13; Recurrent HI 0,5; Angina 3,8 (p=ns). 2D 
echo at 6 me has not demonstrated new LV aneurysm in any 
randomized pt. The cumulative hospital and professional 
charges are: EARLY $12,724 + 2,842 vs. LATE $17,799 + 3,421 
(p(O.OOO1). - -
In conclusion, compared with conventional discharge 
timing, early discharge in selected patients is feasible, 
not associated with an increased rate of adverse clinical 
outcomes, and resulted in a substantial reduction of 
Cumulative charges. 
ABSTRACTS 27A 
LACK OF DIURNAL VARIATION IN THE OCCURRENCE OF NON-Q-WAVE 
MYOCARDIAL INFARCTION: RESULTS OF A PROSPECTIVE STUDY. 
Neal Kleiman, MD, Dennis Goodman, MD, Kenneth Schechtman, 
PhD, Robert Roberts, MD, FACC, for the Diltiazem Rein-
farction Study, Baylor College of Medicine, Houston, Tx. 
Major differences exist between Q-wave (QWI) and non-Q-
wave infarction (NQWI) , notedly that 85-90% of the pts 
with QWI have an occluding coronary thrombus whereas only 
20-30% of pts with NQWI have complete occlusion suggest-
ing early spontaneous reperfusion occurs. Pts with QWI 
exhibit diurnal rhythm occurring predominantly in the 
early AM associated with increased fibrinogen levels and 
platelet aggregability. Thus, we analyzed the results of 
the Diltiazem Reinfarction Study, a multicenter prospec-
tive double-blind study of pts with NQWI. Of the 576 pts, 
32 developed QWI and were excluded. Of the remaining 544, 
data is available for 540. Distribution by time of pre-
sentation with index infarction for all pts (N=540) and 
those not receiving S-blockers (N=397) is as follows 
(M=midnight; N=number of pts; %=% of pts): 
M-2A 2-4 4-6 6-8 8-10 10-Noon-2 2-4 4-6 6-8 8-10 10-M 
All Patlents 
N 26 50 36 36 50 44 58 48 45 55 43 49 
% 4.8 9.3 6.7 6.7 9.3 8.1 10.7 8.9 8.3 10.28.0 9.1 
Patients Not on S-blockers 
N 19 37 26 26 39 33 41 35 32 40 33 36 
% 4.8 9.3 6.5 6.5 9.8 8.3 10.3 8.88.1 10.1 8.3 9.1 
The onset of NQWI does not exhibit even a tendency for a 
diurnal rhythm and may imply a difference in the initia-
ting factors of thrombosis and infarction. Thus, compari-
son of an analysis of the clotting cascade in the two 
groups of patients (QWI and NQWI) may help to elucidate 
the factors initiating coronary thrombosis and determine 
why the thrombotic occlusion is nonsustained in patients 
with non-Q-wave infarction. 
CIRCADIAN FLUCTUATIONS IN ENDOTHELIUM-DERIVED 
FIBRINOLYTIC FACTORS IN RELATION TO THE TIME OF ONSET OF 
MYOCARDIAL INFARCTION AND SUDDEN CARDIAC DEATH. 
Felicita Andreotti MD, Mohamed I Khan MBFC, Anton deBart 
BSc, David Hackett MRCP, Graham J Davies MRCP, Attilio 
Maseri FACC, Cornelis Kluft PhD. Hammersmith Hospital, 
London, UK and Gaubius Institute TNO, Leiden, NL. 
The circadian frequency of onset of myocardial 
infarction and sudden cardiac death is highest in the 
morning. To investigate the possible relation between 
this circadian pattern and variations in endothelium-
derived fibrinolytic factors, we measured the plasma 
activities of tissue plasminogen activator (tPA,mIU/ml) 
and its fast inhibitor (PAI,% pooled plasma) by chromo-
genic assays and the total plasma amounts of tPA (tPA-Ag, 
ng/ml) by enzyme immunoassay from 3-hrly venous samples 
in 6 healthy volunteers over a typical 24hr period. All 3 
of these measurements fluctuated over the 24hrs. T"owest 
PAl actiVity was recorded at 6pm (13+4(SEM» whereas the 
peak occurred at 3am (172+28, p<0.002, paired t test). 
TPA activity showed an inverse pattern, with peak at 6pm 
(779+162) and trough at 3am (4.8+3, p<0.005). Highest 
tPA-Ag was recorded at 9am (7.1+5) whereas the trough 
occurred at midnight (4.3+7, p=0 :008). Although peak to 
trough changes showed -considerable interindividual 
variation (range 115-274 for PAl, 260-1330 for tPA and 
2.4 to 5.5 for tPA-Ag), the timing of peaks and troughs 
was consistent among individuals (SD=1hr, best fit 
curve) • 
These data suggest that 1) endothelial release of 
fibrinolytic factors follows a circadian rhythm; 2) tPA 
acti vi ty shows a closer, but inverse, relationship with 
PAl activity than with tPA-Ag; 3) lowest fibrinolysis at 
3am may contribute to the higher morning incidence of 
thrombotic cardiac events. 
28A ABSTRACTS 
INCREASED RISK OF MYOCARDIAL INFARCTION IN THE MORNING. 
Stefan N. Hilli ch. MD, Thomas L1 nderer, MD, Karl Heg-
scheider, PhD, Rolf Schroder, MD, FACC, ISAM Study 
Group, Kllnlkum Steglltz, Free University of Berlin, FRG. 
The Incidence of myocardial Infarction (MI) has recently 
been reported to exhibit a biphasic circadian variation. 
Therefore, the time of acute MI was determined In all 
1741 ISAM pts based on onset of clinical symptoms and 
evaluation of plasma CK-MB enzyme time-activity curves. 
LVEF and a dyssynergy I ndex were determi ned by angio-
graphy 4 wks after MI. The incidence of MI was increased 
between 6 AM and noon (pe001, chl2) compared to other 
times of day. MI occurred 4 times more frequently 
between 8 and 9 AM than between midnight and 1 AM: 
t~1111111111111111111111111 
, I r i ;0 1~ ; ~ r ~ ;0 
AM Time of day PM 
Time of MI based on clinical and enzymatic methods cor-
related well (r •• 95). Pts (groups of equal size) wlth 
higher or lower LVEF and dyssynergy index demonstrated a 
similar circadian pattern, suggesting that the morning 
Is a risk period for pts with mild as well as severe CAD. 
Concl usi ons: 1. The rl sk of MI I s markedly increased 
from 6 to 12 AM. 2. There does not seem to be the 
previously described secondary MI peak in the evening. 
3. Further investigation of physiologic changes 
occurri ng duri ng the morni ng may 1 ead to better 
understanding and Improved prevention of MI. 
Monday, March 28, 1988 
2:00PM-3:30PM, Room 364, Level Three 
Pediatric Hemodynamic and Interventional Studies 
CAVEATS OF BALLOON DILATION OF CONDUITS AND GRAFTS 
Gregory EnSing, M.D., Donald J. Hagler, M.D., F.A.C.C., 
James B. Seward, M.D., F.A.C.C., Douglas D. Mair, M.D., 
F.A.C.C., Mayo Clinic, Rochester, MN. 
Balloon dilation is the therapy of choice for pulmonary 
valve stenosis. Prosthetic RV to PA conduits progres-
sively calcify and obstruct. Replacement entails surgical 
risk and hospitalization. Balloon dilation may help to 
delay or avoid surgery. 
We reviewed results and complications of percutaneous 
balloon dilation of 10 stenotic RV-PA prosthetic conduits 
and one obstructed RA-LPA Dacron graft (modified Fontan). 
F?r 1~ patient~ (14.5~5* yrs) with,RV-PA conduits, pre 
dllatlon condUlt valve gradient was 57+22*mm Hg. RV 
s~stolic pressure (RVP) was 106~21*mm Hg and RV-PA gra-
dlent was 74+23 mm Hg*. Two pts had additional RPA and 
LPA stenosis-requiring dilation. 
Dilation utilized single (8 pts) or dual (2 pts) balloon 
technique with total balloon area equal to conduit valve 
area! 10%, inflation to 3.2-15 atm, and 2-8 inflations 
per pt. In one patient, the balloon could not be advanced 
across the conduit valve. 
Conduit valve gradient decreased by 59%+15%*, RV-PA gra-
dient by 45+22%* and RVP by 32+11%*. Seven pts had post 
dilation RVP less than 65% systemic though none were less 
than 40%. Surgery was avoided or postponed in 8 of 11 pts. 
Complications included unaccounted balloon fragment 
after rupture during unsuccessful dilation of the RA-LPA 
graft and circumferential balloon rupture requiring 
catheter retrieval of distal balloon from femoral vein 
after successful dilation of the RV-PA conduit. 
We conclude that conduit valve dilation may provide 
reduction but rarely elimination of conduit obstruction. 
Balloon rupture may occur and can result in fragment loss 
or embolization. *=Mean+1SD. 
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PRE- AND POSTOPERATIVE COIL EMBOLIZATION OF AORTOPULMO-
NARY AND ARTERIOVENOUS COLLATERALS AND SHUNTS. 
Wolfgang Radtke, MD, Stanton B. Perry, MD, Kenneth E. 
Fellows, MD, John F. Keane, MD, James E. Lock, MD, FACC, 
Dept. of Cardiology, The Children's Hospital, Boston, MA 
Between 1/84 and 9/87 we attempted coil embolization of 
79 vessels in 65 catheter procedures (50 patients aged 15 
days to 36 years, median 3 yrs 9 mos). 27 procedures pre-
ceeded and 38 followed corrective surgery. Underlying 
lesions were various forms of pulmonary atresia (39 pts), 
sIp Fontan operation, Scimitar anomaly and hepatic hem-
angioma. We embolized 53 aortopulmonary collaterals, 
15 Blalock-Taussig shunts, 9 hepatic vessels and 2 left 
venae cavae with 1 - 6 Gianturco coils per vessel. 
Additional Gelfoam was used in 3 vessels and the double 
umbrella Rashkind occluder was added in 2 vessels. 
Complete occlusion was achieved in 60/79 (76%) vessels, 
subtotal to partial occlusion in 17/79 (22%) and no 
occlusion in 1/79 (1%) 30 min after embolization. One 
attempt of coil placement failed in the first procedure, 
but was successful at a later catheterization. Shunt 
estimation was available before and after 19 of 65 pro-
cedures showing shunt decrease in 17. The Qp/Qs ratio 
dropped by a mean of 25 ±17 % (±SD). Arterial OL satura-
tions before and after coil embolization were available 
in 18/26 cyanotic patients with a decrease found in all 
of them. The mean absolute decrease was 5.2 ±4.0 % (1-15%). 
Inadvertent embolization to a peripheral pulmonary artery 
occurred in 4 procedures (asymptomatic, 1 transcatheter 
retrieval), coil dislodgement in 1 and severe hemolysis 
after 1 procedure. Late recanalization was found in two 
patients. 
We conclude that Gianturco coil embolization is a safe 
and effective treatment for aortopulmonary col laterals 
and shunts pre- and postoperatively. 
HEMODYNAMIC EFFECTS OF CAPTOPRIL IN CHILDREN 
WITH CONGESTIVE OR RESTRICTIVE CARDIOMYOPATHY. 
A Resaj Benillr. M D, Robert H. Beekman, M.D., F.A.C.C., Albert 
P. Rocchini, M.D., Dennis C. Crowley, M.D., Gerald A. Serwer, 
M.D., F.A.C.C., Macdonald Dick, M.D., F.A.C.C., A. Rebecca Snider, 
M.D., F.A.C.C., Amnon Rosenthal, M.D., F.A.C.C., C.S. Mott 
Children's Hospital, University of Michigan, Ann Arbor. 
The acute hemodynamic effects of captopril were evaluated 
at cardiac catheterization in 13 children (ages 0.3-16.5 years) 
with cardiomyopathy (CM, 10 congestive and 3 restrictive). 
Before, 30 and 60 minutes after oral captopril (0.5 mg/kg), 
pressures in the aorta (Ao), pulmonary artery (PA), right 
atrium (RA) and pulmonary capillary wedge (PCW), 02 
saturations in the Ao and PA, and thermodilution cardiac 
outputs were obtained. Data at 30 and 60 minutes were not 
significantly different and are therefore averaged. In 
children with congestive CM, cardiac output (CO) increased 23% 
from 2.27±.0.21 to 2.79±.0.25 I/min/m2 (p = 0.006, mean ±. SEM), 
and stroke volume increased 20% from 22.6+ 1.8 to 28.0+2.0 
ml/m2 (p = 0.004). Systemic resistance (R;) decreased from 
33.5 ±.3.4 to 22.5±.2.4 units/m2 (p = 0.006), while Ao mean 
pressure decreased 5% from 75.7±.4.3 to 72.1±.4.4 mmHg (p = 
0.02). There was no change in heart rate, PA, PCW or RA 
pressures after captopril. In contrast, children with 
restrictive CM had no improvement in CO with captopril 
(2.85±.0.63 to 2.87±.0.S9 I/min/m2, p = 0.87), but Ao mean 
pressure dropped 29% from 82.3±.7.9 to 58.3±.4.1 mmHg (p = 0.01 
compared to congestive group). Thus, in children with 
congestive CM captopril acutely decreased Rs and increased CO 
and stroke volume without affecting filling pressures. In 
children with restrictive CM, however, captopril did not affect 
CO but decreased Ao pressure eltCessively. These data suggest 
that captopril may benefit children with congestive CM, but 
should be used with caution in children with restrictive 
disease. 
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CATHETER ASSESSMENT OF LEFT VENTRICULAR FUNCTION AFTER 
ARTERIAL SWITCH OPERATION AT REST AND AFTERLOAD STRESS: 
M: Vogel MD, LN Benson MD, JF Smallhorn MD, GA Trusler MD 
RM Freedom MD Hospital for Sick Children Toronto CDN 
The theoretical advantage of anatomic versus atrial cor-
rection of transposition of the great arteries is the use 
of LV as systemic ventricle. However LV function under 
stress has rarely been assessed after arterial switch. 
We examined LV function at rest and after Methoxamine in-
duced afterload stress in 10 Pts I.S(.3-3.8)years after 
arterial switch performed at age 1.8(Sdays-S)years.The 
coronary nonperfusion time had been 87(27-1S0) and the by-
pass time 21S(144-324) minutes.LV volumes were measured 
from the levophase of 2 PA injections at rest and after 
stress and ejection fraction (EF) calculated.LV pressure 
was measured with a Hifi catheter. adrenergic Methoxamin 
was infused at 30~g/kg increased by IS ~g until blood pre-
ssure had risen from 94(79-110) to 138(8S-168).Using meas-
ured oxygen consumption CI was assessed amd minute work in 
dex calculted as CI x mean LV systolic pressure X 0.0136. 
Results: Endsystolic and enddiastolic volumes were normal. 
EF was normal at rest at .71(.66-.76) and increased to .74 
(.7-.77) after stress in 9 but fell in 1 Pt.All Pts in-
creased MWI from 3.9(3-S.3) to S.2(4-7.9).Enddiastolic 
pressure rose significantly from 6.3(S-9) to 8.7 (7-1S) 
mmHg at peak stress.By plotting MWI on the y-axis and end 
diastolic pressure on the x-axis at various different sy-
stolic pressures a work function curve was obtained. This 
had an abnormal slope in 6/10 Pts when compared to normal 
published values.Although all Pts had normal LV function 
at rest, the fall of EF after stress in one and the abnor-
mal work function curve in 6 Pts raises concern about 
the long term LV function in Pts having undergone the 
arterial switch operation. 
PREOPERATIVE ASSESSMENT OF RIGHT VENTRICULAR SIZE AND 
MORPHOLOGY IN TRICUSPID ATRESIA. 
Mark M. Boucek, M.D., Jane Sturtevant, and Richard B. 
Jaffe, M.D., Pnmary Chi ldren's Medical Center and 
University of Utah, Salt Lake City, Utah. 
The potential for RV growth and a physiological repair 
in tricuspid atresia (TA) may influence the type of 
Fontan procedure. To evaluate preoperative RV 
assessment, we compared the RV size and morphology by 
selective RV catheterization through the ventricular 
septal defect (VSD) with the RV size as estimated by 
axial LV angiography. Seven consecutive patients (mean 
age 2.9 years) with TA and ventriculo-arterial 
concordance were studied. The VSD was restrictive with 
a mean RV/LV pressure ratio of .39. Biplane RV and 
axial LV injections were performed. RV volume (modified 
Simpson's rule) and RVarea (lateral projection) were 
determined. The RV volume was 12.8 + 3.8 cc wi th a 
predicted normal volume (based on BSA) of 33 + 5.2 cc. 
The mean RV volume was 39% (range 23-78%)* of-normal. 
RV injections outlined an RV area twice that visualized 
from an axial LV injection (33.2 vs 16.5 cm2)*. All 
patients had a well-developed but small trabecular 
portion of the RV often unopacified with LV injection. 
Subinfundibular narrowing adjacent to the VSD was 
invariably present, separating the outlet chamber fran 
the trabecular portion, creating, in effect, a 2-
chambered RV. We conclude that selective right 
ventriculography demonstrates the unique morphology of 
the RV in patients with TA and outlines an RV size at 
least twice that visualized by axial left 
ventriculography. Surgical procedures which include the 
outlet chamber in a Fontan procedure should relieve the 
subinfundibular narrowing to allow for RV growth. 
*p<0.05 
ABSTRACTS 
THE IMPORTANCE OF ANGIOGRAPHY IN ASSESSMENT AND FOLLOW-UP 
OF CORONARY ABNORMALITIES IN KAWASAKI'S DISEASE 
29A 
Elfriede Pahl MD, Marie John, James Clendaniel, William 
Neches MD FACC, Donald Fischer MD FACC, Lee Beerman MD 
FACC, F. Jay Fricker MD FACC, Sang Park MD FACC, and James 
Zuberbuhler MD FACC .. Children's Hospital and University 
of Pittsburgh, PA 
Echocardiography has been advocated as the sole method 
of evaluating coronary involvement in patients with 
Kawasaki's disease. However some of our patients had 
angiographic abnormalities that were not recognized by 
echo. Over 10 years, 170 patients had Kawasaki's disease. 
Cardiac involvement was suspected in 31 (18%). There were 
5 deaths (3%), 4 of them < 1 month after onset of illness 
and 1 late death. 25 patients had cath and 21 had coronary 
abnormalities (CA). Segmental CA were measured and 
classified by shape and location. CA were found in the 
right coronary in 15, left anterior descending in 17, and 
circumflex in 10. The clearance of dye from the coronary 
arteries following aortography was markedly delayed 
compared to normal (p < .01). This suggests that coronary 
artery flow is also abnormal in patients with CA. 
Some distal aneurysms were found that were not detected 
by echo. One patient was thought to have resolution of CA 
by echo and at cath had a distal right coronary artery 
aneurysm. Multiple coronary stenoses were found in 2 
patients (one had angina and required coronary bypass). 
Echo is a good screening modality and extremely useful for 
serial follow-up. However, angiography provides greater 
detail of the coronary circulation and definition of 
abnormalities. Although all of our surviving patients are 
asymptomatic. and CA have resolved in 8 of 21 patients, 
the long term effects of CA are unknown. It is only with 
angiography that the location, extent and complications of 
coronary abnormalities in patients with Kawasaki's disease 
can be adequately evaluated longitudinally. 
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Thrombosis: Mechanisms 
IN VIVO IDENTIFICATION OF NORMAL AND DAMAGED ENDOTHELIUM 
BY QUANTITATIVE CORONARY ANGIOGRAPHY AND INFUSION OF 
ACETYLCHOLINE AND BRADYKININ IN PIGS 
William J. Penny, M.D., James H. Chesebro, M.D., F.A.C.C., 
Magda Heras, M.D., Lina Badimon, Ph.D., Valentin Fuster, 
M.D., F.A.C.C., Mayo Clinic, Rochester, Minnesota. 
Because of the importance of the endothelium (E) in 
the prevention of atherosclerosis and thrombosis, in vivo 
identification of and maintenance of normal E are impor-
tant. Altered E-dependent vasoreactivity to bradykinin 
(B) or acetylcholine (A) may identify intact or denuded E. 
Anesthetized pigs were given intracoronary graded 
infusions (10- 7 to 10-4 M/min, volume < 1% of estimated 
left anterior descending [LAD] flow) of A and B before and 
! hr after (allows injury-induced vasoconstriction (VC) 
to return to baseline) superficial balloon injury (BI, 
confirmed by histology, electron microscopy, Evans Blue, 
and lllIn-platelet deposition). LAD diameter (diam) was 
measured by quantitative angiography (nonionic, Iohexol). 
Prior to BI, compared to 5% dextrose (D, 13 pigs), LAD 
diam did not change with A 10-4M vs D (3.13 vs 3.18 mm) 
and B 10-4M vs D (3.20 vs 3.41 mm). After preconstric-
tion with PGF2a (11 pigs) vasodilatation (VD) occurred 
with B 10-5M vs D (2.50 + 0.18 mm vs 2.03 + 0.19 mm, 
p<O.OOI) but not with A 10-4M vs D (1.67 ~ vs 1.89 mm). 
Following BI, VC occurred after A 10-5M vs D [2.27 + .24 
mm vs 2.89 ~ .32 mm, p<O.OI, no change in heart rate (HR) 
or systolic blood pressure (SPB)] and only occurred after 
B with doses that decreased SBP. The VC response to A 
was confined to the site of BI. The distal uninjured 
LAD diam did not change after A 10-4M (1.88 + .15 mm vs D 
2.05 ~ .19 mm) or B (2.51 + 0.18 mm vs D 2.36 + 0.62 mm). 
Thus in pigs, normal intact and injured E i~ different 
arterial segments of the same coronary artery can be 
positively identified in vivo by quantitative angiography 
and the VD response to B and the VC response to A. 
30A ABSTRACTS 
INHIBITICN OF TI!lOmUS FORMATICN: BLOCItl\GE OF ADHESIVE 
GLYCOPROTEIN MECHANISMS VERSUS BLOCItl\GE OF 'DIE 
CICLOOXYGENASE PATHWAY. 
Lina sadill1Ol1, Ph.D., Juan J. sadill1Ol1, Ph.D., James H. 
Chesebro, M.D., valentin FUster, M.D., Mount Sinai 
Medical Center, New York 
Platelet deposition (PO) on de-endothelialized vessel 
wall (De-V) and collagen type I has been studied using a 
perfusion chamber placed within an extracorporeal cir-
cuit (carotid artery-jugular vein) in a swine model. 
Exposure times of 1 ty 10 min at shear rates typical pf 
stenotic (1690-3380s- ) and un-obstructed (212-424s- ) 
medil.UII size arteries have been studied. PO was determi-
ned by counting Indium 111-labelled platelets deposited 
on the perfused specimen once relllOVed from the perfusion 
chamber. Blood from aspirin (0.5mg/Kg iv bolus; 5mg/Kg 
iv bolus; and 0.5 mg/Kg oral per 6 days) treated swine 
was perfused over the substrates and results compared 
with those obtained perfusing blood from untreated 
normal swine and blood from swine with severe von 
Willebrand's disease (absence of the adhesive glyco-
protein von Willebrand Factor (VWF». Pigs were hepari-
nized in all the procedures. In our experimental condi-
tions aspirin treatment induced 30% reduction in PO; 
however, in the absence of VWF there was 90% reduction 
in PO at shear conditions of stenotic vessels. A Il10l10-
clonal antibody anti-porcine-VWF (Dr. D. Fass, Mayo 
Clinic) was injected in a normal swine and there was 81% 
reduction in PO on De-V determined at shear rate 
condition typical of a stenotic vessel. we can conclude 
that, in comparison with prostanoid blockage by aspirin, 
blockage of the adhesive glycoprotein VWF renders a much 
more powerful inhibition of platelet thrombus formation. 
'l1lis may have future therapeutic implications in 
thrombotic conditions of clinical significance. 
A SERIAL OBSERVATION OF CORONARY THROMBOSIS IN VIVO BY A 
NEW ANGIOSCOPE. 
Kyoichi Mizuno MD, Ko Arakawa MD, Toshio Shibuya MD, Kenji 
Horiuchi MD, Yasusuke Okamoto MD, Akira Miyamoto MD, 
Kazushige Isojima MD, Akira Kurita MD, Kimio Satomura MD, 
Haruo Nakamura MD, Tunenori Arai PhD, Makoto Kikuchi PhD 
NATIONAL DEFENSE MEDICAL COLLEGE, SAITAMA, JAPAN 
Though an angiography cannot reveal the precise features 
and stages of coronary thrombos is, thrombos is format ion 
now can be observed by a new angioscope. A specially made 
balloon, fixed at the catheter tip with an angulation 
mechanism, has been developed, making a preCise coaxial 
alignment possible in the coronary lumen. This angioscope, 
1.1 mm in size, has 4 channels, one for irrigation, 
through which a 0.014 inch guide wire can be used and, 
allows an angulated coronary lumen to be seen with less 
pulsation and less volume of irrigation. 
A thrombosis was induced by copper coil in 5 
closed-chest canines and this angioscope was introduced to 
the coronary artery via the cervical artery by a PTCA 
guide catheter, and was advanced through guide wire. A 
friable meshwork, greyish mass similar to a fibrin 
network, developed a few minutes after insert in of the 
copper coil into the left anterior descending artery. 
Short ly after, a red thrombus was seen among the white 
thrombi and red thrombi soon predominated. The color at 
this stage showed dark red. The coronary arteries were 
found to be occluded at this stage in most canines. From 
an antegrade view during the later stages of our testing, 
the appearance of the thrombosis was mixed and not red. 
The above findings should prove helpful in evaluating 
the various stages of human coronary thrombosis, which can 
provoke an unstable angina or an acute myocardial 
infarction. Of further benefit, this angioscope can be 
used clinically during cardiac catheterization. 
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DOSE DEPENDENT INHIBITION BY HEPARIN OF ACUTE 
PLATELET-THROMBUS DEPOSITION DURING ANG10PLASTY 
Magda Heras, MD, James H. Chesebro, MD, FACC, William J. 
Penny, MD, Kent Bailey, PhD, Lina Badimon, PhD, Valentin 
Fuster, MD, FACC. Mayo Clinic, Rochester, Minnesota. 
We prospectively studied the effect of 5 different 
Heparin (H) dosages (bolus + infusion) on platelet and 
fibrinogen deposition (PD,FD) on the site of carotid 
angioplasty in 20 pigs randomly distributed to one of the 
following regimens. Group 1: 50 U H/kg + 50 U H/kg/hr; 
Group 2: 100 U H/kg + 100 U H/kg/hr; Group 3: 150 U H/kg 
+ 150 U H/kg/hr; Group 4: 200 U H/kg + 200 U H/kg/hr; 
Group 5: 250 U H/kg + 250 U H/kg/hr. After 30 minutes of 
H infusion, they underwent bilateral carotid angiop1asty 
(5 inflations for 30 sec to 6 ATM, 60 sec apart). The 
table lists (mean + SD) plasma concentration of H at 
injury (I) time, total U H/kg, 111 In-labeled PD (x 106 
platelets/cm2) and 125I-Iabeled FD (x 1012 mo1ecules/cm2) 
in segments with subendothelial (S) and deep (D, tissue 
torn into the media) I, and thrombi (PD > 20 x 106/cm2) 
Group I 2 3 4 5 
U H/ml 5 + 4 5 + 1 9 + 3 13 + 2 20 + 9 
U H/kg 88 + 2 173 + 11 261 + 21 359 + 25 431 + 25 
PD Sl 5 + 1 7 + 2 4 + 1 7 + 3 7 + 5 
FD SI 32 + 0 20 + 10 28 + 26 18 + 3 8 + 8 
PD D1 66 + 100 13 + 2 9 + 2 4 + 0 11 + 7 
FD D1 30 + 10 36 + 17 16 + 6 10 + 0 12 + 6 
Thrombi D1 60% 0% 11% 0% 18% 
PD in D1 showed a negative rank correlation between H 
dosage group (pB O.025), U H/kg (p=0.059), U H/ml 
(p=0.052). FD in DI was also negatively correlated to H 
dosage group (p=0.002), U H/kg (p=0.005) and U H/ml 
(pa O.006). No significant effect and no thrombi occurred 
with SI. Heparin, in a dose dependent manner, decreased 
the acute platelet deposition and thrombus formation 
during angiop1asty. 
THROMBOXANE AND SEROTONIN MEDIATE REOCCLUSION 
AFTER THROMBOLYSIS IN A CANINE MODEL OF CORONARY 
THROMBOSIS. 
Paolo Goline, M.D., Juliet H. Ashton, Ph.D., Janice McNatt, L. 
Maximilian Buja, M.D., F.A.C.C., and James T. Willerson, M.D., 
F.A.C.C., Univ of Texas Health Science Center, Dallas, Texas. 
Human recombinant tissue-type plosminogen activator (rt-PA) has 
been shown to be an effective and safe agent for coronory 
thrombolysis. However, thrombolysis is associated with a high 
rate of acute reocclusion (R) after discontinuation of rt-PA. The 
gools of the present study were to ossess whether R is caused by 
platelet aggregation and to determine the role of thromboxane A2 
(TxA) and serotonin (5HT) in mediating this phenomenon. 
Acco?dingly, coronary thrombosis wos induced in 20 open-chest 
dogs by inserting a copper coil into the LAD. LAD blood flow was 
monitored by 0 Doppler flow probe placed proximolly to the coil. 
Thrombolysis was achieved with rt-PA (0.05 mg/kg bolus + 
5 ug/kg/min infusion) in 23 + 3 min. rt-PA was then disconitnued 
and heparin (150 U/kg) was-given every hour. Reperfusion was 
followed by repeated cycles of gradual occlusions followed by 
spontaneous restorations of blood flow (cyclic flow variations, 
CFVs) before a persistent R occurred. In control dogs (n = 6), 
heparin alone did not prevent CFVs and R occurred in 25 + 4 min. 
Administration of 0 bolus of SQ 29548, a TxA receptor 
antagonist, (0.22: 0.05 mg/kg) and L Y 53857, a 5H122 receptor 
antagonist, (0.1 + 0.02 mg/kg) followed by continuous mfusion of 
both drugs (0.2-mg/kg and 0.1 mg/kg over 3 hrs, respectively) 
completely abolished CFVs and prevented R throughout the 
experimental period in 5/5 dogs. SQ alone prevented R in only 2/5 
dogs and L Y in 1/4. Thus, R after thrombolysis is platelet 
dependent in this model of coronary thrombosis and TxA2 and 5HT 
are mediators of this phenomenon. In this model, TxA2 and 5HT 7 
receptor antagonists given together prevent Rafter 
discontinuation of rt-PA. 
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ELEVATED ANTICARDIOLIPIN ANTIBODY AND CORONARY ARTERY 
BYPASS GRAFT OCCLUSION - A PROSPECTIVE, RANDOMISED TRIAL 
OF LOW DOSE ASPIRIN 
Thomas Gavaghan MB, David Baron MB, Steven Kri1is MB, PhD, 
John Hickie MB, FACC, Anne Keogh MB, Colin Chesterman, MB, 
D.phi1. 
St. Vincent's and St. George Hospitals, Sydney, Australia. 
To assess the association of anticardio1ipin antibody 
(ACA) with vein graft occlusion after coronary artery 
bypass grafting (CABG), we prospectively measured serial 
plasma ACA levels in 109 patients randomised to aspirin 
324mg/day or placebo under double blind conditions. 
Therapy was started less than 1 hour (44 t 35mins) after 
surgery. Graft patency was assessed at early (median 7 
days, n=109) and late (median 363 days, n=102) angio-
graphy. Plasma ACA was measured pre-operatively and 
1 week, 3 months and 12 months post-operatively. Of 51 
patients on placebo, 17 (33.3%) had one or more graft 
occlusions, 7 early and 11 late (1 patient had both an 
early and late occlusion), whereas of 58 patients on 
aspirin, 7 (12.1%) had one or more occlusions, 3 early 
and 4 late (p<O.Ol). In the placebo group when the 
maximum ACA level for any patient exceeded 4 SD of the 
mean of normal controls, 6 of 8 patients (75%) developed 
a graft occlusion. If the ACA level was 2-4 SD, 0-2 SD 
or less than 0 SD above the mean of controls, the 
occlusion rates were 5 of 10 (50%), 4 of 21 (19%) and 
2 of 12 (16.6%), p<0.004. There was no correlation of 
graft occlusion with ACA levels in the aspirin group. 
Further, e1 eva ted ACA (> 2 SD) was measured in 18. 7% of 
patients before CABG. This incidence rose to 35% post-
operatively. Very high ACA (> 4 SD) levels are found in 
16.7% overall. 
We conclude that an elevated ACA level is a highly 
significant risk factor for subsequent graft occlusion 
and aspirin (324mg) is effective in preventing graft 
occlusion, particularly in the presence of high ACA 
levels, (p< 0.009). 
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Nuclear Cardiology: Myocardial Perfusion Imaging with 
Technetium RP-30 or Thallium-201 I 
OVERESTIMATION OF PERFUSION IN ISCHEMIC 
MYOCARDIUM BY Rp·30 
Duan-sheng Li, M.D., Dinko Franceschi, M.D., Terry L. 
Frank, C.N.M.T., Henry N. Wagner, Jr, M.D., F.A.C.C., 
Lewis C. Becker, M.D., F.A.C.C. The Johns Hopkins Medical 
Institutions, Baltimore, MD 
Uptake of RP-30 (Tc-99m-2-methoxyisobutyl isonitrile) is 
correlated with regional myocardial blood flow, but has 
been shown to overestimate flow in ischemic zones on 
tomographic images obtained 30-60 minutes after injac-
tion. To study the reasons for this discrepancy, 8 
anesthetized dogs underwent coronary occlusion (CO) for 6 
min followed by 3 hr of reflow. RP-30, Tl-201, and micro-
spheres (MS) were injected after 1 min of CO. In 4 dogs 
tissue contents were compared in serial myocardial biop-
sies. Before reflow, in the center of the ischemic zone, 
MS content (expressed as a fraction of non-ischemic zone) 
averaged .03 vs .19 for RP-30 and .11 for Tl. At the end 
of reflow, RP-30 increased to .40 and Tl to .82, indicat-
ing redistribution of both tracers. RP-30 arteriovenous 
difference across the reflowed bed was always positive, 
compatible with continued uptake. Absolute RP-30 activity 
decreased 18% in normal areas (vs 69% for Tl) and 
increased 82% in post-ischemic areas (vs 369% for Tl), 
with changes approximately linear over time. In the other 
4 dogs, tomographic imaging performed after 30 and 150 
min of reflow also demonstrated an initial excess of RP-
30 in the ischemic zone (ischemic/non-ischemic ratio-.25 
vs .10 for MS), as well as a subsequent increase in the 
RP-30 ratio to .36. Thus, RP-30 demonstrates definite 
redistribution, although less so than Tl. Excessive RP-
30 activity in ischemic zones after reperfusion appears 
to be related to (1) excessive initial tissue uptake and 
(2) redistribution involving both washout from normal 
zones and uptake in previously ischemic zones. 
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PREDICTION OF REVERSIBILITY OF PERFUSION DEFECTS 
WITH A SINGLE POST-EXERCISE TECHNETIUM-99m RP-30A 
GATED TOMOGRAPHIC IMAGE: THE ROLE OF RESIDUAL 
SYSTOLIC THICKENING. 
Joel K. Kahn. M.o .. Eugene B. Henderson. M.o .. Marvin S. Akers. 
B.S.N •• Donald E. Jansen. M.o .. John J. Pippin. M.o .. Padamakar 
Kulkarni. Ph.D.. James T. Willerson. M.o .. F.A.C.C .. James 
R. Corbett. M.o .. University of Texas Health Science Center 
at Dallas. Dallas, Texas. 
Technetium-99m RP-30A. an isonitrile analog. has photon ener9Y 
and radiation dosimetry that allow imaging with gated single 
photon computed tomography (gSPECT). We tested the hypothesis 
that residual systolic thickening in areas of decreased perfusion 
on gSPECT images post-exercise identifies regions of revers-
ible perfusion defects on separate rest and exercise studies. 
Twenty-one Pts with Lj 1 stenosed (>50 % luminal narrowing) 
coronary arteries (RCA 12. LAD 1 B. ex 11) were studied. One 
hour after separate injections at rest and peak exercise. gSPECT 
RP-30A images were obtained (16 frames/cardiac cycleJ. Seg-
mental myocardial perfusion and residual systolic thickening 
were assessed semiquantitatively from long and short axis gSPECT 
sections. 
High quality images were obtained in all Pts. Rest and stress 
gSPECT RP-30A imaging identified 31 reversible perfusion 
defects in stenosed coronary distributions. Residual systol ic 
thickening. suggesting myocardial viability. was present post-
exercise in 19/19 reversible and 10/12 partially reversible perfu-
sion defects. 
Residual systolic thickening in areas of abnormally perfused 
myocardium is readily detected on post-exercise gSPECT RP-30A 
images and corresponds with reversible perfusion defects as 
identified by separate rest and exercise images. Thus. simultan-
eous perfusion and function imaging is feasible. allowing the 
determination of myocardial viability in areas of reduced perfu-
sion on a single post-exercise tomographic image. 
QUALITATIVE AND QUANTITATIVE ANALYSIS OF REST TECHNETIUM 
tSONITRILE IMAGES FOR DETECTION OF OCCLUDED CORONARY 
ARTERIES 
IAsken Di~lizjaj' M D , Thomas P. Rocco, M.D.,H. William trauss,.D.,.A:t.~.,Charles A. Boucher, M.D.,F.A.C.C. 
Massachusetts General Hospital, Boston, MA 
Rest technetium methoxybutyl isonitrile (Tc-MIBI) imaging 
has been suegested as a method of detectin$ acute 
myocardial 1nfarcts due to coronary occlus10n. To 
evaluate this potential, we compared rest Tc-MIBI uptake 
with coronary anatomy in 38 coronary artery disease 
patients who had coronary arteriography ana Tc-MIBI 
1maeing within one week. No patients with unstable 
ang1na or acute-phase ~ocard1al infarct were included. 
Rest left ventricular (LV) Tc-MIBI tracer uptake was 
assessed in the 3 major coronary vascular territories 
qualitatively on a three-point scale from 0 = markedly 
reduced/absent activity to II = normal, and 
quantitativelr in 11 segments/view as a percent of peak 
activity. Co laterals were graded good or poor. 
Frequency of qualitative rest Tc-MIBI scores and mean ± 
S.D. quantitative data in relation to % stenosis follow: 
Coronarr Stenosis Qualitative Quantitative 
(% - Co laterals) (% of each scale) (% Peak Activity) 
100 -
100 -
75-99 
50-74 
<50 
Poor 
Good 
o I II Mean ± SD 
[
100 0 0 [42 + 21 
* 55 18 27} * 61 ± 23] 
31 39 30 73 ± 18 
23 31 46 * 74 ± 19 * 
o 21 79 87 ± 10 
*p<0.01; **p<0.001 
Qualitative and quantitative rest Tc-MIBI uptake is lower 
in occluded coronary arteries with poor co11aterals 
compared to <50% ana 50-99% stenosis. Further, Tc-MIBI 
uptake is also lower in occluded coronary arteries with 
good collaterals when compared to <50% stenosis. Non~ of 
the territories with poor collaterals and only 6 (27%) of 
territories with good col laterals and 100% occlusions had 
normal Tc-MIBI uptake. Because rest Tc-MIBI imaging 
accuratelr predicts coronary occlusion with poor 
col latera s, this method may be useful in evaluating 
patients presenting with acute myocardial infarction. 
32A ABSTRACTS 
JlOIiUVASIVE ASSESSKENT OF KYOCARDIAL FUNCTIOb USING A 
NEW PERFUSION IMAGING AGENT. 
Youssef Najm, L.M., Adam Timmis, M.D., lIicael lIaisey, 
11.0., Ron Mistry, M.Sc. and Edgar Sowton, II.D., F.A.C.C. 
Guy's Hospital, London, England. 
Left ventricular function is an important prognostic 
indicator in patients with coronary artery disease. We 
have assessed a method of providing this information as 
an adjunct to myocardial perfusion studies using Tc-99m 
IIIBI, a new perfusion imaging agent. Studies at rest and 
during exercise were performed following inj ection of 
400-600 IIBq Tc-99m IIIB1 in 62 pts. Cardiac gating 
permi tted excellent myocardial edge definition. 
Radionuclide fractional shortening (RFS) , a new measure 
of LV function, was calculated fromtheend-diastolic 
minus the end-systolic divided bytheend-diastolic pixel 
counts in each oftheanteroposterior (AP)and septum-
lateral wall (S1) axes. Resul ts were compared with 
echocardiographic tractional shortening (FS) and blood 
pool equilibrium Tc-99m scintigraphy ejection fraction 
(EF). The RFS in the AP axis correlated closely with 
echo-cardiographic FS (36 ± 11 versus 37 ± 7%, r=0.89, 
p<O.OOll. In the SL axis it was lower at 32 ± 8%. The 
RFS in both axes was averaged to provide a global RFS. 
Global RFS (34 ± 12%) correlated closely with LV 
radionuclide EF (48 ± 15%), r=0.83, p<O.OOl. Inter and 
intra observer reproducibility studies have shown a 
variability for the procedure of <10%. In conclusion 
gated perfusion imaging with Tc-99m IIIBI, as well as 
providing information about myocardial perfusion, 
provides adequate edge definition for accurate 
noninvasive evaluation of LV function. lIeasurement of 
RFS in the AP axis correlates closely with 
echocardiographic FS and calculation of the global RFS 
provides an al ternati ve assessment of ventricular 
function. 
TECHNETIUM ISONITRILE UPTAKE AT REST UNDERESTIMATES 
VIABILITY AS ASSESSED BY WALL MOTION 
Thomas P. Rpsso. M.D •• Vssken Di1sizian. M.D •• H. William 
Strauss. M.D •• F.A.C.C •• Char1es A. Boucher.M.D •• F.A.C.C •• 
Massachusetts General Hospital. Boston. MA 
To determine the utility of rest injected Technetium-99m 
methoxybuty1 isonitrile (Tc-MlBI) uptake as a marker of 
myocardial viability. the regional distribution of 
Tc-MlBI uptake was compared to regional wall motion by 
gated blood pool scan (GBPS) in 26 patients with coronary 
artery disease. Coronary angiography was performed 
within 1 week of the radionuc1ide procedures. No 
patients with unstable angina or acute-phase myocardial 
infarction were included. Rest LV Tc-MlBI uptake was 
assessed in the 3 major coronary vascular territories as 
grade 0 (markedly reduced/absent) to grade II (normal). 
GBPS wall motion was scored as normal. hypokinetic. or 
akinetic/dyskinetic in corresponding vascular 
territories. Data in 78 vascular territories follow: 
GBPS Wall Motion (% of territories) 
Tc-MlBI Score Normal Hypokinetic Akinetic/Dyskinetic 
o (n=27) 26 26 48 
I (n=18) 39 33 28 
II (n=33) 70 24 6 (p<.OOl) 
Following coronary bypass surgery in 8 patients. Tc-MlBI 
uptake improved postoperatively in 12 of 13 territories 
with reduced Tc-MlBI uptake preoperatively; this included 
all 5 territories with preop Tc-MlBI scores of O. In 
conclusion. while there is an overall relationship 
between rest Tc-MIBI uptake and viability. 26% of 
territories with absent rest Tc-MlBI uptake had normal 
wall motion. Therefore. inferences about viability based 
on rest Tc-MlBI uptake should be made with caution. 
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THALLIUM/TECHNETIUM-PYROPHOSPHATE OVERLAP: A 
NEW NONINVASIVE MARKER OF VERY EARLY CORONARY 
REPERFUSION 
Tetsuo Hashimoto, M.D., Hirofumi Kambara, M.D., 
F.A.C.C., Kenji Uozu, R.T., Tetsuro Fudo, M.D., 
Shunichi Tamaki, M.D., Yoshiki Takatsu, M.D., 
Ryuichi Hattori, M.D., Singo Tokunaga, M.D. and 
Chuichi Kawai, M.D., F.A.C.C. Kyoto University, 
Kyoto, Japan. 
To evaluate clinical significance of thallium-
201 (Tl) / technetium-99m pyrophosphate (Tc) 
scintigraphic overlap, we studied 32 patients 
(pts) in whom coronary reperfusion (Re) was 
attempted for acute myocardial infarction 
(AMI). On day 3 of AMI, all pts underwent dual 
energy emission computed tomography (D-ECT) 
which enabled us to record Tc and Tl images 
simUltaneously and to compare both images in 
the identical slices. 
Scintigraphic resluts of 32 
D-ECT Successful Re 
Overlap(+) 9 (A) 
Overlap(-) 12 (B) 
Clinical Variables 
Residual stenosis(%) 
L:MB-CK(IU/L) 
Time to Re (h) 
A 
68+17 
160+121 
2. S:±:O. 8 
pts are as follows: 
Unsuccessful Re 
o 
11 (X2 :p<O.OS) 
B _P __ 
'53+21 NS 
19f+"41 NS 
4.8:±:1.3 <0.001 
In conclusion, (1) significant Tl/Tc overlap on 
D-ECT suggests very early successful Re and 
reflects the presence of salvaged myocardium 
next to the necrotic tissue, and (2) none of 
the pts with unsuccessful Re showed Tl/Tc 
overlap. 
Monday, March 28, 1988 
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Nuclear Cardiology: Myocardial Perfusion Imaging with 
Technetium Rp·30 or Thallium 201 II 
GATED AND UNGATED TOMOGRAPHIC PERFUSION IMAGING 
WITH TECHNETIUM-99m RP-30A: COMPARISON WITH TI-201 
TOMOGRAPHY IN CORONARY ARTERY DISEASE. 
Joel K. Kahn. M.D .. Eugene B. Henderson. M.D .. Marvin S. Akers. 
B.S.N .. Donald E. Jansen. M.D .. John J. Pippin. M.D .. Padamakar 
Kulkarni. Ph.D .. James R. Corbett. M.D .. University of Texas 
Health Science Center at Dallas. Dallas. Texas. 
Technetium 99m RP-30A. an isonitrile analog. has photon energies 
and radiation dosimetry that allow imaging with gated single 
photon computed tomography [SPECTl. We tested the hypothesis 
that gated and ungated SPECT perfusion images with RP-30A 
are comparable to ungated SPECT TI-20 1 images in the detection 
of significant coronary disease. Twenty-one Pts with 41 stenosed 
coronary arteries [>50% luminal narrowing) were studied. Gated 
and ungated SPECT RP-30A imaging and ungated SPECT TI-201 
imaging was performed following stress testing and rest or 
4-hour redistribution. respectively. RP-30A images were gated 
at 16 frames/cardiac cycle. and segmental perfusion was assessed 
semiquantitatively from long and short axis sections. 
High quality tomographic myocardial RP-30A and TI-20 1 
images were obtained in all Pts. SPECT TI-201 imaging identified 
16/21 Pts and 21/41 stenosed coronary distributions as abnormal. 
Ungated RP-30A imaging identified 17/21 Pts and 23/41 stenosed 
coronary distributions. Gated RP-30A imaging identified 20/21 
Pts and 32/41 stenosed coronary distributions [p < .05). Stenosis 
detection in each of the three coronary arterial distributions 
was increased by gated RP-30A imaging. Gated RP-30A. as 
compared to ungated RP-30A and TI-201 imaging. improved 
the identification of the 23 vessels with 50-90% stenoses [16 
vs B vs 6. P < 0.05). 
Thus. gated tomographic perfusion imaging with RP-30A 
is readily performed and allows accurate assessment of the 
distribution of myocardial perfusion abnormalities. Gated studies 
with RP-30A allows improved detection of significant coronary 
stenoses compared to TI-20 1 and ungated RP-30A imaging. 
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EFFECT OF A CHRONIC LOY FLOY STATE ON MYOCARDIAL UPTAKE 
OF RP-30 AND Tl-201. Albert J. Sinusas MD, James M. 
Cannon ME, Denny D. Yatson PhD, George A. Beller MD, 
FACC. University of Virginia, Charlottesville, VA 
Chronic partial coronary stenosis has been reported to 
cause nontransmural ischemia and regional dysfunction. 
It has been suggested from isolated perfused heart 
studies that the uptake of Tc-99m labeled methoxyisobu-
tyl isonitrile (RP-30) may be more sensitive to ischemia 
than TI-201 (Tl). In 6 open-chest dogs RP-30 (5 mCi) and 
Tl (0.5 mCi) were injected IV during low flow following 
a 40 min partial LAD stenosis which resulted in a de-
crease in mean EMF flow of 34 ± 6%. Regional blood flow 
(RBF) was assessed by radiolabeled microspheres and 
segmental LV function by quantitative 2D echo during 
control condi tions and during chronic underperfusion. 
Regional dysfunction was evidenced by a 59 ± 23% de-
crease in systolic wall thickening in the LAD zone. Dogs 
were killed 20 min after tracer injections and the LV 
divided into 96 segments for gamma well counting. RP-30 
and TI activities for LAD subendocardial (SE), mid-wall 
(MY), and epicardial (EP) segments were normalized to 
nonischemic values derived from 5 segments from the LCx 
zone for each region, respectively. Forty SE segments 
had stenotic flows <60% of control. Mean ± SD values for 
RBF (% control) and normalized RP-30 and Tl activities 
for these SE segments and adjacent MY and EP segments 
during low flow were: 
LCx Flow LAD Flow RP 30 Tl RP-30/Tl 
SE 1.0±.13 .39±.10 .42±.15 .43±.16 .96±.07 
MY 1.04±.20 .56±.17 .5S±.17 .60±.20 .97±.OS 
EP 1.02+.21 .S4+.12 .89±.12 .S4+.13 1.06+.09 
Thus, in this canine model of chronic underperfusion 
resulting in systolic dysfunction, myocardial uptake of 
RP-30 and Tl was comparable and proportional ~o the 
alterations in regional blood flow. 
INTERPOLATIVE BACKGROUND SUBTRACTION AS USED FOR 
TI-201 IMAGING CREATES MAJOR INACCURACY IN 
QUANTITATIVE Tc-99m ISONITRILE IMAGING. 
Kenneth Koster, M.D., Frans J. Wackers, M.D., F.A.C.C., 
Robert Fetterman, R.T.N., Denny D. Watson, Ph.D., 
William H. Smith and Jennifer Mattera, R.T.N., Yale 
University, New Haven, CT 
The diagnostic accuracy of rest/exercise(R/EX) 
myocardial imaging with the new radiopharmaceutical 
Tc-99m-Isonitrile(ISO) requires study. State-of-the-
art Tl imaging involves quantitative analysis(QA) with 
interpolative background subtraction(BS), circumferen-
tial profiles(CP) and comparison to normal(NL) Tl 
database. It is not clear whether the same QA 
analysis can be used for ISO images. We compared 
standard QA, as used for Tl imaging, in 13 patients 
(pts) with angiographic CAD who had both Tl and ISO 
R/EX imaging. QA of Tl images was NL in 4, showed 
fixed(F) defects(D) in 1 and reversible(R) 0 in 8 pts, 
whereas QA of ISO images was NL in 2, showed FD in 10 
(9 erroneous) and RD in 1 pt. The greater subdia-
phragmatic uptake (compared to Tl) on R ISO images 
presumably caused oversubtraction from adjacent 
myocardial areas, thereby producing erroneous FD's. 
Using a new modified BS method, which accounts for 
enhanced subdiaphragmatic uptake, and a new NL ISO 
database (n=8), 7 of 9 erroneous FD were correctly 
interpreted as RD, 2 remained FD. On the other hand, 
4 CAD pts with NL Tl were abnormal with ISO and new 
BS. Thus, standard QA, as used for Tl imaging, tends 
to produce erroneous FD's and can not be used for QA 
of ISO images. The proposed modification of BS method 
and new ISO database appear to provide more accurate 
QA of ISO R/EX images. This new method requires 
testing in a larger series of pts. 
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COMPARISON OF Tc-99m METHOXY ISOBUTYL ISONITRILE (MIBI) 
AND THALLIUY-201 FOR EVALUATION OF CORONARY ARTERY 
DISEASE BY SPECT AND PLANAR METHODS 
Hosen Kiat, MD, Jamshid Maddahi, MD, FACC, Robert Merz, 
MD, Lynne Roy, MS, Kenneth Resser, MS, Pam Kimsey, MS, 
John Friedman, MD, FACC, Daniel S. Berman, MD, FACC, 
Cedars-Sinai Medical Center, Los Angeles, CA 
Tc-99m YIBI was compared with Tl-201 in 25 pts - 13 
with ~50% coronary stenosis (CAD) and 12 normal (nl)s 
«5% likelihood of CAD) - who had stress redistribution 
Tl and same level exercise-rest YIBI studies within 2 
weeks and were imaged by both planar and tomographic 
(SPECT) techniques. YIBI images were obtained 1 hr after 
injection. 3 observers scored 15 segments (seg) on 
planar and 20 segs on SPECT with a 4 point system (O=nl, 
3=severe defect) with score >2=abnormal. % agreement 
between YIBI and Tl for abnormal (abnl) segs and stress 
score were respectively .92 and .84 for SPECT and .94 and 
.89 for planar methods (all Kappa's = .7). SPECT YIBI 
correlated well with type of Tl defect with 94, 84, and 
68% agreement for nl, nonreversible, and reversible 
segments respectively. Normalcy rate (in 12 nls) , 
overall sensitivity (sens) for CAD, sens and specificity 
(spec) for CAD in individual arteries (in CAD pts) were: 
overall nlcy vessel vessel 
sens rate sens spec 
Planar YIBI 62% 92% 59%(16/27) 92%(11/12) 
Planar Tl 77% 92% 59%(16/27) 100%(12/12) 
SPEer YIBI 92% 92% 81%(22/27) 75%(9/12) 
SPECT Tl 77% 92% 70%(19/27) 100%(12/12) 
p=NS for all comparisons. We conclude that YIBI and Tl-
201 correlate well on both planar and SPECT images with 
respect to 1) presence and score of segmental defect, 2) 
overall detection of CAD and 3) identification of disease 
in individual coronary arteries. By SPECT there was also 
high agreement for type of myocardial perfusion defects. 
EF'FlOC!l' OF REmmEICti AND IW:IN:; Cti '1HE ~ 
EX'lRl\CI'ICti OF 'DIAILlIH-201 AND A ~IAIlEUID 
ISCtiI.'.lRIIE 1\NAIDWE (RP30). D.J. Meerdink, Ih. D., M. 
'Ihw:ber, B.S., S. Savage, B.A., J.A. Leppo, M.D., FACC. 
Univ. of Massachusetts Medical Center, Worcester, Mass. 
'!he effects of reperfusion after 30 min. of no-flow on 
the transcapillary transport of [Tc-99m)-labeled hexakis 
(2-methoxy-2"'l\'ethylprqJylisonitrile) (RP30, E. I. duPont) 
ani thallium-201 (TI) were evaluated in isolated, blood-
perfused ralXlit hearts. Five hearts were not paced in 
the no-flow period while four other hearts were 
oontinuously paced to increase oxygen demand. First-
pass extractions (Fltax) ani capillcn:y penneability-
surface area products (PScap; ml/min!g) were detennined 
by paired imicator-d1lution techniques usin3' bolus 
injections of TI, RP30, ani [In-l11)-labeled al.bnnin. 
Cororw:y blood flow was unc:hal¥Jed for serial injections 
in each heart. '!he mean (±SD) results were as follows: 
[Tc)-RP30 TI-201 
Fltax PScap Fltax PScap 
No Pace COn 0.29(.08) 2.62(.89) 0.65(.04) 8.28(2.4) 
5' reflew 0.27(.07) 2.63(.65) 0.57(.03) 7.31(2.0) 
30' reflew 0.32(.15) 3.03(.89) 0.57(.02) 7.29(2.4) 
Paced COn 0.21(.05) 2.18(1.1) 0.62(.05) 8.66(3.1) 
5' reflew 0.26(.04) 2.73(.98) 0.60(.06) 8.52(4.0) 
30' reflew 0.34(.09) 3.90(1.5) 0.56(,02) 7.71(2.0) 
Umerl:inin:J imicates significant statistical difference 
(p<0.05) c::arpared to respective controls. 'Ihese data 
suggest that in blood-perfused ralXlit hearts, reperfusion 
after 30 min. of no-flow results in ilTpiired myocardial 
extraction of TI but not RP30. In ackiition, RP30 
extraction seems to increase after 30 min. of reflow, ani 
increased oxygen demand durin3' no-flow had on! Y a m:inbnal 
effect. 'Ihese alterations in cellular function affected 
tracer kinetics irxieperdent of any perfusion changes. 
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CONTRASTING FLOW AND MYOCARDIAL DISTRIBUTION CHARACTER-
ISTICS OF 201-Tl AND TECHNETIUM RP-30A IN A SWINE MODEL 
OF MYOCARDIAL ISCHEMIA AND INFARCTION. 
Israel Freeman, MD-L Andrew M Grunwald, MD, FACC, 
Bruce Robin, Shlomo Hoory PhD, and Monty M Bodenheimer, 
MD, FACC, Long Island Jewish Med. Ctr. New Hyde Park, NY. 
Therapy following infarction often depends on identifying 
viable but jeopardized myocardium (MYO). The role of 
RP-30A a new technetium perfusion agent, in identifying 
viable MYO remains unclear. Therefore, we studied 10 pigs 
who underwent 30 min of LAD occlusion (Oc) followed by 2 
hrs. of reperfusion (REP). MYO blood flow (BF) was mea-
sured with microspheres prior to Oc. After 30 min of REP 
a second set of microspheres was given simultaneous with 
iv 201-Tl (6 pigs; Gp 1) or with iv RP-30A (4 pigs; Gp 2). 
TTC & Evan's Blue were used to delineate non-ischemic, 
ischemic and infarct areas. MYO samples were analyzed for 
flow, CK, 201-Tl (Gp1) and RP-30A (Gp 2). Tl and Tc are 
normalized to nonischemic zone. BF 30' after REP = 
ml/gm/min. CK = IU/gm.*p<.Ol compared to above. BF at 2 
hrs after REP was similar to control and 30 min of REP. 
Group I Group II 
Tl CK BF Tc-RP 30A CK BF 
Normal 1.08 2372 1.7+0.6 1.0 2549 1.1±0.3 
Ischemic .78* 1902* 2.9+1.1 1.28* 1712* 1.4±0.5 
Infarct .21* 960* 2.7±1.1 .32* 666* 1.4±0.4 
MYO Tl 2 hrs after REP paralleled MYO CK and viability in 
the ischemic and infarct areas. In contrast, MYO Tc 
RP-30A appeared normal in the ischemic-CK depleted area. 
Only the central i.nfarct area showed a decrease in uptake 
with a corresponding greater reduction in MYO CK. In 
summary, when injected after reperfusion, iv thallium 
reflects myocardium at risk while RP-30A shows normal 
uptake in the previously ischemic but CK depleted area. 
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Determinants of Ventricular Filling and Emptying 
RELATION OF LEFT VENTRICULAR FILLING DYNAMICS TO 
ALTERATIONS IN LOADING AND COMPUANCE. 
Edward Harlamert. MD. Anthony N. DeMaria, MD, FACC, and 
Tom Wisenbaugh, MD, FACC, V A and Univ of Kentucky Medical 
Centers, Lexington, KY. 
A large atrial contribution to LV mling (%A) as indicated by a high 
ratio of atrial(A):early(E) integrated transmitral velocity by Doppler 
has been assumed by some to indicate abnormal LV ·compliance. 
Although we have previously examined the relationship of Doppler 
filling dynamics to hemodynamic measures of compliance, the effect 
of short-term changes in loading conditions on %A has not been 
examined. We therefore performed frame-by-frame analysis of 
volume by cineangiography simultaneous with pressure(p) by micro-
manometry in 7 normal subjects using ergonovine, nitroglycerin, or 
nitroprusside to either increase (i) or decrease (.1) LV preload and 
afterload. The atrial contribution to LV filling declined with 
increasing L VEDP such that %A was <25 in 6/8 cines in which 
L VEDP was> 13mmHg, while %A was ?25 in 6/6 in which 
L VEDP~13. In all 7 subjects, both LV operative compliance 
(dV/VdP) and %A were less for i load than for .1 load; heart rate was 
slightly less (72±9 for i load vs 78±12 for .1 load). 
Table (p<.05 for all parameters): 
.1load 
iload 
peakP 
(mmHg) 
114+13 
144±20 
LVEDP EDVI 
(mmHg) (ml/M2) 
1O± 5 69±13 
24±1O 88±1O 
A 
(ml) 
31+9 
23±9 
%A 
35±6 
22±7 
dV/vdP 
(mmHg-l) 
.05+.03 
.02iol 
Thus, short-term changes in loading conditions significantly influence 
the percent atrial contribution to LV filling, which has been used in 
the assessment of diastolic function by Doppler. Furthermore, in 
normals, load-induced alterations in operating compliance produce 
changes in %A which are directionally opposite to those thought by 
some to occur with long-term changes in LV compliance. 
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NIDATIVE LEFT VENTRICULAR PRESSURE DURING BETA-ADRENERGIC 
STIMULATION IN HUMAN SUBJECTS: EVIDENCE FOR DIASTOLIC 
"SUCTION" IN THE NORMAL HEART 
James E. Udelson, M.D., Stephen L. Bacharach, Ph.D., 
Richard O. cannon, M.D., F.A.C.C., Robert O. Bonow, M.D., 
F.A.C.C., NHLBI, Bethesda, Md. 
Negative LV pressure (diastolic "suction") can be record-
ed in experimental models at low LV volume and arterload, 
and in humans with mitral stenosis. To assess whether 
this may occur in normal humans, we studied LV pressure-
volume relations and coronary sinus blood rlow in 8 pts 
with chest pain and normal coronary arteries. Simultaneous 
LV volume and pressure data (by radionuclide angiography 
and micromanometer catheters) were obtained by EOG gating 
(representing the average or at least 250 cycles) in the 
basal state, during rapid atrial pacing, and during iso-
proterenol (Iso) iDrusion to a similar heart rate. Com-
pared to pacing, Iso reduced end-systolic volume (p(.005), 
end-systolio pressure (p(.005), residual rraotion (p( 
.005), and T 1/2, the halr-time or pressure deoline arter 
peak negative dp/dt (p(.OOl). Negative diastolic pressure 
developed in 7 or 8 pts during Iso (range -.5 to -2.4mmHg) 
but in only 1 or 8 during pacing (-.2 mmHg). The magni-
tude or reduotion in minimum diastolic pre sure during Iso 
was related to the change in end-systolio pressure (r=.87, 
p<.OOS), end-systolic volume (r=.86, p(.006), residual 
rraotion (r=.92, p(.OOl), T 1/2 (r=.90, p(.002) and ooro-
nary rlow (r=.83, p(.002). Henoe, negative LV pressure 
develops in the normal heart during Iso, a situation sim-
ilar to exeroise, and is related to LV systolic unloading 
and derormity, to ooronary blood rlow, and to the dynamios 
or isovolumic relaxation. This negative pressure contrib-
utes to the LV-LA pressure gradient, enhancing the rate 
and magnitude or LV filling required to maintain a high 
oardiao output at elevated heart rates. 
AGE RELATED CHANGES IN LEFT VENTRICULAR FILLING ARE 
RELATED TO COMPENSATORY LEFT VENTRICULAR HYPERTROPHY. 
Shimon Braun, M.D., Jadwiga Szlachcic, M.D., Julio 
Tubau, M.D., Steven Henderson, B.S., Barry Massie, M.D., 
F.A.C.C., VAMC and University of California, San 
Francisco, CA 
Left ventricular filling is abnormal in hypertension and 
coronary artery disease (CAD), but both the prevalence 
and severity of these increase with age. To examine the 
influence of aging alone on diastolic filling, we 
studied 40 active normotensive volunteers aged 21-78 
years with an expected prevalence of CAD of <1% by 
mUltiple non-invasive tests. LV ejection fraction (EF), 
peak filling rate (PFR) and first 1/3 filling fraction 
(FFl/3) were derived from list mode radionuclide 
angiograms by standard methods and related to systolic 
blood pressure, echocardiographic LV mass index and 
meridional wall stress. 
LV filling, as reflected by PFR and FFl/3, declined 
significantly with age (r--.61 and -.36, p<.OOl and .02, 
respectively), but there was no significant relation 
between EF and age. Systolic blood pressure and, to a 
lesser extent, LV mass rose with age (r-0.S4 and 0.34, 
p<.OOl and .03, respectively), while wall stress was 
unchanged. Of note is that PFR and LV mass were 
moderately correlated (r--.4S, p<.OOS). 
These findings indicate that LV filling rates decline 
with age even in healthy individuals, and that this may 
largely reflect decreased LV compliance due to 
age-related changes in blood pressure and myocardial 
mass. 
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EARLY INFLATION OF AN INTRA-AORTIC BALLOON AUGMENTS LEFT 
VENTRICULAR RELAXATION RATE: A MANIFESTATION OF LOAD-
DEPENDENT RELAXATION. MR Zile MD,FACC, WH Gaasch MD,FACC. 
Tufts University and VA Medical Center, Boston, MA. 
In isolated cardiac muscle studies, loads imposed late 
in systole cause premature and more rapid relaxation. We 
studied this phenomenon in S conscious dogs by inflatin~ 
an intra-aortic balloon (lAB, descending thoracic aorta), 
immediately prior to aortic valve closure. Animals were 
medicated with morphine (1mg/kg), propranolol (1mg), and 
lidocaine (sc, for arteriotomy). Aortic and LV pressures 
(p) were measured with micromanometers. Peak(-}dP/dt 
(mm Hg/sec), time to peak(-}dP/dt (msec), and time to the 
instant that LVP declined to SO% of its peak value (PSO, 
msec) were taken as indices of the rate of LV relaxation 
and the duration of systole. Initially, the lAB was in-
flated at the aortic dicrotic notch and deflated prior to 
the next systole in a 1:8 sequence (each inflation beat 
was separated by 7 control beats). After 3-S of these 
sequences, the time of inflation was moved progressively 
earlier (in 30 msec steps) and data were obtained through-
out ejection. Data (mean ± SO) below are from lAB infla-
tions 90±S msec prior to aortic dicrotic notch. * = p<O.OS 
vs control. Peak Time to Peak 
LVP (-}dP/dt (-}dP/dt PSO 
Control ~ 3090±26S 304±18 ~ 
lAB 122±12 347S±484* 284±21* 299±19* 
Balloon inflation in the latter 1/3 of ejection caused 
relaxation to be premature (decreased time to peak(- )dP/dt} 
and more rapid (increased peak(-)dP/dt}, resulting in a 
reduction in the duration of systole. The mechanism 
responsible for these findings is the load-dependence of 
myocardial relaxation. Inflating an lAB just prior to 
aortic valve closure may be of clinical benefit to 
patients with impaired relaxation and congestive heart 
fa il ure. 
EFFECT OF ARTERIAL WAVE REFLECTIONS ON VENTRICULAR 
OUTPUT. William G. Kussmaul, M.D., Jeffrey Weiland, 
M.D., H. Graham Parker, M.D., Jonathan Altschuler, M.D., 
Warren K. Laskey, M.D., F.A.C.C. University of 
Pennsylvania, Philadelphia, PA 
To measure the effect of pulse wave reflections at the 
entrance to the arterial tree, high-fidelity recordings 
of pressure (P) and flow velocity were made using 
catheter-tip transducers in the proximal pulmonary artery 
in 11 patients with normal PA pressures and 9 patients 
with chronic PA hypertension, and in the proximal aorta 
in 9 control subjects. Signal-averaged pressure and flow 
wave-forms were mathematically decomposed into forward 
and reflected waves, and peak reflected/forward ampli-
tudes (reflection factor, RF) were determined. BWAT= 
backward wave arrival time (msec from ECG Q-wave). 
~SV=reduction in stroke volume due to the reflected wave 
(measured wave minus forward wave). Mean values are 
given. *p<.05 
Normal Left Heart 
Normal Right Heart 
MEAN P 
96 
* 
13 
* 
RF 
.70 
* 
.29 
* 
SWAT 
348 
* 446 
* 
~SV 
-29 
-19 
Pulmonary Hypertension: 36 .70 288 -36 
(mmHg) (msec) (ml) 
In all 3 groups, reflections resulted in a substantial 
difference between measured and forward waves. In the 
normal PA, reflections are low-amplitude and occur later 
than in the normal left heart. Pulmonary hypertension 
results in earlier, high-amplitude reflections which 
return in mid-systole and, by augmenting right ven-
tricular afterload, may contribute significantly to 
limitation of RV ejection performance. 
ABSTRACTS 
INFLUENCE OF 008UTAMINE ON FUNCTION OF THE TOTAL ARTIFI-
CIAL HEART 
Philip F. Binkley, M.D., Kevin D. Murray, M.D., Stephen 
A. Fahrig, M.D., Kim M. Watson, M.D., P. David 
Myerowitz, M.D., Carl V. Leier, M.D., F.A.C.C., The Ohio 
State University, Columbus, Ohio. 
35A 
Dobutamine is a synthetic catecholamine which increas-
es cardiac output in congestive heart failure. This 
response is largely attributed to direct inotropic ef-
fects on the myocardium. To determine whether vascular 
effects of this agent may contribute to enhanced cardiac 
output, the response to dobutamine was examined in S 
calves after replacement of the native ventricies with 
the Jarvik 7 total artificial heart. Cardiac output, 
pulmonary and systemic pressures were measured at base-
line and during dobutamine infusion. In 3 calves, cen-
tral aortic pressure and flow were measured for deriva-
tion of aortic characteristic and input impedance. 
Cardiac output increased significantly in the S calves 
from a baseline of 6.17±1.90 to a peak of 7.S1±1.9S 
L/min (mean±SD; p<O.OOOl). Systemic and pulmonary 
vascular resistances significantly decreased from a 
baseline of 1539±S86 to 904±342 d-s/cmS (p<.02) and 
4S1±367 to 312±328 d-s/cm5 (p<.OS) respectively. Aortic 
characteristic impedance decreased from a baseline of 
140.3±160 to 9S.5±30.9 d-s/cmS (p=.06) and individual 
moduli of impedance were reduced. These data indicate 
that in addition to positive inotropic activity, 
dobutamine increases cardiac output through peripheral 
vasodilation and reduction of pulsatile hydraulic load. 
Monday, March 28, 1988 
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Abnormalities of Diastolic Function 
EARLY ALTERATION IN DIASTOLIC INFLOW PATTERN I~ RESPONSE 
TO PROGRESSIVE LEFT VENTRICULAR HYPERTROPHY 
Pamela S. Oouglas, M.D., F .A.C.C., Barbara Berko, M.D., 
CynthIa Parr, Alfred loll, MIchael Lesh, M.D., ~athaniel 
Reichek, M.D. University of Pennsylvania, Phila., PA. 
To examine the functional consequences of progressive LV 
hypertrophy, we analyzed diastolic LV inflow and relaxa-
tion parameters in 13 dogs before and 4, 8 and 12 (n=7) 
weeks after creation of perinephritic hypertension. LV 
echograms were digitized for dimensions, mass, and peak 
rates of wall thinning (-dh/dt/h) and cavity enlargement 
(dD/dt/D). Doppler recordings of LV inflow were analyzed 
for peak early (E) and late (A) diastolic velocities, 
their ratio, and atrial filling fraction (%AF; fA/E+A). 
Over 4 wks, systolic blood pressure rose from lS8 to 231 
mm Hg. Heart rate, cavity size and systolic shortening 
were unchanged at all data points. Other results were: 
(*p<.05 v. baseline, ANOVA; wT=diastolic wall thickness) 
LV Mass WI E E/A %AF dD/dt/D -dh/dt/h 
gm cm cm/sec 
Base 77 .64 65 1.94 27 6.2 -13.6 
4 wk 102* .92* 63 1.57 32 5.0 - 9.5 
8 wk 106* .91* S8 1.27* 36* S.O - 8.6 
12 wk 114* .98* 58 1.14* 37* 4.7 - 8.S 
Following the creation of hypertension, LV mass and wall 
thickness rose rapidly, accompanied by alterations in the 
LV inflow pattern, largely due to increased A velocity 
rather than a decrease in E. Dimensional indices of 
relaxation and filling were less markedly changed. 
Thus, an increased atrial contribution to filling is an 
early consequence of hypertrophy, whether due to augmented 
intrinsic function or early diastolic dysfunction. Doppler 
detection of such abnormalities may be useful in the 
evaluation of hypertensive heart disease. 
36A ABSTRACTS 
LIMITATIONS OF THE CDEFFICIENT OF PASS IVE ow.t3ER 
STIFFNESS IN DILATED CARDIOMYOPATHY 
Roberto M. Lang, M.D., FACC, John D. Carroll, M.D., Sol I. 
Rajfer, M.D., FACC, Lynn Weinert, B.S., Alex Neumann, B.S., 
Kenneth M. Borow, M.D., FACC, University of Chicago, IL. 
Perlcardlal restraint and/or ventricular Interaction In dilated 
cardiomyopathy (CM) may be Intermittent and change acutelY 
with drug Interventions. Accordingly, the effects of dopamine 
[(DAl; 6 \.II/kg/min] on end-diastolic dimension (EDD, em), right 
atrial pressure (RAP, mmHg), pressure decay (T, ms), diastolic 
pressure-dimension (P-D) relations, and pass Ive chamber stiffness 
((a); I.e; slope of the log P-Iog D relation] were studied In 15 pts 
with CM using simultaneous micro manometer pressures and 2-D 
targeted M-mode echo. Patients were divided according to their 
LVEDP response to DA: group 1 LVEDP ~ (G1) and group 2 
LVEDP tor NC (G2). IC = control] 
IGp 1 _ 
EDP n~);~r EDD RAP T a ~ £. 
G1 ~A ~:§+ 1~*+ ::;:+ ~: !~:+ ~~§ ~r~z I;;' 
G C 26 14 7.0 13 71 13 
2 DA 33+ 17 6.9 15+ 58+ 49+ LOG LYD 
*:p<O.OS G1 vs G2; §:p<O.Ol G1 vs G2; +:p<O.Ol vs C 
In G1 DA caused an early downward shift In P-D relation with an 
acceleration In T, yet In late diastole the decrease In LVEOP was 
appropriate for the decrease In EDD. In the control state G2 pts 
had t ED D; t RAP and prolonged T when compared to G1. 
Subsequently DA elevated LVEDP without an Increase In EDD 
resulting In Increased a. Thus, (1) changes In chamber stiffness 
occurred In CM (G2) with DA probably reflecting exacerbation of 
perlcardlal restraint/ventricular Interaction due to systemic 
venoconstrlctlon (alpha-adrenoceptor mediated) and (2) prolonged 
relaxation and Its modification by drugs further precludes the 
calculation of true passive chamber properties. 
DIASTOLIC FUNCTION AND STRUCTURE ABNORMALITIES IN 
DILATED CARDIOMYOPATHY. 
Antonio Gaglione, M.D., Adele Chiddo, M.D., Otto 
Hess, M.D., Nicola Locurato10, M.D., Alessandro 
Bortone, M.D., Paolo Rizzon, M.D .. Cardio1ogy, 
University of Bari, Italy. 
Ten controls (C) and 10 dilated cardiomyopathies 
(DCM) were studied by simultaneous micromanometry 
and angiography. Endomyocardia1 biopsies were 
taken in DCM and myocardi a1 damage was eva1 uated 
from semiquantitative score (SC, 1-3). LV 
ejection fraction (EF, %), and myocardial 
stiffness constant (K) using viscoelastic model 
were determined. OCM were divided according to K: 
DCM1 (n=5) K ~ 3.9, OCM2 (n=5) K> 3.9 (normal 
range 1.4-3.9). 
C 
OCM1 
DCM2 
L VEOP 
1 0 ~* 1 
28 J ** 
29 .I 
EF 
64 ~* 1 
36 I ** 
40' .I 
* p < .05; ** P< .01. 
K 
2.2 1 
2.8'** 
6.7 j J 
SC 
1 .5' 
2. 5 ~ 
Conclusions: In DCM, muscle stiffness (K) can be 
normal despite severely 
performance (EF). In DCM2 
increased and myocardi a1 
pronounced. 
reduced ejection 
muscle stiffness is 
damage (SC) more 
Thus, diastolic myocardial stiffness helps to 
identify patients with severe structural 
alterations (SC) representing possibly a more 
advanced stage of the disease. 
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EFFECTS OF VERAPAMIL ON LEFT VENTRICULAR DIASTOLIC FUNCTION 
IN PATIENTS WITH CORONARY ARTERY DISEASE. 
Sandra Betocchi, M.D., Federico Piscione, M.D., Pasquale 
Perrone-Filardi, M.D., Bruno Alfano, M.S., Gabriella 
Giustino, M.D., Maurizio Cappel1i-Bigazzi, M.D., Marco 
Salvatore, M.D., and Massimo Chiariello. M.D., F.A.C.C. 
University of Naples 2nd School of Medicine, Naples, Italy. 
Intravenous Verapamil (V) has been shown to improve LV 
filling in hypertrophic cardiomyopathy, hypertension, and 
coronary artery disease. Such an improvement could be due 
to enhanced relaxation, improved synchrony, or to a negative 
inotropic effect through an increase in filling pressure. 
To assess the mechanism(s) by which V increases peak filling 
rate (PFR) we studied 6 Pts with coronary artery disease by 
simultaneous high temporal resolution radionuclide angio-
graphy, high fidelity LV pressure recording, and right heart 
catheterization, before and duringV(.Ol mg/kg+.007 mg/kg/ 
min, i.v.). With this technique, pressure-volume loops could 
be obtained. Heart rate was held constant at 100 beats/min 
by atrial pacing. V did not affect CO, LV ejection time, 
isovolumic relaxation period, time to PFR, end-diastolic 
volume, and an index of LV asynchrony. In contrast, ejection 
fraction and the end-systoliC pressure/volume ratio decreased 
(61+12 to 56+13%, p<.05and 2.6+1.9to 1.S+.Sml/mmHg, p<.10), 
and-pulmonary wedge pressure -and LVEDP increased (13+5 to 
14+5 mmHg, p<.Ol and 11+4 to 14+3 mmHg, p<.Ol). PFR rose 
(2~1+.8 to 3.1+1.0 end-diastolic volumes/s, p<.Ol), but 
the time constant of isovolumic relaxation worsened 
(36+7 to 43+9 ms, p<.10). Thus, V increases PFR because of 
its-negative inotropic effect and consequent increase in 
filling pressure, whereas LV relaxation worsens and LV 
asynchrony remains unchanged. Late filling is unaltered, 
as the diastolic pressure-volume relationship shows an 
upward-rightward shift. 
DIFFERENCES IN DIASTOLIC FUNCTION INDICES BETWEEN 
NON-REJECTING CARDIAC TRANSPLANTS AND AGE MATCHED NORMALS: 
IMPORTANCE FOR EVALUATION OF HEART ALLOGRAFTS ACUTE 
REJECTION. 
Barbara Czerska, M.D., Robert W. Stewart, M.D., F.A.C.C., 
Fetnat M. Fouad-Tarazi, M.D., F.A.C.C., Norman B. Ratliff, 
M.D., Bernadine Healy, M.D., F.A.C.C •• Cleveland Clinic 
Foundation, Cleveland, Ohio 
The effect of subclinical episodes of rejection on the 
heart are not well explored. Accordingly, left 
ventricular (LV) function was evaluated in 28 patients 
after cardiac transplantation using computer analysis of 
echocardiograms, at 8.7:t9 (SO) mos after surgery. Data 
were first analyzed in six patients studied during their 
non-rejection (NR) and rejection state. Rejection was 
associated with decreased normalized peak rate of _tV 
posterior wall thinning (dH/dt, 10.3:t4.4 to 5.5:t2.0 sec , 
p < 0.005) and decreased diastolic mitral valve slope, 
(14.6:t3.8 to 10.4:t4.8 cm/sec, p < 0.02). LV mass and 
systolic function defined by fractional shortening were 
not altered by rej ection. When compared with 10 normal 
subjects of similar donors' age, non-rejecting allografts 
showed increased dH/dt (Normal a 4.4:t0.9, p < 0.001). 
Results were similar when we compared the total group (10 
patients in rejection with IS without rejection) using 
unpaired t-test. 
We conclude: 1) Rejection impairs ventricular diastolic 
function without changes in systolic function. 2) 
Non-rejecting hearts, however, show faster diastolic 
relaxation than normals; the latter may reflect altered 
adrenergic sensitivity of the denervated heart. These 
findings suggest that functional criteria for normal 
values in the transplanted hearts, may need 
reconsideration. 
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COMPARATIVE EFFECTS OF VERAPAMIL AND NITROPRUSSIDE ON 
LEFT VENTRICULAR FUNCTION IN PATIENTS WITH HYPERTENSION 
John E. Brush, M.D., F.A.C.C., James E. Udelson, MD, 
Hartin B. Leon, M.D., F.A.C.C., Stephen L. Bacharach, 
Ph.D., Terri Rumble, BSN, Robert O. Bonow, MD, FACC. 
NHLBI, Bethesda, Md. 
LV diastolic function is impaired in many pts with hyper-
tension and therapy can have variable effects on LV fil-
ling. We studied the effects of intravenous verapamil 
and nitroprusside on LV function in 10 symptomatic (an-
gina, normal coronary angiograms) pts with hypertension 
using simultaneous radionuclide angiography and microma-
nometer catheters to assess LV pressure-volume relations, 
with atrial pacing to match heart rate. Compared to 
baseline, nitroprusside decreased cardiac in~ex (CI, p< 
• 05), end-diastolic volume index (~DVI, ml/m , p<.005), 
and stroke-volume index (SVI,· ml/m ,p<.OOl). Compared 
to nitroprusside at similar arterial pressure (MAP) vera-
pamil decreased ejection fraction (EF, p<.005) and 
shifted the end-systolic pressure-volume relation down 
and rightward in all pts, indicating.a negative inotropic 
effect. However, verapamil increased CI (p<.05), EDVI 
(p<.005) and SVI (p<O.Ol) and shifted the end-diastolic 
pressure-volume relation down or rightward in B/lO pts 
indicating improved LV filling. 
HR MAP 
Baseline 106+1B ~ 
Nitroprusside 116;13 105;13 
Veupamil l1l::t16 109::t12 
CI 
3.l+.B 
2.7;.6 
3.3::t.7 
EDVI 
56+16 
41;11 
7 o::t3 0 
SVI 
2B+5 
24;5 
3l::tB 
EF 
52+10 
60+"14 
46;!:.10 
W~ conclude 1) in addition to arterial dilatation, the 
hypotensive effect of nitroprusside is due to a reduction 
in preload which impairs LV performance and 2) despite 
the significant negative inotropic effects, verapamil 
maintains SVI and CI by improving LV filling. 
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Effects of Ischemia on Myocardial Metabolism 
GRADIENTS OF MYOCARDIAL ADENINE NUCLEOTIDE DEGRADATION 
DURING TOTAL ISCHEHIA 
Emily A. Hull-Ryde, B.A., Robin G. Cummings, M.D., 
D. James Schumacher, M.D., J. Alan Menius, Jr., B.S., 
James E. Lowe, M.D., F.A.C.C. 
Duke University Medical Center, Durham, NC 
ATP and its catabol1tes (CAT = ADP+AMP+ADO+INO + 
hypoxanthine + xanthine) were assayed to characterize 
left and right ventricular (LV and RV) and 
interventricular septal (IS) metabolism during ischemia 
in a model independent of collateral flow and wall 
tension. LV and RV free wall and IS slabs were created 
immediately after heart excis'ion in 24 dogs and 
maintained at 37°C for sampling at control and IS min 
intervals for 90 min of total ischemia. Protein content 
between regions did not differ (17.2 t 0.3%). 
Adenine Nucleotide Degradation 
Region Control IS min 
ATP LV S.3±0.1 3.4±0.1 
RV S.2±0.2 3.6±0.2 
IS S.OtO.1 3.3±0.1 
CAT LV 1.7±0.1 3.StO.1 
RV 1.6±0.2 3.3±0.1 
IS 2.1±0.2 3.7±0.1 
(llmol/ g wet wt) 
30 min 60 min 
2.3tO.1 0.7±0.1 
2.7tO.1 1.ltO.1 
2.3tO.1 0.7±0.1 
4.S±0.1 6.1±0.1 
4.2tO.1 S.7±0.1 
4.7±0.1 6.3±0.1 
These data are the first to accurately account for the 
entire adenine nucleotide pool during ischemia (recovery 
as % of control 99 ± 1%). ATP degradation was 
significantly accelerated in LV and IS compared to RV 
(p<. OS), suggesting increased risk for both the LV and 
septum during ischemia compared to the right ventricle. 
ABSTRACTS 
EFFECTS OF PRE-ISCHEMIC CATECHOLAMINE DEPLETION ON 
MYOCARDIAL METABOLISM AND TOLERANCE TO TOTAL ISCHEMIA 
D. James Schumacher, M.D., Robin G. Cummings, M.D., 
J. Alan Menius, Jr., B.S., James E. Lowe, M.D., F.A.C.C. 
Duke University Medical Center, Durham, NC 
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Endogenous myocardial catecholamines have been 
implicated in the acceleration of myocardial ischemic 
injury. This study investigated the effects of 
myocardial catecholamine depletion on subsequent 
depletion of ATP, accumulation of lactate, and 
development of ischemic contracture during total ischemia 
in the dog heart. Catecholamine depletion was documented 
in 10 dogs after reserpine treatment (O.S mg/kg/day x 2 
days). Ten dogs served as controls. Hearts were excised 
and maintained at 37.SoC during 90 minutes of ischemia . 
ATP depletion and lactate accumulation were delayed in 
the left ventricle (LV) and right ventricle (RV) of 
catecholamine-depleted dogs (p < O.OS, ANOVA). 
Catecholamine depletion had no differential effect on ATP 
or lactate levels in the LV as compared to the RV. 
Ischemic contracture, which correlates with irreversible 
cell injury, occurred Significantly later in 
catecholamine-depleted myocardium (6S.3±I.S min) than in 
controls (S8.0±1.8 min), p < 0.001. These data show that 
catecholamine depletion prior to ischemia I) preserves 
ischemic myocardial high-energy stores, even though 
anaerobic glycolysis is inhibited, and 2) significantly 
delays the onset of ischemic cell death. These results 
suggest that myocardial catecholamine levels mediate the 
rate of high energy compound utilization and attempted 
production during ischemia. 
TISSUE KIIlETICS OF C-ll ACETATE AS A TRACER OF MYOCARDIAL 
OXIDATIVE METABOLISM IN CANIIIE MYOCARDIUM 
Juergen Armbrecht, M.D., Denis Buxton, Ph.D., Herbert 
Hansen, B.A., Heinrich R. Schelbert, M.D., F.A.C.C., UCLA 
School of Medicine, Los Angeles, CA. 
Tissue kinetics of C-Il acetate (AC) as a tracer of oxida-
ti ve myocardial metabol i.sm were studied in 20 experiments 
in 12 open chest dogs. A 0.2 to 0.4 ml C-ll AC bolus was 
injected into the LAD to minimize tracer recirculation and 
tissue activity monitored with a NaI scintillation 
probe. Oxygen, glucose, lactate and free fatty acid con-
sumption was determined by the Fick method using micro-
sphere blood flow (F). C-ll activity cleared biexpon-
entially from myocardium. From the tissue time activity 
curves, single capillary transit extraction fractions (E) 
and clearance rates (k) were determined by monoexponential 
(only the initial rapid curve component) and biexponential 
least squares curve fitting. E averaged 68.0±8.8% SD and 
was independent of MY02 , F, substrate levels and substrate 
utilization. k determined by bi- and monoexponential 
fitting correlated with MV02 (range 5.1 to 22.6 
ml/min/IOOg) by r=0.74 and r=0.87, respectively, and was 
independent of substrate levels and consumptions. Follow-
ing co-injection of C-14 AC in 7 studies, C-14 CO2 and 
total C-14 activity in coronary sinus effluent were deter-
mined. C-14 COL accounted for 98.4±0.7% of total C-14. 
C-14 CO2 clearance correlated with C-ll tissue clearance 
by r=0.98. Thus, C-Il AC clearance reflects labeled COL 
clearance and hence, tricarboxylic acid cycle flux and 
oxidative metabolism. The close relation between k and 
MY02 , which was independent from substrate levels and 
consumption, supports the utility of C-ll AC as a tracer 
for noninvasive PET measurements of regional myocardial 
oxidative metabolism. 
38A ABSTRACTS 
SIMULTANEOUS MEASUREMENT OF REGIONAL MYOCARDIAL METABOLISM 
AND FUNCTION BY MULTI-CATED POSITRON EMISSION TOMOGRAPHY 
(PET) • 
Christoph Nienaber, M.D., Osman Ratib, M.D., Luc Bidaut, 
Ph.D., Michael E. Phelps, Ph.D., and Heinrich R. 
Schelbert, M.D., F.A.C.C., UCLA School of Medicine, Los 
Angeles, CA. 
Multi-gated PET imaging of normal and ischemic myocardium 
labeled with a metabolic tracer could, in addition to 
regional metabolism, provide information on regional myo-
cardial function. Also, noninvasive quantification of 
metabolic rates requires accurate determination of region-
al tissue tracer concentrations from PET images.. To de-
rive these parameters from gated PET images, we studied 10 
closed chest dogs with 0-15 CO for blood pool and with r-
18 deoxyglucose for tissue labeling. Cross-sectional PET 
images were acqui red at 16 frames per cardiac cycle and 
analyzed by a semi-automated routine for myocardial edge 
detection and sectorial fragmentation that yields regional 
wall thickness and automatically corrects for activity 
spillover and partial volume. Regional wall thickness in 
64 normal and 16 ischemic akinetic sectors by PE:T corre-
lated with simultaneous 2D echo (diastole: 2D echo 
11.4±1.2 mm vs PET 12.8±1.3 mm NS; systole: 2D echo 
4.1±1.0 vs IS.2±1.S,NS). Ischemic wall motion abnormal-
ities were accurately detected using sectorial area 
changes from gated PET (S±IO% vs 34±l1% control; 
p<O.OOll. rDC concentrations from PET images correlated 
closely to in vitro well counting by y=1.02x -500 
cts/min/g; r=0.96 (p<O.OOl). We conclude that in addition 
to accurate measurements of regional tracer tissue 
concentrations as a base for metabolic measurements, 
multi-gated PET imaging provides information on regional 
myocardial function. It allows simultaneous comparison of 
regional metabolism to regional function. 
EFFECTS OF REPERFUSION ON MITOCHONDRIAL FUNCTION IN HEART 
MUSCLE. 
Luc Demaison, Ph.D., A. James Liedtke, M.D., F.A.C.C., 
Earl Shrago, M.D., Stephen H. Nellis, Ph.D., Section of 
Cardiology, University of Wisconsin, Madison, WI 
The purpose of this study was to characterize elements 
of mitochondrial performance in a model of stunned 
myocardium. Intact, working, extracorporeally perfused 
swine hearts (n-9) supplemented with fatty acid substrate 
were used. The anterior descending (LAD) bed was ren-
dered ischemic (-60 IJ. % in flow) for 45 min and then 
reperfused for 35 min. Tissue from LAD and aerobic beds 
were assayed for mitochondrial adenine nucleotides (AN), 
membrane cholesterol, phosphat idyl cholines, phosphat idyl 
ethanolamines, and velocity of adenine nucleotide trans-
locase (ANT). Ischemia induced a 73±10% decrease in LAD 
contractility which recovered only 47t16% during reflow 
but was accompanied by a +111 IJ.% rebound in fatty acid 
oxidation. Mitochondrial LAD-exchangeable AN at end-re-
flow were markedly depleted from aerobic levels (4.61t 
0.15 vs 7.84±.50 nmol/mg protein, p < .010). In vitro ANT 
velocity of LAD mitochondrial membrane was depressed from 
aerobic values (165±23 vs 430±46 nmol/min/mg protein'2P < 
0.001) and correlated closely with exchangeable AN (r • 
0.87, p <.001). Independent of this depletion in AN, 
there was an enhancement of ATP/ADP ratio (+20 IJ.%, P < 
.05) which also suggested an in vivo depression of ANT 
velocity. Membrane LAD cholesterol was increased (+34%, 
p <0.05) while individual phospholipids remained 
unchanged. Thus, despite favorable utilization of 
preferred substrate in reperfused myocardium, a primary 
disorder of energy metabolism persists as reflected by 
matrix AN. This depletion associated with an increase in 
membrane cholesterol contributes to impaired mitochon-
drial ATP transport and may in part explain mechanical 
stunning. 
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SYSTEMIC Ar-ll CARDIAC NEURCJIfJ-1ORAL CHANGES DlJUNG MYOCARDIAL ISCHEMIA IN 
H~NS. IS THERE A RATIONALE FDR CONVERTING-ENZY~ INHIBITION? 
Willem J. Renme, i>{),FACC, Peter de Leeuw, i>{), Dick Kruyssen, i>{), Diederik 
van Hoogenhuyze, i>{), Zuiderziekenhuis, Rotterdam. The Netherlands. 
The evidence for changes in catecholamine levels during myocardial ische-
mia in man is conflicting, whereas no data exist on its effect on the 
renin-angiotensin system. To investigate the occurrence of ischemia-indu-
ced neurohumoral changes, 32 normotensive fasting patients (pts), with 
coronary artery disease, without treatment or premedication, were studied 
during incremental atrial pacing (10 beatsl2 min) with simultaneous arte-
rial (ART) and coronary sinus (CS) sampling for Lactate (L), catecholami-
nes: Norepinephrine (1'£), Epinephrine and Dopamine (COMT Itf'LC) and Angio-
tensin U (AU) at control (C), maximal pacing rates (MAX) and 1,5 and 3D 
min post-pacing (p-p). Based on L-production andlor ST -changes during 
pacing pts were grouped as ischemic (1, n=25) or non-ischemic (NI, n=7). 
Baseline hemodynamic, metabolic and neurohlJlloral parameters were similar 
in I and NI. During pacing maximal heart rates, double product, LV systo-
lic and aortic pressures and coronary flow were equal in both groups. In 
contrast, systemic resistance increased significantly with 24%, 5 min Pop 
in I (p<.D5 vs C). ART and CS Epinephrine and Dopamine levels did not 
change during the study in either group, nor did NE and AIl levels in Gr. 
NI. Changes in L-extraction (%), NE (nmol/l) and AU (pmol/l) in Gr. I 
are given below (xtSEM; *p<.05 vs control). 
L -extraction 
ART 1'£ 
CS NE 
ART AIl 
CS AIl 
Control NIX 1 • P'jI 
20+3 -40+11* -40+12* 
1.8+0.2 2.8+0.3* 3.2+0.4* 
2.6+0.3 3.2+0.4 3.3+0.3 
6.3+1.4 8.8+2.0* 9.5+2.1* 
6.2+1.3 6.8+2.0 7.0+1.6 
11+5 
2.4+0.4 
3.0+0.5 
6.1+1.0 
5.5+1.0 
18+3 
2.1+0.25 
3.0+0.5 
7.1+1.8 
6.3+1.3 
Transmyocardial 1'£ release at baseline (-0.06±0.02 nmol/min) changed to 
uptake during pacing (0.07,±0.05 nmol/min, MAX, p<.05). Thus, whereas pa-
Cing alone does not result in neurohlJlloral changes, systemic 1'£ and AU 
levels increase significantly during pacing-induced ischemia, accompa-
nied by systemic vasoconstriction. These results indicate that conver-
ting-enzyme inhibition may be of additional value to conventional 
treatment of myocardial ischemia. 
Monday, March 28,1988 
4:00PM-5:30PM, Room 202, Level Two 
Autonomic Nervous System Modulation of Cardiac 
Electrophysiology 
HEART INNERVATION AND DYSRHYTHMIAS ELICITED BY SYMPATHETIC 
STIMULATION IN TWO DIFFERENT CANINE INFARCT MODELS 
Isaac S. Aidonidis, M.D., Johannes Brachmann, M.D., Franz 
P. Gerstheimer, M.D.§, Jurgen Metz, M.D.§, Wolfgang Kubler 
M.D., F.A.C.C., Depts. of Cardiology & Anatomy§, Univ. of 
Heidelberg, Germany. 
The structure and function of cardiac sympatthetic nerves 
were investigated in 24 dogs at various time intervals 
after trans luminal coronary occlusion (Occ, n=12) using 
cyanoacrylate injection into the left anterior descending 
(LAD) coronary artery, and by ligation of the same vessel 
in 12 other animals (Lig). Ventricular arrhythmias were 
produced by electrical stimulation of the left stellate 
ganglion (LSS). Stimulation discharges were 3 ms square 
pulses at 20 Hz and 15-20 V for 5 s. Tissues were dissect-
ed following LSS from infarcted and noninfarcted regions 
distal to obstruction. Using neuropeptide Y (NPY) and sy-
naptophysin as immunohistochemical markers for sympathe-
tic nerves, neuronal fibers were found within infarcted 
regions up to 24 days after Occ whereas no fibers were 
detectable in the Lig dogs. Electron microscopical exami-
nation revealed nerve terminals with transmitter vesicles 
only in the ace model. In dogs 4 and B days after Dec, LSS 
induced sustained ventricular tachycardias (rate between 
145 and 190/min) while 16 and 24 days later nonsustained 
polymorphic rhythms (over 6 beats). In contrast, the ani-
mals subjected to Lig exhibited as max. arrhythmias only 
nonsustained ventricular ectopic rhythms 4 days post Lig 
(2 of 12 dogs) but in later phases of infarction no ar-
rhythmias were contemplated. Thus, the better preserva-
tion of cardiac sympathetic nerves as well as neurally in-
duced ventricular arrhythmias up 24 days after coronary 
Occ may this model preferable to antiarrhythmic drug stu-
dies and useful in understanding mechanisms of sudden 
cardiac death. 
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DIFFERENTIAL INFLUENCE OF BET A-ADRENOCEPTOR 
ACTIVATION ON THE NEGATIVE CHRONOTROPIC EFFECT OF 
ADENOSINE ON THE CANINE SINUS NODE AND 
VENTRICULAR PACEMAKERS IN VIVO 
Amir Pelleg, Ph.D., Akihiko Miyagawa, M.D., Carl Hurt, B.A., 
Paul Coady, M.D., leonard S. Dreifus, M.D., F.A.C.C., Eric l. 
Michelson, M.D., F.A.C.C., The lankenau Medical Research 
Center, Philadelphia, PA 
Adenosine has a negative chronotropic effect (NCE) in vivo which 
can be mediated by both direct and indirect (anti-adrenergic) 
actions. To study the effect of fl-adrenoceptor activation on the 
NCE of adenosine, prolongation of sinus (SCl) and ventricular 
(VCl) pacemaker cycle lengths was determined following bolus 
administration {If adenosine (2 to 6llmol/kg) into the right atrium 
of 7 anesthetized, bilateral stellectomized and cervical 
vagotomized dogs with chronic A V block, at baseline (C), during 
continuous infusion of isoproterenol (ISO; 0.2 Ilg/kg/min) and ISO 
plus propranolol (P; I mg/kg). Results: a. Adenosine prolonged 
both SCl and VCl in a dose dependent manner; b. Ventricular 
pacemakers were more sensitive to adenosine than sinus 
pacemakers, c. ISO potentiated adenosine's effect on sinus 
pacemakers but attenuated its effect on ventricular pacemakers; 
and d. P attenuated this differential action of ISO. Thus, B -
adrenoceptor activation has differential influence on the NCE of 
adenosine on sinus node 
and ventricular pace ~ 
makers in vivo. This 
could be related to a 
differential role of the 
indirect, anti-
adrenergic action of 
adenosine on these 
pacemakers. 
MECHANISMS OF CARDIAC MEMORY 
123456 
~moI/kg 
25 
o 1 2 3 4 5 6 
~mol/kg 
Sheldon L. Bro~stein, M.D., James B. Martins, M.D., 
Department of Medicine and VA Medical Center, University 
of Iowa, Iowa City, Iowa 
When the heart is stimulated eccentrically the sequence 
of depolarization, repolarization and contraction is 
altered. After the His-Purkinje system resumes control 
of ventricular activation T-wave abnormalities on the 
surface ECG appear. Examples of this are seen on resump-
tion of sinus rhythm after termination of tachycardia or 
temporary ventricular pacing. Our purpose was to inves-
tigate the intraventricular electrophysiologic and con-
tractile changes resulting from ventricular pacing and 
to evaluate the role of the autonomic nervous system in 
mediating this form of cardiac memory. Ten closed 
chest, chloralose anesthetized dogs were studied. 
Sonomicrometers and multipolar electrodes were placed in 
the right ventricular apex (RVA) and remote sites. The 
surface ECG was recorded and fractional shortening (FS) 
and ventricular functional refractory period (FRP) were 
measured during atrial pacing (BCLm 50Omsec) both before 
and immediately after RVA pacing (BCLm280 msec) for 30 
minutes. Results (mesn ± SEM, *ap(0.05): RVA pacing 
produced ECG T-wave changes in leads II and V5R associat-
ed with diffuse shortening of FRP (FRP at RVA shortened 
from 224±12 to 214±12* msec) and a deterioration of FS 
limited to RVA (from 16±3 to 11±2%*). These changes 
tended to resolve in (1 hour. After cardiac denervation 
(n=5), lengthening of FRP was greater in RVA than remote 
sites (17 vs 8 msec* respectively) and FS in RVA did not 
deteriorate. Conclusions: 1) RVA pacing produces tran-
sient regional electrophysio10gic and contractile chang-
es, 2) cardiac memory is characterized by local changes 
modulated by neural influences. We speculate that FRP 
changes occurring in the region of an ectopic tachycar-
dia may playa role in tachycardia maintenance. 
ABSTRACTS 39A 
LIDOCAINE INDUCED MALIGNANT VENTRICULAR ASYSTOLE IN 
ANESTHETIZED DOGS WITH RECENT MYOCARDIAL INFARCTION 
Isaac S. Aidonidis, M.D., Johannes Brachmann, M.D., Klaus 
Dembowsky, M.D.§, Horst Seller, M.D.§, Wolfgang KUbler, 
M.D., F.A.C.C., Depts. of Cardiology & Physiology§, Univ. 
of Heidelberg, Germany. 
We have previously shown that lidocaine (L) frequently 
provoked induction of ventricular tachyarrhythmias in un-
conscious dog with subacute myocardial infarction. We now 
demonstrated in 9 closed-chest pentobarbital anesthetized 
dogs that postfibrillatory ventricular asystole (Asy) ob-
served after 6 mg/kg IV L administration 4 to 15 days post 
infarction was refractory to the conventional reanimation 
techniques. In order to elucidate this phenomenon, plani-
metric quantitation of postganglionic cardiac sympathetic 
nerve activity (CSNA) was performed in 8 separate open-
chest animals subsequent to infarction; four dogs receiv-
ed L, and 4 served as controls. Recordings were made from 
the central end of the cut anterior ansa corresponded to 
the left stellate ganglion using bipolar Pt electrodes. 
Results: A) During sinus rhythm (SR), L decreased CSNA by 
39% compared to predrug studies in the same animal. B) In 
control dogs, sympathetic discharges were increased by 
165% and 4% 2 and 4 min after beginning of ventricular 
fibrillation, respectively. C) In antithesis to B, dogs 
received L developed a major decrease of CSNA of 40% and 
65% 2 and 4 min post fibrillation compared to SR, respec-
tively. In conclusion, L plus pentobarbital anesthesia 
markedly depress CSNA following ventricular fibrillation 
leading to malignant Asy. The reasons why low postfibril-
latory cardiac sympathetic tone precipitated irreversal 
ventricular Asy are unclear. 
VAGAL DENERVATION OF CANINE SINUS AND ATRIOVENTRICULAR 
NODES CREATES SUPERSENSITIVE RESPONSE TO ACETYLCHOLINE. 
Shunichi Kaseda, M.D. and Douglas P. Zipes, M.D., 
F.A.C.C., Krannert Institute of Cardiology, Indiana 
University School of MediCine, Indianapolis. 
Supersensitivity of the sinus (SAN) and atrioventricular 
(AVN) nOdes to acetylcholine (ACh) has not been demon-
strated conclusively. Using Randall's new technique, we 
denervated the SAN and AVN by removing the epicardial fat 
pad containing parasympathetic ganglia located at the 
right pulmonary vein-LA junction and at the inferior vena 
caval-LA junction, innervating the SAN and AVN, 
respectively. Six to 9 days after surgery, supramaximal 
vagal stimulation prolonged sinus cycle length (SCL) only 
32% and AH interval during constant RA pacing 23J, 
consistent with denervation. We compared dose response 
curves to ACh (lml, 10-8 to 10-4M in 10. 5 steps) infused 
over 15 sec into the cannulated SAN and AVN arteries in 
chloralose anesthetized open chest dogs that were 
denervated (Den) as above vs sham-operated. Den dogs 
compared with sham dogs showed less [ACh] required to 
prolong SCL 50, 100 or 300~ from the value obtained 
during saline injection and to create 20 or 30 AV block' , 
LoglAChJM SCL PROLONGATION AV BLOCK 
mean±SE 50J 100~ 300J 20 30 
Den -6.4±.1 -6.4±.1 -6.1±.1 -6.3±.1 -5.8±.1 
Sham -5.6±.1 -5.6±.1 -5.4±.1 -5.7±.1 -5.3±.1 
p value (0.001 <0.001 <0.001 (0.001 (0.01 
N= 10(Oen), 10(Sham) 10(Oen), l1(Sham) 
Thus the dose response curve in Den dogs Significantly 
shifted leftward. We conclude that dogs with vagally 
denervated SAN and AVN develop a supersensitive response 
to ACh. Such changes may relate to the development of 
sick sinus syndrome or hypersensitive carotid sinus 
syndrome in pts. 
40A ABSTRACTS 
MODULATION OF THE SUMMATION OF ATRIAL INPUTS TO 
THE ATRIOVENTRICULAR NODE DURING INCREASED VAGAL 
TONE 
Todor Mazgalev. Ph.D •• Leonard S. Dreifus, M.D., F.A.C.C., Eric 
L. Michelson, M.D., F.A.C.C., The Lankenau Medical Research 
Center, Philadelphia, PA 
Summation of atrial wavefronts entering the atrioventricular 
node (AVN) simultaneously from the crista terminalis (CrT) and 
the interatrial septum (lAS) can produce facilitation of AVN 
conduction. To study the effect of the vagus on this input 
interaction, we used programmed electrical stimulation in 7 
rabbit atrial-AVN preparations with an anatomically divided CrT 
and lAS, along with phasic postganglionic vagal stimulation 
(PGVS). Atrial and His-electrograms and AVN cellular action 
potentials were recorded. The following protocols were used: a) 
Phasic response curves of A VN conduction time were constructed 
at constant cycle lengths during stimulation at CrT and lAS 
indi.vidually or simultaneously and by applying PGVS during 
various phases of the cycle; and b) The effect of summation of 
inputs was evaluated before and after PGVS by changing the delay 
between CrT and lAS stimulation. Results: (I) Before PGVS, 
. combined stimulation of CrT and lAS produced the shortest A VN 
conduction time; (2) PGVS more markedly depressed conduction 
initiated at lAS versus CrT in all preparations; and (3) Combined 
stimulation of CrT and lAS during PGVS did not always produce 
the short~st A VN conduction time. Microelectrode recordings 
showed dIfferent degrees of vagal-induced depression of action 
potentials depending on the site of atrial stimulation. 
Conclusion: Increased vagal tone accentuates the critical 
dependence of AVN conduction on the orientation of the 
wavefront. Thus, the interaction of the principal inputs to the 
A VN (CrT and lAS) may depend not only on the relative time of 
arrival of the individual wavefronts, but also on the differential 
effect of the vagus on their specific functional pathways of 
conduction through the AVN. 
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Pharmacology of Antiarrhythmic Drugs: Basic 
BLBCftOPBrSIOLOGIC ACrIORS 01' CLDPILI1JM III ISCBBMICALLY-
IIIJlJlUII) MYOCAlIDI1II. III VIVO All) III VITRO srmms 
Eugene Patterson. PhD • Benjamin J. Scherlag. PhD. FACC. 
and Ralph Lazzara. MD. FACC. Univ. of Okla. Health 
Sciences Ctr. and VAMC. Oklahoma City. OK. 
The electrophysiologic actions of clofilium (C) were 
examined in normal (NM) and ischemically-injured 
myocardium (1M). 4 days after left anterior descending 
artery ligation in dogs. C (2 mg/kg) decreased the atrial 
rate needed to produce conduction block in 1M (319~16 bpm. 
predrug vs. 204+16 bpm. p<0.01). While there were no 
changes in electrogram duration or morphology at 60 bpm. C 
caused a rate-dependent truncation of the 1M electrogram 
at faster rates. C failed to alter NH or His-Purkinje 
conduction at all rates from 60 to 330 bpm. Studies with 
superfu~7d epicardium (n=7) did not demonstrate effects of 
C (3x10 M) upon Vmax. action potential amplitude (APA). 
or conduction times (CT) in either NM or 1M. Action poten-
tial duration (APO) was increased only in NH. C increased 
Vmax (V/sec) APA (mV) ERP (msec) 
pre C pre C pre C 
NH 108~9 109+9 94+3 94+2 147+11 172+13* 
1M 100+10 105+5 88+2 90+2 172+13 269+42* 
*p<0.05 CT (msec) APO (mse~) ERP/APD -
NH 13+2 12+2 159+10 188+15* 93+.05 .93+.04 
1M 22+5 21+5 197+25 194+26 1.03+.08 1.26+.09* 
1M refractoriness CERP) by -97 msec without altering Vmax 
or APO. C increased plateau height in both NM and 1M. 
Rapid pacing and premature stimuli in vitro produced 
truncation of 1M electrograms after Co ~ and APA 
recorded from individual 1M cells were not diminished by C 
despite marked increases in refractoriness. The action of 
C to increase 1M refractoriness and produce electrogram 
truncation without altering Vmax or APD may result from a 
rate-dependent uncoupling of contiguous 1M cells. 
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DIFFERENTIAL EPICARDIAL-ENDOCARDIAL RESPONSE TO 
QUINIDINE: I 
Katherine H. tKavanagh, H.D., Vayne R. Giles, Ph.D., Yuji 
Imaizumi, ph.D., Haria Rahmberg, Robert B. Clark, Ph.D., 
Henry J. Duff, H.D., University of Calgary, Calgary 
Previous in vitro studies assessing differences in 
repolarization time between the epicardium and endocar-
dium have shown a larger transient outward K+ current 
(I ) in the epicardium than the endocardium. Data from 
out laboratory obtained using isolated rabbit cardiac 
ventricular myocytes have shown that the quinidine-
induced prolongation of repolarizaton is mediated by 
blockade of It' Accordingly, we compared the effects of 
quinidine on the intracardiac electrocardiogram QT 
repolarization times recorded from epicardium and en-
docardium in 16 chronically instrumented dogs. Results: 
(ms change from baseline; x ± SO) 
RECORDING SITE 
LV epicardium 
RV epicardium 
RV endocardium 
PACING 
LV epicar ium 
Placebo Quinidine 
:z:;:a- ["27+14 
1±6 * 22±19J'" * 5±4 .. 10±25 
SITE 
RV en ocar lum 
Placebo Quinidine 
~["36+20 
-13±25 26±23.., * 
-3±13 .. 0±5 ..J 
In conclusion, prolongation of repolarization time was 
greater in epicardium than endocardium in keeping with 
in vitro data showing a larger I in the epicardium and 
blockade of It by quinidine (10~H~ in vivo. 
ANl'IARRIIll'mMC ACTICNS OF HIIUOOIN, 11M ALFHA.,-AmEN>-
CEl"ltIl ~ IN 'DIE CDINl!'A-PIG CARDIl\C ~ 
Junichi Hasegawa, MD, Shozo Hirai, MD, Mira Hoshio, MD, 
Hiroshi Kotake, MD, Hiroto Mashiba, MD,FACC. Tottori 
University School of Medicine, Yonago, JAPAN. 
The antiarrhythmic actions of bunazosin (buna), a 
newly developed alpha1-adrenoceptor blocking agent was 
examined in cardiac ventricular muscles of reserpinized 
guinea-pigs using the conventional microelectrode 
technique. Therapeutic concentrations (0.1-0.3 pM) of 
buna suppressed the transient depolarization of 
membrane induced by strophanthidin plus high Ca in a 
dose-dependent manner. Buna attenuated significantly 
the facilitatory effect of hypoxia in catecholamine-
induced depolarization and abnormal automaticity in 
high K (27 mM) solution •• The tonic block of buna on 
the maximum rate of rise (Vmax) of fast and slow action 
potentials was appeared in concentrations higher than 
10 pM in normal Tyrode and in high K solution 
respectively. The use-dependent block en the Vrnax ~ 
Tyrode solution was appeared at stimulation rates 
higher than 1 Hz and even at a rate of 0.2 Hz in the 
presence of 10 pM and 100 pM buna, respectively. '!he 
recovery from the use-dependent block of 100 pM buna 
occured at ~ time constant of 16-17 sec when applying 
the extrastl.mulus after termination of train of 2 Hz 
stimulation. 30 pM buna shifted the hoo -curve by 15.7 
mV to a more negative potential so that 75 % 
inactivation appeared at -72.4 mY. 
These results suggest that buna has an anti-
arrhythmic property mediated by a slow channel blocking 
and a use-dependent and voltage-dependent Na channel 
blocking effect. 
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THE COMBINATION OF METOPROLOL PLUS LIDOCAINE ENHANCES 
ANTIARRHYTHMIC EFFECTIVENESS IN A CHRONIC CANINE INFARCT 
MODEL. E. Neil Moore,D.V.M.,Ph.D.,F.A.C.C., C. William 
Balke,M.D., Cees D.J. DeLangen,Ph.D., Robert Hanich,M.D., 
Alan Kadish, M.D., and Joseph F. Spear, Ph.D.,F.A.C.C. 
University of Pennsylvania, Philadelphia, Pa. 
Lidocaine and Metoprolol are both given to suppress 
tachyarrhythmias in the acute treatment of myocardial 
infarction (MI). We used the chronic canine MI dog model 
to investigate the potential ± antiarrhythmic interac-
tions of lidocaine and metoprolol. The programmed 
electrical stimulation protocol (PES) employed single, 
double, and triple extrasytoles at two basic cycle 
lengths. In 26 animals sustained ventricular tachycardia 
(SVT) (15) or ventricular fibrillation (VF) (11) could be 
reproducibly initiated with PES. Lidocaine was given as 
a bolus of 2 mg/kg followed by a constant IV infusion of 
70 ug/kg/min. Metoprolol was administered at a dose of 
0.75 to 4.0 mg/kg. In 7 of 7 VF dogs, 0.1 mg/kg of meto-
prolol prevented reinitiation of VF for 40 to 130 min. 
In contrast, in 7 dogs with SVT, metoprolol was effec-
tive in only 2 animals in preventing SVT even at 4 
mg/kg. In 5 dogs with SVT, lidocaine only and then lido-
caine plus metoprolol was given. SVT could be initiated 
in aIlS dogs following lidocaine, but in only 2 of 5 
following lidocaine plus metoprolol. In 3 SVT dogs the 
sequence of metoprolol and lidocaine was reversed. With 
metoprolol alone, 2/3 had SVT, 1 had NSVT; following me-
toprolol plus lidocaine, 2/3 had no arrhythmias with 
PES. In 4 VF animals lidocaine was effective in 2/4 and 
metoprolol plus lidocaine in 4/4. CONCLUSION: The 
combination of metoprolol plus lidocaine is more 
effective in suppressing SVT than either drug given 
alone. No proarrhythmic effects were observed with the 
drug combination. Metoprolol alone but not lidocaine 
alone is effective in preventing VF. 
THE CLASS III EFFECTS OF AKIODARONE DEPEND 
THYROID FUNCTION. 
Mario Talajic, M.D., Stanley lIIattel, M.D .• 
Melanie Davies, B.Sc., John McCans, M.D., 
Montreal Heart Institute, Montreal, Canada. 
0111 INTACT 
F.A.C.C .• 
F.A.C.C. , 
It has been suggested that amiodarone' s (A) class III 
effects may be due to inhibition of the cardiac effects 
of thyroid hormone. If so, A would not be expected to 
cause QT prolongation in hypothyroid subjects. We 
compared the ECG changes induced after A in male albino 
guinea pigs randomized into euthyroid and hypothyroid 
groups. Hypothyroidism was induced with parenteral 
administration of I mCi 1-131 followed by a 7 week 
latent period. Pilot studies for 4 weeks in euthyroid 
guinea pigs demonstrated no additional A effect beyond 
1 week. Thus, both groups were treated with daily 
parenteral A (80 mg/kg) for 7 days. ECG intervals were 
compared before and after A. 
Resul ts are reported as " increase in ECG intervals 
after 1 week of A (recorded at 250 rom/sec). 
1m PR ~ QI 
r 33tt 17t r 30t ** Euthyroid 
Hypothyroid L 8 12 11 L 3 
*p<O.Ol, **p<O.OOI euthyroid versus hypothyroid groups; 
t p<O.OI, ttp<O.OOI A versus control. 
Plasma levels of amiodarone did not differ between 
groups (0.7±0.4 versus 0.7±0.6 mg/L, for euthyroid and 
hypothyroid groups respectively). 
We conclude that intact thyroid function is a 
prerequisite for class III and sinus node effects of 
amiodarone, supporting the concept that at least Some 
of amiodarone' s effects are mediated by antagonism of 
thyroid action. 
ABSTRACTS 
HYPOTHYROIDISM ELEVATES VENTRICULAR FIBRILLATION 
THRESHOLD IN RABBITS. 
Nalammal Venkatesh, M.D., William G. Kuhle, M.S., 
cr gory K. leld, M.D., I.A.C.C., Bramah N. Singh, M.D., 
F.A.C.C. Wadsworth VAMC Los Angeles, CA. 
Atrial dysrhythmias are common in hyperthy-
roidism(HET) & rare in hypothyroidism(HOT). Myocardial 
repolarization & refractoriness are prolonged in HOT & 
shortened in HET. However, the effects of altered 
thyroid states on the excitability of ventricular 
myocardium(VM) are not known. The fibrillatory proper-
ties of HOT VM (thyroidectomized rabbits) & HET VM 
(administration of 0.05 mg/kg/day L-T1 S.C.-l wk) were compared to those of euthyroid(EUT) VA. Ventricular 
fibrillation threshold(VFT) was determined by rapid 
pacing (3 ms duration pulses at 20 Hz) in isolated, 
perfused, spontaneously beating rabbit hearts. Vulner-
able period(VP) & VP index(VPI) were determined from 
RI-S2 (duration between R-wave & premature stimulus-40 
rnA, 10 ms duration) that resulted in VF & from QT & QTc 
of the preceding electrogram. Results (means ± SD): 
Groups HR RI-S2 QT VP VPI VFT 
(bpm) (ms) (ms) Rl-S2 Rl-S2 (rnA) 
QT QTc 
EUT 114 129 260 0.42 0.26 2.1S 
(n=12) ±25 ±21 +24 :to.OS +0.07 ±0.51 
HOT 90* 155* 333* 0.45* 0.3S* 4.44* 
(n=5) +16 ±34 +42 ±0.06 ±0.09 ±1.14 
HET 211* 51* 196* 0.26* 0.14* 1.25* 
(n=5) ± 9 +10 ± S +0.06 :to.03 ±0.34 
(*p<O.OI significance of difference from EUT) 
Conclusions: VFT is markedly elevated in hypothyroidism; 
the converse in hyperthyroidism. Therefore, selective 
pharmacologic ablation of T~ effect on the VM may be a 
potent antifibrillatory mec anism. 
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THE EFFECT OF DIETARY INTERVENTION ON RESPONSE TO 
PRAVASTATIN IN HYPERCHOLESTEROLEMIC PATIENTS. 
Rubenfire M, Blevins RD, Orringer C, Rosman H, Maciejko 
JJ. Sinai and Henry Ford Hospitals, Detroit, MI; 
University of Michigan Medical Center, Ann Arbor, MI. 
This multicenter, double-blind trial was conducted 
to determine whether diet influences response to pravast-
atin (PV), a new HMG-CoA reductase inhibitor. Included 
were 63 men and women with LDL-C above the 75th percent-
ile for age and sex, and triglycerides (TG) below 250mg/ 
dl. Patients were randomly assigned (1:1) to a control 
diet (GpCTL) or an AHA Phase I diet (GpAHA), followed 
7wks later by baseline studies and randomization (1:2) to 
placebo (P) or PV 10mg BID for Swks, then 20mg BID for 
8wks. Food Record Rating (FRR) scores were calculated to 
estimate fat consumption. Fasting blood samples were 
obtained monthly and analyzed for total cholesterol (TC), 
TG, LDL-C, HDL-C, apoA-I and apoB. Mean FRR scores were 
higher in GpCTL vs GpAHA at baseline (13.3 vs 6.3; 
p<.OOI) and wk16 (15.0 vs 8.3; p<.OOI). The results 
mg/dl were: LDL-C ApoB HDL-C ApoA-I 
Base Wk16 Base Wk16 Base Wk16 Base Wk16 
(P)GpCTL (n=9) IS9 lSI 119 111 39 42 116 122 
(PV)GpCTL(n=22) 19S 136* 116 S6* 43 47 119 126 
(P)GpAHA (n=10) IS5 190 110 112 51 52 131 130 
(PV)GpAHA(n=22) 209 151* 119 97* 43 51* 116 136* 
*p<.05 within diet comparisons to placebo (ACOVA). 
Reductions in TC paralleled reductions in LDL-C, and TG 
were modestly decreased with PV. While reductions in LDL-
C and apoB occurred in PV groups, independent of diet, 
(PV)GpAHA experienced greater increases in apoA-I (p=.02) 
and HDL-C (p=O.OS) compared to (PV)GpCTL. These data 
suggest that pravastatin effectively lowers LDL-C regard-
less of dietary restrictions, but raises apoA-I and HDL-C 
only with appropriate dietary intervention. 
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EFFICACY CF S1l'GE 00ill3 INl'RAVE1'U.5 UR:KlNA$ IN AClJl'!l MYOCARlIAL 
IrFARCl'ICfI: RESJLTS CF A PIUlfECI'IVE RPHXMIZID 'IRfAL. 
Carmelo Cemigliaro M.D. ,r.m-a Sensa M.D. ,Andrea CaJpi M.D. ,Angelo S.Ba1g::l 
M.D. ,Carlo Dellora M.D. ,Cecilia Aq..dli M.D. ,Paolo Raasi M.D. 
Divisiooe eli Cardiologia, Q3pedale Maggiore, l'bvara, Italy. 
The abili t;y of urd<inase (If{) m inix:e 00<'Cl'laI"Y artery reperfusic:n after 
bolus iIrtravm:x.Is injectiw (2 m 4 mirutes), was assessed in 47 patients, 
39 men arxl 8 wanen of 59 ± 10 years of age, wi til angicwaph1cally proven 
00<'Cl'laI"Y occlusic:n in tile crurse of an an.rt;e infarctic:n. After baseline 
angiCJ8T'EP'ly, patients """" renbnized m cbJble bliIrl treatment wi til three 
different 00se levels (500,000; 1 ,25J,ooo; 2,000,000 u'lits)of tile drI1g.T:ime 
fran c:nset of synptaTs m treatment was 183 ± 54 mirutes. 1U:perf\.sic:n was 
assessed by angiograplw at 9J mirutes using TlMI criteria (grade 2,3) by 
t..o indipen:lfl1t cardiologists bliIrl m tile treatment design. Clcct.irrEn::e 
of re-thraItlcsis was evaluated by repeat angiograplw at 8-12 da,ys. 
~: orlninistratic:n of urdd.nase resulted in a rapid and significant 
decl.ire of fibriIXJgel, p~, a
2 
antiplasnin,that lasted 9J mirutes. 
BleediJ'W; recpiring tramfusic:n was d:leerved in 4 patients (8%). The I'€!l"!: 
fusic:n rate was as follClWS: 
If{ 00se Paterr::y at Paterr::y at Reperfusic:n 
9J min re-s"b.lqy time (min) 
500,000 4/16 (2$) 10/15 (!l7J') 361:31 
l,25J,ooo 8/16 (!11)1;) 8/13 (57%) 311:18 
2,000,000 8/15 (53%) 10/13 (77%) 27 1: 14 
Caclusic:n: rur s"b.lqy dEm:xEtrates tile feasibili t;y of tile rapid bolus 
injectic:n of urd<inase. Because of tile siJrplici t;y of Edninistratic:n and 
abseroe of side effects evm. wi til large OOses, urd<inase awears m be a 
sui table fibrinolytic agent far early intraven:u3 treatment of an.rt;e ~ 
nary artery thruItx:s1s. 
DO PLASMA LEVELS OF FLOSEQUINAN CORRELATE WITH 
ITS HEMODYNAMIC EFFECTS IN SEVERE CHRONIC HEART 
FAILURE? Milton Packer MD, FACC, Paul D. Kessler MD, 
R. Stephen Porter PhOrmD, Norma Medina RN, Madeline Yushak 
RN, Stephen S. Gottlieb MD. Mt Sinai Sch of Med, New York, NY 
Flosequinan (FSQ) is a direct-acting vasodilator that produces 
sustained hemodynamic effects in heart failure (CHF). To deter-
mine if these effects are related to plasma drug levels, we 
measured peak & trough levels of parent drug and its S-oxidative 
metabolite (FSQ-P & FSQ-M, IIg/ml) during 3-12 wks of therapy 
(100-15Omg once daily) in 20 pts, who had simultaneous measure-
ments of cardiac index (CI, l/min/m2), mean arterial, LV filling 
& mean right atrial pressures (MAP, LVFP & RA, mm Hg), heart 
rate (HR, bpm) & systemic vascular resistance (SVR, d-s-c); DI 
= 1st dose; D3 = 3rd dase; LT = 3-12 wks; * = p<0.05 vs pre-DI. 
FSQ-P FSQ-M CI MAP LVFP RA HR SVR 
Pre-DI 0.0 0.0 1.9 91 29 12 84 1965 
Peak-DI 2.5 1.0 2.4* 78* 17* 5* 86 1372* 
Pre-D3 0.4 3.5 2.4* 88* 24* 7* 88 1545* 
Peak-D3 2.7 4.2 2.8* 78* 16* 3* 89* 1237* 
Pre-LT 0.4 7.2 2.4* 86* 24* 9* 94* 1484* 
Peak-L T 2.1 8.0 2.5* 80* 18* 6* 95* 1356* 
Daily FSQ dosing prOdUCea similar peak levels of FSQ-P (which 
... to low levels before the next dose), but produced a progressive 
t in the level of FSQ-M (T!,,30 hr), which was associated with 
persistent effects at the end of each 24-hr dosing interval. 
The optimal tfough level of total quinolones (TQ = FSQ-P + 
FSQ-M) was 3.5- .5 119/ml. In pts with trough TQ<3.5 119/ml, no 
effect at end of dosing interval was seen, whereas in pts with 
trough TQ > 7.5 119/ml, the next daily dose produced no additional 
benefits, and such high TQ levels were associated with t in HR & 
plasma renin activity; log TQ varied linearly with t HR (r = 0.58). 
Conclusion: once-daily'FSQ produces 24-hr effects in CHF due 
to persistence of an active metabolite with a long half-life. Yet, 
attempts to produce continuous high drug levels may achieve few 
additional benefits and may activate endogenous neurohormones. 
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CARDIOVASCU..AR RESPONSE TO PHYSICAL STRESS: EVIDENCE FOR AN 
INDEPENDENT ROLE OF PERIPtERAL DOPAMINE ~ RECEPTORS. 
Giuseppe Mel"'cul"'o, M.D. , Antonio Rivano, M.D., GiorgiO Longu, 
Reg~na Manca, M.D. ,Luigi Lai, M.D., Carlo Lai, M.D., and 
Angelo Cherchi, M.D., Univ of Cagliari, Italy. 
The existence of presynaptic dopamine DA2 receptors in the 
human cardiovascular system has been well documented. Howe-
ver, their potential physiological role remains a controver-
sial subject. We studied 9 healthy untrained volunteers du-
ring a maximal exercise performed sitting upright on a bicy-
cle ergometer. In three different sessions, according to a 
double-blind randomized protocol, they received Lv.: a) the 
DA2 agonist dihydroergotoxine (DHET, 6 ~g/kg), b) the DA2 
antagonist domperidone (OOM, 0.3 mg/kg) and c) saline (PI). 
Physical exhaustion was reached by successive work loads cor-
responding to 30%, 50% 70% and 90% of maximal exercise (Ex) 
capacity. Statistical analysis was performed by two-way 
ANOVA; always p<O.05. 
At peak Ex, in comparison to PI, DHET inhibited the increase 
in plasma norepinephrine level (NE) induced by effort (2009± 
212 vs 2397±234 pg/ml; means±s.e.) while OOM enhanced this 
response (2797±211). Plasma epinephrine (E) peak value was 
found increased after DHET (572±76 vs 260±43 pg/ml). DHET 
manifested a negative chronotropic effect (124±4 vs 130±4 
b/min at 50% Ex), whereas OOM produced a positive one(135:!3). 
DHET reduced systolic blood pressure (SBP) at rest (96±3 vs 
108±4 mm Hg), during Ex (from 30% to 70%) and recovery(107±5 
vs 126±3). Conversely, OOM increased SBP maximally at 3cr" of 
Ex (142±4 vs 131±5). Finally, OOM did not inhibit the physio-
logical reduction in diastolic blood pressure induced by Ex, 
while DHET increased this effect at 50% of Ex (61±2 vs 69±2 
mm Hg). 
These observations suggest that DA2 receptors might operate 
in peripheral sympathetic nervous system by modulating car-
diac and vascular responses to stress. Reduction in HR and 
SBP that occurs after DHET is effective in decreasing myocar-
dial oxygen consumption at rest and maximally during Ex.This 
response possibly includes a worsening in cardiac inotropism. 
Thus, the dramatic rise in plasma E after DHET during and 
particularly at the end of Ex might be attributed to a reflex 
evoked by a cardiac impairment produced by DA2 stimulation. 
DEE-~ VASOPRESSCR RESRR>E 'ro EPINEHIRINE 
IlJRIH:; aR IN IUWIS. f'rlrB'r H. Galzalez, Hw:mD; JCJSEPl 
P. Ornato, MD, ~; A. Randolph Garnett, MD; Ronald L. 
revine; Janet L. KarUx, lhazmD; Denise S. y~; Fd M. 
Racht, MD. Medical Cbllege of Virginia, Ridlmcni, VA. 
Recent stuii.es in experimental animal DCdels SI¥J9E!St 
that the dose of epineplrine (EPI) used in clinical 
cardiac resusc:itatioo nay be inadelpate. We prospec 
tively studied 16 pze-blspital cardiac arrest patients 
(11M 5F; age 60+/-8 yr) to detemine the vasq>reSSOr 
respoose and c:ilan1e in eRi-ti.dal. (E1'-<D2) followiIq 
uc:teuental (1, 3, and 5 Dg) doses of IV EPI given 5 min 
apart. All patients weJ:1i! in VFIB 00 arrival of the 
paramedics and did not respcni to stamard l!CIE. aR 
was perfozmed with a OCIIplterized 'ltnmtler ccmpression 
(90jmin with a 50:50 duty cycle); all patients were 
intubated and received 12 ventilatioosjmin at 80% Fio2. 
Arterial pressure was mcnitored by radial artery 
cutdown. Arterial blood gases were Pa02 239+/-53 Tol:r, 
Pi 7.27+/-0.06, PaCD2 32+/-6 Tol:r, and HCD3 15+/-3 
mEqll. EPI' s effect 00 radial artery pressure (nm H:J) 
and E1'-<D2 (%) are shown below: 
systolic p Diastolic p E'K02 P 
Pre-lDg 51+/-6 18+/-3 1.8+/-0.3 
EPI:bIg 70+/-6 .05 25+/-4 .24 1.4+/-0.2 .25 
Pre-3Dg 58+/-6 19+/-4 1. 6+/-0. 2 
EPI 3Dg 81+/-8 .002 29+/-4. .06 1.4+/-0.2 .27 
Pre-5Dg 67+/-4 22+/-3 1.6+/-0.2 
EPI 5Dg 93+/-8 .0001 36+/-5 .003 1.4+/-0.3 .30 
We ClCIlclme that EPI produces a dcse-depement vascpres-
sor respoose withcut significantly dlan;JiIq El'-<D2 (as 
an index of blood flow) duriIq aR in humans. OUr 
fin:iin;Js suwort the need for a trial of higher close EPI 
given earlier duriIq clinical resusc:itatioo. 
JACC Vol. 11, No.2 
February 1988:43A 
NITRATE TOLERANCE AVOIDED BY USE OF A NITRATE 
FREE INTERVAL 
Henry Dargie MD, John Daanfield MD, Kim Fox MD, 
Attilio Maseri MD. Western Infirmary, Glasgow, 
National Heart and Hammersmith Hospitals, London 
Tolerance to the antianginal effects of organic 
nitrates is controversial. We undertook a double 
blind, randomised, placebo controlled cross-over 
study with a continuous dose (CT), 10mg/24hr, of 
transdermal nitroglycerin (TN) and individually 
titrated doses given intermittently (IT). After 
a one week run-in, pts were tested for nitrate 
responsiveness and 13 out of 97 (12%) pts 
screened did not respond and were excluded from 
the study. Pre-study, the median treadmill walk-
ing time (TWT) was 6.45min. IT dose of TN was 
titrated to a 10mmHg drop in systolic BP and the 
mean dose used was 10.6mg/24hr. Patches for IT 
were worn during waking hrs only. Pts were 
randomised to receive either IT or CT; both were 
compared to placebo. After 14 days treatment TWT 
was evaluated 3-5hrs post dose before cross-over 
to alternative treatment. 52 pts completed: 23 
CT, 29 IT. After 14 days IT mean resting supine 
and standing systolic BP fell by 7.46 confidence 
interval (CI) 2.7-12.2 and B.96 CI 3.4-14.5 
respectively (p(0.004); heart rate (HR) was 
unchanged. Mean HR at lmm ST depression rose by 
ll.93bpm (p=0.005, CI=1.14-22.7); mean onset to 
angina increased by 59secs (p=0.046 CI=10.B-
loB). Mean TWT increased by 40 secs (p=0.03B). 
Following CT no such changes were observed. 
These data suggest an attenuation of antianginal 
efficacy with CT regimes of TN and removal of 
the patch at night avoids tolerance. 
TOLERANCE WITH INTRAVENOUS NITROGLYCERIN THERAPY IN ACUTE 
MYOCARDIAL INFARCTION. 
Bodh I.Jugdutt MD .. F A.C.C and J. Wayne Warnica, 
M.D., F.A.C.C., University of Alberta, Edmonton, Canada. 
Low dose intravenous nitroglycerin infusion (NG) has been 
used safely in acute myocardial infarction (AMI) to im-
prove LV function, prevent infarct expansion and improve 
LV topography. The question of vascular tolerance WaS 
examined in 154 patients with transmural AMI who were 
given to NG therapy in a recent randomized study (NG 
versus placebo). The dose of NG was carefully titrated to 
decrease mean arterial pressure by 10% but not below SO 
mm Hg. Tolerance was asswned "true" when the NG dose had 
to be increased in order to maintain this hemodynamic 
effect and "apparent" when the dose was increased only to 
control chest pain. Clinical, hemodynamic and two-
dimensional echocardiographic parameters were monitored 
serially before and after therapy. The main results were: 
Anterior(n-64) Inferior(n-90) P 
Symptom to NG (hours) l5±15(SD) 11±2l NS 
Duration of NG (hours) 42±26 35±27 NS 
Dose range (pg/min) 1-172 2-132 NS 
Minimwn dose (pg/min) 5±1 5±1 NS 
Maximwn dose (pg/min) 4S±32 42±32 NS 
Stayed below 6pg/min(n) 1 (2%) 10 (11%) 0.05 
Needed 6-100 pg/min(n) 57 (89%) 70 (7S%) NS 
Needed >100 pg/min(n) 6 (9%) 10 (11%) NS 
Tolerance suggested(n) 17 (27%) 20 (22%) NS 
"Apparent" Tolerance(n) 6 (9%) 13 (14%) NS 
Tolerance was seen in 24% of patients, with equal 
frequency in anterior and inferior AMI: it was tltrue lt in 
12% and "apparent" in 12%. Thus, although true tolerance 
occurs when using low dose intravenous NG therapy, it is 
rare and not a major problem when NG dosage is titrated 
to a discrete end-point. 
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OVERNIGHT WITHDRAWAL OF NITROGLYCERIN THERAPY 
DOES NOT PREVENT THE DEVELOPMENT OF NITRATE 
TOLERANCE IN SEVERE HEART FAILURE. Milton Packer MD, 
F ACC, Stephen S. Gottlieb MD, Paul D. Kessler MD, Wai Hung 
ceeMD, FACC, Marrick L. Kukin MD, Norma Medina RN, 
Madeline Yushok RN. Mt. Sinai School of Med, New York, NY 
To determine if the brief withdrawal of prolonged nitrogly-
cerin (NTG) therapy can prevent the development of nitrate 
tolerance, we enrolled 48 pts with heart failure (CHF) into a 3-
part study: (I) A II pts received on i ni ti al (I st) test dose of 6.4 
Ilg/kg/min of NTG i.v. to confirm their responsiveness to NTG. 
(II) All pts then received a prolonged infusion of NTG (36-48 hr), 
after which the drug was withdrawn for either 2 hrs (n=12), 4 hrs 
(n=I3), 8 hrs (n=l!) or 12 hrs (n=12). (III) At the end of this 
withdrawal period, NTG was again infusedat 6.4 Ilg/kg/min i.v., 
and the effects of this 2nd test dose were compared with those 
of the 1st test dose. Stroke volume index (SVI, ml/m 2 ), mean 
arterial pressure (MAP), LV filling pressure (LVFP), mean right 
atrial pressure (MRAP, mm Hg) and systemic vascular resistance 
(SVR, d-s-c) were measured before and after the 2 test doses, 
where * indicates that effects of 2nd test dose were less than 
1st (p <.05), despite similar pre-dose hemodynamic variables. 
SVI MAP LVFP MRAp 5VR 
1st test +4.9 -13.1 -10.5 -5.6 -562 
2-hr off +2.9* -3.5* -2.7* ::0.6* -277* 
4-hr off +3.0* -7.1 * -5.2* -3.6* -254* 
8-hr off +2.9* -6.6* -7.6* -3.6* -261 * 
12-hr off +3.9 -10.8 -9.6 -5.0 -424 
The effects of the 2nd test dose were similar to the I st only 
when the intervening NTG infusion was withdrawn for periods of 
at least 12 hr. In contrast, the effects of the 2nd test dose were 
diminished (partial or complete tolerance) when prolonged i.v. 
NTG therapy was withdrawn for only 2-hr, 4-hr or 8-hr. 
In conclusion, long periods without NTG (~ 12 hrs) are needed to 
preserve full NTG efficacy in CHF. Overnight withdrawal (8-hr) 
of the drug appears to be insufficient to prevent NTG tolerance. 
MEIHIctIINE K1l'EN'I'IA'I'E '!HE VlISODlIA'IORY EFFECTS 
OF NI'mOGLYCERIN. 
Warren S. Ieyy, M.D., Richard J. Katz, M.D., F.A.C.C., 
Richard L. Ruffalo, M.D., Roy H. Leiboff, M.D., F.A.C.C., 
Alan G. wasserman, M.D., F.A.C.C. 
George ~ University, Washirgton, D.C. 
'1he vasodilatmy effects of nitroglycerin (Nm) may be 
enhanced by the addition of a sulfhydJ:yl (SH) group 
donor. We studied the effect of IV methionine (Math), a 
SH donor which can also be given orally, on the dose 
response of IV Nm in 10 patients (pts) CXll1pIX"ed to 
placebo (Plac) in 5 pts. Nm was initially infused in 
incremental doses from 1 to 50 ugmsjmin in all pts to 
detennine the dose required to reduce mean arterial 
pressure (MAP) by 10% am pilioonaIy capillcuy wedge 
pressure (PeW) by 30%. Following a washout period, pts 
received either 5 gIllS of IV Meth or an equal volume of 
Plac. NIG dose titration was then repeated. Results are 
expressed as Nm dose (JIleaI1±5m) in ugnVmin required to 
reach a hemodynamic eropoint prior to (pre) am following 
(post) Meth or Plac am the resulting % chan;Je (mean). 
Nm OOSE oro 10% REIXlC1'IOO MAP: Mean 
Pre Post ----12- % change NlG 
Meth 40.7±6.l 19.6±2.6 <.01 -49% }P< 01 
Plac 24.5+5.2 29.2+6.9 NS +14% . 
Nm OOSE oro 30% REwcrroo roq: 
Meth 27.l±4.2 15.7±2.0 <.01 
Plac 21.1+5.6 24.7+5.8 NS 
-36% 
+19% }P<.01 
Meth alone irxiuCed no ~c effects. In every pt, 
Meth reduced the Nm infusion rate required to achieve a 
hemodynamic eropoint. 
Conclusion: IV methionine potentiates the vasodilatory 
effects of acutely administered IV Nm. Whether 
attenuation of the hemodynamic effects of Nm can be 
altered by SH availability needs further investigation. 
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CIMETIDINE, BUT NOT RANITIDINE, ALTERS NIFEDIPINE 
ELIMINATION KINETICS AND EFFECTS. 
Janice B. Schwartz, M.D., F.A.C.C., Robert A. Upton, 
Ph.D., Emil T. Lin, Ph.D., Roger L. Williams, M.D., 
Leslie Z. Benet, Ph.D. University of California, San 
Francisco, CA. 
Since cimetidine is frequently prescribed and can 
markedly impair hepatic drug clearance, we studied the 
effects of cimetidine on nifedipine elimination after 
single and multiple doses in 11 subjects and the 
effects of ranitidine in 12 subjects. Elimination 
kinetics, change in mean blood pressure (BP) and heart 
rate (HR) responses during drug co-administration were 
compared to those after nifedipine(N) alone. 
RESULTS (mean + SD): 
-Halflife Clearance SP Change HR 
(hr) (L/hr) (mmHg) (bpm) 
N 20mg alone 4.0+2.2 66+32 11+8 21+7 
+ Cimetidine 4.9:;:2.9 33:;:14- 17:;:9- 33;£17-
N 20mg alone 3.0:£1.0 53;£29 5+6 19±13 
+ Ranitidine 2.9±1.3 50+20 10;8 22+21 
N chronic alone 4.6+2.0 76:;:39_ ld;r ~~94 N+cH~~fiHd~YSne ~:~¥:~- 43"+20 52'+19 7±7 11±9 
+ Ranitidine ~.5+1.2 46:;:18 10+7 15+13 
- significant difference vs. N alone 
CONCLUSIONS: Cimetidine decreased nifedipine elimina-
tion, but, rani tidine did not alter nifedipine kine-
tics or dynamics. Dose adjustments of nifedipine may 
be necessary during cimetidine co-administration. 
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HYPERLI POPROTEINEMIA FOLLOWING HEART TRANSPLANTATION: 
NATURAL HISTORY AND INTERVENTION WITH LOVASTATIN AND 
GEMFIBROZIL 
Christie M. Ballantyne, M.D., Peter H. Jones, M.D., 
Carlos A. Leon, M.D., James B. Young, M.D., F.A.C.C., 
Wolfgang Patsch, M.D., Charlotte Payton-Ross, H. David 
Short III, M.D., George P. Noon, M.D., F.A.C.C., Antonio 
M. Gotto Jr., M.D., F.A.C.C., Michael E. DeBakey, M.D., 
F.A.C.C. Baylor College of Medicine, Houston, TX. 
Hyperlipoproteinemia (HPL) develops post heart trans-
p~antation (~T) and may accelerate graft arteriosclero-
S1S. We examlned the natural history of HPL in 32 Pts who 
h~ve survived ~t least six months following HT treated 
wlth cyc.losponne and predni sone and report the use of 
Lovastatln ln 2 Pt and Gemfibrozil in 2 Pt. Mean (±SD) 
serum total cholesterol (CHOL) (mg/dl), triglyceride 
(TRIG) and HDL cholesterol levels (HDl) are shown below. 
PreHTR 1 mo 3 mo 6 mo 12 mo 
CHOl 184±71 218±62 245±63 249±74 241±89 
TRIG 137±87 150±81 216±108 204±96 209±105 
HDl 30±9 53±19 45±11 45±10 48±24 
Significant increase in CHOL, TRIG, lDL and HDl occurred 
in the first 6 months without further rise thereafter. 
We found that 8 Pts developed Type IIa, 7 Type lIb and 2 
Type IV HPL patterns. Two Pts with Type II HPl were 
treated with lovastatin (L) and 2 Pts were treated with 
Gemfibrozil (G) as shown in the table. 
Prel Postl Prel Postl PreG PostG PreG PostG 
CHOl 500 251 359 237 346 287 268 217 
TRIG 345 207 117 131 273 179 306 123 
Serum cyclosporine levels were not altered by lovastatin 
and. untoward side effects during 3 and 6 month follow-up 
perl ods have not been noted. 
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THE EFFECT OF DONOR SPECIFIC TRANSFUSION ON CARDIAC XENO 
GRAFTS. -
Elliot Kaplan,MD,Arthur R.Dresdale,MD,James T.Diehl,MD, 
Mark Aronovitz,BS,Marvin A.Konstam,MD,FACC,Nicholas 
Katzen,MD,Raymond J.Connolly,Ph.D.,Kenneth Gould,Ph.D., 
Douglas D.Payne,MD,Richard J.Cleveland,MD,FACC. 
New England Medical Center,Boston,Massachusetts. 
Donor specific transfusions(DST) combined with immunosup-
pression(IS) facilitates experimental and clinical allo-
grafting. To investigate the applicability of this tech-
nique in xenografts we used a hamster to rat heterotopic 
cardiac xenograft model. Transplants were performed as 
described by Ono and Lindsay. Grafts were palpated daily 
and rejection defined as cessation of abdominal heartbeat. 
Group A received no IS. Group B received IS consisting of 
azathioprine(AZA),cyclosporin A(CyA) and methylpredniso-
10ne(MP) beginning the day prior to transplantation and 
continuing postoperatively. Group C received IS as in ( Ollr 
Group B but also received 1 cc DST IV 21,14 and 7 days 
prior to transplantation. AZA and MP were given the day 
prior to, of and post DST. Results are in the table. 
Group 
A 
B 
n 
-6-
13 
SURVIVAL 
Days 
3.3 +/- 0.2 
28.5 +/- 7.7* 
Minutes 
C 7 7.7 +/- 1.4* 
p 0.001 
Standard IS without DST leads to increased graft survival. 
DST accelerated graft rejection greatly. This effect is 
not modified by IS at the time of transfusion. It suggests 
that unlike the salutory effects seen in allografts, DST 
applied to xenografts in this model causes sensitization 
leading to hyperacute rejection. 
HFARI' TRANSPIANI'ATICN IN PATIENI'S REX:mRING PREOPERATIVE 
INOl'roPIC AND MEOlANICAL SUProRl' 
Sara J. ShumNay. M.D., Tllrothy J. GaJ:dner, M.D., olke E. 
cameron, M.D., Sharon Augustine, R.N., Bruce A. Reitz, 
M.D., William A. BauIrgartner, M.D., '!he Jahns Hopkins 
Medical Institutions, Baltim:>re, MMylarxi 21205. 
since July 1983, 76 patients have uniergone heart 
transplantation at '!he Jahns Hopkins Hospital. 'Ihese 
patients (pts) have r.m:JEd in age fran 18 nronths to 57 
years. 'lhirteen pts had previous cardiac smgeIy. 'Ihe 
preoperative recipient diagnosis was cardianyopathy in 
46, ischemic heart disease in 27, arxi =ngenital heart 
disease in 3. Preoperative inotropic support was 
necessary in 16 pts. 'Ihe intra-aortic balloon pt.m1p was 
used as a bridge to transplantation in 10, while left 
ventrialiar assistance with a centrifugal pt.m1p was used 
once. Actuarial survival detenninations arxi NA'IU) status 
are shown in the table below: 
NA'lm status # Patients 
o 
I 
II 
III 
(IABP, LVAD) 
(Inotropes) 
(In hospital) 
(At hane) 
10 
16 
8 
42 
Actuarial 
SurVival-1 yr 
(% ± SE) 
90.0 + 9) 
81.3 ± 9) 84.6 ± 7 
100.0 ± 0/ 88 •6 + 5 
86.l±6) -
Mean 
SurVival 
(nronths) 
27.77 
37.25 
42.32 
37.77 
Base:i on the Breslow-Wilcoxon statistic, mean survival in 
groups 0 arxi I did not significantly differ fran mean 
survival in groups II arxi III (p-value >0.4422). 
'Ihese results confinn the therapeutic potential of heart 
transplantation even in the very ill arxi support the 
continued utilization of preoperative inotropic arxi 
mechanical support for bridging recipients to 
transplantation. _ 
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EXERCISE CAPACITY FOLLOWING CARDIAC TRANSPLANTATION. 
Arthur J. Labovitz, MD, FACC, Leslie W. Miller, MD Ami M. 
Drlmmer, PhD, Lawrence R. McBride, MD, Kirk R. Ka~ter 
MD, Marianne Colletta, RN, Elizabeth J. Merkle, RN D.' 
G!enn P~nnington, MD, St. Louis University, St. Lo~is, 
M1SS0ur1. 
In order to evaluate the exercise response of the 
denervated heart, we performed upright treadmill exercise 
testing in 36 patients 1-3 months and again 6-12 months 
(32 pts) post orthotopic cardiac transplantation (PO). 
Heart rate (HR) response, met level at anaerobic threshold 
(AT) and peak exercise (max) and oxygen consumption (V02) 
were measured. Exercise parameters were compared with 
selected clinical characteristics including patients age 
sex, CHF class, NATCO class, length of hospital stay and' 
number of episodes of rejection. 
HR RETS % 
Months PO Rest --Peak AT ----MAX Inc-HR ~ 
1-3 98+13 132+17 S.0+1.2 6.T+T.S .36+.17 21+S 
6-12 104+11 148+16 S.6+1.7 6.8+1.8 .43+.1S 23+6 
p <.01 <.01 <.01 <.01 .07 <.01 
HR increased significantly only in the latter stages of 
exercise with 32 of 36 (89%) patients achieving their 
maximal HR during the first three minutes of recovery. 
Peak exercise mets obtained at 1-3 months post operatively 
correla~ed inversely with age (r=-0.4, p<.OI) and length 
of hospltal stay (r=-0.4, p<.OI) but not pre-operative CHF 
class, NATCO class, or resting HR. The number of 
rejection episodes in the first six months correlated with 
exercise capacity in the latter six months as measured by 
AT and max mets obtained (both r=-0.4, p<.Ol). Both AT 
and max mets obtained at 1-3 months correlated strongly 
with their respective parameters at 6-12 months (r E O.7, 
p<.Ol, both parameters). Thus, 1) the length of hospital 
stay post operatively is inversely correlated with 
exercise capacity, 2) early exercise testing post 
transplant will predict long term exercise capacity and 3) 
early episodes of rejection will influence late exercise 
capacity. 
THE USE OF TRANSPULMONARY PRESSURE GRADIENT IN THE 
SELECTION OF CARDIAC TRANSPLANTATION CANDIDATES 
Srinivas Murali, M. D., Barry F. Uretsky, M. D., FACC, 
P. Sudhakar Reddy, M. D., FACC, Judy A. Kolesar, R.N., 
Anita M. Valdes, R.N., Robert L. Kormos, M.D., Bartley P. 
Griffith, M.D., Robert L. Hardesty, M.D., University of 
Pittsburgh, PA 
Right ventricular (RV) failure of the donor heart is a 
major cause of early «30 days) mortality after heart 
transplantation (TX). It has been suggested that the 
level of pre-TX trans pulmonary pressure gradient [TPG= 
mean pulmonary artery(PA)-mean PA wedge (PAW) pressure) 
is superior to the pulmonary arteriolar resistance (PAR) 
in predicting donor RV failure. This may be because TPG 
is a better reflection of RV afterload than PAR. To test 
whether TPG can be modulated by drugs, we evaluated the 
acute response of TPG, PAR, and cardiac output (CO) to a 
variety of drugs in 79 potential TX candidates. 
TPG(mmHg) PAR(Wood Units) CO(L/min) 
B D B D B D 
I 12+4 14+6 3.7+1.6 3.2+1.6t 3.S+0.9 4.S+1.2t 
PDEI li+s 12+S 309'+1.8 3.i+1.6t 3.3+1.0 4.S+1.2t 
V 12+4 11+3 3.9+1.1 3.0+1.2* 3.6+0.8 4.1+1.3 
CEI 9+3 9+2 3.0+1.S 2.4+0.7 3.S+1.0 4.0+1.0* 
p<*O.OS to.01 D vs-B; B=baseline; CEI=converting 
enzyme inhibitor, n=12; D=drugs; I=intravenous inotropes 
(dobutsmine, n=4; DPI 201-106, n=14); PDEI=investiga-
tional phosphodiesterase inhibitors (oral enoximone, 
n=28; intravenous CI-930, n=9); V=intravenous vasodi-
lators (nitroglycerin, n=10; nitroprusside, n=2). 
Drugs acutely lower PAR (by increasing CO), but not 
TPG. The inability to decrease TPG by D might explain 
the superiority of the level of TPG over PAR to predict 
RV failure post-TX. Therefore, the level of TPG rather 
than PAR should be used in deciding the suitability of 
patients as good TX candidates. 
ABSTRACTS 
EARLY AND MEDIUM TERM RESULTS OF CARDIAC TRANSPLANTATION 
IN THE SEVENTH DECADE OF LIFE. 
Dan Aravot, MD; Naz Dhalla, FRCS; Azghar Khaghani, 
FRCS; Melissa Fitzgerald, MB, BS; Ravi Pillai, FRCS; 
45A 
Stuart Gibson, Magdi Yacoub, FRCS, FACC. Harefield Hospital 
Harefield, Middlesex, England. 
Between January 1980 and July 1987, 438 patients (pts) 
underwent cardiac transplantation (CTx). Of these 23 
(S.2S%) Were over the age of 60 at the time of CTx. 
This policy was adopted after introducing a protocol 
of Cyclosporin and Azathioprine with minimal or no steroids 
in September 1982. There were 22 males and 1 female; age 
ranged between 60-69 (mean 61.8) years. The etiology of 
their heart disease was ischaemic in 19 pts and idiopathic 
cardiomyopathy in 4 pts. Six pts had previous coronary 
artery bypass graft operation, 1 had repair of abdominal 
aneurysm and 1 had documented pulmonary embolism. Fifteen 
pts were in NYHA Clas IV and 8 pts in Class III. Donor age 
ranged between 14 to 46 years (mean 29.8). The average 
time of hospital stay following CTx was 14.1 days (10-30 
days). In all, there were 3 early (within 1 month) and no 
late deaths during a period of follow-up extending from 
0.5-S0 months (mean 13.7). The 1 year actuarial survival 
was 86.9%. The incidence of rejection was 2.16 episodes 
per pt. There were no serious infections. Six pts required 
antihypertensive treatment, 3 had reversible impairment of 
renal function related to Cyclosporine, 2 had gout and 1 
pt had drop foot which improved with intensive physio-
therapy treatment. None of the pts experienced convulsions, 
transient ischaemic attack or cerebrovascular accident. 
None had significant psychological problems. The 20 pts 
currently alive are in NYHA Class I. Quality of life, 
assessed by the Nottingham Health Profile showed marked 
improvement (preoperative score 51.3%, postoperative score 
11.8%). It is concluded that the early and medium term 
results of CTx in the seventh decade of life are acceptable. 
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Coronary Artery Disease: Clinical 
MEASUREMENT OF ABSOLUTE CORONARY BLOOD FLOW USING 
A DOPPLER CATHETER: VALIDATION IN AN ANIMAL MODEL. 
Paul G 'tack MD FACC, Victor K. Hargrave as, Eric L. Johnson MD, 
Gabe Aldea MD, Hidezo Mori MD, James P. Srebro MD, Thomas A. Ports 
MD, FACC. University of California, San Francisco, California. 
We studied the accuracy of absolute coronary flow measurements by 
Doppler catheter recordings in a canine model with precisely known 
coronary artery cross sections. A subclavian artery to circumflex 
coronary artery shunt was created in six dogs using tubing which 
incorporated an in-line electromagnetic flowmeter (EMF). The 
circumflex artery was occlusively cannulated using a rigid metal stent 
of known internal diameter which was placed 2cm into the vessel. A 
3Fr Doppler catheter with end-mounted transducer was introduced 
into the shunt and pOSitioned with the tip inside the stent region. 
Variable flow rates in each preparation were achieved by restricting 
flow through the shunt and by inducing hyperemic flow post shunt 
occlusion. Analysis of Doppler shift signals was performed using a 
standard, commercial zero crossing detector (ZCD) and with an off-
line fast Fourier transform (FFT) system modified for this 
application. FFT data was then transferred to a microcomputer where 
peak and mean spectral velocities were calculated using specially 
developed algorithms. Mean ZCD values were determined in reference 
to an internal calibration provided with the unit. Peak ZCD velocities 
were not analyzed due to excessive noise. Flow in the stent region was 
calculated as the product of cross-sectional area and measured 
velocity. These data were compared to simultaneous EMF flows. 
RESULTS. Flows derived from peak FFT velocities corresponded 
closely to EMF flows (slope= 1.13, r= 0.93), while mean FFT and 
ZCD velocities underestimated EMF flows (with slopes of 0.50 and 
0.41, respectively) despite a close correlation (r= 0.90,0.93). 
CONCLUSIONS. (1) absolute coronary flows can be successfully 
measured using a Doppler catheter; (2) FFT analysis of the Doppler 
signal with peak velocity determination gives the most accurate 
representation of flow; (3) flow measurements based on ZCD mean 
velocities, the current clinical standard, may significantly 
underestimate absolute coronary flow. 
46A ABSTRACTS 
ESOPHAGEAL PILL ATRIAL PACING WITH QUANTITATIVE 
TWO-DIMENSIONAL ECHOCARDIOGRAPHY IN DETECTING 
CORONARY ARTERY DISEASE 
Ray V Matthews M.D, Richard J. Haskell, M.D., 
F.A.C.C., Leonard E. Ginzton, M.D., F.A.C.C., Michael 
M. Laks, M.D., F.A.C.C. Department of Medicine, 
Harbor-UCLA Medical Center, Torrance, California 
Many patients with chest pain cannot exercise 
adequately during treadmill testing making the 
noninvasive diagnosis of coronary artery disease 
(CAD) difficult. Esophageal pill electrode atrial 
pacing with two-dimensional echocardiography (20E) 
was performed in 26 patients who also had coronary 
angiography. Patients were paced to 90% of maximal 
predicted heart rate. Rest and peak pacing 20E with 
computer assisted calculations of ventricular volumes 
and ejection fraction (EF) were performed. Four 
patients could not be paced (B5% success rate). CAD 
was defined as ~70% stenosis of at least one major 
coronary artery. The peak systolic pressure/end 
systolic volume index ration (P;V) and the change in 
EF with pacing were analyzed. The predictive value 
of P;V was O.Bl and of EF change was 0.70. 
Normal (n-B) 
P;V ll.B±B.l 
EF Change +0.03±0.OB 
CAD (n-14) 
4.7±2.0 
-0. OB±O.13 
p-O.OOS 
p-O.OS 
Conclusions: The P;V was the most significant 
identifier of CAD in this study. Esophageal pill 
electrode atrial pacing with quantitative 20 echo may 
be a useful noninvasive, nonexersize method to 
diagnose CAD. 
AUTOMATED ANALYSIS OF ARTERIAL GEOMETRY: IN VIVO 
VALIDATION USING INTRAOPERATIVE HIGH-FREQUENCY EPICARDIAL 
ECHOCARDIOGRAPHY. 
Steven R. Fleagle, B.S., Maryl R. Johnson, M.D., F.A.C.C., 
Christopher J. Wilbricht, B.S., David D. McPherson, M.D., 
Loren F. Hiratzka, M.D., F.A.C.C., Richard E. Kerber, M.D., 
F.A.C.C., Melvin L. Marcus, M.D., F.A.C.C., David J. Skorton, 
M.D., F.A.C.C., Steve M. Collins, Ph.D., UniverSity of 
Iowa, Iowa City, Iowa. 
Validation of the accuracy of automated coronary border 
identification techniques by comparison to independent 
measures of lesion geometry in humans has been limited. 
To determi ne the abil i ty of a computeri zed border detec-
tion method to define minimal lumen size, clinical cine 
films of 43 atherosclerotic segments were magnified and 
digitized. Our technique used a two-dimensional gradient 
operator and a graph-searching method to identify optimal 
borders. Minimal lumen diameter (MLD), referenced to 
catheter size, was derived without observer modification 
of the computer borders. In 21 discrete lesions, computer 
MLD was compared to minimal lumen area determined directly 
using hi9h-frequency epicardial echocardiography (HFE) 
(Biosoundj. Computer MLD was also compared to MLD derived 
from borders traced by a blinded observer. 
RESULTS: Coronary borders were successfully identified 
in 35 of 43 segments; in the remainder, a closely adjacent 
parallel vessel interfered. By HFE, the mean lesion area 
was 1.8 ± 1.7 (SO) mm 2 • Computer MLD correlated well with 
minimal HFE areas and with observer MLD: 
Comparison N r-value Regression Equation SEE 
Computer vs HFE 18 0.70 y=.55fi + .81 mm .34 
com~uter vs Observer 35 0.95 y=.84 x + .27 mm .23 
his approach to automated analysis of arterial geo-
metry yields, in the majority of cases, information that 
correlates well with an independent measure of minimal 
lumen size, a determinant of coronary lesion significance. 
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THERMAL CORONARY ANGIOGRAPHY: A NEW METHOD FOR 
INTRAOPERATIVE REAL-TIME ASSESSMENT OF CORONARY ANATOMY 
AND BLOOD FLOW. 
Friedrich W. Mohr, M.D., Andrew Jakubowski, M.D., Frank 
Litvack, M.D., Warren Grundfest, M.D., Jack Matloff, 
M.D., F.A.C.C., James Forrester, M.D., F.A.C.C. Cedars-
Sinai Medical Center, Los Angeles, California 
We have developed a new technique, thermal coronary 
angiography (TCA), for real time assessment of coronary 
and graft anatomy and flow during bypass surgery. The 
goal of this study was to compare thermal coronary 
angiography to cine angiography for detecting of 
stenoses. We studied the exposed LAD in both beating and 
arrested hearts of 11 open chest pigs using an AGA 782 
infrared camera (O.lmm spatial and O.loC thermal 
resolution) and a TIC 8000 digital image processor. We 
performed simultaneous thermal and cine ang.iography, 
using Angiovist 370 at different temperatures (10-320C) 
and injection rates (1-2.5 ml/sec). Stenoses were 
created by snares. RESULTS: We obtained high resolution 
TCA images of both the coronaries and of myocardial 
perfusion beds whenever there was >40C difference 
between injectate and epicardial temperature. The TCA 
detection of angiographic stenoses was 29/30 (96.6%) in 
arrested and 36/42 (85.7%) beating hearts. Coronary 
occlusion produced immediate and dramatiC perfusion 
defects. TCA's were highly reproducible. CONCLUSIONS: 
TCA is a highly sensitive, reproducible method for 
intraoperative coronary angiography: it may be of great 
value at CABG surgery for analYSis of native coronary 
and graft perfusion beds, and can be readily applied 
during routine CABG. 
BRONCHIAL CHOLINERGIC HYPERRESPONSIVENESS IN PATIENTS 
WITH VARIANT ANGINA. 
Laure R. CABANES, M.D., Simon N. WEBER, M.D., Regis 
MATRAN, M.D., Jean A. FOUCHARD, M.D., Fran~ois P. GUERIN, 
M.D., Alain LOCKHART, M.D. and Michel E. DEGEORGES, M.D. 
Departments of Cardiology and Physiolog y. University 
Rene Descartes. Hopital eochin. Paris. France. 
Acetylcholine (Ach) is known to induce coronary spasm 
in patients (pts) with variant angina. To evaluate a 
possible diffuse cholinergic hyperresponsiveness in va-
riant angina pts,involving other target organs than the 
coronary arteries, we studied the bronchial response 
to inhaled methacholine (Mc ; the ~ -methyl analog of 
Ach) in 6 variant angina pts, with a positive response 
to ergot derivatives and no significant stenosis at coro-
nary angiography. Ten pts with Significant ( ~ 70%) 
coronary stenosis and purely exertional angina served 
as controls. Pts with atopy or allergic asthma were 
excluded. All variant angina pts responded to Mc ; the 
mean Mc dose eli cit i ng a 20% decrease in forced expira-
tory volume in one second was 456 t 158/1g (i .e. of the 
same magnitude than the dose usually active in sympto-
matic bronchial asthma). In contrast 9 of the 10 exertio-
nal angina pts did not respond to the highest Mc dose 
used (3100~g). The frequency fo Mc responders was signi-
ficantly hlgher (p ~ 0.001) in variant angina pts. We 
postulate that in variant angina, coronary spasm may 
be a paradoxical local response (Ach being vasodilata-
tor on strictly normal coronary arteries) to a more gene-
ralized cholinergic hypersensitivity. 
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ELECTROCAADIOORAPHIC MANIFESTATIONS, IN-HOSPITAL AND LATE 
PROGNOSIS OF TRANSIENT ACUTE MYOCARDIAL ISCHEMIA AT REST. 
Sliva Severl . M,D, Paolo Marrll:Clnl, M.D., Claudio Michelassi, Enrico 
Orsini, M.D., Ylncenza Nassisi, Antonio L'Abbate, M.D., F.A.C.C., !.F.C CNR and 
Un Iv of Plsa, Plsa, Italy. 
During the last 15 years transient electrocardiographic changes at rest were 
documented In 652 consecutive patients (pts) admitted to our coronary care 
unit. The most common electrocardIographic manifestations were ST segment 
elevation (t)(295 pts) and ST segment depression (~)(252 pts), while T 
wave changes (T) were rarer ( 106 pts). Spontaneous spasm, at angiography, 
was more frequent In pts with STt ( 141) than In the other two groups (31) 
(p<O.O 1). In spite of a major severity of coronary atherosclerosis and 
Impairment of left ventricular function In pts with SU, (p<O.OJ), the 
occurrence of acute myocardial Infarction (AMI)( 44 pts) and death ( 13 pts) 
during hospitalization (after the documentation of transient ST - T changes at 
rest) was more frequent In pts with STt (27 A.M.I and 9 deaths). Of the total 
group 86 pts ( 131) underwent coronary by-pass surgery within 8 months 
from discharge. In the medical group (553 pts), the likelihood of death In the 
ten-year period after discharge was 291 on the whole and 201 considering 
cardiac causes only. The fol1owlng characteristics, listed In decreasing order of 
statistical signifIcance, were found to be significant univariate predictors of 
survival: abnormal basal electrocardiogram, left ventricular function, 
historical duration of ischemic heart disease, documented prevIous myocardial 
infarction, posittve exercise stress test, multivessel coronary disease, age, 
hypertenSion, presence of ST~ during episodes of ischemia at rest. The average 
annual mortality rate for pts with T, STt and ST~ was 0.91, 1.81 and 31 
respecttvely; however, no sIgnificant difference In the survival rate of these 
subgroups could be observed according to the number of diseased vessels or left 
ventricular function. Thus, a greater susceptlb111ty to coronary 
vasoconstrIction saems to account for short-term outcome, while long-term 
prognosis is related to the severity of anatomic Impairment, Independently of 
ST -T changes observed during Ischemia at rest. 
MEASUREMENT OF EXPERIMENTAL PAIN AND SERUM B-ENDORPHIN 
IN PATIENTS WITH SYMPTOMATIC (SMI) AND ASYMPTOMATIC MYO-
CARDIAL ISCHEMIA (AMI)- MODIFICATION BY NALOXONE 
Conrad Droste, MD, Hans Meier-Blankenburg, Mark W. Green-
lee*, PhD, Helmut Roskamm, MD, FACC, Rehabiliationszen-
trum Bad Krozingen, *Neurological Clinic, Brain Research 
unit, university of Freiburg, FRG 
Pathophysiology of lacking pain in AMI and the role of 
endogenous opioids are controversially discussed. In a 
double blind study we compared S SMI and 9 AMI patients 
(pts) during exercise (E) under naloxone (N) (6 mg i.v.) 
or placebo (P). B-endorphin was measured before E, at 
maximal E, and 10, 20 and 60 min. after E. Tourniquet 
pain test (on forearm, under control of transcutaneous 
PO,), and electrical pain test (intracutaneous stimulus 
on fingertip, "maximal likelihood two alternative forced 
choice method") were performed before E, inmediately af-
ter, and 60 min. after E. In 5 of 7 SMI pts angina sym-
ptoms started earlier under N than under P. 2 of 9 AMI 
pts developed angina under N. Ischemic pain thresholds 
were significantly higher (p<0.02) in ASI pts, in 
electrical pain test there were no differences; after E 
ischemic pain thresholds were significantly lower under 
N than under P (p<0.006). 
(B-endorphin Ipg/rol) minutes after E 
Rest max E 10 20 60 
P SMI 19 23)* 27)* 24 21 
AMI 26 39 56 42 27 
SMI 21 41 63 42 25 
N AMI 23 51 67 52 35 (*p<O.Ol) 
During E B=eridorphin s1gn1ficantly increases (p<O.OOl) 
in SMI and AMI. At the highest E-Ievel and 10 min. 
after E AMI pts have significantly higher B-endorphin 
levels than SMI pts. After N this difference is no lon-
ger present. The data suggest that endorphinergic regu-
lation is quantitatively different for AMI and SMI pts. 
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ANTIANGINAL THERAPY DIRECTED TOWARDS SYMPTOM CONTROL DOES 
NOT ABOLISH SILENT ISCHEMIC EVENTS. 
Prakash C~~~~~~~±~~M~~~~~.~.C.C.,Enrique Carbajal,M.D., 
John R. Nelson, M.D. ,Kippur Spears,VAMC /UCSF,Fresno, CA. 
Treatment of chronic stable angina(CSA) is primarily 
aimed at symptom control. Whether such treatment abolishes 
silent ischemic events (SIEs) is not known. In this 
prospective, doubleblind study,we evaluated the incidence 
and characteristics of SIEs in 100 male patients(pts) 
with chronic stable angina (CSA) receiving anti anginal 
drugs prescribed by their primary physician for symptom 
control. All pts had established diagnosis of CAD and 
were receiving their antianginal drugs in therapeutic 
doses, 76~ were on combination therapy with two or more 
antianginal drugs and 24% were receiving monotherapy. 
Ambulatory ECG monitoring was performed for 24-48 hrs 
utilizing an FM Holter system to detect SIEs during daily 
activity. All ST-segment >O.lmVat SOmsec from the J-
point and lasting longer than 60 secs were carefully 
analyzed and correlated with symptoms recorded in the 
diary. ECG monitoring was performed for 2407 hrs and 
showed 257 events with significant ST shifts. Of these, 
211(S2~) were silent (SIE) accounting for 79~ of the 
total ischemic period(9045 min).Most of the SIEs occurred 
at rest or with minimal activity during awake period 
between 6am and 6pm. Comparison of SIEs for pts receiving 
mono, double or triple therapy revealed that those on 
triple therapy had fewer events with shorter duration. 
Also, pts receiving beta blocker had fewer and shorter 
SIEs compared to those not on beta blocker. Conclusion: 
1) SIEs occur frequently in CSA pts receiv1Dg- medical 
therapy guided by symptoms. 2) Control of angina may not 
totally abolish SIEs. 3) Treatment directed at relief of 
total ischemic burden should include evaluation of ther-
apy by ambulatory ECG monitoring during daily activity. 
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Coronary Artery Disease: Basic 
INDOMETHACIN ATTENUATES ACETYLCHOLINE-INDUCED CANINE 
EPICARDIAL CORONARY ARTERY CONSTRICTION IN VIVO 
Wayne L. Miller, M.D., Ph.D., Gary E. Lane, M.D., 
Stephen W. Carmichael, Ph.D., Alfred A. Bove, M.D., Ph.D., 
F.A.C.C., Mayo Clinic, Rochester, MN. 
Vasorelaxation to acetylcholine (ACh) in the 
endothelium-intact coronary artery is well recognized, but 
the in vivo response in the endothelium-removed vessel is 
unclear. This study was designed to determine 1) the 
in vivo response to intracoronary ACh infusion in 
endothelium-removed arteries, and 2) if platelet inhibi-
tion would alter the response to ACh. Left anterior 
descending (LAD) artery cross-sectional area (CSA) was 
determined by quantitative angiography in the closed-
chest, anesthetized dog. LAD CSA was unchanged from 
control by endothelium removal. ACh produced an increase 
in LAD CSA in endothelium-intact vessels and a decrease in 
CSA in endothelium-removed vessels. Indomethacin (Indo, 
3 mg/kg, iv) did not alter control CSA or the dilator 
response to ACh in the endothelium-intact vessels. The 
vasoconstrictor response in the endothelium-removed 
vessels, however, was attenuated in the presence of 
indomethacin. 
% Change from Control in LAD CSA 
ACh, pg/min Endo-intact Endo-removed 
ACh +Indo ACh +Indo 
25 +2l±4* +18±S* -21±9* +18±9* 
125 +15±6* +24±8* -31±7* + 5±S 
*p<.05 vs. control, X±SEM, n=5 
These results indicate that endothelial damage alters the 
coronary artery response to ACh to vasoconstriction, and 
that this response may, in part, be platelet-mediated. 
48A ABSTRACTS 
ACB'l'!LCBOLIRB IRDUCBD BPICARDIAL 
VASOCOIIS'fllIC'lIOR DOBS RCW RBDUCB COROllARY PL<M 
John McB. Hodgson. M.p •• FACe; Mark D. Cohen, 
M.D., FACC, McGuire VAMC and Medical College of 
Virginia, Richmond, Virginia. 
Acetylcholine (ACH) causes epicardial coronary 
vasoconstriction (ECV) when endothelium is ab-
normal. Decreased coronary blood flow (CSF) has 
been hypothesized in this setting, however, not 
previously described. Therefore, we studied CBF 
and epicardial diameter (DIAM) responses to 100 
qgm of intracoronary ACH in 10 patients without 
coronary stenoses. CBF velocity was measured by 
subselective Doppler catheter. DIAM was 
measured using digital angiography. A velocity-
area index (VAl) (estimate of volumetric flow) 
was calculated as the product of velocity and 
arterial cross-sectional area. Papaverine (PAP) 
(12mg ic) was given as a non-endothelium 
dependent vasodilator control. Data shown as , 
change from pre-drug (mean ~ 8EM). 
DIAM VAl 
PAP 3±l' p=ns l63~5' 
ACH -11+4' p<0.05 96±:38' 
(PAP vs ACH) p<O :-05 p<O .10 
ACH induced ECV resulted in decreased flow in 
only 2 patients. We conclude that in patients 
with angiographically "normal" coronaries and 
normal responses to PAP, a) ACH may result in 
ECV, but vasodilation of small arterioles. 
b) CSF increases in nearly all patients. 
c) Increased CBF after ACH is less than maximal 
(post PAP). We speculate that early endothelial 
damage does not alter coronary response to ACH 
uniformly and may, therefore, attenuate, but 
not necessarily abolish hyperemia. 
REDUCTION OF FREE RADICAL INJURY AT REPERFUSION BY INTRA· 
ISCHEMIC TREATMENT WITH DEFEROXAMINE. 
Randall E Williams. M.D., Jay L. Zweier, M.D., John T. 
Flaherty, M.D., F.A.C.C., Johns Hopkins Medical 
Institutions, Baltimore, MD 
Previously we have shown improved functional and metabo-
lic recovery in hearts receiving the iron chelator, 
deferoxamine (DEF) at the time of post· ischemic reflow. 
Since intracellular iron stores may be liberated during 
ischemia and since DEF has the ability to enter cells, we 
hypothesized that intra· ischemic treatment with DEF would 
also decrease oxygen radical mediated reperfusion injury. 
In perfused rabbit hearts ATP and phosphocreatine (PCr) 
contents and intracellular pH(pHi) were monitored using 
3l-Phosphorus NMR spectrometry. Following 30 min of 
glObal ischemia at 37'C, 7 control hearts received a 
bolus of perfusate at reflow and were reperfused for 45 
min; 9 hearts received a 50 umole bolus of DEF at reflow 
and 165 umoles during the first 15 min of reflow; 9 
hearts received 215 umoles of DEF only as bolus at the 
onset of ischemia. (*P<.05, # P-.057 vs control) 
After 45 min of Reflow " baseline} 
Treatment ~ ill Developed Pressure 
Control 68±4 36±2 4l±3 
Reflow treated 87±7# 47±4* S9±5* 
Ischemia treated 92±9* 56±6* 63±7* 
At end ischemia there were no significant differences in 
pHi, PCr or ATP. Intra-ischemic treatment with DEF 
reduced reperfusion injury to the same degree as reflow 
treatment. However, the mechanism may differ, with reflow 
treatment most likely chelating intravascular iron and 
ischemic treatment, either chelating intracellular iron 
and/or by being present in the coronary arteries at the 
moment of reflow, chelating the first intravascular iron 
to reach the heart. 
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REOXYGENATION ENHANCES NEUTROPHIL MEDIATED INJURY TO 
ANOXIC ENDOTHELIAL CELLS. 
Johann Wojta, Ph.D., Rhoda L. Jones, B.S., Mervyn B. 
Forman, M.D., F.A.C.C., and Richard L. Hoover, Ph.D. 
Vanderbilt University, Nashville, TN 
We have previously shown that myocardial reperfusion 
exacerbates structural and functional changes in endo-
thelial cells (EC) of epicardial vessels and capillaries 
in the canine occlusion reperfusion model. To simulate 
the clinical situation, we studied the effects of 
stimulated PMN on EC viability (SlCR-release) and 
function (production of plasminogen activator (PA) and 
plasminogen activator inhibitor (PAl» from EC of large 
and small pulmonary vessels under normoxic (N) (95% air, 
5% CO2 ) and anoxic (95% nitrogen, 5% CO2 ) followed by 
normoxic conditions (A+N). 
Large Vessel Small Vessel 
N A+N N A+N 
SlCR (%) 4.8 12.0* 13.3 67.2* 
PA (U/I06) 1.6 0.1* 1.3 0.2* 
PAl (U!l06) 40.0 48.0* 28.5 42.0* 
* p ~ 0.01 
These results demonstrate that hypoxia followed by 
reoxygenation enhances the susceptibility of EC to 
injury, decreases PA release, and increases PAl. They 
also support the hypothesis that microvascular injury 
may be an important limiting factor in reducing myocard-
ial salvage after successful reperfusion. 
DO CORONARY ARTERY 
CYCLE? 
Maria Siebes. M.S., 
Blankenhorn. M.D .• 
Pasadena. CA 
STENOSES OSCILLATE DURING A CARDIAC 
Robert H. 
FACC; Jet 
Selzer. M.S.. David H. 
Propul sion Laboratory. 
The majority of coronary artery stenoses is eccentri c 
and contains an arc of normal flexible wall. whereby 
stenotic dimensions may change. We tested the hypothesis 
that stenosis severity changes in response to the phasic 
nature of arterial pressure. Out of 21 randomly selected 
coronary angiograms one lesion each was chosen for 
computer-assisted analYSis. The variation of normal 
(On) and stenotic diameter (Os) with time was measured 
by applying automatic edge tracking methods to 
consecutive angiographic frames over a period of two 
heart cycles. To determine the frequency content of 
the data, a power spectrum ana lysi s was performed for 
each record. Osci 11 atory behavi our was found for both 
On and Os. Amplitude variations were between 1.9% and 
13.5% around the mean. Although the diameter records 
did not exhibit a distinct variation with the heart 
rate. the power spectrum showed a significant peak 
at a low frequency corresponding to the heart rate. 
In the presence of an obstruction distal to the analyzed 
lesion, a second power contribution came from a region 
of higher frequencies (5-15 Hz). indicating that pressure 
wave reflections resulted in- rapid changes in stenotic 
dimensions. Conclusions: There are periodic oscillations 
in stenosis severity during a single cardiac cycle, 
that are not apparent to the human observer. The 
frequency content of these oscillations depends on 
the presence and severity of di sta 1 obstructi ons. 
Therefore. the computer analysis of a single angiographic 
frame within a cardiac cycle may be seriously prejudiced. 
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INTRAVENOUS COCAINE CAUSES EPICARDIAL CORONARY 
VASOCONSTRICTION IN THE INTACT DOG 
Sharonne N. Hayes, M.D., Thomas P. Moyer, Ph.D., 
Alfred A. Bove, M.D., Ph.D., F.A.C.C., Mayo Clinic, 
Rochester, MN. 
To determine the effect of intravenous cocaine on coro-
nary dynamics, cocaine was given to 23 anesthetized and 
instrumented closed-chest dogs. Hemodynamics, left 
anterior descending (LAD) cross-sectional area (CSA) by 
quantitative angiography, blood flow by radioactive micro-
sphere technique, and blood cocaine levels were measured 
before, and serially for 3 hours after each injection. 
Each dog was designated to receive 1 or 2 of the following 
injections separated by a washout period: I, 3, 6, or 
9 mg/kg of cocaine or normal saline (NS). Cocaine, but 
not NS, caused sustained dose-dependent vasoconstriction 
of LAD CSA that was maximal at 30 min. There was also an 
immediate transient reduction in blood pressure, cardiac 
output, and coronary blood flow and an elevation of heart 
rate after the 6 and 9 mg/kg doses. Two dogs developed 
refractory ventricular tachycardia after cocaine and are 
not included in the analyses. 
Aortic 
Injection LAD CSA* Blood Flow* Heart Rate* Pressure* 
NS +3±7 -7±10 0±2 -2±4 
1 mg/kg -7±7 -1±12 +4±3 +2±S 
3 mg/kg -32±10t -22±7 +S±1 -7±S 
6 mg/kg -33±6t -16±7 +7±4 -16±10 
9 mg/kg -4l±9t -20±S +16±4t -2S±10t 
*Expressed as percent change from control ± SEM; tp<.02 
This investigation demonstrates angiographic evidence of 
cocaine-induced epicardial coronary vasoconstriction and 
hemodynamic compromise and provides a possible mechanism 
for the development of angina and myocardial infarction 
associated with cocaine use. 
THROMBOLYTIC THERAPY (TT) IN UNSTABLE ANGINA (UA) 
Dietrich Gu1ba, M.D., Ph.D.,. Stefan Jost, M.D .• Peter 
zWlcky. M.D., Paul [1chtlen, M.D., F.A.C.C. 
Hannover Medical School, Hannover, FRG 
UA is frequently associated with a non-occlusive coronary 
artery thrombus. This has been confirmed recentiy by an-
gioscopic findings (Sherman, 1986). Thus, TT might be 
equally effective in UA as it is in acute myocardial in-
fraction (AMI). In order to test this hypothesis, we 
treated 10 patients (PAT) suffering from UA with TT. Only 
PAT were selected who, after a 24h period of conventional 
treatment with high doses of iv nitrates and nifedipine, 
still suffered recurrent episodes of angina at rest asso-
ciated with documented spontaneous reversible ST-seg-
ment deviations. This group of PAT was selected, 'as they 
bear a high risk to develop an AMI. 3/10 of these PAT 
were treated with streptokinase iv (2.25 Mio IV/60 min), 
5/10 with 100 mg rt-PA/3h iv and 2/10 with a combined 
therapy of 250 000 U of urokinase and 4.5 Mio U of pro-
urokinase. TT failed in only 2/10 PAT to stabilize UA, 
one had recurrence of angina 60h after TT and underwent 
aortocoronary bypass grafting 5 days after TT. the other 
PAT had recurrent ischemic episodes already 6h after the-
rapy. 8/10 PAT after TT were completely free of symptoms 
until early intervention with PTCA (3/10) or for at least 
3 weeks without further intervention (5/10). 
We conclude from these results, that TT can stabilize UA, 
especially when conventional drug therapy has failed. Our 
findings give further support to the pathophySiological 
role of coronary artery thrombosis in UA. 
ABSTRACTS 
POTASSIUM EFFLUX FROM THE MYOCARDIUM DURING EARLY 
HYPOXIA: ROLE OF LACTATE. 
Tom Grake, M.R.C.P. and Philip A. Poole-Wilson, M.D., 
F.R.G.P., National Heart Hospital and Gardiothoracic 
Institute, London, England. 
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An increase in potassium (K+) efflux from the myocardial 
cells occurs early during hypoxia or ischaemia and 
probably contributes both to changes on the electro-
cardiogram and to the genesis of arrhythmias. The 
mechanism i~ unknown. We have investigated the effect of 
anions on K exchange. Experiments were performed on the 
isolated arterially perfused interventricular septum of 
the rabbit. Temperature was 320 C and stimulation rate 
90 beats/min. Hypoxia for 5 min caused a tissue K loss of 
1.7+0.2 mmol/kg wet tissue (n=7) and this was due to an 
increased efflux (1.3+0.2 mmol/kg wet tissue, n=6). 
Replacement of extracellular chloride with the inert and 
impermeable anion isethionate (30 and 50 mM) had no effect 
on K exchange. Loading the myocardium with the inert but 
permeable anion dimethyloxazolidinedione (30 mM, n=5) or 
lactate (30 mM, n=5) and switching to a perfusate + 
containing isosmolar isethionate caused a tissue Kloss 
in 5 min of 0.9+0.2 and 0.4+0.1 mmol/kg wet tissue 
respectively. Loading the myocardium with lactate (50 mM, 
n=5) and switching t~ isosmolar isethionate resulted in a 
net loss of tissue K of 0.9+0.1 mmol/kg wet tissue. 
Washout experiments (n=7) showed that 56% of the net loss 
of K+ could be accounted for by increased K+ efflux 
(0.5+0.1 mmol/kg wet tissue). The early net loss of K+ 
from-the hypoxic myocardium is partly linked to and can 
be mimicked by the efflux of a~ions and in particular 
by lactate. The net loss of K is at least in part 
related to the metabolic state of the myocardium rather 
than being solely a consequence of altered membrane 
permeability. 
ALTERATION OF ARTERY WALL FLOORESCENCE DU& TO EXCESSIVE 
LASER IRRADIATION 
H.Chaudhry, B.S.; R. RichardS-Kortum, M.S.;T.Kolubayev, 
Ph.D.; C. K1ttrell, B.S.; N. Ratliff, M.D.; M.S. Feld, 
Ph.D., MIT, Cambridge, MA. 
Recent work demonstrates that fluorescence spectroscopy 
can be used to diagnose the presence of atherosclerosis 
in vitro. However, excessive irradiation by 476 nm ex-
cit1ng light can change the spectroscopic properties of 
arterial tissue in two ways: (1) the fluorescence line-
shape changes reversibly and (2) the absolute fluores-
cence intensity changes permanently. This suggests that 
two mechanisms are operative. The net observed tissue 
fluorescence spectrum is due to interaction of the in-
trinsic fluorescence and absorption by anatomic tissue 
layers. It is hypothesized tnat the absolute intenSity 
changes are due to the fluorophores, whereas the line-
shape changes are due to the absorbers. It appears that 
(1) is due to the reversible laser-induced dissociation 
of oxyhemoglobin, CO-myoglobin, or oxymyoglobin. We 
have studied ( 2 ) in detail, and have found that the 
ratio of peak fluorescence intensity taken with weak 
exciting light after to before irradiation decreases 
exponentially with applied fluence (J/h1III2). Spectra 
exhibi ting alterations were used to establish tissue 
tolerance, T, defined as the exposure time at a given 
intensity required to produce observable changes. two 
kinds of alterations were studied: (a) changes in peak 
fluorescence intensity of ~ 11%, and (b) changes in 
fluorescence intensity ratio by ~3%. Over a range of 
exposure times from lOOms to 30 min. tissue tolerance 
was found to depend only upon fluence: T-(78mJ,/DIn )/I, 
with I the exposure intensity (W/IIIII2). This sensitivity 
of tissue spectra to laser light imposes an important 
limitation on the spectral diagnosis of atherosclero-
sis, in that excitation levels used must not alter the 
spectral characteristics of the tissue. 
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INHIBITION OF ATHEROSCLEROSIS BY FISH OIL IN 
CHOLESTEROL FED RABBITS 
6o-qYing Zhy M p, Richard E. Sievers, 6.5., Donald l. Smith, Ph.D. 
William M. Isenberg, Ph.D., William W. Parmley, M.D., F.A.C.C., Moffitt 
HospRal and UniversRy of CalHornia, San Francisco 
To evaluate the effects of dietary fish oil on cholesterol induced 
atherosclerosis, 39 New Zealand rabbRs (4 groups) were fed a .3% 
cholesterol diet for 10 weeks. Group I was the control group. Groups II, 
III and IV received daily oral doses offish oil (Proto-chol, EPA 180 rng/ml). 
Group II received I mVday; Group III, 2 ml/day; and Group IV, 3 ml/day. 
Serum cholesterol at the end of 10 weeks was similar in all 4 groups 
(average 1036 mgldl ). Atherosclerosis of the aorta and pulmonary artery 
was measured by planimetry of sudanophilic lesions. 
~ 
I (Control! II....OmIldl J.I.ll2mILl1l. ~ 
~ 
Aorta 59±22 40±26 
Pul. Art. 48±22 15 ±13t 
61aalliog lima (~aQI 
Control 82±17 70±23 
10 Weeks 59±22' 71±16 
t significantly different than group I p<.05 
• significantly different than Control p<.05 
18±11t 36± 22t 
4±3t 8±9t 
82±15 66±22 
84± 17' 95± 27' 
Thus, dietary fish oil significantly reduced plaque in the aorta and pulmonary 
artery of cholesterol fed rabbRs. There was also a Significant prolongation 
of bleeding time. Plasma thromboxane 62 levels were not significantly 
different between the 4 groups. These data support the potential benefit 
of dietary fish oil in retarding cholesterol induced atherosclerosis and 
confirm Rs antiplatelet effects on bleeding time. 
COCAINE POTENTIATES CAFFEINE-INDUCED 
CONTRACTIONS IN CORONARY ARTERIES 
Roger Karam M,D.. Jose Brum, M.D., Meredith Bond, Ph.D., 
John Vitullo, Ph.D., Carlos M. Ferrario, M.D., F.A.C.C., 
Bernadine Healy, M.D., F.A.C.C., The Research Institute of The 
Cleveland Clinic Foundation, Cleveland, OH 
Coronary vasospasm has been related to myocardial infarction in 
c~caine users. In. this stu<!.~, we eXl!.mined the direct effect of 
hIgh doses of COClllne (3.10 M to 10 3M). known to be toxic in 
humans. on canine coronary vessels. From 16 mongrel dogs 43 
isolated rings (5 mm length) dissected from circumflex and LAD 
coronary arteries. with and without endothelium. were suspended 
in organ chambers. Isometric tension was recorded during 
exposure to cocaine. In all rings no significant contractions were 
produced by cocaine. In rings constricted with KCI (20 mM). 
cocaine caused dose-dependent relaxation (threshold dose 
0.12 mM) independent of endothelium and not significantly 
altered by incubation with Q and fJ blockers, indomethacin 
(I0-5M). atropine (0.78 x 10-6M) and vanadate (2 mM). In 6 
rings exposed to saponin, maximal Ca ++ activated tension was 
not affected by cocaine. To assess whether calcium sequestration 
by the sarcoplasmic reticulum (SR) could be a mechanism of 
relaxation, caffeine-induced contractions were recorded in 20 
rings perfused for 4 minutes at zero Ca++ concentration and then 
following a Ca++ loading period with and without 10-3M 
cocaine. The contractile response to caffeine was significantly 
potentiated (p < 0.001) after exposure to cocaine, even in the 
presence of Q and f3 blockers. This study shows that cocaine at 
high doses increases Ca ++ uptake by the SR and suggests that a 
cocaine-dependent increase in Ca ++ uptake by the SR might 
amplify vasoconstrictor responses to endogenous agonists. 
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MASSIVE REPERFUSIOO INJURY: PARAOOXICAL EFFECT OF 
cnmINED ~IorrnsIN-CCNVERI'ING ENZYME INHIBITlOO PIllS 
MYOCARDIAL REPERFUSIOO. 
Edward J. Brown, Jr., M.D., F.A.C.C., Rita D. 
SW1ntord, B.S., Bennett J. Shatk1n, M.D., Stanton C. 
Hon1g, M.D., Peter F. COhn, M.D., F.A.C.C. SUNY 
Health Sciences center, Stony BrOOk, New York. 
Both reperfusion and an;;!iotensin-convertirg enzyme 
inhibition with enalapril have been shown to reduce 
myocardial infarct size. Our purpose was to study the 
effects of reperfusion and enalapril Sirgly and toge-
ther on ischemic tissue. ~ hypothesized that the 
combined treatments would have a synergistic effect 
since they both salvage myocardium by different 
mechanisns. ~n-chest anesthetized dogs underwent 
left anterior descend in;;! coronary artery ligation and 
were randanized into control, 3 hr reperfusion, 
enalapril or 3 hr reperfusion plus enalapril. Area at 
risk of intarction was detennined with thioflavin-S 
and infarct size with triphenyltetrazolium chloride 
1ncubat10n. Intarct S1ze was expressed as a percent 
ot the area at risk. Results tollow (men + SEM): 
INFARCT Control Enalapril Repertusion R&E 
SIZE (n=9) (n=9) (n=9) (n=9) 
(%AR) 93+3 69+6w 58:t.8wW 83+6 
wp<O.05 vs control, w"p<O.05 vs R&E -
Thus, as expectea, botn j nr repertus10n ana enala-
pr1l alone salvagea ischem1c myocardium. Paradqx1-
cally, when these two 1IKX1a11tles were canbmea there 
was no significant salvage. ~ hypothesized that 
angiotensin converting enzyme inhibition led to 
massive reperfusion injury of potentially salvageable 
myocardll.l11 by as ot yet unknown mechanisns. 
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Cardiovascular Disease Among the Elderly 
PAINLESS MYOCARDIAL ISCHEMIA IN ELDERLY PATIENTS WITH 
CORONARY HEART DISEASE COMPARED WITH MIDDLE-AGED PATIENTS 
AND ITS RELATION TO TREADMILL TESTING AND CORONARY 
HEMODYNAMICS. 
A.Kurita,M.D.,and B.Takase,M.D.,K.Horiuchi,M.D.,T.Maruyama 
,M.D. ,H.Sugahara,M.D. ,S.Kondo,M.D. ,T.Nishioka,M.D. , 
K.Mizuno,M.D.,K.Isojima,M.D.,H.Nakamura,M.D., National 
Defense Medical College, Saitama, Japan. 
Painless myocardial ischemia is common in patients (pts) 
with coronary artery disease (CAD), but its occurrence in 
the elderly has not been the subject of any known previous 
report. The aim of this study was to compare the painless 
ST segment depression (PSTD; 1mm, ~SO msec,and lasting ~30 
seconds) in elderly pts with CAD (Group A;mean 65 years, 
n=20) and that of middle-aged pts (Group B;mean 53 years, 
n=20) by Holter monitoring for 24 hr and to determine the 
relationship between the PSTD and treadmill testing and 
also to investigate the relationship between the PSTD and 
coronary hemodynamics. Accordingly, treadmill testing was 
performed in the following day. The coronary arteriography 
(Gensini's score) and ejection fraction did not differ 
between the two groups. Within two weeks after the above 
testing, the increment of coronary sinus flow (CSF) was 
studied by pacing and transmyocardial lactate extraction 
ratio (LER) was calculated. PSTD in Group A was found to 
be 75% versus 40% in Group B (p<9.01). Exercise induced 
arrhythmia was 45% in Group A versus 10% in Group B 
(p<O.Ol). However, the treadmill exercise score,ST segment 
depression, and ST integral achieved did not significantly 
differ between the two groups. The ~CSF in Group A was 1.4 
±0.3 (SD) versus 1.S±0.3 in Group B (p<0.05), and LER in 
Group A was -50±40% versus -2±15% in Group B (p<0.05). 
These results suggest that episodes of painless myocardial 
ischemia may be associated with CAD due to aging,probably 
the impairment of the coronary vascular reserve and an-
aerobic myocardial metabolism. 
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INCIDENCE AND PROGNOSIS OF UNRECOGNIZED MYOCARDIAL 
INFARCTION IN THE ELDERLY. THE FRAMINGHAM STUDY. 
Pantel S. Vokonas, M.D., F.A.C.C., William B. Kannel, 
M.D., F.A.c.c. and L. Adrlenne Cupples, Ph.D., Boston 
University School of Medicine, Boston, MA. 
Although clinically unrecognized myocardial infarction 
(UMI) is a common manifestation of coronary heart 
disease in older persons, its prognosis remains 
uncertain. This issue was examined in subjects of the 
Framingham Study aged 65 to 94 based on 30 yr. 
follow-up data. The diagnosis of UMI was established 
by the unexpected appearance of new pathologic Q waves 
on ECGs between biennial examinations. The incidence 
of UMI rose progressively after age 65 in both sexes, 
similar to the increase in clinically recognized MI 
(RMI), accounting for nearly equal proportions of total 
MIs in older men and women (33% of 199 and 36% of 162 
MIs, respectively). Nearly one half of such events 
were completely silent. Trends in cardiovascular (CV) 
morbidity and mortality for subjects with UMI were 
compared to those with RMI who survived more than 30 
days using age-adjusted risk ratios based on 10 yr. 
event rates for specific outcomes. Overall risk for 
fatal and nonfatal CV events was lower in UMI than RMI, 
particularly in older women. Differences, however, 
were not significant for the majority of outcomes 
evaluated. Angina pectoris developed less frequently 
following UMI than RMI in both sexes. Recurrent MIs 
were more common in women with RMI than UMI but this 
trend was less apparent in men. The risk of subsequent 
stroke, heart failure and total mortality in men with 
UMI was similar to that following RMI. These findings 
suggest that UMI is not only common in older persons 
but also that its prognosis is nearly as serious as 
RMI, particularly in older men. 
OUTLOOK AFTER ACUTE MYOCARDIAL INFARCTION IN PATIENTS 
OVER AGE 75 YEARS. 
Sidney C. Smith, Jr., M.D., F.A.C.C., Elizabeth Gilpin, 
M.S., Howard Dittrich, M.D., F.A.C.C., Pascal Nicod, M.D., 
F.A.C.C. and John Ross, Jr., M.D., F.A.C.C. and the SCOR 
Collaborative Database, Sharp Hospital, San Diego. 
We compared the clinical course, 30 day, 90 day and 1 year 
mortality in patients age >75 years of age (group 1: 81:!: 
4 years, SD, n-328, 17% of total population) to a younger 
subset between 61-75 years of age (group 2: 67:!: 4 years, 
n=824, 42% of population) who survived 3 days after myo-
cardial infarction (MI). In group I, 213 (65%) had con-
gestive heart failure (CHF with at least 2 of 3 criteria: 
S3 gallop, rales, or pulmonary edema on x-ray) during the 
first 3 days compared to 394 (48%) in group 2, p<.001. If 
CHF was present, both group 1 and group 2 had high mortal-
ity by 30 days, 29% in group 1 and 24% in group 2 (ns), and 
mortality at 1 year was 41% and 35% in groups 1 and 2, 
respectively (ns). However, without CHF, 30 day mortality 
was 8% in group 1 and 4% in group 2 (ns), and it increased 
by only 2% for group 1 patients (from 8% to 10%) between 
30 and 90 days, a period during which intervention might 
be considered. For group 2 patients mortality at 90 days 
was 7%, not different from group 1. However, in patients 
without CHF mortality increased to 18% in group 1 compared 
to 11% in group 2 by 1 year (p<.05). Except for a high-
er proportion of women (45% vs 25%), less diabetes and 
smoking, group 1 patients without CHF had a comparable 
clinical profile to group 2 patients (EF: .51 :!: 15 and 
EF: .51 :!: .13, respectively). We conclude that in pa-
tients>age 75 years without in-hospital CHF, mortality at 
90 days is comparable to a younger group and that further 
evaluation and therapy for this subgroup of the elderly 
might reduce the high 1 year mortality. 
ABSTRACTS 
A CLINICOPATHOLOGIC STUDY OF CARDIAC RUPTURE FOLLOWING 
ACUTE MYOCARDIAL INFARCTION IN THE ELDERLY 
Hisayoshi Tanaka,M.D.,Shin-ichiro Ohkawa,M.D.,Shigeru 
Maeda,M.D.,Yuji Ito,M.D.,Masaya Sugiura,M.D., Tokyo 
Metropolitan Geriatric Hospital,Tokyo,Japan 
To elucidate the clinicopathologic features of cardiac 
rupture following acute myocardial infarction(AMI) in 
the elderly the following study was performed. Cardiac 
rupture was found in 67 cases (31 men, 36 women, with a 
mean age of 78.2 years) among 4,870 consecutive autop-
sies over 60 years, giving an incidence of 17.8% in 377 
cases with AMI. They consisted of 54 cases with free 
wall rupture, 9 with septal perforation and 4 with 
papillary muscle rupture. A past history of hyperten-
sion existed in 66% of them and persistence and/or 
recurrence of chest pain in 34%. In 88% cardiac rupture 
occurred Nithin 5 days from the onset of AMI,of which 
41% appeared within the first 24 hrs. 94% of them died 
during 24 hrs after the rupture. Pathologically the 
size of AMI with rupture showed mostly large MI in 84 
%,the site of free wall rupture revealed 22 cases(41%) 
in the anterior,21(39%) in the posterior wall. The 
frequency of cardiac rupture was 45%(9/20) in the lat-
eral AMI followed by 33%(32/96) in the anterior AMI. 
Heart weight in the free wall rupture group was smaller 
than that in the nonrupture group (359.3±74.3g vs 
387.7±97.2g, p 0.0 5),less associated with old MI(22% 
vs 46%,p 0.0 5). In conclusion, cardiac rupture follo-
wing AMI in the elderly was found in 17.8% among all 
cases with AMI, showing a higher incidence of anterior 
and posterior rupture, a higher frequency in lateral 
infarction, and 41% of them occurred within the first 
24 hrs from the onset of AMI. 
LONG TERM FOLLOWUP AFTER SUCCESSFUL CORONARY ANGIOPLASTY 
IN PATIENTS OF AGE> 70 YEARS. 
51A 
Ruben F. Lewin, M.D~, Gerald Dorros, M.D., F.A.C.C., and 
Lynne M. Mathiak, R.N., St. Luke's Hospital, Milwaukee, WI 
Coronary angiop1asty (PTCA) was successfully performed 
(an angiographic successful dilatation coupled with cli-
nical improvement of the patient at hospital discharge) 
in 144/168 (86%) patients> 70 years (mean age: 75). 
Long term fol10wup showed that a symptom related lesion 
recurrence occurred (mean time: 5.2:!:4 months after 1st 
PTCA) in 27/144 (19%) patients with all 27 patients having 
a successful, uncomplicated 2nd PTCA. Subsequent to the 
1st PTCA and without a second PTCA being attempted, 12 
late cardiac related deaths were reported, and 5 patients 
underwent elective bypass surgery. Control angiography 
at 1 year after the 1st PTCA was done in 20 asymptomatic 
patients: 17 patients (85%) had no recurrence of any 
lesion dilated, while a silent restenosis was found in 3 
patients, all of whom underwent a successful 2nd PTCA. 
Followup was obtained in 97% of patients ~ 1 year after 
PTCA (mean time: 27:!:12 months): 89% were clinically im-
proved (58%, no angina; 31%, less angina). Life table 
analysis showed, at 48 months, a cumulative survival 
probability of 93% which was not affected by the presence 
of ventricular dysfunction, or history of prior bypass 
surgery. Conclusions: these data suggest that: 1) pa-
tients > 70 years can be successfully managed with PTCA, 
2) 19%,-approximately lout of 5 patients, will require 
repeat PTCA, 3) 89% of patients will be clinically im-
proved long term, and 4) at 48 months, their cumulative 
probability of survival was 93%. In view of their 
relatively high risk and morbidity from bypass surgery, 
PTCA would appear to be the treatment of choice in 
suitable coronary anatomy for long term symptomatic 
improvement and survival. 
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SHOULD ELDERLY SE RESUSCITATED fOLLOWING OUT-Of-HOSPITAL CARDIAC ARRESn 
RK Thakyr M.D., Donald D. Tresch. M.D., F.A.C.C., David Olson, M.D., 
The Medical College of Wisconsin, Milwaukee. WI. 
Questions concerning resuscitation of elderly (E) vieti.s of out-of-
hospital (OH) cardiac arrest (CA) have not been addressed. Are E IIOre 
prone to neurological i.pair.ents. prolong hospitalizations, and poor 
Long-ter. survival? In a recent study of 1345 consecutive vieti.s of OH 
CA we found E could be lIS successfully resuscitated 8$ younger (V) pts. 
however, hospitel deaths were significantLy higher in E. We now present 
• study of 214 consecutive pts who were successfully resuscitated and 
hospihlized. Pts were divided into 2 age groups: E > 70 yes, ff:!:. 5.3, 
N-112 and Y < 70 yrs,59 :t B.S, N"102. Prior to CA, 47/112 (60%) E had a 
history of heart failure. co.pared to 19/102 (30%) Y (p<0.001). and were 
.ore co •• only on digitalis (SO% vs 29%. p<O.001). However, Y ItOre co.-
.only sustained an acute .yocardial infarction at ti.es of CA (34/102 vs 
18/112. p<O.007). Although hospital deaths were .ore co.ltOn in E (72% 
vs 52%. p<O.002). the length of total hospital stay (13.5 da vs 17.1 de) 
and stay in intensive care unit (4.7 da vs 5.6 da) were not significant-
ly different between E and Y. Neurological deaths were not significant-
ly different (E 40/81 vs Y 25/54). nor were the nu.ber of pts with re-
sidual neurological deficits (Y 12/48 vs E 12/31) between the age 
groups. 2E and 4Y were co •• tose at the ti.e of hospital discharge. Be-
sides the co.atose pts, only 2E and 1Y required chronic institutional i-
zation. Calculated survival curves de.onstrate no significant differ-
ence between the age groups in long-tera survival; at 24 IIOnths approxi-
a.tely 65% of both E and Y were al ive. 
We conclude even though E victi.s of OH CA are less likely to survive 
hospitalization follo..,ing resuscitation, E are not .ore of e burden on 
hospital or co •• unity resources. E do not require longer hospital stays; 
neurological deficits are not IIOre coallOn; and long-ter. survival is the 
,a.e 8' younger ptl. Increased hospital death .ost likely reflects aore 
severe underlying cardiac disease. 
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Thrombosis and Thromboembolism 
ARE MAST CELLS THE CULPRIT IN CORONARY PLAQUE 
DESTABILIZATION? 
Peter Barath. M.D .• Ph.D., Andrew T. Jakubowski, M.D., 
Michael C. Fishbein, M.D., F.A.C.C., Warren Grundfest, 
M.D., Frank L itvack, M.D., James S. Forrester, M.D., 
F.A.C.C. Cedars-Sinai Med. Ctr, Los Angeles, CA. 
Because mast cells contain abundant stores of both the 
potent coronary vasoconstrictor, histamine, and proteo-
lytic enzymes capable of eroding through a fibrous cap, 
we hypotheSized that mast cell degranulation may contri-
bute to atheroma plaque destabilization. In 46 toluidine 
blue stained human coronary arteries with complicated 
(ulceration, hemorrhage, and thrombus) and uncomplicated 
(fibrous) plaques, we counted the number of mast cells 
in the surrounding fat, adventitia, and subendothelial 
layer, asseSSing both metachromasia and degranulation on 
an ordinal scale from 0 (no metachromasia, non-degranu-
lated) to 2 (highly metachromatic, degranulated). 
Results: In coronaries with uncomplicated plaques non-
degranulated/blue mast cells were 3X more common than 
the highly degranulated/red pattern (1.9 cells/mm2 vs 
0.67 cell/mm2). In coronaries with complicated plaques, 
the converse occurred: the ratio of highly degranulated-
Ired to non-granulated/blue cells was 17:1 (2.15 vs 0.13 
cells/mm2). These differences between complicated and 
uncomplicated plaques persisted when both lesions 
appeared in the same patient. In old total occlusions 
there were very few mast cells (0.2 cells/mm2), predomi-
nantly non-degranulated/non-metachromatic. Conclusions: 
Mast cells degranulation coexists with atheroma 
destabilization. The process is accompanied by increased 
metachromasia, indicating maturation of the mast cells, 
prior to endothelial disruption. The products of mast 
cell degranulation are capable of inducing endothelial 
disruption; and could be an important factor in plaque 
destabilization. 
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MORPHOLOGIC AND DYNAMIC CHANGES OF ATHEROSCLEROTIC PLAQUE 
AT THE CAROTID ARTERY BIFURCATION: SEQUENTIAL IMAGING BY 
REAL TIME B-MODE ULTRASONOGRAPHY. 
Jesse Weinberger, M.D., Luis Ramos, M.D., John Ambrose, 
M.D., FACC and Valentin Fuster, M.D., FACC 
Department of Neurology and Cardiology, The Mount Sinai 
School of Medicine, New York, N.Y. 
Occurence of new symptoms of focal cerebrovascular 
disease, including completed cerebral infarction, 
transient ischemic attacks and amaurosis fugax was 
correlated with changes in size and morphology of 
atherosclerotic plaques at the carotid artery 
bifurcation visualized by Real Time B-Mode ultrasonography. 
Two hundred forty six plaques were imaged twice in 123 
patients over a time interval of 9 to 35 months. There 
was a significantly higher incidence of symptoms 
ipsilateral to plaques that grew (30/121) than to plaques 
that regressed or remained unchanged (8/110) (p( 0.001). 
Plaques that became hemodynamically obstructive by 
causing disruption of laminar flow or reduction of 
distal perfusion pressure at the ophthalmic artery 
were associated with a higher frequency of symptoms 
(12/30) than nonobstructive plaques (26/201) (p<O.OOl). 
There was also a strong association of symptoms to 
plaque configuration. Mural plaques growing in a 
crescentic configuration along the wall of the carotid 
bifurcation had a higher incidence of symptoms (22/56) 
than plaques which grew but maintained a nodular 
configuration (8/65) (p (o.ooll, though the same 
percentage of each became hemodynamically obstructive. 
Sequential visualization of atherosclerotic plaques 
by Real Time B-Mode Ultrasonography of the carotid 
bifurcation may provide a novel method for elUCidating 
the pathogenesis of arterial thrombosis. 
VISUALIZATION OF CLOTS IN EXPERIMENTAL VENOUS THROMBI 
USING MONOCLONAL ANTIBODIES. 
Tomiypshi Saitp. M.D •• James Powers. Naseem D. Nossiff. 
Barry S. Coller. M.D •• Herman K. Gold. M.D •• F.A.C.C •• 
Tsunehiro Yasuda. M.D •• Gary Matsueda. Ph.D., H. William 
Strauss. M.D •• F.A.C.C. and Ban An Khaw. Ph.D. 
Massachusetts General Hospital. Boston. MA and SUNY. 
Stony Brook. NY 
To visualize clots. two different monoclonal antibodies 
were inv~stigated in experimental animals with venous 
thrombi l VI) • 
The localization of radiolabeled antibody was tested in 
six anesthetized dogs. They each had two types of VT: A) 
Thrombin administered in an isolated s~gment of a 
superficial vein of the foreleg; and B) Clots generated 
by damage of endothelium in the femoral vein using a 
Fogarty catheter. In-Ill labeled antifibrin an~ibody 
(59D8) and 1-125 labeled antiplatelet antibody (7E3) were 
administered intravenously. and both energies of In-Ill 
and 1-125 images were followed serially bY gamma camera 
with medium energy collimator. The dogs were killed 5 
hours later and clots. vein surrounding the clots. and 
aliquots of blood were obtained. counted and the data 
expressed as %dose/gram. The results are as follows: 
VI (foreleg. n=6) 
Veins (foreleg) 
VI (femoral. n=7) 
Veins (femoral) 
Blood (5 hrs) 
In-Ill 59D8 
0.072±..0 .037 
0.02B±..0.016 
o .370±.0 .466 ] 
o .0 51±..0 .021 * 
o .0Bl±..0 .02B 
(*: p<0.005) 
1-125 7E3 
0.195±..0.174 
0.017±.0 .OOB] 
0.92B±..0 .91B 
o .0 50±.0 .OOB * 
o .047±.0 .OOil 
In In-Ill 59D8 images. 1 of 6 VI in the foreleg was 
visible. 3 of 6 VI were non-visualized. and the other 2 
VI were equivocal. All 7 VI in the femoral veins were 
visible. In 1-125 7E3 images. all 13 VI were visible. 
These studies suggest that these radiolabeled mon(oclQnal 
antibodies are useful and antiplatelet antibody 7E3) is 
better than antifibrin antibody (59D8) to visualize 
experimental VT. 
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RADIOIMMUNOIMAGING OF EXPERIMENTAL THROMBI IN DOGS USING 
MONOCLONAL ANTIBODIES.: EFFECT OF HEPARIN ON UPTAKE BY 
PULMONARY EMBOLI 
Tgmiyoohi Saitp. M.D •• James Powero. Naseem Noooiff. 
Barry S. Coller. M.D •• Herman K. Gold. M.D •• F.A.C.C •• 
Tsunehiro Yasuda. M.D •• Gary Mataueda. Ph.D •• Ban An 
Khaw. Ph.D •• H. William Strauso. M.D •• F.A.C.C. 
Maooachusetts General Hoopital. Booton. MA and SUNY. 
Stony Brook. NY 
The influence of heparin (H) on the biodiotribution of 
monoclonal antibodieo was determined in 11 dogs (6 dogs 
without H. 5 dogs with H) with experimental pulmonary) 
emboli (PE). The animals each had two types of PE: A 
Stasis clots generated in an isolated fempral vein with 
thrombin and Tc-99m sulfur colloid; and B) Copper coils 
inserted into the femoral vein. The clots were made 
with 1.0-1.5ml of blood and 100 units of thrombin! and 
they were released 3Q minptes later. In-Ill labe ed 
ant1fibrin antibody (59D8) and 1-125 labeled 
antiplatelet antibOdy (7E3) were administered 
intravenously and serial images of both were recorded by 
gamma camera with medium energy collimator. The dogs 
were killed 5 hours later. clots and aliquots of blood 
were harveoted. counted and data expresoed as %dooe/g. 
The reoulto are as followo: 
PE 
Blood 
(5h) 
In-lll 59D8 
H(-) H(+) 
O.104,tO.08l O.084~.0.93 
Cn=37) (n=16) 
O.08l~O.028 0.050~O.020 
(n=6) (n=5) 
1-125 7E3 
H(-) H(+) 
O.80l~0.685 O.486~O.817 
O.047~O.007 O.034,tO.012 
In dogo with H. the weighto of cloto are smaller th,n 
thooe in dogo without H ( 4Ot)O vs 72±.65 mg; p<O.05). 
Theoe data ouggest that heparin decreased the uptake of 
bo~h antibodies. especially that of 7E3, probably due to 
(l}.preyention o~ clot prop~ga~ion a~d \2) loss of 
ant1gen1c determ1nants by f1Dr1nolys1s. 
ABOLISHMENT OF CYCLIC FLOW VARIATION IN 
CONSTRICTED CAROTID ARTERIES OF CONSCIOUS, 
CHRONICALLY INSTRUMENTED DOGS WITH THE 
THROMBOXANE RECEPTOR ANTAGONIST,BM13.505. 
MahmOOd H AI-Wathjquj, M D Ph D , J. Craig Hartman, B.S., 
Garrell J. Gross Ph.D., Harold l. Brooks M.D., F.A.C.C., David C. 
Warltier M.D., Ph.D., Medical College of Wisconsin, Milwaukee, 
WI, 53226. 
Cyclic flow variation (CFV) has been previously demonstrated in 
severly constricted coronary arteries. It is a phenomenon that is 
suggested to be secondary to platelet aggregation followed by a 
sudden dislodgement of the platelet plug at the stenosis site. This 
investigation was undertaken to produce CFV in the carotid artery to 
serve as a model for changes in flow in transient cerebral ischemic 
allacks and to determine the effects of a thromboxane receptor 
antagonist. Nine dogs were chronically instrumented to measure 
hemodynamics and equipped with an Ameroid constrictor and a 
Doppler flow probe around the left carotid artery to induce slowly 
progressive vessel occlusion. CFV was observed in 7 of 9 dogs on 
day 5.1±0.6 (Meant S.E.M.) at a frequency of 6.HO.6 cycles per 
30 minutes with a mean peak flow velocity (MPFV) of 15t3 Hz 
x102 and mean nadir flow velocity (MNFV) of 4±2 Hz x102. The 
vessel was totally occluded by 7.9±O.B days. No dog demonstrated 
focal neurological deficit. When the thromboxane receptor 
antagonist, BM 13.505 (4-[2-(4-chlorobenzene- sulfonamide)· 
ethyl]-benzene acetic acid), was administered at 0.05 and 0.1 
mglkg i.v., CFV disappeared and steady state flow was maintained at 
a mean flow velocity of 20±6 and 20t7 Hz x102 for 30t5 and 
45±15 minutes, respectively. When CFV returned after BM 
13.505, it maintained pretreatment frequency, MPFV and MNFV. 
Neither CFV nor BM 13.505 had any effect on systemic 
hemodynamics. It is concluded that CFV is inducible during carotid 
artery stenosis and that a thromboxane receptor antagonist is 
capable of eliminating this phenomenon. The present model may be 
useful for investigation into cerebral vascular disease. 
ABSTRACTS 53A 
TRANSIENT INCREASE IN ENDOGENOUS PLASMA TISSUE PLASMINOGEN 
ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION 
Kazuo Komamura, MD, Atsushi Hirayama, MD, Kazuhiro 
Yamamoto, MD, Shinsuke Nanto, MD, Masayoshi Mishima, MD, 
Kazuhisa Kodama, MD, Cardiovascular Div., Osaka Police 
Hosp., Osaka, J·apan 
To examine whether pts with acute myocardial infarction 
(MI) have a fibrinolytic activity, we measured endogenous 
plasma tissue plasminogen activator (t-PA) antigen in 44 
pts with coronary artery disease (CAD). Venous t-PA 
antigen levels on the day of administration (1st) on the 
next day (2nd) and the 7 th day (7th) were determined by 
enzyme linked immunoadsorbent assay. Normal plasma t-PA 
level was determined in 19 pts (Control) with normal 
coronary and administration of heparin during the 
catheterization didn't affect it. In 15 pts with acute 
MI within 6 hrs from onset (AMI~6hrs) and 7 pts with 
impending infarction (IMI) in whom intracoronary thrombi 
were angiographically proved, their t-PA level 
significantly increased as compared with normal value. 
(p<O.OI). Twelve pts with acute MI over 6 hrs from onset 
(AMI>6hrs) and 10 patients with unstable angina (UA) had 
normal plasma t-PA levels. 
Group 
AMI(~6hrs) 
IMI 
AMI(~6hrs) 
UA 
Control 
Plasma t-PA level (ng/ml, mean!SD) 
1st 2nd 7th 
11.6+6.1* 6.8+4.8# 
14.5~7.7* 7.4~3.6# 
8.0!3.7 6.9!4.2 
6.7!3.6 
6.8!4.9 
6.0!3.8# 
6.2!4.7# 
(*p<O.OI vs Control, #p<O.OI vs 1st) 
These data suggest: 1) there may be an intrinsic 
protective fibrinolytic activity in hyperacute phase of 
MI; and 2) increased plasma t-PA level rapidly decrease in 
the process of evolving infarction. 
HOW FAST CAN THROMBOLYTIC THERAPY IMPROVE HEMODYNAMIC 
STATUS IN PATIENTS WITH MASSIVE PULMONARY EMBOLISM? 
G.V.R.K. Sharma, M.D., D.A. Pietro, M.D., R. Brody, M.D., 
W.E. Strauss, M.D., K.M. McIntyre, M.D., A.A. Sasahara, 
M.D., Veterans Administration Medical Center, West 
Roxbury, Brigham and Womens Hospital and Harvard Medical 
School, Boston, MA. 
Efficacy of thrombolytic therapy (T) with i.v. 
streptokinase or i.v. urokinase was evaluated in 21 
patients (pts) with angiographically documented acute 
massive pulmonary embolism (PE) by comparing the hemody-
namic improvement to that in a similar group of pts 
treated with i.v. Heparin (H) over a l2-hour period. 
Hemodynamic improvement was assessed by continuously 
monitoring the right atrial (RA), pulmonary artery (PA) 
mean pressures and the cardiac index (eI). 
Mean results in the two groups (H=ll; T=lO) were: 
Time RA(mmHg) PA(mmHg) CI(L/min/M.2 ) 
H T H T H T 
Pre~ 8 10* 33 35** 2.2 2.4*** 
2Hrs 9 8 30 28 2.1 2.7 
4Hrs 9 5* 31 18** 2.3 3.1*** 
8Hrs 9 4 28 16 2.6 3.0 
l2Hrs 4 29 16 2.5 3.2 
* , ** , ***, P=<O.05 
The results indicate that T unlike H can achieve a 
significant lowering of PA and RA with improvement in 
CI within four hours in pts with massive PE. 
Lysis of acute massive PE in pts with compromised 
hemodynamic status can lead to a dramatic improvement 
in the clinical condition. The rapid beneficial effect 
of T can obviate the need for pulmonary embolectomy and 
can be potentially life-saving. 
54A ABSTRACTS 
NITROGLYCERIN AT THERAPEUTIC DOSES INHIBITS PLATELET 
AGGREGATION IN HAN. 
Jean Diodati. II.D., Pierre Theroux, II.D., F.A.C.C., 
Jean-Gilles Latour, Ph.D., Lucie Lacoste, B.Sc., Guy 
B. Pelletier, II.D., F.A.C.C., Denis Roy, II.D., 
F.A.C.C., and David D. Waters, II.D., F.A.C.C., 1I0ntreal 
Heart Institute, 1I0ntreal, Canada. 
Platelet aggregation was measured in 10 pts with coro-
nary artery disease, before nitroglycerin (RTG), at the 
end of a 4S min. perfusion and lS min. later. Doses of 
RTG were titrated to a 10 mmHg reduction in blood pres-
sure or to side effects. lIean dose was 1. 2±O.17 (SEll) 
mg/kg/min (range 0.44 to 1.9). Blood (9 ml) was obtain-
ed from a forearm vein into preheated (37°C) syringes 
containing 1 ml sodium citrate 3.8'-, pH 7.4. Platelet 
aggregation was tested on whole blood diluted in saline 
(1:1) using a dual channel impedance aggregometer 
(Chronolog Corp). Tests were carried out at the bedside 
within 60 sec. of sampling (native blood), and after 30 
min. of incubation (preserved). ADP (20 mH) and throm-
bin (O.lS NIH units) were used as aggregating agents. 
Aggregation: Surface area (cm2) Amplitude (ohms) 
ADP Before RTG After Before NTG After 
~tive 37.6~4 20.1~4* 31.8~ 12~1 6.7±1* 10.4~2 
preserved 39.S~ 39~6 NO 11~1 13±1 ND 
Thrombin 
native 4.7~2 1.6~1* 3.8~2 4.7~1 1.8~1* 4~2 
preserved 6.7~2 6.7~2 ND 7.S±2 7.7~2 ND 
* p<.002 compared to before RTG; ND: not done. 
The inhibition was SO'- or more (mean 71'-, range 
SO-100'-) in all 10 pts with ADP or thrombin. 
Thus, bedside platelet aggregation studies document a 
clear and reversible inhibitory effect of NTG at thera-
peutic doses. This effect is not detected with standard 
tests of platelet aggregation. 
NEW TREATMENT FOR NON-MASSIVE PULMONARY EMBO-
LISM AND ACUTE DEEP-VEIN THROMBOSIS : LOW MOLE-
CULAR WEIGHT HEPARIN. 
R. Faivre, E. Neuhart, D. Ducellier, Y. Kieffer, J.P. Bassand, 
J.P. Maurat. 
University Hospital St Jacques, Besanton, FRANCE 
Low molecular weight heparin (LMWH) has been demons-
trated as antithrombOtic agent without anticoagulant activity. 
In order to assess effectiveness and safety of LMWH, 68 
patients (pts) with acute deep vein thrombosis (DVT) and 
non-massive pulmonary embolism (PE, 2~/68, 35'16) were 
randomly allocated to reCeive either LMWH (CY 222, Choay 
Institute, France, n=33) in a fixed dose of 750' u anti-Xa/kg/ 
2~h or standard heparin (SH, n=35) in a adjusted dose of 
500 u/kg/2~, both given by twice daily subcutaneotJs (sc) 
injections for 10 days (d). Contrast venography and perfusion 
lung scan wer.e repeated on d 10 to determine Marder'S 
score (M) ancf perfusion score (P) variations (*p 0.05): 
LMWH 
n=33 
SH 
n=35 
MdO MdlO PdO PdlO 
I~.I 9.5* 19.3'16 2.2'11>* 
+ 11.7 +8.7 +8.7 + 5.1 
1~.3 8.9* 21.3'16 -1.9'16* 
:!;.10.6 :!;.7.5 +9.1 . :!;.3.8 
No bleeding was observed in LMWH pts, whereas large 
hematoma occured in 3 SH pts. One patient in each gOtJP 
presented a recurrence of PE. PTT was prolonged in SH-pts 
and remained normal in LMWH' pts. In conclusion, LMWH 
an SH were equally effective in pts with acute DVT associated 
with non-massive PE, but, CY 222, a LMWH fraction seemed 
to be ~er than SH. 
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LEUKOTOXIN, 9,10-EPOXY-12-0CTADECENOATE, CAUSES DISSEMI-
NATED INTRAVASCULAR COAGULATION. 
Takayuki Ozawa,M.D., Satoru Sugiyama,M.D., Nobuyuki 
Hi eda, M. D., Aki hi ko Fukushima, M. D., Takuo Ogawa, M. D., 
Yoshihiro Hanaki,M.D., Mika Hayakawa,M.D. University of 
Nagoya, Nagoya, Japan. 
Disseminated intravascular coagulation (DIC) is often 
encountered after surgical procedure such as open heart 
surgery. Although such substances as endotoxin are known 
to induce DIC, the responsible factor remains obscure. 
We revealed that neutrophils biosynthesize linoleate 
epoxide, 9,10-epoxy-12-octadecenoate, which shows a 
highly cytotoxic effect. Thus it was nominated as leuko-
toxin. In this study, we determined whether or not 
leukotoxin causes DIC. Leukotoxin (100 ~mol/kg) was 
injected intravenously into dogs. After administration 
of leukotoxin, fibrin and fibrinogen degenerative 
products (FOP) were increased time-dependently, i.e., 5.6 
± 1.2 ~g/ml (mean ± SO, n=6) for the control, 10 ± 2.2 
for 1 hr after administration, 25.8 ± 3.4 for 4 hr. 
Fibrinogen decreases also time-dependently (221 ± 23 
mg/dl, 152 ± 22, 55 ± 12, for the control, 1 hr, 4 hr, 
respectively). Activated partial thromboplastin time and 
prothrombin time were prolonged in parallel with 
increases in FOP. Plateletes were decreased but 
insignificant. Intravascular coagulation and endothelial 
cell damage were observed especially in the lung by 
morphological examination. In three cases with DIC post 
open heart surgery, we observed leukotoxin in lung 
lavages. Leukotoxin is known to be metabolized by 
hydrolase, which is rich in the liver and kidney. 
Accordingly, a prominent effect of leukotoxin could be 
observed in the lung. 
In conclusion, leukotoxin might be one of the responsible 
factors in the genesis of DIC. 
DOES TISSUE PLASMINOGEN ACTIVATOR REDUCE INFARCT SIZE IN 
AN EXPERIMENTAL MODEL OF MECHANICAL CORONARY ARTERY 
OCCLUSION AND REPERFUSION IN DOGS? 
ColinA. Campbell, Ph.D., Kevin J. Alker, Robert A. 
Kloner, M.D., Ph.D., F.A.C.C., Wayne State University 
and Harper Hospital, Detroit, Michigan. 
Recently there have been suggestions in the litera-
ture that recombinant human tissue plasminogen activator 
(TPA) could reduce acute myocardial infarct size by 
means other than thrombolysis. To test this hypothesis, 
anesthetized thoracotomized dogs were subjected to mech-
anical occlusion of the left anterior descending coro-
nary artery (LAD) for 2 hours followed by 4 hours reper-
fusion. Dogs received saline or TPA (1000 IUfkg/min--a 
dose previously shown to induce thrombolysis in dogs) 
infused for 2 hours beginning 30 minutes after occlusion 
in a blinded randomized manner. In vivo area at risk 
(AR) was determined by intra-atria~injection of monas-
tral blue dye and the area of necrosis (AN) was deter-
mined after excision of the heart 6 hours post-occlusion 
by tetrazolium staining. Myocardial blood flow (MBF, 
ml/min/g) was measured using radioactive microspheres. 
The AR, expressed as a percentage of the left ventricle, 
was l7.3±2.7 in the control group (n-B) and 19.4±2.4 in 
the TPA treated group (n-B; p-NS). The AN/AR was 2B.3± 
B.2' in the control group and 35.S±B.6' in the TPA 
treated group (p-NS). MBF in the LAD endocardium post-
occlusion, pre-randomized was 0.12+0.03 in the control 
group and 0.OB±0.04 in the TPA treated group (p-NS). 
Treatment had no effect on MBF during occlusion. Post-
reperfusion MBF was O.37±0.04 in the control group and 
0.37± 0.06 in the TPA group (p-NS). Thus, TPA had no 
effect on infarct size or MBF. These results suggest 
that at this dose, TPA does not possess any properties, 
other than thrombolysis, which contribute to myocyte 
salvage. 
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THE POTENTIAL RISK OF THROMBOSIS DURING ANGIOGRAPHY 
USING NON-IONIC CONTRAST MEDIA. 
Ming H. "Hwang, M.D., F.A.C.C., Zhen E. Piao, M.D., 
David K. Murdock, M.D., F.A.C.C., John Giardina, M.D., 
Ivan Pacold, M.D., F.A.C.C., Henry S. Loeb, M.D., 
F.A.C.C. and Patrick J. Scanlon, M.D., F.A.C.C., Hines 
VA Hospital, Hines, IL and Loyola Medical Center, 
Maywood, IL. 
The influence of contrast media (CM) on thrombogenesis 
has important implications. Ionic CM appears to have 
anticoagulant effects, however, the effects of newer 
low molecular and non-ionic CM on clotting is unclear. 
Accordingly, 5 ml of canine (N = 10) and 3 ml of human 
(N - 11) whole blood was incubated in glass tubes with 
equal volumes of the non-ionic CM Iohexol (IOH), ionic 
low molecular Hexabrix, Hypaque-76 and normal saline 
(S). Experiments were repeated using blood obtained 
after intravenous heparinization (5000 u to dogs, 2000 
u to pts). Clot formation in gms was determined after 
30 minutes of incubation. Results: In the absence of 
heparinization, clot formation from blood mixed with 
IOH and S were seen both in dogs (4.0 + 0.7 gm) and 
(5.6 + 0.8 gm) and in pts (1.4 ~ 0.9 gm) and (2.9 ~ 1.3 
gm) respectively, whereas no clot was present in mix-
ture of blood with ionic CM, Hexabrix or Hypaque-76. 
Following heparinization no clot developed in blood 
mixed with any CM or saline. Conclusion: Unlike ionic 
CM, non-ionic media appears not to inhibit in vitro 
clot formation and thus may be associated with higher 
risk of thrombotic complications during diagnostic 
angiography. Since heparin inhibits clotting in pres-
ence of non-ionic media its use is particularly recom-
mended when this media is to be used in angiography. 
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Pharmacology-Antiarrhythmic Drugs: Clinical 
tIMITED EFFECTIVENESS OF LIDOCAINE IN TERMINA-
TION OF SUSTAINED VENTRICULAR TACHYCARDIA 
Matthias Manz, M.D., Berndt Luderitz, M.D., 
Dept. of Cardiology, University of Bonn, FRG 
Lidocaine (L) is recommended for the acute mana-
gement of ventricular tachycardia (VT). We 
assessed the efficacy of L (100mg iv) versus 
ajmaline (A,50mg iv) for termination of per-
sistant (>5min), hemodynamically stable VT in a 
prospective trial. 31 patients (pts) with coro-
nary artery disease (23 pts), cardiomyopathy (6 
pts) or valvular disease (2 pts) were randomized. 
No significant differences were present with re-
spect to underlying heart disease, prior thera-
py, age, ejection fraction and VT rate between 
L (16 pts) and A (15 pts). Immediate termination 
of VT was accomplished by L in 2/16 pts (13%) 
and by A in 10/15 pts (67%) (p<O.Ol). Additio-
nal overdrive stimulation ended persistant VT 
after L in 8/14 pts (57%) and after A in 4/5 
pts (80%). RR intervals of VT remained un-
changed by L (control: 380+/-53ms, L 388+/-56ms) 
and increased from 369+/-82ms to 452+/-111ms 
(p<O.OOl) under A. QRS duration during VT was 
unaffected by L and was prolonged by A from 166 
+/-18ms to 200+/-28ms (p<O.OOl). There was no 
difference of the posttachycardia cycle length 
(L 917+/-367ms, A 863+/-296ms). Under L, 9 pts 
had central nervous side effects: A caused 
transient flushing in 10 pts. - We conclude, 
that L is less effective than the I-A antiar-
rhythmic agent ajmaline for acute management of 
VT. 
ABSTRACTS 55A 
CLINICAL SIGNIFICANCE OF CHANGES IN INTRALYMPHOCYTIC 
POTASSIUM AND SODIUM CONTENTS IN AMIODARONE THERAPY 
Guanggen Cui and Luyi Sen, Geriatric Research Laboratory 
and Department of Medicine, Shanghai Sixth People's 
Hospital, Shanghai, People's Republic of China. 
Amiodarone is an extremely effective anti arrhythmia druq 
that has been cardiac clinical use for more than two 
decades. Adverse side effects especially fatal to 
arrhythmias is believed to be dose related and determined 
by the minimal effective and maintenance dosage. 
Determination of intral~mphocytic potassium and sodium 
contents ([K]fL and [NaJIL) and parallel Q-T interval and reverse T3 (r 3) monitoring were performed in 50 patients 
with cardiac arrhythmias (atrial fibrillation 32. frequent 
ventricular premature beat 11, WPW syndrome 7) before and 
during amiodarone therapy or after discontinuation of the 
drug. Fifty normal subjects served as control. The mean 
[KJIL after 5-7 da¥s of treatment in dosage of 400-800 mg 
per day was 67.73 _ 10.32 fmol/cell, significantly higher 
than the potassium level before treatment and that of 
normal control (26.52 ! 2.80 fmol/cell) (p 0.001). The 
cell [K]IL/[Na]IL ratiu (r : 0.59, p 0.01). The values of 
rT3 were also correlated with the daily doses (r = 0.27). 
The difference between thses two correlatiosn coefficients 
was statistically significant (u = 2.004; p 0.05). The 
changes in rx]IL/[NaJIL ratio seemed to correlate well 
with the therapeutic effect. A [K]IL/[Na]IL of 1.92 - B.80 
appeared to be the therapeutic range and over 8.80 may be 
the toxic level. The Q-T intervals shown on ECG and serum 
potassium and sodium were all within normal range. Thus the 
intralymphocytic potassium and sodium determination is if" 
more sensitive monitoring index than Q-T interval and rT3 
testing. 
SOTALOL FOR SUSTAINED VENTRICULAR 
TACHYARRHYTHMIAS: PREDICTORS OF ARRHYTHMIC 
OUTCOME 
Terry ZheuUin MD, Thomas Mattioni MD, Saurabh Choksi MD, 
Jose Nazari MD, Cathy Dunnington RN MS, Michele Parker RN 
MS, Nancy Nebergall RN, Richard Kehoe MD, Northwestern 
University Medical School, Chicago, Il. 
The factors predictive of long-term arrhythmic outcome were 
examined in 42 pts receiving sotalol (Sot) fo.!: the chronic therapy 
of sustained ventricular tachyarrhythmias l22 e.ts, ventricular 
tachycardia (VT); 10 pts, ventricular fibrillatiol!J • Forty of 42 had 
heart disease (31 pts, prior infarction; 6 pts, cardiomyopathy; 3 
pts, valvular). Of the 35 pts with inducible VT (IVT) at drug-free 
programmed stimulation (PS) and the 6 pts with spontaneous VT 
precluding drug-free PS, 27 (66%) were rendered non-inducible by 
Sot. Fourteen had persistence of IVT after Sot therapy. One pt 
was free of IVT at both drug-free and post-Sot PS, Mean Sot dose 
was 586+235 mg/day. 
At 10+8 mos, 32 pts (76%), Gpl, were free of arrhythmic recur-
rence (AR) While 10 (24%), GpII, recurred. The Gps were similar 
for heart disease type, presence of LV aneurysm, mean Sot dose, 
discharge Sot level, % VPB suppression and number of VT runs on 
predischarge Holter monitor. The Gps differed significantly 
(p< 0.05) with respect to prior heart failure (HF), 28% vs 70%; HF 
during follow-up, 13% vs 50%; and NYHA class 3 or 4, 9% vs 60%, 
for Gps I and II respectively. Using life-table analysiS, the 14 pts 
with persistence of IVT despite Sot therapy were significantly 
more likely to sustain AR at 12 mos (49%) as compared to the 27 
pts without IVT (15%), p<0.05. 
We conclude: 1) Persistence of IVT at predischarge PS despite 
therapy with Sot is associated with an increased risk of AR; 2) 
Other factors such as NYHA class 3 or 4 and the emergence of 
HF during follow-up also adversely affect arrhythmic outcome; 
and 3) Other clinical, angiographic and Holter monitor parameters 
are of limited value in further defining arrhythmic risk in pts 
treated with Sot. " 
56A ABSTRACTS 
A PRoSl'ECTlVE STUDY OF INTRAVENIlUS AND ORAl FLECAINIDE IN RIGHT VENTRICULAR 
ARRHYTH"IA 
Klaus-Peter Kunze. n.D" nicha.1 Hofflann, and Karl-Heinz Kuck, n.D. 
University Hospital Epp.ndorf, Hillburg, F.R.G. 
Ne have shoMn that class IC antiarrhythlic agents are highly efftctive in 
suppressing atrial ectopic tachycardia refractory to conventional antiarrhythlic 
agents. Since arrhythlin originating in the RV outfla. tract (RVOTI have 
IlectrophYliologic characteristics lililar to atrial ectopic tachycardia, Me 
prospectively studied the effech of i.v. (1.5 - 2.0 Ig/kg b., and oral (200-300 
Ig/dl f1ecainide in 15 ph (7 I, 8 Mj 38 t 12 years I with arrhythlias frol RVDT. 
All pts had palpitations, I had a history of syncope and doculented sushined 
ventricular tachycardia. In all ph 3 to 6 conventional antiarrhythlic drugs hid 
failed to control the mhythlia. During 24h Halter lonitoring all ph had }30/h 
lonOlarphic ventriculir preHtUrt beats (YPBsl, 3 ph had nan-sushi ned 
ventricular tachycardia, 4 had couplets, and 2 ph had bigHiny. Dne pt had 
exercise induced sustained yentricular tachycardia. Angiography revealed I 
circulscript aneuryu of RVOT in 4 pts and nonal RY larphology in II ph. During 
electrophysiDlogic study 9114 ph bad frequent spontaneous arrhythlias frDl RYDT. 
Progral .. d electrical stinlation (Ill. 3 .. trastinli frol RY apel and RYDTI 
induced sustained ventricullr tachycardia only in the pt with Iyncope and 
clinically doculented vtDtricular tachycardia. In the rHaining ph no sustained 
arrhythlias ere inducible. I.Y. f1ecainide cOlpletely suppressed spontaneous 
arrhythliu in B ph and reduced the incidence in I pt. Sustained ventricular 
tachycardia reHined inducible at I longer cyclt Itngth .... arrhythlias were lot 
induced by i.y. f1ecainide. During a folia. up ptriod of 21 t 8 IOnthl under oral 
f1ecainide, II ph becillt UYlptllHtiC, 4 ph had less palpitations than before 
f1ecainide. In 2 of these 4 ph Halter lanitoring ShOMed recurrences of 
nan-sustained ventricular tachycardia, and in I pt bigeliny. I SylptDHtic and 
all aSylptoHtic pts had (301h 1DD0IDrphic VP8s. 
Conclusions: I. Sustained ventricular tachyclrdia originating in the RVOT 
cannot be induced by prograM electrical StilUlation in pts .ithout clinically 
doculented ventriculir tachyclrdia. 2. Intrayenous f1ecainide capletel y 
suppresses spontanioul arrhythliu frDl RVDT in 901 of the ph. 3. Long hrl oral 
f1ecainide leads to IIrked clinical ilpraveHnt in all pts. 
ANTIARRHYTHMIC DRUG-INDUCED TORSADE DE POINTES: LACK OF 
RELATIONSHIP TO MARKED QT PROLONGATION. 
Anil Bhandari, M.D., F.A.C.C., Rukhsana Siddiqi, M.D., 
Michael Jamison, M.D., Shahbudin H. Rahimtool~, M.D., 
F.A.C.C., LAC-USC Medical Center, Los Angeles, CA. 
Since 1983, 17 pts experienced documented torsade de 
pointes (TdP) caused by antiarrhythmic drugs (AAD). 
They were being treated for atrial fibrillation (8 pts), 
ventricular ectopics (7 pts) or ventricular tachycardia 
(2 pts). TdP was caused by quinidine in 13 (77%) pts 
and procainamide in 4 (23%) and occurred within 3 days 0* starti~ AAD in 12 (71%) pts. At time of TdP, serum 
K and Mg were low in 2 pts each and 1 pt had brady-
arrhythmia. The serum levels of AAD were therapeutic or 
low therapeutic in all. In ECGs obtained within 12 
hours prior to TdP, the heart rate ranged form 55 to 
108/min (75±18), the QT from 392 to 588 (45l±75) ma, and 
the QTc from 391 to 597 (496±55) ms. Only 2 (12%) pts 
had a marked QTc prolongation (>550 ms): 9 (53%) had 
mildly prolonged QTc «500 ms). In 12 (86%) of the ~4 
pts, the rhythm strips just prior to TdP revealed 
ventricular ectopics followed by long pauses and 
postpause T changes. Lidocaine, as an initial 
treatment, suppressed TdP in only 4 (27%) of the 15 pts. 
TdP was controlled in 11 pts with IV MgS0
4 
(3 pts), 
overdrive pacing (4 pts), or both (4 pts). In 2 pts, 
TdP was not correctly diagnosed because the QTc was 
borderline prolonged. Both received procainamide and 
one of them died of irreversible ventricular fibrilla-
tion 48 hours later. In conclusion, AAD induced TdP 
occured in the vast majority within 3 days of starting 
drug. Prior to onset of TdP, marked QTc prolongation 
was rare but post-pause T changes were frequently 
present. IV MgS04 alone or in combination with OVer-drive pacing appeared to be the most effective therapy. 
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LOSS OF ANTIARRHYTHMIC EFFICACY IN THE CHRONIC TREATMENT 
OF PATIENTS WITH BENIGN AND POTENTIALLY LETHAL 
VENTRICULAR ARRHYTHMIAS.: Harold L. Kennedy, MD, FACC, 
Michael K. Sprague, Robert D. Wiens, MD, FACC, Thomas A. 
Buckingham, MD, FACC, Denise L. Janosik, MD, FACC, Robert 
M. Redd, MD. St. Louis University, St. LoUis, Missouri 
To determi.ne the duration of efficacy of chronic 
moricizine (M) antiarrhYthmiC (AA) suppressive therapy in 
Pts with benign and potentially lethal ventricular 
arrhYthmi.a, we followed 28 Pts who deDDnstrated AA 
suppression ()75%) on M therapy for a mean of 19.1'9 
DDnths (range 1 to 36). Pts were examined with 24 hour 
ambulatory ECG and plasma drug levels during baseline 
placebo, AA therapy, and pulsed placebo periods every 6 
months. Ventricular ectopy at baseline placebo was 
253.1'50 VEB/hr and after M was 33±12 VEB/hr. Follow-up: 
Months -r 
12 
18 
24 
ANTIARRHYTHMIC SUPPRESSION 
~ 75% ) 80% ~ 90% 
74% 20n7l b7% ( 18/27) 52% 14/27l 
64% (14/22) 64% (14/22) 55% (12/22) 
53% (8115) 40% (6/15) 27% (4115) 
30% (4111) 36% (4111) 27% (3/11) 
Individual M plasma levels were in the therapeutic range 
throughout the study period. Complete loss of AA 
efficacy despite drug titration occurred in 6/28 Pts, 
delayed side effects necessitated drug witlxlrawal in 5/28 
Pts, and a medical event occurred in 3/28 Pts. 
ProarrhYthm1a and spontaneous resolution of arrhYthmia 
were detected in only one Pt at 30 months. These data 
show a progressive loss of AA efficacy and the 
development of delayed side effects neceSSitating drug 
witlxlrawal in 40% (11/28) of Pts during 24 IOOnths of 
therapy. These observations are important to consider in 
the chronic AA drug treatment of all Pts with benign or 
potentially lethal ventricular arrhythmia, e.g., the CAST 
trial • 
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AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR 
DISCHARGES AND ACUTE MYOCARDIAL INJURY 
Boaz Avitall, M.D., Ph.D., Steve Port, M.D., James 
MCKinnie, M.D., Patrick Tchou, M.D., Mohammad Jazayeri, 
M.D., Mark Cowan, M.D., Jose Caceres, M.D., Masood Akhtar, 
M.D., F.A.C.C. Mount Sinai Medical center, MilwaUkee, WI 
The application of the automatic implantable cardio-
verter defibrillator (AICD) epicardial patches and 
multiple cardioversions have been reported to result in 
localized epicardial damage. However, no data exists 
whether or not evidence of detectable myocardial injury is 
present during the first 48 hours post AICD discharges in 
the human. We examined 8 patients (PTS) with AICDs (7 PTS 
with coronary heart disease and I PT with cardiomyopathy I 
who received 4-12 consecutive discharges either at the 
time of AICD insertion or spontaneously after insertion. 
The total delivered energy ranged from 50-360 joules. 
Four out of 8 PTS had positive pyrophosphate (PYP) scans, 
only 2 of whom had elevated enzymes. A MUGA scan was 
performed in I of the PYP positive PTS which did not 
reveal any new wall motion abnormalities. Serial ECGs 
revealed transient anterior ST segment elevation in I PT 
and transient anterior T wave inversion was noted in 1 PT 
who did not have a positive pyp_scan or elevated enzymes. 
No new Q waves were noted in any of the PTS. 
Fifty percent of the PTS did not have positive PYP 
scans following multiple AICD discharges, 25% had 
positive enzymes and none had longstanding ECG changes 
consistent with acute myocardial injury. Thus, 1) the 
PYP scan is the most sensitive modality for the detection 
of myocardial injury in this setting, 2) 50% of PTS 
receiving multiple AICD discharges do not have any 
detectable myocardial injury using the above modalities, 
31 permanent ECG changes are not seen follOwing multiple 
AICD discharges and thus may discriminate between AICD 
related injury and that due to coronary occlusion. 
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THE IMPORTANCE OF PATCH ELECTRODE PLACEMENT AND SIZE ON 
DEFIBRILLATION: A FINITE-ELEMENT ANALYSIS 
Nestor G. Sepulveda, Ph.D., Debra S. Echt, M.D., 
F.A.C.C., and John P. Wikswo, Jr., Ph.D., Vanderbilt 
University, Nashville, Tennessee 
The addition of a subcutaneous thoracic (SQ) or an epi-
cardial (EP) patch electrode to a transvenous two-elec-
trode cardioverter/defibrillator catheter has been shown 
to lower the energy required for'defibrillation in dogs. 
Our finite-element, mathematical model of the canine 
thorax suggests that these single-pulse electrode con-
figurations improve the current density distributions 
through myocardial regions. We assessed the influence 
of EP and SQ patch size on the current distributions. 
The EC consisting of the distal catheter (-), and the 
proximal catheter and the patch (+) was analyzed for both 
EP and SQ patches of standard size (1& cm'), as well for 
patches with 1.5 and 2.0 times that area. The amount of 
current flowing through the blood in the right heart is 
similar for all cases, with or without the EP or SQ 
patches. The EP patch size affects appreciably the cur-
rent distribution through the myocardium: the larger the 
size of the EP patch the larger the current flowing 
through the apical septum and the left ventricular wall, 
and the lower the current in the basal septum. In con-
trast, SQ patch size does not affect the myocardial cur-
rent distribution. We conclude that epicardial patch 
size is an important factor in implantable defibrilla-
tion systems, but subcutaneous patch size 1s not. 
OPTIMIZING BIPHASIC NONTHORACOTOMY INTERNAL DEFIBRIL-
LATION. 
Jule N. Wetherbee, M.D., James Vetter, M.D., Joseph 
Souza, M.S., Peter D. Chapman, M.D. ,F .A.C.C., Paul 
J. Troup, M.D.,F.A.C.C., Medical College of Wisconsin, 
Milwaukee, WI. 
To assess the optimum configuration of biphasic shocks 
for nonthoracotomy internal defibrillation (using 
RV catheter electrodes as cathode and subcutaneous 
chest wall patch as anode), 6 anesthetized dogs (wt 
20.2 .!. 1.6 kg) underwent defibrillation trials using 
an external defibrillator capable of delivering I 
~PI) or 2 (PI + P2) truncated exponential pulses with lndependently programmable peak voltage(V),pulse width 
(PW) and pulse polarity. Each of 3 configurations 
were tested with total PWs of 7.5, 10, and 12.5 msec: 
I) monophasic, 2) biphasic, PI 90% and P 10% of total 
PW (B 90/10) and 3) biphasic PI 75% ~nd P 25% of 
total PW (B 75/25). P2 was of opposite potarity to 
PI' with ~ ~ t.o that of P I and 250 ps delay. Each 
snock conhguratlon was randomly tested at 5 different 
V levels and defibrillation efficacy curves were con-
structed. Results: At all PWs, B 75/25 shock curves 
were associated with Significantly lower voltage levels 
than B 90/ I 0 shocks (p < 0.00 I) . Energy associated 
with both biphasic shock curves was significantly 
less than that associated with the monophasic shocks 
(p < 0.001). Conclusions: I) In this model, energy 
requirements for biphasic shocks are significantly 
less than for monophasic shocks of similar PW. 2) 
B 75/25 voltage is superior to B 90/10 at all PWs 
tested 3) within the range of 7.5-12.5 msec, PW is 
not an appreciable factor in defibrillation efficacy. 
4) These data provide further support for the application 
of biphasic waveforms for a nonthoracotomy defibrillating 
system in humans. 
ABSTRACTS 57A 
DETERMINATES OF DEFIBRILLATION THRESHOLD 
Michael Oeft M p .. Joseph A. Abbott, M.D.,FA.C.C., Elan D. 
Scheinman, BA, Edward S.Yee, M.D., FAC.C., Melvin M. 
Scheinman, M.D., F.A.C.C., Jerry C. Griffin, M.D., F.A.C.C. 
University of California San FranCisco, San Francisco, CA. 
AnatomiC position and functional parameters of automatic 
cardiovertor defibrillator (AICD) patches might predict 
successful defibrillation thresholds (OFT) and relate to 
complications. Therefore, we acquired Chest X-rays (CXR) and 
Fast CT (Imatron C-1DO) images of the heart in 15 (12M) pts, in 
whom an AICD was placed to control medically resistant 
malignant ventricular rhythms. CXR and CT's were judged for 
patch position. From the CT, combined and individual volumes 
of left and right ventricles and myocardium, and the total space 
interposed between AICD patches (12) or patch and coil (3) 
were calculated. CT gave precise detail of patch position, 
allowed sophisticated quantitative calculation and was thus 
superior to CXR. AICD induction of atrial fibrillation (2/15) did 
not relate to patch malposition over RA or LA. The quality of 
patch position was related to heart size; with 6/11 (55%) large 
hearts (313±80 cc) having poor patch placement. When 
non-ventricular structures were excluded from total volume 
between patches a correlation was found with OFT (p=<:.05, 
r=.7). No correlation was found between total LV volume and 
OFT. 
Conclusions: The volume of both ventricles interposed 
between the patches (coil) and not global LV volume, 
determines defibrillation threshold. Large hearts make patch 
placement difficult and poor position can result. 
COMPARISON OF MONOPHASIC, BIPHASIC, AND TRIPHASIC TRUN-
CATED PULSES FOR NON-THORACOTOMY INTERNAL DEFIBRILLATION. 
Peter D. Chapman, M.D., F.A.C.C., Jule N. Wetherbee, M.D., 
James W. Vetter, M.D., and Paul J. Troup, M.D., F.A.C.C. 
Medical College of Wisconsin, Milwaukee, WI. 
Monophasic (M), biphasic (B), and triphasic (T) truncated 
shocks were compared in 6 anesthetized dogs (wt 19.6 ± 
1.1 kg) undergoing defibrillation trials using a lead 
system consisting of a RV catheter electrode (cathode) 
and a subcutaneous chest wall patch (anode). M shocks 
were 10 msec single cycle truncated exponential. B 
pulses had an initial positive 5 ms phase followed by a 
5 ms negative phase with the leading edge of the second 
phase having half the residual voltage (V) of the first 
phase. T shocks were complex waveforms consisting of a 
2.5 ms negative phase followed by a 5 ms positive phase, 
and ending with a second 2.5 ms negative phase. The 
total pulse width for all types of pulses was 10 ms. 
Ventricular fibrillation was induced by AC and allowed 
to proceed for 10 seconds prior to defibrillation. One 
shock per fibrillation episode was tested. The various 
pulses were tested randomly and the minimum V and energy 
(J) resulting in defibrillation was determined. 
OFT M B T 
J 21.1 10.1 14.3 
V 581 410 488 
Both Band T truncated pulses were associated 'with 
significantly lower OFT than M (P<.Ol). OFT's for B 
were significantly lower than for T (P(.03). 
ConClusion: Band T truncated pulses reduce OFT for 
non-thoracotomy defibrillation compared to M pulses. B 
pulses resulted in the lowest DFT's and may be useful in 
developing small non-thoracotomy internal defibrillators. 
58A ABSTRACTS 
SUPERIORITY OF BIPHASIC SHOCKS IN THE DEFIBRILLATION OF 
DOGS VIA EPICARDIAL PATCHES AND CATHETER ELECTRODE 
John Schuder, Ph.D., Wayne MCDaniel, Ph.D., Harry Stoeckle, 
M.D., Mountasir Dbeis, B.S.E.E., Greg Flaker, M.D., 
F.A.C.C. University of Missouri - Columbia 
CUrrent implantable defibrillators use a uniphasic trun-
cated exponential waveform of about 6 msec. at energy 
levels of 23-33 joules. To determine if improved de fib-
rillat~on could be achieved with a different waveform mor-
phology we implanted 4.5 cm2 titanium patches on the left 
and right ventricles of 28 dogs weighing 20-28 kg. In 
another 7 dogs a trans venous bipolar catheter electrode 
was placed with the distal electrode in the right ventric-
ular apex and the proximal electrode in the superior vena 
cava. Ventricular fibrillation was induced and after 30 
secs. defibrillation was attempted using 7, 12, 13 or 17 
joules applied between patches or 14 joules applied via 
catheter electrode. A 5 msec. rectangular uniphasic wave-
form was compared with a 10 msec. rectangular biphasic 
waveform with a lagging 5 msec. pulse of one-half the amp-
litude of the leading 5 msec. pulse. No animal received 
more than 40 shocks; at least 2.5 minutes elapsed between 
shocks. 
RESULTS 
PATCH-PATCH 
7 Joules 
12 Joules 
13 Joules 
17 Joules 
CATHETER ELECTRODE 
14 Joules 
SUCCESSFUL DEFIBRILLATIONS/TRIALS (%) 
UNIPHASIC BIPHASIC P VALUE 
42/120 (35%) 80/120 (67%) <0.001 
93/120 (78%) 112/120 (93%) <0.001 
106/120 (88%) 113/120 (94%) NS 
114/120 (95%) 115/120 (96%) NS 
32/120 (27%) 115/120 (87%) <0.001 
CONCLUSIONS Biphasic 10 msec. shocks are superior to uni-
phasic 5 msec. shocks delivered via epicardial patches at 
lower energies and by a catheter electrode in dogs. A 
change in waveform morphology may be advisable in future 
defibrillators. 
EFFECTS OF CURRENT STRENGTH AND UNIPOLAR VERSUS BIPOLAR 
PACING AT SITES OF INFARCTION ON MYOCARDIAL ACTIVATION 
TIMES. Malte Meesman, M.D., Francis Marchlinski, M.D., 
F.A.C.C. Onlv of Pennsylvania, Philadelphia, PA. 
Simultaneous depolarization of areas with slow conduction 
may prevent arrhythmias.To compare the effects of current 
strength of bipolar(BP) vs unipolar pacing(UP) of infarc-
ed endocardium on activation times, we performed BP and 
UP (cycle length 400-500 ms) at threshold, 2x threshold, 
lOrnA, and 20rnA from 17 LV sites in 14 patients with chro-
nic (>3 mol infarction. All sites had an electrogram 
width >7Orns and amplitude <3 mV during sinus rhythm and 
were in regions of infarction. BP from poles 1 (cathode) 
and 3 (1 cm apart) of a 4 pole catheter had a threshold 
of 2.7±1.6mA vs UP (pole 1-chest patch lead) with a 
threshold of 2.3±1.2mA (P=NS). Local activation time was 
indexed by the stimulus (S) to end of the electrogram 
(1 cm=lmV calibration) from poles 2 and 4(S-LV total) and 
distant activation times by the S to the rapid deflection 
of an electrogram recorded from the RV apex (S-RV rapid). 
Results: ms ± SO 
1xThreshold 2xThreshold 
BP(S-LV total) 158±52 149±50 J 
BP(S-RV rapid) 149±26 143±26 
UP(S-LV total) 147±45 140±49 
UP(S-RV rapid) 152±31 144±30 
(*p<.Ol, +p<.05 vs Ix threshold) 
lOrnA 
+135±59 
138±34 
+131±54 
*138±37 
20rnA 
*118±48 
*121±35 
+131±55 
*137±36 
BP resulted in a greater mean shortening of S-LV total(38 
vs 16 ms, p<.05) and S-RV rapid (27 vs 14 ms, p<.05) with 
higher current strength (lx threshold vs 2OrnA) than UP.In 
summary. when pacing sites of chronic infarction: l)local 
and distant activation times are critically dependent on 
the current strength used during pacing and 2) BP results 
in more rapid local and distant activation than unipolar 
pacing as the current strength is increased to 20 mAo 
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ELECTRO PHYSIOLOGIC EFFECTS OF DIFFERENT K+ CONCENTRATIONS 
ON THE RABBIT ATRIOVENTRICULAR NODE 
Yusaku Sakakibara. M.D.. Takeshi Noda, M.D., Yoshizumi 
Habuchi, M.D., Masao Nishimura, M.D. and Yoshio Watanabe, 
M.D., F.A.C.C., Cardiovascu~ar Institute, Fujita Gakuen 
Health University, Toyoake, Aichi, Japan 
Electrophysiologic effects of 10w(2mM), normal(4mM) and 
high (8mM) extracellular K+ concentrations were studied 
in the small preparation(0.2xO.2xO;2 mm) of the rabbit 
atrioventricular node(AVN). At 2mM K , spontaneous firing 
frequency(SFF} was significantly increased from 196±17 to 
216±15/min with an increase in the maXimal diastolic po-
tential(MDP) and the rate of diastolic depolariza-
tion(RDD}, whereas the maximal rate of depolarization 
('limax) was significantly reduced from 12.8±2.6 to 
11.5±2.2 V/sec(n=lO}. With the superfusion of 8mM K , 
SFF, ROD and MOP were significantly decreased with little 
change in Vmax. Voltage clamp experiments using dOuble 
microelectrode techniques revealed that the delayed out-
ward current(iK tail) and its deactivating time constant 
w~re largest a.t ~m--r<! and progressively reduced at higher 
K levels. The hyperpolarization activated inward current 
(if) showed opposite changes. Although the peak inward 
current elicited on depolarization from -40mV was mini-
mally and insignificantly decreased at 2mM K+, that on 
depolarization from -60mV was significantly reduced by 
about 10%. This decrease was blocked by 4-aminopyridine 
(3 or 5mM) which is known to block the transient outward 
current(TO). Time course of recovery of the slow inward 
current from inactivation was examined using double pulse 
methods. 50% recovery time at the potential level of 
-40mV following a pre-pulse to -lOmV was 88msec at 2mM, 
100msec at 4mM and 120msec at 8mM K+. This may account 
for the changes in ROD and SFF. It is concluded that 
a~terations in extracellular K+ affect not only membrane 
K conductance but also other ionic current systems of 
AVN. Possible role of TO in reducing the peak inward 
current and vmax (and thus depressing conduction) may be 
suggested. 
ELECTRICAL BEHAVIOR OF A CARDIAC BISYNCYTIUM DURING 
DEFIBRILLATION 
Nestor G. Sepulveda, Ph.D., and John P. Wikswo, Jr., 
Ph.D., Vanderbilt UniverSity, Nashville, Tennessee 
Using an idealized 2-dimensional (2-d) mathematical 
model of a cardiac bisyncytium with anisotropic conduc-
tivities (0) we calculated the intracellular (IC), ex-
tracellular (EC) and transmembrane (TM) potentials re-
sulting from injecting current into the EC space. While 
isopotentials in the IC and EC spaces are elliptical, 
the pattern in the TM space departs markedly from the 
circular or elliptical depolarization wavefront 
(Fig. 1a). For some values of a's depolarized and hyper-
polarized regions are adjacent. The proximity of depo-
larized and hyperpOlarized regions may have implications 
for reentry. The TM potential falls off rapidly as 
function of the distance from the current source (Fig. 1 b). 
We conclude that in 2-d anisotropic tissue, current in-
jection produces complex potential and current distribu-
tions that strongly depend upon the nature of the ani-
sotropy of the bisyncytial tissue. 
1b 
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NOO-INVASlVE LOCAUZATION OF ACCESSORY PATHWAYS USING 
MAGNErOCARDIOORAPHY 
Michael Oeff M D, Sergio Erne, Ph.D., H.D. Hahlbohm, Ph.D., 
Christoph Spielberg, M.D., Rolf Schroder, M.D., F.A.C.C. 
Cardiology Dept., Klinikum Steglitz, Free University Berlin, FR 
Germany 
Non-invasive localization of the AV bypass-tract (AP) In WPW pts 
using electrocardiographic mapping may be inaccurate due to the 
volume conductor effect of the thorax. The magnetocardiogram 
(MCG) records the magnetic field of the heart locally arising with 
current flow and is not disturbed by this effect. 
Five pts with a single AP were investigated both with MCG and 
invasively and, for comparison, the sites of the AP with respect to 
the body surface were determined by both methods. MCG was 
recorded from 36 precordial sites in a highly shielded room using a 
SQUID magnetometer with a noise <8 fTNHz. The depth from the 
body surface to the preexcited ventricular myocardium was 
calculated from the Iso field contours. Electrophysiologic testing 
(EPS) during supraventricular tachycardia localized the site of AP. 
In 2/5 pts with left sided AP additionally the site of ventricular 
preexcitation during sinus rhythm was determined with LV 
mapping. EPS localized AP's left lateral (1), left posteroparaseptal 
(2) and right posteroparaseptal (2). Projected on the body 
surface, the differences between ventricular preexcltation in MCG 
and the atrial end of AP in EPS were 2.O±O.5 cm (mean±SD) with 
the latter always cranial to the former. Determining the 
ventricular end with LV mapping they were only 1 cm. The 
differences in depth were 1.3±O.9 cm. 
Conclusions: The MCG is a reliable method for non-invasive, 
3-dimentional localization of ventricular preexcitation in pts with 
AP. 
ANTIARRHYTHHIC AND ELECTROPHYSIOLOGIC EFFECTS OF Ba++' 
IKl BLOCKADE 
Katherine H. Kavana~h, H.D., Vayne R. Giles, Ph.D., 
Haria Rahmberg, ErWIn F. Shibata, Ph.D., Keith Robinson, 
H. Eng., Teri Ilnicki, H.Sc., Victor Aldrete, H.D., and 
Henry J. Duff, H.D., University of Calgary, Calgary 
Hany class I antiarrhythmic (AA) agents have multiple 
electrophysiologic effects including blockade of Na+, 
Ca++ and K+ currents. The purpose of this study was to 
assess the AA efficacy of blockade of a single K+ cur-
rent, the inward rectifier (IK1 ). Hicroelectrode recordings from human papillary muscle treated with Ba++ 
(100-200 ~H) show a significant increase in the action 
potential duration but minimal change in resting poten-
tial. Higher concentrations produced substantial 
depolarization and spontaneous activity. Computer 
simulations suggest that these effects can be produced 
by decreasing I K1 . AA response to Ba++-induced inhibi-tion of IK1 was assessed in 13 chronically instrumented 
dogs with inducible sustained ventricular tachyarrhyth-
mias (VT) late following infarction. Animals were 
pretreated with propranolol to block sympathetic ef-
fects. Preliminary dose/response relations selected 
Ba++ dosages which prolonged intracardiac QT intervals 
(low dose Ba++) while high dose Ba++ produces spon-
taneous VT. Suppression of inducible VT occurred during 
low dose Ba++ in 7/13, durin~ placebo in 0/10 and during 
propranolol in 0/9. Ba + significantly prolonged 
electrogram QT intervals and ventricular effective 
refractory periods (VERP) at all 8 electrode sites in 
the myocardium. For example, Ba++ increased infarct 
zone VERP from 118 ± 12 to 147 ± ~2 ms; p<O.OOl. In 
conclusion, reduction of IK1 by Ba results in AA 
activity. 
ABSTRACTS 
RAOIOFREQUENCY CURRENT: FREQUENCY DEPENDENCE OF THE 
IMPEDANCE OF DIFFERENT CARDIAC TISSUES 
59A 
Mlcl!!!el Schluter. Ph.D., MatthlasAntz, Karl-Heinz KucIc, M.D., 
KllIUS-Pater Kunze, M.D., end tJiirg MOiler, Ph.D. University Hospital 
EppenOOrf and 'Technical University, H8mburo, F.R.e. 
In recent studies employing rediofrequenc.y (RF) current to ablate 
cardls:: tissues, frequencies h8Ve been chosen arbitrarily from a range 
of (approximately) 500 kHz to 10 MHz. This stlKt( was designed to 
clarify theoretically what type of RF current is best suited for 
electrical ablation of cardls:: tissue. We therefore measured, at 
frequencies ranging from 5 Hz to 13 MHz, the specific impedance Z [in 
oem] of myocardial (M) and fatty tfssue (F) taken from porcine 
hearts (n • 18). Measurements were made 60 min after the animals' 
death with specimens immersed in Ringer solution (RS) and supported 
In a call 35 mm long and 8 mm In diameter within a specially built 
measuring cylinder. Temperature was held constant at 37<'c. As e 
reference, Z of RS and b load (8) were measured for the same renoe of 
frequencies. Results: 
ZofM 
Z ofF 
ZofB 
ZofRS 
5Hz 
363 
149 
168 
50 
I kHz 
352 
149 
166 
50 
100 kHz 
211 
143 
165 
50 
5 MHz 
110 
115 
102 
50 
13MHz 
93 
103 
90 
50 
Due to an increasing capacitive influence, Z of B, F end (most 
prominently) M decline with Increasing RF. At RF l 5 MHz, 1_ Z of M 
is < one third Its velue at 5 Hz and 2_ Is lower then Z of F. 
ConclUSions: For ablation procedures RFs l 5 MHz should be used, 
because I. for M ablation, the low Z requires less RF energy; end 2_ 
for ablation of M imbedded in F (i.e. accessory AV pathways) the 
current is "focused" on M. 
Ca ++ ACI'IVATED TRANSIENT OOI'WARD aJRRENr IN THE RABBIT 
ATRIOVENl'RIClJlJ\R NODE 
Takeshi Noda, M.D., Yoshizumi Habuchi, M.D., Yusaku 
Sakakibara, M.D., Hideo Tanaka, M.D. and Yoshio 
watanabe, M.D., F.A.C.C., Cardiovascular Institute, 
Fujita Gakuen Health University, Toyoake, Aichi, Japan 
Ca++ activated transient outward current (iTO Ca) was 
studied in the small preparation (0.2xO.2xO.2 mm) of the 
rabbit atrioventricular(AV) node. Voltage clamp experi-
ment was carried out by using double microelectrode 
techniques. With the superfusion of high Ca++ (5.4 or 
7.2 mM) solution, an apparent transient outward =rent 
was observed when the membrane was depolarized from the 
holding potential of -40mV to potentials positive to 
-20mV. This transient outward current was blocked by 
10mM caffeine or 10-6M verapamil but not by 4-amino-
pyridine. Hence, it was identified as iro Ca. iro Ca was 
depressed by 1mM Ba++ and 30mM tetraethylammonium 
chloride but not affected by substitution of 50% NaCl 
with LiCl or sucrose. Upon removal of Ca++ and replace-
ment with Sr++, iro Ca was markedly decreased. Applica-
tion of 10-8M isoproterenol exaggerated iTO Ca with a 
concomitant increase in the initial inward current. 
Class I antiarrhythmic agents disopyramide and ~inidine 
at a relatively high concentration (10-5 or 10- M), sup-
pressed iro Ca. From these results, it is concluded that 
1) iTO Ca can develop in the rabbit AV node, and 2) it 
is activated by an intracellular Ca++ increase and is 
probably mediated by K+ current. The role of iTO Ca in 
modifying conduction and automaticity in the AV node is 
suggested. 
60A ABSTRACTS 
ELECTROPHYSIOLOGIC EFFECTS OF HIGH-DOSE INTRAVENOUS 
COCAINE IN DOGS 
Ronald J. Kanter, M.D., C.L. DeVane, M.D., 
Michael L. Epstein, M.D., University of Florida, 
Gainesville, Florida 
To determine the arrhythmogenicity of high-dose cocaine 
hydrochloride (CH), we performed electrophysiologic 
evaluations in 19 anesthetized adult dogs (1) before, (2) 
during, and (3) 2 hours after CH protocol. This consisted 
of an intravenous bolus (IB) (10 or 15 mg/kg), followed by 
continuous infusion (CI) (0.096 or 0.144 mg/kg/min) of CH. 
Cocaine blood levels were measured during periods (2) and 
(3). QRS duration (QRSd), PR interval, and QTc lengthened, 
and cycle length shortened (p<0.05) when comparing pre-
and immediate post-bolus periods. QRSd, QTc and atrial 
effective and functional refractory periods lengthened 
(p<0.05) during CI only, when comparing the 3 study 
periods. During CI, atrial flutter inducibility decreased 
in 12/14 dogs (p<0.005), but ventricular fibrillation 
threshold was not altered. Within 2 minutes of IB, 
ventricular tachycaardia occurred in 5/19 dogs, 
2° atrioventricular block occurred in 4/19 dogs, 
2° sinoatrial nodal block occurred in 3/19 dogs, and 
ST segment depression occurred in 3/19 dogs. Peak serum 
cocaine levels were 29.0 + 2.0(SEM) and 55.8 + 4.2 mcg/ml 
at the 2 doses used. Mean levels during CI w;re 
3.69 + 0.3 and 8.06 + 0.3 mcg/ml. Thus, in this model 
high-dose cocaine hydrochloride acutely causes 
prolongation of atrial refractoriness and prolongation of 
ventricular repolarization. It may cause ventricular 
tachycardia, low-grade sinoatrial and atrioventricular 
nodal block, and ST segment de~ression. 
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Complex Angioplasty 
TRIPLE VESSEL CORONARY ANGIOPLASTY: IMMEDIATE AND LONG 
TERM RESULTS. GermanQ D1SciasciQ. M.D., Michael J. CQwley, 
M.D., F.A.C.C., GeQrge W. VetrQvec, M.D., F.A.C.C., Kim M. 
Kelly, R.N., Steven A. LewiS, M.D., F.A.C.C., Medical 
College of Virginia, Richmond, Va. 
CorQnary angioplasty (PTCA) is being increasingly 
performed in selected patients (pts) with multivessel 
disease; however, results with PTCA of all 3 major 
coronary arteries have nQt been characterized. Triple 
vessel PTCA, defined as angiQplasty of one Qr mQre lesions 
in each majQr corQnary artery (LAD, LCX, RCA) was 
performed in 50 (11%) Qf 469 pts who underwent PTCA Qf 
multiple vessels since OctQber, 1979. There were 32 men 
and 18 women with a mean age of 56 yrs. All 50 pts had 
severe 3 vessel disease, and 8 (16%) had priQr bypass 
surgery (CABG); 23 pts had prior MI and 33 pts (66%) had 
unstable angina; mean LVEF was 57±11%. PTCA was perfQrmed 
in 176 vessels (3.5 vessels/pt, range 3-6/pt) and in 250 
lesions (5 lesiQns/pt, range 3-9/pt) with angiographic 
success in 166 vessels (94%) and 240 lesiQns (96%); 
success in all vessels attempted was aChieved in 40 pts 
(80%). All 50 pts had clinical success (angiographic and 
clinical improvement). NQ pt required urgent CABG and 5 
pts (10%) had nQn-Q wave MI. All 50 pts had follQW up >6 
months (range: 6-63 months, mean 18.4 mQnths). Clinical 
recurrence (return of symptQms and angiographic evidence 
of restenQsis) occurred in 17 pts (34%), 2 pts (4%) had 
late MI, 2 pts (4%) died Qf sudden death. Of the 17 pts 
with recurrence, 15 had successful repeat PTCA, 2 pts (4%) 
had elective CABG. Actuarial event free survival (nQ MI, 
death, CABG) was 90% at 2 years. Including repeat PTCA, 37 
pts (74%) are asymptQmatic and 8 (16%) are class I during 
mean fQlloW up of 18 months after triple vessel PTCA. 
These immediate and long term results suggest that 
triple vessel PTCA is a safe and effective therapy in 
selected patients with 3 vessel cQrQnary disease. 
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DURABll..ITY OF CORONARY ANGIOPLASTY: CLINICAL AND 
ANGIOGRAPIDC OUTCOME AT 5 TO 8 YEARS FOLLOWING 
SUCCESSFUL DILATATION Barry L. Sharaf M 0 Raymon S. 
Riley, M.D., F.A.C.C.,Thomas M. Drew, M.D., F.A.C.C., Alben S. 
Most, M.D., F.A.C.C., David O. Williams, M.D., F.A.C.C., Rhode 
Island Hospital, Brown University, Providence, RI 
Although the immediate results of coronary angioplasty (CA) are well 
described, little data exist regarding its durability. Hence, we attempted 
to obtain clinical and angiographic follow-up in a consecutive series of 
61 patients (PTS) in whom CA had been successful and at least 5 years 
elapsed. Clinical follow-up status was successfully retrieved in 56 
(completeness at follow-up 92%) at a mean time of 74 ± 11 (range 61 to 
101) months post CA. At the time of initial CA, each PT had disabling 
angina pectoris with 46/56 (82%) receiving two or more antianginal 
agents and 47/56 (84%) experiencing unstable angina pectoris. CA 
resulted in a decrease in stenosis from 77 ± 13 to 27 ± 11%. At the time 
oflate follow-up 53/56 (95%) were alive. Non-fatal MI occurred in 6/56 
(11%) ofPTS. MI free survival was 47/56 (84%). Late CABG was 
performed in 11/56 (20%) and repeat PTCA was required in 18/56 
(32%),11/18 (61%) forrestenosis and 7/18 (39%) for new disease. 
Overall, symptoms recurred in 25/53 (47%) ofPTS, 17/25 (68%) due to 
restenosis and 8/25 (32%) new disease. At 5 years offollow-up, 42/53 
(79%) are free of angina. Of survivors, 39/53 (74%) are event free 
without CABG or recurrent MI. Cumulative 5 year angiographic data 
were obtained in 33/53 (62%) of PTS. In PTS who reached 5 years of 
follow-up without CABG (22/33), the dilated artery was patent and free 
of significant stenosis in 21/22 (95%). Despite absence of symptoms in 
each of these PTS, 10/22 (45%) had evidence of new disease (~50% 
stenosis) at sites remote from the initial PTCA. Thus, by clinical and 
angiographic criteria, CA is both an effective and durable therapy in 
relieving disabling angina pectoris. PTS who remain free of ischemic 
events demonstrate sustained angiographic success. 
MULTIPLE VESSEL ANGIOPLASTY: EXPERIENCE IN 1017 CASES 
Michael J. O'DQnnell, M.D., Richard K. Myler, M.D., 
F.A.C.C.~ Richard E. Shaw, Ph.D., SimQn H. Stertzer, 
M.D., F.A.C.C., David A. Clark, M.D., F.A.C.C., Mary C. 
Murphy, RN, M.S., JQdi Fishman, RN, M.S. San FranciscQ 
Heart Institute, Seton Medical Center, Daly City, CA. 
In 4,712 corQnary angiQplasty (CA) procedures, there 
were 1758 patients who had multiple vessel disease 
(MVD), which was defined as 50% or more diameter 
reduction in 2 Qr mQre major coronary arteries. Of 
these 1758, 1017 had CA Qf multiple vessels (MVCA). In 
this cohort, 85% were male, 53% had angina class III or 
IV, 14.7% had a history of diabetes, 12.6% had priQr 
bypass surgery (CABG) and 42.6% had mYQcardial 
infarction (MI). 432 (42.5%) procedures involved 
dilation Qf simple discrete lesions and 585 (57.5%) 
invQlved complex lesiQns (tandem, bifurcatiQn, total Or 
graft). Success was achieved in 93%. Major cardiac 
event rate was 4.3%: Q-wave MI occurred in 31 (3.0%), 
emergency CABG occurred in 31 (3.0%), death occurred in 
5 (0.5%). Of the 822 successful CA patients whQ are at 
least 6 months beyond initial CA, 766 (93%) have been 
followed for a mean of 22.3 months. Event free survival 
(absence of death, MI and CABG) was 93%. 81.9% Qf 
patients had imprQvement Qf at least one or mQre angina 
class. Repeat CA was performed in 194 and was successful 
in 181 (93.3%) of patients. After an experience in 
mUltiple vessel CA in over 1000 patients, a high success 
rate has been maintained, while complicatiQn rate has 
remained low. LQng term outcome appears favQrable in 
this grQUp, and if repeat CA is necessary, success is 
equally favQrable. 
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THE STRATEGY OF INCOMPLETE REVASCULARIZATION IN 
MULTIVESSEL PTCA: IS IT JUSTIFIED? 
Kamran Ghalili, M.D., Thomas R. Varricchione, M.B.A., 
ElaIne M. CfirIstelIs, M.S., Mirle A. Kellett, Jr., M.D., 
F.A.C.C., Thomas J. Ryan, M.D., F.A.C.C., David P. 
Faxon, M.D., F.A.C.C., Boston University, Boston, MA 
Incomplete revascularization (IR) is often viewed as 
an acceptable outcome in multi vessel (MVD) PTCA. To 
evaluate the efficacy of IR, we studied 139 consecutive 
patients with MVD presenting for a first PTCA between 
8/85-5/86. All patients had a successful angioplasty 
and were followed for one year. Revascularization was 
defined as complete when no stenoses of ~ 70% remained 
following PTCA and incomplete otherwise. 
The strategy of IR was accepted in 67/139 (48%) 
patients who had more prior MI, (79% vs 57%), prior CABG 
(28% vs 11%), and lower EF (58% vs 67%) at baseline (p< 
0.05) than the 72/139 (52%) in whom CR was achieved. 
Other characteristics compared included age, sex, risk 
factors, anginal status, and procedural circumstances, 
all of which were similar between groups. As expected, 
major events during initial hospitalization were 
somewhat higher in the IR group vs the CR group: death 
3% vs 1.4%, M1 10.5% vs 4.2%, emergency CABG 4.5% vs 0%, 
and repeat PTCA 3% vs 6.9%, respectively (p=N.S.). 
However, during the year following PTCA, rates of 
adverse events proved to be similar between the two 
groups (IR vs CR): Death 3.4\ vs 2%, MI 3.5% vs 4.1%, 
CABG 8.8% vs 12.2%, PTCA 19.3% vs 26.5%, and Angina 
33.9% vs 22.4% (p=N.S.). 
These data suggest that in higher risk patients with 
MVD, PTCA with lR is an effective treatment over the 
time frame of one year for patients in whom CR cannot be 
achieved. 
PERCUTANEOUS BALLOON ANGIOPLASTY OF LEFT MAIN 
CORONARY STENOSES· 'ACUTE AND LONG·TERM RESULTS 
Peter Demopulos MD, Matthew Selmon, MD, FACC. John Simpson. MD. FACC. 
and Bruce McAuley. MD. FACC. Stanford University Medical Center and Sequoia 
Hospital. Stanford and Redwood City. CA 
To assess the safeiy and efficacy of percutaneous balloon angioplasty (PTCA) of 
left main (LM) stenoses we reviewed 24 patients (pts) who underwent elective LM 
PTCA at Sequoia Hospital between October 1981 and February 1987. Seventeen pts 
(71 %) had "protected" LM lesions (patent bypass graft/s to the left coronary 
distribution); 7 pts (29%) had 'unprotected" LM lesions. None had previous LM 
PTCA. and all were symptomatic with evidence of ischemia by exercise/functional 
·testing (ETl). PTCA was performed in the combined catheterization/operating suite 
with surgical standby. Successful dilatation was achieved in 22 pts (92%) with 
resultant decrease in mean %stenosis from 87% pre-PTCA (range 65-99%) to 37% 
post-PTCA (range 0-50%). and improvement in symptoms andlor EIT. Two acute 
failures (8%) occurred: I)failure to dilate (calcified lesion); 2)acute closure post-PTCA 
requiring bypass graft surgery (CABG). There were no in-hospital deaths or Mrs. 
Follow-up could be obtained in 21 of 22 pts with initially successful PTCA. 
Restenosis occurred in 11 pts (52%). all symptomatic: 9 confirmed angiographically 
(recurrent stenosis>50%). I with recurrent angina and EIT abnormality. and I with 
fatal acute anterior MI preceded by one month of recurrent angina which was not 
reponed to a physician ("protected· LM pt). Mean time to restenosis=3.4 months 
(range I to 7.5 months). Ten pts (48%) remained clinically free of restenosis: 5 
confirmed angiographically. 5 with sustained improvement in symptoms and EIT 
(mean follow-up=20 months; range 7 to 38 months). Of the 10 surviving patients 
with restenosis. 3 underwent elective CABG. I was managed medically. and 6 
underwent repeal PTCA. Five of the 6 pts with repeat PTCA of LM restenosis had 
adequate follow-up. All 5 remained free of subsequent clinical restenosis (sustained 
improvement in symptoms and EIT; mean follow-up=12.2 months. range 10 to 20 
months). The 6th had recent repeat PTCA with long-term follow-up pending. 
We found PTCA of the LM to be safe and effective in our patient population. 
Acute success rate was 92%. Restenosis was frequent (52%) after initial dilatation. 
All patients with restenosis had recurrence of symptoms andlor EIT abnormality 
enabling recognition and management. Careful pt foUow-up with EIT and assessment 
of symptoms is essential. Repeal PTCA of LM restenosis proved to be very effective 
(at least 5 of 6 repeat PTCA pts remained free of clinical restenosis). Including initial 
restenosis-free pts and those free of restenosis after repeat dilatation. PTCA of the LM 
yielded a successful long-term outcome in 15 of 24 patients (63%). 
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LEFT MAIN CORONARY ANGIOPLASTY - A CAUTION. 
Geoffrey O. Hartzler, M.D., F.A.C.C., Barry D. Rutherford, 
M.D., F.A.C.C., David R. McConahay, M.D., F.A.C.C., Warren 
L. Johnson, Jr., M.D., F.A.C.C., Lee V. Giorgi, M.D., 
F.A.C.C., Martha Calkins, R.N., Robert Ligon, M.A., Mid 
America Heart Institute, St. Luke's Hospital, Kansas City, 
Missouri. 
Of 5,000 consecutive procedures, 76 pts underwent 91 
elective left main PTCAs (LMPTCA). There were 64 males, 
12 females, mean age 62 yrs. Poor LV function (PLVF) was 
present in 18 pts (24%) and 57 (76%) had prior CABG. 
Sixty LMPTCAs (66%) were in "protected" pts with at least 
1 patent graft to the left circulation. Multiple lesion 
PTCA was performed in 70% of pts with 92% success. LMPTCA 
was successful in 92%. There were 4 procedural deaths 
(4.4%), 2 urgent CABGs (2.2%) and a MIs. 
Baseline clinical variables, procedural success and 
complications were similar in protected and unprotected 
subgroups. At 16.7 mos follow-up, there were 9 (12%) late 
CABGs, 3 (4%) MIs, and 21 (28%) deaths - 6/48 protected vs 
15/28 unprotected, p (0.01. Actuarial 3-yr survivorship 
was 66% - protected 87% vs unprotected 40%, p(O.Ol. Age, 
sex and PLVF did not correlate with late mortality. 
However, protection and CABG following PTCA were 
associated with improved late outcome. 
Conclusion: LMPTCA can be performed with relatively 
low risk. However, late mortality in unprotected pts is 
high, and LMPTCA cannot be recommended except for those 
pts with no alternative therapeutic option. 
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Advanced Imaging of the Coronary Arteries 
COLOR NMR MICROSCOPY OF ATHEROMATOUS PLACQUES WITHIN 
HUMAN CORONARY ARTERIES J D Pearlman MD ME PhD, J F 
Southern PhD MD, J Ackerman PhD, H L Kantor MD PhD FACC, 
Massachusetts General Hospital, Boston, MA. 
Having identified the phYSicochemical basis for a 
thermotropic spectral signature specific for atheroma 
within arterial vessel walls, we developed a multidimen-
sional method for imaging atheroma by NMR. We report a 
quantitative comparison of NMR microscopy of atheroma in 
coronary arteries to results from histology (HIST). 
The NMR microscopy was performed at 2 Tesla with field 
gradients up to 6 mTesla/cm, using chemical-shift encod-
ing as well as multiple Tl and T2 weightings. Image 
registration was within 20 micron. Color images were 
generated using data derived from different acquisitions 
to supply red, green, and blue separately. Atheroma was 
identified blind to pathology. Arteries were filled with 
agar gel to maintain distension. After imaging, they were 
decalcified, sectioned 1 mm thick, photographed, and 
imbedded in parafin for histology. Contours were digi-
tized for perimeters and area measurements. Shape indices 
(SI) were calculated as the ratios of observed area to 
maximal area with the same perimeter (1.0 for circle). 
Results from 5 studies showed correlation between NMR and 
histology measures of r=0.99. Mean SI was 1.73±0.24 
(HIST), 1. 58±O.3l (NMR). Mean atheroma size was 
1.6l±0.59 mm2 (HIST), 1.83±O.57 mm2 (NMR). 
CONCLUSION: Our multidimension atheroma imaging method 
is applicable to NMR microscopy of human coronary 
arteries, and the quantitative measurements agree well 
with subsequent pathology results. The shape indices 
indicate distortions occur in preparing gross sections 
and histology. These results indicate that the NMR 
data has advantages over pathology, with regards to 
accurate 2D shape and 3D relations of atheromatous 
plaque, lumenal narrowing, and vessel cross-section. 
62A ABSTRACTS 
GEOMETRIC VALIDATION OF A SEMI-AUTOMATED METHOD OF SERIAL 
CORONARY VIDEODENSITOMETRIC ANALYSIS IN HUMANS. 
Maryl R. Johnson, M.D., F.A.C.C., Christopher J. Wilbricht, 
B.S., Steven R. Fleagle, B.S., David D. McPherson, M.D., 
Loren F. Hiratzka, M.D., F.A.C.C., Richard E. Kerber, M.D., 
F.A.C.C., Melvin L. Marcus, M.D .• F.A.C.C .• Steve M. Collins, 
Ph.D., David J. Skorton. M.D., F.A.C.C., University of 
Iowa, Iowa City, Iowa. 
The integrated optical density (IOD) of a user-defined 
region of a coronary stenosis is a videodensitometric mea-
sure which correlates with lesion minimal lumen area. 
As a first step toward making coronary videodensitometric 
analysis less observer dependent and more clinically 
applicable, we tested the geometric validity of a semi-
automated method of defining the minimal 100 along a coro-
nary stenosis. Cine frames of 86 coronary segments (29 
anterior descending, 19 circumflex, 38 right) were digi-
tized. Following user definition of the approximate 
vessel center line and edges, background subtraction was 
performed and serial 100' s along the vessel were calcu-
lated. Two segments were impossible to analyze due to 
branch vessels at the lesion. For the other 84 segments, 
automated minimal IOD's were compared to: (1) user-defined 
IOD's and (2) minimal lumen areas defined by intraopera-
ti ve hi gh-frequency echocardi ography (HFE) (Bi osound) or 
Brown-Dodge quantitative coronary arteriography (QCA). 
RESULTS: 
n r Regression Line 
Automated IOD's vs. User IOD's 84 0.83 y-0.98x-0.38 
Automated IOD's vs. HFE Areas 20 0.85 y=2.55x-0.6 
Automated IOD's vs. gCA Areas 64 0.80 y=1.78x-0.12 
CONCLUSION: A semi -automated method of seri a I corona ry 
videodensitometric analysis can be used to define minimal 
lesion IOD's which correlate with coronary lumen areas 
defined by independent geometric standards. 
VALIDATION OF A DIGITAL ANGIOGRAPHIC MODEL TO 
ASSESS AUTOREGULATORY VASODILATION OF THE 
CORONARY SYSTEM IN RESPONSE TO STENOSIS AT REST 
Andreas M Zeiher. MD, Neal L Eigler, MD, J Martin Pfaff, 
James Whiting, PhD, James Forrester, MD, FACC, HJC. Swan, 
MD, PhD, FACC. Cedars-Sinai Medical Center, Los Angeles, CA. 
Compensatory vasodilation of the distal coronary vascular bed is 
the major autoregulatory mechanism in response to a coronary 
stenosis. Using transfer function analysis(TFA) of digital angio-
graphic time-density curves, myocardial contrast-transit was 
modelled as a two-compartment system to obtain total coronary 
transit times(T) and microcirculation transit times(Tmicro). The 
transit time of each individual compartment is inversely propor-
tional to flow(Q) divided by its distribution volume(V); the ratio 
of Tmicro/T reflects the relative contrast distribution volume 
Vmicro/V. TFA parameters were compared to electromagnetic Q 
in 6 dogs. At rest, Vmicro/V increased significantly (p<O.OI) 
from 0.67±.07 in normal arteries (n=24) to 0.87±.04 in stenotic 
arteries(n=20). With maximal vasodilation during hyperemia, 
Vmicro/V was similar for normal(0.89±.05;n=19) and stenotic 
arteries(0.90±.03;n=I 7).Consequently, there was a clo~e linear 
(r=0.91) correlation between I/Tmicro and Q during hyperemia. 
However, at rest with intact vasomotor tone, I/Tmicro and Q 
were linearly related(r=0.94;n=11) only when Q was reduced by 
tight stenosis; but the relationship became curvilinear in non-Q-
limiting stenosed and normal arteries due to a progressive de-
crease in Vmicro. Instead, resting I/Tmicro demonstrated a very 
close linear correlation(r=0.94;n=44) with maximal Q in response 
to the hyperemic stimulus of contrast material injected to obtain 
the TFA parameters at resting baseline conditions. We conclude 
that two-compartmental modelling of coronary contrast transit 
reflects stenosis-mediated autoregulatory vasodilation of the 
coronary microcirculation. The prediction of the vasodilatory 
capability of the microcirculation bed offers the unique po-
tential to assess the functional significance of a coronary stenosis 
~ .a..sinak parameter in the intact coronary circulation at rest. 
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VARIABILITY IN THE MEASUREMENT OF CORONARY FLOW RESERVE 
FROM DIGITIZED CORONARY CINEANGIOGRAMS. 
F. Zijlstra, MD, A. den Boer, BSc, J.H.C. Reiber, PhD, 
P.W. Serruys, MD, FACC, Thoraxcenter, Rotterdam, The 
Netherlands. 
The assessment of the functional significance of coronary 
artery lesions during cardiac catheterization has recently 
become possible by calculating the coronary flow reserve 
from the myocardial contrast appearance time and density 
in the resting and hyperemic states determined from 
digitized coronary cineangiograma. Knowledge about the 
short-, medium-, and long-term variabilities of the 
coronary flow reserve measurements is an essential 
prerequisite when this technique ia to be used to 
determine the immediate and/or long-term functional 
results of pharmacological therapy or revascularization 
procedures. Variability was defined as the mean difference 
and standard deviation of the difference between duplicate 
determinations of coronary flow reserve. Short-term 
variability based on the analysis of two coronary 
cinesngiograms taken 5 min. apart was (mean difference ± 
SD) - 0.02 ± 0.26. These results demonstrate that image 
acquisition and an~lysis procedures have a reasonable 
reproducibility. Medium-term variability (repeated 
coronary cineangiographies 1-3 hours apart) was - 0.06 ± 
0.52. Long-term variability (repeated coronary 
cineangiographies 3 to 5 months apart) was 0.11 ± 0.63. 
Conclusion: coronary flow reserve measurement from 
digitized coronary cineangiograms is a reproducible method 
for the assessment of the physiological importance of 
coronary artery obstructions. Short-, medium-, and 
long-term investigations of the functional results of 
interventions such as pharmacological therapy or 
revascularization procedures can be performed reliably 
with this technique. 
DElERMINATION OF CORONARY FLOW RESERVE BY DIGITAL 
ANGIOGRAPHY: VALIDATION OF A PRACTICAL MErnOD 
NOT REQUIRING POWER INJECTION OR ECG GATING. 
John C GuIles MD, Steven E. Nissen MD, Jonathan L. Elion MD, 
Joyce Evans, Mike McMinn and Anthony N. DeMaria MD, FACe. 
University. of Kentucky and the V A Medical Center, Lexington, KY. 
Previously, we demonstrated that coronary flow reserve (CFR) may 
be determined by the application of indicator dilution theory to digital 
angiography. However, this methodology requires intracoronary 
power injections of radiographic contrast with precise ECG gating, 
factors which have hindered clinical application. We therefore refmed 
the technique by utilizing high frame rate acquisition and ECG gated 
subtraction to permit hand injection of contrast. We then validated the 
accuracy of this method in an animal model of coronary artery disease. 
Eighteen different coronary stenoses were produced in 5 dogs 
instrumented with an electromagnetic flow probe (EMF) and a 
pneumatic occluder on the circumflex coronary artery. Digital 
subtraction arteriography (DSA) was performed during basal flow and 
following induction of hyperemia by intracoronary papaverine. A 512 
by 512 pixel matrix at 30 frames per second was employed for 
imaging. A contrast time-density curve for each arteriogram was 
generated from a background corrected proximal coronary artery 
region of interest on every frame. The angiographic CFR ratio was 
calculated as (basal area + hyperemic area) x (hyperemic contrast 
volume + basal volume) and was compared to simultaneously 
measured CFR determined by EMF. Absolute coronary flow ranged 
from 9.5 to 163 ml/min by EMF. CFR ratios ranged from 0.7 to 6.9 
by EMF and 0.9 to 6.1 by DSA. Linear regression analysis 
demonstrated good correlation between EMF and DSA methods, r = 
.86, SEE = .87. We conclude that continuous dye density curves 
from digital coronary arteriography permit accurate determination of 
coronary flow reserve. This technique requires only hand injection of 
small contrast doses via conventional catheters, and is readily 
applicable to the study of human coronary artery disease. 
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COMPARATIVE CLINICAL ASSESSMENT OF QUANTITATIVE 
CORONARY ARTERIOGRAPHY USING DIGITAL AND FILM-BASED 
METHODS. G.B. John Mancini, M.D., F.A.C.C., Scott 
R. DeBoe, B.S., Mark J. McGillem, B.S., Stephen G. 
Ell is, M.D., F.A.C.C., University of Michigan and 
VAMC, Ann Arbor, Michigan. 
Recent in vivo animal val idation of a quanti-
tative coronary arteriography (QCA) program 
demonstrated that QCA of 512x512 on-line digital 
images compared favorably with QCA of film and that 
greatest accuracy was seen with non subtracted 
digital images. To see if these results are of 
clinical importance, consecutive, non-selected 
patients underwent QCA of 10 stenoses imaged after 
nitroglycerin dilatation and obtained, in pairs, on 
film an(l by on-line digital imaging. The latter 
were assessed in mask subtracted and nonsubtracted 
modes. Pairs were also acquired by hand- and 
power-injection of contrast. Minimum diameter (mm) 
results from each pair of identically acquired 
images were regressed to assess reproducibility of 
the QCA: _r_ ~ S.E.E.(mm) 
Power-injection .93 .91 .25 
Hand-injection .89 .95 .34 
On-line digital .91 .94 .28 
Film .89 .92 .34 
Nonsubtracted .94 1.02 .26 
Subtracted .89 .87 .31 
In each set of comparisons, r values and 
standard errors were best for power-injection, 
on-line digital imaging and non subtracted proces-
sing. These clinical results confirm the experi-
mental findings and suggest several practical ways 
in which stUdies involving QCA can be optimized. 
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Valvular Heart Disease: Diagnostic Methods 
MANAGEMENT DECISIONS IN AORTIC STENOSIS: USE OF 
RECEIVER-OPERATOR CHARACTERISTIC CURVES 
Michael H. Picard, M.D., Mark Yeager, M.D., Ghassan Ghandour, 
Charles A. Dennis, M.D., Richard L. Popp, M.D., F.A.C.C., 
Stanford University School of Medicine, Stanford, CA 
Decisions regarding the need for cardiac catheterization and 
surgery in patients with aortic stenosis have been facilitated by 
Doppler echocardiography. This study used receiver-operator 
characteristic curves to determine the sensitivity (Se) and 
specificity (Sp) of the Doppler echo pressure gradient cut-off 
which optimally screened pts with aortic stenosis for 
catheteriation and surgery. Doppler echocardiography was 
performed within one day of cardiac catheterization in 66 pts 
(mean age 65 + 13) with elevated aortic blood flow velocity 
(> 1.7 m/sec). "Surgical aortic stenosis was defined as a valve 
area of 0.7 cm2, calculated using hemodynamic catheterization 
data. 
A mean Doppler echo gradient > 32 mmHg maximized the true 
positive (+) and true negative (-) rates, while minimizing the 
false positive (+) and false negative (-) rates with values as 
follows: 
Aortic 
Pts stenosis Se 
All ----:53% 9496 
~ True + True-
6596 9496 6596 
False + False-
~~ 
Age >68 6396 9096 8296 9096 8296 1896 1096 
Conclusions: Using a mean transaortic Doppler echo gradient of 
32 mmHg, surgical aortic stenosis would be correctly identified 
in 9496 of all pts and 9096 of pts over age 68. Serial Doppler 
echocardiography might theoretically be used to monitor the 
progression of aortic stenosis and thereby postpone or eliminate 
invasive studies in 6596 of all pts and 8296 of pts over age 68. 
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OORLIN VALVE AREA VARIES wrm CARDIAC aJTPU.r IN NJRTIC 
S'l'EtCSIS 
Paul N. Casale, MD, Igor F. palacios, MD, FACC, Vivian M. 
Abascal, MD, Ravin Davidoff, MD, Christopher Y. Choong, 
MB, PhD, Peter C. Block, MD, FACC, Charles A. Boucher, 
MD, FACC, Arthur E. Weyman, MD, FACC, Michael A. Fifer, 
MD, FACC. Harvard Medical School and Massachusetts 
General Hospital, Boston, MA. 
To determine the accuracy of the Gorlin formula in 
low flow states, hemodynamic measurements were made at 
baseline and during infusion of dobutamine (mean + SD 
402 ~ 152 meg/min) in 10 patients with aortic stenosis 
and low cardiac output. Seven of 10 subjects were 
studied llumediately following aortic valvotomy, at which 
time moderate residual aortic stenosis was present. Left 
ventricular ejection fraction was 0.37 ~ 0.15. 
Heart rate (beats/min) 
Cardiac output (i/min) 
Stroke volume (ml) 
Mean gradient ~g) 
Valve area (em ) 
Baseline 
75 + 17 
3.46 "+ 0.68 
48"+ 13 
30"+ 7 
0.67"+ 0.18 
Dobutamine 
90 + 17 
4.87"+ 1.01 
56 "+ 14 
38"+ 8 
0.81 "+ 0.22 
.2 
<.005 
<'001 
<.01 
<.0001 
<.002 
Doppler echocardiography was performed simultaneously in 5 
of the 10 subjects. Valve area calcul~ted by the 
continuity equ~tion was 0.69 ~ 0.23 em at baseline and 
0.71 ~ 0.21 em during dobutamine infusion (p=NS). 
Conclusions: (1) Valve area calculated by the Gorlin 
formula is greater at higher flow rates, while valve area 
calculated by the continuity equation remains constant. 
(2) These findings suggest flow dependence of the Gorlin 
formula rather than actual increase in valve opening at 
higher flow rates. 
ISOPROTERENOL INFUSION INCREASES GORLIN FORMULA 
AORTIC VALVE AREA IN ISOLATED AORTIC STENOSIS. 
James W. McCriskin. D.O •• Robert L. Herman, 
M.D., Leo J. Spaccavento, M.D., F.A.C.C., and 
Gregory C. Tomlinson, M.D., Wilford Hall USAF 
Medical Center, San Antonio, Texas. 
Calculation of Gorlin formula aortic valve area 
(GF-AVA) assumes a fixed stenosis unaltered by 
the hemodynamic state. Isoproterenol infusion 
(ISO) alters the hemodynamic variables of the 
GF-AVA. Pressures were measured using fluid 
filled catheters. Cardiac outputs were obtained 
by thermodilution. GF-AVA was calculated at rest 
and during graded ISO in 12 adults, with 
isolated aortic stenosis. Changes at rest to ISO 
for GF-AVA variables, and therfpeutic 
classification (surgery for AVA .$.1. a cm ) were 
compared. 
HR Gradient Flow AVA 
bpm v'mmHg m1/sec cm2 
REST 68±1l 6.3±1.4 227±39 0.86±.29 
ISO 97+16 7.4±1.6 355±84 1. 09±. 35 
CHANGE +42% +17% +56% +27% 
p-value <0.001 <0.001 <0.001 <0.001 
Two of 12 patients changed from a surgical to a 
medical classification during ISO. ISO 
increases all GF variables, flow in excess of 
gradient, resulting in a significantly increased 
GF-AVA. Conclusion: Alterations in the 
hemodynamic state can cause statistically 
significant changes in GF-AVA. Only minimal 
changes in therapeutic classification were 
observed. 
64A ABSTRACTS 
DETECTION AND ASSESSMENT OF SEYERITY OF TRICUSPID 
REGURGITATION USING FIRST PASS RADIONUCLIDE ANGIOGRAPHY: 
A COMPARISON WITH PULSED DOPPLER ECHOCARDIOGRAPHY. 
Ki. A. Willi.... MD. P.trici. E. Wolin.ki. .nd J.... W. 
Ry.n. MD. The Univ.r.ity of Chic.go. Chic.go. IL 60637. 
Noninv •• iv. detection .nd .e.i-qu.ntit.tive ........ nt 
of tricu.pid (TRI r.gurgit.tion h.v. be.n .cco.pli.hed 
prim.rily u.ing pul •• d Doppler .choc.rdiogr.phy. In 
this .tudy. fir.t p ••• r.dionuclid •• ngiogr.phy w •• u.ed 
to d.tect TR by ••• pling • r.gion of int.r.st ov.r the 
RA for .ny tr.cer .ntering the RA during RY .y.tol •• 
Th. rel.tiv ••• ount of trac.r entering the RA wa. quan-
tit.ted .nd the r •• ult. co.pared with ••• i-qu.ntitative 
Doppler echoc.rdiogr.phic e.ti •• tion of TR .everity. 
U.ing the RY tracer curv. to define end-dia.tolic (EDI 
and end-.y.tolic fr..... the RA count. for the 3 cardi.c 
cycl.. following the peak RY counts. wer. .u ... d .nd a 
right .tri.l "injection fr.ction" IRAIFI wa. calculated 
u.ing the following for.ul.: 
[Iend-.y.tolic count. - ED count.l/lED count.l] x 100X. 
The RAIF wa. ex •• in.d in 51 p.tient. who h.d di.gno.-
tic quality pul.ed Doppler echoc.rdiography. Out of 27 
p.ti.nt. with no evid.nc. of TR by Doppler. 26 h.d a 
neg.tive RAIF. All 24 patient. with • positive Doppler 
for TR had a po.itive RAIF. Co.pari.on of RAIF gr.ded 
range. with .e.i-qu.ntit.tive gr.des of TR s.verity on 
Doppler reve.led identic.l gr.de. 1n 21 of the 24. with 
• one gr.de differ.nce in the re .. 1ning thr.e pati.nts. 
Thus. right atr1.1 ti .. -activ1ty curve qu.ntitative 
analy.i. during routine fir.t pa.s radionuclide angio-
graphy allow8 detection and gr.d1ngof the severity of 
tricuspid regurgitation. with re.ults very si.ilar to 
puls.d Doppler .chocardiogr.phy. This siaple procedure 
i. e •• ily .ppended to the evalu.tion of LY and RY 
perfor •• nce with first p ••• r.dionuclide .ngiogr.phy. 
THE GORlIN 'CONSTANT' IS NOT CONSTANT: A HYDRODYNAMIC IN 
VITRO ASSESSMENT 
James 0 Thomas. MD, Christopher Y Choong, MB BChir, PhD, 
Nancy J Herrig, BSE, Shawn McGlew, BS, Robert A Levine, 
MD, FACC, Arthur E Weyman, MD, FACC. Massachusetts 
General Hospital, Boston, MA. 
With the advent of percutaneous mitral valvotomy, it is 
critical that anatomic mitral valve area (MVA) measure-
ments be accurate. The Gorlin equation for MVA contains 
an empiric factor, 38, which includes coefficients of 
contraction and discharge, whose product (K) is the ratio 
of effective to anatomi c ori fi ce area, assumed to be 
independent of MVA and flow rate. We have developed a 
mathematical description of MV flow which predicts, for 
initial gradient (Po) and constant net LA-LV compliance 
(Cn ), that the MV gradient, p{t), has a parabolic decay: 
p(t) z (!PO - (25.2K.MVA/Cn ) t)2. (1) 
To test this prediction and determine K, we built an in 
vitro analog of the lA and LV which allowed canine blood 
to pass by gravity through circular orifices, varying MVA 
from 0.5 to 3.0 cmz ; Po from 3 to 14 mmHg; and Cn from 
17.2 to 30.3 cm3 /mmHg. Observed pressure decay curves 
all fit Equation (1) with individual correlation r > 
0.99. K increased linearly with MVA: K z 0.73+0.035xMVA, 
r=0.82, pz O.Ol, effectively varying the Gorlin factor 
from 37.1 for a valve area of 0.5 cm2 to 41.1 for 2.5 
cmz • With K allowed to vary, 25.2K.MVA/Cn accurately 
predicted the observed pressure decay across the tested 
range of MVA, Po' and Cn with r - 0.9997, p<O.OOOOI. In 
the clinical setting, one may correct for this variation 
in K by solving for MVA in: 
1.76(MVA)2 + 36.8 MVA - MFR/JP z 0, 
where MFR is mitral flow rate and p is mean MV gradient. 
Conclusion: The Gorl in constant varies with MVA, and 
correcting for it may yield more accurate MVA estimations. 
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INCREMENTAL VALUE OF CLINICAL EXAMINATION, ECHOCARDIO-
GRAPHY AND CARDIAC CATHETERIZATION IN THE EVALUATION OF 
LEFT VENTRICULAR DYSFUNCTION AND PULMONARY HYPERTENSION 
IN VALVULAR HEART DISEASE 
Adam Kotlewski, M.D., F.A.C.C., Charles R. McKay, M.D., 
F.A.C.C., Earl C. Harrison, M.D., F.A.C.C., David T. 
Kawanishi, M.D., F .A.C.C., Cheryl L. Reid, M.D., 
F.A.C.C., P.A.N. Chandraratna, M.D., F.A.C.C., Anil K. 
Bhandari, M.D., F.A.C.C., Uri Elkayam, M.D., F.A.C.C., 
Joyce Niland, Ph.D., Shahbudin H. Rahimtoola, M.D., 
F.A.C.C., USC School of Medicine, Los Angeles, California 
We performed a prospective study of 98 consecutive pts 
with symptomatic valvular heart disease to investigate 
the relative value of 1) Clinical examination (CLIN) with 
history, phYSical examination, ECG and CXR; 2) M-mode, 2D 
and Doppler echocardiography (ECHO); and 3) Cardiac 
catheterization (CATH) in clinical decision making. 
Diagnosis (DX) of systolic left ventricular dysfunction 
(LVDYS) and of pulmonary hypertension (PHTN) was made 
sequentially after CLIN alone, CLIN + ECHO and CLIN + 
ECHO + CATH. The accuracy of DX of LVDYS or PHTN (not 
including assessment of severity) was: 
CLIN IMPROVED 
N CORRECT BY ECHO 
DX LVDYS 47 31(66%) 5(11%) 
DX no LVDYS 50 39(78%) 7(14%) 
DX PHTN 73 60(82%) 5(7%) 
DX no PHTN 23 10(43%) 5(22%) 
IMPROVED 
BY CATH 
17(36%) 
4(8%) 
13 (18%) 
10(43%) 
(Numbers add up to )100% because in some pts ECHO 
decreased the accuracy of DX). 
Conclusions: 1) CLIN was accurate in the DX of LVDYS or 
PHTN in over 2/3 of pts; 2) ECHO improved the DX in less 
than 1/4 of pts; and 3) CLIN was substantially more 
accurate in DX of PHTN than of no PHTN. 
Tuesday, March 29, 1988 
10:30AM-12:00NOON, Room 260, Level Two 
New Interventional Techniques 
AIO:LIOUTIOB OF ISCHBKIA DRUG PTCA wrm DIASTOLIC 
COIlOIWI.Y VDOUS IIETROPDl'USIOli. 
Sheila Kar,M.D., J. Kevin Drury, M.D., F.A.C.C., Neil 
Eigler, M.D., F.A.C.C., Neil Buchbinder, M.D., F.A.C.C., 
Frank Licvack, M.D., F.A.C.C., Stephanie Thessomboon, 
R.D.M.S., Istvan Hajduczki, M.D., Eliot Corday, M.D., 
F.A.C.C. Cedars-Sinai Medical Center, Los Angeles, CA. 
To determine the effects of synchronized diastolic 
coronary venous retroperfusion (SRP) during acute 
coronary artery occlusion, we studied 5 pts. during 
percutaneous angioplasty (PTCA) of the left anterior 
descending coronary artery. Each pt. underwent a minimum 
of 4 balloon inflations: 2 treated with SRP and 2 
untreated. Symptoms (angina), hemodynamics and LV 
ejection fraction (2DE) were monitored. 
Angina occurred during 60% of the untreated occlusions 
at a mean time of 48±15 sec. compared to 25% of the SRP 
treated occlusions at 65%7 sec. (p<0.05). LV EF during 
peak occlusion decreased from 55. 8±7. 9% to 34. 2±6% 
without treatment, compared to 51.8%6.2% to 46.8±8.2% 
with SRP treatment (p<.005). The only complication noted 
was a hematoma at the right internal jugular catheter 
introduction site. 
In one patient the LAD became occluded immediately post 
PTCA and attempts to reopen the artery were unsuccessful. 
The patient Was treated with SRP for 150 min. prior to 
emergent CABG surgery. The regional LV function (2DE) on 
leaving the catheterization laboratory prior to surgery 
was normal despite the prolonged occlusion. 
Conclusion: Diastolic coronary venous retroperfusion 
appears to ameliorate ischemia during PTCA induced 
coronary occlusion and may therefore permit prolonged 
balloon inflation times. Furthermore retroperfusion may 
be helpful in the event of abrupt coronary artery 
occlusion during PTCA. 
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CORONARY VENOUS RETROPERFUSION--EFFECTS ON MYOCARDIAL 
NUTRITIVE BLOOD FLOW. Michael V. Cohen, M.D., F.A.C.C., 
Takayuki Matsuki, M.D., and James M. Downey, Ph.D., 
University of South Alabama, Mobile, AL. 
Retroperfusion of coronary veins (RCV) has been used in 
unstable angina to relieve symptoms and in hearts with 
diffuse coronary artery disease for revascularization. The 
beneficial effects of RCV are supposedly related to its 
ability to increase myocardial (M) blood flow (BF). But 
left atrial microsphere injections which have been used to 
measure BF cannot distinguish between an actual increase 
in coronary collateral BF and possible nutritional exchange 
in the venous bed. To better define the origin of the im-
proved M perfusion the left anterior descending (LAD) cor-
onary artery of 7 dogs was cannulated and perfused from a 
carotid artery. The cannulated great cardiac vein (GCV) 
drained into the jugular V. Nutritional MBF was measured 
with LAD injections of 133Xe. LAD MBF decreased from 0.86+ 
0.16 to 0.13+0.02 ml/min/g after LAD occlusion and was not 
changed with-simultaneous GCV occlusion. To initiate RCV 
the GCV was occluded and arterial blood at 60mmHg pressure 
shunted retrogradely. During LAD occlusion and RCV, LAD 
MBF increased by 85~ to 0.23+0.03 ml/min/g (p<0.005). To 
further define the nutritional capacity of the venous cir-
cuit 133Xe was injected into the GCV after initiating RCV. 
The 2 component washout consisted of a very fast component 
probably representing exchange with venous endothelial 
cells and a slower component identical to the washout dur-
ing RCV seen after arterial injection of 133Xe. Extrapola-
tion of count rates recorded during RCV back to zero time 
demonstrated that 133Xe M isotope delivery following ve-
nous injection was only 10.1+l.5~ of that following LAD 
injection. Therefore RCV can-increase M washout presumably 
at the level of venules and venous capillaries and improve 
M nutritive BF, but only a small fraction of the shunted 
arterial blood actually reaches the myocardium. 
PERCUTANEOUS CORONARY ANGIOSCOPY DURING CARDIAC 
CATHETERIZATION. 
Martin Hoeher, M.D., Vinzenz Hombach, M.D., Hans W.Hoepp, 
M.D., Hans H. Hilger, M.D. University of Cologne, Germany 
Coronary angioscopy has been performed mainly during 
cardiac surgery and the clinical resul ts therefore are 
restricted to a certain patients selection. The aim of 
this study was to accomplish percutaneous CA during rou-
tine cardiac catheterization as well as to study the 
intimal effects of PTCA in vivo. CA was performed in 45 
pts suffering from CHD during routine catheterization 
using ultrathin fiberoptic angioscopes (Olympus Co.) with 
an outer diameter of 1.2 to 1.8mm and a length of 120 cm. 
The 1.8mm angioscope was equipped with an additional 
channel suitable for a standard guide wire. The angio-
scope was introduced through a 9F guiding catheter from 
the femoral artery. The viewing field was cleared by 
flushing with Ringer's solution during short time occlus-
ion of the coronary ostium by the tip of the guiding 
catheter. A good visualization of the targeted obstruct-
ion was obtained in 23/45 patients. Insufficient flushing 
or touching of the angioscope's tip against the vascular 
wall were the main reasons for failure. The guide-wire 
technique therefore facilitated the procedure. In 19/23 
patients CA revealed atherosclerotic plaques forming an 
excentric lesion with a rough and irregular surface. In 
4/23 patients ulcerations of the atherosclerotic plaques 
were found. In 3/6 patients with CA pre and post PTCA 
intimal ruptures without clinical or angiographical signs 
of dissection could be visualized. CA gives further in-
formation about stenoses, the presence of occluding or 
adherent thrombi as well as ulcerations of the atheroma-
tous plaques which may be of prognostic relevance. CA pre 
and post PTCA helps in understanding the mechanisms of 
ballon angioplasty and may improve patients selection. 
Technical improvements of the angioscopes are necessary. 
ABSTRACTS 
ANGIOSCOPIC MACROPATHOLOGY OF CORONARY ATHEROSCLEROSIS IN 
UNSTABLE ANGINA AND ACUTE MYOCARDIAL INFARCTION 
65A 
Kiyoshi Inoue, M.D.,F.A.C.C., Keiichi Kuwaki, M.D., Keiko 
Ueda, M.D. and Etsuko Takano, Cardiovascular Disease Ctr., 
Tokyo Metropolitan Police Hospital, Tokyo. 
To determine the intraluminal morphology before and the 
immediate outcome of ICT and PTCA, a percutaneous trans-
luminal coronary angioscopy was done in 30 patients during 
routine coronary arteriography. A sterile and disposable 
angioscopic catheter, applied in the series, was 0.7 mm in 
outer diameter and contains 3000 pixels of imaging fibers 
plus 50 illuminating bundles. A double guiding catheter 
(a regular F#8 Judkins and #5 soft tip) system was used 
for angioscopy. Inner guiding catheter, introduced into 
the proximal of coronary artery through the outer guiding 
catheter and left, was used for inserting the angioscopic 
catheter, manipulating the tip end to let the observation-
al target into sight, and flushing a warm 5% dextrose 
solution at a rate of 1-3 ml/sec in total amounts of 5-9 
ml to obtain the transient bloodless fields. A 130 watt 
Xenon white light was used for illumination. The images 
were stored and displayed in VTR. The angioscopy demonst-
rated plaques, varying in both size and shape, xanthoma-
tous in color, having focal hemorrhage or atheromatous 
abscess in surface, and tipped by thrombi in unstable 
angina, while the occlusive thrombi in acute myocardial 
infarction. A cracking of plaques and thrombus, hemorrhage 
and lysed residual thrombi were noted following ICT and 
PTCA. In conclusion, a necrosis-ridden matured coronary 
plaques, tipped or totally covered by t~e thrombi of its 
cracking seemed to be major intraluminal changes before 
and immediately after leT and PTCA in unstable angina and 
acute myocardial infarction. 
COMBINED ANGIOPLASTY AND VASCULAR STENTING BY A NOVEL 
HEAT-EXPANDABLE THERMOPLASTIC DEVICE 
Peter Barath. M.D.. Ph.D., Frank L itvack, M.D., Warren 
Grundfest, M.D., James Forrester, M.D., F.A.C.C. Cedars-
Sinai Medical Center, Los Angeles, California. 
When heated irradiated thermoplastics regain their 
original diameter after being stretched along their long 
axis into a smaller diameter. This dilation comes about 
with a considerable force. We fabricated this tubing 
into stents. The stent was then inserted into cadaver 
human coronary arteries and in vivo canine peripheral 
arteries over a catheter delivery system that allows us 
to heat (and therefore expand with force sufficient to 
overcome stenoses) the stent within the artery. The 
plastic molds itself to the unique curvature and surface 
of each vessel. In this way angiop1asty and stenting are 
unified in one step. In 35 artherosc1erotic cadaver 
human coronary arteries, stenoses were succesfu11y 
dilated even in the presence of calcification. Stents 
were also placed in 41 normal peripheral arteries 
(diameter 1.2-2.5 mm) in 13 dogs. At 14 to 70 days (mean 
18 days) angiography was performed and the dogs were 
sacrificed. All vessels were patent by angiography. 
Histologically, the stent was covered with new 
endothelium at 70 days (n=4), and in no stents was there 
thrombus. Thus we have developed a unique approach to 
simultaneous angiop1asty and stenting, which molds to 
the curvature of the vessel, and re-endothe1ia1izes 
without thrombosis over a relatively short fo110wup 
period. 
66A ABSTRACTS 
ANALYSIS OF COMPLICATIONS ASSOCIATED WITH 
CORONARY STENTING 
Ulrich Sigwart MD, FACC, Svein Golf MD, Urs Kaufmann 
MD, Lukas Kappenberger MD, Division of Cardiology, 
Centre Hospitalier Universitaire Vaudois, CH - 1011 
Lausanne, Switzerland 
Intracoronary stents seem to prevent restenosis and 
acute occlusion after transluminal angioplasty (PTCA); 
we have noted, however, a higher complication rate as 
compared to PTCA alone. - Among 60 consecutive coronary 
implants 37 were performed for established restenosis, 
IS for bypass graft stenosis, 8 for abrupt closure 
after PTCA. There were no significant complications in 
the bypass graft group. Patients stented for abrupt 
closure had few complications : I local haematoma, I 
false aneurism (requiring surgical removal after 3 
months followed by temporary stent occlusion). In this 
group of patients, S stents were placed in the right 
coronary artery (RCA) and 3 in the left coronary artery 
(LCA). In the group with stents for restenosis we noted 
no complication in RCA implants (N = II) but some 
complications in LCA implants (temporary occlusion N = 
4, sudden death N = I). The use of intracoronary 
nifedipine before stent implantation significantly 
diminished the rate of acute spasm. There was an 
inverse correlation between the length of the stent and 
the number of complications. Since proximal RCA side 
branches are of lesser importance, RCA stents were in 
general chosen longer than LCA stents. 
We conclude that stenting of the left coronary artery 
for restenosis is associated with a higher complication 
rate as compared to RCA or bypass stenting. Longer 
stents have lesser occlusion rates. 
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Electrocardiography, Ischemia and Arrhythmias 
DOES HOLTER MONITORING HAVE CLINICAL UTILITY IN THE 
EVALUATION OF PATIENTS WITH CHEST PAIN? 
Freny Vaghaiwalla Mody, M.D., Koonlawee Nademanee, M.D., 
F.A.C.C., Vanida Intarachot, R.N., Martin A. Josephson, 
M.D., F.A.C.C., Helen Robertson, B.S., Bryna Harwood, 
Bramah N. Singh, M.D., F.A.C.C. Wadsworth VAMC Los 
Angeles, CA. 
With the establishment of silent myocardial ischemia 
(SMI) as an entity in CAD, Holter monitoring (HM) for 
evaluation of severity in patients with documented CAD 
and in those with initial presentation of chest pain is 
increasingly used. To investigate the role of HM in such 
pts we studied 94 pts (mean age 60.4 t 7.7 years) and 42 
normal volunteers (mean age 28.7 t 3.6 years). In all 
pts HM for 24 hours off antianginal therapy preceded 
coronary angiography (CA) by 24 hours to 2 weeks. CA was 
scored for number of vessels (V) stenosed >70% and HM was 
analyzed for ST- segment deviation >1 mm for >30 seconds 
duration. CA showed 27,25,19 and 21 pts with 3V,2V,IV 
and 0v disease respectively. All HM tapes were coded for 
blinded analysis. Eight HM tapes were unanalyzable 
(5 pts and 3 volunteers). Amongst the volunteers only 1 
tape was false postitive while the pts had 4 false 
positive, 24 true positive, 43 false negative and 16 true 
negative. Thus, while the calculated specificity and +ve 
predictive value (PV) of HM was 92% and 86% respectively, 
the sensitivity was 37% and -ve PV 27%. Negative HM were 
distributed evenly in all V categories of CA. 
Conclusions: (1) HM has high specificty but low 
sensitivity in pts with documented CAD. (2) HM appears 
to have little clinical value in detecting or 
establishing severity of CAD. Thus, HM's role in the 
management of CAD is limited to its ability to 
specifically detect SMI during phases of CAD activity. 
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COMBINED AMBULATORY ECG AND ELECTROPHYSIOLOGIC APPROACH 
TO PATIENTS ON AMIODARONE FOR VENTRICULAR TACHYCARDIA. 
Sharon Ma~ro, P.A.C., David Levine, M.D., 
Antonloaclflco, M.D .. Huang-Ta Lin, M.D., F.A.C.C., 
Craig Pratt, M.D., F.A.C.C., 
Christopher Wyndham, M.D., F.A.C.C. 
Baylor College of Medicine, Houston, TX. 
Both electrophysiologic study (EPS) and 24-hr ambulatory 
ECG (AECG) can independently predict outcome in patients 
(pts) with sustained ventricular tachycardia (sus VT) or 
fibrillation (VF) on amiodarone. However, sus VT may 
still be inducible when AECG shows suppression of 
ventricular premature beats. To resolve the prognostic 
conflict when EPS and AECG are discordant, 42 consecutive 
sus VT /VF pts (CAD in B7%) with both tests at basel ine 
and also after 2 or 4 wks were analyzed. Follow-up was 
22t16 mos. Efficacy was reached in 14/42 pts by EPS - of 
these, only 1/14 had recurrence of VT (Rec VT). Efficacy 
was reached in 34/42 by AECG - of these, 10/34 had Rec 
VT. Results of EPS and AECG were concordant in 20/42 
pts - outcome correctly predicted in 13/13 pts with 
efficacy and 2/7 pts without efficacy. Discordant results 
occurred in 22/42 pts (efficacious AECG with non-effica-
cious EPS in 21 pts), 11 of whom had Rec VT. Results of 
EPS at 2 wks did not predict Rec VT. At 4 wks, results of 
EPS correctly predicted Rec in 9/13 pts but AECG in only 
1/13 pts (p =.001). 
Conclusions: 1) Concordant results showing efficacy 
by both EPS and AECG as early as 2 wks are predictive of 
a good outcome. 2) Discordant results at 2 wks are not 
predictive of recurrence. 3) If discordant results exist 
at 4 wks, EPS is significantly more predictive of recur-
rence than AECG. 
INITIAL PATIENT EXPERIENCE WITH TEImlONE REMOTELY 
CONTROLLED CARDIOVERSION AND DEFIBRILLATION 
Lawrence J. Gessmsn MD, Sivaramen Raman MD, Melvin C. 
White MD, Michael Smith BS, Sidney Steinberg PhD 
Deborah Heart and Lung Center, Browns Mills NJ and 
Medphone Corporation, Paramus NJ 
The purpose of this study was to assess whether a 
remotely located physician (MD) could properly diagnose 
and direct treatment of induced arrhythmias in electro-
physiology laboratory patients using the telephone defib-
rillator system (TD). The TD is a home defibrillator 
intended for high risk for sudden death patients that 
sends patient ecg, voice and electrode impedance data via 
standard telephone line to a remote monitoring physician 
at a hospital CCU base station. The MD can defibrillate 
ventricular fibrillation (VF) with 10-360 joules, or 
synchronously cardiovert atrial or ventricular tachy-
cardia (VT) by telephone remote control if necessary. The 
TD was tested in 17 patients who had 1 induced episode of 
VF, 7 VTs with loss of consciousness (LOG), 8 VTs without 
LOG, 4 atrial fibrillations (AF). The remote MDls ecg 
diagnosis, assessment of patient LOG, measurement of 
electrode impedance and treatment decisions to shock VF 
and VT with LOG, and not shock VT without LOG were judged 
to be correct in all episodes by a local MD in the EPS 
lab. 16, 50-360 joule shocks were delivered by the TD. The 
mean time from arrhythmia onset to shock delivery for VT 
and VF with LOG was 47.2 ± 12.4 sec. The charge-discharge 
time measured 12.3 ± 1.5 sec. Electrode impedance 
measured 77 ± 10 ohms by TD, versus 75 :!;9 ohms by local 
impedance meter. 10 synchronous shocks were delivered 
properly wi thin the QRS complex as determined by local 
ecg. We conclude that the TD system provides sufficient 
diagnostic information to make correct and rapid 
arrhythmia treatment decisions including remotely 
controlled synchronous cardioversion and defibrillation. 
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AMBULATORY ECG MONITORING FOR THE DETECTION OF ISCHEMIC 
EVENTS AND VENTRICULAR ARRHYTHMIA:DIFFERENTIAL UTILITY OF 
EVENT RECORDING VERSUS CONVENTIONAL MONITORING SYSTEMS. 
rr~!~~~~~!~M.D. F.A.C.C.,Marc Meissner, M.D., Joel 
Morganroth,M.D.,F.A.C.C.,Leonard Horowitz ,M.D. , F.A.C.C., 
Patrick Golden, M.D., and Enrique Carbajal,M.D., 
VAMC and Univ of California, San Francisco. 
Holter monitoring (HH) is being used for detection of ST 
segment shifts to diagnose transient ischemic events 
during daily activity. Since ischemia is frequently 
accompanied by ventricular arrhythmia(VA), it is impor-
tant to evaluate the accuracy of HH devices in detecting 
ST shifts and VA. We evaluated the accuracy of a real 
time event recorder (RTE) in detecting ST shifts and VA 
in 128 pts by comparing RTE(Q-Med) to conventional HM 
(CHM) (n:36) and exercise treadmill test(ETT) (n:92). The 
comparison of ST anslysis by RTE and ETT revealed that 
the RTE accurstely detected ST ~ (>1mm) in 28/37 (75J) 
pts and its absence in 50/55 (90J) pts. In 14/92 pts the 
RTE and ETT were discordant. Overall sensitivity of the 
event recorder was 75J and specificity 90J, with predic-
tive accuracy of 84J. Fslse positive ST shifts were 
caused by VA and marked baseline wandering. The socuracy 
of ventricular ectopy (VPCs) detection by RTE was com-
pared to hand-counted 1-2 hour CHH samples in 36 pts. 
The timing of anslysis was preCisely correlated between 
the RTE and CHM. RTE was concordant to CHH in 4/9 pts 
with 0 VPCs, in 7/11 pts with 1-10 VPCs, in 4/8 pts with 
11-100 VPCs and 6/8 pts with >100 VPCs. RTE was discor-
dant in all 10 pts with repetitive VPCs (V-couplets or V-
tachycardia) and failed to detect 94 episodes of V-
tachycardia ranging from 3 to 129 beats. Conclusion: The 
real time event recorder reliably detects ST-segment 
shifts but is not accurate for the evaluation of 
ventricular arrhythmia. 
PREDISCHARGE HOLTER MONITORING PREDICTS POST-INFARCTION 
TREADMILL ISCHEMIA. Nisha C. Chandra, M.D., Pamela 
Ouyang, M.D., F.A.C.C., T. Robert Abell, C.V.T., Sidney 
O. Gottlieb, M.D., F.A.C.C., Johns Hopkins Medical 
Institutions, Baltimore, HD 
Post-infarction (MI) treadmill ischemia identifies high 
risk patients (pts). Allhough ischemia detected by Holter 
monitoring also predicts poor outcome in some pt groups, 
the relationship between Holter detected ischemia and 
post MI treadmill (ETT) ischemia is unknown. We screened 
75 pts following MI with a 24 hour Holter monitor 
(HOLTER), and a submaximal Naughton ETT and excluded 28 
pts because of LBBB, LVH, abnormal ST segments or digoxin 
therapy. In the remaining 47 pts the HOLTER was performed 
5.2 ± 2.4 days post MI (mean ± SD) and the ETT 8.3 ± 1.8 
days post MI. Each pt was on the same drugs for both 
studies, and all studies were read blindly. 
ETT was positive (+) for ST changes and/or thallium 
reperfusion defects in 18/47 pts. HOLTER was + for 
ischemia (ST depression ~lmm, > 1 minute) in 12/47 pts 
(Grp I), with 11.2 ± 8.2 ischemic episodes/pt lasting 
12.8 + 7.6 minutes/episode. HOLTER was negative (-) for 
ischemia in the other 35/47 pts (Grp 2). The ETT and 
HOLTER correlation was: 
ETT + ETT -
HOLTER + -8-- -4--
HOLTER - 10 25 p <.02 (x2) 
The predictive accuracy of +HOLTER for identifying +ETT 
was 67% (specificity 86%), and the predictive accuracy of 
-HOLTER for identifying -ETT was 71%. Grp 1 pts were 
older than Grp 2 (63 ± 7 vs 55 ± 11 years p<.02), more 
commonly had painless ETT ischemia (50% vs 20% p=.05), 
and tended to have earlier positive ETT's (385 + 215 vs 
588 + 211 seconds, p=.07). Thus, ischemic ST ch~nges as 
detected by Holter monitoring correlate significantly 
with post MI ETT results. 
ABSTRACTS 
ST SEGMENT DEPRESSION ON THE ADMISSION ECG IS A 
DETERMINANT OF ADVERSE LONG-TERM OUTCOME IN NON-Q WAVE 
MYOCARDIAL INFARCTION: A PROSPECTIVE ANALYSIS FROM THE 
MULTICENTER DILTIAZEM REINFARCTION STUDY (DRS). 
William ~ Boden, MD, FACC, Robert E. Kleiger, MD, FACC, 
Prabodh Mehta, MD, Kenneth B. Schechtman, PhD, David J. 
Schwartz, MD, FACC, Robert J. Capone, MD, FACC, Robert S. 
Gibson, MD, and the DRS Research Group; Harper Hospital, 
Wayne State University, Detroit, Michigan. 
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While ST segment elevation (t) is the dominant acute 
repolarization change (~) in evolving Q wave myocardial 
infarction (MI), pts with non-Q wave (NQ) MI may present 
with ST t , ST depression (.) or T wave ~. To determine 
the prognostic significance of early ST • vs. ST t and/or 
T ~ in NQMI, we analyzed the entry ECGs of 439 DRS pts 
with HB-CK confirmed NQMI who had > 1 mm ST segment shifts 
( t or ~ ) or T wave • in .:: 2 leads within a given ECG 
lead group (anterior, inferior, lateral), and assessed 
comparative event rates in pts with early ST. (n=287) vs. 
ST t and/or T • (n=152) at 14 days and 1 yr followup: 
Clinical variable ST + ~ ST t /T + 
Age (yrs) *63 .004 59 
Sex (female;%) *26 .033 14 
Prior MI (%) *46 .03 34 
Peak CK (I.U.) 620 NS 596 
LV hypertrophy (H);% *77 .004 62 
MI < 14 days (%) 6 NS 8 
MI a:t 1 yr (%) *17 .02 9 
Mortality at 1 yr (%) *19 .010 9 
CONCLUSION: 1) pts with ST • are older, more often 
female and have a higher % of prior MI and LVH than those 
without ST + ; 2) NQMI pts with early ST • have a 2-fold 
increased risk of recurrent MI and mortality at 1 year 
compared to pts with ST t and/or T +. 3) Such pts may 
require close surveillance and management during the early 
post-MI period. 
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Electrocardiographic Refinements With Clinical Significance 
THE PRECORDIAL T-WAVE IS DETERMINED BY TRANSMURAL, NOT 
TRANSEPICARDIAL VENTRICULAR REPOLARIZATION GRADIENTS. 
Ruperto Hsyuga, M.D., Peter Czakanski, M.D., Masao 
Nishimura, M.D., Donald Singer, M.D.,FACe. Northwestern 
University, Chicago, IL. 
Precordial T-wave polarity and magnitude are attributed 
to either transepicardial (EPG) or transmural (TMG) LV 
repolarization g~adients. In previous studies, only 
estimated gradients were used and EPG and TMG were not 
compared. To study the actual gradients, we recorded 
simultaneously precordial ECG and monophasic action 
potentials (MAP)s from opposing endocardial and epi-
cardial sites at the apex and epicardial base of the LV 
in 5 dogs. 'TMG and EPG were measured as ~ differences 
in the degree of repola!'i zation between endocardial and 
epicardial MAPs during peak T-wave deflection. T-wave 
polarity was controlled by epicardial superfusion with 
cold and warm Tyrode's solution. Under control condi-
tions, T-waves were generally flat and TMG and EPG were 
minimal. Epicardial cooling caused T inversion and 
epicardial but not endocardial MAP prolongation (179+12 
to 235+38msec, p< .01), an endocard'ial to epicardial re-
polarization sequence and a greater increase in TMG 
than EPG (18+12~ to 55+11S & 10+8S to 14+7~,respective­
ly, p<' 05). Conversely:- epicardial warming caused T to 
become upright, epicardial MAP but not endocardial MAP 
shortening (193+12 to 158+11msec, P<.05), an epicardial 
to endocardial repolarization sequence and a greater 
increase in TMG than EPG (10+2S to 51 +20S & 11 +4S to 
5+3S, p<.05). Magnitude of Tcorrelated with TMG 
(r=.73) and not with EPG (r=.36) (P<.05). The data show 
that 1) precordial T polarity is influenced by the 
sequence of transmural repolarization, and 2) T 
magnitude parallels TMG but· not EPG. 
68A ABSTRACTS 
FURTHER EVIDENCE SUPPORTING THE CONCEPT OF T-~VE 
MEMORY: OBSERVATIONS IN PATIENTS HAVING UNDERGONE 
CATHETER ABLATION OF THE WOLFF-PARKINSON-WHITE SYNDROME. 
Jeanne E. Poole, M.D., Gust H. Bardy, M.D., F.A.C.C., 
Tom D. Ivey, M.D., F.A.C.C., H. Leon Greene, M.D., 
F.A.C.C. Univ. of Washington, Seattle, WA. 
Previous work has suggested that T_ave memory is a 
real phenomenon in patients (pta) with bundle branch 
block due to unmasking of electrotonic modulation from 
altered depolarization. Patients with antegradely 
conducting accessory pathways (AP' s) might be expected 
to exhibit similar T_ave changes with alteration in 
depolarization. 
Evidence to support this was found in 8 pts with 
manifest AP's who underwent successful catheter ablation 
of their AP. Each pt underwent cardiac catheterization 
and tomographic thallium studies before and after 
ablation. All pts developed new inferior T_ave changes 
post-ablation which resolved over 4 weeks. In no pt was 
there structural left ventricular myocardial injury to 
explain the T_ave changes. This suggests that the 
repolarization abnormalities were secondary to an abrupt 
loss of abnormal depolarization. In contrast, 2 pts 
with concealed AP showed no T_ave changes. Our findings 
support the hypo-
theses that a time 
dependent T_ave II 
~:mo:! :~~~:at~: ~ ~ 
for the occurrence 
of T_ave abnor-
malities in pts 
that have had ~ -..A.v-
depolarization 
abnormalities. 
III AVF 
T 
ST-T CONFIGURATION IN V4R IN ACUTE INFERIOR INFARCTION 
AND THE SITE OF OCCLUSION IN THE CORONARY ARTERY 
Simon R. Braat M.D., Anton P.M. Gorgels M.D., Frits 
W. B~r M.D. and Rein J.J. Wellens M.D., F.A.C.C. 
Department of Cardiology, Acsdemic Hospital of Maas-
tricht, The Netherlands. 
In 107 pts admitted within 2 hours after the onset of 
chest pain and signs of an acute inferior MI. V4R was 
also recorded before intra coronary thrombolysis. Three 
different ST-T segment configurations in lead V4R were 
distinguished: 1) ST segment elevation> 1 mm, 2) no 
ST segment elevation with, however, an upsloping ST-T 
segment, 3) no ST elevation with a downs loping ST-T 
segment. 
Results: 43 Pts had an occluded right coronary artery 
(RCA) proximal to the first branch to the RV, 31 pts 
had a distal occlusion in the RCA and 33 pts had an 
occluded circumflex artery. In 45 pts a ST segment 
elevation > 1 mm was found, 32 pts had an ups loping 
ST-T segment and 30 pts a downs loping ST-T segment in 
V4R. ST segment elevation > 1 mm in V4R predicted a 
proximal occlusion of the RCA with a sensitivity of 
91, a specificity of 91 and a positive predictive 
accuracy of 87%. Lack of ST segment elevation with 
upsloping ST-T segment predicted a distal occlusion of 
the RCA with a 'sensitivity of 81, a specificity of 92 
and a positive predictive accuracy of 81%. Lack of ST 
segment elevation with a downs loping ST-T segment 
predicted a circumflex artery occlusion with a sensi-
tivity of 85, a specificity of 97 and a positive 
predictive accuracy of 93%. 
We conclude that 5T-T segment in V4R can reliable 
predict the site of occlusion in an acute inferior 
infarction. 
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ELECTROCARDIOGRAPHIC AND BLOOD FLOW EFFECTS OF 
RAPID ATRIAL PACING AND DIPYRIDAMOLE INFUSION IN 
DOGS WITH CHRONIC CORONARY ARTERY OCCLUSION. 
David M. Mirvjs MD .. K.B. Ramanathan, MD .• F.A.C.C .• Jack L. 
Wilson. Ph.D. University of Tennessee. Memphis. TN 
Altering myocardial flow by potent vasodilators or increasing 
oxygen demand by exercise are used to detect coronary arterial 
obstruction. This study sought to define the relative abilities of 
these two methods to produce abnormal ECG patterns and to alter 
myocardial blood flow in dogs after ameroid constriction of the 
left circumflex coronary artery. In 15 dogs. atrial pacing to 210 
beats/min was performed. followed by IV administration of 0.25 
and 0.50 mg/kg of dipyridamole. Surface ECGs were recorded 
from 88 electrodes to construct body surface isopotential maps 
during the S-T segment. Flow was measured by serial injections 
of radio labelled microspheres. After 3-5 weeks of ameroid 
constriction. pacing increased epicardial flow by 19.14 ± 7.11% 
but reduced endocardial flow by 35.69 ± 12.32%. with a 
significant reduction [to <0.67] in the transmural flow ratio in 12 
[80%] dogs; both endo and epi flows were significantly lower in 
the ischemic than in the nonischemic bed. Abnormal S-T segment 
responses of subendocardial ischemia developed in 10 dogs. In 
contrast. dipyridamole produced a dose dependent rise in both 
endo [25.33 ± 8.54% and 55.80 ± 9.22% after 0.25 and 0.5 mg/kg. 
respectively] and epi [29.13 ± 7.49% and 66.33 ± 7.64% after 0.25 
and 0.5 mg/kg. respectively] flows without a significant fall in 
the transmural ratio. The increases were. however. Significantly 
less than observed in nonischemic bed flow. resulting in a 
transventricular gradient of blood flow. None developed abnormal 
ECG patterns after dipyridamole infusion. Thus. pacing produced 
both a transmural and a transventricular gradient in blood flow 
whereas vasodilation causes only a transventricular flow 
abnormality; the associated ECG responses are consistent with 
these flow patterns and the critical role of transmural recovery 
time gradients in the genesis of the S-T segment. 
INITIAL ST-SEG£NT OCVIATIrn CAA PREDICT mw .. ELECTROCAADICGlIHC 
MYOCAADIAL Irf"MCT SIZE. 
Peter Clemrensen, M.D. ,Peer Q-ande, M.D. ,Naocy B.H1nctran, B.A., 
HarTy Aldrich, M.D.Galen S.W3g1er, M.D., Me U1iversity f.'ed1cal 
Center, Cardiovascular DiviSion, Durh<ITI, North Carolina. 
Because the decision to adninister traTtlolytic therapy for limitat10n 
of ocute l1!Y«ardial infarct (JV.111 size RUst cccur l'iIen only the 
hiStory, phys1cal examnation CI1d 12-lead EGG of a patient are 
available, a neth:x:l basal on these tests l'tIich could qJickly as-
sess the iIIIJUI1t of jeopardized l1!Y«ardillll, 'IOJld be of great cli-
nical value. A recent study has ~ 2 fornulas to predict 
ultimate extent of JV.1H~ score) fran ST deviat10n in adnission 
ECG in patients rec1eving no reperfusion therapy. The fomulas 
are: Final 'to JV.1I size = 3[1,5(# leads ST1')-o,4] and 3[o,6(I ST1' 
II, III, aWl + 2,1] for anterior and inferior JV.1I respectively. 
The present prospective study assesses the correlation coefficient 
(r) bet\'oE!et1 predicted CI1d final JV.1I size and its relationship to 
llOrtality. Of 135 consecutive patients with first JV.1I 52 had ante-
rior JV.1I (32 11B1, 20 1'OTeIl; rredian age 63 yr) and 83 had inferior 
JV.1I (49 11B1, 34 1'OTeIl; rredian age 64 yr). The correlations beb.een 
predicted CI1d final JV.1I size \Ere: ~,70 for CI'lterior JV.1I CI1d 
~,52 for inferior JV.1I. In 23 patients with inferior JV.1I and ECG 
evidence of apical involvarent, final ~ was greatly lJ1derestima.ted. 
Mxlified fornulas considering either I STtin all leads or application 
of both fornulas in all patients inproved the correlation for inferior 
JV.1I to : ~,63 and ~,65 respectively. [AJring foll<1<l44J period 
(rred1an 3 yr) 19 patients died 1:14Y.). JV.1I size (final ~ score) 
was sign1ficantly larger arong non-survivors CX=8,75) than arong 
survivors (X=6, 45) , (p.o, 025). We cone 1 ude that the iIIIJUI1t of l1!Y«ar-
dillll in jeopardy CI1d long tenn patients prognosis is predictable 
fran adni ssi on ECG in evo 1 vi ng JV.1I. 
lACC Vol. II, No.2 
February 1988:69A 
IMPAIRED QT SHORTENING IS ASSOCIATED WITH EXERCISED-
INDUCED VENTRICULAR TACHYCARDIA IN NORMAL SUBJECTS. 
Michael E. MCIvort M.D., Joseph H. Levine, M.D., Jerome L. Fl eg, M.D., F •• a:: Geronto logy Research Center, 
NIA, and Johns Hopkins Hospital, Baltimore, MD 
Abnormal ities in the time course and/or pattern of 
electrical repo1arization may underlie exercise-induced 
ventricular tachycardia (VT) in some patients. We 
therefore measured the QT interval during rest (R), 
exercise (Ex) and recovery (Post Ex) in 31 volunteers 
from the Baltimore Longitudinal Study on Aging without 
evidence of ischemic or other organic heart disease (by 
history, exam, and resting and stress tha 11 ium 
scintigraphy) who had VT (> 3 consecutive ventricular 
premature beats) during exercise, but not at rest, for 
comparison with 31 age- and sex-matched volunteers who 
had no VT. The mean heart rate (beats per minute) did 
not differ at rest (72 vs 78), exercise (147 vs 142), or 
early recovery (102 vs 98) in the control vs VT group 
respectively. QT intervals were (X! SEM, msec): 
Control 
VT 
P 
R 
394 + 8 
390 +" 6 
NS -
Ex 
270 + 5 
302 +" 5 
<.Oll'l 
R-Ex 
lIE'+? 
88 +" 8 
<.U1 
Post Ex 
TI8+-5 
386 +" 12 
<.0ll'01 
Twenty of the 31 subjects in the control group shortened 
their QT interval by > 25% with exercise as compared with 
only 8 of 31 in the VT group (p <.005 by chi square). 
Thus, exercise-induced VT in subjects without evidence of 
organic heart disease is associated with diminished 
shortening of the QT interval during exercise which 
persists during early recovery. This suggests that 
abnormalities of ventricular repo1arization may 
distinguish otherwise normal patients at increased risk 
for ventricular arrhythmias. 
Tuesday, March 29, 1988 
10:30AM-12:00NOON, Room 367, Level Three 
Surgical Treatment of Congenital Heart Disease 
LONG-TERM PROGNOSIS OF PATIENTS UNDERGOING SURGICAL 
REPAIR OF ISOLATED PULMONARY VALVE STENOSIS: A 20-30 
YEAR FOLLOW-UP 
Stephen L. Kopecky. M.D. FACC. Bernard J. Gersh. M.B •• 
Ch.B •• FACC. Michael D. McGoon. M.D .• FACC. Douglas D. 
Mair. M.D .• FACC. Co-Burn J. Porter. M.D .• FACe. Duane 
Ilstrup. M.S .• Dwight C. McGoon. M.D .• FACC. Gordon K. 
Danielson. M.D .• FACC. Mayo Clinic. Rochester. Minnesota 
We report the long-term follow-up (median 24.3 years 
(yrs). range < 1-30.4 yrs) of 191 consecutive patients 
(pts) undergoing surgical repair of isolated pulmonary 
stenosis between 1956 and 1967. Mean age at surgery was 
14 yrs (range 3 days to 68 yrs). Perioperative mortality 
was 4.2% (18% in pts < 1 yr of age). Among the 193 
perioperative survivors. actuarial survival at 10. 20. and 
25 yrs was 96%. 91%. and 90% respectively. In pts < 20 
yrs old at surgery. the 25 yr survival was no different 
from that expected in an age and sex matched control 
group. In pts aged> 20 yrs at operation. the 25 yr sur-
vival of 71% was poorer than the 85% survival in controls 
(p < .05). There were 11 cardiac deaths (5%). 
Multivariate analYSis identified age> 20 yrs at time 
of surgery and the use of ischemic cardiac arrest intra-
operatively as the only significant predictor of late mor-
tality (overall and cardiac) in hospital survivors. The 
only predictors of perioperative mortality were young age 
at operation and the preoperative administration of medi-
cal therapy. Neither the use of a right ventriculotomy 
inCision nor a postoperative murmur of pulmonary insuf-
ficiency were associated with an adverse late outcome. 
In summary: 1) In pts < 20 yrs of age at surgery. 
long-term survival (25 yrs) is excellent and no different 
from controls. 2) The increased mortality in older pts 
is likely the consequence of long-standing right ventri-
cular pressure overload and hypertrophy. 
ABSTRACTS 
FATE OF THE AORTIC HOMOGRAFT USED FOR RIGHT 
VENTRICULAR OUTFLOW TRACf RECONSTRUCfION FOR 
PULMONARY ATRESIA AND SEVERE FALLOT: A 21ST BIRTHDAY 
CELEBRATION 
Jane Somerville. MD, FRCP, FACC and Donald Ross. FRCS. FACC. 
Paediatric & Adolescent Unit, National Heart Hospital. London. England 
58 consecutive survivo ... with pulmonary atresia or severe FalJot had right 
ventricular outftow tract reconstruction using a cadaver aortic homograft 
between 1966-1984. Patients were aged 4-35 yea ... (mean 15 yea ... ), The 
homograft was 1.6-2.5 em. sterilized by freeze drying (4) 1966-1968. deep 
rrozen (6) 1968-1984. irradiation (1) 1969. and rresb antibiotic solution (47) 
1969-1983_ Attention was given to homograft valve function by recognition or 
audible valve closure (P2). mobile cusps on angiography and 
echocardiography and state or valve cusps at reoperation or necropsy. FIfty-
one patients bad catheterization. with serial stodles In 25. Forty-one were 
rollowed ror > 10 yea.... Reoperation was required In 19 patients (33%) but 
only 5 required homograft replacement ror calcific graft obstruction 9-16 
yea ... later. Reoperation was more common ror residual lesions or Dacron 
tube extension obstruction (24%)_ One or 12 (21%) late deaths was related to 
a pulmonary homograft, probably Infected when used to replace an aortic 
homograft after 10 yea.... Other deaths were from ventricular arrhythmias 
(sudden. 2). ventricular rallure (3). coronary thrombosis (2). and reoperatlon 
(4). Late endocarditis occurred In 3 patients. In one on the homograft. 
Twenty-one pregnancies In 10 patients ended with 19 babies. one miscarriage 
and one maternal death rrom coronary thrombosis. Fifteen aortic homografts 
examined at reoperatlon (8) or necropsy (7) 2 months to 19 yea ... (mean 10.5 
yea ... ) later sbowed thin pUable cusps In 10. Of tbe 39 survlvo .... 37 have 
normal P 2 despite aortic wall calcification and 2 show valve cusp dysfunction. 
Methods or sterilization did not Inftuence long term function. Problems arise 
more commonly rrom myocardial dysfunction and Dacron tubes than from 
the homograft. With a homograft railure/problem rate of 9% in 688 patient 
years. continued use or the aortic homograft is not only justified after 21 
years but strongly recommended In younger patients. 
Myocardial Performance after Arterial Switch for 
Transposition of the Great Arteries 
Steven D Colan. MD. FACC. Eckardt Trowitzsch. MD. 
Gil Wernovsky. MD. Gary Sholler, MB. BS. FRACP. 
Stephen P Sanders. MD. Aldo R Castaneda, MD. 
Dept. of Cardiology. Children'S Hospital. Boston. MA. 
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A group of 28 neonates with d-transposition of the great 
arteries and intact ventricular septum underwent arterial 
switch operation at mean age of 4 days. We report 
prospective study of left ventricular (LV) regional and 
global function. loading status. and contractility up to 
age 5-37m (mean = 12m). In 20/28 patients with adequate 
20 echos. regional wall motion analysis using 
frame-by-frame computer digitization of long and short 
axis views of the LV showed no differences from 
age-matched controls. In 28/28 patients, 2D-directed 
M-mode with calibrated pulse tracing was used to 
calculate end-systolic wall stress (ESWS). fractional 
shortening (FS). and rate-corrected velocity of 
shortening (VCFc). Afterload (end-systolic wall stress) 
was normal or reduced in 27/28. indicating compensatory 
LV hypertrophy adequate for the systemic pressure load. 
The ESWS-VCFc relation, a load-independent index of 
contractility. was normal in 27/28. Decreased FS in 2 
patients was secondary to high afterload in one and 
reduced contractility of uncertain etiology in the other. 
In patients with serial studies. 2/12 had depressed 
contractility 7 days after surgery with return to normal 
by 6 mos. 
Arterial switch with coronary reimplatation can be 
performed in infancy with excellent preservation of 
myocardial performance. The normal regional function in 
these patients suggests that permanent ischemic injury is 
uncommon. 
70A ABSTRACTS 
PRIWRY Q.mR£ CF VEN1RICll.AA SEPTJU. [E'ECT IN Itf"J\tC{ 
Walter t-'elTill, M.D., F.A.C.C., Todd Slulll.ll, M.D., Tham.s Q-ahiJn, Jr., 
M.D., F.A.C.C., JOhn Ha..l11l11, .T., M.D., F.A.C.C., Williilll Frist, M.D., 
Harvey Bender, Jr., H.D., F.A.C.C., Vanderbilt Univ., Nashville, TN. 
PrillBry closure of a ventricular septal cEreet (VSO) in infancy is 
necessary'tilen congestive heart failure does rot respond to i1I!dica 1 
treatrrent. We reviSEd 115 consecutive children less than 12 I11JI1ths of 
age I'oho urden-.ent VSO closure between 1976 arC 1987. Profoorxl hJpo-
thennia am circulata"y arrest ...as used in 9D patients; cardio-
pulrronary bypass arC lIllderate h,WOthennia ...as used in 25 patients. 
Retrospectively the patients ~ classified into 00 groups. (h)up 
A patients (N=32) rl!(JJired operation at age 3 I11JI1ths or less (avg age 
2.2 I1llI1ths). Their wei!tJt...as 3.8 + 1.1 kg. The pull1lJl1ary/systanic 
flOti ratio (~/Qs) ...as 3.8 + 1.3. G-oI.4> B (N=83) ~ qJerated l4JOI1 
after 3 I11JI1ths of age (avg age 5.8 I11JI1ths). Their wei!tJt ...as 5.0 + 1.2 
kg. The ~/Qs ...as 3.6 + 1.2. -
The ~ A mrtality...as 9.3% (3/32). Deaths ~ due to lOtI 
cardiac output in 2 patients arC respirata"y fai lure due to viral 
pneurcnia in 1 patient. Three additional patients rl!(JJired 
reexp loration for bleeding, arC one rl!(JJired a penmnent pace!1Bker. 
The ~ B mrtality...as 2.4% (2/83). Both patients died of lOtI 
cardiac output; in one a left ventricu lotaqy...as necessary to close an 
apica 1 VSO. One patient reqJired a penmnent pace!1Bker, arC 4 patients 
had periqJerative seiztres I'ilich resolved. 
One hundred ten qJerative survivors have been fo 11CW!C1 for an 
average of 39 I1llI1ths. All are as,\l1lltalBtic. None have evidence of 
congestive heart failure, residual VSD, or neurologic inpainrent. 
We conclude that [TillBry ventricular septal cEreet closure in 
infancy llBy be undertaken using either [Tofouro h,WOthennia arC 
circu lata"y arrest or cardiopu 1l1lJl1ary bypass am lIllderate hJpothennia. 
Marta 1 ity am rrorbidity rates are hi!tJer in chi ldren 3 I11JI1ths of age or 
less. w-essive i1I!dicalllBnagerent should be utilized in an attar¢ to 
control heart failure in)Q.l1g babies. W1enever possible, VSO closure 
should be dela~ until the child is greater than 3 I11JI1ths of age. 
INCIDENCE AND SEVERITY OF AORTIC 
INSUFFICIENCY AND SUPRA VALVULAR PULMONIC 
STENOSIS FOLLOWING ANATOMIC CORRECTION OF 
TRANSPOSITON OF THE GREAT ARTERIES. 
Frederick W. Arensman. M.D .. FAC C., Rosemary Radley-
Smith, M.B.Ch., FAe.e., Charles Skinner, II, R.C.P.T., Robert 
D. Martin, M.B.Ch.,FAC.C., Magdi H. Yacoub, M.B.Ch., 
FAe.e., Harefield Hospital, Harefield, Middlesex, U.K 
Potential postoperative sequelae of anatomic correction (AC) 
for tranposition of the great arteries (TGA) include aortic 
insuffiCiency (AI) and supravalvar pulmonic stenosis (SPS). 
Conventional and color flow Doppler echocardiography were 
used to examine 19 postoperative patients (pts) from 7 days to 
45 months (mean = 33.2 mo). Age at AC ranged from 0.5 to 
130 months (mean = 38.6 mo). Sixteen of 19 pts had AC ~21 
days of age while 3 had prior pulmonary artery banding and 
definitive AC from 5 to 7 months later. The LeCompte 
anastomotic technique was employed in 13 pts. Followin~ the 
LeCompte Maneuver 5/13 pts had supravalve PA velocities 
from 2-3 meters per second and 3/13 had velocities ~3.0. 
Supravalve P A velocity in the 5 pts repaired without the 
LeCompte Maneuver was always ~ 1.6. Significant AI was 
demonstrated in 1 of 3 pts who had undergone previous 
pulmonary artery bandm~. No pt who had early primary repair 
$21 days of age had sigmficant AI. Thus, Doppler 
echocardiography demonstrates a 0% incidence of significant 
AI in pts who having undergone early primary repair and a high 
incidence of SPS of variable degree. Doppler assessment 
provides valuable data which direct these patients' need for 
postoperative catheterization. 
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CRITICAL AORTIC STENOSIS IN THE NEWBORN: EARLY 
RISK FACTORS AND LATER PROGNOSIS 
Kevin J. Tveter, M.D., Stanley Einzig, M.D., W. Steves Ring, 
M.D., F.A.C.C. and John E. Foker, M.D., University of 
Minnesota, Minneapolis, MN 
Management and operative results of critical aortic stenosis in 
newborns have recently changed. The purpose of this study is 
to review the 28 newborns ( < 14 days) who underwent aortic 
valvotomy (AV) for critical aortic stenosis from 1971-86 for 
determinants of survival and long-term prognosis. All were in 
severe cardiac failure. Since 1984, echocardiography has been 
used exclusively for preoperative evaluation. There were 17/28 
(61%) early survivors including five infants dying weeks-months 
later from chronic cardiac failure (3) or following hypoplastic 
left heart repair (2). Very young age by itself was not a risk 
factor as six survivors were 1-2 days old at AV. No difference 
was found between survivors and nonsurvivors in severity of 
cardiac failure, preoperative LV-aortic gradient or, more 
recently, LV function assessed by the echocardiographic 
shortening fraction which was 22% (7-40%) in survivors vs 19% 
(8-46%) in nonsurvivors. The main risk factors were the 
presence of a hypoplastic LV (HLV) or significant endocardial 
fibroelastosis (EFE). In the absence of HLV and EFE, 12/14 
(86%) survived. Survival was determined by LV morphology, 
rather than by severity of LV dysfunction. Long-term followup 
(mean 4.8 years) revealed the continUing severity of the prob-
lem when compared to children (> I yr old) at time of first 
AV. Five of 12 survivors have required a second AV or valve 
replacement (7 mos-2 yrs) and another four have mean 
gradients of >40 mmHg across the aortic valve. In summary, 
I) diagnosis of critical aortic stenosis is now exclusively by 
echocardiography, 2) despite severe LV dysfunction and very 
young age, survival is high in the absence of HLV and EFE, 3) 
but persistent valve deformity leads to a high reoperation rate. 
Tuesday, March 29, 1988 
8:30AM-I0:00AM, Room 364, Level Three 
Metabolic and Hormonal Effects on the Myocardium 
ROLE OF RIGHT AND LEFT ATRIA IN THE REGULATION 
OF ANF CONCENTRATION 
~lanfred Dahm. M.D., Srdjan Nikolic, M.S., 
Denise Reub lein, B.S., Edward L. Ye 11 in, Ph.D., 
John C. Burnett, M.D., and Robert W.M. Frater, 
M.D., F.A.C.C., Albert Einstein College of 
Medicine, Bronx, N.Y. 
We controlled RA preload with right heart 
bypass (extra-pericardial cannulae in IVC, SVC 
and PA) and mea sur e d RA P , LA Pan d A 0 Pin 4 
open-chest anesthetized (iaofluorane) dogs. ANF 
concentration [ j ( radioimmunoassay) in RA, 
P V, LA, A 0, S V Can d I V C was use d to de t e r min e 
secretion (S) of ANF in RA (SRA-[RV)-[VCJ) and 
LA (SLA-[Aol-[pv», and to determine clearance 
in the pulmonary (CPu-[RVj-[PVj) and systemic 
(CSy~[Aoj-[IVCj) circulations (assumption: 
[VC]-.75[IVC]+.25[SVCI>. The results for 20 
different hemOdynamic states were ana lyzed 
us in g lin ear reg res s ion. As RA Pin c rea sed: 
[RAJ (p (.01), SRA (p<. .01), [PV] (p< .001) and 
CPu (p <. .001) increased. CPu increased with 
[RA] (p .00l). However, SLA did not correlate 
wit h LA P. S LA inc rea sed wit h RA P (p < .0 S), [RA] 
(p<..OS) and [pvj (p<.OOl). [Ao] did not 
correlate with LAP but with RAP (p(.OS). CSy 
was increased with RAP (p <. .05) and [RA] (p 
<.05). We con c 1 u d e t hat RA pis the m a j 0 r 
determinant of ANF secretion in the RA and LA; 
and that clearance in the pulmonary and 
systemic circulations depends on [RA]. Since 
AN F sec ret ion in the LA is a p par e n t 1 y not 
related to LAP, we may hypothesize that it is 
influenced by some feedback mechanism sensitive 
to RA concentration of ANF. 
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ATRIAL NATRIURETIC PEPTIDE IN SURGICALLY-INDUCEO 
HYPERTENSIVE VENTRICLE OF RATS. 
Jiane Gu, M.D., Ph.D., Lorenlo Gonlalel-Lavin, M.D., F.A ••C. and Nlhal Kulatilake, M.B., F.R.C.S .. Deborah 
Research Institute, Browns Mills, New Jersey. 
The newly di scovered cardi ac hormone atri a 1 natri ureti c 
peptide (ANP) was thought to occur in the atria but 
not in the ventricles. The possible occurrence of ANP in 
surgically-induced hypertensive ventricle of rats was in-
vest i gated usi ng the method of immunocytochemi stry with 
antibodies to a-ANP. The descending aorta of the adult 
rats (n=6) were surgically semi-occluded at the portion 
between the diaphragm and the renal arteries during lapar-
otomy with a polyvinyl tube. After the occlusion the 
intra-aorta pressure proximal to the occlusion was in-
creased from an average of 70-90 mmHg to 120-140 mmHg. 
Ten days later the rats were ki lled and the hearts were 
di ssected for immunocytochemi stry. In addit i on to bei ng 
present in the atria, ANP immunoreactivity was found in 
more that 90% of the myocytes in the left ventricle, ex-
clusively in the cytoplasm and most densely around the 
region of the nuclei. The right ventricle and the intra-
ventricular septum also had ANP immunoreactivity but in a 
smaller quantity. Preabsorption of the anti-ANP with ANP 
(10 nm/ml) abolished the positive immunostaining thereby 
establishing the specificity of the immunoreaction. The 
sham-operated rats (n=6) showed ANP in the atria but not 
in the ventricles. The present finding suggests that the 
ventricular ANP may play an important role in hypertensive 
cardiac pathology and sodium and water regulation in con-
gestive heart diseases. 
BETA RECEPTORS AND MECHANICAL FUNCTION IN THE FAILING 
HEART OF THE SPONTANEOUSLY HYPERTENSIVE RAT. 
Floyd L. Atkins. M D F.A.C.C., Paul G. DiMauro, B.S., 
Kathleen G. Robinson, B.S.,M.T., Oscar H.L. Bing, M.D. 
Lemuel Shattuck Hospital and Boston VA Medical Center, 
Tufts University School of Medicine, Boston MA 
Cardiac hypertrophy and alterations in beta-adrenergic 
receptor function are important adaptations in chronic 
hypertension. Beta receptor characteristics were 
studied in 24 month spontaneously hypertensive rats 
(SHR) and control animals (WRY) by radioligand binding 
techniques using (_)12sI-cyanopindolol. Function was 
studied in isolated papillary muscles during isometric 
contraction at Lmax at 2SoC, stimulated at a rate of 
l2/min. Heart failure was found in 9 of the 15 SHR, 
with LV dilatation, left atrial thrombi, 
pleural/pericardial effusions, and right ventricular 
hypertrophy (SHR-F). Left ventricular hypertrophy was 
present in SHR and SHR-F as compared to WRY. Active 
tension was depressed only in SHR-F. Beta receptor 
number was significantly increased in SHR-F (137±22) 
when compared to SHR (s2±6) and WKY (63±7) fM/mg 
protein). In SHR-F inotropic responses to isoproterenol 
are absent despite an increase in beta receptor number. 
The temporal effects of isoproterenol as measured by 
time to peak tension and time to 50% relaxation are 
preserved. The inotropic response to calcium is also 
intact. Thus, in mechanically depressed papillary 
muscles from SHR-F, there is an apparent uncoupling of 
beta receptor stimulation and contractile performance. 
ABSTRACTS 
DIRECT BUT REVERSIBLE EFFECTS OF COCAINE ON THE 
MYOCARDIUM. 
N. Charle Morcos. M.D .• Ph.D., Alan S. Fairhurst Ph.D. 
Walter L. Henry, M.D., FACC, University of California, 
Irvine, CA. 
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Toxicity of cocaine in humans has been associated 
with ventricular arrhythmias and myocardial infarction, 
the latter presumably a result of intense vasospasm 
induced by cocaine. However, it is not clear whether 
cocaine has a direct effect on the myocardium independent 
of vasospasm. To evaluate this question, the effects of 
cocaine on the myocardium were studied in an isolated 
rabbit ventricular septum preparation. Septa were cannu-
lated and perfused by a constant delivery pump at 3.0 
ml/min with oxygenated Krebs solution at 95% 02, 5% C02, 
through the septal artery as in the natural circulation 
and electrically paced at 48 beats per minute. Rest ten-
sion (RT), developed tension (T), rate of tension devel-
opment (+dT), rate of tension relaxation (-dT) and beat-
ing frequency (R) were ~ontinuou31Y measured. Septa were 
perfused with 10-5, 10- and 10- M cocaine for 30 min. At 
these concentrations, excitation-contraction decoupling 
was seen in 25, 50 and 100% of paced beats, respectively. 
T, +dT and -dT were all depressed to a similar degree at 
eac~ concent~ation and averaged 0, 58, and 100% at 10-~, 
10- and 10- M, respectively. Flow rate was not reduced 
in presence of cocaine because of the constant delivery 
pump nor was (RT) altered. T, +dT, -dT, R and excita-
tion-contraction decoupling completely recovered after 
washout of all levels of cocaine. 
In conclusion, cocaine acutely has direct although 
reversible effects on the myocardium, including depres-
sion of function and uncoupling of excitation and con-
traction which are independent of its effect on coronary 
blood flow. 
DISSOCIATICN OF MYOCARDIAL FREE :mEmY OF ATP HYIR:>I;{SIS, 
Pi, AND INCllQNIC Rr6HJME IEVELS FHH MEXlIANICAL 
FUNCl'ICN AFl'ER ill VIVO REXiICNAL ISClIEK[A 
Roger Rehr. MD, FACC. James Tattnn, MD, Lewis Wetstein, MD, 
Jerry Hirsch, PharmD, am. Geoffrey Clarke, RlD; Medical 
College of Vil:ginia, Ric:.hn¥:lnd, Virginia 
We investigated the relationships between ischemic zone 
myocardial free energy of ATP hydrolysis (FEI:I), !;ii, an:l 
inorganic phosphate (Pi) levels (postulated causes of 
ischemic and post-ischemic myocardial mechanical 
dysfunction) am. myocardial systolic thickening in the lD 
vivo canine model of 1 hour coronary occlusion an:l 
reperfusion. A new gating method allowed automated, 
simultaneous acquisition of metabolic data using 31p NMR 
am. mechanical data using sonomicrometry fran the same (2 
gram) myocardial voltnne. Measurements were made in 4 
animals at baseline am. during occlusion am. 5 hours of 
reperfusion. Normal phosphocreatine levels after 
reperfusion am. post-mortem TTC staining documented 
viability of the selected voltnne. with occlusion !;iI an:l 
FEI:I fell significantly, pi rose significantly, am. 
systolic thickening (normalized to 100 at baseline) was 
replaced by thinning (all p<0.05 vs control). With 
reperfusion pH am. FEI:I normalized am. pi fell markedly, 
but systolic thinning persisted (p<0. 05 vs controlJ. pi 
correlated weakly with systolic thickening (r2=o.33; 
p=O.001); pH am. FEI:I did not correlate with systolic 
thickening. 'Ihese simultaneous in vivo measurements 
suggest that FEI:I, pi, am. !;iI are not inp:>rtant 
contributors in vivo to post-ischemic systolic mechanical 
myocardial dysfunction. 
Time 
Control 
Occlusion 
Reperfusion 
Thickening 
95+/-3 
-126+/-37* 
-124+/-9* 
FEH 110"(M) 
-59.1+/-0.5 
-55.0+/-0.6* 
-57.1+/-0.3 
*p<0.05 vs control 
pi 111M) pH 
5+/-1 7.15+/-0.03 
17+/-4* 6.74+/-0.11* 
8+/-1 7.23+/-0.02 
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THE DESCENDING LIMB OF THE FRANK·STARLING 
CURVE IS DUE TO ENERGY DEPLETION AND 
EXCESS CAz+ ENTRY 
Wolfgang Auffermann M.D. Tom Watters. M.D. Shao Wu. Ph.D .• 
William W. Parmley. M.D .• Charles B. Higgins. M.D .• Joan Wikman-
Coffelt, Ph.D., Univ. of Califomia, San Francisco 
To assess the effect of left ventricular overstretch on cardiac 
chemomechanics and hydrodynamics, we performed 31p-NMR. 
1H-NMR with shift reagent, 2D-echocardiography and atomic 
absorption spectrophotometry in isovolumic perfused rat hearts 
with glucose as the substrate. We assessed the effects of 
incremental balloon volumes on developed pressure (dp). end-
diastolic pressure (ep), oxygen consumption (MV02), coronary 
flow, phosphorylation potential (pp), intracellular pH [pH]i. 
intracellular calcium [Cali. extracellular water. diastolic wall 
thickness and wall stress. A three-phasic response of dp was 
noted: volumes from 0 to 100 Ill, resulted in an increase in dp; 
with 100 to 250 Ill, dp remained constant while ep and diastOliC 
wall stress increased steeply, and with 250 to 400 111. dp fell 
while ep and wall stress continued to rise. MV02 followed the 
same pattern as dp. In contrast, pp and diastolic wall thickness 
fell precipitously after 100 111 of fluid inflation. Coronary flow did 
not change significantly until 250 111 or more of water were 
added to the balloon. [pH]1 fell slightly with 250 111 and steeply 
with 400 111 balloon volume. [Cali rose continuously while 
extracellular water fell with balloon volumes of 250 111 or more. 
These findings suggest that with overstretch of the left ventricle 
there is a deterioration of ventricular function, as indicated by the 
steep increase in end-diastolic pressure and wall stress and a 
decrease in extracellular water. The mechanism of this dele-
terious change is apparently a depletion of high energy phos-
phates aSSOCiated with acidotic [pH]i and excess calcium entry. 
Tuesday, March 29, 1988 
10:30AM-12:00NOON, Room 364, Level Three 
Pathophysiologic Aspects of Heart Failure 
PROGRAMMED VENTRICULAR STIMULATION IN PATIENTS WITH 
DILATED CARDIOMYOPATHY: EFFECT OF HEMODYNAMIC INSTABILITY 
ON INDUCIBILITY OF VENTRICULAR ARRHYTHMIAS 
Daniel Kulick. M.D •• Anil Bhandari. M.D •• F.A.C.C •• 
Robert Hong, M.D., Ronald Petersen, M.D., Uri Elkayam, 
M.D., F.A.C.C., Shahbudin H. Rahimtoola, M.D •• F.A.C.C., 
LAC-USC Medical Center. Los Angeles. CA 
In pts with dilated cardiomyopathy (DCM), hemodynamic 
decompensation has been postulated to increase vulner-
ability to reentrant arrhythmias. To determine this, we 
performed programmed ventricular stimulation (PVS) in 8 
pts with DCM first in hemodynamically (hem) decompensated 
and then compensated state. The protocol for PVS inclu-
ded up to 3 extrastimuli delivered at twice diastolic 
threshold at 2 RV sites. Acute hem improvement was 
achieved by infusion of sodium nitroprusside (NTP) (mean 
dose-l.9tl.3 mcg/kg/min). 
During PVS in hem decompensated state. PVS induced 
sustained (sus) ventricular tachycardia (VT) in 1 pt and 
nonsus VT in 2 pts; S had induction of <4 ventricular 
beats. After NTP, there was a significant decrease in 
pulmonary artery wedge (32t8 to l8±7mmHg). right atrial 
(18±6 to 12±4mmHg) and mean arterial pressure (93±lO to 
79±1OmmHg) • PVS in the acutely hem compensated state 
induced sus VT in the same pt and nonsus VT in 2 dif-
ferent pts. No significant change occurred in the sinus 
cycle length (622t96 vs 606t83ms), RV pacing thresholds 
(O.S±O.l vs O.StO.1Sma) or RV effective refractory period 
(247±19 vs 2S0±14ms). However, acute hem improvement 
caused QTc lengthening from 460t4l to S12t27ms (p<O.04). 
During a mean follow-up of 8 months, 3 pts died suddenly 
and 2 had nonsudden cardiac death. In conclUSion, in pts 
with DCM, acute hemodynamic change did not alter induci-
bility of ventricular arrhythmias. This finding does not 
substantiate hemodynamic decompensation as predisposing 
to reentrant arrhythmia. 
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ARE PATIENTS WITH MILD I-£ART FAILURE AT RISK OF 
MALIGNANT VENTRICULAR ARRHYTHMIAS AND SUDDEN 
DEATH? Prakash Deedwania MD, F ACC; Robert Cody MO, 
FACC; Alan Gradman Mo, FACe; Barry Massie MD, FACC; 
Milton Packer MD, FACC; Bertram Pitt MD, FACC; Sidney 
Goldstein MD, FACC; for the Captopril-Digoxin Research Study 
Group, Univ. of California, VA Medical Center, Fresno, CA. 
Pts with severe heart failure (CHF) have frequent ventricular 
arrhythmias, but it is unknown whether these are seen early in 
the disease, are related to digitalis or ischemia, or presage the 
occurrence of sudden death. We performed 24-hr Holter moni-
toring in 295 pts with mild CHF, who were treated with diuretics 
but not digitalis or vasodilators. Twenty-four of the 295 pts died 
suddenly during long-term follow-4> (6-24 months). 
Ventricular ectopic beats (YEB) & ventricular tachycardia (VT) 
were frequent in these pts, particularly those with nonischemic 
dilated cardiomyopathy (NIOC), and correlated directly with age 
(p<.OOI) and furosemide dose (p<.05) and inversely with LV 
ejection fraction (EF, p<.O\) and exercise time (p<.0S). Only 
age, EF and NIDC provided independent correlative information. 
The n of VEB/hr and % pts with VT (in parentheses) are shown: 
Ischemic Nonischemic 
age <58 age~58 age <58 age).58 
EF 525 II. 7 21.1 12.9 55.7 
(34%) (43%) (41 %) (50%) 
EF >25 3.9 15.0 7.8 50.9 
(7%) (33%) (29%) (56%) 
Despite the relation to diuretic dose, VEB and VT were not 
related to serum Na, K or Mg. During follow-lop, only VT and 
NIDC (but not EF) predicted sudden death. Fifteen of 112 pts 
(\3%) with NIDC died suddenly compared with only 9 of 183 pts 
(5%) with coronary disease (p<.02). Similarly, 14/106 pts with VT 
but only 10/189 pts without VT hod sudden deaths (p <.05). 
In conclusion, C1-F pts have frequent and complex ventricular 
arrhythmias and are predisposed to sudden death, even in the 
absence of digitalis, severe symptoms or ischemic heart disease. 
MAXIMAL CONDUCTANCE VERSUS MAXIMAL OXYGEN UPTAKE IN 
PATIENTS WITH CONGESTIVE HEART FAILURE. 
Clyde W. Yancy, Jr •• M.D •• Susanne Vissing. M.D •• Jay C. 
Buckey. M.D .. Joseph F. Bellomo. M.D .. Brian G. Firth. 
M.D •• F.A.C.C •• C. Gunnar Blomqvist. M.D •• F.A.C.C. 
University of Texas Health Science Center. Dallas TX. 
To characterize determinants of exercise capacity in 
patients with congestive heart failure (CHF). we measured 
maximal leg conductance (Gmax). and maximal oxygen uptake 
(MV02) in 10 pts with depressed LV function. (LVEF 0.28 + 0.08 [mean:!",S.D.]). Using venous occlusion plethysmogra= 
phy. leg conductance (ml/min/100ml/nunHg) and hyperemic 
blood flow were determined after ischemic exercise (time= 
130 .:!: 36 sec) with ar-terial occlusion (Gmax = 0.33 + 
0.12). Maximal bicycle ergometryrevealed the patients to 
have impaired exercise capaCity (MVO = 15+5 ml/min/kg). 
Using linear regreSSion analysis. Gm~x waS-Significantly 
reI ated to MVO (r=O.63: p=0.05). Neither LVEF nor rest 
CO ~/as related ~o MV02• Previous studies in our lab with high fit individuals have shown a correlation of Gmax 
with MV0 2 (r=0.81: n=l1: MVO 67 ml/min/kg). but seden-tary subJects did not show th~s relationship (r=0.3: ~IV02 
= 26+3.5: n=10). For a given increase in Gmax. CHf 
patients have a smaller increase in MVO, when compared 
with high fit subjects (MVO = 7.2 Gmax .. 24 vs MVO = 
50.1 Gmax + 24. p<O.OOl). T~us. our data suggest t~t: 
(1) increases in maximal conductance may significantly 
facil itate maximal oxygen uptake both in patients with 
impaired LV function and in trained individuals. but may 
not be as important in sedentary subjects: and (2) 
peripheral adaptations regulating skeletal muscle blood 
flow may be important determinants of maximal oxygen 
uptake in patients with congestive heart failure. 
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IS THE REDUCED MAXIMAL EXERCISE CAPACITY OF PATIENTS WITH 
LEFT VENTRICULAR DYSFUNCTION DUE TO INTRAMUSCULAR LACTIC 
ACIDOSIS? 
John R. Wilson. H D , Donna H. Mancini, H.D., Nancy 
Ferraro, R.N., Joseph Egler, B.S., University of 
Pennsylvania, Philadelphia, PA 
The maximal exercise capacity of patients with left ven-
tricular dysfunction is frequently reduced. This exer-
cise intolerance has been attributed to the early onset 
of intramuscular lactic acidosis. To test this hypothe-
sis, we examined the effect of dichloroacetate (D), a 
drug which decreases lactate formation by stimulating 
pyruvate dehydrogenase, on the maximal treadmill exercise 
performance of lS patients with reduced ejection frac-
tions (2S±9%). Exercise was performed following IV dex-
trose (Control-C) and following dichloroacetate. The 2 
tests were performed 1 week apart and the sequence of in-
terventions randomized in a double blind manner. 
Dichloroacetate decreased blood lactate at rest (C: 
S.O±2.S vs D: S.6±2.9 mg/dl) , throughout exercise, and 
at peak exercise (C: 26.0±14.3 vs D: 19.4±lO.S (all 
p<.OS). In contrast, dichloroacetate had no effect on 
exercise time (C: lS.2±6.0 vs D: lS.9±6.2 mins) or peak 
exercise V02 (C: l2S0±498 vs D: l3l2±S30 ml/min) 
(both p-NS). In S subjects, D also had no effect on peak 
exercise leg blood flow (C: 2.3±O.3 vs D: 2.9±p.3 
L/min) or peak exercise arteriovenous 02difference (C: 
l6.6±1.6 vs D: l7.l±2.4 ml/dl) (both p-NS). Thus, re-
ducing lactate formation with dichloroacetate had no ef-
fect on maximal exercise capacity. This finding suggests 
that the limited exercise performance of patients with 
left ventricular dysfunction may not be due to intramus-
cular lactic acidosis. 
CAN ACE-INHIBITORS REPLACE DIURETICS AS SOLE THERAPY FOR 
MILD HEART FAILURE? 
G.C. Sutton, MD,FACC, A. Richardson, MRCP, A.Scriven,MRCP, 
J. Parameshwar, MRCP, J. Bayliss, MRCP, and P.A. poole-
Wilson, MD, FRCP, Hillingdon Hospital, Uxbridge,Middlesex. 
Chronic mild heart failure is usually treated with 
diuretics which may have adverse long-term effects from 
inappropriate stimulation of the renin-angiotensin-
aldosterone system. Angiotensin-converting enzyme (ACE) 
inhibition results in more appropriate long-term neuro-
endocrine balance, but is it adequate treatment alone even 
in mild heart failure? Fourteen patients with mild heart 
failure who had been stable for three months On mainten-
ance Frusemide 40mg and Arniloride Smg (UFrumil U) daily 
were studied by randomised double-blind crossover design. 
One two-month period consisted cfCaptopril 2Smg tds and 
the other Frurnil one daily. Clinical status, exercise 
tolerance and neuroendocrine data were assessed. 
During Captopril treatment four patients were withdrawn 
with increasing dysponea and two of these had pulmonary 
oedema. No withdrawals occurred during Frumil treatment 
(p<o.OS). Six of the fourteen patients had pulmonary or 
peripheral oedema within the previous two years; all 
four withdrawals were from this group, while none were 
from patients without previous pulmonary oedema (P(O.02). 
Treadmill exercise time was unaltered by either treatment. 
There were no differences in weight, blood pressure, heart 
rate or plasma and urinary electrolytes. During Captopril 
therapy, resting noradrenaline fell (727~556pg/ml (n.s.», 
plasma renin activity rose (28l3~466pg/ml/hr, p(O.OS) and 
aldosterone fell (400~143 pmol.litre, p(O.Ol). No 
significant changes occurred during Frumil treatment. 
ACE inhibitors alone were inadequate to maintain control 
of mild heart failure in those who had previously had 
pulmonary or peripheral oedema. 
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DOES CONVERTING-ENZYME INHIBITION IMPROVE LIVER 
FUNCTION ABNORMALITIES IN PATIENTS WITH HEART 
FAILURE? David I. Freilich M% Stephen S. Gottlieb MD, Paul 
D. Kessler MD, Wai Hung Lee M ,Marrick L. Kukin MD, Milton 
Packer MD, FACC. Mt. Sinai School of Medicine, New York, NY 
Converting-enzyme inhibitors (CEI) exert no notable short-
term effects on hepatic blood flow, but the long-term effects of 
CEI on liver function are unknown. We measured liver function 
tests (LFTs) before & after 1-3 months of captopril or enalapril 
in 41 CHF pts, who had at least one abnormal LFT at the start of 
therapy. Cardiac index (CI, I/min/m2), mean arterial, LV filling 
& mean right atrial pressures (MAP, LVFP & RA, mm Hg), heart 
rate (HR, bpm) and systemic vascular resistance (SVR, d-s-c) 
were measured simultaneously with LFT determinations. 
In these 41 pts, CEI produced a '" in serum bilirubin (1.5 to 1.1 
mg/dl), aspartate aminotransferase (86 to 29 mU/ml) and alanine 
aminotransferase (lIS to 27 mU/ml), all p<.OI, without a change 
in alkaline phosphatase. Pts were then grouped based on whether 
LFTs improved (Group I) or were uncha~d (Group II~ * -V<.05 
cl MAp LV RA H S R 
Group I Pre-CEI 1.6 83 28 13 88 2068 
(n-25) Post-CEI 1.9* 66* 16* 7* 80* 1493* 
Group II Pre-CEI 1.5 85 27 15 83 2284 
(n-16) Post-CEI 1.7* 74* 24 13 79 1828* 
Although cl t similarly in both groups, LVA> and RA '" only in 
pts whose LFTs improved. LFTs improved despite a greater'" in 
MAP (hepatic perfusion pressure) in Group I > Group II (p<.OS). 
Of all variables, the improvement in LFTs was most closely 
related to the'" in RA and not to the t in CI seen during CEI. RA 
'" > 5 mm Hg in 18 of 25 pts in Group I but in only 3 of 16 pts in 
Group II (p<.OO5). In contrast, a similar % of both groups (8 of 25 
ph in Group I and 5 of 16 ph in Group II) showed an t in CI ~ 25%. 
In conclusion, long-term CEI therapy improves abnormal LFTs 
in CHF we to its ability to '" RA rather than t CI. These data 
suggest that abnormal LFTs in CHF are primarily the result of 
hepatic congestion rather than reduced hepatic perfusion. 
Tuesday, March 29, 1988 
8:30AM-I0:00AM, Room 216, Level Two 
EcholDoppler: New Diagnostic Observations 
ECHOCARDIOGRAPHIC FINDINGS IN PATIENTS WITH TUBEROUS 
SCLEROSIS. William K. Freeman, M.D., Thomas M. Zellers, 
M.D., Catherlne L. Taylor, James B. Seward, M.D., 
F.A.C.C., Manuel R. Gomez, Pd.N. Mayo Clinic and 
Foundation, Rochester, MN. 
Previous reports have demonstrated the efficacy of two-
dimensional echocardiography (2-DE) in diagnosis of 
cardiac rhabdomyoma (CR) in small numbers of patients 
(Pts) with tuberous sclerosis (TS). We report the find-
ings of the largest yet described series of Pts with TS 
undergoing 2-DE with Doppler examination. Between Oct. 
1980 to Apr. 1987, 54 Pts with the clinical diagnosis of 
TS were referred to the Mayo Clinic Echocardiography 
Laboratory. The mean age was 6.6 yrs, range 0.5 to 33 
yrs; 50% were male. Definite diagnosis of CR was made 
in 19(35%) Pts, 5(9%) had suggestive but nondiagnostic 
evidence of CR, and 30(56%) had no evidence of CR. 
Multiple CR were present in 14/19 (74%); CR size ranged 
from 3 to 30 mm. Isolated RV involvement was present in 
37%, isolated LV involvement in 26%, 37% had both RV and 
LV CR. Isolated free wall CR and atrial CR were not 
observed. The ventricular septum (58%) and ventricular 
apices (53%) were most frequently involved with CR. 
Seven Pts (37%) had subendocardial CR. 'One Pt with 
multiple CR had two within the main pulmonary artery. 
Only 1/19 Pt (5%) had evidence of intracardiac obstruc-
tion by CR. In this case, a CR originating from the 
basal ventricular septum obstructed the LV outflow tract. 
Systolic LV function was intact in all Pts (mean LVEF 
0.67+0.04). No Pt had significant valvular dysfunction. 
ConcTusions: 1) CR are commonly (35%) detected by 2-DE 
in Pts with TS, 2) multiple CR predominate, primarily 
involving the ventricular septum and apices, and 3) 
obstructive CR is uncommon. 
74A ABSTRACTS 
COLOR FLOW AND SPECTRAL DOPPLKR EVALUATION OF 
MIDVRNTRICUIAR OBSTRUCTION, HYPERTROPHIC OBSTRUCTIVE 
CARDIOKYOPATHY AND CAVITY OBLITERATION. 
l!e.Xl'!!!.'!!: -,~a~ft,.-'!.:'!?·, Wayne Parry, Morris N. Kotler, H.D., 
F.A.C.C., Albert Einstein Hedical Center, Philadelphia. 
Pulsed wave (PW), continuous wave (OW), color flow 
Doppler (CD) and imaging echocardiography (IE) were 
performed In 9 patients (pts) with midventricular 
obstruction (KYO), 12 pts with hypertrophic obstructive 
cardiomyopathy (HOCH) and 9 pts with left ventricular 
cavity obliteratlon (LVCO). CD localIzed the level of 
obstruction and guided OW and PW for quantification of 
gradients. All 3 groups had similar late-peaking~peak 
systolic gradients, but mean gradients (~) in HOCH were 
larger than KYO or'LVCO. All KYO pta had early diastolic 
gradients (range .25-17 mmHg) seen as an increase in the 
velocity (V) of mitral valve'S' wave (~E) from base to 
apex, whereas HOCH and LVCO had a normal decrease in the 
velocity of E Crom base to apex. By CD and IE, KY inflow 
started 2-3 frames before relaxation of the obstructed 
mid LV in KYO. 
KYO LVCO HOCH 
~p mmHg 31±20.3 .3t~0.0 56±30.3 
~E cm/s .36!32.2 -ll± 7.3 -11~11.6 
*HOCH> , KYO & LVCO ** KYO >LVCO & KOCH 
P 
< 0.05* 
< 0.001** 
In addition, the 7 KYO ph with apical dyskinesia had 
distinct second outflow gradients during isovolumic 
relaxation (peak V ~ 86 ! 35 cm/s) on OW which is thought 
to be due to end-systolic recoll of the dyskinetic 
segment producing Clow through the obstructed mid LV. 
·this was not seen in KOCH or LVCO. Conclusions: 1) Pts 
with KYO, HOCH & LVCO all have late peaking (ski-slope) 
systolic flow patterns. 2) All KYO pts have early 
diastolic gradients between inflow and apical portions of 
LV whereas KOCH & LVCO pts do not. 3) In KYO pts with 
apical dyskinesia a secondary outflow gradient is present. 
ANTERIOR PAPILLARY MUSCLE DISPLACEMENT CAUSES SYSTOLIC 
ANTERIOR MOTION OF THE MITRAL VALVE IN THE ABSENCE OF 
SEPTAL HYPERTROPHY 
Robert A. Levine, MD, FACC, Gus Vlahakes, MD, Arthur E. 
lIeyman,1ib, FACC. MaSs. General Hospital, Boston, MA. 
Systolic anterior motion (SAM) of the mitral valve (MV) in 
hypertrophic cardiomyopathy (HCM) has generally been 
explained by a Venturi effect related to septal 
hypertrophy. Pts with HCM, however, also have PHiary 
abnormalities of the mitral apparatus: anterior pap ary 
muscle displacement (ANT PM DIS) and altered MV geometry. 
These findings have led to the h~pothesis that PM DIf' ~ 
alterin~ the forces actihn
i
g on t e MV, can be a ~
cause 0 SAM. TOtest t s hypotnesis, We created ANT PM 
DIStnl Togs with controlled heart rate and CO. The MV 
was studied by 20 echo. RESULTS: 1) In all 7 dogs, PM 
DIS caused SAM, with an LV-AO gradient (33+19 mm Hg) and 
MV regurgi tation in six. SAM increased following 
extrasystoles. 2) MV geometry was altered as seen in HCM: 
the MV was displaceo anteriorly and the leaflets coapted 
closer to the base of the ANT leaflet, creating a longer 
residual leaflet (RL) which participates in SAM (11+2 vs 
baseline 4+1 mm, p<.OOI). 3) Outflow area at the onset of 
SAM was reduced by only 31+8%. CONCLUSIONS: ANT PM DIS 
alone, in the absence oC septal hypertrophy or markea 
outIIow tract narrowing, causes obstructive SAM and alters 
MV geometry as seen in H~is suggests that PM DIS, by 
interposing the MV into the outflow, decreasing effective 
posterior restraint and increasing RL length, can play a 
primary role in the onset of SAM. 
Production of SAM by PM Tip Displacement (AlaB) 
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CORRELATIiJI OF DISTANCE FROI1 SUBAORTiC IfEHtiAANE TO AORTIC VAlVE 
AND THE DEVELOPIIENT OF AORTIC REIltJlGITATION IN MILD DISCRETE 
5UBAORTIC STENOSIS. 
Michael I'Iotro. M.O .. F.A.C.C., Adaa 5chneeweiss, M.D., 
Avraa SIII",-Tov, ".D .. and Julius Hegesh, M.D. Sheba helhcal Center, 
rei Ha.homer. Israel. 
IIore than SOl of pahents with .lld discrete subaortic sienosls 
develop complications. in parhcular, aorhe rE9urgl tahon. To 
date no sahsfactory ... thad has been founa with IOillch to predict 
those patients Mho will develop such cOAllJlications and thus 
benefit IrDOl early surgery. Toenty-three patients with IUd discrete 
subaorlic stenosis of the IIIEtIOranous type (pressure gradient less than 
4010iit9 peaU llere exaained. Patients llere divided into those wi th 
aorlic regurgitation (9 patients) and those without (14 patients), 
and the distance froa the aortic valve to the subaortic III!Ibrane 
cOAllJared between the two groups. The distance was llleisured uSing 
two-dillellsional echocardiography, the pressure gradient and the 
presence of aortic regurgl tation llere evaluated by echo-Doppler; 
the latter .. s conhrtled in 13 patients by cardiac catheterization. 
In pahents without aortic rE9urgitation, the Ean distance betoeen 
the oeobrane and the aortic valve was 5.5>4. OM, MhereilS 
In the group with regurgitation, this distance lEasured 
11.1t5.5III(p,Q.Oll. This suggests that pahents 
with oe.obranes reIOte froo the aortic valve are at greater risk of 
developing aorhc regurgitation due to the jet striking the iOrlic 
valve. In those in MhOi the III!Ibrane is located closer, the jet 
light be directed through the orifice of the aortic valve, without 
daaaging the cusps. Eight of the nine patients With Iild subaortic 
stenosIs Mho devloped aortic insufficiency had a distance of 11.-
or lOre. It is therefore rECOMended that patients with a disti/ICe 
of 11 .. or IIOre froll the IlEtlbrane to the aortic valve be foII~ 
carefully With an eye towards perfor.ing early surgery. 
AORTIC ROOT DILATATION IN THE MARFAN SYNDROME: PATTERNS, 
FAHILIALITY AND SHORT-TERM CLINICAL COURSE. Mary J. Roman 
M.D., Richard B. Devereux, M.D., F.A.C.C., Randi Kramer-
Fox, M.S., Mariane Spitzer. Cornell University Medical 
College, New York, N.Y. 
Fifty-one adult patients (pts) with the Marfan syndrome 
were studied to determine the prevalence, echocardlograph-
ic (echo) patterns, and phenotypic features associated 
with aortic root dilatatIon. Aortic root dimensions were 
measured by 2-D echo in normal adults to define criteria 
for aortic root dilatation (above the 98th percentile). 
65% (33/51) of Marfan pts demonstrated root dilatation; 
they were less likely to have ectopia lentis (55% vs 89%, 
p LO.05) than without aortic dilatation pts and tended to 
be disproportionately male (58% vs 33%, p·O. 1). Age, 
anthropometric measurements and skeletal findings were 
similar in pts with and without aortic dilatation. Two-
dimensional echo aortic measurements at 4 levels revealed 
two patterns of aortic root dilatation: dilatation local-
ized to the sinuses of Valsalva (n=15 or 29% of pts) and 
aortic root dilatation extending to the supra-aortic ridge 
and/or proximal ascending aorta (n=18 or 35% of pts). Pts 
with generalized aortic root dilatation were more likely 
to have aortic root> 5.0cm (44% vs 0%, P'" 0.02), aortic 
regurgitation (72% vs 13%, p ~0.002) and to undergo surg-
ery 09% vs 0%, P'" 0.03). In six fami lies the pattern of 
aortic root dilatation was consistent In all affected 
members. Patients with the 2 patterns of aortic dilatat-
ion could not be distinguished on the basis of extracard-
iac features. In conclusion: 1) separate patterns of 
aortic root dilatation exist in Marfan pts; 2) generalized 
aortic root dilatation has a worse short-term prognosis 
than localized dilatation; and 3) these patterns of aortic 
dilatation appear to be familial possibly representing 
genetically distinct subtypes of the Marfan syndrome. 
JACC Vol. 11, N.o. 2 
February 1988:75A 
CARDIAC TAMPONADE: PULSED WAVE DOPPLER FINDINGS 
Darryl J. Burstow, M.D., Jae K. Oh, M.D., James B. Seward, 
M.D., F.A.C.C., and A. Jamil Tajik, M.D., F.A.C.C., Mayo 
Clinic, Rochester, MN. 
To determine the characteristic diastolic filling abnor-
malities in cardiac tamponade (TP), mitral, tricuspid, and 
hepatic venous flow velocities were recorded by pulsed 
Doppler echocardiography together with respiration in 17 
Pt (mean age 54 yr) with pericardial effusion (PE). Ten 
Pt had clinical and/or hemodynamic evidence of TP (group 
I) and 7 Pt had PE without TP (group II). Six group I Pt 
underwent repeat Doppler echocardiography within 72 hr of 
pericardiocentesis. Mitral and tricuspid E-wave 
velocities (Em and Et), left heart isovolumic relaxation 
time (IVRT), and percent reversed flow (RF) to forward 
flow (FF) in the hepatic veins were measured at the onset 
of inspiration (i) and expiration (e). Mitral 
deceleration time (DT) was also calculated. 
Normal 
Group I 
Group II 
Post-tap 
IVRT, ms Em, cm/s DT, ms Et, cm/s 
i e i e i e 
74 72 82 85 199 64 56 
106* 73 38 t 60 189 48 29* 
87 86 72 71 189 62 56 
84 76 61 73 170 61 46 
%RF/FF 
y--;-
14 21 
18 254* 
19 36 
16 73 
*p < .05, tp < .01 (for group I vs normal and group II). 
Group I Pt demonstrated significant respiratory variation 
in IVRT, Em, Et, and %RF/FF compared with normals and 
group II Pt. The change in IVRT and Em was consistent 
with respiratory variation in left heart filling. The 
reduction in Et and increase in %RF/FF with expiration 
indicated restriction of right heart filling and coincided 
with increased left heart filling. Conclusion: mitral, 
tricuspid, and hepatic venous flow velocities recorded by 
Doppler echocardiography show distinctive respiratory 
changes in Pt with TP. 
Tuesday, March 29, 1988 
10:30AM-12:00NOON, Room 216, Level Two 
Contrast Echocardiography 
THE BBBAVIOR OP SONICATED ALBUMIN MICROBUBBLES IN THE 
MICROCIRCULAnON: A BASIS FOR THEIR USE AS MYOCARDIAL 
ECHO CONTRAST AGENTS. M. V. Keller, M. D., S. S. Segal, 
Ph.D., S. Kaul, M. D., P.A.C.C., B. R. Duling, Ph.D., 
University of Virginia, Charlottesville, Virginia. 
Myocardial contrast echocardiography (MCE), which in-
volves the intracoronary injection of microbubbles of 
air, has the potential for measuring regional myocardial 
blood flow in-vivo. The purpose of this study was to de-
termine whether the intravascular behavior of these mi-
crobubbles form the basis of their use as myocardial 
echo contrast agents. Accordingly, we injected fluore-
scein albumin microbubbles (AM) and red blood cells 
(RBCs) into the cheek pouch of 8 golden hamsters. The 
intravascular distribution, velocities, transit times, 
and branch point fluxes of both AM and RBCs were studied 
under intravital fluorescent microscopy using a magnifi-
cation of 770x. AM (mean size = 5~) and RBCs exhibited 
similar intravascular distributions (65% in the central 
50% of the arterioles; the rest at the edges) and velo-
cities with a good correlation between the ratios of 
central versus edge velocities for both (r = 0.93, p = 
0.001). The velocity profiles were also similar and re-
sembled a flattened parabola best described ~y the fol-
lowing function: V(r) = Vmax(a-abs(ar/R = b) where V(r) 
is velocity at radial position r, Vmax is maximal velo-
city at center of vessel, R is the radius of the vessel, 
and a and b are scaling factors. Arteriolar to venular 
transit times of AM were similar to those of RBCs in 
vessels ranging in size from 22~ to 45~ an~ufere best 
described by a gamma-variate function: Cte where« is 
a measure of curve width, and t is time. Branch point 
fluxes of both were also similar, showing a good corre-
lation between the AM and RBC fluxes (r = 0.92, p = 
0.001). 
Ve conclude that the behavior of AM in the microcir-
culation may serve as a foundation for their use as in-
travascular tracers of RBC flow during MCE. 
ABSTRACTS 
CONTRAST ECHOCARDIOGRAPHY: ASSESSMENT OF ENDOCARDIAL 
TO EPICARDIAL BLOOD FLOW RELATION DURING DIPYRIDAMOLE 
INDUCED HYPEREMIA IN EXPERIMENTAL CORONARY STENOSIS. 
Jorge Cheirif, M.D., William A. Zoghbi, M.D., F.A.C.C., 
Roberto Bolli, M.D., Padraig G. O'Neill, M.D., William 
L. Winters, Jr., M.D., Miguel A. Quinones, M.D., F.A. 
C.C., Baylor College of Medicine, Houston,"Texas. 
Conventional techniques are presently unable to assess 
regional endocardial (endo) to epicardial (epi) blood 
flow relation in vivo. Accordingly, myocardial contrast 
echocardiography (MCE) was utilized for this purpose 
in 9 open chest dogs subjected to a critical coronary 
stenosis that did not alter resting coronary flow. MCE 
followed injections of sonicated meglumine (6 ml) into 
the aortic root. Hyperemia was induced with intra-
venous dipyridamole, 0.5 mg/Kg. Time intensity curves 
corrected for background intenSity were derived from 
sequential end-diastolic frames (short axis view) for 6 
equidistant transmural segments and their endo and epi 
halves. The area under each curve was used as an index 
of perfUSion. In the control region, dipyridamole 
induced a significant increase in flow from baseline in 
the transmural, en do and epi regions by MCE and micro-
spheres (all p<.05). In the area of critical stenosis, 
no significant change in flow was seen by either tech-
nique. In the control area, the endo/epi ratio at 
baseline was 1.31 ± .75 by MCE and 1.20 ± .17 by micro-
spheres and did not significantly change after dipyri-
damole (1.29±92 and 1.04±.14, respectively). In con-
trast, in the area of critical stenosis, endo/epi ratio 
decreased after dipyridamole from 1.6±1.2 to .B9±.BB by 
MCE and from 1.02±.11 to .BO±.16 by microspheres (both 
p<.01). Thus, MCE provides accurate assessment of 
changes in regional epi/endo flow relations in the in-
tact heart and may have potential clinical applications. 
75A 
DEMONSTRATION OF CORONARY FLOW RESERVE WITH CONTRAST ECHO-
CARDIOGRAPHY. 
Byron F. Vandenberg, M.D., F.A.C.C., Robert Kieso, M.S., 
Karen Fox-Eastham, William Chilian, Ph.D., Richard E. 
Kerber, M.D., F.A.C.C., Univ. of Iowa, Iowa City, IA 
Coronary arteries with no or insignificant obstructive 
lesions have a normal coronary flow reserve (CPR) (i.e., 
the capacity to increase flow by at least 3.5 fold in 
response to a vasodilator stimulus). Our purpose was to 
determine whether contrast echocardiography could demon-
strate the presence of normal CFR. 2D echo was performed 
in 7 dogs during supra-aortic injection of hand-agitated 
Renografin. The injections were repeated after regional 
myocardial blood flow (BF) was either decreased (arterial 
stenosis) or increased (hyperemia induced by intracoronary 
adenosine) or not altered. Regional changes in peak gray 
level (0-255 units) were measured both with and without 
background subtraction. BF was measured with radiolabeled 
microspheres. The % change in BF (n-39) from control cor-
related (curvilinear fit) with change in peak gray level 
(r-.73*) (*p<.OOl) and change in subtracted peak gray lev-
el (r-.75*). Gray level changes distinguished regions 
with normal CFR from regions with <3.5 fold increase in 
BF: (mean±SD) Increase in BF Increase in BF 
by <3.5 fold by > 3.5 fold 
% change in blood flow 
Change in peak gray level 
Change in subtracted peak 
gray level 
(n-18) (n-9) 
30±28 660±364* 
2±20 42±18* 
-1±18 36±19* 
Conclusions: 1) Changes in peak gray level intensity cor-
relate with percent change in blood flow, and 2) contrast 
echo is able to demonstrate normal CFR. This may be 
clinically useful in the evaluation of arterial lesions of 
uncertain severity since functionally significant lesions 
produce impaired CFR. 
76A ABSTRACTS 
SUCCESS OF INTERNAL IlAllMARY BYPASS GRAFTING CAN BE 
ASSESSED INTRAOPERATIVELY USING MYOCARDIAL CONTRAST 
ECBOCARDIOGRAPBY. W. D. Spotnitz, H. D., F.A.C.C., H. W. 
Keller, H. D., S. P. Nolan, H. D., F.A.C.C., S. Kaul, H. 
D., F.A.C.C., University of Virginia, Charlottesville, 
Virginia. 
There is no standard method of assessing success of 
bypass grafting within the operating room. We hypothe-
sized that myocardial contrast echocardiography, which 
involves the intraaortic injection of microbubbles of 
air, may be suitable for assessing success of bypass 
grafting intra-operatively. Accordingly, we injected 
sonicated renografin-76 into the aortic root of 11 dogs 
during cardioplegia delivery. Aortic cross clamp was 
placed distal to the internal mammary artery (IHA). Stu-
dies were performed with left anterior descending artery 
(LAD) patent, totally occluded, and after IHA-LAD graf-
ting. Cardioplegia flow rate was constant for all 3 sta-
ges. Hyocardial contrast echocardiography clearly demon-
strated homogenous myocardial perfusion with the LAD 
patent, lack of perfusion 
in thde LAD bedd wi th the LAD § }§Jr......... ..ft occlu ed, an excellent per- _. ~ 
fusion after IHA-LAD bypass. ,{ .~.-...... __ 
A gamma v~riate f~nction ~i .!, ~ 
(y = Ce- m - Ce- ) was fitted 
to computer derived time-intensity • 
curves where ex denotes contrast 0 III 10 UI ao 
washout and a denotes contrast Tloe "'_ 
appearance. ~was similar during patent LAD and' after 
IHA-LAD bypass (0.11 ± 0.10 vs 0.10 ± 0.10) while a ap-
peared somewhat slower after IHA-LAD bypass (2.5 ± 2.4 
vs 1.1 ± 0.56, NS). 
Conclusions: 1) Hyocardial contrast echocardiography 
can be used intraoperativelv to assess the success of 
IHA bypass grafting; and, 2) This technique, therefore. 
has the potential for assessing success of bypass grafts 
within the operating room. 
DETECTION OF REGIONAL MYOCARDIAL UNDERPERFUSION BY 
CONTRAST-ECHO FUNCTIONAL IMAGING 
Dt.nieie RoyaL M.D. Massimo Lombardi, M.D., hio Maria Ferdeghini, 
Ph.D., Mario Marzilli. M.D., Alessandro Distante, M.D., Luigi Taddei. B.S .. 
LUigi Landini, Ph.D., Antonio Benassi, Ph.D., Antonio L'Abbate, M.D., 
F.A.C.C. C.NR. Clinical Physiology Institute, University of Pisa. 
Pisa, Italy 
In Jlrevious studies a functional imaging of myocardial Jlerfusion by 
contrast echo YIS developed yhich displays, on a Jlixel by Jlilel blSis, 
the time betyeen contrast injection into the aortic root and 
myocardial contrast appearance. PurJlose of this study YIS to evaluate 
the ability of this method in detecting reductions in coronary blood 
floy (CBFl due to coronary stenosis. In six anesthetized oJIBn chest 
dogs an electro-magnetic floy meter and a snare occfuder vere 
imJllanted on the circumflex coronary artery. TYo-D echo in the short 
alis viey YIS recorded from the oJIBn side of the chest. The 
JIOlysaccharide agent SHU--4~ (10 mil YIS bolus injected into the 
aorta either at baseline and during different degrees of coronary 
stenosis. Sequences of at least 20 end-diastolic echo frames yere 
diaitized and analyzed by a computer algorithm vhich measured the 
time to Jleat increment in videodensity (TIP) due to myocardial 
contrast aJlJl8&l'1Lllce. TIP of the antero-seJltal and Jlostero-lateral 
(LAn valls yere measured by an edit Jlrogram IS yell IS TIP in 3 
different reaions corresJlonding to the endo- mid- and epicardial 
layers. At baseline, LAT vall did not shoy a Significant delay relative 
to the anterior yall (mean difference .2' cardiac: cycles). Durina 
stenosis reducina CBF to ,-4:1: 2-4 " of resting flov. the delay of the LAT 
vall significantly increased (mean delay 2.2 cardiac: cycles. P <.05); 
during stenosis not reducina restina CBF the delay of the LAT vall YIS 
not different from basal stale. No significant transmural gradient in 
TIP YIS detected in the 3 myocardial layers either at baseline and 
during coronary stenosis. In conclusion, this computer analysis of 
myoc:ardia1 perfusion by contrast-echo Jlrovides an easily 
interJlretable yay of detecting reaional myocardial underperfusion; 
the sensitivity of the method. hovever. is limited to the identification 
of severe coronary stenosis vithout detectina transmural gradients, 
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PATHOLOGICAL EFFECTS OF SONICATED ALBUMIN KICROBUBBLES 
ON THE KYOCARDIUM, BRAIN AND KIDNEYS: BOV MUCH IS SAFE? 
H. W. Keller, K. D., W. P. Glasheen, H.E., K. Teja, 
H. D., s. Kaul, H. D., F.A.C.C., University of Virginia, 
Charlottesville, Virginia. 
We have previously shown that sonicated albumin mic-
robubbles produce good myocardial opacification without 
producing significant changes in coronary blood flow, 
and left ventricular and systemic hemodynamics: However, 
the safety of this agent has not been previously re-
ported. This study was, therefore, performed in 24 rab-
bits (mean ± lSD = 4.3 ± 0.5 kg) to study the effects of 
intraaortic injection of these microbubbles on the myo-
cardium, brain, and kidneys. Six rabbits each were in-
jected with 10 cc of nonsonicated 0.9% saline (control), 
10 cc of nonsonicated albumin (group A), 10 cc of soni-
cated albumin (group B), and 20 cc of sonicated albumin 
(group C). The animals were sacrificed 48 hours later 
and the heart, brain, and kidneys removed. Sections of 
these organs were obtained in a standard manner, stained 
with hematoxylin and eosin, and examined under light mi-
croscopy for evidence of capillary blockage, microin-
farcts, and hemorrhage. The kidneys did not demonstrate 
these changes in any of the rabbits. Two of the 6 group 
C rabbits demonstrated small areas of hemorrhage in the 
brain (p = 0.45 compared to control), while 5 of 6 rab-
bits in this group demonstrated microinfarcts within the 
myocardium (p = 0.08 compared to controls). In contrast, 
rabbits in groups A and B showed no pathological changes 
in the brain and myocardium compared to controls. 
Ve conclude that the intraaortic injection of soni-
cated albumin is safe in moderate amounts, but may have 
adverse pathological effects on the myocardium and brain 
in larger doses, probably related to microinfarction of 
these tissues. The amount of this agent that would he 
safe in humans must be determined prior to any clinical 
studies. 
Tuesday, March 29, 1988 
8:30AM-I0:00AM, Room 215, Level Two 
Clinical Pharmacology: Antiarrhythmic DrugS/Supraven-
tricular Tachycardia 
INTRAVENOUS FLECAINIDE VERSUS VERAPAMIL FOR ACUTE 
CONVERSION OF ATRIAL FIBRILLATION OR ATRIAL FLUTTER 
TO SINUS RHYTHM. 
MJ Suttorp, M.D., JH Kingma, M.D., EG Mast, M.D., 
Dept. of ICard1010gy, St Antonius Hospital, Utrecht/ 
Nieuwegein, The Netherlands. 
In a single blind randomized study the efficacy of intra-
venous flecainide (2 mg/kg/10 min) versus verapamil 
(10 mg/l min) was assessed in 26 patients with atrial 
fibrillation (AF) or flutter (AFL) lasting shorter than 
6 months. Pts included had a ventricular rate >lOO/min, 
and normal left ventricular function. Pts were observed 
for 1 hour after administration of either drug. Pts 
not converting to sinus rhythm (SR) treated wi th vera-
pamil had a crossover to flecainide and were observed 
another hour. From 13 pts receiving flecainide 9/10 
pts with Af converted to SR (90%), but 3/3 pts with 
AFL flecainide failed. All pts treated with verapamil 
(12 AF, 1 AFLl showed lower ventri cu 1 ar rates after 
1 hour but none converted to SR. After crossover to 
flecainide, 7/12 pts with AF still converted to SR (58%). 
Thus 16/22 pts with AF (73%) and 0/4 pts with AFL 
converted to SR after treatment with flecainide. 
Conversion to SR was obtained in 12/15 pts (80%) with 
AF =:; 24 hours and in 4/7 pts (5-7%) with AF> 24 hours. 
Shortlasting adverse effects after flecainide were noted 
in 5 pts (19%). 
We conclude that flecainide is an effective and safe 
drug for conversion of recent onset AF to SR. Flecainide 
may be 1 ess effecti ve when used in pts pretreated with 
verapamil. Flecainide was not effective at all in pts 
with AFL. Verapamil appears to be of no use for 
conversion of AF and AFL to SR. 
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FLECAINIDE FOR PREVENTION OF PAROXYSMAL SUPRAVENTRICULAR 
TACHYCARDIA: A MULTICENTER, DOU~LE-~LIND, PLACE~O-CON­
TROLLED CROSSOVER STUDY 
Richard W Henthorn. MD FACC, Albert L. Waldo, MD, FACC, 
Jeffrey L. Anderson, MD, FACC, Edward M. Gilbert, MD, 
~arry L. Alpert, MD, FACC, Ani1 K. ~handari, MD, Ronald 
W. Hawkinson, MS, Edward L. C. Pritchett, MD and the F1ec-
ainide Supraventricular Tachycardia Study Group. Case 
Western Reserve University, Cleveland, Ohio. 
The purpose of this study was to assess the efficacy of 
f1ecainide in preventing recurrences of paroxysmal supra-
ventricular tachycardia (PSVT). Fifty-one patients, with 
at least 2 telephone tranmission documented PSVTs during 
one month off medications, initially entered a f1ecainide 
dose titration phase to a maximum of 200 mg po q12h or to 
tolerance. Thirty-one patients who were randomized and 
completed the entire double-blind, placebo-controlled 
crossover (each phase - 2 months) trial were analyzed: 12 
men, 19 women; mean age 50±15 years. Of the 20 unan-
alyzed patients, 7 patients were removed for protocol 
violation, 5 for personal reasons, 4 for proarrhythmia, 
and 4 for noncardiac adverse effects. The median dose of 
f1ecainide used in the randomized active drug phase was 
300 mg/day (range 200-400 mg/day). 
RESULTS: Only 6 of 31 patients (19%) had recurrence of 
PSVT during their 2 month f1ecainide treatment period com-
pared with 26 of the same 31 patients (84%) during their 
respective 2 month placebo period (p<O.OOl). The time to 
first recurrence of PSVT was significantly longer with 
f1ecainide (median >54, range 4 - >72 days) compared with 
placebo (median 11, range 1 - >86 days) (p<O.OOl). The 
time interval between attacks was significantly longer on 
f1ecainide (median >55, range 4.7 - >73 days) than on pla-
cebo (median 10.8, range 0.82 - >87 days) (p<O.OOl). 
CONCLUSION: F1ecainide is an effective antiarrhythmic 
drug for the prevention of PSVT. 
FLECAINIDE FOR PREVENTION OF SYMPTOMATIC PAROXYSMAL 
ATRIAL FIBRILLATION: A MULTICENTER, DOUBLE-BLIND, 
PLACEBO-CONTROLLED, CROSSOVER STUDY. 
Jeffrey L Anderson MD FACC, Edward M Gilbert MD, Barry L 
Alpert MD FACC, Richard W Henthorn MD FACC, Albert L 
Waldo MD FACC, Anil K Bandari MD, Ronald W Hawkinson MS, 
Edward LC Pritchett MD, and the Flecainide Supraventri-
cular Tachycardia Study Group, University of Utah, 
Salt Lake City, UT. 
Paroxysmal atrial fibrillation (PAF) is a problematic 
clinical arrhythmia which is usually symptomatic but often 
resistant to therapy. We thus tested the efficacy of 
flecainide (F) in the prophylaxis of PAF in Pt who had >2 
attacks documented by trans telephonic monitoring within-a 
4 week baseline period. 63 qualifying Pt entered the 
dose finding phase to determine F tolerance. 54 advanced 
to the double-bUnd, randomized, crossover comparison of 
placebo (p) and F (median dose, 300 mg/day), 5 were ex-
cluded because of adverse events (AE), and 4 for other 
reasons. 43 Pt completed the double-blind phase and were 
evaluable for efficacy, 2 discontinued F because of AE, 
and 9 discontinued or were unevaluable for other reasons. 
Evaluable Pt were of average age 58 + 13 years and had 
undergone a mean of 3.8 previous drug trials (range, 1-8); 
27 were men, 17 had hypertension, and 13 had ischemic 
heart disease. The first PAF attack on F occurred at a 
median of 12 days (mean >22.4, range 1->60) versus 3 days 
(mean >10, range 1->58) on P (p<0.003). The median .time 
between attacks on F was 27 days (mean >30, range 1.8->61) 
versus 5 days (mean >14, range 1->60) on P (p<O.OOl). 
During F, 12 (28%) of Pt had no PAF, compared with 4 (9%) 
during P (p<O.06). Thus, F is an effective and generally 
well tolerated treatment for PAF, even in Pt previously 
uncontrolled by standard drugs, and should be a useful 
addition to current therapies. 
ABSTRACTS 
INTRAVENOOS DILTIAZEM FCR TERMINATION OF REIlNTRANT 
SUPRAVENTRICULAR TACHYCARDIA: A PLACEBO-CONTIlOLLED 
RANIXMIZED, OOUBLE-BLINDED S'ruDY. 
¥4~ ... 9~.Jh!Y9~~,_ .. t!,!?~_, .... -",.!\.,.g_,.Q.,., Simon Milstein, M.D., 
Virgil Dias, PharmD, Robert Hariman, M.D., F .A.C.C., 
Edward Platia, M.D., F.A.C.C., and Ruey J. Sung, M.D., 
F.A.C.C., CVRI, Univ of California, San Francisco. 
77A 
To assess safety and efficacy of intravenous diltiazem 
(D) in treatment of supraventricular tachycardia (SVT), 
we studied 54 patients (pts) in whom sustained reentrant 
SVT could be reproducibly induced by progranmed 
electrical stimulation. Their ages ranged from 17 to 79 
(mean 41:,:19) years. 20 pts had atrioventricular (AV) 
nodal reentrant tachycardia, and 34 pts AV reciprocating 
tachycardia involving anomalous pathways (AP). During 
SVT, pts were randomized to receive either placebo or D 
using double-blinded design. Initial dose of intravenous 
D was 0.25 mg/kg/2 min and, if SVT remained sustained, D 
at 0.35 mg/kg/2 min was infused 15 min later. Tennination 
of SVT occurred in 20/28 pts receiving D at 0.25 mg/kg 
and in 4/8 pts receiving D at 0.35 mg/kg. Overall 
response rate was 86% (24/28 pts). In contrast, only 5/28 
(19%) pts receiving placebo responded (p<O.OOI). 
Intravenous D significantly prolonged cycle length of SVT 
(309 :': 52 -> 337:,: 62 msec; p<O.OOl) and increased AV 
nodal refractory period (355 :': 84 -> 381 :': 100 msec, 
p<0.004) but exerted no effects on AP, His-Purkinje 
system, and ventricle. Site of block responsible for SVT 
tennination was invariably located at AV node. Mean blood 
pressure following D infusion was not different from 
bas~line. Side effects were noted in 3/28 (11%) pts -- 1 
sinus bradycardia, 1 fatigue, and 1 atrial flutter, all 
of which were clinically manageable. Thus, safety 
profiles of intravenous D are favorable and intravenous D 
is highly effective in terminating reentrant SVT via its 
depressive action on AV node. 
INTRAVENOUS AND ORAL DIPRAFENONE FOR TREAT"ENT OF PATIENTS NITH THE 
NOLFF-PARKINSON-NHITE SYNDRIIIE 
Klaus-Peter Kunze, ".D. and Karl-Heinz Kuck, ".D. 
University Hospihl Epplndorf, Halburg, F.R.6. 
Ne studied the electrophysiological and clinicll efficacy of diprafenone (D), 
a neM class I antiarrhythlic aglllt Mith additional behsyepatholytic propertits, 
in 15 ph (8 I, 7 M, lean age 43 yurs) Mith the NoIH-P"kinson-Nhite syndrole 
and recurrlllt (1-5 episodes/lonth) syeptoutic atrioventricular rtciprocating 
hchycardia (AYRTl, All ph had been treated unsuccessfully .ith 4 - 7 
conventional antiarrhythlic agents. The accessory path.ay conducted 
bidirectionally in all ph. Prior to drug adlinistration, AVRT could be induced 
by progra_d electrical stilulation (PES) in 14115 pts. Afbr control (C) PES D 
.as given intravlllously <i.v.) at a dose of 1.5 Iglkg bM. Plaua drug 
concllltration I h after injection ranged frol 0.259 to 0.579 ug/il. Results are 
shllllfl as lean ~ I SO. 
SCL APERPant 
761 ~ 92 246 ! 22 
834 ! 75 273 ±24 
(.05 (,05 
APERPret 
239 pO 
276 + 30 
(.005 
AERP 
208 ! 14 
220 tt3 
n.s. 
YERP 
207 ! 16 
227 + 19 
<.05 
A • right atriUII, ant • antegrade, AP • accessory pathway, ERP • eHectivt 
refractory period, rtt • retrograde, V = right vllltricle 
After D, thlre.as antegrade and rttrograde conduction block in the accessory 
pathlay in 3 ph. AYRT hid becOiI non-inducible in 5114 ph. In the other 9 ph 
the cycle length of AYRT had increaHd frOi 326 ! 48 to 370 t 24 (p (,05) due to 
an increase in ventriculoatrial conduction tiM. During a folio. up period of 10 
~ 3 lonth. 13115 ph beea .. asYlIPtoutic under orll 0 at a dOH of 100 Ig t.i.d. 
Hooever, in 2 ph D had to be lithdra.n because of severe gastrointestinal side 
eHects. 
Conclusions: In pts lith the NoIH-Plrkinson-llhite syndroM II i.v. D 
significantly prolongs antegrade and retrograde ERP of the Iccellary pathMay, but 
rarely caUHS conduction block, 2) oral D appears to be efflctiv. in preventing 
recurrences of supraventricular tachycardia, and 3) orll D clues severe side 
eHects in 151 of the pts. 
78A ABSTRACTS 
ELECTROPHYSIOLOGIC EFFECTSA EFFICACY, AND PATIENT TOLERANCE OF CLASS IC ANTI RRHYTHMIC AGENTS IN 
WOLFF-PARKINSON-WHITE SYNDROME. 
Ant~if M~9Q~iS. MI~' Therese Tordjman~ M.D., Melanie ars a IA •• , Ke Mack, R.N., N.A. nark Estes III, 
M.D., F •• C.C., New England Medical Center Hospitals, 
Boston, MA 
To evaluate the electrophyslologlc effects and 
efficacy of the class IC a~nts flecalnlde and encalnide 
In patients (pts) with Wolff-Parklnson-Whlte (WPW) 
syndrome, electrophysiology studies were performed In II 
pts before and during treatment with these dru~. The 8 
male and 3 female ~ts aged 35±19 years (range= 8-69 
years) had presentIng symptoms of syncope (2 pts), 
presyncope {7 pts), and palpitations (2 ~ts). 
Presenting arrhythmias Included atrial fIbrillation with 
rapid conduction over the accessory pathway in 3 pts and 
degeneration Into ventricular fibrillation In I pt, and 
reciprocating tachycardia (RT) In 8 pts. 
Flecalnlde was used with a mean dally dose of 236 mg 
In 10 pts and encalnlde 105 mg in I pt. Complete 
ante~ade block was present in I pt While In the 
remaIning 7 pts in whom It was evaluated the antegrade 
refractory period Increased from 230+59 to 316+42 msec. 
The shortest ~reexclted RR interval dUring atrial 
fibrillation Increased from 224+59 to 321+44 msec with 
drug therapy. Retrograde conduction over the accessory 
pathway was evaluated in 6 pts during therapy. It was 
blocked completely in 4 pts, while in the other two pts 
the retrograde refractory period increased by 110 ms and 
170 ms respectively. Orthodromic RT was inducible at 
baseline In all II pts (mean cycle length [CL)=325~67 
msec). Drug therapy prevented Induction of RT in ~ pts 
while It Increased the CL to 462+33 msec in another 5 
pts. Antidromic RT was inducible-In only 3 pts at 
baseline (CL=287+15 msec) and was nonlnduclble with drug 
therapy In one pt. In 2 pts antidromic RT was inducible 
only with drug therapy but was slow (CL= 440 +110 msec) 
and minimally s~tomatlc. All II pts remained 
asymptomatic during therapy for a mean of 6+3 months 
(range I-II). One pt was switched from flecainlde to 
encalnide because of visual complaints. 
In pts with WPW syndrome we conclude that class IC 
a~nts increase the antegrade and retrograde effective 
refractory period, are effective In preventing 
recurrence of tachycardia, and are well tolerated. 
Tuesday, March 29, 1988 
10:30AM-12:00NOON, Room 215, Level Two 
Arrhythmias in the Wolff-Parkinson-White Syndrome 
SYSTEMATIC DEVIATIONS BETWEEN THE VENTRICULAR 
RESPONSE TO ATRIAL FIBRILLATION AND ANTEGRADE 
ACCESSORY PATHWAY REFRACTORY PERIOD IN WOLFF-
PARKINSON-WHITE SYNDROME. 
Arjyn P Sharma M.D .. FAC.C .. George J. Klein, M.D., 
FAC.C., Raymond Yee, M.D., Tibor Szabo, M.D., Claus 
Rinne, M.D., University Hospital, London, Canada. 
The accessory pathway antegrade effective refractory period 
(APERP) correlates with the shortest RR interval (SRR) in 
atrial fibrillation, and thus, the need to induce atrial fibrillation 
in the assessment of patients (pts) with Wolff-Parkinson-White 
syndrome (WPW) has been questioned. We examined the 
relationship between APERP and the SRR in atrial fibrillation 
in 49 WPW pts. APERP was determined and atrial fibrillation 
was induced. The SRR was determined from measurements 
over a minimum of one minute during atrial fibrillation. When 
the data for the entire group of 49 pts was examined, no 
differences were observed between SRR (303±13 msec), 
APERP400 (286±6 msec) or APERP 600 (292±4 msec). 
However, SRR was weakly correlated with APERP (R=0.605, 
p<.OOI). Therefore pts were then grouped according to their 
SRR: SRR (msec, mean + S.E.M.) 
~ 250 250-300 >300 
APERP600 286±8+ 290±7306±6" 
APERP400 254±8* 277±9 309±9* 
mean SRR 202±9*+ 268±3 381±19*" 
(+:,*,".p<.OOI). Thus, when the SRR is long, APERP 
consistently underestimates the SRR. In contrast, when the 
SRR is short, it is conSistently overestimated by the APERP. 
Thus, APERP is potentially a poor indicator of the SRR in 
those very pts at greatest risk for sudden death in the event of 
atrial fibrillation. 
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ACCURACY OF INVASIVE TESTING FOR DIRECT IDENTIFICATION OF 
SUDDEN DEATH RISK IN THE WOLFF-PARKINSON-WHITE SYNDROME 
Douglas L. Packer, M.D.; Joyce C. Pressley,MPH, 
Lawrence D. German, M.D., F.A.C.C., Eric N. Prystowsky, 
M.D., F.A.C.C., Duke University, Durham, NC 
This study was undertaken to evaluate prospectively the 
accuracy of previously derived electrophysiologic "predic-
tors" in categorizing the risk of ventricular fibrillation 
(VF) in patients with accessory pathways (AP). A shortest 
R-R interval between 2 consecutively preexicted complexes 
during induced atrial fibrillation(SRRPE)~250 msec and 
an anterograde refractory period(ERP) of the APC:270 were 
tested as indicators of risk in 23 subsequent pts with a 
history of VF and a control group of 186 pts without prior 
VF. The SRRPE in VF pts was significantly shorter than in 
controls (176±34 vs. 250±68, p •• 0001), while no difference 
in the AP ERP between groups (253±36 vs.267±45) was seen. 
The accuracy in identifying pts with or without known VF 
is (in percent): 
Sensit. Specif. +pred value -pred value 
SRRPE !;;250 95.7 41.1 17.6 98.6 
APERP<270 55.6 45.8 10.8 89.7 
A SRRPE~250 correctly identified 22/23 pts. with prior 
VF while an APERP< 270 missed 8/18 pts with prior sudden 
death. In contrast, a SRRPE~250 and APERP~270 cor-
rectly identified low risk in 98.6 and 87.7% of cases, 
respectively. The specificity of both markers was low, 
although 4 pts with SRRPE~250 without prior sudden death 
developed VF following induced atrial fibrillation, sug-
gesting ongoing risk without treatment. From these pts we 
conclude: 1) a SRRPEE;250 is a highly sensitive marker 
for sudden death; 2) APERP lacks sensitivity and is less 
predictive than the SRRPE; 3) a long SRRPE and APERP iden-
tify pts at low risk for VF; and 4) pts with a SRRPE~250 
and no prior VF may remain at risk for sudden death. 
DIFFERENT SITES OF ACCESSORY PATHWAY CONDUCTION BLOCK IN PATIENTS WITH RI6HT AND 
LEFT SIDED ACCESSORY PATHWAYS 
Klrl-Heinz Kuck. ".0 .. Klaus-Peter Kunze, ".0. Ind "Infred Seiger, ".0. 
University Hospital Eppendorf, Huburg, F.R.6. 
Recordings of Iccessory plthMlY (AP) potentiils uy give detailed insight into 
the conduction properties along the nis atriul (A) - AP - ventricle (V). We 
investigated the site of block in antegrlde Ind retrogrlde direction in 11 ph 
undergoing shndMd electrophysiologic study. All pts hid the WPW syndroll ind 
sy.ptolltic supraventriculir hchycardii. 1I ph hid a left-sided AP, Ind b had a 
right-sided AP. In all ph AP potentials could be recorded, in pts Mith 
right-sided AP by In octopolir closely spiced electrode cltheter (2 I. 
inter-electrode dishnce), ind in ph Mith I left-sided AP by I catheter Mith In 
orthogonal electrode configurltion. The existence of AP potentills liS suggested 
in all pts by dissociation of A and V potentials frol AP potentials during atrial 
and ventricular pacing. Sites of sponhneaus or sti.ulition-induced AP conduction 
block _e different in pts with left and right-sided APs. The site of Integrade 
block in ph Mith. right-sided AP Mas alMays It the atrial insertion of the AP 
(i.e. A potential not followed by AP and V potentialsl, Mhereas in pts Mith I 
left-sided AP conduction block occurred It the yentriculir insertion of the AP 
(i.e. A potential folloMld by AP but not V patentiil). During ventriculir plcing, 
at incre.ental rates or Mith the extrastilulus technique, retrograde conduction 
block in the AP occurred It the sa.e site as antegradely, i.e. in ph Mith I 
right-sided AP It the atrial insertion of the AP (V potentill foIlaMed by AP but 
not A potential), and in ph Mith I left-sided AP It the ventriculM insertion of 
the AP (V potential not foIloMed by AP Ind A potentiils). 
Conclusion: In the individuil pt, the site of conduction block Ilong the uis 
A-AP-V is the sue in Integrade and retrograde direction. HOMever, in ph Mith I 
right-sided AP black occurs at the Itriil insertion, lIhereas in ph Mith I 
left-sided AP block occurs It the ventriculir insertion of the AP. This oay 
Iccount for different clinical lini fl5htions of the WPW syndra.e. 
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M)OE OF ORlHOmMIC TACHYCARDIA INITIATION 
AS A FUNCTION OF ACCESSORY PA'lHWAY REFRACIDRY PERIOD. 
James McKinnie MD. MohaImnad Jazayeri MD, Jose caceres 
MD, Naz:ih Kadri MD, Imran Niazi MD, TanVir Bajwa MD 
arrl Masood Akhtar MD, FACC. University of Wisconsin, 
Milwaukee, WI. 
No data exist to CCI1pU'e the effectiveness of 
premature ventricular stimulation (V2) arrl premature 
atrial stimulation (~) in initiation of orthodromic 
tachycardia (OT). In 51 consecutive patients (pts) 
with Wolff Parkinson White (WFW) syrrlrane arrl 
dClCUll'el1ted OT the mode of laboratory :imuction with 
~ versus V2 method was analyzed. '!be pts were 
divided intO three groups depending upon the 
anterograde effective refractory period of the 
accessory pathway (ERP-AP). 'lWenty-two pts (group A) 
had ERP-AP ~ 270 msec, 13 pts had ERP-AP >280 msec 
(group B) arrl the remainin;J 16 (group C) had concealed 
WfW syrrlrane. Results: '!he ~ technique failed to 
induce OT in 18/22 in group A, but was successful in 
11/13 group B arrl 13/16 group C cases. On the other 
hand, v2 technique was effective in :in:1ucin;J OT in 
all three groups , Le. 21/22 in group A, 11/13 in 
group B arrl 13/16 in group C. '!be data suggest that 
(1) v2 technique is the choice method for OT 
initiation particularly in patients with short ERP-AP. 
(2) since the v2 method is far l\¥)re effective 
(c::cItpU'ed to 1.,) in inducin;J OT, spontaneous 
ventricular ectopy (rather than atrial ectopy) may be 
a l\¥)re frequent arrl therefore an :inp:>rtant trigger for 
OT initiation in clinical settings. '!his information 
may have sane clinical relevance conoernin;J prevention 
of spontaneous OT initiation. 
CAN EPS PREDICT SUBSEQUENT ARRHYTHMIC EVENTS IN 
WPW PATIENTS WITH INFREQUENT OR NO ARRHYTHMIAS! 
Karen J. BeCkm~ M.D'
b 
Jose L. Gallastegui, M.D., F.A.C.C., 
Jerry L. Bauman; harm.., Robert J. Hariman, M.D., F.A.C.C., 
University of Illinois at Chicago, Chicago, Illinois. 
The ability of electrophysiologic studies (EPS) to predict future 
arrhythmic events in patients (pts) with asymptomatic WPW is 
unknown. To assess its value, we reviewed 42 pts with WPW who 
had EPS but were discharged on no therapy. The population 
consisted of 25 pts without documented arrhythmias and 17 pts 
with infrequent episodes of supraventricular tachycardia (SVT) 
and/or atrial fibrillation (AF). The pts' mean age was 33! 12.5 
years. Pts were followed up (flu) off drugs until the first 
documented arrhythmia (mean 6.8 ! 4.4 years). During flu 3 pts 
had SVT and 6 pts had AF. There were no sudden cardiac deaths. 
The only clinical or EPS parameter that correlated with 
arrhythmias during flu was a history of arrhythmias prior to EPS: 
Arrhythmia prior to EPS 
*APERP < 270 msec 
SVT induced 
AF induced 
Minimum R-R interval 
during AF!:. 240 msec 
Arrhythmia No arrhythmia 
d~rU ~ru n:9 3 
8 9 
6 12 
6 11 
2 7 
1 4 
p 
< .01 
NS 
NS 
NS 
NS 
*Accessory pathway effective refractory period (APERP) 
In pts without prior arrhythmia the predictive value of APERP 
<270 msec or inducible SVTIAF for future arrhythmias was 096 
and 1796 respectively. Conclusion: 1) Pts with WPW but few or 
no arrhythmias have excellent long-term survivals even if they 
have short APERPs. 2) Pts with a single episode of AF are likely 
to have recurrent AF but the risk of sudden death is low. 3) The 
finding of a short APERP or inducible SVT and/or AF has too low 
of a predictive value to warrant doing screening EPS in 
asymptomatic pts with WPW. 
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ATRIAL MAPPING FAllS TO DEMONSTRATE A CONDUCTION DEFECT 
ACCOUNTING FOR ATRIAL FIBRIllATION IN WOlFF-PARKINSON-
WHITE SYNDROME. 
Huan~-Ta Lin, M.D., F.A.C.C., Nancie Robertson, R.N., 
Gera d Lawrle, M.D., F.A.C.C., Antonio Pacifico, M.D., 
Sharon Magro, P.A.C., Christopher Wyndham, M.D., F.A.C.C. 
Baylor College of MediCine, Houston, TX. 
To investigate whether functional conduction delay 
is an important factor leading to atrial fibrillation in 
Wolff-Parkinson-White (WPW) syndrome, atrial epicardial 
activation was mapped during orthodromic tachycardia 
(SVT) in 32 WPW patients with normal left atrial size and 
no mitral valve disease. Group I (11 patients) had 
documented atrial fibrillation while group n (21 
patients) did not. SVT cycle length was 307±46 (mean ± 
SO) msec. In 25 pts (7 group I, 18 group II) atrial map-
ping was also done during sinus rhythm at cycle lengths 
of 665±112 msec. No significant difference was present 
(group I vs group II) in P-A interval (33±5 vs 35±10 
msec), atrial effective refractory period (234±42 vs 
228±59 msec) , cycle length of SVT (315±62 vs 303±36 
msec), or presence of multiple accessory pathways (4/11 
vs 12/21). Mean age was lower in group I (28±17 vs 37±14 
yrs). Total atrial activation time from the earliest to 
the latest electrogram was 112±16 vs 110±25 msec during 
sinus rhythm (p=NS) and 133±29 vs 125±27 msec during SVT 
(p=NS) • 
Thus, despite the shorter cycle length of SVT vs 
sinus rhythm, a functional conduction delay could not be 
found by atrial epicardial mapping that could account for 
atrial fibrillation. The pathogenesis of AF in WPW 
syndrome remains obscure. 
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Nuclear Cardiology: Thallium Imaging 
ABOORMAL THALLIlM-201 SPECT EARLY AFl'ER CORONARY 
ANGIOPIASTY: A PREDIcroR OF RESTENOSIS? E. Gordon DePuey, 
M.D., FACC, Gary S. Roubin, M.D., FACC, Karen G. 
Cloninger, M.D., Ernest V. Garcia, Ph.D., wendy L. 
Robbins, Spencer B. King, M.D., FACC, Dnory University 
School of Medicine, Atlanta, GA 
Exercise thalliu:n-201 SPEC! (Tl) was performed 1-5 
days after percutaneous transhllIinal angioplasty (Pl'CA) 
in 154 patients (pts) who had follow-up angiography at 
0.5-15 months. Since the pts were often restudied due to 
chest symptoms, the population is biased in favor of pts 
with restenosis. For purposes of canparison to Tl, the 
207 vessels dilated were grouped into 172 vascular beds 
(VBs). Imnediate post-exercise Tl images were quantified 
using circumferential profile analysis of short axis 
slices and polar bullseye maps. A regional Tl perfusion 
defect severity "score" was calculated as the sum of the 
number of standard deviations below the mean normal 
gender-matched profiles for all abnormal pixels within 
each VB. 
Post-Pl'CA Tl was abnormal in 64/172 ( 37%) VBs. 
Restenosis (> 50% diameter stenosis) occurred in 70 (41%) 
VBs: Tl oormal Tl abnormal Tl soore 
No Restenosis 69 33 204 :!:. 282 
Restenosis 39 31 155 :!:. 216 
The sensitivity of abnormal Tl for predicting restenosis 
was 44%: specificity was 67%. In the 64 VBs with abnl Tl, 
the Tl score was not significantly different in those 
with and without resteoosis. '!hese results differ fran 
those reported by other investigators for planar imaging 
2 weeks post-Pl'CA. '!hus, pre-discharge Tl after Pl'CA is 
oot predictive of restenosis which may occur later. 
Alternately, abnormal Tl this early after ~ may 
reflect transient coronary flow reserve abnormalltles not 
necessarily resulting in restenosis. 
80A ABSTRACTS 
IS BAYESIAN ANALYSIS VALID FOR THE INTERPRETATION OF THE 
EXERCISE THALLIUM-20t TEST, OR SHOULD ANOTIIBR APPROACH 
BE TRIED? S. Pollock, H. D., S. Kaul, H. D., F.A.C.C., 
D. D. Vatson, Ph.D., R. S. Gibson, H. D., F.A.C.C., 
G. A. Beller, H. D., F.A.C.C., University of Virginia, 
Charlottesville, Virginia. 
Bayes theorem has been used in the interpretation of 
the exercise thallium-201 test where the posttest pro-
bability of CAD by exercise ECG (EE) has been used as 
the pretest probability for thallium-201 test (THT). 
However, this approach is valid only if the two tests 
provide independent information regarding the disease 
process. As both ECG changes and thallium perfusion 
defects reflect inadequate myocardial perfusion on exer-
cise, we hypothesized that these two tests may not be 
independent. Another limitation of Bayesian analysis is 
that it provides only dichotomous information regarding 
a diseased state. For purposes of risk stratification it 
would be more useful to know whether a disease is ab-
sent, mild, or severe rather than only present or ab-
sent. Ve, therefore, examined the independence of these 
two tests in 383 consecutive patients undergoing both 
tests and coronary angiography for the evaluation of 
chest pain, and designed a probability matrix which al-
lows for mUltiple disease states and multiple test ~ut­
comes. Ve found EE and TBT not to be independent (x = 
11.6, p = 0.001). Using a probability matrix, we were 
able to simultaneously assess the influence of each test 
on the posttest probability of CAD despite their lack of 
independence. For example, assuming a pretest prob-
ability of 50% for CAD, using this approach, the post-
test probability was 84% if both EE and THT were +, and 
13% if both were -. If EE was -, and TBT was +, the pro-
bability of CAD was 52%, and if EE is + and THT is -, 
the probability was 29%. Ve conclude that current u~e of 
Bayesian analysis may not be valid in the interpretation 
of the exercise thallium-201 test, and a probability 
matrix may be more suitable in this situation. 
ANALYSIS OF SPECT THALLIUM SEPTAL PERFUSION DEFECTS 
ASSISTS IN DISTINCUISHING ISOLATED LAD OR PDA DISEASE FROM 
DISEASE OF BOTH VASCULAR BEDS. 
Richard C. Brunken, M.D., F.A.C.C., Sophia Kottou, Ph.D., 
Michael E. Phelps, Ph.D., Heinrich R. Schelbert, M.D., 
F.A.C.C., UCl.A School of Medicine, Los Angeles, CA. 
As a structure which derives its blood supply from two 
arterial distributions, the interventricular septum repre-
sents a unique region of the ventricle. To determine if 
an analysis of septal perfusion defects is helpful in 
d,stinguishing single vessel disease (left anterior 
descending [l.AD] versus posterior descending [PDA]) from 
dual vessel di sease (both l.AD and PDA), compari son was 
made between septal perfusion defects noted on SPECT thal-
lium scintigraphy and the results of coronary angiography 
in 33 pat ient 5 wi th ischemic heart di sease. Two observ-
ers, unaware of the results of coronary angiography, 
classified septa: defects as superior, inferior Or com-
plete. Superior defects "ere considered indicative of LAD 
disease, inferior defects indicative of PDA disease and 
complete defects indicative of disease of both the LAD and 
PDA. On coronary angiography, stenoses of >60% were con-
sidered significant. PDA disease was consIdered present 
if a significant right coronary lesion was identified in a 
right dominant circulation Or if a significant circumflex 
lesion was identified in a left dominant circulation. 
Type of LAD PDA LAD and 
Septal Defect Disease Disease PDA Disease 
Superior --3-- --0-- 0 
Inferior 1 6 1 
Complete 2 1 19 
x2=3l.7l, p<O.OOl (4 d.f.) 
Thus, we conclude that a careful analysis of SPECT thal-
lium septal perfusion defects assists in distinguishing 
isolated LAD or PDA disease from disease affecting both 
vascular beds. 
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EXERCISE THAL,LlUM.201 SCINTIGRAPHY FOR DETECTING 
CORONARY ARTERY DISEASE IN ASYMPTOMATIC YOUNG MEN 
Roben S. Schwanz MD, Major, MC, William G. Jackson M Stat, Paul V. 
Cello MD, James R-:-Hlckman MD, Col, MC FACC. USAF School of 
Aerospace Medicine, Brooks Air Force Base, Texas 78235. 
Little Is known about the diagnostic utility of Thalllum·20t scintigraphy for 
detecting asymptomatic coronary anery disease In apparently healthy 
men. We thus evaluated planar Thalllum-20t exercise myocardial scinti-
graphy In 832 asymptomatic male military alrcrew undergoing coronary 
anerlography because of abnormal noninvasive tests suggesting silent 
myocardial Ischemia. 
Patients were stratified by prior disease risk Into nine subgroups using age 
«35, 35-45, and >45) and total-to-hlgh density lipoprotein cholesterol 
ratio «4.5, 4.5-6.0, and >6.0). Significant coronary anery disease (50% 
or greater stenosis) was present In 152 patients (18.20/0 prevalence). The 
sensitivity of Thalllum-201 scintigraphy In these asymptomatic patients 
(76.4%) was comparable to that In clinical populations, but specificity 
(48.6%) was significantly less, and neither value could be shown to vary 
with risk subgroup. Conversely, positive predictive value varied significantly 
across subgroups. A normal Thallium scan Indicated low risk of disease 
(minimum negative predictive value 63.2%), but an abnormal test was 
likely to be a false positive result (maximum positive predictive value 
45.5%). The overall relative risk for an abnormal test was 2.68. 
A logistic equation retrospectively fit to the data was utilized to estimate 
the probability of significant disease given age, ratio, and Thallium result 
In an asymptomatic young man, and varied from less than 3% to 62% 
(age 50, ratio 8.0, and abnormal Thallium scan). 
ExerCise Thalllum-201 scintigraphy Is useful for detecting asymptomatic, 
anatomic coronary anery disease In young men, but Is substantially limited 
by the frequent occurrence of false positive tests In accordance with 
Bayesian probability theory. 
VISUAL VERSUS QUANTITATIVE ANALYSIS OF DIPYRIDAMOLE 
THALLIUM-201 SCINTIGRAPHY 
GertJan Laarman, M.D., J. Fred Verzijlbergen, M.D., 
T. Liam Go, Ph.D., Ernst E. van der Wall, M.D., 
Albert V.G. Bruschke, M.D., and Carl A.P.L. Ascoop, M.D. 
St. Antonius Hospital, Utrecht/Nieuwegein, the Netherlands 
To assess the additional value of quantitative analysis 
(QA) of uptake and washout of thallium-201 after 
dipyridamole infusion, we studied 81 patients with 
suspected coronary artery disease (CAD) undergoing 
coronary arteriography and thallium-201 scintigraphy after 
dipyridamole infusion (0.14 mg/kg/min IV over 4 min) 
combined with mild bicycle exercise (30 Watts, 60 
revolutions/min over 3 min). Three-view, 10 minute images 
were obtained at 10 minutes and 4 hours after thallium-201 
injection. Semi-quantitative visual analysis (VA) was 
performed by two independent observers, blinded to the 
angiographic results. QA: after 9-point smoothing and 
interpolative background subtraction, uptake and washout 
circumferential profiles in each patient were compared to 
the lower limit of normal profiles derived from 20 healthy 
volunteers, with a 1% likelihood of CAD, who were studied 
by dipyridamole thallium-201 scintigraphy. In addition, 
abnormality was defined by any 50· arc falling below the 
lower limit of normal profile&. Results: 
CAD MVD RCA LAD LCX 
VA Sensitivity 78% 70% 74% 82% 48% 
SpeCificity 86% 92% 85% 88% 88% 
QA Sensitivity 76% 73% 65% 79% 52% 
Specificity 73% 75% 81% 67% 71% 
MVD=Multivessel disease, RCA=Right coronary artery, LAD= 
Left anterior descending artery, LCX=Left circumflex ~ 
Thus, QA of dipyridamole thallium-201 SCintigraphy 
compared to VA was not superior to VA for the detection 
of presence, extent, and localization of CAD. 
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COMPARATIVE SPECT 1-123 HETAIODOBENZYLGUANIDINE (HIBG) AND 
THALLIUH 201 CARDIAC IHAGING FOLLOWING MYOCARDIAL 
INFARCTION IN PATIENTS. 
Harshall ~ Stanton. ~., Mahmoud H. Tuli, H.D., James J. 
Heger, H.D., FACC, William H. Hiles, H.D., FACC, Bruce H. 
Hock, Ph.D., Henry N. Wellman, H.D., Douglas P. Zipes, 
H.D. FACC., Indiana Univ. School of Had., Krannert Inst. 
of Cardiology, VAHC, Indianapolis, Indiana. 
1-123 HIBG is taken up by sympathetic nerve terminal 
endings and provides a scintigraphic image of sympathetic 
nervous innervation of the heart. We have previously shown 
that myocardial infarction (HI) in dogs produces areas of 
sympathetic denervation (D) in normal myocardium apical to 
the site of infarction and that these areas can be detect-
ed noninvasively by scanning with HIBG and thallium-201 
(Th). D may play a role in ventricular arrhythmias follow-
ing HI. We performed HIBG and Th scans on 7 patients with 
spontaneous ventricular tachycardia (VT) greater than one 
month after HI. Each pt underwent an electrophysiologic 
study (EPS). Areas of D, defined as regions of thallium 
uptake with corresponding HIBG defect, were found in 6 of 
7 patients. Five of these 6 pts with D and one pt without 
D had inducible sustained VT at control EPS as well as 
after metoprolol 15 mg IV. One patient with a large area 
of D developed repetitive nonsustained VT during exercise 
testing that was completely suppressed by metoprolol. Four 
normal control patients, one syncopal patient without VT 
and one VT patient without HI demonstrated normal homogen-
eous HIBG and Th scans. Thus, areas of sympathetic dener-
vation can be imaged in man following HI. Beta blockade 
did not prevent VT induction at EPS in the setting of D. 
Exercise-induced VT may prove to be related to D, as 
dispersion of refractoriness might be increased in the 
setting of heightened adrenergic tone. Beta blockers may 
be efficacious in this setting by decreasing the elec-
trophysiologic heterogeneity, thus suppressing VT. 
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Hypertension I 
SYSTOLIC BLOOD PRESSURE, NOT AGE, MEDIATES THE AGE-
RELATED INCREASE IN LEFT VENTRICULAR WALL THICKNESS 
WITHIN A NORMOTENSIVE POPULATION. Joao A.C. L,ima, M.D., 
Gary Gerstenbl ith, M.D., F.A.C.C., James C1ielss, M.lJ., 
F.A.C.C., Jerome L. Fleg, M.D., F.A.C.C., Myron Waclawiw, 
M.A., Sandra Lima, Myron L. Weisfeldt, M.D., F.A.C.C., 
Edward G. Lakatta, M.D., Johns Hopkins University and 
Gerontology Research Center, NIA, Baltimore, MD 
Physiologic aging is associated with the development of 
mild left ventricular (LV) hypertrophy. To determine 
whether this relates to the increase in systol ic blood 
pressure (SBP) which also accompanies normal aging, LV 
wall thickness (Th) was measured in short axis 2-D echoes 
obtained from 74 participants of the Baltimore 
Longitudinal Aging population without evidence of 
hypertensive (BP < 140/90) or ischemic heart disease. 
Wall Th from 16 equally spaced points around the LV cross 
section was digitized at the level of the papillary 
muscle tips. The average of 3 contiguous septal wall Th 
measurements normalized for body surface area (WTS) was 
related to age (WTS = 0.66 + 0.0029 [age], r = 0.26, 
P < 0.03), but more strongly to SBP (WTS = 0.32 + 0.0039 
[SBP], r = 0.39, P < 0.001). However, when WTS was 
regressed against age and SBP (multivariate analysis) the 
effect of age became insignificant (p = 0.28) while SBP 
remained a strong determinant of WTS (r = 0.41, P = 
0.0045). Cross-sectional muscle area (MA = epi- minus 
endocardial area) was also calculated, normalized for 
body surface area, and regressed against age and SBP. 
For univariate analysis, MA = 9.59 + 0.04 [AGE], r = 
0.20, P = 0.07, whil e MA = 4.38 + 0.06 [SBP], r = 0.37, 
P < 0.001. With multivariate analysis the effect of age 
disappears (p = 0.52) while that of SBP remains strong 
r = 0.38, P = 0.005). These data suggest that the norma 1 
hypertrophy associated with aging is mediated via an 
increase in SBP. 
ABSTRACTS 
IMPAIRED LEFT VENTRICULAR DIASTOLIC FILLING IN SYMPTOM-
ATIC COMPARED TO ASYMPTOMATIC HYPERTENSIVE PATIENTS 
Frederic L. Sax, MD, John E. Brush, MD. FACC. Richard O. 
Cannon. MD. FACC. Martin B. Leon. MD. FACC. Barry J. 
Maron. MD. FACC. Robert O. Bonow. MD. FACC. NHLBI. 
Bethesda. Md. 
81A 
Many pts with hypertension have altered LV diastolic 
function. To assess the relation between such abnormali-
ties and symptoms. we performed radionuclide angiography 
in 16 hypertensive pts with chest pain (CP) and angio-
graphically normal coronary arteries and another 16 asymp-
tomatic hypertensive pts. The two groups did not differ 
with respect to age. sex. severity of hypertension. rest 
rest or exercise ejection fraction. or LV wall thickness. 
LV internal cavity dimensions or LV mass index by echo. 
However. peak LV filling rate under resting conditions. 
normalized to both end-diastolic volume (EDV) and stroka 
volume (SV). was reduced in the symptomatic pts compared 
to asymptomatic pts: 
CP No CP p value 
Age (years) 49+6 ~ NS 
Blood pressure-systole (mmHg) 160+18 164+19 NS 
-diastole (mmHg) 106+9 105+6 NS 
Ejection fraction-rest (S) 57+7 55+7 NS 
-exercise (S) 64+7 64+7 NS 
Heart rate (bpm) 82+13 72+10 peOl 
LV mass index (g/m2) 128+67 105+21 NS 
Peak filling rate - (EDV/sec) 2.7+.7 3.3~.8 p<.05 
- (SV/sec) 4.7~1.0 5.9+1.0 p<.005 
Pts with CP had reduced filling rate at rest despite 
higher heart rates. These findings indicate that hyper-
tensive pts with CP may have greater impairment of LV 
diastolic function than hypertensive pts without CPo a 
difference that cannot be explained by age. LV systolic 
function. degree of hypertension. or LV mass. 
LEFT VENTRICULAR FUNCTION IN UNTREATED HYPERTENSIVE 
PATIENTS WITH NORMAL Al1BULATORY BLOOD PRESSURE. 
William B. White, H.D., Peter Schulman, H.D., 
F.A.C.C., E.J. HcCabe, R.N., and Vivienne-E. Smith, 
H.D., Hypertension Unit and Division of Cardiology, 
University of Connecticut, Farmington. 
To assess the presence of cardiac disease in 
hypertensive patients with disparities between 
physician and out-of-office BP, we prospectively 
studied never previously treated mild-to-moderate 
hypertensives (casual diastolic BP ~ 90 mmHg and $ 110 
mmHg) with ambulatory BP (ABP) , echocardiography, 
bicycle exercise, and radionuclide ventriculography. 
Patients were divided into a group with awake ABP $ 
130/80 mmHg (Group 1, n - 18), and those with awake 
ABP ~ 140/90 mmHg (Group 2, n - 18). Parameters 
assessed included BP, left atrial (LA) size and LV 
mass, ejection fraction (LVEF) at rest and during 
exercise, and average LV filling rate (LVFR): 
Age, years 
Casual BP 
Awake ABP 
Exer. BP 
LVEF,rest 
LVEF,exer. 
LVFR,edv/s 
LA, cm 
LVH, g 
Group 1 Group 2 
47 ± 14 48 ± 11 
153/99 ± 15/4 150/101 ± 14/6 
124/79 ± 6/5 145/ 97 ± 11/5 
191/91 ± 27/15 218/114 ± 32/11 
63 ± 6 % 60 ± 4 % 
70 ± 7 % 63 ± 8 % 
2.11 ± .40 1.80 ± .30 
3.73 ± .41 4.36 ± .61 
185.6 ± 71.7 239.3 ± 38.2 
NS 
.001 
.001 
NS 
.05 
.03 
.003 
.04 
Thus, patients with hypertensive casual BP but 
normotensive ABP (office hypertensives) have better LV 
function both during rest and exercise compared to 
patients with both hypertensive casual and ABP. These 
data suggest that ambulatory BP is a better predictor 
for the presence of hypertensive heart disease. 
82A ABSTRACTS 
DILTIAZEIf REDUCES LEFT V1!NTRICULAR MASS BUT DOES NOT 
CHANGE DIASTOLIC FILLING IN HILD HYPERTENSION. 
Jadwiga Szlachcic, MD., Julio F. Tubau MD, Barry H. 
Hassie MD, FACC. VAKC and University of California, San 
Francisco, San Francisco, CA. 
Whether antihypertensive therapy with calcium 
blockers can reduce left ventricular mass index (LVKI) 
and improve diastolic filling (DF) in hypertensive (HTN) 
patients (PTS) with mild LV hypertrophy is still 
uncertain. Therefore, 24 HTN PTS receiving either 
placebo (P) or diltiazem (D) in a double blind fashion, 
were studied using H-Hode and pulsed doppler 
echocardiography. We measured blood pressures (BP) 
end-diastolic dimension (EnD), posterior an~ septal 
wall thickness (PWth, SWth) and peak velocity of early 
filling. (E), late fillin, (A) and their ratio (E/A), 
during a placebo baseline (B) and follOWing 16 weeks of 
monotherapy. Echos were read blindly by two independent 
observers. 
SBP(lIIIIiIg) 
DBP(lIIIIiIg) 
EDD(/IIII) 
PWth(DID) 
SWth(mm)2 
LVKI(g/m ) 
E (m/s) 
A (m/s) 
'E/A 
l48±5 I43±11 I5l±14 
99±4 97t6 10It4 
52±6 52±5 53t5 
10.7±1.O 10.5tI.0 lO.5tI.l 
ll.0±1.O lO.8±O.9 lO.8tl.l 
l23±2l 12lt21 l25t2l 
O.84±O.2 O.81tO.1 O.90tO.2 
O.94±O.2 O.92±O.2 O.87tO.3 
O.9ltO.1 O.92tO.l 1.03tO.3 
(* =p<O.05 vs B) 
139t12* 
90t7* 
5l±5* 
10.2t1.0 
10.3t1.1 
113t23* 
O.86tO.2 
O.84tO.2 
1. 02tO.3 
We conclude: 1) D reduced LVKI by significantly 
decreasing EnD and non significant changes in wall 
thickness. 2) Changes in LVKI and BP did not correlate 
suggesting that this response may be also influenced by 
other mechanisms than BP reduction alone. 3) DF was 
unchanged by treatment despite the reduction in LVKI. 
BLOOD PRESSURE LEVELS AND ECHOCARDIOGRAPHIC FUNCTIONS IN 
CHILDREN: THE BOGALUSA HEART STUDY 
Luis F. Soto, M.D., Yu-Kun Chiang, Ph.D., Gregory L. 
Burke, M.D., Rene A. Arcilla, M.D. and Gerald S. 
Berenson, M.D., F.A.C.C., LSU Medical Center, New 
Orleans, Louisiana 
M-mode echocardiograms were obtained on 654 healthy sub-
jects, 7-22 years of age, whose diastolic blood pressure 
levels remained in the same height-, race-, and sex-
specific decile during two biannua~ examinations.. Echo-
cardiographic measures of heart S1ze and dynamlcs were 
compared across the total blood pressure. di stri buti ~n. 
Left ventricular stroke volume, left ventrlcu1ar cardlac 
output, left ventricular ejection f.racti~n, minor a~is 
shortening velocity of circumferentla1 flber shortenlng 
and peripheral vascular resistance were measured and 
compared with blood pressure levels. Significant posi-
tive correlations (p < 0.001) between left ventricular 
output and stroke volume and both systolic and diastolic 
blood pressure levels were found. Measures of body 
size especially height, weight and body surface area, 
were'significant1y related to left ventricular output, 
stroke volume and heart rate (p < O. 001) . Age corre-
lated with left ventricular output and stroke volume. 
When adjusted for systolic blood pressure, he!gh~, 
weight, age and ponderosity, white males had stat1Stl-
cally significant greater cardiac output and stroke 
volume than black males (p < 0.05 and p < 0.001, respec-
tively). Blacks had higher peripheral resistance than 
whites (p < 0.001). Echocardiographic studies suggest 
different mechanisms operative in the early onset of 
hypertension in this biracial (black-white) population. 
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CLINICAL CHARACIERISTICS OF SUBJECfS 
WITH LEFf VEN1RICULAR HYPERTROPHY 
I!aniel 1&:n.. MJ2.. F.A ~"5" Joanne Murabito, M.D:, 
KeaVen M. Aiiderson, P • .~. Jane C. Christiansen, 
M.P.H., William P. Castelli, M.D. Framingham Heart 
Study-NHLBI, Framingham, MA. 
The Framingham Heart Study recently reported new sex-
specific echocardiographlc criteria . for . !eft 
ventricular hypertrophy (LVH). We studied ch';llcal 
characteristics of 863 subjects with and .40.97 subjects 
without LVH. Age-adjusted charactenstlcs and P 
values are summarizedbe1ow. 
MEN WOMEN 
No LVH LVH No LVH LVH 
n=1868 n=352 n=2229 n=511 
AGE 49 56* 49 63* 
SYSTOUC BP 128 135* 124 131* 
DIASTOUC BP 80 83* 75 78'" 
HEART RATE 65 63(ns) 69 68(ns) 
BODY MASS INDEX 26 29* 24 29* 
ECG LVH (%) 2 9'" 1 3'" 
CORONARY DIS (%) 6 15* 4 9* 
VALVE DIS (%) 10 18* 18 22(ns) 
REDUCED FS(%) 2 6'" I 4* 
*=P<O.Ol; ns=not signifcant. 
BP=blood pressure, DIS=disease, FS=echocardiographic 
fractional shortening. 
We conclude that compared to those without LVH, 
subjects of both sexes with LVH are older, more obes~ 
have higher blood I'ressure, higher prevalence of ECv 
L VH ani! coronary iJisease and are more likely to have 
reduced fractional ~horte';ling. Subjec!s with L V 1;1 are 
likely to be at high nsk for cardIOvascular dISease 
complications by virtue of their clinical proflIe. 
Tuesday, March 29, 1988 
Poster Displayed: 9:00AM-12:00NOON 
Author Present: 9:00AM-I0:00AM 
Hail E, Georgia World Congress Center 
Other Adult Cardiology 
ACADEMIC CARDIOLOGY: THE VIEWS OF DIVISION CHIEFS, 
Thomas J. Rtan, M.D" F,A.C.C., R, F, Friedman, M.D., 
Miirk A. MOs owlfz, M.D., ana DOnald A, Weiner, M.D" 
F.A.C,C,, Boston University Medical Center, Boston, ~. 
To assess the current and future status of academic 
cardiology (AC) in 1985, we surveyed by written 
questionnaire the chiefs of cardiology at the major 
hospital affiliates of all U.S. medical schools. The 
questionnaire, consisting of 63 questions, dealt with 
the Size, composition, professional activities, 
recruitment, promotion, and professional productivity of 
AC. Of the 205 questionnaires sent, 46\ were returned 
and represented 62\ of all medical schools with an even 
distribution across the U.S. 
Chiefs ranked their highest priorities as follows: 
providing diagnostic services, inpatient consul~ations, 
fellowship training, and clinical research, MaJor 
factors contributing to their programs' suc~e~s were: 
the ability to retain faculty, generated clInIcal 
income, and faculty promotion rate. Major factors 
limiting success were: time available for research, 
space, and staff salaries, 58\ of respondents indicated 
that their major training focus was the development of 
academic investigators. 85\ endorsed a national cutback 
in the number of clinical trainees, while 56\ supported 
a national increase in the number of research trainees. 
Faculty time is allocated 44\ to patient care, 25\ to 
training, 21\ to research, and 10\ to administration, 
In a majority of programs, faculty earned 50\ less than 
comparable individuals in practice. Extramural research 
support was primarily from industry (45\) with 18\ 
obtained from NIH. These data provide a base for 
developing insights into current trends in AC that are 
likely to bear on future directions. 
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SEPTAL TURBULEltCE: AN IIFORTAIIT SOURCE OF SYSTOLIC IIIIMJR. 
Mindy Finkelstein, B.S., Kalli Voulgaris, M.A., David 
Gainza, Martin E. Goldman, M.D., F.A.C.C., Mt. Sinai 
Medical Center, NY, NY. 
Pts frequently have systolic murmurs felt to be either 
benign outflow murmurs, or significant valvular disease. 
Doppler echo, especially color-flow imaging, can elucidate 
the ori gi n of these murmurs. We i dentifi ed a new source 
of systolic ejection murmur which can mimic severe 
va lvul a r di sease. Of 2000 consecutive pts who had color 
echos, 25 were i denti fi ed who had suspected aorti c or 
mitral disease or hypertrophic myopathy, but were found 
to have no valvular lesions. Instead, there was a 
systolic mosaic turbulent pattern along the anterior 
septum of the LV outflow tract. There were 11 men and 
14 women, aged 56 ± 19 years. Subjects underwent a 
complete 20 color Doppler echo exam from multiple planes. 
The ventricular dimensions, wall thickness and function 
were normal. Septal turbulence was seen in both the 
parasternal long axis and apical five chamber views. 
Once turbulence was seen, the color pulsed repetition 
frequency was increased, which usually decreased the 
mosaic area. The origin of the murmur appeared to be 
the angle of the septal to aortic root plane, which 
was more acute than in subjects without septal turbulence: 
in the parasternal long axis, the systolic angle was 
1160 vs 1300 , and in diastole the angle was 1140 vs 
1280 • The mosaic turbulence was always seen exactly 
at the septal bul ge. None of these pts had any other 
source of murmur. Therefore, the source of harsh systolic 
flow murmur in all 25 pts was systolic septal turbulence, 
which is probably secondary to increased septal/aortic 
angulation. Clinicians should be aware of this benign 
source of systolic murmur, which can mimic more 
significant entities, but can be easily identified by 
color-flow imaging. 
CLINICAL SIGNIFICANCE OF ISOLATED CONUS ARTERY AS A 
PRINCIPAL COLLATERAL PATHWAY IN PATIENTS WITH TOTAL LEFT 
ANTERIOR DESCENDING ARTERY OCCLUSION. 
Masakazu Yamagishi,M.D .. Kunio Miyatake,M.D., Shintaro 
Beppu,M.D" Jun Tamai,M.D., Kazuya Yamamoto,M.D., 
Tsuyoshi Akiyama,M.D., Yasuharu Nimura,M.D., 
National Cardiovascular Center, Osaka 565, Japan. 
Although previous anatomical studies have shown that the 
conus artery which serves as a major collateral pathway 
to the obstructed left anterior descending artry (LAD) 
frequenly arises from the aorta, little is known about 
the clinical significance of such an isolated conus 
artery (ICA). To examine the possible role of the ICA as 
a collateral source, we selectively visualized the ICA 
using small size catheter (5 F) technique. After inser-
tion of the right coronary catheter to the nati ve right 
coronary artery, the catheter was counterclockwisely 
rotated to fix the tip at the orifice of ICA. In 150 
patients (pts) with total LAD occlusion who were selected 
from consecutive 639 pts having diagnostic angiography 
during 18 months, the ICA was found in 45 pts (30%). 
Among them, 30 pts showed the colla teral supp lying ICA 
which opacified the distal LAD. In 9 of these pts, 
conventional right coronary angiography could not reveal 
any collaterals to the LAD and the distal LAD was 
perfused only by the ICA donating collaterals. Neither 
the ICA nor non-isolated conus branch was found only 7 
out of 150 pts examined (4.7%), and no serious complica-
tions such as ventricular fibrillation were experienced. 
These results indicate that the selective visualization 
of the ICA is clinically important when the conventional 
left and right angiography could not demonstrate any 
collaterals to the distal portion of the obstructed LAD. 
The usage of small size catheter may be helpful in 
visualizing the ICA safely. 
ABSTRACTS 
REGIONAL ARTERIAL COMPLIANCE IN VIVO IN HAN AND NONHUMAN 
PRIMATES: A NEW CATHETERIZATION APPLICATION 
Rick Latham, M.D., Pieter Sipkema, Ph.D., Nico 
Westerhof, Ph.D., Bernard Rubal, Ph.D., Robert Schwartz, 
M.D., Cardiology Service, Brooke Army Medical Center, 
Fort Sam Houston, TX. 
Five normal patients and 10 baboons were studied 
during cardiac catheterization to determine the relative 
distribution of arterial compliance in vivo. Both Pts 
and baboons were studied utilizing a multi-sensor micro-
catheter with an electromagnetic flow-velocity sensor 
mounted at the proximal pressure transducer. Simultan-
eouS aortic pressure (AOP) and flow-velocity (AOF) were 
recorded in the aortic root, proximal descending aorta 
(all subjects) and lower descending aorta (baboons 
only). Aortography was used to determine luminal area 
at recording sites. A 3-element Windkessel was used to 
model arterial parameters of characteristic impedance, 
peripheral resistance and compliance (C). Computer-
estimated AOF was compared to measured AOF by a least-
squares analysis and arterial parameters converged by 
the Newton fitting procedure for the best fit. Esti-
mates revealed a systemic compliance (±SE) in man of 
2.16±.5 cc/mmHg measured in the aortiC root and 0.71±.2 
cc/mmHg in the proximal descending aorta resulting in a 
68±2% loss of arterial C from aortic valve to the 
proximal descending aorta. Similarly, baboons revealed 
a 60±4% decrease in C from Ao valve to proximal 
descending aorta and 84±4% decrease by the level of the 
celiac trunk. This study is the first in vivo study to 
demonstrate the significant contribution of the proximal 
aorta to total arterial comliance. Given limitations of 
parabolic flow profiles, this technique should prove 
useful in evaluating regional vascular changes in 
hypertension, atherosclerosis and aging. 
CONTINUOUS TRANSTRACHEAL OXYGEN DELIVERY: AN ALTERNATIVE 
"ETHOD OF YENTILATION DURING CARDIOPUL"ONARY 
RESUSCITATION. Karl B. Kern. ".0 •• Fred K. Branditz, 
".0., Sa amy C. Ca.pbell, ".0., UniverSity of Arizona and 
YA "edical Center, Tucson, Arizona 
83A 
Excellent oxygenation of apneic subjects can be aaintain-
ed by constant flow transtracheal oxygen delivery 
(TTO.), but severe hypercapnic acidosis also develops. 
We investigated the effect of combining TTO •• delivered 
through a small percutaneously placed catheter, with 
chest coapressions during cardiopulmonary resuscitation 
(CPR). Continuous TTO. was evaluated in 21 dogs for 
its ability to oxygenate, control pCO. and pH, and 
contribute to successful resuscitation during prolonged 
CPR. Continuous TTO. achieved PaD. saturations (sat) 
~ 98% in 6 anesthetized and paralysed dogs during sinus 
rhythm. The addition of external chest cos press ions. 
even at only 10/sin, prevented the PaCO. accuaulation 
seen during 30 min of TTO. alone (PaCO.: 35~1 .mHg vs 
94~5 aaHgl p<.OOl'. Increasing the rate of chest coa-
pression significantly decreased PCO. in a linear 
fashion (p<.OOl). Data at 30 ain of VF: 
coapressions/min: ~ 10 20 40 80 120 
PCO. (torr) 98~16 37~3 26~2 23~2 19~4 18~3 
In 6 animals with ventricular fibrillation, 60 sin of 
continuous TTO. and chest coapressions (80/ain) result-
ed in O. sats that were again ~ 96%, and PaCO. levels 
which were lower than baseline (23~1 saHg vs 41~1 saHgl 
p<.OOl). An additional 9 aniaals had siailar PaO. and 
PaCO. results with TTO. and chest coapressions 
(80/ain). Seven of 9 were successfully defibrillated and 
resuscitated after 15 .-in of YF. Continuous TTO. 
coabined with chest coapressions during CPR can provide 
excellent oxygenation and ventilation while duplicating 
resuscitation results seen with endotracheal intubation 
and positive pressure ventilation. 
84A ABSTRACTS 
DETECTION OF VASCULAR GRAFT INFECTION IN HUMAN SUBJECTS 
WITH RADIOLABELED NON-SPECIFIC POLYCLONAL IgG 
~an J. Ft:cbmaQr U.D •• Robert H. Rubin. M.D •• Frances 
eCh. Ro rt W1 k1nson. Mark Nedelman. Ronald J. 
Callahan. Ph.D •• Ban An Khaw. Ph.D •• H. William Strauss. 
M.D •• F.A.C.C •• Massachusetts General Hospital. Boston.MA 
Morbidity and mortality from infections on vascular graft 
can approach 75%. Since diagnosis is often hampered by 
absence of specific signs and symptoms. a reliable 
noninvasive diagnostic imaging technique can be critical 
for many patients. The use of In-lll labeled leukocytes 
for imaging graft infections. while successful in many 
cases. has overall proven to be sub-optimal. In the 
course of studies aimed at localizing bacterial infection 
with antibodies directed against specific organisms. we 
noted that In-lll labeled non-specific human polyclonsl 
IgG accumulated in sites of inflammation. To determine 
if non-specific pOlyclonsl IgG could be used to detect 
vascular graft infections in man. we studied 7 patients 
with suspected sites of infection located in aortic 
axillary or iliac grafts. Between 5 and 48 hours after 
injection of approximately 74MBq of In-lll labeled human 
polyclonal IgG. multiple images of the area of suspected 
infection were obtained with a large field of view gamma 
camera. Scan findings were compared to findings at 
surgery. other imaging modalities and/or clinical 
follow-up. In 3/3 patients. sites of infection were 
accurately localized by the scan. 4/4 patients had 
negative scans and no site of infection could be 
demonstrated by other techniques. One patient had a 
repeat scan. Despite the fact that the patient had 
improved clinically between the two examinations. the 
second scan remained positive. and at surgery. graft 
infection was confirmed. 
These preliminary results suggest that non-specific 
polyclonsl IgG can be used to localize vascular graft 
infections in man. 
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Myocardial and Pericardial Disease 
LEFT ATRIAL COMPRESSION: A NEGLECTED SIGN OF TAMPONADE 
Ivan D'Cruz, M.D., FACC, William Callaghan, M.D., Fred 
Arensman, M.D., Charles Gross, M.D., V.A. Med. Ctr. & 
Depts. of Medicine & Pediatrics, Med. Coll. Georgia, 
Augusta, Ga. 
Collapse or indentation of the right atrial (RA) wall, 
in patients with large pericardial effusions and tampon-
ade, has received much attention. By contrast, little 
data is available on left atrial (LA) collapse, which 
occurs simultaneously (at end diastole-early systole). We 
therefore measured (electronically) areas and transverse 
dimensions of LA and RA, in apical 4 chamber view, in 10 
adults and 3 children with large pericardial effusions 
and tamponade (diagnosis supported by hemodynamic data). 
We found that LA area decreased 55±11% (mean±S.D.) 
and LA transverse dimenston 48±lO%, from a maximum at 
late systole to a minimum a~ end diastole. Corresponding 
decrease for RA area was 24±9% and RA transverse 
dimension 21±11%. These differences between LA and RA 
size decrease were highly significant (p< .00001). We 
made similar measurements in a control group of 15 
normals. Mean decrease (from maximum at end-systole to 
minimum of end-diastole) was 15% for RA area, 10% for 
RA transverse dimension, 7% for LA area, 5% for LA 
transverse dimension. Late diastolic RA wall indentation 
was noted in 11/13 patients; LA wall indentation in 6/13, 
in apical 4-chamber and/or apical long axis view. 
We conclude that a remarkable decrease in LA size at 
end diastole occurs in tamponade, and exceeds decrease 
in RA size. However differences between RA and LA wall 
anatomy (LA wall tethered by four pulmonary veins, but 
RA wall not tethered) may permit indentation of RA wall 
more easily than LA wall. 
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THE IMPORrAICB (F ATRIAL CORrlW.".rION IN BXPBRlMBRrAL 
CAIIU1!C ~ - A IXB'f.I!R lQIrAII)lOGBAl'IIIC SLUJr 
~  ~, Itzhak Kronzon, M.D., F.A.C.C., 
Howard Axelrod, M.D. New York University Medical Center, 
New York, New York. 
Eight episodes of cardiac tanponade (or) were induced in 
5 closed chested dogs by gradual (lOcc/min) infusion of 
l20-200cc of saline into the pericardial sac. Two 
dimensional echocardiography and flow velocity (FV) across 
the tricuspid valve (TV) and the mitral valve (MV) were 
continuously III)rlitored by Doppler echocardiography (D). 
Cardiac output, intracardiac and intrapericardial 
pressures were continuously measured. With severe or (50% 
or more drop in cardiac output), the early diastolic 
intrapericardial pressure exceeded the right atrial 
pressure, and right atrial and right ventricular collapse 
were seen on two dimensional echocardiography. 
sinultaneously, there was a significant decrease in early 
diastolic FV (E wave). The FV during atrial contraction 
(A wave), remained unchanged, but it represented a 
significantly higher percentage of transvalwlar flow. 
rna 
FVI 1< JgnL m,lL19nl. m,1<±m,a 
Control TV 3.3±.5 3.l±.4 .50±.O5 
MV 3.3±.7 2.6±.5 .45±.O5 
or TV .2±.O5 3.3±.5 .94±.O3 
MV .4±.lO 4.l±.6 .85±.O7 
Where FVI=Flow Velocity Integral, E=E wave, A=A wave. 
<XH:Llm(l!i: DoWler echocardiography derronstrates that 
during severe CT, early diastolic cardiac compression 
interferes with transmitral and transtricuspid flows, and 
the ventricular filling depends mainly on atrial 
contraction. 
LACK OF INSPIRATORY VENA CAVAL COLLAPSE IN 
PERICARDIAL EFFUSION: A SIGN OF HEMODYN-
AMIC COMPROMISE? Ronald B Hjmelman MD, Barbara 
Kircher MD, Nelson B. Schiller MD, FACC, University of 
California, San Francisco, CA. 
To assess the diagnostic and prognostic value of lack of 
collapse (lOC) of the inferior vena cava in pericardial effus-
ions, we reviewed clinical data on 73 consecutive pts with 
moderate or large effusions by 2D echocardiography (ECHO). 
Vital signs, physical exam, hemodynamiCS, ECHO, treatment, 
and outcome were compared in 49 pts with lOC « 50% 
collapse in vena cava diameter after supine deep inspiration) 
and 24 with COll (> 50% collapse). Etiologies included 
malignancy (24 pts), cardiac surgery (21), and uremia (8). 
lOC pts had significantly lower values for systolic blood 
pressure (SBP, mm Hg), and higher values for pulsus paradox 
(PP, mm Hg), jugular venous distention (JVD, cm), and RA 
pressure (RAP, mm Hg) than COll pts. PA diastolic pressure 
(PAD, mm Hg), wedge pressure (PCW, mm Hg), and heart rate 
(HR) did not differ Si~~ficantIY. (table, mean ± SD, * P < 0.01) 
~ ~ ....BAe.. EAQ fQ!:J.--1:l..B..-
lOC 111±25* 23±10' 14±5* 18±6* 19±6 20±8 109±17 
COll 132±23 12± 4 8±3 11±5 17±6 18±9 103±20 
A group of 26 pts with hemodynamically significant effusions 
was defined by SBP < 100 mm Hg, PP ~ 30 mm Hg, or 
equalization of diastolic filling pressures. By ECHO, sens-
itivities and specificities for this group were 96 and 49% for 
lOC, 31 and 71% for RA collapse, and 19 and 93% for RV 
collapse, respectively. Pericardial drainage was performed in 
39 lOC (80%) vs 7 COll (30%) pts (p < 0.001); complic-
ations included development of constriction in 14 vs 2 (p < 
0.05), and in-hospital death in 10 vs 0 (p < 0.01), respectively. 
In conclusion, lOC in pericardial effusions IS 1) associated 
with elevated JVD and RAP, 2) more sensitive but less specific 
for hemodynamically significant effusions than RA or RV 
collapse, and 3) of prognostic importance. 
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LATE POTENTIALS CAN INDICATE A DEGREE OF MYOCARDIAL SCAR 
ASSESSED BY THALLIUM-20l MYOCARDIAL PERFUSION IMAGING 
IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY ? 
Tsuyoshi Konta,M.D. , Kanji Hanashima,M.D., lsao Kubota, 
M.D., Kozue Ikeda,M.D., Michiyasu Yamaki,M.D., Mitsuhiko 
Meguro,M.D., rchiro Tono-oka,M.D. and Shoji Yasui,M.D. 
Yamagata University School of Medicine, Yamagata, Japan 
To evaluate whether late potentials (LPs) reflect a 
degree of myocardial scar formation, 13 patients with 
dilated cardiomyopathy (DCM) underwent signal averaged 
electrocardiography (Marquette. MAC 1) and thallium-20l 
myocardial perfusion imaging. LPs were defined as low-
amplitude waveforms with duration of 20 msec or more 
after the end of the QRS complex. Segmental myocardial 
perfusion state waS assessed by uptake index (UI~counts 
of a region of interest(ROI)/ maximal ROI counts) to each 
of anterior, lateral, apical, inferior, posterior and 
septal segment. ur was scored as follows 1 grade 0 (>85%), 
1 (80-85%), 2 (70-79%), 3 (60-69%), 4 «60%). The total 
of UI was defined as a defect score. 
Results: 
n 
defect score 
VT 
LP (+) 
8 
9.l±5.5 
8 
LP (-) 
5 
1.6±0.9 
1 
Defect score which may represent the extent and size 
of myocardial fibrosis or necrosis was higher in the 
patients with LPs than those without it. Our study 
indicates that in idiopathic dilated cardiomyopathy, 
LPs may reflect a degree of myocardial fibrosis or 
necrosis. These fibrosis and/or necrosis may contribute 
to intramural conduction disturbance and relate to the 
occurence of VT. 
MILDLY DILATED CONGESTIVE CARDIOMYOPATHY: CLINICAL COURSE 
WITHOUT HEART TRANSPLANTATION. 
Andre Keren, M.D., Shmuel Gottlieb, M.D., Margaret E. 
Billingham, M.D., F.A.C.C., Dan Tzivoni, M.D. and Richard 
L. Popp, M.D., F.A.C.C. 
Bikur Cholim Hospital, Jerusalem, Israel and Stanford 
University Hospital, Stanford CA. 
Mildly dilated (MO) congestive cardiomyopathy (CM) is a 
rare entity whiCh has been previously reported in 5 heart 
transplant recipients. They showed the typical features of 
end-stage CM (class IV NYHA), but only mildly dilated ven-
tricles «10% above normal range corrected for body surface 
area). The pretransplantation clinical, echocardiographic, 
hemodynamic and endomyocardial biopsy findings of these and 
3 additional transplant recipients with MDCM (Group 1), are 
here compared with similar information in 6 pts with MDCM 
followed for 10.4±6.0 months on medical therapy (Group 2). 
At the time of enrollment, Group 2 pts had at least one 
episode of pulmonary edema and LV ejection fraction. <30%. 
The MDCD was familial in 6 of 8 Group 1 and 2 of 6 Group 2 
pts (p~NS). LV diastolic index, ejection fraction and LVEDP 
were similar in the two groups, but Group 2 pts were older 
(43.2±10.0 vs 28.0±14 years, p <.05) and had a higher CI 
(2.0±0.0 vs 1.s±0.4 L/min/m2, p <.05). Results of endomyo-
cardial biopsies were similar in the two groups, showing 
features typical of CM, but lack of significant myofibril-
lar loss. During the follow-up of Group 2 pts, 2 died and 
3 were in class IV NYHA. Systemic emboli occurred in 1 pt 
and 1 had episodes of sustained ventricular tachycardia. 
Conclusion: Without heart transplantation, advanced stage 
MDCM carries a poor prognosis. The criteria for transplan-
tation in MDCM should be similar to those of typical 
dilated cardiomyopathy. 
ABSTRACTS 
SUBENDOCARDIAL CORONARY FLOW IS DECREASED IN 
SYRIAN CARDIOMYOPA TIllC HAMSTERS 
S Alben Camacho M D., William Holt, M.D., Ph.D., Joan Wikman-
Coffelt, Ph.D., Elias Botvinick, M.D., FACC, Gaetan Jasmin, M.D., 
William Parmley, M.D., FACC. University of California, San 
Francisco. 
85A 
Coronary flow (CF) alterations leading to myocardial ischemia have 
been implicated in the pathogenesis of Syrian cardiomyopathic hamsters 
(CMH). To determine whether regional CF abnonnalities are a feature 
of this cardiomyopathy, we measured left ventricular (LV) 
subendocardial, LV subepicardial and right ventricular (RV) CF in 
isolated heart preparations from 180-200 day old CMH and normal 
hamsters (NH). Approximately 50,000 radioactive microspheres were 
injected 2 cm above the aortic valve during continuous Langendorff 
retrograde perfusion at a perfusion pressure of 110 mm Hg. Total CF, 
LV developed pressure and end-diastolic pressure (L VEDP) were 
monitored throughout the experiment 
NH (n=7) 
subendo/subepi CF ratio (per gm) 1.37 ± 0.16 
subendocardial CF (ml/min/gm dry wt) 103 ± 13 
subepicardial CF (mJ/min/gm dry wt) 81 ± 13 
RV CF (ml/min/gm dry wt) 95 ± 13 
total CF (ml/min) 7.9 ± 0.6 
total CF (ml/min/gm dry wt) 80 ± 14 
LV developed pressure (mm Hg) 213 ± 30 
L VEDP (mm Hg) 5 ± 0.5 
CMH(n-5) 
0.73 ± 0.19* 
49±8* 
78 ± 15 
115 ± 26 
6.6 ± 0.9 
64±13 
110 ± 13* 
22±7* 
(mean ± SE; * p<0.05 when comparing CMH versus NH) 
Conclusion: Although total CF is only minimally reduced, CMH have 
markedly compromised LV subendocardial CF. This finding suggests 
that in CMH, elevated L VEDP and increased wall stress result in LV 
subendocardial ischemia. 
ENDOMYOCARDIAL BIOPSY IN CARDIAC HEMOCHROMATOSIS. 
Lyle ~ Olson, M.D., William D. Edwards, M.D., F.A.C.C., 
William P. Baldus, M.D., Fletcher A. Miller, Jr., M.D., 
F.A.C.C., and David R. Holmes, Jr., M.D., F.A.C.C., Mayo 
Clinic, Rochester, MN. 
The clinical and histopathologic manifestations of cardiac 
iron overload have not been described completely, and the 
role of endomyocardia1 biopsy (EMB) in the evaluation and 
management of cardiac hemochromatosis (CH) has not been 
defined. We describe clinical and pathologic features of 
CH diagnosed by EMB in 6 men 32 to 75 yr old (mean, 52 
yr). Hemochromatosis was of genetic origin in 4 and 
aCQuired in 2. Five Pt presented with progressive dyspnea 
and heart failure. ECGs were abnormal but nonspecific in 
all 6 Pt; 5 had cardiomegaly by chest radiograph. Cardiac 
catheterization, performed in 5 Pt, showed normal coronary 
arteries, increased LVEDP, and decreased LV ejection 
fraction (EF); no Pt had restrictive physiology. 
Noninvasive imaging showed LV dilatation and EF < 32S in 5 
Pt. Wall thicknesses were normal in all 6. From each Pt, 
3 to 5 EMB specimens were obtained; stainable iron was 
present in all specimens from the 5 Pt with cardiac 
dysfunction, but in only 1 of 4 specimens from the Pt with 
normal LVEF. In 2 Pt, CH was not suspected prior to EMB: 
myocardial iron was detected only because of routine 
application of specific stain. Stainable iron was 
detected only within the sarcoplasm of myocytes, not in 
interstitium or other cellular elements. The grade of 
stainable iron varied inversely with EF. All Pt had 
fibrosis and myocyte hypertrophy and degeneration, 
although grade did not correlate with EF. These 
observations indicate that CH is a storage rather than an 
infiltrative disease. Sampling error does not occur in 
EMB of Pt with decreased LVEF due to CH. Iron staining is 
recommended in EMB of all Pt with idiopathic cardiac 
dysfunction. 
86A ABSTRACTS 
IS EARLY DIASTOLIC VENTRICULAR FILLING IIIPAlRED IN 
AIIYLOID RESTRICTIVE CARDIOIIYOPATHY ? 
Vas ken Dilsizian, 11.0., Jonathan F. Plehn, 11.0., FACC, 
Victor Lee, 11.0., lIary Huntington, 11.5., lIartha Skinner, 
11.0. and Alan S. Cohen, 11.0., Boston City Hospital, 
Boston University School of lIedicine, Boston IIA 
The effect of amyloid infiltration on early left 
ventricular (LV) filling is controversial. While some 
reports have described reductions in peak filling rates 
(PFR) others have documented normal or rapid early 
filling using clinical and catheterization techniques. We 
performed radionuclide angiography (RNA) and trans-
mitral, pulsed Doppler (PO) analysis of LV filling in 14 
patients with biopsy-proven primary amyloidosis. Subjects 
(n=7 in each group) with thin ·walls (Group I) were age-
matched to patients with thick walls (Group II) all of 
whom had congestive heart failure, and normal controls 
(Group C). Although there was a mild, though 
statistically insignificant, reduction in LV ejection 
fraction (LVEF) in Group II, PFR normalized for end 
diastolic counts and first third filling percentage (FTP) 
by RNA and peak filling velocity (PFV) by trans-mitral PO 
were no different between groups: 
Group LVEF PFR FTP PFV (cm/sec) 
I .na11 3.3"'0.9 29217 65216 
II .59 ... 13 2.9.0. 7 53~7 86~28 
C .72.10 2.7~0.4 44~13 68.9 
lie an ~ S.D. p=ns for all inter-group comparisons 
Conclusion: RNA and PO confirm that early LV filling 
is unimpaired in amyloid restrictive cardiomyopathy and 
LV systolic function is only mildly reduced. Amyloid-
associated CRF may largely be due to LV compliance 
abnormalities affecting later phases of diastole. 
POSTPARTUM CARDIOMIOPATHY: CLINICAL, MORPHOLOGICAL AND 
FOLLOW-UP ASPECTS. 
Antonio Carvalho,M.O. , Anselmo Brandao,M.D., Valter C.Lima, 
M.D. ,Jose L.Andrade ,M.D. ,Luiz A.Moura,M.O. ,Eulogio Martinez 
F2,M.0. Escola Paulista de Medicina,Sao Paulo, Brazil. 
Postpartum cardiomiopathy (PPCM) is uncommon and its behavior 
not completely understood. We studied prospectively 16 pts 
with diagnosis of PPCM made by: no previous cardiac disease , 
absence of previous hypertension and cardiac failure 
occurring late in pregnancy or till 6 months after delivery 
In 14/16 pts symptoms began early in puerperium, all of them 
presenting as NYHA functional class IV; there were 3 episodes 
of systemic (all cerebral) and one of pulmonary emboli. In 
11/16 pts an endomyocardial biopsy was performed; no biopsy 
was considered normal. Morphological findings included: ' 
mononuclear infiltrate - 82%, hypertrophy - 73%,intersticial 
edema - 55%, fibrosis 45%. Follow-up was 100% complete. At a 
mean follow-up period of 17 months, 7 pts (46%)were doing well 
(mean age 22y/old) with almost complete recovery; however, 9 
pts (54%) did poorly (mean age 30y/old) with 2 deaths and a 
heart transplant in the group; six pts still are NYHA class ' 
III-IV. History, physical, ECG, chest x-rays, hemodynamic ' 
and biopsy findings could not predict late follow-up status; 
the only parameter to do so was initial echocardiographic LV 
diastolic dimension - mean of 69 mm in those who did poorly 
X mean of 59 mm in those who did well (P< 0.05). Conclusions: 
1) PPCM behaves as a severe type of congestive cardiomyopathy; 
2) no endomyocardial biopsy performed was entirely normal; 
3) initial echocardiographic LV diastolic dimension at the 
time of clinical presentation with cardiac failure could be a 
predictor of long term prognosis. 
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Myocardial Infarction: Experimental 
EXPEIUI!IICE Wl'l'H FLAr PYl!OLYl'IC CARBC... DISC BJORK SIIIIEY (BS) 
VERSUS ST. JUIE (SJ) VALVES FOR MITRAL VALVE IIEPLACI!MENT (MVR) 
ArlIn L Singh, H.D., F.A.C.C., Seth Michaelson, PhD, John H. 
Moran, M.D., F.A.C.C., George N. Cooper, Jr., M.D., 8IId Karl E. 
Karlson, M.D., F.A.C.C. 
Rhode Is1811d Hospital, Brown University, PrOVidence, RI 
Either low profile disc (BS, SJ) or tissue valves are used 
for MVR in this institution. Whereas long-term results with 
tissue valves are well known, few parallel series of BS versus 
SJ have been studied. Retrospective analysis of 147 patients 
(pts) fran 1978 to 1984 was carried out. Survivors were inter-
viewed by an :Impartial observer. Both groups were ccmpsrab1e 
for age, sex, incidence of mitral stenosis 8IId regurgitation, 
atrial fibrillation, and prop NYHA Class. More coronary 
bypasses were done in Group II (SJ) (20/76) than in Group I (BS) 
(4/71)(P<O.05). All pts were anticoagulated with coumadin and 
followed for a minimun of 24 months. Survivors in both groups 
improved in NYHA Class. There were no mechanical valve failures 
in either group. 
Group I(BS) Group II(SJ) 
Number of pts 
Operative Mortality (%) 
Mean follow up (months) 
Thranboenbolism (TE)(%) 
Valve thrcmbosis (%) 
# valve ccmp1ications (%) 
Actuarial Survival 7 yrs (%) 
(95% confidence limit) 
71 
4(5.6) 
54+29 
5 (i) 
4(5.6) 
16(22.5) 
65+14 
76 
5(6.6) 
36+12 
1(1.3) 
o 
4(5.3) 
74+12 
Pvalue 
!'-N.S. 
P=N.S. 
P(0.05 
P(0.05 
P(0.05 
P(0.05 
P=fi.S. 
All TE and thrcmboses occured within the first 24 months of 
follow up except one (BS) which occured at four years. Two out 
of four pts with thromboeis were treated with streptokinase 
infusion: one had canp1ete lysis of clot with return of normal 
hemodynamics; the other had partial lysis with improvement fol-
lowed by elective surgery. Although the results are good with 
either prosthesis, valve related ccmplications are significantly 
greater with BS than with SJ in the mitral position. 
CORONARY VENOUS RETROPERFUSION: EFFECT ON FLOW AND METAB-
OLISM IN ACUTELY ISCHEMIC CANINE MYOCARDIUM STUDIED WITII 
POSITRON EMISSION TOMOGRAPHY. 
George T. O'Byrne, M.D., Christoph A. Nienaber, M.D., 
Akira !o1iyazaki, ~.D.t Sheila Kar, M.D., Luis Araujo, M.D., 
J. Kevin Drury, M.D., F.A.C.C., Eliot Corday, M.D., 
F.A.C.C., Heinrich R. Sche1bert, M.D., F.A.C.C., UCLA 
School of Medicine/Cedars Sinai Med. Ctr., Los Angeles, CA 
To investigate the effect of synchronized retroperfusion 
(SRP) on flow and metabolism in the myocardial risk zone 
(RZ) after a coronary occlusion, we studied 12 open chest 
dogs wi th PET, N-13 ammon ia or Rb-82 and F-18 2-deoxy-
glucose (FOG), SRP via the coronary sinus using an SRP 
pump was started 20 min after LAD occlusion. The ri sk 
zone was delineated with the flow tracers Rb-82 or N-13 
ammonia, and with micro spheres injected simultaneously 
into the left atrium. Retrograde flow to the risk zone 
was evaluated with Rb-82 or N-13 ammonia injected into the 
SRP system. RZ metabolism was assessed by i.v. FDG at two 
hours. Myocardial tracer uptake was imaged by PET in 3 
cont iguous eros s-sect ions. Mi crosphere blood f low and FDG 
concentrations were determined by in vitro counting of 
ti ssue samples. Results: In 10 dogs imaged the RZ was 
clearly delineated on the N-13 ammonia or Rb-82 images. 
In all 5 intervention dogs studied with Rb-82 or N-13 
ammonia, PET revealed retrograde delivery and retention of 
flow tracers to the RZ. While FOG uptake was decreased in 
proportion to flow in the 4 control dogs, it was markedly 
elevated in all 5 intervention dogs. Comparison of the 
FDG RZ/normal tissue count ratios in the intervention 
group (n=7) were 1.24±.45 vs. O.38±O.16 in the controls 
(peO.008). We conclude that SRP provides a blood supply 
and enhances glucose utilization in the RZ. Thus, in 
acute coronary artery occlusion, SRP may be beneficial for 
mainti'lning viability in the jeopardized myocardium. 
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LIDOCAINE DELIVERY VIA TIIE CORONARY SINUS RESULTS IN 
HIGH CONCENlRATIONS IN ISCHEMIC MYOCARDIUM. 
Paul Simon, M.D., Alice K. Jacobs, M.D., Davip p. Faxon, 
M.D., F.A.C.C., Anne C. Minihan, William D. Coats and 
Thomas J. Ryan, M.D., F.A.C.C., Boston University 
Medical Center, Boston, MA. 
Pressure-controlled intermittent coronary sinus 
occlusion (PICSO) dramatically reduces experimental 
infarct size by increasing flow to the central ischemic 
zone (IZ). Therefore, retroinfusion (RI) of 
pharmacologic agents during PIesO should provide high 
drug levels in ischemic myocardium. To study whether RI 
of lidocaine (L) during PIesO increases L levels in the 
IZ, 16 open chest anesthetized dogs received a bolus of 
L(l.4 mg/kg) followed by right atrial (RA) infusion of 2 
mg/min. After 30' of LAD occlusion dogs were randomly 
assigned to control or 60' of PIesO which was performed 
by a pump inflated balloon-tipped coronary sinus 
catheter. In the PIesO group, RA L infusion was changed 
to coronary sinus RI during balloon inflation using 
equal volume and [L) to the control group. At 90' 
plasma, IZ and nonischemic tissue [L) were measured. 
[L) ug/ml mean+SE 
PROFOUBD IIIFARCT SIZE REDUCTIOII WITH COROIIAIlY VEIIOUS 
RETROIllFUSIOIi OF DILTIAZEK III PIGS. 
Hiroyuki Tadokoro, M. D., Akira Miyazaki, M.D., Kimio 
Satomura, M.D., Sanjay Kaul, M.D. Michael C. Fishbein, 
M.D., F.A.C.C., Eliot Corday, M.D., F.A.C.C., J. Kevin 
Drury, M.D., F.A.C.C. Cedars-Sinai Medical Center,Los 
Angeles,CA 
To determine the efficacy of retrograde vs. antegrade 
administr~tion of Diltiazem (DL), 25 pigs were subjected 
to 60 min LAD occlusion (0) followed by 3 hours 
reperfusion (R). The pigs were randomly assigned to 1 of 
4 treatment groups. In group A (n=6) DL (225mcg/kg) was 
infused into the great cardiac vein (GCV) via a double 
lumen catheter for 30 min beginning 10 min prior to R. 
In group B (ns 6) DL was infused into the right atrium 
(RA). In groups C (n-6) and D (n-7), saline was infused 
into the GCV and RA respectively. There were no 
differences in regional myocardial blood flow or 
hemodynamics among the four groups during the 0 or R 
period. Infarct size (IS) expressed as a % of risk area 
and ischemic zone systolic shortening (%SS) measured by 
sonomicrometry 3 hrs after R are tabulated (mean±SD, 
*p<.05 vs. group B,C,D). 
Group A 
IS(%) 24.7±10.4* 
%SS 10.6±7.4* 
B 
62.2%12.6 
1.5%3.6 
C 
55.3±lS.8 
-0.3±6.4 
D 
63.8±10.3 
-2.H3.2 
Conclusion: Coronary venous retroinfusion of diltiazem 
resulted in improvement' in regional function and 
reduction in infarct size, whereas IV diltiazem and 
saline were not effective. As there were no differences 
in hemodynamics or regional blood flow, it is suggested 
that di1tiazem has a direct protective effect on the 
myocardium. Therefore retroinfusion, which permits drug 
delivery to jeopardized myocardium even during a total 
coronary artery occlusion may be effective even when IV 
therapy is not. 
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PRJFOIlIID ~ IN VEN'l'RlCUIAR ARRHrDIMDIS IlORI!G 
BUXlD-FREB Rl5PERi'\JSIC2f wrDl OXYGENM'ED l!'IDJSOIrm. 
steven P. Karas. MD, Etlward C. santoian, MD, Ranu 
Vinnani, MD, FACe, Marc s. Visner, MD, FACe, Craig Gold, 
Charles E. Rackley, MD, FACe, Gal:}' L. SChaer, MD, FACe. 
Georgetown University, washin;Jtcn, D.C. 
'Ibxi.c oxygen metabolites may be partly responsible for 
reperfusion arrtlythmi.as. To investigate the !:Ole of 
oxygen in causing reperfusion arrtlythmi.as, 2 groups of 
closed chest dogs un:lenoIent occlusion of the left 
anterior ~ (lAD) coronary artery with a balloon 
amioplasty catheter. After 90 minutes of occlusion, 6 
control dogs \¥ere reperfused with blcxxi by deflating the 
balloon. In 8 other dogs subjected to 90 min of occlus-
ion, the initial 15 min of reperfusion was m:xlified by 
perfusing oxygenated Fluosol-Oi\ (p02>600 Torr-37"C) into 
the distal lAD, while blcxxi entry was restricted by con-
tinued balloon inflation. 
After the 15 min Fluosol:O 700 
infusion, the balloon was ·1 soo ~;!::~:II 
deflated am blcxxi reper-!:l aoo (-'''-''''' 
fusion fran the native ~ .(~:.~. 
circulation was permitted. ~ <00 
RhytlDn was JOOnitored with a ~ JOO 
V3 chest lead am recorded ~ 200 
on a Holter JOOnitor. Total ~ 
ventricular ectopic beats ~ 100 
were suntnated durin:J the 15 e &0-~::n a-15m," l"-JamI" 30-45",," 
min intervals shoIn1: Occlu.ian - - - - R.perfuMln - - - -
ConclusiODS: 1) Blcxxi-free reperfusion with oxygenated 
Fluosol is associated with a marked reduction in ventric-
ular ar:thyt:hmias. Oooe blcxxi reenters followin:J m:xlified 
reperfusion, ventricular arrt1ythmi.as increase. 2) 'lllese 
data suggest that elements in b1cxxi other than oxygen are 
primarily responsible for reperfusion arrtlythmi.as. 
COROllARY VASCULAR. IRJURY APTEll SBOR1'-TEBM COROllARY ARTERY 
OCCLUSIOIf All) RBPElIPUSIOII 
Eugene Patterson. PhD. Robert D. Burow. and Benjamin J. 
Scherlag. PhD. FACC. Univ. of Okls. Health Sciences 
Ctr. and VAMC. Ok1shoma City. OK 
Vsscular function was examined 24 to 72 hrs sfter a 15 min 
(N=25) or 30 min (N=32) transient left anterior descending 
coronary srtery occlusion in the dog. Myocsrdial blood 
flow (MBF) was determined using Tc-99m microspheres. 
vsscu1ar permeability was determined using Tc-99m albumin 
(HSA). or appsrent vascular volume (AVV) was determined 
using Tc-99m RBCs. The 30 min occlusion group demon-
strsted increased MBF (hyperemia). increased HSA permea-
bility. and incressed AVV in the presence of minimal 
myocardial necrosis (0.9 + 0.3% of LV mass). A 15 min LAD 
occlusion produced only HSA extravasation in the absence 
of necrosis. changes in MBF and AVV. or marked leukocyte 
MBF (ml/min/gm) Tc HSA AVV LEUK 
(24 hr) snterior posterior ant/post ant/post ant/post 
control 1.11+.03 1.12+.03 0.99+.03 0.99+.01 1.0+0.1 
30 min 1.47+.09* 0.98+.05 1.31+.04* 1.43+.03* 16+7.2* 
15 min 1.04+.04 1.03~.04 1.32+.08* 1.02~.01 2.2~0.7 
*p<0.01 vs. control -
uptake. The 30 min. but not the 15 min group demonstrated 
a prolonged (48 hr) 12 to 16 fold leukocyte uptake 
coinciding with the altered vascular function. Vascular 
function in the 15 min group returned to normal at 48 hrs. 
RBC and carbon black extravasation with intercellular 
edema were observed in the 30 min group with no histologic 
changes in the 15 min group. The data suggest that 
transient coronary artery occlusion for 15 min produces a 
24 hr duration increase in vascular permeability. Unlike 
the vsscu1ar injury accompanying a 30 min occlusion 
period. the increased permeability oCCurs in the sbsence 
of histologic changes or marked leukocyte uptake. 
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EFFECT OF CHRONIC INFEROPOSTERIOR MYOCARDIAL INFARCTION 
ON ARTERIAL BAROREFLEX SENSITIVITY IN CONSCIOUS DOGS. 
Anthony J. Minisi, M.D .. and Marc D. Thames, M.D.; Mc-
Guire V.A. Med.Ctr., Richmond, Virginia. 
Recent data from our laboratory has demonstrated 
that cardiopulmonary baroreflexes are impaired following 
inferoposterior myocardial infarction (M!). There has 
been a great amount of interest on the effects of MI on 
arterial baroreflex sensitivity (BRS). The purpose of 
our study was to determine the effects of chronic MI on 
BRS in conscious dogs. In 10 dogs, BRS was assessed be-
fore and three weeks after inferoposterior MI producpci 
by circumflex coronary artery ligation and latex injec-
tion. The Mean % LV infarcted as determined by tetrazo-
leum red staining was 26±1.7. Similiar testing was per-
formed on 8 other dogs who underwent sham thoracotomy. 
Arterial pressure (BP) was altered by injection of phe-
nylephrine and nitroglycerin and the response of heart 
interval (HI) was measured. BRS was defined as the slope 
of the regression line relating changes in HI to changes 
in BP. A correlation coefficient of 0.65 was required 
for inclusion. Our results (± SEM) are summarized below: 
LCx SHAM 
Pre Post 
NTG 6.1±1.0 4.5±0.8 
PE 6.4±0.9 7.1±0.8 
NTG+PE 5.6±0.7 4.8±O.7 
Pre vs. Post; all p - NS 
Pre 
6. 6±1. 3 
11.5±1.7 
7. 1±1. 5 
Post 
6.8±1.4 
10.6±1.3 
7.6±0.8 
There were no significant differences in mean BP or mean 
HI before and after surgery. We conclude that there is 
no significant effect of chronic inferoposterior MI or 
sham thoracotomy on BRS. Although cardiopulmonary baro-
reflexes are abnormal following inferoposterior MI, ar-
terial BRS is preserved. 
ANIPAMIL MAY LIMIT MYOCARDIAL NECROSIS BY PRESERVING 
BLOOD FLOW TO ISCHEMIC MYOCARDIUM. 
John G. Kingma Jr., Ph.D., A. Robert Denniss, M.D., 
Ph.D., David J. Hearse, D.Sc., FACC, Derek M. Yellon, 
Ph.D., Cardiovascular Research, The Rayne Institute, St. 
Thomas' Hospital, London, U.K. 
This study examined whether the long-acting calcium 
channel blocker anipamil could (i) limit myocardial 
tissue necrosis following coronary occlusion (CO) and 
(11) affect blood flow to the ischemic zone. 29 dogs 
had CO with a 2.5 mm embolus injected into the left 
coronary vasculature; I " Cerium microspheres were 
injected to delineate the ischemic zone 2 min after CO. 
14 dogs received no drug (controls) and 15 received 
anipamil (0.25 mg/kg iv bolus; 5 min and 12 h after 
occlusion). Arterial pressure and heart rate were 
monitored for 24 hr. 4 control and 5 anipamil treated 
dogs received a second microsphere (ll'Tin or 
,. Scandium) after 24 h of CO to show changes in blood 
flow over 24 hr. Tissue necrosis (tetrazolium staining) 
as a percent of risk zone size (microsphere autoradio-
graphy) assessed after 24 h was 76±4% in controls and 
53±4% (p<0.005) in anipamil treated dogs. Risk zone 
size was similar in both groups (ANOVA). Anipamil did 
not affect arterial pressure or heart rate. In control 
dogs, blood flow to tissue that became necrotic was 
17±4% of nonischemic flow immediately after CO and 16±4% 
at 24 hr; flow in salvaged tissue was unchanged (49±13% 
to 54±12%). In anipamil treated dogs, flow to the 
necrotic zone was unchanged over 24 hr (16±8% to 26±12%) 
but increased in salvaged tissue from 45± 10% to 72± 11% 
(p<0.0l). Thus, anipamll limited tissue necrosis after 
24 hrs of sustsined ischemia and appeared to preserve 
blood flow to the ischemic subepicardium. 
JACC Vol. II, No.2 
February 1988:88A 
NITROPRUSSIDE RETARDS THE RATE OF INFARCTION IN DOGS WITH 
LEFT VENTRICULAR HYPERTROPHY AND HYPERTENSION. 
Kevin C. Dellqperger, M.D., Ph.D., Jennifer L. Clothier, 
Linda M. Haun, and Melvin L. Marcus, M.D., F.A.C.C., 
University of Iowa, Iowa City, Iowa 
FolloWing a one hour occlusion the transmural extent of 
infarction is almost as great in dogs with left 
ventricular hypertrophy and hypertension compared with a 
three hour occlusion in controls. To determine if 
nitroprusside infused one hour after circumflex occlusion 
to reduce hypertension (mean aortic pressure from 141 to 
100 mmHg) would retard the accelerated wavefront of 
infarction in left ventricular hypertrophy and hyperten-
sion , we studied ten conscious dogs with one clip, one 
kidney hypertension (Left ventricular mass increased by 
20%; mean aortic pressure - 140±3 mmg) and six controls 
during a three hour circumflex occlusion and 90 minutes 
of reperfusion. Infarct size (TTC) and risk area size 
(postmortem barium angiography) were determined for the 
endocardi~ (Endo), midwa11 (Mid), and epicardium (Epi). 
Results (x ± SEE, *p < 0.05 left ventricular hyper-
trophy and hypertension versus control or nitroprusside): 
INFARCT/RISK 
TOTAL ENDO MID EPI 
C (n - 6) 44 ± 7* 81 ± 5* 42 ± 10* 14 ± 7* 
LVH-H (n - 5) 64 ± 6 92 ± 2 71 ± 9 41 ± 7 
LVH-H + N (n-5) 40 ± 7* 80 ± 5* 43 ± 10* 8 ± 5* 
We conclude that nitroprusside administered one hour 
after circumflex occlusion retards the rate of infarction 
in dogs with left ventricular hypertrophy and hyper-
tension and restores infarct size to control values. 
Because the time window for effective thrombolysis may be 
narrowed, these findings may have important implications 
for the treatment of patients with left ventricular 
hypertrophy and hypertension and acute infarction. 
THE GLUTATHIONE REDOX PATHWAY AND REPERFUSION INJURY. 
THE EFFECT ON N-ACETYLCYSTEINE (NAC) ON INFARCT SIZE AND 
VENTRICULAR FUNCTION. 
Mervyn B. Forman M D F.A C C Christopher U. Cates, 
M.D., David W. Puett, B.A., Deborah McCroskey, B.S., 
Jeffrey K. Beckman, Ph.D., Harry L. Greene, M.D., Renu 
Virmani, M.D. F.A.C.C., Vanderbilt Univ, Nashville, TN. 
Glutathione peroxidase is an important enzyme in the 
degradative cascade of oxygen free radicals. To assess 
the role of NAC, a low molecular weight compound which 
replenishes glutathione, on reperfusion injury 23 closed 
chest dogs underwent 90 mins of proximal LAD occlusion 
followed by 24 hrs of reperfusion with the 
administration of NAC (n-11) or saline (n-12) 30 mins 
into occlusion and for 3 hrs post-reperfusion. Regional 
myocardial blood flow (RMBF) using microspheres and 
regional ventricular function were determined serially. 
Electron microscopy (EM), total glutathione, glutathione 
peroxidase activity and reactivity to thiobarbituric 
acid (TBA) , an index of lipid peroxidation, were 
determined at sacrifice from ischemic (IZ) and 
nonischemic (NIZ) zones. Infarct size (AN) was 
expressed as a percentage of area at risk (AR)' 
*p<.05,*p<.01. Radial Shortening 
AN/AR (%) 3hrs 24hrs 
NAC 27 ± 5 3.4 ± 2* 9.2 ± 2** 
SALINE 37 ± 6 -2.4 ± 2 -2.5 ± 6 
TBA (%) IZINIZ 
140 ± 20 
170 ± 20 
No Significant differences are noted in hemodynamics, 
RMBF or biochemical parameters. Endothelial disruption 
and neutrophil plugs obstructing capillaries were 
present in both groups on EM. A significant correlation 
was present between TBA reaactivity and infarct size 
(r-0.6, p-O.Ol). This study supports the hypothesis that 
free radicals contribute to myocardial stunning but are 
not primary mediators of myocyte necrosis following 
reperfusion. 
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Cardiac Function: Clinical 
RELATIONSHIP OF STERNAL ANGLE TO RIGHT ATRIUM IN 
CLINICAL MEASUREMENT OF JUGULAR VENOUS PRESSURE 
Donald E. Saunders, Jr., M.D., F.A.C.C., David 
F. Adcock, M.D., Douglas S. Head, M.D. and Brad 
M. Simpson, M.D., University of South Carolina 
School of Medicine, Columbia, South Carolina 
The traditional clinical technique for measure-
ment of jugular venous pressure (JVP) assumes 
that the sternal angle (SA) is 5 cm above the 
right atrium (RA) when horizontal (Hor) or with 
head up tilt. We opacified RA in 5 male and 5 
female adult cadavers and took 6 ft. lateral 
radiographs with an opaque marker over SA. 
Vertical distances from SA to mid-RA were mea-
sured at varying degrees of upright tilt and 
corrected for magnification. Identical mea-
surement technique was used in 2 patients with 
prosthetic tricuspid valves used to locate RA. 
Results in cm with standard deviation (SO): 
Hor 30· 45· 60· 90· Ave. Non-Hor 
Mean 5 9 10 10 9 10 (p=.OOl) 
SO 1 2 2 2 3 2 
Range 3-7 6-11 6-13 5-14 2-13 5-12 
The abrupt increase from horizontal to 30· and 
relative constancy from 30· to 90· is due to a 
simple geometric relationship involving points 
in the arc of a circle. In conclusion, tradi-
tional measurement of JVP has been based on an 
incorrect assumption. Instead, SA is about 5 
cm above RA when horizontal and about 10 cm 
above RA with head up tilt. These observations 
should improve accuracy of both JVP measurement 
and placement of external pressure transducers 
at RA level in right heart catheterization. 
RELEASE OF HUMAN ATRIAL NATRIURETIC FACTOR IS RELATED TO 
INCREASE IN ATRIAL DIMENSION. 
Gordon W. M:le, M.D., Rudo1];i1. Canepa-Anson, M.D., Robert 
J. Hcloard. M.D., F .A.C.C .• and Paul W. Armstrong, M.D., 
F.A.C.C., Univ of Toronto, Toronto, Ontario. 
The release mechanisms of atrial natriuretic factor (ANF) 
in man reI1Bin unclear. Accordirgly we conducted 
simultaneous heur:ldynamic, echocardiographic (echo) am 
plasma ANF studies to evaluate the relationships between 
changes in atrial pressures, LA dimension am plasma ANF 
in 7 Pta with normal heur:ldynamics am echo undergoirg 
routine cardiac catheterisation. Saline was infused at 25 
ml/min for 30 minute (SALINE) follOOled by a 30 minute 
wasbJut period (OFF). Perimeter and area of LA (PER, 
AREA) were planimetered fran 20 echo. The table shcMs 
resul ts (x.±SD) for ~ and LA pressures (RAP, LAP, llllfig), 
PER (an), AREA (an), am plasma iIImunoreactive ANF 
sampled from the PA am AD. ([ANFp], [ANFaJ, in pg/ml) at 
jontrol. 10 am 30 minute into SALINE am OFF. *p<.05, 
p<.01 va control (ANDV). 
RAP LAP PER AREA [ANFp] [ANFa] 
CONTROL 6+2 7±4 14.9+0.8 11.9+2.4 59+30 54+30 
SALINE 10' 8+3 9+5 15.6+1.4 13.3+2.2 64+35 -
30' 9+2# 12+5# 16.6+1.5* 14.8+1.9# 94+72* 80±76 
OFF 10' 8+3* 10+6* 15.9+0.7 14.2+1.1* 90+73* 
30' 7+3 7+6 15.7+0.7 14.0+2.1 69+35 73±50 
Plasma [ANF] sampled from-PA was siDillar to-that from the 
AD. Saline infusion increased RAP, LAP, PER am AREA. 
However the percent increase of [ANF] .rom PA#correlated 
only with that of PER, AREA (r=O.54 , 0.52 ), but not 
with that of LAP and RAP. Durirg OFF, RAP, LAP declined, 
rut the trend for an increase in LA dimensions and plasma 
[ANF] remained. These data supports the hypothesis that 
release of ANF in man ,is primarily mediated by an 
increase in atrial wall tension reflected by changes in 
atrial dimensions. 
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EFFECTS OF ATRIAL NATRIURETIC PEPTIDE 00 LEFT VENl'RIaJIAR 
PERFORMANCE IN ~. 
Ciro Indolfi, M.D., Federico Piscione, M.D., Massimo 
Volpe, M.D., Amelia Focaccio, M.D., Maurizio Cappe11i-
Bigazzi, M.D., Bruno Trimarco, M.D., Massimo Chiarie110, 
M.D., F.A.C.C. University of Naples, 2nd School of 
Medicine, Naples, Italy. 
Recent in ~ and animal studies have suggested that 
atrial natriuretic peptide (ANP) has negative inotropic 
effects. Left ventr icular (LV) pressure and volume 
(cineangiography) were determined at matched paced heart 
rate in 7 subjects undergoing cardiac catheterization 
which did not disclose heart disease. Data were obtained 
at rest and during the steady-state phase of the infusion 
of q -human-(1-28)-ANP (0.5 ug/kg prime, 0.1 ug/kg/min for 
20 min). ANP reduced LV end-diastolic and end-systolic 
volume indeces frCIII 93+6 to 80+5 ml/m2 (p< 0.01) and frCIII 
25,±3 to 17,±1 ml/m2 (p<0.05), respectively. LV ejection 
fraction tended to increase frCIII 72+5 to 77+3 % (NS) while 
mean blood pressure decreased frCIII 105.3+3 to 97.8+4 I!IIfIg 
(p< 0.05). End-systolic pressure/volume ratio (frciii 3+0.4 
to 4+0.8) stroke volume (frCIII 88.1+11.5 to 85.4+10 mll, 
peripheral resistance (frCIII 1183+i22 to 1132+125 dyne sec 
em ) and pulnonary wedge pressure (frCIII 9.1+1 to 8.8+1 
I!IIfIg) did not change Significantly. Initial-AMP plasma 
levels (17.±4.5 fiool/ml) rose to 704,±111 (p< 0.001) during 
the infuson and individual henodynamic responses were not 
related to plasma concentrations of ANP. These data 
suggest that ANP administration has no direct negative 
inotropic effect and changes induced on LV function are 
related to reduced cardiac load. 
EFFECTS OF BUFFER AGENTS ON MYOCARDIAL RESUSCITABILITY 
AFTER CARDIAC ARREST. 
Raul J. Gazmuri, M.D.; Max H. 
F.A.C.C.; Martin von Planta, M.D.; 
F.A.C.C. University of Health 
Medical School, North Chicago, IL. 
Weil, M.D., Ph.D., 
Eric C. Rackow, M.D., 
Sciences/The Chicago 
We previously demonstrated a marked increase in coronary 
vein PC02 during CPR in pigs to levels exceeding 150 mm Hg. Since increased myocardial PC02 has been identified as a cause of irreversible electromechanical dissocia-
tion, we compared the effect of NaHCO as a CO2 generating buffer; Na2C0 3-NaHC03 as a Cb2 consuming buffer; and NaCl placebo in approximately equimolar 
doses. The buffer agents were infused 8 min after start 
of ventricular fibrillation and 3 min after beginning 
precordial compression. Defibrillation was attempted 
after 13 min of VF. Coronary venous PC02, HC03-, and pH were measured prior to (p) and 3 minutes after (A) 
instituting buffer therapy: 
NaHC03 Na2C03-NaHC03 PAP A 
NaCl 
P A 
~ --m- -W- -9-7-- 153----W;-
6.85 7.35t 6.78 7.29t 6.75 6;84 
24 59t 20 43tt 20 19 
tp < 0.05 ttp < 0.01 
Both buffer agents increased coronary venous HC03 and 
pH; however, neither NaHC03 nor Na2C03-NaHC0.1 signifi-cantly altered coronary venous PCO. After NaHCO 4/5 
pigs survived; after Na2C03-NaHC03 ~/5; and after pl~cebo 4/6. We concl~de that reversal of acidemia by the 
administration of either CO2 generating or CO consuming buffer did not alter coronary vein PC0
2 
or 2myocardial 
resuscitability in our porcine model of cardiac arrest. 
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PRESERVATION OF LEFT VENTRICULAR FUNCTION AND 
TOPOGRAPHY WITH COMBINED REPERFUSION AND INTRAVENOUS 
NITROGLYCERIN IN ACUTE MYOCARDIAL INFARCTION 
Wayne J Tymchak M D Bogdan L. Michorowski, M.D., 
Jeffrey R.Burton,M.D.,F.A.C.C., Bodh I. Jugdutt, M.D., 
F.A.C.C., University of Alberta, Edmonton, Canada. 
Whether prompt improvement in LV function occurs con-
sistently after reperfusion (RP) in acute myocardial 
infarction (AMI) is controversial. The effect of RP in 
AMI,by intracoronary streptokinase and/or angioplasty 
combined with intravenous nitroglycerin (NG) , on LV 
asynergy, LV ejection fraction (EF) and expansion 
index (asynergic/normal endocardial segment length) 
was studied in 50 patients within 6 hours of onset of 
pain using serial two-dimensional echocardiography 
before (A) and after therapy at 24 hours (B), 7 days 
(C) and 6 weeks (D). Patients were randomized to 3 
groups: RP+NG (n-16), NG alone (n-18) or saline 
placebo (n-16). Creatine kinase infarct size (CKIS) 
was measured. NG (45 pg/min) was begun on 
admission and continued for 45 hours, RP was achieved 
within 2-6 hours. Results: 
CKIS (g-Eq) 
LV Asynergy % 
RP+NG NG 
42 36 
A 22* 20* 
B 10 12 
C 8 10 
D 5 8 
Expansion Index D 1.1 1. 2 
* p<O.OOl, within gps;t p<O.OOl across 
Saline 
51 
26 
25t 
22t 
20 t 
1. 5t 
gps (ANOVA) 
LVEF and other topographic indexes also improved with 
NG and NG+RP but not saline. Thus, RP+NG after AMI 
produces prompt and persistent improvement in LV 
function and prevents topographic deterioration. 
LEFT VENTRICULAR SYSTOLIC FUNCTION AHD DIASTOLIC FILLING 
CHARACTERISTICS IN PATIENTS WITH SEVERE MITRAL STENOSIS 
B. William Choi, MD, DebOrah J. BarbOur, MD, Martin B. 
Leon, MD, FACC, Kevin E. McCartby, MD, and Robert O. 
Bonow, MD, FACC. NHLBI, Bethesda, Md. 
Previous studies indicate that many pts witb pure mitral 
stenosis (MS) bave evidence of impaired LV B,Ystolic func-
tion. To cbaracterize B,Ystolic dysfunction in pts witb 
MS, we performed radionuclide angiograpby in 26 pts witb 
severe MS, aged 30 to 64 years (mean 4S+9 years). Tbere 
were 8 "n2and 18 women. Mitral valve area index was .63 +.18 em m, mitral valve pressure gralP-ent was 17+7 
iiimHg and cardiac index was 2.4+0.6 Lim (mean + soT. No 
pt bad associated coronary artery disease. Under resting 
conditions, ejection fraction ranged from 33J to S6J (mean 
44+6J), significantly less tban our normal range (SS+6J, 
p<:001) and IS pta (S8J) bad subnormal EF «4SJ). iF was 
related to valve area index (r=0.48 p(O.OS)-and was asso-
ciated witb reduced LV peak filling rate, normalized eitber 
to end-diastolic (EDV) or stroke (SV) volume; peak filling 
rate was 1.9+0.6 EDV/sec and 4.S +1.2 SV/sec, botb less 
tban our normal range (3.3+0.6 and S.7+l.l, respectively, 
bOtb p(.OOl). During maximal supine exerCise (IS pts) EF 
increased normally (44+6 to 57+9J, p<.001) witb only one pt 
manifesting a decrease-in EF. -However, LVEDV decreased 
24+l4J witb exercise compared to resting values (p(O.OOl), 
asSOCiated witb a l3+l8J decrease in stroke volume (p( 
0.02). Tbe magnitude of decrease in SV correlated witb de-
decrease in EDV (r=.76, p(O.OOl). Tbus, improved EF witb 
exercise occurred at tbe expense of reduced SV. These data 
indicate that impaired LV B,Ystolic performance occurs in 
tbe majority of pts with pure severe MS, related to reduced 
LV diastolic filling. LV filling is compromised furtber at 
increased beart rate during exercise, resulting in severe 
reduotion in SV. 
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AORTIC PRESSURE WAVEFORM ANALYSIS IN HEART FAILURE: AGE 
DIFFERENCES AND NITROPRUSSIDE RESPONSE 
John D Carroll. MD, Patricia W. Arand, PhD., Sanjeev 
Shroff, PhD., Mark Halsted, Sol Raj fer, MD, FACC, 
University of Chicago, Chicago, IL. 
Arterial properties and their response to 
vasodilators may be modified by aging. Using a 
multisensor catheter for pressure measurement (Millar) 
and thermodilution cardiac output, arterial mechanical 
properties were quantified from the aortic diastolic 
pressure decay in terms of: proximal (Cl), distal (C2) 
compliances (ml/mmHg), resistance (R,mmHg/ml/sec), and 
inertance (L,mmHg/ml/sec2). Data were obtained before 
(ctr) and after (np) nitroprusside in patients (N-19) 
with congestive cardiomyopathy (CHF). A second aortic 
sensor (25cm distal) allowed calculation of pulse wave 
velocity (PWV, m/sec) and peak systolic preSEure 
amplification. *p<.05 vs age <35; @p<.05 vs ctr. 
AGE R-ctr Cl-ctr M..:..!;,tt R.:..ml. ~ ~ 
<35 1.4±.6 2.6±1.2 4.7±.4 1.1±.5@ 3.9±2.0@ 4.4±.3@ 
35-50 1.8±.5 1.5±.8 6.5±.9* 1.2±.3@ 2.5±1.6@ 5.6±.6@* 
>50 1.7±.6 1.2±.4* 7.7±.6* 1.2±.4@ 2.4±1.2@ 7.2±.5@* 
Under control conditions there is an age-related loss 
of aortic compliance (low Cl and high PWV). After NP 
all groups showed an increased Cl and decreased Rand 
PWV. There were no age or NP differences in C2 and L. 
Systolic pressure amplification was abolished in the 
young (+4 to -2 mmHg@) and minimally changed in the old 
group (+3 to +2). COnclusions' Aortic pressure 
waveform analysis reveals a loss of compliance with age 
in CHF patients. After NP, the qualitative response of 
the arterial system is similar in all age groups. 
However, due to the absolute values of compliance and 
PWV attained with NP in the young, systolic pressure 
falls with distal propagation presumably due to greater 
attenuation and later return of reflections. 
'DIE RElATIOOSHIP OF RmIaw. tMlCARDIAL nH:TIaf TO 
RmIaw. TCJiIlGRAPIlIC 'ftIALLItM-20l PERPUSIaf. 
John Stratton, M.D., F.A.C.C., Sarah Speck, M.D., James 
CaldWell, M.D., Charles Maynard, Ph.D., Kathryn Davis, 
Ph.D., John Nemanich, M.D., Manuel Cerqueira, M.D., J. 
Ward Kennedy, M.D., F .A.C.C., James Ritchie, M.D., 
F.A.C.C., VAMC and univ. of Washington, Seattle. 
To determine the relationship of quantitative 
regional myocardial perfusion and function, we performed 
echo and resting tomographic Thallium-20l imaging 
(torno-TI) in 83 pts 4-12 weeks after MI. Using 5 
left ventricular regions, wall motion was graded on a 4 
point scale and tomo-Tl defects were quantitated 
independently as a percent region infarcted using a 
method previously validated in dogs. 
Among all 415 regions, the severity of the perfusion 
defect correlated directly with the wall motion (WM) 
score (r=0.68, p<O.OOO). Among regions with small 
torno-Tl defects (size 0-4), only 6% were ak-dyskinetic, 
compared to 86% of regions with large defects 
(~20)(p<.01). 
Tl Defect Size 
0-4(n-280 regions) 
5-9 (66 regions) 
10-19 (48 regions) 
~20 (21 rr~ions) 
Normal WM 
84% 
38% 
13% 
14% 
~ 
33% 
27% 
0% 
Ak-,: WM 
29% 
60% 
86% 
Normally contracting regions had a mean defect of 
2+4, while hypo, akinetic and -dyskinetic regions had 
progressively larger defects (6~5, 11~7 and 18~5, all 
p<.OOl vs normal). The global defect score correlated 
inversely with the ejection fraction (rz-.72, p<O.OOO). 
These findings demonstrate the close relation of 
perfusion and function documented previously by invasive 
methods. The combined noninvasive assessment of regional 
perfusion and function may be useful for the evaluation 
of reperfusion strategies in man. 
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LEFT VENTRICULAR DYNAMICS IN CIRCULATORY SHOCK 
Shan Shen Wang MD. Natesa Pandian MD. Deeb 
Salem MD. FACC. Marvin Konstam MD. FACC. 
Herbert Levine MD. FACC. Tutts-New England 
Medical Center. Boston. MA. 
To assess whether circulatory shock causes 
intrinsic myocardial dysfunction. we analyzed 
both load-dependent and load-independent 
parameters of LV function in a canine model of 
circulatory shock by employing two-dimensional 
and Doppler echocardiographic and hemodynamic 
monitoring. In 13 closed-chest anesthetized 
dogs. shock was produced by hemorrhage to 
decrease the mean arterial pressure to 50 mmHg. 
Hemodynamics and echo measurements of LV end-
diastolic cavity area and wall thickness. area 
ejection fraction. % systolic wall thickening. 
end-systolic wall stress and cardiac output 
were analyzed at control and at 2 hours of 
shock. In six additional dogs with atrial 
pacing. serial end-systolic pressure-area 
slopes were computed. Compared to control. the 
following occurred at 2 hours of shock: (x+SE) 
Heart rate increased by 58+13%; cardiac output 
fell by 54~9%; cavity area-decreased by 51~5%; 
ejection fraction increased by 43+17%; wall 
thickness increased by21+4%; % systolic wall 
thickening increased by 55+30%; wall stress 
diminished by 79+4%; (All-p<.05). End 
systolic pressure-area slopes in atrially paced 
dogs did not change significantly during shock. 
Thus. the alterations in left ventricular size 
and function during hemorrhagic shock appear to 
be primarily load related and not due to 
changes in intrinsic contractility. 
EFFECT OF AMIODARONE THERAPY ON VENTRICULAR FUNCTION: 
SERIAL, LONG-TERM ASSESSMENT 
Robert S. Sheldon, M.D., Ph.D., L. Brent Mitchell, M.D., 
Henry J. Duff, M.D., D. George Vyse, M.D., Ph.D., Dante 
E. Manyari, M.D., University of Calgary, Calgary 
Therapy with amiodarone (AMIO) is frequently effective 
in suppressing ventricular tachycardia (VT) but it has 
serious potential long term adverse effects. Many VT 
patients have poor ventricular function. The effect of 
amiodarone on ventricular function was serially studied 
during chronic therapy. Radionuclide angiography (RNA) 
was used to assess left and right ventricular ejection 
fractions (LVEF and RVEF) in 18 patients (64±B yrs) with 
VT while drug-free (DF), during AMIO loading (at 0.5, 
1.5 and 2.5 months), and at l8±16 months (range 5-50). 
AMIO levels (~g/ml) were also determined. 
DF 
LVEF 39±18 
RVEF 39±14 
AMIO ~g/ml 
AMIO therap~, 
0.5 1. 
42±17 40±18 
46±15 43±14 
1. 9±O. 7 1. 7±0. 6 
months 
2.5 
41±20 
44±14 
1.5±0.6 
1B±16 
42±19 
4S±15 
1.5 ±0.7 
To assess ventricular functional reserve 10 patients 
(64±10 yrs, rest LVEF 39±16) had symptom-limited exer-
cise (EX) RNA while drug-free and at 5 months. AMIO 
therapy did not significantly change EX duration, peak 
heart rate, peak systolic blood pressure, double 
product, or EX LVEF or RVEF or wall motion score at rest 
or exercise. Thus this long-term study shows that 
chronic AMIO therapy does not depress ventricular func-
tion in patients with VT. 
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LOADING DOSES OF ORAL PROCAINAMIDE EXERT 
CARDIODEPRESSANT EFFECTS AND ACTIVATE 
NEUROHORMONES IN PATIENTS WITH LEFT VENTRICULAR 
DYSFUNCTION. Stephen S. Gottlieb MD, Marrick L. Kukin MD, 
Peter B. Wilson MD, Norma Medina RNJ Madeline Yushak RN, 
Milton Packer MD, FACe. Mt. Sinai Sch of Med, New York, NY 
Procainamide (PCA) is thought to exert minimal negative 
inotropic effects; yet, the effects of oral doses of the drug have 
not been evaluated in pts with severe LV dysfunction. We admin-
istered a single oral dose of 750 mg of PCA to 30 pts with a LV 
ejection fraction < 35%. Cardiac index (CI, l/min/m2 ), stroke 
work index (SWI, g_m/m2 ), mean arterial, LV filling & mean right 
atrial pressures (MAP, LVFP & RA, mm Hg), heart rate (HR, 
bpm) & systemic vascular resistance (SVR, d-s-c) were measured 
before (Pre) and 60-90 min after PCA (Post)~ where * = p<.05 
cl swl MAp LvFP A HR SVR 
Pre-PtA 2.3 29 87 14 5 80 1812 
Post-PCA 1.9* 22* 79* 15 6 83* 1958* 
pcA decreased CI, sWI and MAp at dases that produced serum 
PCA levels of 0.0 to 15.0 \lg/ml (mean 6.1) 60-90 min after 
dosing. All but 5 pts had a serum PCA level within the thera-
peutic range (4-10 \lg/ml); only one had a serum PCA level> 10 
~g/ml. The'" in SWI after PCA varied linearly with the serum 
level of the drug (r = 0.51). The response to PCA, however, was 
not related to pretreatment hemodynamic variables or to plasma 
renin activity (PRA) or plasma norepinephrine. 
In 16 pts in whom 5WI '" >25%, PRA t after PCA (7.7 to 10.8 
ng/ml/hr), and this was associated with an t in SVR (1863 to 2019 
d-s-c), both p<.05. In contrast, in 14 pts whose SWI '" <25%, 
neither PRA nor SVR changed significantly. Changes in SVR were 
linearly related to the changes in PRA after PCA (r = 0.52). 
In conclusion, loading doses of PCA that praduce therapeutic 
serum levels of the drug can produce important cardiodepressant 
effects in pts with LV dysfunction. The decline in LV 
performance following PCA may evoke reflex systemic vasocon-
striction related to activation of the reni n-angiotensin system. 
MILD MITRAL REGURGITATION IMPAIRS LEFT VENTRICULAR 
PERFORMANCE IN PATIENTS WITH AORTIC STENOSIS. 
Douglas S. Schulman, M.D., Michael S. Remetz, M.D., John 
A. Elefteriates, M.D., Charles K. Francis, M.D., FACC. 
Yale University, New Haven, CT. 
The effect of mild mitral regurgitation (MR)(Grades 1-2) 
on LV performance in Pts with aortic stenosis (AS) was 
evaluated in 42 Pts with critical AS. Ventriculograms 
were digitized and ejection fraction, end-diastolic 
volume index, end-systolic volume index and end-systolic 
circumferential wall stress (ESS) were calculated. The 
slope and intercept (EFO) of the relationship of 
ejection fraction to ESS and the ratio of ESS to 
end-systolic volume index were used to assess LV 
performance. 25 Pts with AS and 17 Pts with AS and MR 
(AS-MR) had similar AD valve area (0.63 vs 0.61 cm2) 
and wall thickness (1.47 vs 1.36 cm) and no Pt had 
coronary artery disease or > 1+ aortic insufficiency. 
(**p <0.005, *p <0.05) AS (N-25) AS-MR (N-17) 
Ejection fraction (%) 58+13 39+17** 
End-diastolic volume index (ml) 83+28 118+35** 
End-systolic volume index (ml) 35+19 73+36** 
ESS (dynes 103cm-2) 103+30 148+54** 
Slope -0.39+.05 -0.24+.05* 
EFO(%) 93- 76* 
ESS/End-systolic volume index 3.54~1.22 2.3~1.12** 
(dynes 103cm-5) 
Among Pts with AS, those with mild MR have decreased LV 
function as measured by ejection fraction and the rstio 
of ESS/end-systolic volume index. The impairment in LV 
function is not a reflection of the increased afterload 
associated with AS~MR, since the slope and intercept of 
the ejection fraction-ESS relationship is depressed 
(despite increased preload, EDVI). Thus, tn Pts with AS, 
mild MR is a marker of impaired LV performance and may 
impact on long term outcome. 
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HYPERKINESIS WITHOUT FRANK-STARLING MECHANISM IN A NON-
ISCHEMIC REGION OF ACUTELY ISCHEMIC CANINE HEART. 
Yoichi Goto. M.D., Yuichiro Igarashi, M.D., Katsuhiko 
Hiramori, M.D., Hiroyuki Suga, M.D., National 
Cardiovascular Center, Osaka, Japan. 
An increase in systolic wall motion, i.e., hyperkinesis, 
in a non-ischemic region (NR) of an acutely ischemic LV, 
has been attributed to a combination of a compensatory 
operation of the Frank-Starl ing mechanism and intra-
ventricular regional interaction. However, it is still 
unclear whether hyperkinesis can occur solely due to 
regional interaction without any operation of the Frank-
Starling mechanism. Therefore, to determine the 
mechanism of hyperkinesis in NR, we assessed global and 
regional function of the excised, cross-circulated 
can i ne LV connected to a volume servo pump before and 
after coronary occlusion. Regional areas were determined 
from pairs of orthogonal subendocardial sonomicrometers 
in the ischemic region (IR) and NR. After coronary 
occlusion with LV end-diastolic and stroke volumes (EDV, 
SV) kept constant, the amount of systolic area shrinkage 
(ll A) in NR increased by 33±41% (p<.05) despite a 
decrease in end-diastolic regional area by 3±4% (p<.05). 
Regional work of NR measured from the wall tension-
regional area (T-A) loop decreased by 50±24% despite the 
hyperkinesis, indicating regional systolic unloading. 
When LV EDV was subsequently increased with SV kept 
constant, lIA in NR further increased at the expense of a 
further decrease in t,A in IR. In addition, the end-
systolic T-A relation in NR did not change whereas that 
in IR was markedly shifted to the right. We conclude: 1) 
hyperkinesis in NR can occur without any operation of 
the Frank-Starl ing mechanism; and 2) the mechanism of 
this phenomenon is regional systolic unloading in NR. 
UNLOADED SARCOMERE SHORTENING VELOCITY AND AMPLITUDE ARE 
UNALTERED WITH AGE. 
Richard A. Josephson, M.D., Robert S. Danziger, M.D., 
Harold A. Spurgeon, Ph.D., Makoto Sakai, M.D., Ph.D., 
Aureli ano Fraticell i, and Edward G. Lakatta, M.D. 
Gerontology Research Center, NIA, NIH, Baltimore, MD. 
To determi ne whether al terati ons in lI\Yocardial perform-
ance that are seen with aging are intrinsic to the II\YO-
cytes themselves, as opposed to alterations in heart 
rate, loading conditions, tissue visoelastic constraints, 
or neurohormonal modulation we isolated single left ven-
tricular lI\Yocytes by collagenase digestion from hearts of 
2, 8, and 24 month old Wistar rats (> 5 rats/age, > 15 
ce1 ~i/rat). Cell s were su~erfused with Hepes burfer 
[Ca ] = 1.0 roM, pH 7.4, 29 C, and field stimulated at 
24/mi n. Cell shorteni ng from sl ack 1 ength was measured 
with an inverted microscope-photodiode arr~ apparatus, 
and. cell length (11m) twitch amplitude (TA, !1m) maximal 
velocity of cell shortening (VC, IIm/secl, and time to 
peak shorteni ng (TTP, msec) were determi ned. Cell and 
sarcomere (SL, 1.84+.01 11m, p = NS for age) were measured 
from di gi ti zed photomi crographs and were 'used to cal cu-
1 ate the maximal amplitude and velocity of sarcomere 
shortening (SS and VS, 11m and 11m/sec). 
Age Length TA SS VC VS TTP 
2 126+3.2 8.5+1.0 .118+.014 169+20.0 2.34+.28 137+7.1 
8 137+6.9 8.5+0.4 .106+.005 162+6.1 2.02+.08 145+7.4 
24 165+4.0 11.4+0.9 .128+.010 192+13.8 2.16+.16 165+3.4 
P .0'0"01 .00'0"2 N! 0-:-04 N! 0.0'0"01 
Cell length increases with age. While the time course of 
contraction is prolonged in isolated lI\Yocytes from older 
rats, the amplitude and velocity of cell shortening are 
actually increased. However, the ampli tude and vel oci ty 
of the unloaded sarcomere, the fundamental contractil e 
unit, is unchanged with aging. 
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TIME COURSE OF LEFT VENTRICULAR HYPERTROPHY 
AND WALL STRESS IN AORTIC REGURGITATION 
J. William Gaynor M. D., Michael p. Feneley MD, 
George W. Maier MD, Stanley A. Gall Jr MD, Joseph 
A. Kisslo MD FACC, J. Scott Rankin MD, FACC 
Duke University Medical Center, Durham, N. C. 
While several hypotheses of the mechanism of 
hypertrophy in aortic regurgitation (AR) have been 
proposed, serial data regarding the time course are 
not available. Nine conscious dogs (18-26 kg) instru-
mented with orthogonal left ventricular (LV) ultrasonic 
diameter transducers and micromanometers were studied 
before and serially (4-9 weeks) after the creation of 
moderate to severe AR by cusp rupture. Ventricular 
dilatation occurred over the first 2 weeks, increasing 
end-diastolic (ED) volume by 15+4 ml, ED pressure 
from 13+1 to 25+3 mmHg, l!titu~nal wall stress (0) 
from 21£2 to 48!4- dynes x 10 fcm '3and2peak systolic 0 
from 171+8 to 202+12 dynes x 10 fcm (all p < .01). 
Echocarmographic r;V wall volume (WV) remained within 
5% of control until 3 weeks, when it increased abruptly 
by 19+3% over the next 2 weeks and then plateaued. 
ED and peak systolic 0 decreased during the develop-
ment of hypertrophy, returning to control in 4 and 6 
dogs, respectively, despite persistent elevations of ED 
volume at 10+6 ml above control and ED pressure at 
22+3 mmHg (p < .05). Thus, hypertrophy in AR is 
delayed until 3-5 weeks, L VWV begins to increase only 
after maximal elevations in ED 0, and hypertrophy 
returns 0 values toward control. These data support 
the hypothesis that increased 0 secondary to LV 
chamber dilatation is the factor stimulating hyper-
trophic adaptation to AR. 
WHAT FACTORS PREDICT RECOVERY OF CONTRACTILE 
FUNCTION OF POSTISCHEMIC STUNNED MYOCARDIUM? 
Karin Przyklenk Ph D and Robert A. Kloner,M.D. Ph.D. F.A.C.C. 
Harper Hospital and Wayne State University, Detroit MI. 
Recovery of contractile function of myocardium 'stunned' by a brief, 
IS min period of transient coronary occlusion is highly variable: in 27 
dogs, segment shortening (SS: measured by sonomicrometry) following 
reperfusion ranged from -84% to 99% of normal, preocclusion values. 
What factors determine the degree of recovery of postischemic 
function? To address this issue, regression analysis was used to 
assess the effects of the following parameters on SS at 2 hr 
postreperfusion; occluded bed size (i.e. area at risk); hemodynamic 
parameters (heart rate, mean arterial pressure and heart rate x mean 
pressure) measured preocclusion, during occlusion and 2 hr postreper-
fusion; regional myocardial blood flow (RMBF) during occlusion and 2 
hr postreperfusion; SS during occlusion; and high energy phosphate 
(adenosine triphosphate and creatine phosphate) content following 
reperfusion: Correlation coefficient 'r' I! 
Area at Risk -0.26 NS 
Hemodynamic parameters -0.17 to -0.36 NS 
RMBF: during occlusion -0.04 NS 
RMBF: 2 hr postreperfusion -0.38 NS 
SS: during occlusion 0.75 p<O.OOI·· 
High energy phosphate content 0.002 to 0.006 NS 
Surprisingly, the degree of ischemia (RMBF) during occlusion was a 
poor predictor of segment shortening following reperfusion. Similarly, 
high energy phosphate content of the stunned tissue did not correlate 
with its function follOwing reflow. Hemodynamic parameters, area at 
risk, and RMBF postreperfusion contributed to, but did not determine, 
postsichemic function. Only SS during occlusion reliably predicted SS 
postreperfusion: (SS postreperfusion)=(0.89)(SS during occlusion) + 
38.2; r-D.7S and p<.OOI. Thus, recovery of contractile function of 
stunned myocardium at 2 hr postreperfusion is determined primarily 
by the degree of dyskinesis exhibited during occlusion. 
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EVIDENCE FOR RIGHT VENTRICULAR ISCHEMIA DURING ACUTE 
PULMONARY HYPERTENSION. 
Veena Raizada. M.D .. F.A.C.C., Thomas Blomquist, Cynthia 
Smith, Beulah Woodfin, Ph.D., University of New Mexico, 
Albuquerque, NM. 
Impairment of right ventricular function during severe 
acute pulmonary hypertension (PH) may be due in part to 
right ventricular ischemia. This study was undertaken to 
determine if RV ischemia occurs during acute PH, and if 
so, the level of PH at which Ischemia is first manifest. 
The development of ischemia was assessed by measuring 
myocardial lactate levels In RV biopsies In a canine 
model of acute pulmonary hypertension. Six anesthetized, 
open chest, adult dogs ventilated with 100~ oxygen were 
instrumented to measure AO, pulmonary (PA) and RV 
pressures. PH was induced by injecting glass microspheres 
into the pulmonary circulation via the right atrium. 
Sequential RV biopsies were obtained during control (C), 
after PA pressure had doubled (moderate PH), tripled 
(severe PH), and at the onset of RV failure (RVEDP 200% 
above and AO pressure 30~ below C). Re1Yl11: At moderate 
and severe PH, RV lactate levels compared to C increased 
by 342~230~ (mean~SEM)(P<O.OI) and 151~48~ (P<O.OI), 
respectively. At the onset of RV failure, lactate 
levels decreased 44~28~ below C (P<O.OI). Conclusions: 
1) Increased RV lactate levels confirm the occurrence of 
RV ischemia during acute PH; 2) RV Ischemia was 
manifest at moderate PH, well before the onset of heart 
failure; 3) The decrease In RV lactate at the onset of 
right heart failure may reflect efflux of lactic acid 
from RV muscle as the Intracellular pH decreases. 
VENTRICULAR/VASCULAR COUPLING DYNAMICS IN A CHRONICALLY 
HYPERTENSIVE BABOON MODEL 
Rick Latham, M.D., Richard Walsh, M.D., Bernard Rubal, 
Ph.D., Pieter Sipkema, Ph.D., Nico Westerhof, Ph.D., 
Cardiology Service, Brooke Army Medical Center, Fort Sam 
Houston, TX. 
To assess the effects of systemic pressure on ventricu-
lar/vascular coupling, hemodynamics were evaluated in 
five chronically hypertensive (Group II) baboons (mean 
arterial pressure I48±16(+SD) mmHg; LV mass/body weight 
ratio 3.4±.8) at different mean arterial pressures and 
compared to five age, sex, diet-matched normotensive 
(Group I) controls (mean arterial pressure 89±3 mmHg; LV 
mass/body weight ratio 2.73±O.5 each p <.05 vs Group 
II). Biplane cineventriculography and simultaneous high 
fidelity pressures were recorded from the left ventricle 
and aortic root with ascending aortic flow at control, 
low and high pressures. A 3-element Windkessel or RC 
model was used to calculate total systemic compliance 
(C). Effective arterial elastance (Ea) was determined 
from simultanous pressure-volume data. C and I/Ea (in 
cc/mmHg) for both groups were: 
GROUP HIGH CONTROL 
C for I .16±.09 .96±.09] * 
C for II .25±.I2 .49±.16 
I/Ea for I .85±.44 1.83±.75] * 
I/Ea for II .48±.08 .96±.I2 
LOW 
I.4I±. 24 J *p 
• 62±. 26 * 
3.I9±1.5IJ .. 
I.47±.26 
<.05 
Plotted as a function of mean pressure, I/Ea and 
systemic arterial compliance followed a parallel 
relationship. Thus, changes in compliance determined 
from simultaneous aortic pressure and flow are reflected 
by parallel changes in I/Ea determined from the ventri-
cular pressure-volume relation and reliably discriminated 
Group II from Group I. Characterization of ventricular/ 
vascular coupling by these methods may provide assess-
ment of very early vascular changes in hypertension. 
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DOES REDUCED OXYGEN DEMAND IMPROVE CONTRACTILE 
FUNCTION OF POSTISCHEMIC 'STUNNED' MYOCARDIUM? 
Karin Przyklenk Ph D and Robert A. Kloner. M.D .. Ph.D .. F.A.C.C. 
Harper Hospital and Wayne State University. Detroit MI. 
Recovery of contractile function of myocardium stunned by a brief 
period of coronary occlusion may be enhanced if 0 3 demand of the 
myocardium is reduced during reperfusion. To test this theory, 12 
dogs underwent I S min of left anterior descending coronary artery 
occlusion followed by 30 hr of reflow. At 30 min postreperfusion (ie. 
when stunned), 6 dogs were randomized to receive a 2 hr infusion of 
the ultrashort acting beta blocker esmolol, while 6 received saline. 
Wall thickening (WT) in the central ischemic zone and % change in 
LV cavity area between end diastole and end systole (% Il A) were 
quantified from 2-D echocardiograms at the mid-papillary muscle 
level: 
Postreflow: 
fu ~ 
WT: ESMOLOL 44±S% -S±S% 
CONTROL 33±4% -1±4% 
% M:ESMOLOL 48±2% 2S±S% 
CONTROL 41±6% 2S±S% 
ll..min. 
6±8% 
I±S% 
34±4% 
3S±6% 
TREAT Posttreat 
'2hr ' ~ 30hr 
3±7% -I±S% 7±7% 
7±7% 2±3% IS±II% 
I S±3%* 36±3% 38±6% 
,36±4% , 33±S% 41±7% 
WT and % IlA were comparably depressed or 'stunned' at 30 min post-
reperfusion (prior to treatment) in both groups of dogs. Esmolol 
reduced hemodynamic indices of O2 demand - ie. during treatment, 
heart rate was II S±S* vs 140±6 bpm, mean arterial pressure was 
86±7** vs I38±S mm Hg, and LV dP/dt was 730±60** vs 1710±150 mm 
Hg/sec for esmolol-treated vs control animals respectively (*p<O.OI 
and **p<O.OOI). Esmolol did not, however, improve WT or %IlA; in 
fact, after 2 hr of treatment, % Il A was significantly ~ in 
esmolol-treated animals vs controls (*p<O.OI). Thus, reduced 0 3 
demand postreperfusion, achieved by infusion of the ultrashort acting 
beta blocker esmolol, did not enhance recovery of contractile function 
of stunned myocardium either during, or after, treatment. 
MORPHOLOGIC CHANGES IN THE NORMALLY DEVELOPING CANINE 
CONDUCTING SYSTEM. Marianne J. Legato, M.D., Gloria 
McCord, Melissa Weintraub, Peter Danilo, Ph.D. and 
Yoshiyuki Morikawa, M.D., F.A.C.C. Columbia, New York 
Significant changes occur in canine conducting system 
morphology between day 0 and week 12 of age. We studied 
37 bundle branches and found that cross sectional area 
doubles in the right and increases 5-fold in the left 
system. Over the time period studied, the % of myocytes 
by volume in the bundle stays constant at about 48% 
compared with the reported value of 28% in adults; bundle 
collagen content increases with age. Individual cell 
volume (4,000 p3 on day 0) and surface area (1200 ~2) 
increase 8 and 6-fold respectively by week 12, while cell 
surface to volume ratio (0.350 on day 0) approaches the 
adult value of 0.137 by week 12. Myocytes are packed 
into bundles or fasicles separated by 10 P or more from 
neighboring groups of cells; these fasicles maintain 
constant dimensions as individual myocytes enlarge: the 
numbers of cells per fasicle diminish from about 20 at 
day 0 to 6 by week 12 of life. The percent of myocyte 
membrane involved in specialized junctions between cells 
changes with development: 40% of the cell surface is 
involved in intercalated discs on day 0; this value de-
creases by 25% by week 12. Nexal junctions increase from 
2.6% of intercalated discs on day 0 to 5% by week 12. 
The percent of myocyte surface area facing on clefts 
increases 6-fold over this same time period. These 
increases in the number of low resistance junctions and 
in the capacity of the anatomic space in which K+ can 
accumulate during,repolarization may help explain the 
increase in conduction velocity that occurs in the bundle 
branches during normal development. 
94A ABSTRACTS 
REPETITIVE ISCHEMIA DELAYS RECOVERY OF 
REGIONAL MYOCARDIAL FUNCTION IN AWAKE DOGS 
Stanley A. Gall Jr MD, George W. Maier MD, 
J. WIllIam Gaynor MD, Michael P. Feneley MD, 
J. Scott Rankin MD FACC 
Duke University Medical Center, Durham, N. C. 
To examine the functional consequences of repeti-
tive reversible ischemia, 8 conscious dogs instrumented 
with left anterior descending (LAD) coronary occlud-
ers, regional sonomicrometer crystals, and left ventri-
cular micromanometers underwent in random sequence, 
72 hours apart, a single 15 minute LAD occlusion 
(SNGL), and two 15 minute LAD occlusions, separated 
by one hour of reperfusion (DBLE). Microsphere 
injections confirmed constant and insignificant coronary 
collateral blood flow during all occlusions. The area 
(A) beneath the regional stroke work - end diastolic 
dimension relationship quantified regional myocardial 
performance. Despite complete functional recovery by 
72 hours, repeated measures analysis of variance 
demonstrated a significantly delayed recovery of per-
formance in DBLE vs SNGL over the first 24 hours (p 
= .032). 
Reperf PERCENT OF CONTROL A 
Hours 0 .25 .5 1 2 4 8 24 
SNGL 14.1 57.958.664.858.2 65.0 76.6 83.9 
DBLE 12.954.3 32.4 26.8 43.6 47.6 68.5 75.5 
The time course of this additive effect supports the 
concept of a metabolic basis for myocardial 'stunning', 
and may correlate with clinical observations of 
prolonged postischemic myocardial dysfunction in 
patients with repeated episodes of unstable angina. 
IS THE RESPONSE OF PERIPHERAL AND PROXIMAL VEINS TO 
PRESSOR STIMULI SIMILAR? 
Vincent J.B. Robinson MB.BS, Linda J. Thorpe RT(R) 
RDMS,Eldon R. Smith MD, John V. Tyberg MD, PhD, FACC" 
David D. McPherson MD, University of Calgary, Calgary, 
Canada. 
It has been assumed that pressor stimuli cause uniform 
venous constriction. However, with peripheral venocon-
striction, blood could be efficiently translocated 
centrally if proximal (conduit) veins dilated. To test 
this hypothesis 11 normal male subjects (mean age 26 ± 
3.4yrs.) were studied supine using 20 ultrasound (2DU) 
(7 .5MHz). Fixed locations in the axillary and basilic 
veins were studied and venous cross-sectional areas (AV) 
measured at 2 separate control intervals (C1, C2) 
valsalva (VAL), mental arithmetic (MA), and with cold 
pressor (CP). Inter and intra observer and rematching 
variability for this technique was excellent 
(n=30,r>0.96) . 
Axillary C1 
AV 2 
(cm ) 
1.0 
±.3 ±.3 
Basilic C1 C2 
VAL 
1.4* 
±.3 
MA 
.25 AV 2 .27 .26 
(cm ) ±.10 ±.OS ±.07 
X ± SO. (+p <0.1, *p <0.05 vs 
Conclusions: 
C1 
1.0 
±.3 
C2 
1.0 
±.3 
CP 
1.3+ 
±.4 
C1 C2 CP 
.27 .26 .21+ 
±.10 ±.OS ±.OS 
C1 by ANOVA) 
1) 2DU can reproducibly assess dynamic venous changes; 
2) proximal veins dilate in response to pressor stimuli; 
3) while peripheral veins are known to constrict. 
The mechanism of this dichotomous response is unknown. 
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HEMODYNAMIC CONSEQUENCES OF THE ELECTRICALLY SILENT RIGHT 
VENTRICLE. 
James A. Goldstein, M.D., Atsushi Harada, M.D., Yoko Yagi, 
M.D., Benico Barzilai, M.D., and James Cox, M.D., 
F.A.C.C., Washington University, St. Louis, Missouri. 
Cardiac performance has been reported to be relatively 
uninfluenced by right ventricular free wall (RVFW) 
contractility. To determine whether impaired RVFW 
contractility is critical in conditions such as RV 
infarction, the RV was electrically isolated in seven dogs 
by surgical disconnection and resuturing of the RV, crush 
of the sinus node and independent pacing of all four 
chambers. With all four chambers paced in physiologic 
sequence, hemodynamics and RVFW motion were normal. With 
discontinuation of the RV pacer, the RVFW became electri-
cally silent and noncontractile resulting in an immediate 
decline in RV systolic pressure (SP) (30 + 5 to 13 + 3 mm 
Hg***). Within several beats there were decreases in 
aortic and LVSP (93 + 1S to 76 + 14 mm Hg*), and CO (5 + 
1.1 to 4.3 + 1 L/min*). RVEDP increased (4.5 + 1.6 to 5.9 
+ 1.6*), while LVEDP declined slightly (10 + 2~5 to 9 + 
2.4, NS). Echo demonstrated absent RVFW motion, increased 
RV end-diastolic area (EDA) (145% + 12% of control***) and 
decreased LVEDA area (76% + 9% of control*). The inter-
ventricular septum was flattened in diastole and bulged 
into the RV in systole. Four chamber pacing promptly 
restored normal RVSP with resolution of all hemodynamic 
and echo abnormalities. 
Thus, RVFW contractility is a major determinant of RVSP 
generation. Loss of RVFW contractility leads to decreased 
cardiac output, in part because of reduced LV preload 
mediated by decreased RV stroke volume. Systolic septal 
bulging may contribute to RVSP generation in the noncon-
tractile RVFW, but may also adversely affect LV perfor-
mance. (P(.05*, P(.01**, P(.005***, NS=not significant.) 
EFFECT OF WALL THICKENING ON END-SYSTOLIC PERFORMANCE: 
SHORTENING DEACTIVATION IN WHOLE HEART. 
Thomas R AverSanO M 0 , W. Lowell Maughan, M.D., Kenji 
Sunagawa, M.D., Lewis C. Becker, M.D, F.A.C.C. Johns 
Hopkins Hospital, Baltimore, Maryland. 
Shortening deactivation has been characterized in papil-
lary muscle as a reduction in end-systoliC force genera-
tion due to muscle shortening. The effect of wall thick-
ening extent on end-systolic performance was studied in 6 
isolated dog ventricles (LV) made to eject into a simu-
lated arterial system. Sonomicrometry was used to measure 
LV percent wall thickening, %6T. Control %6T and the 
end-systolic pressure-thickness relation (ESPTR) were 
measured with simulated peripheral resistance (R) set at 
3 mmHg-sec/ml. To change wall thickening extent (%6T) , R 
was changed from control to either 1.5 or 6 mmHg-sec/ml 
and then %6T was measured at each of 4 preselected levels 
of preload. We obtained 44 pressure-thickness loops at 
the various R's and preloads in the 6 LV's. Each loop's 
end-systolic pressure (ESP) and thickness (EST) was com-
pared with the ESP expected at that EST based on the 
control ESPTR at R-3. When 
R was lowered %6T 
increased and ESP 
was lower than 
expected at all 
EST's; and when 
R was increased %6T 
decreased and ESP 
was higher than 
expected at all 
EST's. This result 
is consistent with 
shortening deacti-
vation in whole heart. 
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IN SITU ANALYSIS OF T CELL SUBSETS AND NATURAL KILLER 
CELLS IN THE MYOCARDIUM OF MICE WITH COXSACKIE B3 VIRUS 
MYOCARDITIS. Hirofumi Deguchi. M.D., Tetsuya Hayashi, 
M.D., Yasushi Kitaura, M.D. and Keishiro Kawamura, M.D. 
Osaka Medical College, Takatsuki, Japan 
It has been proposed that immune mediated processes 
playa crucial role in the development of myocardial 
injury in myocarditis. To evaluate the immune mecha-
nisms, we identified T cell subsets and natural killer 
(NK) cells in the myocardium of 55 C3H mice with 
coxsackie B3 virus myocarditis by the immunoperoxidase 
technique. To identify pan T, helper/inducer T (Th/i), 
Cytotoxic/ suppressor T (Tc/s) and NK cells, cryostat 
sections of the heart were stained with anti Thy 1.2, 
Lytl, Lyt2 and asial0 GM! antibody, respectively. On 
days 9 and 14, numerous T cells and NK cells were 
located in and around the necrotiC foci. Th/i were more 
predominant in the myocardium than Tc/s, resulting in 
high Lytl'/Lyt2' (T4/8) ratios. In months 3 and 12, 
some T and NK cells were identifiable in the healing 
foci. Immunoelectron microscopy revealed that some Tc/s 
and NK cells were in close contact with apparently 
normal, degenerated and necrotic cardiocytes throughout 
the experimental period. Conclusion. 1) T and NK cells 
playa crucial role in the lysis of Virus-infected 
cardiocytes in the early stage. 2) In the chronic 
stage, the presence of residual T and NK cells suggests 
their involvement in sustained cardiocyte injury. 
day 5 day 9 day 14 month 3 month 12 
Pan T 6±3 90±29 113±22 16±3 6±1 
Th/i 6±4 79±23 101±19 14±4 6±2 
Tc/s 4±2 15±3 12±4 4±1 2±1 
T4/8 1.3±0.5 5.5±1.8 9.1±3.6 3.6±0.44.1±1.4 
NK 26+4 180+29 115±16 12+3 7+2 
Number of pan T, T cell subsets and NK cells in the 
myocardium per unit area (0.2 mm 2 )(mean±SD) 
ANTI-MYOSIN REACTIVE IMMUNE RESPONSE IN CARDIAC DISEASE. 
Ivan De Scheerder, M.D., Marc De Buyzere, Joris Delanghe, 
M.D., An Maes, Denis Clement. M.D .• FACC. Roger Wieme. 
M.D., FACC. University Hospital. Ghent, Belgium. 
Myosin has been shown to possess cross-reacting epito-
pes with group A streptococci M proteins and coxsackie B 
viruses. Furthermore. anti-myosin antibodies (AMA) have 
been suggested to playa pathogenetic role in rheumatic 
heart disease and acute myocarditis. 
A sensitive and highly specific ELISA-assay was deve-
loped to determine AMA in 121 patients with various heart 
diseases: acute viral myocarditis (n=10, MYO), infectious 
endocarditis (n=13, ENDO),acute myocardial infarction 
(n=28, AMI). valve surgery (n=35. VALVE),and coronary 
bypass surgery (n=35, COBY). AMA were determined on ad-
mission and serially during a period of 90 days. Anti-
myosin immune response (IgG and I9M) was expressed compa-
ring absorbance of the patients' serum with a reference 
serum. In the different cardiac patient groups signifi-
cantly (p <0.01) higher AMA concentrations (espeCially for 
IgM ENDO and MYO) were found on admission compared with 
age matched control groups without any clinical evidence 
of cardiac disease. During follow-up all patient groups 
showed a significant increase in AMA concentrations with 
an immune response ratio (peak/referral) for AMA IgG and 
IgM respectively of 2.12 and 2.40 for VALVE, 1.90 and 1.99 
for COBY. 1.42 and 1.48 for AMI, 1.66 and 1.25 for MYO, 
and 1.10 and 1.09 for ENDO patients. By the end of the 
study nearly all AMA values were comparable with those 
found at referral,except for the VALVE and ENDO groups. in 
which still significantly increased AMA IgG levels(£<O.Ol) 
were measured. 
These data suggest that anti-myosin mmune response 
does not only depend on cross-reactive mmune response 
out is merely caused by direct cardiac njury. 
ABSTRACTS 95A 
PROONOSl'IC HARKERS 1M PATIENTS wrm TISSUE POOVEN 
HIOCARDITIS 
William J. FrenCh, M.D., F.A.C.C., Shi-Kaung Peng, M.D. 
Ph.D, Michael M. Laks, M.D., F .A.C.C., Harbor-UCLA Medical 
Center, Torrance, CA. 
Myocarditis may result in progressive cardiac disease and 
death. Unfortunately, no clinical, noninvasive, or 
invasive markers exist that define prognosis in these 
patients. The purpose of this study was to correlate 
clinical, electrocardiographic (ECG) and histo~o~ic 
findings with prognosis in patients with myocard~tJ.s. 
Nineteen patients with normal coronary arteries had tJ.ssue 
proven myocarditis on endamyocardial biopsy .(18) or post 
mortem (1) specimens, characterized by aggr~gates of 
inflaIllDatory cell infiltrates and myocyte necrosJ.s. Group 
A comprised 14 patients who were alive at followup and G~oup 
B, 5 patients who died. Age, sex, clinical presentatJ.on, 
left ventricular ejection fraction (Group A mean 27% vs. 
Group B 25%), ECG rate, axis and QRS duration were similar (p 
>0.2). Histologic findings did not differentiate either 
group. An R wave <0.1 and ST >0.1 in V2 or V3 in the absence 
of left ventricular hypertrophy predicted death within a 
mean 3.3 months with a sensitivity of 80% and a specificity 
of 100%. 
R < 0.1 + ST > 0.1 
R > 0.1 + ST < 0.1 
Group B 
--,:r-
Conclusion: Clinical and histologiC findings were not 
prognostiC markers in patients with myocarditis. However, 
evidence of severe ischemia or acute infarction on the 
electrocardiogram predicted prognOSis with a high 
sensitivity and specificity. Recognition of these 
prognostic markers may suggest the need for more intensive 
medical therapy and possibly early cardiac transplantation. 
INTERLEUKIN-l INDUCED INHIBITION OF PROTEIN 
SYNTHESIS IN NEONATAL RAT HEART CELLS VIA A NON-
MYOCARDIAL CELL SOLUBLE MEDIATOR. Stephen M. 
Campbell, M.D. and Jeffrey D. Hosenpud, M.D., 
F.A.C.C. The Oregon Health Sciences University, 
Portland, Oregon. 
Previously reported cardiac depression by 
interleukin-l (lL-l) has been further defined by 
demonstrating inhibition of protein synthesis 
(PT) in isolated cultured neonatal rat heart 
cells (NRHC). To determine whether decreases in 
PT required the participation of non-myocardial 
heart cells (NMC), 2-4 day old NRHC were 
incubated with varying numbers of NMCs without 
(C) or with lL-l (12.5 "/ml). In a separate 
study, supernatant (S) from control (C,) or IL-l 
stimulated NMCs (loe or l00/ml) were incubated 
with NRHC. Uptake of l'+C-phenylalanine ("·ct) 
was used as a marker for PT. Results are 
expressed as counts per second. 
NRHC +loeNMCs +10'~MCs 
C (n=5) 18319±2342 18963±1848 l8403±3178 
IL-l (n=5) 22105±3765 15746±2340Q 13287±2295a 
(Q=P<.OI compared to NRHC alone, a=p<.OI 
compared to 10~MCs). 
NRHC+S( 10"NMC) NRHC+S( 10"'NMC) 
C, (n=3) 15772±10b2 15222±1252 
I L -1 (n=3) 13860±900Q 1 0263± 1135a 
(Q=P(.05 compared to C" a=p<.005 compared to C, 
and loeNMC). 14C~ uptake by NRHC was not 
influenced by the addition NMCs alone or 
supernatant from NMCs. When lL-l was added, or 
supernatant from IL-l incubated NMCs, 14Ct 
uptake was significantly reduced. IL-l appears 
to induce heart NMCs to produce a soluble factor 
which inhibits NRHC protein synthesis. 
96A ABSTRACTS 
EXERCISE INDUCED ABNORMALITIES IN cAMP RESPONSES IN 
CONGESTIVE HEART FAILURE. 
Alan S. Maisel, M.D., F.e.A.A., Paul Lee, C. Michael Wright, M.D., 
Steven Carter, VAMC and University of California, San Diego. 
Exercise has been shown to increase beta-adrenergic receptors (BAR) 
in normal man. We asked whether patients with congestive heart 
failure (CHF), who have decreased cardiac BAR, have altered BAR and 
cAMP accumulation after stimulation with 10uM isoproterenol or 20uM 
forskolin, before and after exercise in 12 healthy patients (N), and in 
15 patients with NYHA class II-III CHF. Prior to exercise, patients 
with CHF had slightly greater BAR than control (2074± 243 sites/cell 
vs. 1819 ±200 sites/cell, p<0.025) with no difference in surface 
receptors (96% vs 95%). The following changes were seen with 
exercise. 
BAR NE (pg/ml) cAMP% control 
iso f orskolin 
N 3096±289 1023 293±114 I 56±60 
CHF 3592±323 711 92±19·· 60±10· 
• = p<O.05, •• = p<O.OI vs. control 
In CHF, exercise led to similar release of NE and BAR as N. 
However, patients with CHF exhibited marked abnormalities in cAMP 
responses to exercise at and distal to the beta receptor. This 
suggests that exercise may uncover an abnormality in regulatory 
control of adenylate cyclase in patients with heart failure. 
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CIRCADIAN VARIATION IN THE HEART RATE RISE OCCURRING 
DURING TRANSIENT ISCHEMIA RECORDED WITH DAILY ACTIVITY 
Keyin M. Cgy. M.D. and Carl J. Pepine, M.D., F.A.C.C., 
University of Florida, Gainesville, Florida 
Transient asymptomatic myocardial ischemia has docu-
mented circadian variation with clustering in the early 
waking hours, the pathophysiologic basis of which 
remains unclear. To further characterize these ischemic 
episodes we investigated heart rate (HR) changes that 
occurred during the interval beginning 1 minute before 
1.0 mm ST segment depression (ST.) to maximum ST •• Ten 
patients with coronary artery disease and positive exer-
cise tests underwent ambulatory ECG monitoring (Oxford 
FM) for 1 to 3 days. A total of 50 silent ischemic 
episodes ~ 1.0 mm ST'" lasting ~ 1.0 minutes were re-
corded with a total ischemiC tin~ of 2722 minutes. HR 
increased during all silent ischemic episodes with the 
greatest (P<0.05) increase between 0600 and 1200 hours 
(HR increased 20 beats per minute [bpm]). The increase 
in HR during ischemia was of lesser magnitude throughout 
the remainder of the day (14 bpm from 1200 to 1800 
hours; 11 bpm from 1800 to 2400 hours and 2 bpm from 
2400 to 0600 hours). When ischemic episodes were grouped 
for HR at onset 1.0 mm ST. the majority occurred at HR 
5% lower than those during exercise testing. These 
below exercise HR threshold ischemic episodes comprised 
100% of ischemic episodes occurring between 2400 and 
0600 hours, 64% between 0600 and 1200 hours and 38% be-
tween 1200 and 1800. However, exercise HR threshold is-
chemic episodes became more frequent as the time of day 
increased. 
In conclusion, HR changes occurring during ischemic 
episodes that occur with daily life can be classified 
into 2 distinct types of episodes which may have 
pathophysiologic importance. 
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FREQUENT ISCHEMIC EPISODES DURING THE MORNING HOURS 
IN CORONARY PATIENTS: A RESULT OF DECREASED ISCHEMIC 
THRESHOLD OR INCREASED MYOCARDIAL OXYGEN DEMAND? 
Dirk Hausmann. M.D., Werner G. Daniel, M.D., Peter 
Nikutta, M.D., Car1.-A. Hartwig, M.D., Paul R. Licht1en, 
M.D., F.A.C.C., Hannover Medical School, Hannover, FRG. 
Frequent ischemic episodes (EP) during the morning hours 
are a common finding on Holter ECG in coronary patients 
(pts). However, it remains controversial whether this is 
based on a reduced ischemic threshold or a higher myocar-
dial demand during this period. We therefore studied 109 
pts with stable angina pectoris and coronary stenosis>70% 
by 24-hour Holter ECG. During 156 days (1-3 d/pt) of Hol-
ter ECG 76 pts (69.7%) showed 437 asymptomatic (asym) and 
143 symptomatic (sym) EP of ST-segment depreSSion (STD; 
~O. 1 mV,~l min). The parameters measured in time periods 
of 3 hours are listed in the table: number of asym and 
sym EP, total dur!tion of STD (D), mean values of STD-
duration per EP (D), of maximal STD-amp1itude (AMP) and 
of heart rate at STD-onset (HR). 
Time: 01-04 04-07 07-10 10-13 13-16 16-19 19-22 22-01 
No. asym EP 11 31 110 77 60 80 38 30 
No. sym EP 2 8 35 28 26 27 10 7 
o (min) 151 600 1992 1032 1052 1514 693 514 
IT (min) 12 15 14 10 12 14 14 13 
AMP (mV) 0.17 0.21 0.22 0.23 0.22 0.23 0.22 0.22 
HR (l/min) 90 94 99 99 100 98 98 101 
The significant increase in number and total duration of 
ischemic EP during the morning hours was confirmed. 
However, STD-duration per EP, STD-AMP and HR at STD-onset 
were comparable during all periods. Hence, the increased 
rate of ischemic EP is not based on a decreased ischemic 
threshold during the morning hours but on an increased 
oxygen demand paralleling patient's activities. 
SILENT ISCHEMIA IN SURVIVORS OF OUT-OF-HOSPITAL 
VENTRICULAR FIBRILLATION. 
Jeanne E. Poole, M.D., Bob Norris, M.D., David B. 
Callahan, B.S., Michael Emery, B.S., Leonard A. Cobb, 
M.D., F.A.C.C. Harborview Medical Center, University of 
Washington, Seattle, ~. 
We evaluated the prevalence and prognostic significance 
of silent ischemia (51) in 43 survivors of 
out-of-hospital ventricular fibrillation (OHVF) who had 
24 hour ambulatory monitor recordings performed within a 
few weeks of their VF event. Ten (23%) of 43 pts had 
one or more episodes of ST segment depreSSion >1 mm 
lasting >1 minute. No patient reported correlative 
symptoms.- These 10 pts form the 51 group. The remaining 
33 pts were asymptomatic during the recording and had no 
episodes of ST segment depression (No 51 group). In the 
51 group the average number of episodes of ST depression 
was 2.3 + 2.1 and the average duration was 12.3 + 12.6 
min. The mean depth of ST depression was 1.6 + 0.7 mm. 
History (HX) of old MI was significantly greater in the 
No 51 pts (14 of 33) than in the 51 pts (1 of 10), 
p ~ .05. However, there was no significant relationship 
to other characteristics including age, sex, VF with 
acute Q-wave myocardial infarction (MI), (HX) of old MI, 
HX of angina, coronary artery disease, and HX of heart 
failure. Recurrence of VF by 8 + 1.3 years occurred in 
2 of 10 (20%) 51 pts and 12 of 33 (36%) No 51 pts, 
P - .2. 
Conclusions: 1) 51 occurred in about one-quarter of pts 
who survived OHVF. 2) Pts with SI were less likely to 
have a HX of an old MI. 3) 51 did not identify a 
subgroup of pts at greater risk for recurrent cardiac 
arrest. 
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VALIDATION OF AMBULATORY ECG FOR DETECTING ISCHEMIA IN 
HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY, 
Julio F, Tubau, M,D" Jadwiga Szlachcic, M,D" Martin J, 
London, M.D., Milton Hollenberg, M.D., Dennis T. Mangano, 
Ph.D., M.D., Barry M. Massie, M.D., F.A.C.C. VAMC and 
University of California, San Francisco, CA 
Ambulatory ECG monitoring (AECG) has been shown to be 
a valuable tool for detecting ischemia (ISCH) in patients 
(PTS) with coronary artery disease (CAD), but its 
validity in PTS with left ventricular hypertrophy (LVH) 
is unknown. Therefore, we studied 14 hypertensive PTS 
with ECG LVH and high probability of CAD undergOing 
elective vascular surgery under general anesthesia using 
continuous 12-lead ECG and AECG and simultaneous two 
dimensional transesophageal echocardiography (TEE). ISCH 
was defined as the appearence of new wall motion 
abnormalities on TEE scored semiquantitatively by 2 
blinded observers. AECG using leads CM5, CC5 or ML and 
12-lead ECG were classified as positive if they showed >1 
mm of ST depression at J+60 and lasting >1 min. 
Intraoperatively 8 PTS developed ISCH by TEE, of whom 
5 (63%) had positive AECG, and 4 (50%) had 12-lead ECG 
changes. Of 15 ischemic episodes by TEE, AECG detected 11 
(73%) and the 12-lead ECG 8 (53%). AECG changes usually 
followed new wall motion abnormalities, but persisted 
longer. In PTS with at least 1 episode of ISCH by TEE, 
AECG and 12-lead ECG diagnosed 2 episodes of ISCH without 
concomitant TEE changes. Of 6 PTS without ISCH by TEE, 
none had AECG or 12-lead ECG changes. 
These results, derived from a unique setting in which 
independent corroboration of ISCH is available, indicate 
that AECG is accurate for detecting ISCH in PTS with LVH. 
However, the low incidence of false positive results 
should be verified in PTS with a lower prevalence of CAD. 
ISCHEMIA AND MYOCARDIAL INFARCTION DURING NON-CARDIAC 
SURGERY: PRELIMINARY RESULTS OF THE PORIS STUDY. 
Zoltan G. Turi, M.D., F.A.C.C., Vincent P. Reyes, M.D., 
Omar Dajani, M.D., Stephanie Revels, R.N., Joshua Wynne, 
M.D., F.A.C.C •• Wayne State University School of 
Medicine and Harper Hospital, Detroit MI. 
Patients with coronary artery disease (CAD) who undergo 
non-cardiac surgery are thought to be at enhanced cardio-
vascular risk. We studied 42 stable patients (mean 
Goldman cardiac risk index score = 1.6) with CAD 
documented by coronary angiography, positive stress test, 
and/or previous myocardial infarction who were undergoing 
elective non-cardiac surgery. Patients were entered 
into a prospective, randomized, double-blind study of 
nifedipine vs. placebo therapy in the perioperative 
period. Holter monitoring for ischemia (defined as 
>O.lmV ST deviation 60 msec after the J point lasting > 60 seconds) was performed from 12 hours pre-op to 96 
hours post-op. CK-MB was determined every 4 hours. 
Myocardial infarction occurred in 7 patients (16.7%) 
and ischemia was demonstrated in 17 patients (40.4%). 
35% of nifedipine treated patients and 45.5% of placebo 
patients developed ischemia (NS). The majority of 
myocardial infarctions (71.4%) and 32.4% of ischemic 
episodes occurred in the first 24 hours post-op. We 
conclude that despite apparent stable CAD, patients are 
at high risk of early post-operative ischemia and 
myocardial infarction during hospitalization for routine 
non-cardiac surgery. 
ABSTRACTS 
EFFECTS OF THERAPEUTIC INTERVENTIONS ON THE 
DISTRIBUTION OF SILENT ISCHAEMIC EPISODES 
THROUGHOUT THE DAY 
97A 
David Mulcah~ MRCPI, Jennifer Keegan MSc, Amanda 
Par~SRN, Peter Crean MRCPI, Arshed Quyyumi MRCP 
Kim Fox MD, National Heart Hospital, London, UK. 
142 pts (mean age 55) had ambulatory ST moni-
toring (total 5936hrs) off routine antianginal 
therapy. 566 episodes of ST change (>.- 1mm) were 
recorded (426 painless). 77% of silent attacks 
occurred during the waking hrs (0730-2230; 
median 1300). 2 subgroups were studied amongst 
these pts. 33 pts also had ST monitoring (1289 
hrs) while taking nifedipine (N) and 41 pts 
(1605hrs) while taking atenolol (A). 44.5% of 
128 silent episodes occurred between 0730-1330 
(AM) in the off therapy N group and 32% between 
1330-1930 (PM) (ratio 1.39). On N 41.5% of 135 
silent episodes occurred AM and 29.5% PM (ratio 
1.41). The median remained at 1300 despite N. In 
the off therapy A group 34.7% of 236 episodes 
occurred AM and 30.5% PM (ratio 1.14). When on A 
22.3% of 139 painless episodes occurred AM and 
36% PM (ratio 0.62). The median shifted from 
1300 to 1400. In summary: the median of the 
distribution of episodes was the same in the 
total group off therapy, the two subgroups off 
therapy and the group on N. A, however, led to a 
reversal of the distribution of episodes from AM 
(0730-1330) to PM (1330-1930) with a shift of 
the median to 1400. This may be of therapeutic 
significance as the incidence of myocardial 
infarction (MI) is greatest AM and, as it has 
been suggested, circadian rhythm of acute MI is 
altered by beta blocking agents. 
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Echocardiography/Doppler 
COLOR ENCODING OF IN-VITRO REGURGITANT JETS BY COLOR 
DOPPLER FLOW MAPPING: AN INDEX OF VELOCITY, FLOW RATE, 
OR REGURGITANT VOLUME? Iaf.n A. Simpson, M.D., Lilliam M. 
Valdes-Cruz, M.D., FACC, David J. Sahn, M.D., FACC. Univ 
of Calif, San Diego, CA. 
To assess the relative contributions of flow velocity 
(VEL) and flow volume (VOL) to color pixel aSSignment on 
color Doppler flow mapping (CDFM) we simulated regurgi-
tant jets in-vitro by controlled, timed, constant flow 
injections of a 0.5% cornstarch/water suspension through 
0.2, 0.5 and 1mm diameter orifices (OR). A constant VOL 
(Sec) was injected through each OR at varying flow rates 
and.also,varying VOLs were injected at constant flow 
rates of 0.2, 1.0 or 2.0 cc/sec through the 0.2, 0.5 and 
1mm OR, respectively. CDFM was performed using a Toshiba 
SSH65A with a 5MHz transducer at constant gain and 4kBz 
pulse repetition frequency. At constant VOL, color jet 
length (JL), jet width (JW) and jet area (JA) varied 
with flow rate at each OR with higher flow rates requ-
ired to produce similar sized jets at larger OR's. How-
ever at constant flow rates, maximal color JL, JW and JA 
remained virtually unchanged though absolute VOL varied 
substantially (1-30cc). The minimum.flow rate required 
to produce color encoding in the VEL-variance mode 
(injected VOLEScc) was 0.07 cc/sec at the 0.2mm OR, 0.2 
cc/sec at 0;5mm OR, and 0.3 cc/sec at 1.Dmm OR. How-
ever, good color assignment was obtained in VEL-variance 
(JA-1.0 cm2 ) and power modes (JA~1.8 cm2 ) from a high 
VEL injection (4 m/sec) of only 0.008 cc/sec through a 
0.04mm OR. Color JL, JW and JA of simulated regurgitant 
jets in-vitro are mainly determined by flow rate, and 
hence, VEL at a particular OR. Color encoding itself is 
almost entirely VEL dependent and much less affected by 
actual regurgitant volume. This may account for Bome of 
the difficulties encountered in assessing the VOL of 
regurgitation by the VEL distribution seen on CDFM. 
98A ABSTRACTS 
COLOR DOPPLER FLOW MAPPING: INTRA AND INTER-MACHINE 
VARIABILITY FOR LOW FLOW VELOCITIES IN AN IN VITRO MODEL 
Krishan K. Aggarwal M D , Elizabeth F. Philpot, M.S., 
Sally Moos, Ajit P. Yoganathan, Ph.D., Navin C. Nanda, 
M.D., F.A.C.C., University of Alabama at Birmingham, AL. 
Low velocities (V) unlike high V flows are not easily 
reproduced in the available color Doppler (CD) systems 
developed by different manufacturers. The flow (32±3 
cm/s) through a 6 mm inside diameter tube in a phantom 
flow model was imaged at a depth of 3 cm using 4 commer-
cially available CD systems (A,B,C & D). Different 
instrument settings (IS) were changed in order to 
produce a flow image with a 6±.S mm diameter. The exact 
IS used for each CD system were recorded because often 
the same IS in different CD systems would not perform 
the same function. Combinations of IS generating flow 
images with a diameter 6±S mm for various CD systems are 
as follows: 
ABC D 
3. S MHz 
Low filter 
PRF 4 KHz 
No reject 
70% flow gain 
3. S MHz 3.0 MHz 3.5 MHz 
Low filter No reject Processing 
PRF 4 KHz PRF 4 KHz Map A 
80% flow gain Compression 24 cm depth 
S frames/s Low V mode 
SO% flow gain SO% flow gain 
In all CD systems, >10% increase in flow gain over-
estimated diameter (8±S mm). Frame rate had no effect 
on diameter except in C. Settings of high pulse 
repetition frequency (PRF) , high filter, high reject, 
high 2D gain in A,B & C and low 2D gain in D under-
estimated the diameter. Thus, to avoid any significant 
error, IS for any given CD system need to be stand-
ardized especially for imaging low velocity flow areas 
such as occur in cardiomyopathies, aneurysms, and "tail" 
end of regurgitation. 
EFFECT OF SCANNING DIRECTION AND FRAME RATE ON THE AREA OF 
FLOW IMAGE IN PHASED-ARRAY COLOR DOPPLER ECHOCARDIOGRAPHY 
Shynei Kyo. M.D.,Yuji kondo, B.S.,Shinichi Takamoto, 
M.D.,Makoto Matsumura, M.D.,Yuji Yokote, M.D.,Ryozo Omoto, 
M.D.,Saitama Medical School, Saitama, Japan. 
Disproportion of the heart rate and scanning frame rate 
(FR) of color Doppler echocardiography can produce various 
grades of distortion in the visualized color flow image 
(CFI). To analyse the influence of scanning direction (SO) 
and FR, CFI of the left ventricular systolic flow was 
obtained in the parasternal long-axiS view in six normal 
adult, using 3.5 MHz probe with 6 KHz of pulse repetition 
frequency and Aloka 860 color Doppler system. The heart 
was scanned with ECG gate at 1/3 (E:early), 1/2 (M: 
middle) and 2/3 (L:late) of systolic interval after R-wave 
with FR of 15, 10 and 7.5/sec in iso-SD(ISD) and reversed 
SD (RSD) to the flow. Area of CFI was measured for three 
times with an average of ten beats. Area (cm2 ) of CFI at 
FR=15 (control), and the percent area of CFI at FR=10 and 
7 5 to the control were tabulated as follows' 
IFR S[ E M 
I (control) Area of CFI (cm") 
1 15 ~SD 7.1±0.4 --s.4±0~ 5.~±O.5 
ISD 3.3+0.2 7.0±0.3 4 .9±0.8 
Percent area of CFI to t e contro 
10 RSD 87± ~\~I l17±lq(%.) 82±11(%) 
ISD 1l7±15(%) 89± 6(%) 81±19(%) 
7.5 RSD 76± ~m 168±2~i~l 60± 7(~~ ISO 162± 8 % 69± 9 % 53±13(% 
n concluslon, scannlng dlrectlon and frame rate cnangea 
the size of CFI significantly (p<0.05) , especially in the 
lower frame rate. Thus influence of these scanning 
conditions on the size of color flow image must be 
reckoned with in the quantification of intracardiac flow 
by phased-array color Doppler examination. 
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COMPARISON OF AMPLITUDE AND VELOCITY MODES IN LOW FLOW 
STATES BY COLOR DOPPLER 
Krishan K. Aggarwal M D , Navin C. Nanda, M.D., 
F.A.C.C., Sally Moos, Elizabeth F. Philpot, M.S., 
Frederick Helmcke, M.D., David Kandath, M.D., and Ajit 
P. Yoganathan, Ph.D. University of Alabama at 
Birmingham, Alabama 
Amplitude (AMP) mode unlike velocity (V) mode depends 
not on angle but on the number of blood cells in a flow; 
thus, this mode would better evaluate low V flows as 
occurring in cardiomyopathies and aneurysms. Flows in a 
6 mm inside diameter tube at a 3 cm depth in a Doppler 
flow phantom were imaged using the AMP mode in the only 
2 available color Doppler (CD) systems with this mode. 
The flow areas derived using the preset settings which 
allow the maximum flow areas to be obtained in the AMP 
mode were compared with the flow areas derived using V 
mode of the respective systems. Flow areas using the AMP 
mode in system B were also compared with flow areas 
generated in system C, which does not have the AMP mode 
but can detect lower velocity flows (3 cm/s) than the 
other present available CD systems. When comparing data 
generated in the AMP and V modes in CD systems A and B 
at V of 10±2 cm/s (n-lO), larger flow areas resulted in 
AMP than V mode (1.23±.23 cm2 vs .22±.01 cm2 , p<.OOl). 
Comparing the flow areas in systems Band C at S . 
different V (20±4 cm/s) , the maximum V derived flow 
areas in CD system C (2.6±.S cm2) and in CD system B 
(2.3±.3 cm2) were lower than AMP derived areas in CD 
system B (3.2S±.17 cm2) (p<.OS). AMP mode displays 
lower V flows with higher sensitivity than V mode 
display, and may have more potential in clinical 
evaluation of low flow states. 
LOW FLOW VELOCITY SENSITIVITY IN COLOR FLOW MAPPING 
DOPPLER: POWER MODE VS DYNAMIC RANGE REALLOCATION FOR 
DISPLAY. Tadashi Tamura, B.S., David J. Sahn, M.D., 
FACC, Kimberly Krabill, M.D., Univ. of Calif, San Diego. 
The power mode for flow mapping encodes color inten-
sity as integrated Doppler power adding together Doppler 
signal amplitudes at all Doppler shift frequencies. 
Theoretically it should have excellent sensitivity for 
detecting low flow velocities (V). We performed in 
~ experiments with steady flow of 0.5 to 1% corn-
starch suspensions in 7.9mm tubes in a water tank with 
flow at varying angular orientations to the transducer. 
Our model allowed actual V to be calculated from the 
volume flow rate. Standard V variance (Va) mode, power 
(P) mode and changes in dynamic range of color alloca-
tion for brighter colors at lower velocity (~DF cont-
rast) were compared on a Toshiba SSH65 (3.75MHz) and 
standard Va mode and a ~DF mode were studied on an Aloks 
880 (3.5MHz) each at 4kHz pulse repetition frequency and 
at fixed gain. On the Toshiba, the P mode produced flow 
encoding to as low as 4.1tl.5 (SD) cm/sec compared to 
standard Va mode 5.5tl.5 cm/sec, ~DF brought low sensi-
tivity to 3 cm/sec. On the Aloks, the Va and ~DF mode 
showed flow to 4.0tl.l cm/sec. While the result of each 
display mode depends upon instrument setup, wall fil-
ters, frequency and gain, both ~DF as well as P mode or 
their combination improve the detection and display of 
low V flow. Clinically,in poorer signal-to-noise situa-
tions such low V flows are rarely detected, but in our 
clinical experience with color flow mapping in pts, 
comparing the P mode and Va mode has routinely confirmed 
P mode to be superior for detecting and mapping low 
velocity vena caval and atrial flows, and flows in 
Fontan connections. The P mode is useful and important 
in Doppler flow mapping. 
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QUANTIFICATION OF VALVULAR REGURGITATION BY GAIN-
CORRECTED DOPPLER IN A PULSATILE FLOW MODEL 
Scott R Cannon, PhD, Kent L Richards, MD, FACC, & 
Michael Lujan, Utah State Univ, Logan, UT; VA & Univ Tx 
Health Science Center at San Antonio, TX. 
Previous work suggests that Doppler can quantitate val-
vular regurgitant volume (RV). Because the technique is 
sensitive to instrument gain, our purpose was to deter-
mine & use accurate gain correction factors. A 15 rom 
Doppler sample volume was placed across the regurgitant 
orifice of a pulsatile flow model. Raw Doppler data was 
intercepted using a computer interface. To characterize 
the effects of gain, Doppler data from two orifices (.15 
& .72 cm2) were studied at RV's of 7, 14 & 32 cc over 
flow periods of .38 & .70 sec over a wide range of gain 
settings. Using standard mathematical methods for 
describing function shapes, diastolic integrals of the 
first four spectral function moments (SFM) were calcu-
lated and compared with gain. Excellent correlations (R 
-.93-.99) were noted. Regression slopes were then used 
to determine gain correction factors. To test 'gain cor-
rection, Doppler records were then obtained at RV's of 2 
-48 cc over a wide variety of orifice sizes (.08-1.29 
cm2) & flow periods (.25-.75 sec) at arbitrary gain 
settings (n-87). Gains were selected to produce displays 
which best separated background noise from flow signals 
without regard to analysis. After gain correction, good 
correlation was noted between diastolic integrals of SFM 
& RV (R-.88; SEE-6.4). Predicted RV differed from actual 
RV by an average of only 5.0 cc (SD-3.7). Only two RV 
estimates were in error by more than 15 cc. We conclude 
that it may be possible to quantify regurgitant volume 
using a simple Doppler technique which can be corrected 
for variations in instrument gain. Further study is 
warranted to investigate this approach in man. 
~oo OF CX)I£R OOPPIER IMl\GES Wl'IH 'lllE CX)I£R 
IMl\GE~ 
S.M. IdlodzinsJd, Bl.p., L.E. Ginzton, M.P., F.A.C.C., 
M.M. laks, M.P., F.A.C.C. Hal:bor-UCIA Medical Center, 
Torranoe, california 
Color DewIer flaor (alF) mappin;J has been viewed as a 
qualitative diagmstic JIDdality used to guide oontinla.Is 
wave «(lq) DewIer alcn;J visualized jets for quantitative 
blcxxl flaor velocity (FV) measurements. Algorithms were 
develqai to analyze the oolor CXII"pCSitien of irxiividual 
pixels, entire jet areas am FV di.stril:uticns across 
oolor jets. FV erXXlded oolor bar intensities of red, 
blue am green were used for oolor calibration. Algo-
rithms were inplerented en a high perfonuance oolor 
image processor (CIP) providin;J the image manipllation 
am storage capability (Dextra 0-200). A series of real 
time alF images produced by an HP 77020 ~ array 
ultrasonic mac:bine with 5 MHz transducer were digitized 
by the CIP am stored. '1hese included nultiple frames 
of aortic, mitral am tricuspid FV at different pllse 
repetition frequencies. '!he resolutien of digitized 
images was 640 x 480 pixels. SiIrultarlerusly, CW DewIer 
measurements were taken at the same FV sites. CDl data 
were analyzed by the CIP en a beat-by-beat basis am 
ca:npared to CW DewIer reoordin;Js. '!he folla.r1n;J was 
obseIved: (A) '!he oolor of irxiividual pixels translated 
by the CIP into 2 basic FV ~ (red or blue) am 
green (variarx:e) produced quantitative measures of FV. 
In the ran;Je fran 0.1 to 0.75 IIVs a gcxxl oorrelation 
bettNeen FV derived by CIPI' am O'l DewIer was fc:mxi (r = 
0.87). (B) '!he oolor jet areas translated by the CIP 
into isd:lars identified a wide dynamic ran;Je of FV 
within the jets. (C) '!he velocity distriWtions alorg 
straight lines across jets sh<:lw nornmifoI1D. velocity 
profiles. '!he quantitatien of alF is clinically 
applicable with FV less than 1 IIVs. 
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:u..uJIID!: ~ ImRr RATR, lEAN 1IRIJIRIAL l'HESSlIGS, FRElOiID, 
AIiD IIOIKPIC S'lM!I: (JiI JMrARDIAL tGlWDIIC Bi!CKSCAT'H!R. 
KB Sagar. M.D .• F.A.e.e., L Pelc, PhD. , TL Rhyne, SCO, 
LS warm, M.P., F .A.e.e., IX: Warltier, M.P., PhD , Medical 
College of Wisconsin, Milwaukee, WI. 
Ultrasonic backscatter is substantially ncdi.fied by 
pathological changes (A) in JIlYOCardimn. Influence of 
physiological A in heart rate (HR), mean arterial 
pressure (MAP), preload, ard iootropic state were studied 
in 16 anesthetized open-chest cbgs. HR was changed with 
atrial pacin;JjuLFs' 40 (bradycanli.ac agent). MAP was 
varied with aortic constriction/nitrcprussicle; preload 
was altered with nitroglycerin/volume infusion; and 
iootropic states were altered with dobutamine (10 u/kg) 
/esJ.!Dlol (100 u/kg). IBRS, an c.ptimlm weighted frequeIx:y 
average ( 4 to 6.8 MHz) of the squared envelope of 
diffraction corrected for absolute backscatter, FAM, 
Fourier Co-efficient of anplitucle DDdulation, an iOOex of 
cardiac cycle cleperv:Ent variation, were neasured fran 6 
sequential ED3 gated intervals througt¥:lut the cardiac 
cycle. HR, MAP, preload, or iootropic state did not 
significantly affect IBRS. FAM iI¥:J:eased fran 3.5 ± .3 
dB (mean ± SEM) to 7.0 ± .4 dB (P < .01) at a HR of 
120/min, ard decreased to 3.9 ± .4 at a HR of 160/min. 
l<b A in FAM was ooted with a rise (70 ± 12 to 116 ± 15 
1IIItiq, mean ± SO) or a fall (70 ± 12 to 45 ± 10 1IIItiq), in 
MAP or preload (an increase or decrease of diastolic 
~t length of ± 10% fran the baseline). Dc:lbltamine 
produced a significant increase in left ventricular dp/dt 
(2600 ± 200 to 3475 ± 275 1IIItiq) and FAM (3.4 ± .1 to 6.4 
[P < .01]). EsnDlol significantly redIx:ed left ventri-
cular dp/dt (2600 ± 200 to 2000 ± 175 1IIItiq, P <.05), ard 
FAM (3.4 ± .01 to 6.4 ± .1, P < .01). We conclude that 
IBRS is in:ieperxlent of HR, MAP, preload, ard iootropic 
state. Cardiac cycle cleperK:lent anplitude mxIul.ation 
follCMS changes in cardiac contraction. 
DELINEATION OF IMPROVED CONTRACTILE PERFORMANCE AFTER 
THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION WITH REAL-
TIME TWO-DIMENSIONAL ULTRASONIC INTEGRATED BACKSCATTER 
Samuel A. Wickline, M.D., Gregory A. Mohr, Ph.D., Thomas 
A. Shoup, Ph.D., Kelth A. Wear, Ph.D., Carl J. Gessler, 
M.D., Philip A. Ludbrook, M.D., F.A.C.C., Allan S. Jaffe, 
M.D., F.A.C.C., Burton E. Sobel, M.D., F.A.C.C., James G. 
Miller, Ph.D., and Julio E. Perez, M.O., F.A.C.C., 
Washington University, St. Louis, MO 
To determine whether quantitative real-time ultrasonic 
backscatter imaging can detect effects of coronary artery 
recanalization and recovery of regional contractile func-
tion after acute ischemic injury, we studied 9 patients 
with acute MI in our Cardiac Care Unit with acute MI 
treated with i.v. tissue-type plasminogen activator at 
2.8 ± .8 hr after onset of infarction. Two-dimensional 
(2-D) ultrasonic images were obtained immediately after 
admission in 5 patients and within 24-72 hr in 4 others. 
Each rf A-line was processed on-line by circuitry that 
computed integrated backscatter in real-time, providing 
either gray-scale or color-coded dynamic 2-D backscatter 
images. For all patients, myocardial regions remote from 
the injured zone demonstrated a physiologic cardiac 
cycle-dependent variation of backscatter, 3.1 dB (SD ± 
1.1). Cyclic variation measured within 24 hr in injured 
regions was blunted significantly: 0.3 ± 0.7 dB (p < 
.05). Patency of infarct-related arteries was documented 
in 6/8 patients by coronary angiography. Cyclic varia-
tion improved in 4 of these patients within 2-11 days 
after reperfusion (6 = 1.3 - 2.9 dB) and was normal (3.4 
dB) upon initial evaluation in 1 patient. Thus, ultra-
sonic tissue characterization defines regions of acute 
ischemic injury, and delineates early recovery of region-
al cardiac function after thrombolysis in man. 
tOOA ABSTRACTS 
INITIAL CLINICAL EXPERIENCE WITH AN ULTRASOUND STETHOSCOPE (A 
RAND-HELD ZD CARDIAC ULTRASOUND DEVICE) (v, 0 Schyvz M D 
Richard S. Mellar. M.D .• FACC. Univ of Rochescer. Rochescer. N.Y. 
We prospectively evalUlled a hand-held baUery-powered 2D 
cardiac ullrUound stethoscope (US) (ScanMate. Damon Corp .. 
Neeclhllll. MA) in the initial evaluation of acutely ill cardiac Pts 10 
test whether immediate cardiac imaain, with such an instrument 
was a u.ful ellenlion 10 the cardiolo,ist's history and physical 
elllll. On 64 con.cutive acutely ill Pts evaluated by the CCU tellll 71 
elllllS were performed. Adequate imqes were obtained in 6'171 
(92'U In thu.. 63/6' (977.) of the findia,s were confirmed inde-
pendently (catheterization. ndionuclide an,io,raphy. standard 
ec;hocll'Clio,raphy. or at sur,ery/pathololY). Information which 
directly influenced ID&Ilqement decisions wu obtained in '9171 
(837.). The US was most often u.d for evaluation of YIll motion 
(WM) and ,lobal LV function ("171 Pts). particularly in the .ttin, 
of postinfarc;tion an,ina or unstable anlina 10 .. IS neY re,iona! 
WM abnormalities (121"). In 4 cues emer,ent cardiac c:atheter-
ization or other invasive proc:edures were appropriately delayed or 
canceUed based on the imqin, information obtained by this device. 
There were no faJ. positives or nelatives in detection of pericardial 
effusions ,realer than ttac:e in '171 Pts. In 14 cues systolic heart 
murmurs were found; the confirmed US diqnu.s were: aortic; sc:1e-
rosis without stenosis in 7. aortic stenosis in 1 . .vere mitral valve 
prolap. in 1. and normal valves in,. .,ur,itant murmurs not 
aseoc1ated with structural valvular abnormalities could not be fully 
u.ssed with this imqin, only device. LA size and mitral valve 
architecture ftS evalUlled in , Pts yith neY on.t atrial fibrillation 
prior 10 cardioversion. A len ventric;ular clot was seen in one Pt. and 
conrlrmed on foUOY-up stanclard echoc:ll'Clio,raphy. In lAother Pt a 
normal sized ,lobally hypotinetic speckled LV was seen; cardiac 
lIllyloid was lU~quently documented at postmortem elllllination. 
The averqe time required 10 c;omplete the sono,raphy was less than 
10 minutes. Conc:1usion: The US provided valuable information that 
frequently influenced therapy lAd yould be othenr_ unavailable 
at the bedside of acutely ill patients 24 hours per day. 
HEMODILUTION DOES NOT AFFECT ULTRASONIC MYOCARDIAL BACK-
SCATTER IN DOGS ¥eorg.e B. Haasler. M.D., Kiran B. Sagar, 
M.D., Theodore L. Rhyne, Ph .D., Lawrence E. Boerboom, Ph .D. , 
Gordon N. Olinger, M.D., L. Samuel Wann, M.D., Department 
of Cardiothoracic Surgery, Medical College of Wisconsin, 
Milwaukee, WI 
Because of conflicting data on the effects of coronary blood 
flow, tissue water content and hematocrit (Hct) on integrated 
myocardial backscatter (IB), the problem was reexamined in 
7 open chest dogs. IB Rayleigh 5 (IBR5), an optimum weighted 
frequency average (4-6.8mHz) of the squared envelope of 
diffraction calibrated for absolute backscatter, and Fourier 
coefficient of amplitude modulation (FAM) , an index of car-
diac cycle dependent variation in IBR5 were measured from 6 
sequential ECG-gated intervals throughout the cardiac cycle. 
Data were obtained at control times, during adenosine infu-
sion to maximally vasodilate coronary arteries and after 2 
hours of hemodilution with Ringers Lactate (Hct 15%). Serial 
water content was determined by drill biopsy and circumflex 
coronary artery blood fll'w with an electromagnetic flow 
prDbe. 
ContrDl(+SEM) Adenosine HemodilutiDn 
IBR5(dB) -44.85+.23 -44.64+.22 -45.55+.09 
FAM(dB) 6.8 - 5.S - 3.S-
HCt(%) 38+1.8 38+1.8 15 
Water content(%) 78:-3:!:..2 SO:-4:!:..3 S1.3+.4 
No change was seen in IBR5 with adenosine or hemodilution 
despite significant increases in coronary artery blood flow 
and water content. The measured changes in water content, 
may be insufficient to alter ultrastructure significantly 
enough to change IB and are less than changes after ischemia. 
Such alteratiDns in ultrastructure may be more important 
determinants of IB than changes in tissue water , blood flDW 
or Hct. 
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DETECTION OF EARLY ATHEROSCLEROSIS BY QUANTITATIVE 
ULTRASONIC METHODS. 
P .A.N. Chandraratna, M.D., F .A.C.C., Tahir Tak, M.D., 
Joie P. JDnes, Ph.D., Stephen Kaiser, Shahbudin H. 
RahimtDDla, M.D., F.A.C.C., LAC-USC Medical Center, Los 
Angeles, CA and UC Irvine, Irvine, CA. 
To assess the value of quantitative ultrasonic methods 
in detecting early atherosclerosis, 12 freshly excised 
specimens of abdominal aorta were Dpened longitudinally, 
suspended in a water tank and scanned using a 
rectilinear ultrasound scanner under computer control. 
A data acquisition system based on the TRW S-bit 20 MHz 
AID board and IBM AT computer was used. A matrix of 
closely spsced A-lines was taken over a specified region 
of interest and the RF waveforms associated with each 
A-line recorded. A number of structural algorithms were 
implemented in software and applied to the data. The 
envelope correlation spectrum (ECS) method had the 
highest sensitivity. From the 12 specimens of aorta, 
data were collected from 42 regions (approximately 2 cm 
by 1 cm each). Twenty-two regions were entirely normal 
on histological examination and 20 exhibited early fatty 
plaques. The ECS algorithm was applied to each A-line 
from the 42 regions. The ECS of A-lines through normal 
regions were distinctly separate from ECS of A-lines 
through regions of early fatty plaque. The ECS from 
regions of early fatty plaque showed two peaks which 
were not seen in normal regions. Conventional B-mode 
imaging and measurement of attenuation failed to show a 
difference between normal regiDns and regions with early 
fatty plaque. 
CONCLUSION: The ECS method reliably detects early fatty 
plaque and this technique may be of value in the study 
of progression and regression of stherDsclerosis. 
Tuesday, March 29, 1988 
Poster Displayed: 9:00AM-12:00NOON 
Author Present: 9:00AM-I0:00AM 
Hall E, Georgia World Congress Center 
Exercise Physiology and Testing 
ENDURANCE TRAINING VERSUS STRENGTH TRAINING IN 
COMPETITIVE ATHLETES: ADAPTATION OF CARDIAC STRUCTURES 
IN REFERENCE TO NORMAL PREDICTED VALUES 
Jesn G. Dumesnil, M.D., F.A.C.C., Andd RDY, Bs.C., 
Martin bOYDn, BS.C., Fernand Landry, Ph.D., F.A.C.C. 
and Jean Jobin, Ph.D., Quebec Heart Institute, Quebec, 
Canada 
There are still disagreements concerning the adaptation 
of cardiac structures (ACS) in relation to different 
training stimuli. To eliminate some of the variance due 
to individual differences in body surface areas (BSA), 
we studied by echocardiography 46 strength (S) (Body-
builders) and 57 endursnce (E) (Runners) athletes in 
training for at least three years and we utilized a neW 
spproach based Dn the percentage of each individual's 
normal predicted value (%NPV) using regression 
equations derived from normal values rather thsn the 
usual spproach of simply dividing by BSA. %NPV 
(mean±SD) for posterior wall thickness (PWT) , left 
venricular (LV) end-diastolic dimension (LVED) , and LV 
vDlume (VOL) and mass in the 2 groups were as follows: 
PWT (%) LVED (%) VOL (%) MASS (%) 
E 116± 11** 109±7** 131±24** 144±22** 
S 104±11* 106±7** 120±26** 134±23** 
P(E vs S) .01 .05 .05 .05 
P vs normal * < .05 ** < .01 
The LV wall thickness to radius (h/r) ratio does not 
vary with BSA and did not differ from normal values in 
either group, 91% of E and 97% of S being within 2 SD 
Df normal values. 
We cDnclude that the extent of ACS is defined more 
precisely using this approach and the comparison 
between grDups is more accurate. Results indicate 
that the predominant stimulus is of s mild volume 
Dverload type in both groups but to a greater extent in 
Ethan S. Tendancy towards LV concentric hypertrophy 
is an exceptional finding in either grDup and may not 
be as prevalent in S as previously suggested. 
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CONTRIBUTION OF THE PERIPHERAL CIRCULATION TO MAXIMAL 
OXYGEN CONSUMPTION. JR Minotti, MD TG Cagle, PhD, TW 
Chick, MD, VAKC, Albuquerque, NM 
Maximal CO is postulated to limit exercise performance 
and maximal oxygen consumption (VO max) in normal 
subjects. In congestive heart failure (CHF), co can be 
acutely increased without improvement in V02 max. Therefore, we postulate that the limited maximal 
vasodilatory capacity (MVC) in patients with CHF 
reduces V02 max by limiting oxygen transport to active skeletal muscle and that fluid retention accounts in 
part for the attenuated maximal vasodilatory capacity. 
To test the hypothesis we administered fludrocortisone 
acetate, a mineralocorticoid to 11 normal subjects. 
Six subjects (group I) concommitantly received 10 gm 
NaCl tablets/day X 7 days. Five subjects (group II) 
received fludrocortisone without supplemental NaCl. MVC 
is the flow response to 10 minutes of arterial 
occlusion measured by venous occlusion plethysmography. 
V02 max was determined by a graded 3 min staged cycle ergometry, and CO was measured by pulsed Doppler blood 
flow velocimetry in the last minute of each exercise 
stage. In group I there was an 18% decrease in MVC 
(p<O.OI), an 8% decrease in V02 max (p<O.OI), an increase in CO at every stage of exercise and a 2.2 Kg 
increase in weight. Group II had no significant changes 
in MVC, VO max, exercise C.O. or weight. These effects 
required t6e combination of mineralocorticoid and NaCl 
excess (group I). Mineralocorticoid alone (group II) 
did not alter VO max, exercise CO, or MVC. We conclude 
that fluid reten~ion attenuates MVC and V02 max despite increased exercise CO. 
AEROBIC CAPACITY, SHORT-TERM DYNAMIC MUSCLE POWER AND 
EFFECTS OF EXERCISE REHABILITATION IN CARDIAC PATIENTS 
Neil B. oldridqe, Ph.D., Neil McCartney, Ph.D, Audrey 
Hicks, M.Sc and Norman L. Jones, M.D., Univ of Wisconsin 
Medical School-MCC, Milwaukee, WI 
Cardiac patients undergoing exercise rehabilitation often 
report functional improvements in exercise tolerance and 
every day activities greater than can be explained by 
changes in aerobic capacity. It is not known whether the 
increased aerobic capacity frequently seen in cardiac 
patients following training is associated with 
improvements in short-term dynamic muscle power (STMP). 
In addition to peak aerobic exercise capacity and heart 
rate measured with routine progressive cycle ergometry, 
STMP was determined during 30 s maximal isokinetic 
cycling on a modified cycle ergometer with measurement of 
peak isokinetic power (PIP) & total work (TW). Patients 
with coronary artery disease were allocated randomly to 
12 weeks of usual care as controls (CTL; n=lO) or 
exercise training (EX; n=12). All initial maximal 
performance variables were similar in CTL and EX groups; 
CTL 
EX 
12 WEEK CHANGE 
CTL 
V02<l!min) HR(bpm) PIP(W) TW(kJ) 
1. 77.:t,. 11 
1. 85.:t,. 12 
+ 1% 
1 27.:t,7 
1 35.:t,8 
-1% - 6% 
U. S.:t,. 7 
12.S.:t,.6 
- 8% 
EX + 18% * +4% + 14%* + 11% 
*p" 0.05 
Significant and similar increases were observed in V02 
and PIP only in the patients randomized to exercise 
rehabilitation. This suggests that both are important 
contributors to the improvement in exercise tolerance and 
in every day activities frequently reported by patients 
undergoing exercise rehabilitation. 
ABSTRACTS lOlA 
AUTONOMIC EFFECTS OF STRESS AND EXERCISE ON INTRACARDIAC 
BLOOD TEMPERATURE: IMPLICATIONS FOR THERMODILUTION 
CARDIAC OUTPUT MEASUREMENT AND RATE-ADAPTIVE PACIN; 
Neal E. Fearnot, Ph.D., and Heidi J. Smith, M.S., 
Hillenbrand Biomedic;l Engineering Center, Purdue 
University, West Lsfayette, Indiana 
Variations in intracardiac blood temperature may cause 
errors in thermodilution cardiac output measurements, 
which are based on the assunption of a constant blood 
temperature. Conversely, temperature variations have 
been used to control heart rate in pacemakers which phy-
siologically adapt pacing rate to patient activity. To 
identify the causes of major variations in baseline 
intracardiac temperature, we recorded right ventricular 
blood temperature in 88 subjects during rest and exer-
cise testing using a thermistor-bearing catheter. Tem-
perature was measureg at 10 second intervals with a 
resolution of .004 C. The orthostatic response, onset 
of exercise, anticipation of exercise onset, abrupt skin 
temperature changes and the startle response caused sig-
nificant'oabrupt decreases in temperature ranging from 0 
to -0.6 C, mediated by peripheral vasodilation and the 
return of cooler peripheral pooled blood to central cir-
8ulation. The maximum rate of decrease was -0.57 
C/m! n. The increase in II¥!tabol1sm associated with 
temperature from .02 to 
rise of 0.22 °C/m! n. 
Temperature rise during emotional anxiety preceeding 
exercise testing was also observed. These temperature 
variations may be sufficient to cause errors in thermo-
dilution cardiac outputs. Events causing these varia-
tions should be considered in a measurement protocol. 
Temperature variations appear to be a reliable indicator 
of activity for physiologic pacing. 
TRAINING EFFECTS OF SHORT VERSUS LONG BOUTS OF EXERCISE 
Robert F. DeBusk. MD, FACC, Ulf Hakansson, Mary Sheehan, 
William L. Haskell, PhD, FACe, Stanford University School 
of Medicine, Stanford, California. 
The threshold duration of exercise required to produce 
training effects is not wetl established. To evaluate 
this,exercise training provided in 3 short bouts (SB) of 
10 minutes per day was compared with 1 long bout (LB) of 30 
minutes 5 days per week for 8 weeks in 36 healthy men aged 
5l±6 years. Men in SB (n=18) and LB (n=18) used portable 
heart rate monitors to maintain the intensity of jogging 
within a range 65-75% of their peak baseline heart rate. A 
solid-state heart rate recorder (Vitalog) worn twice for 48 
hours during the 8 weeks of the study was used to 
corroborate daily self-reports "of exercise intensity and 
duration. RESULTS: V02 max during symptom-limited treadmill 
testing increased significantly in both groups: from 
33.3±3.2 to 37.9±3.5 ml/kg/min (14%) in men of LB and from 
32.l±4.6 to 34.5±4.5 ml/kg/min (8%) in men of SB (p < 0.05 
between and within groups). The increase in V02 max with 
SB was 57% of that with LB. Submaximal heart rates 
decreased by 6% in both groups (p< 0.05) from l22±12 to 
l14±12 and l28±13 to l20±15 beats/min respectively. Body 
weight decreased by 1.8 pounds or 2% in both groups. Total 
duration of training completed by men of LB and SB was 96% 
and 93% of the 1200 minutes prescribed. In both groups 
exercise heart rate measured by the Vitalog was within or 
above the prescribed range for 90% of the prescribed 
duration. Convenience and enjoyability of training were 
generally higher for LB than for SB. CONCLUSIONS: 1) 
Significant training effects are noted with short bouts of 
moderate-intensity exercise training. 2) Long bouts of 
moderate-intensity training increase V02 max to a greater 
extent than short bouts. 3) Most individuals rate long 
bouts of exercise as more convenient and enjoyable than 
short bouts. 
102A ABSTRACTS 
DIRECT AND INDIRECT DIASTOlIC BLOOO PRESSURE IEASUREIENTS 
ON EXERCISE BEFORE AND AFTER CORONARY ARTERY SURGERY 
Fawaz Akhras 11), John Keates, FRCS, Graham Jackson, FRCP 
Cardiac and Cardiothoracic Departments, King's College 
Hospital, london SE5 9RS 
A reduction in left ventricular ejection fraction (EF) 
during exercise in patients (pts) with coronary artery 
disease (CAD) may be responsible for abnormal diastolic 
blood pressure (DBP) response (elevation> 15nrnHg). We 
studied 91 consecutive patients aged 54 ± 7 (SD) years 
with CAD and an abnormal DBP response during exercise. 
11 patients had repeat treadmill tests with direct intra 
arterial pressure measurements. The measurements were 
highly reproducible with significant correlation between 
cuff and intra arterial recordings. Time to 15 mmHg rise 
in DBP (240 ± 31 sees) was significantly shorter than 
for 1 mm ST segment depression (333 ± 39 sees, p(O.Ol) 
38 patients underwent.CABG and 4 had PTCA, 18 of whom had 
no ST segment depression during exercise. 22 patients 
underwent graft restudy at 15 ± 1.5 months, the mean EF 
improved from 53% ±3 to 68% ±3 (p(0.001). 11 of these had 
no ST segment depression during the pre-operative stress 
test and their EF improved from 49% ± 2 to 64% ± 4 
(p<O.OOl). 4 pts with no change in EF had a DBP rise 
similar to the pre-operative test whilst in those with 
improvement in EF the DBP response to exercise reverted 
to normal. Thus, we have shown that cuff DBP measurements 
are accurate and reproducible. An abnormal rise in DBP 
may occur earlier than ST segment depression during 
exercise and prove useful in identification of high risk 
pts. When CABG improves the EF, normalisation of the 
DBP response follows suggesting that vasoconstriction 
secondary to reduced cardiac output on exercise 
is the probable mechanism. 
EXERCISE TRAINING EARLY AFTER VALVE REPLACEMENT. 
Fernand Landry, Ph.D., F.A.C.C., Denis Desaulniers, 
M.D., F.A.C.C., Andre Moisan, M.D .. F.A.C.C .. Colette 
Habel-Verge, M.S., N.-Miche11e ~obitai11e, M.D., M.P.H. 
and Gi11es-R. Dagenais, M.D., F.A.C.C., Laval University 
and Quebec Heart Institute, Quebec City, Canada. , 
Men and women with valve prosthesis can improve their 
cardiovascular (CV) performance by exercise without 
significant hemolytic or signs of prosthetiC dysfunc-
tion. To determine whether similar findings could be 
observed early in rehabilitation, 10 subjects (mean age 
49±6 yrsl were submitted to an 8-week endurance program 
5 weeks after valve replacement (VR). Ergometer train-
ing was done 3 times/week at an intensity 80-85% of the 
tolerated maximal HR. Ten subjects (mean age 50±8 yrs) 
served as controls. Res~lts indicate improvement 1n 
both groups (7 m10:/kg.m- , psO.Ol and 3 m10 / kg.m- , 
psO.Ol). The diffe~ence between the levels a~tained by 
both groups was not statistically significant. ANOVA 
however showed that the 2 groups evolved differently in 
the course of the 8-week period, the advantage in favor 
of the experimental group (psO.OOl). Mean differences 
indicative of improved CV condition were observed in the 
exercise group only, during maximal exercise (workload + 
250 kpm, psO.OOl; HR +llb, psO.05; double product + 
6,779, psO.01) as well as during relative steady state 
and at rest (400 kpm: HR -16b, psO.05; rest HR -lOb, 
pSO.01). There were no signs of concomitant hemolysis. 
Hemoglobin and hematocrit in fact increased significant-
ly in both groups (1.5 vs 1 gm %, psO.01 and 3.6 vs 
2.5%, psO.05). LDH did not increase. Echo.cardiograms 
did not show detectable valvular or ventricular dysfunc-
tion. Early exercise training after successful VR can 
have a significant potentiating effect on the sponta-
neous CV improvement. 
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EXERCISE LEFT VENTRICULI\R PERFORMANCE IN HEART FAIIlJRE 
USING CONTINOOUS WAVE OOPPLER MEllSUREMENI'S OF J\ORI'IC BlOOD 
FU:M. J. Malcolm o. Arnold, M.D., University of Western 
Ontario, London, Ontario, Canada. 
Peak aortic blood acceleration (Acel) is an index of global 
LV perfonnance at rest, and can be rreasured non-invasively 
using a continuous wave Doppler velocity rreter (ExerDop, 
Quinton). To assess its usefulness during exercise, 10 
patients with heart failure (CHF; LVEF 24 + 5%, s.d.) were 
ccmpared to 7 age-roatched nonnal subjects during symptan-
limited treadmill exercise using a modified Naughton 
protocol. In 3 normal subjects the protocol was stopped at 
22 min of exercise. Heart rate (HR), blood pressure (BP) 
qnd suprasternal rreasurements of Accl and peak velocity 
(Vel) were made at rest in the erect pcsition and during 
the second min of each exercise stage. Accl, Vel, HR and 
BP at peak exercise are given as rrean± s.e.: 
Exer Our Accl Vel HR Syst BP 
min rnjs/s rnjs J:pn nnflg 
Normal 17.9+1.7 37.6+2.5 0.90+0.04 158+5 188+9 
CHF 11.8+1.1* 16.6+1. 7* 0.563:0.04* 1473:6 1403:8* 
p<0.01 vs Normal 
There were nc differences at rest in the erect position 
between ncrmal subjects and CHF. However, at peak exercise 
the increases in Acel,Vel and systolic BP were significant-
ly reduced in CHF patients. At peak exercise all normal 
subjects had accelerations of at least 30 mVs/s while all 
CHF patients were less than 30 rnjs/s with no overlap of 
the two groups. 
Conclusion: rreasurement of Accl and Vel are helpful 
indicators of 9'lobal LV perfonnance during upright tread-
mill exercise Ln patients with CHF. 
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Cardiac Transplantation 
CARDIAC TRANSPLANTA~ION FROM LIVE DONORS. 
Magdi Yacoub, FRCS, FACC; Azghar Khaghani, FRCS; 
Dan Aravot, MD; Melissa Fitzgerald, MB, BS; Nicholas 
Banner, MRCP and Rosemary Radley-Smith, FRCP, FACC, 
Harefield Hospital, Middlesex, England. 
A technique of removing the heart, intact, from heart and 
lung transplant (HLT) recipients with subsequent insertion 
of the heart and lung block using separate SVC and IVC 
anastomoses was evolved and used in 16 patients (pts). The 
removed hearts were used for orthotopic cardiac transplant-
ation (CTx). The age of the HLT pts varied from 12-52 
(mean 31) years. The original disease was primary plexogenic 
pulmonary arteriopathy in 5 pts, Eisenmenger ~trial septal 
defect in 2, cystic fibrosis in 5 (of whom 1 underwent HLT 
& liver Tx), emphysema in 2, fibrosing alveolits in 1 and 
bilateral alveolar cell carcinoma in 1. CTx pts whose age 
varied from 13-59 (mean 42) years had ischaemic heart 
disease in 7, cardiomyopathy in 7, rheumstic heart disease 
in 1, and 1 had left isomerism, double outlet RV, AV valve 
regurgitation, pulmonary atresia and 2 previous shunts. 
Four CTx pts had pulmonary vascular resistance >4 Wood 
units and 1 required extensive reconstruction of the peri-
pheral pulmonary arteries. Two pts required intra-aortic 
balloon counterpulsation preoperatively and 3 were in 
established renal failure. Total ischaemic time ranged 
from 80 to 240 (mean 131) minutes. Following CTx, 
immediate heart action was excellent in all; there were 3 
deaths, 11, 20 and 29 days postoperatIvely due to renal 
failure and infection in 2 and acute rejection in 1. 
Hospital stay varied from 8-80 (mean 21) days. Follow-up 
ranged from 11-130 (mean 60) days. Two of the HLT pts 
died 7 and 14 days postoperatively, due to CMV pneumonia 
(88% survival). 
It is concluded that the use of hearts from HLT recipients 
is feasible with excellent early function and is partic-
ularly suitable for pts with elevated pulmonary vascular 
resistance. 
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SINUS NODE DYSFUNCTION IN HEART TRANSPLANT RECIPIENTS 
Roger A. Freedman, M.D., Nelson A. Burton, M.D., Frank G. 
Yanowitz, M.D., F.A.C.C., Susan Lyver, R.N., Dale G. 
Renlund, M.D., and John B. O'Connell, M.D., F.A.C.C. 
University of Utah, Salt Lake City, UT. 
The etiology and natural history of sinus node (SN) 
dysfunction in heart transplant (Tx) recipients are ob-
scure, and optimal pacing mode is uncertain. Six of 81 
(7.4J) consecutive Tx recipients underwent transvenous 
pacemaker (PM) implantation for SN dysfunction. Pts 
receiving PM had sinus or junctional bradycardia <50 bpm 
persisting since Tx, and 2 had prolonged SN arrest 
without escape. Donor age (27 + 8 yr) and donor heart 
ischemic time (148 + 57 min) of-those receiving PM did 
not differ from other Tx pts. PM were implanted 5 + 3 wk 
following Tx; in 3 pts PM were implanted within 48 hr of 
biopsy-proven rejection, but all 3 subsequently manifest 
SN dysfunction following resolution of rejection. No pt 
showed abnormality of AV conduction. Three pts received 
activity-sensing, rate-responsive atrial PM, 2 received 
conventional atrial PM, and 1 received ventricular PM. 
Dissociated recipient P waves visible on ECG were not 
sensed by atrial PM, nor was there pacemaker capture of 
the recipient atrial remnant. At mean flu of 10 mo, no pt 
had had a known bradyarrhythmia and 4 of 6 (67~) were 
still PM-dependent. One pt with rate-responsive PM under-
went treadmill tests comparing fixed-rate and rate-re-
sponsive pacing: max exercise time (840 vs 554 sec) and 
V02max (24.1 vs 15.8 ml/kg/min) were improved with rate-
responsive pacing. CoDcluaioaa: (1) SN dysfunction 
following Tx is not related to donor age, ischemic time, 
or acute rejection, and it is usually chronic. (2) 
Because of the absence of concomitant AV conduction 
abnormality, single-chamber atrial pacing is preferred 
mode. (3) Rate-responsive atrial PM may improve exercise 
performance compared to conventional atrial PM. 
HEMODYNAMIC ABNORMALITIES FOLLOWING CARDIAC TRANSPLANTA-
TION: RELATIONSHIP TO HYPERTENSION AND SURVIVAL 
Sr\nivas Murali, ~. D., Barry F. Uretsky, M. D., FACC, 
P. Sudhakar Reddy, M. D., Bartley P. Griffith, M. D., 
Rebert L. Harde~ty, M. D., FACC, University of 
Pittsburgh, PA 
The relationship of hemodynamic abnormalities (HA) 
present at 1 year (yr) catheterization (cath) to post-
transplantation (TX) hypertension and long-term survival 
was prospectively evaluated in 82 asymptomatic TX 
patients (pts) who were on cyclosporine and prednisone 
immunosuppression and survived >1 yr. The most prevalent 
HA at 1 yr cath were a high (>16 mmHg) left ventricular 
end diastolic pressure (LVEDP), elevated (>0.24) LVEDP -
left ventricular end diastolic volume ratio [(R), a 
measure of "operational compliance"], and low «4S%) 
ejection fraction. These were present in 27%, 23%, and 
14% respectively. TX pts with an abnormal LVEDP, R or EF 
at 1 yr cath had a higher (p<O.OS) mean systemic arterial 
pressure (MAP). Followup of TX pts with HA at 1 yr cath 
showed that 69% (9/13) with a high LVEDP, 44% (4/9) with 
an elevated R, and 60% (3/S) with a low EF had normalized 
at the 2 yr cath. The normalization of the HA was asso-
ciated with a significant (p<O.OS) decrease in the MAP. 
Likewise, followup of TX pts without HA at 1 year cath 
showed that 19% (6/32) with normal LVEDP, 21% (6/28) with 
normal R, and 19% (6/32) with normal EF had become abnor-
mal at 2 yrs. Development of HA in these pts was asso-
ciated with a significant (p<O.OS) increase in the MAP. 
The long-term survival (followup 2.4+1.1 years, range 
1.3-3.S yrs) was similar in TX pts wIth and without HA at 
1 yr cath. 
These data suggest that the development of HA in 
asymptomatic TX pts on cyclosporine and prednisone is 
related to post-TX hypertension and does not affect 
survival over the first 3 yrs post-TX. 
ABSTRACTS 103A 
STUDY OF HEART FUNCTION DURING A 24-HOUR PRESERVATION IN 
A NEW AUTOPERFUSION PREPARATION 
Sufan Chien, M.D., John N. Diana, PhD., Marcus Dillon,M.D. 
Edward P. Todd, M.D.,PhD., F.A.C.C., William O'Connor,M.D. 
University of Kentucky Medical Center, Lexington, 
Kentucky 40S36-0084 
Serial heart function studies were carried out on 
porcine hearts during a 24-hour preservation period in 
which a new autoperfusion preparation had been used. Six 
adult Yorkshire white swine weighing 30-60 kg. were 
anesthetized with pentobarbital and artificially ventil-
ated. In each pig. the heart, lungs, liver,pancreas, 
duodenum, and kidneys were removed while still being 
perfused by the heart and oxygenated by the lungs. The 
organs were placed in a 320 C water bath containing Ringers 
solution. A SO% oxygen and 3% carbon dioxide mixture was 
used for ventilation. D10W plus K+ 2 mg/ml, CA++ 1 mg/ml, 
Insulin O.lu/ml, heparin 0.1 mg/ml, Mannitol 12.5 mg/ml, 
Flagyl 0.5 mg/ml, and penicillin 1000 u/ml were given 
slowly through the portal vein. Additionally, a fat 
emulsion soyacol 2 ml, prednisolone 30 mg and heparin 
10 mg were given every 2 hours. The organs were preserved 
for 24 hours and parameters recorded every hour. During 
this period, function measurements ranged as follows: 
Total urine output 1200-1S00 ml, AOSP 90-125 mmHg, AODP 
40-60 mmHg, AO pulse pressure 25-50 mmHg, CVP 0-3 mmHg, 
Portal VP 0-2.5 mmHg, Heart rate 80-150 bpm, dp/dt max 
1350-2433 mmHg/sec, dp/dt/p l7.9-23.3/sec, lactic acid 
3.75-8.48 mmol/l. No severe arrhythmia occured during the 
studies and heart size was normal after 24 hours of 
preservation. Wet/dry weight ratio of the heart after 
preservation was 5.13 + 0.15 (control 5.09 + 0.40). 
These results demonstrate minimal change in function of 
the heart after 24 hours of preservation. This new 
autoperfusion preparation holds great promise for 
long-term organ preservation and deserves further study. 
INFLUENCE OF DIABEl'ES MELLITUS CN THE COURSE OF CARDIAC 
TRl\NSPLI\NrATICN • 
Michael Badellino, M.D., Barbara Naims, R.N. ,Pasquale 
Fucc~, M.D., Hal Cohan, B.S., Charles Shurr>an, M.D., Jack 
Rolff, M.D., F.A.C.C., Mariell Jessup, M.D., F.A.C.C., 
James M::Clurken, M.D., F .A.C.C., and Nicholas 
Cava=hi, M.D. Terrple University Hospital, 
Philadelphia, PA 19140 
Diabetes rrellitus (I:M) has been considered to be a rela-
tive contraindication to cardiac transplantation (Hl'X). 
We followed 12 patients (pts) (aged 55+9 years) with 
known I:M (6 pts:l IDI:M,5 NIDI:M) or wOO-developed I:M (6pts) 
post-Hl'X to evaluate whether their post-operative course 
was different fran 23 age-matched controls. All pts had 
ischemic cardiat¥OPathy and no evidence of other diabetic 
end-organ disease. Parameters rreasured were survival, 
number of infections, number of rejections and length of 
hospital stay (lffi). Irmn.mosuppression included prednison 
(except in 1 pt), cyclosporin, and Irnuran. Results: 
Survival lffi 
(weeks) Infections Rejections (days) 
Diabetics (n=12) 50+35 .3/pt 1.4!pt 26+12 
Hl'X Controls (n=23) 37+26 .9/pt 1. 2/pt 20+12 
Post HTX, 10 of 12 pts required insulin; 2 required oral 
agents. 3 of 6 non-I:M pts who developed I:M post Hl'X were 
diet controlled by 8 IlOnths. 3 of 5 I:M pts with NIDI:M 
pre Hl'X continue to require insulin. 
COnclusions: Diabetes rrellitus did not appear to signif-
icantly influence OUtcare in Hl'X with respect to infect-
ions, rejections, and survival. Steroid pulse therapy 
did not result in increased insulin requirerent. I:M 
was not an increased risk factor in Hl'X. 
l04A ABSTRACTS 
IMMUNOSUPPRESSION IN CARDIAC TRANSPLAN:TATION 
WITHOUT PREDNISONE: A COMPARISON OF CYCLOSPOR-
INE/PREDNISONE TO CYCLOSPORINE/ AZATHIOPRINE. 
David O. Taylor, M.D., James A. Thompson, M.D., Andrea 
Hastillo, M.D., FACC, Glenn Barnhart, M.D., Richard Lower, 
M.D., Sheelah Rider, R.N., and Michael Hess, M.D., FACC, 
Medical College of Virginia, Richmond, VA 23298 
Maintenance corticosteroids have been a significant component 
of immunosuppressive therapy for cardiac transplantation but 
prolonged steroid therapy is associated with many well-
described sidlHlffects. We have hypothesized that an 
immunosuppressive program of cyclosporine and azathioprine 
can provide acceptable graft protection in the absence of 
prednisone. We compared 15 patients (Group 1) begun on 
cyclosporine and prednisone to 46 patients begun on 
cyclosporine and azathioprine (Group 2). There were no 
statistically significant differences between the groups at 3, 6, 
12, or 18 months with respect to systolic and diastolic blood 
pressure, the number of patients treated for hypertension, 
elevation of creatinine, cyclosporine doses and levels, infection 
rates, or LVEF by MUGA. Leukocyte counts were lower in Gp. 
2 (6.1 vs 8.6 and 5.6 vs 8.0 at 6 and 12 months; p < .01). HDL-
cholesterol was lower in Gp. 2 (49.7 vs. 60.3 and 43.8 vs. 56.1 
mg/dl; p ( .05). Overall survival was equivalent in the two 
groups at 6, 12, and 24 months: Gp. 1 - 9396, 8096, and 7396 vs. 
Gp. 2 - 9296, 8896, and 8796. Group 1 had more patients develop 
diabetes (5096 at 12 mo. vs 996 for group 2). In contrast Gp. 2 
had more episodes of rejection during year one (2.32 per patient 
VB. 1.5 for group 1, p (.01). We conclude that long-term 
immunosuppression with cyclosporine and azathiaprine is a safe 
and effective program. The trade-off appears to be an 
increased number of cell-mediated rejection episodes vs. the 
long term morbidity of chronic prednisone therapy. 
Tuesday, March 29, 1988 
2:00PM-3:30PM, Room 264, Level Two 
Myocardial Infarction Clinical: Thrombolysis I 
AOOITICN OF INm1lC(R(NARY PROOTAGIANDIN El '10 
S'l'REPTClUNASE IMmOVES 'lHRCMBOLYSIS AND LEFl' VEN1'RIaJIAR 
FUtCI'ION IN 1ICU'm ~OCARDIAL INFARCTICN. 
Bimlendra Sharna, M.D., F.A.C.C., Richard P. Wyeth, 
M.A., Frederick M. Heinenann, M.D., Joe K. Bissett, 
M.D. , F .A.C.C. , University of Arkansas for Medical 
Sciences, Little Rock, AR 
Forty-eight patients (pts) with acute myocardial 
infarction were studied. Twenty-four pts receiving only 
intraooronary (IC) streptoltinase (SK) were OCJIilared to 
another 24 pts giveri ICSK plus IC prostaglandin El (El). 
The naxinrum infusion of ICSK was 7.5 x lOS IU while 
the naxinrum rate of IeEl. was 30 ng/kg/min. Prior to 
therapy, there was no statistical difference in duration 
of chest pain (S±2 [SO] hr in both), ooronary disease, 
infarct locus (9 anterior and 15 inferior in both), left 
ventricular ejection fraction (EF, 52+15 VB 50+11%) and 
infarct related segment (IRS ) systolic-shortening (12+6 
vs 10±6%) in pts given only ICSK VB pts given IeEl. pius 
SK. The time to reperfusion (24+14 VB 61+25 minI p<.001) 
and the am:lUllt of SK required- for reperfusion (2+1 VB 
6±2 xlOS IU, p<.001) were significantly reduced. in pts 
given IeEl. plus ICSK VB pts given ooly ICSK. In pts 
successfully recanalized, EF' (61+12 VB 48+11%1 p<.00l) 
and IRS function (16±7 VB 6±9%1 p.:.00l), ~e better in 
pts given IeEl. plus ICSK than in pts given only ICSK. 
When restudied at 10 days 88% of pts receiving IeEl. plus 
SK and 50% of pts given only ICSK had patent infarct 
related vessels (P<.OS). In these pts, EF (52+16 VB 
6l±12%) and IRS function (9±9 VB l6±7%) were greater 
(P<.00l) in pts given IeEl. plus SK. '!bus El nay be a 
powerful adjunct to thranbolytic therapy in acute 
myocardial infarction. 
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THE SECOND MT. SINAI-NYU REPERFUSION TRIAL: RELATIVELY 
LATE THROMBOLYTIC THERAPY IS BENEFICIAL IN PATIENTS WITH 
COLLATERALS, BUT NOT IN THOSE WITH SUBTOTAL LESION. 
K. Peter Rentrop, M.D., F.A.C.C., Frederick Feit, M.D., 
F.A.C.C., Warren Sherman, M.D., F.A.C.C., John C. 
Thornton, Ph.D, Reperfusion Study Group, NYC. 
In 190 pts treated randomly in a double blind fashion with 
intracoronary (ic) streptokinase (5; n=66), or ic nitro-
glycerin (N; n=64), or both icS+N (SN; n-69) we assessed 
prospectively the relation between treatment, ejection 
fraction change from preintervention to day 10 to 14 (Chg 
EF) and baseline angiographic status. The 3 angiographic 
subgroups were: total occlusion of the infarct vessel with 
collaterals (C+; n-S2), total occlusion without collater-
als (C-; n-90), subtotal occlusion without collaterals 
(SO; n=48). Time from onset of infarction to treatment 
was 6.3+2.1 hrs. 
SN S N 
ChgEF(%) p ChgEF(%) p ChgEF(%) P 
C+ 9.8+2.1 .001 1.7+1.9 .4 -3.8+2.3 .1 
C- -0.8+1.7 .64 -3.7+1.6 .02 -5.0+1.S .001 
SO 6.0+2.1 .OOS 6.6+2.2 .01 S.7±2.2 .01 
The difference between SN C+ and SN C- was 10.6+2.6% (p( 
.OS). The difference between S C+ and S C- was-S.4+2.S% 
(P(.OS). There was no difference between N C+ and N C-. 
The difference between SN C+ and N C+ was 13.6±3.1% (P( 
.01). Conclusions: I) In pts with complete obstruction of 
the infarct vessel and collaterals, significant improve-
ment of EF occurs with thrombolytic therapy even beyond 
the presently accepted 4 hr time limit. 2) This benefici-
al effect is potentiated by concomitant application of 
nitroglycerin. 3) The extent of EF improvement in the 
presence of collaterals suggests biologically meaningful 
myocardial salvage. 4) In pts with subtotal occlusion of 
the infarct vessel there is a spontaneous improvement of 
function which is not augmented by thrombolytic therapy. 
PREVALENCE OF PERICARDIAL EFFUSION AND VENTRICULAR 
THROMBUS FORMATION AMONG ACUTE MI PATIENTS RECEIVING 
TISSUE PLASMINOGEN ACTIVATOR 
Robert N. Belkin, M.D .• F.A.C.C., Daniel B. Mark, M.D., 
Hanna Szwed, M.D., Robert M. Califf, M.D., Lynne 
Aronson, B.S., Joseph Kisslo, M.D., F.A.C.C. Duke Uni-
versity Medical Center, Durham, North Carolina 
Serial 2-D echos were performed in 52 patients with 
acute myocardial infarction receiving IV tissue plas-
minogen activator. Echos were performed within 6 hours 
following onset of symptoms and on days I, 3, and 6 fol-
lowing myocardial infarction. Pericardial effusions 
were present in 3/38 patients acutely (8%), 2/44 on day 
1 (5%), 8/43 on day 3 (19%), and 10/42 on day 6 (24%). 
All pericardial effusions were small on the acute study 
and on days 1 and 3. On day 6, 3/10 pericardial effu-
sions were moderate and 1/10 large. No patient devel-
oped pericardial tamponade. The presence of pericardial 
effusion did not depend on infarct location or severity 
of left ventricular dysfunction assessed by echo wall 
motion index. Left ventricular thrombus was present in 
0/38 patients acutely, 4/44 at day 1 (9%), 9/43 at day 3 
(21%), and 6/42 (14%) at day 6. All were associated 
with apical infarcts. 
Thus, (1) pericardial effusions develop frequently in 
patients treated with tissue plasminogen activator in 
the first week following myocardial infarction. They 
are generally small in size. (2) Left ventricular 
thrombus occurs frequently despite treatment with tissue 
plasminogen activator. Its prevalence does not differ 
from that reported in patients not receiving throm-
bolytic therapy. 
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IMPROVED LV &)'ECTION FRACTION AT 21 DAYS FOLLOWING CORON-
ARY OCa..USION TREATED BY EARLY INTRAVENOOS rt-PA INFUSION. 
".O'Rourke HD,FACC and R.Norris HD for Sydney/Auokland 
Thrombolysis in Coronary OOclusion (TIro) Group. 
St.Vinoent's Hospital, Sydney, Australia. 
A double blind placebo oontrolled trial entered 136 pat-
ients <72 years with first evOlving myooardial infarotion 
within 2.5 hours of symptClll onset. Five Sydney hospitals 
and the ambulanoe paramedio service partioipated, with 
data analysis in Auokland. Aotively treated patients 
reoeived rt-PA (suspension oulture preparation) 60mg over 
1 hour, then 40mg over 2 hours by intravenous infusion. 
All patients reoeived heparin over 48 hours, fOllCliled by 
aspirin and dipyridamole. End point was a signifioant 
improvement in global LV ejeotion traotion (LVEF) at 21 
days by radionuolide and oontrast (oardiao oatheterisat-
ion) methods, and was adlieved after entry of 136 patients. 
rt-PA (N=68) Plaoebo(N=68) 2p 
LVEF(oontrast) 
LVEF(radionuolide) 
62 *12~ 54 *15 % 0.002 
54 *12% 48 t13~ 0.008 
Reinfarotion at 21 days 
Death at 21 days 
3 (4~) 
3 (4" 
5 (7%) 
4 (5~) 
NS 
NS 
There was no signifioant difference between the two groups 
at entry. DUfereme between radionuclide and oontrast 
LVEF within each group were attributable to analytio 
method. Time to rt-PA/placebo infusion from symptClll onset 
averaged 1.9 hours. Bleeding oClllplioations were minor 
apart from cerebral hElllorrhage at 6 days in a patient 
without previous oerebral SymptClllS; relationship to rt-PA 
was unoertain. TWo patients given rtPA needed transfusion. 
Conclusion:rt-PA improves LV funotion when admin-
istered <2.5 hours after symptClll onset. 
SYSTEMIC FIBRINOGENOLYSIS AFTER RECOMBINANT HUMAN 
TISSUE-TYPE PLASMINOGEN ACTIVATOR FOR ACUTE MYOCARDIAL 
INFARCTION: INFLUENCE ON CORONARY PATENCY AND BLEEDING. 
Alfred E.R. Arnold M.D., Ronald W. Brower Ph.D., Desire 
Collen M.D., Ph.D., Jacobus Lubsen M.D .. Patri ck W. 
Serruys, M.D., F.A.C.C., Maarten L. Simoons M.D., 
F.A.C.C.,. Marc Verstraete M.D .. Ph.D., for the European 
Co-operative Study Group for rt-PA, 
Thoraxcenter Rotterdam, the Netherlands 
Data of 243 patients (pts) enrolled in the 3 studies of 
the European Cooperative Study Group for rt-PA were 
pooled. After administration of 5000 IU heparin a median 
dosage of 40 mg (range 35-60) of double chain rt-PA (g-
11021) was given intravenously in 90 min. A fibrinogen 
level below 1 g/l was observed in 6% of the pts before, 
and in 22% of the pts at the end of rt-PA infusion. The 
patency rate at 90 min after start of treatment was 65% 
(95% confidence limits 59%-71%). Bleedings were seen in 
26% of the pts. None was fatal. 73% of the bleedings 
occurred within 24 hrs; in 84% at puncture sites. 
The decrease in fibrinogen plasma level, the level of 
fi bri n(ogen) degradation products (FOP), the act i vated 
partial thromboplastin time (aPTT) and the rt-PA antigen 
plasma levels beared no effect on coronary patency. 
However, pts with a FOP serum level of 85 mg/l or more 
at the end of the rt-PA infusion had more frequently a 
bleeding than those with a FOP level below 22 mg/1 (41% 
versus 18%, rate ratio 2.36, 95% confidence interval 
1.24-4.48). Bleeding was more frequent when the aPTT 
exceeded 160 sec at the end of the rt-PA infusion than 
if the aPTT was below 160 sec (38% versus 24%, rate 
ratio 1.60, 95% confidence interval 1.00-2,56). 
This suggests that, above a certai n dose of rt-PA, 
systemic fibrinogeno1ysis occurs with an increase in 
bleeding and without an improvement in coronary patency. 
ABSTRACTS 105A 
RECURRENT ISCHEMIA WITHOUT WARNING: INABILITY TO 
PREDICT ISCHEMIC EVENTS FROM RESIDUAL STENOSIS 
AFTER SUCCESSFUL CORONARY THROMBOLYSIS. Stephen G. 
Ellis, M.D., Eric J. Topol, M.D., F ACC, Darrell Debowey, 
MS, Richard S. Stack, M.D., FACC, William W. O'Neill, M.D., 
Jane M. Boswick, MPH, Barry S. George, M.D., Dean J. 
Kereiakes, M.D., FACC, Charles W. Abbottsmith, M.D., Richard 
J. Candela, M.D. F ACC, Robert M. Califf, M.D., and the T AMI 
Study Group, University of Michigan Hospital, Ann Arbor, MI 
Recurrent ischemic events (RIE) after successful thrombolysis (n 
in acute myocardial infarction (AMI) have been related in small 
series of patients to final percent stenosis ~ 60%, stenosis area 
<0.4 mm, and inadequate anticoagulation. Based upon our cli nical 
impression that RIE were difficult to predict, we analyzed 29 
variables as possible predictors of RIE in 95 consecutive patients 
with T and final stenosis? 50% from the T AMI I trial. 
Cineangiograms from 75 males and 20 females, mean age = 58 + 
12 yrs, with 36 anterior and 59 inferior AMI treated with tPA 3.'!r 
+ 1.0 hours after chest pain onset were analyzed by 0 si ngle 
blinded observer. All patients were treated with aspirin, calcium 
channel blockers and heparin after T. T was defined as final TIMI 
flow ~ 2. RIE was defined as angiographically documented 
reocclusion at 7-10 day angiography (n = 13), urgent coronary 
angioplasty (n" 16) or bypass surgery (n = 2), or in-hospital death 
(n = I) (numbers not mutually exclusive, total n=24). 
Quantitative coronary angiography was performed using a 
validated automated system. 
No variable, including final percent stenosis, final cross-sectional 
area, TIMI flow, presence of thrombus, Ambrose morphology, 
diffuse disease or ectasia achieved a p value of ~ .10 as a 
predictor of RIE. 
Thus, early ischemic events after successful thrombolysis by tPA 
cannot readily be predicted by quantitative coronary angiography, 
stenosis morphology or clinical variables. 
Tuesday, March 29, 1988 
4:00PM-5:30PM, Room 264, Level Two 
Surgical Treatment of Ischemic Heart Disease 
THERMAL CORONARY ANGIOGRAPHY - A NEW METHOD 
FOR ASSESSING CORONARY BYPASS GRAFT PATENCY 
Friedrich Mohr M.D., Aurelio Chaux, M.D., Frank Litvack, M.D., 
Warren Grundfest, MD., Jack Matioff, MD., F.A.C.C., James 
Forrester, MD., F.A.C.C. Cedars-Sinai Med. Ctr, Los Angeles, CA. 
We used an AGA 870 thermal camera, focused on the 
exposed heart, and a TIC 8000 digital image processor to provide 
high spatial (0.1 mm) and thermal resolution (O.I0C) images in 
real time. In 50 patients, thermal angiograms of 137 saphenous 
vein (SY) and 48 internal thoracic artery (IT A) grafts after 
completion of the distal anastomoses, by injection of 30cc of cold 
cardioplegia into the proximal vein graft Or by perfusion with 
warmer blood after bulldog clamp release on the IT A graft. Since 
injection of cold cardioplegia is part of the routine procedures, 
the entire data acquisition and preliminary analysis was 
accomplished in several minutes. The image Quality of the TCA's 
is such that even low grade stenoses are obvious. We used TCA's 
to establish graft and anastomotic patency, the direction of graft 
flow and the presence of stenoses in the native coronaries. We 
believe the images are at least as accurate as probes for this 
purpose. High resolution TCA's were obtained in 173 of the 185 
bypass grafts. We found 172 grafts to be patent. 96 native 
coronary stenoses were precisely located in the recipient coronary 
arteries. Each stenosis was confirmed by intraoperative probes 
and preoperative cine angiograms. Unsuspected stenoses were 
detected at the site of 4 distal anastomoses, and I IT A graft was 
occluded. Based on our TCA findings, two anastomoses were 
successfully revised and three additional grafts performed. We 
~: intraoperative TCA is a sensitive, simple technique for 
determining graft patency, the Quality of anastomoses, and native 
coronary anatomy. Such information had implications for 
decision making during CAB surgery. 
106A ABSTRACTS 
FIFTEEN-YEAR SURVIVAL AFTER CORONARY BYPASS SURGERY FOR 
UNSTABLE ANGINA 
Shahbudin H. Rahimtoola, M.D., F.A.C.C., Cindy L. 
Fessler, Gary L. Grunkemeier, Ph.D., Albert Starr, M.D., 
F.A.C.C., The Heart Institute at St. Vincent Hospital and 
Medical Center and the Oregon Health Sciences University, 
Portland, Oregon • 
We have assessed the long-term results of coronary 
bypass surgery performed for unstable angina in 2,032 
patients from 1970-1986. Their average age (t SD) was 
61t15 years; 36% of the patients were aged >65 years, 49% 
had cardiomegaly, 59% had 3- or more vessel or left main 
coronary artery disease, and 53% had abnormal left ven-
triculsr (LV) function. The revascularization index was 
0.87. 
The operative mortality was 2.9%; for those with 1-, 
2-, >3-vessel disease and left main coronary artery 
disease it was 1.2, 1.5, 3.2, and 5.1%, respectively. 
For those with normal LV funtion, it was 1.5% and with 
abnormal LV function was 3.7%. 
Using actuarial techniques, 5-year, 10-year, and 15-
year survival rates (t SE) were 89tO.9%, 78tl.6%, and 
68t3.1%, respectively, for the whole group. For patients 
with normal LV function, the survival rates were 92t1.2%, 
82t2.2%, and 75t3.3%; and for patients with abnormal LV 
function, the survival rates were 88t1.4%, 74t2.8%, and 
64105.2%. 
The reoperation rates at 5, 10, and 15 years were 
4tO.6%, 16tl.7%, and 34t5.7%, respectively. Currently, 
57% of the survivors have no angina; angina occurs on 
severe exertion only in 20%, on ordinary exertion in 14%, 
and on mild exertion in 5%. 
We conclude that coronary bypass surgery is an 
effective form of therapy for up to 15 years in patients 
with unstable angina. 
TEN YEAR INCIDENCE OF MYOCARDIAL INFARCTION IN THE VA 
COOPERATIVE STUDY OF BYPASS SURGERY. 
Marvin L. Murphy, M.D., F.A.C.C., Peter Peduzzi, Ph.D., 
and the VA Coop study Group, L,ttle Rock, Arkansas. 
Although coronary bypass surgery improves survival and 
reduces the incidence of sudden death in high risk sub-
groups, little is known about the effect of surgery upon 
myocardial infarction. For this reason, the 10-year in-
cidence of non-fatal myocardial infarction was determined 
in 686 patients with stable angina randomly assigned to 
medical or surgical therapy. MYocardial infarction was 
defined as the development of new persistent Q-waves. 
The incidence of non-fatal myocardial infarction was 4% 
medical vs 12% surgical (p <.001) at 1 year, and 16% 
medical vs 17% surgical at 7 years, and 17% medical vs 
22% surgical at 10 years. The incidence of non-fatal 
myocardial infarction increased in surgical patients and 
decreased in medical patients after 7 years, similar to 
our mortality experience. Non-fatal peri operative myo-
cardial infarction occurred in 8% (24/312) of surgical 
patients and in 6% (7/124) of medical-operated patients. 
Since myocardial infarction may result in sudden death, 
another estimate of the incidence of myocardial infarc-
tion is the cumulative event free rate i.e. the prob-
ability of remaining alive and free of myocardial infarc-
tion. The 10-year cumulative event free rate was 54% 
medical vs 52% surgical (NS). Of the baseline angio-
graphic and clinical risk subgroups examined, only 
patients with multiple angiographic (3-vessel disease and 
impaired LV function) and clinical (combinations of ST 
depression, hypertension and myocardial infarction) risk 
factors had a significantly better cumulative event free 
rate with surgical treatment at 10 years (29% medical vs 
52% surgical, p < .05). 
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BENEFIT OF RETROGRADE CORONARY SINUS CARDIOPLEGIA DURING 
REVASCULARIZATION FOR ACUTE MYOCARDIAL INFARCTION 
Farid Gharagoz100, M.D., Jay P. Mashburn, M.D., Hartzell 
v. Schaff, M.D., F.A.C.C., Krishnaswamy Chandrasekaran, 
~.D., Paul J. Pearson, and James R. Pluth, M.D., 
F.A.C.C., Mayo Clinic, Rochester, Minnesota. 
We studied antegrade and retrograde cardioplegia in a 
sheep model of revascu1arization for acute myocardial 
infarction. Following one hour of coronary occlusion, 
animals were placed on cardiopulmonary bypass, and hearts 
were arrested with 500 m1 cold KC1 cardioplegia infused 
into the proximal aorta; an additional 500 cc was given 
in the aortic root (Group A) or through the coronary 
sinus (Group R). Ischemic myocardium was reperfused for 
two hours after global ischemia. Global and segmental LV 
function were determined by quantitative two-dimensional 
echocardiogram, and extent of myocardial injury was 
determined by TTC staining. Results are summarized 
below. NL = normal region, ISCH = ischemic region, 
AN = area of necrosis, AR = area at risk, and TEMP 
lowest temperature during cardiop1egic arrest. 
Group %Shorten,ng AN!AR TEMP 
NL ISCH % ISCH 
A 5.6±8.8 -l.O±7.1 66.l±8.4 20.l±2.3 
R 15.9±3.4 10.4±S.8 3.6±1.6 8.8±2.0 
P value 0.3 0.1 0.001 0.01 
Retrograde cardioplegia provided better cooling of 
ischemic segments and resulted in improved segmental 
LV function and reduced myocardial necrosis compared to 
conventional antegrade delivery. 
VASOMOTOR PROPERTIES OF INTERNAL MAMMARY ARTERY GRAFTS: A 
CLUE TO THEIR FAVORABLE LONG-TERM PATENCY? 
M.F. Rousseau. MD .. F.A C C .. R. Dion, M.D. W. Wyns, 
M.D., C. Ranet, M.D., R. Verhelst, M.D., P. Decoster, 
M.D., R. Pouleur, M.D., F.A.C.C. Catheterization 
Laboratory and Department of Cardio Thoracic Surgery. 
University of Louvain, Brussels, Belgium. 
The response of native and grafted internal mammary 
arteries (IMA) to vasoconstrictor and dilator stimuli was 
studied in 26 left IMA (9 native; 17 grafted on the left 
anterior descending artery). IMA were opacified with 
non-ionic contrast agent, in control state, after 
intravenous ergotamine maleate (MET, 0.4 mg) and after 
intra-INA infusion of isosorbide dinitrate (ISDN, 1 mg). 
INA diameter was measured on end-diastolic 35 mm cine 
frame by automated contour detection with the Coronary 
Angiography Analysis System (CAAS). 
The Diameter of native INA was 2.97±0.39 mm at control, 
it increased slightly after MET (+3\; NS) and 
significantly after ISDN, to 3.12±0.36* mm. Grafted INA 
had greater Diameters than native INA at control 
(3.39±0.35* mm); no change was observed after MET and 
ISDN dilated the graft to 3.58±0.36 mm (** vs Control and 
* vs native INA after ISDN). 
Thus, INA seem unresponsive to non-specific 
vasoconstrictor stimuli; after grafting, INA enlarge but 
retain their ability to dilate. These vasomotor 
properties could play a beneficial role in the favorable 
long-term patency of internal mammary artery grafts by 
preventing vasoconstriction and platelet deposition. 
**P<O.Ol *p<0.05 
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FAVORABLE LONG TERM OUTCOME OF CORONARY BYPASS SURGERY 
BEFORE HOSPITAL DISCHARGE FOLLOWING INTRAVENOUS t-PA 
THERAPY FOR MYOCARDIAL INFARCTION. 
Dean J. Kereiakes, M.D., F.A.C.C., Eric J. Topol, M.D., 
F.A.C.C., Barry S. George, M.D., Charles W. 
Abbottsmith, M.D., F.A.C.C., Richard J. Candela, M.D., 
F.A.C.C., William O'Neill, M.D., F.A.C.C., Richard 
Stack, M.D., F.A.C.C., Robert M. Califf, M.D., John B. 
Flege, Jr., M.D., TAMI Study Group, The Christ 
Hospital, Cincinnati, Ohio. 
In a multicenter trial of thrombolysis and angioplasty 
in acute myocardial infarction, 386 pts received i.v. 
t-PA at 2.9 + 1 hr from symptom onset. Bypass surgery 
(CABG) was performed in 82 (21%) of pts; emergently 
(7.3 + 1.9 hrs after symptom onset) in 24; delayed (9.3 
+ 5.2- days)in 58 pts prior to hospital discharge. 
Indication for surgery differed between emergent vs 
delayed surgery and was left main or equivalent disease 
(29% vs 21%); severe multivessel disease (17% vs 75%), 
and failed PTCA (54% vs 1.8%). Infarct artery was 
patent during acute catheter intervention prior to CABG 
in 88% emergent and 84% delayed pts. Compared to pts 
without CABG (n~301), CABG pts were more high risk with 
pre-op shock (14.6%), older age (p=.03), more 
multivessel disease (p<.OOOl), more anterior MI 
(p=.02), and diabetes (21% vs 12%). There were no 
intraoperative, and 5 (6%) hospital deaths all 
occurring in pts with pre-op shock (hospital mortality 
in non-CABG pts was 7%). At 8.5 + 4 mos follow-up, 
only 1 death and no recurrent MI has occurred in 77 
CABG pts discharged from the hospital. Thus, the use 
of CABG after t-PA thrombolysis for MI is associated 
with favorable in-hospital and long term outcome 
despite high risk clinical descriptors in this group. 
Tuesday, March 29, 1988 
2:00PM-3:30PM, Room 260, Level Two 
Interventional Techniques: Laser 
~ Artery Iaser Imrelizatim: A Cl:inkal~. Q;a:ge 
S. 1\tela, M.D. , JcIIe; M. Sseg;!r, M.D., l\dib I. RnIty, M.S::., 9mrn 
JctllaSd, m, c. Ri.dmd O:nti, M.D., FXI:. Uri.~ty eX Fk:a:1d:i, 
Gairesville, Fkrida. 
~ pts (34 arteries) with ~ ]a.a: ext:mni.ty 
is::iBnia. ..ae e.ellBl:B:i I¥ ~ an aide b:a:trial :i.n:ec QIBI). 
At ~, 32 pts tal 100% cx:rlu:rim eX aprlic:ial feIaal artery 
(~ , {3 to D::m la:g, l'N. ~. <re pt tal a cnmm ilia:; artery 
d::st:ru:tial (~ • Se!Iiel pts ..ae ~ jrqercble d..e to 
:infa::tim at a Ie:X:Il3t:l:u:t site, ct:ee!1t \ein grafts cr early 
~ graft cx:rlu:rim. 'lhra.Jj:l a 9 Fml:t1 (F) int::tI:d..I::: Smth a 
7 F catteter: an <11 qticBl fil:Er with a SCHhire l.ms re::a:ad in a 
ann cp!J aIkl netal C<p WlS a:lIao:.d to tre d::st:ru:tial U"IEr 
fll.II'CEO:pic g.rld;n::e. Iaser m:B'Bl.izaticn WlS d::re I.5irg <11 Arg:n 
laser at irr:::resirJ;J ~ of 1 wrt±/sec am 0.2 sec intetvals (ralJ= 1 
to 10 \<aI:ts). A 0.018" <pid;wire WlS pla::e:i t:hro.Jjl tre re:Erel.i.2Bj 
dB"rel an laser iIra3i.atia1 ~ to ~ tre dB"rel I.5irg a 
2.5 cr :}on <Ellice. If res:idBl IUlB'l sten:sis WlS > 50%, bUlan 
CI'giq>:iast¥ WlS d::re. If U'B.l.:O:'SSful, I?f1:asS ~ WE ~. 
a:allts: 31 eX 34 arteries ..ae re:Erel.i.2Bj with a ann laser <Ellice. 
SJ::o:ssful re:maJ..izat:ic (<50% res:idBl sten:sis) WlS co::rnpllitEd 
with laser jmrljaticn al<re in 7 pts, laser incd:iatim pIlE bUlan 
CI'giq>:iast¥ in 8 pts, laser llTc.di.aticn pIlE bUlan ad:u:t:era::ta¥ in 
3 pts. '1hirtea1 ~ m:p:inD surg:![y. In tre 31 laser re:Erel.i.2Bj 
arteries, d:st:ru::tiaE \\ere re:imj fran 100% to <11 ~ (Av.) 
sten:sis eX 49% (ralJ= 0% to 71%). Blllan a-gicp:iast¥ furtta' 
~ tre dBTel si2e I¥ <I1l'N. 32%. JIBI's:irI::reaserl fran l'N. 0.42 
to 0.72. At 6 m:::nths, arted.al ~ WlS C5 folkW3: laser al<re: 
5 eX 7 pts; laser pllE bUlan: 8 of 8 pts; laser pIlE 
amrtaa::txIty: 1 eX 3 pts; laser pllE~: 9 eX 10 pts. 'lhree 
pts m:p:inD arp.It:ati.cn. Six eX 7 jrqercble pts tal SI:Xl3SSful 
ra::aBli2atim with laser cr laser bUlan a-gi~. O:rdl.5icn: 
laser ra::aBli2atim is a :rellit>le lIl!I:i"ID to re::sali.2e totally 
cx:rlu:Ei wssels b.lt if tre dB"rel ctmterl is S18ll, bUlan 
CI'giq>:iast¥ mw I:e m:p:inD. 
ABSTRACTS 
PERCUTANEOUS PULSED LASER ANGIOPLASTY WITH ATHEROMA 
DETECTION IN HUMANS. 
H.J. Geschwind, M.D., F.A.C.C. ,J.L. Dubois-Rand6, 
M.D., F .R. Bonner, Ph.D., G. Boussignac, M.D., loG. 
Prevosti, M.D., M.B. Leon, M.D., F.A.C.C., University 
Hospital Henri Mondor, Cr6teil, France and NHLBI, 
Bethesda, MD. 
A pilot clinical trial was undertaken in 5 patients 
(pts) (53 to 86 years) with symptomatic total 
occlusion (4-13 cm length) of the superficial femoral 
artery (SFA) to determine the efficacy and safety of 
percutaneous laser atheroma ablation (LAA) with a 480 
nm pulsed laser (MCM Laboratories, Mountain View,CA). 
Spectral analysis of tissue was done through a 600 
micron fiber prior to lasing. In all pts, after failed 
attempts at guidewire recanalization, a laser catheter 
was advsnced against target lesions which had spectral 
featu~es of atheroma. LAA was performed using 150-330 
mJ/mm pulsed at 7 Hz until recanalization was 
achieved and was followed by definitive balloon 
angioplasty (BA). Spectral analysis of plaque and 
normal tissue was achieved in all pts. LAA (4-615 
pulses) was successful in recanalizing all SFA 
occlusions, providing an acceptable lumen for 
subsequent BA. The mean ankle/brachial index increased 
from .41 before to .84 after combined laser assisted 
BA (p<.Ol). In 2 pts, the laser created a channel 
which was wide enough not to require BA. In 2 pts, 
conventional guidewire and catheter manipulation 
resulted in sUbintimal dissection with no apparent 
clinical sequelae. Conclusiona : 1/ The laser system 
is able to spectroscopically recognize atheroma. 2/ 
480 nm pulsed LAA can achieve recanalizat~on of 
occluded arteries. 3/ The possibility of mechanical 
complication requires flexible laser delivery systems. 
FLUORESCENCE SPECTROSCOPY GUIDANCE OF LASER ABLATION OF 
ATHEROSCLEROTIC PLAQUE. Lawrence 1. Deckelbaum M.D •• 
F.A.C.C •• Mark L. Stetz. B.S •• Ken M. O'Brien. B.S •• 
Francis W. Cutruzzola, B.S •• Arthur F. Gmitro. Ph.D. 
VAMC and Yale Un1versity. West Raven, CT. 
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The fact that laser-induced fluorescence (LIF) spectra of 
atherosclerotic (A) arteries differ f,om normal (N) but 
revert to N after endarterectomy has been proposed as the 
basis for developing a "smart" laser angioplasty system. 
However. LIF spectroscopy can only be used for laser 
angioplasty guidance if high power laser ablation does 
not significantly alter this pattern of tissue fluores-
cence. To test this qypothesis. we analyzed LIF during 
laser ablation of human cadaveric A aorta. Baseline LIF 
spectroscopy of N and A aortic specimens (n=lOO) was 
performed using an optical fiber coupled to a He-Cd laser 
and optical multichannel analyzer. An LIF score (A score 
< 0). derived from stepwise linear regression analysis of 
the LIF spectra. correctly classified 93% of specimens. 
The LIF score (mean + SEM) was +0.74 + 0.04 for Nand 
-0.74 +0.08 for A ao~ta (p<.OOl). LIF was then serially 
record~d during Erbium:YAG laser ablation (wavelength 
2.94 p. pulse energy 300 mJ. repetition rate 2 Hz. spot 
size 2.0-2.5mm) of 27 A specimens. Laser ablation was 
terminated when the arterial LIF spectrum visually 
appeared N (avg total energy 23 + 2 J). Initial LIF 
score was -0.64 + 0.09; final score was +0.51 + 0.08 
(p=NS compared to N aorta). Histologic analysIs 
revealed initial plaque thickeness of 1228 + 54 p and 
residual plaque thickness of 198 + 27 p. Ablation of the 
media occured in only 3 specimens~ Therefore LIF 
guidance of laser ablation resulted in minimal residual 
plaque without arterial perforation. These findings 
support the feasibility of an LIF controlled laser 
angioplasty system for selective A plaque ablation. 
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PERCUTANEOUS "HOT-TIP" ANGIOPLASTY IN MAN BY A RADIO 
FREQUENCY CATHETER SYSTEM 
Frank Litvack. M.D., Warren Grundfest, M.D., Friedrich 
Mohr, M.D., Bruno Stru1, Ph.D., Tsvi Goldenberg, Ph.D., 
F.J. Roth, M.D., P.G. Kirchhoff, M.D., James S. 
Forrester, M.D., F.A.C.C. Cedars-Sinai Medical Center, 
Los Angeles, California 
We report the development and successful human applica-
tion of a novel system for thermal angiop1asty. The 
catheter has a 5 Fr shaft and a 2.0 mm diameter conical 
gold tip which is heated up to 5500C in air by a port-
able (30 1b) radiofrequency generator. In pre-clinical 
evaluation we recana1ized 15/17 chronically occluded 
femoropop1itea1 arteries (occlusions up to 12 cm) in 10 
dogs. In 4 arteries dye extravasation was seen when 
vessel diameter was ~ the catheter tip diameter. In the 
5 initial human cases, femoropop1itea1 occlusions up to 
17 cm were effectively recana1ized in 4 patients with 20 
w. One heavily calcified 4 cm total occlusion could not 
be recana1ized. For human use, catheters of 3 different 
column strengths from flexible to rigid were employed. 
The thermal angiop1asty technique created channels of 
2.0-3.0 mm diameter which were further enlarged in all 
but 1 patient with balloon angiop1asty. Following the 
successful procedures there was reappearance of absent 
peripheral pulses and significant increase in ank1e-
brachial index. Conclusions: The radiofrequency thermal 
angiop1asty catheter effectively recana1izes long seg-
ment occlusions in both animals and man in a manner 
comparable to laser thermal angioplasty. As such, the 
radiofrequency system provides a simple, less expensive 
alternative to laser based thermal angiop1asty systems. 
EFFECT OF LASER BALLOON ANGIOPLASTY ON NORMAL DOG 
CORONARY ARTERIES IN VIVO. 
I. Nigel Sinclair F R A C.P .. Ronald D. Jenkins, M.D., 
Leslie M. James, M.S., Edward L. Sinofsky, Ph.D., Maria 
S. Wagner, B.S., Tamas Sandor, D.P., Frederick J. Schoen, 
M.D., J. Richard Spears, M.D., F.A.C.C. Harvard-Thorndike 
Laboratory, Beth Israel Hospital, Boston, MA 
Reduction of arterial vLsco-elastic recoil (R) is a 
potentially useful effect of laser balloon angioplasty 
(LBA). To study the effect of LBA on R of normal coronary 
arteries in vivo, 16 dogs were treated with LBA and 3 
dogs with conventional balloon angioplasty (BA) with 1 
min inflations of a 3 mm balloon. A clinical prototype 
laser catheter system was used for LBA, which was 
performed with 450 to 600 joules delivered in a step-wise 
decremental fashign tooquickly achieve a plateau 
temperature of 90 -120 C within tissue adjacent to the 
inflated balloon during a 20 second exposure to 1.06~ 
Nd:YAG laser radiation. Coronary cineangiography was 
performed before and at various irttervals up to 1 month 
after angioplasty, and computerized image analysis of 
digitized cine frames was used to quantitate lumen 
diameter (D). No Significant adverse effect of LBA on the 
arterial lumen was observed angiographically or histolo-
gically in any dog. LBA increased D from a mean 2.6 mm to 
2.9 mm (P<.01) with no loss in D over time, while D of 
adjacent segments remained unchanged at 2.6 mm. BA 
reduced D from a mean 2.8mm to 2.6mm (p>.05) acutely but 
had no adverse eff~ct on D at 1 month. Microscopic 
infarctions «.2cm ) secondary to thermal coagulation of 
myocardium adjacent to LBA-treated segments occurred at 
high laser doses, but LV angiographic function was 
unchanged by LBA, and no arrhythmias occurred during 
laser exposure. In conclusion, LBA reduces R acutely and 
chronically, in contrast to BA, and is not associated 
with significant adverse effects. 
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EXPERIMENTAL ARGON LASER THERMAL ANGIOPLASTY AS AN 
ADJUNCT TO BALLOON ANGIOPLASTY 
Jack A. Stroh, M.D., Timothy A. Sanborn, M.D., F.A.C.C., 
and Christian C. Haudenschild, M.D., Boston Univ, Boston. 
We evaluated the recanalization of peripheral arterio-
sclerotic stenoses using laser thermal angioplasty (LTA) 
before balloon angiop1asty (BA), as well as the hypothe-
sis that BA induced neointimal fracture can be sealed by 
subsequent LTA to improve luminal patency in the New 
Zealand white male rabbit atherosclerotic model (deendo-
thelia1ization then 2% cholesterol diet for 6 wks with 
50-95% iliac stenoses by angiogram). In Group 1 (12 ves-
sels), a 1.7 mm metal-capped argon laser fiberoptic 
fiber was introduced via femoral arteriotomy and 10 watts 
thermal energy was applied for 5 sec. Thereafter, fluoro-
scopically guided BA was performed in the same vessel seg-
ment with a 2.5 mm Gruentzig balloon catheter inflated 3 
times at 5 atm for 30 sec each. In a second group of 9 
vessels, the sequence was reversed: LTA followed BA. 
Light microscopic sections of Group 1 vessels show 
both thermal and balloon effect with thermal energy in-
duced erosions and partially circumferential burns. Only 
minimal thrombosis was present, and no perforations oc-
curred. In Group 2, only 1 of 9 vessels showed evidence 
of laser sealing. There was 1 probe-related perforation. 
In the other 7 vessels, the thermal effect was either 
not near the neointimal flaps or produced only surface 
charring 2-3 cell layers deep. 
In conclusion: LTA can decrease atherosclerotic plaque 
mass and reduce vascular thrombosis thus faCilitating BA 
recanalization of peripheral arterial stenoses. However, 
LTA appears not to be feasible for sealing after BA be-
cause of the current inability to apply thermal energy 
at the desired location with sufficient intensity. 
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Interventional Techniques: Atherectomy 
BALLOON ANGIOPLASTY AND ROTATIONAL TIP (KENSEY) 
A THERECTOMY CATHETER IN THE RABBIT MODEL OF 
ATHEROSCLEROSIS: ACUTE AND CHRONIC RESULTS 
Peter A Demopulos MD, Evaleen 1. Olin, BS, G. Wendel Yee, MD, Robert S. 
Kemoff, BS, Tim A. Fischell, MD, Robert Ginsburg, MD, FACC. Stanford 
University Medical <;:enter, Stanford CA. 
We compared the acute and chronic (restenosis) results of balloon angiopIasty 
(BA) and high-speed rolalional atherectomy (HSRA) in the cholesterol-fed rabbit 
model of atherosclerosis. Twelve New Zealand White rabbits had bilateral iliac artery 
atheromata induced by endothelial denudation and 6 weeks (wks) of 2% cholesterol 
diet. Each rabbit then underwent HSRA of one iliac artery (2 passes with 5Fr HSRA 
catheter, tip speed=70,OOOrpin) and BA of the other iliac (three serial 45sec/6atm 
inflations with 2.5mm balloon). Rabbits received an additional 4 wks (total 10 wks) 
of cholesterol diet, then were sacrificed with vessel fixation for histology. 
Quantilalive angiography was performed pre- and post-procedure and prior to sacrifice. 
Eight rabbits survived to completion of the study. Stenoses <30% severity were 
excluded, leaving 6 HSRA and 6 BA lesions for analysis. The means (and standard 
errors) of measured stenosis lumen diameter (Diam) for HSRA and BA, immediately 
pre- and post-procedure (PTA) and at the 4 wk post-PTA (restenosis) interval are 
shown (There was no difference in pre-PTA stenosis severity for BA and HSRA): 
Diarn Pre:PTA Djam Post-PTA Djam 4 Wks Post-PTA 
HSRA 1.12mm(.05mm)t 1.46mm(.04mm)· 1.34mm(.03mm)·· t 
llA 1.18mm(.03mm) 1.95mm(.06mm)· 1.15mm(.0Imm)·· 
(n=6 for BA and HSRA; t-p=O.05, ·-IKO.OI, ··-p<O.05, paired t-teSt) 
Both HSRA and BA produced significant acute improvement (post-PTA) in Diam 
(p<O.OO5 for both). BA, however, yielded a greater post-PTA lumen than HSRA. 
Restenosis (defmed as >20% reduction in Diam 4wks post-PTA compared with Diam 
immediately post-PTA) occurred in 6 of 6 BA lesions and only I of 6 HSRA lesions 
(p<.OI, chi-square). This difference corresponded with~ significantly greater Diam at 
4 wks post-PTA for HSRA compared with BA. Preliminary histology reveals 
dissection and disruption of the arterial intima and media in lesions subjected to BA. 
Medial architecture was preserved with HSRA. 
In this model, we conclude: I) Both BA and HSRA produce acute improvement in 
lumen diameter. 2) BA yields greater acute improvement in vessel lumen than HSRA. 
3) HSRA is associated with significantly better chronic lumen diameter (less 
restenosis). Decreased restenosis may be related to the absence of medial disruption 
seen histologically with HSRA. 
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TRANSLLMINAL ATHERECTCNY: EARLY RESULTS IN 
TREATMENT OF ATHEROSCLEROSIS 
THE 
Matthew R. Salmon. M.D .• Gregory C. Robertson. M.D .• 
John B. Slrrpson M.D .. F.A.C.C •• Sequoia Hospital. 
Redwood City. CA. 
Successful removal of atherl7ll!ltous tissue by 
trans luminal atharectamy from 159 stenoses In tha 
peripheral vascular space was achieved in B6/92 
procedures (93%). Demographics showed mean aga for 
the group was 65 years old (range 39-92) and 69% were 
male. AI I patients had claUdication at less than 500 
feat. The locations of the 159 lesions were as 
follows: SFA-7B%. Illac-I3%. popllteal-9%. The 
device was positioned and tha cutter advancad 9B9 
times retrieving BBB specimens. Mean percant 
stenosla was reduced from 71% to 23%. No spaclmen 
was obtalnad whan thara was Insufficient metarlal 
protruding Into the catheter to ba excised by the 
advancing cuttar. Atherectamy was used In 
conjunction with surgary or angloplasty In 7% of the 
patlants. Corrpllcatlons Includad one ambo I Izatlon 
and ona thrombus fo~tlon. No parforatlons or acute 
occlusions occurrad. Three lesions showed 
anglographlc evldenca of dissection without 
Irrpalrmant of blood flow. Histologic study of 
specimens from 103 prlmery stenoses showed 
predominant atherl7ll!ltous plaque (BI). fibrous Intimal 
thickening (IB) and organized thrombus (q) whl Ie all 
17 restanosls lesions showed Intimal hyperplasia. 
In conclualon. atherectamy Is a safe and 
predictable method for removing arterial stenoses 
whl Ie also providing tissue for study of restenosls 
and atherogenesis. 
SHORT TERM FOLLOW UP OF PATIENTS TREATED WITH A RECENTLY 
DEVELOPED ROTATIONAL ATHERECTOMY DEVICE AND IN VIVO 
ASSESSMENT OF THE PARTICLES GENERATED - --
Nadim M. Zacca, MD FACC, Albert E. Raizner, MD FACC, 
George P. Noon, MD FACC, H. David Short III, MD, Donald 
G. Wei 1baecher , MD, Antonio M. Gotto, Jr., MD FACC, 
Robert Roberts, MD FACC. Baylor College of Medicine and 
The Methodist Hospital, Houston, Texas 
Peripheral vascular lesions (range 70-99% diameter 
narrowing) present in the iliac (3), superficial femoral 
(4) and popliteal (2) segments were crossed and atherec-
tomized sU~messfu11y in 6 patients (pts) using the Squibb 
Rotab1ator under the guidance of contrast angiography 
intraoperatively. The Rotab1ator consists of a 
1.25-4.5mm diameter oblong burr with tiny diamond blades, 
mounted on a flexible shaft which tracks over a spring-
tip guide wire and rotates at speeds >120,000 rpm. All 
stenoses were reduced to <30% of the normal 1 umen. No 
Significant comp1ications- occurred. Five pts with 8 
atherectomized lesions were reevaluated by duplex Doppler 
measurements 1. 5-5.5 (mean=3. 5) months post atherectomy 
and found to be patent with only mild residual flow 
disturbance. All were symptomatically improved. With 
improvements in technique, the eff1 uent parti c1 es ana-
lyzed by scanning electron microscopy showed 87% <50 
microns, 11.6% 51-100 and 1.4% 101-180. To study the 
potential effects of these particles on the microcircu-
lation, samples of the effluent from 2 pts were injected 
in vivo into the left coronary system of 2 pigs respec-
tively. The hearts were retrieved for pathology 18-48 
hrs later and showed no evidence of coronary occlusion, 
emboli or myocardial infarction. Our preliminary results 
wi th respect to effi cacy and safety wi th the Rotab 1 ator 
continue to be optimistic. 
ABSTRACTS 
HISTOPATHOLOGY AFTER ROTATIONAL ANGIOPLASTY OF PERIPHE-
RAL ARTERIES IN HUMAN BEINGS. 
109A 
Jean L. Fourrier, M.D., Czeslaw Stankowiak, M.D., Jean M. 
Lab1anche, M.D., F.A.C.C., Alain Prat, M.D., Jean M. Bru-
netaud, M.D., Michel E. Bertrand. M.D., F.A.C.C. Hopital 
Cardio10gique - University of Li11e - France 
A rotating abrasive tipped atherectomy device (RAD) (Bio-
physics International Seattle U.S.A) is capable of remo-
ving experimental atherosclerotic plaque (AP) in rabbits 
but its effect on human arteries is unknown. Therefore, a 
histopathologic study was performed after rotational an-
giop1asty (RA) in four patients. The RAD consists of a 
catheter with a rotating shaft (150.000 rpm), a central 
lumen that permits passage of a guide-wire, and an abra-
sive tip (diameter from 2.5 mm to 4.5 mm). Four patients 
were surgically treated for a femoral atherosc1erosic di-
sease. Before the femoro-poplitea1 bypass, the device was 
introduced through the proximal anastomosis and the RA 
was performed in the diseased segment which was extrac-
ted after the procedure for an histopathologic study. 
RESULTS: 
* Fibrous or calcified AP were partially removed 
* the abrased surface was smooth and free of thrombus 
* the endothelium on the adjacent normal wall vessel di-
sappeared 
* there was no damage of the arterial media and no perfo-
ration 
* dehiscence between plaque and media, and some surface 
irregularities due to residual atherosclerotic parti-
cles, can be seen when the RAD is used with a too low 
speed of rotation < 75.000 rpm. 
In conclusion, the RAD allows the removal of human athe-
rotic plaque by abrasion without risk of perforation and 
with a residual non thrombogenic smooth treated surface. 
IN-VITRO AND IN-VIVO EXPERIMENTAL RESULTS 
USING A NEW WIRE:GUIDED CONCENTRIC ATHERECTOMY DEVICE 
Jose A. Perez, M.D., Tomoaki Hinohara, M.D., Peter J. 
Quigley, M.D., Myoung M. Lee, M.D., Ph.D., Patricia U. 
Hoffman, Eileen M. Mikat, Ph.D., Harry R. Phillips, 
M.D., Richard S. Stack, M.D., F.A.C.C. Duke University 
Medical Center, Durham, North Carolina. 
The safety and efficacy of a new trans luminal 
atherectomy catheter (TAC) was tested in 13 normal 
arterial segments (10 cadaveric human mesenteric and 3 
in-vivo canine femoral) and 11 atherosclerotic human 
cadaveric segments (5 mesenteric, 4 in-situ coronary, 
and 2 in-situ femoral/popliteal). The TAC (Ultramed, 
Inc., San Diego, CA) is comprised of a wire guided, 
motorized rotating stainless steel conical cutting head 
mounted on a flexible torque tube with vacuum applied 
for retrieval of excised material. The TAC was operated 
at 650 rpm using 8-10 passes over a 2 cm excursion. 
Arteriographic and angioscopic studies were performed 
pre- and post-atherectomy, and all segments 
histologically analyzed. The TAC successfully removed 
atherosclerotic plaque from 100% (11/11) of the diseased 
arteries treated. The depth of excision was typically 
limited to the media although occasional disruption of 
the external elastic lamina was noted. Injury to the 11 
normal vessels was limited to superficial intimal 
disruption. Atheromatous emboli were noted in 2 
of 11 diseased segments treated and focal spasm in 
normal canine artery. There was no angiographic, 
angioscopic, or histologic evidence of dissection or 
perforation. 
In conclusion, this TAC can successfully excise 
atheroma from diffusely diseased human cadaveric 
arteries and may be applicable for percutaneous human 
use. 
llOA ABSTRACTS 
PERCUTANEOUS CORONARY ATHERECTOMY 
John B. Simpson MD. Gregory C. Robertson MD. Matthew 
R. Se lmon r-D. Sequo i a Hosp i ta I. Rec$..Jood City. CA. 
Removal of atheromatous tissue In the coronary 
circulation was successfully perfonned In 2 patients. 
using percutaneous coronary atherectamy (PCAI. The 
first patient is a 54 year old male with a 95% mid 
right coronary artery stenosis. previously refrectory 
to coronary angioplasty (CAl. attempted with a 3.Dmm 
balloon Inflated multiple times to 160 psi. The 
balloon deformity fai led to resolva and angiography 
showed a residual 80% stenosis. The atherectamy 
catheter (ACI excised a portion of this laslon. 
reducing the stenosis to 50%. subsequently allowing 
easy dilatation with inflation pressuras of 90 psi 
and yielding a residual stenosis of less than 20%. 
Histology revealed dense fibrous plaque with numerous 
mlcrocalclflcatlon not avldent anglographlcal Iy. The 
second patient was a 54 year old male. with an ostial 
stenosis In a five year old ssphenous vein graft 
Initially dilated with a 3.0 rnn balloon to 60 psi 
leaving an 80% residual stenosis. PCA was then 
performed using 2 passes with the AC. each yielding a 
tissue apeclmen and leaving a 20% residual stenosis 
anglographically. His iO day fol law-up treadmll I 
test exhibited a marked Improvement when compared to 
that performed prior to PCA. In conclusion. PCA ia 
feasible and provides tissue that may Improve our 
understanding of coronary atherosclarosls and 
angioplaaty. 
Tuesday, March 29, 1988 
2:00PM-3:30PM, Room 360, Level Three 
Surgical Therapy for Supraventricular Arrhythmias 
SU1U:RY FOR WOLFF-PARKIN~-WHITE sYNDOCME USnl> THE 
EPICARDIAL APPR:lACH. EXPERIENCE WITH 200 PATIENTS. 
Gerard M. Guirawon, M.D., F.R.C.S. (C), F.A.C.C., George 
J. Kle~n, M.D., F.A.C.C., F.R.C.P.(C), Arjun D. Shanna, 
M.D., F.R.C.P.(C), F.A.C.C., Raymond Yee, M.D., 
F.R.C.P. (C), Douglas G. McLellan, B.Sc., M.A, Edgar A. 
Pineda, M.D. 
Uliversity Ibspital, london, Chtario, canada. 
'l't.o I1mdred patients (pts) with WFW syndrare had 
acoessozy pathways (AP) surgically ablated using an 
epicardial approach. 'lhere ~e 131 left ventricular free 
wall (LVFW), 51 posteroseptal (PS), 16 right ventricular 
free wall (RVFW) and 17 anteroseptal (ASAP). 
'!be epicardial approach carbined mobilization of the 
AV fat pad and exposure and c~lation of the AV 
junction on the nonrothe:r:mic beating heart in the region 
of interest. 9.lbendocardial AP (15 ASAP, 2 LVFW, 3 PS, 5 
RVEWI required an end:lcardial czyoablation or dissection. 
~tiple AP (n=18) ~e ablated in sequence. Associated 
cardiac diseases (n=18) were corrected after AP ablation. 
'1bere was no q?erative death. Canplications included 
postoperative bleeding (n=5) non-cardiac pulnonary edema 
(1) chylq?ericardium (1) and stroke (1). '!here was no 
inadvertant AV block. 'l\oIo Irundred and thirteen AP were 
ablated and 2 AP ~e obtunded. Eight patients required 
reoperation for failed ablation (n=4) or a previously 
undetected second AP (n=4). 
'!be epicardial approach for AP ablation is highly 
efficacious with minimal oamplications. 
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COMPARISON OF BASELINE CHARACTERISTICS AND LONG-TERM 
QUALITY OF LIFE IN 540 WOLFF-PARKINS ON-WHITE PATIENTS 
TREATED WITH PHARMACOLOGIC VERSUS SURGICAL THERAPY. 
Joyce C. Pressley, M.P.H., Lawrence D. German, M.D., 
F.A.C.C., Douglas L. Packer, M.D., James E. Lowe, M.D., 
F.A.A.C., Benjamin D. Burks, Gregg S. Shander, Eric N. 
Prystowsky, M.D., F.A.C.C., Duke University Medical 
Center, Durham, NC. 
The choice of therapy for Wo1ff-Parkinson-White (WPW) 
related arrhythmias involves both clinical and lifestyle 
considerations. This study compares quality of life 
indices pre- and post-therapy for WPW pts treated with 
surgical ablation of the acc'essory pathway (n-365) vs 
e1ectrophysio10gic (EP) and/or ECG-guided medical therapy 
alone (n-175). Fo11owup data were obtained in 90% by 
questionnaire and telephone with a mean fo110wup of 6.2 
years. At baseline, there were no significant differences 
between surgical vs medical pts in age (31 vs 32 yrs) , yrs 
of arrhythmia (14 vs 12,p-.07), or distribution of pre-
senting clinical arrhythmias. Surgical pts had shorter 
preexcited RR intervals during atrial fibrillation (AF) 
(219t59 vs 248t63,p<.001), a higher incidence of ventri-
cular fibrillation (15% vs 4%,p~.001) and multiple accea-
sory pathways (12.6% vs 2%,p<.001) and more drug trials 
(3.1t1.8 vs 2.3t1.9,p<.001). Although both medical and 
surgical pts improved significantly over baseline, im-
provement was greater in surgical pts. Ninety percent of 
surgical and 68% of medical pts report less frequent 
arrhythmias (p<.Ol), and 93% vs 70% had fewer WPW-re1ated 
hospitalizations (p<.Ol). Arrhythmia-related activity 
limitations were lower in surgical pts (2% vs 27%,p<.001). 
New occurrence of AF and overall mortality was not dif-
ferent. We conclude: (1) quality of life is better for 
surgically treated pts, (2) pts with EP/ECG-guided medical 
therapy show Significant long-term improvement. 
PRESENCE OF A BROAD ACTIVATION FRONT IN WOLFF-PARKINSON-
WHITE PATIENTS SUGGESTING ARBORIZING ATRIAL INSERTION OF 
ACCESSORY PATHWAYS 
John E. Batchelder. M.D., F.A.C.C., William M. Miles, 
M.D., F.A.C.C., Yousuf Mahomed, M.D., F.A.C.C., Robert 
D. King, M.D., James J. Heger, M.D., F.A.C.C., Lawrence 
S. Klein, M.D. Douglas P. Zipes, M.D., F.A.C.C. 
Krannert Inst. of Cardiol., Indiana Univ. School of 
Med., VA Medical Center, Indianapolis, IN. 
Some anatomic and electrophysiologic data suggest that 
accessory pathways (APs) fan out and may have multiple 
rather than discrete insertion sites. This type of in-
sertion should produce a broad activation front, defined 
here as ~ cm of mf0cardium at the atrioventricular (AV) 
groove activated within 5 msec or less. Six of 59 
patients undergoing surgical AP interruption using the 
epicardial approach met this criterion during AV groove 
mapping using flexible strips with 8 bipolar electrodes 
spaced 1 cm apart. All 6 had left free wall APs; no 
patient with septal or right free wall APa demonstrated 
a broad activation front. A retrograde broad activation 
front was found on the atrial side of the AV groove 
during both reCiprocating tachycardia and ventricular 
pacing in all 6 patients. All patients with anterograde 
AP conduction (n=4) had focal ventricular activation 
during atrial paCing, without evidence for an antero-
grade broad activation front. In all 6 patients dem-
onstrating a broad activati~n front, a discrete surgical 
plane of dissection during exposure of the AV groove was 
absent; the AV groove tissue was very adherent making 
the dissetion unusually difficult. We conclude that some 
patients, 10% in this series, have APs that appear to 
arborize in their atrial, but not ventricular, inser-
tion, making the surgical dissection more difficult. 
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DIFFERENTIATION OF CONDUCTION OVER A POSTERIOR 
PARASEPTAL ACCESSORY PATHWAY VERSUS NORMAL 
VENTRICULOATRIAL CONDUCTION SYSTEM BY RETROGRADE ATRIAL 
ACTIVATION SEQUENCE AT THE ATRIOVENTRICULAR GROOVE. 
Marshall ~ ~, M.D., William M. Miles, M.D., 
F.A.C.C., Lawrence S. Klein, M.D., Yousuf Mahomed, M.D., 
Robert D. King, M.D., Douglas P. Zipes, M.D., F.A.C.C., 
Indiana Univ. School of Medicine, Krannert Institute of 
Cardiology and VAMC, Indianapolis, IN 
Distinguishing between the retrograde atrial 
activation sequence at the atrioventricular (AV) groove 
in the setting of a posterior paraseptal accessory 
pathway (AP) and that occurring normally over the AV 
node is critical in determining successful surgical 
interruption of the AP. This difference has not been 
well described. Retrograde atrial activation sequence 
during ventricular pacing was obtained intraoperatively 
using a multipolar band electrode after interruption of 
the AP by local dissection of the AV fat pad in 10 
patients. Data from sixteen pOints around the AV groove 
were acquired and used to define the normal retrograde 
atrial activation sequence. The site of earliest atrial 
activation was usually right, but occaSionally left, 
posterior paraseptal. Activation time gradually 
lengthened around the AV groove in each direction before 
beginning to shorten in the anterior and anterior 
paraseptal regions. Compared to these normals, 
activation of the left and right anterior paraseptal and 
anterior regions was statistically significantly delayed 
in 11 patients with functioning posterior paraseptal APs 
(p~.05). We conclude that retrograde atrial activation 
sequences that differ from this defined normal range 
suggest persistant retrograde conduction over a 
posterior paraseptal AP. 
INTRA<PERATIVE ATRIAL MAPp:m:; FOR LOCALIZATICN OF SEPTAL 
ACX:ESSORY PATHWAYS. 
Eklgar A. Pineda, M.D, Gerard M. Gliraudon, M.D, 
F.R.C.S.(C), F.A.C.C. 
University Hospital, London, Chtario, Canada 
Distinguishing retrograde conduction over septal 
accessory pathways (AP) fran that over the AV node is 
inportant for ablation of AP. W;! cx:npared retrograde 
atrial activation (M) during reciprocating tachycardia 
(Rr) vs AA during right ventricular pacing (RVP), in 
patients (pts) with septal AP. Patients with AP had 
intraoperative atrial mapping separating them into 3 
group3. Group 1: 16 pts mawed during RVP after ablation 
of free wall AP. Group 2: 15 pts with septal AP mawed 
during RT. Group 3: 21 pts with septal AP mapped during 
RVP. 'lhe difference in the AA time (D) bebem 
anteroseptal (AS) and posteroseptal region (PS) was 
Ireasured on each patient. 
Group 1 (AV node conduction) had syrmetric retrograde 
AA with sinru1taneous activation of the anterior and 
posterior atriun (D=1.25+2.75; mean+SEM). In group 2 AS 
AP preferentially activated the AS resion (0=41.4 + 8.28) 
and PSAP activated the PS region (1:)=60.6+5.2). Siniilarly 
RVP in group 3 resulted in anterior AA with AS AP 
(D=33.7+8.0) and posterior AA with PSAP (D=52.3 +6.9) • 
Group l-vs group 2 or 3, p .001. -
We conclnde that retrograde atrial mapping during RVP 
can distinguish retrograde AV node conduction fran that 
over septal AP. 
ABSTRACTS lIlA 
EARIX CLINICAL RESULTS OF CORRIIXlR SURGERY FOR TREA'IMENT 
CF CHKNIC ATRIAL FIBRILLIITXON. 
Gerard M. Guiraudon, M.D., F.R.C.S. (C), F.A.C.C, Eklgar A. 
Pineda, M.D, George J. Klein, M.D., F.R.C.P.(C), F.A.C.C, 
Arjun D. Sharma, M.D, F.R.C.P. (C), F.A.C.C, Raymond Yee, 
M.D., F.R.C.P.(C). 
University Hospital, London, Chtario, Canada. 
We describe our early clinical experience with an 
operation which \;QuId prevent manifest atrial 
fibrillation but \;QuId preserve the physiologic pacemaker 
with chronotropic ~tence. 
Under hypothennic bypass and cold cardioplegic arrest, 
3 patients (age 45-65) unde~t sinoatrial-
atriOlTentricular node insulation (corridor operation) for 
chronic atrial fibrillation (10-30 yrs). A strip of right 
atriun harlJouring the sinoatrial node and the atrio-
ventricular node is insulated fran the rest of the atria 
by surgical transection but is still connected to the 
ventricles (corridor segroont). '!he left atrium is 
similarly excluded fran the corridor. '!be heart is 
closed. 
'!bere was no operative mortality or moroidity. '!be 3 
patients are in sinus rhythm and free of atrial 
fibrillation (mean follow-up, 12 months). '1Wo patients 
require drugs and pacing for sinus node dysfunction. <:be 
patient is on no therapy. 
Corridor surgery may provide good therapeutic results 
in a selected group of patients with chronic atrial 
fibrillation. Sinus node dYsfunction may limit the full 
benefits of this procedure in serre patients. 
Tuesday, March 29, 1988 
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Surgical Treatment of Cardiac Arrhythmias 
CRYOSURGICAL MODIFICATION OF ATRIOVENTRICULAR NODE 
CONDUCTION FOR TREATMENT OF ATRIOVENTRICULAR NODE 
REENTRANT TACHYCARDIA. 
D. L. Wood, M.D., F.A.C.C., S. C. Hammill, M.D., 
F.A.C.C., G. K. Danielson, M.D., F.A.C.C., C. J. Porter, 
M.D., F.A.C.C., Mayo Clinic and Foundation, Rochester, 
Minnesota. 
We describe our experience with cryosurgical 
modification tif atrioventricular (AV) node conduction for 
treatment of AV node reentrant tachycardia (AVNRT). 
Three females and one male, aged 3-67 years, with 
AVNRT refractory to drug therapy, were treated with 
cryosurgical modification of AV conduction. AVNRT was 
characterized during electrophysiolgic testing by a VA 
interval of less than 40 msec in 3 of 4 patients and the 
ability to dissociate the ventricle or the atrium during 
tachycardia. Programmed atrial stimulation revealed dual 
AVN refractory curves in two patients. 
Endocardial intraoperative mapping of the atrium was 
carried out both anterior and posterior to the region of 
the AV node. The area of earliest activation was between 
the coronary sinus and the AV node in all patients. 
Three to six cryolesions were placed between the coronary 
sinus and the AV node during normothermic bypass while 
the ECG was continuously monitored for heart block. 
Freezing was stopped if high grade heart block was 
identified. 
Cryosurgical modification of the inputs to the AV 
node resulted in abolition of AVNRT in all patients 
without the development of heart block. In 2-20 months 
of follow-up, no patient has experienced a recurrence of 
tachycardia or required antiarrhythmic drugs. 
We conclude that cryosurgical modification of atrio-
ventricular conduction is feasible, effective, and safe 
treatment for patients with AVNRT. 
112A ABSTRACTS 
COMPUTERIZED GLOBAL MAPPING OF THE ATRIUM IN PATIENTS WITH 
SUPRAVENTRICULAR TACHYCARDIA (SVT) 
Richard B. Schuessler, PhD, Thomas E. Canavan, MD, John P. 
Boineau, MD, FACe, Michael E. Cain. MD, FACe, Byung-Chul 
Chang, MD, James L. Cox, MD, FACe. Washington University 
School of Medicine, Barnes Hospital, St. Louis, MO 63110. 
The ability to map the global activation sequence in 
the human atrium has been hampered previously by the limi-
tations of single-point mapping systems which are time-
consuming and depend on the presence of a stable, sustain-
ed rhythm for complete and accurate mapping. Using a newly 
developed computerized mapping system that records data 
from 156 electrodes simultaneously. global atrial activa-
tion maps were obtained intraoperatively in 22 patients 
during sinus rhythm, left atrial (LA) and right atrial 
(RA) pacing (n=22 for each), reciprocating tachycardia due 
to an AV bypass tract (PSVT-AVB, n=17), PSVT due to AV 
node reentry (PSVT-AVN, n=3), atrial fibrillation (AFB, n= 
17), atrial flutter (AFL, n=l), ectopic atrial tachycardia 
(ET, n=2), and AV junctional tachycardia (AVJT, n=l). 
Atrial maps of PSVT-AVB identified the sites of retrograde 
atrial activation and distinguished between focal and dif-
fuse atrial insertions of accessory pathways in patients 
with the WPW syndrome. Right atrial reentry was documented 
in both AFL and AFB, with associated stable 1:1 right-to-
left atrial depolarization during AFL and multiple chang-
ing left atrial wavefronts during AFB. Comparison of 
atrial septal maps recorded during PSVT-AVN and during LV 
pacing revealed different sites of retrograde septal con-
duction. ET, AFL, and AVJT occurring in a single patient 
could be distinguished only by the different global atrial 
activation patterns recorded during each arrhythmia. These 
observations demonstrate the potential value of global 
atrial activation maps in promoting a clearer understand-
ing of all types of clinical SVT and in developing and 
refining possible surgical approaches for their treatment. 
DOES VENTRICULAR TACHYCARDIA HAPPING INFLUENCE THE SUCCESS 
Of ANTIARRHYTHMIC SURGERY? 
JH Hiller, HD, CD Gottlieb, HD, FE Harchlinski, HD, FACC, 
WC Hargrove, III, HD, FACC and HE Josephson, HD, FACC 
UniverSity of Pennsylvania, Philadelphia,-PA 
To evaluate the influence of ventricular tachycardia (VT) 
mapping on antiarrhythmic outcome after VT surgery, we 
retrospectively evaluated the last 100 patients (pts) with 
uniform sustained VT due to prior infarct who survived 
subendocardial resction and underwent standard postopera-
tive electrophysiologic study (EP). Pts were classified by 
percent of all known VT morphologies (total=350) for which 
a site of origin was identified (>40 msec presystoliC ac-
tivity) at pre- (n=102) or intraoperative (n=195) mapping. 
Outcome was assessed at postoperative EP and long-term 
follow-up. Surgical success was defined as (15 seconds of 
inducible VT at EP and no late VT/arrest on follow-up; 
surQica I f 27 i ibl EP I allures were nduc e at , 1 ate arrest. 
, of all VTs Happed Pt 11 Pts SurQical Success 
0' (no map) 9 5 (56'! 
1-50' 21 11 (52') 
51-99' 29 20 (69') 
100' (all mapped) 41 36 (88') 
Overall p value (0.02 
Eleven of the pts who were cured (and 1 failure) had VT 
mapped to endocardial areas outside the visible scar (8) 
or which ceased only with intraoperative application of 
deep cryoablation at sites of origin (3). In sum, 1) pre-
or intraoperative mapping Significantly enhances the 
success of surgery for VT: the more VTs that can be 
mapped, the greater the success rate. 2) Twelve percent of 
VT pts have VT arising in unusual areas not eradicated by 
scar resection alone. 3) Hore aggreSSive mapping may be 
expected to further increase the surgical success rate. 
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COMPUTERIZED POTENTIAL DISTRIBUTION MAPPING DURING VEN-
TRICULAR TACHYCARDIA IN EXPERIMENTAL MYOCARDIAL INFARCTION 
Atsushi Harada, MD, Richard B. Schuessler, PhD, John P. 
Boineau, MD, FACe, James L. Cox, MD, FACe. Washington 
University School of Medicine, Barnes Hospital, 
St. Louis, MO 63110. 
The purpose o~ this study was to evaluate potential 
distribution mapping (PDM) as a method for localizing the 
size of origin of ventricular tachycardia (VT) in dogs 
post-myocardial infarction. In contrast to activation 
time maps (ATM), PDMs require less editing and thus can 
be more automated and rapidly processed for interpreta-
tion. A series· of PDMs during VT is required for detailed 
analysis. Therefore, an on-line computerized system was 
designed to display PDMs sequentially at 1 msec intervals 
as a color movie. PDMs and ATMs were constructed from 182 
epicardial (EPI) and endocardial (ENDO) unipolar elec-
trodes during 11 episodes of reproducible monomorphic VT 
in 8 dogs 5 days after coronary artery occlusion-reperfu-
sion (mean cycle length = 162 ~ 21 msec, 7 sustained VTs, 
4 nonsustained VTs). At the onset of each depolarization 
during VT, a potential minimum abruptly developed on the 
surviving EPI and another on the surviving ENDO, both im-
mediately adjacent to the subendocardial infarct. The two 
minima on the initial PDM corresponded to the sites of 
earliest EPI and ENDO breakthrough recorded on the ATM. 
These two minima subsequently expanded with increasing 
negativities into the adjacent, initially positive, area 
and coincided with the spread of activation fronts at the 
EPI and ENDO surfaces. Thus, the rapid display of sequen-
tial, computerized PDMs, provides a dynamic means of 
identifying the site of origin of VT, and therefore, 
should facilitate intraoperative mapping in patients 
undergoing surgery for VT. 
EFFICACY OF CRYOABIATICN AUtlE FOR REFRACIORY 
VENIRIClJIAR TAClfYCARDIA REIATED 'ro INFERIOR 
INF2'JlCl'ICN • 
Jose A. caceres, M.D., Paul Werner, M.D., MohaImnad 
Jazayeri, M.D., Patrick Tchal, M.D., Masood 
Akhtar, M.D., F7<CX:. university of Wisconsin, 
Milwaukee, WI. 
In patients (Pr) with inferior (INF) myocardial 
infarction (MI) am sustained m:Jl'lCIOOqilic 
ventricular tachycardias (SMVT), en:locardi.al 
resection is sucx:essful in about 60% of cases 
often requirin:J papillary nuscle (PFM) excision. 
SUccess of CJ:yOSlmJE!J:y (CRYO) alone in these PI's 
has not been established. 
Eleven PI's with SMVT due to INF MI urxlerwent 
elective CRYO. Mean no. of drugs failed per Pr 
prior to CRYO was 3.6 ± 1.8. Intraoperative 
mawin:J was perfonnecl before CRYO. PFM was site 
of earliest activation in 4 PI's, none of loilalI had 
PFM excision. No. of cxyolesions per heart raJ'qed 
fran 7 to 10. Mean ejection fractions before am 
after surgery 1NI3re 39 ± 12% am 41 ± 8%. one Pr 
died of sepsis 56 days post surgery withc:ut 
arrhythmia recurrenoe. Of the remainirg 10 PI's, 
MSVl' was not inducible in 8 (80%) arxi 2 others 
became non inducible after drugs. - At follow up 
of 17 ± 7 1006., all PI's 1NI3re alive withc:ut 
recurrent MSVl' or mitral regurgitation. 
Conclusions: 1) In MSVl' with INF MI, CRYO alone 
was highly suocessful am preserved mitral 
c::arpetency by avoidinJ PFM resection. 2) CRYO 
may be the surgical procedure of choice for 
ablatin:J SMVT related to INF myocardial scars. 
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IMl'ORl'AOCE CF PRroPERATIVE VARIABLES IN PREDICTI~ 
OPERATIVE roRl'ALI'lY IN DIRECT SURGERY FOR DROO 
RESIsrANl' VENl'RICULAR Tl\CHYCAIDIA. 
Gerald M. Lawrie, M.D., F.A.C.C., Christopher R.C. 
wyrrlhaiIl, M.D., F .A.C.C. Baylor College of Medicine, 
Houston, TX 
In 62 pts who underwent map directed vr surgery 
mortality was 14.5% (9 pts) 1-37 days after 
operation. Risk factors for mortality were coopared 
for survivors (8) am expired pts (E). Age of 
S-57.8+2.l (SE) am E-60.l+l.5 yrs were similar 
(p>O.OS) as was sex S-S3%~ E-lOO% male (p>0.05). 
There was less 3 vessel disease in 8 than E: 41.5% 
(22/53) vs 56% (519) p<0.05. ABdodarone therapy was 
more common in E- 56% (5/9) vs 0153 for S (p<0.005). 
Previous CAB was more frequent in E-44 (4/9) vs 
S-14.7% (S/53) (P<0.025). Preop. EF was lower in 
E-23.8+2.S% than S-37.1+2.1% (P<0.02). Incidence 
of nuiEiple vr morphologies in s-62.3% (33/53) am 
E-77.9% (719) were similar (p>0.05)· but ability to 
map all vr morphologies preop. influenced outcane: in 
S-57.5% (19/33) had cooplete data vs 42.9% (317) in 
E. (p>0.05). Inferior site of origin of vr was S-17% 
(9/53) vs E-33% (3/9) (p<0.05). Thus surgical 
mortality was related to extent of coronary disease, 
LV dysfunction, am the use of amiodarone. To reduce 
mortality precise pre-am intraoperative cooputer 
mawin9 is needed to minimize periods of ischemia 
am extent of surgical ablation of II1YOCardiurn 
required in cases at high risk of mortality because 
of limited ~dial reserve. en the other ham, an 
arrhytlJnia free survival rate of 74% at 36 months 
encourages continued efforts at surgical ablation. 
Tuesday, March 29, 1988 
2:00PM-3:30PM, Room 367, Level Three 
Mechanisms of Ventricular Arrhythmias 
DISPERSION OF LEFT VENTRICULAR REPOLARISATION IN MAN 
Campbell Cowan, MRCP, Colin Hilton, FRCS, Clive 
Griffiths, MSc, Suda Tansuphaswadikul, MD, John Bourke, 
MRCPI, Alan Murray, PhD, Ronald WF Campbell, FRCP. 
Freeman Hospital, Newcastle upon T,yne, U.K. 
Little is known of dispersion of repolarisation in man. 
Epicardial monophasic action potentials (MAP) were 
recorded in 10 pts with upright T waves in the surface 
ECG undergoing bypass grafting and 4 pts with T inversion 
due to aortic stenosis undergoing valve replacement. 
Activation time, MAP duration and repolarisation time 
were determined at 8 to 10 LV sites in each pt. 
In pts with upright T waves, there was a close inverse 
relation (r=-0.94, slope = -1.44, p<O.OOl) between 
MAP duration and activation time, such that MAP duration 
was longest at sites of earliest activation. 
Consequently, repolarisation and activation sequences 
were opposite; whereas activation proceeded from septum 
to free wall and from apex to base, repolarisation 
proceeded from free wall to septum and from base to apex. 
Dispersion (max - min) of repolarisation (14ms) was less 
than dispersion of activation (23ms). 
In pts with T inversion, MAP duration was independent 
of activation time. Repolarisation time was 
predominantly determined by activation time (r=0.76, 
p<0.025) and repolarisation sequence resembled activation 
sequence. Dispersion of repolarisation (31ms) was 
greater than dispersion of activation (26ms). 
ConClusions. An inverse relation between MAP duration 
and activation time ensures that repolarisation is more 
uniform than activation - this may represent an intrinsic 
anti-arrhYthmic mechanism. Small repolarisation 
differences do exist and these are responsible for T wave 
concordance. The inverse relation is lost in aortic 
stenosis, resulting in T inversion. 
ABSTRACTS 113A 
ELECTROPHYSIOLO'GIC AND MORPHOLOGIC DETERMINANTS OF 
INTRAMURAL REENTRY IN HUMAN VENTRICULAR TACHYCARDIA 
Robert H. Hoyt. M.D., Steven M. Pogwizd, M.D., Peter B. 
Corr, Ph.D., Michael E. Cain, M.D., F.A.C.C., James L. 
Cox, M.D., F.A.C.C., and Jeffrey E. Saffitz, M.D., Ph.D., 
Washington University, St. Louis, MO. 
Specific electrophysiologic mechanisms and anatomic 
substrates responsible for sustained ventricular 
tachycardia (VT) in humans have not been delineated. 
Accordingly, we analyzed intraoperatively recorded 
activation maps and tissues resected from 10 patients 
with remote myocardial infarction and sustained VT. In 
6 patients, 4-level plunge electrodes were used with a 
computer-assisted mapping system to simultaneously 
record 72 endocardial and intramural electrograms and 
construct 3-dimensional isochronous activation maps 
during normal sinus rhythm (NSR) and VT. Intramural 
macro-reentry, with circuits up to 14 cm in length, was 
identified as the mechanism underlying VT. Reentrant 
pathways were determined by regions of permanent and 
functional conduction block and slow, alternate 
conduction. Zones of permanent conduction block during 
NSR and VT occurred at infarct centers, regions composed 
of fibrosis without viable myocytes. Sites of functional 
block contributing to VT were located at the edges of 
infarcts in areas of preserved endocardial trabeculae. 
Transitional regions between fibrotic and non-infarcted 
zones contained bundles of parallel muscle fibers 
partitioned by bands of collagen. These regions activated 
rapidly during NSR in the long fiber axis but exhibited 
slow conduction during VT when the activation wavefront 
was oriented transversely to the fiber axis. Thus, 
intramural macro-reentry is a mechanism of sustained VT 
in humans. Anisotropic conduction in surviving muscle 
bundles at the edges of infarcts is a critical determinant 
of slow conduction responsible for the reentrant circuit. 
VENTRICULAR TACHYCARDIA IN PATIENTS WITHOUT UNDERLYING 
STRUCTURAL HEART DISEASE: EVIDENCE FOR TRIGGERED ACTIVITY 
IN HUMANS. Joseph H. Levine, M.D., John C. lIerillat, II.D., 
Igor Singer, M.D., Lyle Siddoway, II.D., and Alan H. 
Kadish, II.D., The Johns Hopkins Medical Institutions, 
Bal timore, lI&ryland. 
Ventricular arrhythmias (VPB) may be induced during 
catecholamine infusions in some patients with spontaneous 
ventricular tachycardia (VT) but without structural heart 
disease. To gain inSight into potential mechanisms, 5 
patients with spontaneous VT and 5 control patients 
underwent graded infusions of epinephrine (1-12 mcg/min). 
Changes in repolarization were indexed by measuring the 
QTo interval (global) and monophasic action potentials 
(!lAP) (local). 
Resul tSI 1) VPB were in.duced with epinephrine in 5/5 
csses and VT in 4/5 cases; 0/5 control patients had VPB or 
VT. 2) During epinephrine infusion, aecondary 
depolarizations consistent with early afterdepolarizations 
(EAD) developed during phsse 3 of the IIAP in a dose 
response fashion in case but not control patients. 3) The 
EAD were associated with VPB/VT; they always were present 
prior to VPB/VT and the coupling interval of the EAD was 
nearly the same and closely correlated to that of VPB 
(n=127; R=0.78; P<0.OO1). 4) Overdrive pacing led to 
suppression of VPB/VT and EAD. 5) QTc prolonged during 
epinephrine infUsions in cases (489+16 vs 453+18 msec) and 
controls (460+25 vs 420+31 msec)(p<0.05) but nei ther the 
basal values-nor the extent of prolongation differed 
significantly between the two groups. 
Conclusions: 1) Phenomena consistent with EAD can be 
recorded in IIAP from patients with catecholamine induced 
arrhythmias but not from controls. 2) Catecholamine 
induced arrhythmias in these patients may represent 
triggered activity. 
1I4A ABSTRACTS 
AREAS OF SLOW CONDUCTION COMMON TO VENTRICULAR 
TACHYCARDIAS OF DIFFERENT MORPHOLOGIES 
David M Fitzgerald MD, Karen J Friday MD,FACC, John A 
Yeung Lai Wah MBChB, Anthony J Bowman MD, Ralph Lazzara 
MD, FACC, Eliot Schechter MD,FACC, Paul Heath MD,FACC, 
Warren M Jackman MD,FACC 
University of Oklahoma and VA Med Ctr, Oklahoma City, OK 
Ventricular tachycardias (VT) with different QRS 
morphologies and rates have been postulated to share an 
area of slow conduction in different reentrant circuits. 
In 5 patients, endocardial mapping identified a single 
site which exhibited discrete diastolic potentials during 
two different VTs. The potentials remained associated 
with each tachycardia during initiation, termination and 
resetting with extrastimuli, establishing an integral 
relationship. Further, DC shocks delivered at this site 
successfully ablated both VTs in 3/3 patients. 
Patterns observed during pacing-induced transition 
from one tachycardia (VT1) to another (VT2) include: 
A) No change in timing of the potential with transition 
from VTl to VT2 (same cycle length) suggesting the 
same reentrant circuit with change in exit site 
(1 patient). 
B) A pair of mid-diastolic potentials reversed sequence 
during transition, with earliest activation on 
opposite sides of the septum, suggesting this region 
of slow conduction is traversed in opposite directions 
(2 patients). 
C) Timing from end of the local ventricular potential to 
the diastolic potential was unchanged, but onset of 
ventricular activation occurred earlier on 
transition to the faster VT, suggesting earlier exit 
from the area of slow conduction resulting in a 
shorter reentrant loop (2 patients). 
We conclude: A single area of slow conduction can 
participate in the reentrant circuits of different VTs. 
CXMDI CLlNICAL AND EIE::'ffiOHiYSIOLOGIC CHARACl'ERISTICS 
IN PATIENl'S WI'lH WNDIE BRANaI REENmANI' VEtmUaJIAR 
'l2'<CHYCARDIA. 
Patrick Tdlou. M.D., Jose caceres, M.D., John Don:JaS, 
M.D., M:lhanInad Jazayeri, M.D., Masood Akhtar, M.D., 
FACe. University of Wisconsin, Milwaukee, WI. 
\'bile frequen::y of clinical I:mxlle brarxh reentrant 
(BBR) ventricular tachycardia (VI') is considered rare, 
there are c:ct1IWIl patient (Pr) characteristics which 
can point to the possible existence of BBR vr. 
~ta 'NeI"e fran 6 Pl'S with BBR vr SI.ICOE!SSfu1ly treated 
with right I:mxlle ablation. All Pl'S had dilated 
cardianyopathies (5 idicpathic, 1 ischemic). Left 
ventricular ejection fractions ra!XJE!d fran 15% to 
40%. All patients had clinical syncx:pe or sudden 
death. 'l'N'elve lead ro:;s all shoiIIed intraventicular 
=n:Iuction defects (IVCD) resemblin;J left I:mxlle 
branch block. QRS durations ra!XJE!d fran 116 to 160 
msec. HV intervals durin;J sirus rhythm 'NeI"e all 
prol~ am 'NeI"e similar to those seen durin;J BBR 
vr. Left I:mxlle brarxh block type of BBR vr 'NeI"e 
:in:iuoed in each Pr by pacin;J the right ventricle. In 
one Pr, a right I:mxlle branch block type of 
ventricular tadlycardia ocm.d be :in:iuoed fran the left 
ventricle. cycle 1en;Jths of these tadlymrdias ran;,ed 
fran 250 to 300 msec. 
OJnclusions: 1) Patients with BBR vr c:ct1IWIl1y have 
rapid, hem:xiynamically oc:.upranisin;J tadlymrdias. 2) 
'lhey frequently nave dilated cardianyopathies am His 
PUrkinje system disease fannin:] the substrate for BBR 
vr. 3) Presence of dilated cardianyopathy, IVCD, am 
a rapid vr havin;J typical right or left I:mxlle branch 
block IOOIPtology should pratpt a search for a BBR 
mechanism. 
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CA'lHEI'ER ABIATIOO OF RIGIfI' WNDIE BRANaI: A HIGHUl 
EFFECl'IVE TEalNIOOE; FOR CXlNmOL OF WNDIE BRANaI 
REENI'RANT VENl'RIaJIAR TACHYCARDIA. 
Patrick Tchou. M.D., Jose caceres, M.D., John 
Don:JaS, M.D., Mohammad Jazayeri, M.D., Masood 
Akhtar, M.D., FACe. University of Wisconsin, 
Milwaukee, WI. 
six patients who had doculrented burxlle branch 
reentrant (BBR) ventricular tachycardia (VI') 
associated with syncope or sudden death I.1rdenIent 
catheter ablation of their right burxlle branches. 
All 6 Pl'S failed treatment with antiarrhythmic 
medications • 
D..Irin;J electroJ;:ilysiologic studies, all :in:iuoed 
tachycardia beats 'NeI"e preceded by His burxlle 
electrograms havin;J similar HV intervals to those 
seen durin;J sirus rhythm. Spontaneous c:han]es in 
tachycardia cycle lengths were seen in each case 
which 'NeI"e preceded by similar changes in H-H 
intervals. '!'NO electric shocks 'NeI"e delivered to 
the right burxlle (170-310 joules) in each patient 
which caused inunediate onset of right burxlle branch 
block. Followin;J ablation, no patient had 
irrlucible vr. Follow up of up to 42 months 
revealed no clinical recurrenoe of vr. 
Conclusion: 1) BBR vr is a malignant arrhythmia 
which can cause sudden collapse in patients 
sufferin;J fran it. 2) Treatment with right I:mxlle 
branch ablation can be reliably aCXX1'lplished am is 
highly effective. 
Tuesday, March 29, 1988 
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Mechanisms of Supraventricular Arrhythmias 
ASSESSMENT OF ATRIAL VULNERABILITY USING DYNAMIC CHANGES 
IN ENDOCARDIAL MONOPHASIC ACTION POTENTIAL DURATION. 
Nadia MG Debbas, MD, Ghazwan G Butrous, MD, Davendra 
Mehta, MD, Sarah Kingswell, A John Camm, MD,FACC, 
Department of Cardiological Sciences, St George's Hospital 
Medical School. London, England. 
Atrial endocardial monophasic action potential (MAP) were 
recorded using a contact catheter in 10 patients (6 
males), aged 19 to 69 (mean 41) years, (4 with the Wolff 
Parkinson White Syndrome, 1 with atrial tachycardia. 2 
with AV nodal re-entrant tachycardia, 3 with ventricular 
tachycardia) during routine electrophysiological study 
(EPS). MAP duration was measured during constant high 
right atrial pacing at 100 and 150 bpm for 5 minutes. 
Atrial refractory periods (ARP) were determined using the 
extra-stimulus technique at drive pacing rates of 100 and 
150 bpm. Vulnerability to atrial arrhythmia was defined as 
reproducable i nit i a t ion 0 f sus t a i ned a t ria 1 
tachyarrhythmia with one or two extrastimuli or burst 
atrial pacing. 
Measurements of the MAP duration was consistent at 90% 
repolarisation but not at 50% repolarisation. There was a 
good linear correlation between steady state MAP duration 
at 90% repolarisation and ARP at each pacing cycle (slope= 
0.55, r=O.77, p<O.Ol) in the group of patients. Vulnerable 
atria were demonstrated in 4 patients (group A) and non-
vulnerable atria, in 6 patients (group-a). Rate adaptation 
of MAP duration at 90% repolarisation was 8+2% in group A 
and 22+3% in group B (p<O.Ol). -
There was a good correlation between ARP and MAP duration 
at 90% repolarisa tion. A trial vulnerabili ty to 
tachyarrhythmia could be assessed during EPS by the rate 
adaptation of the MAP duration. These results suggest that 
a rate adaptation of MAP duration at 90% repolarisation of 
less than 10% is predictive of vulnerable atria. 
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tJNIoI1I.S1<IOO AND M:lIXJIATICN OF '].HE EXCITABIE G1\P IN 
A'llUOI1ENIRIClllAR NJtlAL REENnWn' TACHYCARDIA: NEW INSIGHl' 
INlO '].HE MICXlREENlRY SUE!S'nlATE. Claudio D. Schuger, 
H...!b., ~l T. steinman, M.D., Michael H. Lehmann, 
M.D., F.A.C.C., wayne state University and Harper 
Hospital, Detroit, MI 
'!he elect:J:qiJysioloqic nature of the miCtOleenUy 
circuit underlyinI atrio(A)-ventriaIlar(V) nodal 
reentrantCR) tadlycardia(T) :remains elusive. 
Aoool.'din;ly, """ searched for evidence of an excitable(Ex) 
gap in 11 cx::rlSeO.1tive cases of classic AV nodal Rl' (cycle 
length [CL) 337 ± 41 DIS). rurinI Rl', a V extrastiJJW.us 
(V2) was periodically :introduced folla.rin;J a spcrrt:aneaJs 
T beat (Vl), until. V refractoriness. An Ex gap was 
ccnsideredpresent l4len the magnitude of atrial preexcita-
tial (A-Preex), Le., t.AA (- AlAl minus AlA2), was at 
least 20 DIS at sane critical VlV2 interval. In each 
case, the cuter and inner VlV2 of the gap zone wre 
defined. lm"inI cc:ntrol, 4 pta (36%) shewed an Ex gap 
(maxim.lm t. AA 30 ± 7 DIS). Verapamil (Ver) was then 
administered to all 11 pta at a mean dose of 6.8 Dg, so 
as to prolaq Rl' CL by ~ 20 DIS (mean 62 ± 30 DIS), which 
lerqt:hened All interval of Rl' to the same degree. Ver 
1.IlIIIIBSked en Ex gap in 2 additialal pta (maxim.lmt. AA 40 ± 
10 DIS), and widened the gap in all former 4 pta (cuter 
VlV2 prolcn;red by 56 ± 28 DIS and maxim.lm t. AA increased by' 
34 ± 24 DIS, while inner VlV2 increased by 12 ± 8 DIS). 
A-Preex (with or withcnt Ver) was always associated with 
Preex of the antenlgrade His deflectial post-A2, blt to a 
lesser extent than t.AA. Hence, an Ex gap is present, or 
CIUl be ~loqically 1.IlIIIIBSked, in a significant sub-
set of pta with AVNRl'. Ver unmasks and widens the Ex gap 
mainly by delayinI antenlgrade progress of the Rl' lltplise 
prior to retrograde nodal arrival of V2. em- fin:iirgs 
favor a discrete anatanic circuit aver a "1eadin;J circle" 
type of func:tional reentry in many cases of AVNRl'. 
ELECTROPHYSIOLOGIC SPECTRUM OF CONCEALED INTRANODAL 
CONDUCTION DURING ATRIAL RATE ACCELERATION IN A MODEL OF 
2:1 ATRIOVENTRICULAR BLOCK 
James McKinnie, M.D., Imran Niazi, M.D., Mark Cowan, 
M.D_, Mohammad Jazayeri, M.D., Jose Caceres, M.D., 
patrlck Tchou, M.D., and Masood Akhtar, M.D., F.A.C.C., 
Mount Sinai Medical Center, Milwaukee, Wisconsin. 
Concealed penetration of the atrioventricular node 
(AVN) by the blocked beat during atrial pacing induced 
2:1 AVN block has been previously postulated. However, 
the electrophysiologic behavior and magnitude of such a 
concealed conduction OVer a full range of atrial rates 
(and hence atrial tachycardias) has never been explored 
systematically. We therefore examined the response of 
intranodal concealment in 8 patients over a range of 
atrial pacing rates from the longest atrial cycle 
lengths (ACL) resulting in 2:1 AVN block up to the 
development of 3:1 block. None of the patlents had 
evidence of accessory pathways, dual AVN conduction, or 
were on any antiarrhythmic agents. At each pacing rate 
a stable 2:1 AVN conduction was achieved and the ACL was 
abruptly doubled without a missed capture. At each 
pacing CL the PR and stimulus to His (SH) interval was 
measured at 2:1 and corresponding 1:1 AVN conduction at 
twice the ACL. The responses are listed in the table. 
Patient No. _ 1_ _2_ _3 _ 4 _ 5_ _6 _ _7 _ _ 8_ 
Minimum 2:1 180 150 200 180 320 180 150 150 
SH (msec) 1:1 165 110 170 160 260 130 110 130 
Maximum 2:1 190 180 280 200 380 230 170 180 
SH (msec) 1:1 170 130 250 160 280 170 150 160 
The range of paced ACL producing 2:1 AVN block varied 
30-110 msec (mean 57.5+22.2 msec) in individual 
patients. It is concluded: 1) The magnitude of 
concealed AVN conduction is relatively stable and fixed 
over a full range of paced ACL producing 2:1 block. 2) 
A parallel increment of SH with 2:1 and 1:1 responses 
suggests that site of conduction delay with propagated 
impulses is different than site of block. These· 
findings have important electrophysiologic and clinical 
implications. 
ABSTRACTS 
CHARACTERIZATION AND DIFFERENTIATION OF RESET RESPONSE 
CURVES IN AUTOMATICITY AND REENTRY. 
1I5A 
F. Roosevelt Gilliam III, M.D., Lameh Fananapazir, M.D., 
James M. Irwin, M.D., G. Stephen Greer, M.D., Lawrence D. 
German, M.D., F.A.C.C., Eric N. Prystowsky, M.D., 
F.A.C.C., Duke University Medical Center, Durham, NC. 
Sinus nodal automaticity (SAN) and reciprocating 
atrioventricular tachycardia (RT) are paradigms of 
automatic and macroreentrant mechanisms. We invest-
igated whether specific reset patterns could differentiate 
reentry from automaticity (9 pts-RT, 10 pts-SAN). 
Premature intervals scanned the cardiac cycle in 10 msec 
decrements and were plotted against the return cycle 
duration. Five specific reset patterns occurred: 
Flat (F) Flat/Increase 
, 
'" 
Decrease (D) Flat/Decrease 
/ ~ 
Distribution of these reset 
rhythms were: 
Rhythm 
SAN 
RT 
F 
6 
4 
F/I 
2 
1 
(F/I) 
(F/D) 
response 
F/D 
I 
o 
Increase (1) 
--------
patterns by the two 
D 
I 
o 
I 
o 
4 
We conclude that the frequent occurrence of similar 
reset patterns usually prevents differentiation between 
mechanisms of automaticity and reentry. However, F/D and 
D patterns occurred only in automaticity, and I reset 
pattern occurred only in reentry. 
CARDIAC ASYSTOLE IN PATIENTS WITH NEURALLY-MEDIATED 
HYPOTENSION-BRADYCARDIA SYNDROME. Simon rmstein. MD, 
Jeffrey Buetikofer, MD, John Lesser, ~'D, Irvin F. 
Goldenberg, MD, Charles C Gornick, MD, Ann Dunnigan, 
MD, David G Benditt, MD, FACC 
University of Minnesota, Minneapolis, Minnesota 
Natural hi story studies indicate that the majority 
of patients (pts) with neurally-mediated (vaso-vagal) 
syncope (NMS) have an excellent prognosis. However, it 
has been proposed that sudden death from cardiac 
asystole may occur as a manifestation of NMS. 
To assess this possibility, we compared conventional 
EP testing and upright tilt alone (tilt) and during 
continuous IV isoproterenol infusion (1-3 
micrograms/minute, tilt+ISO), in 5 survivors of a docu-
mented asystolic event (Group I: 3 men, 2 women, aged 
16-45), and in 5 sex/age matched pts with neurally-
mediated syncope without asystole (Group II). 
Structural heart disease was absent in all patients. 
Conventional EP testing was negative in the two 
groups. Gro up I pt s exhi bi ted syncope at <4 mi n utes of 
tilt (3 pts) or tilt+ISO (2 pts) preceded by profound 
hypotension (mean BP: 32±9 vs control 76±lB mmHg) and 
bradycardia (sinus cycle length: 1230±175 ms vs 
control 540±lB ms). Group II pts became syncopal at <5 
minutes of tilt (2 pts) or tilt+ISO (3 pts) preceded by 
hypotension (mean BP: 34±14 vs control 75±15 mmHg) and 
bradycardia (sinus cycle length: 1150±92 vs control 
625±102 ms). Intergroup statistical analysis evidenced 
no significant differences. 
These data support the view that in pts without evi-
dence of cardiac disease, both syncope and asystolic 
cardiac arrest may'be manifestations of neurally-
mediated hypotension-bradycardia, and that NMS suscep-
tibility should be considered when investigating sudden 
death in apparently healthy young pts. 
116A ABSTRACTS 
THE SIGNAL-AVERAGED ELECTROCARDIOGRAM AS A SCREENING TEST 
FOR OCCURRENCE OF PAROXYSMAL ATRIAL FIBRILLATION. 
Iwao YamagUChi, M.D., Keisuke Kuga, M.D., Yasuro Sugishita, 
M.D. and Iwao Ito, M.D., University of Tsukuba, Ibaraki, 
Japan. 
The signal-averaged electrocardiogram (SAE) has been 
shown to be a useful technique in identifying patients at 
risk for ventricular tachycardia. However, limited data 
are available on the significance of SAE for atrial 
arrhythmias. Therefore, this study was designed to 
assess the role of SAE in predicting the spontaneous 
occurrence of atrial fibrillation (AF) in 38 patients. 
Sixteen patients had neither sinoatrial disease nor 
atrial arrhythmias (group I), 10 patients had sick sinus 
syndrome with a history of paroxysmal AF (group II), and 
12 patients had idiopathic paroxysmal AF (group III). 
The three groups were compared by tracings from 3 orthog-
onal leads (X, Y, Z), which were simultaneously displayed 
with filtering of 50-250Hz and at an effective time-base 
resolution of lOOmm/s (ART, LVP-IO). Signal averaging of 
256 beats was performed to reduce noise levels to < l~V. 
The following data were obtained from measurements on 
tracings of lead Y, which may reflect the atrial activa-
tion sequence most precisely. Filtered atrial duration 
from the major deflection to the last deflection < 2~V 
(A) was significantly wider in group II (98±25ms, mean±SD, 
p<O.Ol) and group III (93±23ms, p<O.Ol) than in group I 
(73±20ms). Filtered atrial duration from the major 
deflection to the last deflection > 2~V (B) showed no 
significant difference between group I (72±22 ms), group 
II (58±14ms) and group III (62±27ms). The difference 
between A and B was significantly greater in group II 
(40±18ms, p<O.Ol) and group III (31±13ms, p<O.Ol) than in 
group I (lO±13ms). In conclusion, the presence of atrial 
deflection < 2~V, which is detected by SAE, may be a good 
index of a tendency to develop spontaneous AF. 
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Beta Receptors in Heart Failure 
BENEFICIAL EFFECTS OF PI ADRENOCEPTORS STABILIZATION AND 
P2-ADRENOCEPTORS BLOCKADE WITH XAMOTEROL IN SEVERE 
ISCHEMIC HEART FAILURE TREATED WITH ACE-INHIBITORS. 
H. Pouleur, M.D., F.A.C.C., C. Hanet, M.D., O. Gurne, 
M.D. and M.F, Rousseau. M D , F.A C C., University of 
Louvain, Brussels, Belgium. 
Xamoterol (ICI 118,587, Corwin), is a PI partial agonist 
able to stabilize pI-adrenoceptors at 43\ of their 
maximal stimulation by endogenous catecholaaines; at 
therapeutic dose, xamoterol also acts as a P2-antagonist. 
The interest of this drug in severe ischemic heart 
failure was examined in 9 Pts. All Pts remained in 
functional class III of NYHA despite enalapril (n=5) or 
captopril (n=4) therapy combined with nitrates (n=9), 
calcium antagonists (n=5) and diuretics; 8 Pts also had 
angina pectoris. Control LV angiography (+Millar) was 
performed without stopping cardioactive drugs. Xamoterol 
(200 mg twice daily) was then added for 2 months and LV 
angiography repeated. Xamoterol therapy had no effect on 
resting heart rate (83±4 to 86±4 bpm; NS) or on mean AO 
pressure (92±5 to 90±5 mmHg; NS) but LVEDP dropped from 
28±4 to 13±2** amHg. LV end-diastolic volume was 
unchanged (167±20 to 164±21 ml/m2; NS) but end-systolic 
volume (115±19 to 106±19* ml/m2) and ejection fraction 
improved slightly. The isovolumic indices of inotropic 
state, dP/dt Max (+13*\) and (dP/dt)/DP40 (+47**\) and 
the time constant of isovolumic relaxation (-29*\) all 
improved significantly. Subjective improvement was noted 
in all Pts and angina improved in 7/8 Pts. Exercise 
duration increased in 6 Pts and was unchanged in 3. No 
side-effects were noted. Thus, the stabilization of pI 
adrenoceptors activity in the presence of P2 blockade may 
be beneficial in severe ischemic heart failure and the 
combination of xamoterol with ACE-inhibitors deserves 
further trial in this setting. *P<0.05 **P<0.005 
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DOWN-REGULATION OF SKELETAL MUSCLE BETA-ADRENERGIC 
RECEPTORS IN EXPERIMENTAL CANINE HEART FAILURE. 
Hartin J Fr@y. M D , Vita Lanoce, M.S., Nancy Ferraro, 
R.N., Perry B. Molinoff, M.D., and John R. Wilson, M.D., 
University of Pennsylvania, Philadelphia. 
Patients with heart failure are frequently limited by 
muscular fatigue. Down-regulation of skeletal muscle 
beta-receptors (PAR) could potentially contribute to this 
fatigue by impairing muscle vasodilation and substrate 
availability. To determine if such down-regulation oc-
curs in heart failure (HF) , we compared hindlimb va-
sodilatory responses to isoproterenol (Iso) and hindlimb 
muscle beta-receptor density and adenylate cyclase activ-
ity in 13 control dogs (C) and 10 dogs with HF produced 
by rapid ventricular pacing at 260 bpm for 6-8 weeks. 
Dogs with HF exhibited reduced cardiac outputs and ele-
vated pulmonary wedge pressures, plasma norepinephrine, 
and epinephrine (all p<.05). The density of skeletal 
muscle PAR was reduced in both gastrocnemius (mixed 
fiber) (C: 50±5 vs HF: 33±8 fmol/mg prot), and semi-
tendinous muscles (slow fiber) (C: 43±9 vs HF: 27±9 
fmol/mg prot) (both p<.05). There was also a reduction 
in Iso-stimulated adenylate cyclase activity (C: 
16.8±3.1 vs HF: 12.2±1.7 pmo1/mg/min, p<.05). In a sub-
group of dogs, the threshold dose for Iso-induced vasodi-
lation was 2.2-fo1d greater in dogs with HF (C: 3.4±1.2 
vs HF: 7.8±2 x 10- 3 ~g/kg, p-0.025); the dose of Iso re-
quired to produce one-half maximal reduction in hindlimb 
resistance was also greater i~ the dogs with HF (C: 
6.7±2.1 vs HF: 83.0±2.4 x 10- ~g/kg, p<.OOl). Thus, 
low output HF results in down-regulation and desens~tiza­
tion of skeletal muscle PAR and is associated with re-
duced hindlimb skeletal muscle vasodilation to Iso stimu-
lation. This abnormality could impair skeletal muscle 
vasodilation and metabolism during exercise in heart 
failure. 
THE DISTRIBUTION OF B-ADRENERGIC RECEPTORS IN FAILING 
HUMAN MYOCARDIUM: IMPLICATIONS FOR MECHANISMS OF 
DOWN-REGULATION 
S.S. Murphree. M.D., T.K. Tolley, B.S., and J.E. Saffitz, 
M.D., Ph.D., Washington University, St. Louis, MO. 
The density of B-adrenergic receptors is reduced in 
crude membranes prepared from failing human myocardium. 
We have used quantitative autoradiography in intact tis-
sue slices to determine whether the total tissue content 
of receptors is reduced and to characterize the trans-
mural distribution of down-regulation in cardiac myocytes 
and the coronary vasculature in hearts obtained from 9 
cardiac transplant patients with severe congestive 
failure. Binding isotherms were performed by incubating 
transmural tissue slices with 0.6 - 100 pM [125I]cyano-
pindo1o1 ± 10-5 M 1-proprano101. In 2 normal and 10 
failing ventricles, dissociation constants were uniform 
(Kd = 12.7 ± 1.4 pM) but the total tissue content of 
receptors varied from 24.3 to 5&.9 fmo1/mg tissue pro-
tein. The highest receptor densities were observed in 
the 2 normal ventricles and in a patient treated with the 
B1-antagonist metopro101. The lowest densities were 
observed in 2 patients with severe failure who required 
B1-agonists before surgery. Autoradiography in the 2 
normal ventricles showed the highest receptor density in 
subendocardial myocytes (endo/epi density = 1.31 and 
1.05). Coronary arterioles had 60-80% of the receptor 
density of adjacent myocytes. In the failing ventricles, 
receptor densities of both myocytes and arterioles were 
diminished in all regions but down-regulation was due 
primarily to a selective, marked reduction of B-receptors 
of subendocardial myocytes (endo/epi density = 0.48 -
0.77). Thus, the degree of down-regulation appears to be 
related to the greater wall stress and metabolic demands 
of the subendocardium and not simply to elevated levels 
of circulating catecho1amines. 
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IS B1 RECEPTOR DOWN-REGULATION IN THE FAllING HUMAN 
HEART THE RESULT OF EXPOSURE TO CARDIAC-DERIVED 
NOREPINEPHRINE? Anthony Sandoval, M.D., Edward M. 
Gilbert, M.D., Robert Glnsburg, M.D., Randy Rasmussen, 
B.S., Wayne Minobe, B.S., Patti Larrabee, B.S., Michael 
R. Bristow, M.D.,Ph.D. Univ of Utah, Salt Lake City, UT. 
Selective, chamber specific Bl receptor (R) down-
regulation occurs in the failing ~uman heart. We tested 
the hypothesis that exposure to high concentrations of 
cardiac-derived norepinephrine (NE), an endogenous Bl 
selective agonist, leads to B1 R down-regUlation. In 
subjects with heart failure and di lated cardiomyopathy 
plasma NE in arterial (406±101 pg/ml) and coronary sinus 
(604±l01 pg/ml) samples was compared to endomyocardial 
biopsy and lymphocyte B R density. Additionally, in 
failing right and left ventricles explanted at the time 
of transplantation, tissue NE (SS3±66 ng/g) was compared 
to Bl and B2 R density: (value ± S.E.M.) 
Group R R Density NE r value, 
~ IYQL fmol/mg Origin NE vs R 
RV Biopsy Bl+B2 *42.3±S.2 Coronary Sinus -.64** 
(32) Arterial -.42t 
Lymphocyte B2 *64.2±7.9 Coronary Sinus -.10 
(32) Arterial -.10 
Ventricles Bl *36.7±2.0 Tissue +.49** 
(63) B2 2).O±1.3 Tissue +.17 
*p<.OS vs. nonfailing controls (data not shown), 
**p<.OOl, t p<.OS. CONCLUSIONS: In dilated cardio-
myopathy 1) total myocardial B-adrenergic R density 
(which is 60-70% BI) correlates inversely with coronary 
sinus NE. 2) Lymphocyte B2 R density does not correlate 
wi th coronary si nus or arteri a 1 NE. 3) Myocardi a 1 Bl, 
but not B2 R density correlates directly with tissue NE 
dep 1 et ion. These data support the hypothes is that in 
heart failure Bl R down-regUlation is related to 
increased R exposure to cardiac derived NE. 
INTRACELLULAR a-ADRENERGIC DISTRIBUTION IN THE FAILING 
HUMAN MYOCARDIUM. Constantinos J. Limas. M.D., Irvin F. 
Goldenberg, M.D., Gordon Pierpont, M.D., University of 
Minnesota. Minneapolis Heart Institute, Minneapolis. MN. 
Although it is known that the number of membrane-bound 
B-adrenoceptors (aAR) declines in heart failure, the 
mechanisms involved are unclear. Since agonist-induced 
desensitization results in aAR translocation from the 
cell membrane to an intracellular vesicular fraction. we 
determined the intracellular BAR distribution in two 
groups. Group I (n=9) consisted of papillary muscles 
from patients with mild to moderate heart fail ure under-
going valve replacement. Group II (n=8) consisted of 
severely failing hearts removed during orthotopic cardiac 
transplantation; the distribution of BAR between the 
membrane and vesicular fractions was determined in the 
right ventricle. left ventricle. interventricular septum 
and anterior papillary muscle. The density of membrane-
bound BAR was reduced in both groups (I: 27.8±5 fmol/mg 
prot.; II: 18.1±2 fmol/mg prot.). The percent of total 
BAR recovered in the vesicular fraction was 36.8±S~ in 
Group I and 46.7±6~ in Group II. For Group I. but not 
Group II, there was a significant (p<O.Ol) negative 
correlation between the number of membrane-bound BAR and 
the percent aAR recovered in the vesicular fraction. 
A significant correlation (r=-O.71. p<O.Ol) was found 
between membrane-bound BAR and tissue epinephrine but not 
norepinephrine levels. For Group I. a significant 
(p<O.OS) inverse correlation existed between the plasma 
norepinephrine levels and membrane-bound BAR. These 
results indicate that agonist-induced "down" regulation 
may playa role in the decline of membrane-bound BAR in 
mild to moderate heart failure, while in the severely 
failing myocardium additional mechanisms operate. 
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MYOCARDIAL 82 RECEPTOR SUBSENSITIVITY IN THE FAILING 
HUMAN HEART. J.D. Port,B.S., Michael R. Bristow, M.D. 
Ph.D. University of Utah, Salt Lake City, UT. ' 
We have previously shown that in failing human 
ventricular myocardium selective Bl receptor (R) down-
regul at ion resul ts in marked subsens i t i vity to Bl or 
nonselective Bl/B2 agonist stimulation. In these 
previous studies, the B2 population as measured by 
radioligand binding was relatively preserved. In thi~·. 
study, we measured B R subtype dens i ties and adenyl ate 
cyclase stimulation in response to zinterol (zint), a 
highly selective B2 agonist, in both failing and 
nonfailing human ventricles removed at the time of 
cardiac transplantation or organ donor harvest. Maximum 
AC stimulation in response to histamine (Hist) was 
measured as a non B-R control, and the response to NaF 
was measured as a post-R control: (value ± S.E.M.) 
Group and (n) 
Nonfailing 
(13) 
R density, Cyclase Stimulation 
fmol/mg pmol cAMP/min/mg 
Net Net Net Zint/ 
Bl B2 Ii.nL His t jfgL .l!.9L ~3f ~79 15.00 4.94 52.38 0.31 
±3.88 ±2.61 ±1.27 ±.81 ±S.16 ±.07 
Failing 33.41* 15.43 9.Sgr 4.23 45.81 0.23t 
(16) ±3.04 ±1.S8 ±1.IS ±.47 ±S.73 ±.02 
* p<O.OOOI; tp<O.OS compared to nonfailing 
CONCLUSIONS: Although B~ R density measured by radio-
ligand binding is not slgnificantly reduced in failing 
ventricles, B2 agonist stimulation of adenyl ate cyclase 
is mildly decreased. This indicates that the B2 R 
pathway in the failing human heart exhibits mild 
subsensitivity, compared to the markedly subsensitive Bl 
R pathway. These data predict that selective B2 agonists 
coul d be used as i notropi c agents in the fa iT i ng human 
heart, but that high efficacy compounds would be 
required to overcome mild subsensitivity. 
Tuesday, March 29, 1988 
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Atrial Natriuetic Factor in Heart Failure 
EFFECTS OF ATRIAL FIBRILLATION ON PLASMA ATRIAL NATRIURE-
TIC FACTOR RESPONSE TO CHANGES IN ATRIAL PRESSURE. 
Jean-Claude Dussaule, M.D.,/Alec Vahanian, M.D., ~­
LOllis Michel MD., Isabelle Soullier, M.C., Raymond 
Ardaillou, M.D., and Jean Acar, M.D. Tenon Hosp., Paris, 
France. 
To study the relationship between plasma atrial natri-
uretic factor (ANF) and cardiac pressures, we measured 
plasma ANF in 23 patients with mitral stenosis 30 min 
before and 30 min after balloon mitral valvulotomy. All 
patients were indemn of cardiac failure. Normal sinusal 
rythm was present in 14 (group I) whereas the 9 others 
(group II) had permanent atrial fibrillation. There was 
no significant difference between both groups for basal 
mean pressures in RA (1.4±o.6 vs 1.8±0.4 mmHg), LA (21.2 
±2.0 vs 18.4±2.5 mmHg) and PA (31.1±3.7 vs 28.8±3.5 
mmHg). Valvulotomy resulted in both groups in a fall 
(p<0.02) in LA (9.4±1.B and 10.3±1.0 mmHg) and PA (17.1 
±2.3 and 20.1±2.3 mmHg respectively) mean pressures 
whereas heart rate, CI, RA and AO pressures did not 
change significantly. Basal plasma ANF was not different 
in both groups in RA (26~48 vs 266±35 pg/ml), LA (475±86 
vs 682±84 pg/ml), PA (537±89 vs 759±92 pg/ml) and AO (488 
±91 vs 643±70 pg/ml). In contrast, after valvulotomy, 
plasma ANF was markedly greater (peO.05) in group II (372 
±91, 755±152, 805±135 and 708±144 pg/ml) than in group I 
(199±41, 366±55, 417±74 and 397±59 pg/ml) whatever the 
site of blood collection (RA, LA, PA and AO respective-
ly). Pooled values of RA ANF before and after valvulotomy 
were correlated with LA or PA pressure in group I (p < 
0.01) whereas there was no significant correlation in 
group II. Similar results were observed when PA ANF vs LA 
or PA pressure correlations were tested. These data 
demonstrate that atrial fibrillation, during mitral 
stenosis, results in inappropriate high levels of plasma 
ANF in spite of a rapid fall in LA and PA pressures. 
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THE PHYSIOLOGIC ROLE OF ENDOGENOUS ATRIAL NATRIURETIC 
FACTOR DURING ACUTE CONGESTIVE HEART FAILURE. 
Mu E. Lee, M.D., Brooks S. Edwards, M.D., Wayne L. 
Miller, M.D., and John e. Burnett, Jr., M.D., Mayo 
Medical School, Rochester, MN. 
While circulating atrial natriuretic factor (ANF) is 
increased in acute congestive heart failure (eHF), the 
physiologic significance of this elevation is unclear. 
This study was designed to test the hypothesis that 
increased circulating ANF in acute eHF prevents sodium 
retention despite reductions in renal perfusion pressure 
(RPP). To test this hypothesis, renal perfusion pressure 
was reduced by 15~ in three experimental models in 
anesthetized dogs: Group I, acute eHF produced by rapid 
right ventricular pacing (eHF, n • 5) with increased 
right atrial pressure (RAP) and ANF; and Group II, 
thoracic inferior vena caval constriction (TIVee, n z 5), 
with decreased RAP and ANF. Despite equal reductions in 
RPP in eHF and TIVee, sodium retention was prevented only 
when associated with increased ANF. 
tp < .05 eHF vs Tlvee 
lIRPP lIRAP lIUNa V llANF 
mmHg mmHg ~Eq/min pg/ml 
eHF -18 ± 2 +3.1 ± 0.6 +12.5 ± 9.2 +325 ± 61 
Tlvee -17 ± 1 -1.8 ± 0.2 -31.5 ± 13.4 -0.5 ± 4.2 
tp values NS p < 0.001 p < 0.05 p < 0.05 
In a third group, ANF was infused in dogs with TIVee 
to produce circulating concentrations of ANF observed 
during acute eHF produced by RRVP. In this group with 
TIVee and ANF infusion, a decrease in sodium, excretion 
was prevented. 
We conclude that the role of increased endogenous ANF 
in acute eHF is to serve as a homeostatic hormone to pre-
vent sodium retention and intravascular volume overload 
despite decreases in renal perfusion pressure. 
RENAL AND HEMODYNAMIC EFFECTS OF LOW AND HIGH DOSE ANF 
BOLUS DOSES IN CONGESTIVE HEART FAILURE 
Brian G. Firth, MD. PhD, FACC. Rhonda C. Perna, RN, 
Joseph F. Bellomo. MD. and Robert D. Toto. MD. University 
of Texas Health Science Center. Dallas. 
The effects of low (70±25I.1g[mean±SD]) followed by high 
(130±62I.1g) dose ANF bolus administration was assessed 
in 16 pts with chronic heart failure. Measurements 
were made prior to the first bolus (B1). for the next 
60 minutes (T1). after 3 hours (B2). and for the following 
60 minutes (T2). Urine flow rate (9. ml/min). urine 
sodium excretion (UNa. I.IEq/min). PAH and inulin (In) 
clearances (ml/min) were measured. 
n B1 T1 B2 T2 
V 15 0.82±0.23 1.46±0.73t 1.10±0.59 1.75±1.39* 
UNa 15 60±54 81±81t 52±48 88±82* 
PAH 14 179±96 196±93 146±73 223±178 
In 12 54±25 58±22 48±23 57±37 
*=piO.05; t=piO.01. compared to respective baseline. 
Although there was a significant increase in 9 and UNa 
in response to both boluses. there was not a significant 
change in renal blood flow (PAH) or glomerular filtration 
rate (In). There was no significant correlation between 
the change (II) in V versus II PAH or II In. or II UNa and 
IIPAH or II In. at T1 or T2. There was no discernible 
relationship between the response to ANF and baseline 
plasma ANF or aldosterone concentrations. or plasma 
renin activity. at B1 or B2. There was also no 
significant effect on CI. mean Ao or LV filling pressures. 
or systemic vascular resistance. at 30 or 60 minutes 
after B1 or B2. Thus. in patients with congestive heart 
fa i 1 ure: (1) both low and hi gh dose ANF bo 1 uses produced 
an increase in urine flow rate and sodium excretion; 
(2) these effects appear to be independent of changes 
in renal blood flow and glomerular filtration rate. 
suggesting a direct tubular effect of ANF in this setting. 
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MORPHOMETRIC ANALYSIS OF ATRIAL NATRIURETIC PEPTIDE 
GRANULARITY IN PATIENTS WITH HEART FAILURE. 
Robert J. Grop1er, M.D •• Christine E. Lawless, M.D., 
F.A.C.C •• John A. McNulty. Ph.D., Linda M. FOX, Patrick 
J. Scanlon, M.D., F.A.C.C •• Henry S. Loeb, M.D., 
F.A.C.C. and Roque Pifarre. M.D., Loyola Medical 
Center, Maywood, IL and Hines VA Hospital,. Hines, IL 
In animal models of heart failure (HF) atrial tissue 
levels of atrial natriuretic peptide (ANP) and ANP 
granularity (ANPG) are both decreased. In order to 
study the relationship between ANPG in patients (pts) 
with and without HF we obtained RA appendage specimens 
from 7 pts with normal LV function undergoing routine 
aortocoronary bypass surgery (Group I) and 6 pts with 
severe HF undergoing orthotopic heart transplantation 
(Group II). Specimens were processed for transmission 
electron microscopy. Grids were aligned such that each 
cell had a nucleus on one side with the myofibri1s 
oriented in a longitudinal direction. Final print 
magnification was 12.000X. Two blocks per specimen 
were randomly chosen and five prints per block were 
recorded. Number of ANP granules per unit area of 
cytoplasm in um2 (ANPG/AC) were measured by two blinded 
observers. Results were as follows (mean + SD). The 
ANPG/AC ratio for Groups I and II were 0.147+0.030 and 
0.234+0.125, respectively (p > 0.05). Conclusions: 
A1tho~gh there was variability in ANPG in pts with 
severe HF, overall there was no significant difference 
compared to controls without HF. As opposed to animal 
studies, our data in humans suggest normal or increased 
ANP storage in chronic HF. Further studies are 
required to elucidate the relationship between ANP 
storage granules and ANP production and release. 
ELEVATED ATRIAl NATRIURETIC PEPTIDE IN CHRONIC BIVENTRICULAR 
FAIWRE DUE TO DILATED CARDIOMYOPATHY: EVIDENCE FOR 
PREDOMINANT CONTRIBUTION FROM THE LEFT HEART. 
Michael Kwasman MD, Teresa DeMarco MD, David Gardner MD, Debra 
Lau RN, BSN, Chris Wolfe MD, Kanu Chatlerjee MB, FRCP. University 
of California, San Francisco, CA. 
Atrial natriuretic peptide (ANP, pg/ml) levels were measured 
from a peripheral vein (PV), right atrium (RA), pulmonary artery 
(PA), coronary sinus (CS) and radial artery (ART) concomitlant with 
RA and pulmonary arterial diastolic pressures (PAD) before and after 
reduction of RA pressure (RAP) and PAD with an oral vasodilator, 
Floseqinan, in 9 patients with chroniC heart failure. RAP and PAD 
decreased following vasodilator by 2.S and 6.2 mmHg respectively. The 
ANP in the sampling sites before (B) and after (A) reduction of atrial 
pressures were as follows: 
PV RA PA CS·· ART· 
B 1174 1048 1212 3723 991 
± ± ± ± ± 
A 808 770+ 864+ 2S84 721+ 
± ± ± ± ± 
+ p<.OS •• p<.OS vs other sites • p<.OS vs PA 
The differences in ANP concentration in PV, RA, PA and ART were not 
significant. CS ANP level was higher and (CS - ART) ANP gradient was 
significantly higher both before and after reduction of atrial 
pressures. We conclude: 1) ANP levels- are considerably elevated in 
patients with biventricular failure due to dilated cardiomyopathy; 2) 
even modest reduction of atrial pressures is associated with lower 
ANP; 3) left heart is the major source of ANP in these patients. 
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HEMODYNAMIC, HORMONAL, AND RENAL CHANGES 
FOLLOWING INCREMENTAL INFUSIONS OF ATRIAL NATRIU-
RETIC PEPTIDE BEFORE AND AFTER THE INDUCTION OF 
CONGESTIVE HEART FAILURE. 
GUnter A.J. Riegger M.D" Dieter Elsner M.D., Eckhard P. 
Kromer M.D., Medizinische Univ.-Klinik, WUrzburg, FRG 
The role of ANP in the pathogenesis of CHF is unknown. We 
performed dose-response studies by iv infusions (30 min) of ANP 
(0.01; 0.03; 0.1; 0.3; 0.6 Lug/kg/min) in conscious dogs before and 
after the induction of CHF by rapid right ventricular pacing 
(240/min; 10 days). ANP increased in CHF from 7.9 to 49.1 pg/ml 
(pC:: 0.03) and reached max. levels of 1725 (contro!) and 2636 
pg/ml (CHF) during ANP-infusion. Plasma renin and c-GMP 
increased sign. in CHF. The increase of ANP was strongly 
related to the increase of right atrial pressure. C-GMP levels 
were elevated in relation to plasma ANP. In control animals ANP 
induced a dose-dependent increase of urine flow (J.3 vs 5.2 
ml/min) (p<0.03) and urine Na excretion (0.17 vs 1.09 
Lumo!/min) (p<0.03). Similar increases were measured for CI, 
Ca and Mg excretion. The effects on K and P04 were sign. smaller. In CHF the renal effects of ANP were nearly abolished. 
In the control dogs ANP decreased sign. CO, SV, MAP and right 
atrial pressure without changing PVR. This was due to a preload 
reduction with a consecutive reduced SV. In CHF only MAP was 
reduced. ANP suppressed renin release in normal dogs, having no 
effect on renin secretion in CHF. Despite these attenuated 
effects we found no reduction in c-GMP production in CHF in 
comparison to healthy animals. Using a whole dose-response 
study of ANP we found a marked attenuation of hemodynamic, 
renal and hormonal effects in CHF. This may be due to an 
intracellular defect beyond the formation of c-GMP, preventing 
the mediation of the hormonal signal into biological action. 
Tuesday, March 29, 1988 
2:00PM-3:30PM, Room 216, Level Two 
EcholDoppler Assessment of Diastolic Function 
RELIABILITY OF DOPPLER DERIVED INDICES OF LEFT 
VENTRIOJLAR DIASTOLIC FUNCTION IN PATIENTS WITH DILATED 
CARDI<J.1YOPATHY: a:wIPARISON WITH SIMJLTANEOUSLY OBTAINED 
LEFT ATRIAL AND VENTRIOJLAR MICROMANOMETER PRESSURES. 
Daniel David, MD, FACC, Roberto M. Lang, MD, FACC, Ale. 
Neumann, BS, Kirk T. Spencer, Plnhas Sarell, MD, Richard 
Marcus, MD, Kenneth M. Borow, MD, FACC, Unlv of Chicago, IL. 
Controversy e.lsts regarding the ut IIIty of Doppler derived 
Indices of LV diastolic performance. For example, a decrease In 
transmltral Doppler derived EfA ratio Is a commonly used Inde. 
of diminished LV compliance. The diagnostic value of this ratio 
was evaluated In 7 pts with dilated cardiomyopathy (CM) under 
control (CTR) conditions and following treatment with amrlnone 
(AM) (a drug reported to Improve LV compliance). Doppler 
derived AM Induced changes In transm Itral flow criteria: peak E 
and A velocities (E, A; em/sec) and their ratios were compared to 
changes In simultaneouslY recorded LA and LV diastolic 
hemodynamics Including (1) Peak LA-A wave pressure (LA-A: 
mmHg) (2) Peak LA-A wave pressure slope (LAS: mmHgfsec), (3) 
LVEDP (mmHg) (4) Late diastolic LV pressure slope (LVS; 
mmHg/sec). AM Increased SV by 2196, decreased mitral 
regurgitation and did not change HR. (·=p<.05). 
I. ~ ~ EDP ~ 
CTR 64:!:28 38:!:19. 1.6. 21:!:9. 25:!:6. 
AM 45±32' 48±23 0.9 11± 7 14±5 
LVS LAS 
1 53:!:49. 148:!:29 
107±50 123±57 
Following AM, LAS was unchanged. LVS, mean LA-A wave and 
mean LVEDP decreased. Concomitantly, E velocity decreased 
while A velocity Increased resulting In a significant decrease In 
E/A ratio. Thus, In patients with CM,(1) AM resulted In Improved 
diastolic LV function by either a movement down a single 
pressure-volume curve or a shift to a new pressure-volume curve 
characterslstlc of Improved LV compliance. (2) Doppler E/A ratio 
Is an unreliable Inde. for serial assessment of drug Induced 
changes In LV diastolic performance. 
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RELATION OF DOPPLER INDICES TO OTHER MEASURES OF DIASTOLIC 
LEFT VENTRICULAR FUNCTION 
Pamela S. Douelas, M.D., F.A.C.C., Barbara Berko, M.D., 
Alfred 1011, ynth1a Parr, Nathaniel Reichek, M.D. 
University of Pennsylvania, Philadelphia, PA 
Although Doppler derived measures of LV diastolic function 
are commonly used, their relation to dimensional and 
hemodynamic indices of diastolic performance and their 
sensitivity to acute changes in inotropic state are 
unknown. Therefore, we studied 15 open chest normal dogs 
during paired baseline and rapid pacing, dobutamine (10 
mcg/kg/min) and propranolol (.5 mg/kg) interventions. 
Early (E) and late (A) LV inflow velocities, their ratio 
(E/A) and early flow deceleration (dE/dt) were obtained 
from digitized LV Doppler recordings; peak rates of LV 
cavity expansion (dD/dt/D) and wall thinning (-dh/dt/h) 
from epicardial M-mode LV echograms; and isovolumic decay 
constant (Tau; lnP=At+B, Tau= -1/A) from micromanometer 
LV pressures (P). Neither increased heart rate (108 to 
127) nor dobutamine infusion (+dP/dt: 2241 to 3860) 
altered any diastolic parameter. In contrast, propranolol 
(+dP/dt: 2146 to 1280) reduced E (54 to 37), dE/dt (68 to 
44) and dD/dt/D (3.18 to 1.65) and increased Tau (25.5 to 
36.4), all p<.Ol, without affecting E/A or -dh/dt/h. 
Changes in E (6E) correlated with 6Tau (r=-.63), and 
6dE/dt (.78), both p<.OOl, but not with changes in wall 
thinning or cavity enlargement. 6E/A was not strongly 
related to any other parameter. 
Thus, peak early inflow velocity is sensitive to reduced 
contractility and changes concordantly with dimensional 
and hemodynamic parameters. In contrast, E/A was 
unaffected by inotropic state. Early inflow velocity 
patterns appear related to active relaxation and may 
provide a valuable noninvasive index of early diastolic 
perf ormance. 
DETERMINANTS OF THE PEAK VELOCITY OF LEFT VENTRICULAR 
FILLING: INTERACfION OF PRELOAD, AFTERLOAD AND RELAXATION. 
Christopher ~ Choong, MB, PhD, Vivian M. Abascal, MD, 
James D. Thomas, MD, Gerard--r. lIilkins, MB, J. Luis 
Guerrero, BS, Shawn McGlew, BS, Arthur E. lIeyman, MD, 
FACC, Massachusetts General Hospital, Boston, MA. 
Although the peak velocity (PEV) of early LV filling 
is commonly used as an index of diastolic function, its 
relationship to LV loading condi tions and relaxation 
remains poorly defined. lie studied seven dogs on right 
heart bypass, in which LA pressure (LAP), representing 
preload, was varied by controlling blood flow into the 
pulmonary artery, and LV systolic pressure (LVSP), 
representing afterload, was independently varied by 
pumping blood into or from the femoral arteries. Heart 
rate was kept constant by atrial pacing. Mitral inflow 
veloci ty profiles were recorded by pulsed Doppler at 
multiple predetermined levels of LAP and LVSP. Multiple 
regression analysis of data pooled from all dogs 
identified LAP, time constant of relaxation (T) and LVSP, 
in that order, as predictors of PEV (n=83 stages, 
cummulative r=0.61, p<O.OOOl). Similar analysis in 
individual dogs yielded higher cummulative r values (mean 
r = 0.89, range = 0.85 - 0.97), suggesting the presence 
of importa.nt inter-dog differences. IIi th the application 
of simple regression analysis to data from all dogs, a 
moderately strong relationship between PEV and individual 
factors could be demonstrated only when the other two 
factors were kept constant: PEV correlated directly with 
LAP (r=0.72, p<O.OOOl), and inversely with T (r=-0.61, 
p(O.OOOl) and LVSP (r=-0.65, p(O.OOl). 
Conclusion: The PEV varies directly with LV filling 
pressure, and inversely with relaxation ra te and LV 
afterload. These individual relationships are often 
obscured by simultaneous variations in other factors 
between and within animals. 
120A ABSTRACTS 
TRB FILLIRG BATE IRTBGRAI.: A ROR-INVASlVE IRDEI OF 
DIASTOLIC PURCTIOR HOIlllALIZED FOB. III!AB.T BATE ARB CIIAIOIEB. 
VOLUHE. James J Ferguson MD. Warren J Manning MD, 
Sanford E Warren MD, Patricia C Come MD FACC, Jeanne Y 
Wei MD FACC. Harvard-Thorndike Laboratory, Beth Israel 
Hospital, Boston MA. 
Current non-invasive assessments of left ventricular 
filling are difficult to interpret when comparisons are 
made at different heart rates or filling volumes. We 
have therefore developed a new index of left ventricular 
diastolic function which is normalized for heart rate 
and chamber volume. In order to show the utility of this 
index in assessing normal and pathological left ven-
tricular filling, we obtained pulsed Doppler studies in 
20 normal subjects (10 old 73 ± 6 yrs; 10 young, 27 ± 5 
yrs) and 11 elderly (74 ± 8 yrs) subjects with concentric 
left ventricular hypertrophy (LVH). The Filling Rate 
Integral (FRI) was obtained by integrating normalized 
left ventricular filling curves, constructed from mitral 
inflow velocities. Our results (mean ± SD) are summarized 
below: 
In normals, the FRI was 
significantly lower in the 
older group. LVH resulted 
in a further significant 
decrease of FRI, below 
comparably old normals. 
CORCLUSIORS: The Filling Rate Integral is decreased in 
older normal subjects and in patients with LVH. This 
index is a useful, easily measured expression of left 
ventricular diastolic function that largely eliminates 
the confounding influences of heart rate and chamber 
volume. The sensitivity of the Filling Rate Integral is 
enchanced by its applicability on a beat-to-beat basis. 
OOPPLm ASSESSMENT OF RIGIfI' VENffiICUIAR DIASI'OLIC 
FUl'CI'ION IN CARDIAC AMYIDIOOSIS. 
Allan L. Klein, M.D., Liv K. Hatle, M.D., Jae K. Ch, M.D., 
Charles P. Taliercio, M.D., F.A.C.C., Robert A. Kyle, M.D. 
Janes B. Seward, M.D., F .A.C.C., and A. Jamil Tajik, M.D., 
F.A.C.C., Mayo Clinic Rochester, MN. 
The right ventricle is frequently involved in S¥stemic 
amyloidosis (AL). To assess RV diastolic function in car-
diac AL, we prospectively performed p.11sed LOppler studies 
of the tricuspid valve ('IV), and superior vena cava (sve), 
to neasure flow velocities with simultaneous respiratory 
IlOnitoring in 40 pt (28 men, 12 waren; nean age, 59 
years) • All had biopS¥-proven AL and echocardiographic 
evidence of cardiac AL. Measurements were 'IV peak E and A 
velocities (35 pt), deceleration time (1Jl') (40 pt), and 
SVC s¥stolic (S), diastolic (0), and atrial reversal (AR) 
velocities (40 pt). 
Norm 
AL 
P 
E/A 
1.5+0.5 
1.3+0.6 
NS -
lJl',ms 
225+29 
164+43 
<0.0001 
SVC velocity, CllV's 
SOAR 
35+7 23+3 12+2 
32+20 32+17 16+10 
NS- <O~OOI <0~01 
Diastolic function was abnormal in 31/40 pt (78%). The 
major abnormality was restriction, with a short IJl' «160 
ms) in 21/31 pt (68%), and an increased SVC 0 and atrial 
reversal velocities in 13/31 pt (42%). In 7/31 pt (23%), 
an abnormal relaxation pattern was seen, characterized by 
a decreased E/A ratio and a normal 1Jl'. Three of 31 pt 
(9%) had mild abnormalities of SVC flow. Thus, there is a 
range of right ventricular diastolic function abnor-
malities in pt with cardiac amyloidosis; however, a 
restrictive pattern is the predcminant abnormality seen in 
these pt. 
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DOPPLER ASSESSMENT OF LEFT VENTRICULAR FILLING: IMPROVE-
MENT IN THE AGE-RELATED DECREASE OF EARLY DIASTOLIC 
FILLING WITH ORAL DILTIAZEM. WJ Manning MD, JJ Ferguson 
MD, RP Shannon MD, JT Santinga MD, [ Carl BS, PC Come MD, 
FACC, JY Wei MD, FACC. Beth Israel Hospital, Harvard 
Medical School, Boston, MA. 
With advancing age there is an impairment of early 
left ventricular (LV) diastolic filling. To test the 
hypothesis that diltiazem may be an effective therapy to 
reverse this impairment, we prospectively studied 28 
subjects. Pulsed Doppler mitral inflow patterns from the 
apical four-chamber view were obtained before and 3 hours 
following 90 mg of oral diltiazem in 20 normals: 10 young 
(Y, mean age 30 yrs), and 12 healthy old (0, mean age 69 
yrs); and 6 elderly patients with diastolic dysfunction 
(0, mean age 72 yrs), angiographically normal coronary 
arteries and intact LV systolic function. All 28 had 
normal mitral and aortic valves. 
There were clear differences (p<.OOl) in EIA, %E/%A. 
time to 50% filling, and % filling •• 
in the first 1/3 of diastole (%1/3) ~ 
between the Y and 0 at baseline. In ~ ....•. 
the Y group there was no change .. ,.' 
fo 11 owi ng di lti azem in any of these '::; " _ .... E 
indices. In the 0 group there was a M __ ~OST 
si gnificant improvement fo11 owi ng • 
diltiazem in EIA (p<.05) and %1/3 T '" E 
(p<.OOl). In all 0 group subjects there were marked 
improvements in all of the indices studied (p<.005). 
Conclusion: In older patients with diastolic 
dysfunctlon and intact systolic function, diltiazem 
significantly improves LV diastolic filling as assessed 
by Doppler evaluation. In addition, calcium antagonist 
therapy may also benefit a subset of healthy older 
subjects. 
Tuesday, March 29, 1988 
4:00PM-5:30PM, Room 216, Level Two 
Echo/Doppler Assessment of Left Ventricular Systolic 
Function 
INFLUENCE OF ALTERATIONS IN LOADING UPON AORTIC BLOOD FLOW 
ACCELERATION PRODUCED BY LOWER BODY NEGATIVE PRESSURE. 
Martin Berk, M.D., Michael Harrison, M.D., Joyce Evans, 
M.s., Charles Knapp, Ph.D., Paula Taylor, R.N., Theodore 
Kotchen, M.D., Anthony N. DeMaria, M.D., F.A.C.C. 
University of Kentucky, Lexington, KY 
Previous studies have proposed that AO blood flow 
acceleration(ACL) is a measure of LV function which is 
independent of loading, and thereby an index of contrac-
tility. To test this, we studied 14 normals during graded 
lower body negative pressure(LBNP). Echo LV diastolic 
(LVDD), systolic and aortic dimensions and automated cuff 
blood pressure(BP) were obtained. ACL, peak aortic 
velocity(pkV) and flow velocity integral(FVI) were 
recorded by suprasternal notch continuous wave Doppler. CO 
and systemic vascular resistance(SVR) were calculated. 
Results: (* = p<.Ol for overall graded LBNP effect) 
LBNP Rest -10 -20 -30 -40 -50 -60 mm Hg 
ACL 17.4 16.3 16.1 16.3 16.2 14.9 14.1 * 
HR 60.6 61.4 65.5 68.6 71.9 74.6 79.7 * 
SBP 116 115 117 118 118 118 119 
pkV .81 .76 .74 .70 .68 .62 .61 * 
FVI 14.3 12.6 12.1 10.9 9.9 8.6 8.2 * 
SVR 14.9 17.4 17.3 18.4 18.8 20.9 20.3 * 
CO 5.6 5.0 5.1 4.8 4.6 4.2 4.3 * 
LVDD 5.08 4.74 4.47 * 
Graded changes in LBNP reduced LVDD(preload), FVI, CO, pkV 
and ACL, but increased HR and SVR(afterload) progressive-
ly. Percentage fractional shortening and BP did not change 
Significantly. Conclusions: LBNP results in both a 
decrease in preload and reflex increase in after load. 
These LBNP-induced alterations in loading are accompanied 
by small, but Significant, reductions in aortic blood flow 
acceleration. Accordingly, acceleration is not 
independent of loading and is not a pure index of 
myocardial contractility. 
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IS IT POSSIBLE TO OBTAIN AN 
ESTIMATE OF STROKE VOLUME 
DECREASED FORWARD FLOW? 
ACCURATE DOPPLER 
IN PATIENTS WITH 
Alex Neumann, BS, Kirk T. Spencer, Roberto M. Lang, MD, 
FACC, George Palx, MD, Plnhas Sarell, MD, Richard Marcus, MD, 
Kenneth M. Borow, MD, FACC, Unly of Chicago, Chicago, IL. 
Numerous InYestlgators have documented the reliability of 
continuous wave Doppler and Ao annulus size for LV stroke 
yolume determination. To determine If this technique Is reliable 
In estimating SV In pts with markedly decreased forward flow, we 
studied 7 pts with dilated cardiomyopathy at baseline and during 
dobutamlne (DB) or dopamine (DA) Infusion. Doppler recordings 
were performed from the suprasternal notch or apical positions 
and yeloclty time Integrals (VTI) calculated. LV outflow 
diameters were measured by 3 observers at the annulus (A) and at 
the maximum excursion of the base of Ao leaflets (B) using 2-D 
long-axis ylews. Measurements were obtained at control (CTR) 
and repeated during drug therapy. Results were compared with 
simultaneous thermodilution (TO) SV. Heart rates were not 
changed by the drugs. Results were as follows: 
TOsy VTI 
CTR 31±11. 
Dsy 
Annulus 
44±19 
60±23++ 
Dsy 
Leaflet 
29±12. 
44±14 DA/DB 4S±14 
Measurements using Ao leaflets resulted In 9/14 determinations 
within 5% and all within 18% of TO SV. There was a 28% change 
In effectlye orifice size with DA/DB (p<.OS). In contrast, when 
Ao annulus was used, SV was oyerestlmated In all cases with only 
2{14 measurements within 20% of TO values. Conclusions: (1) 
Nonlnvaslye estimates of SV In pts with decreased forward flow 
are more accurately determined using the maximum excursion of 
the base of the Ao leaflets than Ao annulus size. (2) The 
effectlYe Ao orifice size Is dynamic and therefore requires 
measurement with each SV determination. 
DOPPLEIl ECBOCAIIDIOGBAPIIIC ASSESSHDT OF TIlE EFFECT OF 
BALLOOB AOIlTIC VALVULOPLASTY OR LEFT VEllTRICULAIl SYSTOLIC 
FDBCTIOR. James J Ferguson MD, Howard S Bush MD, Edward P 
Riuli MD, Joseph P Murgo MD FACC. Clayton Research 
Foundation, St. Luke's Episcopal Hospital, Texas Heart 
Institute, Baylor College of Medicine, Houston, Texas. 
In order to evaluate the effects of balloon aortic 
valvuloplasty (BAV) on LV systolic function and ejection 
dynamics, we performed Doppler echocardiographic studies 
in 11 patients pre- and 24 hours post-BAY. Continuous wave 
aortic velocity signals were digitized and (with cath lab 
pre- and post-BAY valve areas) used to calculate: stroke 
volume (SV), ejection time (EjT), ejection rate (EjR) time 
to 25, 50, and 75% ejection (T25, T50, T75) accelerative 
(onset systole to peak velocity) ejection volume (AEjV), 
time (AEjT) and rate (AEjR) and deccelerative (peak ve-
locity to end systole) ejection volume (DEjV), time (DEjT) 
and rate (DEjT). Post-BAY there were no significant 
changes in heart rate, T25, T50, T75, AEjT, DEjT, and 
AEjR; there were significant increases in SV, EjR, AEjV, 
DEjV, and DEjR, and a significant decrease in EjT. 
PRE 
POST 
SV* EjT* EjR** REjV*** SEjv** SEjR*** 
(ml) (msec) (ml/sec) (ml) (ml) (ml/sec) 
37±10 332±37 113±33 14±4 23±g 109±32 
50±17 311±38 161±53 18±5 3H14 158±S3 
*-p< 0.05 **-p < 0.01 ***-p <0.005 
Conclusions: BAV has a significant effect on the dynamics 
of left ventricular ejection. There is an increase in 
stroke volume and a decrease in ejection time, with rela-
tively little effect on early systole, and a more pro-
nounced effect in late systole. There is a significant 
increase in deccelerative ejection volume and rate, and a 
decrease in the time required for the last 25% of ejec-
tion. By improving the mobility of calcified leaflets, 
BAV may reduce the forces opposing forward blood movement 
during the deccelerative phase of aortic ejection. 
ABSTRACTS 
CHANGES IN LEFT VENTRICULAR OUTPUT AND FILLING PRODUCED 
BY PRELOAD REDUCTION IN PATIENTS WITH CONGESTIVE HEART 
FAILURE. 
121A 
Peter S. Rahko, M.D., F.A.C.C., Barbara J. Morgan, M.Ed., 
Laurence W. V. DeBoer, M.D., F.A.C.C., Peter Hanson, M.D. 
Cardiology Section, University of Wisconsin, Madison, WI. 
The effect of preload reduction produced by -40 mm Hg of 
lower body negative pressure (LBNP) on LV filling and 
output was assessed in 9 pts with class III congestive 
heart failure (CHF) due to dilated cardiomyopathy. Using 
Doppler echocardiography mitral flow was measured at the 
annulus and forward LV stroke volume at the LV outflow 
tract. Comparing baseline to -40 mm Hg LBNP (mean±SE) 
there was a significant reduction in stroke volume (57±8 
vs 44±6 ml, p <0.005) and LV diastolic dimension (7.2±0.4 
vs 7.0±0.5, p <0.05) but no significant change in percent 
fractional shortening, heart rate or blood pressure. 
Peak early diastolic mitral flow velocity decreased (57±5 
vs 39±4 cm/sec, p <0.001) but atrial velocity showed a 
nonsignificant upward trend (37.6±6.8 vs 42.8±8.5 cm/sec, 
p=O.lO). Similarly, the mitral early diastolic f12w 
velocity integral decreased (6.6±0.6 vs 3.6±0.2 cm , p < 
0.0002) but the atrial flow velocity integral was 
unchanged (3.4±0.7 vs 3.4±0.7 cm/sec, paNS). Mitral 
valve regurgitant fraction did not change significantly 
(29±10% vs 22±10%, p-NS). 
Conclusions: Acute preload reduction by LBNP 
significantly reduces stroke volume and LV dimension but 
does not alter fractional shortening in pts with CHF. 
There is an associated reduction in LV filling which 
occurs only in early diastole manifested by declines in 
both peak flow velocity and flow velocity integral. The 
atrial component of filling remains unchanged. Thus the 
shape of the mitral flow signal and distribution of 
filling during diastole is preload dependent. 
DE~EASE IN 2-DIMENSIONAl EOlOCARDIOGRAAiIC EJECTION 
FRACTION IlJRI1'{3 TRANSPLANT REJECTION: A SlUDY OF 400 
BIOPSIES. .Ja..l.Iu ll.. Morlguchl • .MaD.. lynne W. Stevenson, 
M.D., Jon A. Kobashlgawa, M.D., Chery I Westlake, R.N., 
Hillel laks, M.D., F.A.C.C., John S. Ch II d, M.D., F.A.C.C. 
UCLA Medical Center, los Angeles, California. 
Non-Invasive diagnosis of rejection following cardiac 
transplantation with cyclosporln remains difficult, 
although changes In diastolic function have been 
described. SystoliC dysfunction during rejection has not 
been significant from M-mode echocardlography, but may be 
better quantitated by 2-D echocardlography. We performed 
serial 2-D echo In 49 consecutive pts on cyclosporln (1-38 
mos. post-transp I ant) at the t I me of each biopsy (Bx). In 
40/49 pts endocardial definition was adequate to al low 
serial computer-assisted measurement of lV end-systolic 
and end-diastolic volumes (lVESV, lVEOV) and ejection 
fraction (EF) using Simpson's formula. Changes from 
baseline volumes and EF for each pt were compared to bx 
results for 400 echo/b~ 
EF +.10 or lVESV t 30% from baseline occurred with 2at37 
(76%) -+ex (moderate rejection). These changes occurred In 
13/363 negative Bx, 4 of which were fol lowed by rejection 
on the next B~ The +EF occurred with tlVESV and tlVEDV. 
ill illfSY illfIl.'l 
Absolute Change .~6±.08 ~Z±14cc i 4±24cc *(p<O.OOl) 
% Change 23±8% 64±45% 49±33% 
EF failed to return to ±.10 of baseline by 4 wks In 9 
pts, 5 of whom had recurrent rejection In the next 4 wks. 
CONCLUSION: SystoliC dysfunction Is a significant feature 
of cardiac rejection, which can be detected by serial 2-D 
echo In echogenlc pts. Decreased EF precedes Bx rejection 
I n some cases. Ser I al echo EF may reduce the need for Bx 
dur I ng long-term follow-up. 
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EVAlUATION OF THE HEMODYNAMIC EFFECTS OF CAlCIUM CHANNEL 
ANTAGONISTS BY EXERCISE DOPPLER: COMPARISON OF VERAPAMIL 
AND NIFEDIPINE. Michael Harrison, M.D., Paul Grayburn, 
M.D., Mikel Smith, M.D., F.A.C.C., Anthony N. DeMaria, 
M.D., F.A.C.C. University of Kentucky, Lexington, KY. 
Previous studies in our laboratory using exercise(EX) 
Doppler have shown that beta adrenergic blockade with pro-
pranolol reduces resting and EX contractility, but calcium 
channel blockade with verapamil does not. To study the 
hemodynamic effects imparted by different calcium channel 
blockers, we examined AO blood flow by suprasternal notch 
continuous wave Doppler at rest and EX in 10 normals (mean 
age 31 yrs). Studies were performed pre(CON) and 2 hrs 
post oral 120 mg verapamil(VER) and 30 mg nifedipine 
(NIF). Doppler measurements inclu~ed velocity(VEL) in 
m/sec, acceleration(ACL) in m/sec , and flow velocity 
integral(FVI) in cm. Results: (* p<.05 vs CON) 
HR BJf(11II1 Hg) VEL ACL FVI 
CON 1 Rest 77+14 91+6 J .62+.1 16+5 8.0+3 
EX 166+9 J 100+14 * 1.20+.3 57+15 10.0+4 
VER Rest 79+15 * 88+6 .60+.1 11+2 8.0+2 
EX 161+18 94+13 1.20+.3 '35+12 14.0+3 
CON 2 Rest 76+12] 94+3 J .60+.1
J 
14+3 J 6.8+2 
EX 161+18 * 102+9 j 1.20+.4 * 50+20 * 10.4+4J* 
NIF Rest 87+18 86+6 * .70+.1 16+3 7.5+2 
EX 166+12 88+9 1.20+.3 53+15 10.0+4 
At rest NIF, but not VER~ caused significant-increases-in 
HR, VEL, ACL and FVI. Thus, VER and NIF had differing 
effects on rest cardiac function which appear to be 
secondary to NIF's greater vasodilatory effect and reflex 
sympathetic response. This disparity is abolished with EX, 
during which these agents produced inSignificant hemody-
namic alterations relative to control. With the exception 
of blood pressure, neither verapamil nor nifedipine 
decreases the determinants of myocardial oxygen demand 
with EX in normals. 
Tuesday, March 29, 1988 
2:00PM-3:30PM, Room 215, Level Two 
Exercise Testing in Ischemic Heart Disease 
EXERCISE ASSESSMENT AFTER MYOCARDIAL INFARCTION - LONG-
TERM CHANGES IN PATIENT SELECTION 
R~mond J. Gibbons, M.D., F.A.C.C., Carl J. Lavie, M.D., 
A an R. Zlnsmelster, Ph.D., and Bernard J. Gersh, M.8., 
Ch. 8., D. Phil., F.A.C.C.; Mayo Clinic and Foundation; 
Rochester, Minnesota 
The predictive role of exercise assessment after 
mYocardial infarction (MI) is dependent upon the nature 
of the population group under study. We examined 
temporal changes in patients undergoing exercise radio-
nuclide angiographY (RNA) within one month after MI in 
our institution from 1/1/82 to 1/1/87. A majority of the 
clinical, exercise, and RNA parameters examined demon-
strated significant trends over this five-year period: 
Parameter 
Number of studies 
PTCA/CABG between MI and MUGA (') 
Age 
Beta-blocker usage (') 
Transmural MI (') 
Inferior MI (') 
Exercise heart rate-blood 
pressure product 
METS of exercise 
Exercise ST segment depression 
Change in ejection fraction 
Trend 
Increase 
Increase 
Increase 
Increase 
Increase 
Increase 
Increase 
Increase 
Improved 
Improved 
<J1 
< .001 
<.005 
< .001 
< .001 
< .001 
< .001 
<.001 
<.01 
< .001 
Conclusions: (1) The characteristics of the patients 
selected to undergo exercise RNA early after MI have 
changed significantly over time. 
(2) Previously published results regarding exercise 
assessment after MI need to be reconfirmed in patients 
currently selected for testing, as these results may no 
longer be applicable. 
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ARE RADIONUCLIDE LEFT VENTRICULAR GLOBAL AND REGIONAL 
EJECTION FRACTIONS REPRODUCIBLE DURING EXERCISE IN 
PATIENTS WITH ISCHEMIC HEART DISEASE? 
Udho Thadani, M.D., FACC, Rajesh Prasad, M.D., Jerome 
Anderson, M.D., Robert Burow, Stephen Teague, M.D., FACC, 
OU Health Sciences Center, Oklahoma City, OK. 
Global and regional(Reg) left ventricular(LV) ejection 
fractions(EF) are Widely used to evaluate the effects of 
treatment with the assumption that serial measurements 
are reproducible. We measured reproducibility of radio-
nuclide LV global and Reg EFs at resteR) and during supine 
bicycle exercise(Ex) in 15 patients(pts) with ischemic 
heart disease. The two Ex studies were separated by 1 1/2 
hours recovery period. None of the pts were taking any 
active drugs. Global EF and 6 Reg EFs(l & 2 posterola-
teral, Reg 3 & 4 apical and Reg 5 & 6 septal) were analy-
zed. Mean differences(Df) & ranges between tests I & II 
were: Regional EF% Global 
Rest 
Ex 
1 2 3 4 5 6 En 
Mean Df 5 4 5 .-1 -1 6 --2--
Ranges 
Mean Of 
-14to -23to -14to -16to -19to -15to 
+23 +25 +36 +13 +14 +48 
1 3 o 3 2 -4 
-8to 
+18 
2 
-24to -lOto -16to -13to -37to -4to -16to 
Ranges +11 +13 +16 +20 +20 +16 +16 
Global EF varied by::.5 EF points between test I & II in 5 
pts at R, and in 8 pts during Ex: Efs in Reg 1 to 6 vari-
ed by a5 points during the 2 tests in 14,10,9,9,9, & 13 
pts at R and in 10,9,9,6,8, & 11 pts during Ex. Conclu-
sion: Even though the group values for global & Reg EFs 
were reproducible, there was marked intraindividual vari-
ations in global and Reg EFs during tw Ex studies. These 
results should be taken into consideration when effects 
of therapy are being assessed in individual patients. 
THE IMPORTANCE OF TIME-COURSE BEHAVIOUR OF ST SEGMENT AND 
T WAVE CHANGES FOLLOWING EXERCISE. A RELIABLE AID TOWARDS 
ELIMINATING "FALSE POSITIVES" 
Joel M. Neutel M.B; John B. Barlow, M.D. Jeff King 
M.B, F.C.P (SA); Dirk P. Myburgh M.B, F.A.C.C 
Department of Cardiology, University of the Witwatersrand 
JHB, RSA and Institute for Aviation Medicine. 
In order to differentiate ischemic from "false positive" 
stress tests, the value of assessing the time-course 
patterns of ST segment and T wave (ST-T) changes during 
the 10-minute post-exercise period has recently been 
emphasized. Whereas ischemic ST-T abnormalities, in the 
absence of previous myocardial infarction, significant 
conduction defects or "unstable angina", conSistently 
follow a time-course behaviour of early onset, late offset 
and late onset, early offset, the time-course patterns 
following exercise of non-ischemic ST-T changes are more 
variable. We studied 111 patients (59 males) of mean age 
53.9 years with stress tests that were positive for 
ischemia on the basis of generally accepted criteria for 
ST-T configuration abnormalities but were judged non-
ischemic because of importantly different time-course 
behaviour. Selective coronary arteriography confirmed 
ei ther normal (102 patients) or insignificant ( ethan 40% 
stenosis) coronary stenotic lesions (7 patients) in all 
but 2 patients. We conclude that appraisal of the time-
course behaviour in addition to the configuration of 
post-exercise ST-T changes is invaluable for accurate 
stress testing interpretation. 
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PROGNOSTIC VALUE OF SYMPTOM-LIMITED EXERCISE TESTING 
FOLLOWING MEDICAL STABILIZATION OF UNSTABLE ANGINA. 
James A. Knight, Ph.D., Nancy C. Conlin, M.S., and 
Charles A. Laubach, Jr., M.D., F.A.C.C., Geisinger 
Medical Center, Danville, PAr 
It is presently difficult to evaluate prognosis of 
patients with unstable angina after medical stabilization 
of symptoms. We have therefore reviewed our recent 
experience with exercise testing of these patients to see 
if exercise testing might provide useful prognostic data 
to guide their clinical care. Seventy-four patients who 
had undergone symptom-limited exercise tests (SL-GXT) . 
soon after medical stabilization of symptoms were studled. 
Exercise test abnormalities (angina or anginal equivalent, 
ischemia by exercise ECG or thallium scintigraphy, or 
hypotensive BP response) were correlated with recurrent 
cardiac events (RCE) (recurrent unstable angina, 
refractory angina leading to PTCA or CABG, myocardial 
infarction, or cardiac death) over a 12-month follo~l-up 
period. Mean age of patients was 65 years (ran~e 3B-85). 
Patients exercised to a mean heart rate of 108 (range 63-
180) at an average workload of 6 METS (range 2-14). 
Indications for test termination were onset of anginal 
symptoms, hypotensive BP response, markedly abnormal 
exercise ECG, or fatigue. There were no complications 
during testing. The rate of RCE was 54% over one year. 
There was a 5.4% one-year mortality. Chi-Square analysis 
showed angina during SL-GXT to be an independent pre-
dictor of RCE (p< 0.001). Neither ischemia nor an 
abnormal BP response predicted RCE. We conclude that 
SL-GXT is a safe, useful prognostic tool in patients 
recently stabilized with unstable angina. Angina during 
testing indicates a poor prognosis over the subsequent 
12-month period. 
SAFEIY AND EFFECl'IVENESS OF mMEDIATE 'l'REAJ:MILL TESTING 
'IO SHORl'EN OR ELIMINATE BlSPITAL f§rAY IN SEIECl'ED "RlJIE 
OOT MYOCARDIAL INFARCI'ION" PATIENl'S. 
John S. Tsakonas« M. D., George D. Bittar, M. D., Alan G. 
wasserman, M.D., F.A.C.C., Robert Rosenthal, M.D., Allan 
M. Ross, M.D., F.A.C.C., George washi.n:Jt:on university, 
Washi.n:Jt:on, DC 
Emergency roam (ER) patients triage:! for admission to 
"rule out myocardial infarction" (RIO MI) include a 
subset in whan concem warrants hospitalization but the 
probability of infarct is considered to be relatively 
low. We sought to shorten or eliminate the traditional 
2-3 day stay for serial enzyme (Enz) ani Em m:mi.torin;J 
by performance of an immediate post admission symptom 
limite:! treadmill test (ElT) in such patients if they 
met the followin;J criteria: age below 66 years, atypical 
chest pain, no prior cardiac history or antiarginal 
therapy, nonnal or non-specific Em abnonnalities ani a 
decision to admit havin;J been made by full-time ER 
attenling physician. After ElT patients were ~l 
admitte:! as per usual RIO MI protocol ani had ser~al 
cardiac enzyme ani Em analysis. A total of 21 patients 
un:leIwent ElT usin;J the mcxiifie:! Bruce protocol. A 
positive (+) ElT was define:! as .1 lII'I gr depression 80 
msec. after the J point. A negative (-) ElT was seen in 
16/21 patients ani 5/21 had a (+) ElT. 'Ihallium exercise 
studies were perfonned on 3/5 patients with (+) ElT ani 
did nat show" ischemia. No patients had serial Enz or Em 
evolution ani all patients with a (-) ElT were discharged 
within 18 hours of admission. At a mean of 6 ± 3 month 
follow-up there has been no cardiac =:rbidity o~ =rtal-
ity in the patients with (-) ElT. conclus~on: 1) 
Early ElT of RIO MI patients is safe. 2) A negative 
exercise test prior to admission can preclude unnecessary 
hospitalization. 
ABSTRACTS 123A 
ASSESSMENl' OF SCREENI~ EXERCISE TREADMILL TEST~ PRIOR 
'IO INITIATI~ AN EXERCISE PROORAM: RESULTS IN 2973 
APPARENl'LY HEAL'ffiY INDIVIDUALS 
Todd D. Miller, M.D., Ray W. l:iquires, Ph.D., Gerald T. 
GaU, M.D., F.A.C.C., Mayo Clinic Foundation, Rochester, 
MN. 
The role of screening exerci~ treadmill ~sting (ETT) ~n 
healthy ~le before start1ng an exerCl5e program 1S 
controversial. and is categorized as a Class "II indica-
tion for seientarv males > 40 years of age under llCC 
guidelines. To deEermine the diagnostic yiela of ETT in a 
presumably healthy oooulation .. we retrospectively analyze:! 
test resul.ts fran 2973 indiv1duals (234Om, 633fJ who were 
referred for exercise prescriptiOl). Prior to. testing all 
subjects underwent a general med1cal evaluat10n and were 
foufid to be free of iaentifiable cardiac disease and had 
normal restiQg EXn's. Exercise tests were interpreted by 
the s~isipg cardiolpgists or exercise physiologist on 
the basis of both clinical and EXn cnteria. The 
following results were obtainei (numbers of tests listed 
in cells, percentages in parentheses): 
No ischemic responses were reported in pers~s < 49 years 
of age. The pe]:"centages of abnormal and 1schem1c test 
resuIts increaSed with advancing age. These findings 
indicate that ~forming screening treadmill tests before 
exercise prescription w1ll uncover a small percentage of 
people > 40 years of age with pc>l;sible ocCult coronary 
artery disease. There apQears to be little data to sup-
port lIUltilead ETT for - aiagnostic purposes in healthy 
younger individuals. 
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Pathophysiology of Vascular Responsiveness 
INFLUENCE OF ACETYLCHOLINE ON SPLANCHNIC VOLUME IN THE 
INTACT DOG. Michael A. Morse. A.B., Leonard Bell, M.D., 
& David L. Rutlen, M.D., Yale U., New Haven, CT 
Although acetylcholine (ACh) has been demonstrated to 
increase total splanchnic intravascular volume (IV) in 
splenectomized dogs with intact autonomic reflexes on 
cardiopulmonary bypass, the influence of ACh on total 
and regional splanchnic IV in the intact animal has not 
been determined. Changes in total splanchnic and 
regional IV were determined in 18 anesthetized, 
ganglionically blocked dogs with Tc-99m labelled 
erythrocytes using a radionuclide technique. In the 
intact animal, ACh (5mcg/kg/min for 10 mins, n=25) was 
associated with a decrease in total splanchnic IV of 61 
± 20 ml (P<.Ol) (4 ± 1 X, P<.Ol). The total splanchnic 
IV decrement was due to to a decrease in splenic IV of 8 
± 3 X (P<.Ol) and occurred despite increases in hepatic 
IV of 4 ± 1 X (P<.Ol) and in extrahepatosplenic IV of 5 
± 1 X (P<.Ol). After splenectomy (n=13), ACh was still 
associated with a decrease in total splanchnic IV of 3 ± 
1 X (P<.Ol). However, the increments in hepatic (4 ± 2 
X, P<.05) and extrahepatosplenic (7 ± 2 X, P<.Ol) IV 
were abolished (both decreased 2 ± 1 X, P=NS). Thus, in 
the intact animal in which neurogenic reflexes have been 
abolished by ganglionic blockade, ACh acts to decrease 
total splanchnic IV. The total splanchnic IV decrement 
is due to a decrease in splenic IV and occurs despite 
increases in hepatic and extrahepatosplenic IV. These 
regional volume increments are in turn dependent upon 
the decrease in splenic IV since they are abolished 
after splenectomy. Finally, in the splenectomized, 
areflexic animal with an intact circulation, ACh is 
still associated with a decrease in total splanchnic IV. 
124A ABSTRACTS 
A RELAXING FACTOR RELEASED BY PHOSPHOLIPASE AZ IN THE 
ABSENCE OF ENDOTHELIUM 
Richard J. Bing. M.D. and May them Saeed. Ph.D. 
Huntington Medical Research Institutes 
Pasadena. California 
A close relationship between an endothelium-derived re-
laxing factor (EDRF) and nitric oxide (NO) has been recent-
ly demonstrated. Our experiments with Phospholipase AZ 
(PLAZ) have shown the production of a different relaxing 
factor which causes slow dose dependent relaxation in 
intact and endothelium-deprived precontracted rabbit 
aortic strips. In endothelium-derived strips relaxation 
was inhibited by hemoglobin. methylene blue and parabromo-
phenacylbromide (PBPB). It was potentiated by superoxide 
dismutase (SOD) and indomethacin failed to influence re-
laxation. Relaxation was accompanied by a 50% rise in 
c-GMP. Phospholipase C caused a significant increase 
in tension while Phospholipase D had no effect. In intact 
aortic strips. PLAZ caused a biphasic response and no 
rise in c-GMP. PLAZ produced relaxation was dependent 
and its specific hydrolytic activity. We call the PLAZ 
released relaxing factor the phospholipid-derived relaxing 
factor (PDRF). In contrast to EDRF. PDRF hydrolyzes diacyl-
glycerophophatidylcholine and acts on membranes of a 
variety of cells (i.e. endothelial cells. smooth muscle 
cells) resulting in c-GMP production. Intracellular 
guanylate cyclase by PLAZ is also stimulated through 
interaction with several agents. including acetylcholine. 
It appears. therefore. that PDRF is an important regulator 
of c-GMP activity. which includes smooth muscle relaxation. 
INFLUENCE OF VERAPAMIL ON LIMB INTRAVASCULAll VOLUME. 
Barry S. Weinstock. M.D., Leonard Bell, M.D. and David 
L. Rutlen, M.D. Yale University School of MediCine, 
New Haven, CT 
Since verapamil decreases total intravascular 
volume (IV) due to a decrease in extrasplanchnic and 
extrapulmonic IV in dogs on bypass, it is possible 
that verapamil decreases limb IV. However, no 
vasodilator has been demonstrated to decrease limb 
IV. In 6 dogs undergoing sinoaortic baroreceptor 
denervation and cervical vagotomy, the left limb 
vasculature was isolated. Blood from the right 
femoral artery was pumped at a constant rate (69 ± 13 
ml/min) into the left femoral artery, blood from the 
left femoral vein was drained at a constant pressure 
of 5 cmH20 into an extracorporea1 reservoir, and 
blood from the reservoir was returned to the right 
femoral vein at a constant rate so that changes in 
left limb IV could be measured as reciprocal changes 
in reservoir volume. Intravenous verapami1 (25 
mcg/min) was associated with a prompt and sustained 
decrease in limb IV which was 40 ± 10 m1 (P <.0001) at 
20 minutes. Since limb arterial pressure decreased 
while arterial flow and venous outflow pressure were 
maintained constant, a decrease in the resistance to 
the return of blood to the extracorporea1 reservoir 
must have mediated the limb IV decrement. Thus, not 
all vasodilators are associated with an increase in 
limb IV. Rather, a vasodilator may be associated with 
a decrease in limb IV if the resistance to the return 
of blood to the central circulation is substantially 
decreased. 
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POTENTIATION OF SEROTONIN INDUCED VASOSPASM BY INDOMETHA-
CIN IN ISOLATED PERFUSED CORONARY ARTERIES. 
N. Charle Morcos, M.D .• Ph.D., Minh X. Nguyen, Walter L. 
Henry, M.D., FACC, University of California, Irvine, CA. 
It has been suggested that the endothelium plays an 
important role in minimizing vasospasm and relaxing coro-
nary arteri es. Prostacycl in, a vasodil at ing prostanoid, 
is produced by the endothelium and smooth muscle. The 
purpose of this study, therefore, was to investigate the 
effects of a prostaglandin synthesis blocker, indometha-
cin, on modulation of vasospasm and coronary flow reduc-
tion induced by serotonin (5-HT) in isolated, pharmaco-
logically active and perfused bovine coronary arteries. 
Vessels 3cm long and approximately 1.5mm in internal 
diameter were dissected free, side branches ligated and 
perfused at constant pressure (30mm Hg) with oxygenated 
Krebs bicarbonate solution. 5-HT was introduced into the 
perfusate at various concentrations to construct dose 
response curves of changes in flow in the presence and 
absence of indomethacin. The dose at which 5-HT induced 
50% of its maximum effect (ED5Q) on flow reduction was 4 
X 10-6 M. Maximum flow reductlon occurred at 10-5 M and 
varied between 20 to 40%. Indomethacin alone produced no 
effect on flow. Pre-incubation with indomethacin for 2 
hours prior to 5-HT exposure, however, resulted in a dra-
matic potentiation of 5-HT effects by 260% without chang-
ing the ED50 for 5-HT. The ED50 of indomethacin for the 
potgntiation of 5-HT induced flow reduction was 2 X 
10- M. This potentiation of 5-HT induced coronary flow 
reduction by small concentrations of indomethacin may 
have important clinical implications, especially in pts 
with coronary disease undergoing interventional therapy 
where the endothelium is damaged, platelets accumulate 
and prostanoid synthetic activity likely is compromised. 
PIlEVENTION OF COIlORAllY VASCULAlI. INJUIlY INDUCED BY 
TlIARSIERT HYOCAlIDIAL ISCIIBMIA 
Eugene Patterson, PhD, Robert D. Burow, and Benjamin J. 
Scherlag, PhD, FACC. Univ. of Okla. Health Sciences 
Ctr. and VAMC, Oklahoma City, OK 
2-Mercaptoproprionyl glycine (2-MPG), a scavenger of 
oxygen-derived free radicals, was administered to dogs 
undergoing 15 or 30 min occlusions of the anterior 
descending coronary artery. 2-MPG (40 mg/kg) was given 
over 2 hrs beginning 30 min before occlusion. Vascular 
permeability (Tc 99m labeled albumin) (HSA) , leukocyte 
uptake, and light microscopic studies were performed 24 
hrs after coronary artery occlusion and reperfusion. 
2-MPG pre-treatment reduced HSA extravasation (1.02+0.01) 
compared to saline (1.33+ 0.09 anterior/posterior- wall 
ratio)(p=0.03) and reduced-anterior wall uptake of leuko-
ocytes (2.0+0.3 vs. 5.0+1.3) in the 15 min group. Vascular 
injury in the 15 min group occurred in the absence of 
myocardial necrosis as determined by light microscopy and 
tripheny1tetrazo1ium staining. 2-MPG failed to prevent 
HSA extravasation (1.3:!:,0.04 va. 1. 3:!:,0. 06) , hyperemia 
(1.49+0.10 vs. 1.51+0.09), leukocyte uptake (45+18 vs. 
16+7):- or necrosis (2.3+1.0 vs. 0.9+0.6 % of LV mass) 
present 24 hrs after a 30 min occlusion of the anterior 
descending coronary artery. The data demonstrate the 
ability of 2-MPG to reduce leukocyt~ uptake and increased 
vascular permeability after a 15 min, but not after a 30 
min transient coronary artery occlusion. The beneficial 
actions of 2-MPG upon vascular function may result from 
the drug's actions to acutely scavenge free radicals after 
short-term (15 min) coronary artery occlusion, in the 
absence of extensive leukocyte uptake. Acute 2-MPG fails 
to prevent the extensive leukocyte uptake, myocardial 
necrosis, and vascular injury associated with a more 
prolonged (30 min) duration of coronary artery occlusion. 
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PERFLUOROCHEMICAL MARKEDLY REDUCES NEUTROPHIL ADHERENCE 
TO CULTURED CORONARY ARTERY ENDOTHELIAL CELLS SUBJECTED 
TO ANOXIA AND REOXIA 
David G. Babbitt. M.D., Mervyn B. Forman, M.D., F.A.C.C., 
Rhoda L. Jones, B.S., Richard L. Hoover, Ph.D., 
Vanderbilt University, Nashville, TN 
Intracoronary administration of the perfluorochemical 
Fluosol-DA (FDA) significantly reduces myocardial 
reperfusion injury. Ischemic damage to endothelial cells 
may enhance neutrophil-endothelial interactions at the 
time of reperfusion. To mimic the "in vivo" situation the 
effect of FDA on neutrophil adherence to cultured canine 
coronary endothelial cells (CCEC) was assessed under 
normoxia (N) and anoxia followed by norrnoxic (A+N) 
conditions. Human neutrophils (PMN) labelled with CR-5l 
were stimulated with phorbol myristate acetate (20 
ng/5,OOO,OOO PMN) and added in a concentration of 
250,OOO/well after 60 mins of Nand A+N. PMN adherence 
was assessed at 15 and 30 mins with no treatment 
(control) or with varying concentrations of FDA (10,25,50 
vol/%). *p<O.Ol, control vs. FDA 
A+H N 
15 min 30 min 15 min 30 min 
Control 22.6 23.7 16.8 23.1 
FDA 10% 9.9* 12.9* 9.3* 12.6* 
FDA 25% 7.6* 10.5* 6.2* 9.8* 
FDA 50% 1.8* 2.2* 1.4* 2.2* 
Similar findings were noted with PMN adherence to 
plastic. Pluronic 68 had no effect on PMN binding to 
plastic. These findings demonstrate that anoxia followed 
by reoxia enhances PMN adherence to CCEC and this is 
significantly inhibited by FDA. Inhibition of neutrophil 
adherence at reperfusion by FDA may reduce neutrophil 
mediated endothelial damage and mechanical plugging of 
the microcirculation thereby reducing reperfusion injury. 
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Mitral Valve Prolapse 
PROSPECTIVE STUDY OF MITRAL VALVE PROLAPSE: FURTHER 
EVIDENCE FOR "NORMALITY" OF DISPLACEMENT IN THE APICAL 
4-CHAMBER VIEW ONLY 
Albert A. ~agege, MD, Vivian M. Abascal, MD, Sonia S. 
Novick, lIrt ur E. Weyman, MD, FACC, Robert A. Levine, MD, 
FACC. Massachusetts General Hospital, Boston, MA. 
Mitral leaflet displacement (ML DIS) in the 20 
echocardiographic (2DE) apical 4-chamber view (A4C) often 
appears in otherwise normal individuals without 
corresponding DIS in the long-axis view (PLA). Previous 
studies have shown that this can result from a nonplanar 
annulus without ML distortion; and, in a retrospective 
study, that pts with DIS limited to the A4C view have no 
higher frequency of associated 2DE evidence of abnormality 
than pts without DIS. In this study, 94 consecutive pts 
wi thout other heart disease by 2DE were prospectively 
scanned, with the addition of auscultation and phono 
(AU/PH). ML DIS and thickness (LT) and LA size were 
measured, and regurgitation (MR) graded. 
RESULTS: (* p<.OOl. NS: p>.5) 
No ML DIS A4C DIS only PLA DIS 
n, pts 38 34 -22-
Incr. LT 0 NS 0 * 7 (32%) 
Incr. LA volume 0 NS 0 * 4 (18%) 
MR > 1+ 1 (3%) NS 0 * 6 (27%) 
Click (A/P) 4 (11%) NS 3 (9%) * 13 (59%) 
Apical murmur 12 (32%) NS 14 (41%) NS 12 (55%) 
Multiple regression showed that MR, LT and LA volume 
correlated best with PLA DIS (r>.65). AU/PH findings 
correlated poorly with DIS (r<.40). CONCLUSIONS: 
Isolated A4C DIS is unassociated with independent 2DE 
evidence of abnormality; PLA DIS, on the other hand, 
correlates well wi th abnormality. AU/PH findings often 
occur without DIS or abnormality. These results challenge 
the use of the A4C view alone, or of AU/PH signs alone, to 
diagnose MVP. 
ABSTRACTS 
MITRAL VALVE PROLAPSE ASSOCIATED WITH SUDDEN DEATH: 
MORPHOLOGIC SPECTRUM AND DISTINGUISHING FEATURES. 
Teresa P. Darcy, M.D., Renu Virmani, M.D., F.A.C.C., Ira 
S. Cohen, M.D., Max Robinowitz, M.D., F.A.C.C., Armed 
Forces Institute of Pathology, Washington, D.C. 20306 
125A 
Mitral valve prolapse (MVP) occurs frequently in the 
general population but only occasionally causes 
symptomatic (SYM) disease, and is infrequently associated 
with sudden death (SD). To determine the distinguishing 
morphologic features of MVP in SD pts we reviewed 46 
autopsy cases of MVP accessioned to the AFIP since 1972. 
Cases were divided into three groups: (1) 23 pts (37+12 
yrs) with MVP and SD; 16/23 had no medical history, 4723 
ectopy/angina, and 3/23 history of MVP. (2) 11 pts with 
SYM MVP (57+22yrs); 9/11 had CHF and 2/11 were treated for 
arrythmias.- (3) 12 cases of incidental (INC), asymptr-
matic MVP (60+l5yrs) who died of noncardiac causes. 
Gross hearts were examined for mitral valve annular 
circumference (MVA), length of anterior (AL) and posterior 
(PL) leaflets, extent and location of leaflet (PLT) and 
endocardial plaque (EP) thickening, and chordal insertion 
abnormalities. 
Results: MVA (cm) PL (cm) PLT(%) EP(%) 
Group M+SD length mild mod absent/mild mod 
SYM 13.6+1.8 2.3+.3 55 45 60 40 
SD 12.5+1.7 2.2+.5 45 55 53 47 
INC 9.9+1.3 1.7+.9 80 20 78 22 
All pts with MVP had chordal abnormalities. The morpho-
logic features of mitral valve prolapse in symptomatic and 
sudden death pts were similar. Sudden death pts could be 
distinguished from incidental by their larger mitral valve 
annulus (p <.005), longer and thicker posterior leaflet 
(p < .05) and more extensive endocardial plaques. These 
specific morphologic features may be useful predictors of 
sudden death and should be evaluated by echocardiography. 
A PEPTIDERGIC NEUROTOXIN CAUSES ALTERATIONS OF 
MITRAL VALVE MOTION 
Jose M. Brum, M.D., Krishnawamy Chandrasekaran, M.D., Paul J. 
Rogers, M.D., AUrea A. Bove, M.D., Ph.D., FACC. 
Mayo Clinic Foundation, Rochester, MN 
Sensory nerves containing neuropeptides (substance P) have 
been described in the coronary arteries, myocardium, and cardiac 
valves. Capsaicine (Cp) is a neurotoxin from hot peppers which 
depletes neuropeptides (mainly substance P) from sensory neurons. 
In the present study we observed the cardiac effects of daily 
intravenous injection (30 pg/kg + 10% daily increment) of Cp in 
anesthetized dogs (n = 7) over 6 days. Using two-dimensional 
echocardiography and catheterization procedures, mean aortic 
pressure, heart rate (HR), left ventricle ejection fraction (L VEF), 
left ventricle wall thickness (LVWT), and mitral valve motion 
were recorded pre- and post-Cpo There were no significant 
changes in aortic pressure (pre-Cp: 75.8 ± 4.4 mmHg and post-Cp: 
78.5 ± 10 mmHg), LVEF (pre-Cp: 54 ± 10% and post-Cp: 51 ± 
7%). Mean LVWT following Cp did not significantly change. 
Resting HR was increased (pre-Cp: 61 ± 5.5 bpm and post-Cp: 
97.18 bpm) and 5 dogs (71.4%) developed abnormal mitral valve 
motion (prolapse or bowing) post-Cpo This study indicates that 
mitral valve abnormalities can be caused by neurotoxins and 
suggests that integrity of valvar innervation is a factor for 
maintaining proper valvar function. 
126A ABSTRACTS 
RELATION OF VALVULAR ANATOMY AND COAPTATION TO 
MITRAL REGURGITATION IN MITRAL VALVE PROLAPSE: 
ASSESSMENT BY COLOR DOPPLER FLOW IMAGING. 
Payl A. Gravbyrn. M 0 .. Martin R. Berk, M.D., Oi Ling Kwan, 
Michael G. Spain, M.D., Michael R. Harrison, M.D., Mikel D. 
Smith, M.D., F.A.C.C., Anthony N. DeMaria, M.D., F.A.C.C., 
University of Kentucky Medical Center, Lexington, KY. 
Few data exist regarding the relationship of valvular anatomy and 
coaptation to the presence of mitral regurgitation (MR) in pts with 
mitral valve prolapse (MVP). Therefore, we assessed the pres-
ence, jet area, and direction of MR by color Doppler flow imaging 
(CDFI) in 40 pts in whom MVP was evidenced by location of the 
coaptation point at or behind the plane of the mitral anulus on 20 
echo. MR was present in 18/40 pts. CDFI was performed in 
multiple views, and jet area was measured as the outer border of 
the largest clearly definable flow disturbance in any view. An 
index of leaflet anatomy was derived based upon thickness, 
length, and shape, and leaflet deformity was classified as mild 
(27), moderate (11), or severe (2). Abnormal coaptation 
(identified as junction of the tip of one leaflet to the body of the 
other) was present in 13/18 pts with MR and 4/22 without 
(p<0.001). MR was present in 26% of pts with mild, 82% with 
moderate, and 100% with severe leaflet deformity (p<0.01 for 
moderate-severe vs mild). No consistent pattern of jet flow 
existed, although MR direction tended to be anterior or central 
with posterior leaflet prolapse, and posterior or central with 
anterior leaflet prolapse. Neither the presence of MR nor 
maximal area of the MR jet correlated with left atrial, LV, or mitral 
anulus dimensions, although jet area tended to be larger in pts 
with moderate to severe rather than mild leaflet deformity (3.7 vs 
1.9 cm2, p=NS). Thus, the presence of MR in MVP is related to 
abnormalities of leaflet coaptation and anatomy on 20 echo. 
However, neither the magnitude nor direction of MR jet area is 
related to cardiac chamber size, mitral anular size, leaflet 
deformity, or abnormal leaflet junction. 
LRAPLBT THICKENING INCREASES THE RISK OF BNtlOCARDITIS 
IN PATIENTS VITB MITRAL VALVE PROLAPSE. 
Andrew R. Marks, MD, Christopher Y. Choong, MB, PhD, 
Arthur E. lIeyman, MD, FACC. Massachusetts General 
Hospital, Boston, MA. 
lie reviewed the records of 456 patients who had 
previously been diagnosed °as having mitral valve 
prolapse (MVP) by two-dimensional echocardiography to 
determine factors which may increase the incidence of 
endocarditis and other complications in such patients. 
MVP was defined as systolic displacement of at least 
one valve leaflet above the plane of the mitral anulus 
in the parasternal long-axis view. From these patients 
wi th MVP, two groups were compared: those wi th 
thickened leaflets (>5mm), termed "classic MVP" 
(n=319), and those without leaflet thickening «5mm), 
termed "non-classic MVP" (n=137). There were-no 
Significant differences between the two groups of 
patients with regard to age, sex and other medical 
conditions. Mean follow-up period was 9.6 + 0.7 (SEM) 
months for the classic MVP group and 12.4 +-1.4 months 
for the non-classic MVP group. -
Nineteen patients (6.0%) had endocarditis in the 
classic MVP group, compared with none in the 
non-classic group (p<0.008). Patients with classic MVP 
also had a higher incidence of moderate to severe 
mitral regurgitation (MR) by Doppler echocardiography 
(12% vs. 0%, p<0.001) and mitral valve replacement (7% 
~s. 0.7%, p<0.02). 
Conclusion: Patients with MVP and thickened leaflets 
are at greater risk for endocarditis, moderate to 
severe MR and mi tral valve replacement compared to 
those wi th MVP wi thout leaflet thickening. These 
patients with "classic MVP" represent a subset which 
can be readily identified by two-dimensional 
echocardiography. 
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DIRECT DEMONSTRATION OF MITRAL LRAPLBT ANNULAR 
RELATIONSHIPS BY THREE-DIMENSIONAL ECHOCARDIOGRAPHY: 
IMPLICATIONS FOR THE DIAGNOSIS OF MITRAL VALVE PROLAPSE. 
Mark 0 Handschumacher, Albert A Hagege MD, Pamela 
Harrigan ROMS, Anthony J Sanfilippo MD, Arthur E lIeyman 
MD FACC, Robert A Levine MD FACC. Massachusetts 
General Hospital, Boston, MA. 
Mitral leaflet displacement (MV LOIS) above the annulus 
(MA) in the apical 4-chamber (A4C) view occurs with sur-
prising frequency in normals, without LOIS in orthogonal 
long-axis (LAX) views. This discrepancy can potentially 
be explained by MA nonplanari ty wi th a saddle shape 
suggested by animal studies and pt reconstructions. To 
demonstrate directly that apparent A4C LOIS in 2 dimen-
sions (20) does not constitute true LOIS above the 3D MV 
structure requires a 3D reconstruction of the entire MV. 
lie have developed and validated in vitro a technique for 
non invasive 3D reconstruction oT tJieHv from 20 echo 
scans localized by a spark gap system and gated to 
systole. This method has been applied to 10 clinically 
normal subjects. RESULTS: A coherent MV surface could be 
constructed from scans in A4C and LAX orientations. In 
all cases the HA was nonplanar, with anterior and 
posterior high points and a maximum deviation of 14~3 mm 
from planari ty. Superior LOIS could be measured in at 
least one A4C scan, but always lay below the highest 
points of the 3D structure. 
LA 
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CONCLUSIONS: 1) lie have developed a technique for recon-
structing a 3D map of the MV. 2) This technique confirms 
MA nonplanarity and directl~ demonstrates that leaflets 
can aipear to ascend above t e MA in the A4C view without 
actua LOIS-above the entireMV structure, Challenging 
thediagnosiSOT prolapse by isolated A4C LOIS in 
otherwise normal individuals. 
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Epidemiology and Methods 
SERUM CHOLESTEROL AND CORONARY HEART DISEASE MORTALITY 
OVER 23 YEARS: IMPLICATIONS FOR PRIMARY PREVENTION 
Uri Goldbourt, Ph.D. and Shlomit Yaari, Heart Institute, 
Sheba Medical Center, Tel Hashomer, Israel. 
Data from a long-term follow-up of 10,059 male civil serv-
ants aged 40-65 at baseline were used to assess the nature 
of the association between total serum cholesterol (TC) an 
and coronary heart disease (CHD) as well as all-cause mor-
tality. A total of 207,533 person-years and 3398 deaths, 
including 1078 attributed to CHD, were available for anal-
ysis. The association between TC and subsequent CHD death 
was curvilinear, the death rate (1963-86) in asceQ~ing TC 
deciles being 34, 34, 31, 42, 42, 46, 54, 64, 76 and 93 
per 1Q,000 person-years. Dividing the data for smokers 
and smokers, hypertensives and normotensives and diabetics 
and nondiabetics at baseline, as well as for individuals 
with none of the ahove risk factors, had little ef-
fect on the curvilinearity. Results revealed that the risk 
gradient decile 10/decile 1 associated with TC was compa-
rable to that associated with the presence of at least one 
other risk factor within each cholesterol decile. Death 
rates were inverse~ated to the proportion of TC in 
high density lipoprotein (HDl). All-cause mortality was 
materially increased only in the top two TC deciles (TC> 
241 mg/dl). We conclude that within the limitations inhe-
rent in a long-term follow-up of middle-aged and elderly 
males: (I)The prognosis of long-term CHD mortality rests 
heavily on risk factors other than TC; (2)little or no be-
nefit can be expected by reducin~ cholesterol at moderate 
levels (225 mg/dl and below); (3)The proportion of choles-
terol in HDl is an important determinant of the risk asso-
ciated within a given TC level; (4)If all-cause mortality 
is the yardstick for assessing interventional efficacy, 
efforts to intervene at TC<240 would appear to be unre-
warding. 
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DIAGNOSTIC LABELING IN ECHOCARDIOGRAPHY: 
EPIDEMIC OF VALVULAR REGURGITATION 
AN APPARENT 
David J. Ballard, M.D., Bijoy K. Khandheria, M.D., A. 
Jamil Tajik, M.D., F.A.C.C., Kent R. Bailey, Ph.D., James 
B. Seward, M.D., F.A.C.C., L. Joseph Melton, III, M.D., 
Mayo Clinic, Rochester, MN 
We examined secular trends in utilization of 2-dimensional 
echocardiography (echo) in residents of Olmsted County, 
MN, and the impact of this increasingly sensitive 
diagnostic technology on the prevalence of valvular 
regurgitation (regurg) in patients undergoing echo. Along 
with an increase in utilization from 55 to 144 per 10,000 
population from 1979 to 1985, there was a marked increase 
in the labeling of patients with regurg following the 
in troduc tion of echo Doppler (ED) in 1983 (Table). The 
prevalence of diagnoses dependent only on direct visuali-
zation of cardiac structures (mitral valve prolapse [MVP] , 
bicuspid aortic valve [BAV]) showed no secular trends 
(Table). We have no evidence of a major change in the 
incidence of clinically significant valvular heart disease 
in Olmsted County residents during this time. 
Echo diagnoses in Olmsted County residents (%): 
Year 
1979-80 
1981-82 
1983-84 
1985-86 
Normal Mitral Aortic 
Echo Regurg Regurg 
35 3 6 
30 2 6 
21 11 11 
11 35 18 
MVP 
12 
13 
13 
15 
BAV 
3 
2 
2 
2 
Thus, ED has created an apparent epidemic of regurg. The 
clinical significance of isolated ED detected regurg re-
mains to be defined, however, patients with essentially 
normal valve anatomy and function may be increasingly ex-
posed to medical interventions (e.g. antibiotic prophy-
laxis) which may have untoward clinical and psychological 
consequences as ED diffuses into community practice. 
CHANGING PATI'ERNS OF REFERRAL AFTER DIAGNOSTIC 
CARDIAC CATHETERIZATION 
William S Weintraub, M.D., FA.C.C., Ellis L Jones, M.D., FA.C.C., John S 
Douglas Jr, M.D., FA.C.C., Joseph M Craver, M.D., FA.C.C., Spencer B King 
III, M.D., FAC.C., Douglas C Morris, M.D., FAC.C., Robert A Guyton, 
M.D., FA.C.C. and Charles R Hatcher M.D., FA.C.C. Depts of Medicine, 
Surgery, and Radiology, Emory University School of Medicine, AtI, GA 
New technology may influence referral (ref) to therapeutic procedures. 
Percutaneous transluminaI angioplasty (PTCA) has had a dramatic impact on 
the practice of cardiology and cardiovascuIar surgery. Thus, ref patterns to 
PTCA and to coronary bypass surgery (CABG) were investigated in 11414 
patients (Pts), 8466 at Emory University Hospital and 2948 at Crawford Long 
Hospital having flfst known cardiac catheterization between 1981 to 1986. 4327 
Pts underwent CABG, and 1372 PTCA. Overall fIrSt catheterizations changed 
little, from 1975 in 1981 to 2027 in 1986. While total flfst PTCAs increased 
from 455 to 1363, ref from the internal (int) population to PTCA increased 
from 100 in 1981 to 444 in 1986. This has, in part, resulted in a dramatic change 
in surgical practice. While total flfst CABG remained approximately constant 
(1638 to 1662), the int ref declined form m in 1981 to 562 in 1986. Int ref 
dropped from 47% to 27% of CABG performed at Emory. Thus, the pattern of 
ref to CABG has gradually shifted from int to external. Concommitant with this 
shift the int ref population has aged from 58 ± 9 in 1981 to 62 ± 12 in 1986 
(p < .0001), and the proportion over 65 has increased from 24% to 44%. 
Average ejection fraction fell from 61±14 to 52±13 (p<.oool), and fraction of 
BFs below 50 from 21% to 35%. Percent of 3 vessel or left main disease rose 
from 48 to 54 (p=.001). Similar patterns at Emory and Crawford Long, where 
ref patterns are quite different, suggest that this is not a one hospital 
phenomenon. While many causes for this change in patient population and 
utilization of CABG and PTCA may be suggested, a new technology may result 
in changes in practice, even for established therapeutic techniques. Direct 
referral to CABG or PTCA outside of the internal base is increasingly 
influencing how cardiologists and cardiothoracic surgeons practice. 
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CROSS AND DOUBLE CROSS: SHOULD CLINICAL TRIALS BE ANALYZED 
BY THE PRINCIPLE OF INTENTION TO TREAT? 
John Ferguson, M.D., George A. Diamond, M.D., F.A.C.C., 
H.J.C. Swan, M.D., F.A.C.C., Jeffrey W. Work, M.D. 
CedarS-Sinai Medical Center, Los Angeles, CA. 
We estimated the effect of bidirectional crossover in a 
hypothetical clinical trial of 'medicine' versus 'surgery' 
in patients with coronary artery disease. A logistic model 
was first developed to predict 62 cardiac events (death or 
non-fatal infarction) over the subsequent year in 598 pa-
tients undergoing rest-exercise radionuclide angiography. 
Bootstrap resampling was used to randomly allocate 598 pa-
tients to each of two hypothetical treatment groups: 
'surgery' and 'medicine'. Patients in each treatment group 
were then selected for crossover to the other group based 
on the product of a uniform random number and the logistiC 
probability of an event. The 150 patients with the highest 
product in the 'medicine' group crossed to the 'surgery' 
group (crossover rate-25%), and the 60 with the lowest 
product in the 'surgery' group crossed to the 'medicine' 
group (crossover rate=10%). The entire simulation was re-
peated 20 times and the data were analyzed for significant 
differences in mortality according to 'therapy assigned' 
and, according to 'therapy administered'. No significant 
difference in event rate was observed in the 20 simula-
tions when analysis was done by intention to treat (a sig-
nificant difference was expected by chance alone in 1 out 
of 20 simulations). In contrast, we observed a significant 
difference in 14 of the 20 simulations when analysis was 
by 'treatment administered.' In all 20 cases the event 
rate was higher in the 'surgery' group (12.1% vs 7.8%). We 
conclude that crossover rates usually encountered in the 
course of conventional clinical trials of coronary artery 
bypass surgery materially bias the resultant conclusions 
toward medical therapy. Analysis according to 'intention-
to-treat' minimizes the effect of this crossover bias. 
LACK OF GENDER EFFECT ON PROGNOSIS FOLLOWING MYOCARDIAL 
INFARCTION 
Killian Robinson, Ronan Conroy, Risteard Mulcahy 
~arcfnic-I:fepartffient, St Vincents Hospital, Dublin 4, 
Ireland 
The natural history of myocardial infarction in women 
has not yet been fully elucidated and it has been 
suggested that their prognosis is worse than in men. We 
studied risk-factors and in-hospital course in 337 women 
and 658 men admitted with a first myocardial infarction 
or episode of fcute coronary insufficiency. Women wer2 older than men and had a lower prevaleqpe of smoking 
but a higher pre~alence of hypertension and a higher 
serum cholesterol. Logistic regression analysis showed 
that these risk-factor differences, with the exception 
of hypertension, were not due to the age difference 
between the sexes. 
Women were more like~ to be admitted with acute 
coronary insufficiency, and this difference was 
attributable to the differing risk-factor distribution 
between the sexes. ~omen with infarctions had a higher 
rate of complications. Their death rate, 12.6%, was 
significantly higher than that among men in whom it was 
6.5% (p=0.02). When the confounding effect of age was 
removed using logistic regression, sex no longer 
correlated with in-hospital complications (p=NS) or 
mortali ty (p=NS) . Al though risk-factor differences 
exist between the sexes, gender per se does not 
influence the in-hospital course of a first episode of 
acute coronary heart disease. Previously reported 
differences may be due to the effect of confounding 
variables notably age. 
128A ABSTRACTS 
EVIDENCE THAT HIGH-NORMAL LEVELS OF GLYCOSYLATED 
HEMOGLOBIN CORRELATE WITH THE SEVERITY OF CORONARY 
ARTERY DISEASE. 
Raymond D. Dickson, M.D., Deeb N. Salem, M.D., F.A.C.C., 
Stacey H. Berner, B.A., Eric J. Eichhorn, M.D., Mary M. 
Schaefer, M.D., Ernst J. Schaefer, M.D., Tufts-New 
England Medical Center, Boston, MA 
To study the relationship between coronary artery disease 
(CAD) and normal levels of glycosylated hemoglobin 
(HbAlc), we prospectively studied 154 Pts undergoing 
coronary angiography and measured levels of HbAlc. 
Severity of CAD was graded from 1 = absence of disease 
to 5 - 3-vessel disease with >90% stenoses, by analysis 
of angiograms. Pts were divided into groups (Gp) by 
HbAlc level: Gp A - Low normal (nl) 4.3-6.0; Gp B - High 
nl 6.1-7.7; Gp C - Abnormal >7.7. We analyzed the cor-
relation between HbAlc Gp and severity of CAD with the 
following results: 
HbAlc Group A B C 
CAD severity index 3.0 ± 0.2 3.9 ± 0.1* 4.4 ± 0.2*# 
% Pts free of CAD 28 ± 7 12 ± 4* 0 ± 0*# 
*p < 0.05 vs Gp A #p < 0.05 vs Gp B 
Pts with high levels of HbAlc, Gp B, had a greater 
severity of CAD compared with Gp A. Pts in Gp A had 
a greater likelihood of being free of CAD. This rela-
tionship was independent of age. 
Conclusion: This study demonstrates that variations in 
HbAlc levels, below those characteristic of diabetes 
mellitus, correlate with severity of CAD. Thus, even 
mild elevations in HbAlc may contribute to the process 
of atherogenesis. 
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Angioplasty and Other Interventional Techniques 
CORONARY ANGIOPLASTY IN PATIENTS VITB INCREASING DISEASE 
BURDEN: SUCCESS RATE AND ACUTE COMPLICATIONS. 
George ~ Andreae, M.D., Simon H. Stertzer, M.D., 
F.A.C.C., Richard K. Myler, M.D., F.A.C.C., David A. 
Clark, M.D., F.A.C.C., Richard E. Shaw, Ph.D. San 
Francisco Heart Institute, Seton Medical Center, Daly 
City, CA 
Vith advances in coronary angioplasty (CA), operators 
have been attempting elective CA in patients with 
mulitiple vessels, longer diseased segments and 
progressively reduced systolic function. The rate of 
success, abrupt closure (AC), emergency bypass surgery 
(EMCABG) and a-wave myocardial infarction (aMI) were 
analyzed for samples of subgroups with various measures 
of increasing disease burden undergoing elective CA for 
non-total occlusions between 6/85 and 6/87. 
Subgrou~ ~ Success Rate AC EMCABG aMI 
Vessels dilated 
1 593 88% 6.1% 4.0% 2.7% 
2 286 94% 6.0% 2.6% 2.0% 
3 + 102 99% 3.8% 0% 1.0% 
Segments dilated (mm) 
1-4.9 269 88% 5.2% 3.7% 3.0% 
5-9.9 419 92% 4.5% 2.2% 1.4% 
10-14.9 238 93% 4.6% 1. 7% 1.7% 
15+ 290 93% 6.6% 2.8% 3.1% 
All Patients 981 90% 5.0% 2.8% 2.2% 
In conclusion, increasing disease burden can be 
treated with CA, achieving high initial success rates 
and low incidence of acute complications. 
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FIVE TO SEVEN YEAR FOLLOV-UP AFTER CORONARY ANGIOPLASTY: 
OUTCOME IN SIMPLE AND COMPLEX ANATOMY. 
Kevin ~ Rape~ort, M.D., Richard K. Hyler, H.D., 
F.A.C.C., Richard E. Shaw, Ph.D., Simon H. Stertzer, 
H.D., F.A.C.C., David A. Clark, H.D., F.A.C.C., Ralph 
A. Boucher, H.D., Mary C. Murphy, RN, M.S. San Francisco 
Heart Institute, Seton Hedical Center, Daly City, CA 
Between January 1980 and December 1983, 792 patients 
underwent coronary angioplasty (CA). Success was 
achieved in 82% of these patients. Emergency bypass 
surgery (CABG) was needed in 3.7%. a-wave myocardial 
infarction (MI) occurred in 2.5%, and there was 1 
(.005%) death. CA was performed in 628 patients with 
simple (S) discrete lesions (no total occlusion, tandem, 
bifurcation or graft sites) and 164 patients in whom one 
of more of the sites dilated involved complex (C) 
anatomy. Mean follow-up time for 546 patients after CA 
was 46 months. Event free survival (EFS) - defined as 
the absence of MI, CABG or death - was 91% for all 
patients. Outcomes for single vessel (SV) CA, multiple 
vessel (MV) CA, Sand C Subgroups are listed below: 
~ _N_ ~ ~ CABG Re-CA 
SVCA - S 388 93.8% 3.1% 8.5% 27.8% 
SVCA - C 68 94.5% 2.6% 7.8% 32.5% 
MVCA - S 44 83.7% 6.8% 11.4% 31.8% 
MVCA - C 46 89.4% 6.3% 16.7% 33.3% 
C Subgrou~s 
Tandem 55 90.6% 1.8% 7.3% 47.3% 
Totals 32 96.4% 3.1% 15.6% 18.8% 
Bifurcation 12 91.7% 8.3% 25.0% 25.0% 
Graft 15 86.7% 13.3% 6.7% 26.7% 
In summary, overall EFS is excellent; subgroup analyses 
demonstrate that EFS and Re-CA is affected by S versus C 
anatomy and SV versus MY CA. 
PROPHYLACTIC USE OF COMBINED HEPARINE-UROKINASE 
FOR THE PREVENTION OF CORONARY ARTERY OCCLUSION 
FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY 
ANGIOPLASTY 
Hartmut Gulker, MD, and Hubertus Heuer, MD. 
University Hospital Munster, FRG 
Acute coronary artery occlusion (CO) is a severe 
and practically important complication of PTCA. 
The incidence of CO following PTCA is rated 
between 5% and 10%. It was the aim of this study 
to. analyze the incidence of acute CO following 
PTCA after pretreatment with urokinase in 
addition to heparine. PTCA was performed in 100 
subsequent patients with significant coronary 
artery stenosis and 1-3 vessel disease. In all 
patients a standardized procedure was used by 
the same investigator. Firstly the stenosis was 
passed by a floppy guide wire (0.014 diameter), 
then the stenosis was dilated using Ultra 
Low-Profile dilatation catheter (ACS; Temecula 
USA). 10 min prior to PTCA, heparine (8000 
units) and urokinase (100.000 units) were 
administered intravenously. Results: acute CO 
occurred in only one patient about 30 minutes 
after LAD-PTCA. In this patient a dissection of 
the artery was observed immediately after PTCA. 
The incidence of 1% CO was significantly lower 
than in the group of patients treated with PTCA 
before the beginning of the study (retrospective 
analysis: 6%). No major bleeding complications 
were seen. Conclusions: with combined use of 
heparine - urokinase prior to PTCA the incidence 
of acute CO following PTCA can be significantly 
reduced. 
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BALLOON PROBE: A MEV ULTRA LOV PROFILE CORONARY 
ANGIOPLASTY SYSTEM/CONCEPT. 
Hichael ~. Hooney, M.D., Richard K. Hyler, H.D., 
F.A.C.C., Simon H. Stertzer, M.D., F.A.C.C., David A. 
Clark, H.D., F.A.C.C., Jodi Fishman, RN, H.S., Benito 
Hildago, R.T. San Francisco Heart Institute, Seton 
Medical Center, Daly City, CA. 
A new investigational ultralow profile device, a 
balloon-on-a-wire probe (BP) for coronary angioplasty 
(CA) is presented. This device allows for the lowest 
deflated profile (O.Smm) currently available. The 
device consists of a stainless steel Teflon-coated 
hypodermic tube (0.022 in. diameter) on which a 2.0 or 
3.0mm polyethylene terephthalate (PET) balloon is 
positioned 2.2 em from the distal wire tip. The PET 
balloon wall, though extremely thin (0.00025 in.) -
versus the standard polyethylene balloon wall (0.002 
in.) - has inflation pressure limits of 16 BAR, while 
its compliance ("stretch") is less than Sr.. 
Use of the BP has resulted in successful CA in 6 of 
7 patients in whom currently available angioplasty 
equipment failed. The one BP failure was in a patient 
with a total occlusion of greater than 6 months. All 
lesions were calcified; a mean balloon inflation 
pressure of 12 BAR was required. Diameter stenosis 
reduction from 90-100r. (mean 94) to 28-40r. (mean 36) was 
achieved in the successful cases. There were no 
complications. The extremely low profile allows this 
device to traverse virtually any stenosis that can be 
crossed with a guide wire. The PET balloon also allows 
for high pressure inflation to successfully dilate rigid 
lesions. These two features can allow for angioplasty 
success when standard equipment fails and appears to add 
significantly to the range of application and success of 
coronary angioplasty. 
EFFICACY OF A NEW PTCA CA TIIETER FOR SEVERELY 
NARROWED CORONARY LESIONS Edward S Thomas. M D ; Alan 
L. Neiderman, M.D.; David O. Williams, M.D. F.A.e.e.; Spencer B. 
King, III, M.D., F.A.e.C.; John S. Douglas, M.D., F.A.C.C.; Albert 
S. Most, M.D., F.A.C.C., Rhode Island Hospital, Providence, RI 
Conventional over-the-wire dilatation catheters may be unsuccessful in 
.crossing lesions that are severely narrowed. Hence, we investigated the 
efficacy and safety of anew, extremely low profile catheter designed to 
dilate such lesions. The catheter features a 2 mm (inflated diameter) 
balloon mounted on a guidewire with a deflated profile of 0.020 ± .001 
in. and can be used with 7 or 8 Fr angiographic or guide catheters. The 
device was used in 60 patients (PTS), ages 43 to 86 with predominantly 
Class III-IV angina (72%). Seventy-five lesions were attempted with 
this device. The lesions were characterized as single discrete (60%), 
diffuse (37%), mildly tortuous (11 %), severely tortuous (>75 degrees; 
13%), calcific (25%) and eccenttic (80%). Lesion length measured 5.7 
± 3.1 (mean ± 1 SD), minimal diameter 0.51 ± 0.25 and vessel diameter 
2.27 ± 0.43 mm. Fifty-eight lesions (77%) were successfully dilated to 
< 50% residual stenosis with this catheter alone. Nine patients underwent 
additional angioplasty with a larger balloon catheter. The catheter was 
unable to cross 13 lesions (17%), 11 of which could not be crossed with 
either flexible or steerable wires. The catheter was used after failure of 
conventional dilating catheters in 21 lesions. Sixteen of these lesions 
(76%) were successfully dilated. The catheter was beneficial for lesions 
located distally, vessels less than 2 mm in diameter and lesions 
demonstrating greater than 90% diameter reduction. For those lesions 
crossed, stenosis decreased from 78 ± 12 to 29 ±12% after 2.9 ± 2.7 
inflations and peak inflation pressure of 8.0 ± 2.9 bar. Angiographic 
complications included development of total coronary occlusion in 2 
lesions (3%) and dissection in 3 (4%). Thus, this new PTCA catheter 
system was uniquely effective and safe in patients with severe and distal 
coronary lesions. Importantly, success was often achieved after failure 
of conventional angioplasty catheters. 
ABSTRACTS 
PERIPHERAL ANGIOPLASTY: BELOW THE KNEE - TIBIOPERONEAL 
VESSELS: ACUTE OUTCOME. 
Gerald Dorros, H.D., F.A.C.C., Ruben F. Lewin, M.D., 
129A 
Lynne M. Mathiak, R.N., St. Luke's Hospital, Milwaukee, WI 
Peripheral angioplasty (PTA) was successfully performed in 
56 (40 males, mean age 64±8 years) patients (PTS) during 
114 procedures in the tibioperoneal vessels (TPV) utili-
zing a modified steerable coronary dilatation catheter 
system for symptomatic obstructive peripheral vascular 
disease. Clinical characteristics included significant 
claudication in 93%, diabetes in 55%, nonhealing ulcer or 
gangrene in 22%, and rest pain in 26% of PTS. PTA of the 
superficial femoral/popliteal artery was performed in 15% 
of PTS immediately prior to TPV-PTA. TPV-PTA was success-
fully utilized intraoperatively in 3 PTS (5.4%) during 
fern-pop grafting to increase arterial outflow. Success 
was achieved in 195/214 lesions attempted (91%): 59/63 
in tibioperoneal trunk (94%), 30/39 in peroneal (77%), 
50/50 in posterior tibial (100%), and 56/62 in anterior 
tibial (90%) arteries. Only 1 TPV was dilated in 25 PTS 
(24%), and> 2 TPV's were dilated in 80 PTS (76%). All 
PTS had at least one vessel successfully dilated improving 
the lower leg blood supply. Complications encountered 
included: 4 groin hematomas (3.5%), 1 contrast induced 
renal failure (0.8%), and 2 distal embolizations (1.7%). 
No vascular surgical procedures, including amputation or 
bypass, were necessary. At hospital discharge, all PTS 
(100%) were improved. A second procedure was required in 
26 PTS (46%) because of renarrowing in 31/195 (16%) 
vessels. A success was achieved in 94% of these lesions. 
These data suggest that below the knee PTA can be suc-
cessfully performed in obliterative arterial disease with 
good success, an acceptable complication rate, immediate 
clinical improvement, and without the need for surgical 
backup. 
CORONARY ANGIOPLASTY PERFORMED AT THE TIME OF DIAGNOSTIC 
CATHETERIZATION: SAFETY AND EFFICACY 
James H. O'Keefe, Jr., M.D., Gary A. Miller, R.N., and 
David R. Holmes, Jr., M.D., F.A.C.C.; Mayo Clinic, 
Rochester, Minnesota 
Percutaneous trans luminal coronary angioplasty (PTCA) is 
often performed after diagnostic angiography at a later 
date. If both could be accomplished at the same setting, 
there could be potential savings of patient (pt) hospital 
days and catheterization laboratory use. To assess this, 
we retrospectively reviewed all elective PTCAs performed 
from 1985 to 1986 and compared pts with PTCA at the time 
of diagnostic angiography, Group I (n • 120 pts); to 
those with diagnostic angiography and PTCA on separate 
days, Group II (n = 404 pts). Groups I and II, respec-
tively, had no significant differences in age (60 vs 
61 yrs), male sex (75% vs 71%), indication for PTCA (un-
stable angina in 87% vs 91%), and current congestive 
heart failure (16% in both). A higher percentage of 
Group I had single-vessel PTCA, 93% vs 81% in Group II 
(p < 0.01). 
GrouE I GrouE II P Value 
Bypass surgery in 24 hrs 1.6% 3.4% NS* 
Acute infarction 3.2% 4.2% NS 
Transient azotemia 
(creatinine rise ?,l mg/dL) 3.3% 2.7% NS 
Death due to PTCA 0% 1.2% NS 
Successful PTCAt 82% 87% NS 
HosEitalization < 4 dals 35% 6% < 0.001 
*No significant difference 
tReduction in luminal diameter stenosis > 40% without 
blEass surgerl ' 
Conclusions: 1) Elective PTCA can be performed safely 
and effectively at the time of diagnostic angiography. 
2) This may shorten hospitalization time required for pts 
undergoing PTCA. 
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IMPEDANCE MEASUREMENT OF ABSOLUTE ARTERIAL 
DIAMETER USING A STANDARD ANGIOPLASTY CATHETER. 
Lisa W. Martin. M.D .. F.A.C.C.j Robert Zawodny, M.D.; Robert 
A. Vogel, M.D., F.A.C.C.; University of Maryland, Baltimore, 
Maryisnd. 
As arterial narrowing is difficult to assess during coronary 
an,iopissty, we have developed a nsw method which allows 
measurement of absolute arterial diameter using a standard 
angiopissty catheter. This approach utllillles electrical 
impedance measurements made between two pairs of electrodes, 
positioned at the catheter's tip. Conductance ia then deter-
mined as the inverse of impedance, which in principle, varies 
directly with the conductive chamber sil!:e. Parallel 
conductance effects of the arterial wall and surrounding tissue 
are reduced by use of close electrode spacing (2.5 mm) and 
high frequencies (50 kHIIl). Cardiac stimulation and electrode 
contamination are eliminated by use of small currents (10 uA). 
We validated this method in postmortem canine arteries which 
were placed in a .45% saline bath to simulate parallel 
conductance effects of surrounding tissue. Arterialsegments 
with diameters of 2.61 to 3.52 mm were perfused with .45% 
saline. Ligatures were pisced around the arteries to create 3 
mm long stenoses (diameter range .64 to 2.6 mm). Conductance 
messurements were made continuously as the catheter was 
pulled from a normal segment through a stenosis. A close 
correistion of conductance measurements versus absolute 
diameter, as measured radiographically, was found (r=0.96, 
N=16). Parallel conductance effects were estimated by 
comparison to measurements made in plastic artery phantoms. 
At vessel diameters of 3 mm, the contribution of parallel 
conductance was 10.9% of the total. At smaller arterial 
dimensions, parallel conductance was proportionally greater. 
These data suggest that the angiopissty catheter itself may be 
useful for the objective assessment of absolute arterial 
dimensions. 
SELECTION OF OPTIMAL BALLOON SIZE FOR CORONARY ANGIO-
PLASTY BY CINEVIDEODENSITOMETRIC MEASUREMENTS 
Allen B. Nichols, MD,FACC, Andrew D. Berke, MD,FACC, 
Rachel J. Smith, Richard A. Schlofmitz, MD, and Eric R. 
Powers, MD,FACC, Columbia University, New York, NY 
The effect of balloon size on the success of 
coronary angioplasty was studied to develop quantita-
tive criteria for optimal selection of balloon size. 
Coronary dimensions of 165 stenotic lesions were 
measured by computer-assisted cinevideodensitometry in 
119 patients who had undergone angioplasty with 
balloons selected by visual estimates. Cross-sectional 
areas and diameters of normal and stenotic arterial 
segments were measured before and after angioplasty by 
a previously validated densitometric technique 
independent of geometric assumptions. The diameter of 
the inflated balloon compared to the diameter of the 
normal arterial segment was expressed as a ratio. 
Oversized balloons with ratios exceeding 1.3 (n-35) 
caused a high incidence of dissection (13/35; 37%), 
with 4 severely compromised arterial lumens. Undersized 
balloons with ratios (0.9 (n=29) often resulted in 
significant (>50% diameter stenosis) residual stenotic 
lesions (6/29; 21%) and a significantly (p(0.05) higher 
rate of repeat angioplasty for restenosis. Selection of 
ballon sizes with ratios in the 0.9 to 1.3 range 
(n-101) resulted in a low incidence of dissection 
(4/101, 4%) with few patients having significant 
residual stenosis (3/101; 3%). Mean residual stenosis 
(% diameter) was largest for undersized (35.0+17.7%) 
(P(0.001) or oversized (23.1~19.2%) (p(0.05) balloons, 
and least for balloons with ratios of 0.9 to 1.3 
(18.7+14.0%). Quantitative cinevideodensitometry 
facilitates balloon size selection, and may lower the 
incidence of dissection, inadequate dilatation, and 
need for repeat angioplasty. 
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COMPARISON OF VESSEL APPEARANCE FOLLOWING PTCA AND 
CORONARY FLOW RESERVE BY DIGITAL ANGIOGRAPHY 
John C. Gurley, M.D.; Steven E. Nissen, M.D.; Jonathan L. 
Ellon, M.D.; Paul A. Grayburn, M.D.; Charles Fischer; 
David C. Booth, M.D., FACC and Anthony N. DeMaria, M.D., 
FACC. Univ of Kentucky & VA Medical Centers, Lexington, KY 
Although PTCA frequently improves the angiographic 
appearance of vessels, the correlation between improved 
appearance and improved coronary flow reserve (CFR) is 
unknown. We therefore measured CFR by a previously 
validated digital angiography (DSA) method in normals, in 
16 patients with coronary disease, and in 6 patients 
before and after PTCA. Stenosis severity was assessed by 
CFR and by quantitative arteriography (QA). CFR was 
determined by performing DSA using subselective injection 
of 1-3 ml contrast through the dilating catheter. Each 
patient had 2 imaging sequences before and after PTCA; one 
under basal conditions and one during hyperemia induced by 
8-12 mg intracoronary papaverine. For each sequence, a 
time-intensity curve was generated from a background-
corrected proximal coronary region of interest. CFR was 
calculated as the ratio of integrated area of the basal 
curve divided by integrated area of the hyperemic curve. 
CFR by DSA ranged from 4.1 to 5.4 (mean 4.8) in normal 
coronaries and 1.5-2.9 (mean 2.0) in vessels with greater 
than 70% diameter stenosis. In PTCA patients before 
dilation, CFR ranged from 1.5 to 2.2 (mean 1.8) by DSA and 
stenosis severity ranged from 67 to 95% (mean 85%) by QA. 
CRF improved in all patients following PTCA, ranging from 
2.6 to 5.8 (mean 3.8), p<.OI, and stenosis severity by QA 
decreased, ranging from 46 to 70% (mean 53%). There was, 
however, poor correlation between post-PTCA QA and CRF, r 
= .20, and between improvements in QA and CFR, r= .40. 
These data demonstrate that vessel appearance after PTCA 
does not predict CFR, and may have limitations in 
assessing the results of the procedure. 
REAL-TIME, TWO-DIMENSIONAL CATHETER ULTRASOUND: A 
NEW TECHNIQUE FOR HIGH-RESOLUTION INTRAVASCULAR 
IMAGING 
pall I G '(gels MD FACC David T. Unker MD, Hira V. Thapliyal PhD, 
James W. Arenson PhD, Stein Samstad MD, Ola Saether MD, Bjoern 
A.J. Angelsen PhD. University of California. San Francisco, CA. 
We have designed and tested a new intravascular imaging system 
consisting of a small. highly flexible. 20M Hz ultrasonic catheter 
linked with a custom-designed scanner for real-time display. Images 
are presented as a 360 degree display of vessel cross section 
perpendicular to the catheter tip. High-resolution images are obtained 
from the catheter surface to a radius up to 40mm, with no evidence of 
poSition artifact across the range of display on phantom testing. 
Preliminary trials using pathologic human vessels demonstrated 
high-quality images with clear resolution of vessel morphology and 
plaque distribution. Normal segments showed a characteristic 
appearance with three distinct layers. Pathologic specimens 
demonstrated highly echogenic patches of plaque as well as larger 
regions of diffusely increased back scatter with loss of normal 
architecture. Three-dimensional maps of plaque distribution were 
generated by analyzing sequential images from scans along vessel 
segments. 27 ultrasonic cross-sectional images were matched with 
corresponding histologic sections showing accurate localization of 
plaque by the ultrasound images. 
I n-vivo studies of carotid and iliac arteries in 20-25kg 
anesthetized pigs demonstrated the same pattern of normal tissue 
architecture seen in the in-vitro studies. 
In addition to imaging surface morphology of a vessel. catheter 2-D 
ultrasound reveals the actual distribution and extent of plaque and 
other pathology within the vessel wall. This may provide a unique 
advantage in diagnosis/monitoring of vascular disease and in catheter-
based therapies. 
lACC Vol. 11, No.2 
February 1988: 131A 
Tuesday, March 29, 1988 
Poster Displayed: 2:00PM-5:00PM 
Author Present: 3:00PM-4:00PM 
Hall E, Georgia World Congress Center 
Angioplasty and Other Interventional Techniques 
ULTRASTRUCTURAL FINDINGS OF PROLIFERATING AND MIGRATING 
SMOOTH MUSCLE CELLS AT THE SITE OF PERCUTANEUS 
TRANSLUMINAL CORONARY ANGIOPLASTY 
Tomoki Ohara, MD, Kazuhisa 
MD, Sinsuke Nanto, MD, 
Chikao Yutani, MD, 
The Cardiovasc.Div., Osaka 
Kodama, MD, Masayoshi Mishima, 
Atsushi Hirayama, MD, 
Police Hosp., Osaka,Japan. 
It has been suggested that intimal proliferation of 
smooth muscle cells(SMCs) may explain for restenosis 
after PTCA. In order to disclose the mechanism of 
restenosis we electron-microscopically investigated 
127 areas taken from the site of PTCA in the 7 
necropsy subjects who died early (1, 2 and 6 days) and 
late(20, 30, 60 and 180 days) after successful PTCA • 
In the early PTCA subjects ,no remarkable intimal 
proliferation of SMCs but there were many areas showing 
migration of SMCs from the media into the intima ,based 
upon a morphological findings in which cells stretched 
into the intima through fenestrae of the internal elastic 
lamella. 
In the 4 late PTCA subjects we found intimal 
proliferation of SMCs so-called modified SMCs which made 
clusters with various cellular forms and prominent 
nuclei. Furthermore collagen and elastic fibers 
proliferated around them. 
We could draw the conclusion that migration of SMCs from 
the media into the intima started within a short period 
after PTCA and that intimal proliferation of migrating 
SMCs whould be the cause of restenosis after PTCA. 
CORONARY ANGIOPLASTY FOR ACUlE MYOCARDIAL 
INFARCTION: A REPORT OF 'rnE 1985 NHLBIPTCA 
REGIS-TRY 
David 0 Wmiams M D FA C C , Katherine Petre, M.D., Dr. 
P.H., and Richard Holubkov. Rhode Island Hospital, Brown 
University, Providence,Rhode Island. 
To assess the value of coronary angioplasty (PTCA) in acute 
myocardial infarction (AMI), the results of the 1985 NHLBI PTCA 
Registry were reviewed. PTCA was performed within ten days of 
AMI in 293 patients, 75.1% male, mean age 59.1 years. Mostpatients 
had prior unstable angina (78.8%) and multivessel disease (59.4%). 
The outcome was analyzed in terms of elapsed time from AMI to 
PTCA and compared to a cohort of 1802 patients undergoing PTCA 
for angina pectoris. 
n 
Total occlusion 
Angio PTCA success 
Death 
Emergency CABO 
AbruPt reclosure 
<6hr 
(62) 
64.8 
87.1 
6.5 
9.7 
9.9 
7 -48hr 3-1Od 
(78) (153) 
% 
37.3 17.7 
88.5 88.2 
7.7 2.6 
1.3 2.6 
1.6 5.3 
anginapts 
(1802) 
10.2 
82.2 
1.0 
3.4 
1.5 
p 
<.001 
<.05 
<.001 
<.001 
<.001 
Despite performing PTCA in a high proportion of totally occluded 
coronary arteries, the success rate ofPTCA in AMI is high, and may 
exceed that of patients with angina pectoris. Death occurs more 
frequently than in patients undergoing PTCA for angina but not more 
than anticipated from AMI alone. Emergency CABG and abrupt 
reclosure following successful PTCA are more common among 
patients in whom PTCA is performed acutely. Thus, PTCA is feasible 
for patients with AMI and when performed is usually successful. The 
incidence of technical and clinical untoward events declines as time 
from AMI onset to PTCA is prolonged. 
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FAILURE OF PERCENTAGE DIAMETER STENOSIS MEASUREMENT TO 
REFLECT CHANGES IN THE DILATED LESION FOLLOWING PTCA. 
Kevin J. Beatt MRCP. Hans E. Luijten MD. Harald J. ten 
Katen MSc. Johan C. Reiber PhD, P.W. Serruys MD, FACC, 
Thoraxcenter, Rotterdam. The Netherlands. 
Animal experiments have shown that balloon dilatation of 
non-stenotic coronary arteries may induce a subsequent 
stenosis, but it is not known if a similar response occurs 
in humans. We studied the effect of balloon dilatation on 
both the stenotic and the adjacent dilated but 
non-stenotic coronary artery segments in 342 patients 
following successful PTCA. Measurements were performed 
immediately following PTCA and at a predetermined time 30 
to 120 days later using an automated edge detection system 
(CAAS). Results are expressed as the change in minimal 
lumen diameter (6MLD) reflecting change in stenosis; 
change in reference diameter ~RD) reflecting change in 
adjacent non-stenotic coronary artery. and change in 
percentage diameter stenosis ~DS). 
(* < .0001) 
post PTCA P t:, MLD (_) P t:, DS(%) P Days 
30 
60 
90 
120 
t:, RD(mm) 
-0.02 ns 0.04 ns -1.6 
2.5 
9.0 
9.1 
ns 
-0.01 
-0.17 
ns -0.06 ns 
* -0.37 * 
ns 
* 
-0.26 * -0.42 * 
Up to 60 days postangioplasty there were small 
non-significant deteriorations in both MLD and RD. 
However, between 60 and 120 days there were highly 
significant deteriorations in both these parameters. 
resulting in an important underestimation of the % DS 
measurement. Therefore percent stenosis measurement is 
inadequate for asseSSing the extent of the restenosis 
process and will lead to an underestimation of the 
incidence of restenosis. 
* 
GRADUAL BALLOON INFLATION PROTOCOL REDUCES ARTERIAL DAMAGE 
FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY. 
Michael S. Remetz, MD, Henry S. Cabin, MD, FACC, Susan 
McConnell, RN, Michael Cleman, MD, FACC, Yale University, 
New Haven, CT. 
Angiographic coronary artery dissection (DIS) post PTCA 
increases acute procedure related complications. Although 
a variety of PTCA balloon inflation protocols are 
employed, prior studies have not evaluated the relation 
of rate of inflation to the type and extent of arterial 
damage produced by PTCA. We randomized 79 patients to 
either a gradual (gradual, incremental increase to peak 
inflation pressure) or rapid inflation protocol (rapid 
increase to peak inflatiori pressure). 39 patients with 57 
lesions underwent gradual and 40 patients with 57 lesions 
received rapid inflation protocols. There were no 
significant group differences with regard to age, sex, 
artery dilated, number of diseased vessels, or frequency 
of unstable angina. Post PTCA angiograms were assessed 
for the presence of DIS by a blinded panel of experienced 
angiographers. Results are expressed as mean + standard 
error: 
GRADUAL RAPID P value 
% stenosis pre PTCA 68.8 + 1.8 73-:0+2.3 NS 
% stenosis post PTCA 18.3 + 1.8 22.9 + 2.2 NS 
Inflation pressure (AIM) 7.7 + 0.2 7.9 + 0.2 NS 
Inflation number 5.2 + 0.4 5.4 + 0.4 NS 
Balloon/Vessel Diameter 1.06 + 0.02 1.03 + 0.02 NS 
Frequency of DIS 20/57-(35 %) 32/57-(56 %) 0.04 
Complications 1/57 (8.8 %) 5/57 (1.7 %) 0.21 
Thus a gradual. compared to rapid PTCA balloon inflation 
protocol reduces the frequency of DIS despite similar 
inflation pressure and balloon/vessel diameter ratio. 
Gradual inflations, by limiting arterial damage, may 
reduce the frequency of procedure related complications. 
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ECG AND 2D ECHO ASSESSMENT OF MYOCARDIAL PROTECTION 
ACHIEVED BY DIASTOLIC SYNCHRONIZED CORONARY SINUS 
RETROPERFUSION (DSR) DURING LAD ANGIOPLASTY. 
Jacques Berland,M.D., Jean-Ch Farcot,M.D.,F.A.C.C, 
Annick Barrier, Guy Derumeaux,M.D., Alain Cribier,M.D., 
Jean-P Bourdarias,M.D.,F.A.C.C., Eliot Corday,M.D.,F.A.C.C 
Brice Letac,M.D.,F.A.C.C., Rouen,Los Angeles,Paris, France 
To determine the safety and beneficial effect of a new DSR 
system, 12 patients (Pts) undergoing LAD angioplasty were 
evaluated. The DSR autoinflatable balloon valve tipped 
catheter has a distal side port to monitor coronary sinus 
(CS) pressure. Intra CS positionning of the catheter was 
achieved within 3 min in 11 Pts and failed in 1 Pt after a 
5 min attempt. Following successfull initial LAD balloon 
dilatation, 41 low pressure PTCA balloon inflations (INF) 
were carried out: 15 INF (91+32 sec. duration) supported 
with arterial blood DSR (flow-: 107+37 ml, pressure: 17+5 
mm Hg) and 26 control INF performed before and after the 
DSR INF. ECG anterior (Ant) mapping (VI to V4) and 2D echo 
left ventricular (LV) anterior wall motion (8 Pts) were 
recorded. Occurence of chest pain (CHP), sum of ant ST 
elevation (t,mV) at end INF and 30 sec reperfusion (REP), 
as well as LV area changes (AC) at end INF are tabulated: 
(mean + SD, * p<0.05 DSR versus control inflations). 
- CHP ST ant t ST ant t LV.AC 
end INF REP end INF 
Control INF 17/26 10.9! 8.5 6.2! 5.7 0.22! 0.04 
* *' * * DSR INF 3/15 6.5 + 5.6 3.5 + 3.3 0.30 + 0.06 
In one Pt slow rate atrial fibrillation occurred during 
catheter insertion but did not disturb DSR assistance. 
Conclusion : During LAD angioplasty, DSR significantly 
reduced CHP, ECG and wall motion signs of ischemia. 
Based upon these data, higher DSR flow and pressure should 
be tested to achieve better myocardial protection for pro-
longed angioplasty inflation time. 
ABRUPT RECLOSURE: PREDICTORS, THERAPEUTIC OPTIONS, AND 
LONG-TERM OUTCOME. 
IN Sinclair, F.R.A.C.P., CH McCabe, B.S., ME Sipperly, 
RN, DS Bairn M.D .. F A.C.C. Harvard-Thorndike Laboratory, 
Beth Israel Hospital, Boston, MA 
To ascertain patient and procedural factors related to 
abrupt reclosure (AR) and its management, we analyzed the 
data on 1160 consecutive patients(pts) who had an initial 
PTCA between 12/81-12/86. AR developed in 55 pts (4.7%) -
usually during PTCA (47 pts, 85%), but in 8 pts (15%) it 
was delayed until 11±2 hours post-PTCA. Pts were divided 
into 3 groups: 1) 24 pts (44%) where AR was re-opened 
(REOPEN); 2) 13 pts (24%) where AR was treated medically 
(MED Rx); and 3) 18 pts (33%) where AR lead to emergent 
bypass surgery, (CABG). Clinical and procedural factors 
related to AR were: 
In hosl!ital REOPEN MED Rx CABG I! value 
Female 42% 15% 28% NS 
+Collaterals 33% 62% 12% p<0.02 
+Filling defect(clot) 63% 38% 22% p<0.05 
Large dissection 12% 38% 61% p<O.Ol 
Myocardial Infarction 17% 38% 67% p<O.Ol 
Death 0% 0% 6% NS 
Long-term follow-YI! (20.9 ± 11 months) 
No symptoms 67% 69% 89% NS 
Restenosis/late PTCA 25% 6% NS 
Late CABG 0% 0% 6% NS 
MI/death 0% 0% 0% NS 
We conclude that AR: 1) can be re-opened in nearly half 
of patients; 2) usually requires CABG when associated 
with a large dissection; 3) can be managed with MED Rx 
when collaterals exist; and 4) has a favorable long-term 
outcome. 
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EF'FEX:!I' OF ASPIRIN (ASA) ON a::MPLIC'ATIONS IlJRING 
TRANSIllMINAL CDR:lNARY ANGIOPUIS'IY (TeA) 
Kenneth M. Kent. M.D •• F.A.C.C., carolyn J. Ewels, B.S., 
Mazy K. Kehoe, R.N. James P. lavelle, M.D. Mitchell W. 
Kruooff, M.D. Georgetown University School of Medicine, 
Washington, D.C. 
Antiplatiet agents, ASA arrl dipyridam:lle, have been used 
since the early experience with TeA. However, because of 
concerns of operative blE!Eldin1 in patients (pts) with 
failed TCA, routine pre-TC'A aspirin was discontinued in 
our institution 2 years ago, dipyridam:lle was continued. 
However, pts who THere to be in ongoiIr;J trials, in which 
ASA was part of stan:Iard orders, contined to receive pre-
TCA ASA (65ng). Retrospective analysis of elective TCA 
in 500 consecutive pts done by the same primary operator 
denalstrated that 224 received pre-TC'A ASA (45%) Group A; 
276 bad not, Group B. Successful TeA (all stenoses 
decreased >40% arrl no ccmplications) was 92% in A,80% in 
B (P<.01); oc.uplications (emergency operations arrl 
myocardial infarction) 3/224 in A, 18/276 in B (P<.001). 
'lbe only pt or procedural characteristic different in the 
groups was group' B pts bad m:>re chronic total occlusions 
atteq>ted, 13% in A, 31% in B (P<.01) which may explain 
the difference in suc:oess, but not ccmplications. 'rhus, 
ASA 65nq pre-TC'A significantly reduces carplications 
associated with TeA. 
BENEFICIAL EFFECT OF HEPARIN THERAPY ON PTCA 
OUTCOME IN UNSTABLE ANGINA. Mary Ann Lukas, M.D. 
Ezra Deutsch,M.D., Warren K. Laskey,M.D.,FACC. 
Hospital of the University of Pennsylvania, 
Philadelphia, Par 
To assess the possible influence of heparin 
(hep) therapy prior to PTCA on outcome in 
patients (pts) with unstable angina (USA), 764 
consecutive PTCAs performed over 29 months were 
reviewed. Pts with acute infarction and those 
<24 hours post thrombolytic therapy were 
excluded. 306 pts were referred for PTCA for 
USA (defined as rapidly progressive or rest 
angina). 167 pts (54%) had PTCA after 
intravenous hep had been given for 1-8 days; 
139 pts (46%) received no hep prior to PTCA. 
PTCA outcome was evaluated for the presence of 
uncomplicated success ( 50% residual stenosis), 
thrombus post-PTCA requiring thrombolysis or 
repeated dilitation, and total occlusion. 
Hep No Hep p 
Uncomplicated success 143(86%) 100(72%) <.05 
Thrombus post PTCA 13( 8%) 21(15%) <.05 
Total occlusion 5( 3%) 11( 8%) <.05 
In 6 pts on hep and 7 pts on no hep the stenosis 
could not be crossed(p=NS). In pts with USA, 
performing PTCA following 1-8 days of hep may 
result in significantly improved success rate. 
We observed decreased incidence of both 
nonocclusive thrombus and unresolved occlusion. 
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REVERSIBILITY OF SEGMENTAL LEFT VENTRICULAR DYSFUNCTION 
FOLLOWING CORONARY ANGIOPLASTY: ECHOCARDIOGRAPHIC 
EVIDENCE OF HIBERNATING MYOCARDIUM 
Egerton K. van den Berg, M.D., Gregory J. Dehmer, M.D., 
F.A.C.C., Frank Snow, M.D., Henry Rosenberg, B.S., Steve 
Lewis, M.D.,F.A.C.C., George W. Vetrovec, M.D.,F.A.C.C. 
and J.V. Nixon, M.D.,F.A.C.C. Dallas VAMC and the Univ-
ersity of Texas Health Science Center, Dallas, Texas. 
Chronic ischemia may cause LV dysfunction even in the ab-
sence of angina and ECG changes. Resolution of ischemia 
after coronary bypass surgery has been associated with 
improvements in LV function and, thus has supported the 
concept of myocardial hibernation. To evaluate the 
early effects of coronary angiop1asty(PTCA) on LV seg-
mental function, we performed two-dimensional echocardio-
grams (2DE) on 26 pts 1 day before and 3.2t2.20 days 
after successful PTCA. 2DEs were reviewed blindly and 
segmental LV wall motion analyzed in 4 short-axis views. 
Wall segments were scored by a method described previous-
ly (O=normal, 1=hypokinetic, 2=akinetic). Segment scores 
in each view were summed yielding a total score. Normal 
LV segmental function (total score=O) was present in 13 
pts before and after PTCA. Thirteen pts had abnormal LV 
wall motion scores prior to PTCA. In these pts, there 
was an improvement in wall motion score (S.2t2.73 to 1.3t 
2.14, p<.001) after PTCA. Ten of the 13 with abnormal 
wall motion scores had a prior myocardial infarction. In 
this subset, wall motion score also was improved after 
PTCA (4.4±2.S0 to 1.3±2.21, p<.OOl). Therefore using 
2DE, improvement in LV segmental wall motion could be de-
tected within days following successful PTCA in pts with 
prior abnormal wall motion. These data demonstrate that 
revascularization by PTCA may reverse chronic LV segmen-
tal dysfunction and provide further evidence of myocard-
ial hibernation in pts with chronic coronary disease. 
CLINICAL EVALUATION OF HIBERNATING MYOCARDIUM - SHORT 
TERM EFFECTS OF CORONARY ANGIOPLASTY ON REGIONAL LEFT 
VENTRICULAR WALL MOTION 
Shinji Asada, M.D., Masayoshi Mishima, M.D., Shinsuke 
Nanto, M.D., Atsushi Hirayama, M.D., Kazuo Komamura, 
M.D., Yasushi Matsumura, M.D., Kazuhisa Kodama, M.D., 
Cardiovascular Division of Osaka Police Hospital, Osaka, 
Japan. 
It has been documented that improvement of left vent-
ricular (LV) wall motion after coronary angioplasty 
(PTCA) is observed with reducing myocardial ischemia due 
to severe coronary stenosis by PTCA, but the time course 
of improvement of LV wall motion is to be elucidated. 
The aim of this study is to assess short-term effects on 
regional LV wall motion after elective PTCA for single 
vessel, left anterior descending coronary artery (LAD) 
disease. We studied 20 patients with LAD single vessel 
disease. All of them underwent successful PTCA. Before 
PTCA, soon after PTCA, and a week after PTCA, left vent-
riculogram was recorded and anterior regional ejection 
fraction (rEF) was calculated by Gelberg's area method. 
At the same time, atrial pacing stress test was also 
performed and regional lactate extraction ratio (LER) at 
peak pacing (1S0bpm) was calculated from lactate content 
of arterial and great cardiac venous blood as a marker of 
regional myocardial metabolism. Results are as follows; 
before soon after 1w.after 
rEF 64.S±7.6 61.6±11.2 72.6±7.9* 
LER 13.1±12.6 21.8±9.6* 18.8±7.9* 
* p<.Ol VB pre PTCA 
These results suggest that regional myocardial metabolism 
improves soon after PTCA, but regional LV wall motion 
improves not soon after PTCA. We conclude that it takes 
about a week or So to obtain improvement of regional LV 
wall motion after PTCA. 
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MYOCARDIAL SALV1\GE AFTER FAIlED ANGIOPIASTY'. 
Karen S. Stark M.D., lDwell F. Satler M.D., Mitchell W. 
Krucoff, M.D., Charles E. Rackley M.D., F.A.C.C., Kenneth 
M. Kent M.D., RlD, F.A.C.C. Georgetown UniVersity, 
washin;Jt.on, D.C. 
Patients (pts) un:i&goin] oo:ronazy anJioplasty (TeA) have 
a 2-5% risk of requirin] emergency oo:ronazy artery bypass 
graft surgery (CAB;) for .iJnpen:ii.n:J infarction. 'ihese pts 
are a 1.Ulique IICdel of early reperfusion since the exact 
time of catpranise to blood flow is known. '!he aJOCIlll1t of 
myocardium salvaged is unknown. Beb;een 12/82 am 9/85, 
859 pts had '!'CAs perfonned. Forty-bNo pts had emergency 
CAB; for objective evidence of .iJnpen:ii.n:J infarction. Five 
pts died. 'Ihirty-six pts were contacted for followup. 
Twenty-one of 36 (58%) had RVGs perfonned at a mean of 
39+13 m::mths post CAB;. 'lhese RVGs were c:atpared to the 
pts' p~ ventriculograms. '!he 21 pts were not 
significantly different fran the remai.nin:J groop in terms 
of age, pre- am post-functional class, coronaJ:y anatany 
or clinical course. One pt had a MI 3 yrs post CAB:;. 11 
(55%) of the remainin:J 20 pts had a nonnal RITG at 
followup (EF=65+9%). Five (25%) of 20 had depressed 
ejection fractions (EF=46+4%) with wall JOOtion 
abnonnalities brt: were unchan:;Jed fran the ~ 
studies. Four pts (20%) had a significant decrease in EF 
aver baseline (EF=37+l0%) with new wall JOOtion 
abnonnalities. 'lhese 4 pts differed significantly fran 
the others only in older age (mean age 63 yrs vs 53 yrs 
[P<.001J) with a tren::l towards higher postoperative CPKs 
(2306+1704 vs.410+380), am a higher incidence of new 
post-operative q-waves (50% vs 25%). In conclusion: 1) 
there is an 80% dJance that left ventricular function 
will be unchan:;Jed at 3 year follow-up in pts un:i&goin] 
emergency CAB; for failed TeA; 2) these data suggest that 
early revascularization for .iJnpen:ii.n:J infarction has 
beneficial effects on late outcane. 
PRESERVATION OF DIASTOLIC FONCTION AND CARDIAC OOTPOT 
DORING PTCA WITH DISTAL CORONARY PERFOSION OF 
FLOOSOL-DA 20%. 
Leigh Bowman, Michael Cleman, Henry Cabin, Susan 
Hasselman, and C. Carl Jaffe, Yale Oniversity, New 
Haven, Connecticut. 
Distal coronary perfusion of an oxygen transport fluid 
(Fluosol-DA) has been demonstrated to preserve systolic 
function during PTCA but its impact on diastolic 
function and cardiac output has not been assessed. We 
measured transmitral flow at the mitral anulus using 
Doppler and 2-D echocardiography in 11 pts undergoing 
left anterior descending PTCA during both perfused 
(oxygenated Fluosol-DA 20% at 60 cc/min) (FLO) and 
nonperfused (NON) balloon inflation sequences. Mitral 
annular cross sectional area was multiplied by early 
peak filling Velocity to derive early peak filling rate 
(EPFR) in mIs/sec, and by the time velocity integral of 
mitral inflow to derive stroke volume (SV) in mls. EPFR 
and SV were measured at baseline and after 60 seconds 
of balloon inflation time for FLO perfused and NON 
perfused inflations. 
Baseline 60 Sec % fall p value 
EPFR NON 283+86 213+76 24+17 
FLO 295+76 269+92 10+15 <.02 
SV NON 72+31 54+33 26+18 
FLO 70+22 68+34 6+17 < .02 
(p value compares the %-fall for-NON compared to FLO). 
We conclude that distal coronary perfusion with 
oxygenated Fluosol-DA during PTCA balloon inflation 
significantly preserves cardiac output and diastolic 
function. This manuever offers potent ial applications 
in procedures on high risk angioplasty patients. 
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ATRIAL NATRIURETIC FACTOR AND ARGININE VASOPRESSIN AFTER 
FONTAN PROCEDURE. 
Guillermo A. Zeballos, Ph.D., Julian M. Stewart, M.D., 
Ph.D., Angela Romano, M.D., Bernard J. Clarke, M.D., Paul 
K. Woolf, M.D., William I. Norwood, M.D., F.A.C.C., 
Michael H. Gewitz, M.D., F.A.C.C. New York Medical 
College Valhalla, NY and Children's Hospital of Philadel-
phia, Phila., PA. 
Arginine vasopressin (AVP) and atrial natriuretic factor 
(ANF) have antagonistic effects. Their release is inter-
dependent and altered by atrial stretch. The Fontan Pro-
cedure (FP) raises right atrial pressure (RAP) and 
survival is complicated by disordered fluid balance. 
Therefore, we assessed plasma AVP and ANF simultaneously 
by RIA prior to, during and post FP in 9 children (2-l0y). 
AVP increased (p<.Ol) on cardiopulmonary bypass (CPB) but 
decreased following anastomosis while ANF was increasing 
(p<.OS). When ANF was maximum (days 2-17), AVP decreased 
to less than preop levels (p<.05). We conclude that in-
creased ANF and RAP may inhibit AVP release in FP. This 
may modulate AVP mediated vasoconstriction and fluid re-
tention in these patients. 
preop Anesth On CPB 
ANF (pg/ml) 37±lO 74+21 6l±7 
AVP (pg/ml) 1()±2 9±3 lS2±3l 
RAP (mmHG) 4+1 
Off CPB PODI POD2-17 
ANF(pg/ml) 144±S3 60±1B 254:!:,,0 
AVP(pg/ml) 60±29 39±20 S±l 
RAP (mmHg) 16+1 13+1 lS+2 
FILLER-FREE SILICONE RUBBER COATED DACRON GRAFTS FOR 
RIGHT VENTRICLE TO PULMONARY ARTERY CONDUITS 
John L. Myers, M.D., F.A.C.C., Wayne E. Richenbacher, 
M.D., William S. Pierce, M.D., F.A.C.C. and John A. 
Waldhausen, M.D., F.A.C.C., College of Medicine, 
Pennsylvania State University, Hershey, PA 
Prosthetic conduits, designed with or without an integral 
prosthetic valve, have been plagued with "peel" formation 
resulting in outflow obstruction which may necessitate 
replacement of the conduit. In hopes of preventing 
tissue ingrowth and subsequent neointimal proliferation, 
standard Dacron grafts (DG) were coated with filler-free 
silicone rubber (FFSR) and implanted in goats as a RV to 
PA conduit. The main PA was ligated proximal to the 
distal graft anastomosis. Fifty percent of the uncoated 
DG developed obstruction from "peel" formation within 8 
months. DG coated with FFSR were widely patent with 
either no neointima or a very thin layer of neointima in 
78% of the animals. Six children with valved DC conduits 
inserted at the time of their initial corrective surgery 
(age lS-88 mos. mean 65 mos.) had subsequent caths which 
revealed gradients of 58-80 mmHg (mean 71 mmHg) across 
the valved conduits. All 6 children subsequently 
underwent conduit replacement with a 22 mm non-valved DG 
coated with FFSR. The interval between operations was 5 
to 9 years (mean 6 yrs.). Follow-up since conduit 
replacement has been 4-40 months (mean 26 mos.). All 
patients are doing well clinically. Four patients have 
had Doppler exams shOWing gradients of 15-20 mmHg in 
three and 60 mmHg in the fourth. The results of our 
animal studies and early clinical experience suggests 
that FFSR coated DG may be more resistant to "peel" 
formation than the standard DG. 
JACC Vol. II, No.2 
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NONINVASIVE THREE DIMENSIONAL RECONSTRUCTION OF THE SPEC-
TRUM OF VENTRICULAR SEPTAL DEFECTS WITH PULMONARY STENOSIS 
BY MAGNETIC RESONANCE IMAGING 
John C. Laschinger, MD, Michael W. Vannier, Mo, Thomas L. 
Spray, MD, Charles Canter, MD, Fernando R. Gutierrez, MD, 
James L. Cox, MD, FACe. Washington University School of 
Medicine, Barnes Hospital, St. Louis, MO .63110. 
Computer derived three dimensional (3D) images of the 
heart and great vessels were reconstructed preoperatively 
from noninvasive ECG gated magnetic resonanCe (MR) images 
in 9 patients with ventricular septal defects (VSD) and 
pulmonary stenosis or atresia. Intraoperative findings 
confirmed the accuracy of these images in displaying size 
and location (perimembranous ~ 6, supracristal = 2, 
muscular = 1) of all VSDs and their spatial relationships 
to the outflow tract and great vessel morphology (double 
outlet right ventricle = 4, overriding aorta = 4, pseudo-
truncus = 1). Varying degrees of infundibular, main 
and/or branCh pulmonary artery stenosis or pulmonary 
valvular atresia were demonstrated in each patient. All 
3D MR findings were confirmed intraoperatively. Unique 
information not discovered by cineangiography and/or 
echocardiography was provided in 7 of 9 patients with 
avoidance of cardiac catheterization in one patient. 
Postoperative 3D MR study allows noninvasive assessment 
of anatomic repair. These results suggest that 3D dis-
play of complex pathologic anatomy can be aChieved ac-
curately and noninvasively by preoperative 3D reconstruc-
tion techniques resulting in improved surgical planning. 
LONG-TERM PALLIATION WITH THE CLASSIC 
BLALOCK-TAUSSIG SHUNT. 
Scott Stewart, M.D., Chloe Alexson, M.D., James 
Manning, M.D., University of Rochester Medical 
Center, Rochester, New York 
The length of palliation achieved from a classic B-T 
shunt was evaluated in 85 patients who received this 
shunt between 1973 and 1986. Their median age at 
time of operation was 4 mos. and 35 were less than 
1 mo. Operative mortality was 4.7~(4/85). 
Palliation was considered adequate until either a 
second shunt or a premature corrective operation was 
necessary_ Long-term palliation was excellent for 
all. At 24 mo. after operation 97~ of patients 
older than 1 mo. remained palliated and, at 48 mo. 
87~ of them continued to have satisfactory 
palliation. Of patients less than 1 mo. of age, 87~ 
were well palliated at 24 mo. and 54 ~ at 48 mo. 
Mean duration of palliation for those <1 mo. was 27 
mos. and for those> 1 mo., 37 mos. Important 
distortion of the pulmonary artery by the shunt did 
not occur. The classic B-T shunt provides excellent 
palliation for all patients for a significant 
duration of time. These results compare favorably 
to those in which prosthetic material has been used 
in a modified shunt technique. 
JACC Vol. 11, No.2 
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QUANTITATIVE EVALUATION OF AORTIC REGURGITATION AFTER 
ANATOMIC CORRECTION OF TRANSPOSITION OF THE GREAT 
ARTERIES 
Robin Martin, MRCP; Jose Ettedgui, Shakeel Qureshi, 
MRCP; John Gibbs, MRCP; Rosemary Radley-Smith, FRCP, 
FACC; Michael Tynan, MD, FRCP, and Magdi Yacoub, 
FRCS, FACC. • 
Harefield Hospital, Harefield, Middlesex and Guy's 
Hospital, London, England. 
There is concern about the long term function of 
the aortic valve after anatomic correction of trans-
position of the great arteries. In an attempt 
to define the incidence and severity of postoperative 
aortic regurgitation, 20 patients were studied using 
Doppler echocardiography, aortic root angiography 
and the ratio of left (LV) and right (RV) ventricular 
stroke counts (LV/RV) determined by radionuclide 
angiography (stroke volume index SVI). The age of 
the patients at the time of study was 17-85 (mean 
52) months and the interval from anatomic correction 
was 17 - 78 (mean 47) months. Eight patients (40%) 
who were identified to have a degree of aortic regurg-
itation by Doppler and/or angiography had a SVI of 
0.83-1.24 (mean 1.03) whilst the SVI of the remaining 
12 patients was not significantly different (0.75-1.30 
mean 1.01). None of the patients had an SVI > 1.8 
which is indicative of significant left ventricular 
volume over-load in our laboratory. 
It 1s concluded that postoperative aortic regurgitation 
after anatomic correction of transposition is of 
no haemodynamic significance in the medium term. 
TREATABLE ANATOMIC CAUSES OF PERSISTENT EFFUSIONS 
AND/OR PROTEIN-LOSING ERTEROPATRY AFTER HlDIFIED FONrAH 
OPERATION. Giorgio M. Aru. M.D., Alvin J. Chin, M.D., 
John D. Murphy, M.D., Paul M. Weinberg, M.D., F.A.C.C., 
Wayne H. Franklin, M.D., John D. Pigott, M.D. and 
William I. Norwood, M.D., Ph.D., F.A.C.C. 
The Children's Hospital of Philadelphia, Philadelphia, 
PA 
Since January 1984, modified Fontan procedure was 
performed in 113 pts: tricuspid or pulmonary atresia 31 
(27%), single ventricle 22 (20%), hypoplastic left 
heart syndrome 34 (30%), heterotaxy and other complex 
defects 26 (23%). Postoperatively recurrent 
pleura-pericardial effusions developed in 56 (49%). 
Twenty pts with effusions had the following treatable 
anatomic features: 1) impedance to pulmonary venous 
blood flow (9 pts - 1 death), 2) left-to-right shunt: 
systemic ventricle- to-pulmonary artery (2 pts), 3) 
moderate or severe atrio-ventricular valve 
regurgitation and/or prolapse (3 pts-3 deaths), 4) late 
development of restrictive VSD or bulho-ventricular 
foramen (2 pts), 5) thrombus in systemic or pulmonary 
venous atrium (5 pts-1 death), 6) persistent 
tachyarrhythmias refractory to medical therapy (3 pts-1 
death). Fourteen of the 20 pts developed effusions late 
and 2 of these had associated protein-losing 
enteropathy. Treatable anatomic complications occur in 
more than 1/3 of the patients who developed effusions 
and/or protein-losing enteropathy and are particularly 
prevalent when effusions occur late or are exacerbated 
with time. 
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LATE CARDIAC: EFFECTS OF DOXORUBICIN IN CHILDHOOD ACUTE 
LYMPHOBLASTIC LEUKEMIA. 
Steven E. Lipshullz. M.D .. Steven D. Colan. M.D .. F.A.C.C .. Stephen P. 
Sanders. M.D .. Stephen E. Sallan. M.D .. The Children's Hospital & Dana 
Farber Cancer Institute. Boston. MA. 
All surviving patients (n =260) treated for acute lymphoblastic leukemia (ALL) 
with doxorubicin and followed at this institution without relapse were invited to 
participate in a "udy of the long·term effects of doxorubicin on the heart. To 
date. 65 participants have undergone 2-dimensional and M-mode 
echocardiography as part of a general cardiac evaluation in this ongoing stUdy. 
Patients were studied a to 13 vears (median = 6.7 vears) after completion of 
doxorubicin therapy. The doxorubicin dose was 45~516 mg/m' (median = 319 
mg/m2) and the age at completion of therapy was 1.5-17.5 years (median; 6.0 
years). LV fun"tion was assessed using the resting M-mode shortening 
fraction. End-s::stolic wall stress (ESWS) was used as an index of afterload and 
contractility was evaluated using the previously validated load-independent 
relation between rate-adjusted velocity of fiber shortening and ESWS. Although 
only 5 participallts had ever had evidence of clinical congestive heart failure 
requiring treatment. LV function and/or afterload was abnormal in 36/65 (55 ~O 
patients. No patient who received less than 250 mg/m2 of doxorubicin 
demonstrated anv abnormality of LV function. supp0l1ing a dose-dependent 
effect. Depressed LV contractility was noted in 56% (20/36) of patients with 
abnormal function. Contractility was normal in the remaining 16 patients in 
whom depressed function was due solely to excess afterload. Elevated 
ventricular afterload (61-115 gm/cm2: normal = 40-60 gm/cm2) was obsen'ed 
in 75% (27/36) of patients with abnormal echocardiograms. Serial analyses of 
ventricular after!oad were available for 16 participants. of which 81 % (13/16) 
demonstrated a progressive increase in ventricular afterload with time. Patients 
with elevated ventricular afterload typically had diminished LV wall thickness. 
minimal LV dilation and normal systemic blood pressure. These data indicate 
that doxorubicin therapy in childhood may impair the gl'Owth potential of the LV 
myocardium. Continuing somatic growth may resuit in inadequate LV mass. 
excessive afterload and depressed function. In addition. some patients appear to 
have depressed intrinsic LV muscle function. The surprisingly high incidence 
of cardiac abnormalities in a largely asymptomatic group of children with ALL 
who received dO\OfUbicin is disturbing. Close serial assessment of LV fUIlcti0n 
in this populatio', is strongly suggested. 
THE EFFECT OF PULMONARY HYPERTENSIVE CONGENITAL 
HEART DISEASE ON THE POST-NATAL REMODELLING OF 
THE PULMONARY VASCULTURE. 
Haworth Sheila G. FRCP, FACC. Hall S. PhD, 
Burford B. Allen K. PhD. M~Ils A. PhD. 
Institute of Child Health, London, U.K. 
Quantitative light, scanning and transmission 
electron microscopic and immunolocalisation 
techniques were used to study post-natal pulmon-
ary vascular remodelling in lung biopsies from 18 
children with PA hypertension (mean PA pressure 
47mmHg) ,aged 2m-6yr.(In the normal newborn lung 
vascular smooth muscle cells (VSMC) are immature 
and there is little "fixed" connective tissue). 
Comparison with 15 normal cases of similar age 
showed hypertrophy, hyperplasia of VSMC with 
accelerated peripheral extension and an acceler-
ated post-natal increase in VSMC contractile 
myofilaments, and deposition of connective tissue 
particularly elastin and collagen Type I. 
Abnormally elongated endothelial cells showed an 
increase in micro- and intermediate filaments and 
synthetiC organelles and "lifting" of endothelium 
to expose the subendothelium to mononuclear cells. 
Occlusion of alveolar wall arteries occurred from 
2 months. Early intimal proliferation «6mths) 
obstructed arteries entering the respiratory unit 
originated from undifferentiated medial VSMC and 
was covered by abnormal endothelium. Changes were 
related to age and type of cardiac anomaly. 
Abnormal remodelling will alter the growth 
potential, wall stiffness, reactivity and 
pharmacologic properties of the PAs in an age 
dependant manner. Studies on vascular reactivity 
and cell/cell interaction in the immature lung 
are indicated. 
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EFFECTS OF TOTAL ISCHEMIA ON THE NEONATAL HEART 
Gregory P. Fontana, M.D., Jay S. Markowitz, M.D., 
Robin G. Cummings, M.D., R. Duane Davis, M.D., 
David W. Molter, M.D., James E. Lowe, M.D., F.A.C.C. 
Duke University Medical Center, Durham, NC 
Controversy exists regarding the tolerance of the 
neonatal heart to ischemia. This study was designed to 
distinguish developmental differences in ischemic 
metabolism and time to cardiac rigor, an index of 
irreversible injury. The hearts of adult (A, n-7) and 
neonatal (N,2-4 day old, n-16) dogs were rapidly excised 
and subjected to normothermic total ischemia, a model 
tree of wall tension and collateral blood flow. Slabs 
were created and instrumented with a SF Millar needle tip 
pressure catheters. Tissue samples were taken at control 
and every 15 minutes (min) throughout 75 minutes of 
ischemia. Time to cardiac rigor was similar in the N LV 
(47±1.2 min), RV (47±1.7 min), and septum (47±1.7 min), 
and occurred earlier (p<O.OOl) than A LV (64±1.8 min), RV 
(71±2.4 min), and septum (72±3.6 min). N ATP metabolism 
and lactate (Lac) accumulation were similar in the RV and 
LV (ANOVA p-NS). A LV vs. N LV metabolic data are as 
follows (~mol/g wet wt): 
Time (min) 3 15 45 60 
N ATP 2.9±.1 2.1±.1 1.1±.2 O.S±.l 
A ATP 5.7±.2 3.4±.1 1.4±.2 0.5+.1 
N Lac 0.5±.2 13.7±1.5 32.2±1.5 35.6±2 
A Lac 8.9±.6 15.2±.7 33.7±1.2 45.2±1 
(mean ± SEM) N vs. A, p<O.OOl; ANOVA) 
75 
0.3±.1 
0.2±.1 
39.2±2 
49.2±1 
Compared to the adult, the neonatal heart 1) has a lower 
baseline ATP concentration, 2) has a delayed initiation 
of anaerobic glycolysis after the onset of ischemis, 3) 
is less tolerant to prolonged ischemia, and 4) exhibits 
uniform susceptibility to total ischemia. 
ATRIAL SEPTAL ANOMALIES DIFFERENTIATE TYPES OF 
HYPOPLASTIC LEFT HEART SYNDROME 
Paul M. Weinberg, M.D., F.A.C.C. and Steven Weindling, M.D. 
the Children's Hospital of philadelphia, Philadelphia, PA. 
In light of the current interest in surgical treatment of 
hypoplastic left heart syndrome (HLHS) a study of 110 post 
mortem cases was undertaken to address the diverse anatomical 
consideration~ necessary for the complete diagnosis and 
surgical repair of HLHS. Four groups were identified with 
respect to atrial septal anatomy: I) leftward s!isplacement of 
superior attachment of !,eptum 2rimum (flap valve o! fora~en 
ovale)(DSP) relative to septum secundum (4496) assOCiated With 
a high incidence of mitral and aortic atresia, 2) normal atrial 
septum (3396) - most had endocardial fibroelastosis - accounted 
for 5896 of all cases with valvar aortic stenosis, 3) congenitally 
small foramen ovale (1696), and 4) malaligned AV canal with 
hypoplastic LV (796) usually with hypoplastic aortic valve and a 
relatively high incidence of aortic arch hypoplasia. 
DSP does not occur in normals or in other cardiac defects 
without left heart hypoplasia. Knowledge of the unusual plane 
of septum primum should facilitate its recognition by echo and 
its identification at surgery permitting its successful excision. 
Furthermore this finding supports the embryologic hypothesis of 
cephalad growth of septum primum rather than the popular 
notion of downward growth closing ostium primum. 
The atrial septal morphology permits subgrouping of 
HLHS into 4 categories: DSP, normal atrial septum, 
congenitally small foramen ovale, and ostium primum atrial 
septal defect as part of common A V canal. It is hoped that an 
understanding of these anatomical differences will permit more 
complete analysis of surgical results and allow the 
identification of specific risk factors in the palliation of HLHS. 
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ELEVATED SERUM ATRIAL NATRIURETIC PEPTIDE IN PREMATURE 
INFANTS WITH RESPIRATORY DISTRESS AND PATENT DUCTUS 
ARTERIOSUS. Erkki Pesonen, M.D., Allen Merritt, M.D., 
Sture Andersson,M.D., Ilkka Tikkanen, M.D. Frej 
Fyhrquist, M.D., David J. Sahn, M.D., FACC, snd 
Frederick S. Sherman, M.D. Univ of Calif, San Diego, CA. 
In order to evaluate the time course of changes in 
serum atrial natriuretic peptide (ANP) in infants with 
respiratory distress and determine the effects of ductal 
patency, we studied ANP levels in 20 infants (mean 
weight 1007 g, all <30 weeka gestation) with respiratory 
distress syndrome and related ANP levels to the presence 
of patent ductus arteriosus (PDA) shunting in serial 
studies over the first 3 days of life. Highest ANP 
levels were found at 1 hour of age (mean 475 pg/mI) a 
time when significant left to right PDA shunting was 
demonstrated by Doppler color flow mapping (CD) in all 
infants. There was then a gradual linear decrease in 
serum ANP levels (r- 0.67), although during the first 24 
hours increased PDA shunting was demonstrated in these 
same infants. ANP levels elevated above the mean reg-
ression line for the entire group Were maintained con-
sistently by infants who continued to demonstrate PDA 
shunting over the next 72 hours. Turbulent ductal shunt 
flow area on CD as a percentage of pulmonary artery 
cross-sectional area, as an index of ductal flow corre-
lated well with plasma ANP (r-0.74, p<O.Ol). The timing 
of ANP changes suggested that treatment with indocin 
itself or surfactant treatment did not directly influ-
ence ANP level other than when ductal closure occurred. 
Elevated ANP shortly after birth probably represents a 
change in left atrial filling after lung expansion and 
the increase in pulmonary and left atrial blood flow, 
influenced as well by continued PDA shunting. Ductal 
closure is accompanied by a prompt decrease in ANP in 
premature infants. 
ASYNCHRONOUS OPENING OF THE ATRIOVENTRICULAR VALVES IN 
THE NORMAL NEONATE: A CAUSE FOR ARTERIAL DESATURATION 
Leonard Steinfeld, M.D., F.A.C.C., Orlandino Almeida, 
M.D., Jonathan Strauch, Division of Pediatric Cardiology, 
Mt. Sinai School of Medicine, New York, N.Y. 
In both the normal neonate and adult there is asynchro-
nous opening of the atrioventricular (AV) valves. In 25 
normals studied on consecutive days, in the first week of 
life, mitral (M) uniformly preceded tricuspid (T) opening 
which is the reverse of that reported in the adult. AV 
valve opening was timed from the peak of the R wave of 
the ECG to the onset of diastolic (D) filling. 0 flow was 
recorded using gated pulsed Doppler technology. AV valve 
opening times varied with heart rate and age. M and T 
opening times were recorded sequenti ally at the same RR 
interval, at rates varying from 90-150 BPM. There was an 
average time difference of 17 msec (range 12-36 msec) 
between M and T opening. For the first 10-25% of the 
mitral 0 period there was M, but no T flow. Synchronous 
with M opening the valve of the foramen ovale (VFO), 
viewed on 2-D echo, bowed into the left atrium (LA). 
Bowing into the LA in the first two days of life was 
>5mm, indicating a positive pressure gradient between the 
right and LA. The bowing diminished after the third day. 
For the time that the M was open and the T closed and the 
VFO bowed leftward, there was a right to LA shunt. These 
findings are consistent with perSistence of the fetal 
diastolic compliance relationship between the ventricles. 
The venous admixture at the atrial level explains in 
part, if not complete 1 y, the red uced arter i a 1 PA02 
observed in the rest i ng normal newborn, wh ich heretofore 
was attributed solely to ventilation perfusion mismatch. 
JACC Vol. II, No.2 
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ATRIAL NATRIURETIC PEPTIDE IN CONGENITAL HEART 
DEFECTS WITH RIGHT HEART VOLUME OVERLOAD. 
Klaus G. Schmidt. M.D.; Jean-Louis Cloez, M.D.; Wolfgang 
Rascher, M,D.; Rudolf E. Lang, M.D.; Herbert E. Ulmer, M.D.; 
Children's Hospital, University of Heidelberg, West-Germany. 
Elevated atrial pressure or atrial distention have been shown to 
increase plasma levels of atrial natriuretic peptide (ANP) in 
adult pts. In this study we analyzed the ANP levels in 17 
children aged 6.5±4 years, who had congenital heart defects 
(CHD) with right heart volume overload, and in 30 age-matched 
healthy children. In CHD pts mean right atrial pressure (RAP), 
right ventricular end-diastolic pressure (RVEDP), and pulmo-
nary to systemic flow ratio (Qp/Qs) were measured at cardiac 
catheterization. Right atrial area index (RAAi) was calculated 
from 2D-echocardiograms. We found similar ANP levels in 
control children (25±10 fmollml; mean ± SD) and in 11 CHD pts 
(CHD-I: 25±9 fmollml), but increased ANP levels in the other 6 
CHD pts (CHD-II: 124±75 fmollml; p<0.01). Hemodynamic data 
are given as mean ± SD (* p<0.05 or less compared to CHD-I): 
RAP(mm Hg) RVEDP(mm Hg) Qp/Qs RAAi(cm2/m2) 
CHD-I 3.5±1 4.5±2 1.6±0.3 13±4 
CHD-II 8.7±6* 11.0±7* 3.0±0.9* 28±5* 
Qp/Qs and RMi showed a linear relationship with ANP in CHD 
pts (r=0.5 and r=0.6, respectively; p<0.02). RAP and RVEDP, 
however, were normal in 3 CHD-II pts and did not correlate 
significantly with ANP. We conclude that increased release of 
ANP appears to be related rather to right atrial distention than to 
elevated RAP and RVEDP. ANP may be normal in children with 
CHD and right heart volume overload, when right heart filling 
pressures and atrial size are normal. 
INFLUENCE OF THROMBOXANE A RECEPTOR ANTAGONISM ON 
PULMONARY VASOCONSTRICTOR iESPONSES IN THE NEWBORN. 
Linda M. Bradley, MD, Robert E. Goldstein, MD, FACC, and 
Giora Feuerstein, MD, USUHS, Bethesda, MD. 
Thromboxane A2 (TXA
2
) may contribute significantly to 
pulmonary hypertens10n (PHT) in ill newborns. Platelet-
activating factor (PAF), a leukocyte-generated inflam-
matory mediator, releases abundant TXA2• Local release of PAF and TXA2 could promote severe vasoconstriction in 
immature lungs with inflammatory disorders. To assess 
the protective potential of the potent TXA2 receptor 
antagonist SQ 29,548 (SQ), we measured pulmonary vaso-
constrictor responses to 1) PAF, 0.1 nmol/kg; 2) U46619 
(a stable TXA2 analog), 0.2 ~g/kg.min; and 3) hypoxia 
(12% inspired O2 for 3 min) before and after SQ, 50 ~g/ kg. min (n-9) or vehicle (n-5) in anesthetized, open-
chest piglets. Mean changes (6) ± SEM: 
PAF:pre/pSQ U46619:5re/PSQ ,Og:pre/psQ 
6MPAF(mmHSj 16±4/1±1* 23±3 1±1* 1 ±1/20±1 
6PVR x 10 302±102/2±1* 139±67/1±1* 14±5/23±3t 
6RVEDP(mmHg) 4±2/0±0* 3±2/0±0 0±0/1±0 
6CO(ml/kg/min) -67±5/0±2* -69±15/-6±7t 1±5/-5±3 
MP~mmean pulmonary artery ,pressure, PVR (dyne.sec. 
cm .kg)=pulmonary vascular resistance, RVEDP-right 
ventricular end-diastolic pressure, CO-cardiac output, 
pSQ-postSQ. 
tp<.05 vs. pre SQ, *p<.OI vs. pre SQ. 
SQ completely inhibited pulmonary vasoconstriction and 
related adverse consequences after PAF or U46619. 
Vehicle had no effect. These data suggest that TXA2 
receptor blockers such as SQ may have important 
potential in treating the inflammatory component of PHT 
in the newborn. However, SQ failed to block (and may 
actually worsen) the component of PHT that is a direct 
consequence of hypoxia. 
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FETAL ECHOCARDIOGRAPHY: OUTCOME OF PREGNANCY AS A FUNCTION 
OF THE INDICATION FOR REFERRAL 
Howard P. Gutgesell,M.D.,F.A.C.C., Karen S. Rheuban, M.D., 
F.A.C.C., Debra Smith, B.S., William Hogge, M.D., Siva 
Thiagarajah, M.D., F. J. Bourgeois, M.D., and Guy M. 
Harbert, M.D., Departments of Pediatrics and Obstetrics 
and Gynecology, University of Virginia, Charlottesville,VA 
To determine the relationship between the indication for 
fetal echocardiography and the outcome of the pregnancy, 
we reviewed data from 103 consecutive mothers referred for 
fetal echocardiography. The indication for referral was 
family history of congenital heart disease (CHD) , N=40,fe-
tal arrhythmia, N=34, maternal drug exposure, N=12, poly-
hydramnios, N=8, abnormality on screening ultrasound, N=9. 
The overall incidence of CHD was 13%: 3/40 (8%) among re-
ferrals for family history of CHD, 8/34 (24%) among pat-
ients referred for suspected arrhythmia, 1/8 (13%)in poly-
hydramnios, and 4/9 (44%) when abnormalities were detected 
by screening ultrasound studies. 
In 87/103 (84%) patients, the fetal echocardiogram was nor-
mal or revealed only PAC's, the pregnancy was uneventful, 
and the infant had no cardiac abnormality. Fetal bradycar-
dia (HR less than 80) was detected in 5 fetuses, all had 
structural heart disease. Of these, 2 died inutero,2 died 
in the neonatal period and 1 is alive with an artificial 
pacemaker. Of the 8 additional patients with CHD, 1 was 
stillborn, 5 died in the neonatal period, and 2 are alive. 
Thus, when fetal echocardiography is performed as a screen-
ing test, the detection of cardiac abnormalities is simi-
lar to that anticipated for the known recurrence rates of 
CHD. When performed because of signs of fetal distress 
(polyhydramnios, arrhythmia) or other abnormality detected 
by ultrasound, it identifies a subgroup of fetuses with 
major cardiac disease and high rates of intrauterine and 
postnatal mortality. 
TRE ASSOCIATION OF TRICUSPID INSUFFICIENCY WITH VENTRI-
CULAR SEPTAL ANEURYSMS: A COLOR FLOW DOPPLER STUDY. Lisa 
K. Hornberger, B.A., lain A. Simpson, M.D., Erkki 
Pesonen, M.D., Kimberly Krabill, M.D., Sandra Ragen-
Ansert, RDMS, David J. Sahn, M.D., FACC. Univ of Calif, 
San Diego, CA. 
Ventricular septal aneurysms (VSA) form with a contri-
bution to the margins of the ventricular septal defect 
(VSD) from overlying tricuspid valve tissue (TV). To, 
elucidate the natural history of VSD's related to the 
presence and magnitude of tricuspid insufficiency (TI), 
24 pts with membranous VSD and VSA were examined with 
color flow mapping Doppler in oblique 4-chamber views, 
to determine if they had accelerating regurgitant jets 
from RV to RA; "TI", or accelerating flow from LV 
through the VSD and TV to the RA (trans-VSD TI). TI was 
found in 19/24 which by color jet area; mean-l.85tO.66 
(SD) cm2 was more than the normal TI we have seen in 
children «0.75 cm2 ). In 3/19, jets were from the RV to 
the RA, and 16 had trans-VSD TI directed laterally 
toward the inferior vena cava. A comparison group of 35 
pts with small or medium sized muscular or membranous 
VSD's without VSA showed only the physiologic normal 
amount of TI. Serial studies were available in 11 VSD 
pts (mean followup 6 months). Six patients who had a VSD 
with no VSA and only physiologic TI on initial study 
even when in CRF, showed an increase in TI (p < 0.05) as 
the VSA became more prominent and the VSD size decreased 
(4/6). In 3 there was no change in VSD or TI and in 2, 
TI and VSD size decreased as the VSA tissue became 
noticeably thicker. Our study suggests that pts with 
VSA and especially with progressive diminution of VSD 
size have TI, differing in direction and extent from 
physiologic TI. TI may need to be considered as part of 
the natural history of perimembranous VSD and VSA. 
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CARDIAC GROWTH AFTER ORTHOTOPIC HEART TRANSPLANTATION IN 
EARLY INFANCY. 
Mohammad Kanakri~eh, MD, Eugene Petry, MD, John Mace V, 
Leonard Bailey,D, FACC. Loma Linda University Medical 
Center, Loma Linda, California. 
Sustained growth of cardiac structures after infant ortho-
topic heart transplantation (IOHT) is of major concern. 
To determine whether growth does occur following IOHT. 
five survivors (3 neonates and 2 infants) were followed 
by serial M-mode echocardiography. Mean duration of 
follow up is 13.7 months with range 6-20 months. Mean 
change of body surface area (BSA) is 0.27 m2 (range 0.11-
0.39 m2). The LV dimensions in diastole and systole 
(LVEDD, LVESD), RV internal dimension (RVID), LV posterior 
wall thickness (PW) and ventricular septal thickness (S) 
were measured and plotted against the BSA. The LV end 
diastolic volume (LVV) and the LV mass (LVM) were derived 
and plotted against BSA. Patients are currently on 
maintenance immunotherapy using Cyclosporine with or with-
out Azathioprine. Growth patterns of cardiac dimensions 
in each Pt is compared to published growth patterns in 
normal children. (Table). 
Pt # LVEDD LVESD S PW RVID 
%ile %ile %ile %i le %ile 
1 =SOth =-SOth SO-9Sth SO-9Sth =SOth 
2 SO-9Sth "SOth >9Sth "'9Sth "SOth 
3 =SOth "SOth >9Sth SO-9Sth "SOth 
4 S-SOth S-SOth "9Sth SO-9Sth "SOth 
5 "50th "50th >95th SO-95th "50th 
The LVV and LVM showed comparable growth. Data supports 
sustained growth of tIe transplanted heart. This is the 
first objective study )f cardiac growth after IOHT that 
proves the transplanted heart is capable of sustained 
growth. 
MYOCARDIAL FIBROSIS IN TETRALOGY OF FALLOT: EFFECT OF 
REPAIR OR PART OF NATURAL HISTORY? 
Anita Hegerty, B.Sc., Robert H. Anderson, F.R.C.Path., 
John E. Deanfield, M.R.C.P., Hospital for Sick Children, 
London, U.K. 
Arrhythmia and ventricular dysfunction are recognised 
complications after repair of tetralogy of Fallot (ToF) 
and have been linked to sudden death. We have studied 
right and left ventricular myocardium in 28 ToF pts who 
died before or at repair (<'1 yr 11 pts, 1-5 yrs 12 pts, 
> 5 yrs 5 pts) to determine whether myocardial damage 
occurs as part of the natural history rather than due to 
surgery per se. Semi automated analysis of fibrous 
tissue (FT) content was performed on sections from RV 
and LV inlet apex and outflow tract (60 fields/block) and 
results compared to 62 normal hearts. FT in the LV 
remained normal in all age groups. In contrast, FT in 
the RV was normal in pts < 1 yr (2.1 g ! 0.96 in normals 
v 2.2 ! 1.5 in ToFl but there was an abnormal increase in 
FT with age (19.8 - 9 in normals> 5 yrs v 43.3 g ! 21 in 
ToF > 5 yrs, p< 0.05) • This was maximal in the out flow 
tract and in the subendocardium. Thus, progressive 
damage to the RV occurs with increasing age even before 
ToF repair. This may be the substrate for late 
post-operative complications and argues in favour of 
early repair. 
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INTEREST OF THE SIGNAL AVERAGED ECG TO PREDICT THE ISSUE 
OF PROGRAMMED VENTRICULAR STIMULATION IN PATIENTS WITH TE-
TRALOGY OF FALLOT AFTER INTRA-CARDIAC REPAIR. 
Arnaud Terrier de la Chaise, M.D., Fran90is Mar90n, M.D. 
Beatrice Brembilla, M.D., Karl Isaaz, M.D., Fran90is 
Cherrier, M.D., Claude Pernot, M.D.,F.A.C.C., Cardiology 
department, Brabois Hospital, Nancy-France 
Programmed ventricular stimulation (PVSJ has been proposed 
to identify, after repair of Tetralogy of Fallot (RTFJ,pts 
with high risk of subsequent spontaneous ventricular tachy-
cardia (VT) and sudden death. In this study we analysed 
the interest of the signal averaged ECG (SAE) to predict 
the issue of a PVS in 23 pts with RTF and complete right 
bundle branch block. PVS was performed as usually descri~ 
bed. SAE was obtained by Simson's method, 4 parameters we-
re analysed: duration of averaged QRS signal (Our. QRS), 
amplitude of the signal in the last 50 and 40 ms (V~.O,V40), 
duration of terminal low amplitude signal~40 mcv (Our LA). 
The pts were divided into 2 groups: group I (n=16): RTF 
without induced sustained VT (ISVT), group II (n=7): RTF 
with ISVT 
RESULTS 
Delay of repair (years) 
Delay of PVS after repair (years) 
Our QRS (ms) 
V50 (mcv) 
V40 (mcv) 
Our LA (ms) < 
*p 0.05 
Concerning the inducibility of a 
QRS> 150 ms had a sensi tivi ty of 
66%, a positive predictive value 
predictive value of 100%. 
I 
4.3+4.7 
21+14 
**p< 0.02 
II 
8.4+3.6 
10.8+3** 
180+34* 
SVT the criterion Our 
100%, a specificity of 
of 53% and a negative 
Conclusion: SAE (Our QRS~ 150 ms) permits to 
a high sensitivity, among pts with RTF, those 
risk of ISVT in whom PVS must be performed. 
select, with 
with high 
ARTERIAL REIMPLANTATION: SHORT AND LONG TERM COURSE OF 
PATIENTS WITH ANOMALOUS LEFT CORONARY ARTERY 
Roger A. Hurwitz, M.D., F.A.C.C., Randall L. Caldwell, 
M.D., F.A.C.C., Donald A. Girod, M.D., F.A.C.C., Thomas 
G. Albrecht, M.D., Harold King, M.D., and John Brown, 
M.D., F.A.C.C., Indiana Univ Med School, Indianapolis, IN 
To better define the course of infants and children 
treated by coronary artery reimplantation, we studied the 
clinical history and ventricular function of all 15 pts 
with anomalous left coronary artery (ALCA) presenting 
over the last 20 yrs. Reimplantation of the ALCA into 
the aorta became our treatment of choice during this 
period. Two pts died while awaiting more "suitable" size 
for surgery. Anatomy was not favorable for primary reim-
plantation in 4 pts; 2/3 survived ligation of the ALCA, 
and 1/1 survived an arterial graft. Nine pts were 
operated on by reimplantation with 8 survivors. Surgery 
in these 9 pts was performed at a mean age of 32 mos (3 
were under 9 mOS at operation) The 8 survivors have been 
followed 0.9-11 yrs (mean, 5.1 yrs) and are doing well, 
though one required mitral valve replacement subsequent 
to initial surgery. Left ventricular ejection fraction 
(LVEF), estimated by cineangiography and/or radionuclide 
angiocardiography improved in all. The pre-operative LVEF 
of 0.37~0.16 increased to 0.67~0.07 (p(O.OOl) by 1 yr 
after surgery despite the continued presence of apical 
dyskinesis in 3 pts. This data suggests that reimplanta-
tion of ALCA should be performed when anatomically pos-
sible upon discovery of the leSion, since: 1) successful 
surgery is possible in infants; 2) systolic ventricular 
function improves significantly; and 3) the reimplanted 
artery provides myocardial perfusion adequate for normal 
function for up to 11 yrs. 
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WHAT IS THE FATE OF THE PULMONARY VALVE 
FOLLOWING PULMONARY ARTERY -TO-ASCENDING 
AORT A ANASTOMOSIS? 
Alvin J. Chin, M.D., J. Gregg Helton, M.D., 
Erneno T. A bOhras, M.D., Gerald Barber, M.D., Beth A. 
Aglira, B.H.S., R.C.P.T., John D. Pigott, M.D., 
William I. Norwood, M.D., Ph.D., F.A.C.C. 
The Children's Hospital of Philadelphia, Philadelphia, PA 
Transection of the main PA followed by end-to-side 
proximal PA-to-ascending Ao anastomosis (PA-AAo AN) has 
become accepted palliation for many lesions which have 
nonresectable subvalvar and/or valvar aortic stenosis as a 
shared feature. Since eventual reparative surgery will involve 
a modified Fontan operation in most cases, it is important to 
preserve the competence of the pulmonary valve which will 
have to function as the systemic arterial valve. Because of 
concerns about whether pulmonary valve distortion occurs 
during PA-AAo AN, 45 survivors of this approach for 
hypoplastic left heart syndrome (HLHS) or other lesions such 
as single ventricle with small outlet foramen underwent Color 
Doppler examination a median of 208 da (range 1-1035) 
postoperatively. In 37 pts with HLHS, in whom homograft 
augmentation of the arch was carried proximally to the level 
of the PA-AAo AN, there was mild pulmonary regurgitation 
(PR) in 9 (24%) and moderate PR in I. Among 6 pts with 
transposition, single ventricle and small outlet foramen and 2 
pts with ventricular septal defect, coarctation (or interrupted 
aortic arch), and subaortic stenosis, PR was mild in 2 (25%) 
and moderate in 1. Among 14 PA-AAo AN pts who have 
undergone serial Color Doppler examinations (median time 
from first to last postop study = 56 da, range 9-114), PR 
progressed in 0/14 and disappeared in 4/6. Although J4 of 
survivors of PA-AAo AN develop mild PR, it does not alter 
Fontan candidacy; there is no added risk to the pulmonary 
valve in HLHS in which the arch augmentation patch forms a 
three-way anastomosis with the proximal PA and AAo. 
THE EVOLVING PATTERN OF SURVIVAL FOLLOWING 
PALLIATIVE SURGERY FOR HYPOPLASTIC LEFT HEART 
SYNDROME. 
Gerald Barber M 0 John D. Murphy, M.D., John D. Pigott, M.D., 
William I. Norwood, M.D., Ph.D., F.A.C.C., Children's Hospital of 
Philadelphia, Philadelphia, PA. 
The records of the first 166 patients with hypoplastic left heart 
syndrome (HLHS) surgically palliated at The Children's Hospital of 
Philadelphia were reviewed to determine improvement in survival 
statistics. Patients were divided into 4 groups by year of operation 
(1984 N=29, 1985 N=51, 1986 N=49, 1987 N=37) and survival 
determined by life-table analysis. 
RESULTS: 
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Survival following palliation for HLHS has improved 
significantly over the past 4 years. This improvement is due to: I) 
improvement in postoperative hemostasis secondary to the use of 
fresh blood intraoperatively and postoperatively as well as the use 
of pulmonary homograft in the aortic arch augmentation, 2) 
improvement in postoperative leu management, and 3) a more 
thorough resection of the narrowing at the junction between the 
isthmus of the aorta and the descending aorta. It is expected that, as 
more is learned about this lesion, survival will continue to improve. 
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INOTROPIC AND LUSITROPIC EFFECTS OF MCI-154 ON NORMAL 
HUMAN MYOCARDIUM. Sanford E.Warren. M.D., Yasuki Kihara, 
M.D., Janet Pesaturo, B.A., Judith K.Gwathmey, V.M.D., 
Ph.D., Preston Phillips, M.S.,and James P. Morgan, M.D., 
Ph.D., F.A.C.C. Harvard-Thorndike Laboratory, Beth 
Israel Hospital, Boston, Massachusetts. 
Animal studies of MCI-154 have shown potent positive 
inotropy, mediated neither by beta adrenoceptor stimula-
tion nor by Na-K ATPase inhibition. To test efficacy in 
man and further elUCidate the mechanisms of action, we 
studied inotropiC and lusitropic responses to MCI in 12 
normal ventricular trabeculae carneae isolated from 7 
organ donors in whom the heart was not transplanted. Six 
experiments were conducted with 106 M carbachol added to 
the bath after 3xl04MCI to test for reversal of positive 
inotropy,a marker of cyclic AMP dependence. Three muscles 
were stimulated after loading with the bioluminescent 
calcium indicator aequorin.Peak tension- PT, time to PT-
TPT, time to.5 relaxation-RT.5. Results: I 
MCI: Baseline 106M 105M 104M 3xl04M 
PT, mN/mllfl.7 --z:4 "3:6**5:1** 6.0** 3xl0SMCI 
TPT, msec 297 282 261** 240** 237** 
RT.5,msec 191 167* 158* 158* 168t : 
**p(.0I,*p(.05vs baseline;f p(.05vsl04M. \ 
A typical aequorin expt. ~\ .. ~ ..... 
is shown; light~top fig- ,.;, pre-MCI 1\ I 
ures; tension=-bottom. •.•. J "---- .22, 
Carbachol inhibition of MCI PT was 5±1%.Conclusions: MCI 
resulted in potent positive inotropy, largely due to an 
increase in cytosolic Ca++. While cyclic AMP appears to 
playa role in MCI's action, modest carbachol responses 
suggest a 2nd mechanism. At high doses, partial reversal 
of the drug's positive lusitropic effect occurred, con-
sistent with sensitization of the myofilaments to Ca++. 
EFFECT OF MCI-154 ON Ca2+-ACTIVATION IN SKINNED HUMAN 
AND FERRET CARDIAC MUSCLE. 
Cynthia Perreault, B.S., Roger J. Hajjar, B.S., and 
James P. Morgan, M.D., Ph.D., F.A.C.C. Harvard-
Thorndike Laboratories of the Beth Israel Hospital and 
Harvard Medical School, Boston, MA 02215. 
We investigated the effects of MCI-154, a new 
inotropic agent, on force development in saponin-
skinned human and ferret trabeculae. The skinned 
fibers were activated by bu~~er S?~uti?HS containi~~ 
varying concentrations of Ca (10 -10 M). The Ca 
concentration required for half-maxima~ activation in 
the si~gidal force vs. pCa(-log[Ca +]) curve ~gs 
1.30xlO M for the human fibers (n-6) and 1.71xlO_
4
M 
(n-14) for the fe2~et fibers. In the presence of 10 M 
MCI, the force-Ca relationship was shifted upward by 
36% and leftward by 0:§4 pCa units in the ferret 
myocardium, whereas 10 M MCI induced a 9% upward 
shift and a leftward shift of 0.11 pCa units in the 
human myocardium. At high calcium concentrations 
(pCa-4.5) , MCI enhanced force _6pro~~ction in a 
concentration-2~pendent manner (10 -10 M) increaSing 
the maximal Ca -activated tension development of the 
contractile proteins in both human and ferret 
trabeculae. Our results suggest that the inotropic 
effect of MCI may be due in part to the i~~reased 
sensitivity of the myofilame~~s to Ca and 
enhancement of maximal Ca -activated force 
development. Since MCI2increases the responsiveness of 
the myofilaments to Ca it may represent a new class 
of inotropic agents that will prove beneficial in the 
treatment of various cardiomyopathies unresponsive to 
currently available inotropic agents. 
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DIRECI' VASODIIA'IDRY ACl'ICNS OF AMRINONE DEKlNSTRATED IN 
HUMl\NS WI'lH 'IDl'AL ARl'IFICIAL HEAR1'S 
Irvin F. GoldenbeLg MD, Marc R. Pritzker MD, Charles 
Jorgensen MD, James D. Madison MD, Frazier Eales MD, 
Connie Siebold RN, 'lhanas J. Von Rueden MD, Kristen 
JOOnsan RN, Fredarick L. Gobel MD, 4'le D. Joyce MD, 
Minneapolis Heart Institute, Minneapolis, MN 
In the intact anllnal, it is difficult to assess the 
direct effects of amrinone on systemic vasculature. To 
detennine whether amrinone has direct vasodilatory 
properties, we studied 3 pts (mean age 31 ± 18 years, 1 
female, 2 males) after replacement of their natural 
hearts with a pneumatically-driven total artificial 
heart (TAR). Amrinone was administered (4 studies in 3 
pts) as two 0.75 ngjkg boluses am then a continuous 
infusion (10 ncg/kg/min). Despite l.1I'IC'llan;Jed cardiac 
ootp.It (5.4 ± 0.2 to 5.3 ± 0.6 I1min), stroke volume 
(52 ± 2 to 51 ± 8 ml), ani right atrial pressure (10 ± 
2 to 9 ± 1 1!IIiIg), there was a reduction in total 
vascular res~stance (1433 ± 167 to 1146 ± 114 
dyne-sec:-cm- ) ani mean aortic pressure (91 ± 9 to 73 
± 4 xmnHg) in all pts. All pts also had an increase in 
plasma norepineprrine (194 ± 135 to 288 ± 144 n;0nl) 
ani in electrical atrial activity assessed by P wave 
rate (76 ± 10 to 99 ± 5). '!his data in:licates that 
humans with TAR ani thus an l.1I'IC'llan;Jed inotropic state 
respond to amrinone by decreasing mean aortic pressure 
ani total vascular resistance suworting the hypothesis 
that amrinone exerts a direct vasodilatory effect on 
the systemic vasculature. 'lhis direct vasodilatory 
effect produces an increase in sympathetic nervous 
system activity delronstrated by an increase in 
electrical atrial activity ani plasma norepineprrine. 
'lhe results of this study also document the value of 
the TAR m:rlel as a means of assessing the peri{ileral 
vascular actions of inotropic dnlgs. 
CARDIAC ELECTOOPHYSIOIffiIC ~S OF KEl'ANSERIN. 
Antonio Zaza, M.D., Michael R. Rosen, M.D., F .A.C.C., 
Coltmlbia university, New York, New York. 
Ketanserin (Kt) treat:rrent has been associated with Qr pro-
longation and plearorphic ventricular tachycardias in san= 
patients. We studied Kt (10-8 to 1O-~) effects on trans-
rranbrane action potentials (AP) of canine Purkinje fibers 
(FF) and ventricular muscle (VM) to analyze the basis of 
its arrhythnDgenicity. FF were tested at [~l of 4.0 and 2.7 
11M and drive cycle lengths (CL) of 0.5,1, 3 and 5 s. Kt did 
not affect maximum diastolic potential (MDP)(at [K+l=4 11M, 
CL=1 s: o:mtrol= -91+2 nW,X+SE), AP anplitude (APA)(control 
=130+3nW) and Vrnax (controI=602+62 Vis). Kt increased AP 
duration (APD~ dose dependently-through 1O-~ (control= 
319+8 ms; 10-~399+20 ms, P<O.05) and shortened it at 10-5 
M (EO 352+23 ms, P<0.05). At both [~l the dose-response 
curve for-APD was steeper (P< 0.05) at longer CL. Within 
the sane CL the slwe of dose response curves for APD was 
similar at both [K 1. Earlyafterdepolarizations (FADs) 
occurred in 2/6 PF at 1O-"M Kt ([~1=2. 7; CL=3 s). We + 
studied 6 PF and attached distal VM simultaneously at [K l= 
4.0 11M, CL=O. 5 and 2 s. An int;;rease occurred in FF and VM 
APD through lO-EiM Kt.,A.t 1O-"M Kt, VM APD further increased 
(+5% fram that at 10-"M Kt),While PF APD decreased (-15%, 
P < 0.05), thus decreasing diS\i'Elrsion of repolarization. 
Conduction t:ime, MDP, APAandVrnax were unchanged in both 
tissues. Slow response AP were induced in 5 PF by 22 11M [~l and isoproterenol 1O-~. Kt increased APD (P < 0.05) 
with:>ut affecting MDP, APA and ~rnax. Thus Kt'spotentially 
arrhyt:hnogenic effects are attributable to FADs that occur 
at long CL and may induce tachyarrhythmias. M:Jre<lITer, its 
ability to prolong repolarization with:>ut inducing other 
changes suggests it may have antiarrhythmic (Class III) 
prcperties. 
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THYROXINE REGULATES THE DIHYDROPYRIDINE CALCIUM 
ANTAGONIST RECEPTOR IN RAT MYOCARDIUM 
Helen J. Gordon, M.D., Khiem Nguyen, M.D., Bharati Dave, 
M.S., Diane Rood, B.S., Ray H. Zobrist, Ph.D., John C. 
Giacomini, M.D., Stanford University and PAVAMC, Palo 
Alto, CA. 
The effects of alterations of thyroid state on the 
regulation of the dihydropyridine (DHP) calcium antagonist 
receptors in rat myocardium were investigated in this 
study. Hyperthyroidism was induced in male rats by im-
plantation of Alzet minipumps, with infusion of L-thy-
roxine 500 ug/kg/day for 7 days. Hypothyroidism was 
induced by oral propylthiouracil for 21 days. The effect 
of thyroid hormone on the DHP receptor density (Bmax) 
and affinity (Kd) was determined by radio ligand binding 
studies in rat myocardial membrsnes. 
Hyperthyroid Control Hypothyroid Control 
(n~4) (n=5) (n=4) (n=4) 
Bmax1 204 + 14* 135 ± 16 140 + 25** 181 + 5 
Kd2 .24 :t.04 .20 :t.04 .37 :t.1O .40 +.10 
a fmo1/mg protein + S.D., 2 = nM + S.D. 
" P < .001, *" p < .05 -
Hyperthyroidism increased the DHP receptor density by 50%. 
Conversely, hypothyroidism decreased the receptor density 
by 25%. There was no significant change in receptor af-
finity in either the hyperthyroid or hypothyroid states. 
These results indicate that cardiac DHP calcium antago-
nist receptors undergo dynamic regulation in response to 
alterations in thyroid state. 
EFFECl' OF 'lHIDD)XANE A2 RFX:rProR INlUBITION 00 MY0-
CARDIAL BL<X>D FIDti OORI.NG THREE GRAIES OF CXJlOW{Y OC-
CUSIOO. Lloyd W Klein, MD, FJ\CC, Jai B ~l, MD, 
FJ\CC, Alan~ciiase;--lID;-snige Noma, MD, Ridlard H 
Helfant. MD, FJ\CC. Philade.iplia Heart Institute. 
Presbyterian-university of Pennsylvania Medical 
Center, Philade.iplia, PA. 
The effect of thrad:xlxane A2 receptor inhibitien 
(TXAI) with Alf23848 en re<;fi~l JIlYOCardial blood flow 
(1M3F) at 3 grades of partlal coronary ooclusien (PO» 
~s studied. 11 cpen chest dogs wnerwent· carotid to 
left anterior descend~ (lAD) perfusien with flow am 
perfusicn pressure DlXutorinJ. The 3 PO> grades were 
defined by diastolic perfusicn pressure (IPP). After 
IPP ~s reduced to 64, 42 or 32 II1ti;J (mean), 0.1 ag/lcg 
intracorcnary TXAI ~s infused CNer: 1 lllinute. R!eF in 
mJ../g/lllin ~s _sured by tracer micI'08P1eres in the 
endocardiUII (a'Ido) am apicardiUII (api). 
Results: AIf23848 produced no d:lar¥)es in systemic he.>-
ayniiiiiCs with cc without PO>. Variable mean corcnary 
(em'), tr~l (TF), and 1M3F respcnsea in the lAD 
zcnI were noted at different 1PP(*p<O.05 OOIIIpiU"ed to 
PO»: 
IPP ENOO EPI TF, 6. C8F 
JiiiiiJ ~ PO)~ PO>~ 
64 1.17 1.48* 1.02 1.24* 1.10 1.36* +24* 
42 1.07 1.04 0.98 1.16 1.07 1.11 +11 
32 0.79 0.57* 1.32 1.41 1.16 1.09 -20 
At 64 1I1ti;J, TXAI increased em', TP, endo and api KIF. 
In contrast, at 42 1IIIfig, RM3F am TP did not ~
and at 32 1IIIIHg, endo MY' decreased. 1M3F am TP were 
unchanged in the circwaflex zcnI. Without PO), TXAI 
had no effect en em', 1M3F ex TP. 
Conclusicns: (1) AH23848 has coronary vasolilatory ef-
fects ~ in the preaenoe of flow restricticn. (2) 
These 81!,19est that, in the settin:J of a stenosis, 
TXAI m.y redIstribute flow to the IID8t isdlemic myo-
cardiUlll, whidl has iDportant iDplicaticns for the role 
of flow regulaticn by thrOld:loxane A2. 
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ADRIAMYCIN LIMITS THE CONSEQUENCES OF SODIUM MEDIATED 
CALCIUM GAIN IN THE ISOLATED RAT HEART. Robert G. 
Weiss, M.D., Myron L. Weisfeldt, M.D., F.A.C.~Gary 
Gerstenbl ith, M.D., F .A.C.C., Johns Hopkins Medical 
Institutions, Baltimore, MD 
Sodium-calcium (Na-Ca) exchange may importantly 
contribute to cell Ca loading under certain experimental 
and cl inical conditions. In the intact heart the extent 
of Ca gain via this exchange is evidenced by a transient 
rise in developed pressure (DP), a fall in ATP and 
phosphocreatine (PCr), and an increase in inorganic 
phosphate (Pi) accompanyi ng low. Na perfus i on. Although 
adriamycin limits Na-Ca exchange in subcellular 
preparations, its effects in the whole heart are not 
known. Contractile and metabol ic (at 20 min using 31P-
NMR) parameters during lithium substituted low Na (50 mM) 
perfus i on were exami ned in the presence and absence of 
adriamycin, 25 uM (ADR) in the isovolumic rat heart (mean 
± sem, % of baseline). 
% DP(peak) 
% PCr 
% ATP 
% Pi 
Control (n=4) 
283 ± 9 
65 + 4 
81 :; 4 
399 ± 61 
Adriamycin(n=5) 
169 + 3 
96 :; 2 
94 :; 4 
147 ± 52 
Jl. 
.01 
.01 
.07 
,05 
ADR had no metabolic or functional effects during 20 min 
of 140 mM Na perfusion (n=5). Thus, AOR limits the 
consequences of low Na perfusion in the intact rat heart. 
ADR and other inhibitors of Na-Ca exchange may alter the 
metabol ic and contractile accompaniments of pathologic 
states associated with enhanced Na mediated Ca gain. 
EVIDENCB FOR LOCAL INTRACARDIAC ACTION AND METABOLISM OF CON-
VERTING ENZYME INHIBITORS. 
Klaus Lindpaintner, M.D., Markus J Wllhela, Manwen Jin, and 
Detlev Ganten, M.D. ,Ph.D. Gel'llllll Inst for Higb Blood Pressure 
Res and Dept of Phal'llllcology, U of Heidelberg, Heidelberg, PRG. 
The recent detlonstration of extrarenal, local tissue renin an-
giotensin systeas (RAS) in a nuaber of peripheral organs ex-
pands the classical view of the RAS and mandates their physio-
logical and phal'llllcological characterization. In support of a 
proposed intriosic cardiac RAS we have recently detlonstrated 
expression of the renin and angiotensinogen genes in all four 
cardiac cbaabers and shown that conversion of ANG I to ANG II 
occurs in the isolated, beating heart. To test this systea for 
its susceptibility to pbaraacological .adUlation, we exposed 
isolated, perfused rat hearts to an infusion of 3*10-~ ANG I 
and added either the active diacid foI'll (R031-3113, aC) or the 
inactive ethyl-ester foI'll (R031-2848, iC) of the converting en-
zyae inhibitor (CRI), cilazaprll, in various concentrations. 
The coronary sinus effluent was collected and assayed for ANG I 
and ANG II by HPLC and RIA. Infusion of ANG I resulted in the 
imaediate appearance of ANG II in the effluent at a ~an rate 
of 916;!;,51 fllOl/.in, rejfesen~ing a fractional ,fonversion of 9.4 
;!;,0.8%. Infusion of 10- , 10- , 10-g, and 10-lVN aC resulted in 
suppression of conversion by 1~ ~, ~, and 11 •. Unexpec-
tedly, adainistration of iC at 10 ,3*10-, and 10- M also in-
hibited ANG II generation by 90%, 54%, and 2~. The prodrug was 
without inhibitory effects on converting enzyae activity in in-
vitro testing. Si.ilarly, infusion of vehicle had no effects~ 
Our results newly identify the heart as a specific target for 
the action of CRIs. This suggests that in add! tion to effects 
on systeaic beaodynaaics, direct .adulation of the local cardi-
ac RAS .ay represent an iaportant ~cbanisa of action of these 
agents and contribute to their clinical efficacy. Moreover, the 
inhibitory effects seen with the inactive prodrug which noraal-
ly requires hepatic activation aay indicate that the ~tabolic 
aske-up for activation of such drugs exists within the heart. 
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NICOTINAMIDE ADENINE DINUCLEOTIDE FLUOROMETRY TO EVALUATE 
PRESSURE LOADING OF THE HEART. 
Mary D. Osbakken. M.D •• Ph.D., Avraham Mayevsky, Ph.D., 
Judy Huddell, Jeffery Closter, Britton Chance. Ph.D. 
University of Pennsylvania, Philadelphia, PA. 
Myocardial nicotinamide adenine dinucleotides (NADH) were 
measured in 8 dogs and 8 cats with fluorometry during 
norepinephrine (HE) pressure loading. Each animal was 
anesthetized with nembutal (40 mg/kg) and intubated. 
Arterial and venous canulae were placed for monitoring of 
arterial blood gases and blood pressure and flUid and drug 
administration, respectively. After a left lateral 
thoracotomy, the heart was suspended in a pericardial 
cradle and a fiberoptic light guide was secured to the LV 
with cyanoaccrylate. Excitation light was 366 run and 
transmitted fluorescence was 450 run. Correct response of 
the fluorometer was determined using 100~ N, (also 
definded as maximal NADH response). All re!lponses to NE 
were normalized to maximal response (NE response/maximal 
response). Increase in systolic blood pressure, mean ±. 
S.D. (SBP: from 121 % 35 to 189 ±. 65, Dog; 134 %436 to 
222 ±. 58, Cat) and heart rate x SBP (HR x SBP (xl0 ): 
from 2 % .93 to 3.15 ±. 1.2, Dog; 2.23 ±. 1.0 to 4.2 ±. 1.6 
Cat) was associated with minimal change in NADH (cat: -.06 
% .39; dog: -.23 ±. .22) although there were some instances 
of increase or decrease in NADH levels. Group data from 
both species indicate that acutely applied myocardial work 
loads are aSSOCiated with stable electron transport 
(consumption of NADH) and thus oxidative phosphorylation 
and that the heart maintains functional stability during 
acute pressure loading. In the future, it may be possible 
to evaluate metabolism of selected regions of mfocardium 
with fiberoptic catheters, thus making this technique a 
clinically useful tool to study the effects of loading on 
normal and damaged myocardium in patients. 
EARLY INCREASE OF MYOSIN LIGHT CHAIN-2 mRNA IN RIGHT 
VENTRICULAR PRESSURE OVERLOAD 
Adrian Van Bakel M.D. ,Ph D Lee Chao, Ph.D., Cheryl 
Woodley-Miller, Ph.D., George Cooper, IV, M.D. 
VAMC, Gazes Cardiac Res Inst, Medical Univ S. Carolina 
Charleston, S.C. 
Although it is clear from existing studies that muscle 
specific mRNAs and their respective myofibrillar proteins 
increase within 24-48 hours after acute pressure overload-
ing, it is not known how rapidly increases in hemodynamic 
load are transduced into the biochemical changes that ini-
tiate growth. Given that a relatively well defined, time 
dependent sequence of events occurs after a change in 
loading conditions, such data will be necessary if we are 
to delineate the mechanism(s) that initiate myocardial 
hypertrophy. The purpose of this study was to examine the 
early time course for gene expression of a muscle specific 
mRNA, myosin light chain-2, in right ventricular pressure 
overload. Accordingly, we hybridized in situ a cDNA probe 
for myosin light chain-2 to adult feline right and left 
ventricular myocardium. The tissue was obtained sequen-
tially after pulmonary artery banding. In right ventricu-
lar myocardial cel1s, with data normalized to left ven-
tricular cells from the same heart, we found an 89 + 7% 
and a 119 ± 13% increase in autoradiographic grain den~ity 
versus sham-operated controls at 1 hr. and 24 hrs. respec-
tively (n-48 , p<0.0002). Specific binding was demonstrated 
using a non-homologous probe as a background control. 
This study shows for the first time that changes in gene 
expression inv<'>lving structural proteins occur extremely 
rapidly follOWing a change in hemodynamic load. The 
rapidity of these changes suggests that load itself is 
directly responsible for myocardial growth. These results 
allow a more focused approach to the very early events 
that initiate hypertrophy, particularly with respect to 
the signal transduction between cell loading and growth. 
142A ABSTRACTS 
AMINO ACYL-tRNA VALIDATION OF THE IN VIVO MEASUREMENT OF 
MYOCARDIAL PROTEIN TURNOVER USING AN AMINO ACID TRACER: 
[3H]-PHENYLALANINE. James Revkin,M.D., Eugene Barrett,M.D. 
Lawrence Young,M.D., Robert Ge1fand,M.D., Barry L. Zaret. 
M.D.,F.A.C.C., William Stirewalt, Ph.D. Yale University 
School of Medicine, New Haven, CT. 
Animal studies have revealed disturbances in protein 
turnover during ischemia, reperfusion, and in cardio-
myopathic states. These studies required direct tissue 
sampling. We recently developed a tracer technique to 
measure myocardial protein synthesis and degradation in 
the intact organism. During a continuous infusion of 
L-[3H]-Pheny1a1anine (PHE) we estimated rates of heart 
protein synthesis and degradation from the dilution of 
PHE specific activity (SA) in coronary sinus plasma during 
catheterization. In 9 dogs heart protein synthesis equaled 
degradation and turnover averaged 11% per day. This deter-
mination assumes that the SA of PHE in plasma approximates 
that of PHE-tRNA, the immediate precursor of protein syn-
thesis. To validate this we infused [3H]-PHE in 6 rats 
and compared the PHE SA in plasma, cytosol, heart protein, 
and tRNA. The SA of heart protein increased from 33+1 to 
363+28 dpm/nmo1 (p<0.002) between 10 and 30 min. At 30 
min-the SA of PHE measured 162+20 dpm/pmo1 for plasma, 
150+17 for PHE-tRNA, and 142+23 for intracellular PHE. 
Using the SA of PHE in each of the 3 pools, we calculated 
fractional protein synthetic rates of 12, 12, and 14% per 
day respectively. CONCLUSION: The SA of PHE tracer in 
plasma closely approximates that of myocardial PHE-tRNA 
and can be used to measure heart protein synthesis and 
degradation without tissue biopsy. These data validate a 
metabolic tracer technique which will permit the study of 
heart protein turnover in the intact organism and man. 
EARLY VENTRICULAR DYSFUNCTION IN HYPERTENSIVE 
PATIENTS WITH PRESERVED AEROBIC CAPACITY 
Patricia A. McElroy M.D.. Joseph S. Janicki, Ph.D., and Karl 
T. Weber, M.D., F.A.C.C., Cardiovascular Institute, Michael 
Reese Hospital, Univ. of Chicago, Chicago, II. 
Patients with essential hypertension (HTN) maintain near 
normal aerobic capacity (V02 max) until late in the disease 
when overt LV dysfunction is apparent. However, the stress 
of maximal exercise (Ex) may unmask earlier LV impairment. 
Accordingly, 24 HTN and 6 normal subjects (NLS) underwent 
treadmill (EX) to aerobic capacity with measurement of right 
heart, wedge, and direct arterial pressures (mmHg) and Fick 
cardiac output. 02 ~Ptake ('~02)' C02 production, anaerobic 
threshold (AT) and V02 max were measured. We found: I) 
Standing, resting stroke volume index (SVI, ml/beat/m2) was 
the same in NLS and HTN (34.3±lO.2 vs 31.1±7.0); 2) SVI rose 
(p<O.OOI) in both groups to AT (57.6±14.0 vs 55.9±IO.7, p=NS); 
3) In NLS, SVI continued to increase between AT and V02 
max (63.9±21.1), while in HTN, it fell (52.4±9.6), p<0.05; 4) 
Standing RA pressure rose (p<O.OO I) during EX in both groups, 
but the differences were NS (HTN 5.0±4.3 to 9.7±6.5; NLS 
2.8±l.S to 8.3±4.6); S) Wedge pressure also rose (p<O.OOI) in 
both groups, and the differences were NS (HTN 8.1±3.6 to 
21.0±8.4; NLS 4.7±2.9 to 20.0±5.2); 6) There was a trend for a 
steeper heart rate/V02 slope (beats/ml/kg) in HTN, but the 
difference was NS (3.7±0.9 vs 2.9±0.5). Thus, HTN patients 
demonstrate abnormal SV responses at heavy workloads, 
despite normal increases in LV and R V filling pressures. 
There is a tendency for a steeper heart rate/V02 response, 
which, despite a falling SV, preserves EX cardiac output and 
near normal aerobic capacity. This suggests that early 
ventricular dysfunction may exist in HTN even with preserved 
aerobic capacity. A steep heart rate/V02 slope may 
therefore serve as a noninvasive indicator of early cardiac 
failure, but additional study is necessary. 
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DIFFERENTIAL EFFECTS OF EXPERIMENTAL HEART FAILURE ON 
BAROREFLEX CONTROL OF HEART RATE AND VASCULAR RESISTANCE. 
Vita LaDOce. H S., Nancy Ferraro, R.N., John R. Wilson, 
H.D., Uniyersity of Pennsylvania, Philadelphia, PA. 
Prior studies have demonstrated that heart failure (HF) 
impairs baroreflex control of the heart rate. However, 
it is unknown whether baroreflex control of vascular re-
sistance is similarly altered. Accordingly, we compared 
baroflex control of heart rate and of hindlimb vascular 
resistance in 10 control dogs (C) and 6 dogs with HF pro-
duced by rapid ventricular pacing at 260 bpm for 6-8 
weeks. Under chloralose anesthesia, the left hindlimb 
was vascularly isolated and perfused using a circuit de-
signed to delay arrival of systemic blood to the hindlimb 
for 1-2 minutes. Heart rate and hindlimb vascular resis-
tance were then measured following injections of phenyle-
phrine (2-24 ~gfkg) and nitroglycerin (1-16 ~g/kg). The 
dogs with HF exhibited decreased cardiac outputs (C: 
111±33 vs HF: 73±14 mllkg). elevated pulmonary wedge 
pressures (C: 7±2 vs HF: 22±S mm Hg) (both p<.OS). and 
depressed baroreflex control of the heart rate, as demon-
strated by a reduced slope of the blood pressure to heart 
rate relationship (C: -2.S±1.1 vs HF: -1.2±0.6 beats/mm 
Hg. p<.03). In contrast. dogs exhibited normal barore-
flex control of hindlimb resistance. as demonstrated by a 
normal slope of the blood pressure versus resistance re-
lationship (C: -24±14 vs HF: -29±13 Units/mm Hg; p-NS). 
These data suggest that heart failure does not alter 
baroreflex control of peripheral resistance despite the 
presence of altered baroreflex control of heart rate. 
Thus. changes in baroreflex heart rate control cannot be 
used as a reliable index of overall arterial baroreflex 
control in heart failure. 
ASSESSMENT OF LEFT VENTRICULAR CONTRACTILITY IN DILATED 
CARDICMYOPATHY: CO'.IPARISON OF NON-EJECTION PHASE INDICES 
Kenneth M. Borow. MD, FACC, Alex Neumann. BS, Roherto M. 
Lang, MD,FACC. Plnhas Sarell. MD. Richard Marcus, MD. Sol I. 
Ra/fer. MD, FACC. University of Chicago. Chicago, IL 
Ejection phase Indices of LV function are unable to differentiate 
changes in contractility (CO NT) from load. Isovolumlc and end-
systolic (ES) indices have been suggested as alternative measures 
of CONT. To assess these non-ejection phase indices. we studied 
16 pts with dilated cardiomyopathy (CM) using simultaneous LV 
echo and mlcrotlp pressures. Recordings were made prior to (ctr) 
and during dopamine (DA; 6 Uglkglmln). The Isovolumlc Index 
dpldt max and the ES stress (aes) - rate corrected velocity of 
shortening (Vcfc) relation were evaluated. For the latter, a ctr 
CONT line was generated using niprlde; an Increase In CONT was 
measured as "Vcfc above this line for any level of aes• Pts were 
divided according to EDP responses to DA (gpl=tor no "; gp2=~). 
There were no differences for ctr LV dimensions. stroke volume. 
shortening fraction. dpldt max' ED P, SVR. aes or HR. Thus, the 
CONT effect of DA was expected to be similar In both groups. 
GROUP 1 (n=9) GROUP 2 (n=7) GPlvsGP2 
CTR DA %DIFF CTR DA %DIFF DIFF 
23 -V -1-5- 21 --;s ~ p<.Ol 
124 122 -2 114 91 -21· p<.Ol 
814 1407 81* 932 1116 19· p<.Ol 
0.14 0.13 NS 
[*p<.Ol vs CTR) 
When EDP and aes were maintained (GP1). an excellent 
correlation existed between changes In dpldt and "Vcf c (r=0.94) 
such that both Indices were equal measures of Improved CO NT. 
However. when EDP and aes fell (GP2), the Increase In dpldt was 
blunted compared to GPl despite similar "Vcfc for both groups. 
Thus, dpldt max Is a variably reliable measure of positive 
Inotropic changes. especially when EDP andlor aes fall. The aes-
Vcfc relation. which Is preload Independent and Incorporates 
after load In Its analysis, circumvents this problem. 
JACC Vol. II, No.2 
February 1988:143A 
LACK OF CHRONOTROPIC SUPERSENSITIVITY TO ISOPROTERENOL 
POST CARDIAC TRANSPLANTATION AND SUBSENSITIVITY IN CHF. 
Rebecca J. ~Ui99, MD, John M. Stimac, MD, Michael B. 
Rocco, MO. lane F. Gauthier, RN, Mark A. Creager. MD, 
FACC, L. Howard Hartley, MD, FACC, Wilson S. Colucci, MD, 
FACC. Brigham & Women's Hospital, Harvard Medical 
School, Boston, MA 
The heart rate (HR) response to exercise is attenuated 
in patients post cardiac transplantation (TX), as is the 
in vitro adenyl ate cyclase response to isoproterenol 
(ISO) in post-TX myocardium. In contrast, animal studies 
of denervated myocardium have shown increased 
~-adrenergic receptor number and adenyl ate cyclase 
response, and the HR response to ISO infusion was 
reported to be supersensitive in TX patients. To 
reconcile these observations, we evaluated the HR 
response to a continuous ISO infusion (5,10,15,20 and 25 
ug/kg/min) in 5 normals with atropine (0.01 - 0.02 
mg/kg), 7 normals without atropine, 6 patients 1-2 yrs 
post-TX and 6 patients with NYHA III-IV CHF. Normals 
were age matched to donor hearts. HR response was 
analyzed for ISO dose which increased HR by 25 bpm 
(ISO-25; ug/kg/min), (x ± SEM; * ~ p<:0.05 vs. nls): 
Nl s Nl s + Atropi ne TX CHF 
Pre-ISO HR 58~3 92 ± 5* 86 ± 5* 87~6* 
I SO-25 15 ± 2 8 ± 2* 11 ± 1 40 ± 7* 
Atropine increased HR sensitivity to ISO, suggesting that 
vagal tone had attenuated the HR response. TX patients 
were not supersensitive compared to atropine-treated 
normals. CHF patients were markedly subsensitive. We 
conclude that: 1) cardiac TX recipients do not have 
chronotropi c supersensi tivi ty to ~ -adrenergi c stim-
ulation; 2) patients with CHF are markedly subsensitive 
to the chronotropic effect of ~ -adrenergic stimulation; 
and 3) these abnormalities may contribute to the 
attenuated HR response to exercise in TX and CHF. 
XAMillEROL IN THE MANAGEMENT OF PATIENTS WITH EXERTIONAL 
BREATHLESSNESS AND FATIGUE DUE TO CARDIAC DISEASE. 
Roger Blackwood M.D., Wexham Park Hospital, Slough, England 
and Hilary F. Marlow B.M., B.Ch. 
The efficacy of xamoterol (X) was studied in patients (pts) 
with mild to moderate heart failure (NYHA Class II - III). In 
a multi-centre, double-blind, between-patient study, 917 pts 
(median age 62 years) were randomised to X (n-617) 200 mg bd 
or placebo (P,n-3OO) for 3 months (m). Exercise capacity (Ex) 
was measured by treadmill or bicycle and expressed as kilo-
joules (kJ). Changes in breathlessness and fatigue during 
daily acti vi ties were measured by 100 mm visual analogue 
scales (VAS) •. A clinical examination was made for signs of 
heart failure (peripheral oedema, rales, added heart sounds, 
raised JVP, hepatomegaly). Pts were either untreated or on 
diuretics (45%) and/or nitrates (32%) during the study. At 
baseline 94% of pts had breathlessness, 76% fatigue, 54% 
angina and 26% peripheral oedema. Treatment groups (gp) were 
well matched. Withdrawals in the two groups were comparable. 
Data from 788 patients were analysed. Results are mean! sem. 
After 3 m the X gp improved Ex by 2.98 ! 0.68 kJ, compared 
with P (p<O.OOOl); the mean of individual percentage changes 
over baseline were 37% (X) and 18% (P). 50% of pts in the X gp 
and 31% in the P gp increased Ex by ~25% (p<O.OOOl). Maximum 
exercise heart rate was reduced 12 beats/min by X, (p<O.OOOl). 
Breathlessness and fatigue were improved as shown by changes 
in VAS of 9.8 ! 2.5 mm and 7.1 ! 2.6 mm, respectively 
(p<O.Ol). Signs of heart failure were all significantly 
reduced in the X gp. Two cardiac deaths occurred in each gp; 
the type and incidence of side effects were similar. 
It is concluded that X improves Ex, symptoms and signs in 
patients with mild to moderate heart failure. 
ABSTRACTS 143A 
IS MITRAL REGURGITATION NECESSARY FOr, 
HYDRALAZINE TO BE AN EFFECTIVE AGENT IN 
CONGESTIVE HEART FAILURE ? 
Ernest A, Haeusslein M.D, Barry Massie, M.D., F.A.C.C., Barry 
Greenberg, M.D., F.A.C.C., Diana Dutton, R.N., and Nina Topic, 
R.N., V AMC and University of California, San Francisco. 
Vasodilators are effective therapy for CHF and valvular regurgitation. 
Recently, it has been suggested that hemodynamic improvement with 
hydralazine (HYD) therapy in CHF is dependent on the presence of 
mitral regurgitation (MR). In a retrospective analysis, we compared the 
effects of HYD (50-175 mg po Q6H) in 3 groups of 10 patients each. 
All had a LVEF < 40% and clinical CHF. Group 1 had undergone 
mitral valve replacement and had no residual MR. Group 2 had CHP 
with or williout mild secondary MR. Group 3 had moderate to severe 
MR documented by left ventriCUlography associated with left 
ventricular dysfunction. Hemodynamic measurements were examined 
before and 48 hours after the initiation of HYD. The statistically 
significant changes (±S.D.) from baseline are shown in the table 
below. 
ACI ASWI ~SYR ~PCW 
Gpl ±O6±O.2* +7+47* -314+305* -13+4.5 
Gp2+l.l±O.4* +!0±69* -676+315* -24+6.3 
Gp3+17±O 8 *§ +15+11 1* -756±416 *§ -7 \+92* 
*=p<.05 vs pre-treatment.§=p<.05 GpJ vs. Gp3 by ANOVA. 
All groups showed a beneficial response to HYD, though only patients 
with significant MR exhibited a decline in PCW. Patients with no MR 
(Gp\) had a lesser increase in CI and fall in SVR than those with 
considerable MR (Gp3), while Gp2 had intermediate responses. These 
data indicate that the presence of MR is not required for a benificial 
response to HYD, but that patients with moderate or severe MR exhibit 
quantitatively greater hemodynamic improvement 
MECHANISM OF ACTION OF BUCINDOLOL IN THE FAILING HUMAN 
HEART. Ray E. Hershberger, M.D., Edward M. Gilbert, M.D, 
Jeffrey L. Anderson, M.D., Patrice Mealey, R.N., John R. 
Wynn, B.S., Ellie Soltani B.S., John B. O'Connell, M.D., 
Dale Renlund, M.D, Michael R. Bristow, M.D., Ph.D. The 
University of Utah, Salt Lake City, UT 
We have previously reported that chronic therapy with 
bucindolol (B), a non-selective B-blocking agent with 
mild B\ ISA and vasodilator properties in model systems, 
improves resting cardiac function in idiopathic dilated 
cardi omyopathy. To invest igate the mechani sm of act i on 
of B in the failing human heart we evaluated the effect 
of B in isolated RV trabeculae (RVT) and membrane 
preparat ions (MP) of 1 eft ventri cul ar myocardi um, and 
performed acute hemodynamic measurements before and four 
hours after administration of 12.5 mg of oral B in 
subjects with heart failure. In MP B/ICYP competition 
curves yielded evidence for a high affinity agonis' 
binding site (conSistent right shift by Gpp(NH)p) anti 
non-selective, high affinity (KI 2.55 nM) antagonist 
binding. B did not stimulate adenyl ate cyclase and 
produced high affinity blockade of isoproterenol 
stimulation of cyclase (KB=3.5 nM). In RVT B did not 
produce an increase in mg tension, and produced high 
affinity blockade of isoproterenol. Hemodynamic data 
were as follows:(all values±S.D., **p<O.OI, *p<.05) 
HR** PAWP CI LVSWI MAP** SVR* 
B(-)89±17.5 18±8.1 2.4±0.5 25±10.7 84±9.3 1480±411 
B(+)82±67.0 16±33.1 2.4±3.2 26±55.5 78±SI.7 \353±2236 
CONCLUSION: In the failing human heart B 1) is a high 
affinity (1-3 nM KB) nonselective B-blocking agent 2) 
does not show eVi.dence of functional ISA, despite having 
evidence of an agonist binding site on analysis of ICYP 
competition curves 3) in low doses given orally does not 
produce evidence of cardiac depression, but does show 
evidence of B blockade and vasodilation. 
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THE HEMODYNAMIC EFFECTS OF CHRONIC ORAL MILRINONE 
THERAPY: A MULTICENTER CONTROLLED TRIAL. 
James H. Chesebro, M.D., F.A.C.C., Kevin F. Browne, M.D., 
F.A.C.C., Paul E. Fenster, M.D., F.A.C.C., William T. 
Garland, M.D., F.A.C.C., Marvin A. Konstam, M.D., 
F.A.C.C. for the Milrinone Research Group. Mayo Clinic, 
Rochester, Minnesota. 
Drug tolerance and change in left ventricular (LV) 
function were evaluated in a 3-month, randomized, 
blinded, placebo-controlled trial in 155 patients 
(PTS) with NYHA Class II or III heart failure (HF) using 
digoxin (D) in 51, milrinone (M) in 53, and M plus 0 in 
51 PTS. Hemodynamic measurements (cardiac index [CI), 
L/min/m2; mean pulmonary artery wedge pressure [PAWP), mm 
Hg; stroke volume index [SVI), ml/m2; mean arterial 
pressure [MAP), mm Hg; systemic vascular resistance 
[SVR), dynes-sec/cm5) at baseline (BL) and after> 3 mo 
therapy (CHR, after 24 hrs off therapy) are summarized 
below (* - P < 0.05 for change compared with D): 
M, BL 
CHR 
0, BL 
CHR 
D+M, BL 
CHR 
N CI PAWP SVI MAP 
34 2-:6 14 33 88 
2.3* 16 29* 93* 
30 2.5 19 33 90 
2.5 17 33 88 
30 2.4 20 31 93 
2.3 20 29* 92 
SVR 
1497 
1678* 
1552 
1488 
1485 
1571 
Changes after 10 mg M po at BL and CHR, and proportions 
with death, co-intervention, or discontinuation of 
therapy were similar. The proportion with death or co-
intervention was greater in both groups for patients with 
a left ventricular ejection fraction < 20% compared with 
> 20 < 40%. There was no tolerance to M. There were no 
changes between groups in heart rate or serum sodium. 
Reasons for small changes in LV function from BL to CHR 
in the M group are unclear but are probably related to M 
withdrawal 24 hrs before recatheterization. 
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Cardiac Pacing and Implantable Antiarrhythmic Devices 
ELECTRO PHYSIOLOGIC EFFECTS IN VIVO OF 
BIPHASIC AND MONOPHASIC STIMULI 
[ Marc!!s Wharton M D , David W. Frazier, B.A., Raymond E. 
Ideker, M.D., Ph.D. Duke Univ Med Ctr, Durham, NC. 
Biphasic shocks are usually more effective for defibrillation than 
monophasic shocks of equal duration; however, little is known about 
the relative efficacy in vivo of biphasic stimuli in myocardial activa-
tion. Since the ability of a waveform to stimulate activation may be 
one of the factors determining defibrillation efficacy, in 9 dogs we 
found the pacing threshold (PT), effective refractory period (ERP) at 
twice PT, and ventricular fibrillation threshold (VFT) for a 5.5 ms 
monophasic S2 and for a biphasic S2 with initial-terminal components 
of 3.5-2.0 ms given to a bipolar source after 10 monophasic Sl's. SI 
and S2 sites were 1 em apart in the RV outflow tract. In addition, 
the defibrillation threshold (DFT) and the upper limit of S2 strength 
that can induce VF during the vulnerable period, i.e., the upper limit 
of vulnerability (ULV), were determined with the same monophasic 
and biphasic stimuli for 2 coiled-wire electrodes that covered most of 
the RV and LV epicardium. Results: 
Monophasic 
Biphasic 
P value 
PT(ma) 
0.16±0.03 
0.17±0.05 
NS 
ERP(ms) 
162±11 
168±11 
0.003 
VFT(ma) 
54±27 
61±24 
0.13 
ULV(J) DFT(J) 
2.4±1.5 1.6±0.8 
1.4±0.4 0.7±0.2 
0.04 0.004 
Surprisingly, biphasic stimuli are less effective in stimulating partially 
refractory myocardium, as indicated by the longer ERP; but they are 
not less effective in stimulating fully repolarized tissue. Despite this, 
biphasic stimuli were markedly more effective in defibrillation. This 
'is contrary to the critical mass and total depolarization hypotheses of 
defibrillation which would predict differences in waveform 
defibrillation efficacy based on differences in stimulation efficacy, at 
least for partially refractory myocardium. The parallel decreases in 
ULV and DFT with both monophasic and biphasic stimuli suggest 
similar underlying mechanisms for both, indirectly supporting the 
upper limit of vulnerability hypothesis of defibrillation. 
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DOES DEFIBRILLATION RAISE THE VENTRICULAR 
PACING THRESHOLD? 
Michael J. Reiter. M.D., Ph.D •• F.A.C.C., 
JoAnn Lindenfeld, M.D., F.A.C.C., Susan 
Breckinridge, R.N., and David E. Mann, M.D., 
F.A.C.C., university of Colorado Health 
Sciences Center, Denver, Colorado. 
We examined the effects of transthoracic 
defibrillation (Defib) on the ventricular 
pacing threshold (Thresh) in anesthetized 
dogs. Ventricular pacing was accomplished 
with a computer-controlled constant voltage 
pacemaker which permitted rapid «2 secs) 
determination of Thresh. Defib at 100, 200, 
or 400 joules was administered during 
ventricular pacing and after ventricular 
fibrillation (VF) (induced by burst 
ventriCUlar pacing) of 5, 15, 30, 45, or 60 
sec duration in 12 dogs. Defib during pacing 
or within 15 secs after initiation of VF did 
not increase Thresh, regardless of Defib 
energy. Defib after VF lasting 30 secs or 
longer increased (p ~ .05) Thresh determined 
6 secs after Defib. The increase in Thresh 
(in volts) determined 6 secs after Defib was 
a function of VF duration (30 secs - .29 ± 
.14; 45 secs - .56 ± .20; 60 secs - 2.2 ± 
1.1) but was independent of Defib energy. 
Thresh returned to control by 15 secs 
following Defib. We conclude that Thresh is 
not increased by transthoracic 
defibrillation, but is increased transiently 
when ventricular fibrillation lasts more than 
30 sec. This may have implications for 
pacing thresholds in patients with 
implantable defibrillators. 
THE IMPORTANCE OF PHASE DURATION FOR 
BIPHASIC DEFmRILLATION SHOCKS 
Sejtaro Yabe M D Anthony S. L. Tang, M.D., Raymond E Ideker, 
M.D., PhD., Duke University Medical Center, Durham, NC 
Using the defibrillation threshold (DFT), we have shown that the 
relative duration of the two phases of biphasic shocks markedly 
affects defibrillation efficacy. However, defibrillation efficacy may be 
better represented by a percent success curve than a DFT value. 
Therefore, we evaluated the importance of phasic duration by percent 
succeSs curves as well as DFTs. The following biphasic truncated 
exponential waveforms were examined in 6 anesthetized open chest 
dogs: 3.5-2 (1st phase 3.5 ms and 2nd phase 2 ms), 6-6 and 3.5-8.5. 
Large titanium patch electrodes were sutured to the RV and LV peri-
cardium. Defibrillation shocks were delivered after lOs of 60Hz 
induced fibrillation. DFTs were determined according to a modified 
Bourland protocol 5 times each for all 3 wav-eforms in random order. 
A mean of 22 shocks was given for each waveform in each dog. From 
these shocks a percent success curve was calculated by probit regres-
sion analysis and the 50% and 80% points were determined (ED50 
and ED80) as was the mean of the 5 DFTs. 
waveform 3.5-2 6-6 3.5-8.5 
mean DFT (J) 0.93±0.12 1.26±O.19 9.39±1.68 
mean DFT (V) 114.0±8.4 1l4.0±9.0 313.7±33.1 
EDSO (V) 107.4±8.5 109.8±9.6 310.9±45.0 
ED80 (V) 132.8±lS.2 123.0±8.2 382.6±SO.2 
Mean DFTs for 3.5-2 and 6-6 were lower than for3.5-8.5 (p<0.05). 
Mean DFTs for all 3 waveforms correlated well with ED50 
(Y=1.06X-16.3; r=O.98). Thus 1) biphasic shocks with the 2nd 
phase shorter than or equal to the 1st are more effective than with 
the 2nd phase longer than the 1st and, 2) whether judged by percent 
success or mean DFT, biphasic shocks of appropriate phase durations 
administered via large RV and LV electrodes can defibrillate with 
very low voltage and energy. 
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OPTIMIZED ELECTRODE CONFIGURATION FOR 
DEFIBRILLATION USING SEQUENTIAL PULSE IN PIGS 
Doug L Jones PhD, George J. Klein, MD,FACC, Max F. 
Rattes, MD, Tibor S. Szabo, MD, S. Deborah Lucy, MSc, 
University of Western Ontario, London, Canada. 
The theoretical optimum current density for defibrillation 
should be delivered using orthogonal electrodes and a 
sequential pulse system. We assessed the optimal 
configuration for defibrillation in pigs with 3 tripolar and 2 
orthogonal quadripolar configurations using sequential pulse 
defibrillation. Halothane anaesthetized open chest pigs were 
instrumented with a catheter electrode (Medtronic, 6880), 
and/or mesh (Medtronic, TX-7) electrodes, and defibrillation 
thresholds were determined. Defibrillation thresholds 
averaged 9.1±3.2 joules ( mean±SD, n=165) using th.e 
catheter with electrodes in the superior vena cava-atnal 
junction region and RV apex and a mesh electrode on the 
latero-basal LV free wall (range: 1-23). Using 3 ventricular 
epicardial electrodes on the latero-basal midleft and mid right 
free walls and ventricular apex, defibrillation threshold 
average 10.0±2.5 joules (range: 5.2-13.0) when the apical 
electrode was the common cathode (n=15) and 11.5±3.5 
joules (p<0.05, range: 7.7-19.2) when the left free wall 
electrode was the common cathode. Using the orthogonal 
orientation with a catheter electrode in the superior vena 
cava-atrial junction and 3 epicardial electrodes, defibrillation 
threshold average 9.6±1.3 joules (n=15, range: 3.0-16.0). 
Using 4 epicardial electrodes placed circumferentially 
against the base of the heart, defibrillation threshold 
averaged 4.6±2.6 joules (n=15, p<O.001, range: 1.7-8.5). We 
conclude that orthogonal orientation with 4 electrodes placed 
circumferentially parallel to the base of the heart provides the 
optimal defibrillation threshold. 
OPTIMIZING DEFIBRILLATION EFFICACY IN A NON-
THORACOTOMY ELECTRODE SYSTEM IN THE DOG 
Douglas J. Lang, Ph.D., StanleyM. Bach, M.D., 
B. Tockman, B. S ., and J. Edward Shapland, Ph. D . , 
Cardiac Pacemakers, Inc., St. Paul, MN. 
To optimize the performance of a non-thoracotomy 
electrode system, changes in percent successful 
defibrillation (% SDF) were measured as catheter 
electrode surface area and spacing were varied. 
Truncated exponential shocks were applied from a 
13.5 cm 2 subcutaneous patch anode on the left mid-chest 
to one or two 2.4 cm 2 cathode electrodes on a catheter. 
Three cathode configurations were compared: #1 = one 
electrode in the mid-RA, #2 = electrodes in the mid-RA 
and mid-RV, and #3 = electrodes in the mid-RA and RV 
apex. Defibrillation was attempted for these 
configurations at three energy levels (order 
randomized): E, =0.8·EDFT, E2=EDFT, and E.=1.2·EDFT, 
where EDFT was the defibrillation threshold energy for 
configuration #3. % SDF for E, through E3 for each 
configuration were as follows (mean ± SEM, n=6): 
Config E, E2 E3 
#1 14.0 ± 8.0 16.7 ± 8.6 37.3 ± 14.5 
#2 34.3 ± 12.9 54.0 ± 9.6 64.8 ± 11.2 
#3 53.3 ± 16.0 70.5 ± 9.2 85.0 ± 7.4 
Configurations #2 and #3 had significantly greater % SDF 
than #1 at comparable energies (two-factorial analysis of 
variance, p < 0.004). Of the two systems with 3 
electrodes, configuration #3 had greater values of % SDF 
than #2 (p < 0.055). We infer that of the three 
catheter/patch configurations tested, optimal 
defibrillation is obtained with a three electrode system 
with the anode on the left mid-chest and cathodes placed 
in the mid-RA and RV apex. 
ABSTRACTS 
NEW DEFIBRILLATION ELECTRODE CONFIGURATION: VALIDATION 
OF A MATHEMATICAL PREDICTION 
Nestor G. Sepulveda, Ph.D., John P. Wikswo, Jr., Ph.D., 
Albert K. Dawson, Ph.D., and J. Edward Shapland, Ph.D., 
Vanderbilt UniverSity, Nashville, Tennessee 
There is a clinical need for improved and simplified 
electrode configurations (EC) for implantable defibrilla-
tion systems. Single-pulse, orthogonal EC I s such as 
ECl below (0.1 Amp/line) consist of a distal (D) catheter 
(-), and a proximal (P) catheter and epicardial patch 
(EP) connected in parallel (+). Our numerical model 
shows that in ECl up to 50~ of the current is shunted 
from the myocardium by right-ventricular blood, and does 
not contribute to the defibrillation of cardiac tissue. 
New EC2, consisting of 0 and P connected together (-) 
and EP (+), assures a more uniform flow of myocardial 
current and hence a lower threshold. Defibrillation 
threshold measurements in 10 dogs confirmed our prediC-
tion: 23 ± 11 J for ECl and 16 ± 6 J for EC2 (p<O.Ol, 
paired t). We conclude that an orthogonal configuration 
wi th catheter electrodes of the same polari ty results 
in more homogeneous currents and lower thresholds. 
145A 
COMPARISON OF 3-PATCH SEQUENTIAL AND SIMULTANEOUS PULSES 
AND 2-PATCH SINGLE PULSE DEFIBRILLATION THRESHOLDS IN 
CANINES 
Michael J. Kallok, Ph.D., John G. Keimel, Carolyn K. 
AlmqUlst, Medtronic, Inc., Minneapolis, MN. 
Factors thought to influence defibrillation threshold 
(OFT) include total patch surface area (A), total capaci-
tance (e), pulse duration (D), and mode of shock 
delivery. We compared OFT in 12 pentobarbitol anesthe-
tized, open chest dogs (27.3 ± 2.0 kg, mean ± SO body 
weight) using 2 different epicardial electrode (E) con-
figurations and 3 modes of shock delivery: (1) Sequen-
tial shocks (D=3.9 ms, e=50 uf per pulse) with pulse 1 
delivered from an anterior E to a lateral E and pu2se 2 delivered from a posterior E to a lateral E (A=15 cm per 
electrode); (2) simultaneous shocks (D=7.8 ms, e=100 uf) 
delivere~ from an anterior E and posterior E to lateral E 
(A=15 cm per electrode); (3) Single shock (D=7.8 m~, 
e=100 uf) delivered from a right ve~ricular E (A=15 cm ) 
to a left ventricular E (A=30 cm). Mean ± SO OFT 
voltage{V), impedance{Z), and energy{E) are shown in the 
table below. 
CONFIG MODE n V{volts) Z{ohms) E{joules) 
1 Sequential 12 231 ± 59 57 ± 4 3.0 ± 1.6 
2 Simultaneous 5 378 ± 104 38 ± 3 8.9 ± 4.6 
3 Single 12 280 ± 68 44 ± 4 4.9 ± 2.3 
Analysis of variance revealed that configuration 1 
resulted in lower voltage and delivered energy OFT 
(p<0.005) despite higher impedance (p<O.005) than config-
urations 2 and 3. We conclude that 3 patch sequential 
pul se defibri llation results in lower OFT than 3 patch 
simultaneous and 2 patch single shocks when A, C, 0 are 
held constant for the epicardial electrode configurations 
used in this study. 
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Hypertension 
POTENTIAL CONTRIBUTION OF ANF TO RENAL AND HEltODYNAlHC 
RESPONSES FOLLOWING VOLUME EXPANSION IN CONSCIOUS DOGS. 
Robert Pichet, M.Sc., Jolanta Gutleowslea, Ph.D., Gaetan 
Thibault, Ph.D., Marc Cantin, M.D., Ph.D., and Michel 
Lavallee, Ph.D., Montreal Heart Institute, Clinical 
Research Institute of Montreal, Montreal, Canada 
The hemodynamic and renal responses to physiological 
increases in plasma atrial natriuretic factor (ANF) are 
not clearly established. Accordingly, in 6 conscious 
dogs, ANF was infused to match plasma ir-ANF levels 
attained during acute volume expansion (VE). Mean 
aortic pressure (HAP), right atrial pressure (RAP), 
renal blood flow velocity (RBFv) and heart rate (RR) 
were measured. Thirty min after VE with l8ml/leg of 3'-
dextran in saline, ir-ANF plasma levels increased 
(p<O.Ol) by 50±6 from 34±5pg/ml. Increases in HAP (16t4 
from l02±4mmHg), in RAP (l.5±O.3 from l.3±0.7 mmHg) and 
in RR (22±5 from 85±5b/min) were all significant 
(p<O.Ol). RBFv did not change from baseline (43±3 
cm/sec). Urine flow (V) increased (p<O.Ol) by 2.9l±0.35 
from 0.29±O.03ml/min and Na+ excretion (UNa+V) by 
1l.88±2.37 from 2.80±O.S8 peq/min/leg (p<O.Ol). 
Intravenous ANF (10 ng/leg/min) for 30 min increased 
(p<O.Ol) plasma ir-ANF by 54±5 from 44:1:8pg/ml similar 
to levels achieved during VE. Thirty min after the 
beginning of ANF infusion, HAP, RAP, HR and RBFv did 
not change from baseline but V increased (p<O.Ol) by 
0.33±O.07 from 0.24±O.02ml/min and UNa+v increased by 
3.52±O.63 from 3.48±O.58 peq/leg/min (p<O.Ol). 
Thus in conscious dogs, increases in plasma ir-AN~' 
could exert significant influence on renal function 
following volume expansion. In contrast, hemodynamic 
effects of ANF are trivial within the physiological 
range. 
CIRCADIAN VARIATION OF BLOOD PRESSURE AND LEFT VENTRICULAR 
HYPERTROPHY IN ESSENTIAL HYPERTENSION 
Carlo Alicandri, M.D., Enrico Boni, M.D., Raffaele Fariel-
lo, M.D., Augusto Zaninelli, M.D., Maria Lorenza Muiesan, 
M.D., Giulio Muiesan, M.D., F.A.C.C., Clinica Medica, Uni-
versity of BreSCia, Brescia, Italy. 
In order to evaluate the discussed relationship between 
blood pressure (BP) level and left ventricular hypertrophy 
(LVH) in essential hypertensive patients (EH), a continuous 
ambulatory monitoring of intra-arterial BP (Oxford portable 
device) has been performed in 22 untreated EH, 11 with-LVH 
and 11 with normal LV (NLV), matched for age and cuff BP 
level. The intra-arterial systolic BP decreased only sligh-
tly during the night in LVH and, therefore, the systolic 
circadian variation resulted lower in LVH than NLV (day-ni-
ght difference 3.7~5 vs 10.2~6 mmHg, p<.05). The intra-ar-
terial diastolic BP decreased during the night to the same 
extent in LVH and NLV and the circadian variation of dia-
stolic BP did not differ between LVH and NLV (day-night 
difference: 5.2~4 vs 4.3~5 mmHg, NS). The lower circadian 
variation of systolic BP in LVH induced a higher systolic 
BO in LVH in the night hours and particularly from the 11 
pm to 5 am (p<.05 at least), while daylight systolic and 
diastolic BP and night diastolic BP did not differ between 
LVH and NLV. A negative correlation was found between the 
day-night systolic BP difference and the echocardiographic 
determined LV mass (r=-O.74, ~<.OOl). These data might in-
dieate a possible relationship between a reduced systolic 
circadian variation of BP and left ventricular hypertrophy 
in essential hypertensive patients. 
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SUPERIOR REPRODUCIBILITY OF SERIAL LEFT VENTRICULAR MASS 
MEASUREMENTS BY TWO-DIMENSIONAL VS. M-MODE ECHOCARDIO-
GRAPHY. 
Benjamin F. Byrd. III, MD FACC, H. Wade Collins, MD, W. 
Owen Hartness, MD, Marvin W. Kronenberg, MD, FACe. 
Vanderbilt University, Nashville, TN. 
Both two-dimensional (2DE) and M-mode (MM) echocardi-
ography provide accurate estimates of LV mass, but their 
serial reproducibility has not been compared in a single 
group of patients. We prospectively performed 2DE and MM 
on 3 occasions over 5 months in each of 8 normal adults 
(mean age 29y, 3males). Observers were blinded to patient 
identity. 2DE mass was determined from freely selected 
video frames, using a computerized light pen and 
truncated ellipsoid formula. MM mass was measured from 
mean septal and posterior wall thickness by the Penn 
convention and cube formula. We tabulated LV mass and the 
serial differences in LV mass for each subject. For all 
8, the averages (±SD) were: 
LV Mass Serial Diff. % Serial Diff. 
l1S±20g 4. 8±g 4. 2±3 .0 
l27±37g lB.5±13g l4.9±lO 
The serial reproducibility of our MM mass measurements 
equalled the results of others but was inferior to the 
serial reproducibility of our 2DE mass measurements 
(p-O.Ol). Furthermore, interobserver results for 2DE mass 
correlated closely (r-O.9S, p<O.OOl, n-24). The mean 
difference between 2DE mass by two independent observers 
was only 5. 2g( 4.5%) . Because of its superior 
reproducibility, 2DE should be used rather than MM for 
maximum sensitiVity to serial changes in LV mass. 
PLASMA ATRIAL NATRIURETIC POLYPEPTIDE (ANP) AND PLASMA 
NOREPINEPHRINE (NE) DURING EXERCISE IN ESSENTIAL HYPER-
TENSION. 
Masayoshi Shimizu, M.D., Hiromichi Kitazumi, M.D., Takeo 
Kawaguchi, M.D., Kimihiro Kuramochi, M.D., 'tu.suke Yoshizawa 
M.D., Chuji Noro, M.D., Teruo Tsuyusaki, M.D., Ryuichi 
Kikawada, M.D., Keiji Nakazawa, M.D., Katsumi Ishii, M.D., 
Kitasato University, Kanagawa, Japan. 
To elucidate the hemodynamic role of ANP and NE in essen-
tial hypertension (EH), 0.5 Watt/kg and 1.0 Watt/kg loads 
of ergometer exercise were administered in 29 untreated 
patients with EH (WHO stage I - II) comparing with 13 age-
matched controls eC). Before exercise, LV mass index 
(LVMI) was calculated using M-mode echocardiogram. ANP, 
NE and systoliC blood pressure (Ps) were measured at rest 
(I), at 1.0 Watt/kg load (2), 5 min after exercise (3), 
and 15 min after exercise (4). Then the same protocol was 
repeated to determine LV ejection fraction (EF) by radio-
nuclide multigate method. ANP in EH was not different 
from that in C at (1) (44.2 pg/ml ± 14.6 SD vs 35.1 ± 12.0, 
ns). However, at (2), ANP in EH became higher than that 
in C (75.1 ± 28.8 vs 52.9 ± 20.2, p<0.02) and remained 
higher at (3) and (4) (both, p<0.05). NE in EH showed simi-
lar values with that in C at any stage. In EH, LVMI was 
correlated with ANP at all stages [(1): r= 0.38, p<0.05; 
(2): r= 0.48, p<O.Ol; (3) r= 0.55, p(O.Ol; (4) r= 0.47, p< 
0.011. A positive correlation was seen in EH between ANP 
at (2) and EF at (2) (r= 0.43, p<0.02). But there was no 
significant relation between ANP and Ps at any stage. 
On the other hand, NE at (2) was correlated with Ps at (2) 
(r= 0.45, p<0.02). Conclusions: 1) Elevation in Ps during 
exercise seems to be related with NE. 2) Secretion of ANP 
may modulate systolic cardiac function and be related with 
hypertensive LV hypertrqphy in the early stage of EH. 
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ALTERED SYMPATHETIC NERVOUS SYSTEM FUNCTION IN OBESE 
ADOLESCENTS: BASELINE OVERACTIVITY BUT DIMINISHED 
RESPONSIVENESS TO STRESS. 
M Martin M P , A. Rocchini, M.D., C. Moorehead, M.S., D. Bondie, 
B.S., V. Katch, Ed. D., C.S. Mott Hospital, University of Michigan. 
To assess sympathetic nervous system (SNS) function in obese 
adolescents (Ob adols), we measured resting blood pressure (Bp), 
heart rate (Hr), and plasma norepinephrine concentration (NE), 
and evaluated end-organ responsiveness of the SNS to stress by 
determining the change in Hr and Bp that occurred during a cold 
pressor (CP) test and the change in plasma renin activity (PRA) 
that occurred with maximal bicycle exercise in 107 obese (Ob) and 
25 non-obese (N) adols (age 10-16 years). A heparin lock was 
placed in all and blood was sampled after a one-hour equilibration 
period for NE (in 40 Ob and 15 N adols); PRA was measured prior to 
and at maximal bicycle exercise (in 67 Ob and 10 N adols). On a 
separate day a CP test (immersion of a hand in ice water for 1 min) 
was performed (in 67 Ob and 10 N adols). Bp and Hr changes were 
measured using a Critikon exercise monitor. Resting Bp, Hr and NE 
were higher in the Ob adols (systolic Bp: 125 ± 12 vs 102 ± 8 
mmHg, p<0.Q1; diastolic Bp: 76 ± 13 vs 59 ± 9 mmHg, p<0.01; Hr 
84 ± 11 vs 73 ± 5 beats/min, p<0.01; NE: 481 ± 329 vs 270 ± 
145 ng/mVhr, p<0.01). Resting PRA did not differ between the two 
groups, but the PRA response to exercise was blunted in the Ob 
group (8.5 ± 1.7 vs 14.1 ± 1.1 ng/ml/hr, p<0.01, at peak 
exercise). The Bp and Hr response to CP testing was also blunted in 
the Ob group (%.1.Systolic Bp: 9.31 ± 11 vs 21.48 ± 14%, p<0.01; 
%~diastolic Bp: 20.4 ± 16 vs 40.5 ± 23%, p<0.01; %~heart rate: 
10 ± 14.7 vs 36.5 ± 21%, p<0.01). Thus, although Ob adols have 
increased SNS activity at rest as evidenced by their elevated Hr & 
NE, with stimulation of the SNS by either exercise or CP testing the 
response of the SNS appeared blunted. These findings suggest that Ob 
adols may have diminished end-organ sensitivity to Circulating 
catecholamines. 
CARDIAC Fll'ICTIQIJ IN H'iPERIm3IQIJ :FORCE-VEIJX:ITY RElATICN3HIP CF '!HE 'J\\O 
VEl'IDUClES AND INFUJEl'US CF PREI.OI\D. 
Paolo M:lrI.=i, M.D., Paolo Sganzerla, M.D., Andreina Folli, M.D., 
Maurizio G..azzi, M.D., Inst. of Cardiology, 00, lhiversity of Milan, 
Italy. 
We tested whether qypertensive and mrnotensive hearts differ in tre 
force (F)/ velocity (V) relatiooship of tre left and right side of tre 
heart and tre influen:es m tre sane of changes in preload. Aortic and 
pulJrrnary pressures (intravascular) were taken as :indexes of F; ratios 
of strd<e velure (thenooclilutim) and left and right ventricular 
ejectim times were teed as reflecting mean velocities of fiber 
shortening; F was augnented by tre cold pressor test, ..ruch raises blood 
pressure in tre systanic and pulJrrnary circuits wi 1:inlt synpatretic 
drive to tre heart; preload was diminished by inflatirg a ballocn in 
inferior vena cava suoh as to inpede V€In.lS retllm wi 1:inlt variatim in 
aortic pressure. We investigated 8 mrnotensive (NI') and 8 UllCQrplicated 
twertensive (Hr) patients chJring diagoostic procedures. 
In NI's pressure develcped by either ventricle was inversely related to 
tre velocity of shortening; 10hen preload (filling pressure) was redJced 
tre velocities at any given load were sigpificantly diminished. 
In Hts tre F /V relatiooships were shifted qJWard and to tre right as 
carpared to NI's, indicatirg that tre velocity of shortening of either 
ventricle at any given load was iocreased. lhler V€In.lS retllm 
:inpeOOnce, tre F/V line shifted ~ and left-ward, in a positim 
correspmding to that recorded in NI's for similar redtx:tims in prel~. 
\lie suggest that in twertensim: tre parallelisn of tre two ventricles 
in tre F /V relatiooship is rraintained; an iocreased functim involves 
both sides of tre heart; preload is an essential elerneht aocng tre 
mechaniErnS of tre elevated fux::timal state. 
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DETECTION OF DIASTOLIC DYSFUNCTION IN BORDERLINE HYPER-
TENSIVES BY MEASUREMENT OF SUPINE BLOOD PRESSURE. Robert 
A. Phillips MD PhD, Howard B. Eison MD, Maria Ardeljan 
RN, Yu Buyan MD, Martin E. Goldman MD FACC, Lawrence R. 
Krakoff MD FACC. Mt Sinai Medical Center, New York, NY 
We have previously danonstrated that a mean ambulatory 
blood pressure (AMB BP) of >130/85 during 18 awake 
hours can identify borderline hypertensives at risk for 
having LV diastolic dysfunction ~VDD). In this study we 
determined if 30 minutes of supine BP ISUP BP) could 
also detect LVDD. 31 subjects (age 33+8) with untreated 
borderline hypertension had 6 SUP BP lneasuranents made 
over 30 min with the automatic Infrasonde 04000 device. 
36+14 AMB BP measuranents were made over 18 hrs with 
either the Spacelabs 5200 or the Suntech Accutracker 
devices. LVDD was determined by Doppler echo. A ratio 
of late (due to the atrial contraction) to early LV 
filling velocity (AlE ratio) >1.0 is abnormal in this 
age group and was the index of LVDD. 
Results: None of the subjects had increased LV mass by 
echo. Six patients (20%) had an A/E ratio >1.0. All 
six had a mean AMB BP systolic >130 or a mean diastolic 
>85. A SUP BP >130/85 identified 5 of 6 of the subjects 
with LVDD, but one with LVDD had a SUP BP of 127/60. 
Using 130/85 as cut-off, the sensitivity and specificity 
of SUP BP and AMB BP for detecting LVDD is: 
Sensitivity Specificity 
Supine BP 83% 68% 
Ambulatory SP 100% 48% 
Conclusion: Because of its simplici ty and convenience 
compared to ambulatory BP, 30 min of supine BP may be a 
suitable screen for LV diastolic dysfunction in border-
line hypertensives. 
ANP DIRECTLY DILATES FOREARM ARTERIOLES IN MAN 
ROBERTO PEDRINELLI,GIACOMO BRUSCHI*,GIOVANNI PANA 
RACE,MARZIA SPESSOT,LINDA GRAZIADEI,MASSlMO ORLAN7 
DINI*, ALBERICO BORGHETTI*, ANTONIO SALVETTI. Hyper-
tension Unit,I Clinica Medica,University of Pisa, 
56100,PISA,ITALY 
Whether direct vasorelaxation makes part of the 
effect of ANP in man is disputed.We have infused 
into the brachial artery Hemagel diluted 1-28hANP 
at four approximately log increasing,cumulative 
rates(I:.0008;II:.008;III:.08;IV:.8ng/100ml ti~ 
sue/minx15min each,preceded by a 15min vehicl& 
V- infusion)calculated to increase forearm ANP 
levels from the high physiolological- pathophysio 
logical range up to pharmacological concentra 
tions.N=6 male borderline hypertensive subjects 
were studied. Forearm blood flow (FBF ,ml/100ml/min) 
was measured by strain gauge venous plethysmogra 
phy; intraarterial mean arterial pressure (MAP) 
and heart rate(HR) were continously monitored 
throughout the study. 
Even at the lowest infusion rate, ANP increased 
FBF(from 4.2;1:.3 to 15.3:!:2.5,p<.001vs V),with fUl: 
ther increments during the II and III infusion 
level(to 20.1tl.6 and 29.5~3.4 respectively;p 
.001 vs ei ther V and I )whi th an apparent plateau 
of effect at the IV one(from 29.5t3.4 to 33.3:1:1.6, 
NS) _ MAP and HR did not change during the study_ 
Thus ANP evidently relaxes arteriolar tone in 
man through a direct action and even at concentra 
tions supposedly close to those reached during 
physiological and/or pathological conditions. The 
data imply a potential for ANP as a human endoge 
nous vascular modulator. 
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EFFECTS OF ACUTE AND CHRONIC BETA-ADRENOCEPTOR BLOCKADE ON 
BAROREFLEX SENSITIVITY. 
John Floras, MO,FACC, John Jones, MD, Osman Hassan, MD, 
Peter Sleight, MD,FACC. Dept. of Medicine, University of 
Toronto, Toronto, Ontario a 
To determine whether beta-blockade (b-b) lowers blood 
pressure by potentiating arterial baroreflex sensitivity 
(BRS) ,we studied the effects of acute I.V. and chronic (5 
months) oral b-b on the BRS of 51 subjects (mean age 46) 
with hypertension. Subjects were randomly assigned atenolol, 
metoprolol, pindolol, or propranolol. An increase in BRS 
(phenylephrine technique) ,unrelated to the bradycardia 
with treatment,was seen after acute (9.0±1.5toll.l±l.B 
msec/mmHg;n=4l;p<O.02) and chronic (6.5±O.B to 9.4±1.5msec/ 
mmHg;n=35;p(O.Ol)b-b. Decreases in blood pressure withtreat-
ment were unrelated to increases in BRS indicating that the 
hypotensive action of these drugs is not dependent upon 
augmented baroreflex control of heart rate. Increases in 
BRS correlated with the known lipophilicity and CNS pene-
tration of the 4 drugs and may have been due to selective 
beta-2 rather than beta-l blockade, since propranolol, the 
most lipophilic, increased BRS acutely and chronically, 
whereas atenolol, the least lipophilic,did not. Metoprolol 
and pindolol, with intermediate lipophilicity, did not 
alter BRS individually, but when considered as a "lipo-
philic group" with propranolol, they increased BRS after 
chronic treatment. Although the predominant effect of b-b 
on BRS seems to be mediated centrally, increases in BRS 
with acute and chronic b-b were confined to younger «46 
years) and less hypertensive subjects, suggesting that 
peripheral mechanisms may also contribute to this response. 
Thus, in some hypertensive patients, derangements in the 
autonomic regulation of heart rate can be reversed by b-b. 
This suggests one mechanism by which beta-blockers may im-
prove survival in heart failure or after myocardial 
infarction. 
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FACTORS INFLUENCING OUTCOME WITH CORONARY ANGIOPLASTY: 
1985 - 1986 NHLBI PTCA REGISTRY 
H.J. Cowley, H.D., FACC, S.F. Kelsey, Ph.D, R. Holubkov, 
H.S., K.H. Kent, H.D.,FACC, D.P. Faxon, H.D., FACC, K.H. 
Detre, H.D., DrPH, and· PartiCipating Investigators, 
Hedical College of Virginia, Richmond, Va. 
Data collected on 1857 patients (pts) enrolled in the 
1985-1986 NHLBI PTCA Registry from 14 centers were 
analyzed to assess for factors associated with the outcome 
variables of clinical success, mortality, and acute vessel 
reclosure following PTCA. The study group includes pts 
with first PTCA without recent HI. Clinical success was 
defined as ~OJ angiographic improvement of all attempted 
lesions and no HI, death or CABG during hospitalization. 
Multivariate logistiC regression models were employed with 
stepwise backward elimination of variables identified as 
significant by univariate analysis. Overall clinical 
success rate was 78J; factors associated with lower 
clinical success rate included total occlusion attempt 
(59J vs 82%, p<.001), presence of lesion calcification 
(66J vs 80J, p<.001), and multivessel disease (73J vs 84J, 
p<.001). Overall hospital mortality was 1.1J (20/1857 
pts); predictors of higher mortality rate were: history of 
congestive heart failure (8.6% vs 0.6J, p<.001), age l65 
years (3.3J vs 0.2J, p<.01), left main disease (8.1J, 
p<.01), and 3 vessel disease (2.9J, p<.01) [vs 0.2J for 1 
vessel disease, and 0.7J for 2 vessel disease], and 
history of diabetes (4.3J vs 0.6%, p<.05). In-hospital 
reclosure rate was 7.5J; the only baseline factor 
associated with early vessel closure in both patient-
related and lesion-related models was the presence of 
thrombus in the lesion (14J vs 7J, p<.001). Thus, 1) 
total occlUSion, calcification and multivessel CAD 
adversely influence success, 2) CHF, age l65 yrs and 
extensive CAD are predictors of mortality, and 3) lesion 
thrombus is associated with early vessel closure. 
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SALVAGE OF HIBERNATING MYOCARDIUM AFTER 
TRANSLUMINAL CORONARY ANGIOPLASTY. 
Marc Cohen, MD, FACC, Richard Charney, MD, Peter Rentrop, 
MD, FAce. Mount Sinai Hospital, New York, NY. 
In pts with severe coronary artery disease and significant LV 
systolic dysfunction, coronary artery bypass surgery may 
improve some of the resting wall motion abnormalities. This 
study describes a small series of pts who were evaluated to 
determine whether revascularization using coronary angioplasty 
(TCA) could also salvage chronically ischemic myocardium. 
After an index case of a patient who sustained dramatic 
improvement in a large resting wall motion abnormality after 
TCA, we prospectively identified pts, referred for elective TCA, 
who had potentially reversible chronic ischemia using the 
following criteria: Severe resting LV wall motion abnormalities 
in an area subtended by a severly narrowed coronary artery, and 
at least one of the following: I) Persistent angina pectoris. 2) 
Post-PVC potentiation of motion in the 2Bfynergic zone on 
baseline pre-TCA LV-gram. 3) Thallium uptake in the 
asynergic zone. Over a three year period, I I pts were identified 
as having potentially reversible chronic ischemia. Eight of the 
II, had technically adequote pre and immediate post TCA LV-
grams. Regional wall motion was analyzed using a radial axis 
model, and global ejection fraction was calculated. The age was 
62+7 yrs and duration of symptoms 1.5+0.5 months. 
Results: Comparison of the pre and post TCA LV-grams 
revealed: The heart rate-systolic pressure product during 
injection did not change. Global LV ejection fraction increased 
from 40:.17 to 53:.19% (p<V.01). The % of the LV perimeter 
showing asynergy decreased from 35:.11 to 11:.13% (p<V.01). One 
pt experienced no improvement in LV function. Follow-up 
ranging from 6-24 months revealed: Sudden death n= I (the pt 
with no improvement), repeat PTCA n=2, asymptomatic n=5. 
Conclusions: Application of easily obtainable clinical data 
identifies a subset of pts with hibernating myocardium. TCA is 
useful in salvaging hibernating myocardium. 
MEI'AB)LIC PRElOADnG REWCES IscmMIA r:uRIN:; PROLCNGED 
ANGIOPlASTY OCCIDSlOOS 
Mitchell w. Knlcoff. M.D., Antonio R. Parente, M.D., 
RarxiolIil H. Renzi, M.D., Randy K. Bottner, M.D., SUsan 
W. Ahmed, RlD, Richard A. Shugoll, M.D., Karen s. stark, 
M.D., Yvette R. Jackson, R.N., O1arles E. Rackley, M.D., 
F.A.C.C., Kenneth M. Kent, M.D., RlD, F.A.C.C., 
Georgetc7.m University, washiIxJton D.C. 
Prolc:n;JE!d balloon inflation durin;J iID3'ioplasty (TCA) may 
reduce rest.enosis rate. Balloon inflation tiIre is lllnited 
by isdlemia. Metabolic preloadin:] praoot:es myocyte 
tolerance of anaerobic corrlitions. In a prospective, 
rarxianized, blin:ied trial, =ncentrated gluoose-insulin-
potassi\DII solution (GIK) or placebo (0.45NS) was infused 
at 1.5 cx::/kg/hr in consecutive patients with no 
collaterals prior to elective TCA. Target inflation 
duration (I:IlR) was 2 minutes. Continuoos sr segment 
recor<:iin3s were performed on precalibrated 3-channel 
Holter (Scx:Jle Alta II). CCtIplter assisted (Marquette 
8000) digital quantitative analysis was performed at J+60 
IllS with mean sr level of normal beats given every 15 
seoorx:Is. A total of 36 rarxianized patients had data from 
successful TCA (18 GIK; 18 placebo). Mean GIK infusion 
time was 139 min. Rate of ischemia onset was taken as 
tiIre to lnm sr deviation (1 MM TIME). Results were: 
INFlATION 2 INFlATION 3 INFIATION 4 
GIlt .4SNS GIlt .4SNS GIlt .4SNS 
~ OUR(sec) 74 83 88 85 102 95 
2MININF!lpts) 22 44 84 
lMM TIME(sec) 63 35* 58 37* 72 40* 
*.. p VALVE P =.01 P = .01 P = .004 
'lhus: 1) prolon:Jed inflation can be achieved in JOOSt 
patients, however, 2) metabolic preload:iIg with GIK prior 
to TCA resulted in a delay in the onset of ischemia as 
quantitated by high :resolution sr segment analysis. 
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CARDIAC METABOLISM DURING CORONARY ANGIOPLASTY WITH 
FLUOSOL PROTECTION: DISCORDANCE BETWEEN LV SYSTOLIC 
FUNCTION AND LACTATE METABOLISM 
Lawrence H Young, M.D., F.A.C.C., Leigh K Bowman, M.D., 
James H Revkin, M.D., C Carl Jaffe, M.D., Eugene J 
Barrett, M.D., Henry S Cabin, M.D., F.A.C.C., Michael 
Cleman, M.D., F.A.C.C., Yale University, New Haven, CT 
We have shown protection of systolic LV function in 
man during coronary angioplasty by intracoronary 
infusion of oxygenated fluosol (FLU). The aim of the 
current study was to determine whether intracoronary 
fluosol prevented the onset of anaerobic metabolism 
(myocardial lactate production) during angioplasty of 
the left anterior descending artery. In 8 patients, we 
measured LV ejection fraction by 2-dimensional echo 
during 60 sec balloon inflations and arterial and great 
cardiac vein (GCV) lactate (LAC) during subsequent 
reperfusion. There was net LAC uptake (0.20+0.06mM, 
extraction ratio 30+8%, p < .02) prior to angioplasty. 
During reperfusion,-GCV LAC concentration increased by 
0.90+0.lDmM (p < .001) after control inflations and by 
0.75+0.l5mM (p < .001) after FLU was given during 
balloon inflation. This resulted in net myocardial 
production of LAC (GCV - arterial LAC concentration) 
after both control (0. 59+0.08mM, p < .001) and FLU 
(0.52+0.l5mM, p < .01) inflations. In contrast, LV 
ejection fraction fell during control (61+2 to 44+7%, 
p < .02), but not during FLU (61+2 to 57+1%',p=NS) -
inflations. --
We conclude: 1) despite preservation of systolic LV 
function, intracoronary FLU infusion does not prevent 
the onset of lactate production during coronary 
angioplasty in man 2) this discordance indicates that 
contractile performance may be maintained in the face 
of short term regional myocardial hypoxia sufficient to 
induce anaerobic metabolism in man. 
THE AUTOPERFUSION BALLOON ANGIOPLASTY CATHETER LIMITS 
MYOCARDIAL NECROSIS DURING 90 MINUTES OF BALLOON 
INFLATION. Colin A. Campbell, Ph.D., Shereif 
Rezkalla, M.D., Robert A. Kloner, M.D., Ph.D., F.A.C.C., 
Zoltan G. Turi, M.D., F.A.C.C., Wayne State University 
School of Medicine and Harper Hospital, Detroit, MI. 
The aim of this study was to investigate whether blood 
flow through the autoperfusion balloon angioplasty 
catheter is sufficient to reduce or prevent myocardial 
necrosis during prolonged balloon inflation. Anesthe· 
tized thoracotomized dogs were subjected to circumflex 
angioplasty with either a standard or autoperfusion 
catheter chosen in a randomized fashion. The balloon 
was inflated for 90 minutes followed by deflation and 
4.5 hours reperfusion. Regional myocardial blood flow 
(RMBF) was measured using radioactive microspheres. 
After 6 hours the circumflex artery was occluded at the 
site of balloon inflation, the in vivo area at risk (AR) 
was determined by intra.atrial--injection of monastral 
blue dye and the area of necrosis (AN) was determined by 
tetrazolium staining. The AR was 31.7+3.6% of the left 
ventricle in dogs with the standard c~theter (n-4) and 
26.2±3.9% of the left ventricle in dogs with the auto· 
perfusion catheter (n-5; p-NS). Mean AN/AR was 40.4± 
19.3% (range 9.5% to 91.4%) in dogs with the standard 
catheter and 1.2+1.2% (range 0% to 5.9%) in dogs with 
the autoperfusion catheter (p<0.05, Wilcoxon 2 sample 
test). The RMBF during balloon inflation in the poste· 
rior endocardium was 0.03±O.02 ml/min/g in dogs with the 
standard catheter and O.90±O.24 ml/min/g in dogs with 
the autoperfusion catheter (P<O.Ol). Thus, sufficient 
blood flows through the autoperfusion catheter during 
balloon inflation to allow for prolonged inflation times 
with minimal or no development of myocardial necrosis. 
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EMERGENCY RESUSCITATION WITH EXTRA CORPOREAL 
MEMBRANE OXYGENATION FOR FAILED ANGIOPLASTY. 
Kirk R. Kanter MD, D. Glenn Pennington MD, FACC, Michel 
Vandormael MD, FACC, Morton J. Kern, MD, FACC, Lawrence 
R. McBride MD, Keith S. Naunheim MD, Paul Braun CCP, Jay 
Taub CCP, Vallee L. Willman MD, FACC, St. Louis Univ., St. 
Louis, MO 
Cardiac arrest or cardiogenic shock refractory to standard 
resuscitative measures are uncommon complications of 
percutaneous transluminal coronary angioplasty (PTCA). Since 
July 1986, 6 pts aged 40-75 (mean 51 yrs) suffered cardiac arrest 
(5 pts) or cardiogenic shock (l pt) during PTCA for acute 
myocardial infarction (5 pts) or unstable angina (l pt). All pts 
were unresponsive to conventional resuscitation including an 
intraaortic balloon in 5. Emergency femoral/femoral 
arteriovenous extracorporeal membrane oxygenation (ECMO) was 
instituted in the catheterization lab via femoral cutdown. 
Hemodynamic stability was achieved in all pts with flows ranging 
from 3.3-4.5 L/min (mean 3.9). Three pts either refused or were 
not suitable candidates for coronary bypass grafting. One of 
these had a ventricular assist device (VAD) inserted after 24 hrs 
of ECMO support. The V AD was removed one week later, but the 
patient died of arrhythmias 3 months post ECMO. The other 2 pts 
were weaned from ECMO with inotropic support after 40 and 92 
hrs of perfusion, but died 4 hrs and 6 days later of cardiac 
failure. The remaining 3 pts underwent emergency coronary 
artery bypass grafting within two hours of institution of ECMO. 
One died postoperatively of heart failure complicated by 
respiratory and renal insufficiency. The other two survived and 
are NYHA functional Class I, 5 and 8 months postoperatively. 
This experience indicates that emergency ECMO perfusion 
provides an excellent technique for rapid and mobile resuscitation 
for refractory cardiac arrest during PTCA, allowing for further 
evaluation and treatment with long term survival in selected 
patients. 
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SERIAL CHANGES IN LEFT VENTRICULAR MASS OF THE DONOR'S 
HEART EARLY AFTER TRANSPLANTATION. 
William A. Zoghbi, M.D., F.A.C.C., Carlos A. Leon, M.D., 
James B. Young, M.D., F.A.C.C., Miguel A. Quinones, 
M.D., F.A.C.C., Baylor College of Medicine, Houston, 
Texas. 
Increased LV mass has been reported in long time 
survivors of cardiac transplantation (>3 months) and 
related to rejection. Early changes in LV mass and 
thickness in the transplanted heart, especially as 
compared to baseline (prior to transplantation) have 
not been characterized. Accordingly, two-dimensional 
and M-mode echocardiograms were performed on 11 donor 
pts (ages 19 to 45 yrs, 9 males) just prior to exp1an-
tation, and serially in the recipients (age 17-68 yrs, 
8 males) at weekly intervals for 4 weeks. LV mass and 
thickness (average septal and posterior wall) were 
derived by M-mode, LV volume and ejection fraction by 
2-D echocardiograms. In the first week (3 ± 2 days), a 
significant increase in LV mass (186±62 to 202±67 gm) 
and in t~ickness (10±1 to 11±1 mm) occured compared to 
baseline (both p<.05). This increase did not relate to 
changes in LV volume, BP, systemic vascular resistance 
or degree of rejection. However, a significant relation 
was observed between ischemic time (range 50 to 252 min) 
and the early change in LV mass and thickness (r = .86 
and .84 p<.003, respectively). A further increase in 
LV mass and thickness occurred at 2 weeks (LV mass = 
217 ± 4 gm, thi ckness 12 ± 1 mm) and stabi 1 i zed at 
weeks 3 and 4. This later change in LV mass related 
only to the degree of rejection by myocardial biopsy 
(r = .43, P = .02). Thus, early (1st week) increases 
in LV mass and thickness after transplantation relate 
predominantly to ischemic time while later increases 
are associated with the degree of rejection. 
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ARTERIAL HYPERTENSION AFTER CARDIAC TRANSPLANT WITH TRIPLE-
DRUG IMMUNOSUPPRESSION THERAPY. 
Maria-Teresa Olivari, M.D., Ann Antolick, R.N., W. Steves 
Ring, M.D., F.A.C.C., University of Minnesota, Minneapolis, 
Minnesota. 
Arterial hypertension (HTN) occurs in 90% of cardiac trans-
plant (TX) recipients treated with high doses of cyclospor-
ine A (CSA). The incidence of HTN with lower loading and 
maintenance dose of CSA as used with triple-drug immunosup-
pression is unknown. 56 adults (age 21-64 years) with nor-
mal renal function prior to TX were transplanted in 1984-86 
and received low loading (6-10 mg/kg) and maintenance doses 
of CSA (trough level by HLPC 150-200 ng/ml during first 6 
months (M), 100 ng/ml thereafter) with azathioprine (2 mg/ 
kg/day) and prednisone. Only 4 patients had past history 
of HTN. By 2 weeks 38 of 56 patients were hypertensive 
(diastolic BP> 95 mmHg) and required treatment. 78% of 
patients developed HTN by 1 M, 84% by 2 M, 86% by 3 M. At 
4 M 90% were hypertensive despite normal renal function 
~reatinine - 1.4 + 0.2). No additional patient became hy-
pertensive after 4 M. Only 5 patients never developed HTN. 
Control of HTN required combination of diuretic, vasodila-
tor and a-blocker therapy in 25 patients with addition of 
converting enzyme inhibitor in 5 patients. No correlation 
was found between BP, renal function, CSA levels and plas-
ma norepinephrine (PNE). In 13 patients PNE measured se-
quentially for 3 M after T normalized within 2 W from 590 
+ 208 pg/ml to 321 + 208, p < .05 and remained stable at 1 
M (308 + 239), 2 M (307 + 196) and 3 M (331 + 131). These 
data indicate 1) HTN develops within 4 M after TX in al-
most all patients despite lower dose CSA used with triple-
drug immunosuppression and the absence of significant re-
nal impairment with this regimen, 2) post-TX HTN is not 
due to activation of sympathetic nervous system, 3) con-
trol of HTN requires multidrug therapy. 
PSYCHOSOCIAL FUNCTIONI~ AFTER HEART TRANSPLANl'ATION 
Thanas Kottke, M.D., F.A.C.C. and Therese J. Haney, 
B.S.O.T.R., Univ of MN Hospital and Clinic, Minneapolis. 
To determine levels of psychosocial function after heart 
transplant, we surveyed the 51 surviving heart transplant 
patients in 1986. Forty-four heart transplant recipients 
(39 male, 5 female) completed the forty-five minute 
survey regarding their pre- and post-surgery activity 
levels. Subjects were 2 months to 2 years post surgery. 
Despite physiCian promotion of smoking cessation, eleven 
percent continued to smoke following surgery. 
seventy-three percent of the patients who were working in 
the year prior to transplant had returned to work. OVer 
eighty percent had resumed homemaking tasks such as light 
cleaning and grocery shopping, while sixty-three percent 
were back to heavy home chores (cleaning garage, 
scrubbing floors), Most patients (70%) felt their 
illness did not Significantly interfere with their work 
and duties at home. seventy-three percent of the 
respondents were sexually active and fifty-nine percent 
reported normal or near normal pleasure or satisfaction 
from their post surgery sexual experiences. Home 
conditioning exercise programs were followed by 
Sixty-three percent of the subjects. Eighty-five percent 
of the subjects reported the same or slightly less 
interest in pre-surgery leisure time activities and 
hobbies and continued to participate in them. While only 
2 patients were playing football, basketball and soccer, 
eighteen to twenty-seven percent were playing softball, 
swiIllning, bowling, bicycling, and/or dancing. on the 
State Trait Anxiety Inventory subjects scored lower for 
anxiety than either neuropsych or general medical 
patients. we conclude that the majority of transplant 
recipients can return to previous levels of physical and 
sexual activity without experiencing significant anxiety. 
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CINEVlDEODENSITOMETRIC QUANTIFICATION OF CORONARY ARTERY 
DISEASE FOLLOWING CARDIAC TRANSPLANTATION 
Allen B. Nichols, MD, FACC, Eric Rose, MD, FACC, Craig R. 
Smith, MD, FACC, Rachel J. Smith, BA, Ronald Drusin, MD, 
FACC, Dennis S. Reison, MD, FACC, Eric R. Powers, MD, 
FACC, Columbia University, New York, NY 
The incidence of coronary artery disease (CAD) 
following cardiac transplantation (tx) has been reported 
to be as high as 40% at 2.5 years. In 54 patients (pts) 
undergoing cardiac tx, the incidence and rate of progres-
sion of coronary disease was assessed by annual, serial 
coronary arteriograms with a mean follow-up of 2 years. 
Extent of disease was quantified by computer-assisted 
cinevideodensitometry. All pts received cyclosporine with 
low dose prednisone. Six pts (11%) were found to have 
abnormal arteriograms with diffuse and/or focal lesions; 5 
pts developed CAD within the first year after tx, and I pt 
developed CAD within the second year after tx. In all 17 
pts followed for 3 or more years, no CAD was observed. The 
incidence of post-tx CAD was not significantly increased 
for pts with pre-tx ischemic cardiomyopathy (3/19; 16%) 
compared to pts with pre-tx idiopathic congestive cardio-
myopathy (3/35; 9%). Mean scores for the 7 recognized 
coronary risk factors (age, sex, cholesterol, smoking, 
hypertension, diabetes, and left ventricular hypertrophy) 
were not significantly higher in the pts developing 
post-tx CAD (4.13 vs. 3.70). Serial quantitative cinevid-
eodensitometry showed that pts with visually normal 
coronary arteriograms did not have progressive, diffuse 
narrowing of coronary caliber. Thus, (I) the incidence of 
CAD follOWing tx appears to be less than previously 
reported, possibly reflecting lower steroid doses since 
the advent of cyclosporine, and (2) CAD in this pt series 
appears to develop within the first 2 years following tx. 
INFLUENCE OF CYCLOSPORIN A ON MORTALITY AFTER ORTHOTOPIC 
HEART TRANSPLANTATION. KA Ellenbogen, MD, LB Mohanty, MD, 
MR Katz, MD, S Szentpetery, MD, PK Mohanty, MD, FACC. 
McGuire VAMC and Med. Coll. of VA, Richmond, VA. 
Cyclosporin A (Cy A) has improved survival of pa-
tients (pts) considerably following orthotopic heart 
transplantation (OHT). However, the relative contribu-
tion of acute rejection (AR), chronic rejection (CR), 
infection (I), and graft failure (GF) to mortality in 
Cy A treated pts is unclear. We evaluated autopsy data, 
serial endomyocardial biopsies and clinical records of 
each of 45 deaths out of 150 consecutive pts undergoing 
OHT during 1980-87. In the pre Cy A period (12/80-2/83), 
13 of 17 pts (70%) died whereas 32 of 133 pts (24%) died 
in Cy A period (3/83-present), (p<.05). In the Cy A 
period, 80 pts received prednisone, immuran, and Cy A; 
20 immuran and Cy A; and 33 prednisone and Cy A. Detailed 
results are summarized in table: 
Cause of Death 
AR CR I GF 
Pre Cy A: 7 4** 2" 1 
Post Cy A: 12 3 13*** 4 
Other 
1 
3 
** = 2 patients with evidence of both AR and CR 
***= 2 patients with I following treatment for AR 
Despite improved overall survival in the Cy A treated 
group, AR remains an important mechanism of early death 
(within 6 months) after OHT. The incidence of I is 
higher in the Cy A treated group and is likely related to 
the use of combination immunosuppression. These results 
point to the need for new approaches to the management of 
AR to decrease the incidence of opportunistic infection. 
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REGRESSION OF VENTRICULAR HYPERTROPHY IN CARDIAC TRANS-
PLANT RECIPIENTS UNDER EFFECTIVE ANTIHYPERTENSIVE THERAPY 
Christiane E. Angermann MD. Christoph H. Spes, Rudolf J. 
Hart MS. Bernhard M. Kemkes MD. Karl Theisen MD 
Medizinische Klinik Innenstadt. University of Munich FRG 
Sustained systemic hypertension after cardiac transplan-
tation remains a major problem in patients on cyclosporin 
A and steroids. In this study 10 hypertensive cardiac 
transp 1 ant reci pi ents (9m. 1 L 40,::11 years. 4-41 months 
pop.) with mild to moderate LV hypertrophy were evaluated 
prospectively. in order to assess the effects of antihy-
pertensive treatment on blood pressure maximllm exercise 
capacity and LV mass in these patients. Automated 24 h 
blood pressure monitoring. treadmill testing and echocar-
diography were performed before and during treatment (Tl 
with enalapril (20 mg'd) and furosemide (40 mg/d) alone or 
in combination with verapami1 (120-360mg'd) at regular 
intervals. Follow up at 5.7+1.2 months showed normal sy-
stolic (SBP) and diastolic blood pressure (DBP) throughout 
24 hours in all patients. Maximum exercise capacity was 
unchanged (109+25 W before T versus 119,:: 37 W). LV mass 
(LVM) calculated from 20 echocardiograms with a cylinder-
hemie11ipsoid formula and septal+posterior wall thickness 
(S+PW) had decreased significantly. while heart rate (93,::7 
versus 98+11 beats per min). ejection fraction (64,::2 ver-
sus 61+5%T. SV and CO had remained unchanged. 
- SBP(mmHg)DBP(mmHg) LVM(g) S+PW(mm) SV(m1) CO(l) 
before T 151+7 102+8 204+31 25+4 54+10 5.0+0.8 
T 123+9 79+13 167+18 21+2 50+9 4.9+1.1 
p < 0.001 0.001 0.001 0.01 n.s. n.s. 
Conclusion: Treatment with ena1april and furosemide alone 
or in combination with verapamil is effective in hYD~r­
tension after cardiac transplantation. Maximum exerClse 
capacity. heart rate and LV pump function are nct altered 
by this antihypertensive regimen. Regressi0n of LV hyper-
trophy may be induced also in the transplanted heart. 
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CAN CORONARY DISEASE LOCATION BE DETERMINED BY LOCATION 
AND RADIATION OF CHEST PAIN? 
Edgar Lichstein, M.D., F.A.C.C., Sheldon Breitbart, 
M.D., Jacob Shani, M.D., F.A.C.C., Alvin Greengart, 
M.D., F.A.C.C., Gerald Hollander, M.D. F.A.C.C., 
Maimonides Medical Center, SUNY, Health Science Center 
at Brooklyn, Brooklyn, New York. 
The purpose of this study is to determine whether 
characteristics of chest pain produced by balloon 
occlusion of a coronary artery are helpful in predicting 
the location of the diseased coronary artery. One 
hundred nineteen patients who had pain with balloon 
occlusion were studied; 68 had single vessel disease. 
At the time of dilatation, patients described the 
location and radiation of pain. The locations of chest 
pain included substernal and left precordium, right 
precordium and epigastric. The possible sites of pain 
radiation were limited to neck/jaw, left arm, right arm 
and interscapular. Thirty-four patients had substernal 
pain radiating to the left arm; 25/34 had left anterior 
descending disease; 8/34 had left circumflex disease and 
1/34 had right coronary disease. Sixteen patients had 
epigastric pain with radiation to the neck. None of 
these patients had left anterior descending or left 
circumflex disease. All 16 had right coronary disease. 
Eight patients had epigastric pain with no radiation. 
None of these patients had left anterior descending or 
right coronary disease. All 8 patients had left 
circumflex disease. 
We conclude that location and radiation of chest pain 
are helpful in predicting the location of a diseased 
coronary artery. 
ABSTRACTS ISlA 
THE SYNDROME OF FLASH PULMONARY EDEMA: CLINICAL DEFINITION 
AND ANGIOGRAPHIC FINDINGS. Forrester A. Lee, MD, Henry S. 
Cabin, MD, FACC, Charles K. Francis, MD, FACC. Yale 
University, New Haven, CT. 
"Flash" pulmonary edema is an incompletely characterized 
syndrome which implies sudden, often recurrent episodes of 
life-threatening pulmonary edema (FE). To establish a 
clinical definition of flash PE and determine its anatomIc 
substrate, we reviewed 2069 patients (pts) who were 
catheterized during a 20 month period. In this group, 78 
pts were hospitalized for treatment of PE in the absence 
of Q-wave infarction. We defined two PE subgroups: 
(1) Flash PE (FPE, n=5l) - abrupt onset of PE on a 
baseline of stable cardiac function (2) Acute PE (APE, 
n=27) - gradual cardiac decompensation over> 12 hours 
culminating in PE. Mean age was the same in each group 
(69 years). Angiographic diagnoses included coronary 
artery disease (CAD) 64 pts, valvular heart disease (VHD) 
23 pts, and non-ischemic cardiomyopathy (CM) 7 pts. 
Frequency of preserved ventricular function (ejection 
fraction> 40%) was similar, 55% and 67% of FPE and APE pts 
respectively. A history of hypertension (HTN) was more 
common among FPE than APE pts (76% vs 36%, p<.05). 
The striking angiographic feature distinguishing FPE 
from APE pts was the presence of CAD. Among FPE pts, 47/51 
had CAD compared to 13/27 pts with APE (p<.OOl). Left main 
CAD was present in nearly one-third (16/51) of FPE pts. 
Among FPE with preserved LV function, 23/27 pts had left 
main or severe 3 vessel CAD. FPE pts with CAD commonly had 
a history of HTN (39/47). Of pts with VHD who presented 
with FPE, 16/18 had co-existing CAD. 
We conclude that the flash pulmonary edema syndrome 
occurs primarily in elderly pts with severe CAD, likely 
reflects reversible ischemic ventricular dysfunction, and 
may be related to underlying hypertensive heart disease. 
PREDICTION OF CROSS SECTIONAL AREA OF A CORONARY 
STENOSIS FROM THE CONTINUITY EQUATION USING A PULSED· 
WAVE DOPPLER CATHETER. Eric L Johnson M P , Paul G. Yock, M.D., 
FAC.C., Victor K. Hargrave, B.S., James P. Srebro, M.D., Sergio M. 
Manubens, M.D., Walter Seitz, Ph.D., Thomas A. Ports, M.D., FAC.C. 
University of California, San Francisco, California. 
In a canine model of moderate coronary stenosis, we examined the 
applicability of the continuity equation to predict absolute stenosis cross 
sectional area (CSA) using an end·mounted Doppler coronary catheter. 
Stenosis implants with CSAs of 1.23 mm2 to 2.40 mm2 were fabricated 
from urethane and precision molded wnh circular orifices of known internal 
diameter. Implants were passed over a guidewire into the circumflex and/or 
LAD coronary aneries using contrast angiography in six closed-chest dogs. 
A 3F 20 MHz pulsed-Doppler catheter wnh end·mounted transducer was 
advanced into the stenotic coronary artery. Signals from the nonnal vessel 
immediatedly proximal and from wnhin the stenosis were obtained and 
analyzed by complex spectral analYSis using custom·designed fast·Fourier 
transform instrumentation and by a standard commercially available zero· 
crossing detector. Maximal(Vmax) and mean(Vmean) velocities were 
recorded by both spectral analysis and zero·crossing detector. CSA of the 
stenosis was calculated from the coronary blood flow velocities in the 
normal and stenotic region and the CSA of the normal vessel (from the 
known external diameter of the implant) using the continuity equation. A 
clear increase in velocijy was detected as the catheter approached the 
stenosis in every case. CSA determined with Vmax by spectral analysis 
correlated best wijh true CSA (r=.83) with CSA determined wnh Vmean by 
spectral analysis also correlating well (r=.65). There was no correlation 
between known CSA and that detennined with Vmax or Vmean from the 
zero·crossing detector. Average absolute differences from true CSA for 
10 different stenoses were 0.20±0.03 mm2(spectral analysis Vmax), 
0.49±0.07 mm2(spectral analysis Vmean), 0.69±0.10 mm2(zero·cross 
Vmax), and 0.74±0.11 mm2(zero·cross Vmean). Overestimation of CSA 
occurred primarily in vessels wnh high proximal velocities in which Signal 
aliasing precluded accurate measurement of the high velocny stenosis jet. 
Intracoronary Doppler recording wijh complex spectral analysiS by fast· 
Fourier transform provides a new, accurate method to quantitate stenosis 
CSA and may be useful in assessing the results of catheter·based 
intracoronary interv.entions in humans. 
152A ABSTRACTS 
VISUALIZATION OF CORONARY ARTERIES AND DETECTION 
OF CORONARY BLOOD FLOW USING TRANSESOPHAGEAL 
ECHO!DOPPLER. 
Ingela Schnittger, M.D., F.A.C.C., Ulrich Nellessen, M.D., 
Christopher Appleton, M.D., Gary Oppenheim, M.D., Richard L. 
Popp, M.D., F.A.C.C., Stanford University Schoool of Medicine, 
Stanford, CA. 
Visualization of left main (LM) and right main (RM) coronary 
arteries and detection of blood flow using conventional 
echo/Doppler is limited. In 20 subjects, 19 awake and 1 
anesthetiZed, undergoing transesophageal echo/Doppler (TEE) as 
part of a routine clinical evaluation, we retrospectively assessed 
our ability to clearly visualize the LM and RM coronary arteries 
as well as the presence of blood flow using Doppler color flow 
mapping. The TEE device uses a new high resolution 5 MHz 
transducer. 
In 15/20 subjects the LM was easily and distinctly visualized, 
often including its bifurcation. One subject had poor 
visualization of the LM and in 4/20 subjects there was no 
recording made of the ascending AO root. 
In 7/20 subjects the RM was visualized, while in 9/20 subjects 
the RM was not well defined and again, in 4/20 subjects there 
was no recording made of the ascending AO root. 
In 5/20 subjects Doppler color flow mapping was superimposed on 
the echo image while the LM coronary artery was visualized and 
in all 5 subjects, blood flow could be identified. Two subjects 
had aliased blood flow and 3 subjects had non-aliased blood flow. 
These preliminary retrospective observations using TEE 
demonstrate that it is possible to obtain high resolution images 
of the LM and RM coronary arteries and that coronary artery 
blood flow can be demonstrated using TEE Doppler color flow 
mapping. Further investigation is necessary to clearly define 
sensitivity and specificity for detection of LM/RM obstruction or 
patterns of flow using TEE. 
HIGH DOSE DIPYRIDAMOLE-ECHOCARDIOGRAPHY TEST IN WOMEN: 
CORRELATION WITH EXERCISE-ELECTROCARDIOGRAPHY TEST AND 
CORONARY ARTERIOGRAPHY 
Michele Masini, MD, Eugenio Picano, MD, Fabio Lattanzi, 
MD, Francesco De Prisco, MD, Alessandro Distante, MD, 
Antonio L'Abbate, MD FACC. C.N.R. Clinical Physiology 
Institute, University of Pisa, Pisa, Italy. 
The value of eKercise-electrocardiography test (EET) in 
the detection of coronary artery disease (CAD) in women 
is limited. Recently, the high-dose dipyridamole-
echocardiography test (DET: 2-D echo monitoring during 
i.v. dipyridamole infusion, up to 0.84 mg/Kg over 10') 
has been proposed as an alternative to eKercise for the 
diagnosis of CAD. In order to establish the relative 
diagnostic usefulness of EET and DET for the detection 
of CAD, the 2 tests were performed - on different days 
and in random order - in 83 consecutive women evaluated 
for chest pain syndrome. All women were off medication~; 
15 had a previous myocardial infarction. Positivity of 
DET was based on detection of a transient asynergy of 
contraction, absent or of a lesser degree in resting 
conditions) an EET (by upright cycloergometer) was 
considered positive in case of ST segment shift ~O.I 
mVolt, 0.08 sec. after the J point. Coronary angiography 
showed significant CAD (~70% lumen reduction of at least 
1 major coronary vessel) in 39 women. No significant 
complications occurred in any woman during both tests. 
Sensitivity 
Specificity 
Accuracy 
Predictive value of a positive test 
Predictive value of a negative test 
* = p<O.OI 
Thus, DET appears to be of greater 
than EET for non-invasive detection of 
EET DET 
72% 79Y. 
52Y. * 93Y. 
b2Y. 
57Y. 
bay. 
* 
* 
87% 
91% 
84Y. 
diagnostic value 
CAD in women, 
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QUANTITATIVE DELINEATION OF DIMINISHED RESTING MYOCARDIAL 
PERFUSION IN PATIENTS WITH CRITICAL CORONARY STENOSIS 
ASSESSED WITH POSITRON EMISSION TOMOGRAPHY AND H21S0 
Mary N. Walsh, M.D., Pilar Herrero, M.S., Robert L. 
Steele, M.D., Edward M. Gel tman , M.D., F.A.C.C., Burton 
E. Sobel, M.D., F.A.C.C., Steven R. Bergmann, M.D., Ph.D. 
Washington University, St. Louis, Missouri 
Patients with unstable angina frequently have pain at 
rest presumably because of diminished myocardial blood 
flow (MBFl. However ... studies with the pos itron em itt i ng 
tracers 13NH3 or 8£Rb or the single photon emitter 201Tl 
have failed to demonstrate these perfusion defects at 
rest perhaps because these monovalent cationic tracers 
are not freely diffusible and overestimate perfusion at 
low flow rates because of enhanced extraction. We previ-
ously demonstrated that H21S0 is nearly freely diffusible 
and accurately measures MBF over a wide range of flows. 
Accordingly, in the present study we evaluated 6 patients 
without myocardial infarction but with single vessel 
critical coronary stenosis identified by quantitative 
angiography (average minimal cross-sectional area = O. SO 
± 0.43 mm2, average cross-sectional area reduction = 89. S 
± 11.7%), and compared results to MBF in 4 healthy volun-
teers. Data was acquired in Super PETT I after intraven-
ous administration of 30-40 mCi of H21S0. MBF was 
quantified in absolute terms by fitting partial volume 
and spi llover corrected data to a one-compartment mathe-
matical model. In controls, MBF at rest averaged 0.90 ± 
0.41 ml/g/min. In contrast, MBF distal to stenoses in all 
patients was significantly diminished to less than 0.34 
ml/g/min (p < O.OS). Thus, although not previously demon-
strated in pati ents, myocardi al perfusi on di stal to crit-
ical coronary stenosis is diminished at rest as delin-
eated with PET using H21S0. 
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EFFECT OF ANTI PLATELET THERAPY ON LATE GRAFT PATENCY 
AFTER CORONARY ARTERY BYPASS GRAFTING: VA COOPERATIVE 
STUDY '207. 
Report prepared by St.ven Goldaan. ".D •• F.A.C.C., Jack 
Cop. land, ". D., F. A. C. C., Thoaas "oritz,. ". S., lIil11aa 
Henderson Ph.D., and Karen Zadina, R.N., ".A., Tucson 
VA"C and Univeraity of Arizona, Tucaon AZ, and VA 
CSPCC, Hines, Illinoia. 
To deteraine if apecific anti-platelet th.ra~iea 
iaproved graft patency after coronary artery bypa.a 
grafting (CABG) we coapared 1) aspirin (325 ag qd), 2) 
aspirin (325 ag'tid), 3) aspirin and dipyridaaole 
(325ag and 75 ag reap. tid), 4) aulfinpyrazone (267 ag 
tid), and 5) placebo (tid). Therapy was atarted 48 
hours before CABG except for aapirin. IIhen aapirin was 
a treataent, on. 325 ag do •• waa given 12 houra before 
surgery. Graft patency data were obtain.d .arly 
(within 2 aontha) and th.n later (one year) after 
surgery. The early graft occluaion rat., in 451 
patienta with 1452 graft a, waa 7.5X in all the a'pirin 
groups coabined coapared to 15.1X with placebo 
P<O.Ol). At one y.ar, in 310 patients with 1028 
grafts, the graft occluaion rate in all th. aspirin 
groups coabined waa 15.8X coapared to 22.7X with 
plac.bo (P<0.05). The graft occlusion ratea in .ach 
aapirin tr.ataent group were aspirin qd (15.1X), 
aapirin tid (16.1X), .nd aapirin and dipyridaaole 
(16.3X). If a graft waa open early (269 pati.nta with 
811 graft.), the occlusion rate in the .apirin groupa 
waa 8.5X coapared to 11.5X with placebo. In 
conclusion, graft patency was iaproved both early and 
late after CABG with all aspirin containing treat .. nt 
regi_ns. 
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TRANSPLANT CORONARY ARTERY DISEASE: HISTOPATHO-
LOGIC CORRELATIONS WITH ANGIOGRAPHIC MORPHOLOGY. 
Shao Zhou Gao, MD, Danna Johnson, MD, John S. Schroeder MD, 
FACC, Edwin L. Alderman, MD, FACC, Margaret Billingham, MD, 
Sharon Hunt, MD, F ACC, Edward B. Stinson, MD, F ACC, 
Cardiology, Pathology and Cardiac Surgery Departments, Stanford 
University, Stanford, CA 
Coronary artery disease (CAD), is a major cause of morbidity and 
mortality in the cardiac transplant recipient (Tx pts), accounting 
for 59% of re-Txs at Stanford. Postmortem examination of 61 Tx 
pts included light microscopy of coronary sections. Lesions were 
categorized as fibrointimal thickening by concentric collagen 
(FIBRO-INT), atheromatous plaque with lipoproteinaceous debris, 
collagen and foamy macrophages (ATHERO) and intermediate 
lesions of fibrointimal thickening with early athero changes 
(IN TERM). FIBRO-INT lesions were present in 13 of 18 (72%) pts 
<3 months post-Tx and in 17 of 18 (94%) of pts 3-12 months post-
Tx. Only 2 pts showed INTERM or A THERO lesions. All 25 pts 
> 1 yr post-Tx showed lesions; 80% were of the INTERM or 
ATHERO type. Ten pts expiring within 2 months of arteriography 
permitted direct correlation of angio appearance (normal, diffuse 
concentric, or discrete lesions) with histology in 107 coronary 
segments. HISTOLOGY (mean interval p-Tx: 3.7 yrs) 
Angio FIBRO- INTER- A THERO FRESH OLD 
Appearance INTIM MED THROMBUS THROMBUS 
Normal 19 3 4 2 0 
Diffuse Conc. 12 1 1 1 1 
Discrete 22 13 32 10 11 
Results show that 100% of angiographically normal segments 
exhibit disease with 73% showing FIBRO-INT lesions. Percent 
luminal diameter reduction on angio underestimated 
measurements obtained from histology by 63%. Discrete lesions 
reflected more advanced eccentric INTERMED or A THERO 
lesions, often associated with thrombus. We conclude that Tx 
atherosclerosis is a clinically silent, diffuse, progressive and 
angiographically understated process affecting all cardiac Tx pts. 
CYCLOSPORINE-MEDIATED HYPERCHOLESTEROLEMIA IN CARDIAC 
TRANSPLANT PATIENTS 
Jonathan S Stamler M D., Douglas E. Vaughan, M.D., 
M. Audrey Rudd, Ph.D., Gilbert H. Mudge, M.D.,F.A.C.C., 
R. Wayne Alexander, M.D., Ph.D., F.A.C.C., James 
Kirshenbaum, M.D., F.A.C.C, Pia Young, R.N., and Joseph 
Loscalzo, M.D., Ph.D., F.A.C.C. Harvard Medical School 
and Brigham and Women's Hospital, Boston MA 
Cardiac transplant patients are prone to accelerated 
atherosclerosis. The mechanism by which this occurs is 
not known. Cyclosporin A (cycA), an immunosuppressive a-
gent, has been shown to cause endothelial damage and hep-
atocellular toxicity and thus maybe important in the 
pathogenesis of accelerated atherosclerosis. We have 
hypothesized that this latter effect might accelerate the 
atherosclerotic process by impairing LDL hepatic clear-
ance, which would be reflected in a more atherogenic lip-
oprotein profile. To test this hypothesis we compared 
perioperative cholesterol profiles with postoperative 
values at 6 months in 20 transplant patients with a mean 
age (±SD) of 4l±14yr. Compared with perioperative values 
total cholesterol (TC), LDL cholestol and TC/HDL ratios 
were significantly elevated by 6 months postoperatively. 
Peri transplant ?: 6 months f 
post-transplant 
TC(mg/dl) l26±25 221±33 <0.001 
TG(JDg/dl) 138±65 l55±69 NS 
LDL(mg/dl) 60±19 l46±33 <0.001 
HDL(mg/dl) 38±13 45±16 NS 
TC/HDL 3. 5±0. 8 5. 5±2.l <0.01 
Significant changes in TC and LDL cholesterol values were 
already noted by the second postoperative week of cycA 
therapy. These data suggest that cycA-mediated cellular 
damage results in defective cholesterol clearance, mani-
fested as an atherogenic lipoprotein profile, that likely 
contributes to accelerated atherosclerosis. 
ABSTRACTS 153A 
PROGNOSTIC OUTCOMES IN ANGINA VS. MYOCARDIAL INFARCTION 
William B. Kannel, M.D., M.P.H., F.A.C.C. and L. Adrienne 
Cupples, Ph.D., Boston University School of Medicine 
Over 30 years of follow-up of the Framingham Study 216 
men and 274 women developed uncomplicated angina and 
403 men and 193 women developed and survived myocardial 
infarctions for 30 days or more. ~10rtality and cardio-
vascular event rates were determined over 10 years fol-
lowing onset of these first CHD events. This provides 
information on the outlook for CHD events in the virtual 
absence of effective treatment which can be used as a 
standard of comparison for proposed treatments. 
The data indicate that once overt CHD ensues women lose 
their advantage over men with respect to overall, cardio-
vascular and CHD mortality as well as their protection 
against non-fatal cardiovascular events. Also, myocardial 
infarction carried a more ominous prognostic outlook than 
angina pectoris, especially in women, both for mortality 
and cardiovascular sequelae. Angina carried a greater 
risk in men than women. Age-adjusted risk ratios for 
the cohort aged 35-94 years, for the mortality end point, 
were as follows: 
AGE-ADJUSTED RISK RATIOS 
MORTALITY ANGINA PECTORIS MYOCARDIAL INFARCTION 
OUTCOME MEN Wot~EN MEN WOMEN 
OVERALL MORT. 1.9 ~ 2.6 3F 
CV MORTALITY 2.4 2.0 3.4 5.0 
CHD MORTALITY 3.0 2.3 4.2 8.2 
SUDDEN DEATH 3.4 2.7 4.2 6.2 
EXERTIONAL ISCHEMIA AND PROONOSIS IN MILDLY SYMPTOMATIC 
PATIENTS WITH SINGLE OR DOUBLE VESSEL CORONARY ARTERY 
DISEASE AND LEFT VENTRICULAR DYSFUNCTION AT REST 
Gianfranco Mazzotta, MD. Robert O. Bonow. MD. FACC, 
Leonardo Pace. MD. Erica Brittain. PhD. and Stephen E. 
Epstein. MD. FACC. NHLBI. Bethesda. Md. 
The randomized multicenter trials indicate that in pts 
with 3-vessel coronary artery disease and LV dysfunction. 
survival during medical therapy is reduced in pts with 
exercise-induced ischemia compared to pts without induci-
ble ischemia. A similar relation between inducible ische-
mia and prognosis has not been demonstrated in pts with LV 
dysfunction and 1- or 2-vessel disease (VD). We therefore 
studied 53 consecutive asymptomatic or only mildly sympto-
matic pts with 1- or 2-VD and impaired LV function (ejec-
tion fraction (EF) 20S-40S) by exercise ECG and rest and 
exercise radionuclide angiography. All but 4 pts had pre-
vious MI. By multivariate life table analysis. mortality 
during subsequent medical therapy was associated signifi-
cantly with the ST-segment response with exercise (p(.05) 
and both the exercise EF (p(.05) and the magnitude of 
change in EF with exercise (p(.005). Survival at 6 years 
was 97+3J (+SE) in pts with an exercise EF >30J compared 
to 62+14J in the remaining pts (p(.005). and was 100J in 
pts in whom the EF increased compared to the value at 
rest. COmpared to 74+l0J in the remaining pts (p(.005). 
The likelihood of cardiac events (death. reinfarction. or 
congestive heart failure) was also associated with the 
exercise EF and magnitude of change in EF with exercise 
(both p(.005). Thus. noninvasive indexes of LV function 
and myocardial isphemia are important predictors of the 
clinical course of mildly symptomatic pts with 1- or 2-VD 
and LV dysfunction at rest. and may be used to identify 
subgroups of pts at risk of death. as well as of major 
cardiac events. during subsequent medical therapy. 
154A ABSTRACTS 
PREDICTORS OF CARDIAC DEATH IN PATIENTS WITH CORONARY 
ARTERY ANOMALIES 
Kevin Rogan, M.D., Renu Virmani, M.D., F.A.C.C., Max 
Robinowitz, M.D., F.A.C.C., Rick Latham, M.D., Armed 
Forces Institute of Pathology, Washington, DC. 
Clinicopathologic records of 232 pts referred from 
1967-1987 (largest series to dste) were reviewed to 
clarify the incidence and mechanism of cardiac death 
associated with major congenital coronary artery 
anomalies (CAA). Cardiac deaths were seen in 64% 
(148/232). Sudden death was reported in 42% (97/232). 
CAA with the highest incidence of sudden death were left 
coronary artery (LCA) from right sinus and right coronary 
artery (RCA) from posterior sinus 3/3 (100%), RCA and LCA 
origin from right aortic sinus 29/42 (69%), left main 
from PA 18/36 (50%), RCA and LCA from left sinus 17/36 
(47%), and congenital hypoplasia 4/13 (30%), single 
coronary from left sinus 5/21 (23%), single coronary from 
right sinus 5/22 (22%). Coursing of the LCA between the 
AO and PA was the best predictor of sudden death 30/33 
(90%); however, coursing of the RCA between the AO and PA 
was not as predictive, 11/24 (45%) (p<.05). Incidence of 
atherosclerotic coronary artery disease was greatest with 
origin of both RCA and LCA from either right or left 
sinus, 55/121 (45%), but acute infarction was observed in 
only 14%. Of 32 pts with exercise-related sudden death, 
50% had a left main course between AD and PA; 8% had RCA 
course between AD and PAt The majority of pts with 
sudden death and a left main course between major vessels 
had acute angle origins 21/25 (84%). Diminished flow in 
abnormally angled coronary arteries passing between AD 
and PA predisposes to atherosclerotic coronary artery 
disease and may result in sudden death or infarction. 
Premortem identification of CAA with atherosclerosis 
indicates need for early intervention. 
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IN VIVO ELECTROPHYSIOLOOIC EFFECTS OF ALPHA BUlCKADE IN 
NEONATAL AND AlXlLT CANDIES. 
Jorge McCormack, M.D., Henry Gelband, M.D., P.A.C.C., 
Juan Villafane, M.D., P.A.C.C., Hui Xu, M.D." Adrienne 
Stolfi, and Arthur S. Pickoff, M.D., P.A.C.C., University 
of Miami School of Medicine, Miami, FL. 
In vitro studies suggest that alpha (a) adrenoceptors 
have an inhibitory effect on the adul t (Ad) heart but can 
be excitatory on the neonatal (Nee) myocardium. In order 
to determine whether age related differences in the 
electrophysiologic (EP) effects of a blockade can be 
demonstrated in vivo, 9 Neo dogs, ages 8-14 and 6 Ad 
dogs, were studied. EP studies (S) were performed after 
combined beta adrenergic (propranolol 0.6 mg/kg) and 
parasympathetic (bilat. vagotomies) blockade (B). EPS 
were repeated following a blockade with phentolamine 
(P)(Neo: 0.5 mg; Ad: 5.0 mg). P resulted in a 
significant decrease in Neo HR (166 ±16 bpm, B; 154 ± 16 
bpm, P; p < 0.001) and had no effect on Ad HR. CSNRT was 
prolonged in Nea (129 ± 44 msec, B; 183 ± 90 msec, P; P 
< 0.05) and shortened in Ad (142 + 48 msec, B; 118 + 38 
msec, P;. P = 0.056). Atrial (I.) effective (E)-and 
functiooal (I") refractory periods (RP) were prolonged in 
both groups (AERP: Ad = 140 ± 9 msec, B; 154 ± 14 msec, 
P; p < 0.05/Nea = 68 ± 12 msec, B; 88 ± 18 msec, P; p 
< O.OOl)(AI'RP: Ad. 185 ± 14 msec, B; 193 ± 12 msec, P; p 
< 0.05/Nea = 110 ± 9 msec, B; 128 ± 15 msec; p < 0.05); 
the IIIIIgnitude of ARP ~~ significantly greater 
in Neo. Ventricular (V) ERP and V1'RP were significantly 
prolonged in Neo (VERP: 146 + 17 msec, B; 166 + 26 msec, 
P; P 0.05/VJrRP: 111 ± 21 ...sec, B; 197 ± 32 _ec, P; p 
< 0.05), and unchanged in Ad. P had no effect on the A-V 
node conduction. In conclusion; P has a profoUnd 
inhibitory effect on the Nea conducting tissue and a 
minor effect on Ad heart, suggest~ that a adrenoceptors 
have an important excitatory function in the Nee heart. 
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HIGH PREVALENCE OF FAMILIAL CARDIOMYOPATHY IN A 
TRANSPLANT CENTER POPULATION: IMPLICATIONS FOR 
MANAGEMENT OF IDIOPATHIC DILATED CARDIOMYOPATHY. 
John B. Gordon, M.D., Wilson S. Colucci, M.D., 
F.A.C.C., James Kirshenbaum, M.D., Diane Gauthier, 
R.N., Pia Young, R.N., Frederick J. Schoen, M.D., 
Douglas E. Vaughan, M.D., Gilbert H. Mudge, M.D. 
Brigham and Women's Hospital, Harvard Medical School, 
Boston, MA. 
Although there are sporadic reports of familial 
cases of dilated cardiomyopathy (DCM), the prevalence 
of this entity is not known. Therefore, we performed a 
retrospective analysis of the prevalence of familial 
DCM in a population of patients listed for cardiac 
transplantation. Of 175 patients referred for 
evaluation in a 2 year period, 54 were listed for 
transplantation, of whom 30 were diagnosed as DCM. In 
4 of 30 patients with DCM (13%), careful historical 
evaluation and echocardiography revealed a familial 
tendency. The diagnosis of early DCM was made in 6 of 
8 asymptomatic relatives studied based on 
echocardiographic findings of LV dilation and reduced 
EF, and in one sibling by autopsy following sudden 
death. DCM has been documented in 3 generations in one 
family with an autosomal dominant pattern. Thus, in a 
selected population of patients with advanced CHF due 
to DCM, the prevalence of familial disease was 
surprisingly high. Since many affected relatives may 
be asymptomatic, echocardiographic screening may be 
critical for early detection and may prompt the early 
treatment of OeM. 
DEVELOPMENTAL DIFFERENCES IN SUSCEPTIBILITY OF THE 
CARDIAC CONDUCTION SYSTEM TO GLOBAL ISCHEMIA 
R. Duane Davis, M.D., Gregory P. Fontana, M.D., 
David W. Molter, M.D., Jonathan Dreifus, M.D., 
William C. Buhrman, M.D., James E. Lowe, M.D., F.A.C.C. 
Duke University Medical Center, Durham, NC 
To distinguish age-related differences in functional 
recovery of the cardiac conduction system after ischemia, 
25 pigs (n=15 adult, A and n=lU neonates, 3-7 days, N) 
were subjected to 30 minutes (A, n=7; N, n=5) and 45 
minutes (A, n=8; N, n=5) of in situ normothermic global 
ischemia and 120 minutes of reperfusl.on. His bundle 
electrograms were obtained at control and at 3D, 60 and 
120 minutes of repertus1on. Atrial to His bundle 
conduction intervals (AH) and His bundle to ventricle 
conduction intervals (HV) were obtained using decremental 
pacing from cycle length of 350 msec to 175 msec. AH 
intervals were significantly prolonged relative to 
cQntrols in the N as compared to A· after both 30 and 45 
minutes of ischemia. HV intervals were significantly 
prolonged relative to control in the A as compared to N 
after both 30 and 45 minutes of ischemia. Representative 
data at 300 msec cycle length and 60 min. of reperfusion 
are as follows (mean t SEM; in msec): 
30 minutes 45 minutes 
AHc AH60 HVc HV60 AHc AH60 HVc HV60 
A 66±14 76t17 36±8 58t27 67t15 70±5 37±12 59±28 
N 47±7 61±11 24±3 22t2 44±7 65±11 25±.. 26±7 
After 120 minutes of reperfusion, CHB was present in 
(3/15) A and (l/10) N. All A (15/15) and no N (0/10) 
hearts required defibrillation after 5 minutes of 
reperfusion (p=.03). In conclusion, the neonatal conduc-
tion system is more sensitive to ischemia at the level of 
the AV node and is less sensitive in the His-Purkinje 
conduction system than the adult conduction system. 
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EVOLVING CONCEPTS IN THE W\NAGEMENT OF CONGENITAL 
JUNCTIONAL ECTOPIC TACHYCARDIA: A MULTICENTER STUDY 
Elizabeth Villain, M.D., Arthur Garson, Jr., M.D., 
F.A.C.C., Texas Children's Hospital & Baylor College of 
Medicine, Houston, Texas. 
We reviewed the records of 27 Infants with congenital JET 
fran 7 Institutions to examine the evolution In the 
management of this resistant tachycardia. JET was defined 
electrocardiographically as an Incessant, narrow QRS 
tachycardia with AV dissociation. The ventricular rate 
ranged fran 140 to 370 BPM (230); 16/27 pts had cardiac 
fai lure. Treatment success (5) was defined as a stable 
decrease in the rate of JET, below 150 BPM; partial 
success (PS) was a significant decrease of JET rate with 
alleviation of SYfll)tans. All patients received digoxin 
with no significant effect. Propranolol (P) was given to 
16 pts, with 2 5 and 1 PS. Canblnatlons of other conven-
tional agents were tried In 11 pts with 2 5; 14 pts were 
treated with amlodarone (A) which resulted In 8 5 and 3 
PS. 3 pts died suddenly on medical treatment (A:l, P:l or 
A+P:l) and consequently, 2 later pts had pacemaker 
Implantation as well as medical treatment. His catheter 
ablation was successfully performed twice, but contribut-
ed to death In a newborn; 3 surgical His ablations were 
performed for Intractable JET with 2 5 and 1 death. The 
overall rrortallty was 37%; only 3110 pts who died had 
received amlodarone. Among survivors, treatment has been 
stopped without any canpllcations In 5 pts between 10 rros 
and 8 yrs of age 0.5 yrs). It appears that amlodarone 
alone Is the best drug for treatment of congenital JET; 
necessity for permanent pacing remains unsettled. His 
ablation should be reserved only for Intractable JET. 
VI!NTRICULAR ARRHYTHMIA IN POST-OPI!RATIVI! TI!TRALOGY OF 
FALLOT-(COLLABORATIVE STUDY) ~ Jayachandar. ~. Grace 
S. Wolff. M.D .. F.A.C.C .. for Pediatric Electrophysio-
logical Society. University of Miami.Miami. Florida. 
359 children (pts) operated for Tetralogy of Fallot 
(TOF) from 15 centers were analyzed to identify risk 
factors for ventricular arrhythmia (VA) and to study the 
importance of electrophysiological study(EP). Later age 
of repair(AR). longer time interval from repair to EP 
study(TIl. symptoms (S) of syncope & presyncope(53pts). 
VA on cardioscan (CS)(174pts). right ventricular systolic 
hypertension (RV-SH)(76pts)and EP programmed ventricular 
stimulation (EPS) induced arrhythmia (VT)(60pts) were 
correlated by Statpac statistical program. 
AR TI S CS-VA RV-SH I!PS-VT 
AR 
TI 
S p<0.001 p<O.OOl 
p<0.001 p<O.OOl p<O.OOl 
p<0.001 p<0.001 p 0.66 
p 0.002 P 0.21 
CS-VA p<0.001 p<0.001 p 0.002 P 0.04 
RV-SB p<0.001 p 0.66 P 0.21 P 0.04 
EPS-VT p<0.001 p<O.OOl p<0.001 p<0.001 p<0.04 
p<0.001 
p<0.001 
p<0.001 
p<O.OOl 
p 0.04 
Complex VA on CS [Lown grade >3] did not differ from 
simple VA in their correlation with EPS induced VT. 
however. there was a difference between simple VA and no 
arrhythmia (p 0.005).There was a weak association between 
RV-SH and some of the parameters (above). while RV dias-
tolic pressure was not related. EPS induced sustained 
(sus VT) and nonsustained polymorphic VT (PVT) correlated 
with later AR. longer T1. symptoms and VA on CS. while 
non sustained monomorphic VT (MVT) correlated only with 
later AR and symptoms. 
We conclude that post operative VA after TOF repair is 
more frequent with delayed AR and increased T1 after 
repair. EPS induces VT more frequently in patients with 
symptoms and VA on cardioscan. EP induced sus VT and non 
sus PVT are probably more significant than MVT. 
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IMPROVED VENTRICULAR PERFORMANCE FOLLOWING ARRHYTHMIA 
CONTROL IN CHILDREN WITH AUTOMATIC ATRIAL TACHYCARDIA AND 
DILATED CARDIOMYOPATHY 
Burt I Bromberg M D , Macdonald Dick, II, M.D., FAC.C., William A. 
Scott, M.D., Gerald A. Serwer, M.D., F.A.C.C., A. Rebecca Snider, M.D., 
F.A.C.C., Edward L. Bove, M.D., F.A.C.C. C.S. Mott Children's Hospital, 
University of Michigan, Ann Arbor, Michigan. 
Automatic atrial tachycardia (AAT) has been associated with 
development of dilated cardiomyopathy (CM). Control of MT is often 
resistant to conventional anti-arrhythmic therapy. To examine the 
response to medical and/or surgical treatment of AAT/CM, we 
compared symptoms (palpitations, dyspnea, fatigue), cardiothoracic 
ratio (CTR) by chest x·ray, electrocardiograms (ECG), and 
echocardiographic shortening fraction (SF), in 5 patients (2 females, 
3 males) with dilated CM pre· and post- treatment. The patients 
ranged in age at presentation from 8 months to 11 years; follow-up 
was from 10 months to 13 years. The diagnosis of MT was confirmed 
in 4 by electrophysiologic study and in one by ECG that demonstrated 
ectopic atrial focus and increased atrioventricular block during 
tachycardia. Sinus rhythm (SR) was restored in only one patient 
using digoxin alone, while two patients responded to amiodarone. All 
three had reduction in symptoms. Two patients failed digoxin, 
propranolol and quinidine therapy and elected surgical treatment. The 
2 surgical patients had marked reduction in symptoms and 
arrhythmia (~50%). Following treatment, the CTR was reduced (.53 
±. .04 vs .. 49 ±. .04, P=.Ol, N=4), and the echo SF increased (.22 ±. 
.05 vs. 35 ±. .06 , P < .01, N=4). We conclude that control of MT 
improves ventricular function and reduces symptoms in children with 
AAT/CM. While several medical and surgical alternatives are 
available, we recommend a step-wise approach in the symptomatic 
patient, beginning with conventional medical therapy and progressing 
to newer anti-arrhythmic agents. Surgery is reserved for those 
patients who either fail or do not tolerate or comply with medical 
therapy. 
Wednesday, March 30, 1988 
8:30AM-10:00AM, Room 364, Level Three 
Cine NMR 
EVALUATION OF AORTIC REGURGITATION BY CINE MAGNETIC 
RESONANCE IMAGING 
Gerard Aurigemma, M.D., Nathaniel Reichek, M.D., Mark 
Schiebler, M.D., Leon Axel, M.D., ph.D., Christine 
Harris, R.T., Kathleen Bogin, R.N, Ali Muhammad, pamela 
Douglas, M.D., F.A.C.C., Barbara Berko, M.D., Herbert 
Kressel, M.D. Univ. of Pennsylvania, Philadelphia, PA. 
Cine magnetic resonance imaging (cMRI), a gradient echo 
flow dependent technique, generates high signal from lam-
inar flowing blood and low signal from turbulent flow on 
mUltiple cardiac sections at 8-22 frames/section/cycle. 
We used cMRI to assess aortic regurgitation (AR) in 35 
pts. with valvular and/or coronary disease and in 11 nor-
mals, comparing results to pulsed doppler (PO, n=32) or 
color flow doppler (CFD, n=14) mapping. Repetition time 
of 22 msec, echo time of 12.5 msec, 30 degree flip 
angles, and retrospective ECG gating were used for CMRI. 
Diastolic cMRI low signal jet areas (JA) due to AR were 
found in the left ventricle (LV) in 14/14 with AR by PO 
and 11/12 with AR by CFD; 1 negative by CFD showed mild 
AR by cMRI (sensitivity 100%, specificity 100% vs PO; 
sensitivity 92%, ·specificity· 50% vs.CFD). we also com-
pared single plane maximal JA/LV% by cMRI, PO and CFD 
(0-20% mild, 20-40% moderate, >40% severe AR). CMRI 
class was identical to PO in 31/32 (97%) and to CFD in 
12/14 (86%) with maximal differences of 1 class. CMRI 
JA/ LV correlated well with PO (r=.92) and CFD (r=.89), 
but cMRI also showed the JA at the valve plane, an index 
of regurgitant orifice, in 11 pts. and multiple jets in 
2. All sections of the LV can be imaged by cMRI and the 
3D shape and volume of the flow disturbance due to AR 
determined. We conclude that cMRI is a powerful new 
method for noninvasive evaluation of AR. 
156A ABSTRACTS 
A NEW TECHNIQUE FOR QUANTIFICATION OF LEFT AND RIGHT 
VENTRICULAR STROKE VOLUMES UTILIZING RAPID DYNAMIC 
MAGNETIC RESONANCE IMAGING. 
Roderick B. Meese, M.D., Charles E. Spitzer, M.D., 
Rosa Negro-Vilar, Robert J. Herfkens, M.D., Thomas M. 
Bashore, M.D., F.A.C.C. Duke University Medical 
Center, Durham, North Carolina. 
The technique of rapid gradient recalled cardiac 
imaging (CINE GRASS) may be employed to evaluate 
cardiac volumes in both the short-axis oblique and the 
transaxial planes. Ut~lizing a short TR (21msec), 
limited flip angle (30 ) and a gradient refocused echo 
(TE-12msec), the relationship between left ventricular 
(LV) and right ventricular (RV) stroke volume (SV) was 
assessed, and the ejection fraction (EF) determined in 
each plane. 14 normal volunteers were studied. 
Volumes were determined by manual regions of interest 
drawn from each 1cm thick, contiguous slice. 
Short-Axis Transaxial 
View View 
RVSV(ml) 75 + 13 69 + 13 
LVSV(ml) 78 + 13 75 + 13 
RV!LV 0.96 +.11 0.93 + 0.9 
Using linear regression the RV versus LV stroke 
volume correlates were better in the short-axis 
(R=0.84; p<0.005; y •• 83x + 17.6; SEE=6.7) than trans-
axial plane (R=0.72; p<0.002; y=0.73x + 23.6; SEE=8.5). 
Thus, when determining cardiac volume, there 
appears to be an advantage in using the short-axis 
oblique plane compared to the transaxial. This finding 
may reduce unnecessary acquisition time. It demon-
strates the possible importance of the short-axis 
oblique in development of computer assisted volume 
analysis and allows for the quantification of valvu-
lar regurgitation using CINE MRI techniques. 
EFFECT OF FLOW RATE AND ORIFICE SIZE ON FLOW JETS 
VISUALIZED BY FAST NYR IMAGING: A PHANTOM STUDY 
Stephen L. Cook, MD, Gerald Maurer, MD, FACC, Daniel S. 
Berman, MD, FACC, Enrique Ostrzega, MD, David Allen, 
PhD, Mark Tournie, John Crues, MD, Jamshid Maddahi, MD, 
FACC, Cedars-Sinai Medical Center, Los Angeles, CA 
Gradient recalled acquisition in the steady state (GRASS) 
is a new NYR imaging technique that allows assessment of 
intracardiac flow abnormalities. With this technique, 
which uses TE=12 msec and TR=25 msec, turbulent flow jets 
encountered in valvular regurgitation produce signal 
voids that provide potential for grading the severity of 
regurgitation. We evaluated the determinants of 
turbulent jet area and intensity at three different 
steady flow rates and four different orifice sizes using 
a flow phantom with a 100 cc spherical receiving chamber. 
Long axis GRASS NYR images were obtained at the center of 
jet. The jet area was determined by planimetry, and its 
average signal intensity was calculated. Jet area (cm2) 
results: Orifice Size (cm2) 
0.124 0.178 0.316 0.785 
Flow 4 0.62 0.33 no jet no jet 
Rate 16 6.24 5.53 2.30 1.07 
(cc/sec) 28 9.77 10.12 7.61 5.97 
As shown, jet area was directly related to flow rate and 
inversely related to orifice size. Moreover, jet signal 
intensity was directly related to the orifice size and 
inversely related to flow, presumably due to decreasing 
signal intensity with increased turbulence. 
Conclusion: Identical flow rates produced markedly 
different jet areas and signal intensities with different 
orifice sizes. Caution should be exercised in predicting 
regurgitant volume from NYR jet area and signal intensity 
without knowledge of regurgitant orifice size. 
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LEIT VENTRICUlAR WALL Mal'ION ANALYSIS BY CINE NMR. 
Godtfred Holmvang, M.D., Robert Edelman, M.D., Justin D. 
Pearlman, M.D., Ph.D., Stephen W. Miller, M.D., Thomas J. 
Brady, M.D., Howard L. Kantor, M.D., Ph.D., F.A.C.C.1 
Massachusetts General Hospital, Boston, Massachusetts. 
The gated cine NMR (c-NMR) technique facilitates studies 
of dynamic cardic function. In order to evaluate the use 
of c-NMR f05 the desection of wall motion abnormalities, 
biplane (30 R!\O, 60 LAO) LV angiograms were obtained at 
catheterization in 11 patients (9 with coronary artery 
disease) who were subsequently studied in a 0.6 T NMR 
imaging system. Cine loops were constructed frem single 
plane gradient echo images (echo time 16 to 32 msec) 
obtained at 16 to 32 time points through the cardiac 
cycle. Lmaging planes were oriented to the intrinsic 
cardiac axes, yielding at least two long axis views of the 
heart in each patient, parallel and perpendicular to the 
interventricular septum. Corresponding segments of cath 
and c-NMR ventriculograms were scored as being normal, 
hypokinetic, akinetic or dyskinetic by observers not 
knowledgeable about the results fran the other study. 
One cine loop and one cath ventriculogram were deemed 
technicallY inadequate and excluded frem analysis. The 
wall motion scores were in agreement for 59 segments, 
differed by one grade for 16 segments, differed by two 
grades for 6 segments and differed by three grades for 1 
segment. Ready visualization by NMR of extent of wall 
thickening provided additional helpful information. The 
most llnportant reasons identified for discrepancies in 
score were related to the tomographic vs. projective 
format, and to insufficient contrast between blood pool 
signal and myocardium in the NMR images, particularly 
towards the apex in systolic frames. 
Conclusion: c-NMR is of value for wall motion studies if 
adequate endocardial border contrast can be assured. 
LEFT VENTRICULAR WALL MOTION ASSESSMENT BY CINE NUCLEAR 
MAGNETIC RESONANCE IMAGING: COMPARISON WITH TWO· 
DIMENSIONAL ECHOCARDIOGRAPHY AND THALLIUM-20l TOMOGRAPHY 
Roxann Rokey. M.D. F.A.C.C. Padraig O'Neill, M.D., 
Wolfgang Nitz, M.S., Wesley Vick, M.D., Mario Verani, 
M.D., F.A.C.C., William Zoghbi, M.D., F.A.C.C., Richard 
Wendt, Ph.D., Miguel Quinones, M.D., F.A.C.C., John S. 
Mahmarian, M.D., Donald Johnston, M.D., F.A.C.C., Baylor 
College of Medicine, Houston, Texas. 
Cine nuclear magnetic resonance (CNMR) imaging is a 
promising new method in the noninvasive evaluation 
ischemic heart disease. However, the sensitivity and 
specificity of this technique in assessing LV wall motion 
requires verification. Thus, we compared CNMR images of 
LV wall motion with two-dimensional echocardiography 
(ECHO) and thallium·20l tomography (Tl). Pts with acute 
myocardial infarction (n-13) had short and long axis CNMR 
images of the base, mid, distal and apical LV. ECHO and 
Tl studies were obtained within 6 days of CNMR. For ECHO 
and CNMR, 7 segments (anterior, anteroseptal, 
anterolateral, posterolateral, inferior, inferoseptal and 
apex) were identified and the wall motion graded as either 
normal or abnormal. Tl perfusion defects were compared to 
the identified segments on CNMR. RESULTS: Of the 13 pts, 
wall motion could not be adequately assessed by ECHO in 
one pt and the apex could not be identified by CNMR in 5. 
Thus, 79 segments were available for wall motion analysis. 
When compared to ECHO, 73/79 segments were correctly 
identified as normal or abnormal by CNMR (sensitivity 86%, 
specificity of 100%). The estimated ejection fraction was 
in the mid 40's by CNMR and ECHO. Tl perfusion defects 
corresponded well with CNMR wall motion abnormalities 
(sensitivity 79%; specificity 91%). CONCLUSION' CNMR 
imaging is a sensitive and specific method for evaluation 
of wall motion abnormalities and the abnormalities 
identified by CNMR correspond to Tl perfusion defects. 
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CINE MAGNETIC RESONANCE IMAGING IN CHILDREN WITH TRANS-
POSITION OF THE GREAT ARTERIES AFTER SURGICAL REPAIR 
Kyung J. Chung, M.D., FACC, Renee F. Glass, M.D., lain 
A. Simpson, M.D., John R. Hesselink, M.D., David J. 
Sahn, M.D., FACC. Univ of Calif, San Diego, CA. 
We used cine magnetic resonance imaging (MRI) for the 
postoperative evaluation of 9 patients who had undergone 
intra-atrial baffle procedure for repair of transposi-
tion of the great arteries (TGA) by the Mustard 
technique. Patient's ages ranged from 5 months to 9 
years. All patients < 5 years of age were studied after 
oral chloral hydrate sedation (80-100 mg/Kg). Eight 
have undergone postop cardiac catheterization. Cine MRI 
was performed on a GE Signa System (1.5 Tesla) with a 
30· flip angle, echo time of 12 msec and repetition time 
of 22 msec, with 5-10 mm slices reconstructed using 16 
time frames per cardiac cycle. Six patients had widely 
patent superior and inferior vena cavae, 2 had obst-
ruction of the superior vena cava and one patient with 
dextrocardia had superior vena caval obstruction and 
mild narrowing of the inferior vena caval limb verified 
at catheterization and aurgery. In all 3 patients with 
superior vena caval obstruction, a dilated azygous 
system was imaged. Pulmonary venous (PV) return was 
well visualized in all patients and the PV atrial limb 
showed no evidence of narrowing, except in one patient 
who had narrowing in the middle of the pulmonary venous 
limb on MRI and on echo Doppler, but has not yet had 
postop catheterization. RV and LV ejection fraction 
could be assessed by cine MRI and correlated closely 
with angiocardiographic results. No patient had evidence 
of left ventricular outflow tract obstruction on cine 
MRI or catheterization. Our study suggests that cine 
MRI can provide an accurate and noninvasive method for 
evaluating anatomical and functional results of 
intra-atrial baffling for TGA. 
Wednesday, March 30, 1988 
10:30AM-12:00NOON, Room 364, Level Three 
Quantification of Myocardial Mass by NMR and VFCT 
ASSESSMENT OF MYOCARDIAL MASS IN CHRONIC AORTIC 
INSUFFICIENCY USING MAGNETIC RESONANCE IMAGING 
R. Duane Davis, M.D., Gregory P. Fontana, M.D., 
David W. Molter, M.D., George K. Ibrahim. M.D., 
Robert H. Herfkens, M.D., James E. Lowe, M.D., F.A.C.C. 
Duke University Medical Center, Durham, NC 
Following changes in myocardial mass is a useful 
parameter in evaluating patients with aortic insufficieny 
(AI). The efficacy of magnetic resonance imaging (MRI) in 
estimating myocardial mass in chronic aortic 
insufficiency (AI) was evaluated. In 14 dogs with 3-4+ AI 
tor 3-6 months duration, myocardial imaging utilizing 
spin echo MR (G) and gated gradient recalled cardiac MR 
(CINE) was performed. Using cine end systolic (ES), cine 
end diastolic (ED) and the gated (G) images, myocardial 
(Myo) and left ventricular (LV) wall volumes were 
calculated by summation of areas from individual slices. 
Myo and LV mass was measured 1-2 days following the MRI 
study. Linear regression analysis between mass and 
calculated wall volumes are reported in the form, y = mx 
+ b, using ED, ES, and G images as follows: 
Myo 
LV 
m 
1.0 
1.0 
cine ED cine ES 
b r m b r m 
30 .92 0.93 33 0.93 1.1 
24 .92 0.98 24 0.91 1.1 
(r = correlation coefficient) 
Gated 
b 
10 
9 
r 
0.98 
0.98 
Combined linear regression analysis with ES,ED, and G 
images enhanced the correlation between estimated volume 
and measured mass (r = 0.99). In conclusion, MRI can be 
used to measure myocardial mass in chronic Al using cine 
or gated images. The most accurate estimation is obtained 
using gated images or combining information from gated 
and cine images. MRI may be an accurate means of 
following myocardial mass in patients with AI. 
ABSTRACTS 
WALL MASS REGRESSION AFTER AORTIC VALVE REPLACEMENT, 
MEASURED BY CINE COMPUTED TOMOGRAPHY. 
157A 
Pete~ h Kurnik, M.D~, !""1!~., Joseph D. Wachspress, 
M.D., Michael Innerfield, M.D., William H. O'Connor, M.D., 
F.A.C.C., William C. Groh, M.D., F.A.C.C., William J. 
Untereker, M.D., F.A.C.C., W. Jay Eldredge, M.D., Harvey 
L. Waxman, M.D., F.A.C.C. UMDNJ/Robert Wood Johnson 
Medical School, Camden, New Jersey. 
Left ventricular mass is expected to decrease after 
successful valve replacement (AVR) in patients with aortic 
stenosis (AS) and/or insufficiency. Cine computed 
tomography (CCT) is the most accurate technique for 
measurement of mass. We present the first assessment of 
mass regression after AVR by CCT. Baseline studies have 
been done on 20 patients with mass of 295 ~ 73 gm. Four 
had balloon valvuloplasty, 16 had AVR. Follow-up to 3 
months after AVR/valvuloplas2y is complete in 10 patients 
w1th AS (area = .53 ± .19 cm , gradient = 64 ± 23 mmHg) , 
in 2 with severe insufficiency, and to 6 months in 6 
patients. Excellent images were obtained from base to 
apex in all patients; semi-automated edge detection was 
used and Simpson's rule applied. 
B_aseline J mopth 
Mass 295 ± 73 228 ± 58 
Ejection fraction .65 ± .14 .67 ± .14 
6 month 
180 ± 25 
.70 ± .05 
6 n 20 12 
Mass decreased in 11/12 patients with average 
decrease 23% at 3 months (p ( .002) and 39% at 6 months 
(p ( .0005). Mass at 6 months was within the normal range. 
Clinical status improved in all. Ejection fraction 
showed a small, non-significant increase. End-diastolic 
and stroke volumes did not change in AS patients. 
CCT provides accurate, non-invasive measurement of 
excellent mass regression after AVR, which correlates with 
clinical benefit despite lack of ejection fraction 
increase .. 
VARlABILlT Y 
MEASUREMENTS 
TOMOGRAPHY. 
OF LEFT VENTRICULAR MASS 
BY ULTRAFAST COMPUTED 
Eulalia Roia• M.D.. Eva Chomka, M.D., Concetta LoGalbo, 
B.S.N., Fred Zeller, PharmD., Karen Klamerus, PharmD., 
Elizabeth Kaufmann, B.S.N., Jose Claudio, R.T., Christopher 
Wolfk!el, M.S.E., James Heusner, PhD., Stuart Rich, M.D., 
F.A.C.C., Bruce Bl"Wldage, M.D., F.A.C.C., University of Illinois 
at Chicago, Chicago, fL. 
Ultrafast computed tomography (UFCT) has been reported as an 
accurate method of measuring left ventricular mass (L VM) in 
dogs. LVM was measured in 16 pts with ischemic heart disease 
to assess the variability of L VM measurements by UFCT in 
humans. Pts Wlderwent UFCT at baseline, 2 and 24 hours after 
either placebo or application of a 15 mg slow release 
nitroglycerin patch. The left ventriCle was localized by an 8 
level scan. After injection of 25 ml of contrast into a peripheral 
vein at the rate of 8-10 mllsec, 10 scans were obtained at 8-1 
cm levels over 15-25 sec by EKG gating at end systole. Pts were 
repositioned on the scanner at 2 and 24 hours and the protocol 
was repeated. LVM was calculated in the three studies by the 
same observer. The mean of the 3 LVM determinations in each 
pt and the percent difference from the mean were calculated. 
The absolute difference in the LVM measurement ranged from 
0.06 to 8 grams/patient. The mean percent differences of the 3 
studies are shown in the following table: 
X ! S.D. Range 
Baseline 0.25 + 1.696 3.8 to 1. 796 
2hours -0.28 '+ 1.596 3.1 to -2.596 
24 hours 0.00 I 1.696 2.6 to -3.196 
The mean percent difference of all measurements performed was 
-0.01 ! 1.596 (range 3.8 to -3.196). We conclude that UFCT is an 
accurate method to repetitively measure LVM with a high degree 
of precision. UFCT demonstrates potential for measurement of 
L VM, especially applicable for serial measurement in pts with 
hypertension. 
158A ABSTRACTS 
VALIDATION OF LOW-INTENSITY ZONES IN MAGNETIC RESONANCE 
IMAGES OF HYPERTROPHIED MYOCARDIUM: RELAXATION-TIME 
CHARACTERISTICS. 
Raphael Zahler MD, PhD, FACC, D Chelmow, John Gore PhD, 
HD Sostman MD, C Pope MD, Frans Wackers MD, FACC, Barry 
L Zaret MD, FACC, Yale University, New Haven, CT. 
Preliminary exploratory studies on a 0.15 Tesla 
imaging system performed with cardiac (but not res-
piratory) gating showed that Magnetic Resonance (MR) 
images of hypertrophied human LV myocardium (LVH) 
contained characteristic low-intensity zones ("valleys") 
which correlated with duration of disease and with LVH 
by ECG. Such changes were not present in MR images of 
normal myocardium. Similar results were found in a dog 
model of LVH. To validate these findings in a 
prospective fashion and eliminate possible artifacts, we 
imaged 9 patients with LVH and 3 controls with cardiac 
gating and respiratory compensation at 1. 5 Tesla. 
Normalized valley area (NVA) consistently separated LVH 
patients from controls (.16 vs .04, p=.013). The effects 
of field strength, use of respiratory gating, gating 
point (R-wave or T wave), species (human vs dog) or 
operator-defined edges on NVA was assessed with analysis 
of variance: NVA did not depend on any of these 
variables but showed a significant difference (p<.05) 
between LVH and controls in all comparisons. Noise level 
was not different between patients and controls. Valleys 
occurred in sagittal as well as axial images of LVH 
patients. In 4 patients, valley points corresponded to 
areas of either normal (mean 36.5 ms) or increased 
apparent T2, suggesting that the low signal intensity 
may correspond to increased calculated relaxation times. 
Thus, MR tissue heterogeneity reproducibly distinguishes 
normal from hypertrophied LV myocardium and is not an 
artifact of acquisition or processing technique. It is 
thus likely to reflect pathophysiologic alterations. 
DETECTION OF LEFT VENTRICULAR THROMBI: COMPARISON OF 
MAGNETIC RESONANCE IMAGING, COMPUTED TOMOGRAPHY, 
ECHOCARDIOGRAPHY, ANGIOGRAPHY, AND SURGERY. 
U Sechtem K. Hungerberg, J. Smolorz, H. Deutsch, W. Heindel, 
J.M.Curtlus, H.W. H6pp, H. Schlcha 
Medical Clinic III, University of Cologne, West Germany 
Left ventricular thrombi are common In patients with acute and 
chronic anterior myocardial Infarction. To evaluate the sensitivity and 
specificity of various Imaging techniques In the detection of thrombi, 
14 patients anterior myocardial Infarcts (mean Infarct age 38 months) 
who underwent left ventricular aneurysmectomy were prospectively 
examined by spln·echo magnetic resonance Imaging (MRI) (N=14), 
computed tomography (CT) (N=9), echocardlography (echo) (N=14), 
and angiocardiography (anglo) (N=12). All examinations were 
performed within 4 weeks of each other. 
One (8%) anglographlc and 2 (14%) echocardlographlc 
stud las ware technically Inadequate for assessment. At surgery, 
thrombi were found In 8 patients. 
Sensitivity [%) 
Specificity [%) 
MRI 
7/8 (88) 
5/6 (83) 
CT 
4/6 (67) 
3/3 (100) 
Echo 
5/6 (83) 
5/6 (83) 
Anglo 
5/7(71) 
4/4 (100) 
On. patient had 2 very small thrombi which were not detected 
by all techniques. Larg. apical thrombi were conSistently visualized 
by all technique •• Layerad thrombi located towards the basis of the 
laft ventricle were more difficult to diagnose with echo and anglo. 
Computed tomography and magnetic rasonance Imaging may be 
u.aful In the avaluatlon of patients with left ventricular aneurysms 
and clinical suspicion of thrombi If echocardlography cannot 
establish the diagnosis. Magnatlc resonance has tha advantage of 
avoiding exposura to Ionizing radiation and contrast media. 
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DETECTION AND QUANTITATION OF PERICARDIAL EFFUSION USING 
NUCLEAR MAGNETIC RESONANCE IMAGING TECHNIQUES 
Roxann Rokey. M.D F.A.C.C, , Roberto Bolli, M.D., 
F.A.C.C., Douglas Lewandowski, Ph.D, G. Wesley Vick, M.D., 
Robert Roberts, M.D., F.A.C.C., Donald Johnston, M.D., 
F.A.C.C., Baylor College Of Medicine, Houston, TX 
Pericardial effusions can be detected with nuclear mag-
netic resonance (NMR) imaging techniques. However, the 
sensitivity for detection of and the ability to quantitate 
pericardial effusion using NMR imaging techniques still 
requires verification. Thus, we evaluated NMR images in 
dogs with experimentally induced pericardial effusions. 
Two pericardial catheters were inserted near the apex. 
Control short axis NMR images at the base, mid and distal 
LV were obtained (TE/TR-35 msec/R-R interval). Incremental 
doses of saline (5 to 20cc, up to a total of l80cc) were 
infused into the pericardial space and NMR images were 
taken after each infusion. For each animal, 7-11 incre-
ments of fluid were given. RESULTS: The pericardium was 
not seen on any images. The presence of pericardial fluid 
subsequently seen (decreased signal intensity) was 
delineated by surrounding pericardial fat (rim of bright 
signal intensity). As little as 5cc of fluid were 
visualized at the apex in 3 of 5 animals and fluid was 
clearly present in all at 10cc. With each addition of 
saline, the distance between pericardial fat and epi-
cardium increased linearly: 
BASAL VENTRICLE Y(cm)-0.14+0.006X(cc); r-0.7l 
MID VENTRICLE Y(cm)-O.13+0.008X(cc); r-0.92 
DISTAL VENTRICLE Y(cm)-0.27+0.008X(cc); r-0.9l 
Despite the good correlation of distance measurements to 
fluid content, overlap of individual values between given 
amounts of fluid occurred. However, separation of O-lOcc, 
20-60cc, 80-l40cc and >160cc at the apex could be made. 
CONCLUSION: NMR imaging appears to be a sensitive tech-
nique for the detection and quantitation of pericardial 
fluid. 
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Chronic Aortic Regurgitation: Natural History 
REVERSAL OF LEFT VENTRICULAR DILATATION, HYPERTROPHY AND 
CONTRACTILE DYSFUNCTION BY REPLACEMENT OF REGURGITANT 
AORTIC VALVES. Lisa Klein, B.S., Mary J. Roman, M.D., 
Richard B. Devereux, M.D., F.A.C.C., Nathaniel W. Niles, 
M.D., Clare Hochreiter, M.D., Paul Kligfield, M.D., 
F.A.C.C., Jeffrey S. Borer, M.D., F.A.C.C. Cornell 
University Medical College, New York, N.Y. 
Although aortic valve replacement (AVR) for aortic 
regurgitation CAR) relieves LV volume overload, LV 
geometry does not oonsistently normalize. To assess the 
extent, determinants and functional consequences of 
reversal of LV dilatation and hypertrophy, we studied 38 
pts with severe AR pre- and postop by serial echocardio-
graphy and radionuclide cineangiography. LV end-diastolic 
dimension (LVIDd) normalized in 58' of pts by the first 
post-op study (9~ months), at which time 50' of pts had 
normalized mass; oumulative normalization rose to 66' for 
LVIDd and 68' for LV mass during further followup. All 
pts who normalized LVIDd also had normal postop ejeotion 
fraotions (mean 61~8J). Normalization of dimension and 
funotion was assooiated with a reduotion in after load 
[end-systolio stress (ESS) 129~25 to 76~3 x 103 dynes/cm~ 
p(O.001] and an inorease in LV oontraotile fUnotion to 
normal in all patients [ESS/ES volume index (ESS/ESVI) 
2.3~0.7 to 3.3±9.6 x 107 dynes/om3 , p(O.001]. In oontrast, 
pts in whom the LV remained dilated had a 42' prevalenoe 
of subnormal postop LV ejeotion fraction and signifioantly 
lower ESS/ESVI than pts with normal LVIDd (2.3+0.6 vs 3.3+ 
0.6, p(0.001). Preop LV end-systolio dimension ~5mm -
identified 86' of pts who normalized LVIDd. No partition 
values usefully predioted persistent dilatation or 
hypertrophy. Thus: 1) AVR normalizes LV ohamber size and 
I1188S in 213 of pts ourrently operated for AR; and 2) 
favorable geometrio outoome is assooiated with evidenoe of 
normalization of LV oontraotile funotion. 
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THE NATURAL HISTORY OF ASYMPTOMATIC PATIENTS WITH CHRONIC 
AORTIC RmURGITATION: SERIAL LONG-TERM CHANGES IN LEFT 
VENTRICULAR FUNCTION 
Robert O. Bonow, MD, FACC, Edward Lakatos, PhD, Barry J. 
Maron, MD, FACC and Stephen E. Epstein, MD, FACC. 
NHLBI, Bethesda, Md. 
Many asymptomatic pts with aortic regurgitation (AR) and 
normal LV systolic function remain clinically stable for 
many years, but others ultimately develop symptoms and 
require operation. To identify indexes of LV function 
predictive of symptomatic deterioration during the long-
term course of asymptomatic AR, we studied 104 asympto-
matic pts with chronic severe AR and normal LV ejection 
fraction (EF) at rest. Serial echo (average 6.4/pt) and 
radionuclide angiographic (average 5.5/pt) studies were 
obtained over a mean follow-up period of 8 yrs (range 2-15 
yrs). At 11 yrs, 58+8$ of pts r .. ained asymptomatic with 
normal EF, an attritIon rate <4$/yr; 3 pts died suddenly 
and 18 underwent operation because symptoms developed. By 
life table analysis, many variables on initial stud)' were 
associated with death or symptoas, including age, LV sys-
tolic dimension (SD), diastolic dimension, fractional 
shortening, and magnitude of decrease in EF with exercise 
(all P<.001). In addition, after adjustment for baseline 
values, the average rate of ohange in rest EF, fraotional 
shortening, and LVSD (IISD) provided additional predictive 
value (all P<.01). By multivariate analysis, only age, 
initial LVSD, and IISD during serial studies predicted out-
come. In pta with in1tiiIJ. LVSD >lI5_, the likelihood of 
death or symptoas was 9$/yr; this deoreased to 4$/yr it 
IISD was <lm/yr and increased to 19$/yr it IISD was >lllll/yr. 
Thus, serial ohanges in LVSD helped to atratify asympto-
matio pts with AR and normal rest EF. Pts may be at low 
risk, despite LV dilatation, it there is no progressive 
change in LVSD during the oourse of serial studies. 
FACTORS ASSOCIATED WITH PROGRESSION TO AORTIC VALVE 
REPLACEHENT IN CHRONIC AORTIC INSUFFICIENCY Deirdre 
Siemiem:zuk RN, Barry Greenberg MD FACC, Cynthia-l'IOr'i''i's 
f'fiU;-'1iIiTi',ij'--To'ic RN, Richard A. Wilson MD FACC, J. David 
Bristow MD FA~C, Melvin Cheitlin MD FACC, Barry Massie MD 
FACC. Oregon Health Science Univ., Portland,oR and 
VAMC,San Francisco, CA 
Although previous studies describing the natural history 
of patients (pts) with aortic insufficiency (AI) have 
identified risk factors for progression to aortic valve 
replacement (AVR), they have been retrospective or have 
included pts who, due to clinical unstability or 
presence of mild disease, were of limited interest. We 
therefore analyzed baseline variables in 51 adult pts 
with isolated chronic AI who had left ventricular (LV) 
enlargement as evidenced by an end-dias201ic volume index (EDVll which ranged from 105-273 cc/m (164 + 48 mean + 
SD). All pts were asymptomatic and had a-- preserveCl 
ejection fraction (EF) (.67 + .OB) at rest on initial 
study. During a median follow=up of 42 months (range 9 -
57), II pts progressed to AVR due to onset of symptoms or 
LV dysfunction. There were significant baseline 
differences between the AVR group and th~ stable group 
(n=41) in EDVI (IBO + 62 vs 144 + 34 cc/m : p= .01: AVR 
vs stable), ~nd-systoTic volume index (ESVI) (62 + 35 vs 
40 + 16 cc/m: p =.05), and en~~systolic ~all -stress 
(ESS) (94 + 24 vs 73 + 18 Xlv- dynes/cmF: p=.025). 
Results of'- life-table-' analysis, stratifying pts by 
baseline values and comparing progression to AVR at 54 
C~~~8tEar_~_t>~J-N'~-·-BASELINEYAi.lE--XTbA~P VALUE 
'RestEOVr-----23 "---rr5-0---~ 10 ' 
(cc/m2) 2B (150 23 +" 11 .04 
~~~~!~rS\Ti'-"'-Jf-'--- ~%g'----'''lrrrr---~ 
;nercTs'''-EF'---Jr--- ~%g -----~rf1r----. 0-;;-
;~§-~'y'~:~'~m2;-I~-- ~;g ~$ ~ t~ .04 --
i"fi"usln'lnes-ecTTnlcaTTV-Stabie-'pts-witfi-.rr-'arnr--LV 
enlargement,progression to AVR was uncommon, but more 
frequent in pts with larger EDVI and ESVI, higher ESS, 
and lower exercise EF. We conclude that evaluation of LV 
size and function at baseline is helpful in predicting 
progression to AVR. 
ABSTRACTS 
LONG TERM CHANGES IN LEFT VENTRICULAR DIMENSIONS IN 
PATIENTS WITH AORTIC REGURGITATION WITH AND WITHOUT 
VASODILATOR THERAPY 
Jean G. D\DDesnil, M.D., F.A.C.C., Quang K. Tran, M.D. 
and GiIIes R. Dagenais, H.D., F.A.C.C., Quebec Heart 
Institute, Quebec, Canada 
To determine the long term changes in left ventricular 
(LV) dimensions in asymptomatic ~atients with 
significant aortic regurgitation (AR), echocardio-
graphic data of 19 patients followed yearly for up to 4 
years were reviewed. The patients were divided into 2 
groups: Group I, 12 patients (mean age±SD: 37±8 years) 
not receiving vasodilators and Group II, 7 patients 
(4S± 12 years) receiving Hydralazine at various dosages 
(40 to 200 mg i.d.). All patients were in sinus rhythm, 
without significant aortic stenosis or evidence of 
coronary artery disease; LV end-diastolic (LVED) and 
LV end-systolic (LVES) dimensions and LV fractional 
shortening were measured independently by two observers 
unaware of medication. 
Results 
FoIIow-up >-1 0 1 2 
Group I No Vasodilators 
LVED (mm) 6l±8 62±8** 6S±8** 
LVES (mm) 40±6 4l±6* 44±6** 
FS .34±.OS .33±.OS .34±.OS 
Group II Hydralazine 
LVED (mm) 63±2 68±3** 63±S* 
LVES (mm) 43± 2 4S±4 42±3** 
FS • 32± .03 • 33±.OS • 34± .02 
**p < 0.01 *p < O.OS 
66±3* 
43±3 
.3S±.03 
3 years 
66±8** 
4S±6** 
.31±.OS* 
6S±6 
43±3 
.34±.03 
LV dimensions increased progressively in all patients 
with no vasodilators; with hydralazine, they decreased 
in all patients during the first year but re-increased 
slowly in 3 patients afterwards. We conclude that LV 
dilatation in asymptomatic patients with AR is a slow 
process which can be delayed by the administration of 
Hydralazine. 
ASYMPTOMATIC SEVERE AORTIC REGURGITATION. A PROSPECTIVE 
FOLLOW-UP OF 60 PATIENTS. 
A.M. Yousof, F.R.C.P., M. Mousa, Ph.D., N. Khan, M.D., 
H. Shuhaiber, F.R.C.S., G. Cherian, F.R.C.P., F.A.C.C., 
Chest Hospital and Faculty of Medicine, Kuwait. 
159A 
To study the progression, parameters of left ventricular 
dysfunction (LVD) and effect of aortic valve replacement 
(AVR) on (LVD) , we prospectively followed 60 asymptomatic 
patients with severe aortic regurgitati'on (AR) up to end 
points of death or AVR. All had a pulse pressure ~ 80 
rom Hg and diastolic pressure ~ 60 mm Hg. 
The average age was 26 ± 10 years. Echocardiographic end 
systolic diameter (ESD) ~ 48mm correlated well with an 
angiographic ejection fraction (EF) < 50%.(sensitivity 
89% and specificity 79%). Group A (21 patients) had ESD ~ 
48 mm and group B (39 patients) < 48 mm. Nineteen patients 
crossed over from group B. The rate of progression of ESD 
was slower in group A at 1.93 ± 2.1 mm/year (P=0.01). 
One patient died of cerebral embolism. Twelve required 
AVR after average follow up of 2.52 ± 1.69 years. Of 
these, 9 had become symptomatic. All 12 had significant 
LV» with an EF of 43.7 ± 4.2% and all had ESD > 48 mm. 
(51.9 ± 4.3 mm). There was no mortality and all improved. 
One patient with very low preoperative EF of 25% who had 
initially refused surgery has been excluded from 
postoperative evaluation. After AVR, the ESD decreased to 
37.7 ± 4.2 mm(P=>0.0005) and angiographic EF evaluated in 
7 increased to 66 ± 6.5% (P=>0.0005). 
In conclusion, Severe AR can progress rapidly in some re-
latively young and asymptomatic patients. An ESD ~ 48 mm 
separates a group'of severe AR patients with EF < 50% re-
quiring further evaluation. There was no residual LV» 
after AVR in a group with preoperative LVEDP of 15.3 ± 
5.3 mm Hg, EF of 43.7 ± 4.2% and ESD of 51.9 ± 4.3 mm. 
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EFFECT OF AORTIC COMPLIANCE ON LEFT VENTRICULAR VOLUME 
AND FUNCTION IN PATIENTS WITH AORTIC INSUFFICIENCY. 
Neal Perlmutter, MD, Richard Wilson, MD, Robert McDonald, 
BS, Barry Greenberg, MD, FACC, Lien Nguyen, MD, Nils 
Jacobson, Deirdre Siemienczuk, RN, Barry Massie, MD, 
FACC, Melvin Cheitlin, MD, FACC, J. David Bristow, MD, 
FACC, Oregon Health Sciences University, Portland,Oregon. 
We postulated that an age-related decrease in aortic 
compliance (AC) may contribute to the gradual hemodynamic 
deterioration observed in patients with chronic aortic 
insuffiency (AI). Accordingly, we evaluated 31 patients 
(age 13-79 years) with chronic isolated AI and minimal 
or no symptoms. Ascending aortic diameter was measured 
by 2-D echocardiography at 4 cm above the aortic valve; 
pulse pressure was measured simultaneouslybysphygmomano-
metry. AC was calculated as [change in aortic diameter 
from diastole to systole 7 end-diastolic aortic diameter] 
~ pulse pressure. Left ventricular end-diastolic volume 
(LVEDV) and ejection fraction (EF) were measured at rest 
and during supine bicycle exercise by radionuclide angio-
graphy. 
AC decreased with advancing age (r=.80, p<10-6). As 
AC declined, LVEDV increased (r=.54, p=.002) and the 
change in EF from rest to exercise decreased (r=.37, 
p=.04). 
Eight of these patients eventually required aortic 
valve replacement during a mean follow up period of 
3.9~1.1 years. Those patients with an AC less than 
.20 mmHg- I (n=13) were more likely to require aortic 
valve replacement than patients with higher compliance 
(n=18, p=.006). 
We conclude that the decrease in ascending aortic 
compliance that is seen with advancing age may contribute 
to the gradual LV dilatation and dysfunction seen in 
patients with chronic AI. 
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Cardiovascular Disease Among the Elderly I: Therapy 
AGE IS AN INDEPENDENT PROGNOSTIC FACTOR IN 
DETERMINING LONG-TERM OUTCOME IN PATIENTS WITH 
CONGESTIVE HEART FAILURE. Marrick L. Kukin MD, Milton 
Packer MD, FACC, Stephen S. Gottlieb MD, Paul D. Kessler MD, 
Pet.er B. Wilson MD, Norma Medina RN, Madeline Yushak RN, 
WOI Hung Lee MD, FACC. Mt. Sinai Sch of Med, New York NY 
Previous studies of the long-term outcome of pts' with 
~ongestive heart failure (CHF) have concluded that age is not an 
!mportant factor in determining survival, but these reports 
Includ,;d. few elderly pts. We evaluated the influence of age on 
the cllmcal, hemodynamic and biochemical characteristics of 
CHF and its long-term outcome in 316 pts with severe CHF 
most of whom were elderly (median age, 66 years). ' 
Older pts with CHF (<1;66 years) were similar to younger pts 
«66 years) with respect to cardiac index, LV filling pressure 
mean arterial pressure and systemic vascular resistance, but 
older pts had a lower heart rate (83 vs 87 bpm, p<.OI) and a 
higher LV ejection fraction (0.19 vs 0.15, p<.OOI) and tended to 
have a lower plasma renin activity (7.0 vs 11.1 ng/ml/hr, p = .13). 
Based on the differences in these 3 prognostic factors, we would 
have expected older pts to have fared better than younger pts. 
~owever, older pts were also more likely to have ischemic heart 
disease (68% vs 50%, p <.01) and had worse renal function (serum 
creatinine 2.1 vs 1.6 mg/dl, p<.OOI) than younger pts and these 
differences would be associated with an unfavorable p;ognosis. 
Despite the higher LV ejection fraction and lower heart rate 
and plasma renin activity, older pts with CHF had a significantly 
wor~e long-term survi~al than younger pts (1- and 2-year 
surVival, 39% and 20% In pts <1;66 years compored with 54% and 
33% in pts<66 years, p<.OOI). Age provided independent 
prognostic information, even after these data were corrected (by 
Cox regression analysis) for the higher prevalence of ischemic 
heart disease and renal dysfunction in the older pts. 
In conclusion, advanced age is a poor prognostic factor in CHF 
pts. and <;,ppears t? .outweigh co-existing favorable prognostic 
vanables In determining long-term survival in elderly CHF pts. 
JACC Vol. 11, No.2 
February 1988:160A 
HEART FAILURE IN THE ELDERLY: DIASTOLIC DYSFUNCTION WITH 
PRESERVED SYSTOLIC FUNCTION AND NORMAL CORONARY 
ARTERIES. WJ Mannin~ MD, G Hung MD, JA Parker MD 
DR Rigney PhD, Jy Wel MD, FACC. Beth Israel Hospital 
Harvard Medical School, Boston, MA. ' 
Recently, several studies have documented the high 
prevalence of primary diastolic dysfunction with 
preserved systolic function in elderly patients with 
clinical congestive heart failure (CHF). To test the 
hypothesis that calcium antagonist therapy may improve 
diastolic filling in these patients, we studied six 
elderly heart failure patients with dyspnea, intact 
systolic function, and angiographically normal coronary 
arteries. The mean LV end-diastolic pressure was 18 
mmHg. High resolution gated radioventriculograms (RVG) 
were performed in the supine position from the modified 
LAO view. Left ventricular ejection fraction (LVEF) 
peak filling rate (PFR), and % filling in the first third 
of diastole ~1/3) were all obtained before and 180 
minutes following a single 90 mg oral dose of diltiazem. 
Results (mean*SD) obtained were: 
%1/3 
Baseline 
Post-diltiazem 
LVEF 
.63*.16 
.72*.22* 
PFR 
2.1*1.1 
2.5*1.4** 
.28* .11 
.46*.19*** 
*p<.025, **p<.10, ***p<.05 
Conclusion: In elderly patients with clinical CHF 
diastollc dYsfunction and normal coronary arteries • 
diltiazem significantly improves early LV diastoli~ 
filling as well as the global LV ejection fraction. 
These findings suggest that calcium antagonist therapy is 
beneficial in older patients with CHF due to a primary 
diastolic impairment. 
THE EFFECTS OF AGING ON THE VENODILATORY RESPONSE TO 
NITROGLYCERIN. 
Claude Fanelli, M.D., Robert Zelis, M.D., F.A.C.C., and 
Joseph A. Gascho, M.D., F.A.C.C., Penn State University, 
College of Medicine, Hershey, PA 
Although aging alters arterial impedance, little is 
known about the effects of aging on venous tone. We 
therefore measured venous tone before and after 0.8 mg 
nitroglycerin (NG) spray in 23 healthy elderly volunteers 
(70 ~ [X~SDJ. range 61-91 years) and in 23 healthy 
controls (age 32 ,:: 5·, 22-40 years). Subjects were 
studied supine in a warm quiet environment. The 
equilibration technique was used to determine venous 
distensibility. The increase in forearm volume induced 
by cuff inflation to 30 mmHg above cuff zero (VV [30], 
cc/l00 cc arm) and the increase in volume occurring after 
NG were measured by mercury-in-silastic plethysmography. 
Forearm volume was measured at the plateau occurring 2-3 
min after cuff inflation, and at the plateau 4-6 min 
after NG, with the cuff still inflated. 
RESULTS: HR(b/min) BP(mmHg) VV[30] AVV[30] 
Young PreNG 59+9 81+6 3.26+1.35 
PostNG 66+11 82+8 3.84+1. 53* .58,::.31 
Elderly PreNG 64+10 97+11 + 1.99+0.61 + 
PostNG 72+11* 93~8.+ 2.21+0.72*+ .22+.16* 
*p<0.05 vs preNG; + p<O.05 vs young 
Baseline venous tone was significantly higher in the 
elderly. Both the absolute venodilatory response to NG 
(.22 vs .58 ccll00 cc arm) and the percent increase in 
venous distenSibility (10+6% vs 19+8%) were attenuated in 
the elderly compared to the young. Although BP was higher 
in the elderly, multiple regression analysis showed that 
age, not BP, correlated with the response to NG. 
These results suggest that aging reduces venous 
distensibility and that the venodilatory effect of 
nitroglycerin is attenuated in elderly patients. 
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AORTIC BAlLOON VALVULOPLASTY: TIlERAPY OF CHOICE 
FOR TIlE VERY OLD SYMPfOMA TIC PATIENT wrrn AORTIC 
STENOSIS Sergio M. Manubens MD, Thomas A. Ports MD, 
FACC, James P. Srebro MD, Eric L. Johnson MD, Paul G. Yock 
MD,FACC. University of California, San Francisco, California. 
We reviewed the clinical course of 20 patients (pts) over the age of 
85 who were candidates for aortic balloon valvuloplasty (ABV) at 
UCSF over an 18 month period. All patients were severely 
symptomatic with dyspnea, NYHA class III or IV in 18/20 (90%), 
angina pectoris (class II or III) in 5/20(25%) and syncope in 5/20 
(25%). Mean age of the group was 92 with a range of 85-100. 
ABV was successfully accomplished in 18/20 (90%) ofpts. In one 
pt central access could not be gained from femoral or brachial 
approaches; in a second pt catheters could not be advanced across the 
aortic valve despite successful crossing with a guidewire. 
Hemodynamic measurements before and immediately post-dilatation 
demonstrated an approximate doubling of aortic valve area: 
mean gradient (mmHg) 
aortic valve area (sq cm) 
cardiac output (LImin) 
* p < .05 
PRE-ABY POST-ABY 
68± 23 29± 17 * 
.47±.16 .94± ,30 * 
3.9± .7 4.3± .6 
Complications included: (1) one death (5%) in a pt with severe 
coronary artery disease 5 days post ABV due to myocardial infarction 
following drug-induced hypotension; (2) one pulmonary embolism 3 
days post ABV without sequella; (3) one patient with a laceration of 
the profunda femoral artery requiring surgical repair. 
The length of hospital stay for the 15 patients without complications 
was 3± 1 days. Follow-up data on these patients for a median of 6 
months demonstrated significant improvement in dyspnea with 85% 
of patients in NYHA class I/II. Two patients had recurrence of 
symptoms (13%); both had return of gradients to predilatation values 
by Doppler ultrasound. 
Aortic balloon valvuloplasty can be performed successfully in the 
very elderly patient with an acceptable rate of complications and good 
symptomatic improvement 
PREVALENCE OF EXTRA-CRANIAL CAROTID ARTERY DISEASE IN 
ELDERLY PATIENTS UNDERGOING CARDIAC SURGERY 
William G. Marshall, Jr., M.D., FACC, Marsha A. Marshall, 
B.S.N., R.N., Suzan F. Murphy, R.N., Nicholas T. 
Kouchoukos, M.D., FACC; Jewish Hospital at Washington 
University Medical Center, St. Louis, Missouri 
Extra-cranial carotid artery disease (ECCAD) is a 
significant predictor of neurologic complications 
following cardiac surgery, and the incidence of these 
complications is increased in elderly patients. A 
prospective study to define the prevalence of ECCAD 
determined non-invasively by pre-operative duplex 
scanning (B-mode Ultrasonography and Pulse-Doppler Sound 
Spectral Analysis) was performed in 250 consecutive 
pat·ients > 65 years old undergoing cardiac surgical 
procedure;. Two hundred thirty-five of the 250 patients 
(94%) had coronary artery disease. The mean age was 72 
years (range 65-87) and 155 (62%) were male. Of the 
entire group, 46 patients (18.4%) had stenosis> 50% of 
one or both internal carotid arteries. The degree of 
stenosis was 50%-75% in 19 (7.6%) and> 75% in 27 (10.8%). 
The prevalence was higher in symptomatic patients 
(previous stroke or TIA), (7/19, 37%) than in 
asymptomatic patients (39/231, 17%) (p= 0.057) and was 
higher among patients with cervical bruits (26/46, 57%) 
than among those without bruits (20/203, 9.9%), 
(p < 0.001). Bilateral disease was identified in 13 of 
231 asymptomatic and 5 of 19 symptomatic patients; and 
was> 75% in 14 of these patients (78%). This study 
demonstrates a substantial incidence of ECCAD in elderly 
patients undergoing cardiac surgical procedures; even 
among asymptomatic patients (17%) and patients without 
bruits (10%). Accurate pre-operative non-invasive 
identification of ECCAD may permit design and implementa-
tion of strategies to reduce the frequency of peri-opera-
tive neurolo&ical complications related to this disorder. 
ABSTRACTS 161A 
INCREASED COMPLICATIONS AND PROLONGED HOSPITAL STAY IN 
ELDERLY CARDIAC SURGICAL PATIENTS WITH LOW SERUM ALBUMIN 
Michael W. Rich, MD, FACC, Andrew J. Keller, MD, Kenneth 
B. Schechtman, PhD, William G. Marshall, MD, FACC, and 
Nicholas T. Kouchoukos, MD, FACC, Jewish Hospital at 
Washington University Medical Center, St. Louis, MO 
To determine the effect of pre-operative nutritional 
status on the incidence of post-operative complications 
in elderly patients undergoing major cardiac surgery, 92 
Pts over 75 years of age (range 75-90) were evaluated. 
The operative procedure consisted of aortocoronary bypass 
in 53 Pts, valve replacement in 21 Pts, and a variety of 
other procedures in 18 Pts. Peri-operative mortality was 
15.2% (N-14), and an additional 57 Pts (62%) had at least 
one other major complication. 
Thirteen Pts (Group 1) had serum albumin levels < 3.5 
g/dl, while the remaining 79 Pts (Group 2) had a normal 
albumin. Compared to Group 2, Group 1 Pts had a higher 
incidence of post-operative confusion, congestive heart 
failure, low cardiac output, renal dysfunction, and 
gastrointestinal complications (all p< .05). Post-
operative length of stay was markedly prolonged in 
Group 1 Pts (28.3 vs 12.3 days, pm.003), and mortality 
also tended to be higher (30.8% vs 12.7%, p-.ll). Uaing 
multivariate analysis, serum albumin < 3.5 g/dl was the 
most potent predictor of post-operative renal dysfunction 
(p=.Ol), and also remained as an independent contributor 
to post-operative length of stay (p·.04). 
CONCLUSION: Pre-operative malnutrition, as indicated 
by a serum albumin level < 3.5 gldl, is associated with 
an increased risk of major complications and a prolonged 
hospital stay in elderly Pts undergoing cardiac surgery. 
Increased attention to nutritional factors is warranted 
in these Pts. 
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AUTOMATIC EXTERNAL DEFIBRILLATORS CAN BE USED BY FIRST 
RESPONDERS TO IMPROVE SURVIVAL RATES IN PATIENTS WITH 
OUT-OF-HOSPITAL CARDIAC ARREST. 
W. Douglas Weaver, M.D., F.A.C.C., Carol Fahrenbruch, 
MSPH, Michael K. Copass, M.D., Jenny Martin, BSN, Deborah 
Hill, BA, Leonard A. Cobb, M.D. F.A.C.C., University of 
Washington, Seattle. 
The effect of automatic external defibrillators (AED) 
used by first responders to initially treat 
out-of-hospital cardiac arrest was assessed in 1287 
consecutive patients receiving emergency cardiac care. 
Half (687) of these patients were initially treated by 
first responders using an AED, while the others received 
only basic life support prior to arrival of paramedics. 
The ABD was accurate: it shocked 93% of patients with 
ventricular fibrillation (VF), and delivered no 
inappropriate shocks (1 patient with asystole was 
shocked). Of the 276 patients who were discovered in VF 
and treated with the AED: 163 (59%) were resuscitated and 
84 (30%) survived. Survival rates were lower in the 228 
VF patients not treated with an AED: 123 (53%) were 
resuscitated (psNS) and only 44 (19%) survived (p< 
0.01). Of the 794 patients who were discovered in 
asystole or electromechanical dissociation, 18 (2%) 
survived. In a multivariate analysis of the possible 
factors predictive of survival in VF patients, age (p< 
0.03), a witnessed collapse (p< 0.001), coarse 
fibrillation waveform (p< 0.001), paramedic response time 
(p< 0.04) and initial treatment by an AED prior to 
arrival of paramedics (p< 0.03) were predictive of 
survival. 
We conclude that ~ED are a new and important adjunct in 
the emergency management of out-of-hospital cardiac 
arrest. 
162A ABSTRACTS 
AUTONOMIC, NOT LEFT VENTRICULAR DYSFUNCTION IS THE 
CAUSE OF HAEMODYALYSIS INDUCED HYPOTENSION. 
Mary Heber, MRCP, Avijit Lahiri, MSc, *Frank D 
Thompson, MD, and Edward B Raftery, MD, FACC. 
Northwick Park Hospital and Clinical Research Centre, 
Watford Road, Harrow, Middx, England. *Renal Unit, St 
Paul's Hospital, Endell Street, London EC2. 
Both autonomic and left ventricular (LV) dysfunction 
have been postulated as causes of the serious 
hypotension which is a frequent complication of 
haemodialysis (HD). In 10 patients with chronic renal 
failure (CRF), maintained on RD, intra-arterial 
ambulatory blood pressure (BP) monitoring was used to 
record BP over 24 hours prior to, and continued during 
HD. Autonomic function tests and radionuclide 
ventriculography were performed at the commencement of 
the 24 hour recording. On the day of HD ejection 
fraction (EF) was measured with the Nuclear Stethoscope 
immediately before RD, then after 5, 10, 15 and 30 mins 
and 1/2 hourly throughout HD. Day/night BP and heart 
rate (HR) variation were significantly reduced in 9 of 
the patients with CRF (BP 12/7 + 8/6 mmHg, HR 6+4) 
compared with a control population (BP 36/28 + TO/5 
mmHg, HR 23 + 9), as was their response to the Valsalva 
manoevre. They experienced a progressive fall in BP 
during HD (mean maximum fall 42/21 + 15/11) but their 
heart rate rose little (4.5 + 5), despite the volume 
depletion and hypotension. T patient with less 
autonomic impairment did not drop his BP on RD. All 
patients had normal or high resting EF (mean 66%, range 
55-79%), none dropped their EF during dialysis. Thus 
hypotension was not due to LV dysfunction but to 
autonomic failure, presumably causing failure of 
barorecepter response to volume depletion during HD. 
LONG-TERM PROGNOSIS OF PATIENTS WITH ACUTE 
TYPE B AORTIC DISSECTION TREATED MEDICALLY. 
Gilbert Kil-korian, M.D.,Brigitte Hochmann, M.D., Antoine 
Kassis, M.D., Georges Atallah, M.D., Marie P.Mathieu, 
M.D., Roland Rossi, M.D., Pascal Sagnol, M.D., Paul Touboul, 
M.D •• Hopital Cardiologique, Lyon, France. 
The optimal form of treatment of patients (pts) with 
acute type B aortic dissection (AD) remains controversial. 
Our policy was to treat these pts medically 
(antihypertensive drug therapy) unless complication occurred. 
From 1969 to 1985, 200 unselected consecutive pts with 
acute (less than 14 days old) AD were admitted to our 
intensive care unit. 42 pts had type B dissection. 3/42 died 
shortly after admission (diagnosis at autopsy). The diagnosis 
was confil-med angiographically in the remaining 39 pts 
that comprise the present report. There were 2.8 men and 
11 women. Ages ranged from 2.7 to 83 years and averaged 
58 1: 13 years (mean 1: SD). 2.9 pts were known to have 
hypertension, 1 pt had Marfan's syndrome. Two pts were 
operated upon due to hemothorax (1) or secondary extension 
to the ascending aorta (1). Hospital mortality was 31 %. 
2.7 pts were discharged alive. Average follow-up span was 
381: 33 months (range: 1-111 months). Three pts required 
surgery due to development of a large false aneurysm (1) 
or to a type A AD (2) respectively at 16, 27 and 73 months. 
The 5 year actuarial survival rates for the 27 discharged 
pts were 80 1: 8 % (deaths related to cardiovascular events 
only) and 71 1: 20 % (any death). 
We conclude that medical treatment (unless complication) 
of pts with acute type B AD allows long-term survival 
rates comparable to those reported in surgical series. 
JACC Vol. 11, No.2 
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PULMONARY VEIN BLOOD FLOW IN NORMALS AND IN 
CARDIAC DISEASE. 
Jacques Genest MD. K. McInerney. M. Csldeira. 
Natesa Pandian MD. Tufts-NEMCH.Boston. MA. 
To characterize pulmonary venous (PV) flow 
patterns in normal and abnormal hearts. we 
obtained PV flow velocity (V) recordings with 
pulsed Doppler in lS normals and 26 pts with 
various cardiac disorders. We analyzed peak V. 
duration. and pattern of flow and correlated 
these with echo and clinical data. Results: 
NORMALS: PV flow was pulsatile and biphasic 
with one component during ventricular systole 
(SF) and the other during dissto1e (DF). SFV 
was generally equal to DFV (.47~16 m/sec 
vs.SO+.14 m/sec; p=NS) with an overall SFV/DFV 
ratio-of 1.02. The duration of SF and DF were 
equal with SF/DF ratio of 1.0S. SFV/DFV ratio 
tended to increase with age (y=0.018x + 0.3. 
r=.66). ABNORMALS: Patients with LV 
hypertrophy had increased SFV/DFV ratio 
compared to normals (1.39~.24 vs 1.05~.48; 
p<.OS). In mitral stenosis. duration of DF was 
relatively increased compared with normals 
(SF/DF duration ratio 0.83+.1 vs 1.0S+.18; 
p<.Ol). wheras in mitral regurgitatio; there 
was a relative increase in duration of SF. with 
SF/DF duration of 1.3S+.36 vs 1.0S+.18. 
(p<.OS). Severe mitral regurgitation caused 
attenuation of SF. Constrictive pericarditis 
pts had reduction of SF as well ss delay of 
onset of DF. We conclude that disorders of the 
left heart produce alterations in pulmonary 
vein flow that can be detected and quantified 
non-invasive1y by pulsed Doppler method. 
DIPYRIDAMOLE THALLIUM IMAGING PREDICTS IN1RAOPERATIVE 
ISCHEMIA IN PATIENTS UNDERGOING MAJOR VASCULAR SURGERY 
Martin J London M D, Julio F. Tubau, M.D., David Harris, M.D., Milton 
Hollenberg, M.D., Warren Browner, M.D. M.P.H, Barry Massie M.D. F.A.C.C, 
Dennis T. Mangano Ph.D. M.D. V AMC-University of California, San Francisco, CA 
The presence of redistribution (redist) on dipyridamole thallium imaging (DPT) is 
thought to be a significant risk: factor for postoperative cardiac morbidity in patients 
undergoing major vascular surgery. However, the relation of preoperative DPT 
abnormalities to the development of intraoperative myocardial ischemia has not been 
determined. Therefore, we performed preoperative DPT in 23 high risk: male patients 
(mean age 66 ± 6 yrs) undergoing major vascular (n=20) or other (n=3) non-cardiac 
surgery. Intraoperative ischemia was assessed by continuous two-dimensional 
transesophageal echocardiography (TEE) at the level of the papillary muscles (n=18) 
and/or continuous monitoring of a 12 lead microcomputer augmented ECG (n=23). 
DPT was performed using 0.56 mg/kg IV dipyridamole followed by administration of 
2.5 mCi of Thalliurn-201. Planar scintigraphy was obtained in 3 views within 10 
minutes of DPT and 3 hrs post-tesl Semiquantitative interpretation of TEE, DPT, 
and ECG was performed by 2 independent observers blinded to all other information. 
Preop DPT revealed redist alone in 7 of 23 pts, fixed defect alone in 8 of 23, both 
redist and fIXed defect in 2, and was normal in 10. Ischemia was detected by TEE in 
15 pts and by ECG in 9 pts. Postoperative MI occurred in 2 pts (1 fatal), I with redist, 
1 with fixed defecl TEE and ECG were positive for ischemia in both MI's. 
redist only vs. TEE isch 
redist only vs. ECG isch 
scar or redist vs. TEE isch 
scar or redist vs. ECG isch 
Sensitivity(%) Specificity(%) Pos Pred Value(%) 
33 67 83 
44 79 57 
67 67 91 
78 57 54 
In this series redistribution and fixed defects appeared to have similar implications 
for developing intraop ischemia. Abnormalities on DPT imaging were a good 
predictor of intraoperative ischemia, especially as detected by TEE, although the 
sensitivity was only moderate. Thus, patients with DPT abnormalities are at high 
risk: for intraoperative ischemia and should be monitored closely during major 
vascular surgery. 
JACC Vol. II, No.2 
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SHOULD CARDIAC CATHETERIZATION BE PERFORMED PREOPERATIVELY 
IN ECHO-DIAGNOSED INTRACARDIAC TUMORS? 
Jerome Hines, M.D., Patrick Scanlon, M.D., F.A.C.C., John 
Grieco, M.D., Sarah Johnson, M.D., F.A.C.C., William 
Jacobs, M.D., Roque Pifarre, M.D., F.A.C.C., Loyola Univer-
sity Medical Center, Maywood, Illinois 
There is disagreement about the preoperative need for 
cardiac catheterization (cath) in patients (pts) discover-
ed to have intracardiac tumors by echo. Of 23 adult pts 
operated on for intracardiac tumors at our institution, 18 
were initially diagnosed by echo (15 females, 3 males; 
mean age 53, range 37-81). At surgery a myxoma was found 
in the left atrium of 14 pts, right atrium of 2, and the 
right ventricle of 1; 1 pt had a left atrial myxosarcoma. 
Of these 18 pts, 15 underwent preoperative left heart cath 
and coronary arteriography and 14 of 15 with left atrial 
tumors underwent right heart cath. Three females (ages 
39, 39, and 42) did not undergo left heart cath. Signif-
icant coronary artery disease (CAD) requiring CABG at the 
time of tumor resection was found in 4 of the 15 pts 
studied (27%); their ages were 50, 54, 70, and 81 and none 
had angina. One of these 4 pts was also found to have 
significant unsuspected aortic stenosis requiring aortic 
valve replacement. In 3 pts (20%) with chest pain suspic-
ious for angina, cath revealed no CAD. Of the 14 pts with 
left atrial tumors who had right heart cath 6 were found 
to have significant pulmonary hypertension (PA systolic > 
40 torr). In summary, cardiac cath prior to surgery for-
intracardiac tumor provided important information for the 
surgeon in 7 of 15 (47%) pts studied. We recommend 
that in adult pts, at least those over the age of 40, left 
heart cath and coronary arteriography should be part of 
the preoperative evaluation when echo has diagnosed intra-
cardiac tumor. 
Wednesday, March 30, 1988 
10:30AM-12:00NOON, Room 215, Level Two 
S.O.D.: Effects on Infarct Size, LV Function 
SUPEROXIDE DISMUTASE LIMITS MYOCARDIAL INFARCT SIZE IN 
A PORCINE CLOSED-CHEST ISCHEMIA-REPERFUSION MODEL. 
Ulf NAslund, M.D., Stefan L. Marklund, M.D. and Sebastian 
Reiz, M.D., Cardiology section, Univ of UMEA, Sweden. 
In myocardial ischemia-reperfusion experiments, admini-
stration of superoxide dismutase (SOD) has been reported 
to limit infarct size. To study the therapeutic window of 
SOD treatment, we performed a 24 hour blinded and 
placebo-controlled study in a porcine closed-chest 
occlusion-reperfusion preparation. Forty animals were 
anaesthetized and randomized to 30 or 60 min LAD-
occlusion and treatment with 300 mg SOD or a placebo 
solution 1. v. during the first hour of the reperfusion 
period. Another 5 animals were studied with a 90 min 
occlusion period. The occlusion was achieved by injecting 
a bullet (~-2 mm) in LAD. Reperfusion was established 
by retracting the bullet with a surgical string attached 
to the bullet. l4l-cerium microspheres were injected in 
the left chamber after 10 min occlusion to delineate 
myocardium at risk in post-mortem autoradiograms. After 
24 hours infarct size was determined with TIC-staining 
methodology. Myocardium at risk and infarct size were 
quantified by planimetry. In the group with 30 min occlu-
sion, SOD reduced infarct size from 45.9% (placebo) to 
23.5% of myocardium at risk (p-0.004). In animals with 60 
min occlusion 80.0% (placebo) and 67.0% (SOD) of myocar-
dium at risk was infarcted (P-0.035). Treatment of ani-
mals with 90 min occlusion was worthless. Myocardium at 
risk did not differ between placebo and SOD-treated ani-
mals. This study supports the hypothesis that oxy-ra-
dicals may reduce the benefit of reperfusion procedures. 
If SOD is given early during the reperfusion period a 
protective action is seen. In this model the reperfusion 
and SOD therapy must be introduced within 60 min of the 
coronary occlusion. 
ABSTRACTS 
OXYGEN FREE RADICAL SCAVENGERS DO NOT REDUCE INFARCT 
SIZE IN BABOONS. 
163A 
Whitney M. Limm, M.D., Mark M. Mugiishi, Steven M. 
Schwartz, M.D. and J. Judson McNamara, M.D., F.A.C.C., 
Cardiovascular Research Lab, University of Hawaii School 
of Medicine, Queen's Medical Center, Honolulu, HI. 
Evidence exists that reperfusion of ischemic myocardial 
tissue produces further injury as well as ultimate sal-
vage of some of the ischemic tissue. A number of recent 
studies indicate that this "reperfusion injuryll may be 
due to oxygen free radicals generated as a consequence of 
reperfusion. The addition of oxygen free radical scaVen-
gers in the reperfusate has been found to decrease 
infarct size in dogs and rabbits. We used a baboon 
(Papio anubis) open heart model to determine if these 
oxygen free radical scavengers are equally effective in 
primates. The left anterior descending artery distal to 
the first marginal branch of 16 young baboons (wt 12-18 
kg) was ligated for 2 hrs. At 15 mins prior to release 
of the ligature the animals received the following intra-
venous infusions over 1 hr: Grp 1 (control) lactated 
Ringer's 120cc (N=5); Grp 2, superoxide dismutase 13,000 
U/kg and catalase 55,000 U/kg mixed in 120cc lactated 
Ringer's (N=5); Grp 3, 20% mannitol at .2cc/min/kg (N=6). 
The animals were sacrificed 24 hrs after reperfusion. 
The hearts were then excised and sectioned after the 
perfusion bed (PB) or risk region distal to the ligation 
site was delineated with microvascular dye. The infarct 
(INF) zone was determined from hematoxylin-eosin sections 
and the areas of PB and INF measured by planimetry. The 
infarct to perfusion bed percentages were 65 ± 6% (SEM) 
for controls; 68 ± 5% for SOD/catalase group and 65 ± 11% 
for the mannitol group. 
LONG-TERM RECOVERY OF LV WALL THICKENING AFTER ONE 
HOUR OF ISCHEMIA IS NOT AFFECTED WHEN SUPER OXIDE 
DISMUTASE AND CATALASE ARE ADMINISTERED DURING THE 
1st 45 MINUTES OF REPERFUSION 
Richard W. Asinger M.D., FACC, Douglas A. Peterson, M.D., K. Joseph 
Elsperger, CCPT, David Homans, M.D.. Hennepin County Medical 
Center and the University of Minnesota, Minneapolis, MN. 
We wished to determine the effects of superoxide dismutase (SOD) 
and catalase (CAT) on the long-term recovery of LV wall thickening 
following a one hour ischemic event. Twenty-six closed-chest instru-
mented dogs were subjected to a one hour proximal left circumflex 
coronary artery (LCx) occlusion followed by reperfusion The animals 
were randomized 45 minutes into the hour long LCx occlusion to 
receive either a one hour infusion of normal saline (Group I) or a one 
hour infusion of SOD (14,500 IU/kg) and CAT (55,000 IU/kg) (Group 
II) via indwelling left atrial lines. Nineteen dogs survived the 
ischemia-reperfusion event and were followed for 4 weeks; Group 1=8, 
Group 11= II. Left ventricular posterior wall thickness in millimeters 
(Pwh) and systolic thickening in % (%PW) were determined by two-
dimensionally directed M-mode echocardiography before ischemia 
(Base), at one hour of ischemia (I), and at one hour (I hR), one day 
(ldR), one week (lwR), two weeks (2wR), three weeks (3wR), and 4 
weeks (4wR) of reperfusion. 
Group I (PWh) 
(n=8) (%PW) 
Group II (PWh) 
(n=ll) (%PW) 
Base I 
8.3 
34 
8.9 8.4 
31 
IhR 
8.7 
6 
10.2-
3 
IdR 
8.4 
19 
9.1 
7 
IwR 2wR 3wR 4wR 
8.5 8.7 8.4 8.8 8.3 
38 33 34 36 33 
9.3 8.8 8.6 8.4 
14- 26 28 30 27 
- p < .05 for Groups I vs 2. 
All dogs were sacrificed at 4 weeks. The percent of the left ventricle 
with gross evidence for scar was 2 ± 3 for Group I and 3 ± 3 for 
Group II (p=NS). 
We conclude that infusion of SOD and CAT during the 'Ist 45 minutes 
of reperfusion after I hour of ischemia does not affect the long-term 
recovery of wall thickening or the percent of left ventricle with scar 
in this chronic canine model. 
164A ABSTRACTS 
DESPITE SUPEROXIDE DISMUTASE TREATMENT, POSTISCHEMIC CON-
TRACTILE DYSFUNCTION PERSISTS AFTER 4 HRS OF REPERFUSION. 
Johan Vanhaecke, M.D., Frans Van de Werf, M.D., Ik-Kyung 
Jang, M.D., Willem Flameng, M.D., Hilaire De Geest, M.D. 
University of Leuven, Belgium. _ 
We investigated the effect of superoxide dismutase (SOD) 
treatment on the recovery of postischemic myocardial con-
tractility in a closed chest anesthetized dog model of 
coronary occlusion (OCC) and reperfusion (REP). 
In 16 dogs a thrombotic OCC of the left anterior de-
scending coronary artery was produced with the copper coil 
technique. REP was achieved by thrombolysis: an intra-
venous (IV) infusion of pro-urokinase 20 ~g/kg/min was 
started after 60 min of OCC, together with an IV infusion 
of either SOD 10 mg/min (group A, n=8) or placebo (group B, 
n=8). The SOD or placebo infusion was continued for 60 min.; 
OCC and REP were angiographically documented. Global LV 
ejection fraction and regional segmental shortening of the 
postischemic area were determined by computer analysis of 
LV contours on the enddiastolic and endsystolic frames of 
LV contrast angiograms. Collateral flow during OCC was 
measured with radioactive microspheres. 
Occlusion times were 90+11 min. in group A (SOD treat-
ment) and 96+14 min. in group B (placebo). Collateral 
flows were 18+9 and 25+19 ml/min/100 gr respectively 
(p=NS). Dye staining of the excised hearts demonstrated 
subendocardial infarction in all dogs, with a variable 
per"cion of the subepicardium at risk remaining viable. 
After 4 hrs of REP there were no differences in global 
ejection fraction (29+14 vs 23+14%) or regional segmental 
shortening (-10+11 vs--9+8%) b;tween SOD treated and 
placebo groups.-Exclusion of 2 dogs with high collateral 
flows from the placebo group did not change these results. 
In this model, SOD treatment fails to improve post-
ischemic myocardial contractility during the early hours 
of reperfusion. 
EFFECT OF SUPEROXIDE DISMUTASE ON MYOCARDIAL FREE 
RADICAL CONCENTRATIONS DURING POST· ISCHEMIC REPERFUSION. 
Howard P. Grill, M.D., John T. Flaherty, M.D., F.A.C.C, 
Myron L. Weisfeldt, M.D., F.A.C.C., Jay L. Zweier, M.D. 
Johns Hopkins Medical Institutions, Baltimore, MD. 
Recombinant human superoxide dismutase (h· SOD) given at 
the time of post· ischemic reperfusion (REP) has been 
reported to decrease myocardial infarct size in an intact 
canine model, presumably by free radical scavenging. 
Using electron paramagnetic resonance (EPR) , we demon· 
strated a burst of oxygen free radical (OFR) generation 
upon REP in regionally ischemic in vivo rabbit hearts. To 
determine if h-SOD attenuates this burst of OFR, rabbits 
underwent either 30 min coronary occlusion, 30 min occ-
lusion followed by 60 sec REP with and without h·SOD, or 
normal perfusion (n-B for all groups). h·SOD was admini· 
stered intravenously as a 20 mg/kg bolus 90 sec before 
REP, followed by infusion of 0.17 mg/kg/min during the 60 
sec of REP. Biopsies of ischemic areas of left ventricle 
were freeze clamped at 77 0 K. Injections of radioactive 
microspheres confirmed that during occlusion, blood flow 
in the ischemic region was l2±3% of flow in adjacent non· 
ischemic ventricle, and 115±17% during REP. EPR was used 
to directly quantitate oxygen radical concentrations. 
Group OFR Concentrations V<M) 
Normal Perfusion 2.5 ± 0.5 
30min Ischemia 5.2 + 0.7 
30min Ischemia + 60sec REP 15.9 -:;: 3.0) 
30min Ischemia + 60sec REP+h·SOD 4.3 ± 2.1I P <.002 
Thus, in this in vivo model of regional ischemia the REP 
induced burst of OFR is eliminated by h·SOD given at the 
time of reflow. Because the rabbit, like ~an, has little 
myocardial xanthine oxidase (XO) , these results suggest 
that the prescence of XO may not be necessary for REP 
induced OFR production and its inhibition by h·SOD. 
JACC Vol. 11, No.2 
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PHARMACOKINETICS OF HUMAN RECOMBINANT SUPEROXIDE 
DISMUTASE. 
Howard S Silverman, M.D., Lewis C Becker, M.D., 
F.A.C.C., Lyle A Siddoway, M.D., Ziva Yavin, Ph.D., Amnon 
Gonenne, Ph.D., Myron L. Weisfeldt, M.D., F.A.C.C., Johns 
Hopkins Univ School of Medicine, Baltimore, MD and 
Biotechnology General Corp, New York, NY. 
Superoxide dismutase (SOD) has reduced injury after 
coronary occlusion in some animal studies but not others, 
possibly due to differences in dose or route of admini· 
stration. We therefore studied hSOD kinetics in 4 
conscious dogs, each receiving the following doses of 
hSOD on different days: #1) 5mg/kg left atrial bolus; #2) 
5mg/kg central vein (CV) bolus; #3) l5mg/kg CV bolus; #4) 
5mg/kg CV infusion over 60 min. Additionally, all dogs 
received #5) 5mg/kg CV bolus under anesthesia. Serial 
serum samples (after each dose) and serial myocardial 
samples (after dose 5) were obtained. hSOD concentration 
was measured by radioimmunoassay. Results fit to a 
2-compartment model: distribution Tl/2 -7. B±l. 7 min; 
elimination T
'
/ 2 - 51.1±5.9 min; volume of distribution, 
Vc-Bl±26 ml/kg; Vd- 156±20 ml/kg. Clearance (Cl, 
ml/min/kg) and peak concentration (Cp, mcg/ml) were as 
follows: (* p<.OS vs others) 
#1 #2 #3 #4 #5 
Cl 2.9±.B 2.6±.2 2.l±.1 3.0±.B 1.7±.3 
Cp 76±23 Bl±19 247±59* 25±3* 92± 9 
With continuous infusion hSOD levels rose slowly, and did 
not peak until 48 min. Bolus injection produced peak 
levels three times those found after infusion of the same 
dose. Myocardial levels of hSOD were <1% of serum levels, 
suggesting negligible hSOD penetration into myocardium. 
As with lidocaine for arrhythmias, bolus + infusion may 
be the mode of choice to rapidly achieve and maintain 
blood levels in order to maXimally attenuate reperfusion 
injury. 
Wednesday, March 30, 1988 
8:30AM-I0:00AM, Room 202, Level Two 
Use of Cardiac Pacemakers 
THE EFFECT OF ELECTRODE LOCATION ON ACTNATION 
SEQUENCE AND THRESHOLD DURING EXTERNAL PACING 
Anthony S L Tang, MD, Dean L. Derfus, BEng, J. Marcus 
Wharton, MD, Ned D. Danieley, AM, William M. Smith, PhD, 
Raymond E. Ideker, MD, PhD, Duke U. Med Ctr, Durham, NC 
While external cardiac pacing is commonly used for the treat-
ment of emergency bradyarrhythmia and asystole, little is known 
about the activation sequence of the paced beats. The purpose 
of the study is to compare the cardiac activation sequence for 
three different electrode locations during external cardiac pacing. 
In 7 anesthetized mongrel dogs, we recorded the activations of 
the paced beats simultaneously from 128 recording electrodes 
placed on the atria, interventricular septum, subepicardium and 
subendocardium of the LV and RV. The chest was closed and 
suctioned to keep the thoracic cavity air free. Patch electrodes 
of surface area approx 82 sq.cm were placed on the body surface. 
Excitation thresholds from the following patch electrode pairs 
were determined: 1) posterior-anterior (P A), 2) right lateral-left 
lateral (RL), and 3) right upper-left lower (RULL). The ventric-
ular stimlllation threshold for PA was 70±35.1 mA, which was 
lower (p < .05) than the threshold for the other two electrode 
pairs: 117.1±37.3 mA for RL, and 130±43.2 rnA for RULL. PA 
and RL stimulation captured the ventricles with retrograde VA 
conduction. The ventricular early sites were located in the ante-
rior LV or RV for PA and lateral RV for RL. RULL stimulation 
captured the atrium with antegrade AV conduction at lower 
current, but at higher current simultaneous atrial and ventricu-
lar capture was seen. The ventricular early sites for RULL were 
at the base or the apex of either ventricle. We conclude that: 1) 
the activation sequence varies markedly for different electrode 
locations during external cardiac pacing, 2) either ventricular, 
atrial or simultaneous capture can be produced depending upon 
electrode location and stimulation strength, and 3) the P A elec-
trode location is more effective than the RL and RULL electrode 
locations for ventricular stimulation in the dog. 
JACC Vol. II, No, 2 
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EFFECT OF PROCAINAMIDE ON ATRIAL ELECTROGRAMS DURING 
ATRIAL FIBRILLATION: A POTENTIAL DRUG-DEVICE 
INTERACTION. 
Kristina M. Ropella, M.S., Alan V. Sahakian, Ph.D., 
Jeffrey M. Baerman, M.D., F.A.C.C., and Steven Swiryn, 
M .D., F . A . C . C., Northwes tern Uni versi ty and Evans ton 
Hospital, Evanston, IL. 
The effects of antiarrhythmic drugs on electrograms 
have important implications for arrhythmia detection 
algorithms for implantable devices. Atrial electrograms 
were analyzed in 8 patients who received IV 
procainamide (PCA) (50 mg/min; up to 1 gram) during 11 
episodes of atrial fibrillation (AFIB). Continuous 
recordings were made before, during and after drug 
infusion. Data were digitized, divided into 4.3-second 
segments, and analyzed for atrial rate, median 
frequency in the 2-9 Hz band and amplitude probability 
density. Differences were noted before and after PCA 
infusion for atrial rate (498 • 75 vs 356 • 118 BPM, 
p<.005); median frequency (5.50-.:!:. 1.19 vs 4-:-24 .:!:. 0.99 
Hz, p<.0005); and density (58.3 .:!:. 12.7 vs 69.1 .:!:. 13.5%, 
p< .005). Pre-and post-PCA values were compared to 
published criteria for AFIB detection. Before PCA, 
only 2.3%, 5.7% and 3.4% of the data segments failed to 
meet criteria for rate, frequency content and density, 
respectively. In contrast, after PCA, 50%, 40% and 29% 
of the segments failed to meet these same criteria, 
despite electrograms meeting morphologic criteria for 
AFIB. 
Conclusions: (1) PCA changed atrial rate, frequency 
content and density suffiCient to cause failure of 
published criteria for AFIB detection. (2) These 
changes have broad implications for anti tachycardia 
device function in patients receiving antiarrhythmic 
drug therapy. 
THE EFFECT OF VARIABLE PACING RATE ON MAXIMUM POSITIVE 
RIGHT VENTRICULAR DP/DT: IMPLICATIONS FOR A NEW RATE 
RESPONSIVE PACING SYSTEM. 
ArjUn P Sharma M P FA C C Tom Bennett, Ph.D., Richard Sutton, 
M.D., Mark Erickson, Robert Beck, Raymond Yee, M.D., Universny Hospnal, 
London, Canada. 
A new rate responsive pacing system controlled by maximum posnive right 
ventricular (RV) dP/dt has been developed (Medtronic 2503). This 
pacemaker increases tts pacing rate with increases in maximum posttive RV 
dP/dt. However, increases in the pacing rate may increase the inotropic 
state of the myocardium (Treppe effect) independent of other physiologic 
regulatory mechanisms. This potential feedback mechanism could result in 
aberrant high rate or low rate behaviour of such a pacing system. We 
therefore investigated the effect of changes in pacing rate on RV dP/dt. Six 
pts wtth complete heart block were studied after implantation of a pressure 
sensing lead and pressure telemetering WI pacemaker. The telemetered 
pressure signal was analyzed on a beat to beat basiS. VVI pacing was done 
at rates of 70,90,110 and 130 bpm for periods of 5-120 sec in a 
randomized sequence. The maximum positive RV dP/dt at each paCing 
rate, the probabilny of difference between the upper and lower pacing rate 
(p), and the slope of the regression equation relating RV dP/dt and pacing 
rate were: 
Pacing Pacing Rate 
DurationCsec) Iboml 
70 130 
mmHg/sec 
p Slope 
!TJJ'JI-!gIsec!m 
5 304±69 333±76 .55 .44 .96 
120 281±50 349±71.05 1.15 .99 
Pacing for 2 min was associated wnh an increase in the spontaneous atrial 
rate (0.3 bprn/bpm change in pacing rate, r=0.9) which was potentially due 
to autonomic neural reflex effects on the sinus node. A mu~iprogrammable 
rate responsive pacemaker based upon maximum posnive RV dP/dt was 
implanted in a further 3 pts. Using an increment in paCing rate of - 1 pprn/7 
mmHglsec appropriate pacing responses were observed during exercise. 
Thus, the Treppe effect on RV dP/dt which should be manHest wnhin 5 sec 
is relatively small. However, prolonged rapid pacing may increase RV dP/dt, 
potentially by reflex mechanisms, but this effect was small and did not resun 
in aberrant high or low rate behaviour in a new rate responsive pacemaker. 
ABSTRACTS 165A 
USE OF NONINVASIVE TEMPORARY PACEMAKER DURING PERCUTANEOUS 
TRANSLUMINAL CORONARY ANGIOPLASTY 
Phillip Frankel, M.D., Joel Erickson, M.D., and Robert 
Chesne, M.D., Daniel Freeman Memorial Hospital, Inglewood, 
California 
Use of a temporary pacemaker (p) during percutaneous 
trans luminal coronary angiop1asty (PTCA) has been recom-
mended. This study was designed to determine the need 
for a P during PTCA and the efficacy of an external 
pacing system. 
200 consecutive PTCA patients (pts) were prospectively 
grouped according to clinical and angiographic criteria. 
Pts with poor left ventricular function, prior documented 
bradyarrhythmia, or PTCA of a right coronary or dominant 
circumflex artery were Group I. A Zoll NTP® external 
P was placed and tested prior to PTCA in Group I. All 
other pts were Group II and had no P during PTCA. 
Resu1 ts: In Group I (n=99), the external P demonstrated 
sucessfu1 sensing and capture in all pts. Bradyarrhythmia 
requiring pacing developed in 5 pts (5%), 4 preCipitated 
by balloon inflation and 1 by contrast injection. The 
external P functioned properly in all pts. Skin electrodes 
did not hinder radiographic visualization during the 
procedures. In Group II (n=101), no significant brady-
arrhythmia occurred. 
We conclude that for PTCA pts: (1) clinical and angio-
graphic parameters allow identification of a subgroup 
in whom a pacemaker is not necessary; (2) in a subgroup 
most likely to develop bradyarrhyhmia, pacemaker depend-
ence occurs in 5%; and (3) the external pacing system 
used is a safe and effective alternative to transvenous 
pacing. 
CAN TRANSCUTANEOUS NERVE STIMULATION BE SAFELY USED IN 
PATIENTS WITH PERMANENT PACEMAKERS? 
David L. Hayes, M.D., F.A.C.C.; Ronald E. V1ietstra, M.D., 
F.A.C.C.; Mary Jane Rasmussen, R.N., Mayo Clinic, 
Rochester, MN 
Transcutaneous nerve stimulation (TENS) is often withheld 
as a therapeutic modality in patients with permanent pace-
makers (PPM) because of potential inhibition, interference 
or phantom programming of the PPM by the TENS. To deter-
mine the potential of these problems we subjected 38 
patients with PPM to TENS (using a DYNEX II Stimulator). 
All patients demonstrated an escape rhythm at greater than 
30 beats per minute. Of the 38 PPM, there were 20 single 
chamber and 18 dual chamber devices of which 24 were uni-
polar and 14 were bipolar. The PPM was programmed to a 
rate greater than their intrinsic rate to assure pacing 
throughout the test period. The TENS unit was connected 
to the patient in standard treatment fashion to 4 areas: 
1) lumbar area, 2) cervical spine, 3) left leg, and 4) 
left arm. The TENS unit was set at a pulse width of 40 
and pUlsing rate of 110 adjusted to an output where sti-
mulation was uncomfortable and then decreased slightly to 
a tolerable level. The average amplitude used to cause 
stimulation was 28 units (range 5-60). ECG monitoring was 
done throughout TENS application. Of the 152 total stimu-
lation sites in the 38 patients, there was no evidence of 
inhibition, interference or reprogramming of the PPM. We 
conclude that TENS can safely be used in patients with 
PPM. Patients who are completely pacemaker dependent 
could be monitored during their first TENS treatment to 
assure both patient and physician that this is a safe 
device without monitoring or other special precautions. 
166A ABSTRACTS 
COMBINATIONS OF STIMULUS STRENGTH AND 
REFRACTORINESS NEEDED FOR CONDUCTION BLOCK 
Dayjd W Frazjer SA Wanda Krassowska PhD Patrick 0 Wolf MS 
Anthony SL Tang, Mo, William M Smith, PhD, Raymond E Ideker: 
MD, PhD. Duke University Medical Center, Durham, NC 
Subthreshold cardiac stimuli delivered during phase 3 are known to 
produce graded responses that can prolong the refractory (R) period of 
the local tissue. A sufficient magnitude of graded response should 
presumably produce conduction block for activation wavefronts arriv-
ing during the time of prolonged refractoriness, which could create 
multiple regions of temporary conduction block during defibrillation 
shocks. This hypothesis was indirectly tested for normal myocardium 
by simultaneously recording from 117 epicardial electrodes in 6 dogs 
(30X32mm area) from the RV free wall. Parallel isorefractory and 
isogradient lines were created by SI pacing simultaneously from 8 sites 
on one side of the mapped area and cathodal S2 shocks of 3 ms at 
100-150 V from a mesh electrode (4.5Xl em) on the same side. S2 
shocks scanned the R period of the tissue within the mapped area. At 
long SI-S2 intervals, wavefronts spread rapidly away from the borders 
of the region directly depolarized (DO) by S2, and with decreasing SI-
S2 intervals the DO zone became smaller, with its border closer to the 
pacing sites. After further slight decrease in SI-S2, wavefronts sud-
denly stopped conducting away from the DO border. The region of 
change from conduction to block occurred in a region distant from the 
pacing location, where potential gradients were 4-6 V! em and where 
the cells were relatively refractory. The DO region was still present 
since the SI-S2 interval at which block occurred was longer than the R 
period of part of the region between the sites of pacing and block. 
Thus, for parallel isogradient and isorefractory lines, regions of tem-
porary conduction block distant from the stimulation site can be 
created which prevent conduction away from DO areas when isorefrac-
tory and isogradient fields are appropriately intersected. This may be 
one possible mechanism for extinguishing activation wavefronts during 
defibrillation shocks. In addition, this mechanism could contribute to 
the probabilitiy density function of defibrillation due to the changing 
refractoriness of tissue during fibrillation. 
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RIGHT VENTRICULAR STROKE VOLUME ASSESSMENT 
USING AN IMPEDANCE CATHETER. Eugene Yeh. B.S., 
Victor A. Morant, M.D., Lon W. Castle, M.D., 
F.A.C.C., Sandra Fischer M.S.E.E., James D. 
Maloney, M.D., F.A.C.C., Cleveland Clinic 
Foundation, Cleveland, Ohio. 
The feasibility of using electrical impedance 
(I) from a single multi-electrode catheter to 
measure stroke volume (SV) in the RV was 
assessed. In four Pts, a 20 uAmp, 10 kHz 
electrical current was delivered from the apex 
to the tricuspid valve region. Four segmental 
regions along the length of the catheter sensed 
I changes throughout the cardiac cycle in the 
range of 5 ohms per segment. Using the 
equation, Volume{t)= L'jaZ{t), where L=length 
of segment, a=blood conductivity, Z{t)=I, a 
continuous volume signal was recorded. Blood 
conductivity was measured in each pt. SV 
comparisons were made versus iced 
thermodilution cardiac output (ITCO) 
calculations during sinus rhythm and at atrial 
paced rates of 750 to 450 msec. The following 
table summarizes the results; I= (m * ITCO) + b 
Pt r-Value m b SV ranaefmilliliters\ 
1 .9730 .732 -13.43 32 to 63 
2 .9930 .275 .19 26 to 56 
3 • 9043 .142 1.06 33 to 69 
4 .9390 .207 -1,63 61 to 113 
The I catheter underest1mated SV as compared to 
ITCO. There was a high linear relationship 
between the SV measurements made by the I 
catheter and the ITCO method over a wide 
range of SVs. Using a single lead in the RV, 
a beat-to-beat SV sensor can be incorporated 
into a pacemaker or anti-tachycardia device. 
JACC Vol. 11, No.2 
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ACTIVITY-SENSING RATE-RESPONSIVE VENTRICULAR 
PACING(RRP) VS VENTRICULAR'PACINGIVVI): 
RELATION BETWEEN LEFT VENTRICULAR DIMENSIONS 
AND IMPROVEMENT IN WORK CAPACITY 
Syein Farestrand.M.D. and Ole-J.rgen Ohm,M.D., 
F.A.C.C. University of Bergen, School of 
Medicine, Bergen, Norway. 
Symptom-limited graded treadmill tests were 
performed during RRP and during VVI with the 
pacemaker first programmed randomly to RRP or 
VVI in 14 patients(pts) (mean age 74 years). 
Left ventricular dimensionslend-diastolic:EDD 
and end-systolic:ESD) were measured by 
echocardiography before RRP was started and 
after 6 months of RRP. The maximum treadmill 
timelMTT) increased an average of 28~6X from 
12.1~1.3 min. during VVI to lS.0~1.3 min. 
during RRP Ip<O.OOl). The EDO was reduced an 
average of 0.7+0.2 cm (11+2X) from 6.1+0.3 cm 
before RRP to 5.3~0.2 cm (P<0.02) after 6 
months of RRP. The time-related reduction of 
EOD was positively correlated to the 
improvement of the MTT during RRP vs VVI 
IR=0.74; p<O.OS). The increase in MTT during 
RRP vs VVI was 28~7X in 9 pts with dilated left 
ventricles (EDD=6.6~0.3 cm) and 29~14Z in S pts 
with normal EDD(5.0~0.2 cm); p=NS. The 
improvement in MTT during RRP vs VVI was 2S~9Z 
in 6 pts with enlarged ESDIS.2~0.4 cm) and 
37~87. in 7 pts with normal ESDI3.2~0.2 cm); 
p=NS. This study demonstrates that RRP improves 
work capacity significantly compared to VVI and 
results in a time-related reduction in EDD 
which is positively correlated to the increment 
in exercise capacity during RRP vs VVI. Pts 
with normal or increased EDD have the same 
increase in work capacity during RRP vs VVI. 
Pts with normal ESD seem to have a greater 
improvement in exercise capacity during RRP vs 
VVI than those with dilated ESD. 
A STUDY OF BLOOD TEMPERATURE FOR PHYSIOLOGIC CONTROL OF 
HEART RATE IN PACED PATIENTS 
Bernard Boal, M.D., F.A.C.C., Neal Fearnot, Ph.D., 
Thomas Buckingham, M:-D:-,-F:-A.C.C., lsam Felahy, M.D., 
James Geiger, M.D., Richard Gentzler, M.D., F .A.C.C., 
Wayne Grogan, M.D., F .A.C.C., Edward Platia, M.D., 
F .A.C.C., Lenard Politte, M.D., Gopal Rao, M.D., Robert 
JU!dd, M.D., and Duncan Se11ers, M.D., F.A.C.C., Catholic 
Medical Center of Brooklyn and Queens, Queens, NY 
To assess the clinical benefit of using intracardiac 
blood temperature (lCBT) to control pacing rate of a 
permanent pacemsker, a multicenter trial of the Kelvin 
500 pacemsker (Cook Pacemaker) whose rate is modulated 
by lCBT was undertaken. The 150 implanted pacemakers 
were followed for 6 months. Indications were those 
standard for VVI pacemakers. A thermistor in a standard 
lead determined changes in ICBT, appropriately increas-
ing pacing rate (mean 19 seconds after exercise onset or 
emotional stress, n=56). ICBT sensitivity (8 levels), 
lower rate, an intermediate rate to which the pacemaker 
increases at the initial ICBT change, and an upper rate 
used when the pacemaker confirns exercise are program-
mable. Elevated rates were recorded during walking, 
stair climbing, and rising from a chair. Patients at 
typical ICBT sensitivities increased rate 7 to 328 (mean 
101) times per day. The symptom-limited treadml.11 exer-
cise duration increased for patients with no intrinsic 
rate (VVl=5.1, ICBTs6.8, p<.05). Conclusion: In this 
pacemaker, lCBT has proven to accurately reflect phy-
siologic change with activity and stress, and to modu-
late rate according to patient needs • 
JACC Vol. 11, No.2 
February 1988: 167 A 
VENTRICULAR RATE RESPONSIVE PACING USING FIRST 
DERIVATIVE OF RIGHT VENTRICULAR PRESSURE AS A 
SENSOR 
R Sutton FRCP FACC, A Sharma, A Ingram, J Camm 
FRCP FACC, F Lindemans, T Bennett, Westminster 
Hospital, London, England. 
After a preliminary series of pressure sensing 
non-rate responsive pacemakers, 7 patients mean 
(m) age 69 range 43-87 with complete AV block 
have now had units implanted which offer them a 
rate response based on changes in the first 
derivative of right ventricular pressure. The 
system (Medtronic US) consists of a special 
~~ib~;~rf~~:dth~t~tl~~f~~I~nt~!~~~~~~~.se¥h~·5 
pacemaker has two connection ports and is 
equivalent in size and weight to this company's 
DOD unit. Implantation technique was 
straightforward and in 4 patients qualitative 
pressure and first derivative of pressure 
wave-forms were comparable between those 
telemetered by the pacemaker and a fluid filled 
manometer (3) or micromanometer (1). 
Follow-up mean (m) 2 months has assessed rate 
responsive behaviour by eKercise stress 
testing, Holter monitoring and tilting. Two 
patients have shown occasional periods of over 
sensing of T waves otherwise no complications 
have been encountered. Resting heart rate 
prior to eKercise was m 66 ppm with rapid 
acceleration in the first minute of eKercise 
and the maKimum heart rate achieved was m 114 
ppm. The m rate variability was 48 between 
rest and peak eKercise, rate fallon recovery 
was physiological over 5 mins. Heart rate 
range on Holter monitoring was from m 53 ppm to 
m 90 ppm. Heart rate on tilt increased from m 
64 ppm supine to m 71 ppm at 600 head-up. 
In conclUSion, sensing of the first derivative 
of right ventricular pressure for rate 
responsive ventricular pacing proves in 
practice to be physiological. 
NONINVASIVE TERMINATION OF ATRIOVENTRICULAR 
RECIPROCATING TACHYCARDIA WITH EXTERNAL CARDIAC 
PROGRAMMED STIMULATION. 
N.A. Mark Estes III. M.D •• F.A.C.C .• Antonis 
Manolis. M.D .• Therese Tordjman. M.D •• Keith Mack. R.N .• 
En Hal Han. M.D .• Thomas Deering. M.D .• New England 
Medical Center Hospitals. Boston. MA. 
To determine the efficacy. tolerance and safety of 
noninvaslvely terminating atrioventricular reciprocating 
tachycardia using external cardiac programmed 
stlmu.Jatlon (ECPS) a standard protocol was employed In 8 
patients using an external pacemaker modified to track 
the output of a programmable stimulator. The age of the 
7 male and 1 female patients was 46±9 years. The 
termination protocol Included scanning with single then 
double extrastlmull followed by overdrive pacing. ECPS 
was performed at 5 mA over threshold for ventricular 
capture wIth a pulse width of 40 msec. The threshold for 
ventricular capture was 63±12 mAo If an attempt to 
terminate an epiSode of tachycardia was unsuccessful the 
ECPS protocol was repeated or endocardIal pacing or 
cardloverslon was used. 
ECPS was attempted In a total of 183 epiSOdes of 
orthodromic' atrioventricular reCiprocating tachycardia 
with cycle lengths between 290 and 460 msec. In 7 of 8 
patients ECPS reproducibly terminated the tachycardia. 
Of the 183 episodes of atrioventricular reCiprocating 
tachycardia; 173 (95%) were terminated by this 
noninvasive technique. Arrhythmia acceleration or 
fibrillation did not develop In any patient. Discomfort 
was rated as mild by 2 patients. moderate by 4 patients. 
severe by 2 patients, and Intolerable by no patient. 
ECPS Is an effective. tolerable. and safe technique 
for termination of atrioventricular reclpr.ocatlng 
tachycardia. 
ABSTRACTS 
IS ATRIAL NATRIURETIC PEPTIDE A GUIDE TO THE 
ADEQUACY OF CARDIAC PACING MODE? 
C M Travill MRCP, P Vardas MD, TOM Williams 
MRCP, A Ingram, S L Lightman FRCP. R Sutton 
FRep FACC, Westminster Hospital, London, 
England. 
167A 
Whilst plasma atrial natriuretic peptide (ANP) 
has been shown to be elevated in congestive 
heart failure and during supraventricular 
tachycardia where it reflects high left atrial 
pressure, it has received little attention in 
bradyarrhythmias and their management. We have 
studied 33 patients, 21 male, mean age 69 years 
(range 38-86) with complete heart block but 
without cardiac or renal failure, atrial 
fibrillation or retrograde AV conduction. ANP 
levels in 6 patients with complete heart block 
were 141 % 28 pmol per litre (m t SEM) before 
pacing, 139 * 30 when paced VVI for 30 days and 
53 • 7 when paced DOD for 30 days. 13 patients 
paced long term VVI (m 43 months) had ANP of 
112 % 13 and 13 paced long term DOD (m 40 
months) had ANP of 43 % 7 whilst 13 age and SeK 
matched controls had ANP of 58 • 7. The ANP 
levels before pacing and in short and long term 
VVI pacing were significantly higher than 
controls (p<0.05) but there was no difference 
between short and long term ODD and controls. 
Five patients with VVIR pacemakers showed no 
significant difference in ANP at rest when 
paced VVI or VVIR for 30 days - 133 • 34 vs 134 
~ 39. Both were considerably higher than 
controls. However, during eKercise at 
identical levels of effort ANP was 229 * 91 in 
VVIR vs 299 • 96 (p=0.06) in VVI. Thus ANP may 
offer a useful guide to the adequacy of a 
pacin~ mode but in VVIR units assessment during 
eKerC1se is required. 
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CHRONIC ORAL SOTALOL THERAPY FOR PATIENTS WITH SUSTAINED 
VENTRICULAR ARRHYTHMIAS 
Rolando Gonzalez, M.D., Melvin M. Scheinman, M.D., 
F.A.C.C., John M. Herre, M.D., F.A.C.C., Mary Jane Sauve, 
R.N., D.N.Sc., University of California, San Francisco. 
A total to 40 pts with history of sustained ventricular 
tachycardia (VT) (36) or ventricular fibrillation (VF) 
(4 pts) resistant to at least one type IA drug (and re-
sistant to or intolerant of a mean of 2.8*1.4 drugs) 
underwent baseline and post sotalol (S) VT induction 
studies. All pts had inducible VT during a baseline study 
which included use of up to 3 extrastimuli at 2 right ven-
tricular sites. After S, 7 pts became non-inducible and 
none suffered recurrent VT over a follow-up interval of 
24t12 months. In 12 pts, hemodynamically stable VT was 
induced after S and was associated with prolongation of 
the induced VT cycle length after S (312t62 to 406t80 ms) 
(p<0.02). Recurrent VT was documented in 6 of these 12 
pts (50%) and one died suddenly. The remaining pts did 
not receive S either because of adverse side effects (8) 
and/or induction of hemodynamically unstable VT (17 pts) 
after S. In these 17, there was no significant change in 
VT cycle length after S (310t78 vs 31St71 ms). Twelve pts 
who responded to chronic amiodarone therapy but required 
discontinuance because of toxiCity were tested with S but 
none responded. S side effects included proarrhythmic 
responses (torsade de pointes) in 2 and due to beta block-
ade in 6 pts. Conclusions: (1) Approximately 17% of 
pts with drug refractory VT or VF became non-inducible 
after S. (2) Invasive electrophysiologic studies proved to 
be an excellen~ predictor of drug efficacy and a good pre-
dictor of inefficacy. (3) A favorable response to oral 
amiodarone therapy did not predict a similar response to 
chronic oral S. (4) There is a high incidence of intoler-
able side effects. 
168A ABSTRACTS 
SOTALOL MEDIATED TORSADE DE POINTES 
Thomas Mattioni MD, Terry Zheutlin MD, Joseph Sarmiento MD, 
Michele Parker RN MS, Cathy Dunnington RN MS, Karen Reilly 
RN, Karen Larsen RN, Nancy Nebergall RN, Richard Kehoe MD, 
Northwestern University Medical School, Chicago, n. 
The incidence and characteristics of Torsade de Pointes(TDP) 
were examined in 61 consecutive patients(pts) receiving oral 
sotalol(Sot). Indications for therapy were: sustained ventricular 
tachyarrhythmia(VT) in 51; non-sustained VT (NSVT) in 2;and 
supraventricular tachycardia(SVT) in 8. Forty-two pts had 
coronary disease, 10 cardiomyopathy, 3 valvular disease and 6 no 
heart disease. 
At 10.:!:,8 months, 7 pts(U%) had TDP: 4 within 48 hrs, 2 within 6 
days and 1 at 45 days after the onset of therapy. Multiple 
characteristics of pts free of TDP (GpI) were compared to pts 
who developed TDP (Gpll). QT and QTc intervals were determined 
at baseline and at Sot steady-state(GpIl and at time of TDP(GplI). 
Serum Sot levels were measured at steady-state just prior to 
discharge (GpO and at the time of TDP (Gpll). The groups were 
similar for heart disease type, NYHA class, VPB frequency/grade, 
ejection fraction, baseline QT and QTc intervals, mean daily Sot 
dose (Gp1:557.:!:,25 mg/day vs Gpll:526.:!:,126 mg/day) and serum Sot 
level (Gp1:3484.:!:,1755 ng/ml vs Gpll:4662.:!:.2109 ng/mI). Differences 
during Sot therapy were: 
mean QT meanQTc mean rate 
Gp I (n=54) 490 ms 475 ms 58/min 
Gp 11 (n=7) 610 ms 530 ms 48/min 
p value <0.0001 <0.01 <0.05 
Only 1 of 44 pts (2%) with QT<550 ms had TDP as compared to 6 
of 14 pts (43%) with QT>550 ms. None of 10 pts treated for NSVT 
or SVT had TDP. 
Thus, TDP as a complication of Sot therapy: 1) is unrelated to 
dose or serum Sot level; 2) tends to occur early; 3) is unlikely if 
QT is <550 ms; and 4) cannot be predicted from baseline ECG 
characteristics. 
VENTRICULAR FUNCTION PREDICTS DRUG RESPONSE OF 
VENTRICULAR TACHYCARDIA. 
Antonio Pacifico, M.D., Craig Pratt, M.D. F.A.C.C., Peggy 
Reus, R.N., David Levine, M.D., Sharon Magro, P.A.C., 
Lionel Faitelson, M.D., Huang-Ta Lin, M.D., F.A.C.C., 
Robert Roberts, M.D., F.A.C.C., Christopher Wyndham, 
M.D., F.A.C.C. 
Baylor College of Medicine, Houston, Texas. 
The LV ejection fraction (EF) correlates well with 
prognosis in patients (pts) with inducible sustained 
ventricular tachycardia (VT), but its influence on the 
response to conventional antiarrhythmic drugs during 
serial electrophysiologic studies (EPS) is unknown. Thus, 
we analyzed the results in 105 consecutive pts who were 
tested on 1-7 (mean 2.5) drugs (amiodarone excluded). Of 
the 105, 61 pts (LVEF .30 ± .08) failed to respond to a 
conventional drug and were treated with amiodarone, map-
directed VT surgery or with an AICD. The other 44 
patients (LVEF .36 ± .15) (p=O.OI) responded to a drug in 
the EP lab but only 33/44 pts (LVEF .38 ± .16) were dis-
charged on that drug. The other 11 pts failed clinically 
or died before discharge while on the medication. Long 
term follow-up of these pts revealed that 20/33 pts (LVEF 
.33 ± .12) failed treatment: 7 died (4 sudden, 3 MI) 5 
had VT, 7 had side effects, I was lost to follow-up. The 
other 13 pts (LVEF .45 ± .17) (p=O.OI) remained on the 
drug for a mean follow-up of 916 days. Thus a low LVEF 
correlated with a low chance of finding an effective drug 
by EP study, and also correlated with a poor response to 
long term antiarrhythmic therapy. Multiple EPS might be 
unnecessary in pts with low EF because the likelihood of 
finding an effective drug is very low. Alternative 
therapies should be considered early in pts with sus-
tained VT and low LV ejection fraction. 
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PROARRHYTHMIC POTENTIAL OF MODERATE-DOSE FLECAINIDE 
THERAPY FOR SUSTAINED VENTRICULAR TACHYCARDIA 
Imran Niazi, M.D., Nazih Kadri, M.D., Jose Caceres, 
M.D_/ Mohammad Jazayeri, M.D., James McKinnie, M.D, 
CarOl Gilbert, R.N., and Patrick Tchou, M.D. university 
of Wisconsin, Milwaukee, Wisconsin 
Frequent proarrhythmic effects have been reported during 
high-dose Flecainide (FLEe) therapy of sustained 
ventricular tachycardia (VT-S), (serum levels~ 1000 
ng/dL). This study assessed the proarrhythmic potential 
of moderate-dose therapy with FLEC (serum level= 600+210 
ng/dL). proarrhythmia was defined as development or-
incessant VT, enhanced inducibilit~ with programmed 
stimulation or greater difficulty 1n termination of 
induced VT-S by overdrive pacing (ODP). 
TWenty patients (PTS) with a mean age of 63.5+20 and 
mean ejection fraction = 34.1+20% underwent programmed 
stimulation on FLEC after faiTing 2.4+1 other 
antiarrhythmics. Induced VT-S was terminated by ODP, 
using bursts of 6-10 beats, starting at a cycle length 
(CL) 10 msec VT CL, and decreaSing ODP CL 1n 10 msec 
decrements. LoSS of consciousness prompted 
cardioversion (DCCV). 
RESULTS: 1) On FLEC, incessant VT-S developed in 1 PT 
necessitating discontinuation of the drug. 2) With 
programmed stimulation, VT-S remained inducible in 18 
PTS. Of these, VT-S was more easily induced in 11, less 
easily induced in 4! and equally easily induced in 3 
PTS. Overall, signlficantly fewer programmed 
extrastimuli were required to induce VT-S on FLEC than 
on during the control study (1.9+0.6 vs 2.3+0.7, 
~=.02). 3) On FLEe, a slow "sinusoidal" vT=s was 
1nduced in 6 PTS (mean CL = 373+48 msec, mean QRS = 
282+70 msec) which proved extraordinarily difficult to 
overdrive. In these PTS, 9+6 ODP and 3 DCCV attempts 
were required to terminate {be VT-S, compared to 1.8+1.6 
ODP and 4 DCCV on control study (and 3+2.2 ODP and no 
DCCV on Type la agents). Thus! 60% p~ exhibited 
increased proarrhythmic potentlal on FLEC. 
CONCLUSION: Even when used in moderate doses r FLEC has Significant proarrhythmic potential in PTS wlth impaired 
left ventricular function and VT-S. 
PHARMACOKINETIC INTERACTION BETWEEN PROPAFENONE AND DIGOXIN 
Paul E. Nolan, Pharm.D., Frank I. Marcus, M.D., F.A.C.C., 
Brian L. Erstad, Pharm.D., Gifford L. Hoyer, M.S., 
Caroline Furman, R.N., Edward B. Kirsten, Ph.D. Colleges 
of Pharmacy and MediCine, UniverSity of Arizona,Tucson, AZ. 
To examine the possibility of a pharmacokinetic drug inter-
action between propafenone and digoxin, we gave IV digoxin 
1mg,alone(Phase l);after 1 week of oral propafenone, 150mg 
every B hours (Phase 2); and after 1 week of oral propa-
fenone, 300mg every B hours (Phase 3) to 6 male subjects 
aged 26-38(mean: 32)years and weighing 72-87 (mean:80)kg. 
After each dose of digoxin, serial blood samples and 
consecutive 24-hour urine collections were obtained for 5 
days. Serum and urine concentrations of digoxin were 
determined by RIA. Following each treatment phase, the 
pharmacokinetic parameters of digoxin: area under serum 
concentration vs time curve(AUC) ,half-life (t 1/2), volume 
of distribution(V), total body clearance, renal clearance, 
and nonrena1 clearance were calculated and compared. 
Phase 1 Phase 2 Phase 3 
AUC (ng-hr/ml) 86.995 98.86# 112.1* 
t 1/2 (hr) 44.99 50.67 49.12 
V (L Ikg) 9.43 9.33 8.02# 
Total Body Clearance (ml/min/kg) 2.45 2.17# 1.92* 
Renal Clearance (ml/min/kg) 1.24 1.16 1.16 
Nonrena 1 Clearance (m1/min/kgl 1.21 1.01 0.75# 
* p<0.05; #p<O.l significantly different from control. 
Results indicate that propafenone at doses of 300mg every 
8 hours reduces the total body clearance of digoxin by 
21.9% by reducing the nonrenal clearance of digoxin. This 
could result in an increase in steady-state serum concen-
trations of digoxin of about 28%. This study suggests that 
the dose of digoxin may need to be reduced in patients who 
are concurrently prescribed propafenone. 
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PARENTERAL MAGNESIUM THERAPY IN INTRACTABLE 
VENTRICULAR T ACHY ARRHYTHMIAS. 
Byron J Allen. MD. Michael A. Brodsky, M.D. FACC, Cathy R. 
Luckett, R.N., Edmund V. Capparelli, Pharm.D., Lloyd T. Iseri, 
MD. FACC, 
University of California, Irvine, CA 
Although sustained ventricular tachycardia (VT) and 
fibrillation (VF) usually respond favorably to intravenous 
antiarrhythmic drugs, there are patients (pts) with intractable 
VT or VF resistant to conventional therapy. To demonstrate the 
effectiveness of parenteral magnesium sulfate (MgS04), 9 pts are 
presented who had repetitive episodes of VF (6) or VT (3) 
resistant to multiple antiarrhythmic agents, yet responded to high 
doses of intravenous MgS04. In no patient was the arrhythmia 
associated with an acute myocardial infarction. The underlying 
cardiac disorder was dilated cardiomyopathy (4), coronary artery 
disease (3), rheumatic heart disease (I), and digoxin intoxication 
(I). Four of 9 (44%) patients had documented hypomagnesemia 
and 2 were hypokalemic. 
Despite potassium repletion, repeated countershock (8), 
overdrive pacing (3), lidocaine (9), bretylium (4), procainamide 
(4), phenytoin (2), amiodarone (2), mexiletine (2), and quinidine 
(I), VT or VF persisted. Magnesium was administered as a 2-4 
gram IV bolus (over several minutes) followed by an infusion 
over 4 to 34 (median 5) hours. The mean total magnesium dose 
administered was 104 ± 48 mEq (13 ± 6 gms) which raised the 
mean serum magnesium from 1.68 ± 0.45 to 3.65 ± 1.20 mEq/L. 
The sustained arrhythmia abated within 24 hours of the onset of 
MgS04 administration in these 9 selected pts. No adverse 
reactions were encountered. We conclude that patients with 
intractable VT or VF refractory to multiple antiarrhythmic 
agents may respond to the addition of large doses of intravenous 
MgS04. However, it is likely that the serum magnesium level 
required for arrhythmia control is significantly above the normal 
range. 
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CLINICAL FEATURES OF AMIODARONE PULMONARY TOXICITY 
Raymond E. Dusman. M.D •• Marshall S. Stanton, M.D., 
William M. Miles, M.D., F.A.C.C., Lawrence S. Klein, 
M.D., Douglas P. Zipes, M.D., F.A.C.C., James J. Heger, 
M.D., F.A.C.C. Krannert Inst. of Cardiol., Indiana Univ. 
School of Med., VA Medical Center, Indianapolis, IN 
We examined the incidence and clinical predictors of 
amiodarone pulmonary toxicity (APT) in 498 patients (pts) 
treated with amiodarone (A) for recurrent ventricular 
(406 pts) or supraventricular (92 pts) tachyarrhythmias. 
The majority of pts had ischemic heart disease (318/498 
pts) • APT was diagnosed in 20/498 pts (4~) .based on new 
chest x-ray (CXR) abnormalities in 19/20 pts, and sup-
ported by abnormal biopsy (9/9 pts), pulmonary function 
tests (PFT) (7/8 pts), and/or gallium lung scan (5/7 pts) 
findings. One pt had abnormal PFT and gallium scan with-
out change in CXR, while only 4 pts had APT diagnosed by 
CXR alone. There were no differences between APT posi-
tive (+) vs. APT negative (-) pts with regards to gender, 
arrhythmia, or plasma A or desethyl-A levels. Ages of 
APT+ and APT- pts were not different but APT was not 
observed in pts <49 yrs (N=91). APT occurred between 2 
and 31 months of treatment for a cumulative risk of 7%, 
with the highest incidence during the first 18 months 
(17/20 pts). APT+ pts had a larger average daily mainte-
nance dose of A, 556±115 mg, than APT- pts, 466±157 mg, 
(p<0.05). Pre-A PFTs from 311 APT- and 13 APT+ pts 
showed no significant differences in spirometry, lung 
volume or diffusion capacity (DLCO) determinations. Pre-A 
restrictive and/or obstructive lung physiology was pre-
sent in 148/324 pts, abnormal DLCO in 39/273 pts, neither 
predicting APT. Death due to APT occurred in 2/20 pts 
(10~), both in the group of 7 pts treated with sterOids. 
We conclude: 1) APT occurred in 4% of pts and was related 
to average A maintenance dose, 2) risk of APT was less in 
young pts, and 3) pre-A PFTs did not predict APT. 
ABSTRACTS 
EFF.OCTS OF ORAL FLEX:AINIDE 00 ATRIOVENTRICULAR 
ROCIPROCATI~ TACHYCARDIAS REFRACTORY TO PmCAINAMIDE. 
Liaqat Zaman, M.D., F.A.C.C., Pedro Fernandez, M.D., 
Alberto Interian Jr., M.D_, Richard G. Trohman, M.D., 
F.A.C.C., Agustin Castellanos, M.D., F.A.C.C., and 
Robert J. Myerburg, M.D., F.A.C.C., University of Miami 
Medical Center, Miami, Florida. 
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In this study, 'to'e evaluated the efficacy of oral 
flecainide (FllX::) in 9 patients with orthodromic 
reciprocating tachycardias (ORTs) which remained inducible 
after 10 mg/KG dose of intravenous procainamide. The 
atrioventricular accessory pathways (APs) 'to'\ere manifest 
in 8 and concealed in 1 patient. AP locations 'to'ere: left 
lateral in 3, anterior deptal in 2, posterior septal in 2, 
and right lateral in 1; AP location could not be 
identified in 1 patient. Sustained (~ 2 minutes) 
ORTs 'to'ere induced off antiarrhythmic agents and ORT 
induction was repeated at least 5 half lives after the 
initiation of oral FllX:: at 200-400 mg daily (mean dose = 
278 ;!: 67 mg). FllX:: had clinically beneficial effects in 
5/9 patients; ORT was non-inducible in 2 and non-sustained 
ORT (<30 sec.) terminating spontaneously in the 
retrograde AP was induced in 3. Both non-inducible 
patients had complete retrograde block in the AP after 
FllX:: while 2/3 with inducible non-sustained ORT showed 
significant prolongation of retrograde effective 
refractory period and/or shortest ventricular paced cycle 
length with 1:1 conduction (40-230 msec). FllX:: caused 
complete antegrade AP block in 4 and retrograde block in 2 
patients; 5/6 had AP refractory period ~ 280 msec before 
FllX:: (210-180 msec, mean = 248 ;!: 26). We conclude: 1) 
Orally administered FLEx::: has clinically significant 
beneficial effects on ORTs refractory to intravenous 
procainamide; and 2) FllX::-induced complete block can occur 
in APs with pre-FLEx::: refractory periods ~ 280 msec. 
MAINTENANCE OF SINUS RHYTHM IN PATIENTS WITH 
A TRIAL FIBRILLATION AND A DILATED LEFT ATRIUM. 
Michael A. Brodsky. M.D .. FACC, Byron J. Allen, M.D., Rebecca 
Morton, BS. Edmund V. Capparelli Pharm.D., Cathy R. Luckett 
R.N., Walter L. Henry M.D., FACC, 
University of California, Irvine, California. 
Previous reports have suggested that the finding of a 
dilated left atrium (LA) by echocardiography identifies patients 
who are unlikely to maintain sinus rhythm (SR) following 
conversion of atrial fibrillation (AF). However, many of these 
reports antedate the availability of new antiarrhythmic drugs. 
To analyze the efficacy of current agents in maintaining SR, the 
relationship between LA size and the ability to maintain SR was 
studied in 44 Pts with chronic (28) or paroxysmal (16) AF who 
had echocardiographic evidence of a dilated LA (>45mm). Pts 
had failed 3.9±2.0 drugs due to either recurrent AF or intolerable 
side effects. Follow-up averaged 17.9 ±14.1 months. A variety 
of drugs were tested and patients followed on the most effective 
regimen. The following drugs were utilized for long term 
therapy: Amiodarone (25), Type IA drugs (8), Type IC drugs (4), 
combination amiodarone and IA (6), and beta-blockers (I). 
Digoxin, beta-blockers, and calcium channel blockers were also 
frequently utilized in combination with amiodarone and Type IA 
drugs. The actuarial (%) likelihood of maintaining sinus rhythm 
was as follows: 
n 
I Year 
2 Year 
A!!...fU 
44 
.74 
.58 
LA 45-59mm 
30 
.78 
.67 
LA >60mm 
14 
.56 
.34 
We conclude that patients with LA dimensions of 45-
59mm may often be maintained in sinus rhythm. However, 
patients with LA ~60mm are likely to have recurrent AF 
(Mantel-Haenszel, p = 0.06) despite the use of multiple 
antiarrhythmic drugs including amiodarone alone or in 
combination with Type IA agents. 
170A ABSTRACTS 
ESMOLOL VS VERAPAMIL FOR THE TREATMENT OF RECENT-ONSET 
ATRIAL FIBRILLATION/FLUTTER: A MULTICENTER STUDY 
Edward V. Platia, MD, FACC, Patricia Fitzpatrick, MD,Diane 
Wallis, MD, Elliott M. Antman, MD, FACC, Eric L.Michelson, 
MD, FACC, and Tsushung A. Hua, Ph.D., Washington Hospital 
Center, Washington, DC 
Because catecholamine drive is thought to playa signifi-
cant role in electrogenesis and acceleration of ventricular 
response in recent-onset atrial fibrillation/flutter (afib/ 
flut), treatment with the ultrashort-acting B-blocker 
esmolol (esm) might be particularly effective. In order to 
test this hypothesis, 83 patients with afib/flut of recent 
development (~48 hrs) were entered into this randomized, 
open-label study to compare the effects of esm (na 40) to 
verapamil (verap) (na 43) in conversion to sinus rhythm 
(NSR) and in controlling ventricular rate. Baseline pre-
study variables and demographics were similar between the 
treatment groups. Esm was given by continuous infusion in 
incremental doses from 2-16mg/min for 5-10 minutes each 
following loading-dose boluses of 10 or 2Omg. Verap was 
given in 5 or lOmg IV boluses in 2 titration steps, as needed. 
~ 11m ~ ~!lU2 ~ 
Ventric)llar rate 148±3 ,~±! <.001 p<.05 146±2 87t3 <.001 
(b"u/min) 
Conversion to asl. 15/40(38%) 5/43(12%) 
'---p(.Ol-----· 
With each drug, a fall in ventricular rate was observed 
within 2 minutes of infusion. Side effects included asymp-
tomatic and symptomatic blood pressure reduction in 11/40 
(28%) in the esm group and 9/43 (21%) in the verap group 
(p=NS). We conclude: 1) Esm and Verap are effective in 
promptly controlling ventricular response in recent-onset 
afib/flut, and 2) Esm offers a potential advantage in this 
setting because it is significantly more likely to convert 
the rhythm to NSR. 
INTRAVENOUS DILTIAZEM FOR ATRIAL FIBRILLATION AND 
FLUTI'ER: A MULTICENTER TRIAL 
David M. Salerno, M.D, Ph.D., F.A.C.C., Virgil Dias, Phann.D., 
Robert Kleiger, M.D, F.A.C.C., Magdi Sami, M.D., F.A.C.C., Ruey 
Sung, M.D., F.A.C.C., Victor Tschida, M.D., Lee Giorgi, M.D., 
F.A.C.C., For the Diltiazern/ Atrial Fibrillation Study Group 
Hennepin County Medical Center, Univ of Minnesota, Minneapolis 
This 6 center, double-blind, placebo-controlled trial tested the 
efficacy and safety of intravenous diltiazem for rapid control of the 
ventricular rate (HR) in atrial fibrillation (A Fib) and flutter (A Flut). 
113 pts (mean age 64 ± 13 years) were randomized to either diltiazem or 
to placebo. All had HR ~ 120 bpm, systolic pressure ~ 90 mmHg, and 
no heart failure. 89 had A Fib and 24 had A F1ut. 47 had 
atherosclerotic heart disease, 40 hypertension, 16 lung disease, 13 
valvular disease, and 45 other diseases. Dose was 0.25 mglkg/2 min 
followed 15 min later by 0.35 mglkg/2 min if the first dose was tolerated 
but ineffective. Efficacy was defined as ~ 20% decrease in HR, HR < 
100 bpm, or sinus rhythm. HR and blood pressure were measured at 
baseline, the end of injection and every 5 min x 3. 
42 of 56 pts randomized to diltiazem responded to 0.25 mglkg and 
10 of 14 responded to 0.35 mglkg, for a total response rate of 52 of 56 
pts (93%), whereas 7 of 57 pts (12%) responded to placebo (p < 
0.001). On first dose, the following average data were obtained. 
HR (bpm) Baseline 2 mjn 7 min 12 min 17 mjn 
Diltiazem 149 123 113 115 114 
Placebo 148 144 143 145 143 
Systolic BP (mmHg) 
Diltiazem 126 115 115 117 116 
Placebo 129 128 126 125 126 
After the double-blind protocol, 49 of the 57 pts who received placebo 
were then given diltiazem: 47 of 49 responded, for an overall response 
rate of 99 of 105 pts (94%). Side effects occurred in 14 pts; these 
required protocol interruption but no therapy in 2 pts (hypotension). 
Intravenous diltiazem is rapidly effective in most pts with A Fib and 
A Flut. Blood pressure decreases slightly. Side effects are mild. 
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THE DRUG OF CHOICE FOR ACUTE MANAGEMENT OF PAROXYSMAL 
ATRIOVENTRICULAR REENTRANT TACHYCARDIA: ATP? VERAPAMIL? 
Bernard Belhassen, M.D., F.A.C.C., Aaron Glick, M.D., and 
Shlomo Laniado, M.D., F.A.C.C., Tel-Aviv Center, Israel. 
The efficacy, electrophysiologic effects and side effects 
of adenosine triphosphate (ATP) and verapamil (V) in the 
management of paroxysmal AV reentrant tachycardia (AVRT) 
were compared in 20 pts with inducible sustained (>5 min) 
AVRT. 1~ pts had AVRT involving a retrograde accessory 
pathway (AP) and 6 pts had the "slow-fast" form of AV 
nodal reentry. ATP which has a very short half-life 
(about 10 sec) was first administered (10 mg i.v.!1 sec) 
during sustained AVRT; if AVRT did not terminate within 2 
min, a bolus of 20 mg ATP was given. V (5 mg i.v./15 sec) 
was subsequently administered during sustained AVRT and 
if the latter did not terminate within 3 min, another 
bolus of V 5 mg was given. Cycle lengths of AVRT before 
administration of 10 or 20 mg ATP and 5 mg V were 
similar. AVRT was terminated by 10 mg ATP in 17 pts and 
by 20 mg ATP in the other 3. AVRT was terminated by 5 mg 
V in 15 pts and by an additional 5 mg in 1/5 pts. The 
overall efficacy rate of ATP (20/20) was significantly 
greater than that of V (16/20)(p< 0.05). ATP terminated 
AVRT more quickly than V (2~ sec vs. 51 sec, p< 0.01). 
Termination of AVRT by ATP or V was mostly related to 
block in the AV node in pts with AP's or in the antegrade 
slow pathway in pts with AV nodal reentry. A higher 
incidence of 2nd degree AV block, VPC's, recurrent AVRT 
and noncardiac side effects was observed a~ter ATP. The 
latter were benign and transient but frequently 
uncomfortable. We conclude that although ATP is more 
effective than V in terminating AVRT, it results in a 
higher incidence of cardiac and non cardiac side effects. 
Therefore, we recommend its use only if a cumulative dose 
of 10 mg V has failed or if V is contraindicated. 
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EXOGENOUS CREATINE PHOSPHATE: FAVORABLE CALCIUM-ALTERING 
EFFECTS IN ST. THOMAS' HOSPITAL CARDIOPLEGIC SOLUTION 
Lary A. Robinson, M.D., F.A.C.C.; Deborah L. Harwood, B.S. 
University of Nebraska Medical Center, Omaha, Nebraska. 
The addition of creatine phosphate (CP) to St. Thomas' 
cardioplegic solution (STS) has been shown to improve 
myocardial tolerance to prolonged global ischemia. The 
mechanism of action of CP was investigated in the isolated 
working rat heart model of cardiopulmonary bypass and 
ischemic arrest. CP (10 mmol/L) added to STS significant-
ly improved post-ischemic functional recovery including a 
doubling of aortic flow after 300 minutes of hypothermic 
(200C) ischemia and multidose (every 30 min.) cardioplegia 
from 22.0 ± 5.9% in the control group to 49.1 ± 6.0% inthe 
CP-treated group (p ~ 0.01). Creatinine phosphate (CNP), 
a non-high energy phosphate structural analog of CP and 
not itself a substrate in the creatine kinase reaction, 
added to standard STS (10 mmol/L) also significantly 
improved post-ischemic recovery of aortic flow (22.0 ± 
5.9% control VB. 53.5 ± 9.6% CNP-treated, p < 0.05). 
Both CP and CNP reduced post-ischemic creatine kinase 
leakage. Since CP and CNP have known calcium binding 
effect, a modified STS with lowered calcium (0.6 mrnol!L 
as compared to the standard 1.2 mmol!L) was tested alone. 
Post-ischemic functional recovery was similar to the CP 
and CNP groups and was significantly better than control 
(standard formula) STS. In parallel studies, CP 
(10 mmol/L) added to an acalcemic cardioplegic solution, 
however, gave no improvement in post-ischemic functional 
recovery compared to the CP-free control group. 
Exogenous creatine phosphate most likely provides its 
protective effect in St. Thomas' cardioplegic solution by 
lowering the effective calcium concentration, and less 
likely by an interaction with cellular creatine kinase or 
by direct high energy phosphate metabolism. 
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CLINICAL EVALUATION OF PROSTACYCLIN ANALOGUE AS AN 
ADJUNCT TO CARDIOPLEGIA IN INFANTS AND CHILDREN 
Hikaru Matsuda, M.D., Satoru Kuki, M.D., Yoshiki Sawa, 
M.D., Yasuhisa Shimazaki, M.D., Hajime Hirose, M.D., 
Yasunaru Kawashima, M.D., Osaka Univ., Osaka, Japan 
After experimental studies of prostacyclin analogue 
(OP-41483, PGI2A) for myocardial protective effect, its clinical evaluation was performed applying as an adjunct 
to cardioplegia (CP) in infants and children in whom the 
current CP seems less satisfactory. 14 patients, neonate 
to children, who received potassium CP with PGI A 
(30Omcg/L) were compared to the control group (n=12) 
without PGI2A. Multiple dose CP was used in children and single dose for infants. In children (age; 1-14 yrs) 
with complex cardiac lesions in whom aortic cross clamp 
(AXC) time exceeded 120 min (n=14), PGI2A group (n=8, age; 7.7±3.3 yrs, AXC;152±35 min,mean±SD) showed signif-
icantly lower postoperative peak CPK-MB value (4S±19 vs 
81+34 IU/L, p<.05) compared to the control group (n=6, 
7.1±5.1 yrs, 141±IS min). In infants of age <6 months 
(n=12) who received CP with calcium (1.2 mM), myocardial 
biopsy (LV, pre- and post-AXC) was made, and PGI 2A group (n=6, age;I.5±1.6 mo, AXC;82±21 min) were compared to 
the control group (n=6, 2.2±3.2 mo, 77±31 min ) utiliz-
ing the ultrastructural scores (mitochondrial change; 
0-5, intracellular edema; 0-4). In the mitochondrial 
score for pre- and post-AXC, no significant change was 
seen in PGI A group (0.4±0.4 to 0.7± 0.4), while control 
group showe~ significant increase from pre- to post-AXC 
(0.3+0.2 to 0.7+0.5, p<O.OS). Post-AXC score for intra-
cell~lar edema -was significantly lower in PGI2A group than control group (0.5±0.9 vs 0.9±0.3, p<O.OS). 
This first clinical study of PGI A as an adjunct to CP 
showed the beneficial myocardia! protective effect in 
children with prolonged AXC and small infants in whom 
the myocardial protection with potassium CP was limited. 
DEFEROXAMINE REDUCES NEUTROPHIL-MEDIATED FREE RADICAL 
PRODUCTION DURING CARDIOPULMONARY BYPASS IN MAN. 
Ph. Menasche, MD, C. Pasquier, PhD, P. Jaillon, MD, 
A. Piwnica, MD, FACC, HOpital Lariboisiere, Paris, France 
Cardiopulmonary bypass (CPB) causes complement-mediated 
activation of polymorphonuclear neutrophils (PMNs) with 
subsequent iron-catalyzed production of toxic oxygen me-
tabolites by these cells. We assessed the effects of the 
iron chelator deferoxamine (Dfx) in 24 pts (12 controls, 
12 treated) undergoing CPB for valve or coronary surgery. 
Dfx was given both intravenously (30 mg/kg, starting 30 
min before and ending 30 min after CPB) and in cardiople-
gia (250 mg/L). Right atrial blood samples were serially 
taken at surgery and isolated PMNs were immediately eva-
luated for their superoxide-generating capacity after st~ 
mulation by N-formyl-methionyl-leucyl-phenylalanine fMLP, 
10-7M) and phorbol myristate acetate (PMA, 100 ng/ml). 
Superoxide production was measured by following the supe~ 
oxide dismutase-inhibitable reduction of ferricytochrome 
c at 550 nm in a double-beam spectrophotometer over 4-min 
periods. The CPB time (ffi:SEM) was comparable in control 
(S8:6 min) and treated (102.6) pts. The main biochemical 
data are summarized below : 
Group Superoxide Production (nmole/l06PMN/min, m±SEM) 
FMLP PMA 
Pre-CPB Post-CPB Pre-CP8 Post-CPB 
Contro14.1±0.4 3.7:0.2 11.1±2.0 12.6±2.5 
Treated 3.4:0.3~0.02~1.9±0.3 7.0±1.5 7.1±D.9 
p(ANOVA) NS < 0.05 NS < 0.05 
We conclude that Dfx-exposed PMNs have a decreased oxida-
tive responsiveness, consistent with the hypothesis that 
they have been less "sensitized" during CPB, since inhi-
bition by Dfx of PMN-derived iron-catalyzed free radical 
production may, in turn, limit the free radical-mediated 
amplification of the inflammatory response to CPB. Our 
clinical data support the use of Dfx ~ope~eart surgery. 
ABSTRACTS 
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S&lem. M.D.IAce. Hassan Rasf.eglt. M.D .. Richard J Clevelalld. M.D .. 
FAce. Tufts Univ .• Hew EAglalld Medical. Center. Boston. MA. 
Retrograde cardioplegia has been sullested as & mHAS for im-
proved RV preservation during coronary bypass.We randomized 
20 patients to receive (cold blood) cardioplelia &Ategracie or 
retrograde via the right atrium. Post operatively (op) (24 hrs) LV 
&Ad RV end-diastolic(EDVI) &Ad end-systolic volume indez(ESVI) 
were calculated from radionuclide ejection fractions &Ad 
thermodilution stroke volume measurements at rest &Ad during 
volume1oadUlg at constant p&c:ed heart rates. Mean 1. S.D.;"p(.~ vs 
pre-op; .p(.~ &Ategrade VI retro,rade cardiople,ia: 
LVEDVI LVESVI RVEDVI RVESVI 
ble''''' (ml/m2) (ml/m2) (ml/m2) (ml/m2) 
pre-op 81!.!4 4O!.lO ,7!.!' 
post-op 71!.!6 34!.l1 67!H· .. ." ...... 
pre-op 88!34 46!21 
JIOst-op 67':'13" 28!.l3". 
RV function curves (riaht) indicated 
depressed RV systolic function iA 
&Ate,racIe vs retroaracle arouJlS. 
Conclusio.os: In comparison with 
&Atearacle cardiopleaia. retroarade 
cardioplegia provides: I) comparable 
LV jlresenation, with .realer reduc-
tion iA L VESVI 24 hrs post-op 2) im-
proved RV protection reDected by 
post-op RV volumes &Ad ventricular 
function curves. 
2<C.12 
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IMPROVED CARDIOPLEGIC PROTECTION WITH A NEW LECITHIN-BASED 
PERFLUOROCARBON EMULSION. 
Ph. Menasche, MD, C. Grousset, PhD, C. Mouas, R.E. Moore, 
A. Piwnica, MD, FACC, HOpital Lariboisiere, Paris, France, 
and Adamantech, Marcus Hook, PA. 
Myocardial protection during cardioplegic (CP) arrest can 
be improved by promoting aerobic metabolism throughout the 
ischemic period. Because of the problems associated with 
blood cardioplegia, W~ assessed the effects of a newly 
developed lecithin-based perfluorocarbon (prC) in an iso-
lated isovolumic buffer-perfused rat heart model of CP 
arrest. Thirty hearts divided into 3 equal groups under-
went 90 min of global ischemia at 30DC followed by 45 min 
of normothermic reperfusion. During arrest, hearts were 
infused at 30-min intervals with either standard crystal-
loid hyperk+ CP solution (Group I), lecithin-enriched CP 
solution (Group 2) or lecithin-based prc CP solution 
(Group 3). All perfusates were equally oxygenated (P02tv 
600 mm Hg). Recovery of isovolumic developed pressure (D~~ 
LV dP/dt and diastolic pressure waa ussd to assess 
functional recovery. All data are given as the mean ~ SEM. 
Group DP (mm Hg) dP/dt (mmHg/sec-l ) 
N=lO Baseline Reflow Baseline Reflow 
1 133.8%4.6 96.3±2.4 3989±14B 2812±107 
2 138.7:5.6 100.5±3.9* 4380:238 3340±144** 
3 129.2:3.9 l13.8±2.3 3958±129 3847±145 
*p<0.05 vs Grp 2, p<O.Ol vs Grp 1 **p<O.OOl vs Grp 1 
by ANOVA and Scheffe's test. 
Postischemic diastolic pressures were not different among 
the 3 groups. We conclude that this oxygenated PFC CP so-
lution provides near optimal myocardial protection after 
a severe ischemic. insult, which could be critical in high-
risk surgical pts. The clinical relevance of these data is 
further supported by the fact that, unlike previously de-
veloped pluronic-based prc emulsions, this lecithin-based 
methyladamantane PFC has no complement;.activating effect. 
inA ABSTRACTS 
IMPORTANCE OF TOPICAL HYPOTHERMIA DURING HETEROGENOUS DIS-
TRIBUTION OF CARDIOPLEGIA 
Harold L. Lazar, MD, FACC, Samuel Rivers, BS, Boston Uni-
versity Medical Center, Boston, MA 
Recent studies have concluded that topical hypothermia is 
unnecessary during coronary surgery because of increased 
pulmonary complications. This experimental study was un-
dertaken to determine whether topical hypothermia (TH) is 
necessary for optimal myocardial protection when cardio-
plegia distribution is heterogenous because of coronary 
occlusions. Twenty pigs were subjected to 120 minutes of 
ischemic arrest with multidose, potassium, crystalloid 
cardioplegia (4°C). During arrest, the mid-LAD was oc-
cluded with a snare which was released upon reperfusion. 
Ten of these pigs received TH, while 10 others served as 
controls. Parameters measured included LV temperature 
(temp) and tissue pH in the distal LAD and Circumflex (Cx) 
distribution; end-diastolic volume (EDV) and stroke work 
index (SWI). Results are: Mean±SE, *p < .02. 
Average LAD Temp (OC) 
Average Cx Temp (OC) 
Average pH-LAD 
Average pH-Cx 
Post ischemic SWI(g-m/kg) 
at EDV=60 ml 
Cardioplegia Cardioplegia & TH 
1B.5±.5 7.0±.7* 
15.5±.5 B.9±.5* 
6.73±.07 7.36±.09* 
7.05±.07 7.40±.07* 
. 31±. 07 .64±.06* 
TH resulted in lower temperatures and higher pH values 
beyond the LAD occlusion during cardioplegic arrest. 
This was responsible for a higher SWI in the TH hearts. 
We conclude that TH affords maximal myocardial protection 
when coronary occlusions are present and should be used 
during all coronary surgery. 
CAN INTERMITTENT BOLUS OXYGENATED CRYSTALLOID 
CARDIOPLEGIA MAINTAIN AEROBIC METABOLISM OF THE 
ARRESTED HEART ? 
1~Yr~nf~_~~Y~_Q~~Q~rL_M~Q~L_f~~~g~g~, Ronald R. 
Rabjohns, M.D., David K. Swanson, Ph.D. 
University of Wisconsin, Madison, Wisconsin 
To detail oxygen utilization during surgical 
arrest, oxygen depletion was monitored with 
epicardial NADH fluorscence following bolus 
infusion of OCC or Krebs-Henseleit buffer (KHB) 
into isolated rat hearts (n=13). NADH appears 
when mitochondria exhaust intracellular oxygen. 
We measured time to 10% NADH (sec),to 50% NADH 
(sec) and slope of NADH appearance (%/min) to 
estimate the aerobic state of mitochondria: 
TEMP BUFFER TIO T50 SLOPE 
37 OCC 40+7 85+10 66+8 
KHB 4+.1 13+1 334+38 
30 OCC 70+9 113+12 56+4 
KHB 14+2 28+3 190+20 
20 OCC 99+3 170+13 44+7 
KHB 29+5 50+6 138+12 
13 OCC 123+7 200+20 37+4 
KHB 50+7 82+6 83+6 
For both OCC a~d KHC, TIO: T50 and Sl;pe 
correlated to temperature (r's >.95). The 
aerobic period was significantly (p <.01) longer 
with OCC than KHB. These studies demonstrate 
that intracellular oxygen depletion is slowed by 
cardioplegic arrest and by hypothermia. While 
appreciable aerobic metabolism occurs after OCC 
infusion, current schedules of OCC may cause 
significant periods of anaerobic metabolism. 
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EFFECTS OF VARIABLE ULTRASONIC ENERGY DURATION, 
APPLICATION MODE AND ENERGY ON ATHEROSCLEROTIC PLAQUE 
ABLATION. 
Robert J. Siegel. M.D .• F.A.C.C., Kevin Moore, Michael 
C. Fishbein, M.D., F.A.C.C., T.A. Don Michael, M.D., 
F.A.C.C., Cedars-Sinai Medical Center, Los Angeles and 
Bakersfield, California. 
To determine the optimal application of ultrasonic 
energy for ablation of human atherosclerotic lesions, 58 
pathologic human arterial specimens were studied. 
Ultrasonic energy was applied to atherosclerotic 
arterial segments with a continuous wave (N=27) or a 
pulse wave (N=31) mode. Duration (5 sec - 10 min) as 
well as acoustic power output (5-50 watts) were varied 
using a 2F wire ultrasonic probe (Fixed frequency - 20 
kHz). The application of ultrasound to atherosclerotic 
segments resulted in reduced wall stiffness, disruption 
of gross and microscopiC calcifications, and crater 
formation in the plaque. Totally occluded longitudinal 
segments (N=7) were penetrated and made probe patent in 
<10 sec. Vessel perforation was uncommon (N=6) but 
when present was always associated with thermal damage, 
use of continuous wave mode, ultrasonic energy for >30 
sec (.5/6>60 sec), and >20 watts acoustic power output. 
Vascular damage, thermal injury and vessel perforation 
were not seen using ultrasound in pulse wave mode or 
with a duration < 30 sec. Modification of duration, 
mode and power output of ultrasonic energy permit 
effective plaque ablation in the absence of thermal 
damage or vessel perforation. Thus, ultrasonic energy 
delivery appears to have potential as a method for 
ablation of calcified and fibrous atherosclerotic plaque 
as well as for penetration of complete vascular 
occlusions. 
TRANSLUMINAL ATHERECTOMY: HEMODYNAMIC FOLLOW-uP BY 
DOPPLER ANALYSIS 
Gregory C. Robertson, M.D., Matthew R. Selmon, M.D., 
John B. Simpson, M.D., Sequoia Hospital, Redwood 
City, CA. 
The helOOdynamic and symptomatic effect of 
trans luminal atherectomy (TA) for percutaneous 
relOOval was evaluated in 64 procedures with 
peripheral vascular disease. All patients had 
claudication at less than 500 feet with predominantly 
focal stenoses in the common iliac, superficial 
felOOral or popliteal arteries. All patients were 
treated with TA exclusive of other mechanical 
intervention. The helOOdynamic effect of TA was 
evaluated with pre, I day post TA, and 2 month post 
TA P/W analysis. 
Pre 
I day 
2 IOOnth 
Mean re st ing DP/PT 
0.65/0.70 (n=64) 
0.85/0.85 (n=64) 
0.82/0.78 (n=38) 
Exercise AAI Index 
0.53 (n=35) 
--- (n= ) 
0.74 (n=24) 
57 of 69 (83%) patients were shown to have improved 
Doppler P/W values I day post and 33 of 48 (69%) 
patients continued to exhibit improved Doppler P/W 
values at 2 IOOnth follow-up. ~mmediately following 
TA, 59/64 (92 %) patients had at least a one-fold 
decrease in claudication. 53/64 (83%) patients were 
still improved at 2 month follow-up. In conclusion, 
TA is effective in improving exercise capacity and 
may lead to success ful long-term treatment of 
se lec ted patients with peripheral vascular disease. 
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PRIMARY STENOSES AND RESTENOSES EXCISED 
BY PERIPHERAL ATHERECTDMV: A HISTOLOGIC STUDY 
Danna E. Johnson MD. Matthew R. Selmon MD. John B. 
Simpson MD. Medical College of Virginia. Richmond. VA. 
Tissues obtained via transluminel atherectQm¥ 
(atherectQm¥J fram 120 peripheral arterial stenoses 
in 57 patients were studied by I ight microscopy. 
Stenoses were classified as I of ~ histologically 
dist inct lesions: I J atheromatous plaque (AP. 81 
lesions). 2J fibrous Intimal thickening (FIT. 18 
lesions1. 3J organlz ing thranbus alone (OT. ~ 
leslons1. and ~J intimal hyperplasia (IH. 17 
lesionsJ. One third of AP were complex. with 
calcification. ulceration. or surface thrombus. All 
but 3 patients with FIT or OT had associated AP. The 
morphology of restenosls after atherectamy or 
angioplasty was identical. being IH due to 
myaflbroblast prol iferatlon and without the lipid 
accumulation typical of AP. Twelve patients 
restenased after atherectamy. Arterial media was 
present in the original tissues excised fran" of 12 
restenasis patients. as compared to 10 of ~5 primary 
stenosis patients (p< 0.005J. Newly formed platelet-
fibrin thrombi induced by atherectQm¥ were seen on 
tissues fran 8 of 12 restenosi. cases In contrast to 
only 8 of ~5 primary stenosis patients (p< 0.005J. 
We conclude that IJ tissues removed by atherectQm¥ 
reflect the heterogeneous nature of atherosclerosis 
21 the IH of restenosis post-atherectamy or 
angiaplasty has a distinctive morphology which 
differs from that of AP. and 31 the presence of 
arterial media and fibrin-platelet thrombi In excised 
tissues may be of predictive value In studying 
restenasls after atherectany. 
PERCUTANEOUS CORONARY ANGIOSCOPY USING A STEERABLE 
MICROANGIOSCOPE. 
Stephen R. Ramee, M.D., F.A.C.C., Christopher J. White, 
M.D., F.A.C.C., Alan K. Banks, M.D., Michael Aita, 
Thomas Doyle, Mary Beth Michaels, Goeffrey Graeber, 
M.D., Herman Price, M.D., F.A.C.C., Walter Reed Army 
Medical Center and Institute of Research, Washington, DC 
To determine the feasibility of performing percutaneous 
coronary angioscopy in humans using a steerable, wire-
guided microangioscope, the following study was 
performed. Six adult animals (4 sheep, 2 swine, weight 
40-55 kg.) underwent coronary angiography using standard 
8 French angioplasty guiding catheters placed 
percutaneously in the right femoral artery under general 
anesthesia. A guidewire was used to steer the 
angioscope into the desired artery using fluoroscopic 
guidance. Angioscopic visualization was achieved by a 
combination of balloon inflation (1-4 atmospheres) and 
distal flush with lactated Ringer's solution for 5-45 
seconds. The left anterior descending (n=2), left 
circumflex (n=3), and right coronary artery (n=2) were 
studied and images were stored on videotape. Use of a 
moveable guidewire made selection of any major branch 
possible. Visibility was best in straight segments and 
in segments where balloon occlusion of coronary flow was 
adequate. When coaxial position was achieved, the image 
resolution was excellent. Angioscopic findings included 
normal artery lumen, cardiac motion, collateral blood 
flow, bifurcations, microbubbles, and thrombus. 
Conclusion: High-resolution percutaneous coronary 
angioscopy is feasible using standard angioplasty 
guiding catheters with this fleXible, steerable 
microangioscope. 
ABSTRACTS 
PTCA VS ROTATIONAL ATHEREcroMY (PTRA) IN RABBIT 
ATHEROSCLEROSIS: EARLY AND LATE EFFECTS. 
Marraret Hall, M.D., Dennis Hansen. M.D., Michael 
lnt ekofer, Ph.D., David Auth. Ph.D .• James Ritchie, 
M.D., F.A.C.C., VAMC and Univ of Washington, Seattle. 
After 2 weeks on a high cholesterol diet, 44 iliac 
arteries of juvenile rabbits were treated with 
angioplasty (PTCA) in one artery and a rotational 
atherectomy device (PTRA) in the opposite artery. 
Ten animals were sacrificed acutely. All treated 
segments showed 50-70% intimal removal with disruption 
of up to 25% of the internal elastic lamina. The 
media was intact. Pathologically, there were no 
differences between the PTCA and PTRA arteries. 
Twelve animals had angiography at 8 weeks and were 
then sacrificed. Quantitative stenosis was 34% for 
PTRA and 30% for PTCA (p=NS). There was modest 
intimal and medial hyperplasia in both and no 
distinguishing pathologic features between the PTCA 
and PTRA arteries. 
We conclude that there are no differences in acute or 
chronic arterial response to PTCA vs PTRA in juvenile, 
normal arteries. Since endothelial denudation and 
intimal disruption are common to both devices, and 
stretch occurs only with PTCA, the former may be an 
important injury stimulus in this model. 
IN-VIVO FLUORESCENCE SPECTROSCOPY OF NORMAL AND 
ATHEROSCLEROTIC ARTERIES. Lawrence I. Decke1baum, M.D •• 
F.A.C.C •• Ian J.Sarembock.M.D •• Mark L.Stetz.B.S •• Ken 
M.O'Brien.B.S •• Frances W.Cutruzzo1a.B.S •• Arthur 
F.Gmitro. Ph.D. Michael D.Ezekowitz. M.D •• Ph.D. 
173A 
F.A.C.C. VAMC and Yale University. West Haven. CT. 
Laser-induced fluorescence spectroscopy (LIFS) can dis-
criminate atherosclerotic (A) from normal (N) arteries 
in-vitro and may potentially guide laser angiop1asty. To 
evaluate the feasibility of LIFS in a living blood-filled 
arterial system we performed fiberoptic LIFS in a rabbit 
model of focal femoral atherosclerosis. An LIFS score was 
derived from stepwise linear regression analysis of in-
vitro LIFS spectra to distinguish N aorta (score>O) from 
A femoral artery (score<O). A 400 p silica fiber. coupled 
to a He-Cd laser and optical multichannel analyzer. was 
inserted through a SF catheter to induce and record in-
vivo fluorescence from femoral and aortoi1iac arteries. 
Arterial spectra could be recorded in all animals (n=11: 
5 occlusions. 6 stenoses). Blood spectra were of low 
intensity and were easily distinguished from arterial 
spectra. The scores (mean + SEM) for the in-vivo spectra 
were -0.57 + 0.15 for A fe;ora1. and +0.12 + 0.13 for N 
aortoi1iac ~rteries (p<.OOl; p=NS compared to in-vitro 
spectra). A fiber tip to tissue distance <25 p (in-vitro) 
was necessary for adequate arterial LIFS in blood. At 
larger distances low intensity blood spectra were 
recorded (1/20 the intensity of tissue spectra). 
CONCLUSION: 1) Diagnostic arterial LIFS can be performed 
in-vivo in a blood field; 2) An adequate LIFS signal 
implies short fiber tip to tissue distance. Therefore 
LIFS is a feasible approach for clinical laser 
angiop1asty guidance. It may be useful not only to 
claSSify tissue type but also to ensure close fiber to 
tissue approximation during laser angiop1asty. 
174A ABSTRACTS 
LASER DOPPLER MEASUREMENT OF CANINE CORONARY 
FLOW USING A SHEATH-GIDED OPTICAL FIBER 
Steve M. Teague, MD, MS, FACC, Guy F. Bogar, BS, and 
Thomas W. Burnett, BS, University of Oklahoma, Oklahoma 
City, Oklahoma, and Medpacific Corproation, Seattle WA. 
Current invasive technologies for the measurement of 
coronary flow are limited by size, site, and the Nyquist 
limit. Present methods are not suitable for use with 
laser ablation catheter systems. We attempted to 
overcome some of these limitations in the development of 
a laser Doppler velocimeter catheter. To elucidate the 
laser Doppler spectral correlates of varying arterial 
flow, we studied 7 mongrel dogs instrumented acutely with 
electromagnetic blood flow (EMF) probes surrounding 
femoral and left circumflex coronary arteries. A 5 
milliwatt continuous wave hellium-neon laser Doppler 
system consisting of beam splitter, optical coupler, and 
photomultiplying amplifier was coupled to various 100 
micron optical fibers with direct (D) and reflecting (R) 
tips. 0 type fibers were inserted in femoral arteries, 
while R type fibers were guided to coronary arteries 
fluoroscopically using 7 French coronary catheters. EMF 
flow ranges of 0 to 390 cclmin (femoral) and 0 to lIS 
cclmin (coronary) were achieved by variable occulsion and 
reactive hyperemic manuvers. Both 0 and R fibers 
produced Doppler spectra with amplitude decreasing 
exponentially with frequency, with the maximal spectral 
frequency (Fmax) relating exponentially to flow: Fmax = 
a(l-e-bflOW) where a=13.2, b=O.0143, r=+O.S4 (fiber D), 
and a=7.S, b=O.025, r=+O.S9 (fiber R). Resting flow Fmax 
measurements were reproduceable ~lO%. Although this 
velocimeter appears to detect a boundary layer 
perturbation nonlinearly related to flow rate, laser 
Doppler velocimeters appear capable of assessing coronary 
reactive hyperemia. 
COMPLICATIONS OF ENDOMYOCARDIAL BIOPSY OF THE TRANSPLANTED 
HUMAN HEART - A REVIEW OF 6,200 BIOPSIES IN 550 PATIENTS. 
Dan Aravot, MD; Melissa Fitzgerald, MB, BS; Azghar 
Khaghani, FRCS; Samad Tadgkarimi, MD; Marina Martin, MB, 
BS; Magdi Yacoub, FRCS, FACC. 
Harefield Hospital, Harefield, Middlesex, England. 
Transvenous endomyocardial biopsy is still the most 
useful diagnostic aid in assessing rejection in the donor 
heart. Six-thousand-two-hundred consecutive biopsies of 
donor endomyocardium in 550 patients following orthotopic 
(400) and heterotopic (38) cardiac transplantation (Tx) 
and combined heart and lung (112) Tx were performed 
between January 1980 to July 1987. Right ventricular endo-
myocardial biopsies were performed through the internal 
jugular vein using a locally developed bioptome. Six-thou-
sand-one-hundred-and-seventy-six biopsies (99.6%) were 
performed without complications, including those in pat-
ients who had more than 40 biopsies. Twenty-four patients -
(0.4%) experienced the following complications: 2 prolong-
ed haemhorrages at the puncture site, which was controlled 
by a pressure bandage, 4 pneumothoraces which required 
intercostal tube drainage, 4 transient nerve paresis (1 
recurrent laryngeal paresis, 1 partial brachial plexus 
paresis and 2 Horner's syndrome). Eleven broken bioptomes 
out of which 2 needed exploration of the neck. One patient 
developed carotico-jugular fistula, 1 perforation of right 
ventricle resulting in tamponade which required explorat-
ion and control and 1 fatal exsanguination, due to tear of 
superior vena cava. None of the patients had infection 
related to biopsy, although no prophylactic antibiotics 
were given. No serious arrhythmias were encountered. 
There was no correlation between the incidence of complic-
ations and the number of biopsies in the same patient. 
It is concluded that, in our experience, endomyocardial 
biopsy has a very low, but definite morbidity and 
mortality. 
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MODIFICATIONS OF THE MITRAL FLOW DUE TO THE PRESENCE OF 
A LEFT BUNDLE BRANCH BLOCK (LBBB). 
Robin ZUinsky, M.D., Benoit Diebold, M.D., Hanna Raf-
foul, M.D., Ariel Cohen, M.D., Unite INSERM 256 and Cli-
nique Cardiologique, Hdpital Broussais, Paris, France. 
Doppler recordings of the .itral flow are often proposed 
as a tool for investigating the left ventricular dias-
tolic properties. It has been suggested that beside 
heart rate, preload, and age, local asynchronism may 
modify the mitral flow. This study was designed to eva-
luate the modifications of this flow induced by the pre-
sence of LBBB. Three groups (Gr) of subjects matched for 
heart rate, age and LV enddiastolic diameter were stu-
died : Gr 1 = asymptomatic with normal clinical exami-
nation and ECG (n = 13), Gr 2 = asymptomatic with normal 
clinical examination but isolated LBBB on the ECG (n = 
10), Gr 3 = Left ventricular hypertrophy (LVH) due to a 
chronic pressure overload (n 16). The following 
parameters were recorded using pulsed Doppler at the 
annulus (a) and at the tip (t) of the mitral leaflets : 
the peak early diastolic velocity (E), the enddiastolic 
one (Al and the AlE ratio. The results were the 
following (p < .05 = " p < .01 = ", p < .001 = ••• ) : 
normal (1) LBBB (2) LVH (3) 1/3 
age 44.7 ± 9.7 ns 48.5 ± 8.6 ns 45.7 ± 7.2 ns 
HR 68.9 + 14.3 ns 73.8 ± 11.4 ns 74.2 ± 13.1 ns 
EDD 50.3 ± 3.4 ns 48.1 ± 7.0 ns 46.8 ± 4.9 
Ea .44 ± .09 ns .41 ± .12 .31 ± .10'" 
Et .55 ± .10 ns .53 ± .11 ns .47 ± .13 ns 
Aa .33 ± .06'" .50 ± .09 ... .37 ± .04 
At .39 ± .10" .61 ± .17 ns .54 ± .11'" 
A/Ea .78 ± .23" 1.40 ± .73 ns 1.31 ± .46'" 
A/Et .74 ± .24 1.34 ± .85 ns 1.22 ± .40'" 
Thus, isolated left bundle branch block is associated 
with modifications of the mitral flow simulating a 
decreased relaxation. 
IS DOPPLER ACCURATE FOR MEASURING TRANS-STENOTIC 
CORONARY PRESSURE GRADIENTS? AN IN VITRO STUDY. 
Karl Isaaz,MD,Regis Rieu,MS,Jean Fuseri,BS,Robert 
Pelissier,MS. Cardiology A,Univ. of Nancy;.Insti-
tut de Mecani qL.e des Fl ui des de Marsei 11 e. FRANCE 
The accuracy of DopplerCD) has been validated for 
measu ... ement of blood flowlBF) velocity in great 
vessels and estimation of p ... essu ... e gradientslPG) 
across valvula ... stenosisIS). Howeve ... the diffe-
rent characteristics of BF through small vessels 
like co ... ona ... y arterylC) may influence the accu"'a-
cy of D measurements. Thus we constructed an in 
vit ... o pulsatile flow model of CS to test the accu 
racy of D in measuring trans-stenotic CPG.We tes-
ted cross-sectional flow area reductions(FAR) of 
44 !. ,751. and 94% Idiameter:4-3,4-2,4_1mm)at 
lengths of 5, 10, and 20mm .A phasic CBF was 
simulated at flow rates ranging from 10 to 490ml 
Imn • We measured e><perimenta11y flow rate using 
an .,1 ectr-om"gneti c flowmeter and PG wi th pressure 
taps placed 3 mm on either side of S. RESULTS:A 
high qu"lity D signal (no signal dispersion) w"s 
obt.ai. ned even f or hi gh PG across severe stenosi s. 
We found a high carr-elation between direct PG and 
D-derived PG ( ... -0.97 t.o 0.99 SEE -0.34 to 4 
mmhg, p < o. 001). However ,for 44 % FAR, D ove ... -
est.imated PG by a mean of 171. at 5 and 10mm 
lengths ,and underestimated PG by 211. at 20 10m 
length. D underestimat.ed PG at all lengths for 75 
% FAR(18 t.o 25%) and for 94 I. FAR (28 to 100%) 
CONCUJSION: These ... esul t.s suggest t.hat. Dis accu--· 
rate for measurement o~ changing in trans-steno-
notic CPG. However, absolut.e values cannot. be 
predicted due to p .... abolic velocity profile at 
low flow r.te in mild stenosis and impo ... tant 
viscous losses in long and severe stenosis. 
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NONINVASIVE ESTIMATION OF LEFT VENTRICULAR END-DIASTOLIC 
PRESSURE BY DOPPLER 
Marcus F. Stoddard, MD, Anthony C. Pearson, MD, Arthur J. 
Labov1tz, MD, FACe, Morton L. Kern, MD, Ubeydullah 
Deligonul, MD, St. Louis University School of Medicine, 
St. Louis, Missouri. 
To assess the potential correlation between Doppler 
echo derived indices of diastolic filling and LVEDP{ 28 
pts (22 males and 6 females) age 61+12 years (37-8l) with 
coronary artery disease (CAD) (8 single, 7 double and 4 
triple vessel) and normals (n=9) were studied by 
simultaneous recordings of micromanometer LV pressure and 
transmitral flow by Doppler. Doppler derived indices of 
diastolic filling included: 1) peak early (E) and peak 
atrial (A) diastolic filling velocities, 2) percent atrial 
contribution to filling (%AC) and one-half filling 
fraction (1/2 F%), and 3) E/A ratio. Linear regression 
yielded significant correlations between Doppler 
parameters and LVEDP (Table 1). With increasing LVEDP, 
early diastolic filling was enhanced and atrial 
contribution to filling was reduced. 
Table 1: Correlat10n Coeff1c1ent For boppler 
E EfA 1/2F% 
LVEDP .53** .53* .51 *** 
*p < .05, **p < .01, ***p < .005, tp < .001 
versus LVEDP 
%AC 
-.53*** 
LVEDP > or < 20 mmHg could be predicted by E, E/A, 1/2F% 
or %AC as snown by Chi-square analysis of measured LVEDP 
versus Doppler criteria as predictors of LVEDP (Table 2). 
Table 2: boppler Cr1ter1a Versus LVEDP 
LVEDP (mmHg) E (cm!s) E!A** 1!2F%(%)t %AC(%)** 
>60 <60 >1.5 <1.5 >65 <65 <31 >31 
> 20 (n=IO) 50 60 60 60 
< 20 (n=18) 78 100 100 94 
Values = % correctly predicted by Doppler/*p<0.05,**p<0.OI 
tp<.005; p values calculated using contingency coefficient 
Conclusion: Doppler indices of LV filling correlate with 
LVEDP and permits accurate noninvasive estimation of LVEDP. 
CHARACTERISTIC MITRAL INFLOW DOPPLER VELOCITY PATTERN 
IN SEVERE AORTIC INSUFFICIENCY 
Jae K. Oh, M.D., Liv Hatle, M.D., Larry J. Sinak, M.D., 
James B. Seward, M.D., F.A.C.C., A. Jamil Tajik, M.D., 
F.A.C.C., Mayo Clinic, Rochester, MN. 
Severe aortic insufficiency (AI) is characterized by rapid 
rise in LVEDP. Since mitral inflow Doppler velocity is 
determined by diastolic pressure difference between the LV 
and the LA, the rapid LVEDP rise should be reflected in 
mitral inflow velocity pattern. Therefore, mitral inflow 
velocity was obtained by pulsed wave Doppler in 9 pts (5 
men and 4 women; mean age 56 years) with severe symptom-
atic (class Ill-IV) AI. Al was due to aortic prosthetic 
valve dysfunction (3), endocarditis (2), aortic root 
dilatation (2), aortic dissection (I), or aortic valve 
decalcification procedure (I). All but one pt underwent 
aortic valve replacement. Following Doppler velocity 
parameters were determined: velocity of early filling wave 
(E), late filling wave due to atrial contraction (A), E to 
A ratio (E/A) , and mitral E-wave deceleration time (DT). 
These values were compared to normals: 
Al pts (Mean) 
(Range) 
Normal (Mean) 
E(m/sec) A{m/sec) 
1. 10 0.35 
(0.9-l.2) (0.2-0.6) 
0.84 0.61 
E/A 
3.7 
0.5-6.0) 
1.6 
DT(msec) 
102 
(72-126) 
199 
Late diastolic mitral regurgitation was present in 7 pts 
(78%). M-mode echo of the mitral valve was obtained in 8 
pts and only 3 pts (38%) had premature closure of the 
mitral valve. 
In conclusion: 1) mitral inflow Doppler velocity pattern 
in severe symptomatic Al is characteristic with decreased 
A, increased E/A, and decreased DT, and 2) appears to be 
more sensitive than premature closure of the mitral valve 
on M-mode for detecting hemodynamically significant AI. 
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THROMBUS FORMATION AFTER ACUTE MYOCARDIAL INFARCTION 
PREDICTED BY LEFT VENTRICULAR SPATIAL FLOW PATTERN 
B.J. Delemarre, M.D., H. Bot, Ph.D., C.A. Visser, M.D., 
F.A.C.C., H. de Koning, A.J. Dunning, M.D., F.A.C.C., 
Dept. of Cardiology, Academic Medical Center, Amsterdam, 
The Netherlands. 
In order to determine the predictive value of apical flow 
pattern (AFP) for thrombus formation (TF) after acute myo-
cardial infarction, 62 patients (pts) were serially studied 
with 2D Doppler echocardiography (on admission, and after 
6 and 12 weeks). A "circular" AFP was defined abnormal, 
i.e. with the sample volume in an apical 4 chamber view 
near the lateral wall and septum, a continuous, positive 
and negative Doppler shift, respectively. 
Results: 
In 16/62 pts abnormal AFP was seen on admission, which 
normalized in 6 pts, during follow up and none of these 6 
pts had TF. In 10/62 pts abnormal AFP persisted and 7/10 
had TF. In 46/62 pts normal AFP was found on admission and 
none had TF during the study period. 
We conclude: 
1. persistent abnormal AFP after acute infarct is highly 
associated (70%) with TF; 
2. TF was never seen in pts with normal AFP; 
3. These findings have implications if anticoagulation 
therapy is considered. 
DIAGNOSTIC ACCURACY OF AUSCULTATION IN AORTIC 
REGURGITATION. 
Sreedharan Sadanandan, M.D., Edmond Lee, M.D., Steven 
Khan, M.D., Freny Vaghaiwalla Modi, M.D., Maylene Wong, 
M.D., F.A.C.C. and Pravin M. Shah, M.D., F.A.C.C., 
Wadsworth VA/UCLA Medical Center, Los Angeles, California. 
Three hundred nine patients (ages 26-94 years, mean 65 
yrs.) referred for diagnostic ultrasound, were prospect-
ively assessed independently by cardiac auscultation (A) 
and by pulsed wave Doppler (PWD) for presence and sever-
ity of aortic regurgitation (AR). The diagnostic signal 
by PWD for AR was obtained in 89 patients, 66 being mild 
and 23 being judged of moderate severity by mapping tech-
nique. The AR murmur by A was absent in 50/66 (76%) of 
mild, and in 13/23 (57%) of moderate severity. Twenty 
three patients with mild and 7 patients with moderate AR 
in whom no AR murmur was heard were reexamined by two 
cardiologists independently in a "blinded" protocol. 
Doppler and color flow imaging using Toshiba SSH-65A was 
carried out to confirm severity of AR. Based on ratio of 
the jet width in relation to the left ventricular outflow 
tract width, AR was confirmed as mild in the 23 and moder-
ate in the 7 patients. Both cardiologists reported no AR 
murmur in 20/23 of the mild and 517 of the moderate AR 
either under basal state or with handgrip. In three pat-
ients with mild and 2 patients with moderate AR a faint 
AR murmur was identified during the recall examination. 
Conclusions: (1) Mild and moderate severity of AR may 
occur without audible murmur more often than hitherto 
recognized. (2) Relevance of clinically silent AR needs 
to be elucidated. 
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COMBINED USE OF CONTINUOUS WAVE AND COLOR FLOW 
DOPPLER FOR THE ESTIMATION OF THE REGURGITANT 
VOLUME IN AORTIC REGURGITATION 
Karl Dennig,M.D., Karl-Heinz Heneke,M.D., Serban 
Dacian,M.D., Werner Rudolph,M.D.,F.A.C.C. 
German Heart Center, Munich, F.R.Germany 
To evaluate the diagnostic usefulness of a 
Doppler method for the estimation of the regur-
gitant volume (RV) in aortic regurgitation by 
comparison with invasive measurements, 22 pats 
were studied by continuous wave (CW) and color 
flow Doppler. RV was determined with the aid of 
left ventricular angiography and indicator-dilu-
tion technique as the difference of total and 
effective stroke volumes. Doppler echocardiogra-
phic (DE) estimation of RV was based on regis-
tration of the width (W) of the regurgitant flow 
within the color Doppler image at the level of 
the aortic valve as well as of the velocity 
profile of the jet by CW Doppler. RV was then 
derived as the product of the regurgitant area 
assuming a circular shape times the integral 
(Int v) of the velocity curve. The invasively 
determined RV measured 55+32 ml. W ranged from 
2 to 11 mm and Int v from-85 to 291 cm. DE de-
rived RV measured 52+35 ml and showed a signi-
ficant correlation to the invasively determined 
values (r=0.84,SEE=19 ml). Detection of RV of 
more than 50 ml was achieved with a sensitivity 
of 83% and specificity of 90%. 
These data suggest that the combined use of CW 
and color flow Doppler enables reliable estima-
tion of RV in aortic regurgitation and thus, 
may contribute to the noninvasive assessment of 
this lesion. 
DOES CLINICAL DOPPLER ULTRASOUND INDUCE FREE 
RADICAL PRODUCflON AND LIPID PEROXIDATION OF 
REITNAL CELLS AND HEART MUSCLE? 
Daniela Lax. M D .. James M. Berry, ROMS, Shu L. Zhang, M.D., 
Stanley Einzig, M.D., Ph.D. Univ. of Minnesota, Minneapolis,MN. 
Ultrasound (US) induced free radical fonnation is known to occur in 
aqueous solutions under simulated diagnostic conditions. Clinical 
US is generally considered safe; however, its effect on free radical 
production and subsequent lipid peroxidation in vivo or in vitro is 
unknown. We investigated the effect of a 30 min pulsed Doppler U~ 
exposure (Hewlett-Packard 5500-D, 5MHz transducer, 467mW/cm 
spatial-peak temporal-average at 3.5 cm) in vivo (rabbit LV myocardi-
um, blood) and in vitro (retinal cells, known to be sensitive to oxidant 
damage and 0.1 % nitroblue tetrazolium, (NBT)). The Doppler mode 
was used as it results in higher localized intensity exposure. The 
Doppler sample spanned the entire LV chamber during the in vivo 
study. Lipid peroxidation of 10% LV homogenates, plasma and 
retinal cells was determined using the thiobarbituric acid reaction 
malondialdehyde (MDA) production. Superoxide radical was 
assessed by its ability to reduce NBT; the resulting increased optical 
density was measured spectrophotometrically at 600nm. We found 
that MDA production was not enhanced either in vivo (LV, plasma) 
or in vitro (retinal cells). T ABLE,values are mean±SE (number): 
Retinal cells LY BImIl 
(nmol MDN100 mg protein) (nmol MDA/ml) 
CONTROL 1197±516 (4) 178±27(5} 3.8±1.7(4} 
US 654 ±261 (4) 183±30(5} 4.4±2.1(4} 
There was no change in optical density upon NBT exposure to Dop-
pler US (0.OO9vsO.007,con); however, it was increased 1500 fold 
when the solution was placed in a Bransonic 220 US bath, (l2SW). 
This increase was reduced by 73% when superoxide dismutase, 
1000U/ml, was added. Thus, we found no evidence for free radical 
production during clinical Doppler US exposure in'our in vitro or in 
vivo systems, however, care must still be exercised in the use of US 
especially in the fetus with reduced free radical scavenging enzymes. 
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IMPACT OF DOPPLER ASSESSMENT OF AORTIC STENOSIS ON 
CLINICAL MANAGEMENT: EXPERIENCE IN 500 PATIENTS. 
AUiusto Galan, M.D., Miguel A. Quinones, M.D., 
F •• C.C., W""am A. Zoghbi, M.D., F.A.C.C., Baylor 
College of Medicine, Houston, Texas. 
To evaluate the clinical influence of Doppler echo-
cardiography in the management of pts with aortic 
stenosis (AS) in a large clinical population, we 
reviewed Doppler studies in 500 pts with suspected AS. 
Follow-up was available on 466 pts (ages 67±14) and 
quality of Doppler was adequate in 456 pts (9B%). 
Aortic stenosis was judged severe by Doppler if peak 
gradient was >80 mmHg and/or aortic valve area <0.75 
cm2 , moderate-if valve area >0.75 and <1.00 cm2 and 
mild if peak gradient was <25"" mmHg and/or valve area 
> 1 cm2 • Agreement between IJoppl er and catheteri zation 
in separating critical from non critical aortic 
stenosis in 242 pts was 97%. Of 145 patients with 
severe AS by Doppler, 102 (70%) underwent valve 
replacement (AVR) or valvuloplasty and 43 were followed 
because of age >75 yr (n=2g), asymptomatic status 
(n=5), other medical contra indications (n=2) or 
moderate valve area by catheterization (n=7). AVR was 
done without catheterization data in 16/102 pts. Of 82 
pts with moderate AS by Doppler, 27 (33%) underwent 
AVR, 9 as part of coronary bypass surgery, 3 for 
significant aortic insufficiency and 15 because of AS 
related symptoms. On the other hand, of 187 pts with 
mild AS, 14 (7.5%) underwent AVR: 9 for significant 
aortic insufficiency and 5 as part of coronary bypass 
surgery. Thus, Doppl er assessment of AS severity is 
helpful in the clinical management of AS patients. The 
technique may obviate the need for catheterization in 
the young pt or bypass a lengthy attempt at crossing 
the aortic valve in pts undergoing coronary angiography. 
SERIAL DECREASES IN PRESSURE HALFTIME: A POTENTIAL MARKER 
FOR SIGNIFICANT PROSTHETIC MITRAL REGURGITATION. 
Rajesh Prasad, M.D., Wyatt Voyles, M.D., F.A.C.C., Udho 
Thadani, M.D., F.A.C.C., Steve Teague, M.D., F.A.C.C. 
University of Oklahoma and VAMC, Oklahoma City, Oklahoma 
Serial noninvasive follow-up of patients with prosthetic 
mitral valves has been facilitated by the use of Doppler 
derived pressure halftime (PHT) to calculate valve area 
(MVA). How the subsequent development of MR affects these 
measurements are not known. We have identified four cases 
of prosthetic mitral valve regurgitation (MR) in which 
Doppler studies were done prior to and after the develop-
ment of severe MR. In each case, severe MR was documented 
by left ventriculography. Surgical and pathological find-
ings revealed the etiology of MR to be endocarditis in two 
cases, valve degeneration in one case, and suture line 
breakdown in one case. Doppler studies done before the 
development of MR show that the average PHT was 134 ms 
(range = 110 to 169 ms). After the development of MR, 
the average PHT in follow-up studies was 76 ms (61-92 ms) 
and decreased in each case (average % decrease E 43%; 
range E 32-58%). Accordingly, calculations of MVA demon-
strated increases in orifice areas in these four cases 
as follows: 
MVA (cm2) 
1 2 3 4 
Before MR C3 C7 2-:-0 C7 
After MR 2.4 2.5 3.4 3.6 
% change +85% +47% +70% +111% 
If substantiated by prospective studies, these observa-
tions suggest that substantial (>30%) decreases in PHT, 
and increases in calculated MVA, in the presence of newly 
diagnosed MR may be a marker for significant prosthetiC 
regurgitation. 
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COLOR GUIDED CONTINUOUS WAVE DOPPLER ASSESSMENT OF 
EFFECTIVE PROSTHETIC VALVE AREA. 
Alok Gupta. M.D., Frederick Helmcke, M.D., 
Bhagwatiprasad J. Pandey, M.D., Navin C. Nanda, M.D., 
F.A.C.C., Krishan K. Aggarwal, M.D., Ajit P. Yoganathan, 
Ph.D., University of Alabama at Birmingham, Alabama 
Sixty-five normal prosthetic valves (29 AO-12 St. Jude, 
17 Carpentier-Edwards; 36 mitrals-2l St. Jude & 15 
Carpentier-Edwards) of various sizes were studied within 
3 weeks of valve replacement by color guided con-
ventional Doppler to calculate the effective orifice 
area (DA). DA was estimated using pressure half time for 
mitral and continuity equation for AO valves and was 
compared with haemodynamically (HA) and geometrically 
derived effective orifice areas (GA) provided by the 
manufacturer from in vitro studies. For mitral valves, 
DA was not significantly different from HA (p>.05). But 
for AO prosthesis, DA was significantly different from 
GA as well as HA (p<.OOl). In 22 additional Pts of 
mitral prosthesis who underwent catheterization for 
suspected prosthetic dysfunction DA correlated with cath 
derived areas (r-.82). However, pts of AO prosthesis 
undergoing cath studies have been too few (n-9) so far 
for meaningful comparison. Hence, pressure half time 
does predict DA of prosthetic mitral valves accurately. 
However, continuity equation does not appear to be 
useful for calculating the AO prosthetic valve a~ea. 
This may partially be because of dispersion and nonflat 
velocity profiles expected in multiple orificed mech-
anical prosthesis and flow interference created by 
metallic stents of AO porcine valve. Thus caution should 
be used when applying continuity equation for calcula-
tion of AO prosthetic valve area. 
CORONARY BY-PASS FLOW:ASSESSMENT AND QUANTIFICA 
TION BY INTRAOPERATIVE DOPPLER. 
Pablo Yuste ,M.D. F.A.C.C.,Jose A.Lastra M.D., 
Esteban G.Porrero M.D.,Juan J.Rufilanchas M.D. 
Hospital Ramon y Cajal.Madrid.Espana. 
Intraoperative Doppler has been tested for 
the evaluation of coronary by-pass (BP) flow pro-
file during cardiac surgery.We studied 122 cases 
with 263 BP:240 aorto-coronary vein grafts(AC) 
and 23 mammary artery-coronary implants(MC)du -
ring surgical procedure.We used a standard Dop-
pler machine with a sterile 10MHz. clip probe 
of 3mm. diameter.The probe was located directly 
around the BP and video tape recordings were ob-
tained in normal conditions and with pharmacolo-
gical vasodilation.All the tracings were made 
at the end of cardiopulmonary by-pass correspon-
ding to 100 mmHg. aortic pressure. 
Normal BP flow showed a biphasic velocity pro 
file with a small amount of flow during early 
systole and an important increase of flow during 
diastole.Peak diastolic BP flow velocity ranged 
from 0,4-2,0 m/s.The acceleration time was incre 
ased for MC versus AC grafts.lntragraft infusion 
of vasodilation agents improved diastolic BP 
flow in most cases,in close relation with the 
size of distal anastomosis and the properties 
of the distal coronary bed.S distal occluded BP 
were detected and reoperated. 
In conclusion intraoperative Doppler is a 
helpful tool for assessing BP flow under diffe-
rent conditions. 
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CHOONIC INa::MPIEI'E ATRIOVENTRIaJIAR BIDCK INlXJCED BY 
RADIO~CY CA'IHEI'ER ABIATION. Shoei K. stephen 
Huang.MD.FACC, Saroja Bharati,MD,FACC, Anna R. Graham,MD, 
Graoe Gorman,BS, Maurice I.ev,MD,FACC, Tucson VA Medical 
center anj the University of Arizona, Tucson, Arizona. 
To determine if radiofrequency (RF) catheter ablation can 
in:iuce chronic :inconplete atrioventricular block (A VB} to 
avoid the need of permanent pacing, 20 closed chest dogs 
were studied. Gr.l (10 dogs) received RF energy with a 
fixed power setting (5 or 10 watts) while increasing the 
pulse duration from 10 to 50 sec for each ablation. Gr.2 
(10 dogs) received energy with a fixed setting of pulse 
duration (20 or 30 sec) anj a changing power setting (5w 
to lOW, or lOW to 2OW) during each energy deliVery. RF 
energy was delivered between a chest patch electrode and 
the distal electrode of a His burxlle catheter. For each 
application, the energy delivery was stopped when I} the 
PR interval prolonged >50%, or 2} lID or IIIO AVB 
occurred anj persisted up to 5 sec. The procedure ended 
when there wa~ I} persistent PR prolongation >50% or 
persistent II AVB 30 min after ablation, or 2} occurr-
ence of two =nsecutive transient « 0 min) IIIO AVB 
after each energy delivery, or 3} III AVB lasting >2 
min post fiblatioa. Of 8 dogs in Gr.l anj 6 dogs in Gr.2 
in wham I or II AVB was achieved one hour after the 
procedure, 7 in Gr.l anj 6 in Gr.2 =ntinued to have in-
complete AVB 2-3 no after ablation. The remaining 3 dogs 
in Gr.l anj 4 dogs in Gr.2 had complete AVB at 1-2 no of 
follow-up. G:BSs examination of thO =nduction system in 
2 dogs with I AVB, 2 dogs with II AVB, anj 1 dog 
with complete AVB showed discrete scars involving the 
approaches to the AV node anj the AV node itself. In 
=nclusion, chronic :inconplete AVB can be achieved in the 
majority of dogs studied by careful titration of RF 
energy dosage anj regulation of ablation end-points. 
CLINICAL OUTCOME OF PATIENTS Willi INTACT 
ATRIOVENTRICULAR CONDUCTION AFTER ATRIOVENTRICULAR 
JUNCTION ABLATION FOR REFRACTORY SUPRAVENTRICULAR 
TACHYARRHYTIIMlAS. 
S Saksena. MD. FACC, HL An, MD, SHerman, RN, BSN, D Marcantuono, RN, 
BSN. Newark Beth Israel Med Ctr-Univ of Med & Dent of NJ, Newark, NJ. 
Atrioventricular (A V) junction (IN) ablation can fail to produce interruption of 
1:1 A V conduction in pts with refractory supraventricular tachyarrhythmias 
(SVI'), but this does not preclude a clinically favorable outcome. We examined 
the clinical, electrocardiographic (ECG) & electrophysiologic (EP) characteristics 
of pts WIth recurrent SVT who undelWent A V IN ablation with either D.C. 
shocks or pulsed argon laser energy & subsequently maintained 1: 1 A V conduc· 
tion at rest & during exercise. We correlated these with long-term clinical SVT 
controL 12 pts. with 13 refractory SVTs (paroxysmal SVT-5, atrial flutter/ 
fibnllatlOn-6; atnal tachycardla-2), mean age 62!9 yrs, were examined. EP studies 
were performed prior to & usually >5 days after A V IN ablation. Pts achieving 
SVT control o,? no therapy or prior ineffective therapy (Gp A) were compared 
WIth pts who dId not achieve SVT control (Gp B). Duration of followup ranged 
from 1 to 26 months. 
RESULTS: There were 7 pts in Gp A (mean age 60 yrs) & 5 pts in Gp B (mean 
age 66 yrs). Concomitant cardiac disease was present in 4 pts in Gp A & 3 pts in 
Gp B (p >.6). LV ejection fraction was 42% in Gp A & 31% in Gp B (p >.4). 
Baseline ECG & EP parameters in these two groups were comparable. 
GROUP A GROUP B 
Pre Ablation Post Ablation p Pre Ablation Post Ablation p 
PR Interval(ms) 169!24 230±35 <.02 184+21 180+37 >.6 
AHInterval(ms) 82+12 157~55 <.03 96+31 88+i3 >.6 
HV Interval(ms) 49t9 50~12 >.6 58+9 72+3 .07 
Complete heart block immediately after A V IN ablation was observed in 6 pts in 
Gp A & 5 pts in Gp B (p >.2), but this reverted to 1:1 conduction within 30 min-
utes in 1 pt in Gp A & 4 pts in Gp B (p <.03). The mean A V nodal Wenckebach 
cycle length after ablation was 478 ms in Gp A & 395 ms in Gp B (p >.6). Perma-
nent demand pacemakers for rate support were inserted in 2 pts in Gp A & 1 pt 
m Gp B (p >.2). 2 pts in Gp B subsequently required antitachycardia pacemakers 
for SVT control. Gp A pts without pacemakers are asymptomatic, without high 
degree A V block. 
CONCLUSIONS: 1) SVT control in pts maintaining 1:1 A V conduction after A V 
IN ablation correlates with modification of A V nodal conduction during sinus 
rhythm. 2) Reversion to 1: 1 A V conduction within 30 minutes of A V IN ablation 
predicts inadequate SVT controL 3) Permanent demand pacing may be success-
fully avoided in selected pts with modification of A V nodal conduction. 
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LONG-lERM CLINICAL RESULTS OF INTRAOPERATIVE MAPPING-
GUIDED ARGON LASER ABLATION OF MALIGNANT 
SUPRA VENTRICULAR AND VENTRICULAR TACHYCARDIAS. 
S Saksena.MD.FACC.AN Munsif,MD.sM Hussain,MD,FACC,I Gielchinsky, 
MD, FACe. Newark Beth Israel Med Ctr-NJ Med School, Newark, NJ. 
Intraoperative mapping-guided ablation of refractory supraventricular tachycar-
dia (SVI) &lor ventricular tachycardia (VI) has been successfully performed 
with pulsed argon laser (PAL) energy. We examined the long-term clinical out-
come of 22 pts with either malignant SVT (6 pts) or VT (15 pts) or both (1 pt) af-
ter intraoperative PAL ablation with a 15W argon laser coupled to a 300 Jl optical 
fiber. All VTpts (mean age 63±7yrs) had CAD, with a mean LV ejection fraction 
of 34 ± 10%, & were refractory to 5 :t 2 antiarrhythmic drugs. Four of the 7 SVT 
pis (mean age 44+20 yrs) had WPW syndrome, & one each had AV nodal reentry, 
atrial tachycardia & atrial fibrillation. All pts had spontaneous & inducible sus-
tained SVT &lor VT preoperatively. Mapping-guided PAL ablation of the AV 
node or combined PAL ablation and surgical dissection of accessory pathways was 
performed in the SVT pts. Laser ablation of VT foci was performed in the VT pts 
alone (67%) or in conjunction with mechanical dissection techniques (33%). 
Postoperatively a resting 12-lead ECG & 24-hour Holter monitor were obtained 
at 1 week, & at 3-month intervals. 2-0 EcholDoppler, radionuclide ven-
triculography & electrophysiologic studies were performed at 1 week & 1 year. 
RESULTS: There was no intraoperative mortality. 1) 00: Postop, spontaneous 
& inducible SVT was eliminated in all 5 pis with A V &lor A V nodal reentry 
without need for antiarrhythmic drug Rx. A V nodal conduction was interrupted 
in 1 pt with atrial tachycardia & modified in 1 pt with atrial fibrillation. 2) IT: 
Postop, spontaneous VT was eliminated in all pts (no Rx-15, Preop ineffective 
drug Rx-l), & inducible VT in alliS pts who underwent postop EP studies (no 
Rx-14 pts; drug Rx-l pt). During followup, there has been no arrhythmic mortal-
ity or VT recurrence in all 14 pts on no drug Rx. One pt became drug intolerant 
& required an antitachycardia pacemaker. During followup (range 1 to 16 mos), 
20 pts continue with excellent SVTIVI' control, & 2 pts died of non-cardiac 
causes. In 5 pts, EP studies performed 1 year after PAL ablation demonstrated 
continued arrhythmia control. Postoperative LV EF was unchanged from preop-
erative values (p >.2). 
CONCLUSIONS: Intraoperative PAL ablation is effective for long-term SVT & 
VT ablation & eliminates need for additional antiarrhythmic Rx in most pts. This 
approach improves results of surgical ablation for tachycardias. 
DETERMINANTS OF LESION SIZE AFTER DC SHOCK ABLATION: INFLU-
ENCE OF ELECTRODE-WALL CONTACT AND PREEXISTING FIBROSIS. 
Michel P. Freericks, M.D., Richard N. Hauer, M.D., Fred H. 
Wittkampf, M.Sc., Patricia F. Bakker, M.D., Willem Straks, 
M_D. and Etienne O. Robles de Medina, M.D., F.A.C.C., 
University Hospital, Utrecht, The Netherlands. 
Endocardial catheter ablation of the site of origin of 
ventricular tachycardia by a single DC shock has a varia-
ble clinical outcome. A major determinant of efficacy is 
the size of the ablation lesion which at identical deliv-
ered energy may depend on: 1) electrode-myocardial wall 
contact and 2) preexisting fibrosis in the arrhythmogenic 
substrate. For reproducibility of the experimental model 
epicardial ablation was performed. In 6 beagles with a 
blood filled open chest 250 J cathodal shocks were deliv-
ered through the tip electrode (E) of a 6F catheter per-
pendicular to the left ventricular epicardium. A specially 
designed device was used for stable positioning of the 
catheter. In 4 dogs 8 shocks were delivered (two different 
sites in each dog), 4 with E at 5 mm above the epicardium 
(remote) and 4 with E in close contact. To evaluate the 
effect of fibrosis 2 other dogs had a single shock with E 
in close contact with the epicardial surface at the center 
of a cryolesion which had been applied two months pre-
viously. One week after the shock the dogs were killed for 
histopathologic examination. Lesion volumes in cm' after 
close contact ablation were 4.6, 5.7, 6.0 and 6.8 (all 
transmural), and after remote shock 0.8,2.3 and 2.4 (non-
transmural). The 4th remote shock resulted in multiple 
dispersed microscopical lesions and could not be measured. 
Lesion volumes after shock delivery in a fibrotic area 
were 4.9 and 5.3 (transmural), whereas the volumes of 2 
control cryolesions were 1.3 and 1.9 (nontransmural). 
Conclusions: 1) Electrode-wall contact is a major deter-
minant of ablation lesion size. 2) Fibrosis does not in-
fluence lesion extension in DC shock ablation. 
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EFFECT OF NEODYMIUM: YAG LASING OF THE LEFT POSTERIOR 
PAPILLARY MUSCLE ON MITRAL VALVE FUNCTION. 
Patricia F. Bakker, MD, Robert H. Svenson, MD, FACC, Rienk 
Rienks, MD, Antonius Cornen, MD, Marie-Claire Marroum, MO, 
Lasslo Littmann, MD, John J. Gallagher, MD, FACC, 
J. Francois Hitchcock, MD and Etienne O. Robles de Medina, 
MD, FACC, University Hospital, Utrecht, The Netherlands 
and Heineman Medical Research Center, Charlotte, N.C. 
Nd:Yag laser photo coagulation (LPC) is a new surgical ap-
proach to control drug refractory ventricular tachycardia. 
LPC results in considerable immediate tissue shrinkage due 
to tissue water evaporation. Therefore, lasing of compo-
nents of the mitral valve (MV) apparatus has been avoided. 
However, localization of ventricular tachycardia origin in 
a papillary muscle may necessitate ablation of this struc-
ture. We studied the effect of LPC of the entire left pos-
terior papillary muscle (LPPM) on MV function in dogs of 
21-33 kg. Ten laser and 5 control experiments were perfor-
med. Dogs with preexistent mitral regurgitation (MR) were 
excluded. The LPPM was exposed through the MV during car-
diopulmonary bypass and ventricular fibrillation. At a 
power of 30 Wand a distance of 1-2 cm a total energy of 
5337 ± 738 J (mean ± s.d.) was delivered using a continu-
ous wave Nd:Yag laser coupled to a 600~ gas cooled fiber. 
Postlasing MV function was intraoperatively assessed by 
contrast echocardiography and postoperatively by frequent 
auscultation. At 1 mo. LV angiography was performed. 
Results: At operation no MR was demonstrated. Two dogs de-
veloped a MR murmur. One of them died on day 16. Autopsy 
revealed necrosis of the entire LPPM ; in addition, coagu-
lation and carbonization of one MV leaflet. No rupture of 
LPPM or chordae was noted. MR was demonstrated angiograph-
ically in 1/9 lased dogs (grade 2/4) and in 0/5 controls. 
Conclusion: Nd:Yag laSing of the LPPM can usually be ac-
complished without consequence to MV function. 
IACD - PATIENT AND DEVICE LONGEVITY 
Anthony Mercapdo. M.p., Richard Brodman, M.D., Debra 
Johnston, R.N., Rosemary Frame, R.N., John Fisher, M.D., 
F.A.C.C., Seymour Furman, M.D., F.A.C.C., Montefiore Medi-
cal Center, Bronx, New York 
Between 05/82 and 08/87, 32 pts (24 male and 8 female, 
mean age 59, range 38-76) of approximately 350 evaluated 
for sustained ventricular tachycardia and/or fibrillation 
(VT/VF) underwent implantation of an automatic implantable 
cardioverter defibrillator(AICD). Twenty-five had coronary 
artery disease (CAD), 5 had nonischemic cardiomyopathy (1 
with mitral valve prolapse), 1 had amyloid heart disease, 
and 1 had CAD and rheumatic heart disease. VT/VF had been 
inducible in all pts after mUltiple drug trials including 
5 pts with endocardial resection. The mean ejection frac-
tion (EF) was 31%. Fourteen pts (44%) never had a spon-
taneous shock for VT/VF and all are alive. If the first 
shock prevented death, the cumulative survival rate would 
have been 82% rather than 51% at 12 mos, 82% rather than 
36% at 24 mos, & 67% rather than 24% at 36 mos. Eleven of 
the 18 pts had only app~opriate shocks, but at least 7 pts 
received both appropriate and inappropriate shocks. 34 
units have been explanted: 23 for battery depletion; 2 for 
no output failure; 5 for infection; 3 for problems with 
sensing; and 1 at the time of cardiac transplantation. The· 
23 depleted. units lasted 19.4 mos (4-25). The least (4 mos) 
did not discharge spontaneously, the greatest (25 mos) 
discharged 7 times, and the others discharged up to 50 
times. The 13 units that never delivered spontaneous 
shocks averaged 19.3 Hos (range 4-25) while the units that 
did give shocks averaged 19.3 mos (range 11-25) p = NS. 
The short term survival in pts refractory to other anti-
arrhythmia treatments is increased by AICO implantation. 
Long term pt survival remains poor. 
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IMPACl' OF ~C IMPIAm'ABlE CARDIOVERl'ER 
DEFIBRIUMORS CN SURVIVAL OF PATIENI'S WI'lH lEFT 
VENl'RIClJIAR DYSFUNCl'ICN AND MALIGNANt' VENl'RIClJIAR 
ARRHY'lHMIAS • 
Patrick Tchou. M.p., Nazih Kadri, M.D., Jose caceres 
M.D., MohaImnad Jazayeri, M.D., Masood Akhtar, M.D., , 
FACe. University of Wisconsin, Milwaukee, WI. 
Patients with left ventricular dysfunction (LVD) am 
sustained ventricular tachycardia have a high 
incidence of sudden death (SO). We examined the 
survival an:i oacurrence of SO based on left 
ventricular ejection fraction (LVEF) in 70 P1's treated 
with the autanatic inplantable caroioverter 
defibrillator. 'IWenty-six patients had LVEF ~ 40% 
(groop A), 19 patients had LVEF less than 40% rut 
greater than 30% (groop B) an:i 25 patients had LVEF < 
30% (groop C) • -
Mean follCM up, oacurrence of SO an:i actuarial 
survival an:i recurrence of vr-VF (Re vr-:.VF) at· one 
year are shown helCM. 
FollCM up (days) 
Sudden Death 
SUlvival (1 year) 
Re vr-VF (1 year) 
~ 
557±421 
o 
100% 
35.6% 
~ 
508±331 
o 
89.5% 
37.3% 
~ 
552±358 
1 
86.7% 
43.1% 
Conclusions 1) High incidence of Re vr-VF is 
consistent with the high risk nature of this 
population. 2) '!he incidence of SO is strikin3"ly 
ICM when carpared to reported incidences in similar 
populations. 3) SUlvival of patients with 
decreased LVEF reported here are llU.lch better than 
historical controls an:i can be largely attr:ibuted 
to lCM incidence of SO. 
TERMINA TION OF SUSTAINED SUPRAVENTRICULAR TACHYCARDIA BY 
EXTERNAL NONINVASIVE PACING 
Blair P. Grubb, M.D., Jerry C. Luck, M.D., F.A.C.C., 
Stephen E. Artman, Robert Steckbeck, Michael L. Markel, 
M.D. Penn State Univ. College of Medicine, Hershey, PAr 
We evaluated the usefulness of external noninvasive 
pacing(EXP) as a modality for the termination of 
paroxysmal supraventricular tachycardia(PSVT). EXP was 
compared to traditional endocardial(ENDO) paCing for the 
termination of PSVT. Six pts (mean age +SD, 41+17 
yrs )were sedated wi th 4-8 mg of midazolam. PSVT was 
induced and terminated by burst ENDO ventricular pacing. 
EX? cycle lengths were based on ENDO values, and currents 
were set at threshold initially and increased (20 rnA 
increments) to facilitate ventricular capture during 
PSVT. The mechanism was re-entrant in all 6 pts (4 AV 
nodal, 2 AV with left Kent's). PSVT was terminated by 
burst ENDO ventricular pacing at twice threshold for 2-12 
beats. With a ZMI external pacemaker, EXP successfully 
terminated induced PSVT in all 6 pts. 
PSVT Pace Termination #beats 
Pt Site CL ENDO CL EXP CL ENDO/EXP 
1. A-V node 480 430 430 12/14 
2. A-V node 440 280 300 4/4 
3. WPW 340 280 280 2/4 
4. A-V node 450 400 400 6/7 
5. A-V node 310 220 240 5/10 
6. WPW 320 240 240 3/6 
The cycle length of PSVT averaged 390+75 ms. PSVT was 
terminated at similar pacing cycle-lengths for both 
methods (ENDO 308+86 vs EXP 315+81 ms). For the t ermina-
tion of PSVT, EX? required '4=14 beats and currents of 
42-140 (mean 99+32 rnA). We conclude that if are-entrant 
PSVT can be terminated by ENDO ventricular paCing, there 
is a high likelihood of successful termination by EXP. 
EXP may be clinically useful in termination of PSVT. 
ABSTRACTS 
CATHETER ABLATION OF REFRACTORY VENTRICULAR 
ARRHYTHMIAS: LONG TERM FOLLOW-UP. 
Paul Touboul, M.D .. Gilbert Kirkorian, M.D., Georges A tallah, 
M.D., Bruno Didier, M.D., Fatima Zoheir, M.D., Pierre 
Lavaud, M.D., Pascal Sagnol, M.D., Roland Rossi, M.D., 
Marie P. Mathieu, M.D .. HOpital Cardiologique, Lyon, France. 
We performed catheter ablation (CA) in 30 patients (pts) 
aged 57! 15 years with recurrent ventricular tachycardia 
(VT) unresponsive to drugs. ZZ pts had old myocardial 
infarction. In the others VT was due to valvular (I), 
myocardial (1), congenital (1) and electrical disease (5). 
Immediate complications included: death (following electro-
mechanical dissociation) in 3 pts, transient (5) or permanent 
complete A-V block (Z). After CA, there was no deterioration 
in left ventricular function (ejection fraction: 4Z + Z8 % vs 
40! ZI%). -
Z7 pts were followed for 14!10 months. Only lZ pts 
remained asymptomatic without (8) or with drug therapy 
(Z). 7 had documented recurrent VT and 8 died (6/8 suddenly). 
Z year actuarial survival without arrhythmic events was 
39 %. Risk factors for the return of VT or sudden death 
comprised the classes m-IV NYHA, ischemic heart disease, 
low ejection fraction «35%), Z or more VT morphologies/pt, 
inducibility of VT in the first 3 months after CA. There 
was no difference between follow-up classes relative to 
endocardial mapping data. 
Conclusion : CA is of limited value in pts with refractory 
VT. Severe ischemic cardiopathy is the main determinant 
of failure. 
A RANDOMIZED STUDY COMPARING CATHETER 
ABLATION TO MEDICAL THERAPY IN PATIENTS WITH 
VENTRICULAR TACHYCARDIA. PRELIMINARY RESULTS. 
Gilbert Kirkorian, M.D., Georges Atallah, M.D., Pierre 
Lavaud, M.D., Bruno Didier, M.D., Fatima Zoheir, M.D., 
Paul Touboul, M.D .. HOpital Cardiologique, Lyon, France. 
Catheter ablation (CA) of ventricular tachycardia (VT) 
has been applied to patients (pts) with refractory VT. Since 
this technique may be of interest for recent onset VT, 
we undertook a randomized study aimed at comparing CA 
to medical therapy (amiodarone) in such pts. From January 
1985 to November 1986, 16 pts entered the study. There 
were 14 men and Z women aged 49! 15 years (18-73). 6 
pts had old myocardial infarction, the others had 
cardiomyopathy (5), right ventricular dysplasia (Z), mitral 
valve prolapse (1) and no identifiable heart disease (Z). 
Inclusion criteria were: 1) documented episode of recent 
onset. VT Z) ability to localize the site of VT origin by VT 
mappIng and/or pace-mapping 3) no contra-indication to 
amiodarone. Pts were randomly assigned to Z groups. Group 
I (7 pts) was given amiodarone (loading dose 600-800 mg/day 
for 1 month, maintenance ZOO-300 mg/day). In group IT 
(9 pts), 1-4 cathodal shocks (Z50-300 J) were delivered 
at the site of VT origin without adverse effect. Follow-
up span was IS! 8 months (range 4-Z7 months). 1 pt died 
suddenly and Z pts had recurrences in group II whereas 
no arrhythmic event occurred in group I. 
These preliminary results do not favor CA as first choice 
treatment for pts with recent onset VT. 
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CONCEALED ANTEROGRADE ACCESSORY PATHWAY CONDUCTION DURING 
INDUCTION OF ORTHODR()1IC TACHYCARDIA. William Kou, M.D., Fred 
Morady, M.D., F.A.C.C., Macdonald Dick, M.D., F.A.C.C., Steven 
Nel son, M.D., Michael de Buitleir, M.D., Jeffrey Baennan, 
M.D., University of Michigan, Ann Arbor, MI. 
The purpose of thi s study was to detenni ne whether or not 
conceal ed anterograde accessory pathway conduction occurs 
during the induction of orthodromic tachycardia by atrial 
extrastimuli (A;». Sixteen patients with an overt (10) or 
concealed (6) accessory pathway had i ndud b 1 e orthodromi c 
tachycardia by A" during a drive (Al ) cycle length of 500-650 
ms. A ventrfcular extrastimulos (V) was introduced 
coincident with the His depolarizatio~of A2 during the 
longest A1Az that reproducibly induced orthodromic 
tachycardia. The A"V interval was decreased in 10 ms steps 
ti 11 V:l reached reffactoriness. Retrograde accessory pathway 
conduction of V3 in the presence and absence of A~ was 
compared at the same A V intervals. In the absence 01' A", 
there was retrograde ac~~sory pathway conduction following ~3 
in each patient. In the presence of A", retrograde accessory 
pathway conduction following V3 was ab~ent in 8 patients and 
prolonged by 15-55 ms in 7 patients, demonstrating that 
concealed anterograde accessory pathway conduction was present 
in 15/16 patients at the time of orthodromic tachycardia 
induction. In conclusion, concealed anterograde accessory 
pathway conduction occurs in a majority of patients with both 
overt and concealed accessory pathways during induction of 
orthodromic tachycardia by A". The loss of concealed 
anterograde accessory pathway cOnduction is not a requirement 
for orthodromic tachycardia initiation. These findings 
suggest that the induction of orthodromic tachycardia depends 
on a critical interplay between the degree of anterograde 
concealed conduction and atri a 1 ventri cul ar delay. 
MULTIPLE ATRIOVENTRICULAR BYPASS TRACTS: PRESENCE vs 
PARTICIPATION IN TACHYCARDIA 
JM Miller, MD, CD Gottlieb, MD, FE Marchlinski, MD, FACC, 
AE Buxton, MD, FACC, ME Josephson, MD, FACC. University 
of Pennsylvania, Philadelphia, PA. 
If all atrial (A) activation occurs via a single re-
trogradely-conducting bypass tract (BT) during ortho-
dromic circus movement tachycardia (T), an identical A 
activation sequence should be obtained with A pacing at 
the A site of BT insertion. If 2 or more BTs partiCipate 
in A activation during T, the A tissue activated by the 
2nd BT will be activated earlier during T than during A 
pacing at the site of earliest A activity. To test this 
hypothesis, we A paced (bipolar, 2X threshold) at the site 
of earliest A activity in T in 19 patients (11 men, 8 
women; mean age 32 yr) with Ts proven to use retrogradely 
conducting BTs, and compared the A sequence (timing and 
morphology of A electrograms) thus obtained with that 
during T. Simultaneous recordings were made from His 
catheter, 2 coronary sinus, and 2 RA sites. In all cases 
BT locations were determined by detailed A mapping (8 
operative): 10 had only 1 BT; 7 had 2 BTs, 2 had 3 BTs. 
A activation sequence (Pacing v s T): 
IBTs Same Different 
Single 10 0 
Multiple 3* 6 (p=0.003) 
*in 2 of these 3 cases, BTs were ~2 cm apart 
Thus: 1) If the A activation sequence during A pacing at 
the site of earliest A activity in T is the same as the A 
activation sequence in T, either a single BT is present, 
or if 2 6Ts are present, they are confined to the same 
area. 2) A difference in A activation sequences between A 
pacing and T indicates multiple 6Ts. 3) In cases of 
multiple 6Ts, fusion of A activation during T is frequent 
(6/9 cases). This pacing protocol may be useful to 
preoperatively screen for the presence of multiple 6Ts. 
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ROLE OF BETA-ADRENERGIC STIMULATION IN I!I.'DUCTION OF 
SUSTAINED ATRIOVENTRICULAR NODAL REENTRY IN PATIENTS WITII 
DUAL ATRIOVENTRICULAR NODAL PATHWAYS. 
~.C,fuiycke,l'1.,D".l'.A.C,C" Wen-Ter Lai, M.D., Ngai 
X. Nguyen, M.D., Edmund C. Keung, M.D., and Ruey J. Sung, 
M.D., F.A.C.C., CVRI, Univ of California, San Francisco. 
Dual atrioventricular (AV) nodal pathway conduction is a 
cODll\On electrophysiologic phenomenon. However, patients 
(pts) with dual AV nodal pathways may not clinically 
manifest AV nodal reentrant tachycardia. To assess 
effects of beta-adrenergic stimulation, we infused 
intravenous isoproterenol (Iso) (2-6 ug/min) to 20 pts 
with dual AV nodal pathways, in whom programmed atrial 
and ventricular e:\.-trastimulation and incremental pacing 
had failed to elicit sustained AV nodal reentry. Before 
Iso infusion, inability to sustain AV nodal reentry was 
caused by presence of weak link in anterograde (Ant) slow 
pathway (SP) in 8 pts, and in retrograde (Ret) fast 
pathway (FP) in 12 pt.s. In all pts, Iso accelerated sinus 
rate to approximately 120 beats/min, and significantly 
reduced effective atrial and ventricular refractory 
periods (18:,:7% and 12:,:9%, respectively). In 6 pts (group 
I), sustained AV nodal reentry became inducible following 
Iso-induced improvement of Ret FP conduction while 
preserving dual AV nodal pathway conduction pattern. In 
the remaining 14 pts (group II), persistent inability t.o 
induce sustained AV nodal reentry could be ascribed to 
continuous presence of weak link in Ant SP in 2 pts and 
in Ret FP in 7 pts, and to Iso-induced disappearance of 
dual AV nodal pathway conduction pattern in 5 pts. Of 
note, paroxysms of supraventricular tachycardia had been 
clinically documented in former 6 pts (group I) but not 
in lat.ter 14 pts (group II). Thus, different responses to 
beta-adrenergic stimUlation may account for clinical 
occurrence of paroxysmal AV nodal reentrant tachycardia 
in certain pts with dual AV nodal pathways. 
REIATIONSHIP BEIWEEN I:iUVE CYClE lENG'IH AND REIURN CYClE 
lENGlH rn VENTRIaJIAR REEN'IRY: MEClIANISTIC IMPLICATIONS. 
Mohammad Jazayeri. M.D. « Patrick Tchau, M.D., Jose 
caceres, M.D., Boaz Avitall, M.D., Mark Cowan, M.D., 
James M::Kinni.e, M.D., Masood Akhtar, M.D., F.A.C.C. 
University of Wis=nsin, Milwaukee, WI. 
It has been claimed that durim programmed ventricular 
stinulation (PIIS) with a fixed prerrature cauplim inter-
val (V1V2), an inverse relationship between the cycle 
lergth of basic drive (V1V1 ) am the return cycle 
lergth (RCL) of ventricular tachycardia (V2 to first 
tachycardia oc:.uplex) ~d favor reentl:y. To our 
knowledge, however no cxmvincim data exists to support 
this hypothesis in the humans. since burrlle branch 
reentrant (BBR) process represents the only JOOdel of 
reentrant ventricular tachycardia in the human, with well 
define:i reentrant circuit, we analyzed the relationship 
between Vl V1 am RCL of the first BBR beat (V2-V3)' Eight pahents urrlerwent PIIS with V1V1 of 400-800 msecs 
(100 msec increrrents) am a fixed V1V2 in any given case. 
Results: VlV2 VlVl- 800 700 600 500 
f V2V3 
1 290 330 315 305 295 
2 270 310 295 285 260 
3 270 280 270 255 255 
4 250 340 310 295 275 
5 270 290 280 260 225 
6 280 340 330 325 315 
7 290 325 310 300 285 
8 280 320 300 290 270 
'lhese data clearly dem:mstrate for any given Vl V2 
interval, RCL of the first BBR oatplex has a di.rect 
relationship with V1V1• 'lhus, the direct relationship 
between these two parameters is catpatible with reentl:y 
am not dignostic for other mechanisms (i. g. triggered 
autcmaticity) • 
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ESMOLOL ELEVATES THE VENTRICULAR FIBRILLATION THRESHOLD 
IN HUMANS DURING AUTOMATIC DEFIBRILLATOR TESTING 
Thomas Guarnieri. M,D,. F,A,C,C., John C. Merillat, 
M.D., Igor Singer, M.B.B.S., Lyle A. Siddoway, M.D., E. 
Neil Moore, D.V.M., Ph.D., F.A.C.C., Joseph H. Levine, 
M.D. Johns Hopkins University School of Medicine, 
Baltimore, MD 
Prevention of sudden death by beta blockers may be due 
to an anti-ischemic effect, or in-hibition of 
ventricular tachycardia/fibrillation (VT/VF). We 
measured the effect of esmolol (ultra short beta 
blocker; 2mg. bolus, 200 mcg/kg/min infusion) on the 
ventricular fibrillation threshold (VFT) in 5 patients 
undergoing automatic defi bri 11 at or (AI CD) repl acement. 
The VFT (AC voltage necessary to produce 15 secs of 
VT/VF) was determined by applying 3 secs of 60Hz AC 
through a right ventricular catheter. Voltage was 
stepwise increased until VT/VF. VFT was (volts ± SEM, 
n=5): 
Control ill Esmolol ill 
6.0±1.7Volts 19.6±5.0* 
(* P = .029, ANOVA) 
Post-esmolol 
7.6±2.3 
Esmolol produced beta blocker effects: systol ic 
pressure C = 147±12mmHg, E = 138±10.2mmHg, p=.03; and 
cardiac output C = 3.8±0.2 l/min, E = 2.8±0.2 l/min, 
p=.02. Thus, esmolol in doses that produce significant 
beta blockade is antifibrillatory as measured by a 300% 
increase in VFT in humans. This elevation in the VFT 
may be the mechanism by which beta blockers prevent 
sudden death. 
ARRlffi'HMCGENIC RIGHT VENTRIaJLAR DYSPLASIA; HIS'roLOOlCAL 
AND ELEX:::'l'R:MICOCSCOFY STUDY OF FIVE CASES. 
Colette M. Guiraooon, M.D., F.R.C.P. (C)., F.C.A.P, Gerard 
M. GlirauOOn, M.D., F .R.C.S. (C), F .A.C.C, George J. 
Klein, M.D, F.R.C.P.(C), F.A.C.C. 
university lbspital, rondon, Chtario, Canada 
ArrJvtlurogenic right ventricular dysplasia is a rare 
cardi~tIv predaninately involving the right 
ventricle. Electranicroscopy characteristics have not 
been des=ibed and may be of diagnostic value. ~ report 
5 cases (3 surgical resections of the right ventricular 
free wall, 1 en~dial biopsy and one heart fran 
transplant) • 
'!he If!YOCarcllun is extensively replaced with fat, often 
found tranSllllrally. Scattered nrrocytes are atrophic or 
hypertropuc, isolated within the fat or wrapped in thin 
fibrous sheaths. fure are seen on the endocardial aspect. 
Inflamnation, small vessel disease and subendocardial 
fibrosis are aJ::sent. Electranicroscopy shows muscular 
disa=ay and al::nonnal intercalated discs in both the 
right and left ventricular ~urn: intercalated discs 
are uniformly atropried and attenuated. '!his ananaly 
occurs even \ItIen the left ventricle is nonnal by light 
microscopy • 
~ conclllde that electranicroscopy abnonnalities 
involving both the right ventricle and left ventricle in 
a=lrft:luoogenic right ventricular dysplasia are a 
significant feature. Electrani=osropy assessment may be 
useful for diagnosis of a=hythm::lgenic right ventricular 
dysplasia in suspected patients. 
ABSTRACTS 
INHIBITION OF PROCAINAMIDE USE DEPENDENT CONDUCTION 
DELAY BY LIDOCAINE. 
John R. Windle. M.D •• F.A.C.C, Douglas V. Welsh, M.D., 
Toby R. Engel, M.D., F .A.C.C., University of Nebraska 
College of Medicine, Omaha, NE. 
Procainamide (P) and Lidocaine (L) cause time and 
frequency dependent conduction delay (use dependence) 
wi th different kinetics. Tbe interaction of these 
drugs are unknown. Six patients underwent 15 seconds 
of right ventricular pacing at cycle lengths (CL) of 
400 and 300 ms when drug free (DF) and following P and 
then L (P+L). QRS duration was determined for each 
successi ve beat from surface and intracardiac 
electrograms. After pacing, plasma P = 9.7 meg/ml :!:. 
3.4 SD and L = 2.9 :!:. 0.9. Changes from initial 
(DFi,Pi,P+Li ) to maximal QRS duration (DFm,~,P+Lm) and 
the time to achieve 50:1 response (T 1/2) were 
determined. Prolongation of QRS by P exibi ted use 
dependence. E.g., at CL = 400 ms, Pi = 189 ms :!:. 21 and 
Pm = 205 :!:. 28, p<0.003. There was even greater 
prolongation at CL = 300 ms (Pm = 217 ms :!:. 27, p<O.Ol 
vs Pm at 400 ms). Tbe addition of L did not alter the 
ini tial QRS. However, L significantly shortened 
maximal QRS (for CL = 400 ms, P+Lm = 194 :!:. 28, p<O. 004 
vs Pm' and for CL = 300 ms, P+Lm = 206 :!:. 26, p<O.OOl vs 
P ). Tl/2 was not altered for P or PL at either CL. ~is study confirms that P causes time and frequency 
dependent conduction delay (use dependence). More 
importantly, L attenuates the use dependent P induced 
conduction delay. These results may indicate 
competitive binding of P and' L to the same Na+ channel. 
ISlA 
HEREDITARY AUTOSOMAL DOMINANT VENTRICULAR TACHYCARDIA. 
David A. Rubin, M.D., F.A.C.C., Karen Nieminski, R.N., 
CCRN, Arthur O'Keefe, David Mendelson, M.D'j Michael V 
Herman, M.D., F.A.C.C. New York Medical College, Valhalla 
New York. 
Inherited ventricular tachycardia (VT) and sudden cardiac 
death (SCD) have been reported in long QT syndrome, hyper-
trophic or congestive cardiomyopathy and metabolic 
disorders. We report 5 generations of a family with 
VT/SCD and without other cardiac or metabolic disorders. 
In generation 1, 1 of 3 siblings suffered SCD. In genera-
tion 2, 4 of 7 siblings suffered SCD/VT (2 female, 2 male). 
In generation 3, 5 of 10 siblings (2 male, 3 female) have 
SCD/VT. In generation 4, 4 of 12 siblings (3 female,1 
male) have had SCD/VT. There are 6 children in generation 
5, all under the age of 12. We evaluated 2 siblings in 
generation 5. They are asymptomatic with normal 24 hour 
ambulatory monitors. The mean age of SCD/VT in all 
generations is 36 years. We evaluated 2 siblings in 
generation 4. Physical examination did not reveal 
cutaneous, musculoskeletal, ocular or neurologic disorder& 
ECG's were normal except for identical right bundle branch 
block morphology VT. Cardiac catheterization and non-
invasive studies were normal. Electrophysiologic studies 
confirmed VT that could not be initiated or terminated by 
pacing. Procainamide but not Verapamil or propranolol 
abolished VT. Both siblings have been followed 38 months 
without VT/SCD. 
Conclusions: 1. Familial SCD/VT can occur without other 
abnormalities. 2. The inheritance pattern is autosomal 
dominant. 3. SCD/VT does not occur until adulthood. 
4. Electrophysiologic studies suggest that the mechanism 
is abnormal automaticity. 
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Electrophysiology: Clinical 
INFLUENCE OF ISOPROTERENOL ON THE LEFT VENTRICULAR 
RESPONSE TO EXTRASTIKULI APPLIED TO THE RIGHT VENTRICLE. 
Luis Constantin, M.D., Michael G. Kienzle, M.D., F.A.C.C., 
Sheldon L. Brownstein, M.D., James B. Martins, M.D., 
Department of Medicine, University of Kentucky, Lexington, 
Kentucky 
Isoproterenol (ISO) is often used adjunctive1y during 
right ventricular (RV) extrastimu1us testing. Our purpose 
was to define the effect of ISO on the left ventricular 
(LV) response to RV extrastimuli. Simultaneous 
electrogram recordings from the RV apex and LV apex were 
obtained in 6 patients during RV apex stimulation with 2 
extrastimuli before and during LV stimulation using 2 msec 
pulse width and 4 times diastolic threshold. Results 
(V2-V3 = shortest V2-V3); mean + SEM; * p<0.05 vs. 
Control): During RV stimu1atio;, RV and LV functional 
refractory periods (Vl-V2) were not significantly 
different. 
RV Stimulation 
RV V2-V3 
Control 
207+10 
ISO 
180+9* 
LV V2-V3 
Control 
223+10 
ISO 
184+8* 
LV Stimulation 
LV V2-V3 
Control 
217+11 
p<0.05 p<0.05 
ISO did not alter RV to LV activation time during RV 
pacing at 400 msec, but did prevent the prolongation of RV 
to LV activation time which occurred after a second 
extrastimulus. Conclusions: 1) ISO reverses the delay in 
LV activation due to relative refractoriness during RV 
stimulation. 2) ISO permits achievement of shorter V2-V3 
intervals in the LV than during either RV or LV 
stimulation alone. 
VENTRICULAR ARRHYTHMIAS IN PATIENTS ON ANTIARRHYTHMIC 
DRUGS - PROARRHYTll-tIA OR DRUG FAILURE? 
Alfred E. Buxton, MD, FACC, Mark E. Rosenthal, MO, Francis 
E. Marchlinski, MD, FACC, John M. Miller, MD, Mark E. 
Josephson, MD, FACC. University of Pennsylvania, 
Phlladelphia, PA. 
We performed programmed stimulation (PS, 1-3 extrastimuli, 
2 cycle lengths, 2 RV sites) off antiarrhythmic agents 
(AA) in 5 pts who developed syncope (Group 1) and 36 with 
sustained ventricular tachycardia (VT) or cardiac arrest 
(Group 2) only during empiric therapy with Type IA AA 
after remote myocardial infarction. No pt had long QT 
syndrome. We then repeated PS after procainamide to 
assess proarrhythmic effects of Type IA AA. We defined 
proarrhythmia as conversion of nonsustained VT induced at 
baseline PS to sustained VT at PS after procainamide. PS 
off AA in Group 1 induced uniform nonsustained VT in 4 and 
sustained VT in 1. PS after procainamide induced sus-
tained VT with the same morphology in all 5. PS off AA 
in Group 2 induced no VT or only nonsustained VT in 5, and 
sustained VT in 31 (86%). Procainamide did not convert 
nonsustained to sustained VT at PS in any Group 2 pt. We 
compared these pts to a control (Group 3) of 49 pts with 
sustained VT or cardiac arrest on no AA after myocardial 
infarction. PS off AA in Group 3 induced no VT or only 
nonsustained VT in 9 and sustained VT in ,40 (82%, p=NS vs 
Group 2). Procainamide did not convert nonsustained to 
sustained VT in any Group 3 pt. Sustained VT remained 
inducible after procainamide in 27/31 Group 2 pts and 
36/40 Group 3 pts. We conclude, using criteria of induci-
bility by PS: 1) we observed responses to procainamide 
consistent with proarrhythmia in pts with syncope on AA; 
2) we could not distinguish pts with sustained VT/cardiac 
arrest occurring only on or off AA. In this group, using 
these criteria, sustained VT/cardiac arrest most often 
appears to represent AA failure, not proarrhythmia. 
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SYNCOPE DURING TREATMENT WITH ANTIARRHYTHMIC 
DRUGS IN PATIENTS WITH VTjVF. 
Joep Smeets. M. D., Pedro Brugada, M. D., Paolo 
Della Bella, M.D., Mario Talajic, M.D., Hein 
J.J. Wellens, M.D., F.A.C.C., AcademiC Hospital, 
Maastricht, The Netherlands. 
Pt with documented ventricular tachycardia (VT) 
or ventricular fibrillation (VF) are at high 
risk of sudden death. Despite antiarrhythmic 
drug (AAD) treatment 35% of these Pt have a 
recurrence and 12% die suddenly within 2 years 
in our series. We had observed a high incidence 
of sudden death in Pt presenting an episode of 
syncope during treatment with AAD. Data from a 
group of 100 Pt (31 with documented VF, 69 with 
documented VT) were retrospectively analysed to 
assess the relation between syncope during 
treatment and subsequent risk of sudden death. 
During a follow up of 26 months 24 Pt died of 
cardiac causes of whom 10 suddenly. 20 Pt 
suffered from syncope during treatment with AAD, 
8 of them died suddenly. In contrast only 2 out 
of 80 Pt not suffering from syncope died 
suddenly during follow up. The sensitivity, 
specificity and positive predictive value to 
predict sudden death was 80, 89 and 49%. This 
was higher than sensitivity, specificity and 
positive predictive value of inducibility of VT 
during AAD (80, 25 and 11%) or a LV ejection 
fraction < 40% (70, 25 and 10%). 
Conclusions: Although the exact cause of syncope 
in our Pt remains unknown, Pt suffering from it 
during treatment with AAD are at high risk of 
sudden death and deserve careful reevaluation. 
THE CLINICAL, ELECTROPHYSIOLOGICAL DETERMINANTS 
AND SURVIVAL OF PATIENTS WITH SUSTAINED VENTRICU-
LAR TACHYCARDIA EARLY POST-MYOCARDIAL 
INFARCTION. 
J. Anthony Gomes, M.D., F.A.C.C., Stephen L. Winters, M.D., 
Arisan Ergin, M.D., F.A.C.C., Adria Targonski, M.T., Debra 
Stewart, R.N., Marc Cohen, M.D., Manuel Estioko, M.D., Warren 
Sherman, M.D. The Mt. Sinai Med. Ctr., N. Y., NY. 
The clinical, electrophysiologic determinants and survival of 
patients (pts) with sustained ventricular tachycardia (VTs) early 
post-myocardial infarction (MI), remain undefined. To assess 
this, we studied 1 Z3 pts (age=61±8 yrs) post-MI of which ZO 
pts (Group I) had VTs, 8-60 days post acute MI and 103 pts did 
not (Group TIl. All pts had determination of left ventricular 
ejection fraction (EF), Z4-hour Holter monitOring and signal 
averaging to detect late potentials (LP's). In addition, 16/Z0 
pts from Group I had PES-guided anti-tachycardia (AT) therapy 
(Rx). The most significant determinants of early VTs were: 
Group I Group II Pvalue 
Late potentials 16/Z0(80%) 35/103(34%) .0001 
LV aneurysm 7/Z0(35%) 6/103(6%) .0001 
Ejection fraction Z6±11% 40±1Z% .001 
In contrast, age, site of MI, peak CPK and the presence of high 
grade ectopy were not significantly different between the groups. 
VTs was induced in 15/16 pts (94%) by PES. AT-Rx guided by 
PES included: map-guided surgery (7 pts); antiarrhythmic agents 
(lZ pts) and anti-ischemic agents (1 pth The arrhythmic (5% 
vs 5%) and non-arrhythmic death rate (15% vs 7%) were not 
significantly different between Groups I and n respectively, 
over a follow-up period of 13±6 months. Conclusions: 1. LP's, 
LV aneurysm and EF are the most significant determinants 
of VTs early post-MI. Z. PES-guided AT-Rx (map-guided surgery, 
antiarrhythmic drugs) in VTs early post-MI is associated with 
an excellent arrhythmia-free survival comparable to pts without 
early VTs. 
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EVALUATION OF PATIENTS AT RISK AFTER FIRST ACUTE 
MYOCARVIAL INFARCTION BY PROGRAMMEV VENTRICULAR STIMULA-
TION: INFLUENCE OF ANTIARRHYTHMIC VRUG THERAPY 
An~ea Pod~zeck.M.V.,K.F~ohn~,M.V.,Wilhetm Kattenb~n~, 
M.V.,Ch.H~e6,M.V.,K.Steinba~,M.V.,FACC. Bottzmann A~th 
m<.a RU~~ IfUl.tUute,Wilhelm.i.nefUlp.Uai.. V.ienna.Alu.tJUa 
To ..£denti.6y pa.ti.ent4 at wk 6M aMhythm.i..~ event4(venVU-
cu1.aJr. to.~c.aJUJ..ia/llu.ciden death)a6t~ 6iMt acu..te 1IIIJ0~­
dial .in6~etion(MI) and to evaluate potential bene6.i~l 
e66edll 06 anti.aMhythmi.~ ~ug(AAV) th~PIJ 110 ~ofUlecu­
-ti.ve p.t6. < 10 yeaM (134 male. 36 6emale. mean age 56t9 yM) 
w~e lltJ.uU.ed .in the 3~ week a6t~ 6iMt tltafUllIIJJtal MI 
U6.ing ~og~rmred ventJUcu1.aJr. llUnr.t1.a.ti.on (PVS) .SUnr.t1.a.ti.on 
~oto~ol: S2/S2S3 dulLi.ng 1l..i.nU6 ~hy.thm and pa~ed ventJUcu-
~ ~vu 06 600 and 430 1IkI. 
19/85 p.t6. (g~oup 1) wUh blCludble llU6.ta.i.ned ventJUcu1.aJr. 
~thm<.all(VA)(llVT/VF) ~e~e..(.ved AAV th~py a~~o4ding to 
the ~uuttll 06 ll~l Mug tu-ti.ng. wh~eall 19/85 p.t6. 
(g~oup III wUh bldudble llU6ta..i.ned VA ~e cLU,~ged 
wUhout AAV th~py.AU p.t6. w~e 60Uowed up 6M I y~. 
Ruuttll 06 PVS: 0-3 VE fUlVT llVT VT-CL VF aMh.event4 
(n) g40up t 43 23 13 243t51 6 2 
g~oup II 50 16 8 230i20 II 4 
V~ng 60Uow up, 8 p.t6. cU.ed,4 06 them llu.cidenly, and 2 
p.t6. e.x~en~ed llU6.ta.i.ned VT (total aMhythm<.~ event4 
3, 5 %). None 06 the p.t6. wUh an aMhythm.i..~ event had 
~dble llU6ta..i.ned VA. Although none 06 the p.t6. wUh 
~du.dble llU6.ta.i.ned VA ~e~e..(.v.ing AAV th~PIJ exp~en~ed 
an aMhythm.i..~ event, the llame. Wall VuLe 6M the unbleated 
g40Up Il-p.t6. wUh .indu.dble llU6.ta.i.ned VA. 
Con~lU6.iofUl: I) SU6ta..i.ned VA ~an be ..i.ndu.~ed .in 22t 06 p.t6. 
a6't~ 6.iJl.l>t MI. 2) PVS dou not ..£denti.61J p.t6. at wk. 60~ 
aMhytFuM.~ event4. Thull, one IJ~ 60Uow up ~nnot obje~­
-ti.6y bene6..(.dae e66edll 06 a~thm.i..~ Mug th~PIJ .in 
p.t6. wUh ..i.ndu.dbee llU6ta..(.ned ventJUcu1.aJr. aMhythm<.all. 
SUCCESSFUL REPERFUSION OF INFARCTING MYOCARDIUM IS 
ASSOCIATED WITH REVERSAL OF ELECTRICAL PREDICTORS OF 
SUDDEN CARDIAC DEATH. 
James M. Irwin, M.D., Pamela M. Smith, RN, Richard S. 
Stack, M.D., F.A.C.C., Robert M. Califf, M.D., Eric N. 
Prystowsky, M.D., F.A.C.C. Duke University Medical 
Center, Durham, NC. 
Coronary reperfusion (CR) during acute myocardial 
infarction (AMI) decreases long term cardiac mortality. 
We prospectively evaluated the effect of CR using 
thrombolysis/angioplasty during AMI on the signal-averaged 
ECG (SAECG) in 21 pts, since the presence of late 
potentials (LP+, root mean square voltage ~25 ~V in last 
40 ms of the QRS complex) on SAECG after AMI correlates 
with sudden cardiac death. SAECG was done 229 t 84 min 
after onset of AMI and on day 7, using a 25 Hz high pass 
filter and bidirectional filtering. All SAECG had a noise 
level of< 2 1,JV. At first SAECG, 8 pts had LP+(18 ± 4 1,JV) 
and 13 had no LP (97 ± 79 ~V, p<.Ol). Between LP+ and no 
LP pts, there was no difference in mean residual arterial 
stenosis after CR (38% vs 47%, all revascularized) or time 
to CR (210 ms vs 243 min). On day 7, SAECG showed all 8 
pts with LP+ converted to no LP (52 ± 21 ~V, p <.01), and 
remaining 13 pts still had no LP. In a control group of 
15 pts with stable coronary artery disease, no differences 
occurred between a SAECG done on day 1 and 7 (39.4 ± 30.5 
1,JV vs 34.2 ± 21.1 pV, respectively; r ~ .95). During 
followup at 6 mos, 10/10 study pts continue to be without 
LP (53.3 ± 16 ~ V) or significant change in SAECG. No 
ventricular tachycardia or sudden death has been reported 
in any of 21 study pts for 5.8 mos followup. We conclude 
that successful reperfusion during AMI is associated with 
disappearance of LP+, which may reflect a more stable 
electrical substrate, and may account in part for the 
decreased mortality reported in these pts. 
ABSTRACTS 
USE OF THE SIGNAL AVERAGED ELECTROCARDIOGRAM TO 
PREDICT ELECTROPHYSIOWGIC STUDY RESULTS IN 
UNEXPLAINED SYNCOPE 
Jonathan S. Steinberg, MD, Kelly Michelson, James A. Reiffel, MD, FACC, 
Frank Livelli, MD, Jerry Gliklich, MD, and J. Thomas Bigger, Jr., MD, FACe. 
Columbia-Presbyterian Medical Center New York, NY. . 
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Electrophysiologic study (EPS) is often employed in pts with unexplained 
syncope, particularly for the diagnosis of ventricular tachycardia (VT). In pts 
with previously known VT, the signal averaged (SA) ECG has often revealed 
late potentials. The goal of our study was to determine whether the SAECG, as 
well as clinical variables, can be used to predict inducible VT at EPS in syncopal 
pis without known VT. We studied 18 pis with unexplained syncope who 
underwent diagnostic EPS. All had history, physical, 12-lead ECG, Holter 
recording, LV ejection fraction (EF), and SAECG performed prior to EPS. The 
pt population included 16M and 2F; mean age= 58 ± 13 yrs; 6/18 (33%) had 
coronary artery disease and 12/18 (67%) had no known heart disease. The 
number of syncopal episodes was 2.1 ± 1.5. The ECG was normal in 1/18 (6%); 
9/18 (50%) had >10 VPD's/hr and 5/18 (28%) had unsustained VT on Holter; 
LVEFwas <40% in 4/14 (29%). The SAECG was fIltered at 40Hz 
(bidirectional) and ~200 beats were sampled. Late potential was present if on 
vector magnitude the RMS-voltage in terminal 40ms was 9IJ/lV or the low 
amplitude signal < 4O/lV was ~s. Late potentials were detected by SAECG in 
5/18 (28%) and the fIltered QRS duration was> 110ms in 6/18 (33%). 
Sustained monomorphic VT was induced at EPS in 5/18 (28%). Of the 7 
clinical variables tested, L VEF < 40% (p =.01) and presence of coronary artery 
disease (p = .04) predicted VT at EPS; both SAECG detected late potential 
(p=.Ol) and fIltered QRS duration (p=.04) also predicted VT at EPS. The 
sensitivity/specificity ofthese variables follows: LVEF<40% (80%/100%), 
coronary artery disease (80%/85%), SAECG-Iate potential (80%/92%) and 
SAECG-QRS> l10ms (80%/85%). The combination of LVEF < 40% and 
SAECG-Iate potential improved sensitivity to 100%. 
CONCLUSION: The SAECG has sensitivity/specificity similar to L VEF < 40% 
and presence of coronary artery disease for the induction of VT at EPS in pts 
with unexplained syncope. The SAECG does not always identify the same pts as 
these clinical variables. 
IDEllTII'ICATIOW OF YEImlICULAR LATE POTBIITIAL ACTIVITY 
D SINGLE CARDIAC CYCLES USIlfG SPATIAL AVERAGIlfG AIID 
ADVANCED FILTERIlfG TECHWIQUES. 
Susan J Levis MRCP, Paul T Lander D Phil, Penelope A 
Taylor, Douglas A Cbuberlain MD, Richard Vincent MD 
Royal Sussex County Hospital Brighton East Sussex 
Uni ted nngda • 
Ventricular late potential activity (YLPA) can be 
identified by signal averaging but this technique 
precludes detection of beat to beat infol'lllltion. . To 
acheive sufficient nobe reduction to exuine YLPA in 
Single cardiac cycles ve have tested the errect of 
spatial averaging in combination with advanced 
filtering technique.. High gain ECG .ignala vere 
recorded rro. II clo.ely .paced bipolar che.t le.ds in 
18 patients, 12 known to have YLPA on conventional 
signal averaging and 6 healthy volunteers with no 
YLPA. Single beats obtained with and without spatial 
averaging vere subjected to digital filtering 
techniques. wave fol'llS siailar to tho.e .een in a 
200 cycle sisnal average were identified in single 
cardiac cycles in 9/12 patients known to have YLPA. 
YLPA vere clearly absent in aingle cardiac cycles in 
all 6 healthy volunteers. Most reduction in ST segaent 
background noise resulted from low nOise recording and 
time varying fUtering. Little i.provuent in sisnal 
recovery followed spatial averaging. Low nobe 
recording .ethods and specialised filtering technique. 
al~ov vbual1.ation of YLPA in .ingle cardiac cycles. 
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Coronary Artery Disease: Clinical 
ESOPHAGEAL DISORDERS AS CAUSE OF CHEST PAIN IN SYMPTOMATIC 
PATIENTS WITH DOCUMENTED CORONARY ARTERY DISEASE. 
Jesus Garcia-Pulido, PH Patel, William Hunter, John E. 
Douglas, Eapen Thomas. East Tennessee State University 
Johnson City, TN 
We studied 25 male patients~ age 61 yrs. (range 50-71), 
with symptomatic coronary artery disease (CAD). All 25 
patients complained of anginal chest pain (CP), and 13 
also complained of heartburn. Patients were evaluated by 
Bernstein test, esophageal manometry, and simultaneous 
monitoring of 24 hour Holter ECG and esophageal pH. 
Peri-pain reflux (PPR) was defined as pH ~4 within ten 
minutes of chest pain. 
RESULTS BERNSTEIN MOTILITY 
Symptoms 
, Pts. + - Abn. Nl. r 
Angina 12 3 9 11 1 
Ang1na/tleartourn 13 9 4 9 4 
.otal 25 12 13 20 5 
Percentages 48% 52% 80% 20% 
43 episodes of chest pain were documented in 16 patients 
during combined 24 hour Holter and esophageal pH monitoring 
of 43 episodes of CP in these 16 patients: 
CP with ST Depression CP with Neither 
6*/43 8/43 
14.0% 18% 
*2 simultaneous reflux and ECG changes during CP 
CONCLUSIONS: 1. Chest pain was more often associated 
with peri-pain reflux than with ischemic ST-T wave changes. 
2. Significant esophageal motility disorders are common 
in patients with CAD. 
3. We have demonstrated that esophageal testing in these 
pat~ents is informative, safe, and clinically relevant. 
DOES TOLERANCE DEVELOP TO CORONARY ARTERY DILATATION 
AFTER NITROGLYCERIN PATCH? 
Abel E. Moreyra, M.D., F.A.C.C., Mark N. Porway, M.D., 
F.A.C.C., Stephen B. Presant, M.D., John B. Kostis, M.D., 
F.A.C.C., UMDNJ-Robert Wood Johnson Medical School, New 
Brunswick, New Jersey 
We have shown that transdermal nitroglycerin (NTG) 
applied 2-12 hours before coronary arteriography (CA) 
cause a blunted coronary dilator response to intracoro-
nary (IC) NTG. To further elucidate issues of duration 
of action and tolerance we studied the coronary dilator 
response to graded doses of IC NTG in 25 patients (pts) 
undergoing diagnostic coronary arteriography. Twelve pts 
received a 15 mg/24 hr NTG patch (P) 3-12 h before CA, 6 
pts received a patch 24 h before CA and 7 pts did not 
(control group). High resolution coronary angiograms were 
examined "blindly" before and after administration of 
cumulative doses of IC-NTG (50 to 350 ~g). An electronic 
caliper was used to measure the diameter of mid segments 
of left anterior descending (LAD) and circumflex (Cx) 
arteries. Results: 
LAD Diameter Increase % 
_IC NTG--' 
50~g 100~g 200~g 
20±4 23±4 28±8 Control 
2-12 NTG-P 
24 h NTG-P 
1±4** 
12±5 
4±2** 
13±4* 
1±2** 
14±4 
*P<0.05,**P<0.01 from control 
Cx Diameter Increase % 
-ICNTG-
50~g 100~g 200~g 
22±8 27±7 22±5 
3±7* 
13±5 
1±5* 
14±4 
3±5* 
15±8 
At a cumulative dose of 350 ~ NTG, mean blood pressure 
decrease 9±5 mm Hg in the control group, 7±4 mm Hg in the 
3-12 h group and 10±3 mm Hg in the 24 h group (NS). Thus, 
cutaneous NTG patches causes a blunted coronary dilator 
response at 3-12 h that dissipates at 24 h. Since the 
systemic response is maintained, the data suggest 
development of selective tolerance. 
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'IRANffiER\lAL N!'lRX;LYCERIN MAY PCITVATF. AffiENERGIC Pm RENIN-J\l.IlC6'lERl'l 
SYS'I»E. EWECI' C\'I EFFCRr TOlERAl'O: IN J\N}INA PEC'I'CRIS. 
M. LDrenza M..1i.esm, M.D. ,Ehricc Ag;3bi ti-Rooei, M.D. ,M3rina Beschi ,M.D. , 
M3urizio Castella1o,M.D. ,Gi\.l3eW<! Rrnanelli,M.D. ,M3rio Cefis,M.D. ,Giorgio 
Pollavini,M.D. ,Bru1ello Cerri,M.D. and Giulio M..1i.esm,M.D. ,F .A.C.C., 
Clinica Medica , lliiversity of Brescia, Italy. 
Aim of this sruqy was to evaluate the antianginal efficacy and the effect 
en plasm renin activity(PRA),alcbstercne (PA),catec:mlantines (pNE andlE) 
of a single dose of nitroglycerin in a transdermal systan (Tl'3-I'G) ,aJ rrf!! 
24 hrs,in 18 pts(15 M,3 F,age 47~ yrs) with stable angina pectoris.The 
sruqy was organized as a Placebo(Pl) ccntrolled,cbJble blind,rarrl::mized , 
cross-<l1Ier' trial. Resting PRA,PA,pNE,pE assa,ys and cycloerg:metric exer-
cise tests were performed in basal ccnditicns and 4,8 and 24 hrs after 
Tl'3-I'G or PI. PNE and pE were also rreasured at peak exercise in 9 pts. ~ 
sidering all the cases 'flS.-ru sig)1ificantly increased(p<.CCl) total ~ 
tioo of exercise (ED) 4 hrs post-<b3li"lg ooly. ?ts were subdivided in Ut.o 
grc>.JP6 according to the increase of ED after 'flS.-ru,Le. n(ncn-respcn-
ders,rF9) or n(respcnders,rF9). In ncn-respcnders pNE,PA and PRA were 
sig)1ificantly ir=eased (p(.05 at least) 4 hrs(pNE fran 425.!:lCC to 7fJ7=. 
195 ng/l,PA fran 146::97 to 100::143 pg/ml,PRA fran 3:!4 to 6.9,!:7ng/ml/hr) 
and 8 hrs (pNE fran 243;!;193 to 654::144 ng/l,PA fran 92:!?4 to 165;:110 mI 
ml,PRA fran 3.8:!:.5.5 to 5.5:!7 ng/ml/hr) after 'flS.-ru. In respooders,ED was 
sig)1ifiC<l1tly increased 4 hrs(fran 437=.161 to 6l7=.22:) sec,p<.CC1)and 24 
hrs(fran 437=.159 to :07=.195 sec,p(.02) after 'flS.-ru,1I.hlle PA and PRA did 
not dlange sig)1ificantly and pNE was increased after 4 hrs ooly (p<.04). 
In respcnders,pNE and pE resulted 1"""" also at peak exercise. 
In ccnclusion, treatrrent with Tl'3-I'G is less effective \\hen it is assoc~ 
ted to a sig)1ificant and prol00ged increase of pNE,pA and PRA.In that ca-
se the associatioo of 'flS.-ru with a drug capable of decreasli"lg the adre-
nergic and reni.fl...rucbstercne systans activity seens rational and "-Orl:h d" 
further investigptioo. 
EFFECTS OF NOCTURNAL HYPOXEMIA IN PATIENTS WITH 
CORONARY ARTERY DISEASE AND SLEEP APNOEA 
Ian Wiloox MB, Ronald Grunstein MB, David.T.Kelly MB 
FACC, Colin E. Sullivan MB PhD, Peter J. Fletoher MB PhD 
Dept.of Medioine, Sydney University, Sydney, Australia. 
Patients with sleep apnea syndrome have an inoreased 
risk of death from cardiovasoular oauses, however, it is 
not established whether this is due to myooardial 
isohemia in patients with assooiated ooronary artery 
disease. 
The aim of this study was to determine whether 
nooturnal arterial oxygen de saturation oould preoipitate 
myooardial isohemia in patients with both ooronary 
disease (CAD) and obstruotive sleep apnea (OSA). 
Overnight sleep studies inoluding oontinuous FM 
reoording of 3 bipolar ECG leads and arterial oxygen 
saturation (SaO.) were performed on 10 males, mean age 
57 yrs (range 44-65), with newly diagnosed OSA and known 
CAD (stable angina 8 pts, unstable angina 1 pt 
myooardial infarotion 1 pt). 
In the oontrol study all pts had severe OSA with a 
mean of 54 apneas/hour (range 35-64) and mean minimum 
SaO. of 62% (range 35-67). Signifioant oyolioal heart 
rate (HR) ohanges aooompanied apneas with initial 
bradyoardia (mean minimum HR 44 beats/min, range 25-68) 
and relative taOhyoardia (mean -max HR 89 beats/min, 
range 75-100) at the offset. Apneas were abolished by 
oontinuous positive airways pressure via a nasal mask 
during a seoond study. None of the patients developed 
ECG evidenoe of isohemia during either study. 
We oonolude that these pts did not develop isohemia 
despite severe arterial desaturation. We suggest that 
the bradyoardia whioh aooompanies apneas may proteot 
the heart, even in pts with obstruotive CAD, by reduoing 
myooardial oxygen demand as SaO, deoreases. 
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TRANS-TELEPHONIC MONITORING AND RESPONSE SYSTEM: IMPACT ON 
PRE-HOSPITAL DELAY 
Christopher R.C.Wyndham, M.D., F.A.C.C., James A.Reiffel, 
M.D., F.A.C.C., Patricia S. Windus, R.N., Donald M. 
Stable in , PhD. Baylor College of Medicine, Houston, TX. 
Previous studies of time to presentation into the health 
care system in patients (pts) with myocardial infarction 
(MI) have shown an average of at least 2-3 hrs delay 
from symptom onset; this has adverse implications re: 
risk for arrhythmic death and feasibility of infarct 
size reduction (e.g. thrombolysis). To determine if a 
risk management system(S) utilizing reinforced pt educa-
tion and transtelephonic ECG monitoring (TTM) to a 
central station staffed with trained nurses, guided by 
previously written physician orders would be associated 
with shortened pt response times, the distribution of time 
from symptom onset to TTMS was examined in 1315 pts with 
high risk coronary disease (including 973 with prior MI) 
enrolled in such a system. In all, 385 pts made 814 
symptomatic calls which required prompt intervention 
(emergency physician page, hospital transport, and or 
lidocaine injection). Median time from symptom to TTMS 
access was 30 min., from call to ambulance dispatch was 
10 min., and from dispatch to arrival at pt location was 
10 minutes. Subgroups with symptoms of particular 
concern, e.g. palpitations or syncope, had median times to 
TTMS access of 10 and 6 minutes. We conclude: (1) the 
median time to provision of expert medical care for acute 
MI using a TTMS based pt management system is within the 
1 hr time frame needed for initiation of therapy directed 
toward improved survival; (2) will approximate ~ hr if 
phone directed pt self-administration of therapy is 
utilized; and (3) can be exceptionally short in pts 
educated about symptoms of special concern (e.g. 
arrhythmias). 
NOREPINEPHRINE KINETICS IN ISCHEMIC HEART DISEASE IN 
MAN : PITFALLS OF PLASMA NOREPINEPHRINE AS A MEASURE 
OF SYMPATHETIC TONE 
J Colin Forfar MD PhD and Alastair J McCance MRCP 
John Radcliffe Hospital, Oxford, United Kingdom 
The plasma norepinephrine (NE) concentration is widely 
used as an index of sympathetic tone but is of limited 
value because of its dependence on NE clearance and 
spillover to plasma. Whole body NE kinetics after 
infusion of tracer l-[3H]-NE overcomes this limitation 
and can simultaneously assess both NE clearance and 
spillover. Steady state NE kinetics have been measured 
in 52 patients. 10 controls without cardiac disease 
(group 1); 15 patients with stable angina (group 2); 
8 patients with unstable angina (group 3); 10 patients 
within 10 days of acute infarction (group 4) and 9 
patients with infarction and acute pulmonary edema (group 
5) . NE spillover to arterial plasma wa'2 similar in 
groups 1 and 2 (244[50] and 176[26] ng/min/m respectively 
[SEM]) but significantly higher in troups 3, 4 and 5 
(346[59], 339[46] and 516[96] ng/min/m respectively; 
PC:: 0.001). However, NE cleazance was reduced in these 
three groups (774[33] ml/min/m ) com~red to the controls 
(group 1 clearance 1137[154] ml/min/m, P £ 0.025) so 
that the resulting NE concentration was higher than 
that predicted from changes in NE spillover alone. 
Overall sympathetic tone as judged by NE spillover to 
plasma is increased in patients with unstable angina, 
recent myocardial infarction and pulmonary edema when 
compared to controls and patients with stable angina. 
Changes in plasma NE concentration however do not 
accurately reflect changes in sympathetic tone. The 
true change in sympathetic tone is exaggerated because 
of reduction in NE clearance in these three groups. 
ABSTRACTS 18SA 
ATROPINE REDUCES VENTRICULAR ARRYTHMIAS 
DURING CORONARY ARTERIOGRAPHY 
Yu-Cheng J. Chen M.D., Kenneth G. Lehmann M.D .. F.A.C.C. 
Long Beach VA Medical Center, Long Beach, CA. 
Although the use of atropine sulfate can lessen 
bradyarrythmias during coronary arteriography, its utility in 
preventing ventricular tachyarrythmias (VTNF) has not been 
investigated. We performed a case - control study over a 20 
month period in 648 patients. Controls were matched for age 
and heart rate, with a case:control ratio of 1 :3. VTNF 
occurred in 17 patients and was temporally related to 
arteriography in 11. Of these 11 cases (1.7% of total), none 
exhibited a baseline bradycardia (range = 60 - 110 min-1). 
Eighty-two percent of the VTNF episodes coincided with 
multiple contrast injections into the right coronary artery. 
There were no significant differences between cases (n = 11) 
and controls (n = 33) with respect to mean heart rate (81.8 vs. 
80.7 min-1), age, prior MI, prior arrythmias, antianginal use, 
type of heart disease, number of diseased vessels, ejection 
fraction, LV volume, PA & aortic pressures, or arterial O2 
saturation, although filling pressures (RA & PCW) were 
slightly higher in patients experiencing VTNF (cases). More 
importantly, intravenous atropine was used prophylactically 
prior to coronary arteriography in only 1 of 11 of patients 
with VTNF (9.1 % of cases) versus 18 of 33 patients without 
(54.50k of controls), resulting in an odds ratio of 6.0 (p = 0.01). 
Thus, prophylatic use of atropine prior to coronary 
arteriography reduces the incidence of VTNF six-fold even 
in patients with normal baseline heart rates. 
PREDICfION OF CARDIOVASCULAR RISK IN DIABETIC 
VASCULAR SURGERY REQUIRES QUANTITATIVE DIPYRIDAt'ULE 
THALLIUM SCINTIGRAPHY. Steven E. Lane, M.D., John J. 
Pippin, M.D., Stanley M. Lewis, M.D., F.A.C.C., 
Edward J. Kosinski, M.D., Da\'id CrunpbP.ll, ~J.IJ., 
Thomas Hill, M.D., Hugh Wheeler, P.H.D. New England 
Deaconess Hospital, Harvard Medical School, Boston, 
MA 
Prior stlrlies have shown that reversible dipyridamole 
thallium (IlT) defects in patients undergoing vascular 
surgery (VS) correlate with postoperative cardio-
vascular complications (evC). However, in 101 
prospective diabetic patients undergoing VS (11 with 
evC) a high prevalence (70%) of quantitatively 
defined reversible IlT defects results in inadequate 
positive predictive valve (+PVl for evc (14%). 
Further analysis of clinical and IlT subgroups 
demonstrated imprOVed +PV using (a) ~ 2 reversible 
segments (>2rs) (b) reversibility in the LAD 
distributi~n (LAD) (cl ~2rs or LAD combined with a 
clinical history of angina. 
eve vs no evc 
+ang ~2rs LAD +ang+~2rs +ang+LAD 
+PV 19.6 18.4 26.9 28.0 35.7 
-PV 96.3 96.2 94.6 90.5 87.1 
Sens. 81.8 81.8 63.6 77.8 55.6 
Spec. 58.4 55.5 78.7 51.4 75.0 
P .012 .019 .003 .116 .076 
In summary, 70% of diAbetics undergoing vascular 
surgery have reversible quantitative IlT defects 
reflecting a high prevalence of CAD. Therefore, 
optimum prediction of cardiovascular risk requires 
further quantitative DT analysis. 
186A ABSTRACTS 
THE RELATIONSHIP BETWEEN MYOCARDIUM AT ISCHEMIC RISK AND 
INDUCED INTRAOPERATIVE ISCHEMIA: PROGNOSTIC IMPLICATIONS. 
Thomas A. Watters, MD, Michael W. Dae, MD, Elias H. Bot-
vinick, MD, FACC, John Urbanowicz, MD, Michael K. Cahalan, 
MD, Yu Y. Zhu, MD, David J. Benefiel, MD, and Nelson B. 
Schiller, MD, FACC, Univ of California, San Francisco, CA. 
To assess the relationship between potentially ischemic 
myocardium preoperatively, and manifest ischemia intraop-
eratively, we studied 27 patients (pts) at high risk for 
cardiac complications during peripheral vascular surgery. 
Preoperative IV Dipyridamole perfusion scintigrams (DP) 
were segmentally analyzed for reversible defects (R) and 
compared to the distribution of induced segmental wall 
motion abnormalities (SWA) on intraoperative 2-D trans-
esophageal echocardiograms (TEE). Both DP and TEE were 
analyzed blindly. 
There were 33 R seen in 15/27 pts (56%). There were 
15 SWA seen in 8 pts (30%). SWA were seen in the same 
region as R in 7/8 pts and 15/33 (44%) segments. 1/8 pts 
had a fixed DP defect. Four pts (50%) with Rand SWA had 
postoperative complications: crescendo angina (2), 
ischemic paralysis (1), infarction and death (1). Another 
pt without R or SWA died of non-coronary cause; others 
did well over a mean follow-up period of 7 months. 
Preoperative R identifies potential intraoperative myo-
cardial segments at ischemic risk and was seen in over 
half of such patients. Many of these pts showing R 
actually become ischemic intraoperatively, as indicated 
by developed SWA. In 50% of pts with evident intraop-
erative ischemia identified in this study, postoperative 
prognosis was adversely effected. 
Preoperative R appeared to identify both an intraop-
erative and postoperative risk group. Intraoperative 
developed SWA identified a subgroup likely at highest 
risk postoperatively. 
Wednesday, March 30, 1988 
Poster Displayed: 9:00AM-12:00NOON 
Author Present: 10:00AM-11:00AM 
Hall E, Georgia World Congress Center 
Myocardial Infarction: Clinical 
ARE ADJUNCTIVE THERAPIES NEEDED WHEN t-PA IS 
USED? SUMMAR Y RESULTS OF T AMI I, II, and III TRIALS. 
Robert M Califf. M On Eric J. Topol, MD, FACC, Barry S. 
George, MD, Dean J. Kereiakes, MD, FACC, Lynne Aronson, 
Richard J. Candela, MD, FACC, Charles W. Abbottsmith, MD, 
Richard S. Stack, MD, FACC, and the TAMI Study Group Duke 
University, Durham, NC ' 
In the evaluation of reperfusion strategies, 675 consecutive 
patients (pts) have been treated with intravenous tissue plas-
minogen activator (t-PA) and other adjunctive therapies. In 
TAMI I (386 pts) suitable candidates were randomized to receive 
immediate or deferred angioplasty. In TAMI 2 (147 pts) in-
travenous urokinase was added simultaneously to t-PA in in-
cremental doses. In TAMI 3 (142 pts) 10,000 units of heparin 
were randomly given to half of patients. Overall, reperfusion 
within 90 minutes was achieved with pharmacologic therapy in 
472 pts (70%) and no significant differences in early reperfusion 
were found with any particular pharmacologic therapy. The use 
of immediate angioplasty in pts with failed thrombolytic therapy 
achieved an overall 92% patency rate at the end of the interven-
tional procedure. Emergency coronary artery bypass surgery was 
required in 34 pts (5%) due to failed angioplasty Or high risk 
anatomy. In-hospital mortality was 6.4% and intracranial bleed-
ing occurred in 4 pts (0.5%). In T AMI I and 2 reocclusion oc-
cured in 63 pts (14%), while 34 (6%) required PTCA and 20 (4%) 
required bypass surgery urgently for severe recurrent ischemia 
prior to hospital discharge. Pre-discharge angiography in 90% of 
hospital survivors revealed a patent vessel or bypass graft to the 
infarct area in 91 %. 
In conclusion, I) additional pharmacological regimens have 
failed to improve upon the early patency rate; mechanical inter-
vention (angioplasty) is required to achieve patency in many 
patients; 2) until better pharmacological strategies are developed 
to maintain vessel patency, angioplasty and surgery will be re-
'quired frequently during the hospital course. 
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ADOPTION OF THROMBOLYTIC THERAPY IN THE MANAGEMENT OF 
ACUTE MYOCARDIAL INFARCTION. Mark A. Hlatky, MD, FACC, 
Harvey Cotugno, PhD, Christopher O'Connor, MD, Daniel B. 
Mark, MD, MPH, David B. Pryor, MD, Robert M. Califf MD 
Duke University Medical Center, Durham, NC " 
To document current use of thrombolytic therapy 
for.acute myocardial infarction (AMI), we performed a 
natlona1 survey of 1065 physicians. In early 1987 
thrombolytic therapy was used by 66% of respondent~. 
~ost users of thr?mbolytic therapy (72%) only gave it 
lntravenously, whl1e 5% only gave it intracoronary. 
Despite widespread acceptance of thrombolytic 
therapy, most physicians gave it to <25% of their 
~atients. Duration of ~ymptoms was the single most 
lmportant factor affectlng use of thrombolytic therapy' 
45% had a time limit of < = 4 hours, and 85% had a tim~ 
limit of < = 6 hours. Complications of AMI and 
electrocardiographic findings were factors also 
important factors in the decision to give thrombolytic 
therapy. 
Use of thrombolytic therapy differed 
significantly in different groups of physicians. 
Thrombolysis was used by 86% of cardiologists, 60% of 
internists, and 33% of family/general practitioners (p 
<0.0001). Thrombolysis use was higher among physicians 
who treated more AMIs: from 35% of those treating <10 
AMIs/year to 93% of those treating >50 AMIs/year 
(p<O.OOOl). Physician age <50 or >50 and availability 
of cardiac catheterization also significantly affected 
physician use of thrombolytic therapy (p<O.OOOl). This 
survey documents widespread acceptance of thrombolytic 
therapy for AMI, particularly in patients with short 
duration of symptoms. Acceptance is not universal, 
however, and most patients are still not treated, 
primarily due to the time limits set for thrombolysis. 
COST-EFFECTIVE EVALUATION OF THROMBOLYTIC 
THERAPY: COMPARISON OF CURRENT MODALITIES AND 
IDENTIFICATION OF CRITICAL COST FACTORS - A 
CANADIAN PERSPECTIVE Peter Uu. M.D., FAC.C., John 
Floras, M.D., FAC.C., Amin Haq, M.D., FAC.C., Allan Detsky, 
M.D., Ph.D., Departments of Medicine and Health 
Administration, University of Toronto, Toronto, Canada. 
The potential impact of the widespread use of thrombolytic 
therapy during acute myocardial infarction (MI) on health 
resources has not been addressed from a cost-effectiveness point 
of view. We performed a cost-effective analysis of the current 
treatment alternatives in thrombolytic therapy including IV 
streptokinase (SK), tissue plasminogen activator (r-TPA) or 
angioplasty (PTCA) within 4 hours of MI, or IV SK within 12 
hours of MI as compared to conventional treatment. The direct 
cost was based on real 1987 Canadian dollars taking into account 
complications and additional procedures incurred as the result of 
treatment, and effectiveness was derived from metanalysis of 
rand<?rnized trials published within the last 18 months. The 
marginal cost (Me) over conventional treatment per coronary 
recanalization and per life saved were as follows: 
MC per MC / life MC / life 
~ recanalizn saved(imrn) saved(6 mol 
SK ~ 4 hr $22,121 $ 78,676 $ 79,634 
r-TPA $13,984 $ 61,098 $ 69,922 
PTCA $ 7,917 $ 48,229 $ 70,266 
SK ~ 12hr $47,690 $157,352 $190,760 
i.~ = imme.diate 6 mo ':' 6 mont~s post MI 
The most cntlcal deterrrunant of margmal cost IS the magnitude 
of reduction in mortality and the complication rate. R-TPA 
confers the lowest marginal cost during a 6 months followup, due 
to better recanalization from early administration. Cost-effective 
analysis emphasizes the importance of early treatment, targeting 
the treatment to a subgroup who are most likely to benefit, and 
the need to develop more selectively agents. 
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EFFECTIVENESS AND WHY OF INTRAVEIWS TISSUE PLASMltmEN 
ACTIVATOR THROMBOLYSIS BY MOBILE INTENSIVE rARE UNITS IN ACUTE 
MYOC'ARDIAL INFARCTION. 
Arle Roth MD. eabrlel I. Barbash MD MPH, HenIx:h Hod MD, Hilton I. 
MlllerMD, Sham .. 1 Rath MD, Michaela Modlin MSc., Salomon Beher MD, 
Ellezer HadDs MD, Babeth Rabinowitz MD FNX, Shlomo LIIlIIIItJ MD FNX. Tel 
Aviv end Sheba Medical Canters, Israel 
The feaslblltty end effectiveness of early ministration of rt-PA In AMI pts 
was assessed via Initiation of thrombolysis by the Mobile Intensive Cere Units 
(MICU). Protocol Included rt-PA 120 mg/6hr end !leperln 5,000 lu In bolus 
end mntlnuous Infusion of 25,000 lu124 hr. 11 pts who were ra:rulled by 
the MICU were ranmmlZ8d (by monthly periods) Into 2 !J'OUPS; In 31 pts 
(MCU) treatment was Initiated by the MICU teem at home, end In 40 (CCU) 
only after being mltled to the hospitals' Coronery Cere Unit (CCU). Both 
!J'OUps were Identical in age, sex, body mass Index, MI lalon, end 
distribution of the Infarct-related artery (IRA). Time to treatment, Incidence 
of clinical raperfuslon (defined by pain relief end abrupt resolution of at 
least 501 of the original ST SlVlllIlt elevation within 1 hr from treatmlllt 
Initiation), peak craIItlne kinase (CK), mntrast LVEF at 72 hr., end mortality 
at 60 days were compared: 
" MCU 40 
CCU 31 
P value 
Time to treat. I Clinical 
_.!oJ( mliWjnj.,)I-_ Reoerfusjon 
100:1: 44 55 
134:1: 48 11 
(0.01 (0.03 
CKpeek 
( ju) 
1545:1:1418 
1109:1: 889 
NS 
Contrast 60 days' 
LVEF CI)~ 
54:1:13 0 
60:1:12 3 
= 0.05 NS 
Desplta the later treatment, the CCU group did batter In terms of hlpr rate 
of clinical reperfuslon, hl~ LVEF end lower CK release, Indicating more 
effective myocartl181 selvage. on the other hand, thls!J'OUP encountered hl~ 
Incidence of mortality. 2 of the 3 deaths occured In pts who failed to achieve 
clinical reperfuslon end the third In 8 pt. with reoccluslon of the IRA which 
complicated en elective PTCA. No problems related to rt-PA ministration by 
the MICU teem were encountered. conclusion; Rt-PA can be safely 
administered by the MICU team, shortening the time to treatment initiation by 
at least 30 min. However, 8 larger number of ptsls needed to allow definite 
eveluatlon of the benefit In expediting rt-PA thrombolysis via the MICU. 
PREVENTIVE EFFECTS OF HUMAN SERUM SUPEROXIDE DISMUTASE 
ACTIVITY ON REPERFUSION INJURY WITH SUCCESSFUL 
THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION. 
Atsushi Hirayama, M.D., Masayoshi Mishima, M.D., Shinsuke 
Nanto, M.D., Shinji Asada, M.D., Kazuo Komamura, M.D., 
Kazuhisa Kodama, M.D •. Cardiovascular Div., Osaka Police 
Hospital, Osaka, Japan. 
Generation of oxygen free radicals (FRs) at the time 
of reperfusion has been implicated as a major causative 
factor for myocardial reperfusion injury. In order to 
examine if oxygen-FRs scavenger superoxide dismutase (SOD) 
in human serum prevent reperfusion injury with successful 
thrombolysis and limit the infarct size, we studied the 
relationship between infarct size and serum SOD activity 
in 25 patients received thrombolytic therapy in antero-
septal acute myocardial infarction. Serum SOD activities 
were measured by the nitrate method. There was no varience 
in serum SOD activity in these subjects before and after 
thrombolysis. Infarct size was evaluated by using % 
abnormally contracting segment (%ACS) caluculated with 
left ventriculograpy at chronic stage. Human serum SOD 
activities had a significant negative correlation with 
%ACS (r=-.58, p(0.05) in 17 patients with successful 
thrombolysis. This significant correlation was still shown 
in 14 patients without collaterals before 
recanalization(r=-0.56, p<0.05). On the other hand, 
there was no significant relationship between human serum 
SOD activities and %ACS in 8 patients with a complete 
occlusion after thrombolysis (r=-.081). These results 
showed that human serum SOD prevent the reperfusion 
injury and limit the infarct size in patients with 
successful thrombolysis and imply that generation of FRs 
at the time of reperfusion results in myocardial 
reperfusion injury. 
ABSTRACTS 187A 
PTCA IN ACUTE MYOCARDIAL INFARCTION: EARLY VERSUS LATE 
REPERFUSION 
Mark Yeager, M.D., Ph.D., Paul Teirstein, M.D., Bob Ligon, 
M.A., Barry Rutherford, M.D., F.A.C.C., David McConahay, 
M.D., F.A.C.C., Geoffrey Hartzler, M.D., F.A.C.C., Mid 
America Heart Institute, Kansas City, Missouri 
From 1981-1986 PTCA was performed during acute 
myocardial infarction (MI) in 434 pts without prior 
thrombolytic therapy. Time to reperfusion was 6 hrs 
(EARLY; mean time = 3.4 hrs) in 339 pts and 6 hrs (LATE; 
mean time = II hrs) in 95 pts. EARLY vs LATE pts were 
comparable with respect to age, sex, number of diseased 
vessels, presence of collaterals and infarct location. 
LATE pts had more Q wave infarcts (56% vs 32%, p < 0.01) 
and lower global left ventricular ejection fraction (48% 
vs 54%, p< 0.05). 
PTCA was successful in 92% of EARLY and 95% of LATE pts 
(p-NS). In-hospital mortality was 6.8% in EARLY and 11.6% 
in LATE pts (p=NS). In 211 pts with follow-up angiograms, 
regional ejection fraction in the infarct zone improved in 
42% of LATE and 54% of EARLY pts (p-NS). Global ejection 
fraction increased to 53% in LATE pts (p<0.05) and 60% in 
EARLY pts (p < 0.05). Multivariate analysis selected 
various factors which in combination were significant 
predictors of improved regional ejection frac.tion: in 
EARLY pts [lack of Q waves, severity of regional wall 
motion impairment and higher degree of flow pre-PTCA] and 
in LATE pts [absence of collateral flow to the infarct 
vessel and older age]. 
CONCLUSIONS: 1) There was no significant difference in 
% of EARLY and LATE pts that had improved regional wall 
motion post-PTCA. 2) Multivariate analysis revealed 
different clinical and angiographic factors for EARLY and 
LATE acute MI pts which may be useful to identify those 
pts that may benefit from PTCA. 3) PTCA may be effective 
in improving wall motion in pts presenting late with MI. 
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COLLATERAL FLOW PRESERVES LEFT VENTRICULAR FUNCTION 
DURING ACUTE ISCHEMIA IN MAN. 
K. Peter Rentrop, M.D., F.A.C.C., John C. Thornton, Ph.D, 
Mark Van Buskirk, M.S., Frederick Feit, M.D., F.A.C.C. 
St. Vincent's and NYU Medical Centers., NYC 
We wished to determine whether collateral flow protects 
left ventricular (LV) function during acute ischemia. 
The ratio mean peripheral coronary occlusion pressure/ 
mean aortic pressure (PCOP/PAO) is an accepted index of 
collateral flow in animal studies and can be measured 
during angioplasty (PTCA) in man. In 29 patients with 1 
vessel disease and normal baseline ejection fraction (EF) 
we determined PCOP/PAO and EF during acute ischemia (EFi) 
caused by a 45 to 60sec. inflation of the PTCA balloon. 
Contrast ventriculography was performed via a second ar-
terial catheter. A multiple linear regression model was 
constructed to predict EFi based on PCOP/PAO and lesion 
location. EFi was primarily determined by lesion loca-
tion (p(.OI), but the PCOP/PAO effect was also signifi-
cant (p(.05). Patients with mid LAD and RCA occlusion 
had the same regression equation: EFi=58.8+25.7x[PCOP/ 
PAO); for proximal LAD occlusion the regression equation 
was EFi=24+88.7x[PCOP/PAO]. The R2 for the model was 
.59. Only patients with proximal LAD occlusion and PCOP/ 
PAO <.25 experienced severe reduction of left ventricular 
function with EFi <35%; all patients with PCOP/PAO ).3 
had an EFi '745%, indicating preservation of LV function. 
Conclusion: Although EF immediately after coronary clo-
sure is primarily determined by the location of the ob-
struction, i.e. the amount of jeopardized myocardium, 
collateral flow as assessed by PCOP/PAO can significantly 
modify the extent of ischemic impairment of LV function. 
188A ABSTRACTS 
VENTRICULAR ANEURYSM AFTER AN ACUTE MYOCARDIAL 
INFARCTION 
Magda Heras, M.D., Gines Sanz, M.D., Amadeo Betriu, 
M.D., and Tomas de Flores, M.D. Hospital Clinic, 
University of Barcelona, Barcelona, Spain 
To test whether left ventricular aneurysm (LVA) 
independently affected survival after acute myocardial 
infarction (AMI), we prospectively studied 386 con-
secutive men, aged < 60 yrs with AMI. They underwent 
catheterization within the first month. LVA was 
defined as a diastolic outward bUlging with akinetic or 
dyskinetic systolic motion and was diagnosed in 52 
patients (pts) (13.5%). Mean follow-up was 57 months 
(range 40-100). Univariate analysis showed that LVA 
patients were older (p < 0.01), had more often anterior 
MI (p < 0.001), a higher incidence of previous MI 
(p < 0.01), heart failure in the CCU (p < 0.05), higher 
end-diastolic pressure (p < 0.001), lower ejection 
fraction (EF) (p < 0.001), and a higher mortality 
(p < 0.02). Probability of survival at 60 months was 
70% and 82% for pts with and without LVA, respectively 
(p < 0.02). Cox regression analysis for the whole 
population indentified EF as the most important inde-
pendent predictor of survival; bifascicular block and 
number of diseased vessels were the only other indepen-
dent predictors; and, although survival at 60 months 
was lower for pts with LVA, the difference was not 
significant when adjusted for those variables. Thus, 
LVA does not independently affect survival; the EF is 
also its major determinant in these pts. 
IS REGIONAL OR GLOBAL DYSFUNCTION THE MORE IMPORTANT 
PROGNOSTIC INDICATOR FOLLOWING ANTERIOR MYOCARDIAL 
INFARCTION? 
Dimitrios Alexopoulos, M.D., Steven F Horowitz, M.D., 
F.A.C.C., Margaret Macari, R.N, William Slater, M.D., 
Steven Schleifer, M.D., Martin O'Hara, M.D., Richard 
Gorlin, M.D., F.A.C.C., Mt Sinai Med Ctr, New York, NY. 
Controversy exists concerning the significance of LV 
aneurysm (AN) after anterior myocardial infarction (AMI) 
as a prognostic factor independent of LV ejection 
fraction (EF). Forty pts with AMI and no prior 
infarction had pre-discharge 3 view resting gated blood 
pool imaging and 2 year clinical follow-up. Global LV 
EF was quantified and regional dysfunction analyzed by 
scoring 17 LV segments as normal, hypokinetic, akinetic 
and dyskinetic. AN was defined as i) dyskinesis + 
diastolic deformity, and ii) dyskinesis + diastolic 
deformity + normally contracting adjacent area. In 
addition, the extent of asynergy was assessed as the 
number of dyskinetic and/or akinetic segments. There 
were 7 cardiac deaths yielding a 2 yr mortality of 18%. 
AN was a common finding by both criteria i) 83%, and ii) 
58%. Incidence of AN (i or ii), and extent of asynergy 
did not differ between those who died and survivors. 
However, nonsurvivors had higher CPK (1871 ± 784 VB 862 
± 839, P < 0.006) and lower LVEF (0.22 ± 0.09 vs 0.38 ± 
0.12, p < 0.003). No pt with EF > 0.35 died compared to 
7 out of 21 with EF ~ 0.35 (p < 0.01). Multivariate 
analysis revealed LVEF as the only independent predictor 
of death (p < 0.003). We conclude that global and not 
regional LV dysfunction is an important prognostic 
marker after a first AMI. Presence of AN is common, but 
varies greatly depending on criteria used, and has poor 
discriminative value for prognosis. Pts with first AMI 
and EF > 0.35 have excellent 2 year prognosis. 
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SPONTANEOUS IMPROVEMENT IN LEFT VENTRICULAR FUNCTION 
DURING THE EARLY COURSE OF ACUTE NON-Q WAVE MYOCARDIAL 
INFARCTION: EVIDENCE FOR "STUNNED MYOCARDIUM" ? 
William E. Boden, MD, FACC, Robert S. Gibson, MD, Sarah 
Fenton B~ Paul Ruble MD, George A. Beller, MD, FACC, 
Harper Hospital, Wayne State University, Detroit, MI. 
The natural history of LV function change during the 
early course of acute non-Q wave (NQ) myocardial 
infarction (MI) has not been established, although prior 
studies of Q wave MI indicate little, if any, improvement 
in global or regional LV function at rest between 1 day 
and 10 days post-MI. Since spontaneous early coronary 
reperfusion 2 7 days after NQMI is common, it is poss-
ible that subsequent improvement of LV function in NQMI 
pts may relate to reversible ischemic dysfunction, or 
myocardial stunning. We prospectively performed serial 
early (mean=50.5 + t3 hrs) and late (10 + 2 days) multi-
gated radionuclide ventriculography (RVG) on 74 conse-
cutive MBCK-confirmed NQMI pts. There were no signifi-
cant group mean differences in ejection fraction (EF) for 
early (51 + 12%) vs. late (53 + 11%) RVG, although over-
all 45/74 pts (61%) showed an Increase (t ) in late EF. 
To further explore this observation, pts were subdivided 
on the basis of intact (Group I: EF ~ 50%) vs. impaired 
(Group II: EF < 50%) baseline LV function, and early vs. 
late EFs were compared. Early (60 + 7%) and late (60 + 
8%) EF were identical for Group I pts, whereas Group II 
pts showed a significant t from early (40 + 8%) to late 
(45 + 6%) EF, p = 0.0007 (paired t-test). aVerall, 20/41 
(49%) Group I vs. 25/33 (76%) Group II pts exhibited late 
EF improvement (p = 0.030; Chi square, 2-tail). 
CONCLUSION: 1) NQMI pts with initially impaired LV 
function exhibit significant improvement in EF from day 2 
to day 10; 2) such spontaneous improvement in LV function 
may indicate the presence of early reversible 
post-ischemic dysfunction following acute NQMI. 
POST-INFARCTION VENTRICULAR SEPTAL RuPTURE: CORONARY 
ANGIOGRAPHIC ANATOMY 
Patrick J. Scanlon, M.D., F.A.C.C. and Sarah A. 
Johnson, M.D., F.A.C.C., Loyola University Medical 
Center, Maywood, Illinois and Hines VA Hospital, Hines, 
Illinois 
To gain insight into the underlying pathologic anatomical 
setting which might predispose post infarction pts to ven-
tricular septal rupture (VSR) we evaluated 50 consecutive 
pts with this condition who were studied by cardiac cath 
and angiography, 34 (68%) within 12-48 hrs of VSR onset. 
The infarct-related artery (IA) had 100% obstruction (OB) 
in 42 (84%) and >80% in the other 8. Flow in the IA was 
TIMI grade 0 or T in 41 (82%). Coronary thrombus was seen 
in 20 (40%), and in 11 of 22 (50%) studied within 4 hrs of 
VSR. Collaterals were well seen in only 4 P (8%), 3 
studied >5 days after VSR. Twenty P (40%) had one vessel 
disease (VD), 17 (34%) 2 VD, 13 (26%) 3 VD; one had main 
left disease. In 26 anterior infarctions (Ant MI) the 
LAD OB was beyond the first septal in 19 (73%); in 24 in-
ferior infarctions the RCA OB was below the RV branch in 
16 of 21 (71%), and the CX below the marginal in 3 of 3. 
Females had more One VD (14 of 26, 54%) than 3 VD (4 of 
26, 15%), p<0.05. Ant MI occurred more commonly with 
single VD (14 of 26, 54%) than with 3 VD (2 of 26, 7.7%), 
p<0.005. In P with 2 VD and 3 VD only 5 of 43 (12%) non-
lA's were >90% narrowed (3 totafly). Conclusions: 1) VSR 
is related-to persistent high-grade OB and poor flow in 
the IA; 2) coronary thrombus is common, especially early 
after VSR; 3) collateral protection is poor; 4) one VD is 
common; 5) IA OB is usually beyond a potentially septal-
sparing branch; 6) VSR in females and in Ant MI is most 
commonly related to one VD; 7) VSR rarely requires severe 
OB of flow to both ends of the septum, as non-IA arteries 
are uncommonly highly obstructed. 
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THE EFFECT OF EXERCISE TRAINING ON QUALITY OF LIFE AFTER 
TRANSMURAL ACUTE MYOCARDIAL INFARCTION. 
Alan J. Goble,MD , David L. Hare,MB, R. Graeme Oliver,PhD, 
ME, Michael Reid,MSc, Peter S.Macdonald,MB, Marian c. 
Worcester,PhD, Cardiology Department, Austin Hospital, 
Victoria, 3084, Australia. 
The hypothesis that there are direct physical,psychologic 
and social benefits from group aerobic exercise training 
(ET) was tested. 225 consecutive male patients (pts) with 
transmural acute myocardial infarction (TAMI) were randomly 
allocated to 8 week group programs of ET(n=109) or group 
light exercise(LE) (n=l16). Pts were well matched for age, 
education, occupational class,employment status,smoking 
history,weight,infarct site and size(CK,AST,Killip class, 
Norris prognostic indices) ,anxiety (STAI state) ,depression 
(Ipat D) ,denial (Hackett-cassem) ,occupational ,social and 
marital adjustments , sense of well-being and PWC max. (at 
entry in 3rd week after TAMI on treadmill test) .Test was 
repeated after 8 weeks.Mean PWC max. was ET 10.7±0.3 and 
LE 9. 7±0.2Mets(p=0.005) .All pts were reviewed at 4 and 12 
months.At 12 months no significant differences were found 
between the two groups in PWC max(ET 10.6±0.3,LE 10.5±0.2 
Mets) ,weight(ET 80.1±l.2,LE 79.4±1.lKg) ,state anxiety(ET 
41.5±0.9,LE 41.8±0.9) ,depression(ET 11.5±1.0,LE l3.l±1.2), 
occupational(ET 12.3±0.3,LE 11.7±0.3) ,social(ET l7.0±0.4, 
LE 16.7±0.4),marital(ET l4.9±0.4,LE 15.l±0.3)adjustments 
or in sense of well-being(ET 20.9±1.9,LE 19.4±1.9) .There 
was no difference in resumption of smoking(ET 33%,LE 44%) , 
resumption of work(ET 95%,LE 93%) ,working at 12 months(ET 
85%,LE 81%) ,sexual recovery(ET 75%,LE 83%) ,perception of 
adequate psychologic recovery from pts(ET 85%,LE 80%)or 
from wives(ET 8l%,LE 71%) .Thus no significant long term 
improvement in quality of life was demonstrated from ET. 
It is concluded that the previously claimed benefits from 
ET were an effect of supervised group activity. 
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Myocardial Infarction: Clinical 
CARDIAC EVENT RATE FOLLOWING ANTERIOR NON-Q WAVE 
MYOCARDIAL INFARCTION 
Mihai Gheorghiade, M.D., F.A.C.C., Walter Kao, M.D., 
Kathie Whalen, R.N., and Sidney Goldstein, M.D., F.A.C.C., 
Henry Ford Heart and Vascular Institute, DetrOit, MI 
There is little data correlating cardiac event rate with 
infarct location on the EKG in patients(pts) recovering 
from a non-Q wave myocardial infarction(NQMI). One hundred 
thirty-five consecutive pts with enzymatically proven NQMI 
were followed prospectively for a mean of 62 days.Of these, 
65 pts were classified as having an anterior NQMI: new ST 
and/or T wave changes in leads VI through V4 (Group I) ,and 
70 pts were classified as non-anterior NQMI: ST and T wave 
changes in leads other than VI through V4 (Group II). His-
tory of myocardial infarction was present in 35% (Group I) 
and 21% (Group II) (NS). Peak creatinine phosphokinase was 
1041+1241 IU/L in Group I vs 774+800 IU/L in Group II (NS). 
In Group I: 68% of pts received ~alcium channel-blockers; 
38% beta-blockers; 91% nitrates. In Group II: 66% received 
a calcium channel-blocker; 34% a beta-blocker;87% nitrates 
(NS) • 
GROUP I (%) GROUP II (%) P 
Post Infarction Angina 42 pts (65) 23 pts (33) <0.001 
Reinfarction 18 pts (28) 4 pts ( 6) <0.002 
Mortality Total 17 pts (26) 4 pts ( 6) <0.003 
Mortality in CCU 4 pts ( 6) 0 pts NS 
Mortality or Reinfarction 26 pts (40) 7 pts (10) < O. 001 
PTCA 13 pts (20) 12 pts (17) NS 
CABG 10 pts (15) 12 pts (17) NS 
We conclude that pts who suffered an anterior NQMI are a 
significantly higher short-term risk for post-infarction 
angina, reinfarction and increased mortality than non-
anterior NQMI pts. Further studies are warranted to deter-
mine if percutaneous coronary trans luminal angioplasty(~) 
or coronary artery bypass(CABG) surgery will decrease the 
cardiac event rate in this group of pts. 
ABSTRACTS 189A 
PROGNOSIS AFTER MYOCARDIAL INURCTION IN PATIENTS WITH 
PREVIOU~ CORONARY BYPASS SURGERY. 
Alan Wiseman, M.D., C.M., David D. Waters, M.D., 
F.A.C.C., Ann Walling, M.D., Denis Roy, M.D., F.A.C.C., 
Guy Pelletier, M.D., F.A.C.C. and Pierre Theroux, M.D., 
F.A.C.C., Montreal Heart Institute, Montreal, Canada. 
To assess the long term prognosis of myocardial in-
farction (MI) in pts with previous bypass surgery 
(CABG) , 20S pts with MI 2-162 months (mean 66) post-
CABG were compared to 20S control MI pts. Diagnostic 
criteria, data collection methods and duration of fol-
low-up (37±24 mOnths) were identical in the 2 groups. 
The post-CABG group contained more males (pe02) and 
more pts with previous MI (p<.OS), but the groups were 
otherwise comparable. Infarct size was smaller in post-
CABG pts by QRS score, peak CK (111S±994 vs l77l±1637) 
and CK-MB, and they had more non-Q wave MIs (all 
p<.OOOl). Post-MI ejection fractions were 4S±lS in 
post-CABG pts vs 44±lS in controls (p=NS); in-hospital 
mortality rates were S.9~ and 6.2~ respectively (p=NS). 
Cumulative mortality was similar in the 2 groups; 
however, post-CABG pts had more reinfarctions (p<.OOB), 
more admissions for unstable angina (p<. 04) and more 
revascularization procedures (p<. OS) as determined by 
Kaplan-Meir curves (Mantel-Cox p values). 
Post CABG pts Controls 
L.rr. ~ L.rr. ~ 
Mortality (~) 9.B 30.2 1l.2 2S.7 
Reinfarction (~) 10.0 39.6 6.7 22.9 
unstable angina (~) 8.B 22.7 S.S 17.4 
Revascularization (~) 18.4 33.9 12.3 20.3 
All events (~) 36.0 69.6 29.4 48. B 
Thus, although patients with previous coronat·y bypass 
surgery have smaller MIs, theiL' subsequent mortality is 
similar to other post-MI patients and they experience 
more reinfarction and unstable angina. 
PROSPECTIVE COMPARISON OF PREDISCHARGE PERSANTINE 
THALLIUM AND EXERCISE TREADMILL TESTS FOR PREDICTING EARLY 
EVENTS AFTER UNCOMPLICATED MYOCARDIAL INFARCTION 
GIMPLE LW,MD; HUTTER AM JR,MO; GUINEY TE,MD; MARKS AR,MO; 
BOUCHER CA,MO. Massachusetts General Hospital, Boston,MA 
Forty patients(pts) underwent Persantine-Thallium(PersTI) 
scan, low level exercise treadmill test(ETT) and rest 
radioventriculography(RVG) before discharge after uncom-
plicated myocardial infarction(UMI). By six week followup 
there were 6(15%) post-discharge events: 1 death, 2 myo-
cardial infarctions(Ml) and 3 unstable anginas. Coronary 
surgery or angioplasty was not considered an event. PersTl 
was prospectively defined as positive(POS) if redistribu-
tion occurred only in the vascular zone associated with 
the infarct and as markedly positive(MP) if redistribution 
occurred in one or more vascular zones outside the infarct. 
ETT was defined as POS(lmm ST depression (dep) or angina) 
or MP(>2mm ST dep or 20 mm fall in blood pressure with 
1 mm ST dep). Eight pts had MP PersTl but negative ETT. 
Results follow: 
% of total SENSITIVITY SPECIFICITY 
PersTl POS 77% 83% 27%\ * 
MP 40% 67% 73%) 
POS 38% 83%/ * 70% 
MP 13% 17%5 90% *p< .05 
ETT 
A simple POS PersTI is nonspecific and a MP ETT is insen-
sitive for early events after MI. Rest LVEF was not pre-
dictive of these events. Absence of MP PersTl and absence 
of POS ETT were equally very predictive of no event (pre-
dictive accuracy negative 92% and 95% respectively). Thus 
a MP PersTl or POS ETT appears equally sensitive and 
specific for early events but PersTl appears better for 
identifying additional myocardium outside the infarct 
zone at ischemic risk. Furthermore MP PersTI is the only 
test for predicting events in pts unable to exercise. 
190A ABSTRACTS 
MYOCARDIAL INFARCTION WITH NORMAL CORONARY ARTERIES: 
PATIENT CHARACTERISTICS AND PROGNOSIS. 
Pascal Nicod, M.D., F.A.C.C., Elizabeth Gilpin, M.S., 
Howard Dittrich, M.D., F.A.C.C., John Ross, Jr., M.D., 
F.A.C.C. and the SCOR Collaborative Database, 
University of California, San Diego. 
Clinical characteristics of patients with myocardial in-
farction (MI) and normal coronary arteries have not been 
well described. Furthermore, small series have reported 
variable clinical outcome and incidence of recurrent MI 
in these patients. We therefore analyzed 911 patients 
aged 18 to 88 admitted with acute MI in 5 different cen-
ters, all of whom underwent cardiac catheterization after 
MI and were followed for 1 year. 891 patients had some 
disease of 1 or more coronary artery (group 1). 21 
patients had normal coronary arteries (group 2). Compared 
to group I, patients of group 2 were younger (41 t 18 vs 
57 t 11 years, p <0.001). were more often women (47% va 
16%, p< 0.001) and had an increased incidence of non-Q 
wave MI (43% vs 21%, p<0.05). History of angina (37% vs 
24%, ns) and of previous MI (26% vs 10%, ns) was present 
in group 1 and 2, although more common in group 1. Left 
ventricular ejection fraction at hospital discharge was 
higher in group 2 than in group 1 (.56 t 15 vs .50 t 13, 
P <0. 05) despite similar peak creatine kinase levels (952 
t 911 vs 1002 t 941 UI/l respectively). 1 year mortality 
was 6.4% in group 1 and 0% in group 2, and reinfarction 
rate was 4% and 0% respectively. We conclude that 
patients with MI and normal coronary arteries 1) are 
younger and more often women than those with MI and coro-
nary artery disease, 2) have a good prognosis with a low 
incidence of subsequent reinfarction and 3) have a high 
frequency of non-Q MI, and good residual left ventricular 
ejection fraction despite high creatine kinase levels. 
ANTIARRHYTHMIC DRUG TREATMENT IN HIGH RISK PA-
TIENTS WITH SUSTAINED VENTRICULAR TACHYCARDIA 
FOLLOWING MYOCARDIAL INFARCTION. 
Robert Lemery. M.D., Pedro Brugada, M.D., Paolo 
Della Bella, M.D., Thierry Dugernier, M.D., 
Mario Talajic, M.D., Hein JJ Wellens, M.D., 
F.A.C.C. Academic Hospital, Maastricht, The 
Netherlands. 
Patients with sustained monomorphic ventricular 
tachycardia (SMVT) after myocardial infarction, 
with LV dysfunction and persistent inducibility 
of SMVT in spite of antiarrhythmic drugs (AAD), 
are considered at high risk of cardiac death. We 
evaluated 36 consecutive Pt meeting these crite-
ria and in whom by study design ("parallel" stu-
dy), AAD were not changed because of inducibi-
lity of SMVT. Mean ejection fraction was 30% 
«40% in all), myocardial infarction was ante-
rior in 69%. Results are shown in the table 
below. 
AAD Pt Recurrence Sudden NSCD Follow-
SMVT ('II) Death(%) (%) up 
Class I 16 6 1 2 14+8 
Amiodarone 7 4 1 0 25±13 
Combinations 13 5 2 1 26±18 
Total 36 15(42%) 4(11%) 3(9%) 21+li 
The actuarial incidence of freedom of sudden 
death, non-sudden cardiac death (NSCD) or re-
currence of SMVT were respectively 80%, 70% and 
51% after 48 months of follow-up. Conclusion: In 
spite of persistent inducibility of SMVT and LV 
dysfunction, AAD therapy in this high risk group 
of Pt is associated with acceptable surVival 
rates in spite of a high incidence of recurrence 
of SMVT. 
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PROGRAMMED ELECTRICAL STIMULA TION OF THE 
RIGHT VENTRICLE - ROLE IN RISK STRA TIFlCA TION 
FOLLOWING INFARCTION. 
Mark de SeIder MRCP, Doug Skehan MRCP, Charles Pumphrey 
MD, Peter Mills FRCP, Martin Rothman MRCP FACC. Cardiac 
Dept, The London Hospital, London, England. 
A sub-maximal exercise test (SMET) following myocardial 
infarction (MI) selects out a group at risk of death in the 
subsequent year. To evaluate the role of programmed electrical 
stimulation (PES) of the right ventriCle to enhance risk 
stratification, we studied 262 consecutive stable survivors of MI, 
all of whom undertook an early SMET; those with a positive test 
underwent cardiac catheterisation and PES, using I and 2 
ventricular extrastimuli in sinus rhythm or when paced from the 
ventricle with 600 and 500ms cycle lengths. Pts with a positive 
SMET were 13 times more likely to die in the first year 
following infarction. At PES, 15% of pts with a positive SMET 
had no responses, 65% had up to 4 ventricular responses, 14% 
developed non-sustained and 5% developed sustained ventricular 
tachycardia (VT). The latter response was found to be 
independent of site and extent (Q vs non-Q wave infarction). 
extent of coronary disease and left ventricular dysfunction. 
Lown grading of ambulatory ECG's as well as clinical and 
SMET-induccd ventricular arrhythmias. Multivariable analysis 
revealed that induced sustained VT was the most powerful 
predictor of mortality in the first year; pts with this response 
were 10 times more likely to die than those with no response. 
PES of the right ventricle for pts with a positive SMET thus 
strongly refines risk stratification. 
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Coronary Artery Disease: Basic 
CORONARY RESERVE IN NORMAL AND HYPERTROPHIED HEARTS 
DURING CARDIAC MATURATION AND AGING 
Pierre Wicker, M.D., John Vitullo, Ph.D., Bernadine 
Healy, M.D., F.A.C.C. The Cleveland Clinic Foundation, 
Cleveland, OH. 
The effects of cardiac maturation and aging on coronary 
reserve are unclear both in normal animals and when 
pathologic cardiac hypertrophy is superimposed on normal 
cardiac growth. We therefore measured coronary vasodil-
ator reserve (CVR) [defined as minimal coronary resist-
ance (mmHg/ml/min/g) after maximal dilatation by carbo-
chrome (0.45 mg/kg/min to a total dose of 12 mg/kg)) in 
young (7 and 16 wks) , adult (46 wks) and old (66 wks) 
normal (WKY) and hypertensive (SHR) conscious rats using 
LA injections of radioactive microspheres. Results 
W\{y/SHR (m ± SO): 
~ 7 wks 16 wks 46 wks 
N 11/11 11/12 8/7 
MAP 94/128* 106/146* 106/160* 
LVW/BW 2.44/2.97 2.03/2.68 1.98/2.90 
CVR 5. 4±2 .0 6. 6±1. 0 8. 2±1. 4 
/7.5±1.7 /9.3±1.9* /15.3±3.7* 
MAP in mmHg; LVW/BW: LV wtfbody wt (mg/g), 
age-matched WRY value. 
66 wks 
6/10 
103/155* 
2.02/3.00 
8. 3±1. 5 
/13.6±2.6* 
*p<0.05 vs 
There was a significant (p<O.OOl by ANOVA) age related 
increase in minimal coronary resistance (i.e. I a decrease 
in CVR) in all groups. In SHR, CVR, already mildly 
depressed in young rats, became markedly reduced in older 
rats as hypertrophy was superimposed, with CVR changes in 
aging SHR twice as marked as in WRY. Thus, added patho-
logiC hypertrophy of similar extent across all age groups 
led to a markedly greater loss in coronary reserve in 
older animals, suggesting that age puts the vasculature 
at increased risk in hypertrophy. 
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HYPEREMIC FLOW VERSUS PRESSURE SLOPE INOEX: AN 
I MPROVED METHOD OF MEASURI NG FLOW RESERVE THAT IS 
I NDE PENDENT OF PERFUSION PRESSURE AND HEART RATE. 
G.B. John Mancini, M.D., F.A.C.C., Scott F. DeBoe, 
B.S., Mark J. McGi11em, B.S., University of 
Michigan and VAMC, Ann Arbor, Michigan. 
Measures of coronary flow reserve (CFR) are 
variable when prevailing determinants of blood flow 
(perfusion pressure [PP], LVEDP, HR etc.) fluctu-
ate, as occurs during angiop1asty or when comparing 
patients. A hyperemic flow versus pressure slope 
index (HFVPSI) was calculated in 10 dogs during 
control (C) and 2 incremental stenoses (STl, ST2) 
to see if the slope of the linear regression of F 
and P during diastole in a non-perfusion controlled 
model could be used as a more fiducial index of 
vascular reserve than the standard CFR ratio. CFR 
and HFVPSI were determi ned duri ng adensos i ne-
induced hyperemia in 17 perfusion beds at 5 
different steady-state PP (85 observations). Step-
wi se 1 inear regression analysis demonstrated the 
expected positive correlation of CFR and PP during 
hyperemia and negative correlation with PP and HR 
during the basal state (p < 0.001 for all 3 fac-
tors). In contrast, the HFVPSI was independent of 
these factors. Both indexes discriminated C, STl 
and ST2 at low and high PP whereas at normal, 
intermediate PP only the HFVPSI was useful (CFR at 
C = 3.21+1.36, STl = 2.76+.93 [n.s.]' ST2 = 2.04+ 
.58, P <0.05; HFVPSI at C= 13+4.83, STl = 9.38+ 
4.14 [p < 0.05], ST2 = 6.44+2.6 [p < 0.001]~ 
Thus, in contrast to CFR, the HFVPSI is a more 
fiducial and sensitive index of vascular reserve 
that is insensitive to prevailing PP and HR. 
INFLUENCE OF SEVERITY OF ISCHEMIA ON THE MAGNITUDE 
OF MYOCARDIAL REPERFUSION INJURY 
Giuseppe Ambrosio M 0, Myron L. Weisfeldt, M.D., 
F.A.C.C., John T. Flaherty, M.D., F.A.C.C. Johns Hopkins 
Medical Institutions, Baltimore, MD. 
It is currently believed that, beyond a critical therape-
utic window, reperfusion of ischemic myocardium is not 
beneficial. However, the contribution of reperfusion 
injury is unknown. To determine the relationship between 
severity of ischemia and magnitude of reperfusion injury, 
we analyzed data from 87 rabbit hearts exposed to 30 min 
of 370 C total global ischemia. Severity of ischemia was 
indexed by ATP content just prior to reperfusion, using 
3l-phosphorus NMR spectroscopy; 49 hearts received a free 
radical scavenger (FRS) at the time of reperfusion; 
superoxide dismutase alone (N-17) or in combination with 
catalase (N-12) or mannitol (N-12) or deferoxamine alone 
(N-8) and 38 untreated hearts received standard reperfus-
ion. When recovery of isovolumic developed pressure (DP) 
(% control) was plotted against end-ischemic ATP content, 
regression lines for treated and untreated hearts were 
different both in slope and intercept. (P<.OOl, R-.85). 
Slope of the DP vs. ATP relationship for untreated hearts 
(l. 34) was more than twice that for FRS treated hearts 
(0.68), and the greatest distance between regression 
lines was evident for lower ATP contents. Furthermore, 
distance between regression lines can also be interpreted 
as the magnitude of the oxygen radical mediated component 
of reperfusion injury. These data suggest that the 
magnitude of reperfusion injury is greater in hearts 
experiencing greater severity of ischemia. If later 
reperfusion is associated with more severe ischemia, 
which allows for less reversal of ischemic injury, but 
more reversal of reperfusion injury, then, FRS might 
widen the therapeutic window for effective reperfusion. 
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EFFECTS OF DIETARY SUPPLEMENTATION WITH COD-LIVER OIL ON 
IMPAIRED ENDOTHELIUM-DEPENDENT RELAXATIONS IN 
ATHEROSCLEROTIC PORCINE CORONARY ARTERIES. 
Hiroaki Shimokawa, M,D and Paul M. Vanhoutte, M.D., Mayo 
Clinic, Rochester, MN. 
We have shown that dietary supplementation with cod-liver 
oil augments and atherosclerosis impairs endothelium-
dependent relaxations in porcine coronary arteries. To 
study the effects of dietary supplementation with cod-
liver oil 'on the impaired endothelium-dependent relaxa-
tions in coronary atherosclerosis, 16 male Yorkshire pigs 
were fed a 2% high cholesterol diet for 10 weeks, with 
(treated group, n-8) or without (control group, n-8) 
supplementation with the oil (30 ml/day). All animals 
underwent balloon endothelial denudation of the left 
coronary artery after two weeks of cholesterol feeding in 
order to accelerate the process of atherosclerosis. 
Endothelium-dependent relaxations were examined in vitro 
in the presence of indomethacin. Endothelium-dependent 
relaxations to bradykinin, serotonin and adenosine 
diphosphate were significantly augmented in the treated 
group. Aggregating platelets from control and treated 
animals induced augmented endothelium-dependent 
relaxations in rings with endothelium taken from treated 
animals, while they induced comparable contractions in 
rings without endothelium from both groups. Bioassay 
experiments showed that the release of the endothelium-
derived relaxing factor(s) was greater in the treated 
group. The extent of atherosclerotic plaque was less in 
the treated group, while there was no difference in 
induced hypercholesterolemia or platelet count between the 
two groups. These results indicate that dietary 
supplementation with cod-liver oil improves the impaired 
endothelium-dependent relaxations in atherosclerosis, 
partly because of increased release of endothelium-
derived relaxing factor(s). 
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Myocardial Infarction-Clinical: Thrombolysis/PTCA I 
SAFE AND EFFECTIVE TREATMENT OF ACUTE MI REQUIRES TPA AND 
ELECTIVE PTCA, NOT EARLY HEPARIN OR EMERGENCY PTCA. 
Jeffrey A, Brinker M 0 , Sidney O. Gottlieb, M.D., Alan 
D. Guerci, M.D., Gary D. Walford, M.D., Thomas R. 
Aversano, M.D., David E. Bush, M.D., Paul Chew, M.D., 
Nisha C. Chandra, M.D., Lewis C. Becker, M.D., Gary 
Gerstenblith, M.D., and Myron L. Weisfeldt, M.D., 
F.A.C.C., Johns Hopkins Hospital, Baltimore, MD. 
Concurrent administration of IV tPA and heparin, 
followed by emergency PTCA, is frequently complicated by 
hemorrhage and infarct artery reocclusion. As an 
alternative approach to Killip I to III MI, we studied IV 
tPA (80 to 100 mg over 3 hours) with heparin initiated 1 
to 6 hours after completion of tPA infusion and PTCA 
performed electively as part of a randomized, placebo 
controlled, double blinded trial of tPA. Angioplasty 
candidates were randomized to PTCA of the infarct related 
artery on the third hospital day (n-42) or no PTCA (n-43) 
during the 10 day study period. 
Patency rates 1 to 6 hours after completion of study 
drug infusion were 66% in tPA patients (n-7l) and 24% in 
placebo patients (n-67) (p<O.OOOl). There were no 
intracranial or fatal hemorrhagic events, and the 
incidence of bleeding requiring transfusion was slO% in 
both groups (p-NS). Elective PTCA was successful in 84%, 
with reduction in recurrent ischemic episodes over the 
remainder of the ten day study period from 19% to 5% 
(p<.05). Only 1 patient (2.6%) required emergency CAB 
for angioplasty induced ischemia and only 2 of 85 PTCA 
candidates (2.4%) required PTCA before day 3 for ischemic 
episodes refractory to medical therapy. 
Treatment with tPA alone is associated with high 
patency rates and'few bleeding complications. With 
aggressive medical therapy, PTCA and likely 
catheterization itself can be deferred until hospital day 
3 without excessive risk. 
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EARLY AND LONGTERM PATENCY RATE OF THE INFARCT ARTERY 
AFTER TISSUE PLASMINOGEN ACTIVATOR (t-PA) AND CORONARY 
ANGIOPLASTY FOR ACUTE MYOCARDIAL INFARCTION 
Charles A. Simonton, Tomoaki Hinohara, Thomas Skelton, 
Thomas M. Bashore, F.A.C.C., David Sane, Raymond L. 
Bellinger, Harry R. Phillips, F.A.C.C., Robert M. 
Califf. Duke University Medical Center, Durham, NC 
To determine longterm patency of the infarct-related 
artery (IRA) following tissue plasminogen activator 
(t-PA) and coronary angioplasty for acute myocardial 
infarction (AMI), we performed follow-up coronary 
angiography at 1 wk and after a mean of 6.9 months in 
76 pts receiving t-PA for AMI. Patency rates (as % 
stenosis) of the IRA are shown below for pts receiving 
t-PA and coronary bypass surgery (CABG), emergent PTCA 
at the time of t-PA therapy (acute PTCA) , delayed PTCA 
.24 hrs after t-PA therapy (late PTCA) or t-PA without 
PTCA (no PTCA): 
IRA Stenosis 
1 week 
<50% 
51-99% 
100% 
7 months 
CABG 
(N-I0) 
1 (10%) 
7(70%) 
2(20%) 
Acute PTCA 
(N-38) 
28(74%) 
3 (8%) 
7 (18%) 
Late PTCA 
(N=l7) 
17 (100%) 
o 
o 
No PTCA 
(Nall) 
5 (45%) 
6(55%) 
o 
<50% , 1(10%) 23(61%) 8(47%) 5(45%) 
51-99% 3(30%) 8(21%) 6(35%) 5(45%) 
100% 6 (60%) 7 (18%) 3 (18%) 1 (10%) 
CONCLUSIONS: (1) t-PA and acute PTCA for AMI results 
in a high longterm patency rate (82%) but is limited by 
a significant stenosis (>50%) in 39% of Pts; (2) t-PA 
and delayed PTCA results in a high early success rate 
but with late restenosis occurring in 53% of Pts; (3) 
t-PA without PTCA results in a high rate of significant 
stenosis both early (55%) and late (55%) but with 
continued longterm patency. 
SUSTAINED ARTERIAL PATENCY AITER THROMBOLYSIS AND 
ANGIOPLASTY THERAPY OF INFERIOR MYOCARDIAL INFARCTION 
RESULTS IN LATE IMPROVEMENT IN EJECTION FRACfJON, 
Cindy L Grines M,D" Eric J Topol. M,D"F,A,C,C" Jack E, Juni. M,D" Ed 
G, Anselmo, B,S" William W, O'Neill, M,D" U, of Michigan, Ann Arbor, 
MI and U, ofiCentucky, Lexington, ICY 
The benefit of acute reperfusion therapy for inferior myocardial 
infarction (1M!) remains controversial, To determine whether late 
improvement in ventricular function occurs after reperfusion in 
1M!. we studied <40 patients identified to have right coronary artery 
(RCA) infarct vessel who received intravenous tissue plasminogen 
activator within 4 hrs of symptoms +/- angioplasty (PTCA), 
Quantitative coronary arteriography and ventriculography (VG) was 
performed acutely and at day 7, rest/exercise (Ex) radionuclide 
ventriculography (RNA) on day 30; 27 patients also received rest RNA 
at 2<4 hours, Acute reperfusion was successful in 39/<40 patients 
(98'), There were no differences in Ef by VG between acute and day 
7 study, or in rest RNA Ef between I and 30 days, Subgroup analysis 
revealed that infarct vessel occlusion at day 7 in 10 patients (25") 
was associated with lower 30 day Ef at rest (<48 !. 7 vs 55 !. 10, p • 0,056) 
and exercise (55!. 6 vs 63 !. 11, p = 0,0<46) compared to the patent 
group, Within the sustained patency group, reduction in RCA 
stenosis to i 50" acutely resulted in no improvement in Ef by day 7, 
however, was associated with late improvement in Ef as follows: 
<'iO'(n.12) 51-99"(n=1l) L 
#pts undergoing PTCA 15(72') 2(18') 0,001 
t, Ef Acute-7d (VG) 1.5!.7,5 l.3!.79 NS 
Ef Rest,204HR (RNA) 55!.8 53!.10 NS 
Ef Rest,30d (RNA) 58!.8 49!.10 0,01 
Ef Ex,30d (RNA) 66!.10 57!.13 0,06 
t, Ef Rest Id-30d (RNA) (+ )6!.10 (- )<4!.10 0,07 
In conclusion, no improvement in global LV function is apparent 7 
days after reperfusion therapy of inferior M!. Late improvement in 
ejection fraction occurs with sustained patency of the RCA and is 
further enhanced by reduction in luminal stenosis to <50' by PTCA, 
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RE-THROMBOSIS AFTER SUCCESS~UL THROMBOLYSIS AND 
ANGIOPLASTY IN ACUTE MYOCARDIAL INFARCTION. 
Pierre de Guise, M.D., Pierre Theroux, M.D., F.A.C.C., 
Raoul Bonan, M.D., F.A.C.C., Gilles Levy, M.D., Gilles 
Cote, M.D., and Jacques Crepeau, M.D., Montreal Heart 
Institute, Montreal, Canada. 
Control coronary angiography was obtained a mean of 1I±3 
months after successful thrombolysis and angioplasty in 
118 consecutive AMI pts. Residual stenosis after strep-
tokinase was 75±1~ (lumen reduction) and after PTCA 
36±9". The time from onset of pain to PTCA was 20±27 
hI'S. 
Complete reocclusion of the dilated coronary artery 
segment was found at restudy in 7 pts (14.6"). The 
residual stenosis in the III other pts was 1I0±1~. Four 
of the 7 occluded, and 19 of the III patent coronary 
segments involved the left anterior descending coronary 
artery and respectively 3 and 21 the right coronary 
artery. All pts with patent artery and 6 of the 7 oc-
cluded had taken aspirin. Heparin had been administered 
acutely in all cases. Reocclusion did not correlate 
with the severity of either pre-PTCA or post-PTCA 
stenosis. However the angiographic image of intra-
coronary thrombus at the time of the first angiogram 
was strongly predictive of reocclusion (5/7 pts vs 2/111 
with patent artery, p<.OOOl). Global ejection fraction 
increased from 46±9" to 52±12 (p< .05) between the 1st 
and 2nd angiogram in pts without reocclusion but did 
not change in pts with reocclusion (47±11"). 
Thus the presence of a residual thrombus after fibrino-
lysis may be a key indicator for subsequent rethrom-
bosis after successful PTCA of the infarct related 
coronary artery. 
INTERVENTIONAL THERAPY IN ACUTE MYOCARDIAL INFARCTION: 
CLINICAL AND ECONOMIC DATA FROM A PROSPECTIVE TRIAL. 
Anthony T. Chapekis MD, Eric J. Topol MD, FACC, Karen 
Burek RN, Jennifer Kirscht MPH, and Bertram Pitt MD, 
FACC, University of Michigan, Ann Arbor, Michigan 
To define the population of patients with myocardial 
infarction (MI) who undergo acute intervention (INT = 
thrombolysiS and/or coronary angioplasty), and the 
costs associated with INT therapies, we prospectively 
evaluated 504 MI patients Who presented to our center 
from 5/86 through 8/87. Patients were classified as 
uncomplicated if at 72 hours from admission they were 
free of angina, heart failure and arrhythmias. 
Age (Mean Yrs) 
Sex (S Male) 
Q Wave/Non Q Wave MI 
Mortality (10 Day) 
Uncomplicated 
Hospital Days 
Total Professional 
Cost (Mean $) 
Total Hospital Cost 
INT NO INT 
(N=384) (N=120) 
~ 6-7--
75S 5U 
(~) 90/10 56/44 
($) 
3~ 8S 
44S 18S 
11.0 16.8 
6,101 
24,407 
5,220 
33,641 
P 
<.001 
<.001 
<.001 
.10 
<.001 
<.001 
.10 
<'02 
In conclusion: (1) Although interventional therapy 
may be applied to a selected population (predominantly 
younger, males, with Q wave MI), ~INT is associated 
with decreased mortality and uncomplicated clinical 
course as compared with patients not receiving INT. 
(2) Technologic costs are higher with INT, however 
this was offset by a decrease in length of hospital 
stay (reduced 35S) and total hospital cost (reduced 
27~) with intervention. 
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EARLY RECOVERY OF LEFT VENTRICULAR FUNCTION PREDICTS 
SURVIVAL AFTER THROMBOLYSIS 
Rolf Doerr MD, Florence H Sheehan MD, Wolfgang G Schmidt 
MD, Rainer Uebis MD, Sven Effert MD, Edward L Bolson MS, 
RWTH, Aachen, w.Germany 
Thrombolytic therapy for acute myocardial infarction 
(MI) reduces early mortality, but full recovery of LV 
function after reperfusion (rep) is delayed. Therefore 
the relationship between rep, survival and the time 
course of LV functional recovery was examined in 226 pts 
treated with intracoronary streptokinase. 77% had 
sustained rep (group A). Group B pts had no rep or had 
reocclusion by day 3. Wall motion was measured from 
contrast ventriculograms performed acutely and 3 days 
after MI in the central and peripheral infarct regions 
(IR) and the non infarct region by the centerline method 
in 165 pts. 
Group A pts had better survival (p<.05, mean followup 
4.5 yrs) and a higher ejection fraction (EF) at 3 days 
than group B pts due to the change (~) in peripheral IR 
function between the acute and 3 day studies: *p<.05 
IR: ~central ~peripheral ~non ~EF 3d EF N 
group A 0.2±0.9 +0.1±1.0* -0.8±1.4 -2±10* 52±12* 134 
group B 0.0±0.7 -0.3±O.9 -1.0±1.0 -6± 8 46±lO 31 
On Cox regression analysis, LV function measured at 3 
days was more predictive of survival than function 
measured acutely. Chi square values are: *p<.05 
IR: central peripheral non ~ 
acute 0.40 1.22 5.39* 11.98* 
3 day 1.31 7.96* 9.47* 25.29* 
Although, as previously published, >45% of total LV 
function recovery occurs later, the EF achieved by day 3 
is already predictive of survival. Thus, the mechanism 
by which successful thrombolytic therapy enhances 
survival is improvement of regional and global LV 
function early after MI. 
Wednesday, March 30, 1988 
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Interventions in Acute Myocardial Infarction 
TAMI I VS. TAMI II: DOES CHOICE OF INITIAL THROMBOLYTIC 
THERAPY INFLUENCE OUTCOME OF SALVAGE ANGIOPLASTY? 
Richard S. Stack, M.D., F.A.C.C., William W. O'Neill, 
M.D., F.A.C.C., Tomoaki Hinohara, M.D., Jane M. Boswick, 
M.P.H., Eric Topol, M.D., F.A.C.C., Barry George, M.D., 
F.A.C.C., Robert M. Califf, M.D. and the TAMI Study 
Group. Duke University Medical Center, Durham, NC 
Patients (pts) with persistent occlusion of the 
infarct artery after thrombolytic therapy were managed 
with emergency ("salvage") angioplasty (PTCA) in the 
TAMI I and II Trials. In TAMI I, tissue plasminogen 
activator (tPA) alone was used for thrombolysis (150 mg 
over 6-8 hours), while in TAMI II, pts were treated with 
increasing doses of urokinase (UK) (500,000 to 2,000,000 
units) and tPA (25 mg to 1 mg/kg). Failure to reperfuse 
the infarct-related artery occurred in 96/384 (25%) and 
47/138 (32%) in TAMI I and II respectively. The 
in-hospital mortality rate for pts requiring salvage 
PTCA in TAMI I (n=81) was 12% and the in-hospital 
reocclusion rate was 31%. In TAMI II in-hospital 
mortality rate in the 38 pts requiring salvage PTCA was 
3% and the reocclusion rate was 5%. Paired 
ventriculograms were available in 72% of pts requiring 
salvage PTCA in TAMI I and 63% in TAMI II. The median 
global ejection fraction (GEF) (%) and regional (REF) 
(measured as # of standard deviations below normal) were 
measured acutely and at one week: 
TAMI I GEF 
(n-58) REF 
TAMI II GEF 
(n=24) REF 
Acute 1 Week 
53% ---sT% 
-2.96 -2.79 
47% 55% 
-3.25 -2.63 
Delta Median 
-1% 
.04 
6% 
.36 
There was less mortality, less reocclusion and more 
improvement in both regional and global LV function 
after salvage PTCA following tPA and UK than 
following tPA alone. 
P 
.'06 
.55 
.004 
.009 
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MORPHOLOGIC FINDINGS AT NECROPSY AFTER RECOMBINANT TISSUE 
PLASMINOGEN ACTIVATOR THERAPY FOR ACUTE MYOCARDIAL 
INFARCTION. 
Jay M. Kalan, MD, William C. Roberts, MD, FACC, Eugene 
Braunwald, MD, FACC, and the TIMI Study Group, NHLBI, 
National Institutes of Health, Bethesda, MD. 
The hearts of 35 patients who died from 2 hours to 8.5 
months (median 2 days) after receiving recombinant tissue 
plasminogen activator (rt-PA) for acute myocardial 
infarction were studied as part of the NHLBI Thrombolysis 
in Myocardial Infarction study: 19 patients (54%) had 
successful reperfusion (resolution of symptoms, 
normalization of electrocardiographic changes, early 
creatine kinase peaking, and/or patent coronary artery at 
catheterization), and 16 patients (46%) did not. The 
percent of patients having hemorrhagic myocardial infarcts 
in the 2 groups was different (15/19 [79%) vs 5/15 [33%)). 
Infarct location (9 anterior wall infarcts in each group), 
mean heart weight (427 vs 463 g), and the number of 
patients with left ventricular cavity dilatation (5/19 vs 
8/16) were not significantly different between the 2 
groups. The modes of death in the 2 groups were similar. 
The infarct-related coronary artery was narrowed >75% in 
cross-sectional area by plaque in 13 of 16 patients (81%) 
in each group. Thrombus was present in a coronary artery 
at necropsy in 11 patients, 4 with and 7 without 
reperfusion. Mean percent of left ventricular wall which 
was necrotic at necropsy in patients dying >18 hours after 
infarct onset was 23% in the 10 patients with and 24% in 
the 7 patients without reperfusion. Thus, in patients 
dying after receiving rt-PA and coming to necropsy, the 
mean percent of necrotic left ventricular wall was similar 
in both the reperfused and the non-reperfused patients, 
although the number with hemorrhage into the necrotic wall 
was different. 
Differences in the Clinical Outcome of Patients 
Treated for Myocardial Infarction Using a 
Uniform Dose of rt-PA. Barry S. George M.D., 
Joseph R. Mayo M.D. Ph.D., Richard J. Candela 
M.D. FACC, Eric J. Topol M.D. FACC, Joanne 
Dillon RN, CCRN, Ramona Masek RN, CCRN and 
the TAMI Study Group, Riverside Methodist 
Hospitals, Columbus, Ohio. 
To determine whether uniform dosing of rt-PA 
might influence the outcome of patients being 
treated for myocardial infarction, 381 patients 
receiving 150mg of rt-PA over 4-6 hours were 
divided into those ~ 90kg (Group I, n=286) and 
those )90kg (Group II, n=96). Infarct vessel 
patency 90-minutes post institution of rt-PA 
was 74% in Group I and 69% in Group II (p=.30). 
More patients in Group II required early PTCA 
(58% vs 45%, p=.023) with a lower success rate 
(68% vs 84%, p=.016). Group II also had a higher 
incidence of infarct vessel occlusion at 7-10 
days (22% vs 13%, p=.036). Group I had more 
patients requiring 2 or more units of blood 
(35% vs 20%, p=.006), a higher incidence of 
major bleeding (16% vs 7%, p=.025) and lower 
median nadir fibrinogen and hematocrit levels 
(1.5% vs 1.79%, p=.0007). In summary, no 
significant differences are observed in the 
early patency rate of the infarct vessel 
between patients ~ or > 90kg despite uniform 
dosing of rt-PA. However, bleeding side 
effects appear more frequently in patients < 
90kg. These data suggest a need for furthe~ 
studies to examine dosage based on body weight. 
194A ABSTRACTS 
THE PROGNOSTIC SIGNIFICANCE OF LEFT ANTERIOR DESCENDING 
DISEASE IN ASYMPTOMATIC PATIENTS AFTER ACUTE UNCOMPLI-
CATED INFERIOR MYOCARDIAL INFARCTION. 
David C. Reed MD, Donald L. Kaiser DrPH, Robert S. Gibson 
MD. University of Virginia, Charlottesville, Virginia 
The importance of detecting co-existent left anterior 
descending (LAD) coronary artery disease after inferior 
(INF) wall infarction remains unclear and its treatment 
controversial. To clarify the influence of LAD stenosis 
(~50% luminal narrowing) on long-term outcome, we pro-
spectively evaluated 241 consecutive pts (age ~65 yrs) 
after HBCK confirmed acute uncomplicated MI with submax-
imal exercise TI-20l, 24 hr Holter, radionuclide ventric-
ulography, and coronary angio at 10±3d. The 125 pts who 
had INF changes on admission 12 lead ECG(obtained 4.5 hrs 
after onset of MI) were classified based on the presence 
of LAD disease(n=45, 30 proximal [Gil and 15 [G21 distal 
to the 1st septal perforator) or its absence (G3; n=80). 
There were no between group differences in gender, peak 
CK, prior angina or MI, no. of CAD risk factors, Norris 
index, LV ejection fraction, prevalence of Lown grade ~3 
ventricular arrhythmias, or admission ECG changes in-
cluding no. leads with ST seg t or ,I, and ESTt or ,1,. 
Life table analysis showed similar event-free survival 
rates among the 3 groups during 37 ± 18 mos of follow-up 
(p=NS, Log rank). However, the presence of reversible 
ischemia in the LAD territory by quantitative TI-20l 
cri teria predicted both the presence of LAD disease (Gl 
and G2) and identified a subset within the 2 groups with 
LAD disease at increased risk of adverse outcome; com-
pared to Gl-2 pts wi thout Tl-201 ischemia, those with 
ischemia had a higher cumulative probability of death, 
reinfarction or unstable angina requiring revasculariza-
tion (Kaplan-Meier; p=.Ol). 
Thus, while LAD stenosis after uncomplicated INF MI can 
be identified by angiography, its prognostic significance 
can only be assessed through the use of functional test-
ing such as Tl-201 scintigraphy. 
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Echocardiography: Coronary Artery Disease and Myocardial 
Infarction 
QUANTITATIVE VALIDATION OF ATHEROSCLEROTIC CORONARY 
ARTERIAL LUMEN AND WALL MEASUREr~ENTS BY HIGH FREQUENCY 
ECHOCARDIOGRAPHY. David D. McPherson. M.D .• N.M. Alvarez. 
M.D .• L.J. Thorpe. R.T .• D. German. B.E.E .• N.B. 
Rewcastle. M.D .• Marge Megan. Mark L. Armstrong. M.D .• 
F.A.C.C .• Melvin L. Marcus. M.D .• F.A.C.C .• Steve Collins. 
Ph.D .• Richard E. Kerber. M.D., F.A.C.C .• U of Calgary. 
Calgary. Alberta. and U of Iowa. Iowa City. IA 
We have previously shown excellent correlations between 
high frequency epicardial echo (HFE) and histological 
measurements (histo) of normal coronary arterial wall 
(CAW) and lumen (L). However. HFE measurements of athero-
sclerotic (ATH) arteries with irregular walls and lumens 
have not been validated. Ten fresh autopsy hearts (27 ATH 
CA segments) were perfused at 100 mmHg. imaged using HFE 
(12 MHz probe. Surgiscan. Biosound). then pressure-fixed 
with barium-formal in-gelatin. HFE and histo were compared 
for lumen and wall areas (LA.WA). and eccentricity ratio 
(ECC Ratio: distance between original arterial center and 
residual lumen center. corrected for the size of the ori-
ginal lumen; ECC ratio = 0 if completely concentric). 
Results (E = mean difference between HFE and histo. r = 
HFE vs. histo): 
LA mm 2 WA mm 2 ECC Ratio 
HFE Hi sto HFE Hi sto HFE Hi sto 
x±SD 5.4±2.9 6.5±2.9 9.S±4.7 9.0±5.2 .31±.24 .20±.24 
t, 1.6 1.7 .OS 
r 0.S4 0.91 0.90 
SEE 1.6 2.0 0.11 
HFE and histo were also compared to classify lumen shapes 
as circular (max/min lumen diameter <1.5) or oval (max/ 
min>1.5). HFE and histo agreed in 17/27 segments. had 
minor disagreement (t, ratio 0.4-0.9) in 6/27. and major 
disagreement (t, ratio 1.0-1.4) in only 4/27. Thus. HFE 
defines ATH arterial LA, WA, eccentricity and shape with 
good accuracy. 
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RIGHT VENTRICULAR INFARCTION: AREA AT RISK BY 
CONTRAST MYOCARDIAL 2D ECHOCARDIOGRAPHY 
PREDICTS EVENTUAL INFARCT SIZE. 
Natesa Pandian MD. Shan Shen Wang MD, Barbara 
Brockway BS. 
Tufts-New England Medical Center, Boston, MA. 
Relation between risk area (RA) and infarct 
size (IS), although known for LV, has not been 
defined for RV. Contrast myocardial 2D 
echocardiography (CME) has proven to be useful 
in delineation of RA in LV. To assess its use 
in RV ischemic disease, and to assess RA:IS 
relations for RV, we created experimental RV 
infarction in 9 dogs by coronary occlusion (CO) 
of coronary arteries supplying RV for 6 hrs. 
To obtain RA, we administered agitated 
renograffin-saline mixture into the coronary 
system, in the control state, after CO (early 
RA), and at 6 hrs (late RA). The negative 
contrast area in RV during CME was measured as 
RA, in 3-4 slices per dog. %IS was measured in 
corresponding slices by TTC staining. Results 
(Mean~SD): The mean %IS was 41~27. range 0 to 
77. Early %RA was 40+27, range 0 to 75. Late 
%RA was 37+25. range 0 to 75. Correlation 
between IS-and early RA was: RA=O.92 IS+3.18; 
r=0.93; p<0.01. Correlation between IS and 
late RA was: RA=0.93 IS+0.15; r=0.91; p<0.01. 
In 4 slices where RA was zero %, there was no 
infarct. From this, we conclude that the size 
of RV infarction is closely coupled to the area 
at risk, and that RA determined by CME early 
after CO can predict the eventual RV infarct 
size. This approach may be useful in studying 
the pathophysiology of right ventricular 
infarction. 
Early Prediction of Infarct Expansion Following Acute 
Myocardial Infarction. 
Gerard T Yilkins MB ChB, Michael H Picard MD, Patricia A 
Ray, David E Guyer MD, FACC, Arthur E Yeyman MD, FACC. 
Massachusetts General Hospital, Boston. MA. 
Progressive enlargement in left ventricular size/surface 
area is known to occur after acute myocardial infarction 
(AMI). However, no prospective method identifies patients 
who will go on to evolve significant left ventricular 
dilatation. Ye therefore studied 30 patients (20 male, 10 
female; mean age 53 yrs) with a first AMI, and 30 normal 
individuals (NL) with 2D echocardiography and a 
previously reported endocardial mapping technique. 
Echocardiographic images from 5 standard planes (3 short 
axis, 2 apical) were used to construct quantitative maps 
of the three dimensional endocardial surface area (ESA) 
upon which regions of abnormal wall motion were 
superimposed. Studies were obtained at 1,2,3,& 4 days and 
1,3,6 & 12 weeks after AMI. Patients were divided into 
those with a significant (>5%) increase in ESA and ESA 
index (ESAin = ESA/body surface area) from the acute to 
12 week study, (Group A, n = 8), and those with no 
change, (Group B, n = 22). Mean ESA and ESAin for the 
groups were compared at 24 hrs (acute) and 12 weeks: 
ESA 
A 165cm' 
B 124cm' 
NL 115cm' 
Acute 12 weeks 
ESAin ESA 
85.5cm'/m' 20lcm' 
68.3cm'/m' l27cm' 
68.Bcm'/m' 
ESAin 
101.5cm'/m' 
70.1cm'/m' 
Group A patients differed significantly from Group B 
patients at acute study in ESA (p=.04) and ESAin 
(p=. 003). Conclusion: Echocardiographic surface mapping 
wi thin 24 hours of AMI can be used to prospectively 
identify those patients with significant ESA dilatation 
by 12 weeks. 
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Prevention of Regional Wall Motion Abnormalities 
During Coronary Angioplasty (PTCA). -
Alan R. Maniet, D.O., David Lehmann, M.D., Vidya S. 
Banka, M.D., F.A.C.C., Episcopal Hospital, Philadelphia 
PA 
Two-dimensional echo cardiography has been described as 
a useful technique to observe left ventricular wall 
motion abnormalities that occur during coronary angi-
plasty. Distal coronary perfusion during balloon 
inflation prevents reduction of regional myocardial 
blood flow thus reducing ischemia. The wall motion 
abnormalities detected by two-dimensional echo during 
PTCA were monitored in 44 patients with a total of 48 
vessels. In four views, initial control, peak inflat-
ion, immediate post~inflatio~ and final echocardio-
graphic views were digitized by a Cine 'View 32 com-
puter and reviewed simultaneously in real-time. In 38 
vessels with normal initial left ventricular wall 
motion, balloon inflations produced new wall motion ab-
normalities. Distal coronary perfusion was accomplished 
by hand injection of arterial blood through the central 
lumen at a rate of O.Scc/second in 12 patients with 
observed new wall motion abnormalities. In 9 patients, 
new wall motion abnormalities were not detected during 
distal perfusion. In 2 patients, where balloon in-
flation had produced akinesis, only hypokinesis could 
be elicited during perfusion. In 1 patient distal per-
fusion did not prevent akinesis during balloon in-
flation. The average balloon inflation was <! 60 seconds. 
In summary, wall motion abnormalities occurring during 
balloon inflation are preventable by distal arterial 
perfusion. Two-dimensional echo cardiography serves as 
a useful method for monitoring such wall motion 
abnormali t.ies. 
DISSOCIATION BETYEEN RECOVERY OF VENTRICULAR GEOMETRY AND 
SYSTOLIC FUNCTION FOLLOYING REPERFUSION. 
Ravin Davidoff MB, Thomas L Force MD, Gerard T Yilkins 
MB, Albert A Hagege, MD, James Southern MD,PhD, James 0 
Thomas MD, Vivian M Abascal MD, J Luis Guer~ero, 
Christopher Y Choong, MB, PhD, Arthur E Yeyman MD, FACC, 
Massachusetts General Hospital, Boston, MA. 
The mechanism of improved left ventricular(LV) function 
following reperfusion is not well established. To 
investigate the effects of reperfusion (REP) on 
alteration and recovery of LV geometry and regional 
function, we studied 6 open chested dogs in which the LAD 
was occluded for brief periods (range 9-20 mins) wi th 
subsequen t reperfusion. The LV endocardial surface area 
(ESA) and area of abnormal wall motion (AYM) were mapped 
at baseline, end occlusion, and 5,15,30 and 60 minutes 
post REP with 2D-echocardiography and a previously 
reported technique for quantitatively mapping the ESA and 
superimposing regions of AYM. In order to assess return 
of contraction, systolic thickening (ST) was measured 
within the normal(N) and central ischemic regions. Mean 
results are shown: 
Baseline 
ESA(cm') 38.5+6.0 * 
AYM(cm') 0 
N AREA(cm')38.5+6.0 
ST% 28.2+7.1 
Occlusion 5min REP ---53.4+6.4 *--44.4+5.0 
13.6+5.1-*-- 5. 3+1.5 
39.8+6.5 39.1+5.9 
-34.4+10 -12.8+13 
(* p<.005) -
15min REP 
42.6+6:6 
2.9+1.9 
39.7+6.0 
-4.0+9.5 
The marked increase in overall ESA during ischemia, is 
rapidly reversed by reperfusion, and this reduction is 
directly attributable to the decrease in AYM. However, 
significant shrinkage of the AYM area is not accompanied 
by return of systolic thickening. The data suggest that 
REP favorably reduces ischemic zone dilatation prior to 
recovery of active systolic function. 
ABSTRACTS 
ECHOCARoIOGRAPHIC QUANTITATION OF REGIONAL WALL MOTION 
IN THE THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION 
(TIMI) TRIAL-PHASE II: PRELIMINARY OBSERVATIONS. 
195A 
William A. ZO~hbi, M.D., F.A.C.C., Richard N. Haichin, 
M.D., Jorge C elrlf, M.D., Roxann Rokey, M.D., F.A.C.C., 
Robert Roberts, M.D., F.A.C.C., Miguel A. Quinones, M.D., 
F.A.C.C., Baylor College of Medicine, Houston, Texas. 
To explore the role of echocardiography (20 echo) in 
the serial quantitation of regional wall motion after 
thrombolysis in acute myocardial infarction (MI), 37 MI 
patients, (mean age 57±10 yr; 30 males; 27 anterior, 10 
inferior) enrolled within 4 hrs of chest pain in TIMI 
Phase II, underwent 20 echo 3.2±3 hrs after infusion of 
recombinant tissue plasminogen activator (100-150 mg). 
Apical 4 chamber (n=32) and 2 chamber (n=26) views were 
ana lyzed by an adaptati on of the centerl i ne method in 
34/37 pts. This method provided 100 equidistant chords 
per view normalized for end-diastolic ventricular 
perimeter. Abnormal wall motion, defined as >2 
standard deviation (SO) below respective chord values 
of a normal population (n=29), was detected in all 
involved regions. Extent of regional wall motion abnor-
malities was expressed as average number of abnormal 
chords and as the sum of SO (ESD) in the abnormal 
chords. Comparison at 10 days in 20 patients (15 with 
interval angioplasty) showed reduction in the number of 
abnormal chords from 50±ll to 40±15 and in ESo from 
-160±53 to -132±59 SO (both p =>.01). No significant 
change in LV ejection fraction was observed: .44±.10 to 
.45±.11. Thus, in acute myocardial infarction, regional 
dysfunction can be accurately detected by quantitative 
two dimensional echocardiography. The technique 
provided precise definition of the extent of dysfunction 
and demonstrated at 10 days a 20% improvement in 
regional ventricular function. 
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AIDS HEART DISEASE: RESULTS IN 85 PATIENl'S. 
J.J. Maosuez. M.D., E.L. Kinney, M.D., F.A.C.C., 
D. Vittecoq, M.D., M. Kitzis, M.D., M.F. d'Agay, M.D., 
B. Autran, M.D. Hopital Saint-Louis, Paris, and 
University of Miami School of Medicine, Miami, FL. 
The cardiac findings in 85 patients (pts) with AIDS or 
AIDS related complex (ARC) from 2 cities were analyzed to 
characterize AIDS heart disease. Of 42 pts with AIDS and 
43 pts with ARC, 16 (12 AIDS, 4 ARC) had cardiac 
abnormalities whereas 69 pts (25 AIDS, 44 ARC) did not. 
Some pts had rrore than 1 cardiac abnormality. The rrost 
common cardiac abnormality was pericardial tamponade (11 
pts). The cause of the tamponade was m. tuberculosis 
(tbc) (5 pts), m. avium tbc (1 pt), lymphoma (1 pt) , 
cardiac KapoSi'S sarcoma (1 pt), and non-specific 
pericarditis (3 pts). With pericardiotomy and drug 
therapy, in 9/11 pts, evidence of tamponade resolved and 
did not recur. Other cardiac findings consisted of CHF in 
4 pts, arrhythmia in 3 pts, new murmur in 1 pt due to 
cardiac Kaposi's sarcoma, cryptococcal myocarditis in 2 
pts, toxoplasma myocarditis in 1 pt, and salrronella 
SBE in 1 pt. Two pts with myocarditis had arrhythmias. 
Despite the frequency and seriousness of cardiac disease 
in this population, only 36% of deaths were cardiogenic, 
probably reflecting the surprising effectiveness of 
therapy for this complication of AIDS. By logistic 
regression, the odds of having cardiac involvement were 
inversely related to the number of prior opportunistic 
infections and T4 cell count, and directly related t02 being female and having AIDS rather than ARC (model X = 
21.1, df=4). Conclusions: Clinical cardiac disease in 
AIDS/ARC was found to be due to opportunistic infections 
(rrostly tbc) or turror. It merits agressive treatment, 
despite its association with very low T4 cell counts. 
196A ABSTRACTS 
EFFECT OF METOPROLOL IN ACUTE COXSACKIEVIRUS B3 MURINE 
MYOCARDITIS. 
Shereif Rezkalla, M.D., Riad Khatib, M.D., Ghada Khatib, 
M.D., Frederick E. Smith, M.S., and Robert A. Kloner, 
M.D., Ph.D., F.A.C.C., Wayne State University and Harper 
Hospital, Detroit, MI. 
Recent studies suggest that beta blockers show promise 
in the treatment of cardiomyopathies; however, their 
role in acute myocarditis is unknown. Three week old 
mice were infected with coxsackievirus B3 and randomized 
to receive either metoprolol (M) or normal saline (S) 
intraperitoneally (IP) for 10 days starting on day 1 of 
infection. From each group, 20 mice were observed for 
mortality for 30 days, and remaining mice were sacri-
ficed on day 3, 6, 10, or 30, for cardiac viral titres 
and pathologic changes. Mortality (Fig.) with M was 
60%, compared to 0% in S group (p<0.0003). Viral 
titres on day 10 of infection were 102.6±0.2 for M 
vs l02.1±0.1 for S TCID 50 (p<O.OS). While pathologic 
changes on days 3, 6, and 10 were similar in both 
groups, on day 30 myocardial necrosis score was 2.1±1.2 
in M vs 0.4+0.9 in S (p<O.Ol). 
Six non-infected mice receiving M 
for 10 days IP thrived normally 
with no mortality during 30 days 
of observation. We conclude that 
metoprolol exerts deleterious ef-
fects during acute coxsackievirus 
B3 murine myocarditis. 
D.,. 
MYOCARDITIS IN l\O;lUIRED DMJtU>EFICIEICY SYNDRG1E (AIDS): 
ETIOLCGY J\ND PRCXN:lSIS. 
Antoine Lafont, M.D., Claudie Marche, M.D., Michel Wolff, 
M.D., Cllrlstlan Perronne M.D., Serge Witchitz, M.D., 
Bernard Regnier, M.D., FraIllFis Vachon M.D. 
HOpital Claude Bernard - Paris - France. 
Fifty six cases of ll\YOCarditis were selected by histologic 
examination of heart fran 137 consecutive autopsied 
AIDS patients, between 1983 and 1987. Myocarditis was 
defined by histologic evidence of an interstitial inflam-
matory infiltrate (41 pts) or an interstitial edema(15pts) 
with or without an qlpOrtlIDistic agent. During their last 
stay in hospital the patients were divided into 3 groups 
according to the presence and severity of cardiac signs 
on the basis of clinical, echocardiographic (12 pts) or 
heuDdynamic (11 pts) criteria. Cardiac signs were absent 
(group I : n = 29), mild (group II : n = 13) or severe 
(group III : n = 14). Cardiac involvenent led to death in 
10 out of 14 patients in group III. All other patients 
died of extra-cardiac lesions. A pathogen was identified 
in ll\YOCardium in 14 patients (25 %) : group I : n = 7, 
group II : n = 2, group III : n = 5. 'Ihese pathogens 
were : CytanegalOlTirus (2 pts), Toxoplasma gondii (5 pts) 
Cryptococcus neoformans (3 pts), Candida albicans (2 pts), 
Mycobacterium tuberculosis (1 pt) and Histoplasma 
capsulatum (1 pt). A pathogen was found am:ng 5 of the 
10 patients who died of cardiac failure. '!he nean 
duration of AIDS was 7,2 , 6,1 and 3,lllDl'lths in the 
3 groups respectively. In conclusion : myocarditis is 
frequent but often asynptcmatic in patients with AIDS. 
Severe ll\YOCarditis can lead to death in sane cases. 
However there is no relation between the presence of a 
pathogen and the severity of ll\YOCardial involvement. 
'!he significance of ll\YOCarditis with no deuonstrable pa-
thogen is still 1IDC1ear. 
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MONOCLONAL ANTIBODY THERAPY FOR PREVENTION OF ACUTE 
COXSACKIEVIRAL MYOCARDITIS IN MICE. 
Chiharu Kishimoto. M.D, and Walter H. Abelmann, M.D., 
F.A.C.C., Department of Medicine, Beth Israel Hospital, 
Harvard Medical School, Boston, Massachusetts 
The significance of T cells in the development of murine 
coxsackieviral myocarditis was already demonstrated. 
Thus, we studied the effects of monoclonal antibodies 
against murine T cell subsets in an animal model. Two-
week-old C3HjHe mice were inoculated ip with 3x10
2 
plaque-forming units (PFU) of coxsackievirus B3(CB3). 
Rat anti-m~~se monoclonal antibodies, Lyt l(helper!~ndu­
cer T), 10 mg, Lyt 2(suppressor/cytotoxic T), 10 mg, 
and both were administered sc daily, starting on day 0 
(Exp. I; viremic stage) and on day 10 (Exp. II; aviremic 
stage) for 2 weeks, and compared to infected controls. 
Qrn Regimen Survivors Myocard Lesion Score (1+-4+) 
(n) (n) INF N C 
1 17 None 3 3.1±0.7 3.1±0.7 2.9±0.6 
I 2 12 Lyt1 3 2.9±0.6 2.9±0.9 2.8±1.0 
3 12 Lyt2 3 2.8±1.1 2.8±1.0 2.7±1.1 
---~--!~-~¥~!:~¥~~--?~----~,~~~,~~--~,?~~,~----~,~~~,?--
S 20 None 11 2.3±1.0 2.6±1.1 2.6±1.0 
II 6 10 Lytl 6 1.6±0.9 2.0±1.0 2.0±1.0 
7 10 Lyt2 8 2.0±1.0 2.3±0.9 2.2±0.8 
8 10 Lyt1+Lyt2 9 1.S+0.6* 1.9+0.8* 2.0+0.8 
*p<O.OS vs Grp 1 or 5, INF-infiltration, (±SD) 
N-necrosis, C-calcification. 
In Exp. I, myocardial virus titers on days Sand 6 were 
not s~gnificantly different amo~g 4 Grps (Grp l-4.~± 
6.4xlO PFU/mg, GrP32-4.8±5.3x10, Grp 3-5.6±5.2xlO, 
and Grp 4-6.S±6.lxlO ; each n=5; including 3 additional 
killed mice in each Grp). In conclusion, monoclonal ant~ 
body therapy for total T cells, but not for each T cell 
subset, partially suppressed acute myocarditis in mice, 
regardless of the presence of myocardial CB3 virus. 
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AlIOMALOUS VENTRICULO-ATRIAL COIIlUCTION WHICH SHOWS VAGAL 
IlI)EPKII)BNCB YET RETAINS RATE-DBPElIDBNCB 
Benjamin J. Scherlag, Ph.D., FACC, Ralph Lazzara, M.D., FACC, 
University of Oklahoma Health Sciences Center and VA Medical 
Center, Oklahoma City, OK 
Prior studies have shown that local lidocaine inj ection into 
the A-V junction (AVJ) can caUSe preexcitation of the ventri-
cles and/or V-A conduction in the presence of complete A-V 
block (AVB). In 12 pentobarbital anesthetized dogs, the right 
heart was exposed via a thoracotomy. In addition to standard 
ECG leads, electrograms were recorded from the high and low 
RA, the His bundle and RV. In the control state, RA pacing 
induced Wenckebach cycles (WC) at an average heart rate of 
32S+44/min (mean and standard deviation) : whereas during pacing 
fro;;; the RV, V-A WC occurred at 246+S2/min, p<O.OS. The left 
vago-sympathetic trunk was stimulated at two levels of inten-
sity: Level 1 stimulation lowered the heart rate between 
90-100/minute; level 2 caused complete A-V and V-A block at 
a heart rate between 50-60/minute. In the control state, 
level 1 stimulation induced A-V WC at 210+49/min and V-A WC 
at 147+61/min, p<0.05. Lidocaine, 0.S-1.Clcc, injected into 
the AVJ induced complete AVB. Within 3-15 minutes, during 
persistence of AVB, V-A conduction was found in 7 out of 12 
dogs with no vagal stimulation. In these 7 cases VA conduction 
persisted during vagal stimulation at level 1 and level 2. 
However, there was no significant di~fference between the rates 
at which V-A WC occurred, 126+22/min vs 104+19/min p>0.22. 
We conclude that the induction of A-V block-with lidocaine 
injection into the AVJ regularly promotes the development 
of V-A conduction over ectopic pathways, i,e., outside the 
AVJ specialized tissues. This ectopic conduction is not in-
hibited by vagal stimulation but does conform to rate depend-
ence, characteristic of AVJ conduction. 
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PROPAGATION PATTERNS ACROSS ANATOMIC BARRIERS IN 
ANISOTROPIC TISSUE Alan H. Kadish, M.D., Joseph Levine, 
M.D., E. Neil Moore, DVM., PhD., F.A.C.C., Joseph Spear, 
PhD., F.A.C.C., Univ. of Pennsylvania and Univ. of 
Michigan, Ann ~,rbcr, MI 
The inability to precisely identify areas of block 
may hamper the characterization of impulse conduction. To 
examine propagation patterns in areas where impulse block 
is present, we created an in vitro model of block by pro-
ducing a thin 6 cm. long cut rn-ro epicardial canine 
strips (5 longitudinal (LG) and 5 transverse (TV) to 
fiber orientation (FO)). Bipolar pacing at 1 Hz. was 
performed 3 cm. away from the center of the cut so that 
impulses proceeded across the cut. Forty point 
isochronal activation and vector maps (produced by 
summing orthogonal bipolar electrograms) were examined 
before and after the cut. Results: 1) Microe1ectrode 
impalements showed cell injury or death 5 mm. on either 
side of the cut. 2) On the proximal side of the block. 
propagation was similar before and after the cut. 3) When 
the cut was TV to FO (impulses initially proceeding LG to 
FO), vector and isochronal angles at the cut edges 
indicated impulse spread around the area of block. Impulse 
propagation distal to the block was parallel to the cut. 
4) When the cut was LG to FO (impulses initially pro-
ceeding TV to FO) isochronal maps showed only impulse 
slowing but vector angles suggested impulse angulation 
around the block. 
Conclusions: 1) Vector and isochronal maps distal to but 
not proximal to an area can verify the presence of block 
2) Vector angles can assist in the identification impulse 
block when isochronal activation maps are equivocal. 
TIME DELAYS IN 11ffi PROPAGATION OF CARDIAC ACTION POTENTIALS 
David A. Israel. M.D .. S.M .. David J. Edell, Ph.D., and Roger G. 
Mark, M.D., Ph.D., F.A.C.C., Mass. Inst. of Technology, Cambridge 
Decreased coupling between cells at intercellular connections in 
various pathological states may underlie slow conduction or block 
and so might be involved in arrhythmogenesis. To investigate the 
existence of such time delays, monolayers of IO-day chick-embryo 
ventricular myocytes were grown in cell culture on arrays of 
extracellular microelectrodes fabricated using microelectronics 
technology. The arrays contained 28 planar recording electrodes, 
each 10 Ilm square, 16 of which could be recorded from 
simultaneously. The most closely spaced recording electrodes were 
on 20 Ilm centers. Some pairs of electrodes recorded from different 
points on the same cell while other pairs straddled intercellular 
junctions. The preparation was electrically paced to obtain a 
repeatable propagation pathway. Arrival times of extracellular 
activity at each microelectrode were measured, using the maximum 
negative derivative of the extracellular action potential as the fiducial 
point. After a series of beats was recorded under control conditions, 
the preparation was exposed to medium containing 20 mM NH.Cl for 
15 minutes, and then returned to normal medium. This intervention 
produces transient intracellular acidification which decreases 
intercellular coupling. After acidification, the average (multicellular) 
conduction velocity decreased to about 2/3 of the control value. 
Propagation velocity measured between most electrode pairs 
decreased only proportionately .. However, disproportionately long 
propagation delays of up to 410 IlSec were observed between some 
pairs of electrodes in various experiments. The delays recovered as 
pH returned to normal. The localized long delays were thought to 
be due to decreased intercellular coupling at gap junctions. These 
data suggest that decreasing intercellular coupling does cause 
propagation to be "discontinuous" in this preparation, and that this 
may be a significant mechanism for pathologic slowing of 
conduction in myocardium. 
ABSTRACTS 197A 
EFFECT OF INCREASING JUNCTIONAL RESISTIVITY ON 
ANISOTROPIC CONDUCTION IN CANINE MYOCARDIUM ~
D. Lesh MD. C. William Balke MD. E. Nell Moore DVM PhD FACC. 
Joseph F. Spear PhD FACe UIIvmIIWdPemsylvanla,PhIlaMpuaPA 
Anisotropy has been proposed as one mechanism of slow conduc-
tion required for re-entry and Is felt to result from directional differ-
ences In axial resistance. We evaluated the contributions of cyto-
plasmic and junctional reSIStlVIWu to total Intracellular resistivity 
Ionl(ltudlnal(L) and transverse ( to fiber orientation in 5 canine 
venlr1cular epicardial strips pe used In Tyrode's solution. Pacing 
(cycle length 2 s) was perfOrmed and conduction velocities (e) deter-
mined Land T to the stimulation site. Meaned values are referred to 
as aL and &r. After control measurements. heptanol. an aliphatic 
alcoliol which Increases gap junction resistance. was added to the 
bath to a concentration of briM and measurements made at 20 s in-
tervals for 30 min. Heptanol slowed aL and eT logarithmically. 
reaching a plateau In 20 min. According to cable tlieory. for constanl 
membrane Ionic _properties. a In any alrectlon of propagation Is a 
function of the effectfve resistivity In that direction. Smce heptanol 
acts only on Junctional resistance with other cable parameters re-
maining uncnanged. we can write: 
K/9Lt?O = (Rc+~t?O )1/2 (I); K/Srt=O = (Rc+~t=O )1/2 (2); 
K/9Lt=-r = (Re+~t=-r )1/2 (3); K/~ = (Re+ARlt=-r )1/2 (4); 
where K Is a constant (=926 n mm3 /msec21. t=O Is the control slate 
and t=~ Is a given ttrne after adding heptanol to the bath. Re. the cyto-
plasmic resistivity. Is constant for any direction of propagation and 
with time. RJ Is the effective Junctional resistivity In the L direction. 
and A Is the anisotropic coupling ratio and represents the I(reater 
num~b~unctlonal resistors !ler unit distant T vs. L. USing llb and 
8y at and 30 min we9:llvedforthefotrrnknownsln equations ( -(4): ma:ara:fr,o ~_ mIcuJaIa:l 
R::...-....B.fO _~t;.OO A 
.52.23 .42 .16 (m/g) 2ffi7 1384 3200 (llin) 11.1 
In addition. at each 20 s Interval we used measured aL. Rc as calcu· 
lated. and equation 3 to calculate RI . Using this RI. the calculated A 
and eq. (4). 8y was predicted for each time Interval and compared to 
the measured 8y. The model accurately predicted 8y; using linear 
regression &r pr&dided = 1.031 8y rressued -.004 r=.976. 
In conclus!on.heptanol. by Increasing junctional resistance. al-
terred one component of a two-dimenslona1 cable model of conduc-
tion while other parameters remained constant and gave a "window" 
Into the anisotropy of cardiac tissue. Thus. heptanol decreased e 
more In the T than L direction and the resistivity due to I(ap junc-
tions was ILl times I(reater T than L . Heptanol is a useful tool lo 
study one proposed substrate for reentrant arrythmlas. 
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DIFFERENT INFLUENCE OF ANTIHYPERTENSIVE DRUGS ON THE 
SECRETION OF ATRIAL NATRIURETIC FACTOR (ANF) IN MAN 
Mathias C. Haufe, M.D., Jochen Weil, M.D., 
Rupert Gerzer, M.D., Johanna E. Ernst, Karl Theisen, M.D. 
Medizinische Klinik Innenstadt, Univ of Munich, FRG 
In-vitro experiments suggest that ANF secretion is blocked 
by Ca-antagonists. Little is known about the possible 
influence of antihypertensive drugs on ANF in patients. As 
previously described, rapid RV-pacing (Stirn, 150 bpm) was 
used as a reliable method to increase RA-pressure (RAP) 
and thus ANF-secretion. In 8 ctr pts, RAP was increased by 
Stirn I for 4 min, after a 15 min interval, an identical 
Stirn II was performed. After Stirn I, 8 pts got 5 mg vera-
parnil, 10 pts 5 mg atenolol and 10 pts 4 rng rnolsidomine 
iv, a nitrate "analogon". All pts had a normal hemodynamic 
profile with LVEF > 50%. RAP and ECG were registered con-
tinuously, ANF and its second messenger c-GMP were 
measured before and after both Stirn. RAP increased by 70% 
in all groups during both Stirn. Only molsidomine decreased 
baseline RAP from 5.6+1.4 to 3.8+1.0 mmHg. 
(* p<0.02) Stirn I Stirn II 
Control (ctr) t116 - * 290 
.4 ANF Verapamil (v) 53 - ns - 42 
(pg/ml) Atenolol (Al) ns 85 - * 172 
Molsidomine (M) 53 - ns - 66 
~ =increase caused by Stirn (median values) 
In ctr pts, ANF reached basal values before Stirn II and a 
"priming effect" of Stirn I enhanced the ANF release of 
Stirn II. In contrast to V, which impaired ANF secretion, 
Al did not alter ANF release. After M, ANF release was 
similar for both Stirn but without priming effect. cGMP 
changed concordantly in all pts. Conclusion: V directly 
suppresses ANF secretion without altering RAP. Al shows no 
influence on ANF and RAP. M reduces basal RAP, still pre-
serving the absolute increment caused by Stirn, and appears 
to suppress the "priming effect" seen in control pts. 
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EXERCISE TESTING IN DIURETIC TREATED HYPERTENSIVE 
PATIENl'S. vasilios Papademetriru.MD, Rebecca Costello, MS, 
Aldo Notargiacomo,BS, Elizabeth Sethi,MD, Steven 
Singh,MD,FACC, Ross Fletcher,MD,FACC, Edward Freis,MD, 
FACC, VN!C am Geo:rgetown Univ., Washirqton, D.C. 
Previous studies suggested that aerobic exercise may 
aggravate diuretic-induced hypokalemia and ventricular 
ectopy. Ten patients with uncomplicated hypertension 
urxienIent exercise testin;J twioe on placebo (P) and twice 
on HCl'Z (H) 100nq daily, at 2 to 4 weeks and at 12 weeks 
of therapy. Biochemical measurements were obtained 
following 10 min restin:}, at peak exercise am 10 min post 
exercise. Arrhythmias were quantitated for the duration 
of the experiment. Nine of the patients had evidence of 
LVH by echocardiograIhY. Exercise time was 345 sec on P 
am 399 sec on H. '!he peak HR was 132 on P and 132 on H. 
'lbe following results were obtained: 
PlACEOO DIURErIC 
Rest ~ ~ B@! Rest ~ Post Pval 
PK 3.80 4.05 3.94 .02 2.93 3.37 3.21 .001 
M:; 1.79 1.87 1.78 .003 1.81 1.86 1.80 .04 
EP 50 124 68 .01 63 134 89 .01 
NE 369 1385 447 .001 433 1369 551 .001 
PITC .10 .41 .09 NS .01 .35 .16 NS 
cnJ 0.0 .05 0.0 NS 0.0 .21 0.0 NS 
CXXJ=cruplets;D:lta represent mean values;Pval cx:anpare rest 
to peak. DIURETIC:2 to 4 weeks of therapy;PK=plasma 
potassil.UD; M:]=Magnesil.UD;EP=epi.rteplrine;NE=norep~ine. 
Results remained essentially the same at 12 weeks of 
diuretic therapy. We conclude that in these patients: 
l)exercise testing results in a small but significant 
increase in PK am Mg; 2)exercise induced increase in EP 
and NE does not result in further decrease in PK; 
3)diuretic induced hypokalemia does not predispose to 
increase ventricular ectqly durin:} exercise. 
ISOLATED SYSTOLIC HYPERTENSION IN THE ELDERLY. Ehud 
Grossman, M.D., Guillermo E. Garavaglia, M.D., Shmuel Oren, 
M.D., Franz H. Messerli, M.D., F.A.C.C., Ochsner Clinic and 
Alton Ochsner Medical Foundation, New Orleans, Louisiana. 
In order to dissociate the effects of an elevated systolic 
arterial pressure from those of aging on the cardiovascular 
system, we compared hemodynamic and echocardiographic 
parameters in two groups of elderly patients who were age 
and diastolic blood pressure matched: one group of 10 
patients with isolated systolic hypertension (ISH), and a 
second group of 10 normotensive patients. Results were as 
follows: (Mean ~ ISD) 
Age (years) 
Systolic BP (mmHg) 
Diastolic BP (mmHg) 
Heart rate ~beats/min) 
CI (L/min/m ) 
Total peripheral resistance 
(TPR) (units) 
Systemic arterial 
compliance (mL/mmHg) 
Ejection fraction (%) 
LV peak filling rate 
(dD/dt - diastole) 
LV duration of rapid 
filling (msec) 
Left ventricular mass 
index (LVMI) (g/m2) 
*P(0.001, --P(0.05 
ISH 
73 + 8 
181 :; 12 
75 :; 4 
66 :; 8 
2.64 !: 0.44 
43 ~ 9 
1.23 + 0.45 
60 :; 11 
7.19 !: 1.96 
247 ~ 54 
163 ~ 49 
Normotensives 
70 + 6 
151 :; 5-
73 :; 10 
72 :; 16 
2.75!: 0.35 
1.94 + 0.77-
67 :; 7 
6.66!: 2.43 
320 ~ 110 
122 :!. 22*-
The hemodynamic profile of both groups was similar except 
for an increase in TPR and a decrease in compliance in 
patients with ISH. However, patients with ISH exhibited a 
greater LVMI than the normotensives and also showed early 
left ventricular dysfunction, suggesting a deleterious 
effect of systolic hypertension regardless of age. 
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ABNORMAL LEFT VENTRICULAR VOLUME RESPONSE PREDICTS 
IMPAIRED EXERCISE PERFORMANCE IN HYPERTENSION 
~omas P. Rocco. M.D •• Vasken Dilsizian. M.D. Constantine 
oney. M.D •• H. W. Strauss. M.D •• F.A.C.C •• Randall 
Zusman. M.D •• F.A.C.C •• Charles A. Boucher. M.D •• F.A.C.C. 
Massachusetts General Hospital. Boston. MA 
Systemic arterial hypertension (HBP) has been associated 
w1th abnormalities of left ventricular (LV) function. To 
determine the impact of HBP on LV volume changes with 
exercise. cardio~ulmonary exercise testing was performed 
in 51 asymptomat1c hypertensives and 16 normals. All 
patients had upright bicycle exercise radionuclide 
angio~raphy with measurement of LV ejection fraction (EF). 
end-d1astolic volume (EDV) and 02 uptake. Thirty-one of 
51 patients were on no cardiac medications. and the 
remaining 20 patients took a diuretic only. The RBP 
patients were subdivided by EDV change with exercise: 
Group I = EDV increase >15ml; Group II = EDV change <15ml; 
Group III = EDV d~crease >15ml or >10% for EDV <lOOml). 
The data foll~s lmean ± standard error): 
Exerc1se EDV Peak V02 Peak Workload 
(ml/m2) (ml/kg/min) (Watts) 
Normals 
(n=16) 
88±4 20.7±l.9 103 ±6 
Group I 
(n=27) 
Group II 
(n=13) 
91±,3 
69±,3 
* 
Group III 53±4 
(n=8) 
21.0±l.3 
22.4±l.4 
** 
l5.9± 9 
126 ±7 
120 ±.8 
** 
81.5±] 
PI{ Heart 
Rate (BPM) 
l43±,3 
143±4 
146±.5 
134±,3 
*p<.05-NLS. Ivs.II. III;IIvs.III;**p<.05-NLS. I. IIvs.III 
Group III patients also had a lower cardiac output and 
stroke volume at peak exercise; age. sex. rest EDV. 
rest/exercise BP. HR. rest/exercise EF or diuretic therapy 
did not differ among the groups. 
We conclude that EDV does not fall with u~right exercise 
in normals. A unique subset of hypertens1ve patients 
demonstrates a decrease in EDV at peak exercise. 
associated with impaired exercise ~erformance. This 
response may reflect impaired LV f1lling during 
tachycardia associated with exercise. and may have 
therapeutic implications for such patients. 
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Predictive Value of Electrocardiographic Characteristics 
DECREASED HEART RATE VARIABILITY PREDICTS LATE MORTALITY 
IN PATIENTS UNDERGOING DIAGNOSTIC CORONARY A~GIOGRAPHY 
Michael W. Rich, MD, FACC, Jasbir Saini. MD, Kenneth E. 
Freedland, PhD, Robert M. Carney. PhD, Adriaantje 
teVelde, MS, Robert E. Kleiger, MD, FACC. Jewish Hospital 
at Washington University Medical Center. St. Louis, MO. 
Depressed heart rate variability (HRV), defined as 
the standard deviation of R-R intervals during sinus 
rhythm on 24 hour ambulatory ECG. has been associated 
with increased mortality following acute myocardial 
infarction (MI), and Pts with HRV < 50 msec are at 
particularly high risk. To evaluate HRV in patients 
without recent MI, we performed ambulatory ECGs on 100 
Pts under 70 years of age undergoing non-emergent 
diagnostic coronary angiography. Pts were followed for 
12-18 months and there were 6 deaths during follow-up. 
Eleven Pts (Group 1) had an HRV ~ 50 msec, the remaining 
Pta (Group 2) had HRV> 50 msec. There were no 
differences between groups with respect to age, sex, 
extent of coronary disease, or left ventricular ejection 
fraction. However. mortality was significantly higher in 
Group 1 Pts compared to Group 2 (36.4% vs 2.2%, relative 
risk 16.5, p-.OOl). In the 6 Pts who died, the mean HRV 
was also significantly lower than for survivors (55.0 vs 
88.2 msec, p-.008). No other clinical, angiographic, or 
ambulatory electrocardiographic variable was as effective 
as HRV in predicting late mortality. 
CONCLUSIONS: Decreased HRV is associated with 
increased one year mortality in Pts undergoing diagnostic 
coronary angiography, and this effect is independent of 
left ventricular function, extent of coronary disease, 
and other important prognostic variables. Decreased 
parasympathetiC and/or increased sympathetic tone may 
account for these findings. 
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DIURNAL VARIATION IN SUMMATED QRS VOLTAGE 
IN THE NORMAL ELECTROCARDIOGRAM. 
Gareth Parry MB, Janet M McComb MD, Ronald WF 
Campbell MB, Academic Dept. of Cardiology, 
Freeman Hospital, Newcastle upon Tyne, UK. 
A decrease of >20% in summated peak to peak QRS 
voltage in leads I,II,III,Vl and V6 has been 
associated with rejection in cardiac transplant 
recipients. Although ECG voltage measurements 
are known to vary from day to day the 
possibility of physiological diurnal variation 
in QRS voltage has not been investigated. 
QRS voltage, duration and frontal axis, QTC 
interval and heart rate were studied during 24 
hours in 16 normal subjects. ECGs were obtained 
at 7pm, llpm and 7am. Electrode site, subject 
position and ECG recorder were constant. 
Summated QRS voltage was lower at 7am (mean±SD 
4. 69±0.88mV) than at 7pm (5.36 ± 1.04, p<O.OOl) 
or at llpm (5.34±1.04, p<O.OOl). This QRS 
voltage decrease was >20% in 4 of 16 subjects. 
Heart rate was higher at 7pm (74.9 ± 12.9 bpm) 
than at either llpm (68.8±11.6, p<0.02) or 7am 
(68.7±10.5, p<0.05). Change in QRS voltage did 
not correlate with heart rate change. QTc was 
shorter at 7am (387.2±22.4 ms) than at 7pm 
(398.6±27.4, p<0.05). QRS duration and axis did 
not change. 
There is substantial diurnal variation in QRS 
summated voltage in normal subjects. Similar 
diurnal voltage changes in patients would have 
implications in the diagnosis of cardiac 
rejection and for assessment of infarct size 
and left ventricular hypertrophy by voltage 
measurement. 
SPBCTRo-TBMPORAL NAPPI";: THE NEXT GBIIBRATION III LATE 
PO'l'EIITIAL ANALYSIS 
Paul Lander, Ph.D, David E. Albert, M.D., Edward J. 
Berbari, Ph.D. University of Oklahoma Health Sciences 
Center and VAMC, Oklahoma City, OK. 
Late Potentials (LP) have been analysed using both time 
domain (filtering) and frequency domain (FFT) techniques. 
However, both approaches have shortcomings. In the time 
domain, necessary bandpass filtering presupposes that LP's 
occupy a specific bandwidth - while this is not always the 
case. In the frequency domain, the conventional FFT 
approach loses all LP temporal resolution. Spectro-
temporal mapping (STM) advantageously uses both time and 
frequency information to produce a spectro-temporal 
signature of the QRS, LP and ST periods. Figure 1 is a 
signal-averaged and 40Hz bi-directionally filtered vector 
magnitude from a post-MI patient with VT. No LP's are 
identified. Figure 2 shows STM applied to the unfiltered 
X-lead of that signal average. The pattern of QRS and LP 
activity is clearly revealed. 
Fig 1. Fig 2. 
From a preliminary study of 7 patients, STM shows the 
potential to enhance LP identification and quantification 
by: (1) Lowering residual post-averaging noise, and (2) 
allowing sepsrate definitions of the QRS and LP periods. 
ABSTRACTS 199A 
PERIODIC HEART RATE DYNAMICS IN SUDDEN CARDIAC DEATH 
SYNDROME: SPECTRAL ANALYSIS. 
A.L. Goldberger, M.D., D.R. Rigney, Ph.D., A.D. Berman, 
M.D., J. Mietus, B.S., J.S. Weinstein, M.D., G.B. Moody, 
E.M. Antman, M.D., S. Greenwald, M.S., Beth Israel 
Hospital and Harvard Medical School, Boston, MA. 
Sinus rhythm (SR) variability in normals is represented 
by a broad bandwidth frequencv spectrum. We postulated 
that neuroautonomic perturba~ions would alter sinus 
rhythm dynamics resulting in an abnormal increase in heart 
rate periodicity prior to sudden cardiac death (SCD). We 
performed spectral analysis on Holter data from two 
groups in SR at high risk of SCD: (A) 16 pts who actually 
had a sustained ventricular tachyarrhythmia during the 
recording, and (B) 14 pts with NYHA Class III-IV conges-
tive cardiomyopathy. Results: Group A. 12 of 16 pts 
showed abnormal heart rate periodicity evidenced by pro-
nounced low frequency (.01-.03 Hz) oscillations or a 
HEART RATE OSCILLATION marked overall decrease in 
ONE HOUR BEFORE physiologic heart rate varia-
SUDDEN DEATH bility that "ere represented by 
w_ .... ~!: '''J tt: E ,-
I- ~ :'-t-----..:...-~---
~~ ~ 
UI.o -
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o .0I.1Il.06.0I.10 
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narrow bandwidth spectra 
(figure). Group B. All 14 pts 
showed narrow bandwidth spectra 
due to either overall decreased 
heart rate variability or low 
frequency oscillations. 
Conclusion: Pts at high risk of 
SCD may show periodic heart 
rate dynamics represented by 
narrow bandwidth spectra. 
These SR periodicities are not 
identifiable by traditional 
methods of analysis and may 
reflect autonomic instability. 
A MULTICENTER COMPARISON OF CRITERIA FOR IDENTIFYING LATE 
POTENTIAL S (LP) 
Edward J. Berbari, Ph.D., David E. Albert, M.D., Ralph 
Lazzara, M.D., FACC, OU Health Sciences Center, VAMC, 
Oklahoma City, OK and Late Potential Study Group. 
Several criteria have been used for characterizing LP as 
predictors of inducible, sustained ventricular tachycardia 
(VT). Four methods were evaluated (Simson: vector magni-
tude(VM), 25 Hz bidirectional filter(bF), rms of last 40 
ms (V40) <25 uV and QRS duration(QRSd) >110 ms. Kuchar: 
VM, 40 Hz bF, V40 <20 uV or QRSd> 120 ms. Gomes: VM, 80 Hz 
bF. V40 <17 uV, or QRSd> 107 ms. Nalos: Absolute VM, 100 
Hz unidirectional filter, QRSd>120 ms and duration of LP 
less than 20 uV>30 ms with observer verification). Seven 
centers contributed data from 247 patients using the same 
equipment and parameters, e.g., drug free, 200 beat aver-
age and noise <luV. All patients(drug free) underwent 
programmed stimulation fro evaluation of syncope, VT, VF, 
or complex ectopy. 146/247 patients had inducible, sus-
tained VT and were considered true positives. The methods 
performed as follows: 
Method Sens. Spec. Accuracl Pred. Value 
Simson 56% 76% 64% 77% 
Kuchar 80% 53% 69% 71% 
Gomes 92% 31% 67% 66% 
Nalos 44% 76% 57% 73% 
Conclusions: These methods show a wide disparity in sensi-
tivity and specif.icity but are more comparable in terms 
of accuracy and predictive value. Methods approaching a 
predictive value of 80% indicate a useful non-invasive 
means of screening patients for invasive studies. 
200A ABSTRACTS 
CORONARY ARTERY REPERFUSION: SUCCESSFUL RESPONSE WITH 
THROMBOLYTIC THERAPY DETECTED BY SIGNAL AVERAGED 
ELECTROCARDIOGRAMS DURING ACUTE MYOCARDIAL INFARCTION. 
Dennis M. Cassidy. M.D .• F.A.C.C .• and Suzanne Ranger. 
B.Sc .• Montreal Heart Institute, Montreal, Canada. 
Reliable noninvasive markers of successful thrombolytic 
therapy during acute myocardial infarction do not 
exist. Serial signal averaged electrocardiograms (mean 
of 3 consecutive tracings, 200 complexes, 25 Hz filter) 
were obtained in 26 patients who received intravenous 
streptokinase in the acute phase of myocardial infarct-
ion. The change (iI) in the signal averaged electro-
cardiogram total duration and voltage of the terminal 
40 ms was compared from the onset of treatment to the 
early (1.7±0.7 hr) and late (19.B±5.7 hrs) time record-
ings in 13 patients with reperfusion and 13 patients 
with no reperfusion. Reperfusion was defined by current 
clinical criteria and angiographic findings. The 
results are: 
iI Duration (ms) 
Early Late 
Reperfusion -5.2±7.3* -B.B±11.3* 
No reperfusion -0.5±S.B -0.S±9.0 
*p<.OS vs onset of treatment. 
iI Voltage (pO 
Early Late 
17.0±39.7* 13.5±37.4 
-3.3±16.6 -4.1±36.7 
We conclude: 1) The signal averaged electrocardiogram 
during reperfusion is characterized by a significant 
shortening of the QRS duration and an increase in the 
terminal voltage while that of no reperfusion remains 
unchanged; 2) duration appears more discriminative than 
terminal voltage to detect reperfusion and 3) serial 
signal averaged electrocardiograms provide a new 
noninvasive marker of reperfusion. 
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RV and LV Function and Their Interaction 
COMPARISON OF LEFT VENTRICULAR VOLUMES DERIVED FROM AN 
IMPEDANCE CATHETER WITH THAT DERIVED FROM THE DYNAMIC 
SPATIAL RECONSTRUCTOR. 
Roy S. Small. M.D., Namsik Chung, M.D., Rick A. 
Nishimura, M.D., F.A.C.C., Erik L. Ritman, M.D., David 
R. Holmes, M.D., F.A.C.C., Rodney Salo, Ph.D. 
To determine the accuracy of the impedance catheter (IC) 
in assessing LV volume, 7 anesthetized mongrel dogs 
(15-20 kg) were studied comparing volume derived from an 
IC placed in the LV versus volumes derived from the 
dynamic spatial reconstructor (DSR). Three steady state 
conditions in each dog were studied: control, preload 
reduced' (inferior vena cava occlusion) and a£terload 
increased (aortic occlusion). DSR volumes were measured 
during the levophase of a 30 cc bolus of nonionic 
contrast into the right atrium. Hypertonic saline 
calibrations (SC) were performed for the IC during each 
loading condition. The correlation of end diastolic 
volumes (EDV) between the DSR and IC in the control 
state approached unity (y=1.2x-15, r=.88). However, 
there was a poorer correlation during the two different 
loading conditions when the control state SC for each 
dog was used (y=1.5x-4l, r=.90). A similar comparison 
was present between end systolic volume (ESV) by DSR and 
IC, approaching unity in the control state (y=l.lx + 
2.3, r=.60) and deviating from unity during the two dif-
ferent loading conditions (y=1.8x-33, r=.94). The USe 
of a SC for each loading condition did not improve the 
correlation of volumes between the DSR and IC. 
Conclusion: The IC can accurately measure LV volumes in 
the resting state in the intact canine model. However, 
it becomes less accurate at different loading con-
ditions, which has important implications for future 
investigations, such as calculation of Emax from 
IC-derived pressure volume loops. 
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THE EFFECTS OF PERICARDIAL CONSTRAINT ON LEFT VENTRICULAR 
FUNCTION IN ACUTE PULMONARY EMBOLISM. 
Israel Belenkie, MD, FACC, Rosa Dani MD, Eldon R. Smith 
MD, John V. Tyberg MD, PhD, FACC, Univers i ty of Calgary, 
Calgary, Canada. 
Pulmonary embolism (PE) decreases stroke volume despite 
1 ittle change in LV end-diastol ic pressure (Plved) 
suggesting a decrease in compliance and/or contractility. 
However, Plved may not reflect preload in this situation 
in which external constraint (pericardial pressure = pp) 
to the LV may also be altered. To determine the effect of 
PE on transmural Plved, we studied 7 anesthetized dogs in 
which LV anteroposterior (Dap) and septum-to-free wall 
(Dsfw) diameters were measured with sonomicromet~. 
Pressures were measured in the LV, RV (Mil lars ), 
pericardium (balloon) and aorta. The pericardium and the 
chest were closed. After recording control data during 
volume loading, autologous clots were infused at normal 
and elevated Plved. Transmural Plved (Plved-Pp) 
correlated significantly better with LV area (Alv = Dap x 
Dsfw) and stroke work (SW = JJdPlv x dAly) than did Plved. 
During volume loading in 4 dogs, transmural Plved and SW 
decreased while Plved increased. Correlation 
coefficients, mean (range): 
~v ~ 
Plved .42 (.00-.82)] .43 (.07-.77)] 
Plved-Pp .78 (.61-.94) p<.05 .81 (.68-.90) p<.OI 
Alv .84 (.70-.95) 
The relationship of LV volume to transmural Plved and SW 
were similar during volume loading before and after PE 
suggesting that PE did not alter LV compliance or 
contractility. Because of the increase in Pp, transmural 
Plved is a better index of preload than Plved. Indeed, 
Plved measurements can be very misleading, occasionally 
increasing while LV volume decreases. 
SIGNIFICANT LEFT VENTRICULAR CONTRIBUTION TO 
RIGHT VENTRICULAR CONTRACTION. 
William P. Santamore. Ph.D., Ralph J. Damiano, Jr., M.D., James L. 
Cox, M.D., James E. Lowe, M.D., Martin S. Constantinescu, M.D. 
Bowman Gray School of Medicine, Winston-Salem, North Carolina. 
The derivative of right ventricular (RV) pressure (P) is broad or 
double peaked, with one peak occurring coincidentally with peak 
left ventricular (LV) dP/dt: suggesting a direct LV assistance to RV 
function. Since the ventricles contract nearly simultaneouSly, the 
relative contribution of LV to RV pump function has been difficult 
to determine. We quantified this LV assistance in 6 canine 
experiments, using a unique electrically isolated RV preparation. 
While on heart bypass, the RV free wall was removed and 
reattached, thus producing an electrically isolated RV. This 
preparation allowed for wide variations in the timing interval 
between RV and LV contractions. Double peaked waveforms for 
RVP and pulmonary flow (RVF) occurred over a wide range (0 to 
300 ms) of pacing interval between the RV and LV. One derivative 
peak always followed RV contraction for RVP and RVF 
(r=0.971±.OII, p<O.OI: r=0.972±.012, p<O.OI; respectively). The 
second derivative peak was unrelated to the RV -to-LV pacing 
interval (r=0.297±.l91, p>O.5 RVP; r=0.237±.278, p>O.5 RVF), but 
corresponded to the maximum L VP rise. Additionally, the 
magnitude of the two derivative peaks was similar when the 
ventricles contracted synchronously. When RV contraction preceded 
or followed LV contraction, the derivative peak associated with LV 
contraction was significantly greater (p<0.05, range 2.1±0.6 to 6.7±1.6 
for RVP; p<O.05 range 1.9±0.4 to 6.7±1.5 for RVF) than the 
derivative associated with RV contraction. Even with RV pacing 
stopped in diastole, 68+4% of RVP and 80+4% of RVF were 
obtained in the subseque-;;'t systolic beat. These- data demonstrate a 
normally present, large LV assistance to R V contraction and help to 
explain the RV response to myocardial infarction. 
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EFFECf OF PElUCARDIAL PRESSJRE aEVATIoo 00 ILOCIl l'Wl OO];POOENl' OF 
QJAN;ES IN amw!Y PERFUSIoo l'RFS1mU: IN CANINE HFARTS. 
Jeat B. Martin M.Sc •• Join G. KingJJB. Jr •• Ph.D •• Bernard Omt1n, 
B.SC •• Jacques k. ROUleau. M.D •• F.A.C.C.. Laval University. Quebec. 
Omada. 
Myocardial blood flaor (MBF) is 1npaired dlring CSI:diac taJponade to 
such an extent that ischemia. heIOOrrhage and zonal lesions can occur. 
To evaluate cIRJges in MIlF. corooaxy pressure-flCJo1 relations were 
constructed at control mean periCSI:dial pressure (pp) and when Pp was 
increased to 9±4 1JIIl llg (mean!:ID). MBF was IIESSUred in tle 
subelldocardial (ENlO) and the subepiCSI:dial (];PI) tissue layers (1!>.1m 
radiolabeled spheres) at 4 different levels of diastolic circunflex 
pressure (Pcd). dlring vasodilatation in 7 anestletized dogs. At 
high PP. pressures (1JIIl llg) were decreased in tle aorta (138/107 VB 
103/77) and tle circtJnflex artery (125/81 VB 96/65). During 
diastole. pressure increased in both tle LV (10 VB 15) and corooaxy 
sinus (8 VB 13). Beart rate increased (167 VB 187 bpn) while /!VO, (9 
VB 8 ml/min/100g) was mchanged. ENlO (543 VB 207) and ];PI (589 VB 
365) blood flaor (ml/min/100g) decreased. These changes were all 
significant at a p<0.01 level. ENlO and ];PI corooaxy pressure-flaor 
relations were l1nesr over tle range studied. At hi8h Pp vascular 
cond!ctaoce was unchanged (!p0.50); oo.ever. the pressure intercept 
at :rero flaor increased by 10 and 16 1JIIl llg in the ENlO and ];PI tiasue 
layers respectively. The effect of Pp and Pcd on ENXl and ];PI blood 
flow are sh:non in tle table: 
Pp <l>ntrol High 
Ped (um '\I) <55 >55 <55 >55 
ENOO X 247 463 lOB 202 
SD 112 208 53 75 
EPI X 406 579 258 370 
9) lOB 113 162 95 
By fNNA. both ENXl and ];PI blood flaor were redJced by the effect of 
decreasing Pcd (p< 0.0001) and also by increasing Pp (p < 0.0001). 
We conclude that at high PP. ENlO and ];PI vascular reserve decreased 
more than expected ca..,ared to that which IoOOld be expected with 
decreasing Pcd only. 
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Heart Failure 
TORSADES DE POINTE AND QT PROLONGATION AFTER ORTHOTOPIC 
LIVER TRANSPLANTATION. Michael F. O'Toole. M.D •• Thomas 
A. Mayer. M.D., Rex Winters. M.D., Craig T. January 
M.D., Ph.D., F.A.C.C. and Rory W. Childers, M.D., 
F.A.C.C. The University of Chicago, Chicago. 
Four cardiac arrests occurred in the peri-operative 
period of 27 adult orthotopic liver transplants over a 
two year period at The University of Chicago. Poly-
morphic ventricular tachycardia (PMVT), typical of 
Torsades de pointe, with associated QT prolongation 
corrected for heart rate and sex (QTc) was documented in 
two of the cases. one requiring prolonged over-drive 
pacing. Therefore, we reviewed the corresponding 
changes in the QTc and clinical and laboratory data 
retrospectively. No patient had known cardiac disease 
or was receiving medications that affect the QT inter-
val. Clinical data were grouped into the pre-operative 
phase (previous 10 days), immediate post-operative phase 
(48 hours) and, when available, before discharge or 
transplant failure phases (re-operation or death). 
The QTc pre-operatively was in the upper range of 
normal (446 ± 33 msec, x ± S. D.) and was increased in 
the immediate post-operative period (488 ± 45 msec, 
p < 0.01). There were no significant changes in serum 
electrolytes. but there was a Significant increase in 
total bilirubin in the immediate post-operative period 
(p < 0.01). The QTc normalized with improvement in 
transplant function (436 ± 38 msec) or remained elevated 
(462 ± 27 msec) before death or re-transplantation. 
This is the first report of prolongation of the QT 
interval with liver transplantation. The mechanism of QT 
lengthening is unclear but was most strongly associated 
with hyperbilirubinemia. We suggest that in some 
patients profound cholemia may be a marker for QTc 
prolongation and risk for PMVT. 
ABSTRACTS 
HEMODYNAMIC RESPONSE OF THE DENERVATED HUMAN HEART TO 
DYNAMIC EXERCISE. J.V. Nixon. MD; Henry Rosenburg, 
Donald Romhilt, MD; Andrea Hastlllo, MD; Michael 
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Hess MD. Med Coll of Virginia, Richmond, Virginia. 
'Prolonged survival is now commonplace in ~atients 
(pts) undergoing orthotopic heart transplantatlon (TP). 
Because these pts are now encouraged to undergo post- . 
operative cardiac rehabilitation. data on the hemodynamlc 
response to dynamic exercise is required for reference 
purposes. Thus, the exercise treadmill (ET) data of 29 
pts, mean age 41 years. who underwent ET within 12 months 
of TP [mean 9±1 months] were analyzed. All pts underwent 
a modified Naughton protocol; catheterization at 12 mos 
unifonnly showed normal coronary arteries. Mean [± SE] 
systolic and diastolic blood pressur~s (BP), heart rates 
(HR). and double products [DP ( x 10 )] were: 
Hl\BP Diast BP HR DP 
Rest ± 93±2 99±3 fr.-O 
Stage 1 149±4 89±2 109±3 16.2 
Stage 2 155±5 86±3 117±3 IB.l 
Stage 3 163±5 85±3 124±3 20.2 
Stage 4 169±6 B5±3 134±3 22.7 
Peak 171±6 B5±3 139±3 23.B 
2 Mins Post ET 162±6 89±2 133±3 21.6 
4 Mins Post ET 145±4 86±2 125±2 IB.l 
These data show that the denervated human heart has 
an increased resting HR and a nonnal diastolic BP. 
reflecting loss of va9al tone and nonnal perip~eral va~­
cular resistance (PVR). The response to dynamlc exerClse 
shows [1] delayed increase in HR and delayed return to 
resting HR. [2] a nonnal increase in systolic BP but. 
delayed return to resting BP. and [3] a nonnal reductlon 
in diastolic BP confinning the normalization of PVR after 
TP. The delayed return of HR and systolic BP reflects 
the increased extra-cardiac catecholamines after peak ET. 
SUBMAXlMAL BUT NOT MAXIMAL EXERCISE IMPROVEMENT 
IMMEDIATELY AFTER THERAPY FOR CONGESTIVE HEART FAILURE. 
Michael B. Rocco. MD, Rebecca J. Quigg. MD. Diane 
Gauthier. RN. BSN. L. Howard Hartley, MD, FACC, Wilson S. 
Colucci. MD. FACC. Brigham and Women's Hospital and 
Harvard Medical School. Boston, MA. 
Early improvements in hemodynamic measurements and 
symptoms after acute therapy of patients with congestive 
heart failure are frequently not accompanied by increases 
in maximal exercise capacity. To detennine if submaximal 
exercise perfonnance is improved acutely. B patients 
(NYHA II-III) received 25 mg TID of captopril (CAP) and 7 
patients (NYHA III-IV) received 5 to 7.5 mg QID of 
milrinone (MIL) and underwent upright cycle maximal 
graded (MGE) and submaximal endurance (SEE) exercise 
before and 1-2 days after initiation of treatment. 
Submaximal exercise was perfonned at a single workload of 
75% of the peak workload achieved on MGE. Peak workload 
and exercise time on MGE were not influenced by therapy 
(75±39 vs 76±3B watts; 11.4±4.8 vs 11.8±4.6 min, p~ns). 
No therapy-related differences occurred in peak heart 
rate, blood pressure. oxygen uptake. or venous lactate 
accumulation (VLA) during either MGE or SEE. However. 
patients were able to exercise longer ~uring SEE 
after treatment (9.2±4.0 vs 13.7±6.7 mln, p~.004). 
Similar trends were seen for the 2 treatment subgroups 
(8.B±3.3 vs 11.7±5.6. p=.OB for CAP; 9.7±4.9 vs 15.9±7.7. 
p=.02 for MIL). Before and after therapy peak VLA 
was similar during SEE (4.7 vs 4.5 mM/l. p=ns). but was 
significantly reduced at rest (1.2 vs 1.0 mM/l, p~.02) 
and during the first 3 minutes of SEE (1.9 vs 1.7 mM/l, 
p~.04). Thus. delayed rise in VLA and improv~d 
submaximal exercise capacity are associated wlth acute 
therapy. and may contribute to immediate improvement in 
symptoms and function in the absence of an increase in 
maximal exercise capacity. 
202A ABSTRACTS 
UNIQUE PROTECTION OF RENAL FUNCTION DURING ACUTE 
MYOCARDIAL INFARCTION IN THE DOG. 
Marsaret M. Redfield, M.D., John A. Schirger, Denise M. 
Heu lein, and John C. Burnett, Jr., M.D., Mayo Clinic and 
Foundation, Rochester, MN. 
Previous studies have reported differential cardiovascular 
responses to anterior versus inferior acute myocardial 
infarction (AMI). To date, the renal hemodynamic and 
excretory response to uncomplicated AMI has not been 
examined. Therefore, the renal circulation was examined 
before and for five hours after acute circumflex (CX,n=8) 
and left anterior descending (LAD, n=7) artery ligation in 
open-chested anesthetized dogs. A transient decrease in 
renal vascular resistance occurred immediately despite 
decreases in CO and MAP with no increase in atrial 
pressures or systemic resistance. This response was more 
prolonged during CX (40 min) than LAD (10 min) occlusion. 
During AMI, both groups experienced a natriuresis (UNaV) 
and diuresis (V). A marked increase in glomerular 
filtration rate (GFR) occurred only during CX occlusion. 
Control-CX-Peak Control LAD-Peak 
GFR, ml/min 27+6 57+6* 29+3 31+3 
UNaV, ~Eq/min 27.2+.6 56.6+.1* 44.5+.1 88.3+.3* 
V, ml/min .16+.03 .32+.06* .21+.05 .37+.09* 
CO, I/min 3.3+.2 2.6+.2* 3.3+.2 2.6+.2* 
LVEDP, mmHg 6.1+.5 7.0+.4* 6.8+1.3 8.5+1.0* 
MAP, mmHg 105+5 98+5 106+5 98+4 
ANF, pg/ml 40+5 54+7* 51+11 42+6 
*p< .05 Control vs peak - - -
These studies demonstrate a natriuresis and diuresis 
in AMI. A differential renal hemodynamic response is 
observed in which a more prolonged renal vasodilatation 
and unique increase in GFR occurs during CX occlusion, 
possibly mediated by an enhanced release in atrial 
natriuretic factor (ANF). 
WHICH OBJECTIVE MEASUREMENTS PARALLEL THE 
COURSE OF DISEASE PROGRESSION IN PATIENTS WITH 
CONGESTIVE HEART FAILURE? Milton Packer MD, F ACC and 
Bertram Pitt MD, FACC for the Captopril-Digoxin Research 
Group. Mount Sinai School of Medicine, New York, NY 
Previous survival studies in heart failure (CHF) have related 
pretreatment variables to long-term outcome, but none has 
related the chaner in pretreatment variables dJring follow-up to 
progression of HF. We measured serial changes in exercise 
time (ExT, sec), LV ejection fraction (LVEF, %), ventricular 
ectopic beats (VEB/hr), systolic & diastolic blood pressure (SBP 
& OOP, mm Hg) & heart rate (HR, bpm) in 99 pts with mild CHF 
treated with diuretics (but not digital is or vasodi lators) who were 
randomized to the placebo arm of a multicenter trial comparing 
digitalis and captopril. During 6-24 month follow-up, 28 of 99 
placebo-treated pts died or had worsening CHF requiring new 
therapy, whereas 71 pts remained stable~ * = p < .05 vs boseline 
ExT LVEF V B SBP DBP HR 
Worsening Baseline 522 25 20 115 81 85 
CHF 6-24 mos 453* 22* 32 110 76* 89 
Stable Baseline 563 26 10 122 79 84 
CHF 6-24 mos 625 * 27 II 125 80 83 
In CHF pts Who deteriorated or died, we noted a '" in ExT, 
LVEF and DBP (all p<.05) and an + in VEBs (p<.07) during the 
6-24 months of follow-up. These changes often preceded clinical 
deterioration. In contrast, in CHF pts who remained stable, 
values for LVEF, VEBs and OOP remained constant, whereas ExT 
actually +. When these same 6 variables were evaluated in the 
200 pts treated with digitalis or captopril in the trial, directional 
changes in ExT and LVEF still paralleled the clinical course of 
CHF, despite any direct effects of therapy on these variables. 
By logistic analysis, changes in ExT and EF were the only 
parameters that provided independent predictive information. 
In conclusion, changes in ExT and LVEF parallel the course of 
disease progression in pts with 'mild CHF and may identify a 
subset of pts with worsening CHF and at high risk of death. 
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PATHOPHYSIOLOGIC SIGNIFICANCE OF HYPONATREMIA IN 
EXPERIMENTAL PACING-INDUCED HEART FAILURE. 
Gorgon~~. M;)e ~Jh, cannella Angus, MSc., Terrance P. 
Stopps MSc., am Paul W. Annstrong, M.D., F.A.C.C., 
University of Toronto, Toronto, canada. 
Interpretation of the significance of hyponatremia in 
patients with heart failure is confounded by varyi~ 
severity of heart failure as well as concurrent diuretic 
therapy. Accordi~ly we studied 36 dogs 
ventricular-paced (250 bpm) to severe heart failure (HF, 
4.9+1 . 7 weeks): 15 dogs were recovered for 24 hours 
(24HR) to 4 weeks (4WK) after cessation of paci~. The 
table shows data (X, SO pooled from ANOVA) for serum 
sodilDll, potassilDll, urea am creatinine (Na, K, UREA, cu:d 
CREA in JIDlIOl/l) , plasma norepinephrine (NE, pg/ml) , renin 
activity (PRA, ~/ml/hr), aldosterone (ALD, pg/ml) am 
atrial natriuretic factor (ANF, pg/ml) obtained at 
control (C), HF, and recovery. *p<O.Ol canpared to C. 
Na K UREA CREA NE PRA ALD ANF 
C 148 4.7 6.2 85 392 1.3 130 188 
HF 144* 5.2* 8.0* 101* 1077* 8.2* 577* 476* 
24HR 146 5.2* 6.9 88 600* 2.0 326 354 
48HR 147 4.7 5.5 85 495 1.0 143 223 
4 WK 147 4.9 7.4 84 492 1.3 68 204 
SO 4 0.6 1.8 16 392 342 342 213 
Although the animals developed edeua, ascites am weight 
gain of 10%, Na declined significantly am correlated 
inversely with PRA am ALD (r=O.79, 0.89 respectively, 
p<O. 05) . M:lreover, the percent decline from control of Na 
also correlated with the increase in PRA and ALD (r=O. 71 , 
0.98 respectively, p<0.05). Conversely K, UREA and CREA 
increased iIX1icati~ inpaired renal perfusion. These 
changes !'ere rapidly reversible at recovery. Therefore in 
the IOOdel of paci~-iIX1uced heart failure, hyponatremia 
may be due to a decrease in free water clearance mediated 
in part by the renin-~iotensin-aldosterone system. 
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Cardiac Depression with Ethanol and Other Interventions 
REVERSIBILITY OF ACUTE ALCOHOL CARDIAC DEPRESSION AND 
THE PROTECnVE EFFECT OF VERAPAMIL 
Wolfgang Auffermann. MD .. Shao Wu, PhD .. William W. Parmley, 
M.D .. Charles B. Higgins, M.D .. Richard Sievers, B.S .. Joan 
Wikman-Coffelt, Ph.D .. University of California, San Francisco 
In order to assess the reversibility of acute alcohol cardiac 
depression, isolated hamster hearts were perfused with 2% 
ethanol for 30 minutes and than re-equilibrated with control 
medium. One group of hamsters was untreated. A second 
group was pre-treated with verapamil. A third group recieved 
dlltiazem. Energy metabolites were assessed using 31p-NMR 
standardized with HPLC of freeze clamped tissue. Intracellular 
calcium (Ca)i was measured with atomic absorption spectro-
photometry, marking the extracellular space with K(CoEDTA). 
After 30 minutes of alcohol perfusion, untreated hamster hearts 
showed a 74% decrease in developed pressure, a steep 
increase In end-diastolic pressure, a decrease of ATP from 9.8 to 
8.8 mmol and an increase of inorganic phosphate (Pi) from 6.7 
to 9.8 mmol but no change of phosphocreatine (PCr), intra-
cellular pH (pHli. Verapamil pretreatment prevented cardiac 
depression during alcohol perfusion, while diltiazem had no 
protective effect. After withdrawal, developed pressure and 
oxygen consumption significantly exceeded control values. ATP 
decreased to 8 mmol, while (pHli, PCr and Pi showed no 
significant change. Verapamil pretreated hearts showed better 
performance than untreated hearts without change in PCr and 
Pi, whereas ATP dropped slightly to 8.7 mmol. Thus, functional 
cardiac depression due to acute alcohol exposure is 
reversible. Increased (Ca2+1i during alcohol exposure normali-
zes after removal of alcohol. There is no major change of high 
energy phosphates during alcohol exposure or after removal 
of alcohol. Verapamil protects the heart from functional depres-
sion during alcohol exposure without affecting energy levels. 
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METABOLIC, FUNCTIONAL, AND ANTIARRHYTHMIC EFFECTS OF 
ACUTE ETrlAlWL EXPOSURE IN THE ISOLATED RAT HEART. 
Steven P. Schu 1man, M.D., Robert G. Weiss, M.D., Gary 
GerstenbTith, M.D., FJCr.C., Osamu Hano, M.D., Edward G. 
Lakatta, M.D. Johns Hopkins Medical Institutions and 
Gerontology Research Center, NIA, Baltimore, MD 
The metabolic, functional, and electrical effects of 
acute ethanol (ET) exposure were examined in the 
isovo1umic, retrogradely perfused rat heart using 31-P-
NMR. Under normal conditions ET, 0.75, 1.5, and 3.0 
vo1ume% (n=10 in each group) caused a dose-depeodent 
decline in developed pressure which stabilized by 20 
minutes at 70.7+5.6%, 63.1+5.7%, and 42.6+5.6% (mean+SEM) 
respect i ve 1 y of contro 1 (whl ch averaged T22.8+2.9 mm Hg 
in the 30 hearts and did not differ in the 1 groups). 
There was no change in levels of ATP, phosphocreatine 
(PCr) or pH. This decline could be rapidly and completely 
reversed by increasing perfusate calcium (Ca) to 4 mM or 
by perfusing with ET free sol ution. These resu1 ts 
suggest ET's effects may be mediated by a decrease in 
cell Ca cycling. This cycling is also implicated in the 
genesis of ouabain-induced VF. In 9 hearts, ouabain-
induced VF resu lted in mechan i ca 1 (absence of effect i ve 
systoles and rise in diasto1 ic pressure to 65.2+5.9 mmHg) 
and metabo1 ic deterioration (ATP = 39.8+2.4% or control, 
PCr = 39.3+3.4% of control) over 40 minutes. The addition 
of ET, 3% after 5 min of VF in 9 additional hearts caused 
cessation of VF in all hearts as determined by epicardial 
electrocardiograms, a decline in diastolic pressure, and 
reversal of the metabolic deterioration. Thus ET, results 
in acute but reversible myocardial functional depression 
under normal conditions and an antiarrhythmic and 
metabolic sparing effect in the Ca overloaded heart. 
These effects are not mediated via altered metabolism but 
probably result from an inhibition of cellular Ca cyc1 ing 
dependent contraction processes. 
REVERSIBLE ABOLITION OF CAROIAC CONTRACTION BY ETHANOL 
IS ASSOCIATED WITH DEPLETION OF SARCOPLASMIC RETICULUM 
CALCIUM CONTENT. 
Robert S. Danziger, M.D., Makoto Sakai, M.D., Ph.D., 
Richard G. Hansford, Ph.D., and Edward G. Lakatta, 
M.D. Gerontology Research Center, Baltimore, MD. 
Ethanol (ET) reversibly abolishes contraction (C) in 
the intact heart and may be useful for cardioplegia. 
We examined the mechanism of C depression in single rat 
cardiac myocytes (M) bathed in HEPES buffer (pH 7.4, I 
mM Ca2+) at 370C and stimulated at I Hz. Twitch ampli-
tude (TA) in M, measured via an edge detector as the 
extent of cell shortening relative to resting length, 
was reduced by ET in a concentration-dependent manner 
and abolished at 5% (Fig. A). C was restored following 
ET removal (not shown, P >.95 at 5%). Norepinephrine 
(NE, 10 ~), restored C in continued presence,of ET. 
Sarcoplasmic reticulum Ca2+ content (SRCa) in suspen-
TA A lOt 
I 
sion of cells 
loaded with 
Quin 2 was es-
timated from 
the height of 
the caffeine 
(10 mM) induced 
fluorescence 
transient (Fig. 
B inset). ET depleted SRCa in a concentration-depen-
dent manner. Thus, abolition of C by ET is reversible 
(by removal of ET or adding NE in ET presence) and in 
part may result from SRCa depletion. 
ABSTRACTS 
EFFECTS OF 5-LIPOXYGENASE INHIBITION ON CARDIAC ANAPIIYLAXIS IN 
ISOLATED GUINEA PIG HEARTS. 
Stanley R. Jolly. Ph.D. , East Carolina University School of Medicine, 
Greenville, N.C. 
203A 
Synthesis of the cardioactive peptidoleukotrienes depends on the 
activity of 5-1ipoxygenase. It is unclear whether inhibition of 
endogenous leukotriene biosynthesis can alter vasoconstriction and 
negative inotropic effects associated with infI8IIIDIltory states in the 
heart. In an attempt to study this problem, two 5-lipoxygenase 
inhibitors, AA-861 and RG 6866, N-methyl-4-benzyloxyphenyl-
-acetohydroxamic acid, have been examined in Langendorff-perfused 
guinea pig hearts Wldergoing cardiac anaphylaxiS and compared to 
indomethacin end LY 171883, a cyclooxygenase inhibitor end a 
leukotriene antagonist, respectively. In peced hearts perfused at 
constant pressure, AA-861 directly increased coronary flow but 
decreased developed pressure, while RG 6866 had no apparent direct 
effects (both agents infused Lc. at 20 meg/min, about 3 micromolar). 
LY 171883 but not RG 6866 or indomethacin antagonized coronary 
vasoconstriction by exogenous leukotriene D4.. When hearts were 
challenged with antigen (ovalbumin 1 mg 1. c.) in the presence of 
antihistamines, a significant reduction in coronary flow occured 
within 30 sec which was maximal at 2-3 min, 48±3'0, and perSisted for 
at least 10 min. An initial positive inotropiC effect was followed by 
a 25% fall in developed pressure. Both 5-lipoxygenase inhibitors 
blocked effects of antigen challenge on coronary flow: AA-861, 1l±3%; 
RG 6866, 4±3'0 reduction at 2 min. The late negative inotropic effect 
was also blocked. The leultotriene antagonist, LY 171883, was also 
effective but not indomethacin. These results provide further 
evidence for the contribution of leultotienes to cardiac anaphylaxis. 
More importantly, these findings suggest that 5-lipoxygenase 
inhibitors can be beneficial in situations where endogenous 
leukotrienes produce coronary vasoconstriction and myocardial 
depression. 
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Silent Ischemia and Vasoconstriction 
A NATIONAL SURVEY OF PAINFUL AND PAINLESS MYOCARDIAL 
ISCHEMIA: THE TOTAL ISCHEMIA AWARENESS PROGRAM 
(PRELIMINARY REPORT) 
Peter F. Cohn, M.D., F.A.C.C., George W. Vetrovec, M.D., 
F.A.C.C., Richard Nesto, M.D., F.A.C.C., and the Total 
Ischemia Awareness Program Investigators, SUNY Health 
Sciences Center, Stony Brook, New York 
In order to assess the prevalence, prognostic implications 
and effect of therapy on painful and painless myocardial 
ischemic events throughout the United States, we plan to 
enroll 600-900 patients with angina in the Total Ischemia 
Awareness Program (TIAP). Of the 416 patients enrolled in 
60 participating centers the first year of TIAP, 150 pa-
tients completed 96 hours of Holter monitoring by July I, 
1987. Fifty-two of the 150 (35%) had at least one episode 
of myocardial ischemia during 48 hours of ECG monitoring 
while receiving nitrates and/or beta blockers (Phase I); 
27/52 (52%) had more than one ischemic event. During this 
period, 33/52 (64%) had only painless events recorded on 
Holter monitoring, 5/52 (10%) had both types of ischemic 
events and 14/52 (26%) had only painful events. The total 
number of ischemic events recorded during Phase I in the 
52 patients was 108 (22 painful, 86 painless). Following 
addition of nifedipine (Phase 2), titrated by clinical 
response to maximal tolerated dose, the number of events 
per 48 hours fell 42% to 63 (pc.05); 7 were painful, 56 
painless. Furthermore, II patients had >60 minutes of 
total ischemic time in Phase I, compared to 6 patients in 
Phase 2. In summary, these prelminary data from the 
nation wide TIAP show that I) painless myocardial ische-
mia occurs freq~ently in treated anginal patients in the 
United States, with 74% having only painless events or a 
mixture of painless and painful events, and 2) the 
addition of nifedipine significantly reduces total 
ischemic activity. 
204A ABSTRACTS 
SMOKING AGGRAVATES MYOCARDIAL ISCHEMIA DURING DAILY LIFE. 
Joan Barrb, B.A., Kimberely Mead, B.S., Elizabeth G. Nabel, M .. , Mlchael B.Rocco, M.D., Stephen Campbell, 
M.B., Andrew P.Selwyn, M.D., F.A.C.C. Brigham and 
Women's Hospital and Harvard Medical School, Boston, 
Massachusetts. 
Smoking has been causally linked to coronary heart 
disease. In order to investigate the effect of cigarette 
smoking on transient myocardial ischemia, 69 patients 
with chronic stable angina, positive exercise tests 
(ETT), and coronary artery disease (CAD) underwent 24 -
48 hours of frequency modulated ECG monitoring off 
anti-anginal therapy and during daily life. Number of 
episodes and duration of ST-segment depression (STD) ( 
lmm at J1 and 60 msec at J? in consecutive beats for 30 sec) were quantified. A total of 1063 episodes of 
ischemic STD were detected in 5592 hours of ambulatory 
monitoring. The 24 patients who were chronic smokers (S) 
had a median of 3 episodes/24 hours (range 0-1~ing 
24 minutes/24 hours (range 0-347). The 45 nonsmokers 
(NS) demonstrated fewer episodes, 1/24 hours (range 0-25) 
p 0.05 and shorter duration of 2 minutes/24 hours 
(range 0-282), p 0.05 of STD. These findings remained 
statistically significant when a number of confounding 
factors such as age, sex, NYHA, ETT, MI history, number 
of CAD vessels and risk factors, were partial led out by 
means of logistic regression. In a subsample of 21 Sand 
21 NS matched for all the above variables, the median 
number of episodes was 6 times greater for the S than the 
NS (p=NS), with a significantly longer duration of 42 vs 
6 minutes /24 hours, p 0.02 (range 0-347 vs 0-282). 
This study shows that even with statistical control for 
clinical characteristics and CAD, patients who smoke have 
significantly more active myocardial ischemia during 
daily life. 
MJRNING mCRFASE OF PIATEIEl' ~ m PATIENTS 
WI'IH ~ ARl'ERY DISFASE 
stefan N. willich. MD, sinikka Ptlhjola Sintanen, MD, 
Satimer s. Iilatia, MD, Geoffrey H. Tofler, MD, 'lhanas L. 
Shook, MD, FAcx::, James E. M.ll.ler, MD, FAcx::, Gordon H. 
Williams, MD, Peter H. stone, MD, FACX:, Hazvard Medical 
SChool, Boston, MA 
'!he incidence of MI an:l su::lden cardiac death increases 
durin; the lImTliIY;J. Platelet aggregability (PA) in 
nonnal subjects is also increased in the 1IDmin;J but has 
not been shcMn to increase in patients (pts) with 
ClOrC4'Ial:Y artery disease. Non-seJ.ective beta blockade has 
been reported to increase PA. We studied 10 coronaIy 
artery disease pts durin; rootine activities for two 24-
hour~. Metq>rolol (200 ng bid) was administered in 
a ran:ianized, daJble-blind, plaoebo-controlled, crossover 
study. ADP an:l epi.neImine (Epi) threshold concentra-
tions (c) in:iucin;J biIiJasie PA in platelet-rich plasma in 
the first 6 pts durin; placebo therapy were: 
2 
cADP 
6 
10 
Noon 3pm 6 9 Mid 3am6 9 Noon 
In the 10 pts, ll'etoprolol did not alter the 24-hour 
patte= J'X)r the basal level of PA (n-ean cADP 3.9±.3 
durin; ll'etoprolol vs 3. S±. 3 durin; placebo, n-ean cEpi 
4.6±.6 vs 5.2±.S, p=NS). 
Conclusions: 1) pta with COronaIy artery disease have a 
marked increase in PA fran 6 to 9 a.m. (decrease of cADP 
an:l cEpi). 2) Metoprolol does not adversely affect PA. 
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EVIDENCE OF ENDOTHELIAL DYSFUNCTION IN ANGIOGRAPHI-
CALLY NORMAL CORONARY ARTERIES OF PATIENTS WITH 
CORONARY ARTERY DISEASE. 
Steven W. Werns, MD, FACC, Henry H. Hsia, MD, Joseph 
A. Walton, MD, Mark L. Sanz, MD, Bertram Pitt, MD, 
FACC, University of Michigan, Ann Arbor, Michigan. 
Acetylcholine (A) causes endothelial-dependent dila-
tion of normal arteries in most species. The effect 
of A on human coronary arteries is controversial. In 
view of pathologic evidence that coronary artery 
disease (CAD) is usually diffuse, we postulated that 
angiographically normal coronary arteries in patients 
with CAD would constrict to A due to endothelial dys-
function. Therefore, we examined the effect of intra-
coronary A (0.2mM at 0.8-1.6 ml/min) and 250 mcg 
nitroglycerin (N), an endothelial-independent vasodi-
lator, on the diameter of normal coronary arteries, 11 
from 9 patients with 1 or 2 vessel CAD and 6 from 3 
patients without CAD. The baseline (8) and post-drug 
coronary diameters (mm) were measured by automated 
quantitation of digitized cine-angiograms. Infusion 
of A caused dilation of normal coronary arteries in 
patients without CAD but constriction of normal 
coronary arteries in CAD patients: 
group B N 
no CAD 2.83+.28* 3.06+.25** 3.43+.35* 
CAD 2.83:;:-.30 2.46:;:-.28 ** 2.99:;:-.28 
p .99 .18 .35 
(*mean diameter+SEM) (**p<.05 vs B) 
A-B 
+.23+.06 
-.38:;:-.13 
(,01 
Consistent with previous studies in man, angiographi-
cally abnormal coronary arteries (>50~ stenosis) and 
those with minimal irregularities also constricted ·to 
A. The constrictive effect of A in the normal coronary 
arteries of patients with CAD suggests a diffuse 
abnormality of endothelial function. 
TRANSIENT ISCHEMIC EPISODES AMONG COCAINE USERS: 
EVIDENCE OF CORONARY VASOSPASM. 
Koonlawee Nademanee. M.D .. F.A.C.C, David A. Gorelick, 
M.D., Martin A. Josepbson, M.D. F.A.C.C., Helen A. Robertson, 
B.S., Freny Vagbalwalla Mody, M.D., Van ida Intaraebot, R.N. 
Wadswortb VAMC and Unh of California, Los Angeles. 
Mortality and morbidity from acute myocardial infarction 
related to tbe recreational use of cocaine has increased 
alarmingly in the USA. However, the prevalence of spontaneously 
occurring and/or exercise·induced myocardial ischemia among 
cocaine addicts, is not known. Thus, we studied consecutively 21 
male cocaine addicts (CA) admitted for treatment of substance 
abuse( mean age = 35 years; mean duration of cocaine use = 27 
months) The mean interval of tbe last use of cocaine prior to 
admission is 9 days. All patients underwent serial exercise 
treadmill(ETT), Holter monitoring(H), during a 28 day·in·patient· 
cocaine·free·period. Holter tapes were coded and scanned blindly 
and mixed with those of 42 normal volunteers [V) (age <35 years 
old) and 70 chronic stable angina patients(CSA). All 21 CA except 
one had a negative ETT. However, 8 of the 21 CA had frequent 
episodes of ST elevations on H (6 + 5 episodes of ST elevation> 
1 mm, ranging 1·7mm;lasting>30 sec). Twenty percent of the 
episodes were associated with angina; all episodes were not 
related to QRS complex changes or artifacts. None of the V or 
CSA had ST elevation but 18 of 70 CSA had frequent episodes of 
transient ST depression. The ST changes in CA disappeared on 
the second H after 4 weeks of cocaine withdrawal in 4 patients; 
significantly reduced in I; 3 others did Rot yet have a repeat H. 
Conclusion: Thus, among CA, there is a high incidence of 
transient ischemic episodes, manifesting themselves as ST· 
elevation (both symptomatic and silent) characteristic of coronary 
vasospasm. These episodes disappear after a longer duration of 
cocaine withdrawal indicating the relationship with prior cocaine 
use. Our data support the hypotheses that vasospasm is one of 
the mechanisms of cocaine-related MI. H is of value in 
identifying CA who are at risk of myocardial ischemia. 
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AMINOPHYLtiNE ADMINISTRATION AFTER DIPYRIDAMOLE STRESS 
AS A TRIGGER OF CORONARY VASOSPASM IN VARIANT ANGINA. 
Eugenio Picano, MD, Fabio Lattanzi, MD, Michele Masini, 
MD, Alessandro Distante, MD, Antonio L'Abbate, MD, FACC. 
C.N.R. Clinical Physiology Institute, University of 
Pisa, Pisa, Italy 
DipyridaMOle (D.) stress testing represents an 
alternative to eMercise for the diagnOSis of coronary 
artery disease (CAD). In order to elucidate whether it 
might elicit coronary vasospasm in susceptible pts (as 
eMercise does), 36 in-hospital pts with variant angina 
pectoris underwent D. infusion (up to 0.S4 mglkg over 10 
minutes) with continuous 12 lead ECG and 2-dimensional 
echo monitoring. All were off medications. In all pts, 
the test was pharmacologically stopped with the D. 
antidote. Aminophylline (A., SO to 240 mg i.v. over I to 
3 minutes). Two to siM minutes after starting A. 
infusion, 10 pts (28%) developed ST segment elevation 
()O.IO mVolt), always accompanied by obvious asynergy 
detected by echo, in the same ECG leads showing 
spontaneous or ergonovine induced ST segment elevation 
in those pts. Nitrates promptly resolved ischemia in all 
pts. At coronary angiography 5 of these 10 pts showed 
significant ()70% lumen reduction of at least I major 
coronary vessel), 5 non significant CAD. 
The Rate Pressure Product at the onset of ST segment 
elevation (after 0.+ A.) was copsiderably less than that 
recorded at peak exercise stress test in these pts 
(9600 ± 2200 vs 18400 ± 4900, P < .01). In all pts, the 
infusion of A. alone (at the same dosages and rate as in 
the D. test) was unable to provoke any significant echo 
and ECG alterations or chest pain. 
In conclusion, abrupt withdrawal by A. of arteriolar 
coronary dilation andlor of sympathetic hyper tone induced 
by D. may unmask the vasospastic tendency in a 
significant number of pts with variant angina. 
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Calcium Entry Blockers: Drug Interactions 
NICARDIPINE BUT NOT VERAPAMIL ANTAGONIZES FOREARM 
VASOCONSTRICTION TO ENDOGENOUS~-ADRENERGIC STIMULA 
rION BY LOWER BODY SUCTION. 
ROBERTO PEDRINELLI,STEFANO TADDEI. ANTONIO SALVET 
tI.I Clinica Medica,University of PISA,ITALY 
We reported previously the different effective 
ness of nicardipine(N)and verapamil(V)against 
forearm vasoconstriction(FVc) to exogenous~-stimu 
lation by norepinephrine. The aim of this study 
was to evaluate the effect of those CEBs on FVc 
to ENDOGENOUS~-stimulation by nonhypotensive lower 
body suction(LBS,-20mmHgx5min).Either N or V were 
randomly infused into the brachial artery at two 
cumulatively increasing,systemically ineffective 
rates(10§30pg/minx15min each)in 8 mild uncomplicat 
ed hypertensive pts, at at least 8hrs intervals:' 
Forearm blood flow(FBF,venous plethysmographY),HR 
and ia MAP were recorded throughout. During con 
trol(C.ia salineLLBS decreased FBF by 42.2+9.% 
(from 4.4t.9 to 2.6!.8) without changes in MAP 
and increasing HR(from 76.;t10. to 81.5t7.8, p 
.01).Either ia N or V increased FBF comparably(N: 
4.5,1.8 to 9.lt2. and 14.2;t4.1; V:4.4;t.9 to 9.1!1.6 
and' 15.1;1;1.5 respectively).LBS decreased FBF by 
a peak 29.1:11. and 16.9:9.1% during N(p.C 01 vs 
C) without significant changes during V( 38. 5,;t9. 
and 34. 3t8. 7 %). No changes in FVc during LBS in 
the contralateral F occurred.To validate the assum 
ption of~-stimulation during LBS,phentolamine(PH~ 
80pg/minx15min)was infused ia in 5 additional 
pts:FBF increased from 4.11.9 to 9.9;t2.,and LBS 
mediated FVc was abolished.Thus,even against ENDO 
GENOUS ct- stimulation, N shows d- adrenolytic prope~ 
ties not shared by V.an unrelated CEB.Non specific 
antagonism may contribute to the vascular effect 
of N,and possibly other dihydropiridine CEBs. 
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DILTIAZEM ATTENUATES THE HEMODYNAMIC EFFECTS OF CARDIAC 
GLYCOSIDES. 
~ Hansford Watford, M.D., Richard A. Walsh, M.D., 
F.A.C.C., and Robert A. O'Rourke, M.D., F.A.C.C., UT 
Health Science Center and VA Hospital, San Antonio, Texas. 
In theory, calcium entry blockade might be expected to 
attenuate the positive inotropic effects of cardiac 
glycosides while diminishing the increases in systemic 
vascular resistance often produced by digitalis therapy. 
Accordingly, we studied the influence of diltiazem (D) on 
the hemodynamic effects of ouabain (0) in 7 
preinstrumented awake dogs. Randomly, dogs received 0 
(0.015 and 0.030 mg/kg) alone or after D (100 meg/kg bolus 
+ 60 meg/kg/min IV) with data collected at 10, IS, and 20 
min. Results + 1 S.D. at 20 min. after high dose 0 
included: 
HR LV EDD MAP dP/dt max 
(beats/min) (mm) (mmHg) (mmHg/s) 
C 89+16 49+6 103+11 2923+611 
o 105+14 48+8 113+15* 4077+695* 
DC 120+22 48+6 89+9 * 3000+292 
D + 0 106+19 48+7 87+14*+ 3680+338* 
C = control; DC = control post-diltiazem; EDD =-end-
diastolic dimension; MAP = mean aortic pressure. *p<.05 
compared to C; +p<.005 as compared to 0 with D. Diltiazem 
completely abolished the increase in systemic arterial 
pressure produced by ouabain while mildly attenuating its 
effects upon myocardial contractility (40% increase LV 
dP/dt max pre vs 23% post 0, p<0.05). We conclude that 
calcium entry blockade markedly attenuates the effect of 
cardiac glycosides on arterial blood pressure while 
causing a more mUd decrease in their positive inotropic 
action. These results indicate the need for additional 
studies of the interaction of these 2 drugs in patients 
with CHF. 
NEAR TOTAL REDUCTION IN VERAPAMIL BIOAVAILABILITY BY 
RIFAMPIN: ELECTROCARDIOGRAPHIC CORRELATES 
Rick A. Barbarash, Pharm.D., Jerry L. Bauman, Pharm.D., 
James H. Fischer, Pharm.D., George Kondos, M.D., 
Randall L. Batenhorst, Pharm.D., University of 
Illinois, Chicago, IL. 
To evaluate the clinical significance of the 
interaction between rifampin (RIF) and verapamil (VERI 
we administered to 6 normal volunteers single doses of 
VER 10 mg iv, then 120 mg po 2 days later. After 2 
weeks of RIF 600 mg po qhs, the iv and po doses of VER 
were repeated. ECG and serum for VER were taken before 
and after each VER dose. For iv VER, there was a small 
decrease in area under the serum concentration time 
curve (AUC) from (mean ±SD) 173.7 ± 29.5 to 142.2 ± 
30.4 ng·hr/ml (p<.025) and an increase in clearance 
from 991.0 ± 185.4 to 1228.2 ± 267.8 mllmin (p<.OI) 
after RIF. There were no changes in volume of 
distribution or half-life. The PR interval was 
significantly prolonged compared to baseline after iv 
VER. The maMimum % change in PR interval was 29.6 ± 
17.3 before and after 25.7 ± 8.4 after rifampin (p=NSI. 
For po VER, there were marked decreases in peak serum 
concentration from 194.8 ± 107.8 to 7.2 ± 4.2 nglml 
(p<.OII, AUC from 526.8 ± 173.8 to 34.3 ± 16.2 ng'hr/ml 
(p<.OOI) and oral bioavailability from 26 ± 1.0 to 2.0 
± 1.0 % (p<.OOI). There was no change in half-life. For 
po VER, significant PR interval prolongation only 
occurred before treatment with rifampin; the maMimum % 
change in PR interval was 26.4 ± 16.7 before and 3.9 ± 
2.3 after rifampin (p<.OOI). In conclusion, the marked 
decrease in oral bioavailability and abolition of ECG-
response demonstrates that a clinically significant 
drug interaction exists between RIF and orally 
administered VER. 
206A ABSTRACTS 
VERAPAMIL INCREASES CYCLSPORIN-A BLOOD TROUGH LEVELS 
IN CARDIAC TRANSPLANT RECIPIENTS 
Christiane E. Angermann MD. Christoph H. Spes MD, Mathias 
Anthuber MD, Bernhard M. Kemkes MD, Karl Theisen MD 
Medizinische Klinik Innenstadt. University of Munich. FRG 
An increasing number of drugs is known to interact with 
cyclosporin A (CS). The present study investigates, if an-
tihypertensive therapy with the ACE-inhibitor enalaoril 
(E) 01 us furosemi de (F) alone or in combi nat i on with vera-
pamil (V) interferes with CS pharmacokinetics and thus 
alters its nephrotoxic potential. 20 hypertensive cardiac 
transplant recipients (CTR, 19 m, 1 f. 43+10 years. 15+13 
months pop.), in whom blood pressure could be normalized 
with this drug regimen. were evaluated. CS blood trough 
levels (RIA). serum creatinine and serum urea were deter-
mined and the daily CS d0sages recorded before antihyper-
tensive therapy (control). under E+F (10-20 mg/d and 20-80 
mg/d) and under additional V(120-360 mg/d. 12 /20 CTR). 
Results: (x+SD, *1**1***: p<0.05 10.01 10.001 vs. E+F) 
- Contro 1 E + F E + F + V 
CS-level (ng/ml) 713+210 605+150 798+202 * 
CS-dosage (mg/24h) 441+136 386+103 336+ 75 *** 
Creatinine (mg/%) 1.65+0.49 1.64+0.54 1.90+0.59 ** 
Serum urea (mg/%) 32.9+ 9.3 32.1+10.2 38.7+11.7 * 
In 11 CTR. in whom CS-dosage was not reduced between con-
trol and E+F (399+100 mg/24h), CS-levels remained unchan-
ged during this period (620+134 vs. 594+154 ng(ml, NS). 
Conclusions: Neither renal function nor CS blood trough 
levels are influenced by the theraoy with E+F. The stri-
king rise in CS-levels after addition of V. despite a si-
multaneus reduction in CS-dosage. suggests a pharmacologi-
cal interaction between V and CS, the concomittant dete-
rioration of renal function must be interpreted as conse-
quence of the increased CS-levels. Thus close monitoring 
of CS-levels and dosage adjustments are needed when the 
therapy with V is introduced in patients on CS. 
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CHOLESTEROL AND SATURATED FAT CONTENT OF FISH OIL 
(FO) PREPARATIONS INFLUENCES THE HYPOLIPIDEMIC 
RESPONSE IN TYPE IV HYPERLIPIDEMIC PATIENTS. 
Michael H. Davidson. M.D.. Papasani V. Subbaiah, Ph.D. Jere P. 
Segrest, M.D., Ph.D. and John D. Bagdade, M.D. Rush Medical 
College, Chicago, illinois. 
Dietary supplementation with omega-3 fatty acid (Om3FA) In 
preparations containing high amounts of cholesterol (C) and 
saturated fat has been shown to Increase LDL-C In patients with 
hypertrlglycerldemla. To determine whether this LDL-C elevation 
was in fact related to the cholesterol and saturated fat content 
of FO, we studied 12 Type IV hyperlipidemic patients (mean pre-
treatment triglyceride 704±334 mg/dl; cholesterol 345±117 mg/dl). 
In a crossover sequence, patients received 16 capsules containing 
approximately 30% Om3FA, 25% saturated fat, and 6 mg of Chol 
(Capsule A), the daily dose totalling 4.8 gms of Om3FA. After a 6 
week washout period, patients then received 12 capsules of 
another preparation containing 40% Om3FA, 8% saturated fat, and 
was cholesterol-free (Capsule B), providing the same daily dose of 
4.8 gm of Om3FA. Plasma lipids and very low, Intermediate, low, 
and high density lipoproteins (VLDL, IDL, LDL, and HDL) were 
measured before and 6 weeks post-treatment by vertical spin 
ultracentrifugation. The following responses expressed as a 
percentage change from baseline were observed: 
Capsule A 
Capsule B 
*p<.01 
~ VLDL IDL 
-12.1%* -56.5%* +3.0% 
-25.2%* -62.2%* -7.1% 
LDL ~ !:mba 
+12.3%* +45.1%* +3.1% 
-2.9% +15.9%* -.8% 
These results suggest that the Increase In LDL-C observed 
following dietary supplementation with FO Is caused by the high 
cholesterol and saturated fat content of the oil and that this 
deleterious effect can be avoided by scrupulous attention to the 
contents of the available FO preparations. 
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HYPERTENSION DETECtION AND CONTROL FROM 1973 TO 1986: THE 
MINNESOTA HEART SURVEY. 
J. Michael Sprafka, Ph.D., Aaron R. Folsom, M.D., Stanley 
A. Edlavitch, Ph.D., Gregory L. Burke, M.D., University 
of Minnesota, Minneapolis. 
Blood pressures of adults aged 25-59 years from three 
community surveys in Minneapolis-St. Paul conducted in 
1973-1974, 1980-1982, and 1986 were compared to document 
the changing patterns of hypertension detection and con-
trol. Mean age-adjusted SBP demonstrated an average 1-2 
mmHg decline between 1973-74 and 1980-82 in both men and 
women. Between 1980-82 and 1986 the average age-adjusted 
SBP declined slightly for women « 1 mmHg) with no changes 
noted for men. Mean age-adjusted DBP demonstrated an av-
erage 3-4 mmHg decline between 1973-74 and 1980-82 in both 
men and women with no differences between 1980-82 and 1986. 
Hypertension prevalence has remained essentially unchanged 
ranging from 17% and 12% in 1973-74 to 15% and 10% in 
1986 in men and women respectively. Detection and treat-
ment status of hypertensive persons demonstrated dramatic 
improvements between 1973-74 and 1980-82 with relatively 
little change occurring between 1980-82 and 1986. The 
percentage of undetected hypertension was 43% in 1973-74, 
21% in 1980-82 and 22% in 1986. The percentage of hyper-
tensives treated and controlled increased from 23% to 53% 
between 1973-74 and 1980-82 decreasing to 48% between 
1980-82 and 1986. These findings suggest that the impres-
sive change in hypertension detection and control occur-
ring during the late 1970's has peaked in the 1980's and 
may be declining. Increased effort in hypertension con-
trol is warranted if continued improvements are to be 
seen in the next decade. 
EXERCISE, LOWFAT DIET, AND A HIGH POLYUNSATURATED: 
SATURATED FAT RATIO DO NOT PREVENT THE CHOLESTEROL 
RAISING EFFECTS OF DIETARY CHOLESTEROL. Clifford 
Johnson, M.D. and Philip Greenland, M.D., F.A.C.C., 
University of Rochester (NY). 
Physical activity can lower total cholesterol (TC) and 
LDL-cholesterol (LDL-C). A lowfat diet and a high P:S 
ratio can also lower TC and LDL-C. Can these factors 
together prevent lipid-raising effects of dietary C? We 
evaluated 10 healthy, normolipidemic, men (mean age = 27) 
in a Clinical Research Center to study this question. 
Subjects maintained a constant amount of aerobic exercise 
(at least 25 minutes 4 times per week). Two diets of 4 
weeks each were compared in a crossover design. Diets 
were identical except for C content: one contained 600 
mg/day (HIGH); the LOW contained 200 mg/day. Both diets 
contained 15% of calories as protein, 55% as carbohy-
drates, 30% as fat, and the P:S ratio was 1.5. Caloric 
intakes were selected to maintain constant body weight. 
Diet order was randomly selected for each subject. 
On the HIGH vs. LOW diet, mean TC (158.9 + 7.2 vs. 
149.1 + 8.0 mg/dl), LDL-C (97.2 + 5.6 vs. 88.2 + 6.3 
mg/dl)-and Apo B (86.6 + 5.4 vs.-76.3 + 5.8 mg/dl) levels 
all significantly (p < 0.05) increased~ Mean 
triglycerides, HDL-2 and 3, and Apo A-I levels did not 
change significantly. Individual responses were highly 
variable: e.g., 3 of 10 subjects increased LDL-C levels 
by more than 25% on the HIGH diet. There was no 
significant effect due to diet order. 
Dietary cholesterol can increase blood cholesterol and 
LDL-C significantly in normolipidemic healthy young men 
even when they are exercising regularly and cons" .. ing a 
moderately fat-restricted, low saturated fat diet. 
Dietary cholesterol restriction appears justifiable even 
when these other lifestyle and dietary measures to 
minimize cholesterol are undertaken. 
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WORKSITE-BASED MULTIFACTORIAL RISK INTERVENTION TRIAL 
Nancy Miller RN, Stanford University, Stanford, CA, 
Elizabeth Wagner, RN, Duke University, Durham, NC, Paul 
Rogers, MD, Mayo Clinic, Rochester, MN. 
A multicomponent intervention for reducing cardiovascu-
lar risk was provided to production line personnel of 2 
food processing plants; 2 plants served as controls. Of 
participants (P) undergoing baseline screning, 53% and 59% 
of control (C) and intervention (I) P's returned for 
followup evaluation 1 year later (n-450 and 442, respec-
tively). Mean age of P's in C and I plants was 32±8 and 
34±9 years (NS). Sex of P's in C and I groups was male in 
52% and 42% (NS). A general orientation provided video-
taped information about smoking, nutrition and exercise. 
Interventions consisted of printed self-help materials, 
class and individual instruction by health counselors and 
computer-generated progress reports. A 5-hour smoking 
cessation course with two I-hour followup sessions was 
conducted on·site. Dietary management was provided 
through individual counseling and computerized progress 
reports based on P's completion of written status reports 
(food frequency questionnaires). Exercise training was 
conducted in group sessions on- site and individually at 
home. The proportion of smokers in C and I groups at 
baseline was 38% and 34%, of whom 3% and 23% quit (p < 
0.01). Two thirds of the latter did not participate in 
the smoking cessation course. 
to Body 
Group Weight (lbs) 
C 4.2±1l 
to Systolic 
BP (mm) 
2.7±12 
to Diastolic 
BP (mm) 
4.6±10 
to TI Plasma 
Cholesterol 
(mg/dll 
-2.8±23 
I 0.05±10*** -0.5±13*** -0.7±11*** -9.6±23** 
** P < 0.005 vs. C *** P < 0.001 vs. C 
CONCLUSION: A multicomponent worksite-based intervention 
program favorably influenced smoking, body weight, total 
plasma cholesterol and blood pressure. 
EFFECTS OF SIKVASTATIN VERSUS PROBUCOL. 
SIMVASTATIN MULTICENTER GROUP II. 
J. staggers
b 
Ph.D., L. Washington, R.N., 
M.S., and . Mantell, M.D., Merck Sharp 
Research Laboratories, West POlnt, PA 19486. 
T. 
& 
Cook, 
Dohme 
A 12-week, randomized, double- blind study in 14 
centers investigated the efficacy, tolerability and 
safety of simvastatin (sim), a potent HKG-CoA 
reductase inhibitor, compared to probucol (pro). Sim 
produced clinically important improvements in the 
plasma lipid profile. Total and LDL cholesterol (C), 
triglycerldes, and apolipoprotein (apo) B were 
markedly reduced. Levels of HDL cholesterol and 
apo-AI were moderately increased. Both 20 and 40 JUg 
q/pm doses (sim) were significantly more active in 
lipid profile improvement than pro 500 mg bid. Sim 
was active in patients of both sexes, those with 
baseline total-C above or below 300 mg/dl, baseline 
tri~lycerides above or below 200 mg/dl, and those 
patlents with or without a primat·y diagnosis of 
familial hypercholesterolemia. 
MEAN LIPID LEVELS (mg/dl) AT WEEK 12 
TREATMENT: Iiasehne Slm 20 Slm 40 Pro 
N of patients 243 82 80 81 
Total-C 322.8 239.7*+ 215.5*+ 285.2* 
LDL-C 250.8 167.7*+ 142.2*+ 227.2* 
HDL-C 45.4 49.8*+ 50.4*+ 32.7* 
LDL-C/HDL-C 5.9 3.6*+ 3.0*+ 7.7* 
Apo-B 203.2 137.4*+ 115.9*+ 161. 9* 
Triglycerides 157.7 119.9*+ 120.8*+ 151.9 
*p ~ 0.01 vs Baseline +P ~ 0.01 vs. Pro 
Sim and pro were well tolerated. No patient had a 
serious drug-related adverse event. Serum liver 
transaminases did not vat·y significantly with drug 
treatment. There was no net increase in the number of 
lens opacities in either sim treatment group and only 
one opacity was gained in the pro group. 
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APOLIPOPROTEIN B AND Al CHANGES INDUCED BY CHOLESTEROL-
LOWERING DIET IN PATIENTS WITH HYPERAPOBETALIPOPROTEIN-
EMIA (HYPERAPOB). Jorge F. Trejo-Gutierrez, 
Lora B. Wilder, Peter O. Kwiterovich, Thomas A. Pearson. 
The Johns Hopkins Medical Institutions, Baltimore MD. 
HyperapoB, elevated levels of apolipoprotein B (>120 mg/ 
dl) with normal levels of low-density lipoprotein choles-
terol(LDL-C <90th %tile), may be an important predictor of 
premature coronary artery disease, yet the therapeutic 
interventions for this condition are unknown. To study the 
effect of diet in HyperapoB, we instructed 29 adult male 
pts.to follow a standard low-fat,low cholesterol diet dur-
ing a 3 month period. 3-day diet records at baseline and 
at 3 months were analyzed using a computerized program to 
assess the changes attained in dietary components. Lipid, 
lipoprotein, apolipoprotein and dietary results were: 
Lipoprotein and Before diet After diet 
dietary values (mean + S.D. (mean ± S.D.) P value 
Apo Al(mg/dl) l48±28 l2s±28 ~
ApoB (mg/dl) lsO±23 l48±23 N.S. 
ApoB/Al ratio 1.OS±.27 1.24±.3s .01 
HDL-C/Al ratio 0.32±.06 0.37±.07 .0005 
Total fat(% of Cal.) 32±s.7 27±7.4 .0003 
Saturated fat(% Cal.) 10±3. 2 8. 7±3. 3 .02 
Polyunsat.fat(% CaL) 7.l±2.2 6.l±1.9 .04 
Total calories 2077±s84 l824±s83 .03 
Neither plasma total cholesterol,triglycerides, LDL-C, 
LDL-C/ApoB, high-density lipoprotein cholesterol,nor 
dietary cholesterol,protein or ethanol intake changed sig-
nificantly with diet. ApoB change correlated with protein 
intake change (r=.40, p<.03), without correlation with 
other diet or lipid values. Thus, standard lipid-lowering 
diet does not appear to affect ApoB levels while ApoAl 
levels were deleteriously lowered in HyperapoB pts. Other 
dietary strategies may be necessary in this condition. 
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Free Radicals and Reperfusion Injury 
IMPORTANCE OF LEUKOCYTE DEMARGINATION AND CHEMOTAXIS 
SUPPRESSION IN MYOCARDIAL REPERFUSION INJURY. 
Ashok K. Baja) M.D., Mark Cobb, James C. Gay M.D., Adrian 
Pou, Jeff Clanton, Renu Virmani M.D. ,F.A.C.C., and Mervyn 
B. Forman M.D. ,F.A.C.C .. Vanderbilt Univ, Nashville. 
Although the perfluorochemical Fluosol-DA (FDA) reduces 
myocardial reperfusion lnJury and depresses leukocyte 
(LK) chemotaxis in vitro, its actions in vivo during 
myocardial infarction is unknown. Demargination and 
myocardial infiltration were studied with autologous 
Inll1 labelled LK. Animals were subjected to a 90 min 
proximal LAD occlusion followed by 24 hrs reperfusion 
(rep) and were randomized to FDA(n~8) or Ringer's Lactate 
(RL) (n-10) Icc/kg/min intravenously during the last 30 
mins of occlusion. Total venous LK counts were obtained 
serially. At sacrifice Inlll counts were performed from 
epi- and endocardial segments from ischemic (IZ) and non-
ischemic (NIZ) zones. In11l labeling efficiency and 
dilution were normalized by measuring LK and Inlll counts 
in a reference blood sample. 
LK COUNT: baseline occlusion rep-1S min 
FDA: 8.1 ± 0.6 7.6 ± 1.8 6.2 ± 1.3* 
RL: 8.5 ± 1.2 8.9 ± 1.0 11.3 ± 1.4 
LEUKOCYTIC INFILTRATION: (LK/mm3 tissue) 
IZ-ENDO IZ-EPI NIZ-ENDO 
FDA: 3.2 ± 1.2* 2.9 ± 1.4 3.1 ± 1.1 
RL: 17.6 ± 5.7 5.9 ± 2.6 3.1 ± 0.6 
( X 103 ; mean ± SEM; * p<.OS). 
rep-l hr 
8.2 ± l.4* 
14.1 ± 1.7 
NIZ-EPI 
+2.6 ± l.l 
+2.2 ± 0.3 
Electron microscopy showed preservation of endothelial 
structure and absent LK plugging in the FDA animals only. 
Conclusion: Fluosol-DA reduces leukocyte demargination 
during the critical period of myocardial reperfusion and 
inhibits leukocyte infiltration into the ischemic 
myocardium. Suppression of leukocyte chemotaxis prevents 
leukocytic plugging and endothelial disruption thereby 
reducing reperfusion injury. 
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OXYGEN RADICAL MEDIATED MEMBRANE LIPID PEROXIDATION AFTER 
POST-ISCHEMIC REPERFUSION. 
Giuseppe Ambrosio, M.D., John T. Flaherty, M.D., F.A.C.C., 
Carlo Duilio, M.D., Isabella Tritto, M.D., Giuseppe 
Santoro, M.D., Pietro P. Elia, Massimo Chiariello, M.D., 
F.A.C.C. Divisions of Cardiology, 2nd School of Medicine, 
Naples, Italy, and Johns Hopkins Hospital, Baltimore, MD. 
It has been shown that oxygen radicals are generated upon 
post-ischemic reperfusion, and that scavenging of oxygen 
radicals improves recovery of function and reduces infarct 
size. Oxygen radicals might cause reperfusion injury via 
oxidation of membrane lipids. To test this hypothesis, 
Langendorff-perfused rabbit hearts underwent 30 min of 
global ischemia at 37 ·C. At reflow the hearts received 
either a 60,000 IU bolus of the oxygen radical scavenger 
recombinant human superoxide dismutase (h-SOD) followed by 
an infusion of 100 IUlml for 15 min (n=6), or normal per-
fusate as a bolus followed by standard reperfusion (REP; 
n=6); both groups were then perfused for additional 30 min 
with standard perfusate. At the end of reperfusion period 
the hearts were homogenized. A mitochondrial pellet (MITO) 
and a supernatant (SUPER) were obtained by centrifugation 
at 30,000 x g for 60 min at 4 ·C. Content of malonyl-di-
aldehyde (MDA), an end product of lipid peroxidat~on, was 
measured in the homogenate and in the two fractions by the 
thiobarbiturate method. six normally perfused hearts were 
controls. MDA levels are expressed as nmole/mg protein (*= 
p< 0.05 vs CONTR; **= p< 0.01 vs CONTR; l=p<0.05 vs REP). 
CONTR REP h-SOD 
HOMOG 0.95+0.20 1.47+0.11* 1.11+0.171 
SUPER 0.60+0.11 0.82+0.10 0.79+0.15 
MITO 0.96+0.15 2.08+0.34- 1.1l+0.231 
Thus, post-ischemic reperfusion-induced membrane peroxida-
tion, mostly in the mitochondrial fraction. The beneficial 
effect of h-SOD suggests that oxygen radicals play a major 
role in membrane damage after ischemia and reperfusion. 
ENHANCED FUNCTION RECOVERY IN THE STUNNED CANINE 
MYOCARDIUM BY PRETREATMENT WITH OXYPURINOL 
Henry H. Holzgrefe, B.A. and John K. Gibson, Ph.D. 
The Upjohn Company, Kalamazoo, Michigan. 
Whereas acute administration of allopurinol has little 
effect, chronic pretreatment paradoxically enhances the 
recovery of contractility in post-ischemic, stunned 
myocardium (SM). As allopurinol is rapidly degraded in 
vivo we examined the effect of its major metabolite;-
oxypurinol, on contractility in the canine SM. SM was 
produced in 20 dogs by 15 min. of total Circumflex oc-
clusion followed by 15 min. of restricted reflow and two 
hours of full reflow. Posterior wall thickening (PWT) 
was determined by sonomicrometry and expressed as % 
control function. Regional myocardial blood flow (RMBF) 
was ascertained with microspheres snd expressed in 
ml/min/g. Dogs in the treatment group (n-lO) received 
25 mg/kg oxypurinol as a 5 min. left atrial infUSion, 15 
min. prior to circumflex occlusion. Controls (n-1O) 
received a ssline infusion. During occlusion mean 
circumflex pressure, 17.6 vs. 18.2 mm Hg, and area at 
risk, 31.1% vs 34.6%, were similar for both groups, 
control vs. treated, respectively. Data for the 
posterior wall are shown (mean ± SEM): 
Ischemia 5' Reflow 120' Reflow 
Control -PWT -49 + 9% 12 + 9% 5 + 9% 
RMBF -epicardial .12 + .04 .84 + .11 1.00 ± .11 
-endocardial .02 + .01 .85 + .21 .78 + .06 
Oxypurinol -PWT -26 + 7% 51 + 7%* 54 + 7%@ 
RMBF -epicardial .22 + .04 1.37 + .22* .96 ± .12 
-endocardial .03 + .01 1.83 + .33* 1.04 + .09 
* p(0.05 @ p(0.0003 control vs. oxypurinol 
These results demonstrate that oxypurinol markedly 
enhances recovery of contractile function in SM, with 
improved RMBF immediately following reperfusion. 
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REDUCED INFARCTION IN DOGS GIVEN AZAPROPAZONE PRIOR TO 
CORONARYTHRCMIOlYSlS. 
Robert M Knabb, Ph.D .• Andrew W. Leamy. Martin J.M.C. Thoolen. 
Ph.D .• Pieter B.M.W.M. Tlmmermans. Ph.D. E.1. du Pont de Nemours 
and Company (Inc.). Wilmington. Delaware. 
Azapropazone Is an Inhibitor of xanthine oxidase and the functional 
responses of neutrophlls. two potential sources of myocardial 
Injury during reperfuslon. We examined the effect of 
azapropazone on Irreversible Injury in a model of acute myocardial 
Infarction treated with thrombolytic therapy. To mimic the 
clinical setting 'In which azapropazone could be administered we 
induced thrombotic coronary occlusion In 19 closed chest dogs 
with a copper coil and treated with I.c. streptokinase 60 min later. 
Eight dogs received azapropazone (550 mg/kg over 24 hr) 
beginning just prior to streptOkinase. Blood flow and area at risk 
were quantified with microspheres; Infarction was identified 
with triphenyt tetrazolium chloride 24 hr after reperfusion. In 
control dogs 47 ±. 6% of the area at risk was infarcted as compared 
with 16 ±. 6% In dogs given azapropazone (mean ±. SEM. P < 0.01). 
The two groups were similar with respect to the area at risk (22 
±. 2% of left ventricle) collateral blood flow (.20 ±. .05 vs .. 15 ±. 
.03 mllmin/g). heart rate and mean arterial pressure during 
occlusion (96 ±. 6 vs. 107 ±. 7 bpm. 100 ±. 5 vs. 103 ±. 5 mm Hg. 
all p > 0.10). The results Indicate that azapropazone prior to 
reperfusion protects myocardium and support the use of 
azapropazone as an adjunct to thrombolytic treatment of 
myocardial Infarction. 
Wednesday, March 30,1988 
2:00PM-3:30PM, Room 267, Level Two 
Automatic Implantable CardioverterlDefibrillator 
IMPLANTATION OF A PACEMAKER/CARDIOVERTERI 
DEFIBRILLATOR IN MAN: INITIAL RESULTS OF A NEW GENERATION 
DEVICE. Raymond Yee M P , Gerard M. Guiraudon, M.D., F.A.C.C., 
Douglas L. Jones, Ph.D., Arjun D. Sharma, M.D., F.A.C.C., Michael J. 
Kallok, Ph.D., Caro Norris, R.N. and George J. Klein, M.D., FAC.C. 
UniversHy HospHal, London, Ontario, Canada. 
We report the first implantation of a new muttiprogrammable pacemaker! 
cardioverter/defibrillator (PCO) device in 3 patients (pis) suffering from 
ventricular tachycardia-fibrillation( VTNF). The PCD generator (Medtronic 
model 7215), weighing 180 gms, is interfaced to the epicardial surface by 
3 patch electrodes and 1 ventricular screw-in lead for senSing and 
pacing. Radiofrequency programming permHs adjustment of VTNF rate 
detection crHeria and automatic delivery of up to 4 series of therapies per 
VT and VF episode. Therapeutic options include 1) anti-tachycardia burst 
or ramp pacing, and 2) single or sequential pulse countershock (SqCS) at 
0.2-15 Joules (J). The PCD is also capable Of bradycardia pacing at 30-90 
bpm and noninvasive programmed stimulation. Stored event and therapy 
information are retrievable. 
The 3 pts were males, aged 44-68 yrs, suffering Irom drug refractory 
ventricular tachyarrhythmias secondary to coronary artery disease. Two 
pts had recurrent VT while 1 pt had both VT and VF. The epicardial 
electrodes were applied through a median stemotomy and were inHially 
interfaced to an external cardioverter!defibrillator (Medtronic model 
2376). Successful defibrillation of 3 consecutive episodes of induced VF 
at an energy level 50% (approximately 7.5J) of the maximum output of 
the PCD was required before proceeding wHh PCO implantation. 
Over a follow-up of 1-10 weeks after implant, 19 spontaneous episodes 
of VT and 4 episodes meeting the VF crHeria were detected and treated 
by the PCD. Ramp pacing was utilized to terminate 4 VT episodes and 
was successful on each occasion while the other 15 VT episodes were 
terminated by SqCS(5-10J). All 4 VF episodes were terminated by SqCS 
using 10-15J. Because 01 persistent bradycardia, one patient has 
remained predominantly in ventricular paced rhythm using the PCD. 
These early results demonstrate the potential usefulness 01 a 
programmable device which combines bradycardia pacing and anti· 
tachycardia paciag wHh backup cardioversion and defibrillation. 
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HIGH DEFIBRILLATION THRESroID wrm THE AIm: 
~ WI'IH RIGHT ATRIAL PA'lCH ELEX:'l'RDE. 
Gerald M. Lawrie, M.D., F.A.C.C. Jayne Wright-Hargis, 
R.N., /Huan T. Lin, M.D., Christopher R.C. Wyrrlham. 
M.D., ~~.C.C. Baylor College of Medicine, Houston, 
Texas 
Of 27 pts who received AIm devices for recurrent 
vrIVF, 25 were inserted by left subcostal 
thoracotany. In 21 pts the mean defibrillation 
threshold obtained intraoperatively was 16.3 (range 
5-25) joules. In 4 pts, despite nultiple 
repositioning of 2 large patch electrodes through the 
subcostal incision, thresholds were >40 joules. In 
these pts, the 4th right costal cartilage was 
resected through a Scm incision and a small (3pts) or 
large Upt) patch electrode was placed 
extrapericardially over the right atrium. Thresholds 
were markedly lowered in each case: 20,25,25,20 
joules. A chronic threshold obtained at 25 months was 
25 joules vs 20 joules in one patient initially. 
These 4 pts were younger: 53.8 vs 58.11 years had 
lower preop EFs-22% (range 18-30%) vs 34% (range 
12-65%). All had had previous CAB vs 9121 (43%) of 
the others; 3/4 (75%) had chronic pacemakers and all 
had nultiple vr morphologies as well as sudden death 
in 3 pts. Thus, the right atrial patch electrode 
proved effective in all 4 cases in which high 
defibrillation thresholds were encountered in a high 
risk subgroup. The technique has not been required 
for cardioversion thresholds. Good thresholds have 
always been able to be achieved with patches over the 
left and right ventricles. 
MmAL SENSING 'ro ENHANCE VENl'RIClllAR TACHYCARDIA 
DEl'ECl'IaJ BY THE AUIa9.TIC IMPIANl'ABIE CARDIOVERI'ER 
DEFIBRIJ..IAiUR: A Ul'ILITl! S'IUDY. Claudio D.Schuger. M.D., 
Kenneth Jackson, P.A.C., Russell T. steinman, M.D., 
Michael H. lehmann, M. D., F .A. C. C., Wayne state 
University am Harper Hospital, Detroit, MI 
~iate discharges by the autanatic jJrplantable 
cardiovert.er defibrillator (AICD) duriD;J sirrus or other 
supra(S)-ventric::ular(V) tachycardias(Ts), even in the 
presence of a probability density function algorithm, 
remains a limitatioo of an otherwise highly effective 
device. We systematically investigated the benefit 
theoretically actlievable fran the additioo of atrial (A) 
sensiIq capability to the AICD in 25 pts with 30 
imucible sustained ~c Vl's at clinically 
relevant rates (~ 150 beatsjmin). pts were included only 
if they were not taki.n;J any medication capable of 
depressiIq VA con:1uctioo for at least 5 half-lives prior 
to elec:trq:hysiologic testiIq. Mean vr cycle l~ [CL] 
was 283 ± 47 IllS (ran:Je 220 to 370). We tested the sjJrple 
criterion (C) for vr that V-cL be ~ A-cL (not met in 
sirrus or most other SVl's). In 25 (83%) Vl's, vr-c was 
consistently satisfied. Of the 5 cases in which vr-c was 
not always met, 1:1 VA oorxiuctioo duriIq vr was present 
in 4~ 3 of whan initially had 2:1 VA oorxiuction lastin] 
for 14-21 sec - am therefore 1oiOO.ld have transiently 
fulfilled vr-c. 'lhe remainin] pt who failed to satisfy 
vr-c had cn;lOiIq A flutter duriIq (slower) sustained vr, 
rut this was associated with a varyiIq AV interval (not 
expected duriIq AT with a slower fixed V response) • 
OVerall, then, use of vr-c early after T onset - in 
tamem with AV interval trackin;J - cnlld correctly 
identify 29/30 (97%) Vl's. We oorx:lude that incorporation 
of A sensiIq capability into the AICD may greatly 
facilitate differentiation of vr fran most SVl's, 
especially sinus T. 
ABSTRACTS 
RAPID TRANSVENOUS CARDIOVERSION OF SUSTAINED 
VENTRICULAR TACHYCARDIA BY PROGRAMMABLE 
IMPLANTABLE CARDIOVERTERSIDEFIBRILLA TORS. 
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S Saksena, MD. FACC. HL An, MD, 0 Pantopoulos, ME. Newark Beth Israel 
Med Ctr·NJ Med School, Newark, NJ. 
We prospectively examined 3 sequential pacing & shock algorithms to optimize 
VT cardioversion with non·epicardial electrode systems. 63 pts with sustained VT 
& heart disease were studied. A Medtronic 6880 catheter was positioned at the 
RV apex & a cutaneous patch electrode on the precordium. Slow VT episodes 
(rate <200 bpm) were treated with pacing & shock therapy (Rx) & rapid VT 
episodes (rate >.200 bpm) with shocks alone. Pacing Rx was asynchronous bursts; 
shocks were either unidirectional (6880 only) or bidirectional (6880 plus patch). 
Algorithms examined were: Method A . Pacing (10 & 15 stimuli twice at 3 adap· 
tive rates) followed by 3 unidirectional shocks (2.7, 5.4, & 10 J); Method B • Pac· 
ing (15 stimuli at 3 adaptive rates) followed by 3 bidirectional shocks (5, 15, & 25 
J); Method C· Pacing (6 adaptive rate trains of incremental length) followed by 
two 25 J bidirectional shocks. 
RESULTS: 201 induced VT episodes were analyzed. Slow & rapid VT episodes 
treated with each method had comparable rates. 
EFFICACY Method A (n=63) Method B (n=90l Method C (n=48) 
Slow VT: Total 85% 96% 100% 
a.Pacing Rx 77% 68% 70% 
b.Shock Rx 8% 28% 30% 
Rapid VT: 40% 83% 100% 
INCIDENCE OF VT ACCELERA nON 
a.Pacing (slow VT) 6% 6% 25% 
b.Shocks: Total 26% 29% 0% 
·2.7 or 5.4 J 17% 39% 
·100r15J 17% 24% 
·25J 0% 0% 
Acceleration of slow VT occurred more frequently with shocks than pacing in 
Methods A & B (p <.04). VT acceleration with pacing was more frequent in 
Method C than Methods A & B (p <.03). 
CONCLUSIONS: 1) Incremental pacing trains & intermediate energy shocks in-
crease incidence of VT acceleration. 2) Rate adaptive pacing & high energy bidi· 
rectional shocks should be used in future cardioverter/defibrillators. 
IMPROVED INTERNAL DEFIBRILLATION EFFICACY IN PATIENTS 
WITH BIPHASIC SHOCKS. 
Paul Troup, M.D. ,F .A.C.C., Peter Chapman, M.D. ,F .A.C.C., 
Jule Wetherbee, M.D., Hossein Almassi, M.D., Gordon 
Olinger, M.D. ,F .A.C.C., R.K. Thakur, M.D., Jan Veseth-
Rogers, R.N., Sharon Duquette, R.N., Erin Poole, R.N., 
Medical College of Wisconsin, Milwaukee, WI. 
The automatic implantable cardioverter-defibrillator 
(AICD) employs a monophasic (M) truncated exponential 
shock with the pulse width (PW) determined by impedance. 
We evaluated the efficacy of biphasic (B) truncated 
exponential shocks in 10 pt age 62:4 yrs undergoing 
AICD implant with 2 patch lead systems. Shocks were 
delivered by an external defibrillator capable of deliver-
ing I or 2 pulses with independently progranunable peak 
voltage (V), PW, and peak polarity (+/-). 
In each pt, the total PW for M and B shocks were 
equal (b:n + 1.1 msec) and approximated that of the 
AI CD shock i~ that pt. The second pulse of the B shock 
had a PW < 50% of total PW, reversed polarity, peak 
V equal to that of the initial pulse and a 250)ls inter-
pulse delay. Minimum energy and average current 0) 
resulting in successful defibrillation were determined 
(DFT), as was impedance: 
DFT 
J 
I 
It.. 
M 
10-:-4 
6.5 
37.2 
B 
5.7* 
4.8* 
39. I 
Mean Reduction 
45.4% 
10.8% 
*P<0.02 
*P<0.02 
Conclusion: Biphasic truncated exponential shocks 
with terminally negative components to the initial 
positive component significantly reduce energy and 
average current for internal defibrillation compared 
to monophasic shocks and thereby result in improved 
defibrillation efficacy. 
210A ABSTRACTS 
INAPPROPRIATE AND APPROPRIATE DISCHARGES OF THE 
AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR. 
Jeanne E. Poole, M.D., Charles L. Troutman, R.N., Jill 
Anderson, R.N., Gust H. Bardy, M.D., F.A.C.C., H. Leon 
Greene, M.D., F.A.C.C., Harborview Medical Center, 
University of Washington, Seattle, Washington. 
Early experience with the Automatic Implantable 
Cardioverter Defibrillator (AICD) has been encouraging. 
However, unnecessary AICD discharges have been 
reported. We evaluated the frequency of appropriate 
discharges (APP DC) and inappropriate discharges (INAP 
DC) in 45 patients (pta) who underwent an AICD implant 
over the past 6 years. INAP DC was defined as s DC 
delivered into a rapid atrial arrhythmia exceeding the 
rate cutoff of the device in 5 pts; into normal sinus 
rhythm in 2 pts; and occurred in 2 asymptomatic pts 
without documentation of rhythm. These 2 asymptomatic 
pts have had multiple prior episodes of ventricular 
tschycardia always preceded by pre syncopal symptoms or 
associated with syncope. Twelve of 45 pts had APP DC 
for documented sustained ventricular arrhythmias (6 pts) 
or associated with symptoms 
highly suggestive of a sustained 
ventricular arrhythmia (6 pts). 
Life table analysis shows that 
58% of pts had INAP DC; and 63% 
of pts had APP DC by 3 years. "._ 
Therefore, although APP DC are 
common, !NAP DC are also !.a 
frequent and may be reduced with 
AICD programmability. 
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MEASUREMENT OF THREE DIMENSIONAL POTENTIAL 
GRADIENTS GENERATED BY TRANSTHORACIC SHOCKS 
Anthony S I, Tang MD Patrick D. Wolf, MS, William M. Smith, 
PhD, Raymond E. Ideker, MD, PhD. Duke U. Med Ctr, Durham, NC 
Defibrillation(DF) could probably be improved if the distribution of 
the electric field created through the heart were known. We have pre-
viously developed techniques to measure these fields on the epicardium. 
The purpose of this study was to overcome the limitation of only epi-
cardial measurements by developing a technique to measure the shock 
field near both the endocardium and epicardium and to use this tech-
nique to measure the fields for transthoracic DF. In 5 dogs, 52 plunge 
electrodes were inserted into the LV and RV to record from 104 subep-
icardial and subendocardial sites. Twelve septal and 12 atrial sites 
were also recorded. The chest was then closed in layers to keep the 
thoracic cavity air free. Constant current shocks of 50 rnA were 
delivered in late diastole from a modified Lifepak 7d via 
precordial(PRE) and anterior-posterior(AP) thoracic electrodes. Poten-
tials of the shocks were recorded simultaneously from all 128 elec-
trodes. The heart was then fixed under control pressure, cut into slices 
2.5 mm thick and the electrode locations digitized. Potential gradients 
were calculated from the measured potentials and the electrode loca-
tions. For both electrode configurations, the 5 highest and 5 lowest 
gradients were averaged. For PRE electrodes, the mean highest gra-
dient was 6.5 ± 2.2 V 1m, the lowest gradient was 1.6 ± 0.8 V 1m, and 
the ratio of highest to lowest gradients was 5.0 ± 3.0. For AP elec-
trodes, the highest gradient was 8.3 ± 6.6 V 1m, the lowest was 1.5 ± 
1.0 V 1m, and the ratio was 5.9 ± 2.3 V 1m. For the PRE electrodes, 
the regions of highest gradient were at the posterior apex in 3 dogs and 
at the antero-basal RV in 2 dogs and the region of lowest gradient was 
at the postero-basal RV. For AP electrodes, the region of highest gra-
dient was in the anterior RV or LV and the region of lowest gradient 
was at the apex. As shown by the ratio of highest to lowest gradien ts, 
these fields for thoracic electrodes are much mor" even than for elec-
trodes on the epicardium, where this ratio is about 20. In conclusion, 
it is possible to measure the shock field created by DF electrodes in 
three dimensions. 
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A VOLUME CONDUCTOR MODEL OF THE THORAX 
FOR THE STUDY OF DEFmRILLATION 
Frank I Claydon PhD, Anthony S L Tang, MD, Mary N Morrow, 
MS, Theo C Pilkington, PhD, Raymond E Ideker, MD, PhD, Duke 
University Medical Center, Durham, North Carolina 
Once developed and tested, a computer simulation of the potentials 
created in the torso by defibrillation shocks can easily estimate the 
distribution of potentials throughout the heart for many different 
electrode configurations. These data would be time consuming to 
obtain experimentally in animals and almost impossible to obtain in 
humans. To date, most computer simulations have been two-
dimensional instead of three-dimensional and have lacked experimen-
tal verification. This study develops a three dimensional volume con-
ductor model based on real dog geometry in which boundary integral 
equations are solved to compute epicardial potentials. The model of 
the thorax contains four regions of different conductivities: heart 
[0.00232 (O-cmf!), lungs [0.0005 (O-cmf! ), anisotropic skeletal mus-
cle [0.00667 (O-cmf! along fibers and 0.00043 (O-cmf! across fibers)' 
and the remainder of the body cavity [0.002 (O-cmf!). Simulation 
results for four torso electrode combinations (anterior-posterior, right 
lateral-left lateral, precordial, and neck-waist) were calculated and 
compared to the potentials recorded experimentally in three dogs dur-
ing shocks delivered through these same electrode combinations. The 
experimental potentials were recorded from 60 electrodes on the ven-
tricular and atrial epicardium. The hearts were cut into 40 slices, 
and the 60 electrode locations were digitized. The simulated poten-
tials for all electrode combinations in all dogs correlated with the 
experimentally measured potentials with correlation coefficients rang-
ing from 0.90 to 0.93. These results indicate that it is possible to esti-
mate the cardiac potential distributions created by a large number of 
different defibrillation electrode locations and sizes by computer 
modelling, reserving experimental evaluation for only those 
configurations that appear promising from the simulation. 
WHY DOES TRANSTHORACIC IMPEDANCE DECLINE AFTER DIRECT 
CURRENT COUNTERSHOCKS? Sara J. Sirna, M.D .• Robert Kieso. 
M.S .• Karen Fox-Eastham. Francis Charbonnier. Ph.D .• 
Richard E. Kerber. M.D .• F.A.C.C .• Univ. of Iowa. Iowa 
City. IA. and Hewlett-Packard Corp .• McMinnville. OR 
Transthoracic impedance (TTl) declines up to 10% after 
even a single DC countershock; the mechanism is unknown. 
Blood and interstitial fluid are good conductors of elec-
tricity; we hypothesized hyperemia and edema in the cur-
rent pathway cause TTl to fall. First. to demonstrate 
hyperemia after shocks. we used microspheres to measure 
flow in skin and skeletal muscle before and after 3 100 
joule transthoracic shocks to 7 anesthetized dogs. TTl 
declined 11%. from 38,2±SE3.6 (control) to 35.0±3.2 ohms 
at 1 hr (p<.05). Blood flow increased in muscle: 0.9±0.6 
m1/100gm/min preshock to 11.3±0.7 post shock. p<.Ol and 
skin: 0.7±O.4 to 1.9±O.9 m1/100gm/min. p<.05. Blood flow 
did not change in tissues remote from the current path. 
Second, to demonstrate that tissue blood volume (TBY) as 
well as flow increased after DC shocks. we used 1-125 
labelled albumen and Tc-99 labelled red blood cells to 
determine TBY in 5 additional dogs. TBV in skin increased 
from 7.6±1.5 m1/100gm preshock to 17.S±1.9 m1/100gm 1 hr 
post shock (p<O.Ol); TBY in muscle showed no change: 14.7 
±1.3 m1/100gm preshock to 16.3±2.0 m1/100gm post shock 
(p=NS). Finally. to show that increases in tissue blood 
flow and volume directly reduce impedance even without DC 
shocks. we studied another 5 dogs. Deliberate overper-
fusion of an isolated hindlimb caused edema; limb cir-
cumference increased from 38.2±0.9 to 44.7±1.4 cm (p<.Ol). 
This edema was associated with a fall in trans1imb impe-
dance from 24.8±1.6 to 11.2±1.0 ohms (p<.Ol). Conclu-
sions: DC shocks cause tissue hyperemia and edema in the 
current pathway; the increased fluid_volume is primarily 
in the skin. The increase in blood and interstitial 
fluid causes the decline in TTl. 
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FREQUENCY CHARACTERISTICS OF UNIPOLAR CAR-
DIAC ELECTROGRAMS AND ACTIVATION DETECTION 
Candjdo Cabo S E , J. Marcus Wharton, M.D., Ned D. Danieley, 
M.S., Raymond E. Ideker, M.D., Ph.D., and William M. Smith, Ph.D. 
Duke University Medical Center, Durham, North Carolina 
A current limitation on optimal performance of cardiac mapping stu-
dies is the lack of a robust algorithm for discrimination between local 
and distant electrical activity. The development of such an algorithm 
requires characterization of the frequency content of the waveforms. 
Cryolesions with a diameter and depth of approximately 3 mm were 
created in the ventricles of 3 dog hearts by applying a cryoprobe 
cooled to -60 degrees F. Five days later, plunge electrodes with 8 
recording points were inserted through each freeze lesion and through 
normal myocardium. During sin us rhythm, electrograms from 334 
electrodes in viable tissue (local activity) and 55 in freeze-killed tissue 
(no local activity) were recorded. The waveforms were low pass 
filtered at 4000 Hz, sampled at 8000 samples/sec, digitized, and 
recorded. For each electrogram, FFTs were computed for a series of 8 
ms sliding windows, and the absolute value of selected frequency 
coefficients was plotted as a function of time. For each frequency, a 
receiver operating characteristic (ROC) curve was generated by plot-
ting the probability of detecting an activation in viable tissue [true 
positive--P(TP)[ versus the probability of detecting an activation in 
freeze lesion (false positive--[P(FP)] as the amplitude threshold was 
varied. A "best" threshold was selected where P(TP) was maximized 
and P(FP) was minimized, with the following results: 
From these data, it is clear that the frequency components between 
600 and 800 Hz are important in discriminating between local activa-
tions and distant electrical activity. It follows that a sampling rate of 
1000 samples/sec or less, currently used by most mapping systems, 
may be inadequate for optimal activation mapping. 
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Exercise Physiology and Testing 
EXERCISE II>lJUCED PLATELET ACTIVATION IN Af'(;INA PECnJUS - REOOCTION 8Y 
ClHlINATION THERAPY OF a BLOCKER WITH CALCI~ BLOCKER 
J. Wilson 1013, M.W. 8aig 1013, M.A. Orchard PhD, A. Spencer, E.J. Perrins 
MD, FACC, J.A. Davies MD and C.R.M. Prentice MD 
lk1iv. Dept. Medicine, The General Infirmary, Leeds, LSl 3EX, England, UK. 
Platelet sensitivity may be increased in patients with angina pectoris 
(AP), and exercise induced platelet activation may be exaggerated. 
a blockers and calcilJll antagonists are used to treat AP, and both agents 
have been shown to modify platelet function. The aim of this study was 
to compare the effect of atenolol (50 mg bd) alone (AJ, and in 
combination with nifedipine (20 mg bd) (A+NJ on platelet function both 
at rest and on exercise in patients with AP. 8 patients were studied. 
Each had 3 treadmill exercise tests (El) at 4 weekly intervals. The 
first ET was after 4 weeks treatment with A, following which randomi-
sation into a double blind cross-over treatment phase with either A or 
A+N took place. ETs were performed at the end of each phase. Venous 
blood was collected prior to each ET for beta thromboglobulin (aTG) 
platelet factor 4 (PF4) and for whole blood aggregation studies to 
agonists, ADP and collagen. Duplicates were collected at a fixed time 
during exercise so that sampling time remained constant. This time was 
taken as the maximun exercise time achieved in the first ET. Platelet 
aggregation was quantitated by measuring the area under the curve (AUC) 
of the percentage fall in platelet count with time after addition of the 
agonist. While on treatment with A,exercise increased total platelet 
aggregation (AUC (SEM) Pre-ex 236(18), Post-ex 254 (18) p < 0.050], and 
this effect was not abolished by treatment with A+N [AUC (SEM) Pre-ex 
232 (24), Post-ex 272(25) p< 0.002J. Exercise increased aTC and PF4 
during treatment with A [aTC (SEM) ng/ml Pre-ex 40.3 (3.2), Post-ex 
50.3 (6.3) p<O.Ol, PF4 (SEM) ng/ml Pre-ex 7.5 (0.5), Post-ex 10.2 (1.1) 
NSJ, but this rise was abolished during treatment with A+N [aTG Pre 
44.7 (8.8) Post 43.6 (9.1) NS, PF4 pre 10.3 (2.3), Post 10.7 (2.8) 
NS]. In this study, nifedipine/atenolol combination in the treatment of 
AP produced less platelet activation for a given amount of exercise. 
ABSTRACTS 
IMPAIRED CARDIOPULMONARY FUNCTION WITH EXERCISE IN 
SICKLE CELL ANEMIA. 
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Sharon Norris, M.D., L. Julian Haywood, M.D., F.A.C.C. 
and John Mohler, M.D., University of Southern California 
School of Medicine, Los Angeles, CA. 
Cardiopulmonary function (CPF) of 16 adults with sickle 
cell disease (SCD) was compared with age/race matched 
normals (NL) at progressive levels of exercise (EX). 
Expired gases were sampled using a closed respiratory 
system In which Inspired and expired gases were measured 
using a mass spectrometer. Oxygen debt (020) was cal-
culated from post-EX gas collections using previously 
described methods (Armstrong, Mohler, Haywood). The 
results were as follows: confidence limits for maximum 
oxygen consumption (MV02) In 91%, dead space to tidal 
volume ratio (VD/VT) in 22%, respi ratory rate (F) in 
14%, and ventilatory equivalents for C02 (VEVC02) and 02 
in 14%. Compared to their own predicted EX indices for 
CPF, SCD had the following abnormalities: decreased 
MV02 (100%); increased alveolar-arterial difference for 
02 (AA020) (100%); tidal volume to vital capacity ratio 
(VT/VC) (100%); 020 (91%); heart rate (]9%) and VEVC02 
(50%). A fall in pH and hypoxemia (P02 < 60 mmHg) did 
not develop during EX; the stimulus for increased F 
during EX is not C02, hypoxemia, or a fall in pH. These 
data document abnormal response to EX in SCD, and the 
mechanisms of impaired EX capacity warrant further 
investigation. 
EFFECTS OF MAXIMAL AND SUBMAXIMAL EXERCISE ON MYOCARDIAL 
llC-PALMITATE CLEARANCE ASSESSED WITH POSITRON EMISSION 
TOMOGRAPHY 
Edward M. Geltman, M.D., F.A.C.C., Susanne Kaiserauer, 
M.S., Mary N. Walsh, M.D., Ali A. Ehsani, M.D., F.A.C.C., 
Washington University, St. Louis, MO 
Normal myocardium preferentially utilizes exogenous free 
fatty acids during oxidative metabolism at rest and during 
pacing stress. However, myocardial utilization of unal-
tered fatty acids has not been characterized after dy-
namic exercise in humans. Accordingly, 4 normal subjects 
and 8 patients with coronary artery disease were studied 
wi th dynami cpos itron emi ss i on tomography and llC_ 
palmitate (llC_p, 20 mCi, i.v.) before and after maximal 
bicycle exercise. In normals, clearance of llC_p was homo-
geneous at rest and after maximal exercise. In each normal 
subject, the half-time (T~) of llC_p clearance increased 
substantially from 22.5 + 2.6 (SEM) min to 75.6 ~ 31.1 
(p = .05). Among patients,-r~ also increased in each after 
exercise from 21.6 + 2.1 to 65.4 + 21.3 (p < .001). 
Plasma glucose, glycerol, and free fatty acid concentra-
tions did not change with exercise, but lactate increased 
from 1.3 + 0.1 to 9.9 + 2.9 ~M/ml. To determine whe-
ther elevated lactate levels contributed to the altered 
clearance of llC_p, 4 additional normal subjects were 
studied after submaximal exercise. In contrast to maximal 
exercise, submaximal exercise (58% of max) induced vari-
able delays in llC_p clearance suggesting that increased 
plasma lactate was not the sole cause of decreased llC_p 
utilization. Thus, clearance of llC-palmitate is markedly 
delayed after maximal dynamiC exercise in normal subjects 
and patients with coronary artery disease probably re-
flecting mobilization of endogenous myocardial lipids or 
utilization of alternate substrates. 
212A ABSTRACTS 
'DIE IDIE OF 'DIE FRANK-sTI\RLIN:; MEDfANISM IXJRING UFRIGHl' 
EXERCISE IN SE.VERE lEFT VENlRIaJIAR Dlt'SFllNCTIOO. 
Jaekyeap Hea. MD, A-Hamid Hakki., MD, ~, Alx1n1massih 
S. IsIcarDrian, MD,~, lhiladelpria Heart Institute, 
Presbyterian-U of PA Mad ctr, Ibila., PA. 
'!his stOOy examined the utility ani ilIplicatia'lS of the 
Frank-starlin;J (F-S) medlanism durin;J upright exercise 
(Ex) in patients (pts) with severe left ventricular (LV) 
dysfurx:ticn. '!here loIOBJ:"e 2 grwps of pts: group 1 (n=28) 
had oormal. ~ TN ejecticn fracticn (EF) (!!50%) , 
group 2 (n=70) had severe restin;J TN dysfurx:ticn (EF ~ 
35%). All pts un:ierwent synptan-limited upright Ex test-
in;J: the JNEF ani volUl\le loIOBJ:"e measured by radiau::lide 
arqiography 'Ibe restin;J end~lic volUl\le in:lex 
(ED\7I, MIIm"2) was lower in group 1 (82±19 vs 139±39, 
P < 0.0001). rurin;J Ex, group 1 had nme in::rease ~ 
ED\7I (26±17% vs 11±13%, p<0.0003) ani nme decrease 111 
EF (-7.0±9.0 vs 3±5%, p<O.OOOl) than group 2. If! group 
2, 34 had <10%, 27%, 10-25% ani 9 pts had >25% l.J'CI:'eaSE! 
in ED\7I with Ex. F\lrt:her, there was an inverse relaticn 
between the restin;J ED\7I ani the dIan;Je in ED\7I with Ex 
(r=O.38, p<0.001). In the 22 group 2 pts with no or mild 
TN dilaticn at rest (ED\7I ~ 120), the in::rease in EIJI.II 
with Ex was nme than in the ranainin;J 48 pts with IIlClder-
ate to severe dilataticn (18±3% vs 8±2%, p<0.02). At a 
mean follow-up of 28 1I1OS, there loIOBJ:"e 12 cardiac deaths 
in group 2: 1 pt with mild or no dilataticn died cx:m-
pared to 11 pts with !lDderate to severe dilataticn (4.5% 
vs 22.9%, Mantle-<bx = 0.02). 'Ihus the degree to whidl 
the F-S medJanism is utilized at rest detennines not 
cnly the ability for further dilataticn durin;J Ex, b.Jt 
is also a strcn:J predictor of IIDrtality. pts with no or 
mild dilataticn utilize the F-S medJanism durin;J Ex ani 
have a better prognosis than pts with severe dilataticn. 
RADIONUCLIDE ASSESSMENT OF REGIONAL WALL MOTION ABNOR-
MALITIES IN HEALTHY MASTER ATHLETES. WJ Manning MD, 
E Gervino ScD. R Hauser MD, G Hung MD, JA Parker HO, 
KJ Silverman MD, FACC, W Evans PhD. JY Wei MD, FACC. Beth 
Israel Hospital, Harvard Medical School and USDA Human 
Nutrition Research Center on Aging. Boston, MA. 
Cardiac adaptation to endurance training includes an 
increase in left ventricular (LV) end-diastolic volume 
and LV mass. To test the hypothesis that mild apical 
hypokinesis on resting radioventriculogram (RVG) may be a 
normal finding in athletes, we studied 12 healthy 
subjects - seven master athletes (MA): V02max=49.5±2.7 
ml/Kg-min; age=56~2 yrs; % body fat=19.8~3.3 and five 
normal sedentary controls: V02max=29.1±3.1 ml/Kg-min; 
age=63±2 yrs; % body fat=35.8±4.6. All subjects had 
normal resting RVG LV ejection fraction (LVEF). Serial 
gated RVG was performed during progressive maximal supine 
cycle ergometry. The LV image was divided into five 
regions which were graded by semi-quantitative analysis 
from 0-8 (0 = normal. 8 = severe dyskinesis). 
Compared to controls, the MA had significant focal LV 
apical hypokinesis at rest (p<.005). There were no other 
regional wall motion abnormalities in the MA or 
controls. This apical hypokinesis in the MA disappeared 
with progressive exercise stage. No similar change was 
noted in the sedentary controls. No MA or control 
developed any wall motion abnormalities, angina, or ECG 
evidence of ischemia with exercise. In all subjects, 
overall LVEF improved normally with exercise. 
Conclusion: Left ventricular apical hypokinesis on 
resting radionuclide ventriculography in athletic 
subjects is apparently a normal variant that disappears 
with physical exertion. This finding likely reflects 
increased cardiac reserve present in endurance-trained 
athletes. 
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THE EXERCISE TREADMILL TEST IS A POOR PREDICTOR OF THE 
RISK OF NONFATAL HYOCARDIAl INFARCTION 
Daniel B. Hark. H.D .• Hark A. Hlatky, H.D., F.A.C.C., 
Kerry l. lee, Ph.D., Frank E. Harrell, Jr., Ph.D., 
Robert H. Califf, H.D., David B. Pryor, H.D. Duke Uni-
versity Hedical Center, Durham, North Carolina 
To examine the value of the exercise treadmill test 
(ETT) for predicting subsequent nonfatal myocardial in-
farction (HI), we studied 2,842 consecutive patients 
(pts) with suspected coronary disease referred for Bruce 
ETT and cardiac catheterization. All pts were followed 
annually (median follow-up 5 years). Surgically treated 
pts were excluded from analysis at the date of opera-
tion. The Cox model was used to assess the strength of 
association between treadmill variables and cardiac 
death or nonfatal HI. There were 235 cardiac deaths and 
152 nonfatal HIs during follow-up. Exercise ST devia-
tion was strongly related to cardiac death (X2=II0), but 
only weakly related to nonfatal HI (X2=9). Similar re-
lationships were found for exercise angina (X2=56 for 
death, X2=16 for nonfatal HI) and exercise duration 
(X2=51 for death, X2=0 for nonfatal HI). Using a pre-
viously derived treadmill score to define risk groups, 
the I year risk of death for low risk pts was 1% and for 
high risk pts was 11%. The corresponding I year risk of 
nonfatal HI was 2% for low risk pts and 5% for high risk 
pts. Pts who died in follow-up had a median ST devia-
tion of 1.25 mV and a median exercise time of 5 min 
while pts who had a nonfatal HI in follow-up had a 
median ST deviation of 0 mV and a median exercise time 
of 7 min. 
We conclude that the exercise treadmill test contains 
significantly less information about the risk of future 
nonfatal HI than about the risk of future cardiac death. 
REGIONAL LEFT VENTRICULAR WALL STRESS: A NEW 
APPROACH TO DETECTING REGIONAL ISCHEMIA DURING 
EXERCISE 
Leonard E. Ginzton. M.D •. F.A.C.C., Richard Conant, Ib.D., 
Marianne Brizendine,R.N., Michael M. Laks, M.D., F.A.C.C., 
Harbor-UCLA Medical Center, Torrance, California 
Exercise regional wall motion analysis (RWMA) 
is widely used to diagnose the presence of coro-
nary artery (CA) disease, but is not a reliable 
identifier of specific CA obstructed. Because 
end-systolic (ES) LV wall stress is a major 
determinant of myocardial oxygen demand, the 
purpose of this study was to determine wheth7r estimation of regional wall stress analys1s 
(RWSA) is a more accurate indicator of regional 
LV ischemia than RWMA. Subcostal 4-chamber 20 
echocardiograms were done during maximal upright 
bicycle exercise in 11 normals and 23 CA disease 
patients (6 1-vessel, 17 multi vessel CA dis-
eases). cuff peak systolic blood pressure (BP) 
was used to estimate ES BP. Quantitative RWMA 
and RWSA were done by a micro-computer for 100 
LV segments (segments 1-60 = left anterior de-
scending CA, 61-85 = circumflex CA, 86-100 = 
right CA distribution). The predictive accuracy 
of RWSA in identifying specific CA obstructions 
was better than RWMA (0.76 vs. 0.50, chi square 
< 0.01), with fewer underestimates of CA dis-
ease severity (1 vs. 8). 
Wall Motion: Correct Incorrect 
Wall Correct 18 11 
Stress: Incorrect 0 7 
Conclusions: Regional wall stress analysis is a 
new approach to the study of :egional LV fu~c­
tion, and was superior to reg10nal wall mO~1on 
analysis in identifying specific CA obstruct10n. 
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Nuclear Cardiology/Single PhotonlRadionuciideslPET 
RAPID TRANSIT MEASUREMENT OF CORONARV BLOOD FLOW WITH 
INTRACORONARV 99m TECHNETIUM-DTPA. 
Andrew l. Feiring, M.D., FACC; Ray Grenier, M.S., 
Donald H. Schmidt, M.D., Carl Christensen, Ph.D., Univ. 
of Wisconsin, Mt. Sinai Medical Center, Milwaukee, WI. 
We have developed a new method for accurately measuring 
relative coronary blood flow (CBF) by analyzing the 
first pass time activity curves (TAC) after 
intracoronary injection of 99m Technetium DTPA (Tc). 
In dogs (N=9) carotid to LAD (N=5) or LCX (N=4) artery 
shunts were performed with an in line electromagnetic 
probe to measure absolute CBF. Small volumes of Tc 
(O.lml, 3mCi/bolus) were injected into the shunt 
immediately proximal to the coronary artery. CBF was 
varied over a wide range (7-1S0 ml/min) by coronary 
snare and intracoronary adenosine. Approximately 10 
flows were obtained per dog (N=91). TAC were recorded 
at 0.1 sec count intervals over myocardial regions of 
interest by multicrystal gamma camera. The slope (K) 
of the washout phase was analyzed by the Time (T) to 
One Half method (K=0.b93/T (sec.». 
Results: CBF and K were linearly related within 
individual dogs (range r=0.9b-0.99), average SEE ± 9.b 
ml/min (range: 5-12 ml/min). Inter and intra-observer 
variablility was small (r=0.9S, r=0.9S) respectively. 
Conclusion: Since K is linearly related to CBF this 
parameter provides an accurate and reproducible means 
of measuring pharmacologically induced coronary reserve 
in a dose dependent fashion. Since this technique does 
not perturb CBF (unlike iodinated contrast agents), is 
non-diffusible and does not require subselective 
catheterization, it may be useful in measuring 
myocardial flow reserve during cardiac catheterization. 
RIGHT CORONARY ARTERY DISEASE AND INPI!ROSEPTAL ISCBEKIA: 
EVALUATION BY TOMOGRAPHIC TBALLIUK-201 BDRCISE 
MYOCARDIAL IMAGING. 
Harvey ~ Hecht, ~,F.A.C.C., George Andreae, H.O., 
Simon H. Stertzer, H.O., F.A.C.C., Thomas Bruce, H.O. 
San Francisco Heart Institute, Seton Hedical Center, 
Daly City, CA. 
Although the interventricular septum is perfused by both 
the left anterior descending (LAD) and right (RCA) 
coronary arteries, the contribution of the RCA to 
ischemia of the inferior septum has only been 
appreciated in the rare ventricular septal defect 
following inferior myocardial infarction. Accordingly, 
105 patients with RCA and/or LAD disease undergoing 
tomographic thallium-201 exercise and redistribution 
myocardial imaging (SPECT) were evaluated for ischemia 
of the inferior septum at apical, mid and basal 
ventricular levels in the short axis projection. 
Ischemia of the inferior septum was noted in 51% of 37 
patients with isolated RCA disease, 58% of 33 with 
isolated LAD disease and 57% of 35 with RCA + LAD 
disease. There was always associated ischemia of 
inferior segments in isolated RCA disease and in RCA + 
LAD disease, whereas in isolated LAD disease, inferior 
ischemia was dependent on the extent to which the LAD 
wrapped around the apex. 
Ve conclude that: 1) ischemia of the inferior septum 
secondary to RCA disease is a common clinical event, and 
2) SPECT demonstrates that the amount of myocardium 
routinely jeopardized by RCA disease is larger than 
previously appreciated, encompassing both the inferior 
wall and the inferior portion of the septum. 
ABSTRACTS 
INFLUENCE OF EXERCISE LEVEL ON NORMAL MYOCARDIAL 
THALLIUM-201 UPTAKE AND CLEARANCE 
Jan Erik Nordrehaug, M, D .. PhD, Ragnar Danielsen, HD, and 
Harald Vik-Mo,M.D.,PhO., Dept. of Clinical Physiology, 
Haukeland Hospital, University of Bergen, Norway 
The clearance rate of Thallium-201 (Tl) from the myo-
cardium is widely used to identify patients with coro-
nary heart disease. The effects of the exercise level 
on the myocardial uptake and clearance of Tl were 
studied prospectively in 1 healthy men, mean age 43~1 
(SO) years, range 36-54. Initial and delByed (after 3 
hours) Tl images were obtained in the 45 left anteri-
or oblique view after 3 upright bicycle exercise 
tests: to maximal predicted heart rate (HR), to 801 
and to 601 of maximal predicted HR. The images were 
interpreted by quantitative computer analysis with au-
tomatic background subtraction and determination of 
total left ventriCUlar T1 activity. The mean X (range) 
T1 clearance (initial minus delayed (x 100) divided by 
initial Tl activity) was 60X (54-691), 4al (33-63l), 
and 31% (16-417.) at maximal, aOX, and 601 of maximal 
predicted HR. The differences were significant 
(p(0.05).The mean initial myocardial uptake was higher 
at maximal than at both SOl and 601 of maximal predic-
ted HR, being 16% (p(0.05) and 63% (p(O.OI) of maximal 
activity, respectively. However, the myocardial Tl 
activity in all 3 delayed images were identical. Conc-
lusions: 1) Tl myocardial clearance rates are markedly 
lower at exercise to 80t and SOl than to maximal pre-
dicted HR. 2) The decrease in clearance is due to a 
decreased initial myocardial Tl uptake, while the 
delayed Tl activity is unaffected. 
213A 
COMBINED THALLIUM AND ANTIMYOSIN SPECT IMAGING IN PATIENTS WITH 
ACUTE MYOCARDIAL INFARCTION 
Lynne L Johnson. M.p. FAC.C .. 08Yid W. Seldin, M.D" Andrew M. Keller, 
M.D., FAC.C., Robert M. Well, M.D., Clifford O. Bingh8m )11, BA" Kevin F. 
Smith, B.S., Paul J. Cennon, M.D., FAC.C. - Columbia Unlv., New York, NY 
Seventeen patients (13 male, 4 female) with acute myocardlal Inferetion 
were injected with 2,0 mCi In-III lllbeled 8IItimyosin monoclonel 8lltilxxtt 
within 48 hours of the onset of chest pain. Forty-el",t hours leter patients 
were Injected with 2.2 mCI thallium- 20 I and two sets of SPECT imf1g8S were 
obtained simultaneously USing duel enerw wirmw IICQUlsitlon, The resulting 
long end short axis remnslructions were examined and the patterns of 
myocardial uptake were compared. In 6 patients the thellium defects and the 
er88$ of 8lltimyosln uptake were matched. None of the six tlIKI a history of 
prior Inferetion; In all the matched er911 corresponded to the Q wINe lreation 
on ECO. All heel stable hospital courses; serial EFs (from 2-5 days post 
Inferet thru pre-dlscherge) 8Yallable In 5/6 showed mean change of 
0.2t2.81 (range -4 to +3). In nine patients thallium defects were more 
extensive than 8IItimyosin uptake. Six of these patients heel no history of 
prior Infarets and 4/6 tlIKI In-hospital post-Infaret ISChemic events 
requiring ceth, PTCA, or surgery. The other three patients tlIKI prior 
Infarcts; 1/3 heel subsequent In-hospital Ischemia. Serial EFs available In 
4/9 showed a mean change of + 10.8:t2.81 (range +8 to + 14), significantly 
different from the matched !TOUp (p>,OOI). The remaining two patients, 
neither with prior Infarct, showed ar88$ of en<ilcerdial entimyosln uptake In 
regions where thellium uptake Ilppeared normal One of these patients tlIKI a 
non-Q WfNe Infaret by ECO , the other had a Q WfNe inferet in the distribution 
of 811 lDlitiOllllI aree of matched thlllIium defect/8llUmyosin uptake, These 
results SU!JJIISI. thet simultaneous thallium and indium entimyosin SPECT 
Imaging m~ be useful for Identifying acute infarct patients with further 
myocardium et risk. 
214A ABSTRACTS 
POSITIVE INDItlM-lll PLATELET SCANS FOR LEFT VENl'RICULAR 
'l'HlUmI PREDICf AN :nou;:N;ED ERBOLIC RISK. 
John R. stratton, M.D., F .A.C.C., James L'. Ritchie, 
M.D., F.A.C.C., VAMC arid UnlV. of Washington, Seattle. 
To determine whether a positive Indium-l1l platelet 
scan for a left ventricular thrombus (LVT) predicts an 
increased risk of subsequent embolization, we compared 
the embolic rate in 31 pts with positive Indium-Ill 
scans for LVT to 59 pts with negative scans. All pts 
were imaged to >48 hrs and scans were blindly 
interpreted. Mean followup was 29~22 months. The 
positive and negative scan groups were comparable with 
respect to age (60+12 vs 61+10), injected dose 
(330+96 vs 356+116uCi), history ot myocardial infarction 
(93%- vs 73%),-chronic or paroxsymal atrial fibrillation 
(13% vs 10%) and warfarin therapy (29% vs 20%)(all 
psNS) . 
During followup, 13% (4/31) of patients with positive 
platelet scans had definite emboli compared with 2% 
(1/59) of patients with negative scans (p<.05). The 
actuarial probablilty of being embolus-free at 5 years 
was only 65% if the scan was positive compared to 98% if 
the scan was negative (p-0.02). 
To determine whether platelet imaging offered 
additional predictive information to echocardiography, 
echos (available on 78 pts) were also blindly analyzed; 
48 demonstrated LVT. The risk of emboli was 14% (4;28) 
if both the echo and platelet scan were positive for LVT 
compared to 0% (0/20) if the echo was positive but the 
platelet scan was negative (paO.1l). 
We conclude that a positive platelet scan for a left 
ventricular thrombus predicts a definite increased 
embolic risk. A positive scan, which indicates a 
hematologically active LVT, appears more specific for 
subsequent embolization than a positive echo. In 
patients with echo documented LVT, a negative platelet 
scan is associated with a low risk of embolization. 
INFLUENCE OF CLOT AGE ON THE DETECTION OF LEFT ATRIAL 
APPENDAGE THROMBI BY INDIUM-lll PLATELET SCINTIGRAPHY 
Byron F. Vandenberg, M.D., F.A.C.C., James Seabold, M.D., 
Gary Conrad, M.D., Robert Kieso, M.S., Karen Fox-Eastham, 
Jan Johnaon and Richard E. Kerber, M.D., F.A.C.C., 
University of Iowa, Iowa City, Iowa 
We have previously demonstrated excellent sensitivity and 
specificity of Indium-Ill platelet scintigraphy (In-PS) to 
detect experimentally induced left atrial appendage (LAA) 
thrombi in a canine model, when the labeled platelets were 
injected 24 hours after thrombus induction. Clinically, 
however, thrombi are likely to be older with lower rates 
of platelet incorporation. This may reduce the 
sensitivity of In-PS. Our purpose in this study was to 
determine the influence of clot age on the ability of 
In-PS to detect LAA thrombi. LAA thrombi were induced by 
injecting thrombin and blood into the briefly clamped 
LAA. Indium-Ill labeled platelets were injected 24 hours 
(Group A, n-17) or 4-7 days (Group B, n-ll) after thrombus 
induction. Analog and blood pool subtracted In-PS images 
were obtained 4, 24 and 48 hours after platelet injection 
in Group A and after 24, 48 and 72 hours in Group B. Dogs 
were sacrificed when scintigrams were positive, or at 48 
(Group A) or 72 (Group B) hours. Results: (xtSD; 
*p<.05, **p<O.Ol) 
Gro? A Gro? B 
Thrombi present 17 17 9 11 
Thrombus volume (cc) 1.2tl.O O.4:!:O.3* 
In-PS sensitivity (analog) 14/17(82%} 1/9 (11%)** 
In-PS sensitivity (subt.) 16/17(94%) 1/9 (11%)** 
Conclusions: In-PS has excellent sensitivity for 
detection of acute LAA thrombi, but the sensitivity 
declines markedly as clots age, probably due to lower 
rates of platelet incorporation and smaller thrombus 
volume. This may limit the clinical usefulness of In-PS 
for LAA thrombus detection. 
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SCINl'IGRAPHIC ASSES9o!ENT CF GIDBAL ADRENERGIC NERVE 
DmSI'lY WITH MIB3 WASHOOT MAPS. 
Michael W. Dae, MD, William O'Cormell, Michael C. Chin, MD, 
John M. Herre, MD, John P. Huberty, Elias H. Botvinick,MD, 
F1\CC, University of California, San Francisco. 
Norepinephrine (NE) uptake in the heart is distributed 
to neuronal am nonneuronal stores. '1he rate of NE efflux 
fran nonneuronal stores is more rapid than fran neuronal 
storage sites. Metaiodobenzylguanidine (MIB3) is thou;Jht 
to share these mechanisms with norepinephrine. To assess 
whether the detenni.naticn of global washout of M]B; would 
reflect absolute synpathetic nerve density, in the absenoe 
of regional abnonnalities, we studied 10 dogs (7 during 
the basal state, 4/7 repeated one week: after interventicn; 
3 one week: after intervention). Interventicn consisted of 
injection of either 6-OH dopamine (4) , to cause degenera-
tion of nerve endings, or 6-00 dopa (3) , which is taken up 
by nerve endings but does not cause destructicn. Four to 
six millicuries of 1-123 Mm:; were injected, followed by 
initial 5 minute images in three projecticns and delayed 
images at three to four hours. Initial am delayed images 
were superinposed using a cross correlation technique, 
and functicnal maps, color coded for peroent washout, were 
generated for each projection. Tissue NE content was 
rreasured in 7/10 dogs. 
Mm:; Wasoout (%) NE (ng/gIn) 
Baseline 8.6 + 28.6 935 + 248 
6-OH DOPA 
6-00 OOPAMINE 
19 + 41* 1161 + 484, 
85.6 + 11 (p .001) 204 + 300 
(* vs-: baseline) (p(.02) 
Increased MIB3 wasoout correlates with reduced tissue 
NE, and may provide a noninvasive IreaIlS of detecting glo-
bal decreases in synpathetic nerve density in the absence 
of regional abnomalities. 
DIPYRIDAMOLE-INDUCED INCREASE IN PULMONARY THALLIUM UPTAKE: A 
MARKER OF TRANSIENT GLOBAL LEFT VENTRICULAR DYSFUNCTION IN 
PATIENTS UNABLE TO EXERCISE. S. Reisman, M.D., C. K1epser, 
M.S., J-C Vaugeois, M.S., C. Burgess, M.D., B. Chandramou1y, 
M.D. The Long Island College Hosp., Brooklyn, NY 
Although increased pulmonary thalli urn uptake has been 
described in patients undergoing exercise Tl-20I (Tl) 
scintigraphy, the frequency and significance of this finding 
in pts undergoing Dipyridamole (DP) Tl is not known. We 
studied 78 pts undergoing both coronary arteriography and DP-
Tl by a 4 min infusion of 0.56 mg/kg DP & handgrip exercise. 
Coronary arteriograms were evaluated by the Gensini coronary 
artery jeopardy score which accounts for severity, extent, 
and location of stenoses. Three-view planar Tl scintigrams 
were divided into 15 segments (segs) and Tl uptake was graded 
visually in each seg (4 pOint score) with abnonnal seg=score 
of 2 or 3 . All Tl sc i nt i grams were processed by our 
previously described computerized quantitative severity score 
(QSevS) which integrates area of mYocardial perfUSion defect 
below mean nonna1 (13 nl DP pts). Post-infusion pulmonary Tl 
uptake was graded visually by a 4 point score (0-3) with 
increased pulmonary Tl uptake (score=2 or 3) present in 8 
pts (GpI) and absent in 70 pts (GpII). 
Abn Seas Gensini 
Gp I 7.3 ±2.1 69.9 ±36.9 
Gp II 3.0 ±3.5 * 31.8 ±33.5 ** 
* = P<O.OOI ** - P<O.OI 
OSevS 
2078 +1336 
991 ± 910 ** 
In pts unable to exercise, DP-induced increase in pulmonary 
Tl-201 uptake: 1) is not frequent but 2) when noted 
identifies a group of pts with extensive myocardial 
hypoperfus i on along with severe and extens i ve CAD. Th is 
non· invasive marker of transient global left ventricular 
dysfunction may identify a subset of pts with a high risk 
for futUre cardi ac events. 
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ECG GATING IMPROVES THE ACCURACY OF RADIONUCLIDE RIGHT 
VENTRICULAR EJECTION FRACTION DETERMINATIONS 
Karim Rezai, M.D., Robert Weiss, M.D., Janet Preslar, 
N.M.T., William Stanford, M.D., Majid Rooholamini, M.D., 
Peter Kirchner, M.D., and Melvin Marcus, M.D., F.A.C.C., 
U of Iowa, Iowa City IA 
Validation of nuclear medicine approaches to assessing 
right ventricular ejection fraction (RVEF) have been 
hampered by lack of an appropriate gold standard. Stu-
dies of radio-opaque RV casts and electromagnetic flow 
meter measurements of RV stroke volume indicate that 
ultrafast computed tomography (CT) measures RV end-
diastolic volume and stroke volume ±3-5%. Therefore, we 
compared RVEF measured with ultrafast CT with two ap-
proaches to assessing RVEF: beat-by-beat analysis of 
radionuclide transit through a fixed region of interest 
(ROI) over the RV (conventional approach) and a new 
technique that constructs a composite cycle (MINI-MUGA) 
with ECG gating and permits placement of variable ROls 
in systole and diastole. Studies were performed in 21 
patients whose CT RVEF varied from 29%-71%. With the 
conventional approach, the correlation coefficient with 
CT was r-0.64. The slope of the relationship was 0.48 
and the intercept was 13.0%. Thus, this approach signi-
ficantly underestimates RVEF. With the MINI-MUGA ap-
proach, the correlation with CT was r-0.86. The slope 
of the relationship was 0.79 and the intercept was 
14.0%. Frame by frame review of the RV images disclosed 
substantial translational motion of the tricuspid valve 
plane between systole and diastole by as much as 25% of 
the long axis of the RV. Thus, a fixed ROI systemati-
cally underestimates RV ejection fraction due to incom-
plete sampling of the RV and/or partial inclusion of 
RA. The MINI-MUGA approach provides a much more 
accurate assessment of RVEF. 
PROSPECTIVE PREDICTION OF CLINICAL CORONARY DISEASE IN 
PATIENTS WITH TYPE I DIABETES MELLITUS BY EXERCISE RADIO-
NUCLIDE VENTRICULOGRAPHY. 
Myron C. Gerson, M.D •• F.A.C.C., Jane C. Khoury, B.Sc., 
University of Cincinnati, Cincinnati, Ohio 
Sixty-nine Type I diabetic patients who had no symptoms 
suggestive of coronary artery disease and who were unse-
lee ted with respect to coronary risk factors were studied 
to determine the physiologic and prognostic implications 
of rest and exercise radionuclide ventriculographic test-
ing. During a median follow-up interval of 29 months 
(interquartile range 22 to 39 months) 11 patients devel-
oped clinical coronary artery disease consisting of fatal 
myocardial infarction, sudden cardiac death, or angina 
pectoris with coronary arteriographic documentation of at 
least one 50% or greater luminal diameter coronary artery 
stenosis. Multivariate analysis of clinical and exercise 
variables identified the peak exercise heart rate, exer-
cise duration, and the exercise left ventricular ejection 
fraction as independent predictors of subsequent clinical 
coronary disease. Ninety-seven percent of diabetic 
patients with a normal rest and exercise radionuclide 
ventriculogram remained free of coronary artery disease 
during 29 months of follow-up whereas 40% of patients with 
an abnormal radionuclide study developed clinical coronary 
disease. In this asymptomatic diabetic population that 
was unselected with respect to coronary risk factors, 
correlative exercise thallium-20l scintigraphic studies 
and coronary arteriograms suggested that the coronary 
arteries were not normal in the majority of patients with 
evidence of left ventricular dysfunction by exercise 
radionuclide ventriculography. 
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MYOCAROIAL OXYGEN CONSUMPTION CAN BE PREDICTED BY 
RADIONUCLIDE ANGIOGRAPHIC LEFT VENTRICULAR Emax 
PRESSURE-VOLUME AREAS IN DOGS. Mark R. Starl ing, 
M.D., F.A.C.C. and G. B. John Mancini, M.D., 
F.A.C.C., Univ of MI and VAMC, Ann Arbor, Michigan. 
The pressure-volume area (PVA) obtained using the 
maximum time-varying elastance concept is a 
promiSing new approach to predicting myocardial 
oxygen consumption. This approach, however, has 
not been investigated in the intact animal. 
Accordingly, to determine whether radionuclide 
angiographic (RNA) left ventricular (LV) maximum 
time-varying elastance (Emax) PYA can be used to 
predict myocardial oxygen consumption normalized 
for heart rate (MV02/bt), we instrumented 6 dogs 
with a LV micromanometer and a coronary sinus 
thermodilution catheter. After beta-blockatle, LV 
pressures, MV02/bt, and RNA were obtained in each 
dog during 5 to 7 stable hemodynamic states pro-
duced by aortic or inferior venacaval constriction. 
LV Emax was calculated from the simultaneous 
micromanometer LV pressure and RNA LV vol ume data 
as the maximum linear relations of isochronal, 
instantaneous pressure volume (P-V) data points 
(range 2.73 to B.39 mmHg/ml, r=0.77 to 0.99). PYA 
(mmHg.ml/beat) was obtained using a calibrated 
planimeter for each condition in each dog as the 
area bound by the Emax and end-diastolic P-V lines 
and systol ic segment of the P-V loop. PYA corre-
lated with_~V02/bt (r=0.B2 to 0.94, MV~~bt=0.005 + 
6.0B x 10 PYA to 0.166 + 1.32 x 10 PVA). We 
conclude that Emax PYA calculated using RNA can 
predict MV02/bt in dogs with an intact circulation. 
CLINICAL VALUE OF MEASUREMENT OF VENTRICULAR 
ASYNERGY BY MULTIPLE GEOMETRIC MODELS 
Brian Miller, Ph.D., Christopher Granger, M.D., Timothy Henry, M.D., 
Dennis Kirch, M.S.E.E., William Guess, N.M.T., and Arnold Weissler, 
M.D., F.A.C.C., Rose Medical Center and University of Colorado, Denver, 
Colorado 
Left ventricular asynergy (LV A) quantitated in a four quadrant concentric 
nucleographic model adds significantly to ejection fraction (EF) in mortality 
risk stratification. This study was designed to test whether multiple 
geometric models including those which exclude the inflow-outflow 
segment modify the clinical value of the measurement of LVA. A definition 
of LV A (CoL VA based on the coefficient of variation principle was 
calculated as 1: (GEF-REF)2/n x 100/GEF for the following models: 
<&>®®~~ ( .., segment deleted). The study group included 20 normals 
(N) and 109 patients with recent (n= 72) or remote (n=37) myocardial 
infarction (MI) in each of whom EF and CoL V A by each model was 
determined. Employing 99% confidence limits for CoL VA, all models 
yielded (1) significant separation of N from MI, p< .001, (2) significant 
differences in 4 year cumulative survival among MI patients (synergic 94-
97% vs asynergic 57-61%, prange .002-.02), (3) significant augmentation by 
Cox proportional hanrds in risk stratification by EF dichotomized at 0.40 
(p .008-.06). Intercorrelation of CoLVA among the 5 models was 0.92 to 
.99. In none of the models did CoL VA correlate closely with EF. (r=.63-
.72) Conclusion: The CoLVA measured from multiple models is distinct 
from EF, has high potency in separating N from MI, has high univariate risk 
stratifying capacity and augments EF in mortality risk stratification. 
Deletion of the inflow-outflow segment does nOt significantly influence the 
separation of normals from MI or the risk stratifying capacity of the 4 or 8 
segment models. 
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EXERCISE RADIONUCLIDE ANGIOGRAPHY AFTER NON-Q-WAVE 
MYOCARDIAL INFARCTION 
veroni~ue L. Roger, M.D., Stephen L. Kopecky, M.D., 
Raymon J. Glbbons, M.D., F.A.C.C., Peggy A. Puetz, R.N., 
Vicky S. Hench, M.S., Alan R. Zinsmeister, Ph.D., Bernard 
J. Gersh, M.B., Ch.B., D. Phi1., F.A.C.C., Mayo Clinic 
and Foundation, Rochester, Minnesota 
To assess the prognostic value of exercise radionuclide 
angi ography (ex RNA) performed early after no'n-Q-wave myo-
cardial infarction (NQMI), we analyzed 139 pts (103 males, 
36 females; age 27 to 83, median 62) who underwent ex RNA 
within 3 to 17 days (median 8 days) after NQMI. Median 
value for peak creatine kinase was 231 and 62% of the pts 
had post-infarction angina. Median values for duration 
of exercise, total workload, and rate-pressure product 
were, respectively, 6 minutes, 400 kg-m/min, and 15,600. 
Median value for ejection fraction (EF) was 55% at rest 
and 56% at peak exercise. Twenty-seven pts had a fall in 
EF >5% with exercise. A positive test was defined by 
chest pain, or ST segment depression >1 mm or a fall in 
EF >5% with exercise. 
Median followup was 29 months. Out of 14 deaths, 11 
were cardiac. Cardiac events defined as cardiac death, 
myocardial infarction, or surgery specifically for 
recurrent ischemia, occurred respectively in 8%, 12%, and 
20% of the pts. At 1 year, event-free survival was 95% 
if the exercise test was negative (42 pts) versus 73% in 
case of a positive exercise test (91 pts). By univariate 
analysis, the variables diabetes, exercise duration, peak 
workload, EF, and wall motion score index at rest and at 
peak exercise were significantly associated with time to 
an event (p<.05). 
Thus, after NQMI, ex RNA can identify a lower risk 
group defined by a negative exercise test and therefore 
helps risk stratification among those pts. 
DIPYRIDAMOLE RADIONUCLIDE VENTRICULOGRAPHY HAS HIGH 
SENSITIVITY FOR DETECTING SEVERE MULTIVESSEL CORONARY 
ATHEROSCLEROSIS 
Christopher U. Cates. M.D., H. Wade Collins, M.D., 
Martin P. Sandler, M.D., Marvin W. Kronenberg, M.D., 
F.A.C.C. Vanderbilt University, Nashville, TN 
Dipyridamole (D) can demonstrate myocardial 
malperfusion, but its effects on ventricular function in 
coronary artery disease (CAD) are uncertain. We tested 
the hypothesis that D-infusion would produce myocardial 
ischemia, as manifested by regional wall motion (RWM) or 
global ejection fraction (EF) abnormalities on gated 
radionuclide ventriculography (RVG) in patients with 
severe CAD. We compared D-RVG to standard rest-exercise 
(EX) RVG in a prospective study of 21 patients (15 CAD, 
no Q waves) and graded results blindly. Severe CAD was 
defined as >50% left main (LM) or >70% other vessel (V) 
stenosis. Failure to increase EF ~ 5 units or a decrease 
in RWM score were considered abnormal responses. 
ABNORMAL 
RESPONSE: 
Any CAD>70%: 
sens/spec 
3VCAD,LM: 
EF 
87/83 
EX-RVG D-RVG 
RWM EF RWM 
87/50 73/83 60/83 
sens/spec 100/41 100/29 100/53 100/65 
In addition, a decrease in EF on D-RVG was very specific 
(100%) for anterior descending artery CAD, with or 
without other CAD. These results show that D-RVG was 
quite sensitive for detecting multivessel CAD and 
approached the sensitivity of EX-RVG for detecting any 
CAD>70%. Therefore, D-RVG can demonstrate ischemic 
ventricular dysfunction comparable to EX RVG in pts with 
severe CAD. This technique may provide a useful 
alternative to EX-RVG in the diagnosis of severe CAD in 
patients who cannot exercise. 
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PHASE ANALYSIS PREEXCITATION INDEX AND ITS AUGMENTATION 
BY VERAPAMIL: A NEW METHOD FOR LOCALIZATION OF 
ACCESSORY PATHWAY IN THE WOLFF-PARKINSON-WHITE SYNDROME. 
Raymond J. Lemieux, M.D., Helene Lavoie, Teresa Kus, 
M.D., Ph.D., Pierre Page, M.D., FACC, Mohammad Shenasa, 
M.D., Ph.D., Sacre-Coeur Hospital, Univ. of Montreal, 
Montreal, Canada. 
In 11 patients with the Wolff-Parkinson-White syndrome, 
we investigated the value of calculating, from the phase 
images, a preexcitation index defined as the sum of 
contracting pixels in a region of interest (ROI) over 
the accessory pathway (AP) during 30 ms after the onset 
of phase excitation divided by the number of pixels in a 
ROI over the rest of the ventricles after the injection 
of verapamil (0.15 mg/kg) minus the same ratio before 
injection multiplied by 100. The index can be expressed 
as: ([(ROIap/ROIv)post-verap. - (ROIap/ROIv)] x 100). 
AP localization was validated by intracardiac electrode 
mapping in all cases and intraoperative epicardial 
mapping in 3 patients. AP locations were anterolateral 
in 1, left lateral in 3, left posterior in 1, right 
posteroseptal in 3, and right lateral in 3 patients. No 
patient had multiple APs. Conventional phase images 
showed multiple sites of early contraction in 5 out of 
11 patients. In ROIs over APs, the preexcitation index 
ranged from +6% to 41% (mean +19%). However in ROIs 
over areas of early phase activation not corresponding 
to APs, the index ranged from -2% to -19% (mean -8%). 
Results indicate that measurement of the preexcitation 
index and use of verapamil allows a more accurate 
localization of APs than conventional phase images. The 
potential superiority of this method may be applicable 
in patients with multiple APs. 
AMBULATORY MONITORING OF LEFT VENTRICULAR FUNC-
TION POST INFARCTION PREDICTS RESIDUAL ISCHEMIA 
Warren Breisblatt. M.D •• F.A.C.C •. John Mclean, 
M.D., Frederick Weiland, M.D., Mary J. Burns, 
R.N., Leo J. Spaccavento, M.D., F.A.C.C., Wilford 
Hall USAF Medical Center, San Antonio, Texas. 
Ambulatory assessment of LV function with the 
nuclear VEST was performed in 18 pts post infarc-
tion (MI) to predict pts at risk for ischemia. 
The VEST was positioned using a gamma camera and 
was worn a mean of 182 ± 32 min. During the study 
pt's underwent exercise testing (ETT) , were sub-
jected to mental stress (MS), cold pres~or (CP), 
isometric (I) and other routine activities. All 
pts had cardiac cath and exercise thallium imag-
ing (TI-I) prior to discharge. The correlation of 
VEST ejection fraction (EF) with radionuclide 
angiography was excellent at .975. ETT was posi-
tive for ischemia in 8 pts, while TI-I suggested 
reversible ischemia (RI) in 10, isolated fixed 
defects in 6 and 2 scans were normal. Based on 
the VEST studies ischemic responses were seen in 
12 pts during ETT, 9 MS, 5 CP, 3 I and 2 during 
other periods. When VEST responses were compared 
with RI on TL, ETT and MS were the most powerful 
predictors for ischemia. (*P<.05, pre to peak). 
EJECTION FRACTION % (PRE. PEAK) 
ETT MS- ~ 
Tl+ (n-10) 52 40* 52 43* 52 48* 
Tl- (n= 8) 45 43 45 45 46 40* 
Ambulatory assessment of LV function was more 
accurate then ETT in predicting ischemia and gave 
complimentary information to Tl-I. The 
demonstration of ischemia during periods other 
than exercise may be valuable in the post MI pt. 
I 
52 
46 
48 
45 
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LEFT ATRIAL VOLUME MEASUREMENT: CINE COMPUTED TOMOGRAPHY 
AND ECHOCARDIOGRAPHY. Byron F. Vandenberg, M.D .• 
F.A.C.C .• Robert Weiss, M.D., Joe Kinzey, Mark Acker, 
William Stanford, M.D., Melvin L. Marcus, M.D., F.A.C.C., 
Richard E. Kerber, M.D., F.A.C.C., U of Iowa, Iowa City, 
IA. 
Numerous measurement techniques for left atrial (LA) 
volume determination by biplane two-dimensional echo-
cardiography (2DE) have been suggested. Our purpose was 
to use cine computed tomography (CT), a highly accurate 
and reproducible imaging technique, as an independent 
standard against which biplane 2DE could be compared. We 
first validated the accuracy of CT measurement of LA vol-
ume. The radio-opaque casts of the LA of 3 dogs, 4 pigs, 
and 1 calf were measured by CT and water displacement of 
casts. Cast volumes ranged from 21-130 cc. Results: CT 
volume (y) = 1.0B water displacement (x) - 6.5, r=0.99, 
SEE = 2 cc. Then, 2DE and CT were performed in 16 humans. 
2DE was performed with an annular array transducer. LA 
volume by cine CT was determined by Simpson's rule recon-
struction of serial 1 cm thick tomographic images of the 
entire LA, following intravenous contrast administration. 
LA volumes by CT ranged from 47-109 cc. LA volume was 
calculated from 2DE 4 and 2 chamber apical views using an 
Area (A)-Length (L) method: Volume = BA1A2f3rrL. Multiple 
suggested measurement conventions were evaluated. -The 
best correlation was achieved when the areas were obtained 
from orthogonal 2 and 4 chamber apical views, and the LA 
lengths used were maximum in any direction: 2DE volume 
(y) = .61 CT volume (x) - 2 cc, r=0.B3, SEE = B cc, p< 
.001. Conclusion: 2DE measurements of LA volume using bi-
plane techniques underestimate the LA volume when compared 
to cine CT. However, the correlation between these two 
measurements is reasonably close. 
THE ROLE OF INTRAOPERATIVE ECHOCARDlo;;RAPHY DURING 
CARDIAC VALVULAR SURGERY. 
William J. Stewart, M.D., F.A.C.C., Philip J. currie, 
M.B.B.S., Bruce W. Lytle, M.D., F.A.C.C., Carl C. Gill, 
M.D., F.A.C.C., Deborah A. Agler, Helga P. Lombardo, 
Delos M. Cosgrove, M.D., F.A.C.C. 
The Cleveland Clinic Foundation, Cleveland, OH. 
Intraoperative echocardiography with color flow mapping 
(IOE) can provide the surgeon with an immediate, direct 
appraisal of cardiac structure and function. To deter-
mine the frequency with which IOE influences intraopera-
tive decision-making, we reviewed 150 consecutive pts 
who had IOE over a 9 month interval, performed before 
cardiopulmonary bypass (CPB) in 21, after CPB in 33, and 
both before and after CPB in 96 pts. Ninety-nine had 
mitral regurgitation (MR), 22 had mitral stenosis (MS), 
23 had aortic stenosis, 25 had aortic regurgitation (AR), 
5 had IHSS, and 4 had tricuspid disease; 28 pts had mixed 
lesions; for a total of 178 lesions in 150 pts. 
Results: IOE led to a change in surgical treatment in 
22 (15%) of pts. In the remainder, IOE substantiated 
the appropriateness of previous therapy and plans. IOE 
prior to CPB was useful in 9 pts to avoid surgery where 
the preop data was suboptimal or discordant (B MR, 1 MS), 
especially with complex multi valvular lesions. IOE after 
CPB led to further surgery in 13 pts: 6 pts after repair 
for MR (persistent MR in 2 pts and LV outflow tract 
obstruction in 4 pts), 5 pts with persistent AR after 
aortic surgery (valvular in 3 pts and paraprosthetic in 
2 pts), and 2 pts with new regional wall motion 
abnormalities treated with further coronary bypass. 
Conclusions: Intraoperative echocardiography is a 
valuable adjunct in intraoperative decision making which 
has become part of our routine. IOE is particularly 
useful in valve repair and multi valvular surgery. 
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INTRAOPERATIVE TRANSESOPHAGEAL COLOR DOPPLER IMAGING: 
ADVANTAGES AND LIMITATIONS 
Ann Bolger. M.D., Larry S. Czer, M.D., F.A.C.C., Arnold 
Friedman, M.D., Jody Kleinman, M.D., Michele DeRobertis, 
R.N., Aurelio Chaux, M.D., F.A.C.C., Gerald Maurer, 
M.D., F.A.C.C. Cedars-Sinai Medical Center, Los Angeles, 
California. 
To compare the utility and limitations of intraoperative 
transesophagea 1 (TE) and epi cardi a 1 (EPI) color Doppl er 
(CD) imaging, we examined 9 patients (coronary artery 
disease and mitral regurgitation in 6, rheumatic mitral 
and aortic disease in 1, type A aortic dissection in 1, 
Ebstein's anomaly with secundum ASD in 1). A flexible 5 
MHz TE probe was placed in the anesthetized patients and 
multiple views recorded with an Aloka B60 CD system. 20 
TE studies were performed and 9 compared with hemodynam-
ically and temporally matched EPI studies (3.5 MHz tran-
sducer). TE detected reversible wall motion abnormal-
ities, unsuspected intraoperative aortic dissection, and 
bidirectional shunting at a secundum ASD which were not 
seen with EPI. Grade of valvular insufficiency was simi-
lar in 15/17 estimates; regurgitant jets were seen 
behind 4/4 mitral prostheses by TE versus 1/4 by EPI. 
The pulmonic valve was seen in 1/15 TE versus 7/9 EPI 
studies. Conclusions: TE imaging is more informative 
than EPI regarding mitral prosthetic regurgitation, 
shunt flow and aortic dissection, and comparable to EPI 
for estimation of insufficiency in native mitral valves. 
TE views are more limited than EPI, however, and may not 
allow adequate visualization of the pulmoniC or 
tricuspid valves. 
SAFETY OF HIGH DOSE DIPYRIDAMOLE-ECHOCARDIOGRAPHY TEST 
Fabio Lattanzi, MD, Eugenio 
MD, Alessandro Distante, MD, 
C.N.R. Clinical Physiology 
Pisa, Pisa, Italy. 
Picano, MD, Michele Masini, 
Antonio L'Abbate, MD FACC. 
Institute, University of 
Over the last 4 years, we performed 560 high dose 
Dipyridamole (D.)-Echocardiography tests (2-D echo and 12 
lead ECG monitoring during D. infusion, up to 0.B4 mg/kg 
over 10') in 418 pts referred for a chest pain syndrome. 
The D. infusion protocol was: 0.56 mg/kg over 4', 
followed by 4' of no dose, and, if still negative, 0.28 
mg/kg over 2'. There were no vomiting, severe 
hypotension )30 mmHg blood pressure decrease), 
sustained arrhythmias (i.e.,)3 consecutive ventricular 
beats), myocardial infarction or death. 
Out of the 418 study pts, a subset of 324 was studied 
without therapy and underwent cardiac catheterization, 
showing significant coronary artery disease (CAD, )70Y. 
lumen reduction of at least one major vessel) in 243 
pts. A transient dyssynergy was recorded in 175/243 CAD, 
and in 6/81 no CAD pts (75Y. vs 7Y., p<.OI). ST segment 
shift ()O.I mVolt) was found in 134/243 CAD, and in 
24/81 no CAD pts (55Y. vs 30Y., p<.OI). While ST segment 
depression was by far the most common ECG pattern, 16 
pts had ST segment elevation. Chest pain was present in 
131/243 of CAD, and in 33/81 of no CAD pts (54Y. vs 41Y., 
p=ns). At least one of the following extracardiac side 
effects (headache, flushing, dyspnea, nausea, dizziness) 
occurred in 70Y. of CAD and in 68Y. of no CAD pts (p=ns), 
but no side effects were severe, so that the test was 
completed in all pts. In 10 pts D.-induced dyssynergy 
reversed sponta'neously; 171 pts required i.v. amino-
phylline (up to 240 mg over 3'); IS of these 171 pts also 
needed nitrates for relief of myocardial ischemia, 
Thus, high-dose D, combined with 2-D echo monitoring 
is a safe exercise-independent test for detection of CAD. 
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COMPARISON OF DIPVRIDAMOLE-ECHOCARDIOGRAPHV TEST AND 
EXERCISE THALL I UM-20 1 SCANNING FOR DIAGNOSIS OF CORONARY 
ARTERY DISEASE. 
Eugenio Picano, MD, Oberdan Parodi, MD, Fabio 
Lattanzi, MD, Gianmario Sambuceti, MD, Michele Masini, 
MD, Claudio Marcassa, MD, Alessandro Distante, MD, 
Antonio L'Abbate, MD, FACC. C.N.R. Clinical Physiology 
Institute, University of Pisa, Pisa, Italy. 
Two noninvasive tests to detect and localize coronary 
stenoses were compared in a fully blinded protocol. 
ThaI I ium-201 myocardial perfusion imaging during 
cycloergo.eter exercise (TET) and high dose Dipyridamole 
Echocardiography test (DET: 2D echo monitoring with 
dipyridamole infusion, up to 0.84 mg/kg over 10') were 
performed in 61 pts with a chest pain syndrome. 
Criteria of positivity were' for TET, a reversible 
defect of perfusion, as quantitatively assessed by the 
post-exercise and redistribution images; for DET, a 
transient dyssynergy of contraction, absent or of a 
lesser degree in resting conditions. All pts underwent 
coronary angiography; 43 had significant CAD (at least 
one major artery with ~ 70% luminal diameter narrowing). 
The sensitivity for predicting angiographically assessed 
CAD was 86% for TET and 79% for DET (p=ns); the 
specificity was, respectively, 56Yo and 100Yo (p<.05). In 
28 of the 31 pts in whom both TET and DET yielded 
positive responses, the Same myocardial region was 
involved. 
In conclusion, DET represents a reasonable diagnostic 
alternative to TET, showing a similar sensitivity and a 
higher specificity for the detection of angiographically 
assessed CAD. DET needs an acceptable acoustic window 
to be performed: it is however less expensive than TET, 
requires a much shorter imaging time and can be also 
performed in pts unable to exercise. 
ASSESSMEVT OF CARDIAC RISK BY EXERCISE ECHOCARDIOGRAPHY 
PRIOR TO PERIPHERAL VASCULAR SURGERY 
Blair Halperin, H.D., Robert Scott, H.D., Monica Hofmann, 
Robert T. Palac, H.D., F.A.C.C., VAHC and Oregon Health 
Sciences University, Portland, OR. 
We evaluated tbe ability of pre-operative treadmill 
exercise(EX) two-dimensional ecbocardiograpby(2DE) to 
predict cardiac complications(COHP) in 46 stable patients 
witb suspected coronary artery disease baving peripberal 
vascular surgery. Regional wall motion(WH) was assessed 
at rest and post-stress(PS). In 20 patients not reacbing 
85~ pred. max HR for age, tbe procedure was repeated with 
low dose dobutamine infusion during exercise(DbEx). 
Regional WH was scored as normal = 4, bypokinetic = 2, 
akinetic z 0, and dyskinetic = -2. A WH score(S) was 
calculated as: sum of segments/total # segments 
analyzed. Results: dobutamine increased double product 
during exercise in 19/20 pts compared to EX alone (20.2 + 
4.2 x 103 vs 16.3 ± 3.5 x 103; p(.Ol). Seven pts bad -
further decline in WHS witb ObEx vs exercise alone (mean 
-.84 ± .42). Twelve pts receiving dobutamine bad no 
cbange in WHS. Seven of 46 (15~) pts bad cardiac 
complications. Resting WHS was not different in COHP vs 
non-COHP pts (3.3 ± .5 and 3.5 ± .7, respectively; 8S). 
However, in COHP pts post-stress WHS was lower (1.9 + .6 
vs 3.2 ± .2; p<.OOl) and tbe cbange ~) in WHS betwe;n 
rest and PS was greater (-1.3 ± .3 vs -0.3 ± .6; p < 
.001). ST segment depression occurred in 5/7 (.71) COHP 
pts and all bad WHS~-0.8; in non-COHP pts 9/39 (.23) 
bad ST segment depression and 27/39 (.69) bad WHS > 
-0.8. This data suggests 1) tbat tbe severity of wall 
motion abnormality during exercise ecbocardiograpby can 
be used to predict peri-operative cardiac COHP in 
vascular pts, and 2) dobutamine may be used to supplement 
exercise in evaluating iscbemic wall motion abnormalities 
in pts witb submaximal exercise. 
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PERCuTANEOUS MITRAL BALLOON VALVULOPLASTY - INTERMEDIATE 
FOLLOW-UP STUDY. 
Alec VAHANIAN M.D., Olivier LEBORGNE M.D., Pierre-Louis 
MICHEL M.D., Slawa TRABELSI M.D., Bertrand CORMIER M.D., 
Michel SLAMA M.D., Christian SPAULUING M.D., Mohamed 
BEN ISMAIL M.D., Jean ACAR M.D.,H6pita1 TENON,PARIS,FRANCE 
To assess the outcome after percutaneous mitral balloon 
valvuloplasty (BV), 34 consecutive patients (pts) were 
followed for a mean of 8±3 months (range 4-15) after BV. 
Mean age was 44 ± 17 yrs (13-76). Before BV, 7 were in NYHA 
class II, 26 in class III and 1 in class IV. Nine had 
calcified valves. 
No pt died during BV and follow-up (FU). Three pts were 
operated on 1 to 2 months after BV : 2 because of severe 
mitral regurgitation with perSisting symptoms ; 1 because 
of insufficient hemodynamic improvement. The remaining 31 
pts, who underwent successful BV, were followed clinically 
and by imaging (20) and doppler (D) echo with dp.termination 
of the mean gradient (GR) and valve area (VA). 27/31 (87 %) 
showed marked functional improvement >1 NYHA class. Only 
4 pts remained in class III, however paroxystic dyspnea 
disappeared in 3. 
Echocardiographic 
20 VA (cm') 
o VA (cm') 
GR (mmHg) 
results were mean! SO 
Before BV After BV 
1.1±.2 1.9!.4* 
1. 1 ! .2 1. 9 ! .4* 
10 ! .4 6 ! 3* 
* p < .001 between before and after BV. 
1.9 
1.8 
6 
FU 
± .4 
! .4 
! 2 
During FU, 
increment. 
only 2 pts lost> 50 % of their post BV VA 
Conclusion : this intermediate FU study shows that 
per~istent improvement in functional status and valve 
function was obtained after successful BV in most of the 
cases (87 %). However, when severe post BV mitral regur-
gitation occurs, surgical repair may be required. 
EVALUATION BY COLOR DOPPLER OF THE EFFECTS OF LOADING 
ALTERATIONS ON MITRAL REGURGITANT JET IN PATIENTS WITH 
MITRAL VALVE PROLAPSE 
Sabino Iliceto M.D., Paola Coluccia M.D., Margherita 
Sorino M.D., Gaetano D'Ambrosio M.D., Antonio Amico M.D., 
Paolo Rizzon M.D. 
Division of Cardiology, University of Bari-Ita1y 
Color Doppler was performed in 32 patients with typical 
auscultatory and/or echocardi ographic fi ndi ngs of mi tra 1 
valve prolapse, in 6 patients with fibrotic mitral valve 
and in 6 normals. A mitral regurgitant jet (MRJ) was 
present in 12 patients with mitral valve prolapse and in 
none of normals and patients; with fibrotic mitral valve. 
MRJ area was assessed by color Doppler before (control) 
and after methoxamine (M) infusion (increased afterload) 
and after amyle nitrate (AN) inhalation (decreased 
afterload). In mitral valve prolapse patients after M a 
new MRJ appeared in 2 more patients, while after AN the 
preexisting MRJ disappeared in 6. MRJ area (cmL) was 
1.8+0.9 during control, 3+0.9* after M and 0.9+0.9* after 
AN (*= p<.Ol vs control).-In none of normals and patients 
with fibrotic mitral valve did MRJ appear after M or AN. 
Conclusions: 1) in patients with mitral valve prolapse, 
MRJ area is markedly influenced by variations in loading 
conditions; 2) in these patients, loading changes may 
induce appaearance or disappearance of MRJ: this may 
expl ai n the extreme vari abil ity of auscultatory findings 
in mitral valve prolapse patients. 
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LEFT ATRIAL SIZE AND PRESSURE REFLECTS THE "HISTORY" OF 
CHRONIC MITRAL REGURGITATION. D. Reed, H. D., H. 
Smucker, H. D., F.A.C.C., S. Hanning, S. Kaul, H. D., 
F.A.C.C., University of Virginia, Charlottesville, VA. 
A great deal of emphasis has been placed on para-
meters of left ventricular function as pre-operative 
indicators of survival following mitral valve replace-
ment (HVR). However, other clinical, echocardiographic 
and hemodynamic variables have not been studied in as 
great detail. Accordingly, 30 clinical, hemodynamic, 
angiographic, and echocardiographic pre-operative para-
meters were examined using Cox regression analysis in 85 
patients undergoing HVR. Thirty-six patients died within 
2.2 ± 2.0 years (mean ± 150). The pre-operative vari-
ables that predicted post-operative mortality were left 
atrial volume ~91 ± 34 cc in survivors vs 119 ± 41 cc in 
nonsurvivors x = 11.6 P = 0.01) which was measured from 
two echocardiographic planes ~parasternal long axis and 
apical 4-chamber) and PCVP (x = 4.7, P = 0.03). Only 1 
of the 10 patients with normal left atrial size «55cc) 
died compared with 35 of 75 with enlarged left atrium (p 
< 0.05). In contrast, pre-operative functional class, 
left ventricular end-systolic size, existence of conco-
mitant coronary artery disease, previous mitral valve 
surgery, and pulmonary artery pressure did not predict 
survival. 
Conclusions: 1) Left atrial volume and pressure pre-
dict survival after HVR in patients with chronic mitral 
regurgitation. 2) These parameters might reflect the 
"history" of mitral regurgitation as they are influenced 
by both amount and duration of mitral regurgitation, and 
may not be influenced by transient changes in the 
loading conditions of the left ventricle. 3) Left atrial 
volume and PCVP/LA pressure should, therefore, be evalu-
ated in patients being considered for HVR. 
IS TRANSESOPHAGEAL ECHOCARDIOGRAPHY A RISK FOR PATIENTS 
WITH CARDIAC DISEASE? 
Annette Geibel, M.D., Abdullah Behroz, M.D., Ulrike Prze-
wolka, M.S., Thomas Hofmann, M.D., Wolfgang Kasper, M.D., 
Thomas Meinertz, M.D., Hanjoerg Just, M.D. Innere Medizin 
III, Univ. of Freiburg, West Germany. 
Transesophageal echocardiography (TEE) was shown to be of 
diagnostic value in a variety of heart diseases. However, 
data on the risk of this procedure in patients with 
cardiac diseases are lacking. In 860 pts studied with TEE 
we observed 2 pts with non-sustained ventricular tachy-
cardia. TEE has to be interrupted in 2 pts with congeni-
tal heart diseases and right-to-left shunt. 24h-Holter 
monitoring (H) and continous blood pressure monitoring 
were performed in 37 consecutive pts (17t ' 20i',age: 19-
75 years) with clinically suspected endocarditis (9 pts), 
mitral (8 pts) and aortic valve disease (13 pts) or other 
heart diseases (7 pts). 
Results: The mean duration of the TEE procedure was 8.5 
min (range: 3-14 min). During TEE single premature ven-
tricular beats (PVB) were observed in 11/37 pts, 2 pts 
had ventricular pairs. 1 pt developed a second degree AV-
block. Heart rate increased during TEE by a mean of 6.5 
beats/min. Systolic blood pressure increased by a mean of 
8.3\. No pt suffered from myocardial ischemia or myocar-
dial failure during the TEE procedure. 
Conclusions: TEE seems to be safe, even in pts with 
cardiac diseases. 
ABSTRACTS 
COMPARISON OF lRANSESOPHAGEAL ECHOCARDIOGRAPIDC 
AND SCINTIGRAPHIC ESTIMATES OF LEFf VENTRICULAR 
END-DIASTOLIC VOLUME AND EJECTION FRACTION. 
Jobn H Urbanowicz MD. M. Jamil Shaaban. M.D., 
Neal H. Cohen, M.D., Michael A. Matthay, M.D .• 
Michael K. Cahalan, M.D .• Elias H. Botvinick. M.D .• 
Kanu Chatterjee. M.B .. F.R.C.P. and Michael Dae, M.D. 
University of California. San Francisco. 
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The assumption that changes in short axis internal diameter 
reflect changes in LV volume has lead to the use of 
transesophageal echocardiography (TEE) for estimation of LV 
filling. To study the ability of TEE to estimate LV volume and 
ejection immediately following CABG, 10 pts were studied 
using blood pool scintigraphy, TEE and thermodilution cardiac 
output. A single TEE sbort axis cross-sectional image of the L V 
at tbe mid-papillary muscle level was used for area analysis. 
Between I and 5 hr postop. simultaneous data set s 
(scintigraphy. TEE and CO) were obtained 3 to 5 times in each 
pt. End-diastolic (EDa) and end-systolic (ESa) areas were 
measured by light pen. Ejection fraction area (EFa) was 
calculated (EFa=(EDa-ESa)!EDa). When EFa was compared to EF 
by scintigraphy correlation was good (r=.84 SEE=.06). Changes 
in EFa were always concordant with changes in EF but TEE did 
not consistently over or underestimate EF. EDa was taken as 
an indicator of LV volume and compared to LVEDV which was 
derived from CO and EF by scintigraphy. Correlation between 
EDa and LVEDV was also good (r=.78 SEE=3.56). There was no 
consistent relationship between the magnitude of the EDa and 
LVEDV. Of more importance however. was the fact that for 
5/10 individual pts. discordant changes were observed when 
comparing EDa to LVEDV. We conclude that immediately 
following CABG. a single cross-sectional TEE image may not 
accurately reflect changes in LVEDV but that it doe s 
accurately track directional changes in EF. 
ECHOCARDIOGRAPHIC AND DOPPLER ANALYSIS OF COUGH 
CARDIO:RJlKWlRY RESUSCITATION (CPR) OORING ASYS'IOIE 
Andrew Cohen. M.D .. F.A.C.C., John Gottdiener, M.D., 
F.A.C.C., Jeffrey Brown, M.D., Marc Wish, M.D., Ross 
Fletcher, M.D., F.A.C.C., VAMC washington, DC 
TO ~ the medruurism by which cough may generate 
flow durirl3' =ugh CPR we analysed 2-D echocardiograms 
(2DE) ,brachial artery pressure and Doppler(D) flows 
durirl3' asystole and cough CPR in 10 pts with permanent 
pacemakers (PMs) who were PM dependent. PMs were 
inhibited for 5-10 seconds and pts were instructed to 
cough at 1 se=rxl intervals after 2 seconds of asystole. 
0lrirl3' asystole,prior to cough, (l)LV area was 86±16% of 
diastolic area in 4 chamber view or in short axis 
views (2) the mitral valve stayed partially open and the 
aortic valve remained closed (3)0 flow in the aorta was 
seen durirl3' atrial systole in 1 pt. 0lrirl3' cough (1) LV 
area was 96±5% of diastolic area in 4 chamber view or 
short axis views (2) the mitral valve and aortic valve 
cpened slightly (3)peak arterial pressure was l62±33nun Hg 
(82% of systolic pressure) (4)mean flow velocity through 
mitral valve was .06 ±.03111/s and velocity flow integral 
was .03 ±.02m. All pts became dizzy during cough. In 
conclusion, durirl3' asystole, cough that generates high 
arterial pressure does so in the absence of LV 
catpression and with low transmitral flow. 
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Angioplasty and Other Interventional Techniques 
PERCUTANEOUS ~ITRAL COMMISSUROTOMY : A REPORT OF 90 CASES 
Jean ACAR M.D., Alec VAHANIAN M.D., Pierre-Louis MICHEL MD 
Slawa TRABELSI M.D., Michel SLAMA M.D., Pierre DERMINE M.D 
Mohamed BEN ISMAIL M.D., Bertrand CORMIER M.D. 
Hopital TENON - PARIS - FRANCE. 
Percutaneous mitral commissurotomy (PMC) was attempted in 
90 patients (pts) with severe mitral stenosis (MS) = 70 
women and 20 men, mean age 45 : 17 years (13-79), 8 being 
over 70. 12 were in NYHA class II, 73 in class III, 5 in 
class IV. 31 pts had extensive valvular and subvalvular 
disease. The procedure was discontinued in 9 due to 
compl ications (C)(pericardial hemorrhage :2, embol ism: 1) 
or failures (F) (inability to cross: 6). Five out of 6F 
occurred during the first 15 attempts. PMC was performed 
in 81 pts using a single balloon in 9 then 2 balloons (2B) 
in 72. After BV, there was a significant improvement in 
pulmonary wedge pressure (20 ± 7 to 10 : 4 mmHg, p < .001) 
mean mitral gradient (16 : 6 to 6 ± 2 mmHg, p < .001), 
cardiac index (2.7 ! .7 to 3 ± .7 1/mn/m2, p < .001) and 
valve area (VA){I.1 ± .2 to 2.1 : .4 cm2, p < .001). Post 
PMC increase in VA was greater with 2B : +1.1 ± .3 vs 
+.6! .3 cm2, p < .001. VA derived from doppler recordings 
also increased from 1 ! .2 to 1.95 ! .2 cm2, p < .001. 
No pt died. Embolism occurred in 4 pts with no further 
sequellae. 10 pts had small atrial septal defects. After 
BV, severe mitral regurgitation (MR){grade 3+) was noted 
in 4 pts with extensive subvalvular disease. Subsequent 
surgery was needed in 13 pts because of C.(3), F.(3), 
severe MR (4) or unsatisfactory hemodynamic results after 
PMC (VA < 1.5 Cm2 in 3). Conclusion: 1) PMC can be an 
effective alternative to surgery in a large spectrum of 
pts with MS ; 2) Success rate increases with experience 
3) The best results are obtained with the 2B technique. 
INCRENENTAL CHANGES FOLLOWING SINGLE AND DOUBLE CATHETER BALLOON 
VALVULOPLASTY OF 12 STENOTIC NITRAL VALVES: Norphologic Analysis of 
Operatively-Excised and Intact Necropsy Nltral Valves With and Without 
Previous Clinical C_lssurotOllY Procedures. 
Bruce F. Wa II er ND F ACC, Char I es R. Nckay ND F ACC, Larry Hook.an ND, 
Shah6udln H. Rahiltoola ND FACC. Indiana University, Indianapolis, IN 
Early reports describing IOrphologic results of Iitral valve (NV) 
catheter balloon valvuloplasty (CBV) are IIlited to the use of one 
balloon. We perforaed a detailed IOrphologlc study of NVCBV using a 
spilt l.age video recording systea to evaluate changes following single 
and double CBV. Of 12 NV, 10 were operatively-excised and 2 were Intact 
necropsy IV frOll pts aged 44-13 years (9 feaales) with NV lean 'I) end 
diastolic !radlents of 10-29 '1=15.2) .Hg and NV areas of 0.4-0.9 
'1=0.7) CI during life. Three pts had NV c_lssurotOllY procedures 
10-24 yrs before CBV with 'healed splits' clearly Identified. Balloon 
sizes were selected frOllleasureaent of NV internal ,orifice) dl_ter 
sililar to clinical settings. IVCBV using single balloons resulted in 
superficial splitting (cracking) of I or 2 fused c_lssures In 10 of 12 
IVs. Progressive therapeutic Injurr resulted frOil double balloon 
dilation: deeper splitting of prey ous cracks, splitting of re.ainlng 
intact c_lssures and leaflet cracking (3 IV). Oversized balloons were 
U5ed to dilate I necropsy NV which resulted In pathologic Injury: 
disruption of NV annulus and a left atrial vall tear. Deeper Cricks 
were found In areas of Ilid or absent calcific deposits and in leaflets 
without calcific nodule~llenslons of NV orifices Increased after CBV 
but the .ajor result was IlIProved IOblllty of previously rigid, fixed 
leaflets. Potential eIibolic debris was not liberated during CBV. NVs 
with previous c_lssurotOilles had CBV splits adjacent to (2 IVs) or at 
the site (I NV) of previous healed cracks. These IOrpllologlc findings 
SU,gest that CBV di lates stenotic NVs by c_lssural and leaflet 
sp Ittlng. NV splitting and leaflet IOblllty are illProyed with double 
balloon dilation. NV splitting occurs In Ilnl.ally calcified areas and 
adjacent to or at previous c_issurotOilY sites. 
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PERCUTANEOUS DOUBLE BALLOON VALVOTOMY IN 
RHEUMATIC TRICUSP[D STENOSIS: IMMEDIATE AND 
SHORT TERM FOLLOW-UP RESULTS. 
Muayed AIZaibag, MRCP, Paulo A Ribeiro, MD, 
Saad A1Kasab, MRCP, Murtada Railm, MRCP, 
Mohammed Idris, MRCP, Moheeb Abdulla, MRCP, 
Maie S Shahid, MRCP. Adult Cardiology Division, 
Riyadh Military Hospital, Saudi Arabia. 
We attempted percutaneous double balloon 
tricuspid valvotomy in 4 symptomatic pts (mean 
age 36+12 yrs) with severe tricuspid stenosis 
and mf"ld mitral valve disease. The protocol 
included angiography, measurement of tricuspid 
valve (TV) gradient by planimetry, calculation 
of the TV area (Gorlin formula) before, after 
valvotomy and at 6 weeks follow-up study. 
Resting and peak treadmill exercise CO was mea-
sured before balloon valvotomy and at the 
follow-up study, by the thermodilution 
technique in all pts, and repeated by the green 
dye method in the 2 pts who had moderate 
tricuspid regurgitation. The TV was traversed 
by 2 preshaped 0.038" exchange guidewires 
?ositioned in the RV apex. Two 9 French 
(Meditech) balloon catheters (15 to 20mm) were 
advanced over the guide wires across the TV and 
inflated simultaneously. In all pts the TV are2 
increased from 0_75+0.1 to 1.8+0.6 cm 
(p(0.05), with a decrease in mean TV" gradient 
from 6+1 to 1.8+0.6 mm Hg (p(O.OI) and in end-
diastoTic gradient from 6+2 to 0.5+1 mm Hg, 
(p(O.OI). Angiographically, there- was no 
increase in the degree of tricuspid 
regurgitation' in all patients. 2 At follow-up 
study the TV area was 1.9+0.6 cm , the mean TV 
gradient was 2.6+1.7 mm Hg and the end-
diastolic gradient- was 0.25+0.5 mm Hg. There 
was coincid-ental symptomatic 1mprovement and an 
increase in the mean resting CO from 2.3+0.4 to 
3.4+1 l/min (p(O.OI) and at peak exercise from 
5.6"1.5 to 7.3+1 l/min (p(O.OI), at similar 
heart rates. We-conclude that in selected pts, 
severe tricuspid stenosis can be successfully 
relieved by a percutaneous double balloon 
valvotomy technique, without complications, and 
with the 150% increase in TV area persisting 
at short term follow-up. 
THE EARLY RISE IN AORTIC GRADIENT FOLLOWING AORTIC 
VALVULOPLASTY IS DUE TO IMPROVED LEFT VENTRICULAR 
PERFORMANCE. 
Charles J. Davidson, MD, David A. Harpole, MD, Thomas 
N. Skelton, MD, Katherine b. Kisslo, RDMS, Joseph A. 
Kisslo, MD, FACC, Robert H. Jones, MD, FACC, Thomas M. 
Bashore, MD, FACC, Duke Medical Center, Durham, N.C. 
Hemodynamic changes following percutaneous aortic 
valvuloplasty (PAV) arc complex and yet to be well 
defined. This study examined 17 pts. immediately 
pre-PAV, immediately post-PAV and 2-4 days following 
PAV using both continuous wave Doppler and first-pass 
radionuclide angiography (RNA). 
Doppler Data 
Peak Grad. (mmHg) 
Mean Gr2d. (mmHg) 
AVA (cm ) 
RNA Data: 
Results (mean ± S.D.) 
Pre-PAY Post-PAV 2-4 
i9+2l" 52 + 14 -. 
48 + 14 30 + 8 
0.4 ~ 0.2 0.6 ~ 0.3 
Days Post-PAV 
63 + 17 
37 + 10 
0.5 + 0.2 
LVEDV (ml) 190 + 45 161 + 38 156 + 35 
LVESV (ml) 119 + 62 90 + 54 82 + 50 
EF (%) 40+1848+21 51+21 
Doppler data revealed a significant (p<O.OOl) fall 
in peak and mean grGdient (GRAD) and rise in aortic 
valve area (AVA) post-PAY. By 2-4~days later, however, 
a significant (p<O.OOl) return of gradient occurs. The 
change in AVA between post-PAY and at 2-4 days is not 
Significant. The RNA data reveal a fall (p<O.OOI) in 
LV end-diastolic (EDV) and end-systolic (ESV) volume 
and a rise in ejection fraction (EF) that continues to 
increase (p<O.OOI) at 2-4 days follOWing PAY. 
These data reveal a rise in aortic valve gradient in 
the early period post-PAV. This is associated with 
evidence for improved ventricular performance rather 
than early restenosis. 
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DIRECT CATHETER FULGURATION OF ATRIAL FLUTTER IN MAN. 
Nadir Saoudi, M.D., Paul Touboul, M.D., Gilbert Kirkorian, 
M.D., Alain Cribier, M.D., Jacques Berland, M.D., F.A.C.C. 
Brice Letac, M.D., F.A.C.C. 
Universities of ROUEN and LYON (FRANCE) 
The chief drawbsck of catheter fulguration (Fg) of the AV 
node-His Purkinje system for atrial arrhythmias is the 
induction of s pacemaker dependency state. Attempts of 
direct atrial automatic foci Fg have already been reported 
with good success rates. Thus, we expanded this technique 
to drug resistant atrial flutter (AF) in 2 patients (Pt). 
In both cases, 5 standard USC I 6 F electrode catheters 
were introduced using conventionnal approach, and atrial 
mapping (M) was performed in both sinus rhythm (SR) and 
AF. Pt 1 was a 63 y.o. female with a history of repetitive 
type I AF, which was easily induced and terminated by 
overdrive atrial pacing. M during both SR and AF revealed 
the presence of 2 zones of fragmented e1ectrograms (Eg), 
one located in the sinus node (SN) area, the other in the 
low posterior right atrium (LPRA). Attempted entrainment 
(Et) was able to dissociate the SN-Eg from AF, whereas 
this was impossible for LPRA-Eg without actually termina-
ting AF. 2 shocks (l00 and 150 J) were delivered in the 
latter area and clinical AF was no more indUCible. 16 
weeks of follow up were uneventful despite drug withdra-
wal, and control study (Day 90) did not induce clinical 
AF. Pt 2 was a 60 y.o. male with recurrent episodes of 
poorly tolerated type I AF. No fragmentation was found in 
the LPRA area, which showed the earliest Eg (-8Oms) in 
reference to the abrupt sscending phase of the flutter 
wave. Et was achieved without dissociation and 2 shoks 
(260 and 160 J) were delivered. At post shock, and at a 
control study (day 10) AF was not inducible despite 
Isoproterenol infusion. In conclusion : Et guided Fg of AF 
is feasible, with good early results, and deserves confir-
mation by further studies. 
PERCUTANFmS TRANSV'ENO(]S AORTIC VAI.VlJLOPIASTY BY A SELF-
POSITIONING BALLOON (INOUE BAJ.L<XJN) 
Kanji Inoue,MD, Masakiyo Nohuyoshi,~IO, Kazllaki 
Mitsuto,MD, Shigeru Sait.o,MD, Noriaki Nakamura,MD, Hideo 
Tarnai ,MD, Sachiro Watanabe,MD, Takahiko Suzuki ,MD, 
Nobuhiko Koga,MD, Kochi municipal hospital, Kochi, 
Japan ,and eight collaborating insti t.utions. 
A new procedure has been developed to treat aortic 
stenosis by adapting the balloon cathet.er (Inoue balloon) 
prp.viollsly devised for transvenous mit.ral cOlJlllissurolomy. 
The balloon r-IID changp. the shape i.n thrP.e stages 
ru:,eording to the volume infused :Fi rstly ,distal- half 
inflat.es; then hour-glass shape appP.ars; and fully 
inflates. The balloon is introduced into the left atrium 
transReptally, wherp.upon the distal half is slightly 
inflst.ed with carbon dioxide gas and manipulated to be 
carT'iOO along the blood flow to the aorta without 
guidwi re like a SWAN-GANZ C'.Btheter. Once insertOO in thP. 
aort.a, thp. distal hal f of t.he balloon is inflatoo wi th 
contrast. JOOdium, and withdrawn until some resistance is 
fp.lt ,whieh bri.ngs thp. balloon into contact with the 
aortic valve, and then fully inflated in place separat.ing 
the fusOO COIllIli ssureR. The procOOure was performed in 
twelvp. patient.s(pt.s) aged between 16 and 83. All pts 
except onp. had severe calcification. The balloon used was 
18 to 23D11l in diameter at inflat.ion and 3.3UIIl at 
deflation. The inflation time was kept less than 5 
seconds. A peak aort.ic gradient. decreased from 81:1:26 to 
4fi:t21D11lHg. There were no complications and no major 
change of aortic regurgitat.ion. Conclusion: The Inoue 
balloon allows easy and proper balloon placement, and i t.s 
position is maintained during dilation, which may reduce 
complications such as fatal bleeding from the femoral 
artery or releasing of calcified fragment.s from the 
aortic valve. 
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BALLOON AORTIC VALVULOPLASTY INDUCED INJURY AND REPAIR: A 
POSSIBLE MECHANISM OF RESTENOSIS. 
Jeffrey W. Moses, M.D., F.A.C.C., Andrew Farb, M.D., 
Jeffrey P. Gold, M.D., F.A.C.C., and Valavanur A. 
Subramanian, M.D., F.A.C.C., New York Hospital-Cornell 
Medical Center, New York, New York. 
Balloon aortic valvuloplasty(BAV) is increasingly being 
employed as a therapy for aortic stenosis in patients of 
poor surgical risk. While initial hemodynamic and 
symptomatic results are frequently dramatic, valvular 
restenosis is becoming an increasing clinical problem in 
the months following the procedure. The mechanism of 
restenosis has not been defined. Moreover, there are no 
published histologic studies of aortic valves after BAV. 
We have therefore performed pathological exams on 3 
aortic valves of patients with successful BAV at 0.5, 2 
and 4.5 months post-procedure (1 postmortem, 2 surgical). 
Microscopic and macroscopic fissuring of calcific nodules 
were evident in the 0.5 and 2-month specimens. 
Microscopic examinations revealed: 
F N L M G Gr Me 
Pt 1 0.5 mo. 3+ 3+ 2+ 1+ 2+ 2+ 1+ 
Pt 2 2 mo. 0 4+ 4+ 2+ 1+ 4+ 3+ 
Pt 3 4.5 mo. 0 1+ 1+ 0 0 0 4+ 
F=fibrin; N=neutrophils; L=lymphocytes; M=macrophages; 
G=giant cells; Gr=granulation tissue; Me=mesenchymal 
cells; My=myxoid change 
~ 
0 
0 
4+ 
Thus, BAV engenders an acute inflammatory response to 
injury which evidently leads to scarring, particularly in 
the areas of nodular disruption. Organization and 
scarring in these areas may be a potential mechanism of 
restenosis. These observations open the door to 
therapeutic trials aimed at its prevention. 
SEVERITY OF STENOSIS, DEGREE OF CALCIFICATION, AND 
BALLOON DIAMETER ARE DETERMINANTS OF SUCCESSFUL AORTIC 
VALVULOPLASTY IN VITRO 
H.Aoun,M.D., P.Aoun,M.D., G.M.Hutchins,M.D., D.Ton 
Inat,Ph.D., L.Shimada,M.S., C.Romero,B.S., and 
J.A.Brinker,M.D., F.A.C.C., The Johns Hopkins Medical 
Institutions, Baltimore, MD 
Using formalin-fixed human aortic valves mounted in a 
pulsatile flow duplicator (PFD), we correlated valve 
morphology, severity of stenosis, degree of 
calcification, and balloon diameter with the immediate 
hemodynamic effects of balloon aortic valvuloplasty 
(BAV). The PFD allowed for adjustment of cardiac output 
and pressures to simulate hemodynamic conditions present 
in aortic stenosis (AS). Seven valves were heavily 
calcified (HC) and 5 had none or minimal calcification 
(MC). BAV was performed using 15 and 21 mm diameter 
balloon catheters. For each dilatation video recordings 
of valve motion were made and the effects on pressure, 
flow, aortic valve area (AVA), and aortic regurgitation 
(AR) determined. Results o~ dilatation follow: 
Baseline AVA (em ) % Increase in AVA 
Post 15 mm Post 21 mm 
HC 0.43 + 0.09 28 63 
MG O. 73 + O. 11 0 8 
For all valves;- the mean increase in AVA caused by 
dilatation with a 21 mm diameter balloon was twice that 
obtained with 15 mm diameter balloons (43% vs 19%, 
p<O.OS) without the occurrence of AR or other adverse 
effects. All valves were visibly dilated to the 
diameter of the fully inflated balloon, but the MG 
valves rapidly ret~rned to their previous configuration 
follOWing BAV. These data suggest that BAV is more 
effective in severely stenotic HC valves than in MC less 
stenotic valves; and that when compared to 21 mm 
diameter balloons, 15 mm diameter balloons produce 
lesser increases in AVA, offering no obvious advantages 
in safety. 
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FIFTEEN YEAR COMPARATIVE FOLLOW-UP IN PATIENTS WITH 
ANTERIOR AND INFERIOR MYOCARDIAL INFARCTION. 
Killian Robinson, Ronan Conroy, Risteard Mulcahy. 
stV1ncents-Hosp1 tal, Dublin, Ireland. 
The relationship between infarct site and long-term 
clinical outcome following a first myocardial 
infarction has not been fully elucidated but the 
prognosis is thought to be worse after anterior, rather 
than inferior, infarction. We studied 684 patients, 
629 males and 55 females, aged(+ SD) 50.8 (+ 6.6) years 
who were 28-day survi vcrs of a-first episode of acute 
coronary heart disease. In 319, the infarct was 
si tuated anteriorly and in 365 it was located on the 
inferior wall. Age, sex, infarct size and incidence of 
in-hospital complications were the same in both groups. 
413 patients were available for 5-year, 211 for 10-year 
and 60 for l5-year follow-up. During this time, the 
prevalence of angina pectoris was the same in the two 
groups. Non-fatal episodes of acute coronary heart 
disease occurred during follow-up in 37.7%, 28.4% and 
31.3% of patients with anteroseptal, anterolateral and 
inferior infarction respectively (p=NS). l5-year 
mortality was 60.3% following inferior, and 60.7% 
following anteroseptal infarction. A marginally higher 
15 year mortality 68.1% was seen following 
anterolateral infarction but this was not statistically 
significant (p=0.73). Furthermore, a cause-specific 
mortali ty analysis, examining sudden death rates and 
deaths due to re-infarction, showed no differences 
between the groups. Thus, in 28-day survivors of a 
first acute coronary episode, the site of the 
infarction appears to be unimportant in determining 
either the number of subsequent episodes of acute 
coronary heart disease or the long-term prognosis. 
Sex Specific Regulation of BP Development Throughout 
Puberty. H Rtiddel, E Gogolin, U Jacobs, H Neus, H Otten, 
AW von Eiff, Dept. of Medicine, University of Bonn, FRG. 
In a 5 year prospective study we examined possible 
mechanisms of the sex specific BP regulation between the 
age of 11 and 15. 100 healthy children ( 63 c1', 37 ~ ) 
at t~e onset of pubescence (TANNER stage I and II) had 
a clinical examination including hemodynamic monitoring 
during experimental emotional and physical stress and 
assessment of testosterone and estradiol. Ambulatory BP 
was monitored 4 to 9 times per year non-invasively with 
the Remler M 2000 system. At the age of 11 years no dif-
ferences between the sexes were observed in clinical 
casual BP, average ambulatory BP during the day and BP-
reactivity during stress. Throughout puberty systolic 
pressure significantly increased in boys ( 103~8 vs.113± 
10 mm Hg, p<.05 ) whereas no significant increase was 
observed in girls. BP increments correlated with the in-
crease in weight ( multiple regression analyses: per 1 kg 
weight gain 0.8 - 1.0 mm Hg increase in systolic pressure) 
Testosterone levels of boys at the end of puberty corre-
lated with BP ( p<.OS). Estrogen levels of girls were 
related to lower BP increases during emotional stress 
(p<.OS). These results suggest that the sex specific BP 
development during puberty is both the result of a 
testosterone mediated "maturation" of the vascular 
system in boys and a protective effect of estrogen in 
girls. 
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IPIDIMIOLOGY OF TOTAL-CHOLISTIROL-TO-BDL (RATIO) IN 
II,eeD AIR FORCI PIBSOJlIL AID CORONARY ARTIRY ANATOMY 
IN 305 RlALTHY AVIATORS. 
Philip D. Houck, M.D., USAF Regional Medical Center 
Clark, Clark AB, Philippines. 
The total-cholesterol-to-BDL ratio is highly predictive 
of the presence and severity of coronary artery disease. 
This hypothesis is tested in 305 aviators selected for 
occupational cardiac catheterization. The cardiac 
catheterization population is healthier than the 
general population in that blood pressure and weight 
were controlled. From August 1978 through September 
1983, 1460 aviators were referred for aeromedical 
evaluation. Of this referral popUlation, 305 
individuals with an average age of 41 had aeromedical 
cardiac catheterization. Their distributions of 
cholesterol, BDL, and ratio were compared with 11,669 
Air Force members and 1046 aviators from a previous Air 
Force study. This comparison demonstrates the age 
dependency of the ratio. The catheterization population 
did not have significant difference in the distribution 
of the ratio from age matched general Air Force 
population at a p value of .05 student t test. In the 
cath selected population, 23.6% had a ratio greater than 
or equal to 6.0. In this group, 62.5% had measurable 
obstructive coronary artery disease and 41.7% had 
significant disease defined as greater than 50% 
obstruction of at least one major coronary artery. In 
comparison, 19.3% of the cath population had a ratio 
less than or equal to 3.5. Of these individuals, 13.6% 
had measurable coronary artery disease and 6.8% had 
significant disease. The ratio is a significant 
predictor of development of coronary artery plaques in 
asymptomatic individuals and should be used in risk 
stratification. 
CHANGES BETWEEN 1978 AND 1985 IN FATAL AND NON 
FATAL ACUTE MYOCARDIAL INFARCTION IN BLACKS 
AND WHITES IN RURAL SOUTH CAROLINA. 
Julian E. Keil, Dr. P.H., Peter C. Gazes, M.D., 
F.A.C.C., Donald E. Saunders, Jr., M.D., F.A.C.C., 
Martin C. Weinrich, Ph.D., Mark S. Litaker, Medical 
University of South Carolina, Charleston, South 
Carolina. 
There was a 32% (p=.OOI) decline of all criteria acute 
myocardial infarction (AMI) rates in white men (WM) 
during the period of 1978-85 in the rural Pee Dee area 
of South Carolina. This area has had the highest coro-
nary heart disease (CHD) mortality rates in the U. S. 
Other race-sex groups showed non--significant changes 
although there was a downward trend (p= .18) in black 
males (BM). Among WM, AMI rate reductions occurred 
in each of the decades of age 35-64 but in all race-
sex groups there was a sharp increase in rates between 
1978 and 1985 for those 65-74 years of age suggesting 
that the incidence of AMI was delayed to a later age. 
Out-of-hospital AMI death rates declined markedly in 
all race-sex groups: WM, 63%; white females (WF), 
62%; black males (BM), 49%; and black females (BF), 
39%. Case fatality rates of hospitalized definite criteria 
AMI cases declined in WM, 40% (p= .18); and WF, 65% 
(p=. 085). In BM, case fatality declined only 2% but 
increased 223% (p=.147) in BF. These findings suggest 
interaction of race, sex, risk factor reduction, therapy 
and access to medical care in evaluating the benefits 
of primary prevention vs improvements in medical 
care in explaining the decline in CHD mortality. 
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ASYMPTOMATIC GALLSTONES ARE OFTEN PRESENT IN 
HYPERLIPIDEMIC PATIENTS PRIOR TO LIPID LOWERING DRUG 
THERAPY. David T. Nash, M.D., F.A.C.C. and Mark 
Levinsohn, M.D., SUNY Health Science Center, Syracuse, 
New York 
We examined a group of asymptomatic hyperlipidemic 
patients who were recruited for a lipid-lowering drug 
trial. Each patient had a cholesterol or triglyceride 
level above the 95th percentile while on a lipid 
lowering diet. Gall bladder sonography was performed 
prior to the initiation of drug therapy. Patients with 
secondary hyperlipidemia, pregnant females, and 
patients with previous drug therapy were excluded. Of 
the thirty-one hyperlipidemic patients studied, nine 
demonstrated silent gallstones (29%) This is a 
significantly higher incidence of gallstones when 
compared to a series of 581 asymptomatic subjects 
examined by ultrasound. (p < .01) 
The occurrence of gallstones folloWing treatment with 
lipid-lowering drugs has been preViously noted. In 
most instances routine sonography did not precede drug 
therapy. Asymptomatic gallstones are frequently 
present in hyperlipidemic patients. The significance 
of these results requires re-examination of the 
incidence of gallstones found after lipid lowering drug 
therapy. 
INFLUENCE OF DIET ON THE LDL-CHOLESTEROL LOWERING EFFECT 
OF THE HMG COA REDUCTASE INHIBITOR PRAVASTATIN 
Kevin J. Graham, M.D., Denise M. Hibbard, BS,MT, Larry P. 
Bell, M.D., Elaine S. Quiter, MS,RD, Donald B. Hunninghake, 
M.D., University of Minnesota, Minneapolis, MN 
Twenty four patients, (21M, 3F) with non-familial hyper-
cholesterolemia with mean baseline values in mg/dl for 
total cholesterol (TC-B) of 294 and LDL cholesterol (LDL-
B) of 221 were treated for 8 weeks with the HMG-CoA reduc-
tase inhibitor pravastatin (total daily dose-40 mg). The 
LDL-lowering effect was evaluated by diet, body mass index 
(BMI), adherence to medication (Adh) and LDL-B. Diet was 
assessed with a Food Record Rating Score (FRR). A FRR of 
<IS was required for entry into the study(lS=total fat=3S%, 
P:S=0.8, cholesterol=400mg; a FRR of 9 approximates the 
AHA Stage 1 diet (total fat=30%, P:S=l.O, cholesterol~300 
mg). The response after 8 weeks of therapy was analyzed by 
degree of dietary intervention (FRR <9 & FRR >9): 
TC-B TC-Rx ~%TC LDL-B LDL-Rx- ~%LDL 
FRR<9 299 21S* -28 229 lSO* -37 
FRR>9 288 224* -24 214 lSl* -30t 
*=p<.OOl compared to B; t=p<.OS between FRR<9 & FRR~9 
There were no significant differences between the two 
groups in baseline lipids, BMI or weight for both Band Rx 
periods, and Adh. There was a statistically significant 
greater decrease in LDL (7%,p<0.OS) in the group with FRR 
<9. The change in LDL during Rx was negatively correlated 
with the FRR (r=-0.42,p<0.OS) and was positively correlat-
ed with the LDL-B (r=0.90,p<0.001). When BMI, Adh and LDL-
B were incorporated into a multivariate analysis, FRR was 
still a statistically significant predictor of the LDL-
lowering effect of pravastatin (p<0.03). We therefore con-
clude that the degree of dietary intervention was a sig-
nificant predictor of the response to pravastatin in this 
patient population. 
ABSTRACTS 
TREATMENT OF PATIENTS WITH HIGH RISK SERUM 
CHOLESTEROL LEVELS. 
223A 
Joel S. Landzberg, H.D. and Craig Heim, H.D., 
Vanderbilt Univ.; Nashville, TN 
To assess physician behavior regarding hypercho-
lesterolemia (HC) , we evaluated the treatment of all 
patients aged 18 to 59 with cholesterol levels greater 
than 265 mg/dl, over a 2 month period. Pregnant 
patients and those with evidence of terminal disease 
were excluded. 111 patient charts were reviewed at one 
year fol!owup, to determine if HC waS ever noted as a 
problem, and if any treatment was undertaken (dietary, 
pharmacologic or correction of a secondary process 
causing HC). There were 65 women and 46 men, wJ..th a 
mean age of 44 and a mean cholesterol of 314. HC was 
noted by physicians in 62 patients (567.), and treated 
in 34 patients (317.). Gender and cholesterol level 
were independently associated with the likelihood of 
treatment, age was not. 447. of men were treated, as 
compared to 22" of women (p=.02). Cholesterol levels 
averaged 345 in the treated group versus 300 in the 
untreated group (p=.02). The service the patient was 
evaluated by significantly correlated with the likeli-
hood of treatment (p<.Ol). a" of patients evaluated by 
surgical services, 26" of patients evaluated by medical 
subspecialties and 58" of patients evaluated by the 
general medicine department received treatment for 
their HC. Of 15 patients evaluated by cardiologists, 
10 were noted to be HC, and 5 were treated. 
We conclude that despite the strong recommendations 
made by the Consensus Conference, the identification 
and treatment of patients with hypercholesterolemia 
remains suboptimal, even in high risk patients. 
LONG TERM EFFECTS OF LOW FAT DIET AND INTENSIVE PHYSICAL 
EXERCISE ON SERUM CHOLESTEROL AND MYOCARDIAL ISCHEMIA IN 
PATIENTS WITH STABLE ANGINA PECTORIS 
Gerhard Schuler. MD, GUnter Schlierf, MD, Anneliese 
Obermoser, RN, Alfred Wirth, MD, Johann Mautner, MD, 
Sabine Methfessel, RT, Gabriele Vogel, RT, Wolfgang 
KUbler, MD, FACC; Medizinische Universitatsklinik 
Heidelberg, Germany 
The purpose of this study was to assess the long term 
effects of low fat diet (20% fat) and intensive phYSical 
exercise on serum lipoproteins, myocardial oxygen 
consumption, and perfuSion. Sixteen patients (pts) with 
symptomatic coronary artery diseases were studied at en-
try (E), at 1 year (y), and at 3 y. Results were compared 
to a group of 16 pts (CONTROL) on 'usual care'. Exercise 
induced myocardial ischemia (EMI) was assessed by Tl-201 
scintigraphy and expressed in degrees (0) of left ventri-
cular Circumference. Myocardial oxygen consumption was 
estimated from rate-pressure product at peak exercise. 
TRAINING CONTROL 
CHOL RPP EMI (0) CHOL RPP EMI (0) 
E 232±36 26±6 44±33 214±32 22±7 38±30 
1 y 199±30. 28±6· 2~19· 213±43 25±4 41±23 
3 y 231±20 31±5·$ 18±25.$ 236±37 21±3 35±38 
RPP: Maximal rate pressure product (x 1000); CHOL: Serum 
cholesterol (mg%); • different from ENTRY (p<0.02); 
$ different from CONTROL (p<0.05) 
CONCLUSIONS: Restriction of dietary fat intake and regu-
lar physical exercise resulted in significant , but tran-
sient lowering of serum cholesterol. In contrast, myo-
cardial oxygen consumption improved, and stress induced 
ischemia decreased significantly as compared to CONTROL, 
indicating long term and persistent improvement of myo-
cardial perfusion at 3 years after entry. No significant 
changes were observed in the control group. 
224A ABSTRACTS 
COMPARISON AND COMBINATION OF FISH OIL 
CONCENTRATE AND NEOMYCIN AS THERAPY OF 
HYPERLIPIDEMIA 
Georpe T. Kondas, M.D., Fred P. Zeller, Pharm.D., Stuart Rich, 
M.D., F.A.C.C., University of minois at Chicago, Chicago, 
Illinois 
Neomycin has been known to lower cholesterol levels. Fish oil 
has variable effects but may protect from coronary artery 
disease. We evaluated the effects of Neomycin (500 mg TID), 
Maxepa fish oil (4 goo TID) and the combination in 18 patients 
302 + 56 mg/dl). The patients were randomized and double-
blinded with regimens at 8 week intervals. Neomycin resulted in 
a significant lowering in cholesterol (277 + 51 to 236 + 39, P = 
0.02) while triglycerides were W1changed (169 + 100 to 179 + 86). 
Fish oil had no effect on cholesterol (301 + 62-to 305 + 57)'000 a 
modest lowering on triglyceride (193 ! 6"-to 141 ! 79), p = ns). 
7896 of patients taking neomycin had their cholesterol reduced 
below the moderately increased risk level compared to 1196 
taking fish oil. The combination 'therapy was no different than 
Neomycin alone. There were no adverse reactions to either 
agent. We conclude that 1) Neomycin effectively lowers 
cholesterol in most patients whereas fish oil does not. 2) Fish oil 
has no influence on the effectiveness of neomycin. Chronic 
therapy with Neomycin should be useful in reducing coronary 
artery disease in patients whose cholesterol levels place them at 
moderately increased risk. If fish oil reduces the risk of 
coronary artery disease, it must do so by ways other than 
lowering cholesterol. 
ECG AND X-RAY ESTIMATES OF CARDIAC SIZE AND 
THE RISK OF CARDIOVASCULAR MORTALITY AMONG 
WOMEN IN THE NHANES I FOLLOWUP STUDY 
Andrea Z. LaCroix. Ph.D., Pentti M. Rautaharju, M.D., F.A.C.C., 
Daniel D. Savage, M.D., F.A.C.C., Jennifer H. Madans, Ph.D., 
Suzanne G. Haynes, Ph.D., Hermann K. Wolf, Ph.D., Wilbur 
Hadden, M.S., Jacob Keller, M.A., Joan Cornoni-Huntley, 
Ph.D., National Center for Health Statistics, Hyattsville, MD 
Although left ventricular (LV) hypertrophy by ECG and 
relative heart volume (RHV) and cardiothoracic ratio (CTR) 
on the chest X-ray have been shown to predict 
cardiovascular disease (CVD), little is known about racial 
differences in their predictive value. We compared relative 
risks (RR) of CVD mortality for RHV, CTR and LV mass index 
(LVMI, g/m2) estimated by a new ECG model in 1884 white 
and 259 black women aged 35 to 77 years. During the 7 to 
12 years of the NHANES I follow-up, there were 78 and 22 
CVD deaths in white and black women, respectively. RRs 
with 95 % confidence intervals (CI) for CVD mortality 
comparing the 80th vs. 20th percentile points of the 
distribution for each cardiac size measure were determined 
using Cox regression models to adjust for age, systolic blood 
pressure, and history of heart attack as shown below: 
Varjable White Women Black Women 
LVMI 1.4 (1.1, 1.8 ) 2.0 (1.4,2.7) 
RHV 1.5 (1.1, 2.0 ) 2.4 (1.5, 3.8 ) 
CIR 1.9 (1.3, 2.8 ) 2.7 (1.4, 5.4 ) 
These results suggest that all three cardiac size measures 
are important predictors of CVD death in both white and 
black women. 
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ACUTE ALCOHOL CARDIAC DEPRESSION IS ASSO-
CIATED WITH A DECREASE IN INTRACELLULAR 
WATER AND A REDUCTION OF THE REDOX STATE 
Wolfgang Auffermimn M D , S. Albert Camacho, M.D., Shao Wu, Ph.D" 
Lawrence Lilt, M.D., Ph.D., William W. Parmley, M.D., Charles B. Higgins, M.D., 
Joan Wikman-Coffe~, Ph.D., University of California, San Francisco 
Cardiac depression in the isolated rat heart perfused with 4% 
ethanol was correlated with intracellular phosphate energetics 
and tissue water distributions. Energy metabolites were 
assessed using 31 P-NMR. The NADH redox state was 
assessed using epicardial surface fluorometry. Changes in 
myocardial water compartmentation were measured with 1H-
NMR spectroscopy using the chemical shift reagent, Dy-TTHA-3. 
Dynamic morphology was assessed using 2D-
echocardiography. For these studies the heart was made 
isovolumic by introducing a balloon into the left ventricle. During 
alcohol perfusion there was a significant decrease in developed 
left ventricular pressure and in coronary flow. There was a 35% 
left ventricular wall thinning with alcohol. No change was seen 
in ATP, PCr, [pHli and Pi. After discontinuing alcohol perfUSion, 
the hemodynamics reverted to control values, and per, ATP and 
[pHli did not change. Pi increased slightly after alcohol was 
removed. During alcohol perfusion 1H-NMR showed a marked 
redistribution of water from the intra- to the extracellular space. 
The NADH redox state was decreased during alcohol perfUSion, 
probably due to an inhibition of the Krebs cycle that cannot keep 
pace with the electron-transport. The results indicate that 
reversible hemodynamic cardiac depression occurs during 
acute alcohol perfUSion, and that it is not associated with 
intracellular acidosis or energy depletion. Left ventricular wall 
thinning due to a decrease in intracellular water is reversible 
after withdrawal of alcohol. 
CARDIAC ENERGY METABOLISM AND PERFORMANCE DURING ACUTE 
HYPOGLYCENIA AND HYPERKETONEMIA: BIOCHEMICAL AND NMR 
STUDIES. Johannes Breuer, M.D., Erkki Pesonen, M.D., 
Brian D. Guth, Ph.D., Richard H. Haas, M.D., David J. 
Sahn, M.D., FACC, Kyung J. Chung, M.D., FACC, Univof 
Calif, San Diego, CA. 
Whether severe hypoglycemia (HG) as well as hyperket-
onemia (HK) cause cardiac failure or angina has been the 
subject of recent controversy. We studied the influence 
of HG, with and without HK, on cardiac energetics and 
function in 10 dogs. During acute HG «30 mg%) and HK 
(1.3 and 3.3 mM) each maintained for 45 min, heart rate 
decreased and aortic pressure, total peripheral resist-
ance and myocardial oxygen consumption increased. 
Cardiac output and % myocardial segment shortening by 
sonomicrometer increased slightly. In-vivo phosphorus-
31 magnetic resonance spectroscopy showed stable levels 
of myocardial a-adenosine triphosphate (a-ATP; 91-101% 
of control), phosphocreatine (Pcr; 95-102% of control) 
and Pcr to 6-ATP ratios (2.9-3.2). Arterial and coro-
nary sinus measurements of oxygen, lactate, pyruvate, 
ketone bodies (KB), glucose and free fatty acids showed 
that the myocardium switched from oxidation of exogenous 
glucose and lactate during control state to KB during HK 
and HG. With acute HG alone, glucose extraction 
remained high and endogenous substrates compensated for 
the decreased exogenous substrate availability. Utili-
zation of KB led to sn increase in plasma concentrations 
of the citric acid cycle intermediates, citrate, aconi-
tate, and a-ketoglutarate and a decrease in oxaloace-
tate. Despite these changes within the citric acid 
cycle induced by metabolism of KB, the energy supply to 
the heart was not impaired as shown by magnetic 
resonance spectroscopy and normal cardiac performance 
was sustained at these levels of HG and HK. 
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MEASUREMENT OF LACTATE IN SKELETAL MUSCLE BY PROTON NMR 
John R. Hamm. Ph.D •• M.D.! Hoby P. Hetherington, M.S., 
Jullie W. Pan, M.S., Douglas L. Rothman, M.S., and 
Robert G. Shulman, Ph.D., Yale University, New Haven, 
CT. 
To observe regional ischemia and acidosis we have 
developed a proton nuclear magnetic resonance technique 
that simultaneously measures intracellular pH and 
tissue lactate. This is the first MRS measurement of 
lactate in human muscle. The method utilizes a 2.5 cm. 
diameter, doubly tuned (proton and phosphorous) surface 
coil that is placed directly over the flexor digitorum 
superficialis muscle of the forearm. By combining a 
variant of a depth pulse localization technique with a 
spectral editing sequence we have obtained a fully 
localized, water suppressed, and proton homonuclear 
edited spectrum of lactate. Complete elimination of 
the lipid from the subcutaneous fat was achieved by 
applying a frequency selective 90 degree pulse in the 
presence of a pulsed field gradient, followed by a 
dephasing gradient. Experiments were done in a 4.7 
Tesla, 30 cm. bore Bruker spectrometer. Finger 
flexions were performed against resistance until 
exhaustion. Proton and phosphorous spectra were 
collected alternately. Lactate was measured as a 
percent of the lactate peak height at two minutes after 
exercise (signal to noise 20). Results of four 
experiments are: 
recovery time (min) 5 9 12 16 
lactate(') 85 10 72 10 30 10 22 15 
Muscle pH was 7.11 before exercise, 5.91 at the end of 
exercise, and 7.11 at the end of recovery. It is now 
possibe using MRS to monitor tissue lactate 
noninvasively and repeatedly. We expect that these 
proton NMR measurements of muscle lactate will form the 
basis for lactate measurements in ischemic myocardium. 
MYOCARDIAL DISTRIBUTION OF GADOLINIUM-DTPA: A POTENTIAL 
AGENT FOR QUANTITATIVE FLOW ASSESSMENT BY MAGNETIC 
RESONANCE IMAGING. 
Gerald Wisenberg, M.D., Leo Diesbourg, B.Sc., Frank S. 
Prato, Ph.D., University of Western Ontario, London, 
Canada. 
To assess the distribution of Gadolinium-DTPA (Gd-DTPA), 
and its relationship to regional myocardial blood flow 
(RMBF), and NMR Tl and T2 relaxation times, 15 dogs were 
studied. Relaxation times (msec) were determined by in 
vitro spectroscopy at 6.25 MHz, RMBF by the microsphere 
technique, and Gd-DTPA concentration by well-counter 
tissue measurement of radioactive Gd-153 DTPA. In 9 dogs 
sacrificed 20 seconds after a bolus injection of 0.5 mrnol/ 
kg Gd-DTPA, there was a direct linear relationship between 
Gd-DTPA concentration vs l/Tl (r=0.97), vs 1/T2 (r=0.96), 
and RMBF (r=0.97) over a range of Tl from 27-300, T2 
20-59, and RMBF 1-461 ml/min/lOO g. In 3 dogs, sacrificed 
5 minutes after a bolus injection, the correlations were 
maintained, but over a narrower range of Tl, 112-308, and 
T2, 39-66, despite similar range of RMBF. However, in 3 
dogs studied 1-5 days after infarction, with a bolus fol-
lowed by a continuous infusion 0.01-0.02 mrnol/kg/min, 
relaxation times and Gd-DTPA concentration were indepen-
dent of RMBF within non-infarcted tissue: RMBF 83-367 
ml/min/lOO g, Tl, 100-127, T2, 38-44. The lowest Tl 
values were observed in the periphery of the infarction 
65-70, and highest in the central infarct zone, 162-204. 
Thus, quantitative measurement of RMBF may be feasible 
with rapid imaging techniques and short TR and TE pulse 
sequences following a bolus injection. With a continuous 
infusion, Gd-DTPA primarily produces contrast between non-
infarct, central, and peripheral infarct zones. 
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DETECTION OF ACUTE MYOCARDIAL INJURY BY NUCLEAR MAGNETIC 
RESONANCE IMAGING WITHIN 24 HOURS OF THE ONSET OF CHEST 
PAIN 
Donald L. Johnston. M.D. F.A.C.C, Padraig G. O'Neill, 
M.D., Wolfgang Nitz, M.S., Richard Cashion, M.D., 
F.A.C.C, Robert Roberts, M.D, F.A.C.C., Roxann Rokey, 
M.D., F.A.C.C., Baylor College of Medicine, Houston, 
Texas. 
The ability to detect and assess myocardial injury and 
infarction (MI) with nuclear magnetic resonance (NMR) 
imaging at < 24 hours of onset of chest pain remains to 
be established. Accordingly, we studied 7 pts (first MI) 
with acute transmural ischemia on ECG within 22±4 hours 
of onset of chest pain; 6/7 pts had thrombolysis within 4 
hours of chest pain onset. All pts had a patent infarct-
related coronary artery at catheterization performed at 
variable times during hospitalization. T2-weighted (TE=60 
ms), spin echo images were obtained in the short axis of 
the LV at 3 levels (base, mid-portion and apex) in end-
diastole and end-systole (total image time - 30 min). 
Images were subdivided into 14 segments and assessed for 
changes in both signal intensity (SI) and wall motion 
abnormalities. Wall motion abnormalities by NMR 
correlated well with echocardiography performed within 
one day of the NMR study. Increased myocardial SI 
compatible with tissue injury was noted in 5/7 pts. One 
other pt had normal wall motion and 1 had hypokinesis 
without an increase in Sl. Nine segments had increased 
SI and normal wall motion suggesting that NMR may detect 
injured, yet viable myocardial tissue. There were no 
adverse effects associated with NMR imaging and all pts 
tolerated the procedure well. In conclusion, NMR imaging 
can be safely performed and provides useful information 
regarding tissue injury and wall motion abnormalities 
within the first 24 hours following acute MI. 
MYOCARDIAL SALVAGE FOLLOWING ISCHEMIA AND REPERFUSION: 
ASSESSMENT BY MAGNETIC RESONANCE IMAGING AND 
SPECTROSCOPY 
~, Mosley ME, Wendland M, Sievers R, Wikstrom M, Ogan MD, 
Brasch RC, Parmley WW. Univ. of Califomia, San Francisco, CA. 
With current potential to reestablish coronary flow in patients with acute 
myocardial infarction (MI), it is important to develop techniques to assess 
myocardial salvage following reperfusion. To test the hypothesis that 
magnetic resonance imaging (MRI) and magnetic resonance spectroscopy 
(MRS) can differentiate reversible from irreversible myocardial injury, these 
modalities were used to study ischemia and reperfusion in a rat model. 
After injection of albumin-(Gd-DTPA), contrast enhanced, T1 weighted, spin 
echo proton images were acquired during 15, 30, 60, and 90 min ischemia 
and reflow. In separate experiments, 31 P spectra were acquired during 
similar periods of ischemia and reflow. After 15 min occlusion, ischemic 
subendocardium was enhanced compared to normal myocardium on MRI 
(232=/-65% vs 80+/-36, mean +/- SD, n=14) and MRS showed reduced PCr 
and ATP (60+/·9%,77+/-10%, n=30). After 15 and 30 min ischemia, reflow 
resulted in normalization of subendocardial enhancement on MRI and 
recovery of PCr and ATP(94+/-12%,89+/·13%, n~7) on MRS. Reflowafter 
60 and 90 min ischemia resulted in enhancement of ischemic subendo and 
subepicardium (163+/-44, 200+/-25%, n=7) compared to nonmal myocardium 
on MRI(60+/-20%) and no recovery of PCr and ATP on MRS (65+/11%, 
66+/11o/~,n=13). Triphenyltetrazolium chloride (TTC) staining revealed trans· 
mural Mis in 20/20 hearts with 60 or 90 min ischemia! reflow and nontrans· 
mural Mis in 5/18 hearts w~h 15 or 30 min ischemia! reflow. We conclude 1) 
myocardial ischemia is characterized by subendocardial enhancement on MRI 
and a decline in PCr and ATP on MRS. 2)After reflow, reversible myocardial 
injury results in nonmalization of the enhanced sub-endocardium on MRI, 
recovery of PCr arid ATP on MRS, and correlates with absence of (or 
minimal) infarction by TTC staining. 3) Irreversible injury after reflow results 
in transmural enhancemenf of ischemic myocardium on MRI, lack of PCr and 
ATP recovery on MRS, and transmural MI by TTC staining. 
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PARADOXICAL EFFECT OF POST-ISCHEMIC LOW-CALCIUM 
REPERFUSION IN RAT HEART; A 31-P NMR STUDY. 
J .. Ham; Kirkels,. MD; Tom J.C. Ruigrok, PhD FACC; Cees J.A. 
vanEch-ielil,PliD;Frits L. Meljler, MD FACC. Interuniversity 
Cardiology Institute, Utrecht, The Netherlands. 
High -energy phosphate content and contractile function of 
Isolated perfused rat hearts (37"C, 300 beats/min) were 
studied during global ischemia (30 min) and reperfusion (30 
min). In one group (n=ll) the normal (Ca++) of the 
perfusate 0.3 mM) was lowered to 0.06 mM during the first 
10 min of reperfuslon. In controls (n=9) the (Ca++) was not 
changed. During the 10 min of low Ca" reperfuslon 
recovery of ATP and creatine phosphate (CP) was 
significantly better than in controls. However, upon return 
to 1.3 mM Ca++ ATP and CP rapidly declined to levels lower 
than in control hearts (Fig.). In addition, there was no 
recovery of contractile function whereas controls regained 
40±IB '" (mean±SD) of pre-ischemic function. In non-
Ischemic hearts re-exposure to 1.3 mM Ca++ after 10 min of 
perfusion with 0.06 mM Ca++ did not cause such detrimental 
effects. In conclusion. temporary lowering of the (Ca++) 
during post-Ischemic reperfusion may have unexpected 
deleterious effects. 
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CORONARY TRANSIT KINETICS MAY HINDER ACCURATE MEASUREMENT 
OF PERFUSION WITH ULTRAFAST COMPUTED TOMOGRAPHY. 
Robert Weiss, M.D., Michael Shonka, Wei Chang, M.D., and 
Melvin L. Marcus, M.D., F.A.C.C. U of Iowa, Iowa City IA 
Correlations between Ultrafast Computed Tomography (UFCT) 
derived myocardial perfusion measurements and those from 
microspheres are less than ideal especially at high flows. 
Indicator dilution prinCiples dictate that tissue meas-
urements must occur before venous efflux. When arterial 
influx and venous efflux overlap, erroneous determina-
tions of both the peak and area of the tissue indicator 
dilution curve occur--yielding inaccurate flow calcula-
tions. To define the limits this imposes on myocardial 
perfusion, we assessed myocardial and coronary sinus (CS) 
transit times in 6 open-chest dogs. Green dye (GD) and 
125-I-albumin were injected simultaneously (N- 21) over 1 
or 6 sec into the aortic root. Myocardial concentration 
of 125-1 was measured with a gamma probe. CS concentra-
tion of GD was measured vith a fiber-optic catheter. 
Myocardial 125-1 arrival time was taken as T-O. CS arri-
val time was 2.3±0.B (x±SE) sec for control states 
and 1.9±1.2 sec during vasodilation with iv adenosine. 
Under control conditions CS dye arrival occurred O.B±O.B 
sec after peak myocardial concentration with a 1 sec in-
jection but 2.0±0.6 sec before peak myocardial concentra-
tion with a 6 sec bolus--simulating a rapid venous injec-
tion. Peak trans-myocardial transit time was 2.7±.7 sec. 
We conclude: 1) coronary venous clearance begins very 
early after myocardial arrival; 2) with simulated venous 
injection, CS clearance begins well before peak myocar-
dial concentration; 3) this violation of indicator-
dilution principles imparts significant error to 
myocardial perfusion measurements with UFCT using current 
algorithms when contrast is injected intravenously. 
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ASSESSMENT OF MYOCARDIAL IRON BY NUCLEAR MAGNETIC 
RESONANCE IMAGING 
Donald L. Johnston, M.D .. F.A.C.C, Lawrence Rice, M.D., G. 
Wesley Vick III, M.D., Ph.D, Robert Roberts, M.D., 
F.A.C.C., Roxann Rokey, M.D., F.A.C.C., Baylor College of 
Medicine, Houston, Texas. 
Pts with iron overload syndromes and symptoms of 
cardiac involvement exhibit a rapidly progressive clinical 
course which, in the untreated state, terminates in 
fulminant cardiac failure. To test the hypothesis that 
nuclear magnetic resonance (NMR) imaging can provide an 
early diagnosis of myocardial involvement by detecting 
tissue ferritin, 20 pts with iron overload due to mUltiple 
blood transfusions and 18 normal subjects were studied. . 
Seven pts had <50 units of blood (mean 33±12) and 13 had 
~50 units (mean 108±56). Short axis images were obtained 
of the LV at 3 levels (base, mid-portion and apex) in end-
diastole and end-systole. Signal intensity (SI) ratios 
were obtained for myocardium, spleen and liver using the 
skeletal muscle as an internal standard (i.e., 
liver/skeletal muscle). Cardiac function was assessed by 
measuring LV systolic wall thickening and mid-chamber 
fractional shortening. ST ratios decreased (iron present) 
with increased transfusions (N-normal); spleen (N-l.85 vs 
<50 units-l.3 vs ~50 units-.77, p<.OOl); liver (N-l.55 vs 
<50 units-.6 vs ~50 units-.27, p<.OOl). SI ratios for 
myocardium changed only minimally (N-l.43 vs <50 
units-l.28 vs >50 units-l.2, p-<.07). Consistent with the 
lack of myocardial iron, wall thickening and fractional 
shortening did not change. We conclude that i) NMR imaging 
is a valuable technique for the detection of tissue iron 
overload ii) iron deposition in the heart is a late event 
in pts with multiple blood transfusions compared to the 
liver and spleen and iii) this study indicates that pre-
cise quantification of myocardial tissue iron will be 
possible using NMR techniques. 
MRI GUIDED PHOSPHORUS 31 SPECTROSCOPY OF THE HUMAN LEFT VENTRICLE 
Saul Schaefer, M.D., Joel Gober, Ph.D., Mario Valenza, M.D., Gregory S. 
Ie.rezmer. Ph.D., Gerald 8 .. Matson, Ph.D .. , Albert Callacho, M.D., Elias 
H. 80tvinick., M.D., F.A.C.C., 8arry Massie, M.D., F.A.C.C., Michael W. 
Weiner, M.D. VAMC and Univ of Cal Hornie, San Francisco, CA 
31P nuclear magnetic resonance spectroscopy (31P MRS) can determine 
the status of high energy phosphates in vivo. Animal studies have 
shown that cardiac diseases can disturb the high energy phosphate 
metabolism of the heart. However, successfuL use of 31P MRS in the 
human hear! requires precise tissue local ization. Previous 
investigations have rel fed on the 81 profi les of surface coi ls to 
define the lateral borders of the volume of interest (VOl), thus mak.ing 
it difficult to avoid contamination from the right ventricle and 
skeletal MUscle. To correct this problem, we used ISIS, a 80 technique 
which allows 3-dimensional localization of the VOL We performed 
proton magnetic resonance imaging (MRI) to select the VOl for the ISIS 
experiment. 31P MRS was used to determine normal values of 
phosphocreatine (PCr) and adenosine triphosphate (ATP) in the human 
left ventricle. Studies were performed on 8 normal subjects using a 
Phillips Gyroscan imaging and spectroscopy unit operating at 1.5 Tesla. 
Using MRt, the VOl was chosen to encompass the left ventricular apex, 
distal septum, and anterolateral free wall. 31P MRS was performed with 
a 9 centimeter single turn surface cof l placed on the chest for 
excitation and detection. Signal acquisition was gated to the ECG and 
1000-1200 repetitions were averaged. ~verage time for acquisition of 
each spectra was 35 min (range 27 to 46 min). Spectra were obtained 
over a mean volume of 80 cc (range 56 to 103 cc). Cardiac muscle 
comprised approximately 571 of the VOl. Peaks for PCr and ATP were 
clearly resolved on atl spectra. The ratio of peak heights of PCr to 
ganlna ATP was 1.46 :t: 0.44. All spectra had prominent peaks in the 
phosphomonoester region, presumably due to 2,3 DPG of blood. In 
conc lusion, these experi'ments demonstrate the feasibi 1 i ty of image 
guided, local ized 31P MRS of the human heart. This technique should 
prove useful for the study of metabolic disturbances in cardiac disease. 
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Pharmacology Antiarrhythmic Drugs: Clinical 
NEGATIVE CHRONOTROPIC EFFECTS OF ADENOSINE 
TRIPHOSPHATE ON THE SINUS NODE ARE MEDIATED 
BY MUSCARINIC CHOLINGERIC AND NOT PURINERGIC 
RECEPTORS. 
Mun P Sharma M P FA C C , Claus Rinne, M.D., George 
J. Klein, M.D., FAC.C., Raymond Yee, M.D., and Tibor 
Szabo, M.D., University Hospital, london, Ontario, Canada. 
The mechanism of the negative chronotropic effects of 
adenosine triphosphate (ATP) on the sinus node(SN) is 
controversial. We have previously observed atropine to 
block the negative chronotropic effects of ATP on 
spontaneous sinus cycle length in man. To clarify the role 
of purinergic receptors in mediating the response to ATP, 
we studied the effects of intravenous(IV) aminophylline 
(AM) in 6 pts with normal SN and AV nodal function. A 
rapid IV bolus of 4 mg ATP was given in control (C) and 
after each of Propranolol (P) 0.15 mglkg; AM 7 mg/kg; and 
atropine (AT) 0.03 mg/kg. The increment in cycle length 
(ICl, bradycardic effect) and the decrement in cycle length 
(DCl, tachycardic effect) were: 
C P AM. AT 
ICl (msec) 152±20 141±22 197±75 16±5* 
DCl(msec) 91±1S 101±19 104±17 17±2* 
(* ,p<.01). Thus, ATP has both negative and positive 
chronotropic effects which are not attenuated by P or AM. 
However, AT significantly attentuated the longest and 
shortest spontaneous sinus CL. In contrast, AM prevented 
ATP induced AV block and prevented AV interval 
prolongation. Thus, the negative chronotropic effects of 
ATP are mediated by a muscarinic cholinergic receptors 
and not purinergic receptors. However, the negative 
dromotropic effects are mediated primarily via purinergic 
receptors. 
ADENOSINE PRODUCES DIFFERENT EFFECTS ON MONOPHASIC 
ACTION POTENTIALS IN HUMAN ATRIUM AND VENTRICLE. 
John P. DiMarco MD, FACC, Bruce B. Lerman MD, FACC, 
Glenn Kabel! MD, Luiz Belardinelli MD, David E. Haines 
MD, FACC. University of Virginia Medical Center, 
Charlottesville, Virginia. 
Adenosine, an endogenous nucleoside that inhibits 
sinus node automaticity and prolongs AV nodal conduc-
tion, has also been shown to increase KA h conductance 
in isolated atrial but not ventricular myo~ytes. Its ef-
fects on the latter tissues in man have not been de-
scribed. lie recorded atrial and ventricular monophasic 
action potentials during fixed rate pacing at 500 msec 
using an Ag-AgCl bipolar electrode in 8 patients un-
dergoing electrophysiologic study off all antiarrhythmic 
drugs. After injection of the dose of adenosine required 
to produce transient AV block (108 ± 47 IIg/kg), right 
atrial monophasic action potential duration at 90% 
recovery (MAPD •• ) shortened from 276 ± 30 msec to 185 ± 
38 msec (p < 0.001) suggesting an adenosine induced 
increase in K h conductance. During infusion of iso-
proterenol (3."l ± 1 IIg/min), adenosine produced a sim-
ilar decrease in atrial MAPD. o from 261 ± 28 msec to 193 
± 37 msec (p < 0.005). Under baseline conditions aden-
osine did not significantly affec t the MAPD
9
• in the 
right ventricle (275 ± 15 msec vs 268 ± 13 msec, p = NS) 
but did produce a slight decrease in ventricular MAPD9 • in the presence of isoproterenol (276 ± 26 sec vs 252 ± 
17 sec, p = 0.001). These data suggest that K h chan-
nels sensitive to adenosine exist in the rig~t atrium 
under baseline conditions and responses are not de-
pendent upon catecholamine stimulation. In contrast 
effects of adenosine on MAPD
9
• in the right ventricle 
are minor and are probably mediated via an anti-
adrenergic effect. 
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SOTALOl AND "ET01'ROLOL IN YENTRICULAR TACHYCARDIA: PRELI"INARY DATA OF A 
DOUBlE-BLIND PROSPECTIYE STUDY 
"ichlll Ktntsch ".D., Kliul-Pehr Kunze ".0., and Karl -Heinz Kuck ".0. 
University Hospital Epptndorf, Halburg, F.R.S. 
Prtlilinll"Y blinded dah analysis , .. perfarled in a prospective, doUble-blind 
clinical study calparing the efficacy of latalal ISOTl and etapraJaI (~Tl in 
patitnts lith sustained lanalDrphic ventricular tachycardia IsuYTI. Dah 
analysis included 20 patients lith a fallal-up period of at least 6 lanths. Of 
the 20 ph 118 I, 2 f; 57 ! 9 years I , 15 pis had coronary artery disease and 5 
ph had congestive cardiaeyapathy. Left ventricular ejection fraction ,as 44 ! 17 
I, cycle length ICLl of clinical YT ,as 308 ! 49 II and did not differ bebltn 
both groups. Pts "'" randOily aSSigned to double-blinded oral long-terl 
treatent ITREATl lith SOT 160-320 Ig/d 110 pisl or ~T 150-200 Ig/d 110 phI. In 
the off-drug control Ihte and 3 lonths after ltart of TREAT ph underlent 24-h 
Holter lonitoring IHOLl and progralled electrical stilUlation IPESI. COlpared to 
control PES, during TREAT loan right ventricular effective refractory period 
IYERPI deterlined at first and lecond ventriculii' extflstilUJuS IYERP I, YERP 2) 
las prolonged in both groups; I~T, YERPI 228 ! 19 vs 250 ! 27 IS, P ( .05, YERP2 
187 ! 20 VI 216 ! 24 IS, n.s.; SOT, YERPI 243 ! 16 vs 275 ! 12 IS, P ( .&5; YERP2 
205 ! 30 VI 221! 20 II, n.I.; paired t-tests). During off-drug PES susYT NiS 
induced in 9 pts of the ~T group and in 8 pts of the SOT group, IhereiS during 
TREAT 4 pts of each group re.ained inducible. There NlS no liginificant change of 
CL of PES-induced sUIYT during TREAT Ni th MET or SOT. 24-h Hoi shooed a 
Significant reduction of ventricular prelature beats IYPBI and couplets during 
TREAT in both groups I"ET, YPB 606 vs 530, p ( .05; couplets 10 vs 6, P ( .05; 
SOT, VPB 845 vs 620, P ( .05; couplets 19 vs 10, P ( .05; I!dian, paired t-testl. 
There IIrt no differences concerning clinical and helodynlic parateters beloeen 
groups. During a follao-up of 19 ~ 8 lonths, I pt died suddenly in the SOT 
treated group; 2 pts under SOT and 1 pt under "ET had a recurrence of susYT; in 1 
pt of each group the drug had to be lithdraon because of intolerable side 
effech. Conclusion: Prelilinary dah analysis of a double-blind study suggests 
that "ET lay be as effective is SOT in the clinical treahent of susYT. 
EFFECTS OF d-SOTALOL ON THE HIS PURKINJE SYSTEM 
Janet M. McComb. MD. John P. Bourke, MB, 
Ronald W.F. Campbell, MB, Hasan Garan, MD, FACC, 
Jeremy N. Ruskin, MD, FACC. Cardiac unit, 
Freeman Hospital, Newcastle upon Tyne, UK. 
d-Sotalol prolongs action potential duration 
and has effects on atrial and ventricular 
refractoriness consistent with class III 
acitivity_ To determine its effect on the His 
Purkinje system, measurements were made before 
and after intravenous infusion of d-sotalol, 
1-2 mg/kg, in 16 pts. The following results (in 
ms) were obtained: 
pre 
post 
p< 
AH 
100±22 
113±34 
0.05 
HV 
49±11 
53±12 
ns 
ERP AVN 
342±65 
39l±85 
0.01 
FRP AVN 
429±74 
465±87 
0.01 
FRP HP 
429±71 
471±85 
0.001 
Although the HV interval did not change 
significantly at rest, HV prolongation was 
demonstrated either after atrial premature 
beats, or by rapid atrial pacing, after but not 
before d-sotalol infusion in 6 pts. Second 
degree infra Hisian block, either type 1 or 2, 
was demonstrated in 4 pts only after d-sotalol 
infusion. 
d-Sotalol has marked effects on the His 
Purkinje system, increasing refractoriness in 
all 16 pts, and causing infra Hisian block in 4 
of 16 pts. These changes have been observed 
after amiodarone, and may be another 
manifestation of class III activity. 
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RATE-DEPENDENT FAILURE OF VENTRICULAR CAPTURE IN 
PATIENTS TREATED WITH ORAL PROPAFENONE. 
Jesus M. Almendral, MD, Javier Soriano, MD, Daniel San 
Roman, Angel Arenal, MD, Juan L. Delcan and Mark E. 
Josephson, MD, FACC, Hospital Provincial de Madrid, 
Madrid, Spain and University of Pennsylvania, Phila. 
The effects of propafenone (PF) on ventricular excita-
bility were studied in 18 pts after 9+6 days on PF 
therapy (300 mg qid). Late diastolic-threshold was 
determined during bipolar stimulation at the RV apex at a 
paced rate just above sinus rhythm. Twice threshold 
stimulation was performed at variable rates. A local 
ventricular electrogram was recorded from the proximal 
pair of a quadripolar catheter and stimulation was 
performed from the distal pair. In 5 pts (28%, Group 1) 
an intermittent, rate dependent failure of ventricular 
capture was reproducibly observed during stimulation at 
rates >sinus but <150 bpm. In 4 pts loss of capture was 
preceded by gradual prolongation of the interval between 
the stimulus artifact and the local RV electrogram. Such 
findings were not observed in the remaining 13 pts (Group 
2) on PF nor in 28 studies in the same pts on different 
antiarrhythmic agents. Group 1 vs Group 2 pts had longer 
RV refractory periods on PF at cycle lengths of 600 ms 
(360+62 vs 258+22, p<.OOl), and 400 ms (317+23 vs 245+26, 
p<.oI), greater ~ QRS duration (QRS on PF-baseline QRS) 
during sinus rhythm (42!32 vs 15!13, p<.05) and during RV 
stimulation at a paced cycle length of 600 ms (79+26 vs 
31+30, p<.05). We conclude: 1) PF can produce rate-
dependent failure of ventricular capture which is 
associated with marked prolongation of refractoriness and 
QRS duration. 2) This phenomenon is rare with other 
antiarrhythmic agents. 3) These findings suggest a marked 
use-dependent effect of PF in selected pts which may 
contribute to its antiarrhythmic action. 
EFFICACY OF FLECAINIDE IN THE TREATMENT OF ATRIAL 
TACHYARRHYTHMIAS 
Antonella Quattromani, M.D., Priscilla R. Smith, R.N., 
Kenneth B. Schechtman, Ph.D., Chi-Sung Zee-Cheng, M.D., 
F.A.C.C., Jean T. Barbey, M.D., Rodolphe Ruffy, M.D., 
F.A.C.C., Jewish Hospital at Washington University, 
St. Louis, MO 
Flecainide (F) is effective in paroxysmal supraventricular 
tachycardias, but its value in atrial tachyarrhythmias is 
less well defined. We treated 29 patients (P) with F who 
had symptomatic atrial fibrillation (AP,15P), paroxysmal 
atrial flutter (AFL,5P), both (7P), or other atrial 
tachyarrhythmias (2P). Previous antiarrhythmic therapy 
(Rx) included 0-6 drugs (mean=3.6). Mean left atrial size 
was 3.9cm. F was discontinued within 2 months due to 
proarrhythmia (PA) in 9P (3l%), other adverse effects 
in 1, and ineffectiveness in 2. PA consisted of new 
ventricular arrhythmias in 3P and incessant ~PL in 6P. 
Incessant AFL occurred in 3/5P treated for AFL, in 3/7P 
with a history of both AFL and AP, but in none of the 
other l7P (p 0.005). Seventeen P (59%) received chronic 
Rx for a mean of 17 (range 1 to 39) months; eight P have 
had no recurrence of symptomatic tachyarrhythmias, eight P 
have had only mild recurrences, easily controlled with 
minor adjustments in Rx when necessary, and in one P, 
flecainide was discontinued after 11 months because of 
loss of efficacy. We conclude: 1) flecainirle is 
effective in the treatment of patients with symptomatic 
atrial tachyarrhythmias; 2) proarrhythmia, incessant 
atrial flutter in particular, is common in patients 
treated with flecainide for atrial tachyarrhythmias and is 
more likely to occur in patients with a history of 
paroxysmal atrial flutter. 
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FLECAINIDE FOR RECURRENT ATRIAL FIBRILLATION: 
PREDICTORS OF EFFICACY 
William C. Lindsay, MD, Charles I. Haffajee, 
MD, FACC, Robert L.Gold, MD, FACC, Karen 
Rofino, RN U Mass Med Ctr, Worcester, MA 
Flecainide(F)was given to 23 patients with 
recurrent atrial fibrillation(AF) resistant to 
class IA agents, ~ blockers, digoxin singly and 
in combination. 
Underlying disease, duration of AF, previous 
cardioversions, left atrial size,and age were 
examined to assess response to oral F.2D 
echocardiograms for LA size were done prior to 
and during F therapy. 
Flecainide was initiated at 100 mg/day, 
titrated to effectivness or adverse reactions 
up to a maximum of 400 mg/day. The mean age of 
the pts was 65 yrs (range 25-82),LA size ranged 
from 28-46 (mean 39.0 mm).Mean F dose was 244 
mg/day(range 100-400). 
During a mean fol1owup of 3.5 mos(range 1-8)F 
singly controlled AF in 74%.No pt discontinued 
F for adverse reactions.None of the 
predisposing factors were predictive of 
efficacy for F.We conclude that F is a safe and 
effective agent for recurrent AF irrespective 
of age, LA size, underlying disease and 
previous cardioversions. 
ANALYSIS OF ANTIARRHYTHMIC DRUG LEVELS DURING 
ELECTROPHYSIOLOGIC DRUG TESTING 
Je~ L. Bauman, Pharm.D., Nada S. Berry, Pharm.D., Jose L. 
Gaastegut, M.D., F.A.e.e., Karen J. Beckman, M.D., Robert J. 
Hariman, M.D., F.A.C.C., University of IlLinois at Chicago, 
Chicago, Rlinois 
To assess the value of obtaining serum drug concentrations 
(SDCs) of the type IA antiarrhythmics and to analyze the 
correlation between SDCs and concordant and discordant 
responses, we reviewed the records of 123 patients (pts) with 
inducible paroxysmal supraventricular tachycardia (PSVT) or 
ventricular tachycardia (VT) who had SDCs determined during 
electrophysiologic studies (EP). All pts had drug-free control 
and repeat EP after quinidine (Q), procainamide (P) and/or 
disopyramide (D). Drug response was defined as inability to 
induce the tachycardia after drug therapy, or induction of only 
nonsustained « 20 beats) PSVT or VT. Tachycardia induced 
after drug therapy that was similar to control was defined as 
nonresponse. Mean SDCs (mcg/ml) for responders \IS. 
nonresponders were: Q - 3.1 1;. 1.7 vs. 3.01;. 1.6 (NS); P - 7.41;. 4.0 
\IS. 7.4 + 3.8 (NS); D - 5.5 + 1.1 vs. 4.7 + 1.5 (NS). Of 26 pts with 
discordant responses, 12 (4696) could tJe explained by SDCs that 
were outside of the therapeutic range (Q 2-6, P 6-12 and D 2-5 
mcg/ml). These 12 pts consisted of 4 responders with isolated 
high SDCs and 8 nonresponders with isolated low SDCs. 
However, of 16 pts with positive concordance, 9 (5696) responded 
despite subtherapeutic SDCs. Conclusions: 1) Isolated SDCs and 
currently cited therapeutic ranges are of little value in 
determining acute response to Q, P or D. 2) Discordant 
responses may, in some cases, be explained by difference in 
SDCs, yet some pts display responses that appear to be 
insensitive to SDC. 3) Effective SDCs are extremely variable 
and should be highly individualized based upon an objectively 
determined response, independent of cited therapeutic ranges. 
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Valvular Disease 
ULTRASONIC AORTIC VALVE DECALCIFICATION: DOPPLER 
ECHOCARDIOGRAPHIC EVALUATION. William K. Freeman, M.D., 
Hartzell V. Schaff, M.D., R. Michael Klng, M.D., Thomas A. 
Orszulak, M.D. Mayo Clinic and Foundation, Rochester, MN. 
Aortic valve (AV) decalcification is an alternative to 
replacement in selected patients (Pts) with senescent 
aortic valve stenosis. Intraoperative AV decalcification 
was performed in 16 Pts using the Cavitron Ultrasonic 
Surgical Aspirator (CUSA). The mean age was 78.6±6.0 
yrs, range 63 to 87 yrs; 9 Pts were female. All Pts had 
symptomatic senescent AV stenosis. Doppler examination 
of the AV was performed before AV decalcification and 
prior to hospital dismissal; significant improvement in 
maximal instantaneous pressure gradient (MIG), mean 
pressure gradient (R), and AV area were observed: 
Pre-AV decalclflcation Post-AV decalclflcatlon 
MIG (nrnHG) 77.9 ± 21.9 28.7 ± la.2* 
M (nrnHG) 48.7 ± 14.2 15.1 ± 5.8* 
AV area (cm2) 0.67 ± 0.16 1.33 ± 0.28* 
(mean ± SO), ·p<O.OOOOl 
Semiquantitation of aortic insufficiency (AI) was done 
with color flow Doppler. Severity of AI was decreased 
in 10 Pts, unchanged in 4, and worsened in 2 Pts (from 
trivial to mild in both) after AV decalcification: 
AI (pts) Pre-AV decalclflcatlon Post-AV decalclflcation 
Tnvlal 5 8 
Mild 6 8 
Moderate 5 0 
Left ventrlcular ejectlon fractlon was not signlflcantly 
different postoperatively (0.60±0.08 vs 0.58±0.10; p>0.2). 
Conclusions: 1) These preliminary results demonstrate 
that AV decalcification employing the CUSA significantly 
reduces AV stenosis, and 2) The majority of Pts have 
improvement in AI, presumably due to improved AV cusp 
coaptation following AV decalcification. 
RIGHT AND LEFT VENTRICULAR FUNCTIONAL RESPONSE TO SUPINE 
EXERCISE IN PATIENTS WITH ASYMPTOMATIC MITRAL 
REGURGITATION. 
Steven F. Horowitz M.D., F.A.C.C., Deborah Matza R.N., 
Josef Machac M.D., Dimitrios Alexopoulos M.D., Michael 
D. McGoon M.D., F.A.C.C., Raymond J. Gibbons M.D., 
F.A.C.C., Valentin Fuster M.D., F.A.C.C. Mt. Sinai 
Medical Center, New York, NY & Mayo Clinic, Rochester, 
MN. 
Rest (R) and exercise (Ex) abnormalities of RV and LV 
function occurring before symptoms are not well studied 
in mitral regurgitation. We studied RV and LV ejection 
fractions (EF) at R and Ex using gated blood pool 
imaging in 15 patients with asymptomatic, isolated 
mitral regurgitation and 13 normal volunteers. None of 
the mitral regurgitation patients had clinical evidence 
of congestive heart failure or RV dysfunction. 
RESULTS: 
Subjects RVEF-R RVEF-Ex LVEF-R LVEF-Ex 
Mitral 
regurgitation 
Normals 
29±10] 33±14] 58±9 
* ** 
37±8 52±8 61±6 
56±12 ] 
*** 
73±6 
(Mean % ± S.D.; *p<.03, **p<.0002, ***p<.0001) 
Both the R and Ex RV EF was significantly decreased in 
mitral regurgitation pts compared to normals. Resting 
LV EF was similar in both groups, but the LV response to 
exercise in mitral regurgitation pts was abnormal. 
CONCLUSION: Abnormal RV function at R and Ex is present 
in asymptomatic pts with mitral regurgitation before 
resting LVEF abnormalities occur, suggesting occult 
pulmonary hypertension may be present. Although LVEF is 
similar to normal subjects at rest, exercise LVEF abnor-
malities antedate symptoms in mitral regurgitation. 
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PATHOLOGIC FINDINGS AFTER IN VIVO AORTIC AND MITRAL 
BALLOON VALVULOPLASTY. Jeffrey M. Isner, M.D., F.A.C.C., 
Constance D Fields, M D, Kimberly R. Halaburka, B.S., 
Geralyn A. Slovenkai, B.S., Mark R. Desnoyers, M.D., 
Thomas J. Houg~n, M.D., K. Ramaswamy, M.D.,F.A.C.C., Deeb 
N. Salem, M.D., F.A.C.C., TuftS-New England Medical 
Center, BostOD, MA 
Previous pathologic studies have used necropsy or excised 
surgical specimens to investigate the effects of 
simulated balloon valvuloplasty (BV) of the aortic (AV) 
and mitral (MV) valves. There have been few reports , 
however, describing pathologic findings in adult pts 
following AV or MV BV performed during life. Accordingly, 
this report describes findings in 10 pts, 66 to 86 yrs in 
age, who underwent BV of the AV (8) or MV (2). Among 4 
pts studied at necropsy following BV of AV during life, 2 
died during BV: both had heavily calcified, congenitally 
bicuspid AVs, and in 1 calcific deposits were cracked at 
3 sites. In both cases, a single 20 mm balloon totally 
occluded the AV orifice during post-mortem BV. Two other 
pts died 1 day and 5 mo post-BV: both had 3-cuspid AVs 
with multiple cracked calcific nodules. AVs were 
operatively excised from 4 other pts following 
unsuccessful BV: 3/4 were congenitally bicuspid. One pt 
was studied at necropsy 1 day after unsuccessful BV of 
MV: the MV leaflets and sub-MY apparatus were severely 
fused and calcified; and the trans-septal puncture site 
was in the muscular inter-atrial septum, immediately 
superior to the foramen ovale. In 1 other pt, the MV was 
operatively excised after unsuccessful BV: the chordae 
tendineae were severely fused and calcified, while the 
extent of MV leaflet fusion and calcification was only 
mild. These preliminary findings suggest that: 1) heavily 
calcified congenitally bicuspid AVs are less amenable to 
and pose increased risk for BV; 2) cracking of nodular 
calcific deposits is the mechanism underlying acutely 
successful BV of AV; and 3) occasional pts may be 
refractory to BV of MV due to extensive deformity of the 
sub-leaflet apparatus. 
LONG-TERM FOLLOW-UP ON THE ST. JUDE PROSTHETIC VALVE. 
Chandra K. Nair, M.D. S F.A.C.C., Syed M. Mohiuddin, M.D., F.A.C.C., Rlchard J. chultz, M.D., Robert T. Baily, Jr., 
Pharm.D., William P. Forbes, Pharm.D., Wade H. Thomson, 
M.S., and Daniel E. Hilleman, Pharm.D., CreiQhton Univer-
sity School of Medicine, Omaha, NE -
One-hundred and fourteen St. Jude bil eafl et valves (70 
aortic, 44 mitral) were implanted in 103 patients (pts) 
(59 males, 44 females) between 1978 and 1982. There were 
92 pts with single and 11 pts with double valve replace-
ment. Average duration of follow-up was 5.3±2.0 years. 
Fifty-one (50%) pts received warfarin, 6 (6%) pts re-
ceived antiplatelet therapy, 38 (37%) pts received both, 
and 8 (7%) pts received neither. Of the 19 (18%) pts who 
expired, 5 (26%) died peri operatively. There were 13 
(69%) cardiac deaths, and 1 (5%) noncardiac death, during 
follow-up. Of the 13 cardiac deaths, 4 (21%) died of 
congestive heart failure (CHF), 3 (16%) from sudden car-
diac death, 2 (11%) from surgery for repeat valve re-
placement, 1 (5%) from myocardial infarction (MI) and 1 
(5%) from embolic cerebrovascular accident (CVA). Compli-
cations are reported for total pts and according to posi-
tion of valve. 
EVENT LINEAR ACTUARIAL 
l=%/pt-yr % Free at 5 yrs 
A" Aortic Mitral All Aortic Mitral 
CVA 3.04 2.47 4.13 83.9 86.9 78.1 
CHF 5.42 4.94 6.28 71.3 73.8 66.7 
MI 0.9£ 0.58 1.62 94.9 96.9 91.4 
Valve Failure 0.37 0.27 0.43 98.1 98.6 97.7 
All Morbidity 9.34 3.58 5.28 70.0 81.0 72.0 
Mortality 2.92 2.83 4.62 81.6 85.0 76.0 
We conclude that the St. Jude valve represents a safe and 
reliable alternative to other available mechanical pros-
theses in both the aortic and mitral positions. 
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VALVULAR CARDIAC PROSTHESIS AND PREGNANCY: A HIGH-RISK 
SITUATION FOR BOTH THE MOTHER AND THE FETUS. 
Eulogio Martinez FQ,M.D. ,Daniel Born, M.D., Pedro A. Almei-
da,M.D. ,Dirceu V. Santos FQ,M.D., Antonio C. Carvalho, 
M.D., Oscar P.Portugal,M.D. Escola Paulista de Medicina , 
Sao Paulo, Brazil. 
Young women with valvular cardiac prosthesis may become 
pregnant during childbearing age. To assess whether 
pregnancy with a prosthesis would bring any high-risk 
situation to the mother or the concept we prospectively 
followed up 33 pts during 41 pregnancies. Severe 
bioprosthesis dysfunction occurred in 2/13 pts (1 stenosis, 
1 rupture) during 15 pregnancies with 1 maternal death ' 
(6.7%) and 3 cases of cardiac failure. In the mechanical 
prosthesis group, acute valvar thrombosis developed 3 times 
in 20 pts during 26 pregnancies, with 2 maternal deaths ' 
(7.6%) and 7 episodes of congestive failure (P=NS-Fisher' s 
test for events in bioprosthesis X mechanical prosthesis) . 
When analysing obstetrical events we observed a 10% abortion 
rate and 1 case of hydatidiform mole. Fetuses of 
anticoagulated mothers demonstrated a significant increase 
in the incidence of prematurity (41.7% with X 10.0% without 
anticoagulants P < 0.05) and of low birth weight (59.0% with 
X 0% without anticoagulants - P < 0.05). Moreover, 
prematurity was significantly associated with the mother's 
NYHA functional class (60% in classes III-IV X 20.8% in 
classes I-II - P ( 0.05). There were 4 cases of neonatal 
deaths, all of them in concepts of anticoagulated mothers 
(1 hypoplastic LV syndrome, 1 cerebral hemorrhage, 2 preterm 
babies). We conclude that women with valvular cardiac 
prosthesis are at high-risk for maternal death and 
obstetrical and neonatal events, specially if 
anticoagulated. 
Wednesday, March 30, 1988 
Poster Displayed: 2:00PM-5:00PM 
Author Present: 2:00PM-3:00PM 
Hall E, Georgia World Congress Center 
Valvular Disease 
PLATELETS AND SURFACE MICROSTRUCTURE OF SPONTANEOUSLY 
DEGENERATED PORCINE BIOPROSTHETIC VALVES. 
~ Stein~ F.A.C.C., Chin-Hua Wang, M.D., Jeanne M. 
Riddle, Ph.D., Stephen R. Kemp, Ph.D., Donald J. Magilligan, 
Jr., M.D., F.A.C.C., Henry Ford Heart and Vascular Institute, 
Detroit, Michigan. 
The microstructure of degenerated porcine bioprosthetic valves 
was assessed by scanning electron microscopy with the hope of 
relating the structural changes to pathophysiological 
processes. Particular emphasis was made in relation to the 
possible role of platelets in the degenerative process. 
Scanning electron microscopy was performed on 33 spontaneously 
degenerated porcine bioprosthetic valves (24 mitral and 9 
aortic) removed from 32 patients (14 males and 18 females). 
The duration of insertion was 7.7 + 2.4 years (Jllean + SD). 
All of the degenerated valves were glutaraldehyde stabilized 
bioprosthetic valves (Hancock Laboratories, Johnson and 
Johnson, Anaheim, CA). The degenerated valves on gross 
examination showed one or IIOre torn leaflets in 31 of 33 
(94%) ; incompetent, but untorn cusps in 1 of 33 (3%); and 
stenosis not associated with valvular incompetence in 1 of 33 
(3%). Moderate to severe gross calcification was obsel'ved in 
15 of 33 (45%). All valves showed denudation of endothelial 
cells and exposure of the subendothelial fibrous tissue. 
Platelet deposits were common on the surface of 22 of 33 
valves (67%). Leukocytes were also obsel'ved on the surface of 
27 of 33 valves (82%). Regarding platelets, there was a 
comparable involvement of the valve whether in the mitral 
position (15 of 24) (63%) or in the aortic position (7 of 9) 
(78%). We have shown enhanced platelet reactivity in the 
blood of patients with bioprosthetic valves. Whether platelet 
interaction with the leaflets of porcine bioprosthetic valves 
contributes to the degenerative process or only reflects an 
interaction with the leaflets' collagenous framework is 
undetermined. 
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ISOMETRIC EXERCISE MEDIATED HEMODYNAMIC WORSENING AND 
ITS PREVENTION WITH NITROGLYCERIN IN PATIENTS WITH 
CHRONIC MITRAL REGURGITATION. 
Uri Elkayam, M.D., F.A.C.C., Arie Roth, M.D., Shahbudin 
H. Rahimtoola, M.D., F.A.C.C., LAC-USC Medical Center, 
Los Angeles, CA. 
Isometric exercise (lEX) increases ausculatory findings 
in pts with mitral regurgitation (MR). However, only 
little information is available regarding its hemo-
dynamic consequences in such pts. Nitrate therapy has 
been proven beneficial at rest in MR but its hemodynamic 
effect during lEX has not been established. We evaluated 
the hemodynamic response and the effect of nitroglycerin 
(NTG) in 11 pts with chronic severe MR. Hemodynamic 
measurements including heart rate (HR) , mean blood 
pressure (MBP) , cardiac index (CI) , mean pulmonary 
artery (PA) and wedge (PAW) pressures, systemic vascular 
resistance (SVR) and V wave of PAW were measured at rest 
and during lEX prior to and during intravenous NTG 
infusion titrated to lower PAW )20% (IEX+NTG). 
Results were as follows: -
HR MBP CI PA PAW SVR V WAVE 
(bpm) (mmHg) (L/min/m') (mmHg) (mmHg) (d.s.cm-S) (mmHg) 
Rest 87 88 2.4 35 23 1734 33 
lEX 94 97* 2.3 42* 29* 2029 41* 
IEX+NTG 91 92 2.6 30** 19** 1764 27** 
*p<0.05 vs. Rest ** p<0.05 vs lEX 
CONCLUSIONS: 1) In pts with chronic MR lEX results in 
unfavorable hemodynamic responses including a signifi-
cant increase in PAW, worsening of MR and pulmonary 
hypertension and mild increase in LV afterload; 2) 
venodilation with NTG prevents hemodynamic deterioration 
during lEX and should have a protective effect in pts 
with chronic MR. 
MITRAL REGURGITATION INOUCEO BY CONGENITAL "ABSENCE OF 
THE COMMI SSURAL CHORDAE": A NEW ETI OLOGY 
Shin-ichiro Ohkawa,M.D.,Takashi Sugawara,M.D.,Chizuko 
Watanabe,M.D.,Keiji Ueda,M.D.,Masaya Sugiura,M.D., 
Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan 
Twelve cases of congenital absence of the mitral com-
missural chordae were found among 4,800 consecutive 
autopsies over 60 yrs.,with an incidence of 0.25%. 
Among them six cases(A) showed mitral regurgitation(MR) 
due to this anomaly, remaining 6(B) without MR. (A) 
consisted of 4 men and 2 women with a mean age of 
70yrs.,showing CHF in 4, AF in 2, an average CTR of 
57.7%, the mean duration of MR with 9.8 yrs. Phonocar-
diogram showed pansystolic murmur with Grade 3/60 in 5 
without significant 3rd and 4th sounds. On echocardio-
gram(2DE) 2 patients were diagnosed as having MR due to 
ruptured chordae tendineae(RCT) because of the presence 
of abnormal echoes in the left atrium. Only 2 cases 
showed cardiac death. Pathologic findings revealed the 
average heart weight of 430g in (A),303g in (B), slight 
coronary sclerosis in all. Absent commissural chordae 
of the mitral valve associated with a moderate degree 
of the mitral valve prolapse were remarked in all 
cases. They were located in the anterolateral commis-
sure in 5, in the posteromedial one in 7. In addition 
in 10 among 12 cases(83 %) there were several accessory 
chordae in the region of the adjacent involved commis-
sure, which should be differentiated from the findings 
of abnormal echoes in patients with RCT on echocardio-
grams. In conclUSion, we should recognize that some 
patients with MR could be induced by such "absence of 
the commissural chordae", highly associated with acces-
sory chordae, which has not been reported. 
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CONTRASTING HISTOARCHITECTURE OF CALCIFIC DEPOSITS IN 
LEAFLETS FROM BICUSPID VERSUS TRICUSPID AORTIC VALVES 
John Braimen, M.D., Anthony DeFranco, M.D., Kimberly R. 
Halaburka, B.S., Geralyn A. Slovenkai, B. S., Roberta 
F.Donaldson, B.S., Constance D.Fields, M.D., Jeffrey M. 
Isner, M.D., F.A.C.C. Tufts University School of 
Medicine/New England Medical Center, Boston, MA 
Preliminary findings from clinical trials of balloon 
valvuloplasty for calcific aortic stenosis have 
suggested that calcified, congenitally bicuspid (Bi) 
aortic valves (AVs) may be more refractory to balloon 
dilation than calcified, congenitally normal 3-cuspid 
(Tri) AVs.Accordingly, we evaluated the histoarchitec-
ture of calcific deposits in operatively excised AVs, 
selected according to 2 criteria: calcific deposits 
were observed on in vitro radiographs of the excised 
AV, and the excised AV could be classified with 
certainty as congenitally Bi (n~14) or Tri (n~16). 
Examination of light microscopic sections taken through 
the calcified AV leaflets and stained with trichrome 
and von Kossa stains disclosed 2 types of 
histoarchitecture illustrated below. In Type A, bulky 
calcific deposits were superimposed upon a fibrotic AV 
leaflet; in Type B, calcific deposits were diffusely 
distributed throughout the body (spongiosa) of the AV 
leaflet. All 14 Bi AVs were Type B; in contrast, only 
3/14 Tri AVs were Type B, while 11/14 were Type A (p < 
0.01). Two Tri AVs could not be classified 
histologically. Thus, the distribution of calcific de-
posits is different for Bi AVs than for Tri AVs. The 
more diffuse distribution of calcium throughout the 
body of Bi AV leaflets may render these valves less 
amenable to balloon valvuloplasty than Tri AV leaflets 
A 
'aJi!!!;9 
B 
on which calcific deposits are 
typically superimposed in nodular 
form. Such contrasting histoar-
chitecture may thus play a role 
in determining suitability of AV 
for balloon valvuloplasty. 
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Myocardial Infarction-Clinical: Thrombolysis II 
LACK OF EVIDENCE FOR ENHANCED TIlROMBOLYSIS WITIl COMBINED 
UROKINASE PLUS TISSUE PLASMINOGEN ACTIVATOR C(}1PARED WITIl 
TISSUE PLASMINOGEN ACTIVATOR ALONE USING QUANTITATIVE 
ANGIOGRAPHY • 
Mark L. Sanz MD, Eric J. Topol MD, FACC, Barry S. George MD, 
Dean J. Kereiakes MD, FACC, Charles W. Abbottsmith MD, FACC, 
Richard J. Candela MD, FACC, Richard S. Stack MD, FACC, 
Willian, W. O'Neill MD, Robert M. Califf MD and the TAMI 
Study Group, University of Michigan, Ann Arbor, MI. 
To evaluate early enhanced clot lysis through synergistic 
actioo of contlination thrombolytic agents in acute myo-
cardial infarction, we measured absolute diameter (milli-
meters) of the infarct vessel 90 minutes after thrombolytic 
therapy, before mechanical intervention. Of 112 patients 
given full dose tissue plasminogen activator (t-PA) at 1 
mg/kg and simultaneous incremental doses of urokinase (0.5-
2.0 mill U), 73 patients had angiograms of sufficient 
quality for quantitative analysis of stenosis using an 
automated centerline and edge detection program. 1lie three 
groups given urokinase in increasing doses were compared 
using analysis of variance. Data were analyzed excluding 23 
patients who had occluded vessels since no benefit of 
improved thrombolysis would be measurable. Values are mean 
:!:.SE. 
Overall Patenc:z: Quantitative Data 
Urokinase Dose n ~ n Abs Dia 
500,000 U 24 f1 8 .86+.21 
1,000,000 U 33 72 10 1.30;-.14 p=.29 
2,000,000 U 55 75 32 1.22!:.12 
No improvement in patency of the infarct vessel was 
demonstrated with t-PA and incremental urokinase dosing. 
Luminal diameter failed to increase with combination therapy 
further demonstrating the lack of synergism of t-PA and 
urokinase for achieving acute coronary thrombolysis. 
ABSTRACTS 
COMBINATION THROMBOLYTIC THERAPY: IMPROVED 
PRE-DISCHARGE VESSEL PATENCY WITHOUT INCREASED 
HEMORRHAGE 
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Robert M. Califf, MD, Eric J. Topol, MD, FACC, Barry S. 
George, MD, Dean J. Kereiakes, MD, FACC, Cass A. 
Pinkerton, MD, Jane M. Boswick, MPH, Donald A. Rothbaum, 
MD, Richard J. Candela, MD, FACC, Charles W. Abbottsmith, 
MD, Richard S. Stack, MD, FACC, and the TAMI Study Group, 
Duke University, Durham, NC 
In the TAM I I I Pilot Study 112 pts wi th acute 
myocardial infarction were given 1 mg/kg of tissue 
plasminogen activator (t-PA) and 500,000 to 2,000,000 
units of urokinase (UK) simultaneously over 1 hr. 
Results were compared with 386 PTS from the TAMI I trial 
treated after similar entry criteria with 150 mg of t-PA 
over 6-8 hrs. Hemorrhage was quantified using nadir 
hematocrit (HCT) and need for transfusion of >2 units. 
Infarct artery patency 90 minutes post treatment and 
before discharge was determined with angiography in 93% 
of patients. 
Despite lower nadir fibrinogen levels (36.9 mg/dl vs 
129 mg/dl, p<.OOOI) with t-PA + UK, less bleeding 
occurred compared with t-PA alone: nadir Hct (33.5 vs 
31.2, p=.09) and 2 unit transfusions (23% vs 31%, p=.06). 
Although 90 minute infarct vessel patency did not differ, 
the pre-dis~arge IRA status was more favorable for 
t-PA + UK (X4 =16.2, p=.003) 
Bypass 
Patent Graft Occluded Dead 
t-PA alone ~ ~ 10% --r% 
t-PA + UK 79% 15% 4% 2% 
These results suggest that persistent IRA patency can 
be enhanced with combination therapy compared with t-PA 
alone, without increasing bleeding complications. Thus, 
urokinase may be a preferable substitute for a 
maintenance infusion of t-PA. 
BLEEDING TIME MEASUREMENT PREDICTS SPONTANEOUS BLEEDING 
DURING THROMBOLYSIS WITH RECOMBINANT TISSUE-TYPE 
PLASMINOGEN ACTIVATOR(rt-PA) 
Lawrence W.Gimple, M.D.; Herman K.Gold, M.D., F.A.C.C.; 
Robert C.Leinbach, M.D., F.A.C.C.; Tsunehiro Yasuda, M.D.; 
Jennifer A.Johns, M.D.; Andrew A. Ziskind, M.D.; Desire C. 
Collen, M.D., Ph.D., Massachusetts General Hospital, 
Boston, MA 
Thirty-two patients(pts) receiving rt-PA for myocardial 
infarction or unstable angina were monitored with serial 
Surgicutt bleeding times(BT) and fibrinogen levels at 
pre-, mid- and end therapy. Pts with control BT greater 
than 9 minutes were excluded from rt-PA therapy. Total 
rt-PA dose ranged from 55 to 212 mg (mean = 109 mg) and 
duration of infusion ranged from 60 to 720 minutes (mean 
= 207 minutes). Predictors of spontaneous bleeding (SB, 
defined as bleeding not related to catheterization or 
puncture sites) were analyzed using stepwise logistic re-
gression. Variables examined were total dose of rt-PA, 
longest BT, end therapy fibrinogen levels, PTT 4-6 hours 
after initiation of rt-PA, prior aspirin use, and total 
duration of rt-PA therapy. Seven pts showed SB. Only 
prolongation of the BT predicted SB (p=0.0005). BT pro-
longation predicted SB with a sensitivity of 70 ± 17% 
(SEE) and specificity of 88 + 6%. The four pts known to 
be taking aspirin prior to therapy had a mean maximal BT 
prolongation to 21.5 + 8.7(SD) minutes. Pts not taking 
aspirin had a mean of-6.7 + 7.8 minutes (p<O.OOl). 
Thus pts receiving rt-PA-therapy who develop a pro-
longed BT are at increased risk of SB. Prior use of 
aspirin prolongs the BT following rt-PA administration 
despite normal bleeding times prior to rt-PA therapy. 
Monitoring BT is a useful investigative tool in deter-
mining which patients are at increased risk of spontane-
ous bleeding. 
232A ABSTRACTS 
RESULTS OF A lARGE RANlXMISED '!RIAL OF INrnAVEOOUS 
S'lREF'lOKINASE AND CRAL ASPIRIN IN ACUTE MYOCARDIAL 
INFARCITON 
ISIS Collaborative Group (co-ordinating centre: 
Radcliffe Infinnary, Oxford OX2 6ER, England). 
'I11e Secxmd Internaticrtal Study of Infarct Survival 
(ISI8-2) is a rand::mised factorial placel:x:Hx>ntrolled 
trial of the effects of intravenous streptokinase 
(1.5 megaunits 'Streptase' infused over one oour), 
oral aspirin (160 mg enteric-coated aspirin daily over 
one rronth), both, or neither, in acute myocardial 
infarction (MI). 
Patients with suspected acute MI presenting within 24 
OOurs of the onset of pain that led to hospital 
admission were eligible for ISI8-2 provided there was 
no clear contraindication to, or indication for, 
imnediate streptokinase or aspirin, in the view of the 
responsible physician. Between March 1985 and Decenber 
1987, over 16,CXX) patients admitted to 400 collatorating 
oospitals in 20 countries were randanised. During this 
period of recruitrrent, interim results were reviewed 
confidentially by an independent data rronitoring 
cx:mni.ttee. In January 1987 this ccmnittee released 
results for nearly 4aJO patients randanised within 4 
oours of pain onset, because in their opinion the data 
available at that time provided "proof beyond reasonable 
doubt" that streptokinase reduced the in-oospital 
rrortality of such patients by about 1/3 (fran about 12% 
arrong placebo-allocated patients to about 8% arrong 
those allocated streptokinase). 
Results for the assessment of streptokinase and of 
aspirin in all rand:mised patients will be available by 
the time of presentation. 
A MULTICENTER, RANIXJUZED, CONTROLLED TRIAL OF INTRAVENOUS 
TISSUE PLASMINOGEN ACTIVATOR AND EARLY INTRAVENOUS HEPARIN 
IN ACUTE MYOCARDIAL INFARCTION 
Eric J. Topol, MD, FACC, Barry S. George, MD, Dean J. 
Kereiakes MD, FACC, Richard J. Candela MD, FACC, Charles W. 
Abbottsmith MD, FACC, Lynne Aronson BS, Willian W. O'Neill 
MD, Richard S. Stack MD, FACC, Robert M. Califf, MD and the 
TAMI Study Group, Univ. of Michigan, Ann Arbor, MI 
Several recent studies have demonstrated heparin's 
facilitation of the fibrinolytic effect of tissue plasmino-
gen activator (t-PA) • To determine the importance of the 
heparin-t-PA interaction in acute myocardial infarction, we 
randomly allocated 131 patients to receive either intra-
venous (iv) t-PA (n=70) at a dose of 1.0 mg/kg for the first 
hr and 15 mg/hr for 4 hrs or to heparin (n=61)( 10,000 U iv 
bolus) plus t-PA (sane dose). All patients underwent cardiac 
catheterization to determine the patency status of the 
infarct related artery at 90 minutes after therapy. The 
control t-PA pts did not receive heparin until after patency 
had been determined. Angiographic patency, including TIMI 
Grades 2 and 3, for the heparin plus t-PA pts was 47 of 59 
(79. 7~) vs. 53 of 69 (76.8~) control t-PA pts (p=. 70). 
Significant bleeding episodes, requiring > 2U transfusion in 
the first 24 hrs of therapy, occurred in 2t-PA plus heparin 
pts (3.3S) compared with 4 control pts (5.7%) (p=.51l. The 
bleeding site for t-PA plus heparin vs. t-PA control pts was 
as follows: peri-access 1, 1; gastrointestinal 1,2; intra-
cranial 0,1, respectively. Minor bleeding, not requiring 
transfusion occurred in 23~ of t-PA plus heparin vs. 25. 7S 
of t-PA control pts, chiefly at the peri-access site. 
In conclusion, the data does not support an important 
facilitative effect of heparin on t-PA. Although bleeding 
complications were not increased by the addition of heparin, 
the lack of a higher infarct vessel patency rate argues 
against routine early heparin use when t-PA is administered. 
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A MULTICENTER DOUBLE-BLIND TRIAL OF INTRAVENOUS 
APSAC VERSUS HEPARIN IN ACUTE MYOCARDIAL INFARC-
TION. FINAL REPORT OF THE APSIM STUDY 
J.P. Bassand MD., J. Machecourt MD., J. Cassagnes MD., 
T. Anguenot MD., J.R. Lusson MD., J.E. Wolf MD., D. Ducel-
lier MD., E. Borel MD., P. Peycelon MD. 
University Hospital 25000 BESANCON FRANCE 
Two hundred and thirty patients (pts) suffering from a 
first acute myocardial infarction (AMI) were randomly alloca-
ted within 5 hours following the onset of symptoms either 
to Anisoylated Streptokinase Plasminogen Activator Complex 
(APSAC) 30 mg over 5 minutes or to conventional Heparin 
(H) therapy 500 IU/kg/24H. 115 pts received APSAC and 
115 H. Both APSAC and H groups were similar in age, location 
of AMI, Killip class and time of randomisation. Elective 
coronary arteriography was performed on average 2.9:!:,1.2 
days after initial therapy with immediate angioplasty of 
the infarct-related artery if suitable for the procedure. 
Follow-up radionuclide angiography and thallium 201 compute-
rized tomography (Ti 201 CT) were performed before hospital 
discharge. The infarct size was estimated from Ti 201 CT 
and expressed in percent. 7 APSAC pts and 7 H pts died 
during the in-hospital course. The arterial patency rate was 
77 % in APSAC and 37% in H (P <. .001). 
LVEF INFARCT SIZE % 
APSAC HEPARIN APSAC HEPARIN 
Overall .52+.13 .47+.13* 14+11 18+13* 
Anti.AMI .4i'.13 .40+.16* 18+14 25+16* 
Inf.AMI .56+.11 .51+.09* 11+7 12+7 
*p <: 0.05 - - - -
A close inverse relation was found between LVEF values 
and infarct size (r = - 0.73, P <"0.01). We concluded that 
early infusion of APSAC in AMI produced a high short term 
patency rate, a significant limitation of the infarct size 
and a significant preservation of the LV systolic function 
namely in anterior AMI. 
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Unstable Angina 
THROMBUS AND COMPLEX LESIONS AT EARLY ANGIOGRAPHY IN 
UNSTABLE ISCHEMIC SYNDROMES. 
Anne E. Williams, H.D., Hichael R. Freeman, H.D., 
F.A.C.C., Chris E. Beok, B.Sc.N., Robert J. Chisholm, 
H.D., Norman L. Patt, H.D., Paul W. Armstrong, H.D., 
F.A.C.C •• University or Toronto, Toronto, CANADA. 
Complex morphology (CH) occurs rrequently in unstable 
angina, however its relationship to symptomatic 
presentation is unknown. Aocordingly, we perrormed 
coronary angiography 4.9~.1 days arter qualifying 
rest pain in 102 consecutive patients presenting with 
acute coronary insurriciency (ACI)(n=68) or crescendo 
angina(CA)(n=34). Significant coronary artery disease 
was derined as any 250~ stenosis and CH as any stenosis 
with irregularity, overhang or thrombus. Nine or 68 
patients presenting with ACI later proved to have a HI 
as their qualifying event (CPK)2x Normal).There were no 
HI's in the CA group. The results (%) are shown: 
ACI ...!lA...- ACI & CA 
NO HI HI NO HI NO HI 
NO DISEASE 11/59(19) 019(0) 4/34(12) 15(16) 
HULTIVESSEL 37/59(63) 919(100) 26/34(76) 63(68) 
CH 32/59(54) 919(100). 20/34(59) 52(56) 
THROMBUS 15/59(25) 719(78)· 10/34(29) 25(27) 
.p(0.005 vs ACI and CA. 
Complex morphology occurred in 61% or patients. 
Thrombus alone ocourred in 27% or patients with 
unstable angina without HI, with similar rrequencies 
between clinical groups. In contrast, intraluminal 
coronary artery thrombi were identified in 78~ of ACI 
patients who later proved to have a HI as the 
qualifying event. 
Thrombolytic therapy may thererore be of value early in 
unstable angina, especially in subset of ACI patients 
who prove to have an evolving myocardial inrarction. 
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PLASMA HBRINOPEPTlDF. A LEVELS IN THE VARIOUS CLINICAL 
FORKS OF UNSTABLE ANGINA: RELATION TO EARLY PROGNOSIS. 
H,Hene ouimet. K.D., Claudette Leger-Gauthier, Ph,D., 
Jean-Gilles Latour, Ph.D., Pierre Theroux, K.D., 
F.A.C.C., Guy B. Pelletier, K.D., F.A.C.C .• Kartin 
Juneau, K.D., and David D. Waters, K.D., F.A.C.C .• 
Kontreal Heart Institute, Kontreal. Canada. 
Plasma fibrinopeptide A (FPA) levels were assessed by 
radioimmunoassay on admission to hospital in SO pts 
with unstable angina and in a control population of 30 
pts with stable angina. Unstable angina was classified 
as crescendo angina with rest pain (33 pts) or prolong-
ed rest pain (17 pts) without myocardial infarction 
(KI). Previous stable angina was present in 3S pts and 
absent in IS. Other clinical features include recent 
«7 days) KI (3 pts) and previous (>1 year) bypass sur-
gery (11 pts). 
FPA levels were significantly higher in unstable 
(S.S3±8.6 (SEK) ng/ml) compared to stable angina 
(l.97±0.16, pe02). SUbsets of unstable angina showed 
no intergroup differences and were all significantly 
higher than stable angina: 
Crescendo angina 4.32±1.3 
Previous angina 4.9S±1.2 
Prolonged pain 
No previous 
angina 
4.49±1.0 
3.82±1. 2 
Recent KI 8.ll±3.2 Bypass surgery 4.64±1.S 
Hospital course was uneventful in 33 pts; their admis-
sion FPA level was 2.98±O.S7. In the 16 pts with re-
fractory angina and the 1 who suffered KI in hospital, 
admission FPA levels were 10.1±3.4 (p<.02). 
These results document thrombin generation in all 
clinical forms of unstable angina, suggesting a common 
pathophysiological link. Higher levels of plasma 
fibrinopeptide A on admission may discriminate higher 
risk patients. 
THROMBOLYSIS IN PATIENTS WITH UNSTABLE ANGINA REFRACTORY 
TO MAXIMAL MEDICAL THERAPY. 
Clcu:tio Brunelli MO, PCKllo Spallarossa MO, Giorgio Gligliotti MO, Mario 
Iannetti MO, Salvatore Caponnetto MO. Dept. of Cardiology, liliversity of 
Genova, Genova, Italy. 
Patients (pts) with unstable angina I'i1o failed intensive ITedical therapy 
usually lJ'1der9> to either coronary angioplasty or coronary by-pass surge-
ry. To evaluate in these pts the efficacy of thrariJolytic therapy before 
invasive managarent, we studied in the coronary care unit 15 pts 46-69 
years old (nean 57.1) with unstable angina refractory to full standardi-
zed therapy including intravenous nitrates, calciLl11 antagonists, beta bl~ 
ckers and antiaggregating agents. During this treatrrent all pts sIlcJ.ej 
persistence of ischerric episodes detected by 48 hours of continuous elec-
trocardiogrill*lic nnnitoring (period 1). Thus they received a bolus of 
2.000.000 units of i .v. urokinase follONed by i .v. heparin and oral anti-
coagulants. After thrariJolysis, occurrence of ischerria was assessed du-
ring a one week period. TI«l 24 hrurs continuous electrocardiogrill*lic nnni 
taring at the beginning and at the end of the week were perforITed (peri<X! 
2) • All pts l.I'1derve1t coronary cr1gi ogrill*lY and ventri cu 1 ogrill*lY. No major 
cmplication occurred. In period 1 all pts had ischerric episodes, 13 had 
silent ischerria. The nl.I11ber of ischerric episodes was 70, 54% of lIilich we-
re as)1Tptcrnatic. In period 2, 6 pts becane free of angina and ischerria, 7 
pts had episodes of silent ischerria, 2 pts had alwi\}'S sjflptrnatic ische-
mia. 64 ischerric episodes (56% silent) occurred in 9 pts. 1 pt had a fa-
tal nyocardial infarction, 3 had coronary by-pass surgery and 3 l.I'1derve1t 
coronary angiop 1 asty. 
In conclusion: since prolonged clinical stabilization of unstable angina 
is achieved with this drug regirren, thrariJolytic therapy has to be taken 
into accrunt before proceeding to invasive managarent. 
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FLESTOLOL, A TITRATABLE, SHORT-ACTING BETA ADRENERGIC 
ANTAGONIST IN THE MANAGEMENT OF UNSTABLE ANGINA. 
Richard Conti, M.D., F.A.C.C., John Somberg, M.D., 
F.A.C.C., Deborah Keefe, M.D., F.A.C.C., Martin 
Emanuele, Ph.D., Prasad Turlapaty, Ph.D., Atul Laddu, 
M.D., F.A.C.C., University of Florida College of 
Medicine, Gainesville, FL. 
Flestolol (FL) is an intravenous, titratable, short-
acting, non-selective p-blocker. Unstable angina (UA) 
Pts in a CCU were randomized to either FL and 
nitroglycerin (NG; N=23) or NG alone (N=12). Heart rate 
(HR), blood pressure (BP), anginal episodes, ST events 
and duration (L1 mm change over 30 sec), and premature 
ventricular contractions (PVC's) were assessed over a 48 
hour period. During titration, FL (1.0-7.5 pg/kg{min) 
plus NG (10-200 pg/min) caused dose dependent reductions 
in HR and rate pressure product (RPP). At steady state, 
FL plus NG infusion (4.7±0.6 pg/kg/min and 64±14 pg/min, 
respectively) resulted in a greater reduction in HR, 
RPP, ST events and duration compared to NG alone (B7±24 
pg/min) . 
Variable* 
HR (bpm) 
SBP/DBP (mmHg) 
RPP (bpm X mmHg X 10-3 ) 
ST events/24 hr 
ST duration (min) 
Anginal Episodes/24 hr 
PVC's/24 hr 
NG (N=12) 
84:!:6.0 
l34±617h2 
115±12 
1.4±0.6 
66±22 
0.B±0.2 
190;BO 
FL + NG (N=23) 
67±2.5** 
11B±5171±2 
80±5.0*'" 
0.9±0.4 
33;7 
0.7:!:0.3 
234± 112 
*Values are mean ± SEM **p (0.01 vs NG 
FL plus NG was well tolerated in most Pts. These 
results suggest that FL plus NG treatment may provide 
better acute control of the UA Pt than NG alone. 
ISCHEMIC ST CHANGES ON ADMISSION ECG AND 24 HOUR HOLTER 
PREDICT UNFAVOURABLE OUTCOME. MULTI VESSEL DISEASE. AND 
LEFT MAIN STENOSIS IN UNSTABLE ANGINA. Anatoly Langer. 
H..Il.... Hicbael R. Freeman. H.D.. F.A.C.C •• Paul W. 
Armstrong. M.D •• F.A.C.C •• Univ. of Toronto. Canada. 
We prospectively evaluated 136 pts witb unstable 
angina to define predictors of multivessel disease 
(MVD). left main stenosis (LM). and unfavourable out-
come (UO). Hospital UO was: deatb 4.4J. non-fatal MI 
9.6J. urgent revascularization 35.3J. Angiograpby 4.~ 
2.6 days after admission sbowed MVD in 60% and LH in 
13% of pts. Tbe table sbows tbe distribution of UO. MVD 
and LM according to results of two-cbannel ST Holter 
monitoring performed in tbe 1st 24 CCU brs; no ST ~ 
(1.e.2.1mm ST.j. ort). ST 6. <60 min. and ST 6. 2.60 min: 
llQ lim lJ1 
1)No ST ~ (0=46) 22~ 54J 4% 
2)ST ~ < 60 min (n=44) 32% 64J 9J 
3)ST ~2. 60 min (n=46) 67~· 89J· 29J· 
·p<.025 3 vs.1 
·p<.05 3 vs.2 
Of tbe 90 pts witb ST ~ asymptomatic ST ~ occurred in 
61 pts. symptomatic ST 6. alone in 5 pts. and tbey co-
existed in 24 pts. Overall. 89J of a total of 845 
episodes of ST ~ were asymptomatic. Tbe presence of 
ST 6 2. 60 min on Holter bad a 56% sensitivity and 82% 
specificity for predicting UO wbile addition of ST .j. on 
admission ECG (present in 39 pts) resulted in 70% sensi-
tivity and 67% specificity. Of tbe 18 pts witb LH. ~ 
2. 60 min detected 12 (67J); moreover. 151M pts (83%) 
were detected by tbe addition of admission ECG ST~ to 
Holter Sf!::,. 2.60min. Ischemic ST A was of longer duration 
in pts witb UO (131i159 min). MVD (102i146 min), and LM 
(147i149 min) tban in tbose pts witbout (53i118. 38%98. 
and 7~131 min P<.01. respectively). Tbese data sbow 
tbat total iscbemic burden of symptomatic and asympto-
matic ST ~predicts unfavourable outcome, multivessel 
disease and left main stenosis in unstable angina. 
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QUALITY OF LIFE AFTER TREATMENT FOR UNSTABLE 
ANGINA PECTORIS: THE VA COOPERATIVE STUDY OF 
MEDICAL VS SURGICAL THERAPY FOR UNSTABLE ANGINA 
PECTORIS 
David C Booth. MD. FAC.C., Robert J. Luchi, M.D.,F.A.C.C., 
Stewart M. Scott, M.D., Robert H. Deupree, M.D., Anthony N. 
DeMaria, M.D., F.A.C.C., and the Study Co-Investigators, V.A. 
Medical Center, Lexington, KY. 
To assess the effect of bypass surgery on outcome from unstable 
angina (VA), 468 patients (P) were randomized to medicine (M, 237P) 
or to surgery plus medicine (S, 231P) and thusfar have been followed 
five years for comparison of survival and quality of life. Data were 
available at 3 and 5 years for 78% and 72% of M pts and 75% and 
63% of S pts, respectively. At 3 mos, 79.8% of S patients vs. 58% of 
M reported general improvement, 12.6% S vs. 24.5% M no change, 
and 5.5% S vs. 14.5% M worsening, p by chi-square < .01 (2.2% of 
Sand 3.0% of M irretrievable). The treadmill exercise duration was 
increased at 6 mos in the S group compared to M, 6.5 ± .25 vs. 5.3 ± 
.25 min, p < .01, remained greater in S through 4 years, but at 5 years 
no longer differed between the two groups. A trend toward decreased 
recurrence of UA was present in the S group at one year, 6/168 
(3.6%) for S vs. 13/187 (6.9%) for M, p = .158, but the two groups 
were similar at 3 and 5 years. Patients in the S group used less 
nitroglycerin and less propranolol than those in the M group at 1 and 3 
years (p<.OI), but by 5 years these variables were similar. Working 
status never differed at follow-up for the two groups. Thus, bypass 
surgery produces immediate improvement in quality of life vari~bles, 
and the effects persist for at least three years postoperatlvely. 
However, many beneficial effects of surgery diminish by five years, 
and return to work is generally independent of these two modes of 
therapy. 
Thursday, March 31,1988 
10:30AM-12:00NOON, Room 314, Level Three 
Balloon Valvuloplasty 
SPONTANEOUS VARIATION AND EXERCISE-INDUCED CHANGES IN 
MEASUREMENT OF MITRAL VALVE AREA USING THE GORLIN 
FORMULA: IMPLICATIONS FOR EVALUATION OF CHANGES FOL-
LOWING CATHETER BALLOON VALVULOPLASTY FOR MITRAL STENOSIS 
David T. Kawanishi, MD, FACC, Charles R. McKay, MD, FACC, 
Cheryl L. Reid, MD, FACC, Shahbudin H. Rahimtoola, MD, 
FACC, LAC-USC Medical Center, Los Angeles, CA 
To establish a basis for evaluation of immediate and 
long-term changes in mitral valve area (MVA) following 
double-balloon catheter balloon valvuloplasty (CBV) for 
mitral stenosis, MVA pre-CBV was measured at rest (Gorlin 
Formula) in triplicate and at the peak of supine bicycle 
exercise (EX) in 10pts, mean age 37t14 yrs (meantSD). At 
3 mos post-CBV, MVA was measured at rest in duplicate and 
at peak EX in the 7 pts who had no evidence of residual 
atrial septal defect. 
RESULTS: Pre-CBV, the average coefficient of variation 
of~ rest was 7%, range 0-17%; a change of >2x7% or 
>15% was considered significant. 
- MVA(MeantSD) Mean % {; MVA, Rest vs Ex 
Pre-CBV: Rest 1.OtO.2 cm2 
Pre-CBV: Ex 1.OtO.2 cm' 9% (range 0-27%) 
Post-CBV: Rest 2.0tO.4 cm2] =0.01 
Post-CBV: Ex 2.4tO.7 cm' p 23% (range 0-44%) 
One of 10 pts had >15% increase in MVA with EX Pre-CBV 
compared to 5 of 7 jiis post-CBV. 
CONCLUSIONS: 1) Spontaneous variation in determination 
of MVA at rest using the Gorlin Formula is small, the 
average coefficient of variation at cardiac 
catheterization was 7%; 2) For an individual patient a 
difference in MVA of >15% probably represents a 
significant change; and 3)-In pts with mitral stenosis, 
although pre-CBV the MVA does not change beyond this 
range with EX, in some pts post-CBV the increased MVA at 
rest increases further during EX. 
JACC Vol. II, No.2 
February 1988:234A 
MID-TERM FOLLOW-UP AFTER PERCUTANEOUS TRANSLU-
MINAL AORTIC VALVULOPLASTY IN THE ELDERLY. 
Bernard Lancelin,M.D.,Bernard Chevalier ,M.D., Thierry Bourdin, 
M.D., Jean-Paul Aziza,M.D., Benoit Diebold,M.D., Alain 
Francillon,M.D., Jean-Leon Guermonprez,M.D. 
Hopital A. Mignot, Versailles, France. 
In order to estimate mid-term situation of Pts who underwent 
percutaneous transluminal aortic valvuloplasty (PT AV), 46 
Pts aged 79,4 +/ - 6,5 years whose aortic valve ar;a (AVA) 
gained more than 20 % (from 0,43 +/- 0,18 cm to 0,72 
+/ - 0,26 cm 2, P < 0,00 1) were selected among 57 Pts totalizing 
61 PTAV (2 hospital deaths, 3 lost, 6 failures). After 7,1 +/-
3,4 months(m), 10 Pts (21,7%) were dead, 8 (17,4%) from 
cardiological event (2 at 1m, 2 at 2m, 1 at 7m, 1 at 11m, 
I at 13m), 7 Pts (15,2%) underwent aortic valve replacement 
(I death), 19 Pts (41,3%) were asymptomatic (4 after a second 
PTAV at 8,4 +/- 4,7m), 4 Pts (8,7%) were in class 2, 2 (4,4%) 
in class 3, 4 (8,7%) in class 4. When cardiological death 
occured, the AV A post-PT AV was not significantly (p=0,2) 
different (0,56 +/- 0,27 cm') compared to 0,71 +/- 0,28 cm' 
in Pts alive, but ejection fraction was inferior before PTAV 
(40,4 +/- 16,8%) compared to alive Pts (56,5 +/- 17,6%) 
(p (0,05). 7 hemodynamic controls were performed at 8,6 
+/-4m for clinical suspicion of restenosis, confirmed 5 times, 
trea ted by 4 PT AV and one aortic valve replacement. For 
18 other Pts, AVA was estimated by Doppler echocardiography 
(continuity equation) at 7,3 +/- 3,2m with 5 restenosis, defined 
as loss of 50% of the initial gain, treated by 2 aortic valve 
replacements and 3 medical treatments. . 
Mortality appears to be important, dependant on left ventrIcular 
function impairment before PT AV .Restenosis rate is high in this 
group and a new therapeutic act is frequently necessary. 
FOLLOW-UP OF PATIENTS UNDERGOING PERCUTANEOUS AORTIC 
BALLOON VALVULOPLASTY BY DOPPLER ECHOCARDIOGRAPHY 
Rick A. Nishimura, M.D., F.A.C.C., David R. Holmes, Jr., 
M.D., F.A.C.C., Guy S. Reeder, M.D., F.A.C.C., 
Patricia J. Wagner, R.N., Thomas A. Orszulak, M.D., and 
A. Jamil Tajik, M.D., F.A.C.C.; Mayo Clinic, Rochester, 
Minnesota 
In order to evaluate the short-term efficacy of percuta-
neous aortic balloon valvuloplasty (PABV), follow-up was 
obtained in 27 of the first 35 (77%) consecutive pts 
undergoing PABV from April 1986 to April 1987. At pre-
sentation, the mean age was 81 yrs with a male-to-fe~ale 
ratio of 1.0:1.5, 75% were> NYHA Class III heart fa11ure 
and 25% had> NYHA Class III angina. During follow-up, 
there were 3-deaths and 3 pts underwent aortic valve op-
eration. The remaining 21 pts all underwent detailed 
clinical and Doppler evaluations at baseline, immediately 
after valvuloplasty, and at a mean follow-up periGd of 
5.1 mos. At follow-up, 15% had ~ NYHA Class III heart 
failure and 5% had> NYHA Class III angina. Mean gradi-
ents and aortic valve area (AVA), determined by Doppler 
echocardiography and the continuity equation, were: 
Before After Follow-Up 
AVA (cm2) .49 ± .12 .86 ± .23* .69 ± .17*t 
Mean Gradient (mmHg) 55 ± 12 36 ± 14* 47 ± 17*t 
* = p < .05 versus before, t = p < .05 versus after 
When restenosis was defined as >50% loss of the initial 
improvement in AVA, there were 8 of 21 (38%) who had re-
stenosis. 
Conclusion: Percutaneous aortic balloon valvuloplasty is 
initially effective in the treatment of severe aortic 
stenosis. However, despite symptomatic improvement, there 
is a high incidence of restenosis in short-term follow-up. 
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TIME RELATED CHANGES IN LEFT VENTRICULAR CONTRACTILITY 
AFTER BALLOON AORTIC VALVULOPLASTY 
Kenneth M. Borow, MD, FACC, Ted Feldman, MD, FACC, Alex 
Neumann, BS, Roberto M. Lang, MD, FACC, Y. Christopher Chlu, 
MD, John D. Carroll, MD, Unlv. of Chicago, Chicago IL 
The effects of balloon Ao valvuloplasty (BAV) on LV contractile 
state are difficult to assess due to reduced afterload which can 
improve LV function without changes in contractility. To 
determine the time related effects of BAV on LV mechanics, we 
studied 7 pts (mean age 82±6 yrs) with severe AS. LV dimensions, 
rate corrected velocity of shortening (Vcfc)' and end-systolic wall 
stress (ae ) were determined 1 day pre and post BAV (echo and 
calibrateif carotid pulse tracings) as well as im mediately pre and 
post BAV (echo and LVfAo pressures). BAV increased AV area 
(O.6±.3 to 1.0±.3 cm 2;p<.Ol) and decreased LV peak systolic 
pressure (23l±27 to 19S~34 mm Hg; p<.Ol), peak systolic stress 
(144±69 to 106±44 gfcm ;p<.05) and LVEDP (2S±5 to l8±10 mm 
Hg; p<.05). The relation between LV performance (Vcf c) and 
after load (aes) was determined from the 2 pre studies. Changes in 
contractility post BAV were measured as oVcfc from this line. 
IMMED IMMED 1 DAY 1 ' DAy 'OST 
PRE POST POST 1.0 \ 
Vcf c .8S±.23 .92±.21 * 1.04±.19*~.u . \0 "OIlED 'OST 
aes 51±37 42±30* 34±16*;:, DAY 
Wef c .Ol±.02 .10±.02~ 0.. 'R. IMMED 
(*p<.OS vs pre; ~p<.05 vs im med post) '(,t,,, '~E 
Post BAV, afterload fell and LV function '3D 50 70 
improved. Contractility was unchanged END-SYSTOLIC "R"S 
immediately post but improved significantly by 1 day post BAV. 
Conclusion: Time related changes in LV performance post BAV 
are due to changes In contractility rather than afterload 
reduction alone. Relief of AS improves muscle function at 24 hrs, 
but this may be masked Immediately post BAV by procedure 
related myocardial depression. Thus, immediate hemodynamic 
data may not predict subsequent changes in LV performance. 
BALLOON VALVULOPLASTY IN RE·STENOSIS AFTER SURGICAL MITRAL 
COMMISSUROTOMY. 
Alec VAHANIAN M.D., Pierre Louis MICHEL M.D., Michel SLAMA 
Mr.1[, Slawa TRABELSI M.D., Pierre DERMINE M.D., Bertrand 
CORMIER M.D., Mohamed BEN ISMAIL M.D., Jean ACAR M.D., 
HOpital TENON, PARIS, FRANCE. 
To assess the role of percutaneous balloon valvuloplasty 
(BV) in patients (pts) with prior surgical commissurotomy 
(MC), BV was performed in 15 pts with re-stenosis 19 ! 7 
years (8-29) after MC. The previous surgical procedure was 
closed MC in 12, closed MC ando sub5equently open MC in 1, 
open MC associated with aortic replacement in 2. There 
were 11 women and 4 men, mean age was 50 ! 11 years (33-77) 
All pts were in NYHA class III. Seven were in atrial 
fibrillation. Five pts had valvular calcification and a 
mitral regurgitation (grade 1+) was present in 5. Five pts 
were poor surgical candidates because of age> 70 yrs (3), 
chronic respiratory failure (1) or cancer (1). 
BV was performed using a single balloon technique in 1 and 
two balloons in 14. 
BV Significantly improved valve function : 
Cardiac index (1/mn/m2) 
Mean gradient (mmHg) 
Valve area (cm2) 
Before BV 
2.5 ! .6 
13 ! 5 
1.1 :t .2 
After BV 
2.7 ± .2 
6 ! 2 
1.9 + .4 
P 
N.S 
<.001 
<.001 
In one pt, mitral regurgitation increased from grade 1+ to 
3+ reqUiring subsequent surgery. No other complication 
occurred. In one case valve replacement was carried out 
one month after BV because of insufficient hemodynamic 
improvement. 
CONCLUSION: These preliminary results suggest that BV can 
be performed effectively and safely in selected pts with 
re-stenosis after MC and could postpone reoperation in 
many cases. 
ABSTRACTS 
LEFT VENTRICULAR PRESSURE-VOLUME RELATIONSHIPS BEFORE, 
DURING AND AFTER AORTIC VALVULOPLASTY. 
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P K BJanksma MD R.B.v.Dijk, MD, P.den Heijer, MD, 
J.Meeder, K.I.Lie MD, Dept.of Cardiology, University Hosp. 
Groningen, The Netherlands. 
In order to evaluate the influence of aortic valvuloplasty 
(AVPTA) on left ventricular (LV) function, we performed LV 
pressure and volume measurements before and after AVPTA in 
10 patients. LV pressure was measured with a catheter-tip 
manometer. Cyclic LV volume changes were measured with the 
calibrated signal of a nuclear probe. These signals were 
fed into a computer system, displayed on the monitor 
screen until a satisfactory tracing was obtained, and sub-
sequently stored on disk for later evaluation and constru~ 
tion of pressure-volume loops. Measurements were per-
formed immediately before, after and in some patients also 
during AVPTA. To do the latter, the balloon was inflated 
without guide wire in it and fluoroscopy was interrupted 
for the time of the measurement(lO sec)in order to avoid 
interference of radiation with the probe measurement. 
The following results were obtained: AVA: before AVPTA: 
0.4l±0.19 cm2, after 0.62±0.34 cm2 , LV-Ao gradient: before 
AVPTA: 87±39 mmHg, after: 34±24 mmHg, LV enddiastolic vo-
lume: before AVPTA: l87±5l ml, after 195±72 ml, EF: before 
AVPTA 28±lO7., after 30±l57.,Systolic work: before AVPTA: 
2046±l565 mJ, after: lOl6±390 mJ, Diastolic work:83±29 mJ, 
after 60±35 mJ. During AVPTA we saw in some cases a 
serious drop of left ventricular pressure, instead of the 
expected rise,in one case followed by ventricular fibril-
Lation afterwards. It may be concluded that although LV-
function does not improve significantly immediately after 
~VPTA,systolic and diastolic work decrease along with 
'aortic valve area.The safety of the procedure can be im-
proved, when not only arterial pressure, but also LV 
pressure is monitored during the procedure. 
Thursday, March 31,1988 
8:30AM-I0:00AM, Room 260, Level Two 
Angioplasty: Restenosis 
HOW CUMULATIVE IS THE RISK OF RESTENOSIS WITH MULTI LESION 
DILATATION? 
David R. Holmes, Jr., M.D., F.A.C.C., Ronald Vlietstra, 
M.D., F.A.C.C., Guy Reeder, M.D., F.A.C.C., John 
Bresnahan, M.D., F.A.C.C., Dennis Bresnahan, M.D., 
F.A.C.C., LaVon Hammes, Kent Bailey, Ph.D., Mayo Clinic, 
Rochester, Minnesota. 
In single vessel (SV) disease, restenosis (R) rates after 
coronary angioplasty (PTCA) range from 20-35%. There is 
less information on R rates when multiple lesions are 
dilated. Depending on if R results from local factors, 
constitutional effects, or both, R rates may be similar or 
markedly increased. To assess this, we evaluated 
angiographic findings in 451 pts undergoing follow-up 
angio after successful PTCA of subtotal stenoses not asso-
ciated with acute infarction. R was defined as >30% 
increase in visual luminal diameter stenosis compared to 
immediate post PTCA stenosis. Pts were divided into 4 
groups: Group A SV dilatation (SV dill, single segment 
dilated; Group B SV dil, multiple segments dilated; Group 
C Multivessel dilatation (MY dill with a single segment 
dilated in all dilated vessels; Group D MV dil with 
multiple segments dilated in at least 1 dilated vessel. 
Group A Group B Group C Group D 
Total No. of pts 331 54 SO 16 
Total No. of 
segments dilated 
No. of segments 
with restenosis 
Relative risk of 
331 
152(46%) 
114 
40(35%) 
104 58 
36(35%) 21(36%) 
restenosis per pt 1.13 1.26 1.77 
Conclusion: I}In pts with multiple arterial segments 
dilated (Group B-D) the percentage of segments showing R 
was similar irrespective of number of vessels dilated. 
2)The relative risk of R per patient increases modestly 
with number of segments dilated. 
236A ABSTRACTS 
IS THERE REALLY A DIFFERENCE IN THE INCIDENCE OF 
RESTENOSIS AFTER PTCA IN PATIENTS WITH STABLE AND 
UNSTABLE ANGINA? 
Hans E. Luijten, MD, Kevin J. Beatt, MaCP, Pim J. de 
Feyter, MD, Johan C. Reiber, PhD, P.W. Serruys, MD, FACC. 
Thoraxcenter, Rotterdam, The Netherlands. 
While some studies have indicated that angioplasty for 
unstable angina carries an increased risk of restenosis, 
this observation has not been corroborated by others. To 
address this issue, a change in stenosis severity after 
PTCA was assessed quantitatively by automated edge-
detection rather than visual analysis. To prospectively 
compare incidence and time to restenosis (Re) in cohorts 
with stable (SA) versus unstable angina (UA), 4 successive 
groups of patients were recatheterized at one of four 
preset times to follow-up (FU): 30, 60, 90 or 120 days. UA 
was defined as prolonged chest pain at rest with reversi-
ble ST-T changes. Of a consecutive series of patients with 
a successful PTCA « 50% diameter stenosis post-PTCA), 
206/241 with SA (FU%=86) and 133/154 with UA (FU%=86) 
underwent repeat angiography. Percent restenosis per pt 
was defined as: 1.;: 50% loss of gain; II. ;: 50% DS at FU; 
III. ;:0.72 mm decrease in minimal lumen diameter. Results: 
Re Criteria Type AP 30d 60d 90d 120d OVERALL 
1. SA 6% * 30% 34% 35% 27% 
UA 15% 8% 41% 35% 25% 
II. SA 2% * 15% 26% 16% 15% 
UA 7% 0% 24% 16% 12% 
III. SA 0% 17% 21% 31% 18% 
UA 2% 8% 35% 30% 18% 
*p < 0.05 (SA versus UA; chi-square) 
Conclusions: 1) The incidence of restenosis varies with 
time and is dependent upon the criterion applied; 
2) Except for a difference at 60 d for criteria 1 and 2, 
the incidence of restenosis in stable and unstable angina 
patients is compara.ble regardless of the criterion used. 
LONG-TERM DECREASE IN THE SEVERITY OF RESIDUAL STENOSES 
AFTER CORONARY ANGIOPLASTY. 
Angel Ceguier. H.D., Raoul Bonan, H.D., F.A.C.C., 
Pstrick Joly, H.D., Jacques Crepeau, H.D., Pierre de 
Guise, H.D., Gilles Cote, H.D., Jacques Lesperance, 
H.D., and David D. Waters, H.D., F.A.C.C., Hontreal 
Heart Institute, Hontreal, Canada. 
To examine the long-term evolution of the residual le-
sion, 69 consecutive patients (pts) with 75 coronary 
stenoses successfully dilated (81±12 to 37±13"), and 
without restenosis at 5.8±2 months underwent another 
restudy at 32±17 months post-PTCA. A progressive de-
crease in the residual stenosis diameter was observed, 
to 33±16" at the 6 month (pc 01 vs inunediately post-
PTCA) and to 23±16" at the late restudy (p<. 001 vs 
early restudy). Excluding 1 pt with late restenosis, a 
decrease ~25" in stenosis severity was seen in 19 of 
the 68 pts. Residual stenosis inunediately post-PTCA 
(38±11" vs 36±13", p~NS) and time to angiographic 
follow-up (34±16 vs 30±l8 months, p~NS) were similar 
between pts with and without stenosis reduction. Resi-
dual stenosis at the last restudy was 9±11" in the ste-
nosis reduction group vs 28±l4" in the others (p<. 001) . 
Hultivariate stepwise logistic regression analysis of 
13 clinical, 6 angiographic and 8 procedural variables 
revealed that 2 factors were related to stenosis re-
duction: a longer duration of angina pre-PTCA (p=.015) 
and absence of smoking (p=.013). 
In conclusion, post-PTCA pts without restenosis, parti-
cularly non-smokers with a long history of angina, have 
a progressive long-term decrease in the severity of 
their residual stenosis. 
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A RANDOMIZED TRIAL OF ASPIRIN IN PTCA: EFFECT OF HIGH vs 
LOW DOSE ASPIRIN ON MAJOR COMPLICATIONS AND 
RESTENOSIS. 
Larry Mufson MD, Alexander Black MD, Gary Roubin MD FACC, Jim 
Wilentz MD, Sue Mead RN, Kim McFarland RN, William Weintraub MD 
FACC, John S Douglas Jr MD FACC, Spencer B King III MD FACe. 
Andreas Gruentzig Center, Dept of Medicine, Emory U School of Medicine, 
Atlanta,GA. 
It has been suggested that high dose (HD) aspirin (ASA) given before and after 
coronary angioplasty (PTCA) may reduce the risk of restenosis (RS). To 
examine the effects of HD vs low dose (LD) ASA on restenosis and acute 
complications after PTCA, 495 patients (Pts) presenting for elective PTCA of 
native, subtotally occluded vessels were randomized to LD (ASA 80 mg/day, 
n~253) or HD (ASA 1500 mg/day, n=242), starting on the day prior to PTCA. 
Mean age was 58 ± 11 years (± lSD) and 76% were male. Unstable angina was 
present in 78% of both groups. Vessels dilated were similar between the 
groups: left anterior descending (48% LD, 49% HD); left circumflex (32% 
LD, 29% HD); right coronary artery (33% LD, 30% HD); all p~NS. 
Multivessel disease (MVD) was present in 43% of LD Pts and 37% of HD Pts 
(p=NS). The angiographic characteristics of the lesions dilated were similar: 
calcified in 5.5% LD, 6.6% HD (p=O.08); eccentric in 63% LD, 62% HD 
(p=NS); tortuous in 14% LD, 17% HD (p=NS). Following dilatation there 
was intimal tear in 30% LD Pis and 34% HD (p~NS), and dissection in 7.5% 
LD Pts and 7.9% HD (p=NS). 
There was no significant difference in major complications (myocardial 
infarction: 3.6% v 3.9%.; Emergency coronary bypass: 3.6% v 3.7%). 
Angiographic success «50% diameter stenosis post-PTCA) was 94% in the 
LD group and 95% in the HD group. There were no deaths. 
Angiographic follow-up was available in 166 of 453 Pts followed for at least 1 
month at a mean of 142 ± 62 days after PTCA. LD and HD Pts presenting for 
restudy were similar with respect to age, sex, vessel dilated, intimal tear, 
multivessel disease,post-PTCA diameter stenosis (29±18% LD vs 32± 19% HD 
p~NS), and post-PTCA gradient (14±l1mmHg LD vs 14±7mmHg HD, 
p ~ NS). Angiographic restenosis per patient (diameter stenosis 2':50% 2':1 site) 
47% LD and 51% HD, p~NS. Conclusion: Restenosis after PTCA is not 
influenced favorably by the use of high dose aspirin. Primary success and acute 
complications were not alTected by aspirin dose in this study. 
FAILURE OF ANTIPLATELET AGENTS TO RiDUCE RESTENOSIS 
A1TER PTCA IN A DOUBLE BLIND PLACEBO CONTROLLED TRIAL. 
Leonard Schwartz. H.D .• F.A.C.C. , Hartial G. Bourassa, 
H.D., F.A.C.C., Jacques Lesperance, H.D., Harold 
Aldridge, H.D., F.A.C.C., Paul R. David, H.D., F.A.C.C., 
Hark Henderson, H.D., Gilles Hudon, H.D., Farouk Kazim, 
Ph.D., Toronto General Hospital, Toronto, Hontreal Heart 
Institute, Hontreal, Canada. 
The effectiveness of antiplatelet agents in reducing the 
rate of restenosis (RS) in the first 6 mos after PTCA 
was evaluated in 376 pts in a multicentre prospective 
double blind parallel group trial. Pts randomized to 
active treatment received oral Dipyridamole (Dip)/Aspi-
rin (ASA) combination (75mgs/33Omgs) 3 times daily be-
ginning 24 hrs before PTCA and at 8 hrs prePTCA oral Dip 
was replaced with I. V. Dip at IOmgs/hr for 24 hrs While 
oral ASA was continued. At 16 hrs postPTCA oral combina-
tion capsule was reinstituted every 8 hrs. Pts random-
ized to the control group received matching oral and 
I. V. placebo formulations. Oral treatment was continued 
in successful pts until follow-up angio at 4 to 7 mos 
postPTCA or earlier if symptoms dictated. Coronary 
angios were evaluated with the use of a computer aided 
quantitative method. RS was defined as a late lumen 
diameter stenosis of >50". Placebo DIP/ASA 
Successful dilated segments/patient 144/127 140/122 
Number of segments restenosed 53(36.8") 52(37.1") 
Hinimal } Pre O. 94±. 033 1. OO±O. 36 
obstruction Post 2.13±0.36 2.15±0.47 
diameter* Final 1.68±0.64 1.74±0.61 
(mm) Post-final 0.45±0.67 0.42±0.63 
* 132 segments in each group; post-final: p = 0.74 using 
pre as covariate. Conclusion: A comprehensive periproce-
dural and postPTCA antiplatelet regimen offers no benefit 
in reducing the 6 month restenosis rate following PTCA. 
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DIETARY SUPPLEMENTATION WITH N-3 FATTY ACIDS REDUCES THE 
RATE OF RESTENOSIS AFTER CORONARY ANGIOPLASTY 
Gregory J. Dehmer, M.D., F.A.C.C, Egerton K. van den Berg, 
M.D., Jeffrey J. Popma, M.D., Jacquin P. Prewitt, B.S., 
James T. Willerson, M.D., F.A.C.C. and James M. Schmitz, 
M.D. Dallas VA Medical Center and the University of 
Texas Health Science Center, Texas. 
Despite the use of antiplatelet agents, restenosis after 
coronary angioplasty(PTCA) limits the overall effective-
ness of the procedure. Because of evidence indicating a 
high dietary intake of N-3 fatty acids imparts a protect-
ive effect against the development of atherosclerosis, we 
postulated that they could affect restenosis after PTCA. 
To test this hypothesis and assess the safety of this 
therapy, we performed a randomized study comparing a 
standard antiplatelet regimen (aspirin 325mg/day and per-
santine 225mg/day; Control Group) to a similar regimen 
supplemented with 3.2 grams of eicosapentaenoic acid 
(Treated Group) started 1 week prior to PTCA. In 58 male 
pts, 77 lesions were dilated. There was no difference in 
mean age, the incidence of unstable angina, prior myocar-
dial infarction, smoking, diabetes or distribution of 
vessels dilated between the 2 groups. Also, the groups 
were similar with respect to the severity of coronary 
stenoses before and after PTCA and the prevalence of in-
itial stenoses >90%, residual stenoses <35% and small in-
timal dissections after PTCA. The incidence of vessel 
restenosis, determined by a second angiogram in all pts 
was 37.2% in the Control and 14.7% in the Treated Group. 
(p<.03) Multiple logistic regression analysis and a Man-
tel-Haenszel test, both considering other factors known 
to affect restenosis rate, demonstrated a significant in-
dependent effect of the N-3 treatment. No important 
bleeding complications occurred in the Treated Group. 
Thus, N-3 treatment reduces restenosis after PTCA. 
Thursday, March 31, 1988 
10:30AM-12:00NOON, Room 260, Level Two 
Angioplasty: Acute Effects II 
MAJOR COMPLICATIONS DURING PTCA: AN ANALYSIS OF 5413 CASES 
David D. Park, MS, Louise A. Laramee, MD, Paul Teirstein, 
MD, Robert W. Ligon, MA, Lee V. Giorgi, MD, FACC, Geoffrey 
O. Hartzler, MD, FACC, Ben D. McCallister, MD, FACC. 
Mid-America Heart Institute, Kansas City, Missouri 
Of 5413 consecutive elective PTCA procedures, major 
complications occurred in 124 pts (2.3%). (Subtotal or 
total occlusion occurred as a complication in 94% and CPR 
and/or intraaortic balloon pump was required in 35% of pts 
during the procedure.) Ninety-seven pts (1.8%) underwent 
emergency surgery(ES); the remaining 27 pts (0.5%) expired 
prior to ES. Eighty-two pts (85%) survived ES; 44% 
developed Q-wave MI. The overall mortality for elective 
PTCA was 0.8%. Factors associated with higher mortality 
following a catastrophic lab event were ejection fraction 
(EF)<30%, age}70, multivessel disease (MVD), and unstable 
angina (p=<O.OOI for all variables). Left main or equiv-
alent disease, prior CABG or sex did not affect the mor-
tality; prior PTCA was associated with a lower mortality. 
The study population was compared in three time periods: 
MAJOR LAB ES TOTAL 
PERIOD PTS COMPLICATION DEATH ES DEATH DEATH 
1)1980-84 1844 3.3% 0.8% 2.5% 13% 1.1% 
2)1984-85 1795 2.1% 0.4% 1.7% 20% 0.8% 
3)1985-86 1774 1.4% 0.2% 1.2% 14% 0.4% 
Periods 1) vs 3): p~.OOI p-0.02 p=0.003 p=NS p=O.OI 
These favorable trends have occurred despite a greater 
proportion of pts in the higher-risk groups: poor ejection 
fraction (p-<D.Ol), age)70 (po(O.OI), and MVD (p=0.05). 
CONCLUSIONS: 1) Low EF, age)70, MVD, and unstable angina 
are associated with a higher mortality following a major 
complication at PTCA. 2) The mortality rate forpts under-
going ES has not changed over time. 3) However, mortality 
and need for ES have decreased during our PTCA experience 
in spite of an increased number of higher-risk pts. 
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DOES THE ADDITION OF DIPYRIDAMOLE TO ASPIRIN DECREASE 
ACUTE CORONARY ANGIOPLASTY COMPLICATIONS? THE 
RESULTS OF A PROSPECTIVE RANDOMIZED CLINICAL TRIAL 
Nicholas J. Lembo, M.D., FA.C.e., Alexander J. Black, M.D., Gary S. 
Roubin, M.D., FA.e.C., Larry H. Mufson, M.D., James R. Wilentz, M.D., 
FAe.e., John S. Douglas, Jr., M.D., FA.e.C., Spencer B. King III, M.D., 
FAe.e. Andreas Gruentzig Center, Dept. of Medicine and Radiology, Emory 
U. School of Medicine, Atlanta, GA. 
Dipyridamole has been suggested as an adjunctive anti-platelet agent to 
aspirin which may decrease the incidence of acute complications in patients 
undergoing coronary angioplasty (PTCA). To test this hypothesis, we evaluated 
the results of a prospective trial in which 268 patients were randomly assigned 
to receive either aspirin 325mg po TID (ASA group; n = 139) or aspirin 325mg 
po TID plus dipyridamole 75mg po TID (ASA + DIP group; n = 129) prior to 
PTCA. Medications for both groups were continued post discharge. Patients 
were excluded if they had contraindications to high dose anti-platelet agents. 
Clinical Data: Patient age, sex, and presence of unstable angina were similar 
between both groups. 
Angiographic Data: Extent and distribution of coronary artery disease, vessel 
tortuosity, lesion shape and length, calcification, and branch point stenosis were 
similar in both groups. 
PTCA Data: Pre and post-PTCA diameter stenosis, pre and post-PTCA 
gradients, intimal tears, dissections, and acute closures were similar in both 
groups-
Complications: 
I Event 
I Q Wave Myocardial Infarction 
I Emergency Surgery 
I Death 
ASA 
4/139(2.9%) 
5/139(3.6%) 
0/139(0%) 
ASA + DIP 
5/129(3.9%) 
7/129(5.4%) 
1/129(0.8%) 
p I 
I 0.74 I 
0.56 I 
0.48 I 
Conclusion: The addition of dipyridamole to aspirin as pre-treatment of 
patients undergoing PTCA showed no reduction in acute complications 
compared to aspirin alone. 
AIEQllATE HEPAR.ImZATION OOR1J.'lG PTCA: ASSESSMiNr l.5ING 
AcrIVATED CLDITING TIM::. J. D:lvid Ogilby, ID, FACe, 
Harry A. Kq;lelman, MD, FilI:X-; ~w.~, MD, FA'Zr, 
Jai B. Agarwal, MD, FACe. Philadelphia Heart Insti-
tute, Presb'{terian-{Jniversity of Pennsylvania Medical 
Center, Philadelphia, PA. 
To prevent thrODbus (T) <bring percutaneous translumi-
nal coronary angioplasty (PTCA), intravenous heparin 
(H) is usually given as a 10,000 unit (10K) bolus. 
However, this dose may not result in adequate systemic 
anticoagulatien (SI'.C) in every patient [pt) , exposiBJ 
some pts to risk of T and its potential ocnsequences. 
Thus, we tested SAC <briBJ PTCA by measuriBJ activated 
clotting times (ACl') in 108 ocnsecutive pts. All pts 
had normal baseline PT and PTl'. Pts en H before PTCA 
were excluded. 39 patients (pts) had stable angina 
(AP) and 69 pts unstable angina (UA). Baseline ACl' was 
163+36 sec and 162+49 sec in the AP and UA groups 
resPectively. Average ACl' in AP and UA 5 min after 
10K tl was 433+108 sec and 396+109 sec respectively 
(p=ns). A level below 300 sec- allows formatien of 
small T during extracorporeal bypass. 12 pts, 2 SI'. 
(5.1%) and 10 UA (14.5%), had levels below 300 sec 
after 10K H with average ACl' of 272+4 sec for AP and 
253+25 sec for UA (p=ns). These pts required 3K-IOK 
additicnal tl to have SAC duriDiJ PTCA. Aalte reclosure 
wi thin 24 hours was observed 1n 1 pt and T was ooted 
at PTCA site. Successful repeat PTCA was performed. 
1 pt was ooted to have T en post-PTCA with 00 apparent 
clinical ocnsequences. Calclusien: H needs of pts un-
dergoing PTCA 1S variaJ:lle. ACl' l101itoring is essen-
tial to ensure adequate SAC. In our study group, 12% 
of pts needed initial additicnal H DOre than 10K 
bolus. 
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THERAPY OF lARGE INTRACORONARY THROMBI IN 
CANDIDATES FOR PERCUTANEOUS TRANSLUMINAL CORONARY 
ANGIOPlASTY 
John S. Douglas, Jr., M.D., FA.C.C., Jerre F. Lutz, M.D., FA.C.C., Stephen 
D. Clements, M.D., F AC.C., Paul H. Robinson, M.D., Gary S. Roubin, M.D., 
FAC.C., Nicholas J. Lembo, M.D., FAC.C., Spencer B. King III, M.D., 
F A.C.C. Andreas Gruentzig Center, Dept. of Medicine and Radiology, Emory 
U. School of Medicine, Atlanta, GA. 
Patients with unstable angina pectoris, critical coronary artery stenosis, and 
extensive intraluminal coronary artery thrombus formation have increased 
complications and suboptimal results with immediate coronary angioplasty 
(PTCA) with or without thrombolytic agents. We tested the efficacy of 
prolonged intravenous heparin therapy in achieving thrombus regression and 
subsequent complication-free PTCA. Of 1928 consecutive patients undergoing 
PTCA, 19 (1%) had large intracoronary thrombi in the absence of evolving 
myocardial infarction (AMI). All 19 patients had the recent onset or 
progression of angina, 9 patients had a recent small AMI, 7 had prolonged pain 
without AMI. None had received prior thrombolytic therapy. A continuous 
heparin infusion was maintained for 7.0±1.9(SD) days (range 5-13 days) in all 
patients. Two patients received warfarin for 1 month. At repeat angiography at 
12.0± 10 days (range 5-32 days), thrombus resolution appeared complete, or 
nearly so, in 13 patients, substantial in 4 others, minimal in 1 patient, and 1 
patient had an asymptomatic progression to total occlusion. No ischemic or 
bleeding complications occurred during heparin therapy. PTCA attempted in 
15 patients was successful in all without cardiac complications. Two patients 
were found to have mild residual stenoses and a revascularization procedure 
was not required. One patient underwent elective CABG. Thus, prolonged 
heparin therapy resulted in substantial clot lysis and/or retraction in a majority 
of patients. This therapeutic approach permitted complication-free PTCA 
avoiding unneccesary revascularization procedures and complications of 
thrombolytic therapy. 
DOES PRETREA'IMENT WITH HEPARIN PREVENT ABRUPT CLOSURE 
FOLWWING PI'CA? 
Thomas K. Pow
6 
M.D., Thomas R. Varricchione, M.B.A., 
AlIce K. Jaco s, M.D., Nicholas A. Ruocco, M.D., Thomas 
J. Ryan, M.D., F.A.C.C., Elaine M. Christelis, M.S., 
and David P. Faxon, M.D., F.A.C.C., Boston University 
Medical Center, Boston, MA. 
Abrupt Closure (AC) is recognized as a serious 
complication following PI'CA. Since the mechanism of AC 
is felt to be due to intracoronary thrombus, we retro-
spectively examined the effect of pretreatment with 
continuous IV heparin in 110 consecutive patients (pts) 
with unstable angina undergoing first successful PI'CA. 
In 41 pts, continuous IV heparin was given for an 
average of 3.7 days (group H), while 69 pts did not 
receive heparin (group NoH). There were no significant 
differences in clinical characteristics or risk factors 
between the two groups. The morphology and geometry of 
the lesion, the incidence of intraluminal filli~ defect 
{10.1% (H) vs 14.4% (NoH)} and post procedural intimal 
dissection {18.6% (H) vs 24\ (NoH)} were similar in 
both groups and unrelated to AC. AC occurred in 7 pts 
(3 in lab and 4 out). All 7 were in group NoH (10.1% vs 
0%, p<.05). Major clinical complications (MI, emergent 
CABG and death) were low in group H (4.9%) while nearly 
3 x greater in group NoH (14.5%, p<.13). Six month 
follow-up revealed no difference in the occurrence of 
clinical restenosis {24% (H) vs 23% (NoH)}. 
In conclusion, this retrospective analysiS 
demonstrates that pretreatment with heparin prevents 
abrupt closure and reduces major clinical complications 
in patients with unstable angina following PICA. We 
hypothesize that pretreatment with heparin may reduce 
the risk of abrupt closure by preventing the 
propagation of intraluminal thrombus. 
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THE ROLE O~' ANTIPLATELET AGENTS IN REDUCING PERIPROCE-
DURAL CORONARY ANGIOPLASTY (PTCA) COMPLICATIONS. 
Martial G. Bourassa, M.D .• F.A.C.C., Leonard Schwartz, 
M.D., F.A.C.C., Paul R. David, M.D., F.A.C.C., Harold 
Aldridge, M.D., F.A.C.C., Jacques Lesperance, M.D., 
Raoul Bonan, M.D., F.A.C.C., Mark Henderson, M.D., 
Vince Salvatori, Ph.D., Montreal Heart Institute, 
Montreal, Toronto General Hospital, Toronto, Canada. 
To evaluate the role of antiplatelet agents in PTCA a 
multicentre prospective double-blind parallel group 
trial was undertaken on 376 pts recruited between 1984 
and 1986. Pts randomized to active treatment received 
oral Dipyridamole(Dip)/Aspirin(ASA) combination (75mgsl 
33Omgs) 3 times daily beginning 24 hrs before PTCA and 
at 8 hrs pre-PTCA the ora 1 Dip was replaced with I. V. 
Dip at lOmgs/hr for 24 hrs while the oral ASA was con-
tinued. At 16 hrs post-PTCA the oral combination capsule 
was reinstituted every 8 hrs. Pts randomized to the con-
trol group received matching oral and I.V. placebo for-
mulations. Death, non-fatal Q wave infarct or emergency 
bypass surgery (CABG) and rePTCA were major periproce-
dut'al events if they occurred within 48 hrs of PTCA. 
There were no death. Placebo DIP/ASA 
(N~189) (N~187) 
Q infarct 8 1 
CABG or t with Q infarct 5 2 
rePTCA \ without Q infarct 4 
There were 16 Q wave infarcts, 13 in the placebo arm 
(6.9~) and 3 in the treatment arm (1.6~). This differ-
ence was statistically significant (p~.Ol13). Emergency 
revascularization was almost identical in the two arms 
of the trial. Thus oral Dip/ASA therapy started 24 hrs 
before PTCA combined with I.V. Dip during the procedure 
markedly reduced the incidence of Q wave infarcts during 
or early after PTCA. 
Thursday, March 31,1988 
8:30AM-10:00AM, Room 360, Level Three 
Atrial Natriuretic Peptide 
RESPONSE OF ATRIAL NATRIURETIC POLYPEPTIDE TO ISOPRO-
TERENOL AND ACETYLCHOLINE INFUSION IN HUMANS 
* * * ~enjj Obata, M D , Ryuj~ Sonoda, M.D., Ken Q~umura, M.D., 
Hirofumi Yasue, M.D., Kazuwa Nakao, M.D., Hiroo Imura 
*M.D. 
Division of 
Kumamoto and 
Univ Medical 
~~rdiology, Kumamoto Univ Medical School, 
Department of Internal Medicine, Kyoto 
School, Kyoto. Japan 
The role of autonomic nervous system in the regulation of 
secretion of atrial natriuretic polypeptide(ANP) still 
remains unclear. To clarify this, the effects of intra-
venous infusion of isoproterenol(ISP)(0.02 ~g/Kg/min for 
10 min) and injection of acetylcholine(ACh)(50 ~g) into 
the left coronary artery on plasma ANP were examined in 
adult patients without congestive heart failure. In 17 
patients(12 men and 5 women, mean age: 44), plasma ANP in 
the peripheral vein significantly increased from 84 ~ 41 
pg/ml to 108 ± 62 pg/ml(p<0.05) during ISP infusion with 
a significant increase of the heart rate(p<O.OI). In 18 
patients(12 men and 6 women, mean age: 55), plasma ANP in 
the coronary sinus Significantly decreased from 1063 ± 
427 pg/ml to 745 ± 332 pg/ml(p<O.OI) after intracoronary 
ACh with a significant increase of coronary sinus blood 
flow(CSBF) from 107 ± 38 ml/min to 155 ± 56 ml/min(p<O.Ol 
). Thus, secretion rate(plasma ANP level x CSBF) of ANP 
in the coronary sinus didn't change significantly after 
ACh(from 100 ± 46 ng/min to 106 ± 59 ng/min). 
Conclusions: ISP increases plasma ANP, suggesting that 
increase in the sympathetic nerve tone facilitates 
secretion of ANP although the role of increased heart 
rate should be also considered. Stimulation of muscarinic 
receptor does not influence secretion of ANP in the 
coronary sinus. 
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LOW DOSE ATRIAL NATRIURETIC FACTOR IS A SELECTIVE RENAL 
VASODILATOR IN HUMANS WITH CONGESTIVE HEART FAILURE. 
John C. Burnett, Jr., M.D., Brooks S. Edwards, M.D., 
Thomas R. Schwab, M.D., Robert S. Zimmerman, M.D., 
Ronald D. Smith, M.D., Bernard J. Gersh, M.D., F.A.C.C., 
Denise M. Heublein, Peggy A. Puetz, RN, Mayo Medical 
School, Rochester, MN. 
Previous infusion studies of atrial natriuretic factor 
(ANF) in humans with congestive heart failure (CHF) have 
reported a failure of ANF to improve impaired renal hemo-
dynamic and excretory function. However, such studies 
have employed vasoactive doses of ANF which decrease 
cardiac filling pressures and arterial pressure. Such a 
vasoactive action may activate renal sympathetic nerve 
activity to offset the renal action of ANF. 
We studied the renal, cardiovascular, and endocrine 
effects of ANF in 6 subjects with CHF (NYHA Class III) 
at a dose (7 ng/kg/min) infused for two hours. This dose 
did not alter arterial pressure, cardiac output, cardiac 
filling pressures or systemic vascular resistance. 
Low dose ANF did not alter absolute or fractional 
excretion of sodium. ANF, however, increased glomerular 
filtration rate (+50 ± 16%, p<.05) and renal plasma flow 
(+58 ± 17%, p<.05) and decreased renal vascular 
resistance (-27 ± 9%, P<.05) and plasma renin activity 
(-45 ± 14%, p<.05). 
The present acute study demonstrates that low 
dose administration of atrial natriuretic factor at a 
concentration which does not alter cardiac filling 
pressure or cardiac output has a favorable renal action. 
Specifically, in congestive heart failure in humans, ANF 
may serve as a potent and selective renal vasodilator and 
inhibitor of renin. 
PHARMACODYNAMICS AND PHARMACOKINETICS OF 
ATRIAL NATRIURETIC PEPTIDE IN SEVERE CONGESTIVE 
HEART FAILURE. 
Cesar R Molina.M D., Michael B. Fowler, M.B.B.S., Shelley 
McCrory, R.N., Craig Peterson, B.S., Brian Myers, M.D. & Ferid 
Murad, M.D., Stanford University Medical Center, Stanford CA. 
The cardiac release and total body and renal clearances, and the 
hemodynamic, renal and endocrine effects of various doses of atrial 
natriuretic peptide (ANP) were investigated in 12 patients with severe 
chronic congestive heart failure. Immunoreactive arterial plasma levels 
of ANP were tenfold higher than normal. There was no correlation 
between aortic ANP and cardiac filling pressures. The heart released 
ANP into the coronary sinus. The kidney was a major clearance site, 
but only accounted for 33% of the total body clearance. The 
administration of 0.3 Jlg/kglmin ANP produced significant changes in 
heart rate (95 ± 4 to 85±4 bpm), and mean arterial (92 ± 8 to 77 ± 9 mm 
Hg), right atrial (13 ± 3 to 8 ± 2 mm Hg), and mean pulmonary artery 
occluded (27 ± 3 to 14 ± 3 mm Hg ) pressures. ANP increased cardiac 
(2.25 ± 0.18 to 2.83 ± 0.3 Vmin/m2) and stroke work (21 ± 1.5 to 29 ± 
3.4 glm2) indeces, while systemic vascular resistance (1424 ± 139 to 
1033 ± 97 dynes- sec-cmoS) decreased. 'The infusion of 0.1 Jlg/kglmin 
ANP increased urinary flow 128% (1.22 ± 0.25 to 2.78 ± 0.8 mVmin), 
fractional excretion of sodium 133% (0.22 to 0.52 ± 0.16%), and 
fractional excretion of potassium 35% (18.6 ± 2.4 to 25.6 ± 4.8%). 
The fIltration fraction increased from 22 ± 2 to 26 ± 4%. This 
represented a disproportionate rise in glomerular filtration rate over renal 
blood flow. Plasma aldosterone and norepinephrine decreased, while 
plasma renin activity remained unchanged. Associated with the above 
hemodynamic, excretory and endocrine changes the urinary excretion of 
cyclic GMP doubled from 1027 ± 315 to 2091 ± 612 pmoles/min. 
Placebo had no effect These results show that despite the high 
circulating levels of ANP, the administration of this hormone in heart 
failure is associated with potentially beneficial hemodynamic, renal, and 
endocrine effects. 
ABSTRACTS 
ATRIAL NATRIURETIC PEPTIDE INCREASES CARDIAC OUTPUT IN 
NORMAL HUMANS. 
239A 
John S. Floras,MD,FACC, Bev Morris, John C. Fulop,MD,FACC 
Dept. of Medicine, University of Toronto, Toronto, Canada. 
Atrial natriuretic peptide (ANP) is thought to lower blood 
pressure (BP) in hwnans via a cardiodepressor rather than a 
vasodilator effect. To test this hypothesis in S normal men 
(mean age 27) we compared the effects on systemic and forearm 
hemodynamics of consecutive I. V. infusion of (1) ni troprusside 
(NP) O.S ug/kg/min (5 min), (2) saline (NS) as vehicle for 
ANP(15 min) and (3) hwnan ANP(l-2S) (SO ug bolus then SO 
ng/kg/min;15 min). Doppler estimated CO and stroke volwne 
(SV) were obtained using the method of Quinones. Systemic 
vascular resistance(SVR) was derived from CO, mean arterial 
pressure (MAP) and central venous pressure(CVP). Forearm 
vascular resistance(FVR) was calculated from forearm flow 
(plethysmography) and MAP. 
Results (mean±s.e.) *p(0.05 vs NS 
MAP (mmHg) 
CVP(mmHg) 
Heart Rate(HR) (bpm) 
CO (L-min- l ) 
SV(ml-min- l ) 
SVR(dynes-sec-cm-5) 
NP reduced baseline 
NP 
73±1* 
0.S±1.1* 
70±2 * 
4.5±0.7* 
NS 
SO±3 
3.6±1.0 
59±2 
3.6±O.4 
ANP 
77±2* 
2.0±1.0* 
63±2 
4.6±0.7* 
63±9 61±6 72±S* 
l532±239* lS76±207 1477±161* 
FVR from 34±3to22±4 Units(p(O.Ol). 
The change with ANP(2S±3 to 23±3 Units) was not significant. 
Conclusions: ANP and NP have similar, not contrasting, 
effects on cardiac output. Compared with NP, the systemic 
vasodilatatory effect of ANP tended to be greater and fore-
arm vasodilatation less. Since the modest hypotensive res-
ponse to ANP was countered by an increase in SV, these data 
do not support the concept that ANP lowers BP by a cardio-
depressor mechanism in normal subjects. 
TRANS PULMONARY DEGRADATION AND LEFT ATRIAL SECRETION OF 
ATRIAL NATRIURETIC FACTOR IN HAN. 
Angel Cequier, M.D., Raoul Bonan, M.D., F.A.C.C., Andre 
Pasternac, M.D., F.A.C.C., Josep Closas, M.D., Marc 
Cantin, M.D., Ph.D., Gaetan Thibault, Ph.D., and Ihor 
Dyrda, M.D., F.A.C.C., Montreal Heart Institute, 
Clinical Research Institute of Montreal, Montreal, 
Canada. 
Pulmonary degradation and left atrial secretion of 
atrial natriuretic factor (ANF) have been inferred from 
indirect measurements. In 23 pts with aortic and/or 
mitt'al valve disease undergoing transseptal catheted-
zation, we simultaneously measured ANF levels and pres-
sures in femoral vein (FV), right atrium (RA), pulmo-
nary artery (PA), pulmonary vein (PV), left atrium (LA) 
and aorta (Ao). Mean ANF concentration increased in RA 
compared to FV (93±l02 vs 55±43 pg/ml; p;O. 01). Eight 
pts showed a ~20'l. decrease in AN~' levels across the 
pulmonary circulation. Comparing them to the other 15 
pts, the following results were observed (mean±SD): 
FV (pg/ml) 
PA (pg/ml) 
PV (pg/ml) 
LA (pg/ml) 
Transpul. Decrease No decrease 
54±72 56±18 
82±84* 
59±61** 
83±88** 
80±26* 
77±23 
77±24 
*p<O.OI; **p<0.05 compared to previous value 
The decreasF! in ANF across the pulmonary circulation 
correlated positively with systolic PA pressure 
(r;0.94; p<O.OOl). ANF levels in the LA increased only 
in the group with a transpulmonary decrease. 
In conclusion, direct measurements suggest that pulmo-
nary degradation and I.A secretion of ANF is present in 
some pts with valvular heart disease. This degradation 
seems to be related to pulmonary pressures. 
240A ABSTRACTS 
Increased Release of Atrial Natriuretic Factor During 
Sustained Ventricular Tachycardia. K.A. Ellenbogen, P.K. 
Hohanty, R.R. Rogers, J.R. Sowers, HcGuire VAHC and Hed. 
ColI. of VA, Richmond, VA 
During sustained ventricular tachycardia (VT) there is 
usually a fall in mean arterial pressure (AP) and 
activation of the sympathetic nervous system. These 
changes tend to induce antidiuresis and vasoconstriction. 
Atrial natriuretic peptide (ANP) is a substance released 
by the atria in response to increased right atrial 
pressure (RAP) which causes vasodilation and diuresis in 
man. Ye hypothesized that induction of sustained VT, and 
elevation of RAP would cause an increase in ANF secretion. 
Ye determined HAP, VT cycle length, atrial rate, central 
ANF, and plasma norepinephrine (NE) before and after 5 
minutes of VT in 10 patients during 15 episodes of 
sustained VT. Results are summarized in table form 
(*p<0.05, baseline vs. VT). 
Baseline VT 
HAP(mmHg) 88 ± 3 70 ± 3* 
RAP(mmHg) 3 ± .4 10 ± .9* 
ANP(fml/ml) 86 ± 14 145 ± 26* 
NE(pg/ml) n=6 126 ± 19 275 ± 35* 
VT cycle length(msec) 335 ± 70 
Atrial cycle length(msec) 562 ± 190 
Our data demonstrates that significant increases in ANP 
levels occur during sustained VT and are associated with 
increased RAP. Ye speculate that elevation of ANP may 
counteract some of the changes induced by activation of 
the sympathetic nervous system (increased catecholamines) 
during VT. 
Thursday, March 31, 1988 
10:30AM-12:00NOON, Room 360, Level Three 
Echo/Doppler: Assessment of Shunt Flow 
CONTRAST COLOUR CODED DOPPLER FLOW IMAGING FOR EVALUATION 
OF RIGHT HEART DISEASE. 
Helene von Bibra, M.D., Franz Hartmann, Maria Petrik, 
Reinhard Schlief*, M.D., Hans Blamer, M.D. 
I. Med. KLinik, Technical University, Munich, F.R.G. 
RA and RV flow patterns are often difficult to visualize by 
colour coded doppler flow imaging (CDF) because of low flow 
velocities and atte~uation in the depth. An increase in 
the echogenicity of blood by intravenous injection of 10 ml 
of a saccharide microbubble solution (Echovist, E) was 
therefore used when assessing diagnostic flow patterns in 
8 normals and 35 patients and compared to the control CDF 
prior to E. 
In 25 patients with tricuspid regurgitation (TR) the blue 
coded area of reflux was 26±22% of RA area at control CDF 
and 65±27% RA (p<O.OOl) with E in a parasternal+view. With 
an apical approach reflux area increased from 9_10% RA to 
53±26% RA (p<O.OOI) with E. Thus the severity of TR, if 
graded from 0 - 3 by the distance of the jet into the RA, 
increased by 0.8±O.5 (p<O.OI) in the parasternal view and 
by 1.5±0.6 (p~O.OOl) in the apical approach when using E. 
The maximal flow velocity (continuous wave doppler) of the 
jet and antegrade or retrograde flow velocities in the 
hepatic vein (pulsed doppler) remained unaltered. In 10 
patients with atrial septal defect the diagnosis was con-
fidently made in 3 at control CDF and in 9 with E due to 
improved visualization of shunt flow patterns. 
In conclusion: The intravenous injection of microbubbles, 
when using colour coded doppler flow imaging for evaluation 
of right heart disease, provides a safer and more rapid 
qualitative diagnosiS of tricuspid regurgitation and atrial 
septal defect particularly due to enhancement of flow 
imaging in the low velocity range. New criteria need to 
be defined for grading the severity of TR in the presence 
of contrast agents. 
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COMPARISON OF COLOR FLOW DOPPLER AND MICROCAVITATIONS 
FOR THE DETECTION OF INTERATRIAL FLOW COMMUNICATIONS 
F. Bennett Pearce, M.D., Joseph Kisslo, M.D., 
F.A.C.C., Duke University Medical Center, Durham, 
N.C. 
On the hypothesis that color flow Doppler would 
obviate the need for saline microcavitation injection 
for the detection of interatrial flow communications, 
color flow doppler and microcavitation injection data 
were retrospectively reviewed in 101 patients with 
clinical suspicion of interatrial flow communica-
tions. There were 42 children (age 2 days to 17 
years) and 59 adults (age 18 to 76 years). Of these, 
both color flow doppler and microcavitation injection 
data were available in 58 patients (3 children and 
55 adults). Of these, 56/58 (97%) had no interatrial 
flow communications by color flow doppler (only 2 
children). Subsequent microcavitation injections 
revealed interatrial flow communications in 20/56 
(36%). In the remaining 2 with interatrial flow 
communications by color flow doppler the 
microcavitation injection communications was also 
positive. During the study period it was not common 
practice in this laboratory to perform microcavita-
tation injection evaluations in children. In adults, 
however, microcavitation injection was always 
performed in patients with suspected interatrial flow 
communications when the color flow doppler was 
negative and accounts for differences in 
microcavitaiton injections between the 2 groups. 
These data indicate that a surpriSingly high number 
of interatrial flow communications may be found in 
patients with negative color flow doppler. 
COLOR DOPPLER ASSESSMENT OF SHUNT FLOW ACROSS LARGE 
ATRIAL SEPTAL DEFECTS. 
Frederick Helmcke M.D., Krishan K. Aggarwal, M.D., 
Navin C. Nanda, M.D., F.A.C.C., Sally Moos, Dinyar F. 
Daruwala, M.D., Alok Gupta, M.D., University of Alabama 
at Birmingham, Alabama 
Two dimensional and color Doppler (2D/CD) assessment was 
done in 12 Pts (mean age 35 years) with large atrial 
septal defects (ASD) within 2 weeks of surgery/cath. 
Eleven Pts had a left to right shunt of more than 1.5:1 
[2.9(±1.1):1] and 1 Pt had net right to left shunt of 
1.1:1 all by cath. Maximum diameter of ASD by CD was 
measured using 2 orthogonal planes (right parasternal & 
short axis views). Maximum CD flow area across ASD shunt 
was planimetered and corrected for body surface area. 
Mean and peak velocities over 1 cardiac cycle were 
derived from pulsed Doppler or by using a previously 
validated method of computer analysis of pixel color 
intensity from color M-mode across shunt flow. Shunt 
volume was thus derived by multiplying ASD area (calcu-
lated from CD diameter, ASD assumed to be circular) by 
mean velocity, flow duration and heart rate and was 
compared with QP-QS at cath. Planimetered flow areas of 
the shunt were l5.5±5.6 cm2 and 10.7±4.22 cm2/m2 
(corrected for body surface area). Peak and mean 
velocities of the shunt flow were .75±.lS m/s and 
.53±.12 m/s respectively. Shunt flow volume across ASD 
calculated by CD was 7.8± 3.0 l/min and correlated well 
with the cath QP-QS of 10.4±5.3 l/min (r-.88). Net shunt 
flow volume in 1 Pt with significant right to left shunt 
calculated by subtracting right from left flow was .2 
l/min and by cath was .4 l/min. CD is helpful i.n 
hemodynamic assessment of ASD. 
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EVALUATION OF TRANS FORAMEN OVALE FLOW DURING THE 
EARLY NEONATAL PERIOD - A COLOR DOPPLER ECHOCAR-
DIOGRAPHIC STUDY 
Kai S. Hsieh,M.D., Be T. Hwang,M.D., Kwan S. Yeh, 
M.D., Laura C. Meng, M. D., Veterans General Hospital 
and National Defense Medical Center, Taipei. 
Foramen ovale allows blood flow from RA to LA 
during fetal life. To study the postnatal blood 
flow changes across the foramen ovale, we evalu-
ate 42 normal full term newborns using color 
Doppler flow mapping through standard subxiphoid 
windows. within 12 hours of life, all 42 newborns 
had right to left trans foramina 1 atrial shunt 
during late diastole, while left to right shunt 
from late systole to early diastole. The late 
diastolic right to left flow soon disappeared 
and pure left to right flow during late systole 
- early diastole could be demonstrated among 
78.6%, 47.7%, 33.3%, 23.9%, 19.1% and 14.3% of 
the neonates at day 1 through day 7. Follow up 
data showed disappearance of left to right tran-
sforaminal flow within 3-6 months (median: 2.5 
months). We conclude that during the transition 
from fetal to neonatal life, blood flow patterns 
changes from pure RA~ LA flow to bidirectiohal 
flow and then pure LA. RA flow, which gradually 
disappeared within 7 days of life but some may 
persist beyond 7 days. This flow is associated 
with high mobility of foramen ovale flap in early 
neonatal period. Its cause is probably related 
to the presence of PDA shunt and decreased com-
pliance of left ventricle at neonatal period. 
ADVANCES IN FLOW QUANTIFICATION BY COLOR FLOW MAPPING IN 
AN ANIMAL MODEL OF PATENT DUCTUS ARTERIOSUS. Erkki 
Pesonen, M.D., lain A. Simpson, M.D., Johannes Breuer, 
M.D., Robert T. Reichman, M.D., Richard E. Swensson, 
M.D., FACC, William Elias, RDMS. Univ of Calif, San 
Diego, CA. 
Doppler studies have used ductal flow towards the 
transducer, as well as distal main pulmonary artery and 
peripheral pulmonary artery flow velocities (VEL's) away 
from the transducer as indices of ductal shunting. To 
refine non-invasive methods for ductus arteriosus flow 
quantification, we inserted a Dacron graft (8mm) between 
the left subclavian artery and the pulmonary artery (PA) 
in 7 mongrel dogs (variable shunt flow rates measured by 
electromagnetic flow meters on the aorta and the shunt 
were Qp:Qs's between 1:1 and 5.5:1). The Doppler for-
ward flow VEL time integral for the left PA showed a 
strong correlation (r-0.88 - 0.92) with (Qp:Qs) in 
individual dogs; however, for data combined for all 
dogs, correlation was poor. Color flow Doppler (CFD) 
images were digitized using a Sony RGB computer for 
analysis of forward, reverse and turbulent flows with a 
numerical VEL assignment. The peak systolic VEL in the 
main PA decreased linearly with increasing Qp:Qs (r-
-0.86) and the combined length of the ductal jet into 
the PA and the swirling forward diastolic flow component 
on the medial PA wall was correlated positively with 
Qp:Qs (r-0.85). However, for all dogs combined, the 
computed maximal area of turbulent diastolic flow in the 
PA showed the highest correlation to Qp:Qs (r-0.88). The 
complex patterns observed for ductal shunting by CFD in 
this model are similsr to those seen in pts and repre-
sent the intrusion of the ductal jet and the reverse 
swirl of flow displaced by the jet. When both are 
included in the assessment, useful quantitative indices 
of PDA shunting by CFD can be developed. 
ABSTRACTS 
COLOR DOPPLER FLOW MAPPING SHUNT PATTERNS IN AV CANAL 
DEFECTS: COMPARISON WITH ANGIOGRAPHY. Azucena Murillo, 
~I.D., Frederick S. Sherman, M.D., Lilliam M. Valdes-
Cruz, M.D., FACC, Richard E. Swensson, M.D. FACC, David 
J. Sahn, M.D., FACC. Univ Calif, San Diego, CA. 
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We compared shunting patterns seen on color Doppler 
flow ~apping (CDFM) with angiocardiography (ANGlO) and 
saturation data in 13 catheterized patients (pts) with 
atrioventricular canal defects (AVCD): 5 with complete 
AVCD, 4 atrial septal defect primum type (1°ASD), and 4 
ventricular septal defect, inlet-{canal) type (VSD). In 
all 5 pts with complete AVCD, CDFM revealed LV to RA, LA 
to RA, and LV to RV shunts; 4 showed mitral regurgita-
tion (MR) to the LA. The ANGlOs showed 4 pts with LV to 
RA shunts, 3 with LV to RV shunting but neither LA to RA 
shunts nor MR were clearly defined on ANGlO. All 4 pts 
with 1°ASD demonstrated LV to RA shunting on both CDFM 
and ANGlO's. Only one 1°ASD pt showed clear LA to RA 
shunt on ANGlO, while all pts showed it with CDFM. Both 
CDFM and ANGlO demonstrated the LV to RV shunt in all 4 
pts with VSD. In addition, 3/5 pts with complete AVCD, 
2/4 with lOASD and 2/4 with VSD displayed clear and 
definable tricuspid regurgitation (TR) on CDB1, but TR 
on ANGlO could not be appreciated. We conclude that 
CDFM displays MR and interatrial shunt components better 
than ANGlO in AVCD. Both techniques are equally useful 
in demonstrating LV-RV and LV-RA shunts. TR could be 
separated from LV-RA shunting on CDFM when low gains 
were used,by imaging proximal acceleration beginning in 
the RV and proceeding to the RA whereas in LV-RA shunts, 
the acceleration originated on the left side of the 
septum. The anatomical and flow details seen on CDFM 
provide unique information about the physiology of AVCD, 
they aided selection of appropriate saturations for 
shunt calculation and complemented angiographic observa-
tions even in patients undergoing catheterization. 
Thursday, March 31, 1988 
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Coronary Circulation: Drug Effects 
EFFECTS OF DIBUTYRYL CYCLIC AMP ON CORONARY HEMODYNAMICS 
IN ISCHEMIC HEART DISEASE: COMPARISON WITH DOPAMINE AND 
DOBUTAMINE . 
Kiminari Kobayashi,M.D., Toshio Sano,M.D. Hiroshi 
Yoshimura,M.D. Hideo Kobayashi,M.D. and Tei Hakuta,M.D. 
Yokohama City Univ., Yokohama, Japan. 
Dibutyryl cyclic AMP(DBcAMP}, a new derivative of cyclic 
AMP, easily passes through cell membrane and causes a po-
tent inotropic response. However, the consequences of that 
effects on coronary circulation and cardiac metabolism 
have yet not been understood. Thus, these effects of 
DBcAMP(50pg/Kg/min, 3Omin} were compared with dopamine (DA, 
5pg/Kg/min, 3Omin} and dobutamine(DB, 5pg/Kg/min, 3Omin} 
in 33 patients with ischemic heart disease. Coronary sinus 
flow (CSF) was measured using a continuous thermodilution 
method. DBcAMP decreased both arterial blood pressure and 
pulmonary artery pressure slightly but significantly. 
Cardiac output(2.90 to 3.22l/min/m2 , p(O.OOl} as well as 
stroke volume increased significantly. Heart rate was 
slightly increased, while rate pressure product ramained 
unchanged. Resting CSF were increased by DBcAMP(95 to 142 
ml/min, +49%, P(O.OOl}, DA(+31%, P(O.OOl} and DB(+29%, p( 
0.001}. Myocardial oxygen consumption(MV02} were also in-
creased by DBcAMP(11.5 to 13.2mg/min, +15%, P(0.05}, DA( 
+24%, P<O.Ol} and DB(+27%, P(O.Ol}. Myocardial lactate 
extraction ratio were significantly decreased by both DA 
and DB, while unchanged by DBcAMP. CSF during rapid atrial 
pacing did not change significantly after all drugs. In 
conclusion, DB cAMP seems to reduce both after load and pre-
load and have a pr~mary coronary vasodilating action. On 
the contrary, increases in CSF by both DA and DB were 
largely dependent on increase in MV0 2. Thus DA and DB 
aggravated myocardial ischemia, while DBcAMP did not. Our 
data suggest that DBcAMP appers to have valuable effects 
for the treatment of heart failure in patients with 
ischemic heart disease. 
242A ABSTRACTS 
Cffi(»lARY AI{) SYSTEMIC f£MOOYNAMIC EFFECTS OF HIGH- VERSUS LOW-OOSE INTRA-
VENOUS LABETALQ IN PATIENTS WITH CffiONARY ARTERY OlSEASE. 
Willem J. Renvne, t-I), FAce, Dick Kruyssen, t-I), Hanne Krauss, MJ, Diederik 
van Hoogenhuyze, MO, Zuiderziekenhuis, Rotterdam, The Netherlands. 
Labetalol (L), a complex substance with both 0( - and non-selective IJ -
blocking properties, is widely used as an antihypertensive agent. Whether 
it also has anti ischemic properties depends on the degree of ~ - vs co( -
blocking activity, which is dose-dependent, and subsequent effect on myo-
cardial O:z demand and, particularly, on coronary hemodynamics. The rela-
tive impact of both components of L on systemic and coronary hemodynamics 
at rest was studied in 28 normotensive untreated patients (pts) with co-
ronary artery disease, receiving either O.S mg/kgllmin (LL, n=14) or 2 
mg/kg/lmin (ft., n=14). Hemodynamic variables were measured during control 
(C) and 1,3,S,1O,lS and 3S min after L. Baseline angiographic and hemody-
namic data were similar in both groups. L inrnediately reduced systemic 
resistance in both groups [131 (LL) and 17% (ft.); both p<'OS vS C, LL vs 
HL p<.OS], resulting in a prompt, significant decrease in left ventricu-
lar (LV) systolic and mean arterial pressure [111 and lSI (LL), resp., 
and 22!l and 211 (ft.), resp., LL vs HL p<.OS] persisting until 3S min af-
ter L. In ft. this was accompanied by an initial 9% increase in heart rate 
(foR, p<.OS vs C), gradually returning to control values. In LL pts HR de-
clined from 87!} (C) to 78;1;3 beats/min at 10 min after L(p<'OS). Contrac-
tility parameters, measured during fixed HR, did not change in LL, but 
decreased in HL (12% vs C, p<'OS) , accompanied by a significant reduction 
in cardiac index (12!l) and stroke work (22%). In LL cardiac and stroke 
index remained unaltered, but stroke work declined with l2!l (p< .OS vs C). 
LV filling pressure did not change in either group. Despite a shortlas-
ting, significant 16% reduction in coronary resistance in HL pts only, 
coronary flow did not change in either group. Neither was myocardial 02 
consumption altered, despite a significant reduction in 02 demand in both 
groups [17% (LL) and 22!l (ft.), LL vs HL ns]. Thus, hemodynamic effects of 
LL are compatible with predominant rI.. -blocking effects and of HL with 
prominent 0( andl>-blocking properties. As, under resting conditions, co-
ronary flow is not restricted and myocardial 02 demand similarly affected 
by both ft. and LL, the latter dose seems preferable in ischemia as LV 
pump function is better preserved. 
NICARDIPINE:ASSESSMENT OF V ASOSELECTIVITY BY 
INfRACORONARY ADMINISlRATION IN MAN 
Charles R. Lambert, M.D., Ph.D. and Carl J. Pepine, M.D., F.A.C.C. 
V AMC and University of Florida, Gainesville. 
In order to separate peripheral hemodynamic and associated reflex changes 
from possible direct cardiac effects of nicardipine (Nic), 10 men were 
studied during cardiac catheterization. Nic was administered as a 0.1 (N=5) 
or 0.2 (N=5) mg intracoronary bolus given over 15 seconds diluted in 
arterial blood. Measurements were taken in the control state, at 30, 60, and 
90 seconds, and at 5 and 7 minutes after Nic. Measurements and derived 
variables included HR, aortic systolic, diastolic, and mean 
(SAP,DAP,MAP) pressures, L VEDP, dP/dt, time constant for left ventricu-
lar isovolumic relaxation (1), LV energy averaged power density (APD), 
SVR, coronary blood flow (CBF) and resistance (CR). Neither the 0.1 orO.2 
mg dose of Nic produced changes in HR, SAP, DAP, MAP, or LVEDP. 
160 Other responses were similar for both doses, transient, and are sum-
marized below. CO (+28%±12) and stroke volume 
(+27%±12) were both significantly (P<O.05) in-
creased 5 minutes after Nic administration. These 
1I!It------ data indicate that Nic is a relatively 
selective and potent coronary 
vasodilator with very minimal di-
-fr:::lIIIIIn-.. .L..J ..... r-!I!III"I....I....,=1II' rect myocardial depressant activity 
in man. In addition, improved car-
diac function was seen 5 minutes 
after administration without altera-
-80 tions in loading or HR. This latter 
+dP/dt APD CBF CR T -dP/dt finding has not been described 
with other dihydropyridines and may result from amelioration of silent is-
chemia or favorable alteration of diastolic compliance. 
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A COMPARISON OF THE EFFECTS OF INTRAVENOUS ISRADIPINE AND 
VERAPAMIL ON CORONARY AND SYSTEMIC HEMODYNAMICS IN MAN 
Egerton K. van den Berg. M.D. and Gregory J. Dehmer, M.D., 
F.A.C.C. Dallas VA Medical Center and the University of 
Texas Health Science Center, Dallas, Texas 
Isradipine is a new calcium antagonist that can be admin-
istered intravenously. In 16 male patients, hemodynamic 
changes were assessed at baseline and 30 minutes after 
isradipine (0.015mg/kg, n=8) or verapamil (0.15mg/kg, n-
8). There was no difference in the mean age or the in-
cidence and severity of coronary disease between the 
groups. Coronary sinus blood flow (ml/min) and CO (L/min) 
were measured by thermodilution techniques. Myocardial 
arteriovenous 02 difference (AV02d) in ml/L was deter-
mined and RA, AO and LVEDP measured by fluid-filled or 
micromanometer catheters, respectively. Myocardial 02 
consumption (ml/min), systemic vascular resistance (SVR) 
in dyne sec cm-5 and coronary vascular resistance (CVR) 
in mmHg/ml ~ere derived. Isradipine caused an increase 
in coronary sinus blood flow (122±47 to l69±58, p<0.03, 
mean±standard deviation) and CO (6.6±1.55 to 9.6±1.7l, 
p<O.OOl). There was a decrease in CVR (0.97±0.45 to 0.53 
±0.20, p<O.Ol), SVR (13l5±54l to 690±153, p<O.OOl) and 
AV02d (118±22.4 to 86±18.2, p<O.Ol) with no significant 
change in LVEDP or myocardial O2 consumption. In con-
trast, verapamil caused an increase in LVEDP (16±3.l to 
22±4.l, p<O.OOl) while coronary sinus blood flow, CVR, 
SVR, AV02d and myocardial 02 consumption did not change 
significantly. Therefore, isradipine causes coronary 
and systemic vasodilation without a measurable change in 
myocardial 02 consumption and, in contrast to verapamil, 
does not cause an elevation in LVEDP. These effects 
offer advantages over those of verapamil and, thus may 
make intravenous isradipine useful in the therapy of 
certain cardiac diseases. 
EFFECTS OF LOW DOSE NISOLDIPINE ON SYSTEMIC AND CORONARY 
HEMODYNAMICS AND PROSTAGLANDIN METABOLISM DURING EXERCISE 
IN PATIENTS WITH ISCHEMIC HEART DISEASE. 
A.Uehata,M.D.,A.Kurita,M.D.,B.Takase,M.D.,H.Sugahara,M.D., 
T.Nishioka,M.D.,Y.Kanda,Ph.D.,Y.Yoshio,M.D.,H.Nakamura,M.D. 
National Defense and Nippon Medical College, Tokyo, Japan 
Nisoldipine(NIS), a new calcium antagonist,structually sim-
ilar to nifedipine, has been reported to feature lasting 
longer and greater coronary than systemic vasodilator ca-
pacity. Recent studies suggest that prostaglandin(PG) plays 
an important role in patients(pts) with ischemic heart dis-
ease(IHD). Ten pts with IHD were studied in two hours be-
fore and after oral NIS(5mg) to determine if NIS without 
systemic effects benefits ischemic pts and improvesthei~. PG 
metabolism during stress. Plasma 6-KetoPGFla(6PGFla) and 
thromboxane B2 (TXB2) were measured by radioimmunoassay and 
plasma NIS by liquid chromatography. Their coronary sinus 
flow (CSF),brachial arterial pressure (BAP) and coronary 
sinus pressure (CSP) were measured. The effects were com-
pared at rest and during an exercise-induced(EX; supine 
bicycle ergometer) myocardial ischemia. The plasma NIS 
level was 3.8±3.l (SD) ng/ml prior to second EX. As ex-
pected, NIS decreased systolic BAP from l64±9 mmHg by 25% 
(p<O.Ol) at rest and from 2l0±9 mmHg by 15% (p<0.05) during 
EX, whereas it did not significantly change the diastolic 
BAP at rest and during EX. NIS decreased CSP from 20±9 mmHg 
by 40% during EX (p<O.05). NIS increased CSF from 90±11 
ml/min by 20% (p<0.05) and decreased coronary vascular re-
sistance 1.0±O.1 mmHg/ml/min by l8%(p<O.05) at rest. NIS 
decreased TXB2/6KPGF1a from 1.3±0.5 by 30%(p<0.05) in bra-
chial artery blood,whereas it decreased from 1.9±O.6 by 20 
% (p<O.lO) in coronary sinus blood during EX. These results 
suggest that oral low dose of NIS can decrease the pre loads 
and afterloads moderately, maintain coronary perfusion 
pressure, and may sssist in improving the PG metabolism in 
pts with IHD during EX. 
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ABSENCE OF CORONARY AND SYSTEMIC HEMOOYNAMIC EFFECTS OLIUNG INTRAVENOUS 
CONVERTING-ENZYME INHIBITION IN NORtoIJTENSIVE PATIENTS WITH CORONARY 
ARTERY DISEASE DESPITE SIGNIFICANT NEUROHUtoIJRAL CHANGES. 
Willem J. Rerrme, MO, FAce, Peter de Leeuw, MO, Dick Kruyssen, M), Oiede-
rik van Hoogenhuyz€, MO, Zuiderziekenhuis, Rotterdam, The Netherlands. 
Although ACE-inhibition may result in anti ischemic effects in normotensi-
ve patients (pts) with coronary artery disease (CAO), presumably by in-
creasing coronary flow, no data are available on the acute coronary and 
systemic hemodynamic effects of ACE-inhibition in such pts and their re-
lation to concomitant neurohumoral changes. Enalaprilat (E, 1.5 mg bolus 
injection) was aclninistered in 11 untreated normotensive pts with CAO but 
without heart failure. After a 30 min stabilization period hemodynamic 
and neurohumoral variables were measured in duplo before E (C) and 1,3,5, 
10,15 and 35 min post E. Hemodynamic variables included: heart rate (bl 
min), cardiac index (l/min/m2) , stroke index (mllbt/m2), systemic resis-
tance (d.s.cm-5), LV systolic, LV end diastolic and mean aortic pressure 
(rTITIHg, resp.) I contractility parameters (Vmax, sec- l ), coronary flow and 
resistance (ml/min and mmHg/ml/min, resp.) and myocardial 02 consumption 
(mIl min). Arterial (ART) and coronary venous (CV) blood was sampled si-
multaneously for catecholamines (Norepinephrine, Epinephrine, Dopamine, 
nmoll 1) and Angiotensin II (All, pmol/l) and arterial samples taken for 
ACE (u/l). No side-effects were observed. Baseline ACE 00;1;.0.36 u/l) de-
creased to 0.97j;0.2 ull at 5' post E (p<.05) and remained low thereafter. 
ART and CV catecholamine levels were in the normal range during control 
and did not change anymore during the study. In contrast, ART All fell 
from 6.4t1.1 pmolll (C) to 3.2tO.4 pmoll 1 (5' post E, p<'05 vs C), re-
maining at this level until the end of the study. Likewise VEN All levels 
decreased from 5.5;1;.0.8 to 3.2;1;.0.5 pmolll (5' post E) and to 3.08±.9.3 
pmolll at 10' post E (p<'05 vs C). Despite this inmediate effect on sys-
temic and coronary venous All levels neither coronary nor systemic hemo-
dynamic variables changed throughout the entire study period, Subdivi-
ding the pts in baseline ART All > 10 pmol/l and <lOpmol/l did not affect 
the results. Thus, in normotensive pts with coronary artery disease, 
without heart failure, ACE inhibition, under resting conditions, does not 
modi fy myocardial 02 demand or supply, despite a significant reduction in 
circulating Angiotensin II. 
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Cardiovascular Disease Among the Elderly II: Normal 
Versus Abnormal 
NORMAL AGING IS ACCOMPANIED BY DISPROPORTIONATE THICKENING 
OF THE VENTRICULAR SEPTUM. 
Dalane W. Kitzman, M.D., David G. Scholz, M.D., Philip 
T. Hagen, M.D., Duane M. Ilstrup, M.S., and William 
D. Edwards, M.D., F.A.C.C., Mayo Clinic, Rochester, 
Minnesota. 
To determine the relationship between age and ventricular 
septal thickeness (VST), left ventricular free wall 
thickness (LVT), right ventricular free wall thickness 
(RVT), and heart weight, 765 normal hearts obtained 
from autopsy were examined. Specimens were excluded 
if there was a history of hypertension, or autopsy 
evidence of cardiopulmonary disease or significant 
coronary atherosclerosis (reduction of luminal 
cross-sectional area >50%). VST, LVT and RVT were 
measured midway between the cardiac base and apex; 
epicardium and trabeculae were excluded. Results: there 
was no significant difference in mean heart weight between 
the oldest (age 90-99) and youngest (age 20-29) groups. 
Mean VST, LVT and RVT are shown below, indexed by body 
surface area (cm!m'). Asterisk indicates p<O.OOl, old 
vs. young. 
mean ratio range 
Age n LVT RVT VST VST!LVT VST!LVT 
20-29 100 0.73 0.23 0.79 1.10 0.78-1.45 
90-99 65 0.74 0.23 0.88* 1.20* 0.91-1.56 
Thus 1) mean indexed LVT and RVT remain relatively 
constant with age, while VST increases significantly, 
2) there is a significant age-related increase in the 
mean ratio of septal to left ventricular free wall 
thickness such that, by age 90, the range exceeds that 
used in the diagnosis of hypertrophic cardiomyopathy. 
These age related changes, when combined with left 
ventricular hypertrophy due to chronic hypertension, 
may play a role in the development of hypertrophic 
cardiomyopathy in the elderly. 
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HYPERl'ROPHIC CARDIOMYOPATHY IN 'lllE EWEFLY: DISTINcrIOOS 
FRCM 'lllE YOUNG BASED CN CARDIAC SHAPE 
Harry Lever, M.D., F .A.C.C., lbger Karam, M.D., and 
Bernadine Healy, M.D., F.A.C.C., Cleveland Clinic 
Foundation, Cleveland, Ohio 
'Ihe striking clinical and pathologic features of hypertro-
phic cardiOll¥Opathy (HC) have been defined alrrost exclu-
sively in the young. Little is known about HC in the 
elderly, although they are assuned to be part of the sane 
disease spectrum. Ac=rdingly, we studied 28 patients 
> 65 years of age (mean 71 ± 6.4) with a diagnosis of HC 
by M-rrode, 2-D and D::Jppler echocardiography (echo) and 
CO!!pU"ed their findings to a group of 16 consecutive 
patients with HC by echo <40 years of age (mean 26 ± 
lO.5). 'l'here was no clinical difference between roth 
groups, except for an increased incidence of mild hyper-
tension in the elderly. Echo in roth groups showed hyper-
trophy with a small LV cavity and no significant differ-
ences in the presence of systolic anterior notion of the 
mitral valve or of a gradient as measured by Doppler out-
flow tract velocity. Significant differences were seen 
between roth groups with regard to LV shape: the elderly 
had a nore tubular cavity contour with nonnal septal 
cw:vature in roth hypertensive and non-hypertensive. In 
contrast, in the young group the well-known markedly 
abnormal cardiac shape predominated (p<.OOl), with rever-
sed septal cw:vature and a crescent-shaped LV. Unexpec-
tedly, right ventricular hypertrophy predaninated in the 
young group (p<.OOl). 'Ihe findings show that HC, when 
present in the elderly, has similar clinical features, 
except for a greater history of mild hypertension in the 
fonrer, likely related to age. However, the elderly had 
a strikingly different and generally unappreciated 
cardiac shape by echo, supporting the notion that HC in 
the elderly is a disease distinctively different fram 
that seen in the young. 
HYPERTROPHIC CARDIOMYOPATHY IN THE ELDERLY--OLINICAL 
COURSE AND PROGNOSTIC INDICES. 
William P. Fay, M.D., Charles P. Taliercio, M.D., 
F.A.C.C., A. Jamil Tajik, M.D., F.A.C.C., Duane M. 
Ilstrup, M.S., and Bernard J. Gersh, M.B., Ch.B., 
D.Phil., F.A.C.C., Mayo Clinic, Rochester, Minnesota 
Prior studies of hypertrophic cardiomyopathy (HCM) in the 
elderly have been limited by small numbers and minimal 
follow-up. To better define the clinical course and 
prognosis of elderly Pts with (HCM), we followed all 
patients first diagnosed with HCM at >65 years of age who 
underwent 20 echocardiography at our Institution from 
1978 to 1985. Seventy Pts were identified (40 female, 30 
male, mean age 71.6 years) and followed for a mean of 4.2 
years. At the beginning of follow-up, 73% of patients 
were symptomatic, defined as chest pain, syncope, or 
dyspnea. Mean diastolic septal and free wall thicknesses 
were 20 and 14 mm, respectively. There were 13 deaths (5 
cardiac, 6 non-cardiac, 2 cause unknown). However, 
overall actuarial survival was no different from that 
expected for an age- and sex-matched control group. At 
the end of follow-up, 41% of survivors were in NYHA func-
tional class I, 41% in class II, and 18% in class III or 
IV. NYHA functional class III dyspnea (p <.04), 
increasing septal thickness (p <.05), and increased LA 
size (p <.01) were all associated with decreased sur-
vival, with an indexed LA dimension of >26 mm/m2 being 
the best predictor of cardiac death during follow-up. In 
conclusion I 1) HCM in the elderly has a relatively benign 
course, at least over a 4-5 yr period, and 2) certain 
clinical and echocardiographic parameters may be of use 
in identifying a subgroup of Pts at increased risk of 
death. 
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AGE-RELATED CHANGES IN NORMAL CARDIAC VALVE DIMENSIONS. 
Dalane w. Kitzman, MO, David G. Scholz, MO, Philip T. 
Hagen, MD, Duane M. Ilustrup, MS, and William D. Edwards, 
MD, FACe, Mayo Clinic, Rochester, Minnesota. 
To determine the relationship between normal cardiac 
valve circumference (ve) and age, ves were measured 
by placing a flexible plastic ruler along the opened 
val ve annuli of 765 normal adult hearts obtained from 
autopsy. Significant coronary artherosclerosis (>50% 
luminal reduction), cardiopulmonary disease and 
hypertension were excluded. VCs were indexed by body 
surface area. The mean indexed valve circumference 
(IVC) of all cardiac valves increased progressively 
with each decade for both sexes. The oldest and youngest 
groups are compared below (*p<O.OOl, old vs. young). 
Women mean lve cm/m2 Men mean lVe cm/m 2 
age n AV MV PV TV age n AV MV PV TV 
20-29 50 3.6 5.2 3.6 6.5 20-29 50 3.1 4.9 3.2 5.9 
90-99 42 5.7* 5.9* 5.2* 7.2* 90-99 23 5.2* 5.6* 4.4* 7.0* 
The mean ratios of ves are shown below to compare the 
relative degree of age-related change in each valve 
(**p<0.05, old vs. young). There were no differences 
between men and women, so the results were combined. 
Age n AV/MV AV/PV MV/TV 
20-29 100 0.67 0.99 0.83 
90-99 65 0.96** 1.13 0.82 
Thus 1) the mean lve of all the cardiac valves increases 
significantly with age for both sexes, 2) the aortic 
valve undergoes the greatest age-related increase in 
VC. These findings suggest that age-related dilatation 
may contribute to the multi-valvular regurgitation, 
as detected by Doppler echocardiography, that is 
frequently found in the elderly. Furthermore, age-related 
dilatation of the aortic valve should be taken into 
account when evaluating elderly patients with aortic 
regurgitation. 
EFFECTS OF AGING ON SUBJECTS WITH NORMAL HEARTS. A 
SEVEN-YEAR PROSPECTIVE STUDY. 
John B. Kostis, M.D., F.A.C.C., Narayanan Jeganathan, 
M.D., Bennett Salamon, M.D., Abel E. Moreyra, M.D., 
F.A.C.C., Nora Cosgrove, R.N., UMDNJ-Robert Wood Johnson 
Medical School, New Brunswick, NJ 
In order to separate the effects of true aging and 
subclinical disease and define the range of normal 
cardiac rhythm and rate, we performed a 7-year prospec-
tive study of 43 subjects (age 51±9 range 16-65) who were 
free of cardiac disease by extensive noninvasive and 
invasive testing at baseline and by noninvasive evalua-
tion at follow-up. Twenty-four hour ambulatory electro-
cardiography (AECG) and maximum exercise stress tests 
were performed at baseline and 7±1 years later. 
During the 7-year interval, weight increased by 
2.8±7.1 kg, cholesterol by 8±38 mg/dL, blood pressure by 
15±18/4±12 rom Hg (r<0.01). 
Premature atrial complexes increased from 7±34 to 
126±230/24h; premature ventricular complexes (PVC) from 
44±133 (O to 613) to 104±231/24 h (O to 973); percentage 
of subjects with 0<PVC!24h from 42% (18/43) to 60% 
(26/43) (P <0.05). No subject had repetitive forms or 
PVC >1000/24h at either the baseline or follow-up exams. 
Exercise tolerance decreased by 1.04±2.05 METS, 
submaximum heart rates by 2±19 bpm and maximum heart rate 
by 8±24 bpm (P<O.Ol). On AECG average hourly heart rate 
increased by 4±14 bpm but maximum and minimum heart rates 
decreased by 4±19 and 3±9 bpm respectively (P<0.05). 
Conclusions: 1) Subjects free of heart disease have 
low frequency PVC and no repetitive forms; 2) By both 
cross-sectional and longitudinal analysis age is associ-
ated with higher PVC frequency and lowering of exercise 
and ambulatory ECG heart rates; 3) These changes with age 
are not due to subclinical heart disease. 
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COMPARISON OF LEFT VENTRICULAR MASS AND SYSTOLIC AND 
DIASTOLIC FUNCTION IN YOUNG AND OLD NORMALS 
Chalapathirao V. Gudipati, MD, Anthon~ C. Pearson, MD, 
Arthur J. Labovitz, MD, FACC, St. LOU1S Unlverslty, St. 
Louis, MO. 
Aging is known to alter the diastolic properties of 
the LV, however, the effect of age on LV systolic 
function and LV mass is controversial. Therefore, we 
studied 23 normal, asymptomatic normotensive elderly 
(>60 yrs) volunteers and 23 young (<35 yrs) normals 
using Doppler-echocardiography. From the M-mode 
echocardiograms, posterior wall (PW) and septal 
thickness, and LV end-diastolic dimension index were 
measured, and LV mass index (LVMI, g/m2) and peak rates 
of dimension increase (DD/DT in mm/s) and decrease (max 
VCF in mm/s) were calculated. From Doppler 
interrogation of LV outflow tract velocities, the peak 
velocity (PV) was measured and CO was calculated using 
the LV outflow tract flow velocity integral and 
cross-sectional area. Doppler indices of diastolic 
function included the ratio of peak early to peak atrial 
velocity (PE/PA) and percent atrial contribution (%AC) 
determined from transmitral flow recordings. Results: 
Mean + SD 
PW I LVEDDI I SYSTOLIC FUNCTION 
I (cm) I (cm/ml) I MaxVCF PV CO (lIm) 
Young 25+ I 84+28 I 1. 78+. 5 24+5 157+46 
Old 69+5 177+21 I .87+-:-18* 44+7* 96+24* 
• p < .05 young versus old 
We conclude that in comparison to normal young 
subjects, elderly normals have in addition to previously 
recognized abnormal diastolic function: (1) increased PW 
thickness, but no significantly different LV mass index, 
and (2) reduced cardiac output and ejection-phase 
indices of systolic function. 
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Indices of Systolic Function 
THE END-SYSTOLIC PRESSURE-DIMENSION RELATION:A RELIABLE 
MEASURE OF LEFT VENTRIOJLAR CONTRACTILITY IN MYOPATHIC 
VENTRICLES? 
Kenneth M. Borow, M.D., F.A.C.C., Alex Neumann, B.S., RobertO 
M. [ang, M.D., F.A.c.c., Unlyerslty of Chicago, Chicago, IL 
The LV end-systolic (ES) pressure (P)-yolume (V) relation Is a 
clinically useful, load Independent Index of contractility. Echo 
derlyed ES dimension (D) has been substituted for ESV In this 
relation. Howeyer, since V and 0 are exponentially related, 
similar changes In ESP may result In widely disparate changes in 
ESD and ESV especially oyer the larger ranges of ESV. To study 
the ESP-D slope as a contractility Index, we evaluated 20 normals 
(NL) and 21 pts with diffuse LV dysfunction [shortening fraction 
(% 110)<28%]. Pts were dlylded into Gl (n=8; ESD~S.O cm) and G2 
(n=13; ESD>S.O cm). Groups were of similar ages. LV echo and 
central Ao mlcrotlp pressures or calibrated carotid pulse tracings 
were used. The ESP-D relation was calculated from at least 4 
data points generated using methoxamine or nitroprusside. The 
following were determined: ESP-D slope, CO (L/mln), % 110, rate 
corrected yeloclty of fiber shortening (Vcfc), clrcumfer2ntlal ES 
wall stress (aes;g/cm
2), and VCfc. at a aes = 200 glcm (a load 
Independent inaex of LV contractility). 
--------BASELINE VALUES-------------- Vcfc at ESP-D 
ESD HR %&> CO VCf c aes aes =200 Slope 
NL 3.0 Tf 34 s-:O 1.04 129 -.9-1--108 
Gl 3.9* 80 23* 4.8 0.67* 183* .6S* 63* 
G2 6.2*# 93*# 10*# 3.4*# 0.37*# 247*# .41*# 76* 
*p<.Ol YS Nl.; #p<.Ol-Gl YS G2 
For Gl (mild CM), 1/8 pts had nl ESP-D slope. This pt had a 
resting % 110 of 24. For G2 (seyere CM), 3/13 ~ts had nl slopes 
despite low CO, % liD, and Vcf~ at ae~=200g/cm • Moreoyer, the 
ESP-D slope was unable to distingUISh mild from seyere CM. 
Thus, the ESP-D slope Is a reliable measure of contractility In 
myopathic yentricles with mildly but not markedly Increased 
ESD. This limitation probably reflects the non-linearity of the 
relationship between LV dimension and yolume. 
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LIMITATIONS OF THE END-SYSTOLIC PRESSURE-DIAMETER 
RELATIONSHIP IN PATIENTS WITH SEVERE CONGESTIVE HEART 
FAILURE. 
Peter S. Rahko, M.D., F.A.C.C., Judith E. Orie, M.D., 
F.A.C.C., William P. Miller, M.D., F.A.C.C., Haytham 
Jabi, M.D., Peggy Wiederholt, RN, CCRN. Section of 
Cardiology, Univ. of Wisconsin, Madison, WI. 
The purpose of this study was to determine if the end-
systolic pressure-diameter relationship (ESPDR) can be 
utilized to assess LV contractility in pts with severe 
congestive heart failure (CHF). In IS pts with class III 
CHF (ejection fraction 26±11%) the ESPDR was determined 
using M-mode echocardiography and intraarterial pressure 
monitoring (end-systolic pressure at dicrotic notch). 
Simultaneously, the end-systolic pressure-volume relation-
ship (ESPVR) was measured with radionuclide ventriculo-
graphy. The ESPDR and ESPVR were obtained by linear 
regression at 3 levels of after load resulting from IV 
phenylephrine. Individual slope values of ESPVR and 
ESPDR correlated poorly (r-0.25) because in 7 pts the 
ESPDR slope was negative. Comparing the responses of the 
7 pts with a negative ESPDR slope to the other 11 pts: a 
similar rise in end-systolic pressure (3S±S vs 35±9 mm 
Hg, p-NS) and LV volume (37±30 vs 31±IS ml) was achieved, 
but the increase in LV dimension was significantly less 
(0.5±5.5 vs 4.9±2.6 mm, p=0.04). The ESPVR slopes were 
not signif~cantly different (O.22±1.53 vs 0.71±0.74 
mm Hg/ml/m ,p-NS). However, baseline end-systolic 
dimension (65±13 vs 55±6 ~, p=0.05), end-systolic volume 
index (90±25 vs 5S±23 ml/m , p=0.22) and end-systolic 
wall stress (121±33 vs 90±21 g/cm , p=0.03) were greater 
in the negative ESPDR group. We conclude that the ESPDR 
cannot be substituted for the ESPVR in patients with 
severe CHF, particularly those with large end-systolic 
volumes and a high end-systolic wall stress. 
NONINVASIVE OETERMINATION OF LATE SYSTOLIC INDICES OF 
INOTROPY IN CONGESTIVE CARDIOMYOPATHY. 
Philip F. Bink1eyc M.D., Robert Lewe, M.D., Carl V. 
Leier, M.D., F.A: .C., The Ohio State University, Colum-
bus, Ohio. 
Late systolic indices of left ventricular function 
have been derived by echocardiographic techniques and 
shown to reflect inotropic state in normals. This 
noninvasive technique was used to derive ventricular 
pressure/dimension relations in 10 subjects with 
congestive cardiomyopathy (mean EF=23±S%) to determine 
its feasibility in this population, to assess the linear-
ity of the relationships, and to compare the slopes of 
the relations with those reported in normals. 
Phenylephrine was infused to increase systolic blood 
pressure as least 30mmHg above baseline. Peak systolic 
pressure (PSP), end-systolic pressure (ESP) measured 
from the calibrated carotid pulse tracing, 
echocardiographic end-systolic dimension (ESD) and 
end-systolic volume (ESV) were determined for each level 
of after10ad. Least squares regression of pressure 
against dimension and volume was performed using 4 to S 
points for each subject. The relations were linear in 
each case with the mean correlation coefficients ranging 
from 0.94±0.OS to 0.9S±0.04. The slopes were: 
ESP/ESD=42.8±2.7mmHg/cm; PSP/ESD= 48.7± 32.2mmHg/cm; 
ESP/ESV=0.S9±0.42mmHg/m1. All were significantly re-
duced compared to normal values with ESP/ESD and PSP/ESD 
reduced by SO% and ESP/ESV reduced by 80%. These data 
indicate that the noninvasive determination of ESP/ESD, 
ESP/ESV, PSP/ESD in congestive cardiomyopathy is feasi-
ble and yields linear relations with reduced slopes 
reflecting the decreased inotropic state clinically 
evident in this population. 
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THE POWER-AITERLOAD RELATIONSHIP IN THE FAILING HUMAN 
VENTRICLE 
Y. Christopher Chiu M.D.} Patricia W. Arand, Ph.D. & 
John D. Carroll, M.D. Un1v. of Chicago, Chicago, IL. 
Animal studies have shown that ventricular power 
is related to afterload by a bell-shaped curve and the 
normal ventricle operates near the maximum power point 
for maximum efficiency. We studied this relationsh1p in 
5 patients with dilated cardiomyopathy. A high-fidelity 
catheter with micromanometer pressure and 
electromagnetic velocity transducers was used to measure 
pressure and flow in the ascending aorta. The latter was 
calibrated to flow with simULtaneously determined 
thermodilution cardiac output. After control recordings 
were made, blood pressure was lowered by incremental 
doses of intravenous nitroprusside until the systolic 
aortic pressure (AOP) was less than 90 mrn Hg. Recordings 
were made at each new drug dose. A personal computer was 
used to acquire (at a rate of 400 Hz) and analyze the 
data. Total power was given by dividing the integral of 
the AOP-flow product by the duration of the cardiac 
cycle. 
In all 5 
patients, total 
maximum powet' 
dUf+ng nitroprusside 
infusion 
Control 
power increased as .... 
systolic AOP was ~ 
reduced. In 3 of the 0 
patients total power 2 
reached a maximum 
and then declined as ~ 
AOP was further ~ 
reduced. The result .. 
from one of these ! 
patients is shown in 
the diagram. For the 
entire group, the 
average maximum 
increase of power 
was 22.7 ± 7.71%. 
'+--r--.--r--.--r--.--r--.-~ .. .J .5 
By.toMe AOP (nwn Hg) 
Conclusions: 1) The failing ventricle operates far to 
the right of the maximum power point. 2) Afterload 
reduction increases the power output of a failing 
ventricle. 3) The power-afterload relationship in these 
patients is described by a bell-shaped curve similar to 
that found in animal studies. 
EVALUATION OF VENTRICULAR FUNCTION BY FRANK-STARLING CURVES 
DERIVED FROM DOPPLER-ECHO DURING LOWER BODY NEGATIVE 
PRESSURE 
Martin Berk, M.D.; Joyce Evans, M.S.; Charles Knapp, Ph.D.; 
Mlchael Harrlson, M.D.; Theodore Kotchen, M.D.; Bernard 
Ngai, M.D.; Oi Ling Kwan, B.S.; Anthony N. DeMaria, M.D., 
FACC. University of Kentucky, Lexington, Kentucky 
Application of lower body negative pressure(LBNP) is cap-
able of producing progressive alterations in left ventri-
cular volume. In conjunction with measurement of Ao blood 
flow velocity by Doppler, therefore, LBNP offers the 
potential to assess LV function under variable conditions 
of loading. Few data exist regarding the magnitude of 
change or feasibility of deriving Starling curves from 
LBNP. We studied 14 normals during graded LBNP before (tNa) 
and after (+Na) acute salt and water depletion induced by 
diet and diuretics. Aortic and LV diastolic dimensions 
(LVDD), and flow velocity integra1(FVI), were recorded by 
echo and suprasternal non-imaging continuous wave Doppler. 
Automated cuff blood pressure was obtained. CO and vascular 
resistance(SVR) were calculated. Results: (tNa) 
LBNP Rest -10 -20 -30 -40 -SO -60 
HR 60 61 6S 68 72 74 79 
FVI 14.3 12.6 12.1 10.9 9.9 8.6 8.2 
CO 5.6 5.0 5.1 4.8 4.6 4.2 4.3 
SVR 14.9 17.4 17.3 18.4 18.8 20.9 20.4 
LVDD 5.08 4.74 4.47 
(Statistics report overall graded LBNP effect) 
mmHg 
p<.OOOl 
p<.OOOl 
p<.OOl 
p<.Ol 
p<.0004 
Salt and water depletion reduced LVDD, FVI, CO and in-
creased HR and SVR at rest, and resulted in similar graded 
responses to LBNP. Plotting FVI or CO vs LVDD yielded typi-
cal Frank-Starling'curves, and combining values before and 
after salt depletion resulted in one continuous curve, con-
sistent with a constant contractile state. Thus, LBNP pro-
duces significant changes in LVDD and FVI, which enable 
construction of Frank-Starling curves. 
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EFFECT OF ECG-GATED HIGH FREQUENCY VENTILATION ON CARDIAC 
OUTPUT IN DOGS. Douglas S. Schulman, M.D., James W. 
Biondi, M.D., Leonard Bell, M.D., David L. Rutlen, M.D. 
Yale University, New Haven, CT. 
High frequency ventilation (HFV) has been proposed as an 
alternative to conventional positive pressure ventilation 
in certain Pts, since HFV is associated with decreased 
intrathoracic pressure and improved CO. The present 
study was designed to examine whether CO can be further 
enhanced with gating of HFV to the cardiac cycle hy 
studying the effects of HFV and ECG-gated HFV in 5 
anesthetized closed chest dogs (2 dogs were also studied 
with an open chest). CO was measured with an AO flow 
probe and pericardial pressure (PP) with a pericardial 
balloon. LA transmural pressure (measured LA 
pressure-PP), CO, pulmonary vascular resistance (PVR) and 
PP were compared at ungated HFV (40 to 120 breaths/min), 
ECG-gated HFV with 1 breath:l systole (1:1) and ECG-gated 
HFV with 1 breath:2 systoles (1:2) at driving pressures 
10-25 psi. 
HFV 1:1 1:2 
CO (Llmin) 1. 3+0. 3 1. 2+0. 2 1.6+0.4*a 
PVR (dseccm-5) 476+182 434+161 224+121*a 
PP (mmHg) 4.5+0.6 5.1+1.1 4.1+0.7* 
LAP(mmHg) 1.4+0.7 1.6+0.7 2.5+0.8*a 
With an open chest, all modes of ventilation were 
similar. Systemic vascular resistance was also similar 
in all modes. (p <0.05" 1:1 vs 1:2, a 1:2 vs HFV) 
Although (1:1) ECG-gated HFV was not associated with 
increased CO compared to ungated HFV, (1:2) ECG-gated HFV 
was associated with a significant increase in CO. It is 
likely that this enhancement of CO is secondary to 
decreased RV afterload (PVR) and increased LV preload 
(LAP). Therefore (1:2) ECG-gated HFV may be superior to 
ungated HFV and may be useful in Pts with compromised 
respiratory and cardiac function. 
Thursday, March 31, 1988 
10:30AM-12:00NOON, Room 364, Level Three 
Hormonal and Neural Regulation in Exercise 
EXERCISE TRAINING AND RESPONSIVENESS OF CORONARY 
ARTERIES. P. J. Rogers, M.D., B. A. Bauer, 
J. M. Brum, M.D., A. A. Bove, M.D., Ph.D., F.A.C.C., 
and P. M. Vanhoutte, M.D., Ph.D. 
Mayo Clinic and Foundation, Rochester, MN 55905. 
Acute exercise is associated with catecholamine 
release. Recurrent exposure to catecholamines modifies 
the sensitivity of receptors. As such, exercise training 
may affect the sensitivity of the epicardial coronary 
arteries to adrenergic stimulation. To test this 
hypothesis, in vitro studies were performed on coronary 
arteries from 14 male dogs with demonstrated ability to 
run on a treadmill. The animals had been randomly 
separated into two groups: sedentary (n=7) or exercise 
training (n=7). After 11 weeks, rings of left circumflex 
and left anterior descending coronary arteries were 
studied in vitro for ~l-adrenergic, ~2-adrenergic, and 
a-adrenergic sensitivity and for sensitivity to 
substance P and vasoactive intestinal polypeptide. 
Contractions to ~l-adrenergic agonists (norepinephrine 
and phenylephrine) showed no significant change with 
exercise training. Relaxation was determined in rings 
contracted with prostaglandin F2~' Endothelium-dependent 
relaxations (to norepinephrine [~2-adrenergicl, UK14304, 
and substance p) showed no significant change with eXer-
cise training. Endothelium independent relaxation to 
norepinephrine (B-adrenergic), isoproterenol, and epi-
nephrine was decreased in rings from exercise-trained 
animals. Reiaxation to vasoactive intestinal polypeptide 
was decreased in rings with endothelium from exercise-
trained animals. These findings demonstrate a decrease 
in sensitivity of vascular smooth muscle to relaxation 
with B-adrenergic agonists and with vasoactive intestinal 
polypeptide after exercise training. 
JACC Vol. 1\, No.2 
February 1988:246A 
EFFECT OF EXERCISE CONDITIONING ON ACTION POTENTIAL 
DURATION AND NOREPINEPHRINE CONTENT IN HEART MUSCLE FROM 
SENESCENT RATS. 
Mara T. Slawsky M D Ph D G. Maurice Briggs, Ph.D., 
Cynthia L. Perreault, B.S., Jeanne Y. Wei, M.D., Ph.D., 
F.A.C.C., JUdith K. Gwathmey, V.M.D., Ph.D. Harvard-
Thorndike Laboratory, Harvard Medical School, Boston, 
MA. 
It has been shown that cardiac muscles from exercised-
trained aged rats (EAR) have shortened isometric con-
traction duration (CD) when compared to sedentary aged 
rats (SAR). To test the hypothesis that EAR also have 
altered cardiac electrophysiological properties and 
norepinephrine content (NE) , right ventricular papillary 
muscles were studied at Lma~ and bathed in a physiologi-
cal salt solution at 30 C. Standard microelectrode 
techniques were used. NE content in ventricular tissue 
was measured using liquid chromatography. CD was shorter 
in (EAR, but action potential duration (APD) in the EAR 
appeared prolonged. There were no differences in resting 
membrane potential and action potential amplitude. Heart 
weight(body weight ratios were not different (EAR .29 ± 
0.5, SAR .29 ± .01). Ventricular tissue NE was increased 
EAR 1212 ± 25 ng/tissue, SAR 630 ± 105; p<.03). 
Conclusions: APD and CD changes may reflect direct NE 
effects and/or effects of adrenergic stimulation. 
Alterations in excitation· contraction coupling may 
indicate increased catecholamine availability and/or 
responsiveness, to exercise training. 
EFFECf OF CARDIAC FUNCTION ON HEMODYNAMIC, 
HORMONAL AND METABOLIC RESPONSES TO DYNAMIC 
EXERCISE. 
FeUx E. Tristani M D F.A.C Cn Lois M. Sheldahl, Ph.D., Scot 
Levandoski, B.S., James Dunnick, M.D., Anthony B. Gustafson, 
M.D., Ronald Kalkhoff, M.D., James Kalbfleisch, Ph.D. V A Medical 
Center and Medical College of Wisconsin, Milwaukee, WI. 
This study was performed to assess the effect of LV dysfunction 
secondary to myocardial infarction (MI) on the hemodynamic, hormonal 
and metabolic responses to exercise in post-MI patients not limited by 
congestive heart failure (CHF) or angina pectoris. Twenty post-MI pts 
(2-6 mos) and 10 age-matched normal (N) men underwent treadmill 
e~ercise testing at 40, 60, 80 and 100% peak oxygen consumption 
(V02). All stopped for fatigue and none were physically trained. To 
compare degree of LV function, pts were subdivided into LV ejection 
fraction (LVEF) S4O% (10 pts) and ~50% (lOpts). Beta blockers were 
discontinued for 3 days. Heart rate (HR), systolic blood pressure 
(SBP), respiratory exchange ratio (R), and venous plasma levels of 
lactate (L), norepinephrine (NE) and epinephrine (BPI) were measured. 
Means ±.SD at peak are shown: 
V02 HR SBP L 
(mllkglmin) (bpm) (mmHg) (mM) 
MI 26.6±5.6t 166±15 184±19 8.4±1 .ot 
N 34.0±3.6 176±14 191±15 15.8±3.1 
(*P <0.05: t P <0.01 compared \0 N) 
EPI 
(pg/ml) 
112±70* 
361±406 
NE 
(pg/ml) 
2429±1082* 
3317±1492 
Similar levels of R (1.14 vs 1.20) and HR suggest relative equal peak 
effort. There were no differences in SBP and HR. V02, L, EPI and 
NE were significantly different The peak V02 was lower in L VEF ~O 
compared to ~O% (24.7±6.1 vs 28.3±4.7: P <0.05) at similar peak 
HR (168±10 vs 164±20). There were no significant differences in any 
other measured variables between the twoMi groups. We conclude that 
post-MI pts not limited by CHF or angina have abnormal hormonal and 
metabolic responses to exercise, although their hemodynamic response 
is preserved. Pts with moderately reduced or ,preserved LV function 
responded similarly to exercise except for peak V02. 
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B-RECEPTOR DENSITY AND VASCULARITY VARY MARKEDLY IN 
SKELETAL MUSCLES WITH HIGH AND LOW RESPIRATORY CAPACITIES 
WH Martin. MD. FACC, SS Murphree, MD, TK Tolley, BS, and 
JE Saffitz, MD, PhD, Washington University, St. Louis, MO. 
Patients with chronic congestive heart failure have 
abnormal skeletal muscle blood flow and aerobic 
metabolism. Endurance exercise training enhances both 
vasodilatory and metabolic capacities. These effects may 
be due to down- or up-regulation of B-adrenergic recep-
tors (BAR) associated with heart failure or endurance 
training, respectively. To delineate potential roles of 
BAR, we have characterized BAR densities in myocytes and 
arterioles in rat soleus (S), a slow twitch red muscle 
with high metabolic and vasodilatory capacity; white 
vastus (WV), a fast twitch white muscle with low aerobic 
metabolism and vasodilatory capacity; and gastrocnemius 
(G), a mixed fiber muscle. Muscle slices were incubated 
with 0.1 to 100 pM [125I]cyanopindolol ± 10-5 M 
I-propranolol. Myocytic and vascular binding sites were 
quantified autoradiographically. Total BAR content of 
red muscle was nearly 3 times that of white muscle and 
1.B times that of mixed muscle (Bmax = 23.5 ± 5.4 (S), 
B.l ± 0.1 (WV), 13.1 ± 2.4 (G) fmol/cm2 section area; 
n=4, all p<.02). BAR/vessel was similar in resistance 
arterioles (grains/104 ~m2 = 151 ± 20 (S), 136 ± 13 (WV), 
131 ± 30 (G» but varied in myocytes in proportion to 
Bmax (grains/104 ~m2 = 254 ± 21 (S), B9 ± 23 (WV), 
130 ± 3B (G); all p<.Ol). Although BAR/vessel area was 
similar, the number of resistance vessels was much greater 
in red than white or mixed muscles (arterioles/cm2 
section area = B2 ± 13 (S), 18 ± 10 (WV), 11 ± 2 (G); all 
p<.05). Thus, red muscle has significantly greater 
myocyte BAR density and arteriolar supply, potentially 
reflecting its greater aerobic metabolic and vasodilatory 
capacities. These findings shed light on possible roles 
of BAR in muscle pathophysiology. 
MODULATION OF VAGAL ACTIVITY DURING AND 
IMMEDIATELY AFTER EXERCISE: INVESTIGATION 
WITH HEART RATE SPECTRAL ANALYSIS 
J. Philip Saul. MD. Yutaka Ami, MD, Paul Albrecht, PhD, 
L. Howard Hartley, MD, FACC, Leonard S. Lilly, MD, FACC, 
Richard J. Cohen, MD, PhD, and Wilson S. Colucci, MD, FACC. 
Harvard-MIT Division of Health Sciences and Technology, 
and Brigham and Women's Hospital, Boston, MA. 
Periodic fluctuations in heart rate (HR) which occur with 
respiration at frequencies above 0.15 Hz reflect vagal modulation of 
sino-atrial node activity, and are dependent on both the amplitude 
and frequency of respiration. To noninvasively assess the alterations 
of vagal activity which occur with exercise, we determined the power 
spectrum of HR and respiratory fluctuations before, during and after 
graded-workload exercise on a cycle ergometer in 43 normal 
subjects, 8 patients with severe chronic congestive heart failure 
(CHF) and 6 patients sIp cardiac transplant. Prior to exercise HR 
variability (spectral power) at respiratory frequencies between 0.15 
and 0.80 Hz was markedly higher in normals (3.0 ± 2.5 (beats/min)2) 
than either CHF (0.2 ± 0.1 (beats /min )2, p <0.05) or transplant subjects 
(0.1 ± 0.05 (beats/min )2, p<O.05); however, in spite of a 400 % increase 
in respiratory tidal volume during exercise, HR power in the 
respiratory frequency range rapidly and progressively decreased in 
normals until at peak exercise it was not different from the other two 
groups (0.3 ± 0.2 (beats/min)2 vs 0.3 ± 0.2 (CHF) and 0.3 ± 0.1 
(transplants ). HR power in the normals gradually increased during 
recovery to 1.0 ± 0.2 (beats/min)2, but remained significantly below 
baseline (p <0.05). CHF and transplant subjects were never 
significantly different from each other, and neither group changed 
significantly with exercise. 
The findings confirm the absence of significant vagal 
modulation of HR in patients with CHF or sIp transplant, and support 
a progressive withdrawal of vagal activity during exercise in normal 
subjects with a slow gradual increase during recovery. 
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REPRODUCIBILITY OF THE HEART RATE RESPONSE TO 
EXERCISE IN PATIENTS WITH ATRIAL FIBRILLATION 
Rodney H. Falk, M.D., F.A.C.C., Anne A. 
Knowlton, M.D., Nancy J. Battinell.i, R.N. and 
Mary Huntington, M.S. Boston City Hospital and 
Boston University Medical School, Boston, MA 
Exercise tolerance testing (ETT) is frequently 
used to assess the efficacy of therapy for 
heart rate (HR) control in patients with atrial 
fibrillation (AF). However, reproducibility of 
ETT in AF has not been established. To 
determine the HR & BP reproducibility in AF 
during ETT we studied 10 patients, receiving a 
stable digoxin dose (0.125-0.5 mg/day), with a 
modified Bruce ETT protocol on 2 occasions 1-7 
days apart. There was no significant 
difference in mean (±SE) baseline or peak HR 
nor HR at 3, 6 & 9 minutes as follows: 
Base HR Peak HR 3 min 6 min 9 min 
Test 1 79+5 180+7 130+9 148±8 163+6 
Test 2 77+4 179+7 128+8 150+9 165~7 
Mean variability-in peak HR for the same 
individual was 3.2% (range 0-6%) and at 3, 6 & 
9 mins was 6.6% (0-9%), 6.8% (0-18%) and 6% (0-
23%) respectively. Exercise duration varied 
<7% between the 2 tests in all patients. 
CONCLUSIONS: 1) Exercise testing in AF is 
reproducible both for peak HR and exercise 
duration, 2) Despite the abnormally rapid HR 
rise during ETT in AF, HR at each stage of 
treadmill testing is remarkably reproducible in 
most patients, 3) Thus, ETT is likely to be an 
accurate method for assessing drug-induced 
changes of HR in patients with AF. 
Thursday, March 31, 1988 
8:30AM-I0:00AM, Room 216, Level Two 
Pediatric Cardiac Imaging 
THREE DIMENSIONAL MOTION PICTURES OF THE BEATING 
HEART WITH CONGENITAL HEART DEFECTS FROM IN VIVO 
MAGNETIC RESONANCE IMAGES ---
Paul M. Weinberg. M.D .• F.A.C.C., Alvin J. Chin, M.D., Leon 
Axel,M.D.,Ph.D., RaJu Venugopal,I'v1.S., Bernard J. Clark, I'v1.D., 
Gabor Herman, Ph.D., Nathaniel Reichek, M.D., F.A.C.C., 
University of Pennsylvania, Philadelphia, PA. 
Because of limitations encountered with planar displays, three-
dimensional (3D) reconstruction from in vivo magnetic 
resonance imaging (MRO was applied to the study of complex 
congenital heart disease. Four pts ranging in age from 12-31 
mos. with the following diagnoses were studied using 
multiphase, multislice ECG-gated spin echo technique on a 1.5 
Tesla GE Signa MRI system and body coil: 1) single LV, 
restrictive ventricular septal defect (VSD), 2) transposition of 
the great arteries, VSD, subpulmonic stenosis, after Rastelli 
repair, 3) double outlet RV, VSD, subpulmonic stenosis, and II) 
pulmonary atresia after outflow tract reconstruction in the 
neonatal period. Axial slices at 3-5mm intervals were obtained 
over 5-10 cardiac phases. TE was 20-25msec; 2-11 signal 
averages were used. Heart rates ranged from 90-138. The 
number of slices varied from 6-10 according to the heart size. 
Data acquisition took 80-95 minutes (pts sedated using 
l20mg/kg chloral hydrate). Three-D reconstruction algorithms 
with automated segmentation of heart cavities and manual 
segmentation of valves were used to produce movie loops of the 
cavities and valves: the restrictive VSD in the single LV, 
narrowing at the take-off of the external conduit and within the 
intraventricular baffle of the Rastelli repair, the small size of 
the LV in the double outlet RV, and the adequate size of the RV 
sinus and outflow tract in the pulmonary atresia case. Three-D 
reconstruction from ECG-gated MRI is feasible for the 
evaluation of complex spatial relationships and irregular 
chamber shapes encountered in congenital heart disease. 
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CINE MAGNETIC RESONANCE IMAGING FOR THE EVALUATION OF 
PULMONARY ARTERY BANDING IN INFANTS AND CHILDREN. lain 
A. Simpson, M.D., Kyung J. Chung, M.D., FACC, Jack ~ 
Powell, M.D., David J. ·Sahn, M.D., FACC, Dean P. 
Berthoty, M.D., Univ of California, San Diego, CA. 
To define anatomy and physiology of the right ventri-
cular outflow tract after pulmonary artery banding, we 
performed ECG-gated magnetic resonance imaging (MRl) and 
cine ~ffiI using a GE Signa 1.5 Tesla superconducting 
magnet in 6 infants and children l4~11 months after PA 
banding, whose age at the time of the study was, 9-36 
months. All pts were studied after chloral hydrate 
sedation and were placed within a round coil (24 cm 
diameter) for higher resolution imaging. MRI was 
performed in sagittal and rotated coronal views with 5mm 
slice thickness and flow-enhanced imaging in the cine 
mode was obtained by gradient r~called acquisition in 
steady state (GRASS) scanning with a 30· flip angle and 
22 maec repetition time. All patients had postop 
cardiac catheterization (CAUl) for comparison. High 
resolution images of the PA band anatomy were obtained 
in all pts using ECG-gated MRI and the measured PA band 
diameter correlated well with the pressure gradient 
across the PA band at CATH (r- -0.94). Flow through the 
PA hand was seen in all pts by cine MRI and was always 
associated with a Significant high velocity systolic and 
early diastolic signal void distal to the band confirmed 
by continuous wave Doppler as being> 3.0 m/sec. The 
band position and size of the distal main and branch 
PA's correlated well with observations at angiography. 
The combination of ECG-gated and cine MRI provides non-
invasive dynamic spatial and temporal information about 
flow in the outflow tract proximal and distal to the PA 
band as well as high resolution anatomical information, 
assisting clinical evaluation and the timing and 
planning of surgery. 
USE OF NUCLEAR MAGNETIC RESONANCE IMAGING FOR THE 
EVALUATION OF PULMONARY ARTERIES AND RIGHT VENTRICULAR 
OUTFLOW TRACT OBSTRUCTION: COMPARISON WITH 
ECHOCARDIOGRAPHY AND ANGIOGRAPHY 
G. Wesley Vick III. M.D .• Ph.D .• Roxann Rokey, M.D., 
F.A.C.C., Sharon L. Mulvagh, M.D., James C. Huhta, M.D., 
F.A.C.C., Robert Roberts, M.D., F.A.C.C., Donald L. 
Johnston, M.D., F.A.C.C., Baylor College of Medicine, 
Houston, TX. 
We assessed the usefulness of nuclear magnetic 
resonance (NMR) imaging in determining RVOT and PA anatomy 
in pts with congenital heart disease. Eleven pts, (mean 
age 20±9 years) with congenital heart disease and 
suspected right ventricular outflow tract (RVOT) 
obstruction or PA stenosis were studied. Of these, 10 had 
prior surgery [aorticopulmonary (AoPA) shunt placement in 
7]. RVOT obstruction and continuity of the right and left 
PA were assessed by NMR imaging in planes analogous to 
axial angiographic views. Results were compared to two-
dimensional echocardiography (EC) and angiography. 
Identification of the anatomic structures for the 11 pts 
is shown: EC Angi ography NMR 
Right PA 10/11 10/11 11/11 
Left PA 5/11 10/11 11/11 
PA Continuity 5/11 9/11 9/11 
RVOT obstruction 4/11 9/11 9/11 
AoPA shunt 3/7 7/7 7/7 
Compared to EC and angiography, NMR imaging was superior 
in defining proximal and distal PAs in 2 pts with 
discontinuous PAs. The PA size measured by NMR correlated 
linearly with angiography (r=0.95) and EC (r=O.83). We 
conclude that in pts with congenital heart disease, NMR 
imaging augments, and in some cases is superior to EC and 
angiography in the evaluation of PA and RVOT anatomy. 
These findings suggest a central role for NMR imaging in 
the postoperative follow-up of these pts. 
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EVALUATION OF PULMONARY OUTFLOW TRACT ANATOMY BY CINE 
}~GNETIC RESONANCE IMAGING USING ANGLED VIEWS. Kyung J. 
Chung, M.D., FACC, lain A. Simpson, M.D., David J. Sahn, 
M.D., FACC, John R. Hesselink, M.D. Univ of Calif, San 
Diego, CA. 
To evaluate cine magnetic resonance imaging (MRI) as 
a technique for assessing pulmonary outflow tract (OT) 
anatomy and physiology, we studied 30 pts (ages 5 mo-14 
yrs) with various forms of congenital heart diseases 
(CHD) using oblique plsne cine MRI. Twelve pts had pre-
or postop tetralogy of Fallot (TOF), 8 pts had transpos-
ition of the great arteries (TGA) after atrial baffling, 
6 had undergone PA banding (PAB), and 4 had undergone a 
Fontan operation. Cine MRI was performed on a GE 1.5 
Tesla Signa system with images obtained using a flip 
angle of 30·, repetition time of 21 msec, echo time of 
12 mscc and acquired with a 5 to lOmm slice thickness. 
In TOF, a narrow RVOT and PA were seen in all pre-op 
pts. Postoperatively, a widened RVOT was seen in all and 
pulmonary regurgitation as a signal void area in the 
RVOT was visualized. In l'GA the left ventricular out-
flow area and PA were well visualized in all pts and 
none had signs of LV outflow tract obstruction. In pts 
after Fontan procedure, free swirling flow through the 
RA to PA connection was seen clearly and 1 pt had a 
stenotic area at the site of the FA connection. In the 
infants with PAB, the diameter of the band site corre-
lated well with the gradient at cardiac catheterization 
(r- -0.94) and high velocity lucent flow jets distal to 
the band, all associated with Doppler velocities, > 3 
m/sec, the anatomy of the PAB site, and the anatomy of 
the PA's were well outlined. Cine MRI can provide 
accurate anatomical assessment and unique observations 
about flow in pre-and postoperative CHD and should be a 
safe and serially applicable noninvasive method for 
diagnosis and followup. 
REGIONAL PULMONARY PERFUSION IN PIGS WITH AoRTD-PULMONARY 
SHUNT ESTIMATED BY HIGH-SPEED COMPUTED TOMOGRAPHY. 
Xuesi Wu, M.D., Larry A. Latson, M.D., F.A.C.C., Tao Wang, 
M.D., David J. Driscoll, M.D., F.A.C.C., Gregory J. 
Ensing, M.D., Erik L. Ritman, M.D., Ph.D., Mayo Medical 
School, Rochester, MN. 
We have used a fast multislice computed tomography 
scanner, the Dynamic Spatial Reconstructor (DSR), to 
obtain measurements of regional pulmonary blood flow. 
Five juvenile pigs were studied from 5 to 9 months after 
three had AD-to-PA shunts created surgically and two had 
sham thoracotomy. After anesthesia with ketamine and pen-
tobarbital, 60-per-second scans were recorded for 20 
seconds during injection of a 32 cc Iohexol bolus. One 
scan was performed during RA and one during LV injection. 
Transaxial images were computed, one for each heart cycle. 
From average image brightness in selected regions of 
interest over the lung field, we derived radiopaque dye 
dilution curves from which, in turn, regional pulmonary 
parenchymal blood flow was calculated using FlownSR speak 
increase in roentgen opacity over lung/area under PA curve 
when RA injection, or area under AO curve wh~n LV injec-
tion. DSR flow was compared to distribution, at autopsy, 
of previously injected radiolabeled microspheres 
(pspheres). FlownSR = 0.83 Flow (psphere) + 0.52; 
r = 0.964 with flow range from 0.1 to 12.6 ml/gm/min. 
Slope <1 is attributed to increased psphere packing den-
sity due to partial collapse of lungs at postmortem sec-
tioning. Intra-observer (5 tries) estimates of Flow = 0.99 
F low (average of intra) + 0.03; r = 0.993 and inter-
observer (4) estimates of Flow = 0.99 Flow (average of 
inter) + 0.01; r s 0.993. We conclude that regional 
pulmonary perfusion, both RV and AO components, can be 
measured by fast CT scan during passage of a bolus of 
contrast medium. 
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SPONTANEOUS CLOSURE RATE OF ATRIAL SEPTAL DEFECTS 
DIAGNOSED IN INFANCY. 
Rae-Ellen W. Kavey, MD FACC, Marie S. Blackman MD FACC, 
Craig J. Byrum, MD, Frank C Smith MD; SUNY-Health Science 
Center at Syracuse, New York. 
Two-dimensional echocardiography(2DE) has allowed con-
firmation of the clinical diagnosis of secundum atrial 
septal defect(ASD) in infancy. To evaluate the incidence 
of spontaneous closure of such defects, the records of all 
pts in whom a clinical diagnosis of ASD was made after 
July 1st, 1980, when 2DE became routine in this institution 
were reviewed. Pts were included when an auscultatory 
diagnosis of ASD was supported by typical electrocardio-
graphic, radiographic and 2DE studies. Only pts who were 
followed for 2 or more yrs were included. 43 pts met the 
criteria for inclusion in this retrospective review. Of 
these, 17 ultimately underwent repair of an atrial septal 
defect; 7 pts still carry this diagnosis and surgical re-
pair is anticipated. In 2 pts the diagnosis of ASD was con-
sidered retrospectively to have been erroneous. However, 
in 17 pts there is no longer any evidence to support a 
diagnosis of ASD. On serial follow-up, physical findings 
changed first with loss of diastolic murmur by a mean of 
2 yrs of age. 2DEs were read as normal or showing only a 
patent foramen ovale by a mean of 4 yrs of age. The high 
spontaneous closure rate of 39.5% in this retrospective 
clinical series suggests that significant left to right 
shunting at atrial level diagnosed in infancy can decrease 
with time. It is possible that shunting occurs through a 
patent foramen ova Ie in these young pts or that true spon-
taneous diminution of an ASD does occur. In this time of 
decreasing age for open heart repair, the study results 
suggest that asymptomatic pts in whom a diagnosis of ASD 
is made in infancy should be followed prospectively until 
at least 4 yrs of age before elective surgical repair is 
considered. 
Thursday, March 31, 1988 
10:30AM-12:00NOON, Room 216, Level Two 
Post·Op Evaluation of Surgical Results 
RELATIONSHIP OF PRE-OPERATIVE LEFT VENTRICULAR 
MUSCLE MASS TO THE OUTCOME OF FONTAN PROCEDURE 
IN PATIENTS WITH TRICUSPID ATRESIA 
Mohamed Seliem, M.B., CH.B., Alexander Muster, MD, FACC, 
Milton Paul, MD, FACC, D. Woodrow Benson Jr, MD, PhD, 
FACC. Children's Memorial Hospital, Chicago, IL 60614 
To evaluate the relationship of pre-operative left ventricular 
muscle mass (LVM) to the outcome of Fontan procedure in 
Pts with tricuspid atresia, the L VM was determined retrospec-
tively by Rackley's method from LV angiograms of 22, Pts 
considered suitable candidates for this procedure by conventional 
selection criteria. Pts were divided into 2 groups based on 
the outcome assessed up to 9 years postoperatively: Group 
A (13 Pts) without clinically significant systemic venous hyper-
tension (SVH) and not on long-term diuretic therapy; Group 
B (9 Pts) with clinically significant SVH and on long-term diu-
retic therapy or death (3 Pts). Age at surgery, pulmonary 
vascular resistance, LV ejection fraction, LV end diastolic 
volume (EDVl, LVEDP, systemic O. saturation, and pulmonaryl 
systemic flow ratio were not statistically different between 
the two groups. The LVM (gm/m') in Group A (92 ± 31, mean 
± So) was not significantly greater than normal mean value 
(86±11, Graham et ai, 1971). The LVM in Group B (146 ± 61) 
was significantly greater than both normal (p .::: .(01) and Group 
A (p < .02). Further, the LVMI LVEDV ratio, reflecting relative 
degree of LV hypertrophy in response to volume overload was 
significantly greater in Group B (1.1 ± .28) than in Group, A 
(,84 ± .21), p < .05. This indicates greater hypertrophy With 
stiffer, less compliant LV in Group B than in Group A. The 
sensitivity of LVM in predicting outcome of Fontan procedure 
in this sample was 89%, with specificity of 85% and predictive 
value of 80%. Conclusion: preoperative LVM appears to be 
a sensitive variable for anticipating the outcome of Fontan 
procedure in Pts with tricuspid atresia who fulfill other conven-
tional selection criteria. 
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EVALUATION OF RIGHT VENTRICULAR FUNCTION 
BY REGIONAL WALL MOTION ANALYSIS IN PATIENTS AFTER 
TRANSPULMONARY-TRANSATRIAL REPAIR FOR TETRALOGY OF FALLOT 
Takuya Miura, M.D., Hikaru Matsuda, M.D., Susumu Nakano, 
M.D., Yasuhisa Shimazaki, M.D., Hajime Hirose, M.D. and 
Yasunaru Kawashima, M.D., Osaka Uni versi ty, Osaka, Japan. 
Transpulmonary-transatrial (PA/RA) repair for tetralogy 
of Fallot (TF) has been proposed as advantageous to the 
conventional trans-right ventricular (RV) repair, but the 
late hemodynamiC result has not been well evaluated. 39 
patients (pts) after PA/RA repair (age:4.3+4.5yrs) were 
compared to 23 pts after trans-RV repair (5.5+4.7yrs) by 
assessing regional RV wall motion. The pts were divided 
into 3 groups, Group-A: PA/RA repair without RV-tomy, 
Group-B: PA/RA repair with minimal RV-tomy and small 
transannular patch, Group-C: conventional trans-RV repair 
(transannular patch in 26%). Postoperative interval were 
23±13, 25±17, 78±60 months, respectively. RV/LV pressure 
ratio showed no significant difference among 3 groups. 
Area system for regional RV wall motion analysis was 
applied in the lateral view of RV-graphy, and fractional 
area change (FAC) was obtained for 3 divided areas of RV 
free wall, upper(u), middle(m) and lower(l). RV ejection 
fraction (EF) was also compared. 'llhe analysj s were made 
at rest and during isoproterenol (Isp) infusion. 
Group N FACu FACm FACI RVEF 
A 17 32±11* 38±5* 37±7* 57+7* 
rest B 22 21±8 35±7* 32±7* 57±6* 
C 23 18±7 25±6 25±6 48±7 
A 7 41±11*# 50±7*# 49±7*# 65+6*# 
Isp B 14 24±13 43±6*# 44±7*# 61±6*# 
C 10 23±12 28±10 36±12# 53±5 
*:p<O.05 vs other groups, #:p<O.05 vs rest, (%,mean±SD) 
The results indicated that the PA/RA repair provided 
better postoperative RV function with preserving the 
regional RV wall motion. 
ATRIOVENTRICULAR VALVE INSUFFICIENCY: CONTRAINDICATION TO 
THE MODIFIED FONTAN? 
Thomas M. Zellers, M.D., Richard A. Humes, M.D., Co-burn 
J. Porter, M.D., F.A.C.C., Francisco J. Puga, M.D., 
F.A.C.C., Gordon K. Danielson, M.D., F.A.C.C., Mayo 
Clinic, Rochester, Minnesota. 
Atrioventricular valve insufficiency (AVVI) has been 
stated to be a contraindication to modified Fontan opera-
tion (FO). To test this exclusion criteria, we compared 
85 pts with preop AVVI (mild, mod., severe) to 102 "ideal" 
controls all of whom underwent FO for tricuspid atresia, 
double i~let left ventricle or complex single ventricles. 
Of the AVVI pts, 57% had ~3 exclusion criteria (PAP >15 mm 
Hg: 69%; RP >4 U: 45%; EF <60%: 66%). 
Preop VEDP, volume and duration of postop pleural effu-
sion and late death were higher in AVVI pts compared to 
controls. However, hospital death, pre- and postop 
arrhythmias, postop (R) and (ll atrial pressure, incidence 
of ascites were not different between the 2 groups. 
Patients with severe AVVI had increased risk of hospital 
death compared to pts with mild or moderate AVVI. 
AVVI Control P 
VEDP (mean; mmHgl 14.5 12.5 0.017 
Effusion Vol (median) 3.82 l 2.15 l 0.0008 
Effusion Our (median) 12 days 8 days 0.004 
Hospital Death 12 % 14 % 0.69 
Late Death (2 yr) 13 % 6 % 0.023 
Of the late surV1vors w1th AVVI, 90% are NYHA Class 1-2, 
98% are working/attending school, but after at least 1 yr 
follow-up, 75% and 50% are still taking digo~in and diure-
tics, respectively (compared to 36% and 20% 1n controls). 
For pts with AVVI, we conclude: 1) Except for postop 
pleural drainage, hospital morbidity and mortal~ty is not 
increased 2) late death is higher compared to 1deal pts, 
but late ~urvivors are doing well, with 75% still taking 
cardiac medications: 
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GLENN SHUNTS: EFFECT UPON PLEURAL DRAINAGE AFTER FONTAN 
OPERATION 
Thomas M. Zellers, M.D., Richard A. Humes, M.D., David J. 
Drlscoll, M.D., F.A.C.C., Robert H. Feldt, M.D., F.A.C.C., 
Francisco J. Puga, M.D., F.A.C.C., Gordon K. Danielson, 
M.D., F.A.C.C., Mayo Clinic, Rochester, MN. 
Theoretically, pleural drainage after Fontan operation 
(FO) may be less in patients (pts) with a prior Glenn 
shunt (G) compared to those without because of unaltered 
innominent vein and thoracic duct pressure in the former 
group. We compared patients with G (n=46) to controls (C; 
n=46) matched for age, sex, dx, number of prior shunts, 
and prior R thoracotomy; all had a FO between 1973 and 
1986. The volume of pleural drainage was significantly 
less in the G group. There was no significant difference 
between the groups with regard to EDP, RAP, PAP, duration 
of total or differential (right vs left) effusion, hospi-
tal stay, hospital or late death. 
Effuslve vol. (medlan) 
Duration of effusion 
VEDP 
RAP 
PAP 
hospita 1 death 
late death (5 years) 
G 
1959 cc 
9.6 days 
15 
17 
17 
15% 
16% 
C 
3200 cc 
13.8 days 
14 
18 
16 
7% 
7% 
p value 
= 0.03 
0.06 
0.25 
0.07 
0.8 
0.2 
0.9 
Among the late survivors in both groups, >90% were in NYHA 
Class 1 or 2, and >95% were working or attending school. 
We conclude: 1) pleural drainage after Fa is signifi-
cantly less in pts with a prior Glenn shunt; 2) Less 
drainage may, in part, be related to unaltered innominate 
vein pressure in the G gro~p; 3) Mortality and morbidity, 
otherwise, were no different in the two groups. 
EARLY VARIATIONS OF RIGHT VENTRICULAR SIZE AND 
FUNCTION AFTER VALVOTOMY IN NEWBORNS WITH 
PULMONARY ATRESIA OR CRITICAL STENOSIS AND INTACT 
VENTRICULAR SEPTUM. 
Jean-Louis Cloez M 0 , Klaus G. Schmidt, M.D., Edward Verrier, 
M.D., Kevin Turley, M.D., F.A.C.C., Norman H. Silverman, M.D., 
F.A.C.C., University of Califomia, San FranCiSCO, CA. 
Early variations of right ventricular size and function after balloon 
(nal) or surgical (n=ll) valvotomy (V) were evaluated by 20 echo 
in 12 newborns with pulmonary atresia or critical stenosis and 
intact ventricular septum. Studies were performed before and 4 ± 2 
days after V in all newborns and also 15 ± 3 days after V in 6 
newborns. From subcostal planes, we determined RV end diastolic 
volume (EOV) and stroke volume (SV) using a Simpson's rule 
algorithm. We also measured the ratio of RV/LV end diastolic cavity 
areas (RV/LV areas) from the apical four-Chamber view. Results are 
expressed as mean ± SO. (* P < 0.05 or less compared to pre V 
values) 
RVEOV RVSV RVlLVareas 
(ml) (mil 
Pre V 2.9 ± 1 1.3 ± 0.4 0.57 ± 0.1 
Post V (4 days) 2.3 ± 1* 1.3 ± 0.6 0.36 ± 0.1* 
Post V (15 days) 2.7 ± 0.6 1.6 ± 0.8' 0.54 ± 0.1 
In the early period after valvotomy, RV EOV and RV/LV areas 
significantly decreased (by 26% and 58%, respectively) without 
change in RV stroke volume. Right ventricular EOV only returned to 
pre V level over two weeks with an improvement in stroke volume 
(by 19%). These data indicate that the noncompliant right ventricle 
in pulmonary atresia or pulmonary critical stenosiS is not able to 
supply alone pulmonary blood flow immediately after decompression. 
Until RV performance recovers, prostaglandin El therapy to 
maintain duct patency appears necessary for survival. 
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Effect on Cardiac Output of a Cardiac Rehabilitation Program 
in Children After Surgical Repair of Congenital Heart Disease 
Frank M. Galioto, Jr., M.D., F.A.C.C., Teresa L. Tomassoni, 
M.A., Paul Vaccaro, Ph.D. Jane Vaccaro, M.S. Children's 
Hospital National Medical Center, Washington, D.C. 
Cardiac output (Gl) measures at rest and peak exercise were 
made in eight children with repaired congenital heart defects 
(Mustard operation for d-transposition of the great arteries - 3, 
mitral valve replacement - 1, tetralogy of Fallot - 2, and 
Fontan operation - 2) to determine the effects of physical 
training. Children ranged in age from 4.5 to 15 years, mean 
8.5 years. Subjects participated in a 24 session, 12 week, I to I 
1/2 hour hospi tal-based aerobic exercise program of graduated 
intensity and duration. Graded exercise testing on a treadmill 
was performed prior to and following the training program. 
Pre- and post-training values of a at rest and at peak exercise 
were obtained by acetylene rebreathing. Following training, 
mean values of Q at rest increased from 2.19 to 3.19 Jlmin 
(p < 0.05) and at peak exercise from 4.91 to 6.05 Ilmin 
(p <.0.05). Indexed values of ~ also increased significantly 
from pre-training to post-training. Other parameters that 
increased significantly included total treadmill time and peal< 
systolic blood pressure. These data indicate that a monit3red 
aerobic exercise program can increase cardiac output and 
other measures of cardiac performance in children following 
surgery for congenital cardiac defects. 
Thursday, March 31, 1988 
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Hypertrophic Cardiomyopathy 
RELATIONSHIP BETWEEN THE LOCATION OF 
HYPERTROPHY AND DIASTOLIC FUNCTION IN PATIENTS 
WITH HYPERTROPHIC CARDIOMYOPATHY. 
Anatoly Lan~er. M D.. Peter Liu, M.D., F.A.C.C., Mark 
Henkelman, h.D., Susan WiIansky, M.D., FAC.C., Harry 
Rakowski, M.D., FAC.C, Ron Unrau, Ph.D., E. Douglas Wigle, 
M.D., F.AC.C. Toronto General Hospital, Toronto, Canada. 
To test the hypothesis that the location of hypertrophy in 
patients (pts) with hypertrophic cardiomyopathy (HCM) bears an 
lffiportant relationship to the presence of abnormal diastolic 
function, 33 patients with HCM (aged 20-71 years) were evaluated 
for myocardial mass with nuclear magnetic resonance imaging 
(NMRI) and diastolic function with time resolved resting 
radionuclide angiography (RNA). Computerized automated 3-D 
reconstruction of NMRI tomograms allowed calculation of left 
ventricular mass. Visual assessment of the NMRI classified the 
location of hypertrophy to be septal only in 5 pts (SEP), apical 
only in 9 pts (API), and diffuse in 19 pts (DIF). The RNA 
diastolic relaxation parameters included: time to peak filling 
(TPF), atrial contribution fraction (AS), and peak filling rate 
(PFR) expressed in stroke volume (Sv) per second. 
The results were as follows: 
Mass(iffi} PFR(Sv (sec) TPF<msec) ASi.%l 
API 358+40 S.1+.6** 161+37* 17+S* 
SEP 34O±108 4.S±I.4 218±SI* 27±18 
DIF 411.±.123 3.9.±..8** 271.±.182* 27.±.12* 
·p<.OS, "p<.OI amongst HCM class by ANOVA 
Therefore despIte similar myocardial mass, apical hypertrophy 
group had the least abnormal diastolic functIOn, and diffuse 
hypertrophy group had the most abnormal diastolic function. 
Septal involvement, despite its relative small impact on mass, 
confers global diastolic abnormalities similar in degree to diffuse 
hypertrophy. This suggests that the location of hypertrophy may 
have a very significant bearing on the diastolIc function in 
patients with hypertrophic cardiomyopathy. 
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OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN THE ELDERLY: A 
UNIQUE GROUP OF PATIENTS WITH SMALL LEFT VENTRICULAR 
OUTFLOW TRACT. MITRAL ANULAR CALCIFICATION. AND LATE 
ONSET OF SEVERE SYMPTOMS 
Jannet F. Lewis. M.D •• F.A.C.C •• Barry J. Maron. M.D •• 
F.A.C.C •• NHLBI. Bethesda. Md. and Howard University 
College of Medicine. Washington. D.C. 
Hypertrophic cardiomyopathy (HCM) is a primary disease of 
cardiac muscle characterized by onset of symptoms usually 
before the 5th decade of life. We evaluated 50 pts with 
HCM (age 60-84 years. mean 71) who developed abrupt onset 
OF severe and progressive functional limitation late in 
life (age 56-81 years. mean 68); vast majority were women 
(44. 88J). Most pts (38 or 76J) did not improve on drug 
therapy. although 12 improved after operation. Left ven-
tricle was characterized by these echocardiographic fea-
tures: 1) small left ventricular outflow tract (LVOT); 2) 
systoliC anterior motion (SAM) of the mitral valve; 3) 
mitral anular calcification. LVOT was particularly small 
with diastolic mitral valve to septum distance 18 mm+2. 
(vs. 22 mm+4 in a control group <40 years with obstruc-
tive HCM; p<O.OOl); this reflects marked anterior dis-
placement of mitral valve in LV. Mitral anular calcifi-
cation was severe in 37/50 (74J) pts and contributed to 
reduced LVOT size. Therefore. mitral-septal contact and 
dynamic subaortic obstruction in elderly pts with HCM 
was achieved by mild SAM of a markedly anteriorly dis-
placed mitral valve and associated systolic posterior 
septal excursion. In conclusion. we have described a 
unique subset of elderly pts (primarily women) with ob-
structive HCM who developed severe progressive symptoms 
late in life and manifested unusual LV morphology 
characterized by a particularly small outflow tract 
with mitral anular calcification. severe anterior dis-
placement of the mitral valve. and SAM. 
VERAPAMIL IMPROVES SILENT MYOCARDIAL PERFUSION 
ABNORMALITIES IN ASYMPTOMATIC HYPERTROPHIC CARDIOMYOPATHY 
James E. Udelson. MD. Robert O. Bonow. MD. FACC. Patrick 
T. O'Gara. MD. Stephen L. Bacharach. PhD. Arthur 
Van Lingen. PhD. Steven M. Larson. MD. and Stephen E. 
Epstein. MD. FACC. NHLBI. Bethesda. Md. 
Recent studies have shown that reversible thallium perfu-
sion defects. oompatible with LV ischemia, oommonly devel-
op during exeroise in asymptomatio or mildly symptomatic 
(Asx) pts with hypertrophic cardiomyopathy (HCM). To as-
sess the effeot of therapy. we studied 22 Asx HCM pts. age 
18-52 (mean 29). with exeroise thallium emission computed 
tomography under control oonditions and again after 1 week 
of oral verapamil (V). mean dose 453 mg/day. Treadmill 
time inoreased slightly during V (21.2 to 22.0 min ~<0.5). 
but double produot was unchanged (26.9 vs 25.8 X 10 • p= 
NS) • Two midventrioular short axis images per study were 
divided into 5 regions eaoh; each of these 10 regions was 
then analyzed on a 0-2 scale by 3 observers blinded to 
therapy. Average regional soores <1.5 were oonsidered 
perfusion defeots and a change in regional soore >.5 
between studies was oonsidered a signifioant ohange. On 
control studies. all pts showed normal homogeneous perfu-
sion at rest. but 13 pts (59J) had reversible perfusion 
defects during exercise. averaging 3.5 regions per pt. 
During V. exercise perfusion scores in 9 of these 13 pts 
(69J) improved. with overall improvement in 31 of 45 (69J) 
initial perfusion defects. In 6 pts. all regional perfu-
sion defeots that were apparent during exercise under con-
trol conditions (average 4/pt) normalized completely dur-
ing V. No region worsened during V in any pt. Thus. ex-
ercise-induced regional myocardial perfusion defects im-
proved during V in the majority of these Asx pts. in many 
cases completely. These data suggest that V may diminish 
inducible silent ischemia in many Asx pts with HCM. 
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DOPPLERVELOCITY- AND CINEANGIOVOLUMETRIC MEASUREMENTS IN 
FIXED AND DYNAMIC OBSTRUCTION. 
Folkert J. Ten Cater M.D •• Patrick W. Serruys. M.D •• Cees 
Slager. MSc. Inge Zorn. Thoraxcenter. Erasmus University 
Rotterdam. The Netherlands. 
It has been suggested that both pulsed and continuous 
wave (CW) Doppler (D) show the presence of obstruction 
as a cause for the gradient in Hypertrophic Cardiomyo-
pathy (HCM). To test whether these suggestions are valid 
we studied seven pts with so called "obstructive" HCM 
(m: gradient: 50 + 12 mmHg) by Doppler and Angiocardio-
eraphy (A). The results were compared to findings out of 
normals (n=12) and valvular aortic stenosis (AS) (n=7; 
m: gradient: 60 + 18 mmHg). Frame to frame volume mea-
surements of A were performed giving a representation 
of percent stroke volume (% SV) during ejection time 
(% ET). 
%SV 
ET 
AS 
normals 
HCM 
Routine D was performed to relate the presence of peak 
velocity by CW to % ET. In HCM peak velocity occurred 
at 69% ET at which % SV remaining for Ejection was only 
15%. whereas in AS peak velocity occurred at 50% ET at 
which SV to be ejected was almost 60%. Thus the high 
late systolic velocity in HCM proposed as a sign of ob-
struction have an alternative explanation as well. Since 
% ejected SV is virtually absent at this time these fin-
dings support the concept of an early emptying left ven-
tricle rather than obstruction to flow. 
CHORDAL GEOMETRY DETERMINES THE SHAPE AND EXTENT OF 
SYSTOLIC ANTERIOR MITRAL MOTION: IN VITRO STUDIES 
Robert A. Levine, MD, FACC, A. Jimoh, Diane Simons, Edward 
G. Cape-;- Ajit P. Yoganathan, PhD, Arthur E. lIeyman, MD, 
FACC. Massachusetts General Hospital, Boston, MA. 
In hypertrophic cardiomyopathy (HCM) , the mitral valve 
(MV) moves anteriorly (SAM), assuming a unique cowl shape 
with mitral-septal contact centrally and preserved orifice 
area la terally. Echocard iography (2DE) reveals an terior 
and inward papillary muscle displacement (PM DIS) in HCM. 
It has been suggested that such DIS, by decreasing central 
and anterior (ANT) chordal tension (CT), can promote SAM 
with central cowl formation, which has been reproduced in 
vivo by PM DIS. To test the hypothesis that ~ nonuniform 
distribution of f!: can promote SAM, a horizontal leaflet 
mounted in a flow chamber was attached by chords at its 
distal end to a series of upstream rods. CT could be 
varied by turning the rods or shifting their position 
anteriorly or posteriorly within the model. Leaflet shape 
was recorded by 2DE as CT was released and flow varied. 
RESULTS: 1) Cowl formation occurred when central CT was 
released and lateral CT maintained. 2) Directing CT 
anteriorly caused larger cowls to form (with smaller 
orifice areas) at earlier stages of CT release. 3) 
Increasing flow had a similar effec t. CONCLUSIONS: 1) 
Anterior redirection of the CT vector promotes ANT motion 
of a tethered leaflet in a flow field, suggesting a role 
for ANT ~ DIS in promoting SAM. 2) The configuration of 
SAM can be reproduced by decreased central CT, suggest-
ing that a nonuniform distribu- OflIF!CEAREAvsCHOROALRELEASE 
tion of CT, which may result ~-~,_, 
from PM DIS, can play an 'i, "_, " 
important role in determining ~ ~ 
obstructive geometry in HCM. ~, . ,-, '""- "--. ~ -....-
a Upp",,,,,",',,, 
2 , • ~ 6 1 8 9 
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ELECTROCARDIOGRAM AS A PREDICTOR OF DEVELOPMENT AND 
PROGRESSION OF LEFT VENTRICULAR HYPERTROPHY IN 
HYPERTROPHIC CARDIOMYOPATHY 
Julio A. Panza. M.D. and Barry J. Maron. M.D •• F.A.C.C •• 
NHLBI. Bethesda. Md. 
Children with hypertrophic cardiomyopathy (HCM) may show 
striking increases in left ventricular (LV) wall thick-
ness or even de novo development of LV hypertrophy (LVH). 
To determine the utility of 12-lead EOG in predicting and 
describing such changes in LV mass. we analyzed serial 
EOGs and 2-D echos of 38 asymptomatic young relatives of 
pts with HCM who were <15 years of age when first evalu-
ated. Mean ages at first and last evaluations were 11 
and 16 years. pts were divided into 3 groups according 
to changes in LV wall thickness during follow-up: 1) nor-
ma! 2-D echo when first seen and subsequent development 
of HCM (7 pts); 2) HCM at first evaluation and then mark-
ed progression of LVH during follow-up (24 pts); 3) HCM 
when first seen. without subsequent progression of LVH (7 
pts). EOG voltage score was obtained by adding voltages 
of precordial and standard leads; estimation of LV mass 
by 2-D echo was calculated by adding thickness of 4 LV 
segments. EOG voltages did not change substantially dur-
the study period in any of the 3 groups; furthermore. 
only 9 of the 38 pts (23%) showed any substantial change 
in EOG pattern. All 7 pts who developed LVH de novo had 
an abnormal EOG prior to appearance of LVH on echo. Volt-
age on the initial EOG showed linear relationship with 
magnitude of LV mass at last echo (r=.65; p<O.OOl). 
Hence. 1) analysis of serial EOGs is not useful in des-
cribing changes in LV wall thickness over time; 2) EOG 
voltages are predictive of further progression of LVH in 
children with HCM; 3) an abnormal EOG can be initial man-
ifestation of HCM even before appearance of LVH on echo. 
Thursday, March 31, 1988 
10:30AM-12:00NOON, Room 215, Level Two 
Ventricular Responses to Ischemia and Infarction 
PHARMACOLOGIC MODIFICATION OF LEFT VENTRICULAR REMODELING 
DURING HEALING AFTER MYOCARDIAL INFARCTION IN THE DOG 
Bodh I Jugdutt. M.D. F.A.C.C .. Bogdan L. Michorowski, 
M.D. Brian F. O'Kelly, M.D., University of Alberta, 
Edmonton, Canada. 
Pharmacologic interventions can modify remodeling during 
healing after acute myocardial infarction (AMI) via 
diverse mechanisms. The effect of prolonged therapy with 
different drugs on LV topography (expansion index -
infarct/non-infarct containing segment length; thinning 
ratio-infarct/normal wall thickness) at 6 weeks and LV 
function (serial twodimensional echocardiography) over 6 
weeks were compared in 64 instrumented dogs randomized to 
therapy, in optimal doses used clinically, 48 hours after 
left anterior descending coronary artery occlusion. The 
main results were: 
Group 
Verapamil 
Propranolol 
Ibuprofen 
Indomethacin 
Captopril 
Enalapril 
Nitroglycerin 
Sham 
Control 
Duration of Thinning 
n therapy(wks) ratio 
8 6 0.43±.14* 
6 6 0.36±.19* 
8 1 0.5l±.10 
4 1 0.38±.07* 
7 6 0.8l±.14* 
7 6 0. 64±. 19 
5 6 O.89±.09* 
7 (6) 0.99±.02* 
12 (6) 0.58±.12 
*p < 0.025 vs control (ANOVA) 
Expansion 
index 
2.73±.80 
2.70±1.15 
2.23±.47 
3. 32±. 60* 
1. 56±. 24* 
1. 58±. 52* 
1. 74±.21* 
1. 64±. 63 
2.42±.39 
Changes in regional and global LV function were con-
sistent with changes in regional and global LV topo-
graphy. Thus, prolonged therapy with nitroglycerin, 
captopril or enalapril after MI produced greatest benefit 
on LV topography and function,with less infarct expansion 
and thinning. 
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RECOVERY OF LEFT VENTRICULAR FUNCTION FOLLOWING 
CI-RONIC SUSTAINED CORONARY OCCLUSION. 
Charles A. Lefkowitz, M.D., Xue-Han Ning, M.D., Kim P. 
Gallagher, ph.D., Andrew ]. Buda, M.D., F.A.C.C. University of 
Michigan Medical School, Ann Arbor, Michigan. 
It is well documented that substantial functional recovery 
occurs by one week following coronary occlusion and 
reperfusion. However, limited data is available on the temporal 
and spatial patterns of left ventricular (LV) functional recovery 
following sustained occlusion. In view of this, we studied 8 
chronically instrumented dogs with 2 dimensional 
echocardiography (2D Echo) performed at baseline and at 24 hrs, 
7 days and 14 days after left circumflex coronary occlusion. 
Results are shown below (mean + sol: 
Baseline 24 Hrs. i4 DOH 
% WTh-NZ 64+1'3 5L+T) + t 
%WTh-IZ 48"+14 -1"+6* 29"+15*t 
areaEF(%) 65"+5 45"+7* 57+7t 
EOD(degrees) 196+ 46 106+ 81 t 
DOD (units) 24 +"16 13 + lit 
*p < 0.05 compared with baseline, t p < 0.05 compared with 24 
hours, WTh = wall thickening, NZ=normal zone, IZ=ischemic 
zone, EF =ejection fraction, EOD=circumferential extent of 
dysfunction, DOD=degree of dysfunction. 
There was no significant further improvement in LV 
function at 14 days. These data indicate that improvement in 
L V function by 7 days is related to increased wall thickening in 
both the normal and ischemic zones as well as reduction in the 
extent and degree of dysfunction. Despite sustained coronary 
occlusion without reperfusion, substantial recovery of 
ventricular function occurs by one week. 
REGIOOAL B-AOOENmGIC RErnPIORS AND AlENYLAlE CYaA'iE ACl'IVl'lY AFlER 
HEALIN:; OF MYOCARDIAL INFARCl'IOO IN CATS. 
Patricia L. Kozlovskis, Ph.D •• Marcel J.D. Sioots. Arti"aJr L. Bassett. 
PhD. Shinichi KimJra, M.D., Robert J. Myer\"aJrg, M.D., FAa:, University 
of Miami, Miami, FL. 
Regional B-adrenergic receptors (BAR) am adenylate cyclase activity 
(AC) ..,re studied in cats with apical, transwral healed myocardial 
infarcts (1f.1D:2Jmths). 3H-dihydroalprenolol (3IHllA) biniing am AC 
..,re reasured in l'aOOte, adjacent, am infarcted tissues in 5 00 am in 
corresponling sites in 6 umperated controls (e). 
BAR 
Raoote DB 
C57.2:tl7.8 
!MI 42.0:tl4.3 
Adjacent 
KD 
1.05:!O.38 
0.79:tO.46 
C 64.l±15.8 1.13:!O.43 
00 39.0±11.7* 0.63:!O.33* 
Infarct 
pools c»IP /Tr{l/min 
Basal Max ISO Forskolin 
53.9± 4.4 99.6± 7.5 155.7±12.1 
79.5±l2.6* 116.9±11.2* 193.5±28.l* 
54.6± 6.0 
66.0±J.O.6 
92.6± 5.4 
%.1±J.3.9 
l49.7:±J.3.1 
166.7:i25.6 
C"62.'4±14.9 1.06..+0.31 57.l± 7.2 92.4±l2.4 l46.3:!J.6.8 
l43.3±2l.2 00 25.5± 9.9* 0.21:!O.15* 53.0±16.5 8l.3±18.3 
Table values are mean :lSD. *Signif1cant, p < 0.05. 
Maxim.tn biDiing (DB) of 31HlIA ""-S reduced am ligan:! affinity increased 
(P(O.05) ir. tissues fran the scarred area (infarct) am adjacent to the 
scar. Basal AC activity, am max:lnun isoproterenol (ISO, 10 -"11) am 
forskolin (10 _4 M) st:i.twlated AC, ..,re increased (P<0.05) in l'aOOte 
tissues. '!he increase in st:im.1lated AC activity , relative to control, 
""-S due to increased basal activity. It is concluded that: (1) BAR 
runbers are reduced am AC activity is normal in infarcted am adjacent 
tissues after!MI; am (2) that raoote tissues have normal BAR runbers 
with increased net AC activity that is not receptor mediated. '!he 
regional variations in BAR am AC activity may contribute to BOO>! of the 
persistant alnormalities observed in this lIllde1. 
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REPERFUSION OF ISCHEMIC CANINE HEARTS PREVENTS PRESSURE 
MEDIATED LEFT VENTRICULAR DILATATION. 
Marvin J. Slepian M.D., Jochen D. Schipke, Ph.D., 
Seriyo Segiura, M.D., David A. Kass, M.D., W. Lowell 
Maughan, M.D., The Johns Hopkins Medical Institutions, 
Baltimore, Maryland. 
Transmural myocardial ischemia is accompanied by 
regional di la ta tion. Evidence sugges ts that 
reperfusion, even without return of contractile 
function, may limit dilatation. We studied the effect 
of reperfusion with hypoxic hyperkalemic reperfusate on 
the extent of dilatation in the globally ischemic canine 
heart. Hearts were isolated, potassiwn arrested and 
subjected to 1 hour of global ischemia followed by~' 
second hour of ischemia and simultaneous sustained LV 
pressure-100mmHg., via LV balloon. Seven hearts were 
reperfused (coronary p -150 mmHg) during the second hour 
of ischemia with hypoxic, hyperkalemic (6meq/L) 
isosmotic 10% Dextran/O. 9% NaCl. 7 hearts, not 
reperfused, served as control. Dilatation was assessed 
by measuring volume at 100 mmHg (VplOO). In non 
reperfused hearts VplOO (baseline 76.9+10 ml) 
increased 11.2% (p<O.OS), but in reperfused hearts VplOO 
(baseline - 62.4+9 ml) decreased 34% (p<O.OS) despite 1 
hour of sustained LV pressure. Thus, the dilatation 
accompanying globally ischemic canine hearts subj ected 
to sustained LV pressure is prevented by reperfusion 
even with a reperfusate which prevents return of 
contractile function. 
EFFECT OF HEPARIN ON THE ANGIOGENESIS RESPONSE TO 
EXPERIMENTAL MYOCARDIAL ISCHEMIA 
Ellis F. Unger M.D., Cedric D. Sheffield, M.D., and 
Stephen E. Epstein, M.D., F.A.C.C. NHLBI, Bethesda, Md. 
The ability of heparin to promote angiogenesis was assessed 
in a canine model of myocardial ischemia. Ameroid devices 
were placed on the proximal left anterior descending cor-
onary artery (LAD) of 32 dogs. The left internal mammary 
artery (IMA) was implanted intramyocardially in the LAD 
zone. Dogs randomly received continuous infusions direct-
ly into the lMA: heparin, 15 units/hr (group 1), heparin, 
15 units/hr for 14 days, then 150 units/hr (group 2), or 
saline (group 3). After 8 weeks, conductances from the lMA 
to LAD (CIL) and left circumflex to LAD (CCL) were assessed 
during adenosine- induced vasodilatation using microspheres. 
Conductances are reported as ml/min/100g/mmHg ± SEM. 
GROUP -E lMA TO LAD CONDUCTANCE LCX TO LAD CONDUCTANCE 
1 10 0.64 ± 0.18 2.44 ± 0.76 
2 8 0.73 ± 0.37 2.53 ± 0.48 
3 14 0.45 ± 0.15 2.66 ± 0.28 
There was a trend towards higher lMA to LAD conductance 
in heparin treated dogs, although this was not statistical-
ly significant. In saline but not heparin treated dogs, 
CIL was linearly related to CCL (R-.77, p<.OS). For any 
given intrinsic response (reflected by CCL) , CIL tended to 
be greater in heparin treated dogs. The differences were 
reflected in the variance of CIL/CCL ratios (0.05 vs 4.53; 
saline vs heparin; p<.09). Thus, in the absence of hepa-
rin, the degree of collateral formation between nonoccluded 
coronary vessels and the LAD bed was predictive of the pro-
pensity for neovascularization to occur between the lMA and 
the LAD bed, suggesting that intrinsic factor(s) normally 
control collateral growth. The greater variance and trend 
towards higher conductance in heparin treated dogs suggests 
that collateral formation may be responsive to heparin. 
ABSTRACTS 
'mE EFFECl' OF BRIEF O)~ OCCLl.EIooS 00 INTERSI'I-
TIAL PH AND MYCCARDIAL FUNcrIoo 
Alan D. Askenase, M.D. , Shigetaka Noma, M.D. arrl 
RiChatd H. HeUant, M.D., F.A.C.C., PhiladelFhia Heart 
Institute, Presbyterian-University of Pennsylvania 
Medical Center, PhiladelFhia 
We tested mether progressive dysfuncticn after re-
petitive brief coronary occlusicns was related to ac-
cumulaticn of products of anaerobic metabolism. In 6 
dogs the left anterior descending artery was occluded 
for 5 min (0) follONed by 10 min reflew (REP) 8 times 
mile segment length was assessed with sonomicrome--
ters. Interstitial pH was m:nitored with a miniature 
fiberoptic pH [robe in the ischemic subendocardium. 
The accuracy 0 this probe has been previoosly shown 
to be +0.02 pH units. Results: pH fell with each 0), 
althougn the magnitude --oraecrease in pH lessened 
between the first arrl fifth 0) arrl was unchanged 
thereafter. Here are occlusicn data: 
Centrol 0)#1 0)#5 0)#8 
~ 7.22+0.09 6.84+0.16* 7.11+0.14*+ 7.07+0.13*+ 
~ 27.8!9. 9 -5.6!3.0* -5.6!2.1* -4.3!2.3* 
where *p<0.05 vs centrol; +p<0.05 vs 0)#1. 
pH returned to normal with REP after each 0), althoogh 
segmental shortening (~) progressively decreased. 
Here are reperfusicn data: 
Centrol REP#1 
pH 7.22+0.09 7.19+0.13 
~ 27.8f9.9 19.5+11.1* 
REP#5 
7.22+0.11 
15.6!l2.6*+ 
REP#8 
7.19+0.11 
14. 3!l3. 6*+ 
where *p<0.05 vs centrol; +p<0.05 vs REP#1. 
The progressive change in ~ was iooependent of 
changes in hemodynamics which were similar in each 
successive period of 0) arrl REP. Cenclusicns: 1) With 
successive 5 min O)s the decrease 1n pa 1S attenuated. 
2) pH returns to normal with 10 min REP even after 
multil?le brief O)s. 3) There is progressive loss of 
funct1cn in the ischemic zcne with brief O)s despite 
normal pH suggesting that "stunning" is iooependent of 
changes in interstitial pH. 
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Sodium Current ~lodifications by Anthopleurin-J\ 
and Their Role in Early Afterdepolarizations 
William Craelius, Ph.D. V KH Chen, Ph.D., N. El-
Sherif, M.D., SUtN Health Sciences Center and 
VAMC, Brooklyn, NY 11209 
We studied whole cell currents and potentials in 
myocytes isolated from neonatal rat ventricles 
with gigohm seal electrodes before and after 
exposure to anthopleurin-A (APA), a peptide 
inotropic agent (10-7 - 10-5 ~!). Ca++ current 
was blocked with Mn++. Prior to APA, peak inward 
current, measured during steps from -80 to -40 
mY, averaged 0.4nA and inactivation was a simple 
exponential process having a time constant of 
0.9ms + .2 (N = 6) which declined at increasing 
depolarizations. One to five minutes after APA, 
peak inward current increased to 1.0nJ\ (N= 4) 
and inactivation was at least a 2 phase process, 
with the early time constant being 41ms (+ 11, N 
= 5), and the later one> 200ms. These time 
constants increased with increasing 
depolarization. Fast inward currents of 5 to 100 
pA occurred spontaneously during the slow 
inactivation phase. Outward current magnitudes 
were not affected by APA. Action potential 
durations were prolonged ten-fold to 1000msec at 
pacing rates> 2 sec. During the plateaus, early 
after depolarizations (EADs) were seen that 
corresponded in timing and magnitude with the 
spontaneous currents recorded during clamp steps 
near the plateau'level. Thus, (1) the marked 
prolongation of action potentials by APA can be 
explained by slowed sodium inactivation and (2) 
EADs appear to be caused by membrane current 
fluctuations spontaneously occurring during the 
prolonged inactivation process. 
254A ABSTRACTS 
DIFFERENTIAL RESPONSE OF EARLY AFTERDEPOLARIZATIONS AND 
VENTRICULAR TACHYCARDIA DURING RIGHT AND LEFT STELLATE 
STIMULATION IN THE DOG TREATED WITH CESIUM. 
~ Ben-Payid. ~. Naomi R. Gerbig, B.S. and Douglas P. 
Zipes, M.D. FACC, 
Krannert Inst. of Cardiology, Indiana Univ. School of Med., 
Indianapolis, Indiana. 
Early afterdepolarizations (EADs) are depolarizing poten-
tials prior to complete repolarization that may cause the 
long QT syndrome (LQTS) and ventricular tachycardias (VT). 
We studied the effects of sympathetic stimulation on EADs 
and VT in 20 open chest dogs with ansae cut. Dogs were 
treated with cesium chloride (Cs, 84 mg/kg IV) alone or 
combined with left (LAS), right (RAS) or bilateral (BAS) 
ansae subclaviae stimulation (2 Hz, 4 ms, 2 mAl. Interven-
tions were in random order at 30 min intervals. We compared 
the EAD amplitude as a ~ of monophasic action potential 
(MAP) amplitude recorded simultaneously with contact 
electrodes from RV and LV endocardium, and the prevalence 
of VT induction during each intervention. LAS and BAS 
produced larger EADs (p<0.05) than did RAS, or cesium. 
~ lW. W u.s. 
U~ n ~ n ~ n ~ n ~ 
~ MAP 29.7 29.1 32.6 30.0 36.9 40.0 31.8 44.1 
Cesium produced VT in 6/20 dogs, RAS in 3/20, BAS in 12/20 
and LAS in 16/20. Norepinephrine (NE, 0.5-1.5 ug/kg/min) 
caused VT in all dogs by producing a dose-related increase 
in EAD amplitude that was similar in RV and LV, suggesting 
RV and LV EADs were not intrinsically different. Based on 
the increased LV amplitude of cesium-induced EADs during 
LAS and BAS but equal RV-LV EAD amplitude during NE infu-
sion it is possible that more NE released into LV during 
LAS and BAS compared with RAS causes larger amplitude LV 
EADs that reach threshold to cause VT more often. "Tonic 
sympathetic imbalance" may not cause VT in LQTS. 
2:1 BLOCK OF AN EARLY AFTERDEPOLARIZATION AS A MECHANISM 
FOR TU ALTERNANS 
Nabil E1-Sherif, M.D., F.A.C.C., Robert Zeiler, Ph.D., 
William Craelius, Ph.D., William B. Gough, Ph.D., Raphael 
Henkin, M.S., SUNY, Health Science Center and VA Medical 
Center, Brooklyn, N.Y. 
The mechanism(s) of TU a1ternans is unknown. We observed 
TU alternans in dogs given the inotropic polypeptide 
Anthopleurin-A (AP-A). In vitro, AP-A (50 ~g/l) caused 
bradycardia-dependent prolongation of action potential 
duration (APD) , early afterdepolarizations (EAD) and 
triggered activity only in Purkinje fibers. 2:1 alter-
nation of EAD was not observed. In 13 anesthetized 
mongrel dogs we simultaneously recorded: 1) surface ECG 
leads, 2) monophasic action potential (MAP), from endo-
cardial and epicardial surface of left ventricle using 
Ag/AgCl catheter contact electrode and 3) epicardial 
transmembrane potential (TMP) using a floating micro-
electrode. AP-A (4 ~g/Kg) resulted in bradycardia-
dependent prolongation of action potentials and the 
development of EAD. The EAD corresponded to a distinct 
U wave in 4 dogs and to the terminal prominent portion of 
a TU complex in 4. Ectopic action potentials arose from 
the peak of EAD and corresponded to ectopic QRS from the 
summit of U wave. These initiated polymorphic ventricular 
tachyarrhythmias. TU alternans occurred in 5 dogs. In 
one, it was due to alternation of APD with EAD arising 
alternately from high and low levels of phase 3. In 4 
dogs, TU alternans was associated with 2:1 recording of 
EAD. Slowing the heart rate resulted in disappearance of 
TU alternans, 1:1 recording of EAD and initiation of the 
arrhythmia. In summary, tachycardia_dependent TU 
alternans occurred in dogs exposed to AP-A associated 
with 2:1 recording of EAD. This may represent 2:1 con-
duction of EAD rather than 2;1 generation of EAD at a 
cellular level. 
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MAGNESIUM ABOLISHES EARLY AFTERDEPOLARIZATIONS INDUCED BY 
CESIUM, 4-AHINOPYRIDINE OR QUINIDINE IN CANINJ!: PURKINJE 
FIBERS. 
Shunighi Kaseda. M.D., Robert F. Gilmour Jr., Ph.D. and 
Douglas P. Zipes, M.D., F.A.C.C., Krannert Institute of 
Cardiology, Indiana Univ. School of Med., Indianapolis. 
Intravenous magnesium has been shown to suppress torsades 
de pointes (TdP) in some pts with the long QT syndrome by 
an unknown mechanism. Because early afterdepolarizations 
(EADs) and triggered activity (TA) have been proposed as 
causes of TdP, we used standard microelectrode techniques 
to test whether HgC12 suppressed EADs and TA elicited by 
quinidine (1-4~, n=5) at high temperature (38.5-400 C), 
cesium chloride (5-12mH, n=3), and 4-aminopyridine (1.5-5 
mH, n=7) in canine Purkinje fibers (PF) super fused with 
modified Tyrode solution (KCl =2. 7mH) • HgC12 (3-5mH) 
reversibly abolished TA in all preparations and suppressed 
EADs completely in 14/15 preparations. To determine 
whether HgC12 suppressed EADs directly or indirectly, by 
shortening action potential duration, we studied the 
effects of HgC12 on depolarization-induced PF automaticity 
using a single sucrose gap technique (n=4). Maximum 
diastolic membrane potential (HOP) was progressively 
reduced from -90mV to -10mV using variable intensity, 2sec 
duration current pulses and the resulting acceleration of 
automaticity was monitored. HgC12 (5mM) abolished auto-
matiCity arising from HOPs more negative than -70mV and 
prolonged the spontaneous cycle length at less negative 
HOPs (e.g. from 348±13 to 480±47msec (p<0.05) at HOP=-45~ 
mV). Thus, HgC12 suppressed EADs and TA induced by three 
diverse agents that reduce potassium conductance. Sup-
pression of depolarization-induced automaticity by HgC12 
suggests that HgC12 suppressed EADs directly rather than 
by shortening action potential duration. These data may 
help to explain the effects of magneSium on TdP in pts. 
MAGNESIUM SUPPRESSES EARLY AFTERDEPOLARIZATIONS AND VEN-
TRICULAR TACHYARRHYTHMIAS INDUCED IN DOGS BY CESIUM. 
Dayid S. Ballie. B.S., Hiroshi Inoue, M.D. and Douglas P. 
Zipes, M.D., FACC, Krannert Inst. of Cardiology, Indiana 
UniverSity SchoOl of Medicine, Indianapolis, Indiana. 
The mechanism by which magnesium sulfate (HgS04) therapy 
suppresses some ventricular tachyarrhythmias (VT) charac-
terized by a prolonged QT interval (e.g. torsades de 
pointes) is unknown. Since early afterdepolartzations 
(EADS) have been proposed as a cause of the long QT 
syndrome and the related VT, we tested the hypothesis in 
anesthetized open chest dogs that HgS04 therapy would 
suppress both EADS and the related VT. Using monophasic 
action potentials (MAP) recorded with a contact electrode 
from the right ventricular endocardium to demonstrate 
EADS, cesium chloride 168 mg/kg was administered before, 
during and 1-2 hours after a HgS04 infusion (1-2 JDg/kg/min 
for 20 to 30 min). Prior to HgS04 infuSion, cesium induced 
EADS that were 49.7 ± 1 .6~ (mean ± SE) of the corre-
sponding MAP amplitude. The amplitude of the EADS 
decreased to 31.2 ± 3.8~ (p<0.003) of the MAP amplitude 
during HgS04 infusion and increased to 48.0 ± 4.0~ 1-2 
hours after the termination of HgS04 infusion. Cesium 
induced sustained monomorphic ventricular tachycardia, 
torsades de pOintes or ventricular fibrillation in 12 of 
13 dogs before HgS04 infusion and in 8 of 11 dogs 1-2 
hours after stopping the infusion, but in only 3 of 13 
dogs during the HgS04 infusion (p<O.Ol). CeSium prolonged 
the QTc interval from a control of 338 ± 16 msec to 387 ± 
12 msec before, 356 ± 12 msec during and 406 ± 16 msec 1-2 
hours after stopping the HgS04 infusion (p<0.003). These 
data support the observation that HgS04 suppresses early 
EADS, prolonged QT interval and ventricular tachy-
arrhythmias, induced by cesium. Successful responses in 
pts may occur by a similar mechanism of EAD suppression. 
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EFFECT OF THE THYROID STATE ON OUABAIN-INDUCED DELAYED 
AFTERDEPOLARIZATIONS. 
Bella Felzen, B.Sc. and Ofer Binah, D.Sc., Rappaport 
Inst, Technlon-Israel Inst of Technology, Haifa, Israel. 
Mammalian species differ in their cardiac response to 
ouabain; whereas ouabain induces a markedly positive ino-
tropic effect in species such as human, dog and guinea 
pig, the rat is virtually insensitive. We investigated 
this phenomenon by testing the hypothesis that it results 
from interspecies differences in the thyroid state. We 
therefore studied ouabain-induced delayed afterdepolari-
zations (DAD): 1) in guinea pigs, rats, mice and shrews, 
which include a wide range of thyroid states, and 2) in 
guinea pigs in which the thyroid state was increased or 
decreased by thyroxine or propylthiouracyl, respectively. 
DAD were readily indu~ed in guinea pigs (30 min in 10-6 M 
ouabain and 5.4 mM Ca +), in rats only in 8.1 mM Ca2+, 
but were absent in mice and shrews. In guinea pigs and 
rats (cycle length=500 ms), DAD amplitude was 3.3±O.3 
(SE) and 1.I±O.4 mV, respectively. DAD dV/dt was 4.2±O.6 
in guinea pigs and 0.4±O.2 mV/ms in rats. In guinea pigs 
DAD amplitude and dV/dt were markedly dependent on thy-
roid state. In eu (EU)-, hyper (HYPER)- and hypo (HYPO)-
thyroid guinea pigs, DAD amplitude (cycle length=500 ms) 
was 3.3±0.3, 1.2±0.4* and 7.5±O.6* ms, respectively. In 
EU, HYPER and HYPO guinea pigs, DAD dV/dt was 4.2±0.6, 
0.5±O.2* and 6.3±O.7* mV/ms, respectively. The occur-
rence of triggered beats was also dependent on thyroid 
state and was more frequent in HYPO and less frequent in 
HYPER than in EU guinea pigs. In conclusion, we suggest 
that interspecies (and intraspecies) variations in the 
response to ouabain are modulated by the thyroid state. 
~p<0.005 vs EU guinea pigs. 
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Antiarrhythmic Drug Mechanisms of Action 
QUANTITATIVE MODELLING o~' ANTIARRHYTHMIC DRUG- INDUCED 
CONDUCTION SLOWING IN VIVO. 
Wuhua Jing. M.D., and Stanley Nattel, M.D., F.A.C.C., 
Mont~eal Hea~t Institute, Montreal, Canada. 
The~e is conside~able information available a!>out the 
interval-dependence of drug effects on Vmax in 
vitro, but much less knowledge about frequency depen-
dent drug action on conduction in vivo. We developed 
mathematical models to predict the time-dependent re-
covet'y from drug-induced conduction slowing, assuming 
either a linear or quadratic relationship between con-· 
duction velocity and Vmax ' The present experiments 
were designed to evaluate these models, using procai-
namide (PA) as the test drug. Ten morphine--chloralose 
anesthetized dogs with formalin-induced AV block were 
used to study the relationship between PA-induced QRS 
prolongation and S1S2 coupling interval. Loading 
and maintenance infusions were used to produce a se-
ries of stable PA concentrations. PA produced up to 
90'- QRS prolongation at a basic (S1S1) cycle 
length of 300 msec, with 88±31. (M±SD) recovery from 
PA-induced block occurring over a mean maximum 
Sl S2 pause interval of 5. 4±0. 7 sec. Non-linear 
least squares (LS) curve fitting showed that the re-
covery curve fitted significantly better with the ·qua-
dratic model (LS=l. 6±. 4 X 10-2 ) than the linear one 
(LS=2±.4 X 10-2 , p<0.01). The mean recovery time 
constant from the quadratic model was 2. 2±0. 6 sec, 
similar to previous in vitro observations of time-
dependent recovery from PA effects on vmax . These 
experiments confirm the possibility of quantitative 
assessment of use-dependent drug action in vivo, and 
support in vitro observations which suggest a quadra-
tic relationship between drug-induced changes in 
Vmax and conduction. 
ABSTRACTS 
Frequency-Dependence of Antiarrhythmic Drug Effect 
on Post-Repolarization Refractoriness In Vivo 
255A 
Angelika Costard MD, Michael R. Franz MD, Cardiology 
Division, Stanford University School of Medicine, CA. 
Frequency-dependent suppression of sodium channel conduc-
tance (Vmax) is useful to differentiate and quantitate 
receptor kinetics of antiarrhythmic drugs (AADs); however, 
Vmax cannot be measured in vivo. We tested the hypothesis 
that frequency-dependent effect of AAD on effective refrac-
tory period (ERP) may serve a similar purpose. To exclude 
cycle length (CL) dependent effects on ERP that are simply 
due to changes in action potential duration (APD) , we 
determined both, APD and ERP simultaneously and at the 
same ventricular site using a new single-bipole monophasic 
action potential probe. Measurements were made in 22 
open-chest dogs in the drug-free state and during thera-
peutic concentrations of lidocaine (L), quinidine (Q) and 
mexiletine (M) during steady-state pacing at CL from 600 
to 250 ms. The table shows the CL-dependent effect on 
post-repolarization refractoriness (ERP minus APD) in % 
change from baseline (mean±SEM): 
CL 250 300 400 500 600 
L 12±ll 20±19 27±14 30±12 36±35 
Q 40±11* 22±8* 7±5 6±3 7±4 
M N/A 55±15* 17+4* 11 +3* 14+4* 
(*p<. 05-.0005 ;N/A-unmeasurab1e because ERP was-or>basic 
CL, resulting in intermittent capture.) 
Conclusion:Frequency-dependence of AAD effect (1) is 
disclosed by post-repolarization refractoriness (ERP 
minus APD) , (2) differs markedly for L,Q, and M, consistent 
with in vitro measurements of Vmax, ahd (3) can be assessed 
in vivo. This method is applicable in man and should be 
useful in the differentiation and quantification of AAD 
effects in the clinical setting. 
USE-DEPENDENT EFFECTS OF QUINIDINE ON THE CANINE HIS-
PURKINJE SYSTEM: ONSET, MAGNITUDE AND RECOVERY 
John M. Herre, M.D., F.A.C.C., Michael Chin, B.S., and 
Bertram Katzung, M.D., Ph.D., University of Cal ifornia, 
San Francisco. 
In-vitro studies have demonstrated use-dependent effects 
of class I antiarrhythmic agents in the canine His-
Purkinje system (HPS). Using right vagal stimulation to 
achieve sinus bradycardia and lon~ pauses, we character-
ized use-dependence of quinidine (Q), in vivo, in 7 alpha-
chloralose anesthetized dogs. Stimulus-to-V (SV) during 
selective His pacing and HV intervals during atrial extra-
stimulation and pacing were used as an indices of HPS con-
duction in control (pre-Q) and after Q (mean level 4.7 
mg/L). With abrupt change of the cycle length (Cl) from 
1000 to 333 ms during His pacing, SV increased by the 
third beat and reached a stable maximum (20% greater than 
at CL 1000 ms) after 10 beats. Steady-state use-depen-
dence was evident at all atrial paced Cls but HV in-
creased from 10% over control at Cl 1500 ms to 27% at CL 
500 ms to 38% at Cl 200 ms. Following atrial pacing at 
Cl 350 ms for 20 beats, recovery from use-dependent block 
was measured for intervals from 200 to 2500 ms. At 200 
ms, HV was 33% over control but by 2500 ms, HV had re-
turned to 10% over control. Using a non-linear, least 
squares fit, time constant (~) for recovery was 2.23±0.61 
(meantSEM) sec. Conclusions: Use-dependence of Q can be 
demonstrated in vivo at therapeutic levels. Onset is de-
layed and recovery is slow but significant effects are 
present over a wide range of CLs suggesting maximal bene-
fit of use-dependence against sustained arrhythmias or 
against arrhythmias occurring during more rapid sinus 
rates. These data may be useful in individualizing drug 
selection and in considering drug combinations. 
256A ABSTRACTS 
RATE-DEPENDENT EFFECTS OF AMIODARONE ON CONDUCTION AND 
RECOVERY IN VIVO. Kelley P Anderson. MD. FACC, Richard 
Walker, Ted Dustman, ME, Philip R Ershler, PhD, Robert l 
lux, PhD, University of Utah, Salt lake City, Utah 
To determine the effects of amiodarone (Am) on 
conduction velocity (CV) and repolarization in vivo we 
determined activation (A) (minimum dVjdt of local QRS) 
and recovery (R) times (maximum dVjdt of local T wave) 
from a rigid, closely spaced (2mm) 64 unipolar electrode 
array sewn to the left ventricle of 9 dogs who received 
24g of Am over 3 weeks and 8 control (C) dogs. CV in the 
longitudinal (l) and transverse (T) directions were 
calculated between pairs of electrodes along the major 
and minor axes of the elliptical A pattern. Activation-
recovery intervals (ARI)=R-A obtained from 1 site each 
in the land T directions were not significantly 
different, only ARI-T are reported. ARI correlated 
highly with refractory period measurements at 3 pacing 
cycle lengths (PCl) (rtse=.99±.04 for C- and Am-dogs). 
0.7 250 
0.6 r- ~ 05 -a CCv.I. ! 200 I + AmCV·L 0.' • CCV·T ~ > • AmCV-T 
" 0.3 C 150 ~ , • 02 ·p<_O.05 
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CV-l and CV-T declined with decreasing PCl in Am-dogs 
but not in C-dogs, differences were significant only at 
short PCls. ARIs were prolonged in Am-dogs at all PCl, 
but the differences were significant only at longer PCl. 
We conclude that AM reduces CV in a rate-dependent 
fashion in vivo, and that its effects on prolongation of 
recovery are lessened at short cycle lengths. 
ANTIARRHYTHMIC EFFEx::TS OF 5-{)H PR)PAF'ENCNE. 
Gabriella Malfatto, M.D., Brad Sodowick, B.A., Michael 
Forster, B.A., Peter Danilo, Jr., Ph.D., and Michael R. 
Rosen, M.D., F .A.C.C., Columbia University, New York. 
5-hydroxypropafenone (5-{)HP), a rretabolite of propafenone 
(P), has cellular electrophysiological effects resembling 
those of the parent catpOund. We carpared the anti-
ii..--rhythmic effects of both drugs on the ventricular 
tachycardia (Vr) that occurs in conscious dogs 24 hours 
after acute myocardial infarction. We injected P or 
5-{)HP 2 mg/kg rJ over 10 min, followed in 15 min by 
1 mg/kg and in 10 min by another 1 mg/kg, while 
nonitoring the EXX. P did not restore sinus rhythm in 
any of the 6 dogs studied, but it significantly increased 
the sinus and VT cycle length (CL) (sinus CL: +9+2% from 
431+32 IllS; VT CL: +17+3% fran 361+24 IllS, both P <" 0.05) . 
In Contrast 5-oHP not-only increaSed sintfs CL (+6+2% fran 
456+24 IllS, P < 0.05) and VT CL (+28+7% fran 346+32 IllS, 
P <-0.05), but it also restored sinus rhythm in-6 of 9 
dogs. 5-oHP was nore effective in dogs with repetitive 
nonarorphic VT (n = 4, VT CL 39l±.18 IllS) than in dogs with 
faster, polynorphic VT (n = 5, VT CL 309+30 IllS). In the 
4 dogs with nonarorphic VT, sinus rhythm-was fully 
restored for> 45 min; in those with polynorphic VT, 
sinus rhythm was restored in only 2 of 5 dogs and for < 
30 min. In addition, we administered 5-oHP to 3 dogs in 
which P had been ineffective, and 5-{)HP unifonnly 
abolished VT. In contrast, P did not abolish VT in 2 
dogs in which the rretabolite had previously restored 
sinus rhythm. Thus, 5-0HP has antiarrhythmic potency 
superior to that of P in the 24 hour infarct; especially 
in the setting of repetitive nonarorphic VT. 
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BETA ADRENOCEPTOR UP REGULATION IN HUMAN CIRCULATING LYMPHOCYTES 
AFTER ORAL TREATMENT BY PROPAFENONE. 
Mjlou P orjcj M p, Valerie Sbirrazzuoll, Ph.C., Philippe Siard, Ph.D, Andre Wajman, M.D., 
Pierre Gibelln, M.D., and Philippe Morand. M.D. Hopllal Pasteur, Umversily 01 Nice, France. 
Radioligand binding studies on lymphocytes have greatly advanced 
knowledge on changes in B adrenoceptor density, which is regulated by a 
variety 01 drugs and pathological conditions (up and down regulation). The 
regulation 01 these receptors on the human heart has only been 
extrapolated. The aims 01 this study are to evaluate the link between 8 
adrenoceptor density in purilied human circulating lymphocyte membranes 
and that 01 human right auricle biopsies obtained Irom the same subjects, 
and to determine the variation occured after treatment with propalenone, 
a new class I antiarrhythmic agent with beta antagonist potencies. In order 
to evaluate the relation between cardiac and lymphocyte B adrenoceptor 
density, human lymphocytes and pieces 01 atria were obtained from 5 
patients (40 ml blood, and biopsies excised during the inlroduction 01 
tubes Irom the heart lung machine during coronary bypass surgery). 5 
patients were given Propalenone 450 to 900 mg a day. B adrenoceptor 
evaluation was perlormed lor each patient belore and after 10 days 01 
treatment. B adrenoceptor density (Bmax) and Kd (125 1_ICYP) were 
characterized by radioreceptor assay. Prote," measurement was perlormed 
by Biorad method; Mann and Whytney test was used lor statistical 
8\,aluation. 
t): B adrenoceptor density in purilied human lymphocyte membranes is 
highly significantly related to that in the corresponding auricles 
(r. 0.90, p < 0.03). Mean lymphocytes Bmax is 43.2 t 20 fmollmg protein, 
Kd : 69.±. II pM. The Bmax in the myocardial cell membrane particles is 56 
± 18 fmol/mg protein and Kd 80.5 ± 20 pM. 
2): Mean receptor density in patients undergoing antiarrhythmic treatment 
was 22.68 + 9 fmol/mg protein before treatment and 43.75 + 8.9 fmol/mg 
protein attel10 days (p<O.Ol). Kd were 24.7 +20 and 27 +18 pM respectively. 
Conclusion : We show in this study, that radioreceptor assay enables the 
extrapolation from B adrenoceptor density human lymphocyte to the 
corresponding human heart. This density seems to be "up regulated" by 
propafenone, with an increase 01 nearly 100% 01 the total number of 
lymphocyte B adrenoceptors. This data assesses then one aspect 01 the 
beta antagonist properties of Propafenone . 
